nctId,briefTitle,officialTitle,overallStatus,startDate,primaryCompletionDate,completionDate,studyType,phase,enrollmentCount,conditions,condition,leadSponsor,collaborators,countries
NCT05972551,Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta,"A Phase 3, Open-Label, Multicenter, Randomized Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta",RECRUITING,2024-04-22,2027-06-01,2027-08-25,INTERVENTIONAL,PHASE3,106,['Osteogenesis Imperfecta'],Osteogenesis Imperfecta,Amgen,[],"['Belgium', 'Japan', 'Hungary', 'Turkey (Türkiye)', 'China', 'Austria', 'United States', 'France', 'Germany', 'Slovakia', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Australia']"
NCT07278544,Harnessing Communication Preferences,Harnessing Communication Preferences to Enhance Its Persistence and Mitigate Relapse of Challenging Behavior,RECRUITING,2025-08-15,2031-03-31,2031-03-31,INTERVENTIONAL,NA,60,"['Intellectual Disability', 'Autism Spectrum Disorder', 'Self-Injurious Behavior', 'Communication Disabilities', 'Communication, Nonverbal']",Intellectual Disability,Joel E. Ringdahl,"['University of Iowa', 'University of Florida', 'Virginia Polytechnic Institute and State University', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT05554328,"Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial",A Randomized Trial of Selumetinib and Olaparib or Selumetinib Alone in Patients With Recurrent or Persistent RAS Pathway Mutant Ovarian and Endometrial Cancers: A ComboMATCH Treatment Trial,RECRUITING,2023-04-25,2028-10-01,2028-10-01,INTERVENTIONAL,PHASE2,165,"['Recurrent Endometrial Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']",Recurrent Endometrial Carcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['Puerto Rico', 'United States']"
NCT07278609,The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions,The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions,RECRUITING,2025-10-29,2028-03-31,2028-06-30,OBSERVATIONAL,,100,"['Rheumatic Diseases', 'Inflammatory Arthritis', 'Systemic Lupus Erthematosus (SLE)', 'Vasculitis', 'Muskuloskeletal Diseases', 'Systemic Autoimmune Diseases']",Rheumatic Diseases,McGill University Health Centre/Research Institute of the McGill University Health Centre,"['The Arthritis Society, Canada']",['Canada']
NCT06489483,Action Regulation Behavioral,Revealing the Action Regulation Mechanisms in the Human Brain,RECRUITING,2024-04-24,2026-11,2027-11,INTERVENTIONAL,NA,50,['Parkinson Disease'],Parkinson Disease,University of Texas Southwestern Medical Center,"['University of California, Riverside']",['United States']
NCT07278960,Enhancing Management Algorithms for Children Conceived Via Assisted Reproductive Technologies,Enhancing Algorithms for the Management of Children Conceived by Assisted Reproductive Technologies Based on a Comprehensive Assessment of the Impact of Modern Methods of Conception on Their Health Status,RECRUITING,2025-10-01,2026-06-30,2027-11-30,OBSERVATIONAL,,300,"['Children', 'ART', 'Anthropometric Characteristics', 'Somatic Health Status', 'Neurological Condition', 'Urogenital Pathology']",Children,"Kazakhstan's Medical University ""KSPH""","['International Clinical Center for Reproductology ""PERSONA""']",['Kazakhstan']
NCT06368193,The Neuralert Stroke Monitor Pilot Trial,The Neuralert Stroke Monitor Pilot Trial,RECRUITING,2024-12-12,2026-05-01,2027-05-01,INTERVENTIONAL,NA,50,"['Stroke', 'Surgery']",Stroke,Neuralert Technologies LLC,[],['United States']
NCT04278521,Mechanism of Action of Transcranial Magnetic Stimulation,Mechanism of Action of Transcranial Magnetic Stimulation,ACTIVE_NOT_RECRUITING,2011-11,2026-06,2026-06,INTERVENTIONAL,NA,54,"['Major Depressive Disorder', 'Depression']",Major Depressive Disorder,Massachusetts General Hospital,[],['United States']
NCT06662955,Exercise With Audible Cues on Motor Unit Behavior in Athletes With Anterior Cruciate Ligament Reconstruction,Terminal Knee Extension Exercise Synchronize With Audible Cues on Motor Unit Behavior of Vastus Medialis Muscle in Athletes With Anterior Cruciate Ligament Reconstruction,RECRUITING,2024-10-20,2026-10-19,2026-12-30,INTERVENTIONAL,NA,40,"['Therapeutic Exercise', 'Physical Therapy Techniques', 'Neuromuscular Function']",Therapeutic Exercise,Mahidol University,[],['Thailand']
NCT07228364,"Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease","A Phase I Randomised, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD1613 Following Multiple Ascending Dose Administration in Participants With Autosomal Dominant Polycystic Kidney Disease",RECRUITING,2025-11-10,2027-01-04,2027-01-04,INTERVENTIONAL,PHASE1,40,['Autosomal Dominant Polycystic Kidney Disease'],Autosomal Dominant Polycystic Kidney Disease,AstraZeneca,[],"['China', 'United Kingdom', 'United States']"
NCT04166409,A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma,A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1),RECRUITING,2020-01-31,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE3,170,"['Low Grade Astrocytoma', 'Low Grade Glioma', 'Metastatic Low Grade Astrocytoma', 'Metastatic Low Grade Glioma', 'WHO Grade 1 Glioma', 'WHO Grade 2 Glioma']",Low Grade Astrocytoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT03664609,Deep Brain Stimulation (DBS) Retrospective Outcomes Study,Deep Brain Stimulation (DBS) Retrospective Outcomes Study,RECRUITING,2019-03-12,2028-12,2028-12,OBSERVATIONAL,,5000,"['Parkinson Disease', 'Essential Tremor', 'Dystonia']",Parkinson Disease,Boston Scientific Corporation,[],"['Belgium', 'United States', 'France', 'Spain', 'Italy', 'Germany']"
NCT07279493,Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke,"A Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Phase Ⅱb Clinical Trial to Evaluate the Efficacy and Safety of the KPCXM18 Injection at Different Doses in The Treatment of Acute Ischemic Stroke",RECRUITING,2025-11-22,2026-10-18,2026-10-18,INTERVENTIONAL,PHASE2,300,['Acute Ischemic Stroke'],Acute Ischemic Stroke,"Kunming Pharmaceuticals, Inc.",[],['China']
NCT06952907,Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients,Femoral Versus Radial Artery Catheterization for Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients: the FERARI Randomized Superiority Study,RECRUITING,2025-06-15,2027-07-01,2027-08-01,INTERVENTIONAL,NA,340,"['Vasoplegia Syndrome', 'Vasoplegia', 'Cardiac Surgical Procedures', 'Arterial Pressure', 'Hypotension During Surgery', 'Hypotension Postprocedural', 'Norepinephrine']",Vasoplegia Syndrome,Guillaume BESCH,[],['France']
NCT06860594,"Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma",A Phase I Trial Combining Triapine With Radiation Therapy for Recurrent Glioblastoma or Astrocytoma,RECRUITING,2025-07-30,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE1,30,"['Astrocytoma, IDH-Mutant, Grade 2', 'Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant', 'Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant', 'Recurrent Astrocytoma, IDH-Mutant', 'Recurrent Astrocytoma, IDH-Mutant, Grade 3', 'Recurrent Astrocytoma, IDH-Mutant, Grade 4', 'Recurrent Glioblastoma, IDH-Wildtype']","Astrocytoma, IDH-Mutant, Grade 2",National Cancer Institute (NCI),[],['United States']
NCT05143957,"A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera","A Phase 2a, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 702843 Administered to Patients With Phlebotomy Dependent Polycythemia Vera (PD-PV)",ACTIVE_NOT_RECRUITING,2021-12-30,2025-06-26,2026-06,INTERVENTIONAL,PHASE2,50,['Phlebotomy Dependent Polycythemia Vera'],Phlebotomy Dependent Polycythemia Vera,"Ionis Pharmaceuticals, Inc.",[],"['United States', 'Canada', 'United Kingdom', 'Poland', 'Australia']"
NCT04963153,Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy,Phase Ib Trial of Erdafitinib Combined With Enfortumab Vedotin Following Platinum and PD1/L1 Inhibitors for Metastatic Urothelial Carcinoma With FGFR2/3 Genetic Alterations,ACTIVE_NOT_RECRUITING,2022-07-07,2026-12-01,2026-12-01,INTERVENTIONAL,PHASE1,30,"['Locally Advanced Bladder Urothelial Carcinoma', 'Locally Advanced Renal Pelvis Urothelial Carcinoma', 'Locally Advanced Ureter Urothelial Carcinoma', 'Locally Advanced Urethral Urothelial Carcinoma', 'Locally Advanced Urothelial Carcinoma', 'Metastatic Bladder Urothelial Carcinoma', 'Metastatic Renal Pelvis Urothelial Carcinoma', 'Metastatic Ureter Urothelial Carcinoma', 'Metastatic Urethral Urothelial Carcinoma', 'Metastatic Urothelial Carcinoma', 'Recurrent Bladder Urothelial Carcinoma', 'Recurrent Renal Pelvis Urothelial Carcinoma', 'Recurrent Ureter Urothelial Carcinoma', 'Recurrent Urethral Urothelial Carcinoma', 'Recurrent Urothelial Carcinoma', 'Stage IIIB Bladder Cancer AJCC v8', 'Stage IV Bladder Cancer AJCC v8', 'Stage IV Renal Pelvis Cancer AJCC v8', 'Stage IV Ureter Cancer AJCC v8', 'Stage IV Urethral Cancer AJCC v8']",Locally Advanced Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT06051695,"A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression","A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod™ CAR T Products, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression",RECRUITING,2024-04-03,2028-06,2029-06,INTERVENTIONAL,PHASE1,474,"['Solid Tumor, Adult', 'Colorectal Cancer', 'NSCLC', 'Non Small Cell Lung Cancer', 'NSCLC, Recurrent', 'Non-Small Cell Squamous Lung Cancer', 'Pancreas Cancer', 'Pancreatic Neoplasm', 'Colorectal Adenocarcinoma', 'CRC', 'Colon Cancer', 'Rectal Cancer', 'Cancer', 'Ovarian Cancer', 'Ovarian Neoplasms', 'Mesothelioma', 'Mesothelioma, Malignant', 'Ovary Cancer', 'Lung Cancer', 'MESOM']","Solid Tumor, Adult",A2 Biotherapeutics Inc.,['Tempus AI'],['United States']
NCT05676476,The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.,The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.,RECRUITING,2023-02-14,2026-12,2027-06,INTERVENTIONAL,NA,132,"['Preeclampsia', 'Gestational Hypertension', 'Hypertensive Disorder of Pregnancy']",Preeclampsia,University of Alabama at Birmingham,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT04502316,Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry),Real-World Experience -- Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) A Post-Market Registry With the Barostim™ System,ACTIVE_NOT_RECRUITING,2020-06-26,2028-06,2028-06,OBSERVATIONAL,,5000,['Heart Failure'],Heart Failure,"CVRx, Inc.",[],['United States']
NCT06645015,The AIDPRO-CRC Trial,AI-Driven Personalized Perioperative Management in Colorectal Cancer: A Randomized Controlled Clinical Trial - The AIDPRO-CRC Trial,RECRUITING,2025-10-24,2027-02-01,2028-02-01,INTERVENTIONAL,NA,1200,['Colo-rectal Cancer'],Colo-rectal Cancer,Zealand University Hospital,"['Aalborg University Hospital', 'Randers Regional Hospital', 'Gødstrup Hospital', 'Odense University Hospital', 'Hvidovre University Hospital', 'Viborg Regional Hospital', 'Hillerod Hospital, Denmark']",['Denmark']
NCT04504825,A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES),"A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment Naïve Patients With Mayo Stage IIIb AL Amyloidosis",ACTIVE_NOT_RECRUITING,2020-08-25,2025-05-10,2027-10-22,INTERVENTIONAL,PHASE3,125,['AL Amyloidosis'],AL Amyloidosis,"Alexion Pharmaceuticals, Inc.",[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy']"
NCT07268989,Evaluation of Mechanical Power and Ventilator Parameters to Predict Weaning Success in the Intensive Care Unit,Evaluation of Mechanical Power to Predict Weaning Success in the Intensive Care Unit: A Prospective Observational Study,RECRUITING,2025-07-01,2026-07-01,2026-07-01,OBSERVATIONAL,,60,"['Weaning Mechanical Ventilation', 'Mechanical Power', 'Negative Inspiratory Force', 'Airway Occlusion Pressure']",Weaning Mechanical Ventilation,Anıl Berkay Balıtatlı,[],['Turkey (Türkiye)']
NCT07279480,Communication and Health Investments for Elderly Women,Household Communication and Health Investments for Elderly Women in Tamil Nadu,RECRUITING,2025-11-10,2026-08-01,2026-10-01,INTERVENTIONAL,NA,1200,"['Take-up of Preventative Care', 'Communication About Health Information']",Take-up of Preventative Care,Abdul Latif Jameel Poverty Action Lab,[],['India']
NCT06492538,Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study,Biometric Changes After Intervention of Anterior Chamber Angle : an Observational Study,RECRUITING,2023-12-01,2025-12-30,2025-12-30,OBSERVATIONAL,,300,"['Angle-closure Glaucoma', 'Minimally Invasive Glaucoma Surgery', 'Goniosynechialysis', 'Goniotomy', 'Glaucoma']",Angle-closure Glaucoma,"Zhongshan Ophthalmic Center, Sun Yat-sen University",[],['China']
NCT06693908,"A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis","A Phase Ic Open-label Study to Evaluate the Pharmacodynamic Effects, Pharmacokinetics, and Safety of Vixarelimab in Patients With Moderate to Severe Active Ulcerative Colitis",RECRUITING,2025-03-31,2026-04-03,2026-05-06,INTERVENTIONAL,PHASE1,24,['Moderate to Severe Ulcerative Colitis'],Moderate to Severe Ulcerative Colitis,"Genentech, Inc.",[],['Germany']
NCT05691478,A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma,A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma,RECRUITING,2023-03-03,2030-03-20,2030-03-20,INTERVENTIONAL,PHASE2,1122,"['High Grade Osteosarcoma', 'Localized Osteosarcoma', 'Metastatic Osteosarcoma', 'Secondary Osteosarcoma']",High Grade Osteosarcoma,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Canada', 'Australia']"
NCT02905591,A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC,A Phase 2 Trial of Pharmacological Ascorbate With Concurrent Chemotherapy and Radiation Therapy for Non-small Cell Lung Cancer,ACTIVE_NOT_RECRUITING,2018-11-16,2025-07-17,2027-12-31,INTERVENTIONAL,PHASE2,43,"['Carcinoma, Non-Small-Cell Lung', 'Non-Small Cell Lung Cancer', 'Nonsmall Cell Lung Cancer', 'Non-Small-Cell Lung Carcinoma', 'NSCLC']","Carcinoma, Non-Small-Cell Lung","Joseph J. Cullen, MD, FACS","['National Institutes of Health (NIH)', 'National Cancer Institute (NCI)', 'Holden Comprehensive Cancer Center']",['United States']
NCT06625320,Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC),"RASolute 302: A Phase 3 Multicenter, Open-label, Randomized Study of Daraxonrasib (RMC-6236) Versus Investigator's Choice of Standard of Care Therapy in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)",ACTIVE_NOT_RECRUITING,2024-10-16,2026-06,2027-12,INTERVENTIONAL,PHASE3,501,"['Pancreatic Cancer', 'PDAC', 'PDAC - Pancreatic Ductal Adenocarcinoma']",Pancreatic Cancer,"Revolution Medicines, Inc.",[],"['Japan', 'United States', 'France', 'Puerto Rico', 'Spain', 'Italy', 'Germany']"
NCT06828276,Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants,Culturally and Language-Adapted i-CBT for Common Mental Health Problems: A Randomized Controlled Study With Farsi/Dari-Speaking Migrants,RECRUITING,2025-03-25,2026-12-31,2026-12-31,INTERVENTIONAL,NA,128,"['Depressive Symptoms', 'Anxiety Symptoms', 'Grief', 'Psychological Trauma', 'Insomnia', 'Resilience', 'Stress', 'Psychological Well Being', 'Marital Relationship', 'Wellbeing', 'Common Mental Health Problems', 'Rumination']",Depressive Symptoms,Karolinska Institutet,['Linkoeping University'],['Sweden']
NCT06972446,A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis,"A Phase 2, Multicenter, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderately to Severely Active Rheumatoid Arthritis",RECRUITING,2025-06-20,2027-02,2027-11,INTERVENTIONAL,PHASE2,180,['Rheumatoid Arthritis'],Rheumatoid Arthritis,AbbVie,[],"['Puerto Rico', 'United States', 'Canada', 'Germany']"
NCT05312879,Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease,"A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease",RECRUITING,2022-03-30,2026-05-31,2026-06-30,INTERVENTIONAL,PHASE2,466,['Proteinuric Kidney Disease'],Proteinuric Kidney Disease,Vertex Pharmaceuticals Incorporated,[],"['Brazil', 'Belgium', 'Netherlands', 'United States', 'France', 'Ghana', 'Puerto Rico', 'Nigeria', 'Spain', 'Colombia', 'Canada', 'United Kingdom', 'Portugal']"
NCT07001280,A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE),"Garadacimab Real-world Treatment Outcomes of Effectiveness, Safety, and Quality-of-Life in Patients With HAE (GREAT Study)",RECRUITING,2025-07-21,2028-08-31,2030-08-31,OBSERVATIONAL,,200,['Hereditary Angioedemas'],Hereditary Angioedemas,CSL Behring,[],"['United States', 'Germany']"
NCT05556096,Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis",ACTIVE_NOT_RECRUITING,2022-11-21,2025-05-27,2027-08-31,INTERVENTIONAL,PHASE3,260,['Generalized Myasthenia Gravis'],Generalized Myasthenia Gravis,"Alexion Pharmaceuticals, Inc.",[],"['Japan', 'Netherlands', 'China', 'Israel', 'France', 'Denmark', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT05099003,A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG),A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG),RECRUITING,2022-05-31,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE1,132,['Malignant Glioma'],Malignant Glioma,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Canada', 'Australia']"
NCT07278700,The Fever Clinic Acute Respiratory Cohort,"The Fever Clinic Acute Respiratory Cohort (FACTS): A Prospective Real-World Cohort Study of Patients Presenting to Fever Clinics: Clinical Features, Laboratory and Radiographic Findings, and Long-Term Outcomes of Acute Respiratory Infections",RECRUITING,2025-10-10,2028-10,2028-10,OBSERVATIONAL,,1000,"['Acute Respiratory Infections', 'Febrile Illnesses', 'Community-acquired Pneumonia', 'Viral Respiratory Tract Infections', 'Influenza-like Illness']",Acute Respiratory Infections,Fudan University,['Huadong Hospital'],['China']
NCT04633239,Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer,A Phase 1/1b Dose Escalation Study of Abemaciclib and Olaparib for Recurrent Platinum-Resistant Ovarian Cancer,RECRUITING,2021-07-02,2026-11-01,2026-11-01,INTERVENTIONAL,PHASE1,42,"['Recurrent Ovarian High Grade Serous Adenocarcinoma', 'Recurrent Platinum-Resistant Ovarian Carcinoma']",Recurrent Ovarian High Grade Serous Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT06534411,"A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both","Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) 1.0 mg/1.0 mg s.c. Once Weekly Versus Tirzepatide 5 mg s.c. Once Weekly in Participants With Type 2 Diabetes Inadequately Controlled on Metformin, SGLT2 Inhibitor or Both",ACTIVE_NOT_RECRUITING,2024-11-05,2026-06-02,2026-07-14,INTERVENTIONAL,PHASE3,1023,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",Novo Nordisk A/S,[],"['Brazil', 'Israel', 'Hungary', 'India', 'United States', 'Germany', 'Spain', 'Taiwan', 'Canada', 'Romania', 'Greece', 'Poland', 'Argentina', 'Australia']"
NCT07280507,Comparing Microneedling and Injectable Platelet Rich Fibrin to Hyaluronic Acid In Papilla Reconstruction,Comparative Evaluation of Microneedling With Injectable PRF and Hyaluronic Acid for Papilla Reconstruction: A Randomized Clinical Trial,ACTIVE_NOT_RECRUITING,2025-11-24,2026-03,2026-09-30,INTERVENTIONAL,EARLY_PHASE1,7,['Papilla Reconstruction'],Papilla Reconstruction,King Abdulaziz University,[],['Saudi Arabia']
NCT06937177,Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy,Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy,RECRUITING,2025-04-28,2026-06,2026-09,INTERVENTIONAL,PHASE2,120,['Cancer Weight Loss'],Cancer Weight Loss,Endevica Bio,[],"['United States', 'Canada']"
NCT04310020,Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients,A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients With Borderline Performance Status,RECRUITING,2021-01-13,2026-09-01,2026-09-01,INTERVENTIONAL,PHASE2,47,"['Lung Non-Small Cell Carcinoma', 'Stage II Lung Cancer AJCC v8', 'Stage III Lung Cancer AJCC v8']",Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT07218510,"Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial",A Phase 2 Study of Venetoclax + Obinutuzumab Followed by Epcoritamab in Previously Untreated Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (LonGEVity),RECRUITING,2026-01-09,2029-06-08,2029-06-08,INTERVENTIONAL,PHASE2,33,"['Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma']",Chronic Lymphocytic Leukemia,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07241117,CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma,CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma,ACTIVE_NOT_RECRUITING,2025-11-15,2027-11-15,2028-11-15,INTERVENTIONAL,PHASE4,2000,['Moderate to Severe Asthma'],Moderate to Severe Asthma,Washington University School of Medicine,"['National Heart, Lung, and Blood Institute (NHLBI)', 'Doris Duke Charitable Foundation', 'Affinia Healthcare', 'Family Care Health Centers']",['United States']
NCT05066503,Nutritional Therapy for Delirium in Elderly Hospitalized Subjects,Nutritional Therapy for Delirium in Elderly Hospitalized Subjects,RECRUITING,2020-11-16,2026-01,2026-08,INTERVENTIONAL,NA,60,['Subacute Delirium'],Subacute Delirium,University of Arkansas,[],['United States']
NCT07278401,Community Pharmacies as Social Determinant of Health Navigators,Community Pharmacies as Social Determinant of Health Navigators,RECRUITING,2025-10-01,2026-12,2027-06,INTERVENTIONAL,NA,1600,['Social Needs Status'],Social Needs Status,State University of New York at Buffalo,"['CPESN-NY Pharmacies', 'Tops Pharmacies', 'National Center for Advancing Translational Sciences (NCATS)']",['United States']
NCT02971501,Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases,A Phase II Trial of Osimertinib (AZD9291) With or Without Bevacizumab in Patients With EGFR Mutation Positive NSCLC and Brain Metastases,ACTIVE_NOT_RECRUITING,2018-06-27,2025-02-18,2026-07-01,INTERVENTIONAL,PHASE2,7,"['Metastatic Lung Non-Small Cell Carcinoma', 'Metastatic Malignant Neoplasm in the Brain', 'Stage IV Lung Cancer AJCC v8']",Metastatic Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT07244536,Effects of Physical Exercise and Cognitive Training on Quality of Life in Elderly Adults,Health-related Quality of Life in Elderly Adults Following Physical Exercise and Cognitive Training: a Randomized-controlled Trial,RECRUITING,2025-11-15,2027-10-31,2028-10-31,INTERVENTIONAL,NA,156,['Elderly (People Aged 65 or More)'],Elderly (People Aged 65 or More),University Hospital of Ferrara,['Università degli Studi di Ferrara'],['Italy']
NCT01550575,Patient Retrospective Outcomes (PRO),Patient Retrospective Outcomes (PRO),RECRUITING,2012-04-03,2030-12,2030-12,OBSERVATIONAL,,15000,['Chronic Pain'],Chronic Pain,Boston Scientific Corporation,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Switzerland', 'Puerto Rico', 'Spain', 'Italy', 'United Kingdom', 'Australia', 'Portugal', 'Sweden', 'Germany']"
NCT07278388,Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2,Motivated Decision-Making and Performance,RECRUITING,2025-07-16,2029-12-31,2029-12-31,INTERVENTIONAL,NA,200,"['PASC Post Acute Sequelae of COVID 19', 'Fatigue']",PASC Post Acute Sequelae of COVID 19,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",['National Institute of Neurological Disorders and Stroke (NINDS)'],['United States']
NCT05445843,Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.,KontRASt-06: An Open-label Phase II Trial Evaluating the Activity and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.,ACTIVE_NOT_RECRUITING,2022-12-06,2024-11-04,2026-12-31,INTERVENTIONAL,PHASE2,95,['Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation'],Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation,Novartis Pharmaceuticals,[],"['Netherlands', 'China', 'Belgium', 'Hungary', 'France', 'Thailand', 'India', 'Spain', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05421689,Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia,"A Multi-Center, Double-Blind, Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Cells (AMDC) for the Treatment of Tongue Dysphagia Resulting From the Treatment of Head and Neck Cancer",ACTIVE_NOT_RECRUITING,2022-05-26,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,66,['Oropharyngeal Dysphagia'],Oropharyngeal Dysphagia,"University of California, Davis","['California Institute for Regenerative Medicine (CIRM)', 'Cook MyoSite']",['United States']
NCT07280494,To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT,"An Open-label, Clinical Study of CD7-targeted CAR-T Cells for the Treatment of Measurable Residual Disease of T-lymphoblastic Leukaemia/Lymphoma Post Allogeneic Stem Cell Transplantation",RECRUITING,2025-08-18,2026-08-30,2027-12-31,INTERVENTIONAL,PHASE1,18,['CD7+ T-ALL/LBL'],CD7+ T-ALL/LBL,Peking University People's Hospital,[],['China']
NCT06861686,A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores,A Modified Baveno Classification of Obstructive Sleep Apnoea Based on Sleepiness and Cardiovascular Scores: A Prospective Observational Cohort Study,RECRUITING,2025-03-24,2030-03-31,2030-03-31,OBSERVATIONAL,,1800,['Obstructive Sleep Apnea (OSA)'],Obstructive Sleep Apnea (OSA),Wissenschaftliches Institut Bethanien e.V,[],"['Belgium', 'Turkey (Türkiye)', 'Slovenia', 'France', 'Switzerland', 'Italy', 'Romania', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT04750954,"Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors",A Phase 1b Trial of M3814 (Peposertib) in Combination With Lutetium 177 Dotatate for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs),ACTIVE_NOT_RECRUITING,2021-07-22,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,29,['Neuroendocrine Neoplasm'],Neuroendocrine Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT03553095,Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis,Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis,ACTIVE_NOT_RECRUITING,2018-07-12,2019-12-30,2026-12-30,INTERVENTIONAL,NA,92,"['Chronic Periodontitis', 'Depression']",Chronic Periodontitis,University of Alabama at Birmingham,[],['United States']
NCT07233239,"A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures","A Phase 1b, Multicenter, Open-Label, Single-arm Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) in Participants Aged 12 to 75 Years for the Treatment of Focal-Onset Seizures",RECRUITING,2025-11-26,2027-11-29,2027-11-29,INTERVENTIONAL,PHASE1,100,['Focal Seizures'],Focal Seizures,Jazz Pharmaceuticals,['Jazz Pharmaceuticals Research UK Ltd.'],['United States']
NCT05646901,Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control,Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control (GMBCrossTalkFood),RECRUITING,2022-12-12,2026-08,2026-08,OBSERVATIONAL,,108,['Obesity'],Obesity,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,[],['Spain']
NCT06851481,The Ladera Suture-Mediated Large Bore Closure Study,"A Prospective, Multi-Center, Single-Arm Study to Evaluate the Safety and Performance of the Ladera Medical Suture-Mediated Closure System When Used to Achieve Hemostasis of Common Femoral Arteriotomies in Patients Undergoing Percutaneous Catheter-Based Interventional Procedures (the FASTEN Study)",RECRUITING,2025-08-18,2025-12-30,2025-12-31,INTERVENTIONAL,NA,55,"['Vascular Closure', 'Femoral Arteriotomy Closure']",Vascular Closure,Ladera Medical,[],"['Belgium', 'Netherlands', 'Australia']"
NCT07267962,LLM-Guided Rehabilitation in Degenerative Knee Disease,"The Effect of ChatGPT-5, Gemini 2.5 Pro, and DeepSeek V3.1 Guided Rehabilitation on Clinical Outcomes in Individuals With Degenerative Knee Disease",RECRUITING,2025-11-26,2026-01-26,2026-02-10,INTERVENTIONAL,NA,80,['Degenerative Knee Disease'],Degenerative Knee Disease,Kirsehir Ahi Evran Universitesi,[],['Turkey (Türkiye)']
NCT07162506,DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI,Definitive Concurrent Chemoradiotherapy Versus Surgery in Patients With Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (ESCC) Who Achieve Complete or Partial Response After Neoadjuvant Camrelizumab Combined With Chemotherapy: A Single-arm Phase II Clinical Study (SORT Trial),RECRUITING,2025-08-01,2027-08-30,2030-08-30,INTERVENTIONAL,PHASE2,120,['Esophageal Cancer'],Esophageal Cancer,Tianjin Medical University Cancer Institute and Hospital,[],['China']
NCT05094336,A Study of AMG 193 in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101),"A Phase 1/1b/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 Alone and in Combination With Docetaxel in Subjects With Advanced MTAP-null Solid Tumors",RECRUITING,2022-02-01,2026-07-02,2028-06-01,INTERVENTIONAL,PHASE1,649,['Advanced MTAP-null Solid Tumors'],Advanced MTAP-null Solid Tumors,Amgen,[],"['Belgium', 'Japan', 'Hong Kong', 'China', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT07157254,A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS),"A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects With Deletion- or Nondeletion-type Angelman Syndrome",RECRUITING,2025-10-13,2030-01,2030-01,INTERVENTIONAL,PHASE2,60,['Angelman Syndrome'],Angelman Syndrome,Ultragenyx Pharmaceutical Inc,[],"['Brazil', 'Israel', 'United States', 'France', 'Italy', 'United Kingdom', 'Portugal', 'Argentina']"
NCT05999994,A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer,CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research,RECRUITING,2020-01-22,2027-05,2027-05,INTERVENTIONAL,PHASE2,105,"['Neoplasms', 'Child', 'Adolescent']",Neoplasms,Eli Lilly and Company,[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Australia', 'United Kingdom', 'Germany']"
NCT05668013,A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease,"A Phase 2b, Randomized, Double-Blind Long-Term Extension Study to Evaluate Pharmacokinetics, Efficacy, Safety, and Tolerability of TEV-48574 in Adult Patients With Moderate to Severe Ulcerative Colitis or Crohn's Disease Who Completed the Treatment Phase of the Dose-Ranging Study (RELIEVE UCCD LTE)",ACTIVE_NOT_RECRUITING,2023-01-11,2025-12-20,2031-03-08,INTERVENTIONAL,PHASE2,218,"['Crohn Disease', 'Colitis, Ulcerative']",Crohn Disease,Teva Branded Pharmaceutical Products R&D LLC,['Sanofi'],"['Bulgaria', 'Israel', 'Japan', 'Hungary', 'Norway', 'Austria', 'United States', 'Georgia', 'Slovakia', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Ukraine', 'Germany']"
NCT03866382,Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors,"A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)",RECRUITING,2019-05-13,2026-02-28,2026-02-28,INTERVENTIONAL,PHASE2,314,"['Bladder Adenocarcinoma', 'Bladder Clear Cell Adenocarcinoma', 'Bladder Mixed Adenocarcinoma', 'Bladder Neuroendocrine Carcinoma', 'Bladder Small Cell Neuroendocrine Carcinoma', 'Bladder Squamous Cell Carcinoma', 'Chromophobe Renal Cell Carcinoma', 'Collecting Duct Carcinoma', 'Invasive Bladder Giant Cell Urothelial Carcinoma', 'Invasive Bladder Lymphoepithelioma-Like Carcinoma', 'Invasive Bladder Nested Urothelial Carcinoma', 'Invasive Bladder Plasmacytoid Urothelial Carcinoma', 'Invasive Bladder Sarcomatoid Urothelial Carcinoma', 'Invasive Bladder Urothelial Carcinoma', 'Kidney Medullary Carcinoma', 'Large Cell Neuroendocrine Carcinoma', 'Malignant Testicular Leydig Cell Tumor', 'Malignant Testicular Sertoli Cell Tumor', 'Metastatic Bladder Carcinoma', 'Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma', 'Metastatic Bladder Giant Cell Urothelial Carcinoma', 'Metastatic Bladder Large Cell Neuroendocrine Carcinoma', 'Metastatic Bladder Lipid-Rich Urothelial Carcinoma', 'Metastatic Bladder Micropapillary Urothelial Carcinoma', 'Metastatic Bladder Plasmacytoid Urothelial Carcinoma', 'Metastatic Bladder Sarcomatoid Urothelial Carcinoma', 'Metastatic Bladder Small Cell Neuroendocrine Carcinoma', 'Metastatic Bladder Squamous Cell Carcinoma', 'Metastatic Chromophobe Renal Cell Carcinoma', 'Metastatic Kidney Medullary Carcinoma', 'Metastatic Malignant Genitourinary System Neoplasm', 'Metastatic Papillary Renal Cell Carcinoma', 'Metastatic Penile Carcinoma', 'Metastatic Prostate Small Cell Neuroendocrine Carcinoma', 'Metastatic Sarcomatoid Renal Cell Carcinoma', 'Metastatic Urethral Carcinoma', 'Papillary Renal Cell Carcinoma', 'Sarcomatoid Renal Cell Carcinoma', 'Stage IV Bladder Cancer AJCC v8', 'Stage IV Penile Cancer AJCC v8', 'Stage IV Renal Cell Cancer AJCC v8', 'Stage IV Urethral Cancer AJCC v8', 'Stage IVB Prostate Cancer AJCC v8', 'Urachal Adenocarcinoma', 'Urethral Clear Cell Adenocarcinoma']",Bladder Adenocarcinoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06962839,A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema,"A Randomised, Double-masked, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Oral BI 1815368 in Participants With Centre-involved Diabetic Macular Edema for 48 Weeks of Treatment (THULITE)",RECRUITING,2025-06-05,2027-09-01,2027-09-29,INTERVENTIONAL,PHASE2,300,['Macular Edema'],Macular Edema,Boehringer Ingelheim,[],"['Japan', 'Hungary', 'China', 'United States', 'Slovakia', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07278999,"Photobiomodulation, Er:YAG Laser, and Clobetasol in the Treatment of Oral Lichen Planus.","Effectiveness of Photobiomodulation, Er:YAG Laser, and Clobetasol in the Treatment of the Erosive Form of Oral Lichen Planus - a Randomized Clinical Trial.",RECRUITING,2025-12-01,2026-06,2026-06,INTERVENTIONAL,NA,60,"['Oral Lichen Planus', 'Erosive Lichen Planus', 'Mucosal Lesions']",Oral Lichen Planus,Medical University of Silesia,[],['Poland']
NCT06066528,A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight,"A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes Mellitus",ACTIVE_NOT_RECRUITING,2023-11-27,2025-12-12,2026-04-03,INTERVENTIONAL,PHASE3,755,"['Obesity', 'Diabetes Mellitus, Type 2']",Obesity,Boehringer Ingelheim,[],"['Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'United States']"
NCT04610697,Cognitive Remediation in Forensic Mental Health Care,Cognitive Remediation in Forensic Mental Health Care,RECRUITING,2020-02-10,2026-02-10,2026-02-10,INTERVENTIONAL,NA,30,"['Psychotic Disorders', 'ADHD', 'TBI (Traumatic Brain Injury)', 'Aggression', 'Substance Use Disorders', 'Violence', 'Cognitive Dysfunction', 'Anxiety', 'Depression', 'Schizophrenia', 'Offenders', 'Antisocial']",Psychotic Disorders,The Royal Ottawa Mental Health Centre,[],['Canada']
NCT03604978,Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma,A Phase I/II Study of Nivolumab Plus or Minus Ipilimumab in Combination With Multi-Fraction Stereotactic Radiosurgery for Recurrent High-Grade Radiation-Relapsed Meningioma,ACTIVE_NOT_RECRUITING,2019-06-17,2026-01-06,2026-01-06,INTERVENTIONAL,PHASE1,38,"['Grade 2 Meningioma', 'Grade 3 Meningioma', 'Recurrent Meningioma']",Grade 2 Meningioma,National Cancer Institute (NCI),[],['United States']
NCT06779929,Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes,Comparative Study of Tirzepatide vs Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes,ACTIVE_NOT_RECRUITING,2024-11-01,2025-12-01,2026-03-01,OBSERVATIONAL,,70000,['Type 2 Diabetes'],Type 2 Diabetes,Brigham and Women's Hospital,[],['United States']
NCT06652503,The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program,"The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program: A 6-week Coaching Program Designed For NSU Undergraduate Students to Decrease Anxiety, Depression, and Stress and Improve Mental Health, Quality of Life, and Resiliency",RECRUITING,2025-01-13,2026-08,2026-09,INTERVENTIONAL,NA,160,"['Anxiety', 'Depression', 'Stress', 'Wellbeing', 'Quality of Life']",Anxiety,Nova Southeastern University,[],['United States']
NCT06179888,Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma,Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients,RECRUITING,2024-08-27,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE2,78,['Multiple Myeloma'],Multiple Myeloma,National Cancer Institute (NCI),[],['United States']
NCT06886815,Popliteal Nerve Block for Acute Achilles Tendon Rupture Repair Surgery,The Effects of Popliteal Nerve Block on Pain and Nerve-Related Symptoms After Acute Achilles Tendon Rupture Repair Surgery: A Randomized Controlled Trial,RECRUITING,2026-01,2027-11,2028-03,INTERVENTIONAL,NA,80,['Acute Achilles Tendon Rupture'],Acute Achilles Tendon Rupture,Women's College Hospital,[],['Canada']
NCT05625204,High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans,High Intensity Interval Training (HIIT) to Reduce Frailty and Enhance Resilience in Older Veterans,RECRUITING,2024-01-29,2027-07-01,2027-09-30,INTERVENTIONAL,NA,200,['Frailty'],Frailty,VA Office of Research and Development,[],['United States']
NCT06150664,A Phase 1 of CTX-8371 in Patients With Advanced Malignancies,"A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-8371 in Patients With Advanced Malignancies",RECRUITING,2024-03-19,2026-12,2027-05,INTERVENTIONAL,PHASE1,73,"['Non Small Cell Lung Cancer', 'Triple Negative Breast Cancer', 'Hodgkin Lymphoma', 'Head and Neck Squamous Cell Carcinoma', 'Malignant Melanoma']",Non Small Cell Lung Cancer,Compass Therapeutics,[],['United States']
NCT06672952,"Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators","Dose-Response Impact of Glucosyl-Hesperidin (CitraPeak) on Exercise Performance, Blood Flow, Stress, Cognition, and Other Perceptual Indicators",RECRUITING,2025-04-15,2026-01-01,2026-01-01,INTERVENTIONAL,NA,60,"['Exercise Performance', 'Exercise Recovery', 'Cognitive Function', 'Nitric Oxide', 'Blood Flow', 'Endurance Exercise']",Exercise Performance,Lindenwood University,"['Increnovo, LLC']",['United States']
NCT06465147,REACT-01: Reversing Autoimmunity Through Cell Therapy,REACT-01: Reversing Autoimmunity Through Cell Therapy,RECRUITING,2024-12-16,2028-10,2041-10,INTERVENTIONAL,PHASE1,12,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,Seattle Children's Hospital,[],['United States']
NCT07229937,A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of HRS-1301 in Participants With Dyslipidemia",RECRUITING,2025-11-25,2026-08,2026-08,INTERVENTIONAL,PHASE2,189,['Hyperlipidemia'],Hyperlipidemia,"Shandong Suncadia Medicine Co., Ltd.",[],['China']
NCT07025629,Dapagliflozin for Cardio-renal Protection After ICU Discharge,"Dapagliflozin for Cardio-renal Protection After ICU Discharge: A Prospective, Randomized, Double Blinded, Multicenter Study: ""DAPA-ICU Trial""",RECRUITING,2025-12-02,2029-01-15,2029-01-15,INTERVENTIONAL,PHASE3,600,['Heart Failure and Chronic Kidney Disease Post-ICU'],Heart Failure and Chronic Kidney Disease Post-ICU,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT07071519,A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis,"A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Open-Label Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2025-07-28,2034-07,2034-07,INTERVENTIONAL,PHASE3,120,['Ulcerative Colitis'],Ulcerative Colitis,AbbVie,[],"['Belgium', 'United States', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Greece', 'Serbia', 'Sweden', 'Germany']"
NCT07235046,A Study of DII235 in Adults With Elevated Lipoprotein(a),"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate Efficacy, Safety, and Tolerability of DII235 in Adults With Elevated Lipoprotein(a)",RECRUITING,2025-12-02,2027-09-08,2028-09-08,INTERVENTIONAL,PHASE2,200,['Lipoprotein Disorder'],Lipoprotein Disorder,Novartis Pharmaceuticals,[],"['Japan', 'United States']"
NCT04325529,Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation),Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making,ACTIVE_NOT_RECRUITING,2021-01-19,2026-06-30,2026-06-30,OBSERVATIONAL,,148,['Major Depression in Remission'],Major Depression in Remission,Mclean Hospital,[],['United States']
NCT02496663,Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor,A Phase I Trial of Osimertinib (AZD9291) and Necitumumab in EGFR-Mutant Non-Small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor,ACTIVE_NOT_RECRUITING,2016-05-11,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE1,138,"['Metastatic Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage IV Lung Cancer AJCC v8']",Metastatic Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05814055,The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence,The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence,RECRUITING,2024-06-06,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE2,76,['Smoking'],Smoking,University of Florida,"['National Center for Complementary and Integrative Health (NCCIH)', 'National Institutes of Health (NIH)']",['United States']
NCT05564390,MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial),Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials,RECRUITING,2024-06-18,2029-05-15,2029-05-15,INTERVENTIONAL,PHASE2,2000,"['Acute Myeloid Leukemia', 'Myelodysplastic Syndrome']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT05675410,"A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab",A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma,RECRUITING,2023-05-11,2031-04-28,2031-04-28,INTERVENTIONAL,PHASE3,1875,['Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8'],Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT07086976,"A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia","A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)",RECRUITING,2025-08-18,2028-05-31,2029-12-26,INTERVENTIONAL,PHASE3,90,['Autoimmune Haemolytic Anaemia'],Autoimmune Haemolytic Anaemia,Sanofi,[],"['Brazil', 'Israel', 'Japan', 'Hungary', 'Netherlands', 'China', 'Austria', 'United States', 'Denmark', 'Spain', 'Italy', 'Czechia', 'Greece', 'Poland', 'Argentina', 'Sweden', 'Germany']"
NCT07076797,Effects of Lower Extremity Functional Exercise Program and Neuromuscular Electrical Nerve Stimulation in Older Adults,"The Effects of Lower Extremity Functional Exercise Program and Neuromuscular Electrical Nerve Stimulation on Muscle Strength, Muscle Thickness, Gait and Fall Risk in the Elderly",RECRUITING,2025-10-15,2026-01-10,2026-05-15,INTERVENTIONAL,NA,42,['Neuromuscular Electrical Stimulation'],Neuromuscular Electrical Stimulation,Biruni University,[],['Turkey (Türkiye)']
NCT05967195,Trial to Increase FEP Attendance,"Financial Incentives to Increase Treatment Attendance in First-Episode Psychosis Care: A Non-Randomized, Adaptive Pilot Study",ACTIVE_NOT_RECRUITING,2025-02-01,2026-01-01,2026-01-31,INTERVENTIONAL,EARLY_PHASE1,145,['First-Episode Psychosis'],First-Episode Psychosis,University of Pennsylvania,['Penn Innovation in Suicide Prevention for Implementation Research (INSPIRE) Center'],['United States']
NCT06900595,"Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer",A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer,RECRUITING,2026-07-19,2029-06-02,2029-06-02,INTERVENTIONAL,PHASE2,48,"['Locally Advanced Adrenal Cortical Carcinoma', 'Metastatic Adrenal Cortical Carcinoma', 'Recurrent Adrenal Cortical Carcinoma', 'Stage III Adrenal Cortical Carcinoma AJCC v8', 'Stage IV Adrenal Cortical Carcinoma AJCC v8', 'Unresectable Adrenal Cortical Carcinoma']",Locally Advanced Adrenal Cortical Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05122767,Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS),"Safety, Tolerability and Drug-drug Interactions of Short-course Treatment of Latent Tuberculosis Infection With High-dose Once-weekly Rifapentine and Isoniazid (3HP) Among Infants, Children and Adolescents Living With HIV Taking Dolutegravir-based Antiretroviral Treatment",ACTIVE_NOT_RECRUITING,2023-05-24,2025-07-04,2025-12-31,INTERVENTIONAL,PHASE1,92,"['Tuberculosis', 'HIV']",Tuberculosis,The Aurum Institute NPC,['Johns Hopkins University'],['South Africa']
NCT06538220,"Evaluation of the Care Pathway Offered by the ""Chronic Disease Unit"" to Obese Patients","Evaluation of the Care Pathway Offered by the ""Chonic Disease Unit"" to Obese Patients",RECRUITING,2024-10-16,2028-04,2028-04,INTERVENTIONAL,NA,133,['Obesity'],Obesity,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"['Maison de la Maladie Chronique', ""Institut d'Etude de la Maladie Chronique""]",['France']
NCT06943469,Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function,Synbiotics in Partially Hydrolysed Formula for Improved skiN Barrier Function in Infants at Risk for Allergy (SPHINX Study),RECRUITING,2025-04-10,2027-10,2028-11,INTERVENTIONAL,NA,400,['Atopic Dermatitis (AD)'],Atopic Dermatitis (AD),Société des Produits Nestlé (SPN),[],"['Belgium', 'Spain', 'France', 'Germany']"
NCT07279545,The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding,The Effect of Placental Cord Drainage on the Third Stage of Labor and the Amount of Postpartum Bleeding,RECRUITING,2025-11-17,2026-06-20,2026-07-01,INTERVENTIONAL,NA,80,['Postpartum Hemorrhage'],Postpartum Hemorrhage,Saglik Bilimleri Universitesi Gulhane Tip Fakultesi,[],['Turkey (Türkiye)']
NCT06943612,Colorectal Resections in Patients With Retroperitoneal Sarcoma,Colorectal Resections and Reconstructions in Patients With Retroperitoneal Sarcoma: Evaluation of Surgical Strategies and Postoperative Quality of Life,RECRUITING,2025-01-27,2026-03,2026-03,OBSERVATIONAL,,120,"['Sarcoma, Soft Tissue', 'Retroperitoneal Sarcoma']","Sarcoma, Soft Tissue",Heidelberg University,[],"['Switzerland', 'Germany']"
NCT05514054,A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer,"EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence",RECRUITING,2022-10-04,2027-10,2032-03,INTERVENTIONAL,PHASE3,8000,['Breast Neoplasms'],Breast Neoplasms,Eli Lilly and Company,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'South Korea', 'Czechia', 'Poland', 'India', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07064473,"A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease","A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease",RECRUITING,2025-07-22,2029-12-14,2029-12-21,INTERVENTIONAL,PHASE3,11800,"['Diabetes Mellitus, Type 2', 'Hypertension', 'Cardiovascular Diseases']","Diabetes Mellitus, Type 2",Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Puerto Rico', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'United Kingdom', 'Sweden', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Egypt', 'Argentina', 'Philippines']"
NCT05058651,Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung,Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC),RECRUITING,2022-06-28,2028-10-01,2028-10-01,INTERVENTIONAL,PHASE2,189,"['Advanced Extrapulmonary Neuroendocrine Carcinoma', 'Metastatic Extrapulmonary Neuroendocrine Carcinoma', 'Recurrent Extrapulmonary Neuroendocrine Carcinoma', 'Unresectable Extrapulmonary Neuroendocrine Carcinoma']",Advanced Extrapulmonary Neuroendocrine Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT03940703,A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2),"A Phase II, Two-arm Study to Investigate Tepotinib Combined With Osimertinib in MET Amplified, Advanced or Metastatic NSCLC Harboring Activating EGFR Mutations and Having Acquired Resistance to Prior Osimertinib Therapy (INSIGHT 2)",ACTIVE_NOT_RECRUITING,2019-09-19,2023-05-11,2026-05-01,INTERVENTIONAL,PHASE2,140,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,"EMD Serono Research & Development Institute, Inc.","['Merck KGaA, Darmstadt, Germany']","['Singapore', 'Belgium', 'Japan', 'Hong Kong', 'Netherlands', 'China', 'Russia', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Malaysia', 'Thailand', 'Vietnam', 'Germany']"
NCT06909188,The Study of Association of Helicobacter Infections in Biliary Tract Cancers,The Study of Association of Helicobacter Infections in Biliary Tract Cancers,RECRUITING,2025-03-31,2026-03-31,2026-05-31,OBSERVATIONAL,,250,['Biliary Tract Cancer'],Biliary Tract Cancer,"Institute of Liver and Biliary Sciences, India",[],['India']
NCT04745754,The Engaging Primary Care in Cancer Survivorship (EPICS) Study,The EPICS (Engaging Primary Care in Cancer Survivorship) Study: A Trial of Novel Models of Care for Cancer Survivors,ACTIVE_NOT_RECRUITING,2021-09-21,2026-02-28,2026-02-28,INTERVENTIONAL,NA,2450,"['Breast Cancer', 'Colorectal Cancer']",Breast Cancer,Kaiser Permanente,['National Cancer Institute (NCI)'],['United States']
NCT06424860,"Fish Oil, Metformin and Heart Health in PCOS",Dietary Fish Oil and Metformin Intervention for Heart Health in PCOS,RECRUITING,2025-11-01,2026-12-30,2027-12-30,INTERVENTIONAL,PHASE1,146,"['PCOS', 'Cardiovascular Disease', 'Atherosclerotic Cardiovascular Disease', 'Atherosclerotic Plaque', 'Cardiac Hypertrophy']",PCOS,University of Alberta,['Heart and Stroke Foundation of Canada'],['Canada']
NCT05987241,"Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study",MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer,RECRUITING,2024-02-02,2030-09-02,2030-09-02,INTERVENTIONAL,PHASE2,992,"['Muscle Invasive Bladder Urothelial Carcinoma', 'Muscle Invasive Renal Pelvis Urothelial Carcinoma', 'Muscle Invasive Ureter Urothelial Carcinoma', 'Muscle Invasive Urethral Urothelial Carcinoma', 'Stage II Bladder Urothelial Carcinoma AJCC v6 and v7', 'Stage III Bladder Urothelial Carcinoma AJCC v6 and v7', 'Stage IV Bladder Urothelial Carcinoma AJCC v7']",Muscle Invasive Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT05515341,A DirEct to PatieNt Study in Chronic Pain,A DirEct to PatieNt Study in Chronic Pain,RECRUITING,2023-01-10,2029-12,2029-12,OBSERVATIONAL,,50000,['Chronic Pain'],Chronic Pain,Boston Scientific Corporation,[],['United States']
NCT04858334,"APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation","APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation",RECRUITING,2021-06-22,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE2,152,"['Pancreatic Acinar Cell Carcinoma', 'Pancreatic Adenosquamous Carcinoma', 'Pancreatic Squamous Cell Carcinoma', 'Resectable Pancreatic Acinar Cell Carcinoma', 'Resectable Pancreatic Adenocarcinoma', 'Resectable Pancreatic Adenosquamous Carcinoma', 'Resectable Pancreatic Carcinoma']",Pancreatic Acinar Cell Carcinoma,National Cancer Institute (NCI),[],"['Israel', 'Puerto Rico', 'United States']"
NCT07226011,Accelerated High-Dose tDCS for Depression,Accelerated High-Dose tDCS for Depression: An Open-Label Outpatient Pilot Study,RECRUITING,2025-12-15,2026-04,2026-06-01,INTERVENTIONAL,NA,20,"['Major Depression', 'Major Depression Disorders']",Major Depression,Medical University of South Carolina,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT07215325,Got Doxy- 'Flipping the Script' on STI PEP,The Effects of Doxycycline on Inflammation and the Microbiome: 'Flipping the Script' on STI PEP,RECRUITING,2025-10-22,2028-09,2028-09,INTERVENTIONAL,PHASE4,200,['Sexually Transmitted Infections (STI)'],Sexually Transmitted Infections (STI),Emory University,['National Institute of Allergy and Infectious Diseases (NIAID)'],['United States']
NCT07266142,Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker,"Prospective Collection of Clinical Data and Human Body Material (HBM): Blood (Serum, Plasma, DNA) and Tissue of Cutaneous Melanoma and Non Melanoma Patients. Biobank Huidkanker",RECRUITING,2025-11-17,2050-01,2051-01,OBSERVATIONAL,,7500,"['Skin Cancer, Non-Melanoma', 'Skin Cancer Melanoma']","Skin Cancer, Non-Melanoma",Universitaire Ziekenhuizen KU Leuven,[],['Belgium']
NCT05433454,Impact of Outreach on Medicaid Enrollment,Outreach and Maintenance of Medicaid Enrollment: Evidence From Wisconsin's Navigator Program,ACTIVE_NOT_RECRUITING,2023-05-17,2026-05,2026-05,INTERVENTIONAL,NA,119308,['Health Insurance'],Health Insurance,"University of Wisconsin, Madison",['Covering Wisconsin'],['United States']
NCT05539430,"Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma","A Phase 1, Open-Label, Dose Escalation and Expansion, Multicenter Study of Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma",ACTIVE_NOT_RECRUITING,2023-04-18,2027-12,2027-12,INTERVENTIONAL,PHASE1,56,"['Gastric Cancer', 'Gastroesophageal-junction Cancer', 'Esophageal Cancer', 'Pancreatic Cancer']",Gastric Cancer,Legend Biotech USA Inc,[],['United States']
NCT05531565,A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus,"A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)",RECRUITING,2022-09-13,2026-10-20,2027-12-14,INTERVENTIONAL,PHASE2,474,"['Subacute Cutaneous Lupus Erythematosus', 'Chronic Cutaneous Lupus Erythematosus']",Subacute Cutaneous Lupus Erythematosus,Biogen,[],"['Bulgaria', 'Japan', 'Saudi Arabia', 'China', 'Slovakia', 'Serbia', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Peru', 'South Korea', 'Colombia', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT06539195,DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9),"A Phase 2, Open-label, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma",ACTIVE_NOT_RECRUITING,2024-03-13,2026-01,2026-08,INTERVENTIONAL,PHASE2,59,['Diffuse Large B Cell Lymphoma'],Diffuse Large B Cell Lymphoma,Dizal Pharmaceuticals,[],['China']
NCT06096324,Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE),Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE),RECRUITING,2023-09-19,2027-03-31,2027-03-31,INTERVENTIONAL,NA,500,"['Economic Hardship', 'Condomless Sex', 'Utilization, Health Care']",Economic Hardship,"University of North Carolina, Chapel Hill",['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT07280923,Reliability and Validity of the PReFS,Reliability and Validity of the Pressure Relief Frequency Scale,RECRUITING,2025-12,2026-12,2027-01,OBSERVATIONAL,,15,"['Neurologic Disorders', 'Spinal Cord Injury', 'Stroke', 'Traumatic Brain Injury']",Neurologic Disorders,Baylor University,[],['United States']
NCT06998758,Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC,Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Patients With Locally Advanced Colorectal Cancer: A Multicenter Randomized Controlled Clinical Trial,RECRUITING,2025-11-11,2027-05-10,2028-12-31,INTERVENTIONAL,PHASE3,60,"['Neoadjuvant Chemotherapy', 'Weight Loss']",Neoadjuvant Chemotherapy,"Sixth Affiliated Hospital, Sun Yat-sen University",[],['China']
NCT05705258,A Study to Collect Data on the Use of Eylea in Babies Born Too Early Who Have a Condition of the Eye Where Blood Vessels Grow Abnormally in the Retina (Retinopathy of Prematurity),Special Drug Use Investigation for Eylea for Retinopathy of Prematurity (ROP),RECRUITING,2023-03-27,2026-04-01,2027-03-30,OBSERVATIONAL,,75,"['Retinopathy of Prematurity', 'Newborns', 'Infants']",Retinopathy of Prematurity,Bayer,[],['Japan']
NCT06172296,"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma",A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma,RECRUITING,2024-04-19,2029-12-31,2029-12-31,INTERVENTIONAL,PHASE3,478,"['Ganglioneuroblastoma, Nodular', 'Neuroblastoma']","Ganglioneuroblastoma, Nodular",National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Canada', 'Australia']"
NCT06424262,Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622),"A Pivotal, Prospective, Multi-centre, Randomised Controlled, 6-month Blinded Investigation Followed by a 6-month Open-label Phase Evaluating the Efficacy of a Dexamethasone Eluting Slim Straight Electrode (CI622D) in the Reduction of Impedance as Compared to a Standard Slim Straight Electrode (CI622) in a Newly Implanted Adult Population With Post-linguistic, Bilateral, Moderately Severe to Profound Sensorineural Hearing Loss.",ACTIVE_NOT_RECRUITING,2024-06-17,2025-12,2026-05,INTERVENTIONAL,NA,48,"['Hearing Loss, Bilateral Sensorineural', 'Hearing Loss, Sensorineural', 'Hearing Loss, Bilateral', 'Hearing Loss, Cochlear']","Hearing Loss, Bilateral Sensorineural",Cochlear,"['QbD Clinical', 'Avania']","['United Kingdom', 'France', 'Germany', 'Australia']"
NCT07279441,Cochlear Implants and Listening Effort: the Interaction of Cognitive and Sensory Constraints,Cochlear Implants and Listening Effort: the Interaction of Cognitive and Sensory Constraints,RECRUITING,2025-01-02,2030-01-02,2030-01-02,INTERVENTIONAL,NA,460,['Cochlear Implant Users'],Cochlear Implant Users,NYU Langone Health,['National Institute on Deafness and Other Communication Disorders (NIDCD)'],['United States']
NCT07090135,Power Nap With TES-TI,Enhance the Restorative Power of Sleep Through TES-TI Power Naps,RECRUITING,2025-12,2027-04,2027-04,INTERVENTIONAL,NA,25,"['Non-restorative Sleep', 'Healthy Volunteer']",Non-restorative Sleep,"University of Wisconsin, Madison",['Corundum Convergence Institute'],['United States']
NCT07196774,A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer,"A Randomized, Open-label, Multicenter Phase III Study of SHR-A1811 Compared to Docetaxel+Carboplatin+Trastuzumab+Pertuzumab as a Neoadjuvant Therapy for the Initial Treatment of Early-stage or Locally Advanced HER2-positive Breast Cancer",RECRUITING,2025-10-23,2027-12,2028-12,INTERVENTIONAL,PHASE3,650,['Early-stage or Locally Advanced HER2-positive Breast Cancer'],Early-stage or Locally Advanced HER2-positive Breast Cancer,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT06438588,"Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial",Effect of Fasting Mimicking Diet (FMD) on Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors: The FMD-ICI Feasibility Pilot Study,RECRUITING,2024-03-06,2027-03-15,2027-03-15,INTERVENTIONAL,NA,10,['Advanced Malignant Solid Neoplasm'],Advanced Malignant Solid Neoplasm,Mayo Clinic,[],['United States']
NCT04071223,"Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study",A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis (RadiCal),RECRUITING,2020-07-29,2026-10-01,2026-10-01,INTERVENTIONAL,PHASE2,134,"['Advanced Renal Cell Carcinoma', 'Chromophobe Renal Cell Carcinoma', 'Clear Cell Renal Cell Carcinoma', 'Collecting Duct Carcinoma', 'Kidney Medullary Carcinoma', 'Metastatic Malignant Neoplasm in the Bone', 'Papillary Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer AJCC v8', 'Unclassified Renal Cell Carcinoma']",Advanced Renal Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06491862,RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil,RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy in Brazil,RECRUITING,2024-07-25,2026-06-30,2026-06-30,OBSERVATIONAL,,250,['Non-squamous Non-Small Cell Lung Cancer'],Non-squamous Non-Small Cell Lung Cancer,AstraZeneca,[],['Brazil']
NCT05354232,Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD),Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD),RECRUITING,2022-07-01,2026-05,2026-05,INTERVENTIONAL,NA,60,"['Attention Deficit Disorder', 'Attention Deficit Disorder With Hyperactivity']",Attention Deficit Disorder,Massachusetts General Hospital,[],['United States']
NCT07254078,Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension,Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Russia: Determinants of Long-term Outcomes in Real Clinical Practice,RECRUITING,2025-05-01,2035-05-01,2035-05-01,OBSERVATIONAL,,500,['Chronic Thromboembolic Pulmonary Hypertension'],Chronic Thromboembolic Pulmonary Hypertension,Irina E. Chazova,[],['Russia']
NCT06604858,Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer,Neoadjuvant Phase II Study of Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer (The TELESCOPE Study),RECRUITING,2025-05-29,2026-10,2026-10,INTERVENTIONAL,PHASE2,30,"['Breast Cancer', 'Triple Negative Breast Cancer']",Breast Cancer,MedSIR,['Merk Sharp & Dohme España S.A.'],['Spain']
NCT07278622,Virtual Group Prehabilitation Education (Surgery School) Feasibility Trial,Feasibility Testing and Process Evaluation of a Virtual Group Preoperative Prehabilitation Education Intervention (GoPREPARE),RECRUITING,2025-09-02,2026-07-01,2026-07-01,INTERVENTIONAL,NA,24,"['Cancer Surgery', 'Elective Surgery', 'Patient Education', 'Prehabilitation']",Cancer Surgery,University Hospital Southampton NHS Foundation Trust,"['University Hospital Plymouth NHS Trust', 'University of Southampton']",['United Kingdom']
NCT06850922,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema","A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Patients With Diabetic Macular Edema",RECRUITING,2022-06-22,2027-04-30,2027-04-30,INTERVENTIONAL,PHASE1,546,['Diabetic Macular Edema'],Diabetic Macular Edema,"Genentech, Inc.",[],"['China', 'Puerto Rico', 'United States']"
NCT07190807,Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control,Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control (MOSAIC Study),RECRUITING,2025-11-07,2027-11,2029-05,INTERVENTIONAL,NA,70,"['Chronic Pain', 'Intractable Pain', 'Low Back Pain', 'Chronic Low-back Pain', 'Chronic Leg Pain', 'Leg Pain']",Chronic Pain,Boston Scientific Corporation,[],['United States']
NCT04671667,Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma,A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features,RECRUITING,2021-04-27,2029-06-30,2029-06-30,INTERVENTIONAL,PHASE2,188,"['Recurrent Head and Neck Squamous Cell Carcinoma', 'Recurrent Hypopharyngeal Squamous Cell Carcinoma', 'Recurrent Laryngeal Squamous Cell Carcinoma', 'Recurrent Oral Cavity Squamous Cell Carcinoma', 'Recurrent Oropharyngeal Squamous Cell Carcinoma']",Recurrent Head and Neck Squamous Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06606028,Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma,Tumor-informed ctDNA Testing for Minimal Residual Disease Monitoring Following Curative-intent Treatment of Squamous Cell Carcinoma of the Head and Neck.,RECRUITING,2024-10-09,2028-12-30,2029-12-30,OBSERVATIONAL,,250,"['Squamous Cell Carcinoma of Head and Neck', 'Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)', 'Squamous Cell Carcinoma of Skin', 'Cutaneous Squamous Cell Carcinoma (CSCC)']",Squamous Cell Carcinoma of Head and Neck,"University of California, San Francisco","['Haystack Oncology, Inc.']",['United States']
NCT05976763,Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma,A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy With Zanubrutinib as Upfront Treatment in Older Patients With Mantle Cell Lymphoma,RECRUITING,2023-10-20,2038-08-31,2038-08-31,INTERVENTIONAL,PHASE3,421,['Mantle Cell Lymphoma'],Mantle Cell Lymphoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT06455787,J-Valve Transfemoral Pivotal Study,J-Valve to Treat Aortic Regurgitation Via Transcatheter Therapy,ACTIVE_NOT_RECRUITING,2024-10-17,2027-12,2031-12,INTERVENTIONAL,NA,194,"['Aortic Valve Regurgitation', 'Aortic Valve Disease Mixed']",Aortic Valve Regurgitation,"JC Medical, Inc., an affiliate of Edwards Lifesciences LLC","['Minneapolis Heart Institute Foundation', 'Cardiovascular Research Foundation, New York']",['United States']
NCT04886804,Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene),"Beamion LUNG-1: An Open Label, Phase I Dose Escalation Trial, With Dose Confirmation and Expansion, of Zongertinib (BI 1810631) as Monotherapy in Patients With Advanced or Metastatic Solid Tumors With HER2 Aberrations",RECRUITING,2021-07-02,2026-12-30,2028-08-30,INTERVENTIONAL,PHASE1,554,"['Neoplasm Metastasis', 'Non-Small Cell Lung Cancer']",Neoplasm Metastasis,Boehringer Ingelheim,[],"['Singapore', 'Belgium', 'Israel', 'Japan', 'Hong Kong', 'Netherlands', 'China', 'Austria', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Portugal', 'Sweden', 'Australia']"
NCT05353439,Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer,Phase I Dose Escalation and Expansion Study of Tazemetostat in Combination With Topotecan and Pembrolizumab in Recurrent Small Cell Lung Cancer,RECRUITING,2022-07-27,2027-04-01,2027-04-01,INTERVENTIONAL,PHASE1,60,"['Extensive Stage Lung Small Cell Carcinoma', 'Limited Stage Lung Small Cell Carcinoma', 'Platinum-Resistant Lung Small Cell Carcinoma', 'Platinum-Sensitive Lung Small Cell Carcinoma', 'Recurrent Extensive Stage Lung Small Cell Carcinoma', 'Recurrent Lung Small Cell Carcinoma']",Extensive Stage Lung Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06995677,"Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer","A Phase 2 Multicenter, Open-Label Study Evaluating the Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)",RECRUITING,2025-06-27,2028-02,2028-09,INTERVENTIONAL,PHASE2,90,"['Low-grade NMIBC', 'FGFR Gene Amplification', 'FGFR Gene Alterations', 'FGFR3 Gene Alteration', 'FGFR3 Gene Mutation', 'FGFR3 Gene Fusions']",Low-grade NMIBC,"Tyra Biosciences, Inc",[],"['United States', 'Italy']"
NCT05668741,A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF),"A Phase 1/2 Dose Escalation Study Evaluating the Safety, and Tolerability and Efficacy of VX-522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator Therapy",RECRUITING,2023-02-27,2026-12-23,2027-05-12,INTERVENTIONAL,PHASE1,39,['Cystic Fibrosis'],Cystic Fibrosis,Vertex Pharmaceuticals Incorporated,"['Moderna, Inc']","['Belgium', 'Netherlands', 'United States', 'Spain', 'Italy', 'Canada', 'Australia', 'United Kingdom', 'Sweden', 'Germany']"
NCT05995899,Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation,"An Open-label, Single Center Investigator Sponsored Study Assessing the Effect of Tenapanor on Metagenomic and Metabolomic Markers in Patients With Irritable Bowel Syndrome With Constipation",ACTIVE_NOT_RECRUITING,2024-02-06,2026-01,2026-01,INTERVENTIONAL,PHASE4,30,"['IBS', 'IBS - Irritable Bowel Syndrome']",IBS,"Kyle Staller, MD, MPH",['Ardelyx'],['United States']
NCT05554393,Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial),"A Measurable Residual Disease (MRD) Driven, Phase II Study of Venetoclax Plus Chemotherapy for Newly Diagnosed Younger Patients With Intermediate Risk Acute Myeloid Leukemia: A Tier 1 MYELOMATCH Clinical Trial",RECRUITING,2024-09-13,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,153,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT05934526,Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)",ACTIVE_NOT_RECRUITING,2023-12-28,2025-11-27,2025-12,INTERVENTIONAL,PHASE3,390,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,"GB002, Inc.",[],"['Japan', 'Netherlands', 'Saudi Arabia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Singapore', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Latvia', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT04548752,"Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations",Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients With Germline BRCA1 or BRCA2 Mutations,ACTIVE_NOT_RECRUITING,2021-02-22,2026-10-01,2026-10-01,INTERVENTIONAL,PHASE2,88,"['Metastatic Pancreatic Adenocarcinoma', 'Stage IV Pancreatic Cancer AJCC v8']",Metastatic Pancreatic Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT06906640,Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2),Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 2) (IRIS-CKD),RECRUITING,2025-10-28,2027-04-01,2027-04-01,INTERVENTIONAL,NA,420,"['Chronic Kidney Disease(CKD)', 'Type 2 DM', 'Type 2 Diabetes Mellitus (T2DM)']",Chronic Kidney Disease(CKD),Duke University,"['Bayer', 'Boehringer Ingelheim', 'Eli Lilly and Company']",['United States']
NCT05442216,Tagraxofusp and Azaxitadine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents,Phase II Study of TAGraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Previous Exposure to HypOmethylatiNG Agents,RECRUITING,2024-05-01,2027-08,2027-12,INTERVENTIONAL,PHASE2,53,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,Joshua Zeidner,"['Stemline Therapeutics, Inc.', 'University of North Carolina, Chapel Hill']",['United States']
NCT06632327,Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer,Perioperative Versus Adjuvant Systemic Therapy in Patients With Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG,RECRUITING,2024-12-11,2029-04-30,2030-04-30,INTERVENTIONAL,PHASE3,1100,"['Resectable Lung Non-Small Cell Carcinoma', 'Stage II Lung Cancer AJCC v8', 'Stage IIIA Lung Cancer AJCC v8', 'Stage IIIB Lung Cancer AJCC v8']",Resectable Lung Non-Small Cell Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT07109297,Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India,"A Phase 4, Open-label, Single-arm Clinical Study to Describe Safety and Efficacy Outcomes Associated With the Use of Nirsevimab in Neonates and Infants Born During or Entering Their First Respiratory Syncytial Virus (RSV) Season and in Children up to 24 Months of Age Who Remain Vulnerable to Severe RSV Disease Through Their Second RSV Season",RECRUITING,2025-07-31,2026-11-30,2026-11-30,INTERVENTIONAL,PHASE4,110,['RSV Immunization'],RSV Immunization,Sanofi,[],['India']
NCT07036562,Time-restricted Eating and High-intensity Interval Training for Metabolic Health in Adults With Overweight/Obesity,Time-restricted Eating and High-intensity Interval Training for Long-term Improvement in Metabolic Health,RECRUITING,2025-09-11,2027-07,2027-07,INTERVENTIONAL,NA,100,['Overweight and Obesity'],Overweight and Obesity,Norwegian University of Science and Technology,[],['Norway']
NCT07280546,Analysis of Breath Sounds During Surgery,Analysis of Breath Sounds During Surgery,RECRUITING,2025-09-03,2026-02-28,2026-09-30,OBSERVATIONAL,,30,"['General Anesthesia', 'Intraoperative Monitoring', 'Respiratory Sounds']",General Anesthesia,"Taipei Veterans General Hospital, Taiwan",[],['Taiwan']
NCT07279883,Length of Hospital Stay and Postoperative Analgesic Requirements After Introduction of a Specific Maxillary Nerve Block in Children Undergoing Cleft Palate Surgery,Length of Hospital Stay and Postoperative Analgesic Requirements After Introduction of a Specific Maxillary Nerve Block in Children Undergoing Cleft Palate Surgery: a Before-and-after Chart Review Study,RECRUITING,2017-01-01,2018-12-31,2025-12-31,OBSERVATIONAL,,150,['Cleft Palate Children'],Cleft Palate Children,Karolinska Institutet,[],['Sweden']
NCT06066515,A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight,"A Phase 3, Randomised, Double-blind, Parallel-group, 76-week, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity Without Type 2 Diabetes",ACTIVE_NOT_RECRUITING,2023-11-25,2025-10-28,2026-02-13,INTERVENTIONAL,PHASE3,726,['Obesity'],Obesity,Boehringer Ingelheim,[],"['Belgium', 'Japan', 'New Zealand', 'Netherlands', 'China', 'United States', 'Germany', 'Finland', 'South Korea', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Australia']"
NCT04491942,"Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer",A Phase 1 Trial of the ATR Inhibitor BAY 1895344 in Combination With Cisplatin and With Cisplatin Plus Gemcitabine in Advanced Solid Tumors With an Emphasis on Urothelial Carcinoma,ACTIVE_NOT_RECRUITING,2021-08-25,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,74,"['Advanced Bile Duct Carcinoma', 'Advanced Breast Carcinoma', 'Advanced Cervical Carcinoma', 'Advanced Endometrial Carcinoma', 'Advanced Esophageal Carcinoma', 'Advanced Gastric Carcinoma', 'Advanced Head and Neck Carcinoma', 'Advanced Lung Non-Small Cell Carcinoma', 'Advanced Lung Small Cell Carcinoma', 'Advanced Malignant Solid Neoplasm', 'Advanced Ovarian Carcinoma', 'Advanced Penile Carcinoma', 'Advanced Pleural Malignant Mesothelioma', 'Advanced Urothelial Carcinoma', 'Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Clinical Stage III Gastric Cancer AJCC v8', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Stage III Cervical Cancer AJCC v8', 'Stage III Distal Bile Duct Cancer AJCC v8', 'Stage III Intrahepatic Bile Duct Cancer AJCC v8', 'Stage III Lung Cancer AJCC v8', 'Stage III Ovarian Cancer AJCC v8', 'Stage III Penile Cancer AJCC v8', 'Stage III Pleural Malignant Mesothelioma AJCC v8', 'Stage IV Cervical Cancer AJCC v8', 'Stage IV Distal Bile Duct Cancer AJCC v8', 'Stage IV Intrahepatic Bile Duct Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8', 'Stage IV Ovarian Cancer AJCC v8', 'Stage IV Penile Cancer AJCC v8', 'Stage IV Pleural Malignant Mesothelioma AJCC v8', 'Triple-Negative Breast Carcinoma', 'Unresectable Urothelial Carcinoma']",Advanced Bile Duct Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT04628767,Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer,A Phase II/III Trial of Durvalumab and Chemotherapy for Patients With High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy,RECRUITING,2021-11-12,2027-09-30,2027-09-30,INTERVENTIONAL,PHASE2,249,['Renal Pelvis and Ureter Urothelial Carcinoma'],Renal Pelvis and Ureter Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT04439292,Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H),"MATCH Treatment Subprotocol H: Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF V600E or V600K Mutations (Excluding Melanoma, Thyroid Cancer, Colorectal Adenocarcinoma, and Non-Small Cell Lung Cancer)",ACTIVE_NOT_RECRUITING,2015-08-12,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,35,"['Advanced Lymphoma', 'Advanced Malignant Solid Neoplasm', 'Hematopoietic and Lymphoid Cell Neoplasm', 'Refractory Lymphoma', 'Refractory Malignant Solid Neoplasm', 'Refractory Multiple Myeloma']",Advanced Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT06918132,Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer,Phase II Single Arm Study of Neoadjuvant Dual Checkpoint Blockade With Programmed Death-ligand 1 (PD1) and Lymphocyte Activation Gene 3 (LAG-3) Inhibition in Resectable Non-Small Cell Lung Cancer (N-PLANC),RECRUITING,2025-04-29,2027-04-29,2027-04-29,INTERVENTIONAL,PHASE2,60,"['Lung Non-Small Cell Carcinoma', 'Stage IB Lung Cancer AJCC v8', 'Stage II Lung Cancer AJCC v8', 'Stage III Lung Cancer AJCC v8', 'Stage IIIA Lung Cancer AJCC v8', 'Stage IIIB Lung Cancer AJCC v8']",Lung Non-Small Cell Carcinoma,Mayo Clinic,[],['United States']
NCT07217236,Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG,Evaluation of an Artificial Intelligence-Enhanced Electrocardiogram Strategy Versus Standard Care to Identify Patients Requiring Cardiac Implantable Electronic Devices: A Randomized Controlled Trial,RECRUITING,2025-11-01,2026-10-31,2026-10-31,INTERVENTIONAL,NA,11492,"['Artificial Intelligence (AI)', 'Cardiac Implantable Electrical Devices', 'Conduction Disorder of the Heart']",Artificial Intelligence (AI),"National Defense Medical Center, Taiwan",[],['Taiwan']
NCT06250192,Educational TOolS for Pregnant Women With Diabetes Mellitus,A Randomized Controlled Trial Evaluating the Effect of Virtual Patient-centered Education on Infant Birthweight in Women With Diabetes Mellitus,ACTIVE_NOT_RECRUITING,2023-09-01,2026-06-01,2026-06-01,INTERVENTIONAL,NA,502,"['Diabetes Mellitus', 'Pregnancy Complications']",Diabetes Mellitus,Odense University Hospital,[],['Denmark']
NCT06465316,Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma,A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma,RECRUITING,2024-12-06,2026-09-16,2026-09-16,INTERVENTIONAL,PHASE1,26,"['Recurrent Multiple Myeloma', 'Refractory Multiple Myeloma']",Recurrent Multiple Myeloma,National Cancer Institute (NCI),[],['United States']
NCT06649812,Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma,"A Phase 2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed or Refractory CD10-Negative Diffuse-Large B-Cell Lymphoma (DLBCL) and High-Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements (HGBCL-DH-BCL2)",RECRUITING,2025-10-07,2027-09-01,2027-09-01,INTERVENTIONAL,PHASE2,120,"['High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements', 'Recurrent Diffuse Large B-Cell Lymphoma', 'Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified', 'Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements', 'Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements', 'Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified', 'Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma', 'Refractory Diffuse Large B-Cell Lymphoma', 'Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified', 'Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements', 'Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements', 'Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified', 'Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma']",High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,National Cancer Institute (NCI),[],['United States']
NCT05896839,Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer,A Phase 2 Study of Nivolumab and Ipilimumab in Combination With Sirolimus and Prednisone in Kidney Transplant Recipients With Selected Unresectable or Metastatic Cutaneous Cancers,RECRUITING,2024-07-24,2027-01-31,2027-01-31,INTERVENTIONAL,PHASE1,16,"['Clinical Stage III Cutaneous Melanoma AJCC v8', 'Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8', 'Metastatic Basal Cell Carcinoma', 'Metastatic Carcinoma in the Skin', 'Metastatic Melanoma', 'Metastatic Merkel Cell Carcinoma', 'Metastatic Skin Squamous Cell Carcinoma', 'Unresectable Basal Cell Carcinoma', 'Unresectable Melanoma', 'Unresectable Merkel Cell Carcinoma', 'Unresectable Skin Squamous Cell Carcinoma']",Clinical Stage III Cutaneous Melanoma AJCC v8,National Cancer Institute (NCI),[],['United States']
NCT06145477,Parenting for Tomorrow: A New Model for Supporting Preschool Children's Mental Health in Head Start,Parenting for Tomorrow: A New Model for Supporting Preschool Children's Mental Health in Head Start,RECRUITING,2023-11-15,2028-11,2028-11,OBSERVATIONAL,,160,"['Parenting', 'Parenting Intervention']",Parenting,Johns Hopkins University,"['The Rita and Alex Hillman Foundation', 'Richman Foundation', 'Sherman Family Foundation', 'Blanket Fort Foundation', 'Wright Family Foundation', 'Abell Foundation', 'Baltimore Community Foundation']",['United States']
NCT04032470,Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET),Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET):ET Registry,RECRUITING,2019-10-23,2028-12,2028-12,OBSERVATIONAL,,500,['Essential Tremor'],Essential Tremor,Boston Scientific Corporation,[],"['Belgium', 'Hungary', 'Austria', 'Spain', 'Italy', 'Canada', 'South Korea', 'Portugal', 'Germany']"
NCT07227883,Secretome Treatment for Facial Rejuvenation,"Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for Facial Rejuvenation",RECRUITING,2025-12-05,2026-12-20,2026-12-20,INTERVENTIONAL,EARLY_PHASE1,24,"['Facial Aging', 'Rejuvenation', 'Stem Cell', 'Stem Cell Banking']",Facial Aging,Acorn Biolabs Inc.,[],['United States']
NCT06568237,A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study,"A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients With Multiple System Atrophy",RECRUITING,2024-10-02,2027-05-20,2027-06-17,INTERVENTIONAL,PHASE2,200,['Multiple System Atrophy'],Multiple System Atrophy,"Teva Branded Pharmaceutical Products R&D, Inc.",[],"['Israel', 'Japan', 'United States', 'France', 'Spain', 'Italy', 'Germany']"
NCT05851430,Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry,Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry,RECRUITING,2025-06-23,2028-06-30,2028-12-31,OBSERVATIONAL,,1000,['Soft Tissue Lesion'],Soft Tissue Lesion,"Galvanize Therapeutics, Inc.",[],['United States']
NCT05647265,Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma,Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma,RECRUITING,2024-11-27,2026-12-15,2026-12-15,INTERVENTIONAL,PHASE2,26,"['Pleural Biphasic Mesothelioma', 'Pleural Sarcomatoid Mesothelioma']",Pleural Biphasic Mesothelioma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT03808467,Cognitive Training for Patients With Eating Disorders,Transdiagnostic Cognitive Remediation Therapy for Patients With Eating Disorders: a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2019-03-01,2024-06-22,2026-07,INTERVENTIONAL,NA,100,"['Feeding and Eating Disorders', 'Anorexia Nervosa', 'Bulimia Nervosa', 'Binge-Eating Disorder']",Feeding and Eating Disorders,Norwegian University of Science and Technology,"['St. Olavs Hospital', 'Helse Nord-Trøndelag HF']",['Norway']
NCT07239232,"""Knee Joint Position Sense and Dynamic Balance in Females With Primary Dysmenorrhea",Assessment Of Knee Joint Position Sense And Dynamic Balance IN Female With Primary Dysmenorrhea,RECRUITING,2025-11-18,2026-01-20,2026-01-30,OBSERVATIONAL,,62,['Primary Dysmenorrhea'],Primary Dysmenorrhea,Cairo University,[],['Egypt']
NCT06765109,Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC,A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR),RECRUITING,2025-07-17,2029-12,2029-12,INTERVENTIONAL,PHASE3,450,"['Non-small Cell Lung Cancer', 'Anaplastic Lymphoma Kinase-positive']",Non-small Cell Lung Cancer,Nuvalent Inc.,[],"['Japan', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Malaysia', 'United Kingdom', 'Greece', 'Germany', 'United States', 'Italy', 'Argentina']"
NCT06980038,Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer,A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery,RECRUITING,2026-08-21,2027-11-24,2027-11-24,INTERVENTIONAL,PHASE2,44,"['Head and Neck Cutaneous Squamous Cell Carcinoma', 'Head and Neck Squamous Cell Carcinoma', 'Hypopharyngeal Squamous Cell Carcinoma', 'Laryngeal Squamous Cell Carcinoma', 'Nasal Cavity Squamous Cell Carcinoma', 'Oral Cavity Squamous Cell Carcinoma', 'Oropharyngeal Squamous Cell Carcinoma', 'Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma', 'Recurrent Head and Neck Squamous Cell Carcinoma', 'Recurrent Hypopharyngeal Squamous Cell Carcinoma', 'Recurrent Laryngeal Squamous Cell Carcinoma', 'Recurrent Nasal Cavity Squamous Cell Carcinoma', 'Recurrent Oral Cavity Squamous Cell Carcinoma', 'Recurrent Oropharyngeal Squamous Cell Carcinoma', 'Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8', 'Stage III Laryngeal Cancer AJCC v8', 'Stage III Lip and Oral Cavity Cancer AJCC v8', 'Stage III Nasopharyngeal Carcinoma AJCC v8', 'Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8', 'Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8', 'Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8', 'Stage IVA Laryngeal Cancer AJCC v8', 'Stage IVA Lip and Oral Cavity Cancer AJCC v8', 'Stage IVA Nasopharyngeal Carcinoma AJCC v8', 'Stage IVB Laryngeal Cancer AJCC v8', 'Stage IVB Lip and Oral Cavity Cancer AJCC v8']",Head and Neck Cutaneous Squamous Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06667999,The Intensive Care Platform Trial,The Intensive Care Platform Trial (INCEPT),RECRUITING,2025-06-26,2035-12,2035-12,INTERVENTIONAL,PHASE4,10000,"['Intensive Care Patients', 'Intensive Care Unit Patients', 'Critical Illness']",Intensive Care Patients,Anders Perner,"['Rigshospitalet, Denmark', 'Bispebjerg Hospital', 'Herlev Hospital', 'Hillerod Hospital, Denmark', 'Kolding Sygehus', 'Zealand University Hospital', 'Slagelse Hospital', 'Viborg Regional Hospital', 'Aalborg University Hospital', 'Aarhus University Hospital', 'Gødstrup Hospital', 'Copenhagen University Hospital, Hvidovre', 'Odense University Hospital', 'Randers Regional Hospital', 'Section of Biostatistics University of Copenhagen, Copenhagen', 'North Denmark Region', 'Region Capital Denmark', 'Region Zealand', 'University Medical Center Groningen', 'Steno Diabetes Center Copenhagen', 'Karolinska Institutet', 'Oslo University Hospital', 'University Hospital, Basel, Switzerland', 'Tampere University', 'Collaboration of Research in Intensive Care', 'Danish Intensive Care Database', 'The National University Hospital of Iceland']",['Denmark']
NCT06160791,Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH),"Frontline Ruxolitinib With De-Intensified HLH-94 for Adult Hemophagocytic Lymphohistiocytosis (HLH): A Multicenter, Single-Arm Phase 2 Study",RECRUITING,2024-10-01,2027-12-31,2029-11-30,INTERVENTIONAL,PHASE2,36,['Hemophagocytic Lymphohistiocytoses'],Hemophagocytic Lymphohistiocytoses,"Jerry Lee, MD, MSc, MPhil","['Incyte Corporation', 'UC Hematological Malignancies Consortium (UCHMC)']",['United States']
NCT06932562,A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant,"A Randomized, Open-Label, Controlled Phase 3 Study of Comparing Daratumumab, Lenalidomide and Dexamethasone Induction Followed by Linvoseltamab Versus Continued Daratumumab, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients",RECRUITING,2025-12,2036-12,2036-12,INTERVENTIONAL,PHASE3,1000,['Multiple Myeloma'],Multiple Myeloma,European Myeloma Network B.V.,['Regeneron Pharmaceuticals'],"['Turkey (Türkiye)', 'Netherlands', 'Estonia', 'Norway', 'Austria', 'Germany', 'Finland', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Czechia', 'Portugal', 'Australia']"
NCT07245368,Study of PRA-216 in Healthy Participants and Participants With Mild-to-Moderate Asthma,"A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single Ascending and Multiple Ascending Dose Study Investigating PRA-216 in Healthy Volunteers Followed by a Phase 2a Randomized, Double-Blind, Placebo-Controlled Study in Participants With Mild-to-Moderate Asthma",RECRUITING,2025-11-04,2026-10-01,2027-01-31,INTERVENTIONAL,PHASE1,96,['Mild to Moderate Asthma'],Mild to Moderate Asthma,Prana Therapies Inc,[],['Australia']
NCT07013760,Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain,Observational Retrospective Study to Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain,RECRUITING,2025-06-23,2025-12-31,2025-12-31,OBSERVATIONAL,,400,['Asthma'],Asthma,AstraZeneca,[],['Spain']
NCT06744647,Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation,"A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation",RECRUITING,2025-03-07,2027-10-11,2028-11-07,INTERVENTIONAL,PHASE2,45,"['Antibody-Mediated Rejection', 'Kidney Transplantation', 'Biopsy-proven Histologic Scores', 'AMR']",Antibody-Mediated Rejection,"Alexion Pharmaceuticals, Inc.",[],"['Brazil', 'China', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom']"
NCT04519619,Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG),Drug Use Investigation for Eylea for Neovascular Glaucoma (NVG),RECRUITING,2020-11-27,2027-06-30,2028-06-30,OBSERVATIONAL,,480,['Neovascular Glaucoma'],Neovascular Glaucoma,Bayer,[],['Japan']
NCT04314401,"National Cancer Institute ""Cancer Moonshot Biobank""",Cancer Moonshot Biobank Research Protocol,RECRUITING,2020-11-11,2027-04-30,2027-04-30,OBSERVATIONAL,,1600,"['Acute Myeloid Leukemia', 'Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Clinical Stage IV Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Esophageal Carcinoma', 'Fallopian Tube Carcinoma', 'Gastric Carcinoma', 'Hormone Receptor-Positive Breast Carcinoma', 'Invasive Breast Carcinoma', 'Lung Non-Small Cell Carcinoma', 'Lung Small Cell Carcinoma', 'Malignant Solid Neoplasm', 'Melanoma', 'Metastatic Prostate Carcinoma', 'Multiple Myeloma', 'Ovarian Carcinoma', 'Ovarian High Grade Serous Adenocarcinoma', 'Primary Peritoneal Carcinoma', 'Stage III Fallopian Tube Cancer AJCC v8', 'Stage III Lung Cancer AJCC v8', 'Stage III Ovarian Cancer AJCC v8', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IV Fallopian Tube Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8', 'Stage IV Ovarian Cancer AJCC v8', 'Stage IVB Prostate Cancer AJCC v8', 'Triple-Negative Breast Carcinoma']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT05536609,Cast Or ePineural Suture for Digital Nerve Injuries - a Randomised Controlled Study,Cast Or ePineural Suture for Digital Nerve Injuries - a Randomised Controlled Study,RECRUITING,2022-08-29,2030-12-31,2031-12-31,INTERVENTIONAL,NA,166,['Digital Nerve Injury'],Digital Nerve Injury,Karolinska Institutet,[],['Sweden']
NCT03640624,Multidisciplinary Treatment of Chronic Vulvar Pain,Multidisciplinary Treatment of Chronic Vulvar Pain - a Randomized Controlled Study,ACTIVE_NOT_RECRUITING,2018-09-18,2024-11-10,2027-06,INTERVENTIONAL,NA,106,"['Vulvodynia', 'Chronic Pain']",Vulvodynia,Norwegian University of Science and Technology,['St. Olavs Hospital'],['Norway']
NCT06862869,Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy,"Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy in China: A Multicenter, Prospective Cohort Study",RECRUITING,2025-04-30,2029-06-30,2029-12-31,OBSERVATIONAL,,800,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Hoffmann-La Roche,[],['China']
NCT07278986,CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer,Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Imaging of Patients With Endometrial Cancer Planned for Surgery,RECRUITING,2025-10-18,2027-10,2029-02,INTERVENTIONAL,EARLY_PHASE1,10,"['Endometrial Cancer', 'Near Infrared Fluorescence Imaging', 'CYTALUX (Pafolacianine) Injection', 'Planned Diagnostic Laparoscopies']",Endometrial Cancer,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT03237780,Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer,"A Randomized, Phase 2 Trial to Evaluate the Safety and Efficacy of Eribulin Mesylate in Combination With Atezolizumab Compared to Atezolizumab Alone in Subjects With Locally Advanced or Metastatic Transitional Cell Urothelial Cancer Where Cisplatin-Based Treatment is Not an Option",ACTIVE_NOT_RECRUITING,2018-07-20,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE2,72,"['Locally Advanced Bladder Urothelial Carcinoma', 'Locally Advanced Renal Pelvis Urothelial Carcinoma', 'Locally Advanced Ureter Urothelial Carcinoma', 'Locally Advanced Urethral Urothelial Carcinoma', 'Metastatic Bladder Urothelial Carcinoma', 'Metastatic Renal Pelvis Urothelial Carcinoma', 'Metastatic Ureter Urothelial Carcinoma', 'Metastatic Urethral Urothelial Carcinoma', 'Recurrent Bladder Urothelial Carcinoma', 'Recurrent Renal Pelvis Urothelial Carcinoma', 'Recurrent Ureter Urothelial Carcinoma', 'Recurrent Urethral Urothelial Carcinoma', 'Stage III Bladder Cancer AJCC v8', 'Stage III Renal Pelvis Cancer AJCC v8', 'Stage III Ureter Cancer AJCC v8', 'Stage III Urethral Cancer AJCC v8', 'Stage IV Bladder Cancer AJCC v8', 'Stage IV Renal Pelvis Cancer AJCC v8', 'Stage IV Ureter Cancer AJCC v8', 'Stage IV Urethral Cancer AJCC v8', 'Unresectable Bladder Urothelial Carcinoma', 'Unresectable Renal Pelvis Urothelial Carcinoma', 'Unresectable Ureter Urothelial Carcinoma', 'Unresectable Urethral Urothelial Carcinoma']",Locally Advanced Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05664178,Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology,Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology (Remote REPS - GI),RECRUITING,2023-02-20,2026-08-22,2026-08-22,INTERVENTIONAL,PHASE1,100,['Gastrointestinal Cancer'],Gastrointestinal Cancer,H. Lee Moffitt Cancer Center and Research Institute,['National Cancer Institute (NCI)'],['United States']
NCT07217379,The DART DELIVER-02 Study,"IGHID 12430 - Deliver-02 - A Phase 1, Open Label, Randomized Study To Evaluate The Safety And Tolerability Of MGD014 And MGD020 With A Latency Reversal Agent Versus Temporary Treatment Interruption In Persons With HIV-1 On Antiretroviral Therapy",RECRUITING,2025-10-02,2026-12,2027-02,INTERVENTIONAL,PHASE1,24,['HIV (Human Immunodeficiency Virus)'],HIV (Human Immunodeficiency Virus),"University of North Carolina, Chapel Hill","['Henry M. Jackson Foundation for the Advancement of Military Medicine', 'US Military HIV Research Program', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'United States Department of Defense']","['Kenya', 'United States']"
NCT07279701,The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access,The Effect of Near-infrared Spectroscopy on the Success of Peripheral Venous Access: a Pilot Randomized Controlled Study,RECRUITING,2025-12-01,2026-12-31,2026-12-31,INTERVENTIONAL,NA,200,['Intravenous Cannulation'],Intravenous Cannulation,Brno University Hospital,[],['Czechia']
NCT06597006,"Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia","Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Children (2 to Less Than 12 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol",RECRUITING,2025-02-28,2028-03-23,2029-04-15,INTERVENTIONAL,PHASE3,9,['Familial Hypercholesterolemia - Homozygous'],Familial Hypercholesterolemia - Homozygous,Novartis Pharmaceuticals,[],"['South Africa', 'Turkey (Türkiye)', 'Netherlands', 'China', 'Austria', 'United States', 'Taiwan', 'Malaysia', 'United Kingdom', 'Greece', 'Germany']"
NCT02159755,Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma,A Phase I Trial of Ibrutinib Plus PD 0332991 (Palbociclib) in Patients With Previously Treated Mantle Cell Lymphoma,ACTIVE_NOT_RECRUITING,2014-08-13,2018-06-25,2026-12-01,INTERVENTIONAL,PHASE1,28,['Recurrent Mantle Cell Lymphoma'],Recurrent Mantle Cell Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT06498635,"Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial",Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in The AdjuvanT Setting (INSIGHT),RECRUITING,2025-04-01,2039-07-15,2039-07-15,INTERVENTIONAL,PHASE3,306,"['Lung Non-Small Cell Carcinoma', 'Stage II Lung Cancer AJCC v8', 'Stage IIIA Lung Cancer AJCC v8', 'Stage IIIB Lung Cancer AJCC v8']",Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06075147,The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema,An Observational Study Program to Investigate the Effectiveness of Aflibercept 8 mg Used in DME and nAMD in a Real-world Setting,ACTIVE_NOT_RECRUITING,2024-02-15,2027-10-30,2028-01-31,OBSERVATIONAL,,2500,"['Visual Impairment', 'Neovascular Age-related Macular Degeneration (nAMD)', 'Diabetic Macula Edema (DME)']",Visual Impairment,Bayer,[],"['Japan', 'United Kingdom', 'Netherlands', 'Norway', 'Saudi Arabia', 'France', 'Germany', 'Finland', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Arab Emirates', 'Portugal', 'Sweden', 'Australia']"
NCT06283212,"A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome","EXPEDITION: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome",ACTIVE_NOT_RECRUITING,2024-05-09,2030-10,2030-10,INTERVENTIONAL,PHASE1,5,['Dravet Syndrome'],Dravet Syndrome,Encoded Therapeutics,[],['United Kingdom']
NCT06179329,One-year Patency Comparison Between Radial Artery and No-touch Saphenous Vein Grafts in Women Undergoing Isolated CABG,No-Touch Saphenous Venous Harvesting TechniQue versUs Radial artEry in Coronary Artery Bypass Grafting in womEN: The QUEEN Multicenter Randomized Controlled Trial,RECRUITING,2024-01-01,2025-01-01,2027-12-30,INTERVENTIONAL,NA,150,"['Cardiac Disease', 'Surgery-Complications', 'Graft Failure']",Cardiac Disease,University of Sao Paulo General Hospital,"['Instituto Nacional de Cardiologia', 'Hospital Unimed João Pessoa', 'Hospital do Coração Alagoano Prof. Adib Jatene', 'Hospital Hernan Henriquez Aravena', 'Hospital Norte Paranaense']",['Brazil']
NCT06837324,Effect of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder,A Multicenter Confirmation Clinical Trial of Untact Upper Extremity Rehabilitation Using Smart Glove for Late Subacute and Chronic Patients With Brain Disorder - a Randomized Single-blinded Controlled Trial,RECRUITING,2025-04-11,2025-12-31,2025-12-31,INTERVENTIONAL,NA,40,"['Brain Disorder', 'Home Based Rehabilitation']",Brain Disorder,Samsung Medical Center,['Korea Health Industry Development Institute'],['South Korea']
NCT07178990,Mobile Platform for Optimizing Wellness and Engagement in Recovery,Mobile Platform for Optimizing Wellness and Engagement in Recovery,RECRUITING,2025-12-08,2027-07-01,2027-07-31,INTERVENTIONAL,NA,50,"['Opioid Agonist Treatment', 'Alcohol Use Disorder', 'Opioid Use Disorder']",Opioid Agonist Treatment,University of Michigan,"['National Institute on Alcohol Abuse and Alcoholism (NIAAA)', 'DynamiCare Health']",['United States']
NCT07185113,A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects,"A Phase 1, Single Dose, Open-label Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects",RECRUITING,2025-10-29,2025-12,2025-12,INTERVENTIONAL,PHASE1,6,['Healthy Adult Male'],Healthy Adult Male,GEn1E Lifesciences,"['InClin, Inc.']",['New Zealand']
NCT07220642,Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide,Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity,RECRUITING,2025-11-05,2027-05-26,2027-07-14,INTERVENTIONAL,PHASE3,300,"['Obesity', 'Overweight']",Obesity,Novo Nordisk A/S,[],"['Norway', 'United States', 'France', 'Germany', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT07256119,Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients,Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients,RECRUITING,2024-08-06,2025-12-28,2025-12-28,INTERVENTIONAL,NA,40,['Prevention'],Prevention,Ain Shams University,[],['Egypt']
NCT03786081,Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer,A Phase 1b/2 Open-Label Trial of Tisotumab Vedotin (HuMax®-TF-ADC) Monotherapy and in Combination With Other Agents in Subjects With Recurrent or Stage IVB Cervical Cancer,ACTIVE_NOT_RECRUITING,2019-02-27,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE1,214,['Cervical Cancer'],Cervical Cancer,"Seagen, a wholly owned subsidiary of Pfizer","['Genmab', 'European Network of Gynaecological Oncological Trial Groups (ENGOT)', 'Belgian Gynaecological Oncology Group', 'GOG Foundation', 'Merck Sharp & Dohme LLC']","['Belgium', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Czechia', 'United Kingdom']"
NCT07011667,A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term,Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c. (CagriSema s.c.) Once Weekly for Weight Management and Long-term Weight Maintenance in Participants With Obesity,ACTIVE_NOT_RECRUITING,2025-06-03,2027-03-01,2028-10-17,INTERVENTIONAL,PHASE3,609,['Obesity'],Obesity,Novo Nordisk A/S,[],['United States']
NCT06477172,Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures,"A Multi-site, Prospective, Observational Study of Autologous Hair Follicle Secretome (aHFS) as an Adjunct to Medical Aesthetic Procedures",RECRUITING,2024-09-09,2026-02,2026-08,OBSERVATIONAL,,500,['Post Procedural Erythema'],Post Procedural Erythema,Acorn Biolabs Inc.,[],"['United States', 'Canada']"
NCT06709404,Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers,Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy,RECRUITING,2025-01-31,2026-12,2026-12,INTERVENTIONAL,NA,50,"['Hematopoietic and Lymphatic System Neoplasm', 'Malignant Solid Neoplasm']",Hematopoietic and Lymphatic System Neoplasm,Wake Forest University Health Sciences,['National Cancer Institute (NCI)'],['United States']
NCT07213804,A Two-Part Phase 3 Study of LY4170156 in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer,"FRAmework-01: A Two-Part Phase 3 Study of LY4170156 Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and LY4170156 Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.",RECRUITING,2025-10-22,2028-04,2031-08,INTERVENTIONAL,PHASE3,1080,"['Ovarian Neoplasms', 'Fallopian Tube Neoplasms', 'Peritoneal Neoplasms', 'Neoplasm Metastasis']",Ovarian Neoplasms,Eli Lilly and Company,"['GOG Foundation', 'European Network of Gynaecological Oncological Trial Groups (ENGOT)', 'Asia-Pacific Gynecologic Oncology Trials Group (APGOT)']","['Brazil', 'Belgium', 'Japan', 'China', 'Austria', 'United States', 'France', 'Mexico', 'Switzerland', 'Italy', 'Canada', 'Czechia', 'Romania', 'South Korea', 'Poland', 'Australia']"
NCT07280403,Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss: a Pilot Trial.,Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss: a Pilot Trial.,ACTIVE_NOT_RECRUITING,2024-09-12,2025-12-15,2025-12-20,INTERVENTIONAL,NA,60,['Weight Loss'],Weight Loss,INQUIS Clinical Research,"['Simply Good Foods USA, Ltd.']",['Canada']
NCT06446739,LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM),LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM): A Pilot Randomized Trial,RECRUITING,2024-11-14,2026-04,2026-07,INTERVENTIONAL,NA,100,"['Acute Kidney Injury', 'Dialysis; Complications']",Acute Kidney Injury,University of Alberta,[],['Canada']
NCT06065384,Neural Plasticity and Motor Recovery After Upper Extremity Motor Training in People With c-SCI,Central and Peripheral Neuroplasticity in Cervical Spinal Cord Injury Following Intensive Upper Limb Motor Training,RECRUITING,2024-10-09,2027-03-28,2027-08-28,INTERVENTIONAL,NA,44,['Spinal Cord Injuries'],Spinal Cord Injuries,Annemie Spooren,"['Research Foundation Flanders', 'University of Aarhus', 'University of Sydney', 'University Hospital, Ghent', 'Universitaire Ziekenhuizen KU Leuven', 'Adelante, Centre of Expertise in Rehabilitation and Audiology', 'Rehabilitation Hospital RevArte']","['Belgium', 'Netherlands']"
NCT07279610,N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy,N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy,ACTIVE_NOT_RECRUITING,2024-05-01,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,44,['Thrombotic Microangiopathy'],Thrombotic Microangiopathy,The First Affiliated Hospital of Soochow University,[],['China']
NCT03347838,Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers,PD-1 Immune Checkpoint Inhibition for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers With or Without a History of Lung Cancer,ACTIVE_NOT_RECRUITING,2019-01-30,2025-06-18,2026-12-31,INTERVENTIONAL,PHASE2,19,"['Bronchial Dysplasia', 'Tobacco Smoking', 'History of Non-Small Cell Lung Cancer', 'History of Head and Neck Cancer']",Bronchial Dysplasia,"University of Colorado, Denver",['Bristol-Myers Squibb'],['United States']
NCT07280260,Clinical Performance of Nobel N1 System,Effects of Early Loading Protocol on the Survival of the Nobel N1 Implant System: A Pilot Randomized Controlled Trial,RECRUITING,2025-12-15,2027-12-31,2028-01-30,INTERVENTIONAL,PHASE4,50,"['Tooth Loss', 'Dental Implant']",Tooth Loss,Louisiana State University Health Sciences Center in New Orleans,['Envista (Nobel Biocare)'],['United States']
NCT06023459,Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR),Randomized Controlled Pilot Trial of Extended-released Buprenorphine vs. Sublingual Buprenorphine-naloxone in Rural Settings,ACTIVE_NOT_RECRUITING,2024-10-14,2025-10-31,2026-02-28,INTERVENTIONAL,PHASE3,144,"['Opioid-Related Disorders', 'Substance-Related Disorders', 'Narcotic-Related Disorders']",Opioid-Related Disorders,Yih-Ing Hser,"['National Institute on Drug Abuse (NIDA)', 'National Institutes of Health (NIH)', 'The Emmes Company, LLC', 'University of California, Los Angeles', 'RAND', 'Cornell University', 'Oregon Health and Science University', 'University of Illinois at Chicago', 'University of Washington', 'West Virginia University']",['United States']
NCT06317662,Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia,A Phase 2 Study of Blinatumomab in Combination With Chemotherapy for Infants With Newly Diagnosed Acute Lymphoblastic Leukemia With Randomization of KMT2A-Rearranged Patients to Addition of Venetoclax,RECRUITING,2025-06-05,2028-12-31,2028-12-31,INTERVENTIONAL,PHASE2,153,"['Acute Leukemia of Ambiguous Lineage', 'B Acute Lymphoblastic Leukemia']",Acute Leukemia of Ambiguous Lineage,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT07265453,A Family-centred Approach Enhancing Cardiovascular Health in Ugandan Adolescents and Their Families,A Family Centred Approach to Enhance Lifestyle Change and Behavioural Modification for Prevention of Cardiovascular Diseases Among Adolescents and Their Families in Uganda,RECRUITING,2025-07-05,2027-01,2028-01,INTERVENTIONAL,NA,1280,"['Adolescent Behavior', 'Lifestyle Modification', 'Cardiovascular Disease Other']",Adolescent Behavior,MRC/UVRI and LSHTM Uganda Research Unit,"['University of California', 'The AIDS Support Organization', 'University of British Columbia']",['Uganda']
NCT07280455,Effectiveness of Gold Fixed Retainers Compared to Conventional Stainless Steel Retainers,The Effectiveness of Gold Fixed Retainers Compared to Conventional Stainless Steel Retainers: A Randomized Clinical Trial,RECRUITING,2025-11-01,2026-10,2026-12,INTERVENTIONAL,NA,40,"['Orthodontic Retention Appliance', 'Orthodontic Relapse']",Orthodontic Retention Appliance,Noor Sattar Raheem,[],['Iraq']
NCT00950118,"Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science","Diaphragmatic Hernia Research & Exploration, Advancing Molecular Science",RECRUITING,2005-06,2026-09,2026-09,OBSERVATIONAL,,3000,['Congenital Diaphragmatic Hernia'],Congenital Diaphragmatic Hernia,Columbia University,"['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'National Institutes of Health (NIH)']","['Egypt', 'United States']"
NCT04394858,"Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer","A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma",ACTIVE_NOT_RECRUITING,2021-03-17,2026-02-28,2026-02-28,INTERVENTIONAL,PHASE2,46,"['Advanced Adrenal Gland Pheochromocytoma', 'Advanced Paraganglioma', 'Metastatic Adrenal Gland Pheochromocytoma', 'Metastatic Paraganglioma', 'Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8', 'Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8', 'Unresectable Adrenal Gland Pheochromocytoma', 'Unresectable Paraganglioma']",Advanced Adrenal Gland Pheochromocytoma,National Cancer Institute (NCI),[],['United States']
NCT06107413,"Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab","A Phase 2, Randomized Study to Evaluate Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination With Fluorouracil, Folinic Acid, and Bevacizumab and to Evaluate Safety and Efficacy of ABBV-400 in Combination With Bevacizumab in Previously Treated Subjects With Unresectable Metastatic Colorectal Cancer",ACTIVE_NOT_RECRUITING,2023-11-12,2026-12,2026-12,INTERVENTIONAL,PHASE2,280,['Unresectable Metastatic Colorectal Cancer'],Unresectable Metastatic Colorectal Cancer,AbbVie,[],"['Belgium', 'Japan', 'Israel', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Germany']"
NCT06769048,A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy,"JADE: Phase II Trial in Patients With Geographic Atrophy: A Randomized, Double-masked, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of BI 1584862",RECRUITING,2025-01-31,2027-02-15,2027-02-26,INTERVENTIONAL,PHASE2,138,['Geographic Atrophy'],Geographic Atrophy,Boehringer Ingelheim,[],"['Puerto Rico', 'United States']"
NCT06252649,"Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation","Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)",RECRUITING,2024-07-17,2028-01-31,2031-08-31,INTERVENTIONAL,PHASE3,450,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,Amgen,[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'Hungary', 'Estonia', 'France', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05051735,PARASTOP - Paracetamol With Strong Opioids,"PARASTOP - Paracetamol With Strong Opioids. A Randomized, Double-blind, Parallel-group Non-inferiority Phase III Withdrawal Trial of Paracetamol Versus Placebo in Conjunction With Opioids for Moderate to Severe Cancer-related Pain",RECRUITING,2021-10-20,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE3,204,"['Cancer Pain', 'Cancer']",Cancer Pain,Oslo University Hospital,['Sykehuset Telemark'],"['Uganda', 'United Kingdom', 'Italy', 'Norway']"
NCT06855836,Motivational Interviewing to Increase Uptake of Drug Checking and Safe Drug Use Behaviors to Reduce Overdose,Efficacy and Implementation Considerations for a Peer-led Motivational Interviewing Intervention to Promote Uptake of Drug Checking Services and Safe Drug Use Behaviors to Reduce Overdose,ACTIVE_NOT_RECRUITING,2025-03-03,2029-02,2029-05,INTERVENTIONAL,NA,588,['Overdose'],Overdose,"University of California, San Diego",['Harm Reduction Coalition of San Diego (HRCSD)'],['United States']
NCT05746273,Depressed Mood Improvement Through Nicotine Dosing 3,Nicotinic Modulation of the Cognitive Control System in Late-Life Depression (R33 Phase),RECRUITING,2023-04-15,2026-07-31,2026-09-30,INTERVENTIONAL,PHASE2,60,['Depressive Disorder'],Depressive Disorder,Vanderbilt University Medical Center,['National Institute of Mental Health (NIMH)'],['United States']
NCT06238622,A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast,An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON),RECRUITING,2024-05-06,2027-04-28,2027-05-05,INTERVENTIONAL,PHASE3,1700,"['Idiopathic Pulmonary Fibrosis', 'Progressive Pulmonary Fibrosis']",Idiopathic Pulmonary Fibrosis,Boehringer Ingelheim,[],"['Japan', 'New Zealand', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'Slovenia', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT04643041,Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer,"Watch and Wait in Patients With dMMR/MSI-H Distal Rectal Cancer Accessed Pathological Complete Response After PD-1 Monoclonal Antibody Therapy-an Open Label, Multicenter, Prospective Study (BASKET)",RECRUITING,2021-01-01,2025-12-31,2026-12-31,INTERVENTIONAL,NA,47,['Rectal Cancer'],Rectal Cancer,"Sixth Affiliated Hospital, Sun Yat-sen University",[],['China']
NCT07243522,The Effect of Birth Positions on Labor,"The Effect of Birth Positions on Pelvic Floor Muscle Strength, Severity, and Quality of Perineal Pain in Primiparous Pregnant Women: A Randomized Controlled Trial",RECRUITING,2025-10-07,2025-12-31,2026-10-07,INTERVENTIONAL,NA,70,"['Primipara Pregnant', 'Primipara Labour']",Primipara Pregnant,Ege University,[],['Turkey (Türkiye)']
NCT06524544,A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer,A Phase III Randomized Trial of Pembrolizumab in Combination With Sacituzumab Govitecan vs Standard of Care in Anti-PD(L)1-Resistant Advanced Urothelial Cancer,RECRUITING,2025-12-02,2028-12-31,2028-12-31,INTERVENTIONAL,PHASE3,320,"['Locally Advanced Urothelial Carcinoma', 'Metastatic Urothelial Carcinoma', 'Unresectable Urothelial Carcinoma']",Locally Advanced Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT07280611,The Hering-Breuer Reflex in Bilateral Lung Transplant Patients,The Hering-Breuer Reflex in Bilateral Lung Transplant Patients,RECRUITING,2025-10-07,2026-01,2026-06,INTERVENTIONAL,NA,22,['Hering-Breuer Reflex'],Hering-Breuer Reflex,Policlinico Hospital,[],['Italy']
NCT07280806,Biopsychosocial Model-based Care Versus Routine Physical Therapy in Chronic Back Pain,Biopsychosocial Model-based Care Versus Routine Physical Therapy in Chronic Back Pain,RECRUITING,2025-11-04,2026-05-15,2026-06-15,INTERVENTIONAL,NA,80,['Chronic Low-back Pain (cLBP)'],Chronic Low-back Pain (cLBP),Lahore University of Biological and Applied Sciences,[],['Pakistan']
NCT04778371,The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults,"The Effects of Almond Consumption on Functional Performance, Aerobic Capacity, and Physical Activity in Overweight Active Older Adults",ACTIVE_NOT_RECRUITING,2021-03-02,2025-09-01,2026-05-01,INTERVENTIONAL,NA,50,['Overweight'],Overweight,Florida State University,['Almond Board of California'],['United States']
NCT05829733,6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis,6-month Evaluation of the Efficacy and Safety of Synolis VA 80/160 in the Treatment of Symptomatic Hip Osteoarthritis,RECRUITING,2024-05-27,2027-04,2027-04,INTERVENTIONAL,NA,70,"['Osteoarthritis, Hip']","Osteoarthritis, Hip",Aptissen SA,[],['France']
NCT04226716,"The Role of Proprioceptive Deficits, Psychosocial Factors and Inflammation in Pregnancy-related Pelvic Girdle Pain","The Role of Lumbar Proprioceptive Deficits, Psychosocial Factors and Inflammation in Pregnancy-related Pelvic Girdle Pain: a Follow-up Study in Multiparous Pregnant Women",RECRUITING,2020-06-01,2027-09-30,2028-09-30,INTERVENTIONAL,NA,192,"['Pelvic Girdle Pain', 'Low Back Pain']",Pelvic Girdle Pain,Hasselt University,['Ziekenhuis Oost-Limburg'],['Belgium']
NCT07116551,"Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis","Abbott BE TAVI Early Feasibility Study: Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis",RECRUITING,2025-10-30,2031-06,2031-06,INTERVENTIONAL,NA,20,['Symptomatic Severe Aortic Stenosis'],Symptomatic Severe Aortic Stenosis,Abbott Medical Devices,[],['United States']
NCT07280364,Metabolomics in the Diagnosis and Treatment of Asthma in Children,Metabolomics in the Diagnosis and Treatment of Asthma in Children,RECRUITING,2024-03-13,2026-06,2026-08,OBSERVATIONAL,,100,['Asthma'],Asthma,I.M. Sechenov First Moscow State Medical University,[],['Russia']
NCT07161258,"A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)","An Open-label, Single-arm Study to Evaluate Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis",RECRUITING,2025-10-06,2027-06-08,2029-02-13,INTERVENTIONAL,PHASE2,12,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,Hoffmann-La Roche,[],"['Brazil', 'Mexico', 'Spain', 'Ukraine', 'Poland', 'Portugal', 'Argentina']"
NCT06589804,"Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment",Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease,RECRUITING,2025-03-27,2029-11-30,2029-11-30,INTERVENTIONAL,PHASE3,158,"['Metastatic Head and Neck Squamous Cell Carcinoma', 'Metastatic Hypopharyngeal Squamous Cell Carcinoma', 'Metastatic Laryngeal Squamous Cell Carcinoma', 'Metastatic Oral Cavity Squamous Cell Carcinoma', 'Metastatic Oropharyngeal Squamous Cell Carcinoma', 'Recurrent Head and Neck Squamous Cell Carcinoma', 'Recurrent Hypopharyngeal Squamous Cell Carcinoma', 'Recurrent Laryngeal Squamous Cell Carcinoma', 'Recurrent Neck Squamous Cell Carcinoma of Unknown Primary', 'Recurrent Oral Cavity Squamous Cell Carcinoma', 'Recurrent Oropharyngeal Squamous Cell Carcinoma', 'Refractory Head and Neck Squamous Cell Carcinoma', 'Refractory Hypopharyngeal Squamous Cell Carcinoma', 'Refractory Laryngeal Squamous Cell Carcinoma', 'Refractory Oral Cavity Squamous Cell Carcinoma', 'Refractory Oropharyngeal Squamous Cell Carcinoma', 'Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8', 'Stage IV Hypopharyngeal Carcinoma AJCC v8', 'Stage IV Laryngeal Cancer AJCC v8', 'Stage IV Lip and Oral Cavity Cancer AJCC v8', 'Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8']",Metastatic Head and Neck Squamous Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06758401,This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.,"AN OPEN-LABEL, RANDOMIZED, CONTROLLED PHASE 3 STUDY OF SIGVOTATUG VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH PD-L1 HIGH (≥50% OF TUMOR CELLS EXPRESSING PD-L1), LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC NON-SMALL CELL LUNG CANCER (BE6A LUNG-02)",RECRUITING,2025-07-23,2028-09-05,2029-03-01,INTERVENTIONAL,PHASE3,714,"['Non-Small Cell Lung Cancer', 'Carcinoma, Non-Small-Cell Lung', 'Carcinoma, Non-Small-Cell Lung (NSCLC)']",Non-Small Cell Lung Cancer,Pfizer,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'South Korea', 'Czechia', 'Poland', 'India', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT02339571,"A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma",Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma,RECRUITING,2015-11-23,2033-06-30,2033-06-30,INTERVENTIONAL,PHASE2,600,"['Stage III Cutaneous Melanoma AJCC v7', 'Stage IV Cutaneous Melanoma AJCC v6 and v7']",Stage III Cutaneous Melanoma AJCC v7,National Cancer Institute (NCI),[],['United States']
NCT07061964,"Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial",Single Arm Phase II Study of Bladder Preservation With Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (BRIGHT),RECRUITING,2025-11-25,2027-07-31,2027-07-31,INTERVENTIONAL,PHASE2,111,"['Muscle Invasive Bladder Urothelial Carcinoma', 'Stage II Bladder Cancer AJCC v8', 'Stage IIIA Bladder Cancer AJCC v8']",Muscle Invasive Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT04270409,Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma,"A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma",ACTIVE_NOT_RECRUITING,2020-06-16,2030-10-14,2033-10-21,INTERVENTIONAL,PHASE3,337,['Plasma Cell Myeloma'],Plasma Cell Myeloma,Sanofi,[],"['Japan', 'New Zealand', 'China', 'Lithuania', 'Australia', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Ireland', 'Italy']"
NCT06806592,A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases,"A Double Blind, Randomised, Placebo-controlled Trial Evaluating the Efficacy and Safety of Nerandomilast Over at Least 26 Weeks in Patients With Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases (SARD-ILD)",RECRUITING,2025-09-13,2027-07-17,2027-07-30,INTERVENTIONAL,PHASE3,400,"['Interstitial Lung Diseases', 'Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases']",Interstitial Lung Diseases,Boehringer Ingelheim,[],"['Japan', 'Netherlands', 'Norway', 'China', 'Austria', 'United States', 'France', 'Germany', 'Mexico', 'Switzerland', 'Puerto Rico', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Australia']"
NCT06935370,A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart,"EASi-HF Reduced - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Chronic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) < 40%",RECRUITING,2025-05-20,2029-02-04,2029-02-22,INTERVENTIONAL,PHASE3,4200,['Heart Failure'],Heart Failure,Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Belgium', 'Hungary', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT03719339,VIRTUUS Children's Study,Validating Injury to Renal Transplant Using Urinary Signatures in Children,ACTIVE_NOT_RECRUITING,2017-08-10,2024-05-31,2026-03-31,OBSERVATIONAL,,445,"['Renal Transplant Rejection', 'Pediatric Kidney Disease', 'End Stage Renal Disease', 'Nephropathy', 'BK Virus (Nephropathy)', 'Antibody-mediated Rejection', 'Acute Cellular Graft Rejection']",Renal Transplant Rejection,Children's Hospital of Philadelphia,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],"['United States', 'Canada']"
NCT03375307,Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other Genitourinary Tumors With DNA-Repair Genetic Changes,A Phase II Study of Olaparib (AZD2281) in Patients With Metastatic/Advanced Urothelial Carcinoma and Other Genitourinary Tumors With DNA-Repair Defects,RECRUITING,2020-11-03,2025-12-16,2025-12-16,INTERVENTIONAL,PHASE2,60,"['Advanced Bladder Carcinoma', 'Advanced Genitourinary System Carcinoma', 'Metastatic Bladder Carcinoma', 'Metastatic Genitourinary System Carcinoma', 'Stage III Bladder Cancer AJCC v8', 'Stage IV Bladder Cancer AJCC v8']",Advanced Bladder Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06732401,Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer,A Randomized Phase III Trial of Checkpoint Blockade in Lung Cancer Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR),RECRUITING,2025-08-07,2028-06-30,2028-06-30,INTERVENTIONAL,PHASE3,630,"['Lung Non-Small Cell Carcinoma', 'Stage II Lung Cancer AJCC v8', 'Stage IIIA Lung Cancer AJCC v8', 'Stage IIIB Lung Cancer AJCC v8']",Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT07278336,"A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer","A Phase 1 First-in-Human, Open-Label Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-901 as a Monotherapy and in Combination With Bevacizumab in Adult Subjects With Ovarian Cancer",RECRUITING,2025-11-27,2029-01,2029-01,INTERVENTIONAL,PHASE1,207,['Ovarian Cancer'],Ovarian Cancer,AbbVie,[],"['Israel', 'United States']"
NCT06203600,"Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial",Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-L1 CPS &gt;/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE),RECRUITING,2024-06-24,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE2,224,"['Advanced Esophageal Adenocarcinoma', 'Advanced Gastric Adenocarcinoma', 'Advanced Gastroesophageal Junction Adenocarcinoma', 'Clinical Stage II Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage III Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage III Gastric Cancer AJCC v8', 'Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Clinical Stage IV Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Metastatic Esophageal Adenocarcinoma', 'Metastatic Gastric Adenocarcinoma', 'Metastatic Gastroesophageal Junction Adenocarcinoma', 'Unresectable Esophageal Adenocarcinoma', 'Unresectable Gastric Adenocarcinoma', 'Unresectable Gastroesophageal Junction Adenocarcinoma']",Advanced Esophageal Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT05638295,Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial),A Randomized Phase II Study of AMG 510 (Sotorasib) With or Without Panitumumab in Advanced Solid Tumors: A ComboMATCH Treatment Trial,RECRUITING,2024-08-01,2028-12-31,2028-12-31,INTERVENTIONAL,PHASE2,105,"['Advanced Malignant Solid Neoplasm', 'Metastatic Malignant Solid Neoplasm']",Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT06816147,HealthyW8_60+ Pilot,Empowering Healthy Lifestyle Behavior Through Personalized Intervention Portfolios to Prevent and Control Obesity in the Elderly,RECRUITING,2025-11-19,2026-09-30,2026-12-31,INTERVENTIONAL,NA,30,['Obesity Prevention'],Obesity Prevention,Luxembourg Institute of Health,['European Commission'],['Luxembourg']
NCT07232849,A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer,Study on Efficacy and Safety of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer,RECRUITING,2025-12-04,2027-12,2028-12,INTERVENTIONAL,PHASE2,100,['Lung Cancer'],Lung Cancer,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT02344355,A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme,Pharmacological Ascorbate Combined With Radiation and Temozolomide in Glioblastoma Multiforme: A Phase 2 Trial,ACTIVE_NOT_RECRUITING,2017-03-13,2026-12-31,2028-12,INTERVENTIONAL,PHASE2,90,['Glioblastoma Multiforme'],Glioblastoma Multiforme,Bryan Allen,"['Holden Comprehensive Cancer Center', 'National Cancer Institute (NCI)', 'Gateway for Cancer Research']",['United States']
NCT06876233,Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication,Mobile Cued Adherence Therapy (mCAT): A Scalable Habit Formation Intervention to Improve Blood Pressure Medication Adherence Based on a Widely Used Smartphone App,RECRUITING,2025-09-01,2028-12-31,2029-03-30,INTERVENTIONAL,NA,600,"['Medication Adherence', 'Hypertension', 'Habits']",Medication Adherence,Chad Stecher@asu.edu,"['National Heart, Lung, and Blood Institute (NHLBI)', 'Wellth Inc.', 'Arizona State University']",['United States']
NCT05852938,A Study of Zigakibart in Adults With IgA Nephropathy,"A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults With IgA Nephropathy (The BEYOND Study)",ACTIVE_NOT_RECRUITING,2023-07-06,2026-02-19,2028-06-07,INTERVENTIONAL,PHASE3,383,"['IgA Nephropathy', 'Immunoglobulin A Nephropathy']",IgA Nephropathy,Novartis Pharmaceuticals,[],"['Japan', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Croatia', 'South Korea', 'Czechia', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT05122026,Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV,Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV,ACTIVE_NOT_RECRUITING,2024-01-17,2025-10-24,2025-12-31,INTERVENTIONAL,PHASE1,252,"['HIV Seropositivity', 'Pregnancy', 'Tuberculosis Infection']",HIV Seropositivity,The Aurum Institute NPC,"['Johns Hopkins University', 'Weill Medical College of Cornell University', 'University of Washington']",['South Africa']
NCT06902558,A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD),"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)",RECRUITING,2025-06-09,2029-08,2029-08,INTERVENTIONAL,PHASE2,240,['Autosomal Dominant Polycystic Kidney Disease'],Autosomal Dominant Polycystic Kidney Disease,AbbVie,['Calico Life Sciences LLC'],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'Australia', 'Portugal', 'Germany']"
NCT07037420,ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly,"A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose Range-finding, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ALXN2420, a Growth Hormone Receptor Antagonist, Administered Subcutaneously in Combination With Somatostatin Analogs in Adult Participants With Acromegaly",RECRUITING,2025-10-28,2027-01-19,2027-11-11,INTERVENTIONAL,PHASE2,60,['Acromegaly'],Acromegaly,"Alexion Pharmaceuticals, Inc.",[],"['Brazil', 'Hungary', 'Netherlands', 'China', 'United States', 'Denmark', 'Italy', 'Romania', 'Poland', 'Argentina', 'Lithuania']"
NCT06593522,A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201),"A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of AMG 193 in Subjects With Methylthioadenosine Phosphorylase (MTAP)-Deleted Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)",RECRUITING,2024-12-26,2028-11-29,2030-11-29,INTERVENTIONAL,PHASE2,200,['MTAP-deleted NSCLC'],MTAP-deleted NSCLC,Amgen,[],"['Brazil', 'Singapore', 'Japan', 'Turkey (Türkiye)', 'Hong Kong', 'Netherlands', 'China', 'United States', 'Switzerland', 'Taiwan', 'South Korea', 'Canada', 'Czechia', 'Latvia', 'Portugal', 'Australia']"
NCT06280755,Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.,Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study,RECRUITING,2024-03-01,2027-04,2027-04,OBSERVATIONAL,,7000,"['Multiple Sclerosis', 'NMO Spectrum Disorder', 'Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease', 'Radiologically Isolated Syndrome', 'Clinically Isolated Syndrome']",Multiple Sclerosis,icometrix,"['Charite University, Berlin, Germany', 'Ruhr University of Bochum', 'Technische Universität Dresden', 'University Hospital, Lille', 'Casa di Cura IGEA', 'General University Hospital, Prague', 'Hoffmann-La Roche', 'Bristol-Myers Squibb', 'Imcyse SA', 'AB Science', 'Nocturne UG', 'Aalto University']","['Germany', 'Czechia']"
NCT06419374,A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH,A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ENLIGHTEN-Cirrhosis),RECRUITING,2024-05-24,2028-06,2031-08,INTERVENTIONAL,PHASE3,762,['Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis'],Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,"89bio, Inc.",[],"['Bulgaria', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'South Korea', 'Poland', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06321302,A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy,"CRIMSON: A Multicentre, Randomised, Sham-controlled (and Active Controlled in the USA), Double-masked, 72-week Trial to Study the Safety, Tolerability, Pharmacokinetics, and Efficacy of 3 Dosing Regimens of Intravitreal BI 764524 in Patients With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy",RECRUITING,2024-05-15,2027-04-30,2027-09-17,INTERVENTIONAL,PHASE2,178,['Diabetic Retinopathy'],Diabetic Retinopathy,Boehringer Ingelheim,[],"['Japan', 'Hungary', 'United States', 'Puerto Rico', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Germany']"
NCT06333951,AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).,"A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)",RECRUITING,2024-09-17,2028-10-27,2031-10-27,INTERVENTIONAL,PHASE1,500,"['Thoracic Tumors', 'Non-small Cell Lung Cancer']",Thoracic Tumors,Amgen,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'South Korea', 'Poland', 'Spain', 'Taiwan', 'Canada', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT04664179,EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma,Constitutive IL7 (C7R) Modified EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma,RECRUITING,2022-10-31,2026-04-01,2039-03-30,INTERVENTIONAL,PHASE1,52,"['EBV-Related Hodgkin Lymphoma', 'EBV-Related Lymphoproliferative Disorder', ""EBV Related Non-Hodgkin's Lymphoma""]",EBV-Related Hodgkin Lymphoma,Baylor College of Medicine,"['The Methodist Hospital Research Institute', 'National Cancer Institute (NCI)']",['United States']
NCT06921694,"A Combined Exercise Programme Involving Strengthening, Flexibility and Aerobic Exercise for Lower Back Pain","A Combined Exercise Programme Involving Strengthening, Flexibility and Aerobic Exercise for Lower Back Pain: a Randomised-controlled Study",RECRUITING,2025-04-01,2026-09-30,2026-09-30,INTERVENTIONAL,NA,88,"['Low Back Pain, Chronic']","Low Back Pain, Chronic",University of Nottingham,[],['United Kingdom']
NCT07280481,Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress,Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress,RECRUITING,2025-11-16,2026-02-28,2026-05-22,INTERVENTIONAL,NA,500,"['Depression, Anxiety', 'Emotional Disorders']","Depression, Anxiety",Peking University,[],['China']
NCT06794775,SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma,SWE-NEO: Swedish NeoAdjuvant Trial Comparing Anti-PD-1 Monotherapy to Combined Anti-CTLA-4/Anti-PD-1 Blockade in Resectable Stage III Melanoma,RECRUITING,2025-07-10,2032-04-15,2032-04-15,INTERVENTIONAL,PHASE3,128,['Malignant Melanoma Stage III'],Malignant Melanoma Stage III,Hildur Helgadottir,[],['Sweden']
NCT05198830,"Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer",A Phase 2 Randomized Study of the BER Inhibitor TRC102 in Combination With Standard Pemetrexed-Platinum-Radiation in Stage III Non-Squamous Non-Small Cell Lung Cancer,RECRUITING,2022-12-15,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE2,42,"['Lung Adenocarcinoma', 'Lung Large Cell Carcinoma', 'Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage III Lung Cancer AJCC v8']",Lung Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT06203912,Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma,A Phase Ib Study of TGFbi NK Cells and Isatuximab for Myeloma Relapsed/Refractory to BCMA Targeting Therapy,ACTIVE_NOT_RECRUITING,2024-03-05,2026-01-31,2026-01-31,INTERVENTIONAL,PHASE1,3,"['Recurrent Multiple Myeloma', 'Refractory Multiple Myeloma']",Recurrent Multiple Myeloma,Elvira Umyarova,['Sanofi'],['United States']
NCT06568939,A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC),"A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer",RECRUITING,2025-01-20,2028-02,2028-02,INTERVENTIONAL,PHASE2,150,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,AbbVie,[],"['Singapore', 'Israel', 'Japan', 'China', 'United States', 'Serbia']"
NCT04665739,Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors,Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors,RECRUITING,2023-02-03,2026-07-01,2033-01-16,INTERVENTIONAL,PHASE2,70,"['Advanced Lung Neuroendocrine Tumor', 'Functioning Lung Neuroendocrine Tumor', 'Locally Advanced Lung Neuroendocrine Neoplasm', 'Lung Neuroendocrine Neoplasm', 'Lung Neuroendocrine Tumor G1', 'Lung Neuroendocrine Tumor G2', 'Metastatic Lung Neuroendocrine Neoplasm', 'Metastatic Lung Neuroendocrine Tumor', 'Non-Functioning Lung Neuroendocrine Tumor', 'Recurrent Lung Neuroendocrine Neoplasm', 'Unresectable Lung Neuroendocrine Neoplasm', 'Unresectable Lung Neuroendocrine Tumor']",Advanced Lung Neuroendocrine Tumor,National Cancer Institute (NCI),[],['United States']
NCT07061977,Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer,NRG-GY037: A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab Versus Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer,RECRUITING,2025-11-05,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE3,336,"['Locally Advanced Cervical Adenocarcinoma', 'Locally Advanced Cervical Adenosquamous Carcinoma', 'Locally Advanced Cervical Squamous Cell Carcinoma', 'Stage IIIA Cervical Cancer FIGO 2018', 'Stage IIIB Cervical Cancer FIGO 2018', 'Stage IIIC1 Cervical Cancer FIGO 2018', 'Stage IIIC2 Cervical Cancer FIGO 2018', 'Stage IVA Cervical Cancer FIGO 2018']",Locally Advanced Cervical Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT04166526,A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease,A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease,RECRUITING,2019-10-25,2027-05-01,2027-08-01,OBSERVATIONAL,,8,['Sickle Cell Disease'],Sickle Cell Disease,Boston Children's Hospital,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT05112601,Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma,A Randomized Phase II Trial of Nivolumab and Ipilimumab Compared to Nivolumab Monotherapy in Patients With Deficient Mismatch Repair System Recurrent Endometrial Carcinoma,RECRUITING,2022-06-02,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE2,81,"['Endometrial Adenocarcinoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Dedifferentiated Carcinoma', 'Endometrial Endometrioid Adenocarcinoma', 'Endometrial Mixed Cell Adenocarcinoma', 'Endometrial Mucinous Adenocarcinoma', 'Endometrial Undifferentiated Carcinoma', 'Endometrioid Adenocarcinoma', 'Recurrent Endometrial Carcinoma']",Endometrial Adenocarcinoma,National Cancer Institute (NCI),['NRG Oncology'],['United States']
NCT04176172,Optimizing Tobacco Use Treatment for PLWHA,Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers With HIV,RECRUITING,2020-02-17,2026-08-31,2026-08-31,INTERVENTIONAL,PHASE3,340,"['HIV/AIDS', 'Nicotine Dependence']",HIV/AIDS,University of Pennsylvania,"['National Cancer Institute (NCI)', 'Northwestern University']",['United States']
NCT03761121,Developing Fast Pediatric Imaging,Developing Fast Pediatric Imaging,RECRUITING,2019-04-15,2027-09-01,2028-03-01,INTERVENTIONAL,NA,300,['Pediatric Low-grade Gliomas'],Pediatric Low-grade Gliomas,Boston Children's Hospital,"['National Institute for Biomedical Imaging and Bioengineering (NIBIB)', 'Dana-Farber Cancer Institute']",['United States']
NCT05564377,"Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial",Molecular Analysis for Combination Therapy Choice (ComboMATCH),RECRUITING,2023-04-07,2030-07-01,2030-07-01,INTERVENTIONAL,PHASE2,2900,"['Advanced Malignant Solid Neoplasm', 'Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Locally Advanced Malignant Solid Neoplasm', 'Malignant Female Reproductive System Neoplasm', 'Metastatic HER2-Negative Breast Carcinoma', 'Metastatic Malignant Solid Neoplasm', 'Recurrent Endometrial Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Malignant Female Reproductive System Neoplasm', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Unresectable HER2-Negative Breast Carcinoma', 'Unresectable Malignant Solid Neoplasm']",Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT04770519,"Genetic Studies of Strabismus, Nystagmus, and Associated Disorders","Genetic Studies of Strabismus, Nystagmus, and Associated Disorders",RECRUITING,2021-09-03,2030-12,2030-12,OBSERVATIONAL,,400,"['Strabismus', 'Nystagmus, Congenital']",Strabismus,Boston Children's Hospital,['National Eye Institute (NEI)'],['United States']
NCT06150157,A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms,"A First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-88549968, a T-cell Redirecting Bispecific Antibody for CALR-mutated Myeloproliferative Neoplasms",RECRUITING,2023-12-20,2026-12-04,2027-12-15,INTERVENTIONAL,PHASE1,220,"['Myeloproliferative Disorders', 'Essential Thrombocythemia', 'Neoplasms', 'Myelofibrosis']",Myeloproliferative Disorders,"Janssen Research & Development, LLC",[],"['Israel', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT04841668,Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly,Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly,RECRUITING,2021-04-10,2025-06-01,2026-02,OBSERVATIONAL,,136,['Type 2 Diabetes Mellitus'],Type 2 Diabetes Mellitus,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,[],['Spain']
NCT06155643,EKO SENSORA: Detecting Clinically Significant Murmurs,EKO SENSORA: Detecting Clinically Significant Murmurs,RECRUITING,2023-10-26,2026-07-26,2026-07-26,INTERVENTIONAL,NA,300,['Heart Murmurs'],Heart Murmurs,Corewell Health South,[],['United States']
NCT07160634,A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE),"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males With Duchenne Muscular Dystrophy",RECRUITING,2025-10-22,2029-01,2034-01,INTERVENTIONAL,PHASE3,80,['Duchenne Muscular Dystrophy'],Duchenne Muscular Dystrophy,Solid Biosciences Inc.,[],['Canada']
NCT06422806,Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas,"A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Dedifferentiated Liposarcoma (DDLPS), Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas",RECRUITING,2024-09-11,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE3,365,"['Metastatic Dedifferentiated Liposarcoma', 'Metastatic Undifferentiated Pleomorphic Sarcoma', 'Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8', 'Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8', 'Unresectable Dedifferentiated Liposarcoma', 'Unresectable Undifferentiated Pleomorphic Sarcoma']",Metastatic Dedifferentiated Liposarcoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT07148414,A Study of SPY072 in Rheumatic Disease,Phase 2 Study to Assess the Efficacy and Safety of SPY002-072 in Adults With Moderately to Severely Active Rheumatologic Disease,RECRUITING,2025-08-21,2026-10-31,2028-03-31,INTERVENTIONAL,PHASE2,285,"['Rheumatoid Arthritis', 'Psoriatic Arthritis', 'Axial Spondyloarthritis', 'Rheumatic Diseases', 'Rheumatic Joint Disease', 'PsA (Psoriatic Arthritis)', 'AxSpA', 'Rheumatologic Disease']",Rheumatoid Arthritis,"Spyre Therapeutics, Inc.",[],"['United States', 'Georgia', 'Moldova']"
NCT07263932,PENG vs PHPB for Hip Arthroplasty Analgesia,Postoperative Analgesic Effectiveness of Pericapsular Nerve Block (PENG) and Posterior Hip Pericapsular Block (PHPB) in Hip Arthroplasty,RECRUITING,2025-12-01,2026-04-01,2026-07-01,OBSERVATIONAL,,132,"['PENG Block', 'Hip Arthroplasty, Total', 'QoR-15', 'Numeric Rating Scale']",PENG Block,Ankara City Hospital Bilkent,[],['Turkey (Türkiye)']
NCT04127578,Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL),A Phase 1/2a Open-Label Ascending Dose Study to Evaluate the Safety and Effects of LY3884961 in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL),RECRUITING,2020-01-03,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE1,32,['Parkinson Disease'],Parkinson Disease,Prevail Therapeutics,['Eli Lilly and Company'],"['Israel', 'United States']"
NCT06773195,A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis,A Phase 1/2 Study of Combined JAK/ERK Inhibition in Patients With Myelofibrosis,RECRUITING,2025-01-07,2028-01,2028-01,INTERVENTIONAL,PHASE1,37,['Myelofibrosis'],Myelofibrosis,Memorial Sloan Kettering Cancer Center,"['BioMed Valley Discoveries, Inc', 'Incyte Corporation']",['United States']
NCT06961370,"A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","A Phase I, Multi-center, Multi-part Study to Investigate Safety, Tolerability, PK, PD, and Immunogenicity of RO7669330 Intravitreal Injections in Participants With GA Secondary to AMD: Part 1A: Open-label, MAD; Part 1B: Randomized PD Pilot; Part 2: Masked, Randomized, Active-comparator-controlled",RECRUITING,2025-07-16,2027-01-03,2027-01-03,INTERVENTIONAL,PHASE1,132,"['Geographic Atrophy', 'Age-related Macular Degeneration']",Geographic Atrophy,Hoffmann-La Roche,[],['United States']
NCT06400472,A Study of LY4170156 in Participants With Selected Advanced Solid Tumors,"A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4170156, an Antibody-Drug Conjugate Targeting Folate Receptor α-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors",RECRUITING,2024-05-20,2027-02,2027-04,INTERVENTIONAL,PHASE1,495,"['Ovarian Neoplasms', 'Endometrial Neoplasms', 'Uterine Cervical Neoplasms', 'Carcinoma, Non-Small-Cell Lung', 'Triple Negative Breast Neoplasms', 'Pancreatic Neoplasm', 'Colorectal Neoplasms']",Ovarian Neoplasms,Eli Lilly and Company,[],"['Japan', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'Australia']"
NCT04821622,Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC,"TALAPRO-3: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER",ACTIVE_NOT_RECRUITING,2021-05-12,2026-02-18,2027-08-28,INTERVENTIONAL,PHASE3,599,['Prostate Cancer'],Prostate Cancer,Pfizer,['Astellas Pharma Inc'],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Hungary', 'Russia', 'France', 'Finland', 'South Korea', 'Czechia', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Ukraine', 'Germany', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT07011615,Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use,Feasibility/Acceptability of a Brief Motivational Intervention Integrating Online Personalized Feedback & Tailored Text Messages for Frequent/High-Intensity Cannabis Use in Post-Legalization Landscape,RECRUITING,2025-12-08,2026-12,2026-12,INTERVENTIONAL,NA,120,['Cannabis Use'],Cannabis Use,University of Washington,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT06041048,Investigation of Locus Coeruleus Function in Sustained Attention,Investigation of Locus Coeruleus Function in Sustained Attention,RECRUITING,2023-10-01,2025-12-30,2025-12-30,INTERVENTIONAL,PHASE4,40,['Attention - no Condition is Being Assessed - Healthy Adults'],Attention - no Condition is Being Assessed - Healthy Adults,"University of California, Davis",[],['United States']
NCT05185843,A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen,An Open-Label Safety Study of AKCEA-APOCIII-LRX Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen (ISIS 304801),ACTIVE_NOT_RECRUITING,2022-02-25,2027-06,2027-06,INTERVENTIONAL,PHASE3,24,['Familial Chylomicronemia Syndrome'],Familial Chylomicronemia Syndrome,"Ionis Pharmaceuticals, Inc.",[],"['United States', 'Sweden', 'Canada']"
NCT07279740,Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia,Methylphenidate Primed iTBS for Apathy in Neurocognitive Disorders,RECRUITING,2026-01,2027-10-01,2027-10-01,INTERVENTIONAL,PHASE2,12,"['Alzheimer s Disease', 'Alzheimer Dementia (AD)', 'Alzheimer Dementia', 'Alzheimer Disease', 'Apathy', 'Apathy in Dementia']",Alzheimer s Disease,Sunnybrook Health Sciences Centre,"['Alzheimer Society of Canada', 'Sunnybrook Research Institute', 'Brain Canada']",['Canada']
NCT00201526,Bipolar Research And Innovation Network - BRAIN,Bipolar Research And Innovation Network - BRAIN,RECRUITING,2003-01,2030-01,2030-01,OBSERVATIONAL,,3000,['Bipolar Disorder'],Bipolar Disorder,Norwegian University of Science and Technology,['University of Oslo'],['Norway']
NCT07278674,Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）,Clinical Study of Eflornithine After Immunotherapy for High-risk Neuroblastoma（CSHEIN）,ACTIVE_NOT_RECRUITING,2025-04-08,2029-10-31,2029-10-31,OBSERVATIONAL,,20,['High Risk Neuroblastoma'],High Risk Neuroblastoma,Shanghai Children's Hospital,['Ruijin Hospital'],['China']
NCT07280143,The Development of MASLD Among Survivors of Breast or Colorectal Cancer,The Development of MASLD Among Survivors of Breast or Colorectal Cancer,RECRUITING,2025-11-14,2027-07-14,2027-11-30,OBSERVATIONAL,,200,"['Breast Cancer Survivors', 'Colorectal (Colon or Rectal) Cancer Survivors', 'MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)']",Breast Cancer Survivors,University of Bern,"['Insel Gruppe AG, University Hospital Bern']",['Switzerland']
NCT06772025,A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung Machine,Methodology Study in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass to Investigate Mechanisms Involved in Cardiac Surgery-associated Acute Kidney Injury.,RECRUITING,2025-02-03,2027-01-31,2027-01-31,INTERVENTIONAL,NA,200,['Cardiac Surgery-associated Acute Kidney Injury'],Cardiac Surgery-associated Acute Kidney Injury,Bayer,[],"['United Kingdom', 'Germany']"
NCT06477588,J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations,J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations,RECRUITING,2024-08-13,2028-06-30,2028-06-30,INTERVENTIONAL,NA,350,"['HIV', 'Contingency Management', 'Justice Involved Populations', 'Status Neutral Interventions', 'Mental Health', 'Substance Use']",HIV,University of Chicago,"['Northwestern University', 'NORC at the University of Chicago', 'Frontline Legal Services', 'Capitol Area Reentry Program Inc.', 'National Institute of Mental Health (NIMH)', 'Nefuse Case Management and Training Services']",['United States']
NCT06906627,Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD),Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD),RECRUITING,2025-10-28,2027-04-01,2027-04-01,INTERVENTIONAL,NA,750,"['Chronic Kidney Disease(CKD)', 'Type 2 DM', 'Type 2 Diabetes Mellitus (T2DM)']",Chronic Kidney Disease(CKD),Duke University,"['Bayer', 'Boehringer Ingelheim', 'Eli Lilly and Company']",['United States']
NCT06780449,A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity,Long-term Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) Once Weekly Versus Placebo in Participants With Obesity,ACTIVE_NOT_RECRUITING,2025-02-10,2028-08-28,2028-11-17,INTERVENTIONAL,PHASE3,400,['Obesity'],Obesity,Novo Nordisk A/S,[],"['Belgium', 'United States', 'Denmark', 'Canada', 'United Kingdom', 'Portugal']"
NCT06619990,Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis.",RECRUITING,2024-10-10,2028-04,2029-01,INTERVENTIONAL,PHASE1,270,['Ulcerative Colitis (UC)'],Ulcerative Colitis (UC),"Xencor, Inc.",[],"['United States', 'Australia']"
NCT05392114,A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE),"An Open-Label, Long Term Safety and Efficacy Study of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)",ACTIVE_NOT_RECRUITING,2022-07-13,2026-12,2027-03,INTERVENTIONAL,PHASE3,154,['Hereditary Angioedema'],Hereditary Angioedema,"Ionis Pharmaceuticals, Inc.",[],"['Belgium', 'Bulgaria', 'Israel', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'France', 'Puerto Rico', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT07280026,"Effectiveness of an Edge AI-based Augmented Reality System for Hand Hygiene Training: a Multi-centre, Mixed-methods Cluster Randomised Controlled Trial","Effectiveness of an Edge AI-based Augmented Reality System for Hand Hygiene Training: a Multi-centre, Mixed-methods Cluster Randomised Controlled Trial",RECRUITING,2025-12-15,2027-08-01,2027-09-01,INTERVENTIONAL,NA,1000,"['Hand Hygiene Training', 'Infection Prevention and Control', 'Healthcare-Associated Infections (HAIs)', 'Health Education']",Hand Hygiene Training,The Hong Kong Polytechnic University,"['Chinese University of Hong Kong', 'Tongji Hospital']","['China', 'Hong Kong']"
NCT06055920,The PEERLESS II Study,PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism,RECRUITING,2023-11-17,2026-07,2026-07,INTERVENTIONAL,NA,1200,['Pulmonary Embolism'],Pulmonary Embolism,Inari Medical,[],"['Belgium', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Canada', 'Poland', 'Germany']"
NCT04609046,Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma,"Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma",RECRUITING,2021-05-24,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE1,47,['Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System'],Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,National Cancer Institute (NCI),[],['United States']
NCT07221474,A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013),"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)",RECRUITING,2025-12-16,2029-07-02,2031-05-06,INTERVENTIONAL,PHASE2,180,['Squamous Non-small Cell Lung Cancer'],Squamous Non-small Cell Lung Cancer,Merck Sharp & Dohme LLC,"['ModernaTX, Inc.']",['Australia']
NCT05008809,Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418),"Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer Prospective, Randomized, Open, Multicenter Phase III Trial to Investigate the Efficacy of Active Post-resection/Ablation Therapy in Patients With Metastatic Colorectal Cancer",RECRUITING,2021-12-06,2027-11,2030-11,INTERVENTIONAL,PHASE3,507,['Colorectal Cancer'],Colorectal Cancer,Dominik Paul Modest,"['German Research Foundation', 'Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest']",['Germany']
NCT03889132,"Glucose, Brain and Microbiota","Integrated Analysis of the Interactions Between Glycemia and Microbiota Composition, and Their Impact on Brain Iron Deposition and Cognition in Subjects With Obesity",ACTIVE_NOT_RECRUITING,2019-03-05,2024-01-31,2025-12,OBSERVATIONAL,,128,['Obesity'],Obesity,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,[],['Spain']
NCT05980949,Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT and KarXT + KarX-EC in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3),Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT and KarXT + KarX-EC in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3),RECRUITING,2023-07-11,2027-09-07,2027-09-07,INTERVENTIONAL,PHASE3,800,"[""Psychosis Associated With Alzheimer's Disease""]",Psychosis Associated With Alzheimer's Disease,Karuna Therapeutics,[],"['Bulgaria', 'Japan', 'China', 'Slovakia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Croatia', 'Peru', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT05071144,Advanced SPinal Innovations With Robotics and Enabling Technology Registry,Advanced SPinal Innovations With Robotics and Enabling Technology Registry,RECRUITING,2021-12-13,2030-12,2031-12,OBSERVATIONAL,,700,"['Spine Deformity', 'Idiopathic Scoliosis', 'Adolescent Idiopathic Scoliosis', 'Spondylolisthesis', 'Congenital Scoliosis', 'Neuromuscular Scoliosis']",Spine Deformity,Boston Children's Hospital,"['Pediatric Orthopaedic Society of North America', 'Medtronic', ""Children's Hospital Colorado"", 'Hospital for Special Surgery, New York', ""Children's Healthcare of Atlanta"", ""Rainbow Babies and Children's Hospital"", ""Dell Children's Medical Center of Central Texas"", 'Cedars-Sinai Medical Center', ""Medical University of South Carolina Shawn Jenkins Children's Hospital"", ""St. Luke's Medical Center""]",['United States']
NCT06522737,A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype,"A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype",RECRUITING,2025-05-19,2028-02,2028-12,INTERVENTIONAL,PHASE3,124,['Lymphoma'],Lymphoma,SecuraBio,[],"['Belgium', 'Netherlands', 'France', 'Denmark', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07043647,An Agricultural Livelihood Intervention for Pregnant Women,A Randomized Controlled Trial of an Agricultural Livelihood Intervention to Improve Maternal and Newborn Health and Nutrition in Kenya: Mama Shamba,RECRUITING,2025-09-05,2029-02-19,2029-02-19,INTERVENTIONAL,NA,410,"['Food Insecurity', 'Pregnancy', 'Birth Outcomes', 'Livelihood Interventions', 'Infant Health Outcomes']",Food Insecurity,"University of California, San Francisco","['Kenya Medical Research Institute', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['Kenya']
NCT06837363,Effect of Untact Upper Extremity Rehabilitation Using a Smart Board for Late Subacute and Chronic Patients With Brain Disorder,A Multicenter Confirmation Clinical Trial of Untact Upper Extremity Rehabilitation Using Smart Board for Late Subacute and Chronic Patients With Brain Disorder - a Randomized Single-blinded Controlled Trial,RECRUITING,2025-04-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,40,"['Home Based Rehabilitation', 'Brain Disorder']",Home Based Rehabilitation,Samsung Medical Center,[],['South Korea']
NCT06654063,Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients,Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients: A Randomized Controlled Clinical Trial.,RECRUITING,2025-04-01,2025-06-01,2025-12-01,INTERVENTIONAL,NA,72,['Vitamin D Deficiency'],Vitamin D Deficiency,Cairo University,[],['Egypt']
NCT06052267,A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations,"A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma",RECRUITING,2023-08-30,2026-07-17,2026-07-17,INTERVENTIONAL,PHASE3,2196,['Asthma'],Asthma,"Teva Branded Pharmaceutical Products R&D, Inc.",[],"['Bulgaria', 'New Zealand', 'Slovakia', 'Australia', 'Israel', 'Hungary', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'South Africa', 'Mexico', 'Spain', 'Canada', 'Romania', 'Latvia', 'Greece', 'Germany', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT04130516,"Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab","A Multicenter Phase 1-2A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of LNS8801 in Patients With Advanced Cancer With and Without Pembrolizumab",RECRUITING,2019-10-21,2026-12-31,2027-12-15,INTERVENTIONAL,PHASE1,200,"['Solid Tumor, Adult']","Solid Tumor, Adult","Linnaeus Therapeutics, Inc.",['Merck Sharp & Dohme LLC'],['United States']
NCT05726838,The Belgian REAL (BE.REAL) Registry,A Belgian Registry to Evaluate the Real Life Treatment With Inclisiran on Top of Standard of Care Lipid-lowering Therapy in Patients With Atherosclerotic Cardiovascular Disease,RECRUITING,2022-04-15,2029-03-31,2029-03-31,OBSERVATIONAL,,600,['Atherosclerotic Cardiovascular Disease'],Atherosclerotic Cardiovascular Disease,Novartis Pharmaceuticals,[],['Belgium']
NCT06742008,Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis,DCM Anti-Heart Antibody Diagnostic Kit Study--assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis,RECRUITING,2024-12-17,2028-12-30,2028-12-30,OBSERVATIONAL,,300,['Viral Myocarditis'],Viral Myocarditis,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",[],['China']
NCT06014762,P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies,"Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-CD19CD20-ALLO1 in Subjects With Selected Relapsed/Refractory B Cell Malignancies",RECRUITING,2024-04-16,2029-03,2041-03,INTERVENTIONAL,PHASE1,120,"['Diffuse Large B-Cell Lymphoma, Not Otherwise Specified', 'High-grade B-cell Lymphoma', 'Primary Mediastinal Large B-cell Lymphoma (PMBCL)', 'Transformed Follicular Lymphoma (tFL)', 'Follicular Lymphoma Grade 3B', 'DLBCL', 'DLBCL - Diffuse Large B Cell Lymphoma', 'DLBCL Arising From Follicular Lymphoma', 'DLBCL, Diffused Large B Cell Lymphoma', 'DLBCL NOS']","Diffuse Large B-Cell Lymphoma, Not Otherwise Specified","Poseida Therapeutics, Inc.",['Roche-Genentech'],['United States']
NCT04323774,Intervention For AYAS With Cancer Risk Syndromes,"AYA-RISE: Refining a Scalable, Patient- and Family-centered Intervention to Improve Cancer Risk Communication and Decision-making Among Adolescents and Young Adults With Cancer Risk Syndromes",ACTIVE_NOT_RECRUITING,2021-03-01,2025-07-11,2027-06-30,INTERVENTIONAL,NA,115,['Cancer Risk Syndrome'],Cancer Risk Syndrome,Dana-Farber Cancer Institute,['National Cancer Institute (NCI)'],['United States']
NCT06577441,"Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)",A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study,RECRUITING,2025-06-12,2027-03-01,2027-03-01,INTERVENTIONAL,PHASE2,54,['Myelodysplastic Syndrome'],Myelodysplastic Syndrome,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06027671,Structured Peer-delivered ART and Reentry Community Strategy,Structured Peer-delivered Antiretroviral Therapy (ART) and Reentry Community Strategy to Overcome Barriers to HIV Care Continuity During Community Re-entry From Incarceration in South Africa,ACTIVE_NOT_RECRUITING,2024-11-18,2028-07-31,2028-07-31,INTERVENTIONAL,NA,640,['Retention in Care'],Retention in Care,Johns Hopkins University,"['Aurum Institute', 'Seoul National University', 'National Institute of Mental Health (NIMH)']",['South Africa']
NCT04402788,"Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial",RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial,RECRUITING,2021-01-07,2027-04-30,2027-04-30,INTERVENTIONAL,PHASE2,138,['Extensive Stage Lung Small Cell Carcinoma'],Extensive Stage Lung Small Cell Carcinoma,National Cancer Institute (NCI),['NRG Oncology'],['United States']
NCT05579392,A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis,Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis,RECRUITING,2022-09-22,2026-05-01,2026-05-31,INTERVENTIONAL,NA,30,['Inflammatory Bowel Disease'],Inflammatory Bowel Disease,Rush University Medical Center,[],['United States']
NCT04242095,Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects,Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events,RECRUITING,2020-03-12,2026-10-01,2026-10-01,OBSERVATIONAL,,240,['Malignancy'],Malignancy,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT06431763,A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.,"A Randomized, Multicenter, Open-label Trial Comparing the Effectiveness of Inclisiran to Bempedoic Acid on LDL Cholesterol (LDL-C) Lowering in Participants With Atherosclerotic Cardiovascular Disease (VICTORION-CHALLENGE)",ACTIVE_NOT_RECRUITING,2024-06-21,2025-12-01,2025-12-15,INTERVENTIONAL,PHASE4,402,['Hypercholesterolemia'],Hypercholesterolemia,Novartis Pharmaceuticals,[],['Germany']
NCT05008848,Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program,Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions,RECRUITING,2022-04-01,2028-03-26,2028-08-26,INTERVENTIONAL,PHASE3,600,['Cigarette Smoking-Related Carcinoma'],Cigarette Smoking-Related Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT05411081,"Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial",A Phase II Randomized Trial of Cabozantinib (NSC #761968) With or Without Atezolizumab (NSC #783608) in Patients With Advanced Papillary Renal Cell Carcinoma (PAPMET2),RECRUITING,2023-03-24,2027-07-01,2027-07-01,INTERVENTIONAL,PHASE2,200,"['Metastatic Papillary Renal Cell Carcinoma', 'Stage IV Renal Cell Cancer AJCC v8']",Metastatic Papillary Renal Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT03360539,Nurse-Family Partnership Impact Evaluation in South Carolina,Nurse-Family Partnership Impact Evaluation in South Carolina,ACTIVE_NOT_RECRUITING,2016-04-01,2023-04-01,2046-04-01,INTERVENTIONAL,NA,5670,"['Preterm Birth', 'Injuries', 'Maternal Behavior']",Preterm Birth,Harvard School of Public Health (HSPH),"['Abdul Latif Jameel Poverty Action Lab', 'University of Chicago']",['United States']
NCT07220460,Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder,"Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder",RECRUITING,2025-09-30,2027-04,2027-04,INTERVENTIONAL,PHASE2,200,['Bipolar I or II Disorder'],Bipolar I or II Disorder,AbbVie,[],['United States']
NCT06875310,A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4),"A Randomized, Double-Blind, Phase 3 Trial of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)",RECRUITING,2025-04-24,2029-09-07,2032-04-30,INTERVENTIONAL,PHASE3,630,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Mirati Therapeutics Inc.,[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Croatia', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06419413,"A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population","A Transnational Study to Describe Asthma Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population",RECRUITING,2024-01-08,2026-10-08,2026-10-08,OBSERVATIONAL,,355,['Asthma'],Asthma,AstraZeneca,[],['China']
NCT06877013,Tolerance Profile of Soluble Fibers in Individuals With Self-perceived GI Sensitivity to Fibers (Tarine),"An Exploratory, Randomized, Single Blinded, Monocentric, Parallel Group Study to Explore the Tolerance Profile of Soluble Fibers in Individuals With Self-perceived Gastrointestinal Sensitivity to Fibers",RECRUITING,2025-11-13,2026-05,2026-05,INTERVENTIONAL,NA,138,['Population With Self-perceived Gastro-intestinal Sensitivity to Fibers'],Population With Self-perceived Gastro-intestinal Sensitivity to Fibers,Danone Global Research & Innovation Center,[],['France']
NCT06892288,A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDG,"A Phase 2b, Multicenter, Double-blind, Randomized, Placebo Controlled Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 Administered Intravenously to Participants With PMM2-CDG (POLAR Trial)",RECRUITING,2025-07-09,2026-01-31,2026-08-31,INTERVENTIONAL,PHASE2,50,"['Phosphomannomutase 2 Deficiency', 'PMM2-CDG']",Phosphomannomutase 2 Deficiency,"Glycomine, Inc.",[],"['Belgium', 'United States', 'France', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Portugal', 'Germany']"
NCT07231783,The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults,"A Confirmatory, Randomised, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Effects of a Dietary Supplement Containing Urolithin A (Mitopure®) on Muscle Strength and Performance in Healthy Middle-Aged Adults",RECRUITING,2025-12-10,2027-10-31,2027-10-31,INTERVENTIONAL,NA,120,"['Healthy Aging', 'Muscle Function']",Healthy Aging,Amazentis SA,['Atlantia Food Clinical Trials'],['Ireland']
NCT07030257,Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors,"A Multi-Center, Open Label, Phase 1/2 Study of CP-383, in Patients With Advanced or Metastatic Solid Tumors",RECRUITING,2025-08-27,2028-08-15,2029-02,INTERVENTIONAL,PHASE1,150,"['Solid Tumor Malignancies', 'Colorectal Carcinoma', 'Small Cell Lung Cancer ( SCLC )', 'Head and Neck (HNSCC)', 'Bladder Cancer', 'Non-Small Cell Lung Cancer', 'Pancreatic Cancer, Advanced or Metastatic']",Solid Tumor Malignancies,Tasca Therapeutics,[],['United States']
NCT06568172,"Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer",Randomized Phase III Trial of Neoadjuvant Immunotherapy With Response-Adapted Treatment Versus Standard-of-Care Treatment for Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma (C-PRE),RECRUITING,2025-02-18,2031-08-14,2031-08-14,INTERVENTIONAL,PHASE3,420,"['Eyelid Squamous Cell Carcinoma', 'Recurrent Eyelid Squamous Cell Carcinoma', 'Recurrent Skin Acantholytic Squamous Cell Carcinoma', 'Recurrent Skin Clear Cell Squamous Cell Carcinoma', 'Recurrent Skin Lymphoepithelial Carcinoma', 'Recurrent Skin Spindle Cell Squamous Cell Carcinoma', 'Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation', 'Resectable Eyelid Squamous Cell Carcinoma', 'Resectable Skin Acantholytic Squamous Cell Carcinoma', 'Resectable Skin Clear Cell Squamous Cell Carcinoma', 'Resectable Skin Lymphoepithelial Carcinoma', 'Resectable Skin Spindle Cell Squamous Cell Carcinoma', 'Resectable Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation', 'Skin Acantholytic Squamous Cell Carcinoma', 'Skin Clear Cell Squamous Cell Carcinoma', 'Skin Lymphoepithelial Carcinoma', 'Skin Spindle Cell Squamous Cell Carcinoma', 'Skin Squamous Cell Carcinoma With Sarcomatoid Differentiation', 'Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8', 'Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8']",Eyelid Squamous Cell Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada', 'Australia']"
NCT07270237,A Study of Multiparametric Ultrasound Imaging Methods,Development and Evaluation of Ultrasound Imaging Acquisition and Analysis Methods,RECRUITING,2025-11-24,2027-11,2027-11,INTERVENTIONAL,NA,85,"['Pancreatic Cancer', 'Thyroid Nodule']",Pancreatic Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06091930,A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6,"Phase I, Non-randomised, Open-label, Multi-centre Dose Escalation and Expansion Trial of BI 765049 and BI 765049 + Ezabenlimab Administered by Repeated Intravenous Infusion in Asian Patients With Malignant Solid Tumours Expressing B7-H6",RECRUITING,2024-02-16,2028-06-09,2028-09-10,INTERVENTIONAL,PHASE1,97,"['Gastrointestinal Cancer', 'Lung Cancer', 'Pancreatic Cancer', 'Colorectal Cancer', 'Head and Neck Cancer', 'Liver Cancer']",Gastrointestinal Cancer,Boehringer Ingelheim,[],"['China', 'Japan', 'Taiwan', 'South Korea']"
NCT06096844,"Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial",A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study,RECRUITING,2024-07-19,2026-06-01,2026-06-01,INTERVENTIONAL,PHASE3,304,"['Advanced Lung Non-Small Cell Carcinoma', 'Stage IIIB Lung Cancer AJCC v8', 'Stage IIIC Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8']",Advanced Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05014984,WOOP VA: Promoting Weight Management in Primary Care,WOOP VA: Mental Contrasting With Implementation Intentions to Promote Weight Management in Primary Care,ACTIVE_NOT_RECRUITING,2022-02-15,2025-06-30,2026-02-27,INTERVENTIONAL,NA,405,['Obesity'],Obesity,VA Office of Research and Development,['New York University'],['United States']
NCT07095036,Sensory Spinal Cord Stimulation,Generating Artificial Sensory Perceptions Using Spinal Cord Stimulation,RECRUITING,2026-02-01,2028-09-01,2028-09-01,INTERVENTIONAL,NA,10,"['Pain Management', 'Pain, Intractable', 'Pain, Chronic Disease']",Pain Management,"University of North Carolina, Chapel Hill",['National Institute of Neurological Disorders and Stroke (NINDS)'],['United States']
NCT03090633,Fetoscopic Repair of Isolated Fetal Spina Bifida,Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida,ACTIVE_NOT_RECRUITING,2017-05-11,2027-04,2027-04,INTERVENTIONAL,NA,30,"['Spina Bifida', 'Myelomeningocele', 'Chiari Malformation Type 2', 'Neural Tube Defects', 'Spinal Dysraphism', 'Congenital Abnormality']",Spina Bifida,Johns Hopkins University,[],['United States']
NCT07280182,Effect of the Quadratus Lumborum Block Versus the Lumbar Plexus for Spiral Thighplasty Surgery,Comparing the Early Postoperative Analgesic Effect of the Transmuscular Quadratus Lumborum Block Versus the Lumbar Plexus Block for Patients Undergoing Spiral Thighplasty Surgery,ACTIVE_NOT_RECRUITING,2025-11-27,2026-02-10,2026-02-10,INTERVENTIONAL,NA,42,['Analgesia'],Analgesia,Menoufia University,[],['Egypt']
NCT06355778,"Adversity, Brain and Opioid Use Study",A Mechanistic Investigation of Risk Factors for Opioid Use Disorder: Examining Hippocampal-based Context-dependent Learning and Memory Associated With Adverse Childhood Experiences,RECRUITING,2025-01-09,2028-04,2028-04,INTERVENTIONAL,NA,185,"['Opioid Use Disorder', 'Healthy']",Opioid Use Disorder,University of Michigan,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT07137598,A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors),"A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response or Intolerance to TNF and/or JAK Inhibitors",RECRUITING,2025-12-05,2027-07-09,2027-07-09,INTERVENTIONAL,PHASE2,160,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Hoffmann-La Roche,[],['United States']
NCT06528314,A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Compensated Cirrohosis Due to NASH/MASH",RECRUITING,2024-09-04,2029-09,2029-10,INTERVENTIONAL,PHASE3,1150,"['NASH - Nonalcoholic Steatohepatitis', 'MASH - Metabolic Dysfunction-Associated Steatohepatitis']",NASH - Nonalcoholic Steatohepatitis,"Akero Therapeutics, Inc",[],"['Australia', 'Israel', 'France', 'Chile', 'Puerto Rico', 'South Korea', 'Poland', 'India', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07159763,A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza,"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications",ACTIVE_NOT_RECRUITING,2025-09-25,2027-01,2027-01,INTERVENTIONAL,PHASE3,6000,['Influenza'],Influenza,Cidara Therapeutics Inc.,[],"['United Kingdom', 'United States']"
NCT07238114,Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors,Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors,ACTIVE_NOT_RECRUITING,2025-08-01,2027-07-31,2027-07-31,OBSERVATIONAL,,450,"['Liver Cirrhosis', 'Viral Pneumonia', 'Fungal Infection', 'Invasive Pulmonary Aspergillosis', 'Intensive Care Medicine']",Liver Cirrhosis,Universitaire Ziekenhuizen KU Leuven,['Gilead Sciences'],['Belgium']
NCT07149870,Pain Management Teams Using Whole Health to Optimize Function and Safety in Veterans: The TEAMWORK Trial,Pain Management Teams Using Whole Health to Optimize Function and Safety in Veterans: The TEAMWORK Trial,RECRUITING,2025-11-20,2029-10-01,2029-10-01,INTERVENTIONAL,NA,432,['Chronic Pain'],Chronic Pain,VA Office of Research and Development,[],['United States']
NCT06531824,EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin),"A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease",RECRUITING,2024-08-13,2028-08-30,2028-08-30,INTERVENTIONAL,PHASE3,11000,"['Kidney Disease, Chronic']","Kidney Disease, Chronic",Boehringer Ingelheim,[],"['Brazil', 'Japan', 'New Zealand', 'United Kingdom', 'China', 'India', 'United States', 'Mexico', 'Germany', 'Denmark', 'Taiwan', 'Italy', 'Canada', 'Malaysia', 'South Korea', 'Portugal', 'Argentina', 'Australia']"
NCT07278843,Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A,Natural History of Photoreceptor Degeneration Related to USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A,RECRUITING,2025-10-13,2032-09,2032-09,OBSERVATIONAL,,60,['Usher Syndrome'],Usher Syndrome,Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts,[],['France']
NCT06678490,Support C Post-Market Registry,PMCF Registry Study Paclitaxel-eluting Balloon Catheter Support C,RECRUITING,2025-07-09,2027-05,2029-08,OBSERVATIONAL,,278,['Coronary Arteriosclerosis'],Coronary Arteriosclerosis,OrbusNeich,"['Eucatech AG', 'European Cardiovascular Research Center']","['Malaysia', 'Spain', 'Germany', 'Czechia']"
NCT04267848,"Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])",Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO),RECRUITING,2020-06-16,2025-12-15,2025-12-15,INTERVENTIONAL,PHASE3,1210,"['Lung Non-Small Cell Carcinoma', 'Lung Non-Small Cell Squamous Carcinoma', 'Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage II Lung Cancer AJCC v8', 'Stage IIIA Lung Cancer AJCC v8', 'Stage IIIB Lung Cancer AJCC v8']",Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],"['Guam', 'United States']"
NCT07157787,Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN),"A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression",RECRUITING,2025-09-19,2027-02-12,2027-02-12,INTERVENTIONAL,PHASE2,30,['Primary Membranous Nephropathy'],Primary Membranous Nephropathy,"Alexion Pharmaceuticals, Inc.",['AstraZeneca'],"['Brazil', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'United Kingdom', 'Argentina', 'Australia']"
NCT06993116,A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors,"A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-4712 in Patients With Advanced Solid Tumors",RECRUITING,2025-06-09,2027-05,2027-05,INTERVENTIONAL,PHASE1,126,['Advanced Solid Tumor'],Advanced Solid Tumor,"Guangdong Hengrui Pharmaceutical Co., Ltd",[],['China']
NCT05945485,A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults,"A Phase 1, Comparator-Controlled, Dosage-Escalation Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults",ACTIVE_NOT_RECRUITING,2023-10-16,2026-05-26,2026-05-26,INTERVENTIONAL,PHASE1,50,['Influenza'],Influenza,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06009926,Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters,"Phase II Randomized, Double-Blind, Placebo-Controlled Trial of Broccoli Seed and Sprout Extract (BSSE) to Evaluate Detoxification of Carcinogens in Firefighters",ACTIVE_NOT_RECRUITING,2023-12-04,2027-03-31,2027-11-01,INTERVENTIONAL,PHASE2,66,"['Hematopoietic and Lymphatic System Neoplasm', 'Malignant Solid Neoplasm', 'Occupational Malignant Neoplasm']",Hematopoietic and Lymphatic System Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT06854614,Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial),Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial),ACTIVE_NOT_RECRUITING,2025-03-01,2027-04-28,2028-04-28,INTERVENTIONAL,PHASE4,150,['Obesity'],Obesity,The Cleveland Clinic,[],['United States']
NCT07159555,Assessment of Neurofilaments Levels in Premature Newborns: Study of Their Early Development,Neurofilaments Levels in Premature Newborns,RECRUITING,2025-12-01,2026-08-31,2026-12-31,OBSERVATIONAL,,15,['Healthy Participants'],Healthy Participants,Centre Hospitalier Universitaire de Liege,['Centre Hospitalier Régional de la Citadelle'],['Belgium']
NCT07046585,Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC),Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC),RECRUITING,2025-05-30,2027-07-10,2033-09-30,OBSERVATIONAL,,25000,['Colo-rectal Cancer'],Colo-rectal Cancer,"Natera, Inc.",[],['United States']
NCT04628026,Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2,"A Randomized, Placebo-Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2",RECRUITING,2022-09-13,2029-03,2032-02,INTERVENTIONAL,PHASE3,650,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,University of Ulm,['Stichting Hemato-Oncologie voor Volwassenen Nederland'],"['Belgium', 'Netherlands', 'Estonia', 'Norway', 'Austria', 'Finland', 'Lithuania', 'Germany']"
NCT06881784,Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301),"RASolve 301: Phase 3 Multicenter, Open Label, Randomized Study of RMC-6236 Versus Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic RAS[MUT] NSCLC",RECRUITING,2025-05-06,2027-12-01,2030-12-01,INTERVENTIONAL,PHASE3,420,"['NSCLC (Non-small Cell Lung Cancer)', 'Non-Small Cell Lung Cancer', 'NSCLC', 'NSCLC (Non-small Cell Lung Carcinoma)', 'NSCLC (Advanced Non-small Cell Lung Cancer)']",NSCLC (Non-small Cell Lung Cancer),"Revolution Medicines, Inc.",[],"['Singapore', 'Belgium', 'Japan', 'Hong Kong', 'Netherlands', 'United States', 'France', 'Switzerland', 'Puerto Rico', 'Ireland', 'Spain', 'Italy', 'South Korea', 'Taiwan', 'Australia', 'Poland', 'Germany']"
NCT06751784,Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression,Randomized Placebo-controlled Phase II Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression,RECRUITING,2025-05-22,2026-07,2026-07,INTERVENTIONAL,PHASE2,38,"['Working Memory', 'Mild to Moderate Depression']",Working Memory,University of Basel,"['Clinical Trial Unit, University Hospital Basel, Switzerland']",['Switzerland']
NCT07264153,Laser Therapy in the Isotretinoin-Induced Sacroiliitis,Efficacy of High-Intensity Laser Therapy (HILT) in the Management of Isotretinoin-Induced Sacroiliitis: A Randomized Controlled Trial,RECRUITING,2025-11-24,2026-04-11,2026-05-11,INTERVENTIONAL,NA,50,['Sacroilitis'],Sacroilitis,Uşak University,[],['Turkey (Türkiye)']
NCT05746546,Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension,Open Label Extension Study of Depressed Mood Improvement Through Nicotine (Depressed MIND3),RECRUITING,2023-04-15,2026-07-31,2026-10-31,INTERVENTIONAL,PHASE2,60,['Depressive Disorder'],Depressive Disorder,Vanderbilt University Medical Center,['National Institute of Mental Health (NIMH)'],['United States']
NCT06439082,A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE),"A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Frequent Vaso-Occlusive Crises",RECRUITING,2024-10-24,2029-03-23,2030-04-19,INTERVENTIONAL,PHASE3,315,['Sickle Cell Disease'],Sickle Cell Disease,Novartis Pharmaceuticals,[],"['United States', 'Colombia']"
NCT07279402,TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%,TRIMPACT: A Prospective Real-World Study of Atezolizumab Monotherapy as First-Line (Stage IV) Treatment in Patients With Non-Small Cell Lung Cancer With PD-L1 Tumor Cell Expression ≥50% and No Targetable Mutations,RECRUITING,2025-09-15,2027-05-01,2027-10-01,OBSERVATIONAL,,150,"['NSCLC Stage IV', 'PD-L1 Gene Mutation', 'Atezolizumab', 'Real World Study']",NSCLC Stage IV,Antalya Training and Research Hospital,['Hoffmann-La Roche'],['Turkey (Türkiye)']
NCT07153939,Pivotal Study of the Velocity™ pAVF System,Multicenter Pivotal Study of the Velocity™ Percutaneous Arterio-Venous Fistula System,RECRUITING,2025-10-21,2026-09,2030-09,INTERVENTIONAL,NA,126,"['Chronic Kidney Disease', 'Hemodialysis Access', 'Arteriovenous Fistula', 'End Stage Renal Disease (ESRD)']",Chronic Kidney Disease,Venova Medical,[],['United States']
NCT06325683,Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma,Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma,RECRUITING,2024-11-08,2028-07-15,2028-07-15,INTERVENTIONAL,PHASE2,184,"['Progressive Glioblastoma', 'Recurrent Glioblastoma']",Progressive Glioblastoma,National Cancer Institute (NCI),[],['United States']
NCT06484062,"Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes",A Phase I Study Evaluating the Safety of Cirtuvivint as Monotherapy and in Combination With ASTX727 in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML),RECRUITING,2025-08-15,2028-06-01,2028-06-01,INTERVENTIONAL,PHASE1,54,"['Acute Myeloid Leukemia', 'Myelodysplastic Syndrome', 'Recurrent Acute Myeloid Leukemia', 'Recurrent Myelodysplastic Syndrome', 'Refractory Acute Myeloid Leukemia', 'Refractory Myelodysplastic Syndrome']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],['United States']
NCT07128888,Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection,"A Study to Evaluate the Effect of GZR18 Injection on Gastric Emptying and Its Drug-Drug Interactions With Digoxin, Rosuvastatin Calcium and Warfarin Sodium in Obese or Overweight Subjects",RECRUITING,2025-11-17,2026-07-05,2026-07-05,INTERVENTIONAL,PHASE1,60,['Obesity or Overweight'],Obesity or Overweight,Gan & Lee Pharmaceuticals.,[],['China']
NCT06512883,A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases,"Phase 3, Open-label Trial to Evaluate Safety, Pharmacokinetics, and Efficacy of Benralizumab in Children With Eosinophilic Diseases (CLIPS)",RECRUITING,2025-04-17,2026-10-06,2027-12-29,INTERVENTIONAL,PHASE3,4,['Eosinophilic Granulomatosis With Polyangiitis (EGPA)'],Eosinophilic Granulomatosis With Polyangiitis (EGPA),AstraZeneca,[],"['Brazil', 'Turkey (Türkiye)', 'United States', 'Mexico', 'Canada']"
NCT04335799,Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools,Improving Weight Loss Outcomes of Black Women Using a Culturally-Relevant Stress-Management Enhanced Behavioral Weight Loss Intervention,ACTIVE_NOT_RECRUITING,2021-10-12,2026-03-31,2027-03-31,INTERVENTIONAL,NA,341,['Obesity'],Obesity,H. Lee Moffitt Cancer Center and Research Institute,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT05993728,Virtual Body Project Groups Led by Peers Versus Clinicians,Effectiveness of the Body Project to Prevent Eating Disorders in Young Females at Risk: a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2024-02-15,2027-12-31,2029-12-31,INTERVENTIONAL,NA,441,"['Eating Disorders', 'Body Image']",Eating Disorders,Oslo University Hospital,"['Karolinska Institutet', 'Stanford University', 'Oslo New University College, Norway']",['Norway']
NCT06988709,Examining the Most Effective Method to Reduce Running Ground Contact Time,Examining the Most Effective Method to Reduce Running Ground Contact Time,RECRUITING,2025-05-01,2026-12-01,2026-12-01,INTERVENTIONAL,NA,30,['Healthy Runners'],Healthy Runners,Keller Army Community Hospital,[],['United States']
NCT06770036,Caregiver Implementation Strategies Field Pre-Test,"Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions With ADHD: A Pilot Study, Aim 1",ACTIVE_NOT_RECRUITING,2025-07-30,2026-01,2026-01,INTERVENTIONAL,NA,20,['Attention Deficit Hyperactivity Disorder Symptoms'],Attention Deficit Hyperactivity Disorder Symptoms,Children's Hospital of Philadelphia,['National Institute of Mental Health (NIMH)'],['United States']
NCT05378100,Ketamine for Multiple Sclerosis Fatigue,Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS),RECRUITING,2023-01-01,2026-06-01,2026-10-01,INTERVENTIONAL,PHASE2,110,['Multiple Sclerosis Fatigue'],Multiple Sclerosis Fatigue,Johns Hopkins University,['United States Department of Defense'],['United States']
NCT04713722,Early Life Stress and Depression: Molecular and Functional Imaging,Early Life Stress and Depression: Molecular and Functional Imaging,RECRUITING,2021-02-01,2026-06-30,2026-06-30,OBSERVATIONAL,,160,"['Depression', 'Trauma, Psychological']",Depression,Mclean Hospital,[],['United States']
NCT07081503,Phase 1 Study of ADX-626 in Healthy Participants,"A Phase 1, Randomized, Blinded, Placebo-Controlled Study to Assess ADX-626 in Healthy Participants",RECRUITING,2025-08-12,2027-01-22,2027-01-22,INTERVENTIONAL,PHASE1,44,['Healthy Adult Participants'],Healthy Adult Participants,"ADARx Pharmaceuticals, Inc.",[],['United Kingdom']
NCT03854474,"Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced Urothelial Carcinoma",A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma,ACTIVE_NOT_RECRUITING,2019-11-18,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,30,"['Locally Advanced Urothelial Carcinoma', 'Metastatic Urothelial Carcinoma', 'Stage III Bladder Cancer AJCC v8', 'Stage IV Bladder Cancer AJCC v8']",Locally Advanced Urothelial Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT06473779,Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.,"A Multicentre, Randomised, Open-Label, Parallel-Group, Phase IIIb Study to Assess the Potential for Tezepelumab-treated Patients With Severe Asthma to Reduce Background Therapy While Sustaining Asthma Control and Clinical Remission",RECRUITING,2024-09-30,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE3,300,['Severe Asthma'],Severe Asthma,AstraZeneca,['Fortrea'],"['Belgium', 'Bulgaria', 'United States', 'France', 'Mexico', 'Denmark', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Argentina', 'Germany']"
NCT06628310,"A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma","A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Subjects With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA-977)",RECRUITING,2024-12-13,2030-10,2030-10,INTERVENTIONAL,PHASE2,180,"['Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma', 'Gastroesophageal Junction Adenocarcinoma', 'Esophageal Adenocarcinoma']",Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma,AbbVie,[],"['Israel', 'Japan', 'China', 'United States', 'Puerto Rico', 'Taiwan']"
NCT06690489,An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events),Impact of Dermatological Toxicities on Quality of Life in Patients With Early Breast Cancer Exposed to Adjuvant Endocrine Therapy: a Real-world Cross-sectional Study. BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events),RECRUITING,2024-11-22,2026-03,2026-03,OBSERVATIONAL,,156,"['Early Breast Cancer', 'Skin Condition', 'Quality of Life']",Early Breast Cancer,Pierre Fabre Medicament,[],"['Greece', 'Spain', 'Italy', 'France']"
NCT06058377,"Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer",Phase III Trial Of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone For Adults With MammaPrint High 2 Risk (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer,RECRUITING,2023-11-27,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE3,3680,"['Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8', 'HER2-Negative Breast Carcinoma', 'Hormone Receptor-Positive Breast Carcinoma']",Anatomic Stage II Breast Cancer AJCC v8,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06770582,"Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial",Randomized Phase II Trial of Pembrolizumab and Radiation vs. Radiation and Concurrent Chemotherapy for High-Grade T1 Bladder Cancer (PARRC Trial),RECRUITING,2025-06-03,2032-02-01,2032-02-01,INTERVENTIONAL,PHASE2,160,"['Non-Muscle Invasive Bladder Urothelial Carcinoma', 'Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma', 'Stage I Bladder Cancer AJCC v8']",Non-Muscle Invasive Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06065540,"A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor","Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4/2.4 mg and 1.0/1.0 mg Once Weekly Versus Semaglutide 2.4 mg and 1.0 mg, Cagrilintide 2.4 mg and Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Metformin With or Without an SGLT2 Inhibitor",ACTIVE_NOT_RECRUITING,2023-09-27,2025-11-19,2026-01-05,INTERVENTIONAL,PHASE3,2734,['Type 2 Diabetes Mellitus'],Type 2 Diabetes Mellitus,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'China', 'Slovakia', 'Australia', 'Israel', 'Hungary', 'Slovenia', 'Finland', 'Croatia', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT06869941,Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis,Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis (POINSETTIA Study),RECRUITING,2025-08-05,2028-04,2028-04,OBSERVATIONAL,,60,['Obesity'],Obesity,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,[],['Spain']
NCT05840159,A Study of Doxycycline to Treat Chlamydial Infection,A Phase 4 Study of a 3-Day vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection,RECRUITING,2024-01-19,2026-02-28,2026-02-28,INTERVENTIONAL,PHASE4,664,['Chlamydial Infection'],Chlamydial Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],"['Kenya', 'United States']"
NCT06872892,The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis,"A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of BI 1291583 2.5 mg Administered Once Daily for up to 76 Weeks in Patients With Bronchiectasis (The AIRTIVITY™ Study)",RECRUITING,2025-06-09,2028-09-14,2028-10-12,INTERVENTIONAL,PHASE3,1755,['Bronchiectasis'],Bronchiectasis,Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Puerto Rico', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'Kazakhstan', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Latvia', 'United Kingdom', 'Portugal', 'Vietnam', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Egypt', 'Argentina', 'Philippines']"
NCT06150716,"Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)","A Phase 1b Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION356 in Patients With Pelizaeus Merzbacher Disease",RECRUITING,2024-04-10,2028-06,2028-06,INTERVENTIONAL,PHASE1,24,['Pelizaeus-Merzbacher Disease'],Pelizaeus-Merzbacher Disease,"Ionis Pharmaceuticals, Inc.",[],"['Japan', 'Netherlands', 'United States', 'France', 'Germany']"
NCT06353191,Biomarkers to Predict Cancer Therapy-related Cardiotoxicity,Biomarkers to Predict Cancer Therapy-Related Cardiotoxicity,RECRUITING,2019-05-03,2026-06-01,2026-06-01,OBSERVATIONAL,,1000,"['Hematopoietic and Lymphatic System Neoplasm', 'Malignant Solid Neoplasm']",Hematopoietic and Lymphatic System Neoplasm,Mayo Clinic,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06980623,Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction,Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction,ACTIVE_NOT_RECRUITING,2025-01-01,2025-11-30,2026-03-01,OBSERVATIONAL,,26000,"['Type 2 Diabetes', 'Heart Failure']",Type 2 Diabetes,Brigham and Women's Hospital,[],['United States']
NCT07000084,"Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy",GAIN-BCG: Gemcitabine Alternating With INtravesical BCG Randomized Against BCG Alone for Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer,RECRUITING,2025-07-17,2028-06-05,2028-12-05,INTERVENTIONAL,PHASE3,330,"['Recurrent Non-Muscle Invasive Bladder Carcinoma', 'Stage 0a Bladder Cancer AJCC v8', 'Stage I Bladder Cancer AJCC v8']",Recurrent Non-Muscle Invasive Bladder Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT05333458,"Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial",A Phase 2 Study of Atezolizumab With Selinexor in Alveolar Soft Part Sarcoma (AXIOM),RECRUITING,2022-08-29,2027-05-01,2027-05-01,INTERVENTIONAL,PHASE2,27,"['Advanced Alveolar Soft Part Sarcoma', 'Advanced Soft Tissue Sarcoma', 'Metastatic Alveolar Soft Part Sarcoma', 'Refractory Alveolar Soft Part Sarcoma', 'Unresectable Alveolar Soft Part Sarcoma']",Advanced Alveolar Soft Part Sarcoma,National Cancer Institute (NCI),[],['United States']
NCT06131437,A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight,Efficacy and Safety of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly Compared to Tirzepatide 15 mg s.c. Once-weekly in Participants With Obesity,ACTIVE_NOT_RECRUITING,2023-11-27,2025-12-02,2026-01-13,INTERVENTIONAL,PHASE3,809,['Obesity'],Obesity,Novo Nordisk A/S,[],['United States']
NCT03422198,Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer,Short Course Adjuvant Vaginal Cuff Brachytherapy (VCB) in Early Endometrial Cancer Compared to Standard of Care (SAVE),RECRUITING,2018-02-02,2026-11-30,2029-10-31,INTERVENTIONAL,PHASE3,188,"['Endometrial Clear Cell Adenocarcinoma', 'Endometrial Endometrioid Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Stage I Uterine Corpus Cancer', 'Stage IA Uterine Corpus Cancer', 'Stage IB Uterine Corpus Cancer', 'Stage II Uterine Corpus Cancer', 'Uterine Corpus Carcinosarcoma', 'Uterine Corpus Sarcoma']",Endometrial Clear Cell Adenocarcinoma,University of Utah,['Huntsman Cancer Institute'],['United States']
NCT07218887,ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy,"A Phase 1/2, Open-Label, Multicenter, Dose Finding and Dose Expansion Study to Investigate the Safety, Tolerability, and Efficacy of ALXN2350 Gene Therapy in Adult Participants With BAG3 Mutation Associated Dilated Cardiomyopathy",RECRUITING,2025-10-24,2032-01-27,2032-01-27,INTERVENTIONAL,PHASE1,18,['BAG3 Mutation Associated Dilated Cardiomyopathy'],BAG3 Mutation Associated Dilated Cardiomyopathy,"Alexion Pharmaceuticals, Inc.",[],['United States']
NCT05433584,A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes,"A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes",ACTIVE_NOT_RECRUITING,2022-08-01,2025-10-21,2027-11,INTERVENTIONAL,PHASE4,780,['Type 2 Diabetes'],Type 2 Diabetes,Eli Lilly and Company,[],"['Israel', 'United States', 'Mexico', 'Slovakia', 'Puerto Rico', 'Italy', 'Canada', 'Romania', 'United Kingdom', 'Argentina', 'Germany']"
NCT06692907,Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults,"A Phase 2b, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy of Intramuscularly Administered CssBA+dmLT Against Moderate-severe Diarrhea in a Controlled Human Infection Model With Enterotoxigenic Escherichia Coli (ETEC) Strain B7A in Healthy Adults",ACTIVE_NOT_RECRUITING,2025-03-31,2026-02-20,2026-08-20,INTERVENTIONAL,PHASE2,72,['Escherichia Infection'],Escherichia Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06619587,"A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors","A Phase I/II Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors With a KRAS G12D Mutation",RECRUITING,2024-11-14,2028-05-31,2028-05-31,INTERVENTIONAL,PHASE1,410,['Solid Tumor'],Solid Tumor,"Genentech, Inc.",[],"['Singapore', 'Israel', 'United States', 'Spain', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT06676098,The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD),The Optimal Injection Site for a 3D Guided Inferior Alveolar Nerve Block Device (IANBD): A Randomized Control Trial,RECRUITING,2026-01,2027-11,2027-11,INTERVENTIONAL,NA,10,['Inferior Alveolar Nerve Block'],Inferior Alveolar Nerve Block,Boston University,[],['United States']
NCT07279636,A Study to Evaluate Single Doses of Alpha-0261 in Healthy Adult Volunteers,"A Randomized, Double-blind, Placebo-Controlled, Dose-Escalation, Phase Ia Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Oral Administration of Alpha-0261 Tablets in Adult Healthy Participants",RECRUITING,2025-07-21,2026-03-20,2026-05-30,INTERVENTIONAL,PHASE1,60,['Healthy Volunteers'],Healthy Volunteers,AlphaMol Science Ltd. (Shanghai),[],['China']
NCT06102044,Zinc Supplementation for Young Infants With Clinical Severe Infection in Tanzania,Trial of Zinc Supplements for Young Infants With Clinical Severe Infection in Tanzania,RECRUITING,2024-12-27,2027-10-30,2027-10-30,INTERVENTIONAL,PHASE3,3250,['Neonatal Infection'],Neonatal Infection,Harvard School of Public Health (HSPH),['Muhimbili University of Health and Allied Sciences'],['Tanzania']
NCT04994717,Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia,"Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in (Golden Gate Study)",RECRUITING,2021-11-02,2029-09-07,2031-09-30,INTERVENTIONAL,PHASE3,304,['Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)'],Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL),Amgen,[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Chile', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT05047250,"A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer","A Phase III, Single-Arm Multicenter Study of Atezolizumab (Anti-PD-L1 Antibody) in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2022-06-14,2026-06-30,2027-08-30,INTERVENTIONAL,PHASE3,60,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Hoffmann-La Roche,[],['China']
NCT02523014,"Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas",Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations,RECRUITING,2015-09-28,2026-01,2028-01,INTERVENTIONAL,PHASE2,124,"['Intracranial Meningioma', 'Recurrent Meningioma', 'NF2 Gene Mutation']",Intracranial Meningioma,Alliance for Clinical Trials in Oncology,"['National Cancer Institute (NCI)', 'GlaxoSmithKline', 'Genentech, Inc.', 'Brain Science Foundation']",['United States']
NCT04579224,Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer,"A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy",RECRUITING,2021-06-28,2030-08-15,2030-08-15,INTERVENTIONAL,PHASE3,184,"['Metastatic Bladder Urothelial Carcinoma', 'Metastatic Urothelial Carcinoma', 'Refractory Bladder Urothelial Carcinoma', 'Refractory Urothelial Carcinoma', 'Stage IV Bladder Cancer AJCC v8']",Metastatic Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06606990,Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers,Pilot Study of Pidnarulex Pharmacodynamics in Patients With Advanced Solid Tumors,RECRUITING,2025-07-01,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,40,['Metastatic Malignant Solid Neoplasm'],Metastatic Malignant Solid Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT05554380,"Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial",Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With PTEN/AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial,RECRUITING,2023-09-22,2026-08-31,2026-08-31,INTERVENTIONAL,PHASE2,33,"['Locally Advanced Malignant Solid Neoplasm', 'Metastatic Malignant Solid Neoplasm', 'Unresectable Malignant Solid Neoplasm']",Locally Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT05808764,A Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy,"A Phase II, Open-label Study to Investigate the Pharmacokinetics and Safety of Risdiplam in Infants With Spinal Muscular Atrophy",RECRUITING,2024-04-26,2026-04-17,2026-04-17,INTERVENTIONAL,PHASE2,10,"['Muscular Atrophy, Spinal']","Muscular Atrophy, Spinal",Hoffmann-La Roche,[],"['Belgium', 'Netherlands', 'Norway', 'United States', 'Italy', 'Canada', 'Poland', 'Germany']"
NCT04269902,"Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study","Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study",RECRUITING,2021-03-02,2028-10-01,2028-10-01,INTERVENTIONAL,PHASE3,247,"['Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma']",Chronic Lymphocytic Leukemia,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT06997029,A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors,A Phase 1 First-in-human Study of BMS-986500 as Monotherapy in Advanced Solid Tumors and as Combination Therapy in CDK4/6 Inhibitor Pre-treated Advanced Breast Cancer,RECRUITING,2025-08-01,2028-12-14,2028-12-14,INTERVENTIONAL,PHASE1,234,"['Advanced Solid Tumor', 'Advanced Breast Cancer', 'Advanced Ovarian Cancer']",Advanced Solid Tumor,Bristol-Myers Squibb,[],"['Japan', 'United States']"
NCT06003387,Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs),"Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies",RECRUITING,2024-01-30,2028-10-04,2032-04-02,INTERVENTIONAL,PHASE3,35,['Hemophilia B'],Hemophilia B,CSL Behring,[],"['Singapore', 'Israel', 'South Africa', 'Hong Kong', 'Saudi Arabia', 'Turkey (Türkiye)', 'United States', 'Mexico', 'Taiwan', 'South Korea', 'Canada', 'Australia']"
NCT05920356,A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202),"A Phase 3, Multicenter, Randomized, Open-label Study Evaluating Efficacy of Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers, Negative for PD-L1, and Positive for KRAS p.G12C (CodeBreaK 202)",RECRUITING,2023-11-16,2026-06-30,2031-06-30,INTERVENTIONAL,PHASE3,750,['Non-Small Cell Lung Cancer (NSCLC)'],Non-Small Cell Lung Cancer (NSCLC),Amgen,[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07110337,Diagnosing Epilepsy To EffeCT Change,A Prospective Study to Evaluate the Use of the Minder Device to Aid in Developing a Treatment Plan After Inconclusive Prolonged EEG in Patients With Epilepsy,RECRUITING,2025-12,2027-06,2027-06,INTERVENTIONAL,PHASE4,210,"['Epilepsy', 'Epilepsy (Treatment Refractory)']",Epilepsy,"Epiminder America, Inc.",[],['United States']
NCT04530565,Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults,A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction With Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) in Adults,RECRUITING,2021-01-25,2028-07-01,2028-07-01,INTERVENTIONAL,PHASE3,348,['B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1'],B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,National Cancer Institute (NCI),[],"['Israel', 'Puerto Rico', 'United States']"
NCT07270185,Measuring Outcomes With Validated Exercise,Measuring Outcomes With Validated Exercise,RECRUITING,2025-12-04,2026-12,2026-12,OBSERVATIONAL,,54,['Physical Activity'],Physical Activity,Boston University,['Pfizer'],['United States']
NCT05130450,A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS),An Open-Label Extension Study of AKCEA-APOCIII-LRx Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS),ACTIVE_NOT_RECRUITING,2021-11-18,2028-02,2028-02,INTERVENTIONAL,PHASE3,60,['Familial Chylomicronemia Syndrome'],Familial Chylomicronemia Syndrome,"Ionis Pharmaceuticals, Inc.",[],"['Netherlands', 'Norway', 'United States', 'France', 'Slovakia', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Portugal', 'Sweden']"
NCT07280676,The Effect of Cosmetic Formulations on the Appearance of Grey Hair.,The Effect of Cosmetic Formulations on the Appearance of Gray Hair,RECRUITING,2025-12-15,2026-10,2026-10,INTERVENTIONAL,NA,380,['Hair Graying'],Hair Graying,Unilever R&D,"['Comprehensive Research Group, Inc.']",['United States']
NCT06118515,A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus,A Phase I Pharmacokinetic and Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus Disease,RECRUITING,2025-02-19,2026-05-15,2026-08-31,INTERVENTIONAL,PHASE1,12,['Congenital Cytomegalovirus Infection'],Congenital Cytomegalovirus Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06157892,A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors,A Phase 1b/2 Open-Label Study of Disitamab Vedotin in Combination With Other Anticancer Therapies in Solid Tumors,RECRUITING,2024-05-20,2029-07-28,2029-07-28,INTERVENTIONAL,PHASE2,172,"['Breast Neoplasms', 'Gastroesophageal Junction Adenocarcinoma', 'HER2 Low Breast Neoplasms', 'HER2 Positive Breast Neoplasms', 'Stomach Neoplasms', 'Triple Negative Breast Neoplasms', 'Metastatic Breast Cancer', 'Metastatic Gastric Cancer', 'Advanced Breast Cancer', 'Advanced Gastric Cancer']",Breast Neoplasms,"Seagen, a wholly owned subsidiary of Pfizer","['RemeGen Co., Ltd.']","['United States', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'Australia', 'United Kingdom', 'Germany']"
NCT06058793,Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma,"Brightline-4: A Phase III Open-label, Single-arm, Multi-center Study to Assess the Safety and Efficacy of Brigimadlin (BI 907828) Treatment in Patients With Treatment-naïve or Pre-treated Advanced Dedifferentiated Liposarcoma",ACTIVE_NOT_RECRUITING,2023-12-13,2025-12-18,2025-12-18,INTERVENTIONAL,PHASE3,138,"['Liposarcoma, Dedifferentiated']","Liposarcoma, Dedifferentiated",Boehringer Ingelheim,[],"['Brazil', 'Japan', 'United States', 'Canada', 'United Kingdom', 'Argentina', 'Australia']"
NCT07279909,Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation,Pre-Clinical & Clinical Studies on Poly Herbal Anti-Diabetic Formulation,ACTIVE_NOT_RECRUITING,2024-03-09,2025-08-01,2026-05-20,INTERVENTIONAL,PHASE3,500,"['Diabetes Type 2', 'Diabetes Mellitus, Experimental', 'HbA1c', 'Urinary Glucose', 'Ability of Experimental Drug to Lower HbA1c Compare to Metformin']",Diabetes Type 2,Hamdard University,['Jinnah Postgraduate Medical Centre'],['Pakistan']
NCT05244733,Culture and Well-Being for Latinos,Culture and Well-Being for Latinos: Study Protocol for Cultural-Social Engagement and Suicide Among Hispanics (K23MH125078),RECRUITING,2022-06-01,2026-07-31,2026-07-31,INTERVENTIONAL,NA,65,"['Social Isolation', 'Loneliness', 'Suicidal Ideation']",Social Isolation,University of Rochester,['National Institute of Mental Health (NIMH)'],['United States']
NCT07269977,mSCI: Mobile Health App for Veterans With SCI and Caregivers,mSCI: mHealth for Supporting Psychosocial Health of Military Service Members With SCI and Their Family Caregivers,RECRUITING,2025-12-01,2029-11,2029-11,OBSERVATIONAL,,100,"['Spinal Cord Injuries (SCI)', 'Spinal Cord Injury', 'Spinal Cord Injuries (Complete and Incomplete)', 'Family Caregivers', 'Families of Veterans', 'Disabled Veterans']",Spinal Cord Injuries (SCI),University of Pittsburgh,['Congressionally Directed Medical Research Programs'],['United States']
NCT05837767,A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue,A Pilot Study of Spatially Fractionated Radiation Therapy in Patients With Extra-Cranial Soft Tissue Metastases,RECRUITING,2023-07-24,2026-07-24,2026-07-24,INTERVENTIONAL,NA,26,"['Invasive Ductal Breast Carcinoma', 'Invasive Ductal Breast Carcinoma Stage IV', 'Lobular Breast Carcinoma', 'Lobular Breast Carcinoma Stage IV', 'Non Small Cell Lung Cancer', 'NSCLC', 'Gastrointestinal Cancer', 'Gastrointestinal Squamous Cell Cancer', 'Gastrointestinal Adenocarcinoma', 'Pancreatic Cancer', 'Bladder Cancer', 'Renal Cell Carcinoma', 'Melanoma', 'Sarcoma', 'Metastatic Solid Tumor']",Invasive Ductal Breast Carcinoma,Memorial Sloan Kettering Cancer Center,['Varian Medical Systems'],['United States']
NCT07003295,"Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy",A Phase II Study of Glofitamab for Relapsed/Refractory Mantle Cell Lymphoma in Patients Previously Treated With CD19-Directed CAR T-Cell Therapy,RECRUITING,2026-08-14,2027-08-31,2027-08-31,INTERVENTIONAL,PHASE2,20,"['Recurrent Mantle Cell Lymphoma', 'Refractory Mantle Cell Lymphoma']",Recurrent Mantle Cell Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT02650414,CD22 Redirected Autologous T Cells for ALL,Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells in Pediatric Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia,ACTIVE_NOT_RECRUITING,2016-01-13,2037-12,2037-12,INTERVENTIONAL,PHASE1,41,"['B Cell Leukemias', 'B Cell Lymphomas']",B Cell Leukemias,University of Pennsylvania,"[""Children's Hospital of Philadelphia""]",['United States']
NCT06670755,ID93/GLA-SE Vaccination + BCG Challenge,A Clinical Trial Evaluating the Safety of an Aerosol BCG Controlled Human Infection Model in Assessing the Immunogenicity of Historical BCG Vaccination and Vaccination With ID93/GLA-SE in Healthy Adult Volunteers,ACTIVE_NOT_RECRUITING,2024-12-18,2027-07,2027-07,INTERVENTIONAL,NA,48,['Tuberculosis'],Tuberculosis,University of Oxford,[],['United Kingdom']
NCT05450432,Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression,Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression,RECRUITING,2022-10-13,2026-06-01,2026-06-01,INTERVENTIONAL,PHASE4,100,['Major Depressive Disorder'],Major Depressive Disorder,Massachusetts General Hospital,['American Foundation for Suicide Prevention'],['United States']
NCT06418282,Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema,"An Open-label, Multi-center, Prospective VA Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema",RECRUITING,2024-05-13,2025-12-31,2026-01-31,INTERVENTIONAL,NA,100,"['Phlebolymphedema', 'Lymphedema', 'Chronic Venous Insufficiency']",Phlebolymphedema,"Koya Medical, Inc.",[],['United States']
NCT05832177,Outreach Core Activities,Outreach Core Activities,RECRUITING,2023-03-22,2028-07,2028-07,OBSERVATIONAL,,1200,"['Cancer Education', 'Spanish Language Cancer Education']",Cancer Education,H. Lee Moffitt Cancer Center and Research Institute,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT07279766,Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19,"A Phase 4 Pragmatic, Randomized Trial to Evaluate the Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19",RECRUITING,2025-12-11,2026-08,2026-08,INTERVENTIONAL,PHASE4,285000,['COVID-19'],COVID-19,Tor Biering-Sørensen,"['ModernaTX, Inc.']",['Denmark']
NCT05814627,Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis,"A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and Who Had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)",ACTIVE_NOT_RECRUITING,2023-06-15,2026-07,2026-07,INTERVENTIONAL,PHASE3,487,['Rheumatoid Arthritis'],Rheumatoid Arthritis,AbbVie,[],"['Bulgaria', 'Japan', 'China', 'Belgium', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Croatia', 'South Korea', 'Colombia', 'South Africa', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT06621524,EucaLimus Post-Market Registry,Coronary Angioplasty With Sirolimus Drug-coated Stent System to Treat Patients With Symptomatic Ischemic Coronary Heart Disease: a PMCF Study.,RECRUITING,2025-03-14,2026-10,2028-10,OBSERVATIONAL,,251,['Coronary Arterioscleroses'],Coronary Arterioscleroses,OrbusNeich,"['Eucatech AG', 'Centre Européen de Recherche Cardiovasculaire']","['Spain', 'Malaysia', 'Czechia']"
NCT05464667,Preoperative Irradiation for Stage I Breast Cancer,Preoperative Irradiation for Stage I Breast Cancer: A Phase IB Study,RECRUITING,2023-07-07,2026-04-30,2028-03-31,INTERVENTIONAL,NA,21,['Breast Cancer'],Breast Cancer,Parul Barry,[],['United States']
NCT07266298,TCR-engineered T Cells (NW-101C) in Patients With Solid Malignant Tumors,"A Phase I, Multicenter, Dose-escalation, Single-arm Study of PRAME Antigen-targeted TCR-T Cells(NW-101C) in the Treatment of Subjects With Advanced Solid Malignant Tumors.",RECRUITING,2025-12,2028-12,2030-12,INTERVENTIONAL,PHASE1,24,['Solid Metastatic Tumor'],Solid Metastatic Tumor,Neowise Biotechnology,[],['China']
NCT06287216,Preliminary Evaluation of a Mental Health Program: a Comparison Study,Preliminary Evaluation of a Mental Health Program: a Comparison Study,RECRUITING,2024-02-29,2026-04-30,2026-04-30,INTERVENTIONAL,NA,200,['Mental Wellbeing'],Mental Wellbeing,The Royal Ottawa Mental Health Centre,[],['Canada']
NCT04543591,Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ravulizumab in Adult and Adolescent Participants Who Have Thrombotic Microangiopathy (TMA) After Hematopoietic Stem Cell Transplant (HSCT)",ACTIVE_NOT_RECRUITING,2020-12-10,2025-09-19,2026-03-20,INTERVENTIONAL,PHASE3,148,['Thrombotic Microangiopathy'],Thrombotic Microangiopathy,"Alexion Pharmaceuticals, Inc.",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Greece', 'Sweden', 'Australia']"
NCT06968780,Buccal Fat Pad vs. Palatal Rotation Scarf Grafts for Soft Tissue Management Around Zygomatic Implants,Buccal Pad of Fat Graft vs. Palatal Rotation Scarf Graft for Soft Tissue Enhancement and Prevention of Dehiscence Around Zygomatic Implants Placed in Patients With Severely Atrophic Maxilla: A Randomized Clinical Trial,RECRUITING,2025-06-01,2026-07-01,2026-12-01,INTERVENTIONAL,NA,8,"['Zygomatic Implants', 'Atrophic Maxilla', 'Soft Tissue Defect', 'Soft Tissue Healing']",Zygomatic Implants,Cairo University,[],['Egypt']
NCT05630820,Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2),"Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B Virus (B-Well 2)",ACTIVE_NOT_RECRUITING,2022-12-06,2025-11-03,2026-04-29,INTERVENTIONAL,PHASE3,857,"['Chronic Hepatitis B', 'Hepatitis B, Chronic']",Chronic Hepatitis B,GlaxoSmithKline,[],"['Bulgaria', 'Japan', 'New Zealand', 'China', 'Australia', 'Hungary', 'Panama', 'France', 'South Korea', 'Thailand', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT06745323,"A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC","A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With Small Cell Lung Cancer (SCLC) (DeLLphi-309)",RECRUITING,2025-02-26,2029-02-13,2029-02-13,INTERVENTIONAL,PHASE2,240,['Small Cell Lung Cancer (SCLC)'],Small Cell Lung Cancer (SCLC),Amgen,[],"['Brazil', 'Belgium', 'Japan', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Greece', 'Argentina', 'Australia']"
NCT06337318,Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma,Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma,RECRUITING,2024-10-23,2032-03-31,2032-03-31,INTERVENTIONAL,PHASE3,600,"['Classic Follicular Lymphoma', 'Follicular Lymphoma With Unusual Cytological Features']",Classic Follicular Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT04181060,Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer,Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC),RECRUITING,2020-12-28,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE3,300,"['Advanced Lung Non-Squamous Non-Small Cell Carcinoma', 'Metastatic Lung Non-Squamous Non-Small Cell Carcinoma', 'Recurrent Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage IIIB Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8']",Advanced Lung Non-Squamous Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05691361,"Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients","A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers and a Phase 2a, Open-Label Study in Patients With Hereditary Angioedema to Evaluate the Safety, Tolerability, PK and PD of ADX-324",RECRUITING,2022-12-14,2025-09-30,2026-01-31,INTERVENTIONAL,PHASE1,53,['Hereditary Angioedema'],Hereditary Angioedema,"ADARx Pharmaceuticals, Inc.",['Avance Clinical Pty Ltd.'],['Australia']
NCT03321643,"Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma",A Pilot Phase I Study of Atezolizumab (MPDL3280A) in Combination With Immunogenic Chemotherapy (Gemcitabine-Oxaliplatin) and Rituximab for Transformed Diffuse Large B-Cell Lymphoma,ACTIVE_NOT_RECRUITING,2018-09-18,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,24,"['Recurrent Diffuse Large B-Cell Lymphoma', 'Recurrent Transformed Non-Hodgkin Lymphoma', 'Refractory Diffuse Large B-Cell Lymphoma', 'Refractory Transformed Non-Hodgkin Lymphoma', 'Richter Syndrome', 'Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma']",Recurrent Diffuse Large B-Cell Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT02297724,MRI Assessment of Placental Health,MRI Assessment of Placental Health,RECRUITING,2014-04,2027-09,2028-09,OBSERVATIONAL,,80,['Intrauterine Growth Restriction'],Intrauterine Growth Restriction,Boston Children's Hospital,"['Massachusetts General Hospital', 'Massachusetts Institute of Technology', 'National Institute for Biomedical Imaging and Bioengineering (NIBIB)', 'Madrid-MIT M+Visión Consortium']","['Spain', 'United States']"
NCT06952660,Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer,A PROSPECTIVE LOW-INTERVENTIONAL PHASE 4 SINGLE ARM STUDY OF OCULAR ASSESSMENTS IN PATIENTS TREATED WITH TIVDAK® IN RECURRENT OR METASTATIC CERVICAL CANCER,RECRUITING,2025-05-07,2028-12-13,2028-12-13,INTERVENTIONAL,PHASE4,100,['Cervical Cancer'],Cervical Cancer,Pfizer,['Genmab'],"['Puerto Rico', 'United States']"
NCT06555289,Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery,Visual and Refractive Outcomes of the Clareon PanOptix Pro IOL in Patients With Prior Myopic Refractive Surgery,RECRUITING,2024-10-23,2026-09-01,2026-09-01,OBSERVATIONAL,,40,['Cataract'],Cataract,Juliette Eye Institute Research Center,['Sengi'],['United States']
NCT05925608,Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells,Phase I/II Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells (hMSCs) in Patients With Ischemic Heart Failure With Reduced Ejection Fraction (HFrEF),ACTIVE_NOT_RECRUITING,2023-08-23,2026-12,2027-12,INTERVENTIONAL,PHASE1,39,"['Heart Failure, Systolic']","Heart Failure, Systolic","BioCardia, Inc.",[],['United States']
NCT06064097,"A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)","A Phase 2 Study Using Chemoimmunotherapy With Gemcitabine, Cisplatin and Nivolumab in Newly Diagnosed Nasopharyngeal Carcinoma (NPC)",RECRUITING,2024-06-25,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,50,"['Stage II Nasopharyngeal Carcinoma AJCC v8', 'Stage III Nasopharyngeal Carcinoma AJCC v8', 'Stage IV Nasopharyngeal Carcinoma AJCC v8']",Stage II Nasopharyngeal Carcinoma AJCC v8,National Cancer Institute (NCI),[],"['Puerto Rico', 'New Zealand', 'United States', 'Canada']"
NCT05111574,Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery,A Randomized Phase II Trial of Adjuvant Nivolumab With or Without Cabozantinib in Patients With Resected Mucosal Melanoma,RECRUITING,2022-08-11,2025-12-19,2025-12-19,INTERVENTIONAL,PHASE2,99,"['Anal Melanoma', 'Bladder Melanoma', 'Cervical Melanoma', 'Esophageal Melanoma', 'Gallbladder Melanoma', 'Head and Neck Mucosal Melanoma', 'Mucosal Melanoma', 'Nasopharyngeal Mucosal Melanoma', 'Oral Cavity Mucosal Melanoma', 'Penile Mucosal Melanoma', 'Rectal Melanoma', 'Recurrent Mucosal Melanoma', 'Sinonasal Mucosal Melanoma', 'Urethral Melanoma', 'Urinary System Mucosal Melanoma', 'Vaginal Melanoma', 'Vulvar Melanoma']",Anal Melanoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT07263243,Immediate Effect of Whole-Body Vibration on Cardiovascular Response and Functional Capacity in Overweight/Obese Young Women,Immediate Effect of Whole-Body Vibration on Cardiovascular Response and Functional Capacity in Overweight/Obese Young Women,RECRUITING,2026-01-24,2026-02-24,2026-02-24,INTERVENTIONAL,NA,26,"['Overweight , Obesity']","Overweight , Obesity",Cairo University,[],['Saudi Arabia']
NCT04884815,A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease,"An Operationally Seamless Phase 1/2/3 Study Consisting of a Safety and Dose-finding Phase 1/2 and Randomized, Open-label, Active-controlled Phase 3 to Evaluate UX701 AAV Gene Therapy in Adults With Wilson Disease",ACTIVE_NOT_RECRUITING,2021-09-27,2029-03,2034-03,INTERVENTIONAL,PHASE1,82,['Wilson Disease'],Wilson Disease,Ultragenyx Pharmaceutical Inc,[],"['United States', 'Spain', 'Canada', 'United Kingdom', 'Portugal']"
NCT07258758,Diabetes Intervention Involving Person-centred Nutritional Education,Diabetes Intervention Involving Person-centred Nutritional Education (DINE) - Exploring the Benefits and Challenges of a Person-centred Education on the Nordic Diet for Adults With Type 1 Diabetes.,RECRUITING,2025-09-01,2027-06,2027-06,INTERVENTIONAL,NA,54,['Diabetes Type 1'],Diabetes Type 1,Umeå University,['Lasarettet i Enköping'],['Sweden']
NCT05554406,"Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7 + 3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who Are Considered High-Risk (Adverse) Acute Myeloid Leukemia As Determined by MYELOMATCH; A MYELOMATCH Clinical Trial",RECRUITING,2024-09-25,2027-03-31,2027-03-31,INTERVENTIONAL,PHASE2,335,"['Acute Myeloid Leukemia', 'Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm', 'Acute Myeloid Leukemia Post Cytotoxic Therapy', 'Acute Myeloid Leukemia, Myelodysplasia-Related']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT07049913,TBE Zone 2 PMS in Japan,GORE® TAG® Thoracic Branch Endoprosthesis Zone 2 Post-Market Surveillance in Japan,RECRUITING,2025-12,2034-02,2034-02,OBSERVATIONAL,,200,"['Aneurysm Thoracic', 'Dissection of Aorta, Thoracic', 'Trauma']",Aneurysm Thoracic,W.L.Gore & Associates,"['CMIC Co, Ltd. Japan']",['Japan']
NCT07278882,Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL,A Randomized Controlled Trial of Mobile Technology-assisted Outpatient Maintenance Therapy in Children With Acute Lymphoblastic Leukaemia (ALL),RECRUITING,2025-12-01,2027-11-20,2027-11-20,INTERVENTIONAL,NA,200,['Pediatric Acute Leukemia'],Pediatric Acute Leukemia,"Institute of Hematology & Blood Diseases Hospital, China",[],['China']
NCT06536517,The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.,A Randomized Controlled Trial to Study the Effects of One-time Intra-operative Dosing of Methadone During Laparoscopic or Robotic Hysterectomy in Reducing Opioid Prescription.,RECRUITING,2025-03-07,2026-04,2026-12,INTERVENTIONAL,PHASE2,100,['Fibroid Uterus'],Fibroid Uterus,Johns Hopkins University,[],['United States']
NCT07280377,A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab,"A Phase 1 / 2 Multiple-indication Biomarker, Safety, and Efficacy Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab",RECRUITING,2021-10-27,2027-07-30,2028-12-31,INTERVENTIONAL,PHASE1,122,"['Anal Cancer Metastatic', 'Squamous Cell Carcinoma of the Anus Stage Unspecified', 'Pancreatic Cancer Metastatic', 'Unresectable Pancreatic Carcinoma']",Anal Cancer Metastatic,Oncolytics Biotech,"['Crolll Gmbh', 'AIO-Studien-gGmbH']",['Germany']
NCT07220759,Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide,Efficacy and Safety of Cagrilintide for Weight Management in Participants With Overweight or Obesity and Type 2 Diabetes,RECRUITING,2025-11-05,2027-06-09,2027-07-28,INTERVENTIONAL,PHASE3,330,"['Overweight', 'Obesity', 'Type 2 Diabetes']",Overweight,Novo Nordisk A/S,[],"['Hungary', 'United States', 'Slovakia', 'Switzerland', 'Croatia', 'South Korea', 'Canada', 'Czechia', 'Romania', 'United Kingdom', 'Argentina']"
NCT05485961,Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis,"A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis",RECRUITING,2022-10-21,2029-08-30,2029-08-30,INTERVENTIONAL,PHASE2,2310,"['Atherosclerotic Cardiovascular Disease', 'End Stage Kidney Disease', 'Atherosclerotic Cardiovascular Disease in Patients With ESKD']",Atherosclerotic Cardiovascular Disease,CSL Behring,[],"['Bulgaria', 'Japan', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Poland', 'Spain', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06707883,A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease,"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease",ACTIVE_NOT_RECRUITING,2024-12-31,2026-12,2027-09,INTERVENTIONAL,PHASE2,258,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.",[],['China']
NCT06648239,CCTA to Optimize Diagnostic Yield of Invasive Angiography With AI,Coronary Computed Tomographic Angiography to Optimize Diagnostic Yield of Invasive Angiography for Low-risk Patients Screened With Artificial Intelligence,ACTIVE_NOT_RECRUITING,2025-01-09,2026-02,2026-02,INTERVENTIONAL,NA,251,['Coronary Artery Disease'],Coronary Artery Disease,Hamilton Health Sciences Corporation,"['Population Health Research Institute', 'Hamilton Academic Health Sciences Organization']",['Canada']
NCT06754462,"A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis","A Phase 2b, Multicenter, Double-blind, Placebo-controlled Randomized Withdrawal Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat, ACPA-Positive Rheumatoid Arthritis",ACTIVE_NOT_RECRUITING,2025-01-10,2027-09,2027-09,INTERVENTIONAL,PHASE2,120,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Immunovant Sciences GmbH,[],"['Bulgaria', 'Hungary', 'United States', 'Georgia', 'Spain', 'Romania', 'Czechia', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT06611072,OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study,OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study,RECRUITING,2025-01-01,2027-10,2027-12,INTERVENTIONAL,NA,90,"['Ovarian Neoplasms', 'Ovarian Cancer', 'Ovarian Carcinoma', 'Immune Suppression', 'Immune System Suppression']",Ovarian Neoplasms,Gynaecologisch Oncologisch Centrum Zuid,"['Eindhoven University of Technology', 'Radboud University Medical Center']",['Netherlands']
NCT06198712,A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease,"A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease",RECRUITING,2023-01-12,2028-02-23,2029-08-08,INTERVENTIONAL,PHASE2,50,['Sickle Cell Disease'],Sickle Cell Disease,"Forma Therapeutics, Inc.",['Novo Nordisk A/S'],"['Lebanon', 'Turkey (Türkiye)', 'Kenya', 'France', 'Nigeria', 'Canada', 'United Kingdom']"
NCT06205121,Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis,"A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)",RECRUITING,2024-03-21,2027-08,2027-09,INTERVENTIONAL,PHASE2,96,['Pulmonary Sarcoidosis'],Pulmonary Sarcoidosis,Molecure S.A.,[],"['Netherlands', 'Norway', 'United States', 'France', 'Denmark', 'United Kingdom', 'Greece', 'Germany']"
NCT07279623,Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine,"Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Preventative Treatment for Migraine - A Prospective, Randomized, Open Label, Delayed-Start Study to Evaluate the Safety and Performance of the Walther System",RECRUITING,2025-10-21,2026-09,2026-09,INTERVENTIONAL,NA,110,['Migraine'],Migraine,Abilion Medical Systems AB,"['Aurevia', 'Insamlingsstiftelsen för främjande av forskning avseende INMEST']",['Sweden']
NCT06056024,A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus,"Open-label Dose-finding Trial to Explore Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 3706674 Given Orally as Monotherapy in Patients With Unresectable Metastatic KRAS Wild Type Amplified Gastric, Oesophageal, and Gastroesophagealjunction Adenocarcinoma",ACTIVE_NOT_RECRUITING,2023-12-06,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE1,47,"['Solid Tumor, KRAS Mutation']","Solid Tumor, KRAS Mutation",Boehringer Ingelheim,[],"['Japan', 'Taiwan', 'United States', 'South Korea']"
NCT06424288,A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure,"EASi-HF Preserved - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) ≥40%",RECRUITING,2024-06-17,2028-05-22,2028-05-22,INTERVENTIONAL,PHASE3,6000,['Heart Failure'],Heart Failure,Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'Belgium', 'Hungary', 'Slovenia', 'Chile', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT05861986,A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy,A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Patients With Spinal Muscular Atrophy After Gene Therapy,RECRUITING,2024-05-30,2028-03-31,2029-03-31,INTERVENTIONAL,PHASE4,28,"['Muscular Atrophy, Spinal']","Muscular Atrophy, Spinal",Hoffmann-La Roche,[],"['United Kingdom', 'Poland', 'United States', 'Germany']"
NCT06812754,A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause,"A Phase 2, Randomized, Placebo-controlled, 12-week, Double-blind Study to Assess the Efficacy and Safety of Fezolinetant 45 mg in Chinese Women Suffering From Moderate to Severe Vasomotor Symptoms (Hot Flashes) Associated With Menopause",ACTIVE_NOT_RECRUITING,2025-03-10,2026-02-28,2026-03-31,INTERVENTIONAL,PHASE2,150,['Hot Flashes'],Hot Flashes,"Astellas Pharma Global Development, Inc.",[],['China']
NCT05064709,Assessment of CCM in HF With Higher Ejection Fraction,Assessment of Implantable CCM in the Heart Failure Group With Higher Ejection Fraction,RECRUITING,2022-02-03,2029-02-01,2029-02-01,INTERVENTIONAL,NA,1500,"['Heart Failure', 'Heart Failure With Preserved Ejection Fraction', 'Heart Failure With Mid Range Ejection Fraction', 'Heart Failure With Moderately Reduced Ejection Fraction', 'Diastolic Heart Failure']",Heart Failure,Impulse Dynamics,[],['United States']
NCT06635980,Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer,A Randomized Phase II Trial of Hypofractionated Radiotherapy for Non-Metastatic Breast Cancer Before or After Breast Surgery for Different Breast Cancer Risk Groups,RECRUITING,2025-05-14,2031-10-21,2034-10-21,INTERVENTIONAL,PHASE2,120,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8', 'Breast Carcinoma', 'Triple-Negative Breast Carcinoma']",Anatomic Stage I Breast Cancer AJCC v8,Mayo Clinic,[],['United States']
NCT06773962,A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease,"A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease",RECRUITING,2025-03-20,2026-03-01,2026-09-01,INTERVENTIONAL,PHASE2,62,"[""Parkinson's Disease (PD)""]",Parkinson's Disease (PD),"TrueBinding, Inc.",[],['United States']
NCT07232589,A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022),A Study to Evaluate the Effect of Multiple Oral Doses of Diltiazem on the Single-Dose Pharmacokinetics of Nemtabrutinib in Healthy Participants.,RECRUITING,2025-12-08,2026-02-01,2026-02-13,INTERVENTIONAL,PHASE1,24,['Healthy'],Healthy,Merck Sharp & Dohme LLC,[],['United States']
NCT04144725,Ruling Out Coronary Artery Disease and Myocardial Injury by Biomarkers,Ruling Out Coronary Artery Disease and Myocardial Injury by BiOmarkers: Light'n Easy,RECRUITING,2019-10-23,2023-12-31,2030-01,OBSERVATIONAL,,1000,['Coronary Artery Disease'],Coronary Artery Disease,"University Hospital, Akershus",['Haukeland University Hospital'],['Norway']
NCT06126276,Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial),"A Randomized Trial of Neratinib, A Pan-ERBB Inhibitor, Alone or in Combination With Palbociclib, a CDK4/6 Inhibitor, in Patients With HER2+ Gynecologic Cancers and Other Solid Tumors: A ComboMATCH Treatment Trial",RECRUITING,2024-05-07,2027-02-20,2027-02-20,INTERVENTIONAL,PHASE2,70,"['Malignant Female Reproductive System Neoplasm', 'Malignant Solid Neoplasm', 'Recurrent Malignant Female Reproductive System Neoplasm', 'Recurrent Malignant Solid Neoplasm']",Malignant Female Reproductive System Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT06992089,SHort Of Pace - Heart Failure (SHOP-HF),"Pacemaker Implantation in Patients With Heart Failure With Preserved Ejection Fraction, Chronotropic Incompetence and Small Ventricular Volume. The SHOP-HF Trial",RECRUITING,2025-06-17,2026-06,2026-06,INTERVENTIONAL,NA,30,['Heart Failure With Preserved Ejection Fraction'],Heart Failure With Preserved Ejection Fraction,Fundación para la Investigación del Hospital Clínico de Valencia,[],['Spain']
NCT02686125,Vercise™ DBS Dystonia Prospective Study,Prospective Study of Deep Brain Stimulation With the VERCISE™ System for Treatment of Dystonia,RECRUITING,2016-03-07,2030-12,2030-12,OBSERVATIONAL,,300,['Dystonia'],Dystonia,Boston Scientific Corporation,[],"['Belgium', 'Israel', 'Hungary', 'Netherlands', 'Russia', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Germany']"
NCT05256225,Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma,"A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma",RECRUITING,2022-11-16,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE3,360,"['Endometrial Carcinoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Dedifferentiated Carcinoma', 'Endometrial Endometrioid Adenocarcinoma', 'Endometrial Mixed Cell Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Endometrial Undifferentiated Carcinoma', 'Uterine Corpus Carcinosarcoma']",Endometrial Carcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['Puerto Rico', 'United States', 'South Korea']"
NCT07211750,Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT,Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT,RECRUITING,2025-10-01,2026-10-01,2027-10-30,INTERVENTIONAL,NA,82,"['Multimorbidity', 'Older Adults (65 Years and Older)', 'Mood Disorders', 'Depression - Major Depressive Disorder', 'Bipolar', 'Integrated Care']",Multimorbidity,KU Leuven,['Universitaire Ziekenhuizen KU Leuven'],['Belgium']
NCT06996249,Prospective Data Collection Initiative on Thoracic Malignancies,Prospective Data Collection Initiative on Thoracic Malignancies - a Prospective Observational Cohort Study,RECRUITING,2025-08-15,2029-01-01,2030-01-01,OBSERVATIONAL,,12000,"['Lung Cancer', 'Thoracic Cancer', 'Lung Cancer, Nonsmall Cell', 'Adenocarcinoma', 'Squamous Cell Carcinoma', 'Large Cell Lung Cancer', 'Thymus Cancer', 'Mesothelioma']",Lung Cancer,Dutch Society of Physicians for Pulmonology and Tuberculosis,[],['Netherlands']
NCT07139223,The Effect of Laughter Yoga on Premenstrual Syndrome Symptoms and Quality of Life in Young Women,The Effect of Laughter Yoga on Premenstrual Syndrome Symptoms and Quality of Life in Young Women: A Randomized Controlled Trial,RECRUITING,2025-10-15,2025-11-15,2025-12-15,INTERVENTIONAL,NA,72,['Premenstrual Syndrome-PMS'],Premenstrual Syndrome-PMS,Lokman Hekim University,[],['Turkey (Türkiye)']
NCT04597125,"Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH","A Phase 4, Randomized, Open-label, Multicenter Efficacy and Safety Study of Standard Dose of Radium-223 Dichloride vs. Standard Doses of Novel Anti-hormonal Therapy (NAH) in Patients With Bone Dominant Metastatic Castration Resistant Prostate Cancer (mCRPC) Progressing on/After One Line of NAH",ACTIVE_NOT_RECRUITING,2020-11-09,2025-11-21,2026-10-10,INTERVENTIONAL,PHASE4,654,['Metastatic Castrate Resistant Prostate Cancer (mCRPC)'],Metastatic Castrate Resistant Prostate Cancer (mCRPC),Bayer,[],"['Hong Kong', 'Lithuania', 'Australia', 'Israel', 'Hungary', 'Russia', 'France', 'Finland', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'United Kingdom', 'Germany', 'Turkey (Türkiye)', 'Austria', 'Italy']"
NCT06247215,Building Resilience for Advance Care Planning (ACP) in Chinese Americans,Development of a Culturally Tailored Resilience-Building Intervention to Facilitate Advance Care Planning Discussions Between Chinese American Patients and Their Family Caregivers,RECRUITING,2023-11-08,2025-12-31,2025-12-31,OBSERVATIONAL,,121,['Advance Care Planning'],Advance Care Planning,University of Illinois at Chicago,"['University of Chicago', 'Rush University Medical Center', 'National Institute on Minority Health and Health Disparities (NIMHD)']",['United States']
NCT04190550,"Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia",A Phase 1b Study With Expansion Cohort of Escalating Doses of KRT-232 (AMG 232) Administered in Combination With Standard Induction Chemotherapy (Cytarabine and Idarubicin) in Newly Diagnosed Acute Myelogenous Leukemia (AML),ACTIVE_NOT_RECRUITING,2021-02-04,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,24,"['Acute Myeloid Leukemia', 'Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],['United States']
NCT06976268,"A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease","A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants With Early Parkinson's Disease",RECRUITING,2025-05-28,2027-08,2027-09,INTERVENTIONAL,PHASE2,550,['Parkinson Disease'],Parkinson Disease,Biohaven Therapeutics Ltd.,[],['United States']
NCT07245420,Evaluation Of Cardiovascular Health Outcomes Among Survivors 2,Evaluation Of Cardiovascular Health Outcomes Among Survivors 2 (ECHOS2),RECRUITING,2026-01,2029-12,2030-12,INTERVENTIONAL,NA,350,['Health Behavior'],Health Behavior,St. Jude Children's Research Hospital,['National Cancer Institute (NCI)'],['United States']
NCT06585774,A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease (AXemplify-357)",RECRUITING,2025-01-21,2027-09-28,2030-03-31,INTERVENTIONAL,PHASE3,240,['Chronic Graft-versus-host-disease'],Chronic Graft-versus-host-disease,Incyte Corporation,[],"['Japan', 'Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT06609226,A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia,"An Open-label, Multi-centre, Rollover Study to Characterise Long-term Safety and Efficacy of Etavopivat in Adults, Adolescents and Children Who Have Sickle Cell Disease or Thalassaemia and Have Completed a Treatment Period in an Etavopivat Study",RECRUITING,2025-01-10,2030-12-30,2030-12-30,INTERVENTIONAL,PHASE3,480,"['Sickle Cell Disease', 'Thalassemia']",Sickle Cell Disease,Novo Nordisk A/S,[],"['Lebanon', 'Oman', 'Turkey (Türkiye)', 'Saudi Arabia', 'India', 'Kenya', 'United States', 'France', 'Ghana', 'Nigeria', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Greece', 'Egypt', 'Germany']"
NCT07050732,Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons,Immunogenicity and Safety of Multiple-Dose Adjuvanted RSVPreF3 (Arexvy®) Vaccination Among Immunocompromised Persons,RECRUITING,2025-12-04,2026-11,2028-04,INTERVENTIONAL,PHASE2,170,['Respiratory Syncytial Virus (RSV)'],Respiratory Syncytial Virus (RSV),Johns Hopkins University,['GlaxoSmithKline'],['United States']
NCT04175041,A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC,A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC,ACTIVE_NOT_RECRUITING,2019-07-09,2026-05,2026-05,INTERVENTIONAL,NA,104,['Attention Deficit Hyperactivity Disorder'],Attention Deficit Hyperactivity Disorder,Massachusetts General Hospital,[],['United States']
NCT06682494,Enhancing Oral Cancer Awareness,Comparative Study on Enhancing Oral Cancer Awareness: Classical Educational Materials vs. AI-Powered Chatbot,RECRUITING,2025-09-24,2026-10-31,2026-10-31,INTERVENTIONAL,NA,60,"['Oral Cancer', 'Chatbot', 'Patient Education', 'Prevention', 'Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer', 'Oropharyngeal Cancers']",Oral Cancer,Virginia Commonwealth University,['American Association for Cancer Education'],['United States']
NCT02503722,Testing the Combination of MLN0128 (TAK-228) and AZD9291 in Advanced EGFR (Epidermal Growth Factor Receptor) Mutation Positive Non-small Cell Lung Cancer,A Phase 1 Trial of MLN0128 (TAK-228) in Combination With Osimertinib (AZD9291) in Advanced EGFR Mutation Positive Non-Small Cell Lung Cancer (NSCLC) After Progression on a Previous EGFR Tyrosine Kinase Inhibitor,ACTIVE_NOT_RECRUITING,2017-03-23,2026-06-05,2026-06-05,INTERVENTIONAL,PHASE1,36,"['Metastatic Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage III Lung Non-Small Cell Cancer AJCC v7', 'Stage IIIA Lung Non-Small Cell Cancer AJCC v7', 'Stage IIIB Lung Non-Small Cell Cancer AJCC v7', 'Stage IV Lung Non-Small Cell Cancer AJCC v7']",Metastatic Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT01810913,"Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer","Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck",RECRUITING,2013-03-22,2027-01-01,2027-01-01,INTERVENTIONAL,PHASE2,613,"['Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma', 'Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7', 'Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7']",Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['United States', 'Hong Kong', 'Canada']"
NCT07111559,Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial,A Multicenter Randomized Controlled Trial Comparing Tissue Plasminogen Activator With Dual Antiplatelet Therapy for Patients With Hyperacute Single Perforating Artery Infarction,RECRUITING,2025-08-01,2028-03-31,2029-03-31,INTERVENTIONAL,PHASE4,500,"['Lacunar Stroke', 'Stroke', 'Ischemic Stroke']",Lacunar Stroke,Nippon Medical School,"['Japan Research Foundation for Clinical Pharmacology', 'Takeda Science Foundation - Medical Research Grant']",['Japan']
NCT07224269,Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis,A Pilot Study of the Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis,RECRUITING,2026-01-15,2026-07-01,2026-12-31,INTERVENTIONAL,EARLY_PHASE1,15,"['Amyotrophic Lateral Sclerosis', 'Adenosine Triphosphate Activities']",Amyotrophic Lateral Sclerosis,University of Iowa,[],['United States']
NCT05334069,Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection,Blinded Reference Set for Multicancer Early Detection Blood Tests,RECRUITING,2022-08-18,2026-01-31,2027-02-28,OBSERVATIONAL,,2000,"['Acute Lymphoblastic Leukemia', 'Acute Myeloid Leukemia', 'Ann Arbor Stage I Lymphoma', 'Ann Arbor Stage II Lymphoma', 'Ann Arbor Stage III Lymphoma', 'Ann Arbor Stage IV Lymphoma', 'Chronic Lymphocytic Leukemia', 'Chronic Myeloid Leukemia', 'Gastroesophageal Junction Adenocarcinoma', 'Head and Neck Carcinoma', 'Hematopoietic and Lymphoid Cell Neoplasm', 'Invasive Breast Carcinoma', 'Kidney Carcinoma', 'Malignant Hepatobiliary Neoplasm', 'Malignant Solid Neoplasm', 'Melanoma', 'Muscle-Invasive Bladder Carcinoma', 'RISS Stage I Plasma Cell Myeloma', 'RISS Stage II Plasma Cell Myeloma', 'RISS Stage III Plasma Cell Myeloma', 'Sarcoma', 'Stage I Bladder Cancer AJCC v6 and v7', 'Stage I Breast Cancer AJCC v7', 'Stage I Colorectal Cancer AJCC v6 and v7', 'Stage I Esophageal Cancer AJCC V7', 'Stage I Gastric Cancer AJCC V7', 'Stage I Lung Cancer AJCC v7', 'Stage I Ovarian Cancer AJCC v6 and v7', 'Stage I Pancreatic Cancer AJCC v6 and v7', 'Stage I Prostate Cancer AJCC v7', 'Stage I Uterine Corpus Cancer AJCC v7', 'Stage II Bladder Cancer AJCC v6 and v7', 'Stage II Breast Cancer AJCC v6 and v7', 'Stage II Colorectal Cancer AJCC v7', 'Stage II Esophageal Cancer AJCC v7', 'Stage II Gastric Cancer AJCC v7', 'Stage II Lung Cancer AJCC v7', 'Stage II Ovarian Cancer AJCC v6 and v7', 'Stage II Pancreatic Cancer AJCC v6 and v7', 'Stage II Prostate Cancer AJCC v7', 'Stage II Uterine Corpus Cancer AJCC v7', 'Stage III Bladder Cancer AJCC v6 and v7', 'Stage III Breast Cancer AJCC v7', 'Stage III Colorectal Cancer AJCC v7', 'Stage III Esophageal Cancer AJCC v7', 'Stage III Gastric Cancer AJCC v7', 'Stage III Lung Cancer AJCC v7', 'Stage III Ovarian Cancer AJCC v6 and v7', 'Stage III Pancreatic Cancer AJCC v6 and v7', 'Stage III Prostate Cancer AJCC v7', 'Stage III Uterine Corpus Cancer AJCC v7', 'Stage IV Bladder Cancer AJCC v7', 'Stage IV Breast Cancer AJCC v6 and v7', 'Stage IV Colorectal Cancer AJCC v7', 'Stage IV Esophageal Cancer AJCC v7', 'Stage IV Gastric Cancer AJCC v7', 'Stage IV Lung Cancer AJCC v7', 'Stage IV Ovarian Cancer AJCC v6 and v7', 'Stage IV Pancreatic Cancer AJCC v6 and v7', 'Stage IV Prostate Cancer AJCC v7', 'Stage IV Uterine Corpus Cancer AJCC v7', 'Thyroid Gland Carcinoma']",Acute Lymphoblastic Leukemia,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT07276646,Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy,Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy: A Randomized Clinical Trial.,RECRUITING,2025-12-10,2026-06-10,2026-07-10,INTERVENTIONAL,NA,80,['Perioperative Analgesia'],Perioperative Analgesia,Zagazig University,[],['Egypt']
NCT06029270,Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer,A Randomized Phase II Study of Nivolumab Versus Nivolumab and BMS-986016 (Relatlimab) as Maintenance Treatment After First-Line Treatment With Platinum-Gemcitabine-Nivolumab for Patients With Epstein-Barr Virus-Associated Recurrent/Metastatic Nasopharyngeal Carcinoma (REMAIN),RECRUITING,2024-07-15,2029-04-30,2029-04-30,INTERVENTIONAL,PHASE2,156,"['Metastatic Nasopharyngeal Carcinoma', 'Recurrent Nasopharyngeal Carcinoma', 'Stage IV Nasopharyngeal Carcinoma AJCC v8']",Metastatic Nasopharyngeal Carcinoma,National Cancer Institute (NCI),[],"['Singapore', 'Hong Kong', 'United States', 'Canada', 'Australia']"
NCT05782907,"Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.","A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib With Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy",RECRUITING,2023-11-06,2028-08,2033-10,INTERVENTIONAL,PHASE3,110,['Ulcerative Colitis'],Ulcerative Colitis,AbbVie,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'United States', 'Italy']"
NCT07161544,A Study of AAVB-039 in Participants With Stargardt Disease (STGD1),"An Open-label, Multicenter, Two Part, Ascending Dose Followed by a Controlled Trial to Assess the Safety and Efficacy of a Subretinal Administration of AAVB-039 in Participants With Stargardt Disease (STGD1) (CELESTE)",RECRUITING,2025-09-29,2032-07,2032-07,INTERVENTIONAL,PHASE1,75,['Stargardt Disease'],Stargardt Disease,AAVantgarde Bio Srl,['AAVantgarde Bio UK Ltd'],"['United Kingdom', 'United States']"
NCT04929041,Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative,"A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without Radiation Therapy for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer",RECRUITING,2022-10-07,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE2,427,"['Lung Adenocarcinoma', 'Lung Adenosquamous Carcinoma', 'Lung Non-Small Cell Carcinoma', 'Stage IIIB Lung Cancer AJCC v8', 'Stage IIIC Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8']",Lung Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT07170527,Long-Term Outcomes and Post-Intensive Care Syndrome: Investigating the Associations Between Metabolic Signatures and Physical Functioning in Critically Ill Patients,"Long-Term Outcomes and Post-Intensive Care Syndrome: An Explorative, Prospective, Observational Cohort Study to Investigate the Associations Between Metabolic Signatures and Physical Functioning in Critically Ill Patients",RECRUITING,2025-10-13,2027-09-01,2028-09-01,OBSERVATIONAL,,200,['Post-Intensive Care Syndrome (PICS)'],Post-Intensive Care Syndrome (PICS),"ARH van Zanten, MD PhD","['Danone Global Research & Innovation Center', 'Wageningen University and Research', 'TKI Agri & Food']",['Netherlands']
NCT05828069,"A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis",Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis,RECRUITING,2024-03-28,2028-09-30,2028-09-30,INTERVENTIONAL,PHASE2,48,"['Recurrent Langerhans Cell Histiocytosis', 'Refractory Langerhans Cell Histiocytosis']",Recurrent Langerhans Cell Histiocytosis,National Cancer Institute (NCI),[],"['United States', 'Canada', 'Australia']"
NCT03598595,"Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma",A Phase 1/2 Study of Gemcitabine and Docetaxel in Combination With Hydroxychloroquine (Autophagy Inhibitor) in Patients With Recurrent Osteosarcoma,ACTIVE_NOT_RECRUITING,2019-01-28,2026-01-31,2026-01-31,INTERVENTIONAL,PHASE1,31,"['Recurrent Osteosarcoma', 'Refractory Osteosarcoma']",Recurrent Osteosarcoma,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT01627041,"Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia",Randomized Phase II Study of Epigenetic Priming Using Decitabine With Induction Chemotherapy in Patients With Acute Myelogenous Leukemia (AML),ACTIVE_NOT_RECRUITING,2011-09-16,2016-02-11,2026-02-01,INTERVENTIONAL,PHASE2,178,"['Acute Myeloid Leukemia', 'Adult Acute Basophilic Leukemia', 'Adult Acute Monoblastic Leukemia', 'Adult Acute Monocytic Leukemia', 'Adult Acute Myeloid Leukemia With Maturation', 'Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2A', 'Adult Acute Myeloid Leukemia Without Maturation', 'Adult Acute Myelomonocytic Leukemia', 'Alkylating Agent-Related Acute Myeloid Leukemia', 'Secondary Acute Myeloid Leukemia']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],['United States']
NCT07279194,Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes,"Efficacy and Safety of HDM1005 Once Weekly in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial",RECRUITING,2025-10-14,2026-09-20,2026-12-13,INTERVENTIONAL,PHASE3,825,['Obesity & Overweight'],Obesity & Overweight,"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.",[],['China']
NCT06124157,"A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)",An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors With Blinatumomab in Patients With Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia,RECRUITING,2025-05-30,2030-12-01,2030-12-01,INTERVENTIONAL,PHASE3,222,['B Acute Lymphoblastic Leukemia'],B Acute Lymphoblastic Leukemia,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada', 'Australia']"
NCT06401044,A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease,"A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects With Moderate-to-Severe Active Thyroid Eye Disease",RECRUITING,2024-05-30,2027-02-22,2027-08-13,INTERVENTIONAL,PHASE1,88,['Thyroid Eye Disease'],Thyroid Eye Disease,Amgen,[],"['United States', 'France', 'Spain', 'Taiwan', 'Poland', 'Australia']"
NCT07278271,Decision-Making in Labor Admission Using Transperineal Ultrasound vs. Vaginal Examination,Toma de Decisiones en la Admisión Hospitalaria al Parto Con Ecografía Transperineal vs. Tacto Vaginal: Estudio Aleatorizado Controlado,RECRUITING,2024-01-29,2026-01,2026-03,INTERVENTIONAL,NA,170,['Labor Active Dilated Cm'],Labor Active Dilated Cm,Hospital Universitario La Paz,[],['Spain']
NCT07278505,Study of Cannabidiol and Neuroimaging on Stress,Pathophysiological Mechanisms of Cannabidiol in Stress Regulation,RECRUITING,2025-10-28,2030-02-28,2030-02-28,INTERVENTIONAL,PHASE1,160,"['Early Life Adversity', 'Trauma', 'Stress']",Early Life Adversity,Icahn School of Medicine at Mount Sinai,"['Jazz Pharmaceuticals', 'National Institute of Mental Health (NIMH)']",['United States']
NCT05411094,Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer,A Phase 1 Study of Olaparib in Combination With Durvalumab (MEDI4736) and Concurrent Radiation Therapy Following First-Line Chemotherapy in Locally Advanced Unresectable Pancreatic Cancer,RECRUITING,2023-05-22,2026-07-01,2028-07-01,INTERVENTIONAL,PHASE1,18,"['Locally Advanced Pancreatic Carcinoma', 'Stage II Pancreatic Cancer AJCC v8', 'Stage III Pancreatic Cancer AJCC v8', 'Unresectable Pancreatic Carcinoma']",Locally Advanced Pancreatic Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT07209241,Different Approaches for CART-EGFR-IL13Ra2 Dosing in Recurrent GBM,"Phase Ib, Open-Label Study of CART-EGFR-IL13Rα2 Cells Administered Following Lymphodepleting Chemotherapy or Prior to Surgical Resection in Patients With EGFR-Amplified Recurrent Glioblastoma",RECRUITING,2025-12-03,2042-11-01,2042-11-01,INTERVENTIONAL,PHASE1,12,['Recurrent Glioblastoma'],Recurrent Glioblastoma,University of Pennsylvania,[],['United States']
NCT05118490,Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients,"A Randomized Trial Comparing Treatment Completion of Daily Rifapentine & Isoniazid for One Month (1HP) To Weekly Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in HIV-negative Household Contacts of Recently Diagnosed Tuberculosis Patients, The ""One To Three"" Trial",ACTIVE_NOT_RECRUITING,2023-07-19,2025-07-11,2025-12-31,INTERVENTIONAL,PHASE4,1000,"['HIV Seropositivity', 'Tuberculosis', 'Household Contact']",HIV Seropositivity,The Aurum Institute NPC,['Johns Hopkins University'],"['Indonesia', 'South Africa', 'Mozambique', 'India']"
NCT05136196,"BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study",Biomarker Stratified CaboZantinib (NSC#761968) and NivOlumab (NSC#748726) (BiCaZO) - A Phase II Study of Combining Cabozantinib and Nivolumab in Participants With Advanced Solid Tumors (IO Refractory Melanoma or HNSCC) Stratified by Tumor Biomarkers - an immunoMATCH Pilot Study,RECRUITING,2022-12-06,2027-01-01,2027-01-01,INTERVENTIONAL,PHASE2,150,"['Clinical Stage III Cutaneous Melanoma AJCC v8', 'Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Locally Recurrent Head and Neck Squamous Cell Carcinoma', 'Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma', 'Locally Recurrent Laryngeal Squamous Cell Carcinoma', 'Locally Recurrent Oral Cavity Squamous Cell Carcinoma', 'Locally Recurrent Oropharyngeal Squamous Cell Carcinoma', 'Metastatic Head and Neck Squamous Cell Carcinoma', 'Metastatic Hypopharyngeal Squamous Cell Carcinoma', 'Metastatic Laryngeal Squamous Cell Carcinoma', 'Metastatic Melanoma', 'Metastatic Oral Cavity Squamous Cell Carcinoma', 'Metastatic Oropharyngeal Squamous Cell Carcinoma', 'Recurrent Melanoma', 'Stage III Hypopharyngeal Carcinoma AJCC v8', 'Stage III Laryngeal Cancer AJCC v8', 'Stage III Lip and Oral Cavity Cancer AJCC v8', 'Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8', 'Stage IV Hypopharyngeal Carcinoma AJCC v8', 'Stage IV Laryngeal Cancer AJCC v8', 'Stage IV Lip and Oral Cavity Cancer AJCC v8', 'Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8', 'Unresectable Melanoma']",Clinical Stage III Cutaneous Melanoma AJCC v8,National Cancer Institute (NCI),[],['United States']
NCT04079712,"Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors",A Phase 2 Study of XL184 (Cabozantinib) in Combination With Nivolumab and Ipilimumab for the Treatment of Poorly Differentiated Neuroendocrine Carcinomas,ACTIVE_NOT_RECRUITING,2020-08-06,2025-01-10,2026-08-19,INTERVENTIONAL,PHASE2,17,"['Metastatic Large Cell Neuroendocrine Carcinoma', 'Metastatic Neuroendocrine Carcinoma', 'Metastatic Neuroendocrine Neoplasm', 'Metastatic Small Cell Neuroendocrine Carcinoma']",Metastatic Large Cell Neuroendocrine Carcinoma,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT07258849,A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis,"A Phase 1, Multicenter, Randomized, Placebo-Controlled, Investigator- and Participant-Blinded, Single- and Multiple-Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of LY4213663 in Healthy Participants, and Two Open-Label, Multiple-Dose Evaluations of LY4213663 in Patients With Rheumatoid Arthritis.",RECRUITING,2025-12-02,2028-03,2028-03,INTERVENTIONAL,PHASE1,134,"['Healthy', 'Rheumatoid Arthritis (RA)']",Healthy,Eli Lilly and Company,[],['United States']
NCT05345106,"Inter-relationships Among Glucose, Brain, Gut Microbiota and MicroRNAs (IRONmiRNA).","Inter-relationships Among Iron Stores, the Gut Metagenome, Glucose Levels, and Different Cognitive Domains: the Role of Circulating MicroRNAs (IRONmiRNA Study).",RECRUITING,2022-03-28,2025-12-12,2026-12-12,OBSERVATIONAL,,133,['Obesity'],Obesity,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,[],['Spain']
NCT03388788,"Body Weight, Sleep, and Heart Health",Circadian Mechanisms of Cardiovascular Risk in Obesity,ACTIVE_NOT_RECRUITING,2018-05-01,2024-09-30,2026-06-30,OBSERVATIONAL,,16,"['Cardiovascular Risk Factor', 'Circadian Dysregulation', 'Obesity']",Cardiovascular Risk Factor,Oregon Health and Science University,"['National Heart, Lung, and Blood Institute (NHLBI)', 'National Center for Advancing Translational Sciences (NCATS)']",['United States']
NCT05399056,Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling,Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling,RECRUITING,2023-02-24,2026-02-28,2026-08-31,INTERVENTIONAL,NA,305,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,Baystate Medical Center,"['University of Michigan', 'University of Massachusetts, Worcester', 'COPD Foundation', 'National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07243483,Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia,"Prospective, Multicenter, Clinical-biological Cohort Study to Assess Pharmacokinetics and Pharmacodynamics (PK-PD) of Venetoclax (VEN) in Patients With Acute Myeloid Leukemia (AML)",RECRUITING,2026-01-01,2028-01-01,2029-01-01,INTERVENTIONAL,NA,100,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,Centre Leon Berard,['Fédération Leucémie Espoir'],['France']
NCT06151574,Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment,"Beamion LUNG 2: A Phase III, Open-label, Randomized, Active-controlled, Multi-centre Trial Evaluating Orally Administered Zongertinib (BI 1810631) Compared With Standard of Care as First-line Treatment in Patients With Unresectable, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Harbouring HER2 Tyrosine Kinase Domain Mutations",RECRUITING,2024-02-09,2026-11-01,2028-01-28,INTERVENTIONAL,PHASE3,416,"['Lung Cancer, Non-squamous, Non-small Cell']","Lung Cancer, Non-squamous, Non-small Cell",Boehringer Ingelheim,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Puerto Rico', 'South Korea', 'Poland', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06856837,- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases,- IKF/AIO-QUINTIS - A Randomized Phase II Trial Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases,RECRUITING,2025-10-27,2029-12-31,2029-12-31,INTERVENTIONAL,PHASE2,140,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,[],"['Austria', 'Germany']"
NCT07278245,"Effects of Active Upper-Limb Exoskeleton Training in Simulated Hyper-Gravity on Fine Motor Performance, Brain-Muscle Connectivity, Cardiovascular System and Stress Responses in Real Hyper-Gravity","Effects of Active Upper-Limb Exoskeleton Training in Simulated Hyper-Gravity on Fine Motor Performance, Brain-Muscle Connectivity, Cardiovascular System and Stress Responses in Real Hyper-Gravity: the EGOS Pilot Study.",ACTIVE_NOT_RECRUITING,2025-10-27,2025-11-27,2026-01-27,INTERVENTIONAL,NA,14,['Motor Learning and Physiological Adaptation'],Motor Learning and Physiological Adaptation,Centre National d'Etudes Spatiales,"['MEDES Institut de Médecine et de Physiologie Spatiales, Toulouse']",['France']
NCT07254377,Design and Validation of Innovative Strategies Based on Dual-Task Approach,START: Design and Validation of Innovative Strategies Based on Dual-Task Approach for Neuro- Rehabilitation Technologically-supported in People With Chronic Neuro-inflammatory Disease,ACTIVE_NOT_RECRUITING,2025-11-01,2026-03-30,2027-02-28,INTERVENTIONAL,NA,48,"['Stroke', 'Multiple Sclerosis', 'Parkinson Disease', 'Dual Task Exercises', 'Long COVID']",Stroke,I.R.C.C.S. Fondazione Santa Lucia,"['Vito Fazzi Hospital', 'ASL Frosinone', ""Azienda Ospedaliera San Giovanni di Dio Ruggi d'Aragona""]",['Italy']
NCT07221162,"A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes","A Phase 1, Open-Label, Safety and Immunogenicity Trial of Boost-2867, an IgG-Fc-RBD Fusion Protein Next Generation SARS-CoV-2 Booster Vaccine, Via Intranasal and Intramuscular Routes in Previously Vaccinated Adults",RECRUITING,2025-11-17,2026-11-24,2026-11-24,INTERVENTIONAL,PHASE1,140,['COVID-19'],COVID-19,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07137442,Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques,Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques,RECRUITING,2025-12-16,2034-08-01,2034-08-01,OBSERVATIONAL,,75,"['Tics', 'Functional Tics']",Tics,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06769165,EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors,EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors - a Pilot Study,RECRUITING,2025-07-02,2026-08-01,2026-08-01,INTERVENTIONAL,NA,20,['Cancer Survivors'],Cancer Survivors,University Medical Center Groningen,[],['Netherlands']
NCT06375187,A Study of GC203 TIL in Advanced Malignant Solid Tumors,A Phase I Study to Evaluate the Safety and Efficacy of Engineering Tumor Infiltrating Lymphocytes Injection (GC203 TIL)in Patients With Advanced Malignant Solid Tumors,RECRUITING,2024-05-29,2026-11-01,2027-05-01,INTERVENTIONAL,PHASE1,18,"['Solid Tumor', 'Gynecologic Cancer', 'Breast Cancer', 'Gastrointestinal Cancer', 'Lung Cancer']",Solid Tumor,Shanghai Juncell Therapeutics,[],['China']
NCT03659916,Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC,An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of A4250 in Children With Progressive Familial Intrahepatic Cholestasis Types 1 and 2 (PEDFIC 2),ACTIVE_NOT_RECRUITING,2018-09-28,2024-02-15,2025-12-02,INTERVENTIONAL,PHASE3,116,['Progressive Familial Intrahepatic Cholestasis'],Progressive Familial Intrahepatic Cholestasis,"Albireo, an Ipsen Company",[],"['Belgium', 'Israel', 'Turkey (Türkiye)', 'Netherlands', 'Saudi Arabia', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Australia']"
NCT06267729,Study of AZD0754 in Participants With Metastatic Prostate Cancer,"A Phase I/II Open Label Study to Evaluate the Safety, Cellular Kinetics, and Efficacy of AZD0754, a Chimeric Antigen Receptor (CAR) T-cell Therapy Directed Against STEAP2, in Adult Participants With Metastatic Prostate Cancer: APOLLO",RECRUITING,2024-03-12,2026-11-24,2026-11-24,INTERVENTIONAL,PHASE1,60,['Metastatic Prostate Cancer'],Metastatic Prostate Cancer,AstraZeneca,[],"['Spain', 'United States', 'Australia']"
NCT05167994,Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma （SPARE-01）,Preoperative Intensity-modulated Radiotherapy (IMRT) With Concurrent Anlotinib Hydrochloride for Localised Extremity or Trunk Sarcoma,RECRUITING,2020-05-01,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE2,30,"['Sarcoma,Soft Tissue', 'Extremity', 'Trunk', 'Anlotinib', 'Intensity-modulated Radiotherapy', 'Major Wound Complications']","Sarcoma,Soft Tissue","Cancer Institute and Hospital, Chinese Academy of Medical Sciences",['Beijing Jishuitan Hospital'],['China']
NCT06919354,A Study of GNTI-122 in Adults Recently Diagnosed With T1D,"POLARIS: A Phase 1, Single Dose, Open-label Study of GNTI-122 in Adults With Recently Diagnosed Type 1 Diabetes (T1D)",RECRUITING,2025-09-03,2028-02,2028-02,INTERVENTIONAL,PHASE1,16,"['Type 1 Diabetes (T1D)', 'Type 1 Diabetes Mellitus']",Type 1 Diabetes (T1D),"GentiBio, Inc",[],['United States']
NCT05028712,Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision,Development of a Multi-sensory Rehabilitation Program for People With Ultra Low Vision,RECRUITING,2024-03-08,2026-01,2026-07,INTERVENTIONAL,NA,36,"['Low Vision Blindness', 'Visual Impairment', 'Quality of Life', 'Functional Visual Loss']",Low Vision Blindness,State University of New York College of Optometry,[],['United States']
NCT01617408,Brain Stimulation and Vision Testing,TMS Investigations of the Human Visual System,RECRUITING,2013-03-04,,,OBSERVATIONAL,,665,"['fMRI', 'Dorsal Pathway', 'Ventral Pathway']",fMRI,National Institute of Mental Health (NIMH),[],['United States']
NCT07139327,A Pivotal Study to Evaluate the Efficacy and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults,"A Pre-market, Prospective, Interventional, Multicenter, Pivotal Study to Evaluate Efficacy and Safety of a Totally Implantable Cochlear Implant System in an Adult Population With Sensorineural Hearing Loss",RECRUITING,2025-12-01,2027-04,2027-10,INTERVENTIONAL,NA,36,"['Hearing Loss, Bilateral Sensorineural']","Hearing Loss, Bilateral Sensorineural",Cochlear,[],"['France', 'Australia']"
NCT07221526,SPO2 VALIDATION STUDY - PHILIPS FAST 2025,SPO2 VALIDATION STUDY - PHILIPS FAST 2025,RECRUITING,2025-10-28,2026-01-09,2026-01-09,OBSERVATIONAL,,72,['PULSE OXIMETRY'],PULSE OXIMETRY,Philips Clinical & Medical Affairs Global,[],['United States']
NCT05414903,Reading Outcomes in Children With Vestibular Loss,Reading Outcomes in Children With Vestibular Loss,RECRUITING,2022-06-06,2026-06-30,2026-06-30,OBSERVATIONAL,,90,"['Vestibular Disorder', 'Hearing Loss, Sensorineural']",Vestibular Disorder,Father Flanagan's Boys' Home,[],['United States']
NCT06338774,Cognitive Control to Boost Physical Activity Adherence,Targeting Cognitive Control to Improve Physical Activity Adherence in Midlife for Alzheimer's Risk Reduction,RECRUITING,2024-09-01,2027-05-01,2027-11-30,INTERVENTIONAL,NA,264,['Physical Inactivity'],Physical Inactivity,University of Iowa,"['Northeastern University', 'National Institute on Aging (NIA)']",['United States']
NCT07225179,mHealth for Early Psychosis Caregivers in Statewide Program Outreach,Bolster-NC: A Pilot Study of the Bolster mHealth Intervention Within Early Psychosis Program Outreach in North Carolina,RECRUITING,2025-12-01,2026-07-30,2026-07-30,INTERVENTIONAL,NA,30,"['Caregiver', 'Caregiver Distress', 'Caregiver to a Young Adult With Early Psychosis', 'Family Caregivers']",Caregiver,"University of North Carolina, Chapel Hill",['North Carolina Department of Health and Human Services'],['United States']
NCT06747117,A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II),STRIDE II: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System II,RECRUITING,2025-05-18,2028-06,2029-01,OBSERVATIONAL,,300,"['Lower Extremity Acute Limb Ischemia', 'LE ALI']",Lower Extremity Acute Limb Ischemia,Penumbra Inc.,[],"['United States', 'Italy', 'Germany', 'Australia']"
NCT07277517,The Effect of Integrating Pain Neuroscience Education(PNE) With Conventional Physiotherapy on Pain and Functional Disability in Patients With Acute Low Back Pain,The Effect of Integrating Pain Neuroscience Education(PNE) With Conventional Physiotherapy on Pain and Functional Disability in Patients With Acute Low Back Pain,RECRUITING,2025-10-05,2026-04,2026-08,INTERVENTIONAL,NA,48,['Acute Low-back Pain'],Acute Low-back Pain,Iran University of Medical Sciences,[],['Iran']
NCT06903078,A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.,Pathogenic Exosomes During Herpes Zoster Mediate Increased Vascular Dementia Risk.,RECRUITING,2025-02-13,2029-07-31,2030-08,OBSERVATIONAL,,375,"['Herpes Zoster (HZ)', 'Vascular Dementia']",Herpes Zoster (HZ),"Center for Clinical Studies, Texas",['National Institute on Aging (NIA)'],['United States']
NCT00026650,Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy,Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy,RECRUITING,2000-02-14,,,OBSERVATIONAL,,700,['Cancer'],Cancer,National Cancer Institute (NCI),[],['United States']
NCT04563520,SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis,aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis),RECRUITING,2026-01,2027-01,2027-01,INTERVENTIONAL,PHASE3,5,['Hemophilia A'],Hemophilia A,Emory University,"['Takeda Pharmaceuticals North America, Inc.']",['United States']
NCT04068610,COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC,"A Phase Ib/II, Open-label, Multicenter Study of Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First-line Therapy in Metastatic Microsatellite-stable Colorectal Cancer (COLUMBIA-1)",ACTIVE_NOT_RECRUITING,2019-09-13,2022-10-10,2026-11-24,INTERVENTIONAL,PHASE1,61,['Metastatic Microsatellite-stable Colorectal Cancer'],Metastatic Microsatellite-stable Colorectal Cancer,MedImmune LLC,[],"['United States', 'France', 'Spain', 'Canada', 'Australia']"
NCT06132958,Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005),"A Phase 3, Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Immunotherapy (MK-2870-005/ENGOT-en23/GOG-3095)",ACTIVE_NOT_RECRUITING,2023-12-06,2028-01-10,2028-01-10,INTERVENTIONAL,PHASE3,710,['Endometrial Cancer'],Endometrial Cancer,Merck Sharp & Dohme LLC,"['European Network for Gynaecological Oncological Trial groups(ENGOT)', 'GOG Foundation']","['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT01132885,Defining the Brain Phenotype of Children With Williams Syndrome,"Defining the Brain Phenotype of Children With 7q11.23 Copy Number Variation, Including Williams Syndrome and 7q11.23 Duplication Syndrome",RECRUITING,2011-01-23,,,OBSERVATIONAL,,415,"['Williams Syndrome', 'Duplication']",Williams Syndrome,National Institute of Mental Health (NIMH),[],['United States']
NCT06246955,Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer,"""Live Fully With Cancer"": Assessing the Impact of an Acceptance and Commitment Therapy and Compassion-Based Virtual Group Intervention for Diverse Cancer Patients",RECRUITING,2024-01-08,2027-12-31,2027-12-31,INTERVENTIONAL,NA,200,"['Hematopoietic and Lymphoid System Neoplasm', 'Malignant Solid Neoplasm']",Hematopoietic and Lymphoid System Neoplasm,Mayo Clinic,[],['United States']
NCT06103838,18F-Fluciclovine PET/CT in Multiple Myeloma,A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma,RECRUITING,2024-03-25,2026-12-06,2031-12-06,INTERVENTIONAL,PHASE2,60,"['Multiple Myeloma', 'Newly Diagnosed Multiple Myeloma (NDMM)', 'Relapsed and/or Refractory Multiple Myeloma (RRMM)']",Multiple Myeloma,National Cancer Institute (NCI),[],['United States']
NCT07193680,NOPE37: Angiogenic Factors for Managing Term Preeclampsia,"Angiogenic Markers for Confirming Term Preeclampsia (noPE-37 Trial): An Open-Label, Randomized Controlled Trial",RECRUITING,2025-12-04,2027-12,2028-04,INTERVENTIONAL,NA,750,['Preeclampsia'],Preeclampsia,Hospital Universitari Vall d'Hebron Research Institute,['Instituto de Salud Carlos III'],['Spain']
NCT05183074,MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02),Phase II Prospective Trial of MR-linac Based Stereotactic Ablative Radiotherapy for Patients With Localized (SAMRT-P01) and Oligo-metastatic (SMART-P02) Prostate Cancer,RECRUITING,2021-02-01,2027-12-31,2027-12-31,INTERVENTIONAL,NA,50,"['Prostate Cancer', 'Radiotherapy Side Effect', 'Magnetic Resonance-linac', 'Stereotactic Ablative RT', 'Adaptive Radiotherapy', 'Localised Disease', 'Oligometastatic Disease']",Prostate Cancer,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT03199300,Investigating Cardiovascular Adverse Events Related to Cancer Treatment,Investigating Cardiovascular Adverse Events Related to Cancer Treatment: a Study of Extreme Toxicity Using Induced Pluripotent Stem Cells,ACTIVE_NOT_RECRUITING,2017-12-12,2025-02-06,2027-01,OBSERVATIONAL,,20,"['Toxicity Due to Chemotherapy', 'Cardiovascular Morbidity', 'Cancer, Treatment-Related']",Toxicity Due to Chemotherapy,University Medical Center Groningen,[],['Netherlands']
NCT06375681,Effectiveness of Cognitive Training in Older and Younger Adults,Examining the Effectiveness of Cognitive Training,RECRUITING,2024-10-01,2028-01,2028-01,INTERVENTIONAL,NA,1600,['Cognitive Change'],Cognitive Change,"University of Wisconsin, Madison",['National Institute on Aging (NIA)'],['United States']
NCT00814827,Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma,Mycobacterial and Opportunistic Infections in HIV-Negative Patients Associated With Autoantibodies to Interferon-gamma,ACTIVE_NOT_RECRUITING,2010-01-07,,,OBSERVATIONAL,,224,"['Nontuberculous Mycobacteria', 'Mycobacterium Tuberculosis', 'Opportunistic Infections']",Nontuberculous Mycobacteria,National Institute of Allergy and Infectious Diseases (NIAID),[],"['China', 'Taiwan', 'Thailand']"
NCT07277855,Floor-Lift Series Pulmonary Rehabilitation for COPD: Short- and Long-Term Outcomes in a North African Setting,Evaluation of the Floor-Lift Series (FLS) Pulmonary Rehabilitation Program on Short- and Long-Term Clinical and Functional Outcomes in COPD by Program Adherence: A Single-Center Quasi-Experimental Study in a North African Setting,ACTIVE_NOT_RECRUITING,2024-12-01,2026-12-01,2027-06-30,INTERVENTIONAL,NA,16,"['COPD (Chronic Obstructive Pulmonary Disease)', 'Muscle Weakness | Patient']",COPD (Chronic Obstructive Pulmonary Disease),Benazzouz Redouene Sid Ahmed,[],['Algeria']
NCT05900570,Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure,The Effect of Acute Peri-Urethral Neurostimulation on Intra-Urethral Pressure In Women With Stress Urinary Incontinence (SUI) - Urodynamic Early Feasibility Study,RECRUITING,2024-02-26,2027-01,2027-01,INTERVENTIONAL,NA,20,['Stress Urinary Incontinence'],Stress Urinary Incontinence,Corewell Health East,[],['United States']
NCT06828328,A Phase I Study of GC203 TIL in PDCA (RJ),A Phase I Study of Engineered Tumor Infiltrating Lymphocytes Injection (GC203 TIL) in Patients With Pancreatic Ductal Adenocarcinoma,RECRUITING,2025-02-10,2028-01-31,2028-01-31,INTERVENTIONAL,EARLY_PHASE1,10,"['Pancreatic Cancer', 'Pancratic Ductal Adenocarcinoma', 'Treatment Side Effects', 'Tumor Infiltrating Lymphocytes']",Pancreatic Cancer,Shanghai Juncell Therapeutics,[],['China']
NCT06312137,A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019),A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery,RECRUITING,2024-04-03,2034-02-21,2034-10-23,INTERVENTIONAL,PHASE3,780,['Non Small Cell Lung Cancer'],Non Small Cell Lung Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Peru', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05438095,Medication Adherence in Patients With Sarcoidosis,Medication Adherence and Clinical Outcomes in Sarcoidosis,ACTIVE_NOT_RECRUITING,2022-05-11,2026-08-31,2026-08-31,OBSERVATIONAL,,150,"['Medication Adherence', 'Sarcoidosis']",Medication Adherence,Johns Hopkins University,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07277751,Validity and Reliability of the L Test in Geriatric Individuals,Investigating the Validity and Reliability of the L Test in Geriatric Individuals,ACTIVE_NOT_RECRUITING,2025-10-22,2026-03-21,2026-04-21,OBSERVATIONAL,,70,"['Geriatric Individuals', 'Geriatric']",Geriatric Individuals,Hasan Kalyoncu University,[],['Turkey (Türkiye)']
NCT07273136,Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery,Safety and Efficacy of Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery,RECRUITING,2025-12-10,2026-04-01,2026-04-01,INTERVENTIONAL,NA,50,"['Subcostal', 'Lateral', 'Transversus Abdominis Plane Block', 'Postoperative Analgesia', 'Thoracic Epidural Analgesia', 'Major Abdominal Cancer Surgery']",Subcostal,Assiut University,[],['Egypt']
NCT07179679,A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors,A Phase I Clinical Study to Evaluate the Safety and Pharmacokinetics of TQB2934 Subcutaneous Preparation for Injection in Subjects With Malignant Plasma Cell Tumors,RECRUITING,2025-12-09,2027-10,2028-06,INTERVENTIONAL,PHASE1,42,['Multiple Myeloma'],Multiple Myeloma,"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.",[],['China']
NCT06665594,Effect of TXA on Reducing Bruising After Filler Injection,Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study,RECRUITING,2025-12-05,2026-11,2026-11,INTERVENTIONAL,PHASE2,40,"['Facial Filler Injections', 'Hyaluronic Acid', 'Tranexamic Acid']",Facial Filler Injections,"University of Wisconsin, Madison",[],['United States']
NCT05930483,"Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial","Using a SMART Design to Evaluate Remotely Delivered, Community-aligned Weight Loss Interventions Among Breast Cancer Survivors: The ¡Vida! Study",RECRUITING,2025-04-08,2028-03-01,2028-03-01,INTERVENTIONAL,NA,640,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8']",Anatomic Stage I Breast Cancer AJCC v8,Fred Hutchinson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT06856694,RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer,Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men With Clinically Localized Prostate Cancer,RECRUITING,2025-10-22,2029-05,2029-12,INTERVENTIONAL,NA,283,"['Prostate Cancer', 'Shared Decision Making', 'Risk Communication']",Prostate Cancer,Cedars-Sinai Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT06813820,RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial,RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial,RECRUITING,2025-09-29,2028-08,2032-08,INTERVENTIONAL,NA,135,"['Left Ventricle Remodeling', 'Left Ventricle Dilated', 'CHF']",Left Ventricle Remodeling,BioVentrix,[],['United States']
NCT06153277,Does Edema Affect the Adjustment of TENS Amplitude,Does Edema After Knee Arthroplasty Affect the Adjustment of TENS Amplitude,RECRUITING,2023-12-07,2026-04,2026-04,OBSERVATIONAL,,125,"['Edema Leg', 'Pain']",Edema Leg,Karamanoğlu Mehmetbey University,['Karaman Training and Research Hospital'],['Turkey (Türkiye)']
NCT07277257,Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome,Evaluating TRYPTYR as a Novel Therapy for Dry Eye in Patients With Sjögren's Syndrome,RECRUITING,2025-12-02,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE4,35,['Sjogren Syndrome With Keratoconjunctivitis'],Sjogren Syndrome With Keratoconjunctivitis,Center For Sight,[],['United States']
NCT07004465,Effectiveness of Vitamin b12 Versus Kenalog on Traumatic Ulcer Associated With Orthodontic Treatment,Effectiveness of Vitamin b12 Versus Kenalog in Orabase on Traumatic Ulcer Associated With Orthodontic Treatment: Randomized Control Trial,RECRUITING,2025-08-19,2025-12-19,2025-12-19,INTERVENTIONAL,NA,76,['Mouth Ulcer'],Mouth Ulcer,Hawraa Ali Abdullah,[],['Iraq']
NCT07277907,Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation,"Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation: A Multicenter, Randomized Controlled Trial",RECRUITING,2025-11-13,2027-10-31,2027-11-30,INTERVENTIONAL,PHASE3,346,"['Slow Transit Constipation', 'Pharmacotherapy']",Slow Transit Constipation,Third Military Medical University,[],['China']
NCT06534047,Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial,"Integrating Transcranial Magnetic Stimulation as a Treatment for Nicotine Dependence in the Clinic: A Pragmatic, Hybrid Effectiveness-Implementation Trial",RECRUITING,2024-09-01,2026-09-01,2026-12-01,INTERVENTIONAL,PHASE4,40,"['Tobacco Use Disorder', 'Psychiatric Disorder', 'Nicotine Dependence']",Tobacco Use Disorder,Centre for Addiction and Mental Health,[],['Canada']
NCT05677490,"mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma",Randomized Phase III Trial of mFOLFIRINOX vs. FOLFOX With Nivolumab for First-Line Treatment of Metastatic HER2- Gastroesophageal Adenocarcinoma,RECRUITING,2023-01-31,2028-11-08,2028-11-08,INTERVENTIONAL,PHASE3,382,"['Advanced Esophageal Adenocarcinoma', 'Advanced Gastric Adenocarcinoma', 'Advanced Gastroesophageal Junction Adenocarcinoma', 'Clinical Stage III Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage III Gastric Cancer AJCC v8', 'Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Clinical Stage IV Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Metastatic Esophageal Adenocarcinoma', 'Metastatic Gastric Adenocarcinoma', 'Metastatic Gastroesophageal Junction Adenocarcinoma', 'Unresectable Esophageal Adenocarcinoma', 'Unresectable Gastric Adenocarcinoma', 'Unresectable Gastroesophageal Junction Adenocarcinoma']",Advanced Esophageal Adenocarcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT06576271,"A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants","A Phase 1, First-time-in-human, Three-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK4527363 in Healthy Participants (Part A), Participants With Active Systemic Lupus Erythematosus (Part B), and Healthy Participants of Chinese and Japanese Descent (Part C)",RECRUITING,2024-09-02,2028-01-11,2028-01-11,INTERVENTIONAL,PHASE1,142,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,GlaxoSmithKline,[],"['Brazil', 'United States', 'Spain', 'United Kingdom', 'Poland', 'Argentina']"
NCT06546696,The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings,The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings,RECRUITING,2024-10-23,2028-12-01,2028-12-01,INTERVENTIONAL,NA,750,['Childhood Obesity'],Childhood Obesity,Vanderbilt University Medical Center,[],['United States']
NCT06314477,Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial,Effect of CPAP Treatment on Asthma Control in Patients With Severe Uncontrolled Asthma and Obstructive Sleep Apnea: The ASTHMA-SLEEP Study,RECRUITING,2023-12-27,2026-12,2026-12,INTERVENTIONAL,NA,138,"['Obstructive Sleep Apnea', 'Asthma']",Obstructive Sleep Apnea,Hospital Clinic of Barcelona,[],['Spain']
NCT06059547,Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder Cancer,A Multi-center Phase 2 Study of Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for the Treatment of Muscle Invasive Bladder Cancer,ACTIVE_NOT_RECRUITING,2023-09-06,2025-10-16,2026-10-16,INTERVENTIONAL,PHASE2,31,"['Bladder Cancer', 'Adult Solid Tumor']",Bladder Cancer,CatalYm GmbH,[],['Italy']
NCT05248230,4D-710 in Adult Patients With Cystic Fibrosis,"An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis",RECRUITING,2022-03-29,2026-12,2030-01,INTERVENTIONAL,PHASE2,40,['Cystic Fibrosis Lung'],Cystic Fibrosis Lung,4D Molecular Therapeutics,[],['United States']
NCT04960072,A Phase I Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital),A Clinical Safety and Efficacy Study of Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) in Patients With r/r Gastrointestinal Tumors,RECRUITING,2021-06-30,2025-12-30,2026-07-30,INTERVENTIONAL,EARLY_PHASE1,50,['Gastrointestinal Tumor'],Gastrointestinal Tumor,Shanghai Juncell Therapeutics,"[""Shanghai 10th People's Hospital""]",['China']
NCT06989853,Methamphetamine and Troriluzole,Advancing Troiluzole as a Treatment for Methamphetamine Use Disorder: A Human Laboratory Study,RECRUITING,2025-08-25,2029-02-28,2029-02-28,INTERVENTIONAL,EARLY_PHASE1,40,['Methamphetamine Use Disorder'],Methamphetamine Use Disorder,University of Kentucky,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT07199478,Ntelligently Integrated Digital Rehabilitation Model Combining mHealth and ERAS in Total Hip and Knee Arthroplasty,Application of an Intelligently Integrated Digital Rehabilitation Model Combining mHealth and ERAS in Total Hip and Knee Arthroplasty,ACTIVE_NOT_RECRUITING,2025-09-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,140,"['Total Knee Arthroplasty', 'Total Hip Arthroplasty', 'ERAS']",Total Knee Arthroplasty,The Affiliated Hospital Of Southwest Medical University,[],['China']
NCT07066657,A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors,"An Open-Label, Multi-Center, Dose Escalation, Confirmation, and Expansion Phase I Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of MRG007 (ARR-217) in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors",RECRUITING,2025-07-25,2029-05,2030-12,INTERVENTIONAL,PHASE1,405,"['Locally Advanced or Metastatic Solid Tumors', 'Colorectal Cancer', 'Gastric Cancer', 'Pancreatic Cancer']",Locally Advanced or Metastatic Solid Tumors,"Lepu Biopharma Co., Ltd.","['ArriVent BioPharma, Inc.']","['China', 'United States']"
NCT05969002,Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias,Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias,RECRUITING,2023-08-25,2025-12-31,2026-04-30,OBSERVATIONAL,,36,"['B Cell', 'Acute Lymphoblastic Leukemia', 'Relapsed/Refractory']",B Cell,National Cancer Institute (NCI),[],['United States']
NCT07013201,A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis,"A Proof-of-concept Phase 2a, Double-blind, 2-arm Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream 20 mg/g Compared With Cream Vehicle During a 16-week Treatment Period in Adult Subjects With Mild to Severe Palmoplantar Pustulosis",RECRUITING,2025-09-11,2026-12-14,2026-12-14,INTERVENTIONAL,PHASE2,135,['Palmoplantar Pustulosis'],Palmoplantar Pustulosis,LEO Pharma,[],"['Poland', 'United States', 'Canada', 'Germany']"
NCT06358521,Determining the Impact of a Physiotherapist-led Primary Care Model for Hip and Knee Pain - A Cluster Trial,Determining the Impact of a New Physiotherapist-led Primary Care Model for Hip and Knee Pain - A Cluster Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2023-10-02,2025-11-25,2025-12-19,INTERVENTIONAL,NA,728,"['Hip Osteoarthritis', 'Knee Osteoarthritis']",Hip Osteoarthritis,Queen's University,"['Canadian Institutes of Health Research (CIHR)', 'The Arthritis Society, Canada']",['Canada']
NCT01432847,Cell Collection to Study Eye Diseases,Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls,RECRUITING,2011-09-07,,,OBSERVATIONAL,,930,"['Retinal Disease', 'AMD', 'Retinal Degeneration', 'Retinitis Pigmentosa']",Retinal Disease,National Eye Institute (NEI),[],['United States']
NCT06326684,Suvorexant and Alcohol,Influence of Orexin Antagonism on Motivation for Alcohol,RECRUITING,2024-06-07,2027-03-15,2027-03-15,INTERVENTIONAL,EARLY_PHASE1,30,['Alcohol Use Disorder'],Alcohol Use Disorder,University of Kentucky,['National Institute on Alcohol Abuse and Alcoholism (NIAAA)'],['United States']
NCT07277335,Neuromuscular Variables and Performance in Mexican Weightlifters,Association Between Neuromuscular Variables and Competitive Performance in Weightlifting: an Observational Study With Mexican Athletes [The Kraft Project],RECRUITING,2025-12-27,2025-12-30,2025-12-31,OBSERVATIONAL,,50,"['Isometric Muscle Strength', 'Jumping Performance', 'Weightlifting', 'Performance Measures']",Isometric Muscle Strength,Ángel Rodríguez,[],['Mexico']
NCT04590963,Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer,"A Phase 3 Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination With Cetuximab in Participants With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With an Immune Checkpoint Inhibitor",ACTIVE_NOT_RECRUITING,2020-10-02,2022-05-11,2026-09-24,INTERVENTIONAL,PHASE3,370,['Squamous Cell Carcinoma of the Head and Neck'],Squamous Cell Carcinoma of the Head and Neck,AstraZeneca,['Innate Pharma'],"['Bulgaria', 'Japan', 'Netherlands', 'Australia', 'Belgium', 'Russia', 'France', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT03683680,Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers,Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers,RECRUITING,2018-10-31,2030-01-01,2030-10-01,INTERVENTIONAL,NA,240,['Mesothelioma'],Mesothelioma,Dana-Farber Cancer Institute,['National Cancer Institute (NCI)'],['United States']
NCT06595953,Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety,Phase II Efficacy Study of Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety,RECRUITING,2024-12-04,2029-10-01,2029-10-01,INTERVENTIONAL,PHASE2,150,"['Psychiatric Disorders', 'Anxiety Disorders']",Psychiatric Disorders,National Institute of Mental Health (NIMH),[],['United States']
NCT04171323,The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia,ACTIVE MIND: An Adaptive Clinical Trial of Cognitive Training to Improve Function and Delay Dementia,RECRUITING,2020-03-03,2028-08-31,2028-08-31,INTERVENTIONAL,NA,1305,"['Age-related Cognitive Decline', 'Mild Cognitive Impairment', 'Dementia']",Age-related Cognitive Decline,University of Alabama at Birmingham,"['University of Florida', 'University of Minnesota', 'National Institute on Aging (NIA)', 'Clemson University', 'University of California, San Francisco']",['United States']
NCT06087640,"A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age","A Phase 3/3b, Randomized, Observer-blind, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Subunit Inactivated Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age",ACTIVE_NOT_RECRUITING,2023-10-23,2026-11,2026-12,INTERVENTIONAL,PHASE3,35800,"['Influenza, Human']","Influenza, Human",Seqirus,[],"['Bulgaria', 'New Zealand', 'Netherlands', 'Lithuania', 'Zimbabwe', 'Australia', 'Belgium', 'Finland', 'South Korea', 'Czechia', 'Poland', 'South Africa', 'Georgia', 'Spain', 'Taiwan', 'Romania', 'Turkey (Türkiye)', 'United States', 'Italy', 'Philippines', 'Serbia']"
NCT07276932,Clinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Patients Undergoing Chemotherapy,"Clinical Study on Acupoint Application Based on the Theory of ""State-target Syndrome Differentiation"" in Relieving qi Deficiency and Constipation in Patients With Colorectal Cancer Undergoing Postoperative Chemotherapy",RECRUITING,2025-07-16,2025-12-31,2027-12-31,INTERVENTIONAL,NA,106,"['Postoperative Chemotherapy', 'Chemotherapy']",Postoperative Chemotherapy,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT04452344,Opioid Analgesic Reduction Study,Opioid Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain,ACTIVE_NOT_RECRUITING,2021-01-04,2023-07-07,2025-12-31,INTERVENTIONAL,PHASE3,1815,['Opioid Use'],Opioid Use,"Rutgers, The State University of New Jersey","['National Institute of Dental and Craniofacial Research (NIDCR)', 'University of Rochester', 'University of Maryland, Baltimore', 'University of Illinois at Chicago', 'University of Michigan']",['United States']
NCT05320692,A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma,"A Phase III, Randomized, Open-Label, Multi-center Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) or TACE Alone in Patients With Incurable Hepatocellular Carcinoma",ACTIVE_NOT_RECRUITING,2022-08-09,2026-07-30,2026-07-30,INTERVENTIONAL,PHASE3,423,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT05509777,A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease,"A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn's Disease",RECRUITING,2024-03-13,2027-12,2028-04,INTERVENTIONAL,PHASE3,90,"[""Crohn's Disease""]",Crohn's Disease,Eli Lilly and Company,[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'Norway', 'Austria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Portugal']"
NCT05213234,Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis,Chronotherapy of 5-Aminosalicylic Acid in Ulcerative Colitis: A Randomized Crossover Trial,ACTIVE_NOT_RECRUITING,2021-07-09,2026-03-31,2026-03-31,INTERVENTIONAL,NA,32,['Ulcerative Colitis'],Ulcerative Colitis,Rush University Medical Center,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06454344,The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies,"Associations of Adverse Childhood Experiences, Sleep Disruption, and Vascular Dysfunction in Young Adults: The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies",RECRUITING,2024-05-01,2027-12-15,2028-10-31,INTERVENTIONAL,NA,70,"['Adverse Childhood Experiences', 'Vascular Dilatation', 'Sleep', 'Sleep Disturbance', 'Psychosocial Stressor', 'Psychological Trauma', 'Endothelial Dysfunction', 'Inflammation', 'Oxidative Stress']",Adverse Childhood Experiences,Nathaniel Jenkins,[],['United States']
NCT04898543,QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors,Phase 1 Open-Label Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors,ACTIVE_NOT_RECRUITING,2021-06-21,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE1,50,['Metastatic Solid Tumor'],Metastatic Solid Tumor,"ImmunityBio, Inc.",[],['United States']
NCT06284317,"A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.","An International, Multicentre, Open-label Randomised Phase III Trial to Evaluate the Benefit of Adding Adjuvant Durvalumab After Neoadjuvant Chemotherapy Plus Durvalumab in Patients With Stage IIB-IIIB (N2) Resectable NSCLC",RECRUITING,2025-01-15,2029-10,2030-03,INTERVENTIONAL,PHASE3,290,['Non Small Cell Lung Cancer'],Non Small Cell Lung Cancer,ETOP IBCSG Partners Foundation,['AstraZeneca'],"['Belgium', 'Netherlands', 'Estonia', 'Austria', 'France', 'Switzerland', 'Ireland', 'Italy', 'United Kingdom', 'Australia']"
NCT06899776,Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department,Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department,ACTIVE_NOT_RECRUITING,2025-02-07,2025-09-15,2026-07,OBSERVATIONAL,,600,['ACS (Acute Coronary Syndrome)'],ACS (Acute Coronary Syndrome),Wake Forest University Health Sciences,['Abbott Point of Care'],['United States']
NCT06582615,Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer,Food for Thought - Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Triple Negative Breast Cancer,RECRUITING,2024-10-28,2026-12,2026-12-31,INTERVENTIONAL,NA,60,"['Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8', 'Triple-Negative Breast Carcinoma']",Anatomic Stage II Breast Cancer AJCC v8,Ohio State University Comprehensive Cancer Center,['American Institute for Cancer Research'],['United States']
NCT07216482,A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037),"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate Coadministered With Rosuvastatin in Adults With Hyperlipidemia",RECRUITING,2025-11-11,2026-12-02,2027-03-01,INTERVENTIONAL,PHASE3,975,['Hyperlipidemia'],Hyperlipidemia,Merck Sharp & Dohme LLC,[],"['United Kingdom', 'Israel', 'United States', 'Australia']"
NCT07239141,Two Video Laryngoscopes (Laringocel® and C-MAC®) for First-Attempt Intubation in Adults Undergoing Elective Surgery,Estimation of the Non-Inferiority of the Laringocel® Videolaryngoscope Compared With the C-MAC D-BLADE (Karl Storz®) for First-Attempt Intubation in Adult Patients Undergoing Elective Surgery,RECRUITING,2025-12-04,2026-04,2026-04,INTERVENTIONAL,NA,252,"['Airway Management', 'Intubation, Endotracheal']",Airway Management,Mario Zamudio,[],['Colombia']
NCT06135870,Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study),Role of Senescent Cells in Uterine Fibroid Pathogenesis,RECRUITING,2023-11-01,2027-12-31,2027-12-31,OBSERVATIONAL,,150,"['Fibroid', 'Leiomyoma']",Fibroid,Johns Hopkins University,"['National Institutes of Health (NIH)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT07095231,"Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults","A Phase 1 Dose Escalation Study to Assess the Safety, Reactogenicity, and Immunogenicity of STX-S for Prevention of SARS-CoV-2 Infection as a Booster Dose",RECRUITING,2025-08-11,2026-02-02,2026-10-05,INTERVENTIONAL,PHASE1,60,['COVID-19'],COVID-19,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07261202,Impact of Indoor Overheating on Physiological Strain in Children,A Preliminary Study Assessing the Effectiveness of a 26 °C Indoor Temperature Limit on Physiological Responses in Children,RECRUITING,2025-11-08,2026-06-01,2026-12-31,INTERVENTIONAL,NA,10,"['Heat Stress', 'Physiological Stress', 'Cognitive Change']",Heat Stress,University of Ottawa,[],['Canada']
NCT07221344,Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease,"A Phase 1/2a Placebo-Controlled Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease",RECRUITING,2025-11-18,2027-06,2027-06,INTERVENTIONAL,PHASE1,112,"['Alzheimer Disease', 'Alzheimer Disease, Early Onset']",Alzheimer Disease,Arrowhead Pharmaceuticals,[],['New Zealand']
NCT06966700,"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer",RECRUITING,2025-06-30,2033-03-23,2034-12-29,INTERVENTIONAL,PHASE3,2400,"['Breast Neoplasms', 'Triple Negative Breast Neoplasms', 'HR Low-Positive/HER2-Negative Breast Neoplasms']",Breast Neoplasms,Merck Sharp & Dohme LLC,[],"['Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Finland', 'Guatemala', 'Peru', 'South Korea', 'Poland', 'Singapore', 'South Africa', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Ukraine', 'Sweden', 'Brazil', 'United States', 'Argentina']"
NCT06993610,Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense,"A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Hidradenitis Suppurativa",RECRUITING,2025-05-16,2026-09,2027-03,INTERVENTIONAL,PHASE2,180,['Hidradenitis Suppurativa (HS)'],Hidradenitis Suppurativa (HS),Zura Bio Inc,[],"['Hungary', 'United States', 'Spain', 'Canada', 'Poland', 'Germany']"
NCT06655883,A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098),"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Suvorexant for the Treatment of Insomnia in Participants With Opioid Use Disorder",RECRUITING,2025-10-09,2027-06-24,2027-06-24,INTERVENTIONAL,PHASE3,300,['Insomnia'],Insomnia,Merck Sharp & Dohme LLC,[],['United States']
NCT06305754,"Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)","A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors",RECRUITING,2024-06-11,2028-09-12,2030-06-14,INTERVENTIONAL,PHASE3,520,['Non-small Cell Lung Cancer (NSCLC)'],Non-small Cell Lung Cancer (NSCLC),Merck Sharp & Dohme LLC,[],"['Japan', 'China', 'France', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Vietnam', 'Sweden', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT05584631,IVIG vs SCIG in CIDP,The Influence of Body Composition on Immunoglobulin Disposition After Intravenous and Subcutaneous Administration,RECRUITING,2022-09-11,2026-12-01,2026-12-01,INTERVENTIONAL,PHASE1,20,"['CIDP', 'Immunoglobulin Deficiency', 'Chronic Inflammatory Demyelinating Polyneuropathy']",CIDP,"Rutgers, The State University of New Jersey",[],['United States']
NCT07225010,Tele-PCIT for Healthy Relationships,Fostering Healthy Relationships Through Tele-PCIT for Families of South Carolina,RECRUITING,2026-01,2028-08,2028-08,INTERVENTIONAL,NA,50,"['Disruptive Behavior', 'Pediatrics']",Disruptive Behavior,Medical University of South Carolina,['The Duke Endowment'],['United States']
NCT06104618,Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis,Phase II Study of Enfortumab Vedotin Treatment for Metastatic Squamous Cell Carcinoma of the Penis,RECRUITING,2023-12-21,2026-11-01,2026-11-01,INTERVENTIONAL,PHASE2,28,"['Metastatic Penile Squamous Cell Carcinoma', 'Stage III Penile Cancer AJCC v8', 'Stage IV Penile Cancer AJCC v8', 'Unresectable Penile Squamous Cell Carcinoma']",Metastatic Penile Squamous Cell Carcinoma,Mayo Clinic,[],['United States']
NCT06292013,A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event - ACCLAIM-Lp(a)",RECRUITING,2024-03-05,2029-03,2029-03,INTERVENTIONAL,PHASE3,16700,"['Atherosclerotic Cardiovascular Disease (ASCVD)', 'Elevated Lp(a)']",Atherosclerotic Cardiovascular Disease (ASCVD),Eli Lilly and Company,[],"['Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05910567,A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma,A Randomized Controlled Trial of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma,RECRUITING,2023-04-17,2027-04-30,2027-04-30,INTERVENTIONAL,NA,4346,"['Blunt Trauma to Abdomen', 'Wounds and Injuries', 'Abdomen Injury', 'Abdominal Injury', 'Abdomen, Acute']",Blunt Trauma to Abdomen,"University of California, Davis","['Pediatric Emergency Care Applied Research Network', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT07261345,Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease,The Safety and Efficacy of Allogenic Anti-CD19/BCMA CAR-T Cell Therapy for Refractory Graves' Disease,RECRUITING,2026-12,2027-12,2027-12,INTERVENTIONAL,EARLY_PHASE1,4,"[""Graves' Disease""]",Graves' Disease,Shanghai Zhongshan Hospital,[],['China']
NCT07263776,Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2,"Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial-2 (IRIS-2)",RECRUITING,2025-12-05,2027-03-01,2027-03-01,INTERVENTIONAL,PHASE3,692,['Acute Ischemic Stroke'],Acute Ischemic Stroke,Capital Medical University,[],['China']
NCT06972303,Mindfulness Meditation for Insomnia,A Pilot Feasibility and Acceptability RCT of an App-Based Mindfulness Meditation Intervention for Sleep Among Patients With Insomnia Disorder,RECRUITING,2025-12,2028-07-31,2028-12-29,INTERVENTIONAL,PHASE1,30,"['Sleep Initiation and Maintenance Disorders', 'Insomnia', 'Insomnia Chronic', 'Mindfulness', 'Telemedicine']",Sleep Initiation and Maintenance Disorders,Brigham and Women's Hospital,['National Center for Complementary and Integrative Health (NCCIH)'],['United States']
NCT06623461,LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma,A Phase II Randomized Trial of LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Patients With Advanced Melanoma,RECRUITING,2025-04-07,2028-12-31,2029-12-31,INTERVENTIONAL,PHASE2,128,['Melanoma'],Melanoma,Canadian Cancer Trials Group,"['Canadian Institutes of Health Research (CIHR)', 'Canadian Cancer Society (CCS)', 'Weston Family Foundation']",['Canada']
NCT04859985,The SELUTION DeNovo Study,"Selution DeNovo - A Prospective Randomized, Multi-centre, International, Open Label, Clinical Trial Comparing the Selution DEB Strategy Versus DES Strategy.",ACTIVE_NOT_RECRUITING,2021-05-15,2025-09-15,2030-10-31,INTERVENTIONAL,NA,3326,['Coronary Artery Disease'],Coronary Artery Disease,M.A. Med Alliance S.A.,[],"['Singapore', 'Netherlands', 'Austria', 'France', 'Finland', 'Switzerland', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT03686124,ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors,Phase 1/2 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Nivolumab in Patients With Recurrent and/or Refractory Solid Tumors,RECRUITING,2019-05-14,2028-12,2032-06,INTERVENTIONAL,PHASE1,375,"['Refractory Cancer', 'Recurrent Cancer', 'Solid Tumor, Adult', 'Cancer']",Refractory Cancer,"Immatics US, Inc.",[],"['United States', 'Germany']"
NCT06107673,Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）,"A Phase II Randomized, Non-inferiority Study Comparing the Efficacy and Safety of Dalpiciclib Combined With AI With Neoadjuvant Chemotherapy in ER+ HER2- Postmenopausal Breast Cancer Patients",RECRUITING,2023-09-30,2026-12-01,2028-12-01,INTERVENTIONAL,PHASE2,144,['Breast Cancer'],Breast Cancer,Hebei Medical University Fourth Hospital,[],['China']
NCT03554356,Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE),Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE),ACTIVE_NOT_RECRUITING,2018-09-04,2026-08,2027-08,INTERVENTIONAL,NA,70,"['Barrett Esophagus', 'Intestinal Metaplasia', 'Esophageal Dysplasia']",Barrett Esophagus,"University of North Carolina, Chapel Hill","['PENTAX of America, Inc.', 'Johns Hopkins University']",['United States']
NCT06518057,Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer,A Multi-Center Phase 2 Study of Hippocampal Avoidance in Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumors,RECRUITING,2025-03-03,2026-12-30,2027-12-30,INTERVENTIONAL,PHASE2,22,"['Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic Breast Carcinoma', 'Metastatic Lung Non-Small Cell Carcinoma', 'Metastatic Malignant Neoplasm in the Leptomeninges', 'Stage IV Lung Cancer AJCC v8']",Anatomic Stage IV Breast Cancer AJCC v8,University of Washington,[],['United States']
NCT03705234,A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease,HPS-4/TIMI 65/ORION-4: A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease,ACTIVE_NOT_RECRUITING,2018-10-30,2026-10,2049-12,INTERVENTIONAL,PHASE3,16124,['Atherosclerotic Cardiovascular Disease'],Atherosclerotic Cardiovascular Disease,University of Oxford,"['The TIMI Study Group', 'Novartis Pharmaceuticals']","['United Kingdom', 'United States']"
NCT03538639,Vascular Disease Discovery Protocol,Vascular Disease Discovery Protocol,RECRUITING,2018-07-30,2027-11-30,2037-05-15,OBSERVATIONAL,,1000,"['Vascular Dysfunction', 'Genetic Mutations', 'Genetic Predisposition']",Vascular Dysfunction,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07076446,"An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)","An Open-label, Multicenter Study to Assess the Pharmacokinetics, Safety, and Tolerability of Immune Globulin Subcutaneous (Human) IgPro20 in IG Treatment-naïve Subjects With Primary Immunodeficiency",RECRUITING,2025-07-15,2026-05-04,2026-05-04,INTERVENTIONAL,PHASE4,8,['Primary Immunodeficiency'],Primary Immunodeficiency,CSL Behring,[],['United States']
NCT06419088,Effect of Preoperative Individualized Education on Anxiety and Recovery.,Effect of Preoperative Individualized Education on Anxiety and Recovery in Patients Undergoing Minimally Invasive Lung Surgery,ACTIVE_NOT_RECRUITING,2024-05-30,2025-11-25,2026-03-30,INTERVENTIONAL,NA,156,['Education'],Education,Fujian Medical University Union Hospital,[],['China']
NCT05793151,Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy,A Stepped Wedge Cluster Randomized Trial Comparing a Navigation-Based Multilevel Intervention With Treatment as Usual to Improve Initiation of Timely Postoperative Radiation Therapy in Adults With Head and Neck Cancer,RECRUITING,2023-10-30,2028-03-30,2028-03-30,INTERVENTIONAL,NA,532,"['Head and Neck Cancer', 'Head and Neck Squamous Cell Carcinoma', 'Oropharynx Cancer', 'Oral Cavity Cancer', 'Larynx Cancer']",Head and Neck Cancer,Medical University of South Carolina,['National Cancer Institute (NCI)'],['United States']
NCT06143956,A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight,"A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants With Obesity or Overweight",RECRUITING,2023-11-17,2026-06,2026-09,INTERVENTIONAL,PHASE2,1217,"['Obesity', 'Overweight']",Obesity,Eli Lilly and Company,[],"['Argentina', 'United States']"
NCT04331769,Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study,Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study,RECRUITING,2020-12-21,2026-12-31,2030-12-21,INTERVENTIONAL,NA,400,"['Heart Failure With Reduced Ejection Fraction (HFrEF)', 'Dilated Cardiomyopathy']",Heart Failure With Reduced Ejection Fraction (HFrEF),"Ancora Heart, Inc.",[],"['Belgium', 'Netherlands', 'United States', 'France', 'Belarus', 'Italy', 'Czechia', 'Greece', 'Serbia', 'Germany']"
NCT04082520,"Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy","A Prospective, Phase II Study of Lutetium Lu 177 Dotatate (LUTATHERA®) in Patients With Inoperable, Progressive Meningioma After External Beam Radiation Therapy",RECRUITING,2020-04-14,2026-07-06,2031-01-06,INTERVENTIONAL,PHASE2,41,"['Grade 1 Meningioma', 'Grade 2 Meningioma', 'Grade 3 Meningioma', 'Recurrent Meningioma', 'Unresectable Meningioma']",Grade 1 Meningioma,Mayo Clinic,[],['United States']
NCT05945732,DESTINY Breast Respond HER2-low Europe,"A Prospective, Non-interventional Study (NIS) With Trastuzumab Deruxtecan For Patients With HER2-low Expressing Unresectable and/or Metastatic Breast Cancer Accompanied By a Disease Registry of Patients Treated With Conventional Chemotherapy (DESTINY Breast Respond HER2-low Europe)",RECRUITING,2023-10-24,2028-09-01,2028-09-01,OBSERVATIONAL,,1155,"['Unresectable Breast Cancer', 'Metastatic Breast Cancer', 'HER2-low Expressing Breast Cancer']",Unresectable Breast Cancer,"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",[],"['Belgium', 'Norway', 'Austria', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Portugal', 'Sweden']"
NCT07278193,Foam Rolling and Dynamic Stretching in Piriformis Syndrome,Combined Effects of Foam Rolling and Dynamic Stretching in Patients With Piriformis Syndrome,ACTIVE_NOT_RECRUITING,2025-10-31,2025-12-25,2026-01-02,INTERVENTIONAL,NA,40,['Piriformis Syndrome'],Piriformis Syndrome,University of Lahore,[],['Pakistan']
NCT07218016,The AccelERate Trial,Accelerometer Measured Early Recovery After Prolapse Surgery,RECRUITING,2025-10-02,2028-03-31,2028-12-31,INTERVENTIONAL,NA,288,"['Pelvic Organ Prolapse', 'Pelvic Organ Prolapse (POP)', 'Pelvic Organ Prolapse Vaginal Surgery', 'Pelvic Organ Prolapse, Patient Education']",Pelvic Organ Prolapse,NICHD Pelvic Floor Disorders Network,"['RTI International', 'University of California, San Diego', 'University of Chicago', 'Duke University', 'Women and Infants Hospital of Rhode Island', 'University of Pennsylvania', 'Kaiser Permanente', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06891755,Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3,Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3,RECRUITING,2025-07-15,2027-09-30,2029-12-31,INTERVENTIONAL,NA,250,"['COPD', 'Emphysema']",COPD,"Apreo Health, Inc.",[],"['United States', 'Netherlands']"
NCT07089043,A Study in Subjects With Neurogenic Orthostatic Hypotension,A Single-Blind Dose-Ranging Study in Subjects With Neurogenic Orthostatic Hypotension to Evaluate the Effect of CST-3056 on Symptoms and Signs of Orthostatic Hypotension,RECRUITING,2025-09-12,2026-01-31,2026-02-28,INTERVENTIONAL,PHASE2,12,['Neurogenic Orthostatic Hypotension'],Neurogenic Orthostatic Hypotension,"CuraSen Therapeutics, Inc.",[],['United States']
NCT05653440,Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia,Integrating Complementary Learning Principles in Aphasia Rehabilitation Via Adaptive Modeling (Sub-study 1: Balancing Effortful and Errorless Learning Via Adaptive Naming Deadlines),RECRUITING,2023-11-27,2027-01-31,2028-01-31,INTERVENTIONAL,PHASE2,30,"['Aphasia', 'Stroke']",Aphasia,University of Pittsburgh,"['University of Massachusetts, Amherst', 'National Institute on Deafness and Other Communication Disorders (NIDCD)']",['United States']
NCT06059209,Enfamil NeuroPro Study,The Role of Milk Fat Globule Membrane and 2'-Fucosyllactose in the Infant Gut Microbiota,ACTIVE_NOT_RECRUITING,2023-01-05,2025-08-26,2026-05-31,INTERVENTIONAL,NA,240,"['Infant Development', 'Infant ALL']",Infant Development,University of Arizona,['Mead Johnson Nutrition'],['United States']
NCT05026723,Food as Medicine for HIV and Diabetes,Food as Medicine for HIV: A Randomized Trial of Medically Tailored Meals and Lifestyle Intervention,RECRUITING,2021-10-04,2026-08,2027-02,INTERVENTIONAL,NA,200,"['Diabetes Mellitus, Type 2', 'HIV Infections', 'PreDiabetes']","Diabetes Mellitus, Type 2","University of North Carolina, Chapel Hill","['Community Servings', 'Massachusetts General Hospital', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']",['United States']
NCT05797246,Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP),A Phase II Study of Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP),RECRUITING,2023-08-02,2027-07-31,2029-01-01,INTERVENTIONAL,PHASE2,50,"['Respiratory Tract Diseases', 'Neoplasms', 'Neoplasms by Histologic Type', 'Neoplasms, Glandular and Epithelial', 'Neoplasms, Squamous Cell', 'Tumor Virus Infections', 'Infections', 'Virus Diseases', 'DNA Virus Infections', 'Pathologic Processes', 'Disease Attributes', 'Recurrence', 'Papilloma', 'Respiratory Tract Infections', 'Papillomavirus Infections']",Respiratory Tract Diseases,National Cancer Institute (NCI),[],['United States']
NCT05167318,Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit,Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit,ACTIVE_NOT_RECRUITING,2022-01-15,2023-10-02,2026-03-30,INTERVENTIONAL,NA,150,"['Microbial Colonization', 'Ventilator Associated Pneumonia']",Microbial Colonization,University of Florida,[],['United States']
NCT05644561,"Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants With Generalized Myasthenia Gravis (gMG)","A Phase 3, Open-label, Single-arm, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizumab Administered Intravenously in Pediatric Participants (6 to < 18 Years of Age) With Generalized Myasthenia Gravis (gMG)",RECRUITING,2023-06-24,2026-07-15,2028-06-30,INTERVENTIONAL,PHASE3,12,"['Generalized Myasthenia Gravis', 'gMG']",Generalized Myasthenia Gravis,"Alexion Pharmaceuticals, Inc.",[],"['Japan', 'Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Serbia']"
NCT07106762,Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy,"IZABRIGHT-Bladder01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy for Metastatic Urothelial Cancer in Participants With Disease Progression on or After an Immunotherapy-based Treatment",RECRUITING,2025-09-30,2029-01-26,2033-11-18,INTERVENTIONAL,PHASE2,470,['Urothelial Cancer'],Urothelial Cancer,Bristol-Myers Squibb,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Czechia', 'Switzerland', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06948110,Deciphering the Genetic Architecture of Autoimmune Diseases,Deciphering the Genetic Architecture of Autoimmune Diseases,RECRUITING,2025-12-16,2030-04-22,2030-04-22,OBSERVATIONAL,,300,['Autoimmune Diseases'],Autoimmune Diseases,National Human Genome Research Institute (NHGRI),[],"['United States', 'Peru']"
NCT05238961,Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy,Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy,RECRUITING,2028-04-01,2028-04,2028-04,INTERVENTIONAL,PHASE1,20,"['Critical Asymptomatic Carotid Artery Disease', 'Non-Critical Asymptomatic Carotid Artery Disease']",Critical Asymptomatic Carotid Artery Disease,University of Alabama at Birmingham,[],['United States']
NCT07202598,Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis,A Phase 2 Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis,RECRUITING,2025-11-12,2031-03-31,2031-09-01,INTERVENTIONAL,PHASE2,10,['Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis'],Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07277439,"Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma","A Prospective, Open-label, Randomized, Controlled Phase II Clinical Trial Exploring the Efficacy and Safety of Thymosin Alpha 1 Combined With PD-1 Monoclonal Antibody and Neoadjuvant Chemoradiotherapy for cStage III Gastroesophageal Junction Adenocarcinoma.",RECRUITING,2025-12-16,2027-02-16,2029-02-16,INTERVENTIONAL,PHASE2,48,['Gastric Cancer'],Gastric Cancer,The First Affiliated Hospital with Nanjing Medical University,[],['China']
NCT06780085,A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01),"KEYMAKER-U01 Substudy 01H: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC)",RECRUITING,2025-05-13,2032-03-12,2032-03-12,INTERVENTIONAL,PHASE2,96,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Hungary', 'United States', 'Chile', 'Spain', 'Italy', 'Greece', 'Poland', 'Germany']"
NCT04873037,BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder,"A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Overactive Bladder",RECRUITING,2021-11-22,2028-06,2028-12,INTERVENTIONAL,NA,166,"['Overactive Bladder Syndrome', 'Overactive Bladder', 'Urinary Frequency', 'Urinary Urgency']",Overactive Bladder Syndrome,Corewell Health East,[],['United States']
NCT06518551,Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM,A Phase I/II Study of Elotuzumab and Iberdomide and Dexamethasone Post Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma,RECRUITING,2024-11-01,2029-12-31,2034-12-31,INTERVENTIONAL,PHASE1,49,"['Myeloma', 'Multiple Myeloma', 'Refractory Multiple Myeloma']",Myeloma,"Omar Nadeem, MD","['Celgene', 'Bristol-Myers Squibb']",['United States']
NCT05788666,Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease,Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease,RECRUITING,2024-01-18,2027-03-01,2027-12-31,INTERVENTIONAL,NA,150,['Ischemic Heart Disease'],Ischemic Heart Disease,NYU Langone Health,['National Institutes of Health (NIH)'],['United States']
NCT05098171,A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital),A Clinical Study on Signal Switch Receptor Modified Tumor Infiltrating Lymphocytes Injection (GC201 TIL) in Patients With Gynecologic Tumors,RECRUITING,2021-09-26,2026-09-25,2027-09-25,INTERVENTIONAL,EARLY_PHASE1,50,"['Advanced Gynecologic Tumors', 'Signal Switch Receptor Modified TIL', 'Treatment Side Effects', 'Effects of Immunotherapy']",Advanced Gynecologic Tumors,Shanghai Juncell Therapeutics,"[""Shanghai 10th People's Hospital""]",['China']
NCT06406465,A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity,A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity,RECRUITING,2025-12-16,2027-07-30,2028-07-30,INTERVENTIONAL,PHASE2,60,"['Carcinoma, Neuroendocrine', 'Tumor, Neuroendocrine', 'Tumors, Neuroendocrine', 'Neuroendocrine; Carcinoma', 'Small Cell; Receptors']","Carcinoma, Neuroendocrine",National Cancer Institute (NCI),[],['United States']
NCT04793685,Prazosin for Alcohol Use Disorder With Withdrawal Symptoms,Prazosin Treatment for Alcohol Use Disorder With Alcohol Withdrawal Symptoms,RECRUITING,2021-07-01,2026-06-30,2027-06-30,INTERVENTIONAL,PHASE2,150,['Alcohol Withdrawal'],Alcohol Withdrawal,Yale University,['National Institute on Alcohol Abuse and Alcoholism (NIAAA)'],['United States']
NCT06393374,Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012),"A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery",RECRUITING,2024-06-24,2030-12-16,2037-12-14,INTERVENTIONAL,PHASE3,1530,['Triple-Negative Breast Cancer'],Triple-Negative Breast Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'Hong Kong', 'Australia', 'Belgium', 'Israel', 'France', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT04255160,Impact of Estradiol on Endothelial Function in Peri-Menopausal Women,Impact of Estradiol on Endothelial Function in Peri-Menopausal Women,RECRUITING,2020-10-01,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE4,80,"['Perimenopause', 'Vasodilation', 'Estrogen']",Perimenopause,University of Delaware,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06459180,A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20),"A Phase 3 Randomized, Active-controlled, Open-label, Multicenter Study to Compare the Efficacy and Safety of MK-2870 Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (TroFuse-020/GOG-3101/ENGOT-cx20)",RECRUITING,2024-07-24,2028-06-15,2028-06-15,INTERVENTIONAL,PHASE3,686,['Cervical Cancer'],Cervical Cancer,Merck Sharp & Dohme LLC,"['European Network of Gynaecological Oncological Trial Groups (ENGOT)', 'GOG Foundation']","['Bulgaria', 'Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'South Korea', 'Colombia', 'Poland', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07276490,Central Haemodynamics and Pacing for AV Block,"The Pacing in Atrioventricular Block: a Comparative Evaluation of Central Haemodynamics, Cardiac Function, and Quality of Life",RECRUITING,2025-11-28,2027-06-01,2027-12-31,INTERVENTIONAL,NA,124,"['Atrioventricular Block', 'Pacing Therapy', 'Right Ventricular Pacing', 'Conduction System Pacing']",Atrioventricular Block,University of Tartu,"['North Estonia Medical Centre', 'Tartu University Hospital']",['Estonia']
NCT05858580,The Bennett Kids PowerUP Project,Pilot Study of a Home-based Program to Promote Healthy Diet and Activity in Rural-dwelling Children,ACTIVE_NOT_RECRUITING,2024-03-01,2026-03,2026-03,INTERVENTIONAL,NA,60,"['Obesity, Childhood', 'Type2diabetes']","Obesity, Childhood",Wake Forest University Health Sciences,['American Diabetes Association'],['United States']
NCT03826524,Epinephrine Dose: Optimal Versus Standard Evaluation Trial,CanROC Epinephrine Dose: Optimal Versus Standard Evaluation Trial (CanROC EpiDOSE Trial),RECRUITING,2023-05-24,2027-12,2028-12,INTERVENTIONAL,PHASE4,3790,"['Cardiac Arrest, Out-Of-Hospital', 'Sudden Cardiac Arrest', 'Ventricular Fibrillation', 'Ventricular Tachycardia-Pulseless']","Cardiac Arrest, Out-Of-Hospital",Unity Health Toronto,"['Canadian Institutes of Health Research (CIHR)', 'Pfizer']",['Canada']
NCT04889430,Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy,"A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy",ACTIVE_NOT_RECRUITING,2022-01-17,2028-09-19,2029-03-29,INTERVENTIONAL,PHASE3,34,['Atypical Hemolytic Uremic Syndrome'],Atypical Hemolytic Uremic Syndrome,Novartis Pharmaceuticals,[],"['Brazil', 'Japan', 'China', 'Austria', 'United States', 'Slovakia', 'Taiwan', 'South Korea', 'Czechia', 'United Kingdom', 'India']"
NCT03823144,Intravital Microscopy in Human Solid Tumors,Intravital Microscopy (IVM) in Human Solid Tumors,RECRUITING,2019-02-28,2026-09-30,2026-09-30,INTERVENTIONAL,NA,85,"['Solid Tumor, Adult', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Malignant Solid Neoplasm', 'Metastatic Colorectal Carcinoma', 'Metastatic Gastric Carcinoma', 'Metastatic Primary Malignant Brain Neoplasm', 'Metastatic Sarcoma', 'Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8', 'Resectable Colorectal Carcinoma', 'Resectable Liver and Intrahepatic Bile Duct Carcinoma', 'Resectable Pancreatic Carcinoma', 'Resectable Sarcoma', 'Stage IV Colorectal Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Malignant Brain Neoplasm', 'Metastatic Breast Carcinoma', 'Metastatic Liver Carcinoma', 'Metastatic Pancreatic Carcinoma', 'Resectable Brain Neoplasm', 'Resectable Breast Carcinoma', 'Resectable Gastric Carcinoma', 'Stage IV Hepatocellular Carcinoma AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8']","Solid Tumor, Adult",Mayo Clinic,[],['United States']
NCT06595940,Genetic Analysis of Uncommon Disease Presentations in Non-US Populations,Genomic Sequencing for Evaluation of Uncommon Disease Manifestations Through the Childhood Complex Disease Genomic Section,RECRUITING,2025-12-16,2034-08-21,2034-08-21,OBSERVATIONAL,,400,"['Undiagnosed Diseases', 'Rare Diseases']",Undiagnosed Diseases,National Human Genome Research Institute (NHGRI),[],['Mauritius']
NCT06643455,"Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial",Mindfulness Intervention for Nutrition in the Digital Kitchen (MIND) Study: A Pilot and Feasibility Study,RECRUITING,2025-05-16,2026-01-14,2026-01-14,INTERVENTIONAL,NA,100,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8']",Anatomic Stage I Breast Cancer AJCC v8,Fred Hutchinson Cancer Center,['Apex Foundation'],['United States']
NCT06492733,"FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW","A Pivotal, Single-arm, Multi-centre, Prospective Clinical Investigation to Assess the Efficacy and Safety of the FastWire REvascularisation of Extremities, (For LOWer Limbs) (FREEFLOW).",RECRUITING,2024-11-05,2026-05,2026-07,INTERVENTIONAL,NA,65,['Chronic Total Occlusion of Artery of the Extremities'],Chronic Total Occlusion of Artery of the Extremities,Versono Medical Ltd,[],['United States']
NCT07276750,Coaching and Leadership in Autism Support Settings,Coaching and Leadership in Autism Support Settings,RECRUITING,2026-02-01,2030-06-30,2030-08-31,INTERVENTIONAL,NA,373,['Autism Spectrum Disorder (ASD)'],Autism Spectrum Disorder (ASD),"University of California, Los Angeles",['University of Washington'],['United States']
NCT07120503,"Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma","A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants With Moderate or Severe Asthma",RECRUITING,2025-07-24,2027-07,2027-10,INTERVENTIONAL,PHASE2,136,['Asthma (Diagnosis)'],Asthma (Diagnosis),Windward Bio,[],"['Bulgaria', 'United States', 'France', 'Spain', 'Australia', 'Sweden', 'Germany']"
NCT06453928,Starting Technology in At Risk Type 1 Diabetes Study,Starting Technology in At Risk Type 1 Diabetes (STAR-T1D) Study,RECRUITING,2024-09-05,2026-12,2027-06,INTERVENTIONAL,NA,40,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1","University of California, Los Angeles","['Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'Olive View-UCLA Education & Research Institute']",['United States']
NCT06423300,Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration,Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration,RECRUITING,2024-06-19,2027-09,2031-09,INTERVENTIONAL,NA,245,['Patellofemoral Osteoarthritis'],Patellofemoral Osteoarthritis,ZKR Orthopedics Inc,[],['United States']
NCT06420271,Effects of Cerebellar tACS-iTBS in Ataxia,Effects of Combined Transcranial Electrical and Magnetic Stimulation of Cerebellum on Balance Function in Ataxia Patients,RECRUITING,2025-05-01,2026-09-30,2026-12-31,INTERVENTIONAL,NA,30,['Ataxia'],Ataxia,I.R.C.C.S. Fondazione Santa Lucia,[],['Italy']
NCT06632444,LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis,"A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase III Trial Evaluating Long-term Efficacy and Safety of Survodutide Weekly Injections in Adult Participants With Noncirrhotic Non-alcoholic Steatohepatitis/Metabolic Dysfunction-associated Steatohepatitis (NASH/MASH) and (F2) - (F3) Stage of Liver Fibrosis",RECRUITING,2024-10-14,2031-12-27,2031-12-27,INTERVENTIONAL,PHASE3,1800,"['Metabolic Dysfunction Associated Steatohepatitis (MASH)', 'Liver Fibrosis']",Metabolic Dysfunction Associated Steatohepatitis (MASH),Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'Saudi Arabia', 'China', 'Jordan', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'India', 'Singapore', 'Kazakhstan', 'South Africa', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06705842,APPI-Cost Trial for Perforated Appendicitis,The APPI-Cost Trial: Cost Assessment of Povidone-Iodine Irrigation for Prevention of Intra-abdominal Abscess in Perforated Appendicitis,RECRUITING,2025-04-07,2026-06-30,2027-03-31,INTERVENTIONAL,PHASE4,346,['Perforated Appendicitis'],Perforated Appendicitis,"The University of Texas Health Science Center, Houston",['National Center for Advancing Translational Sciences (NCATS)'],['United States']
NCT07245615,Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia,The Effects of Different Vibro-tactile Stimulation Intensities on Head Posture in Cervical Dystonia,RECRUITING,2025-12-05,2026-05,2026-06,INTERVENTIONAL,NA,50,['Cervical Dystonia'],Cervical Dystonia,University of Minnesota,[],['United States']
NCT04287413,Determining the Impact of a New Physiotherapist-led Primary Care Model for Low Back Pain,Determining the Impact of a New Physiotherapist-led Primary Care Model for Low Back Pain - a Cluster Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2023-10-02,2025-11-25,2025-12-19,INTERVENTIONAL,NA,1560,"['Back Pain, Low']","Back Pain, Low","Jordan Miller, PT, PhD",['Canadian Institutes of Health Research (CIHR)'],['Canada']
NCT06339008,A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1),"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis",RECRUITING,2024-04-26,2026-09,2028-10,INTERVENTIONAL,PHASE3,450,['Perennial Allergic Rhinitis (PAR)'],Perennial Allergic Rhinitis (PAR),Eli Lilly and Company,[],"['Belgium', 'China', 'United States', 'South Korea', 'Poland', 'Germany']"
NCT04905082,HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics,Helping Oncology Patients Explore-Genomics (HOPE-Genomics) Web Tool Randomized Clinical Trial,ACTIVE_NOT_RECRUITING,2021-12-30,2024-08-14,2025-12-31,INTERVENTIONAL,NA,465,"['Breast Carcinoma', 'Colorectal Carcinoma', 'Lung Carcinoma', 'Malignant Solid Neoplasm', 'Ovarian Carcinoma', 'Pancreatic Carcinoma', 'Prostate Carcinoma']",Breast Carcinoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07197905,Restoring Iron Deficiency in POTS,Restoring Iron Deficiency to Expand Blood Volume and Improve POTS,RECRUITING,2025-11-24,2026-10,2026-12,INTERVENTIONAL,PHASE2,12,['POTS - Postural Orthostatic Tachycardia Syndrome'],POTS - Postural Orthostatic Tachycardia Syndrome,Vanderbilt University Medical Center,['Dysautonomia International'],['United States']
NCT07276347,Comprehensive Assessment of Multiple Products (CAMP),Comprehensive Assessment of Multiple Products (CAMP),RECRUITING,2025-12,2026-09,2026-09,INTERVENTIONAL,NA,250,"['Hyperopia', 'Myopia']",Hyperopia,CooperVision International Limited (CVIL),[],['United States']
NCT06451445,"A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer","A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer: The WIRED Study",RECRUITING,2024-05-16,2028-05,2033-05,INTERVENTIONAL,NA,100,['Prostate Cancer'],Prostate Cancer,"University Health Network, Toronto",[],['Canada']
NCT03556228,VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma,"A Phase 1/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 as Monotherapy and in Combination With Pembrolizumab in Subjects With Solid Tumors or Lymphoma",RECRUITING,2018-06-08,2027-12,2028-06,INTERVENTIONAL,PHASE1,242,"['Head and Neck Carcinoma', 'Adenoid Cystic Carcinoma', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Pancreatic Cancer', 'Mesothelioma', 'Esophageal Cancer', 'Any Solid Tumors Progressed After a Prior Immunotherapy', 'Head and Neck Squamous Cell Carcinoma', 'Head and Neck Squamous Cell Carcinoma HNSCC', 'Salivary Gland Carcinomas', 'Head and Neck Cancers - Salivary Gland', 'Head and Neck Cancers - Nasopharyngeal', 'Head and Neck Cancers - Throat', 'Small Cell Lung Cancer ( SCLC )', 'Lung Cancer (Locally Advanced or Metastatic)', 'Head and Neck Cancers - Tonsils', 'Head and Neck Cancers Hypopharynx', 'Head and Neck Cancers Larynx', 'Head and Neck Cancers Lip', 'Head and Neck Cancers Nasopharynx', 'Head and Neck Cancers Oral Cavity', 'Head and Neck Cancers', 'Head and Neck Cancers Oropharynx', 'Head and Neck Cancers Trachea']",Head and Neck Carcinoma,"VM Oncology, LLC",[],"['Puerto Rico', 'United States']"
NCT07277127,Percutaneous Electrolysis Plus Exercise Versus Exercise Alone in Chronic Lateral Epicondylitis,Percutaneous Electrolysis Combined With Exercise Versus Exercise Alone on Pain and Function in Chronic Lateral Epicondylitis: A Randomized Controlled Trial,RECRUITING,2025-09-05,2026-02-20,2026-02-25,INTERVENTIONAL,NA,60,['Lateral Epicondylitis'],Lateral Epicondylitis,Sivas State Hospital,[],['Turkey (Türkiye)']
NCT05451589,A Trial of a Positive Psychology Intervention for Older Adults (RESET) During the COVID-19 Pandemic,Improving Physical and Psychosocial Functioning in Underserved Older Adults During the COVID-19 Pandemic: A Community Health Worker-Led Intervention,ACTIVE_NOT_RECRUITING,2023-03-01,2026-06,2026-06,INTERVENTIONAL,NA,456,"['Depressive Symptoms', 'Anxiety', 'Chronic Pain', 'Fatigue', 'Loneliness', 'Stress, Psychological']",Depressive Symptoms,University of Michigan,"['National Institute of Nursing Research (NINR)', 'Detroit Department of Health']",['United States']
NCT06821269,Functional Recovery After Total Knee Arthroplasty,Functional Recovery After Total Knee Arthroplasty,RECRUITING,2023-09-01,2026-05-01,2027-05-01,OBSERVATIONAL,,30,['Arthritis Knee'],Arthritis Knee,University of Pittsburgh,[],['United States']
NCT07139938,Spontaneous Correction of Sagittal Imbalance After Isolated Lumbar Decompression,Multicenter Study of Spontaneous Correction of Sagittal Imbalance After Isolated Decompression Surgery Without Corrective Fusion Procedure for Lumbar Spinal Stenosis,RECRUITING,2025-10-06,2026-10-06,2027-10-06,INTERVENTIONAL,NA,165,"['LUMBAR STENOSIS', 'Sagittal Imbalance', 'Degeneration Lumbar Spine', 'Lumbar Decompression']",LUMBAR STENOSIS,N.N. Priorov National Medical Research Center of Traumatology and Orthopedics,"['Burdenko Neurosurgery Institute', 'Pirogov National Medical Surgical Center']",['Russia']
NCT06024668,Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision,Monocular Visual Confusion for Field Expansion,ACTIVE_NOT_RECRUITING,2024-08-04,2025-10-28,2026-10-28,INTERVENTIONAL,NA,1,"['One Eye Blindness', 'Blind Left Eye', 'Blind Right Eye']",One Eye Blindness,Massachusetts Eye and Ear Infirmary,['National Eye Institute (NEI)'],['United States']
NCT06819891,A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease,"A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease",RECRUITING,2025-05-12,2028-12-31,2029-04-30,INTERVENTIONAL,PHASE3,425,['Moderately to Severely Active Crohns Disease'],Moderately to Severely Active Crohns Disease,Hoffmann-La Roche,['Chugai Pharmaceutical'],"['Bulgaria', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Croatia', 'Colombia', 'Czechia', 'Poland', 'India', 'Spain', 'Canada', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05098197,A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital),A Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes Injection in Patients With Advanced Hepatobiliary-Pancreatic Cancers,RECRUITING,2021-09-26,2026-09-25,2026-09-25,INTERVENTIONAL,EARLY_PHASE1,50,"['Advanced Liver Cancers', 'Tumor Infiltrating Lymphocyte', 'Treatment Side Effects', 'Effects of Immunotherapy', 'Advanced Pancreatic Cancers']",Advanced Liver Cancers,Shanghai Juncell Therapeutics,"[""Shanghai 10th People's Hospital""]",['China']
NCT07265570,Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis,"A Phase IIa, Multicenter, Randomized, Double-blind, Placebo-controlled, Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Efficacy of ISM5411 in Adult Patients With Active Ulcerative Colitis",RECRUITING,2025-12-10,2027-08-15,2027-08-30,INTERVENTIONAL,PHASE2,80,['Ulcerative Colitis'],Ulcerative Colitis,InSilico Medicine Hong Kong Limited,[],['China']
NCT03655769,fMRI Analysis of Aging and Awareness in Conditioning,Functional Magnetic Resonance Imaging (fMRI) Analysis of Aging and Awareness in Conditioning,ACTIVE_NOT_RECRUITING,2010-11-09,2026-12-31,2026-12-31,INTERVENTIONAL,NA,16,['Transcranial Direct Current Stimulation'],Transcranial Direct Current Stimulation,Johns Hopkins University,['National Institute on Aging (NIA)'],[]
NCT06743529,Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia,Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia: A Randomized Controlled Trial,RECRUITING,2025-11-11,2028-12-11,2029-02-11,INTERVENTIONAL,NA,686,['Ventilator-Associated Pneumonia (VAP)'],Ventilator-Associated Pneumonia (VAP),Nantes University Hospital,[],"['Guadeloupe', 'France']"
NCT07062861,Proximal and Distal Radial Artery Cannulation in Children,Comparison of Proximal and Distal Cannulation of the Radial Artery by Ultrasonography in Pediatric Patients Undergoing Elective Surgery,RECRUITING,2025-08-28,2026-01-01,2026-01-01,OBSERVATIONAL,,50,"['Arterial Catheterization', 'Radial Atrery Cannulation']",Arterial Catheterization,Marmara University,[],['Turkey (Türkiye)']
NCT06383390,The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and Major Adverse Kidney Events in Participants With Body Mass Index ≥27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease",RECRUITING,2024-04-30,2029-02,2029-02,INTERVENTIONAL,PHASE3,10000,"['Atherosclerotic Cardiovascular Disease (ASCVD)', 'Chronic Kidney Disease (CKD)']",Atherosclerotic Cardiovascular Disease (ASCVD),Eli Lilly and Company,[],"['Bulgaria', 'New Zealand', 'Netherlands', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Denmark', 'Peru', 'Colombia', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT02015013,Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models,Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models,RECRUITING,2014-01-15,2026-10-31,2026-10-31,INTERVENTIONAL,PHASE2,40,"['Idiopathic CD4-Positive', 'T-Lymphocytopenia']",Idiopathic CD4-Positive,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07205900,Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus,"A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus",RECRUITING,2025-12-02,2027-01,2027-01,INTERVENTIONAL,PHASE2,250,"['Obese', 'Obesity']",Obese,Hanmi Pharmaceutical Company Limited,[],['United States']
NCT05142475,A Study of GC101 TIL in Advanced Breast Cancer (10hospital),A Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes Injection in Patients With Advanced Breast Cancer,RECRUITING,2021-11-19,2026-12-20,2027-12-20,INTERVENTIONAL,EARLY_PHASE1,50,"['Breast Cancer', 'Treatment Side Effects', 'Advanced Breast Cancer', 'Effects of Immunotherapy']",Breast Cancer,Shanghai Juncell Therapeutics,"[""Shanghai 10th People's Hospital""]",['China']
NCT06587243,"""Facts Tell… and With Stories Sell?"" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake","""Facts Tell… and With Stories Sell?"" Combining Viewer-tailored Personal HPV Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake",RECRUITING,2025-11-24,2026-02,2027-01,INTERVENTIONAL,NA,1100,['Vaccination'],Vaccination,Johns Hopkins Bloomberg School of Public Health,['Merck Sharp & Dohme LLC'],['United States']
NCT05187897,CHV-NEO: Community-based Digital Communication to Support Neonatal Health,CHV-NEO: Community-based Digital Communication to Support Neonatal Health,RECRUITING,2024-01-10,2026-06-30,2026-06-30,INTERVENTIONAL,NA,3000,"['Neonatal Death', 'Perinatal Death']",Neonatal Death,University of Washington,"['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'BRAC University', 'Bill and Melinda Gates Foundation']",['Kenya']
NCT07133555,Safe Spaces 4 Sexual Health,"Expanding Safe Spaces 4 Sexual Health, a Mobile Van HIV/STI Testing and Care Linkage Strategy, for MSM in Online Spaces",RECRUITING,2025-08-10,2026-03-31,2026-05-01,INTERVENTIONAL,NA,100,"['HIV Counseling and Testing', 'HIV Risk Behavior', 'HIV Prevention']",HIV Counseling and Testing,Johns Hopkins University,['National Institute of Mental Health (NIMH)'],['United States']
NCT03784014,Molecular Profiling of Advanced Soft-tissue Sarcomas,Molecular Profiling of Advanced Soft-tissue Sarcomas. A Phase III Study,ACTIVE_NOT_RECRUITING,2019-10-19,2023-12-01,2026-01-13,INTERVENTIONAL,PHASE3,603,['Soft Tissue Sarcoma'],Soft Tissue Sarcoma,"Institut National de la Santé Et de la Recherche Médicale, France","[""Commissariat A L'energie Atomique"", 'Institut Bergonié', 'Plateforme labellisée Inca - Institut Bergonié, Bordeaux', 'Plateforme labellisée Inca - Hôpital Européen Georges Pompidou, Paris', 'EUCLID Clinical Trial Platform']",['France']
NCT05370651,Emsella Chair vs Sham for Male Sexual Dysfunction,"A Single-Blind, Randomized Study of the BTL Emsella Chair Versus Sham for the Treatment of Male Sexual Dysfunction",RECRUITING,2022-12-14,2027-07,2027-12,INTERVENTIONAL,NA,117,"['Male Sexual Dysfunction', 'Ejaculatory Dysfunction']",Male Sexual Dysfunction,Corewell Health East,[],['United States']
NCT06376045,"A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma","A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma",ACTIVE_NOT_RECRUITING,2024-05-24,2026-10-19,2026-12-11,INTERVENTIONAL,PHASE2,317,['Asthma'],Asthma,Amgen,[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Australia', 'Hungary', 'Chile', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Mexico', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'United States', 'Argentina']"
NCT06115499,The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer,Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM),RECRUITING,2024-08-13,2029-01-15,2029-12-09,INTERVENTIONAL,PHASE2,100,"['Pancreatic Acinar Cell Carcinoma', 'Pancreatic Adenocarcinoma', 'Pancreatic Adenosquamous Carcinoma', 'Pancreatic Carcinoma', 'Pancreatic Ductal Adenocarcinoma', 'Pancreatic Squamous Cell Carcinoma', 'Stage IV Pancreatic Cancer AJCC v8']",Pancreatic Acinar Cell Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT03952637,A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis,A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis,RECRUITING,2019-08-19,2028-01-01,2028-01-01,INTERVENTIONAL,PHASE1,54,"['Lysosomal Diseases', 'Gangliosidosis', 'GM1']",Lysosomal Diseases,National Human Genome Research Institute (NHGRI),['Sio Gene Therapies'],['United States']
NCT00018044,Study of Mycobacterial Infections,"Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections",RECRUITING,2001-01-01,,,OBSERVATIONAL,,1000,['Mycobacterium Infections'],Mycobacterium Infections,National Institute of Allergy and Infectious Diseases (NIAID),"[""Children's National Research Institute"", 'University of Miami']",['United States']
NCT06526793,Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL,"A Modular Phase 2, Single-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Surovatamig (AZD0486) in Participants With Relapsed or Refractory (R/R) B-cell Non-Hodgkin Lymphoma (SOUNDTRACK-B)",RECRUITING,2024-11-27,2027-03-10,2029-06-14,INTERVENTIONAL,PHASE2,240,"['B-cell Non-Hodgkin Lymphoma', 'Follicular Lymphoma (FL)', 'Large B-Cell Lymphoma (LBCL)']",B-cell Non-Hodgkin Lymphoma,AstraZeneca,[],"['Brazil', 'Japan', 'Hong Kong', 'China', 'United States', 'France', 'Germany', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Sweden', 'Australia']"
NCT06943521,A Study of MT-4561 in Patients With Various Advanced Solid Tumors,"A Phase I/II, Dose-escalation and Dose-optimization Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of MT-4561 in Patients With Various Advanced Solid Tumors and to Evaluate Effect of MT-4561 on Pharmacokinetics of Oral Midazolam",RECRUITING,2025-04-18,2028-08,2028-08,INTERVENTIONAL,PHASE1,27,"['Head and Neck Squamous Cell Carcinoma (HNSCC)', 'Non-small Cell Lung Cancer (NSCLC)', 'Esophageal Cancer', 'Gastric Cancer', 'Biliary Tract Cancer', 'Pancreatic Ductal Adenocarcinoma (PDAC)', 'Breast Cancer', 'Ovarian Cancer', 'Cervical Cancer', 'Endometrial Cancer', 'Prostate Cancer', 'Urothelial Carcinoma', 'Neuroendocrine Tumor (NET)', 'Neuroendocrine Carcinoma (NEC)', 'Soft Tissue Sarcoma', 'Nuclear Protein in Testis (NUT) Carcinoma']",Head and Neck Squamous Cell Carcinoma (HNSCC),"Tanabe Pharma America, Inc.",[],"['Japan', 'United States']"
NCT07094906,Handgrip Exercise Training and CKD,Neural and Vascular Modulation With Isometric Handgrip Training in Chronic Kidney Disease,RECRUITING,2026-01,2027-12,2027-12,INTERVENTIONAL,NA,50,['Chronic Kidney Diseases'],Chronic Kidney Diseases,Emory University,['American Heart Association'],['United States']
NCT00794352,Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System,Comprehensive Multimodal Analysis of Patients With Neuroimmunological Diseases of the CNS,RECRUITING,2008-10-01,,,OBSERVATIONAL,,2400,"['Central Nervous System Disease', 'Multiple Sclerosis']",Central Nervous System Disease,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07278102,A Prospective Observational Study on Efficacy of TARE for Early Stage HCC,A Korean Multicenter Prospective Observational Study on Efficacy of 90Y for Hepatocellular Carcinoma-early Stage,ACTIVE_NOT_RECRUITING,2022-03-28,2026-01-31,2026-05-31,OBSERVATIONAL,,200,"['Radioembolization', 'Hepatocellular Carcinoma (HCC)', 'Early Stage']",Radioembolization,Seoul National University Hospital,"['National Cancer Center, Korea', 'Severance Hospital', 'Samsung Medical Center']",['South Korea']
NCT06627335,An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis,Pregnancy Outcomes Study of Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis,RECRUITING,2023-03-27,2027-08-15,2028-08-15,OBSERVATIONAL,,5621,"['Pregnancy Related', 'Atopic Dermatitis']",Pregnancy Related,Incyte Corporation,[],['United States']
NCT06790966,Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma,"A Phase 3 Open-Label, Randomized Study of PDS0101 and Pembrolizumab vs Pembrolizumab Alone in First-Line Treatment of Unresectable Recurrent and/or Metastatic HPV16+ Head and Neck Squamous Cell Carcinoma",ACTIVE_NOT_RECRUITING,2025-05-30,2029-02,2029-02,INTERVENTIONAL,PHASE3,351,"['Recurrent Head and Neck Cancer', 'Metastatic Head and Neck Cancer', 'HPV Positive Oropharyngeal Squamous Cell Carcinoma', 'Neoplasms, Head and Neck', 'Unresectable Head and Neck Squamous Cell Carcinoma']",Recurrent Head and Neck Cancer,PDS Biotechnology Corp.,[],['United States']
NCT06948422,A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening),"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",RECRUITING,2025-04-30,2027-09,2027-09,INTERVENTIONAL,PHASE3,974,['Hypertension'],Hypertension,Eli Lilly and Company,[],"['Japan', 'China', 'India', 'United States', 'Puerto Rico', 'Spain', 'Czechia', 'Greece', 'Poland', 'Argentina', 'Germany']"
NCT07277361,Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment,Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment,RECRUITING,2024-10-08,2029-10-14,2031-10-14,OBSERVATIONAL,,100,"['Fabry Disease', 'Aged 65 Years or Older', 'Alpha Galactosidase A Deficiency', 'Galactosidase A Gene Mutation']",Fabry Disease,"Wladimir MAUHIN, Dr","['University Hospital, Angers', 'University Hospital, Bordeaux', 'Centre Hospitalier Bretagne Atlantique', 'Centre Hospitalier Universitaire de Caen', 'University Hospital, Clermont-Ferrand', 'Centre Hospitalier Universitaire Dijon', 'University Hospital, Lille', 'University Hospital, Limoges', 'University Hospital, Marseille', 'Nantes University Hospital', 'Necker Hospital, 75015 Paris', 'Rennes University Hospital', 'University Hospital, Tours', 'Hôpital Raymond Poincaré', 'University Hospital, Rouen', 'Hospital, Vannes', 'University Hospital, Brest', 'University Hospital, Grenoble', 'University Hospital, Strasbourg', 'Hospices Civils de Lyon', 'Centre Hospitalier de la côte Basque', 'University Hospital, Montpellier', 'Centre Hospitalier Universitaire de Nice']",['France']
NCT06904066,Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies,"A Phase I Study of Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Other Hematologic Malignancies",RECRUITING,2025-12-16,2029-04-30,2029-04-30,INTERVENTIONAL,PHASE1,86,"['Malignancy, Hematologic', 'Neoplasms, Hematologic', 'Neoplasms, Hematopoietic', 'Blood Cancer', 'Hematological Neoplasms', 'Hematopoietic Malignancies', 'Dysmyelopoietic Syndromes', 'Hematopoetic Myelodysplasia', 'Myeloid Leukemia, Acute', 'Nonlymphoblastic Leukemia, Acute', 'Leukemia, Lymphocytic, Acute']","Malignancy, Hematologic",National Cancer Institute (NCI),[],['United States']
NCT04194775,A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma,"A Multi-Center, Double-Blind, Randomized, Phase III Study to Investigate the Efficacy and Safety of Nofazinlimab (CS1003) in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Advanced Hepatocellular Carcinoma (HCC)",ACTIVE_NOT_RECRUITING,2019-12-13,2025-06-18,2026-09-30,INTERVENTIONAL,PHASE3,534,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,CStone Pharmaceuticals,[],"['China', 'United States', 'Spain', 'Taiwan', 'Italy', 'Poland']"
NCT06745804,Study of 68Ga-R10602,Phase 1 Imaging Study of 68Ga-R10602-101 in Hormone Receptor-Positive Breast Cancer,RECRUITING,2024-12-10,2026-03,2026-03,INTERVENTIONAL,PHASE1,36,"['Locoregionally Recurrent Hormone-receptor Positive Breast Cancer', 'Metastatic Hormone Receptor Positive Breast Cancer', 'Hormone Receptor Positive Breast Adenocarcinoma']",Locoregionally Recurrent Hormone-receptor Positive Breast Cancer,Radionetics Oncology,[],['United States']
NCT05562830,A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A),A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents With or Without Pembrolizumab in Participants With PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma (KEYMAKER-U04): Substudy 04A,ACTIVE_NOT_RECRUITING,2022-11-16,2028-06-20,2028-06-20,INTERVENTIONAL,PHASE1,48,['Urothelial Carcinoma'],Urothelial Carcinoma,Merck Sharp & Dohme LLC,[],"['Israel', 'Netherlands', 'United States', 'Chile', 'Denmark', 'Spain', 'South Korea', 'United Kingdom', 'Australia']"
NCT06300892,Surgical Site Infections and the Microbiome: Understanding the Pathogenesis of Surgical Site Infections,Surgical Site Infections and the Microbiome: Understanding the Pathogenesis of Surgical Site Infections,RECRUITING,2024-04-01,2026-05-01,2026-05-01,OBSERVATIONAL,,300,['Open GI Surgery'],Open GI Surgery,University of Minnesota,[],['United States']
NCT06150599,Sacral Neuromodulation for Chronic Pelvic Pain,Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain,RECRUITING,2025-06-30,2028-04-01,2028-12-01,INTERVENTIONAL,NA,25,['Chronic Pelvic Pain Syndrome'],Chronic Pelvic Pain Syndrome,Corewell Health East,[],['United States']
NCT05656105,Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection,PET Imaging of Neuroinflammation in Patients With Neurological Dysfunction After SARS-CoV-2 Infection,RECRUITING,2023-11-10,2028-06-01,2028-06-01,INTERVENTIONAL,EARLY_PHASE1,60,['SARS CoV-2 Post-Acute Sequelae'],SARS CoV-2 Post-Acute Sequelae,University of Alabama at Birmingham,[],['United States']
NCT06632457,LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis,"A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis",RECRUITING,2024-11-12,2029-06-05,2029-06-05,INTERVENTIONAL,PHASE3,1590,['Metabolic Dysfunction Associated Steatohepatitis'],Metabolic Dysfunction Associated Steatohepatitis,Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'New Zealand', 'Saudi Arabia', 'China', 'Jordan', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'India', 'Singapore', 'Kazakhstan', 'South Africa', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07130929,Functional Electrical Stimulation to Treat Critical Neuromyopathy After Severe Stroke: a Pilot Study.,Intensive Rehabilitation by Functional Electrical Stimulation for the Treatment of Critical Neuromyopathy in Patients With Severe Stroke Admitted to the Highly Specialized Intensive Rehabilitation Unit: a Pilot Study,RECRUITING,2025-09-23,2026-09-23,2027-03-23,INTERVENTIONAL,NA,24,"['Intensive Care Unit (ICU) Acquired Weakness (ICU - AW)', 'Acquired Brain Injury (Including Stroke)']",Intensive Care Unit (ICU) Acquired Weakness (ICU - AW),Fondazione Don Carlo Gnocchi Onlus,['University of Florence'],['Italy']
NCT07070219,A Study of CTD402 in T-ALL/LBL Patients,"A Single-Arm, Open-Label, Multi-Center, Phase 1b/ 2 Study to Evaluate the Safety, Efficacy, and Cellular Pharmacokinetic Profile of CTD402 in Participants With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) (TENACITY-01)",RECRUITING,2025-10-07,2028-09-30,2028-12-30,INTERVENTIONAL,PHASE1,54,"['Acute Lymphocytic Leukemia Refractory', 'Lymphoma, Lymphoblastic']",Acute Lymphocytic Leukemia Refractory,BIOHENG THERAPEUTICS US LLC,[],['United States']
NCT02726711,Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic,Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Aim 1 of Rare Diseases Clinical Research Network (RDCRN) Project 2,ACTIVE_NOT_RECRUITING,2016-04,2026-02,2026-02,INTERVENTIONAL,PHASE1,2,"['Multiple System Atrophy', 'Orthostatic Hypotension', 'Supine Hypertension']",Multiple System Atrophy,Vanderbilt University,[],['United States']
NCT07170085,Positioning of Children With Acute Respiratory Insufficiency,Positioning of Children With Acute Respiratory Insufficiency,RECRUITING,2025-11-24,2026-04-01,2027-04-01,INTERVENTIONAL,NA,40,['Acute Respiratory Disease'],Acute Respiratory Disease,Odense University Hospital,[],['Denmark']
NCT03609216,Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations,A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations,RECRUITING,2018-12-10,2027-02-01,2029-02-01,INTERVENTIONAL,PHASE2,271,"['Infiltrating Bladder Urothelial Carcinoma', 'Stage II Bladder Urothelial Carcinoma', 'Stage III Bladder Urothelial Carcinoma']",Infiltrating Bladder Urothelial Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT02938858,French Registry of First-line Treatment of Acute Promyelocytic Leukemia,The French Registry on the First-line Treatment of Non High-risk Acute Promyelocytic Leukemia (APL) in Patients Aged ≤ 70 Years,ACTIVE_NOT_RECRUITING,2015-10,2026-07,2026-07,OBSERVATIONAL,,400,['Acute Promyelocytic Leukemia'],Acute Promyelocytic Leukemia,Groupe Francophone des Myelodysplasies,['Teva Pharmaceuticals USA'],['France']
NCT05727891,Evaluation of Tonabersat for DME,A Phase 2 Evaluation of Tonabersat for Diabetic Macular Edema (Protocol AN),ACTIVE_NOT_RECRUITING,2023-05-02,2025-06-27,2026-01,INTERVENTIONAL,PHASE2,128,['Diabetic Macular Edema'],Diabetic Macular Edema,Jaeb Center for Health Research,"['National Institutes of Health (NIH)', 'National Eye Institute (NEI)', 'Juvenile Diabetes Research Foundation']",['United States']
NCT07277673,Aerobic Exercise Addition to Cognitive Behavioural Treatment in Impotence Metabolic-syndrome Drinkers,Is There a Benefit of Aerobic Exercise Addition to Cognitive Behavioural Treatment in Heavy Drinking Men With Impotence and Metabolic Syndrome?,RECRUITING,2025-10-10,2026-02-15,2026-02-15,INTERVENTIONAL,NA,40,"['Heavy Drinking', 'Metabolic Syndrome', 'Impotence']",Heavy Drinking,Cairo University,[],['Egypt']
NCT03809351,UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy,UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy,RECRUITING,2020-07-08,2028-07,2028-07,INTERVENTIONAL,PHASE1,160,['Alzheimer Disease'],Alzheimer Disease,University of Alabama at Birmingham,['National Institute on Aging (NIA)'],['United States']
NCT07169630,PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI),PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer s Disease (AD) or Mild Cognitive Impairment (MCI),RECRUITING,2025-12-16,2029-04-11,2030-04-11,INTERVENTIONAL,PHASE1,90,"['Alzheimer s Disease', 'Mild Cognitive Impairment', 'Healthy']",Alzheimer s Disease,National Institute of Mental Health (NIMH),[],['United States']
NCT07277153,Clinical Study on the Effect of Tegileridine on Postoperative Pain in Patients Undergoing Abdominal Surgery.,Clinical Study on the Effect of Tegileridine on Postoperative Pain in PatientsUndergoing Abdominal Surgery：A Randomized Controlled Double-blind Trial.,RECRUITING,2025-10-18,2025-12-30,2026-01-10,INTERVENTIONAL,PHASE4,150,['Laparoscopic Surgery for Cholecystitis'],Laparoscopic Surgery for Cholecystitis,Xin Chen,['The Second Affiliated Hospital of Hainan Medical University'],['China']
NCT06422143,Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023],Phase 3 Study of Pembrolizumab in Combination With Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab With or Without Maintenance MK-2870 in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer,RECRUITING,2024-06-10,2029-01-12,2031-02-12,INTERVENTIONAL,PHASE3,851,"['Non-small Cell Lung Cancer', 'NSCLC']",Non-small Cell Lung Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'China', 'Israel', 'Hungary', 'France', 'Chile', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Arab Emirates', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07054190,"A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer","A Phase II, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Neoadjuvant Treatment With Inavolisib Combinations in Patients With Untreated, Early-stage, PIK3CA-Mutated Breast Cancer",RECRUITING,2025-09-09,2027-07-31,2027-10-31,INTERVENTIONAL,PHASE2,60,['Breast Cancer'],Breast Cancer,Hoffmann-La Roche,[],"['Brazil', 'Spain', 'South Korea', 'Canada', 'Argentina']"
NCT06494241,Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study,A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer,RECRUITING,2024-11-22,2027-11-28,2027-11-28,OBSERVATIONAL,,1000,"['Carcinoma, Non-Small-Cell Lung', 'Lung Neoplasms', 'Respiratory Tract Neoplasms', 'Thoracic Neoplasms', 'Neoplasms by Site', 'Neoplasms', 'Lung Diseases', 'Respiratory Tract Diseases', 'Carcinoma, Bronchogenic', 'Bronchial Neoplasms']","Carcinoma, Non-Small-Cell Lung",AstraZeneca,[],['China']
NCT06676059,SMART-r: Substance Monitoring and Active Relapse Tracking Repository,SMART-r: Substance Monitoring and Active Relapse Tracking Repository,RECRUITING,2025-12-16,2044-12-31,2044-12-31,OBSERVATIONAL,,10000,"['Alcoholism', 'Substance-Related Disorders']",Alcoholism,National Institute on Drug Abuse (NIDA),[],['United States']
NCT05465070,Leg Heat Therapy in Peripheral Artery Disease,Leg Heat Therapy to Improve Functional Performance in Peripheral Artery Disease,RECRUITING,2022-11-07,2026-12-31,2026-12-31,INTERVENTIONAL,NA,106,['Peripheral Artery Disease'],Peripheral Artery Disease,Indiana University,"['Purdue University', 'National Institute on Aging (NIA)']",['United States']
NCT06623422,A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009),A Phase 3 Randomized Double-blind Study of Adjuvant Pembrolizumab With or Without V940 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy (INTerpath-009),RECRUITING,2024-10-21,2033-05-16,2038-01-26,INTERVENTIONAL,PHASE3,680,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Merck Sharp & Dohme LLC,"['ModernaTX, Inc.']","['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Peru', 'South Korea', 'Colombia', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06841354,"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)",RECRUITING,2025-03-16,2030-05-18,2030-05-18,INTERVENTIONAL,PHASE3,1000,['Triple Negative Breast Neoplasms'],Triple Negative Breast Neoplasms,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07272577,Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries,Efficacy of Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries,RECRUITING,2025-12-10,2026-04-01,2026-04-01,INTERVENTIONAL,NA,50,"['Erector Spinae Plane Block', 'Postoperative Analgesia', 'Laparoscopic Abdominal Surgeries']",Erector Spinae Plane Block,Assiut University,[],['Egypt']
NCT07185919,"A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea","Registry to Document Treatment Effectiveness, Safety, Including Prospective Long-term Outcomes in Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay)",RECRUITING,2025-10-30,2032-09-30,2032-09-30,OBSERVATIONAL,,10,['Progressive Familial Intrahepatic Cholestasis'],Progressive Familial Intrahepatic Cholestasis,Ipsen,[],['South Korea']
NCT06939751,OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels (Optimal),OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels (Optimal),RECRUITING,2025-10-28,2031-01-01,2032-01-01,OBSERVATIONAL,,250,"['Cardiac Failure', 'Graft Rejection']",Cardiac Failure,Inova Health Care Services,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06890884,"A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)","A Randomized, Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL)",RECRUITING,2025-04-11,2027-12-13,2032-12-16,INTERVENTIONAL,PHASE2,594,"['Lymphoma, Large B-Cell, Diffuse']","Lymphoma, Large B-Cell, Diffuse",Merck Sharp & Dohme LLC,[],"['Belgium', 'Israel', 'Japan', 'United States', 'Ireland', 'Italy', 'United Kingdom', 'Poland', 'Germany']"
NCT07213947,Comparison of Demand and Substitution for Nicotine Pouches as a Function of Nicotine Dosage,Demand and Substitution for Nicotine Pouches Across Dosage,RECRUITING,2025-12-04,2026-02,2026-02,INTERVENTIONAL,NA,4000,"['Tobacco Use', 'Nicotine Pouch Self-Administration']",Tobacco Use,William Middleton,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT06780098,Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I),"KEYMAKER-U01 Substudy 01I: A Phase 2, Randomized, Umbrella Study With Rolling Arms of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC)",RECRUITING,2025-05-28,2032-03-02,2032-03-02,INTERVENTIONAL,PHASE2,144,['Lung Neoplasm'],Lung Neoplasm,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Hungary', 'China', 'United States', 'Chile', 'Spain', 'Italy', 'Greece', 'Poland', 'Germany']"
NCT06667414,Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers,Frequency of Selected Single Nucleotide Polymorphisms in Phase With the Mutant and Wild-Type HTT Alleles in Huntington Disease Gene Expansion Carriers,RECRUITING,2024-09-02,2028-09-24,2028-09-24,OBSERVATIONAL,,600,['Huntington Disease'],Huntington Disease,Hoffmann-La Roche,[],"['New Zealand', 'United States', 'Germany', 'Denmark', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Portugal', 'Argentina', 'Australia']"
NCT05281328,A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD,"A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Symptomatic Polycystic Liver Disease",ACTIVE_NOT_RECRUITING,2022-06-28,2025-02-05,2027-08,INTERVENTIONAL,PHASE2,71,['Polycystic Liver Disease'],Polycystic Liver Disease,Camurus AB,[],"['Belgium', 'United States', 'Netherlands', 'Germany']"
NCT06154356,Action Observation and Motor Imagery Therapy in Parkinson's Disease,"Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Parkinson's Disease, Randomized Controlled Trial",RECRUITING,2023-12-14,2026-06,2026-06,INTERVENTIONAL,NA,54,"[""Parkinson's Disease""]",Parkinson's Disease,Karamanoğlu Mehmetbey University,['Karaman Training and Research Hospital'],['Turkey (Türkiye)']
NCT06863272,A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02),"MK-2400-01A Substudy: A Phase 1/2, Open-label Umbrella Substudy of MK-2400-U01 Master Protocol to Evaluate the Safety and Efficacy of Ifinatamab Deruxtecan-based Treatment Combinations or Ifinatamab Deruxtecan Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (IDeate-Prostate02)",RECRUITING,2025-07-03,2030-02-18,2030-02-24,INTERVENTIONAL,PHASE1,360,"['Castration-Resistant Prostatic Cancer', 'Metastasis']",Castration-Resistant Prostatic Cancer,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Brazil', 'Israel', 'New Zealand', 'Netherlands', 'United States', 'France', 'Germany', 'Chile', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT06967181,A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults,A Phase 1 Trial of CVM150 and CVM26 Intranasal Mumps Virus Vaccines in Healthy Adults,ACTIVE_NOT_RECRUITING,2025-05-14,2027-12,2027-12,INTERVENTIONAL,PHASE1,60,['Mumps'],Mumps,CyanVac LLC,[],['United States']
NCT06922591,"Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients","A Phase 1/2, Multicenter, Open-Label Study to Evaluate Safety, Tolerability & Antitumor Activity of TNG462 in Combination With Other Agents in Patients With Pancreatic Cancer With MTAP Loss and Pancreatic or Non-Small Cell Lung Cancer With MTAP Loss & RAS Mutation",RECRUITING,2025-05-31,2027-06,2027-12,INTERVENTIONAL,PHASE1,183,"['PDAC', 'PDAC - Pancreatic Ductal Adenocarcinoma', 'NSCLC', 'RAS Mutation', 'MTAP Deletion', 'Lung Cancer', 'Pancreatic Cancer Metastatic', 'Thoracic Cancer']",PDAC,"Tango Therapeutics, Inc.","['Revolution Medicines, Inc.']",['United States']
NCT05981092,A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM),A PROSPECTIVE MULTINATIONAL STUDY OF THE NATURAL HISTORY OF PARTICIPANTS WITH BAG3 MUTATION ASSOCIATED DILATED CARDIOMYOPATHY,ACTIVE_NOT_RECRUITING,2022-10-14,2027-08-12,2027-08-12,OBSERVATIONAL,,35,"['Cardiomyopathy, Dilated', 'Bcl-2 Anathogene-3 (BAG3) Dilated Cardiomyopathy (DCM)']","Cardiomyopathy, Dilated","Alexion Pharmaceuticals, Inc.",[],"['Netherlands', 'United States', 'Spain', 'United Kingdom', 'Poland']"
NCT06780137,A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002),A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer,RECRUITING,2025-02-27,2029-08-31,2029-08-31,INTERVENTIONAL,PHASE1,242,['Small Cell Lung Cancer'],Small Cell Lung Cancer,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Japan', 'Turkey (Türkiye)', 'China', 'United States', 'Chile', 'Spain', 'Taiwan', 'South Korea', 'Australia']"
NCT05581004,"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors","A Phase Ia/Ib, Open Label, Multicenter, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors",RECRUITING,2022-10-20,2027-02-28,2027-02-28,INTERVENTIONAL,PHASE1,450,"['Locally Advanced or Metastatic Solid Tumors', 'NSCLC', 'HNSCC', 'Melanoma', 'TNBC', 'Esophageal Cancer', 'Gastric Cancer', 'Cervical Cancer', 'Colorectal Cancer', 'Urothelial Carcinoma', 'Clear Cell RCC', 'HCC']",Locally Advanced or Metastatic Solid Tumors,"Genentech, Inc.",[],"['Belgium', 'Netherlands', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Greece', 'Sweden', 'Australia']"
NCT05657405,Observational Study of Advanced Data Analytics in Genetic Conditions,Observational Study of Advanced Data Analytics in Genetic Conditions,RECRUITING,2025-12-16,2032-12-31,2032-12-31,OBSERVATIONAL,,1250,['Genetic Conditions'],Genetic Conditions,National Human Genome Research Institute (NHGRI),[],['United States']
NCT05610072,"Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)",Glutamatergic Mechanisms in Opioid and Cocaine Co-Use,RECRUITING,2022-12-15,2026-12-31,2026-12-31,INTERVENTIONAL,EARLY_PHASE1,24,"['Cocaine Use Disorder', 'Opioid Use Disorder', 'Stimulant Use Disorder']",Cocaine Use Disorder,William Stoops,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT06223568,Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer,Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer,RECRUITING,2024-06-10,2028-01-10,2028-01-10,INTERVENTIONAL,PHASE2,70,"['Squamous Cell Carcinoma of the Head and Neck', 'Oropharynx', 'Human Papillomavirus Viruses', 'Drug Therapy', 'Cancer Vaccine']",Squamous Cell Carcinoma of the Head and Neck,National Cancer Institute (NCI),[],['United States']
NCT06838676,ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas,A Phase II Trial of ACT001 in Children and Adolescents With Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas,RECRUITING,2025-07-10,2028-07,2035-07,INTERVENTIONAL,PHASE2,60,"['Diffuse Intrinsic Pontine Gliomas (DIPG)', 'Progressive DIPG', 'Refractory DIPG', 'Recurrent DIPG', 'H3K27-altered High Grade Glioma']",Diffuse Intrinsic Pontine Gliomas (DIPG),Nationwide Children's Hospital,['Accendatech USA Inc.'],"['New Zealand', 'United States', 'Canada', 'Australia', 'Germany']"
NCT06147258,The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury,The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury,RECRUITING,2024-05-03,2026-12-31,2026-12-31,INTERVENTIONAL,NA,60,"['Spinal Cord Injuries', 'Transverse Myelitis']",Spinal Cord Injuries,University of Alabama at Birmingham,[],['United States']
NCT07277868,Effect of Scapular Stabilization Exercises on Pain and Functional Outcomes in Subacromial Impingement Syndrome: A Randomized Controlled Trial,Effect of Scapular Stabilization Exercises on Functional Outcomes in the Treatment of Subacromial Impingement Syndrome: A Controlled Clinical Study,RECRUITING,2025-08-30,2025-11-30,2025-12-30,INTERVENTIONAL,NA,60,['Subacromial Impingement Syndrome'],Subacromial Impingement Syndrome,Kanuni Sultan Suleyman Training and Research Hospital,[],['Turkey (Türkiye)']
NCT06553768,Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND),Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Participants With Cholestatic Pruritus,RECRUITING,2024-10-14,2026-10,2027-02,INTERVENTIONAL,PHASE3,90,"['Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)']","Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)","Mirum Pharmaceuticals, Inc.",[],"['Brazil', 'Lebanon', 'Saudi Arabia', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT07027826,The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States,Use of the Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States,RECRUITING,2025-12-16,2027-08-31,2027-08-31,INTERVENTIONAL,NA,70,"['Dysphagia', 'Eosinophilic Esophagitis']",Dysphagia,National Institute of Allergy and Infectious Diseases (NIAID),[],"['Mali', 'United States']"
NCT07277491,Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity,Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity,RECRUITING,2023-01-01,2025-12-30,2025-12-30,OBSERVATIONAL,,460,"['Spondyloarthritis (SpA)', 'Psoriatic Arthritis (PsA)', 'Systemic Lupus Erythematous (SLE)', 'Systemic Sclerosis (SSc)', 'Rheumatoid Arthritis (RA']",Spondyloarthritis (SpA),Cairo University,[],['Egypt']
NCT07276321,Preliminary Efficacy of an mHealth Intervention in West Africa,Preliminary Efficacy of an mHealth Intervention in West Africa,RECRUITING,2025-11-03,2027-08-30,2027-08-30,INTERVENTIONAL,NA,150,['Schizophrenic Spectrum Disorder'],Schizophrenic Spectrum Disorder,University of Washington,[],['Ghana']
NCT04436640,"A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants With Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis",ACTIVE_NOT_RECRUITING,2020-06-16,2026-08-07,2026-08-07,INTERVENTIONAL,PHASE3,508,"['Axial Spondyloarthritis', 'Ankylosing Spondylitis', 'r-axSpa', 'Nr-axSpa']",Axial Spondyloarthritis,UCB Biopharma SRL,[],"['Belgium', 'Bulgaria', 'Japan', 'Hungary', 'Turkey (Türkiye)', 'Netherlands', 'China', 'United States', 'France', 'Spain', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT04430738,Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers,A Phase 1b/2 Dose Escalation and Expansion Study of Tucatinib in Combination With Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers,ACTIVE_NOT_RECRUITING,2020-09-15,2024-07-31,2025-12-31,INTERVENTIONAL,PHASE2,40,"['Colorectal Carcinoma', 'Gastric Adenocarcinoma', 'GEJ Adenocarcinoma', 'Esophageal Adenocarcinoma', 'Cholangiocarcinoma', 'Gallbladder Carcinoma']",Colorectal Carcinoma,"Seagen, a wholly owned subsidiary of Pfizer",[],"['Japan', 'United States']"
NCT06083480,Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty,Reducing Perioperative Oxidative Stress to Prevent Postoperative Chronic Pain Following Total Knee Arthroplasty,RECRUITING,2024-12-06,2028-09,2029-03,INTERVENTIONAL,PHASE4,148,"['Osteoarthritis, Knee', 'Total Knee Arthroplasty', 'Chronic Postsurgical Pain']","Osteoarthritis, Knee",Vanderbilt University Medical Center,['National Institute on Aging (NIA)'],['United States']
NCT05224934,Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01),Full-target Ultra-hypofractionated Stereotactic Irradiation Orchestrated With Nodule Boost for Retroperitoneal Sarcoma,RECRUITING,2022-01-01,2027-12-31,2027-12-31,INTERVENTIONAL,NA,50,"['Soft Tissue Sarcoma', 'Retroperitoneal Sarcoma', 'Radiotherapy Side Effect', 'Ultra-hypofractionated Radiotherapy', 'Stereotactic Ablative Radiotherapy']",Soft Tissue Sarcoma,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT07275814,A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System (CNS) Lesions,"A Multicenter, Randomized, Double-Blind, Positive-Controlled, Cross-Over Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of HRS-9231 for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)",RECRUITING,2025-11-17,2026-03,2026-03,INTERVENTIONAL,PHASE3,250,['For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions'],For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions,"Shanghai Shengdi Pharmaceutical Co., Ltd",[],['China']
NCT06618287,"A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors","A Phase 1/2a, Open-label, Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BMS-986507 (BL-B01D1) Combinations in Adult Participants With Advanced Solid Tumors",RECRUITING,2025-02-04,2026-12-16,2028-08-24,INTERVENTIONAL,PHASE1,238,"['Lung Cancer', 'Breast Cancer']",Lung Cancer,Bristol-Myers Squibb,[],"['Netherlands', 'United States', 'France', 'Chile', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT05526755,A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC),"An Open-label, Single-arm, Phase II, Multinational, Multicentre Study to Assess the Efficacy and Safety of 5 Years of Osimertinib in Participants With EGFRm-positive Stage II-IIIB NSCLC, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",ACTIVE_NOT_RECRUITING,2023-03-06,2029-11-22,2029-11-22,INTERVENTIONAL,PHASE2,188,['Stage II-IIIB Non-small Cell Lung Carcinoma'],Stage II-IIIB Non-small Cell Lung Carcinoma,AstraZeneca,[],"['Singapore', 'Hong Kong', 'United States', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Malaysia', 'Thailand', 'United Kingdom', 'Philippines']"
NCT04512235,A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES),"A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment Naïve Patients With Mayo Stage IIIa AL Amyloidosis",ACTIVE_NOT_RECRUITING,2020-11-03,2025-04-08,2027-04-08,INTERVENTIONAL,PHASE3,284,['AL Amyloidosis'],AL Amyloidosis,"Alexion Pharmaceuticals, Inc.",[],"['Japan', 'China', 'Australia', 'Belgium', 'Israel', 'Russia', 'France', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy']"
NCT06507917,"Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV","Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV",RECRUITING,2025-11-28,2026-12-28,2027-01-02,INTERVENTIONAL,NA,398,['HPV Infection'],HPV Infection,Centre Hospitalier Universitaire de la Réunion,[],['Reunion']
NCT06414460,Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors,"A Phase 1, Open-Label, Multicenter, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Preliminary Efficacy of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors",RECRUITING,2025-04-25,2028-03-31,2029-03-31,INTERVENTIONAL,PHASE1,80,['Locally Advanced/Metastatic Solid Tumors'],Locally Advanced/Metastatic Solid Tumors,InSilico Medicine Hong Kong Limited,[],"['China', 'United States']"
NCT05557695,Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom,"A Non-interventional, Observational Cohort Study of Chronic Lymphocytic Leukaemia Patients Treated With Acalabrutinib in the First-line Setting Through the UK Early Access Programme: Early Access Programme Outcomes In aCalabrutinib (EPIC).",RECRUITING,2022-10-17,2027-04-01,2027-04-01,OBSERVATIONAL,,350,"['Chronic Lymphocytic Leukemia, CLL']","Chronic Lymphocytic Leukemia, CLL",AstraZeneca,['UKCLL Forum'],['United Kingdom']
NCT03668041,National Adaptive Trial for PTSD Related Insomnia,CSP #2016 - National Adaptive Trial for PTSD Related Insomnia,ACTIVE_NOT_RECRUITING,2021-02-25,2026-02-28,2026-02-28,INTERVENTIONAL,PHASE3,673,['Insomnia'],Insomnia,VA Office of Research and Development,[],['United States']
NCT06052631,Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene,Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene,RECRUITING,2025-12-16,2026-12-31,2026-12-31,OBSERVATIONAL,,16,['PIEZO2-Deficiency Syndrome'],PIEZO2-Deficiency Syndrome,National Center for Complementary and Integrative Health (NCCIH),[],['United States']
NCT06830798,"Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation","A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation",RECRUITING,2025-05-19,2028-02-04,2028-11-06,INTERVENTIONAL,PHASE3,450,"['Delayed Graft Function', 'DGF', 'Kidney Transplant']",Delayed Graft Function,"Alexion Pharmaceuticals, Inc.",[],"['Brazil', 'Japan', 'United Kingdom', 'China', 'Austria', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Poland', 'Portugal', 'Argentina', 'Australia']"
NCT04775706,"Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects","A Multicenter, Proof-of-concept, Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15912 (Sonefpeglutide) in Adult Subjects With Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)",RECRUITING,2022-03-03,2027-12,2028-05,INTERVENTIONAL,PHASE2,18,['Short Bowel Syndrome'],Short Bowel Syndrome,Hanmi Pharmaceutical Company Limited,[],"['Belgium', 'United States', 'France', 'Denmark', 'South Korea', 'United Kingdom', 'Poland', 'Germany']"
NCT06703398,"A Phase II, Multicenter, Open Label, RCT of GC101 TIL in Advanced Melanoma","A Multicenter, Randomized, Controlled,Open Label, Phase II Trial of Autologous Tumor Infiltrating Lymphocytes (GC101 TIL) in Subjects With Advanced Melanoma",RECRUITING,2024-12-20,2026-07-10,2026-12-20,INTERVENTIONAL,PHASE2,98,['Melanoma'],Melanoma,Shanghai Juncell Therapeutics,[],['China']
NCT06338995,A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP),"A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Efficacy and Safety Study of Lebrikizumab/ LY3650150 in Adults With Chronic Rhinosinusitis With Nasal Polyps on a Background Therapy With Intranasal Corticosteroids",RECRUITING,2024-04-29,2027-05,2028-03,INTERVENTIONAL,PHASE3,510,['Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)'],Chronic Rhinosinusitis With Nasal Polyps (CRSwNP),Eli Lilly and Company,[],"['Bulgaria', 'Japan', 'China', 'Belgium', 'Hungary', 'Denmark', 'South Korea', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Portugal', 'Germany', 'United States', 'Italy', 'Argentina']"
NCT06873529,"The Experiences of Women With Spinal Cord Injury Regarding Fertility, Contraception and Pregnancy","The Evaluation of Experiences of Women With Spinal Cord Injury Regarding Fertility, Contraception and Pregnancy",RECRUITING,2025-03-20,2026-03-20,2026-03-20,OBSERVATIONAL,,94,['Spinal Cord Injury'],Spinal Cord Injury,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital,[],['Turkey (Türkiye)']
NCT06667661,A Mobile App to Improve 24-Hour Movement Guideline Adherence in Preschoolers,A Home-Based Intervention to Improve Adherence to the 24-Hour Movement Guidelines in Young Children,RECRUITING,2025-01-29,2026-12-31,2026-12-31,INTERVENTIONAL,NA,80,"['Healthy', '24-Hour Movement Guidelines', 'Feasibility Studies', 'Sleep', 'Physical Activity', 'Screen Time', 'Sedentary Behaviors', 'Motor Skills', 'Cognition', 'Parent-Child Relations', 'Mobile Application', 'Health Education', 'Child Development']",Healthy,University of Kansas Medical Center,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT06795009,Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer,Phase I/IB Study of Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer,RECRUITING,2025-10-17,2029-11-30,2035-04-30,INTERVENTIONAL,PHASE1,36,"['Uterine Cancer', 'Endometrial Cancer']",Uterine Cancer,Washington University School of Medicine,"['National Cancer Institute (NCI)', 'Exelixis']",['United States']
NCT06562192,"Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers","Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers",RECRUITING,2024-10-15,2031-01-15,2031-01-16,INTERVENTIONAL,PHASE1,162,"['Pancreatic Ductal Adenocarcinoma', 'Non-small Cell Lung Cancer', 'HR+/HER2- Ductal and Lobular Breast Cancer', 'Triple Negative Breast Cancer', 'Colorectal Cancer']",Pancreatic Ductal Adenocarcinoma,Novartis Pharmaceuticals,[],"['Belgium', 'Israel', 'Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada']"
NCT06651632,WATER IV Prostate Cancer,WATER IV Prostate Cancer: Aquablation Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer,RECRUITING,2025-02-03,2027-07,2037-01,INTERVENTIONAL,NA,280,['Localized Prostate Cancer'],Localized Prostate Cancer,PROCEPT BioRobotics,[],"['Hong Kong', 'United States', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Germany']"
NCT07225881,Eatwell Clinical Trial (R01),Efficacy of a Multi-level Intervention Designed to Promote Adherence to WCRF/AICR Dietary Guidelines for Cancer Prevention,RECRUITING,2026-01-01,2029-11-30,2029-11-30,INTERVENTIONAL,NA,472,"['Cancer Prevention', 'Dietary Guidelines']",Cancer Prevention,Drexel University,"['National Institutes of Health (NIH)', 'National Cancer Institute (NCI)']",['United States']
NCT03221036,Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Examine the Efficacy and Safety of Intravenous Vedolizumab (300 mg) Infusion Treatment in Chinese Subjects With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2017-08-03,2027-09-24,2028-01-30,INTERVENTIONAL,PHASE3,402,['Moderately to Severely Active Ulcerative Colitis'],Moderately to Severely Active Ulcerative Colitis,Takeda,[],['China']
NCT06561828,Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making,Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making,RECRUITING,2025-12-16,2044-11-01,2044-11-02,INTERVENTIONAL,EARLY_PHASE1,600,['Normal Physiology'],Normal Physiology,National Institute on Drug Abuse (NIDA),[],['United States']
NCT04483466,Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH),Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH): A Phase III Randomized Controlled Clinical Trial of the Efficacy of Methotrexate Monotherapy in the Treatment of Chronic Arthritis After Chikungunya Infection,ACTIVE_NOT_RECRUITING,2023-07-18,2027-08-30,2027-08-30,INTERVENTIONAL,PHASE3,150,['Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity'],Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity,George Washington University,[],['Colombia']
NCT06099457,SIBTime Phase II: Web Application for Typically Developing Siblings,SIBTime: Media-enhanced Technology for Promoting the Behavioral Health and Family Relationships of Typically Developing Young Siblings,RECRUITING,2023-10-27,2026-01-15,2026-01-31,INTERVENTIONAL,NA,160,['Early Life Stress'],Early Life Stress,"Oregon Research Behavioral Intervention Strategies, Inc.",['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT05812924,A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause,A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause,ACTIVE_NOT_RECRUITING,2023-09-26,2026-09-30,2026-09-30,INTERVENTIONAL,PHASE2,18,"['Breast Cancer', 'Genitourinary Syndrome of Menopause']",Breast Cancer,University of Miami,[],['United States']
NCT07164625,Telerehabilitation vs. In-person Physiotherapy in Young Elite Baseball Players,The Effectiveness of Telerehabilitation vs. In-person Physiotherapy in Young Elite Baseball Players With Rotator Cuff Pathology: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2024-10-10,2025-12-31,2026-09-20,INTERVENTIONAL,NA,50,"['Rotator Cuff Tear', 'Rotator Cuff Tendinopathy']",Rotator Cuff Tear,Taichung Veterans General Hospital,[],['Taiwan']
NCT07095504,A Study of Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes,Destination Cardiac Rehab: A Multicenter Feasibility Clinical Trial of an Enhanced Virtual World-based Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes Among Cardiac Patients,RECRUITING,2025-12,2026-06,2026-06,INTERVENTIONAL,NA,15,['Cardiovascular Health'],Cardiovascular Health,Mayo Clinic,[],['United States']
NCT05652478,Early Metabolic Effects of Dolutegravir or Tenofovir Alefenamide in Healthy Volunteers,A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy Volunteers,RECRUITING,2025-12-16,2028-01-31,2030-01-31,INTERVENTIONAL,PHASE2,120,"['Healthy Volunteer', 'Weight Gain', 'Metabolic Effects', 'Integrase Strand Transfer Inhibitors']",Healthy Volunteer,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT01251861,Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer,"Androgen Receptor Modulation Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy",ACTIVE_NOT_RECRUITING,2010-12-23,2018-07-17,2026-03-18,INTERVENTIONAL,PHASE2,108,"['Recurrent Prostate Carcinoma', 'Stage I Prostate Cancer AJCC v7', 'Stage IIA Prostate Cancer AJCC v7', 'Stage IIB Prostate Cancer AJCC v7', 'Stage III Prostate Cancer AJCC v7']",Recurrent Prostate Carcinoma,National Cancer Institute (NCI),[],"['Ireland', 'United States']"
NCT06188689,Evaluation of A Clinical Diagnostic Test for CRDS,Evaluation of a Clinical Diagnostic Test for Calcium Release Deficiency Syndrome: The DIAGNOSE CRDS Study,RECRUITING,2023-02-02,2025-12,2026-03,INTERVENTIONAL,NA,400,['Calcium Release Deficiency Syndrome (CRDS)'],Calcium Release Deficiency Syndrome (CRDS),Population Health Research Institute,['Canadian Institutes of Health Research (CIHR)'],"['Belgium', 'Israel', 'United States', 'France', 'Denmark', 'Canada', 'United Kingdom']"
NCT02870738,Bladder Directed vs. Pelvic Floor Therapy in IC/BPS,Comparison of Bladder Directed and Pelvic Floor Therapy in Women With Interstitial Cystitis/Bladder Pain Syndrome,RECRUITING,2017-04-21,2026-08,2026-08,INTERVENTIONAL,PHASE2,128,"['Cystitis, Interstitial', 'Painful Bladder Syndrome']","Cystitis, Interstitial",Corewell Health East,['Baylor College of Medicine'],['United States']
NCT06684847,A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome,"A Phase 3 Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial With Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 Subcutaneous Administered by Prefilled Syringe in Adult Patients With Primary Sjögren's Disease",RECRUITING,2025-01-15,2027-07,2028-07,INTERVENTIONAL,PHASE3,580,['Primary Sjogrens Disease'],Primary Sjogrens Disease,argenx,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Jordan', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Tunisia', 'Estonia', 'France', 'Chile', 'South Korea', 'Colombia', 'Poland', 'Lebanon', 'Mexico', 'Georgia', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Philippines']"
NCT06789367,The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery,The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Pediatric Hip Surgery,RECRUITING,2025-02-01,2026-02-28,2026-03-31,INTERVENTIONAL,PHASE4,60,"['Hip Dysplasia', 'Hip Disease']",Hip Dysplasia,Poznan University of Medical Sciences,[],['Poland']
NCT06602232,A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo,"A Pilot, Safety and Clinical Activity, Phase 1b Study of DR-01 in Adults With Alopecia Areata or Vitiligo",RECRUITING,2024-10-30,2026-09,2026-09,INTERVENTIONAL,PHASE1,80,"['Alopecia Areata', 'Vitiligo']",Alopecia Areata,Dren Bio,[],"['New Zealand', 'United States', 'Australia']"
NCT07002398,Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease),"A Single Arm, Ph1/2, Open-label, Multicenter Trial With Dose-exploration Via Subretinal Injection to Evaluate the Safety and Preliminary Efficacy of VG801 for Treatment of ABCA4 Mutation-associated Recessive Hereditary Retinal Dystrophy (Stargardt Disease)",RECRUITING,2024-12-23,2026-05,2026-05,INTERVENTIONAL,PHASE1,15,"['Retinal Dystrophy Due to Biallelic ABCA4 Mutations', 'Stargardt Disease 1']",Retinal Dystrophy Due to Biallelic ABCA4 Mutations,VeonGen Therapeutics GmbH,[],['China']
NCT07096193,Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus,"Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta",RECRUITING,2025-07-31,2029-02,2029-02,INTERVENTIONAL,PHASE1,107,['Chronic Hepatitis Delta'],Chronic Hepatitis Delta,Gilead Sciences,[],"['United States', 'Moldova']"
NCT05434598,Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS,A Prospective Study of Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS,RECRUITING,2022-07-27,2027-07-31,2027-08-31,INTERVENTIONAL,NA,60,"['Whole Genome Sequencing', 'Myelodysplastic Syndromes']",Whole Genome Sequencing,Washington University School of Medicine,"['American Society of Hematology', 'Edward P. Evans Foundation', 'National Cancer Institute (NCI)']",['United States']
NCT04548999,"A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)","A Phase IIIB Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis",ACTIVE_NOT_RECRUITING,2020-12-03,2025-06-30,2027-09-08,INTERVENTIONAL,PHASE3,769,['Multiple Sclerosis'],Multiple Sclerosis,Hoffmann-La Roche,[],"['Bulgaria', 'Belgium', 'Hungary', 'Russia', 'France', 'Denmark', 'Peru', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06059638,BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT,BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT,RECRUITING,2023-12-27,2026-12,2029-08,INTERVENTIONAL,NA,500,"['Hypertension', 'Hypertension, Systolic', 'Hypertension, Essential']",Hypertension,"Orchestra BioMed, Inc",['Medtronic'],"['Belgium', 'Hungary', 'Netherlands', 'United States', 'Spain', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT06418204,Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics,Complementary Options for Symptom Management In Cancer (COSMIC): Assessing Benefits and Harms of Cannabis and Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics,RECRUITING,2025-01-30,2028-08,2028-08,OBSERVATIONAL,,2000,"['Breast Carcinoma', 'Colorectal Carcinoma', 'Lung Non-Small Cell Carcinoma', 'Melanoma', 'Non-Hodgkin Lymphoma']",Breast Carcinoma,Wake Forest University Health Sciences,['National Cancer Institute (NCI)'],['United States']
NCT06274749,Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial,The Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults >= 55 Years Old. A Randomized Triple-Masked Controlled Clinical Trial,RECRUITING,2025-12-16,2027-03-31,2027-03-31,INTERVENTIONAL,NA,180,['Healthy Volunteer'],Healthy Volunteer,National Institute on Aging (NIA),[],['United States']
NCT01168271,"Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali","Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali",RECRUITING,2010-08-30,,,OBSERVATIONAL,,15000,['Malaria'],Malaria,National Institute of Allergy and Infectious Diseases (NIAID),[],['Mali']
NCT06717347,"A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)","A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)",RECRUITING,2025-01-27,2029-07-02,2032-03-29,INTERVENTIONAL,PHASE3,1046,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Merck Sharp & Dohme LLC,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'Guatemala', 'Peru', 'Colombia', 'South Korea', 'Thailand', 'Poland', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Portugal', 'Ukraine', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06732284,Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task,Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task,RECRUITING,2025-11-04,2027-03,2027-03,OBSERVATIONAL,,110,"['Major Depression', 'Sleep Inertia']",Major Depression,Centre Hospitalier Universitaire de Nīmes,[],['France']
NCT07277816,Photo-experiencing and Reflective Listening (PEARL) to Promote Healing Engagement for Survivors of Violence,Photo-experiencing and Reflective Listening (PEARL) to Promote Healing Engagement for Survivors of Violence: A Feasibility Study,RECRUITING,2025-12-01,2026-08-01,2026-08-01,INTERVENTIONAL,NA,40,['Violence and Victimization'],Violence and Victimization,Temple University,['National Institute of Nursing Research (NINR)'],['United States']
NCT06577454,Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder,Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder,RECRUITING,2025-12-16,2027-08-06,2027-08-06,INTERVENTIONAL,NA,60,"['Opioid Use Disorder', 'Healthy Volunteers']",Opioid Use Disorder,National Institute on Drug Abuse (NIDA),[],['United States']
NCT05157282,Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia,Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia,RECRUITING,2023-01-25,2026-01-30,2026-02-02,INTERVENTIONAL,NA,86,['Spinal Cord Injury'],Spinal Cord Injury,VA Office of Research and Development,[],['United States']
NCT07071337,"A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy","A Randomized, Open-label, Multicenter Phase III Clinical Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2-negative (HER2-) Breast Cancer Who Have Previously Failed Endocrine Therapy",RECRUITING,2025-07-18,2027-07,2031-02,INTERVENTIONAL,PHASE3,430,['Metastatic Breast Cancer'],Metastatic Breast Cancer,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT03747458,OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps,16-Week Randomized Double-Blind Placebo Controlled Parallel-Group Multicenter Study Evaluating the Efficacy and Safety of OPN-375 186 μg Twice a Day in Adolescents With Bilateral Nasal Polyps Followed With 12-Week Open-Label Treatment Phase,RECRUITING,2018-12-31,2026-03,2026-03,INTERVENTIONAL,PHASE3,72,['Bilateral Nasal Polyposis'],Bilateral Nasal Polyposis,Optinose US Inc.,[],"['Argentina', 'United States']"
NCT06664814,An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis,An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis,RECRUITING,2025-12-16,2027-11-30,2027-12-01,INTERVENTIONAL,PHASE2,30,['Focal Segmental Glomerulosclerosis'],Focal Segmental Glomerulosclerosis,National Human Genome Research Institute (NHGRI),[],['United States']
NCT07214207,Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking,Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking,RECRUITING,2025-12-04,2030-09,2030-09,INTERVENTIONAL,PHASE2,250,['Alcohol Use Disorder'],Alcohol Use Disorder,Ohio State University,['National Institute on Alcohol Abuse and Alcoholism (NIAAA)'],['United States']
NCT07205536,Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy,A Clinical Study on the Safety and Efficacy of Mecapegfilgrastim in Preventing Myelosuppression Induced by Concurrent Chemoradiotherapy for Thoracic Malignancies,RECRUITING,2025-08-01,2027-12,2027-12,INTERVENTIONAL,PHASE2,30,"['Myelosuppression', 'Thoracic Neoplasms', 'Chemoradiotherapy']",Myelosuppression,Affiliated Hospital of Nantong University,[],['China']
NCT05005975,Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP),"A Phase 3, Multicenter, Open-label, Long-term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)",RECRUITING,2021-08-10,2027-12,2027-12,INTERVENTIONAL,PHASE3,301,"['EPP', 'XLP']",EPP,"Tanabe Pharma America, Inc.",[],"['Belgium', 'Japan', 'Netherlands', 'Norway', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Sweden', 'Australia']"
NCT06860607,Environment and Alcohol: A Pilot Study,Environment and Alcohol: A Pilot Study,RECRUITING,2025-12-16,2027-03-01,2028-03-01,INTERVENTIONAL,PHASE1,44,['Alcohol Use Disorder'],Alcohol Use Disorder,National Institute on Drug Abuse (NIDA),[],['United States']
NCT05723198,A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata,"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata",RECRUITING,2023-02-27,2027-09,2029-08,INTERVENTIONAL,PHASE3,595,"['Areata Alopecia', 'Alopecia', 'Hypotrichosis', 'Hair Diseases', 'Skin Diseases', 'Pathological Conditions, Anatomical']",Areata Alopecia,Eli Lilly and Company,[],"['Japan', 'Hungary', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Poland', 'Argentina', 'Australia']"
NCT07204977,Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS),Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS),RECRUITING,2025-12-16,2027-09-30,2028-09-30,INTERVENTIONAL,PHASE1,30,"['Amyotrophic Lateral Sclerosis', 'Motor Neuron Disease']",Amyotrophic Lateral Sclerosis,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06938854,Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries,"Prospective, Multi-center, Single-arm Investigational Study of SWM-831 to Treat Moderate and Severely Calcified Femoropopliteal Arteries",ACTIVE_NOT_RECRUITING,2025-03-10,2027-01-31,2028-03-01,INTERVENTIONAL,NA,81,['Peripheral Arterial Disease'],Peripheral Arterial Disease,"Shockwave Medical, Inc.","['Iqvia Pty Ltd', 'Massachusetts General Hospital', 'Yale University']",['Japan']
NCT07042594,Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants,"A Randomized, Single-blind, Placebo-Controlled Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of Subcutaneously Administered RBD1119 in Healthy Participants",RECRUITING,2025-08-26,2026-06,2026-09,INTERVENTIONAL,PHASE1,32,['Healthy Volunteers'],Healthy Volunteers,Suzhou Ribo Life Science Co. Ltd.,[],['Australia']
NCT07275723,A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Body Parts (Non-Central Nervous System) Lesions,"A Multicenter, Randomized, Double-Blind, Positive-Controlled, Cross-Over Phase III Clinical Trial Evaluating the Efficacy and Safety of HRS-9231 for Body Parts (Non-Central Nervous System) Magnetic Resonance Imaging (MRI)",RECRUITING,2025-11-14,2026-04,2026-04,INTERVENTIONAL,PHASE3,306,['For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS)'],For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Abnormal Vascular Lesions in Body Regions Excluding the Central Nervous System (CNS),"Shanghai Shengdi Pharmaceutical Co., Ltd",[],['China']
NCT03968445,Neuroinflammation After Myocardial Infarction - Imaging Substudy,Neuroinflammation After Myocardial Infarction - Imaging Substudy,ACTIVE_NOT_RECRUITING,2019-10-17,2028-10,2028-10,INTERVENTIONAL,PHASE1,6,['Myocardial Infarction'],Myocardial Infarction,University of Alabama at Birmingham,[],['United States']
NCT04044365,Pediatric cGVHD Symptom Scale,Development and Psychometric Testing of a Pediatric Chronic Graft- Versus-Host Disease (GVHD) Symptom Scale (PCSS),RECRUITING,2019-10-02,2026-12-31,2026-12-31,OBSERVATIONAL,,420,['Graft vs Host Disease'],Graft vs Host Disease,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT06615973,Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke,Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke,RECRUITING,2025-12-16,2026-02-01,2026-02-01,OBSERVATIONAL,,450,"['Stroke', 'Brain Disease', 'Vascular Diseases', 'Cerebrovascular Disorder']",Stroke,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT04629729,FT819 in Subjects With B-cell Malignancies,A Phase I Study of FT819 in Subjects With B-cell Malignancies,ACTIVE_NOT_RECRUITING,2021-07-12,2025-06-18,2039-09-30,INTERVENTIONAL,PHASE1,54,"['Lymphoma, B-Cell', 'Chronic Lymphocytic Leukemia', 'Precursor B-Cell Acute Lymphoblastic Leukemia']","Lymphoma, B-Cell",Fate Therapeutics,[],['United States']
NCT07184996,An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis,"A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis.",RECRUITING,2025-10-08,2028-05-09,2028-05-09,INTERVENTIONAL,PHASE3,980,['Ulcerative Colitis'],Ulcerative Colitis,Sanofi,['Teva Branded Pharmaceutical Products R&D LLC'],['United States']
NCT06166862,Action Observation and Motor Imagery Therapy in Stroke,"Effect of Action Observation and Motor Imagery Therapy on Balance, Functional Status and Quality of Life in Stroke, Randomized Controlled Trial",RECRUITING,2023-12-12,2026-06,2026-06,INTERVENTIONAL,NA,56,['Stroke'],Stroke,Karamanoğlu Mehmetbey University,['Karaman Training and Research Hospital'],['Turkey (Türkiye)']
NCT07276269,Survival and Success of CAD/CAM Restorations After 5 Years of Intraoral Use,Comparative Study of Survival and Success of Restorations Exclusively Using the CAD/CAM Digital Method After 5 Years of Intraoral Use,ACTIVE_NOT_RECRUITING,2023-11-30,2028-11-30,2029-11-30,INTERVENTIONAL,NA,80,['Tooth Wear'],Tooth Wear,Aristotle University Of Thessaloniki,[],['Greece']
NCT04387734,Effects of Ocrevus in Relapsing Multiple Sclerosis,Effects and Mechanisms of Ocrevus on Ambulatory Functions in People With Relapsing Multiple Sclerosis,ACTIVE_NOT_RECRUITING,2021-02-05,2025-02-17,2025-12-30,INTERVENTIONAL,PHASE4,60,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,Georgia State University,['Multiple Sclerosis Center of Atlanta'],['United States']
NCT03833921,Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer,"Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity, PSA Decline and Genetic Variation in Proteins Involved in Androgen Metabolism in Metastatic Hormone Naive Prostate Cancer",RECRUITING,2019-05-23,2028-11,2038-04,INTERVENTIONAL,PHASE2,130,"['Prostate Cancer Metastatic', 'Prostate Cancer']",Prostate Cancer Metastatic,Martha Mims,[],['United States']
NCT07140614,"A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.","A First-in-human, Multi-center, Randomized, Participant- and Investigator-blinded, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With Charcot-Marie Tooth Type 1A (CMT1A).",RECRUITING,2025-09-30,2028-02-25,2028-02-26,INTERVENTIONAL,PHASE1,28,"['Charcot-Marie-Tooth Disease, Type 1A']","Charcot-Marie-Tooth Disease, Type 1A",Novartis Pharmaceuticals,[],['Canada']
NCT05116384,Renal Denervation + PVI vs PVI Alone for Persistent AF,A Trial to Evaluate Renal Artery Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation,RECRUITING,2023-07-30,2026-06-30,2026-06-30,INTERVENTIONAL,NA,50,['Atrial Fibrillation'],Atrial Fibrillation,University of Rochester,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT04967833,A Study of GC101 TIL in Advanced Solid Tumors (TR),A Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes Injection in Patients With Advanced Malignant Solid Tumors,RECRUITING,2021-04-22,2025-12-22,2026-04-22,INTERVENTIONAL,EARLY_PHASE1,20,['Advanced Solid Tumors'],Advanced Solid Tumors,Shanghai Juncell Therapeutics,['Shanghai Tong Ren Hospital'],['China']
NCT06923072,Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement,A Phase IIa Trial of Baricitinib in the Treatment of Kohlmeier-Degos Disease Patients With Neurological Involvement,RECRUITING,2025-12-16,2030-12-14,2030-12-15,INTERVENTIONAL,PHASE2,12,"['Kohlmeier-Degos Disease', 'Malignant Atrophic Papulosis', 'Degos Disease', 'Papulosis, Malignant Atrophic']",Kohlmeier-Degos Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT05499507,The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART),The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART),RECRUITING,2023-01-24,2027-07-15,2028-12-10,INTERVENTIONAL,NA,432,"['Pregnancy Related', 'Hypertension', 'Obesity', 'Racism']",Pregnancy Related,Temple University,['Patient-Centered Outcomes Research Institute'],['United States']
NCT06835751,Optimizing HIV Pre-exposure Prophylaxis (PrEP) Among Women Who Use Drugs in Tanzania,Optimizing PrEP Among Women Who Use Drugs in Tanzania,RECRUITING,2025-07-25,2026-03-31,2026-05-31,INTERVENTIONAL,NA,200,"['HIV', 'Mental Health', 'Substance Use (Drugs, Alcohol)']",HIV,Johns Hopkins Bloomberg School of Public Health,"['Muhimbili University of Health and Allied Sciences', 'National Institute on Drug Abuse (NIDA)']",['Tanzania']
NCT06483334,A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04),"A Phase 1/2 Randomized, Umbrella Study to Evaluate the Efficacy and Safety of MK-2870 Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab, as Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04C",ACTIVE_NOT_RECRUITING,2024-07-17,2028-03-31,2028-03-31,INTERVENTIONAL,PHASE1,38,"['Metastatic Urothelial Carcinoma', 'Locally Advanced Urothelial Carcinoma']",Metastatic Urothelial Carcinoma,Merck Sharp & Dohme LLC,[],"['Israel', 'Netherlands', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom']"
NCT06998134,Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults,Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults: Exploratory Observational Analysis of Novel Robotic Control Strategies,RECRUITING,2025-12-16,2028-08-18,2028-08-18,OBSERVATIONAL,,23,"['Muscle Weakness', 'Problems Moving Their Arms and Legs']",Muscle Weakness,National Institutes of Health Clinical Center (CC),[],['United States']
NCT05942339,Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury (BoxSwitch),Study on Preliminary Safety and Efficacy of the ARC Therapy Using the ARC-IM Lumbar System to Support Mobility in People With Chronic Spinal Cord Injury,RECRUITING,2023-08-30,2027-08-30,2027-08-30,INTERVENTIONAL,NA,8,['Spinal Cord Injuries'],Spinal Cord Injuries,Ecole Polytechnique Fédérale de Lausanne,[],['Switzerland']
NCT06646276,A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).,"A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).",RECRUITING,2025-02-25,2028-04-06,2031-09-05,INTERVENTIONAL,PHASE3,530,['Extensive-Stage Small Cell Lung Cancer'],Extensive-Stage Small Cell Lung Cancer,Bristol-Myers Squibb,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'Chile', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05673148,"Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study","A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)",RECRUITING,2023-10-09,2028-07-03,2032-08-12,INTERVENTIONAL,PHASE3,364,"['Metastatic Colorectal Adenocarcinoma', 'Stage IV Colorectal Cancer AJCC v8']",Metastatic Colorectal Adenocarcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT06666764,Normobaric Oxygen in AIS Transferred for EVT,Adjuvant Normobaric Hyperoxia in Acute Ischemic Stroke Patients Transferred for Thrombectomy,RECRUITING,2024-12-13,2027-10,2027-10,INTERVENTIONAL,PHASE3,1500,['Ischemic Stroke'],Ischemic Stroke,Capital Medical University,[],['China']
NCT06937099,Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight,"A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight",RECRUITING,2025-06-26,2028-05,2028-05,INTERVENTIONAL,PHASE3,290,"[""Crohn's Disease"", 'Obesity or Overweight']",Crohn's Disease,Eli Lilly and Company,[],"['Bulgaria', 'Netherlands', 'Slovakia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Denmark', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Canada', 'Romania', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT05993234,A Study of Trastuzumab DeRuxtecan for Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies (PROSPERITY),"A Prospective Non-interventional Study (NIS) of Trastuzumab DeRuxtecan (T-DXd) for Adult Patients With Advanced HER2-pOsitive GaStric or GastroesoPhageal Junction (GEJ) AdEnocarcinoma Who Have Received a PrIor Trastuzumab-based Regimen, Accompanied by a Disease RegistrY of Patients Treated With Conventional Therapies in a Real-world Setting in Europe (PROSPERITY)",RECRUITING,2023-12-05,2026-12-01,2027-09-01,OBSERVATIONAL,,257,"['HER2-positive Advanced Gastric Cancer', 'HER2-positive Gastroesophageal Junction Adenocarcinoma']",HER2-positive Advanced Gastric Cancer,"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",[],"['Belgium', 'Austria', 'Italy', 'Portugal', 'Germany']"
NCT06905587,Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue,"Effect of Methylphenidate on Cancer-related Fatigue in Patients Treated for a Brain Tumor During Childhood or Adolescence: Protocol for a Randomized, Double-blind, Placebo-controlled Crossover Trial - the EMBRAIN Trial",RECRUITING,2025-09-02,2029-12,2029-12,INTERVENTIONAL,PHASE3,50,"['Brain Tumor, Pediatric', 'Cancer-related Fatigue', 'Methylphenidate']","Brain Tumor, Pediatric",Odense University Hospital,"['Aarhus University Hospital Skejby', 'Aalborg University Hospital', 'Rigshospitalet, Denmark', 'University of Southern Denmark']",['Denmark']
NCT05098184,A Study of GC101 TIL in Advanced Melanoma (10hospital),A Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes Injection in Patients With Advanced Melanoma,RECRUITING,2021-09-26,2026-09-25,2026-09-25,INTERVENTIONAL,EARLY_PHASE1,50,"['Advanced Melanoma', 'Tumor Infiltrating Lymphocyte', 'Treatment Side Effects', 'Effects of Immunotherapy']",Advanced Melanoma,Shanghai Juncell Therapeutics,"[""Shanghai 10th People's Hospital""]",['China']
NCT06479837,Modeling Host-Pathogen Interaction Using Lymphoid Organoids,Modeling Host-Pathogen Interaction Using Lymphoid Organoids,RECRUITING,2025-12-16,2043-12-01,2044-12-01,OBSERVATIONAL,,500,['Staphylococcal Infections'],Staphylococcal Infections,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06643936,E3 Diabetes - Closing the Gap in Diabetes Control,E3 Diabetes - Closing the Gap in Diabetes Control,ACTIVE_NOT_RECRUITING,2024-11-18,2026-04-01,2026-04-01,INTERVENTIONAL,NA,150,['Type 2 Diabetes'],Type 2 Diabetes,Rush University Medical Center,['Novartis Pharmaceuticals'],['United States']
NCT06925737,A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001),"A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)",RECRUITING,2025-05-13,2028-06-26,2031-01-06,INTERVENTIONAL,PHASE3,1440,"['Prostate Cancer', 'Prostatic Neoplasms']",Prostate Cancer,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Israel', 'France', 'Chile', 'Denmark', 'Guatemala', 'Peru', 'Colombia', 'Czechia', 'South Korea', 'Thailand', 'Poland', 'Singapore', 'South Africa', 'Switzerland', 'Spain', 'Taiwan', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT05917106,Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study),Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study),RECRUITING,2022-12-26,2028-06,2030-06,OBSERVATIONAL,,450,"['Carcinoma', 'Renal Cell Carcinoma', 'RCC', 'Kidney Neoplasms', 'Kidney Cancer']",Carcinoma,"Jinling Hospital, China",[],['China']
NCT07069400,An International Observational Study of Adults With Acute Infection,An International Observational Study of Adults With Acute Infection,RECRUITING,2025-08-25,2027-06-08,2027-06-08,OBSERVATIONAL,,1500,['Infectious Disease'],Infectious Disease,University of Minnesota,[],"['Argentina', 'Denmark', 'United States', 'Ukraine']"
NCT05319730,A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B),"A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer Previously Exposed to PD-1/PD-L1 Treatment (KEYMAKER-U06): Substudy 06B",RECRUITING,2023-05-16,2026-11-07,2029-04-10,INTERVENTIONAL,PHASE1,230,['Esophageal Squamous Cell Carcinoma'],Esophageal Squamous Cell Carcinoma,Merck Sharp & Dohme LLC,[],"['Brazil', 'Singapore', 'Japan', 'Turkey (Türkiye)', 'Norway', 'China', 'United States', 'Chile', 'Switzerland', 'Taiwan', 'Italy', 'South Korea', 'Thailand', 'Germany']"
NCT06473961,A Phase Ib Study of GC101 in NSCLC,"An Open, Single-armed, Phase Ib Study to Evaluate the Safety and Efficacy Using Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) in Patients With Non-Small Cell Lung Cancer",RECRUITING,2024-10-14,2026-01-01,2027-07-01,INTERVENTIONAL,PHASE1,20,"['Non Small Cell Lung Cancer Metastatic', 'Non Small Cell Lung Cancer']",Non Small Cell Lung Cancer Metastatic,Shanghai Juncell Therapeutics,[],['China']
NCT07277920,Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions,Evaluation of Reflectance Confocal Microscopy (RCM) Features in Surgically Excised Atypical Melanocytic Lesions and Their Correlation With Next-Generation Sequencing (NGS) Patterns,RECRUITING,2023-11-01,2025-12-31,2026-12-31,OBSERVATIONAL,,200,"['Melanocytic Nevi', 'Melanoma (Skin Cancer)', 'Next Generation Sequencing (NGS)']",Melanocytic Nevi,University of Modena and Reggio Emilia,['European Union'],['Italy']
NCT06819878,A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease,"A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease",RECRUITING,2025-03-17,2028-12-31,2033-12-31,INTERVENTIONAL,PHASE3,600,['Moderately to Severely Active Crohns Disease'],Moderately to Severely Active Crohns Disease,Hoffmann-La Roche,['Chugai Pharmaceutical'],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Dominican Republic', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Croatia', 'Denmark', 'Guatemala', 'Thailand', 'Colombia', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Arab Emirates', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT03311503,Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning,Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning,RECRUITING,2018-02-26,2028-01-01,2028-01-01,INTERVENTIONAL,PHASE1,12,"['Severe Combined Immunodeficiency, X Linked', 'Gene Therapy']","Severe Combined Immunodeficiency, X Linked",David Williams,[],['United States']
NCT05320198,Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia,"RALLY-MF: A Phase 1b/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia",RECRUITING,2022-06-06,2026-09,2026-09,INTERVENTIONAL,PHASE1,150,"['Myelofibrosis; Anemia', 'Anemia', 'Myelofibrosis', 'Myelofibrosis Due to and Following Polycythemia Vera', 'Primary Myelofibrosis', 'Post-essential Thrombocythemia Myelofibrosis', 'Myelodysplastic Syndromes']",Myelofibrosis; Anemia,"Disc Medicine, Inc",[],['United States']
NCT03564873,Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS,Concomitant Omacetaxine Mepesuccinate and Azacitidine for Patients With Previously Untreated High Grade Myelodysplastic Syndromes,ACTIVE_NOT_RECRUITING,2018-09-17,2025-10-07,2027-06,INTERVENTIONAL,PHASE1,28,['High Grade Myelodysplastic Syndromes'],High Grade Myelodysplastic Syndromes,"University of Colorado, Denver",[],['United States']
NCT07262372,Supervision in Substance Use Disorder Treatment Programs,Supervision Strategy for Substance Use Disorder Treatment Programs: A Pilot Study,RECRUITING,2025-07-21,2027-05-31,2027-06-30,INTERVENTIONAL,NA,43,"['Self Efficacy', 'Burnout, Professional', 'Substance Use Disorders', 'Supervision']",Self Efficacy,University of Arkansas,"['National Institute on Drug Abuse (NIDA)', 'Chestnut Health Systems']",['United States']
NCT07093801,Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer,"Real-world Experience of Lutetium (177Lu) Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer, an Observational, National, Multicenter, Prospective Cohort Study (PLU4REAL).",RECRUITING,2025-07-30,2029-03-30,2029-03-30,OBSERVATIONAL,,300,['Metastatic Castration Resistant Prostate Cancer'],Metastatic Castration Resistant Prostate Cancer,Novartis Pharmaceuticals,[],['Italy']
NCT07216131,A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 to 55 Years,"A Fixed-sequence, Open-label Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Metformin in Healthy Volunteers",RECRUITING,2025-11-10,2025-12-29,2025-12-29,INTERVENTIONAL,PHASE1,14,['Healthy Participants'],Healthy Participants,AstraZeneca,['Parexel'],['United States']
NCT06695910,Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).,Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA) in Volunteers Who Reported Suffering From Haze or Mental Fatigue on a Regular Basis. Exploratory Study (NBF-MG01).,RECRUITING,2024-11-06,2027-05-01,2027-07-01,INTERVENTIONAL,PHASE4,48,"['Brain Fog', 'Cognitive Health']",Brain Fog,Samuel Fortin,['Institut de recherche clinique du littoral (IRCL)'],['Canada']
NCT07230210,Smart Tech-Based Nutrition and Exercise for Sarcopenia Risk.,The Effectiveness of Smart Technology Interventions Combining Nutrition and Exercise for Older Adults at Risk of Sarcopenia,RECRUITING,2025-12-03,2028-12-31,2028-12-31,INTERVENTIONAL,NA,60,['Sarcopenia'],Sarcopenia,HSIAO MEI LAN,[],['Taiwan']
NCT05413304,Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis,Feasibility of Evaluating Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis,RECRUITING,2023-04-07,2025-12-31,2026-08-31,INTERVENTIONAL,PHASE1,17,['Glioma'],Glioma,National Cancer Institute (NCI),[],['United States']
NCT04133675,BTL Emsella Chair Versus Sham for the Treatment of Stress Urinary Incontinence,"A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Stress Urinary Incontinence",RECRUITING,2019-12-18,2027-10,2028-12,INTERVENTIONAL,NA,110,['Stress Urinary Incontinence'],Stress Urinary Incontinence,Corewell Health East,[],['United States']
NCT07278206,Brain Stimulation in Long COVID,Mitigating Cognitive Problems and Fatigue With Brain Stimulation in Long COVID,RECRUITING,2025-11-17,2028-11-17,2029-05-12,INTERVENTIONAL,NA,66,"['Long COVID', 'PASC Post Acute Sequelae of COVID 19', 'Post COVID-19 Condition (PCC)']",Long COVID,"Amsterdam UMC, location VUmc","['ZonMw: The Netherlands Organisation for Health Research and Development', 'Post Covid Netwerk Nederland']",['Netherlands']
NCT06922448,Study of BLU-808 in Allergic Rhinoconjunctivitis,"A Phase 2a Randomized Double-blinded Placebo Controlled Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Clinical Activity of BLU-808, a Wild-type KIT Inhibitor, in Participants With Ragweed (Ambrosia Artemisiifolia)-Induced Allergic Rhinoconjunctivitis",ACTIVE_NOT_RECRUITING,2025-04-14,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,54,['Allergic Rhinoconjunctivitis'],Allergic Rhinoconjunctivitis,Blueprint Medicines Corporation,[],['Canada']
NCT06856226,Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant,Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant,RECRUITING,2025-12-16,2027-12-01,2028-12-01,OBSERVATIONAL,,88,"['Leukemia', 'Lymphoma', 'Hematologic Malignancy']",Leukemia,National Cancer Institute (NCI),[],['United States']
NCT05805826,To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults,"A PHASE 1/2 RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, IMMUNOGENICITY, AND IMMUNOPERSISTENCE OF A CLOSTRIDIOIDES DIFFICILE VACCINE ADMINISTERED WITH NOVEL ADJUVANTS IN HEALTHY ADULTS",ACTIVE_NOT_RECRUITING,2023-03-23,2031-06-19,2031-06-19,INTERVENTIONAL,PHASE1,936,['Clostridoides Difficile Associated Disease'],Clostridoides Difficile Associated Disease,Pfizer,[],['United States']
NCT05953233,School Inner City Air Study,School Inner City Air Study,RECRUITING,2024-09-15,2029-08,2030-08,INTERVENTIONAL,NA,200,['Viral Infection'],Viral Infection,Massachusetts General Hospital,"[""Boston Children's Hospital"", 'National Institute of Allergy and Infectious Diseases (NIAID)']",['United States']
NCT04102098,A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation,"A Phase III, Multicenter, Randomized, Open-Label Study of Atezolizumab (Anti-PD-L1 Antibody) Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation",ACTIVE_NOT_RECRUITING,2019-12-31,2022-10-21,2027-07-16,INTERVENTIONAL,PHASE3,668,"['Carcinoma, Hepatocellular']","Carcinoma, Hepatocellular",Hoffmann-La Roche,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Russia', 'France', 'Peru', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'Singapore', 'Costa Rica', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT06356311,A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015),"A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physician's Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma)",RECRUITING,2024-05-03,2027-01-04,2027-05-06,INTERVENTIONAL,PHASE3,450,['Gastroesophageal Cancer'],Gastroesophageal Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'Hong Kong', 'China', 'Belgium', 'Israel', 'France', 'Chile', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT07060807,A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016),"An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04)",RECRUITING,2025-07-21,2033-07-14,2033-07-14,INTERVENTIONAL,PHASE3,1000,['Breast Neoplasms'],Breast Neoplasms,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Japan', 'Hungary', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'Colombia', 'Canada', 'South Korea', 'Greece', 'Poland', 'Argentina']"
NCT03807973,Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.,Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.,RECRUITING,2021-10-05,2028-10,2028-10,INTERVENTIONAL,PHASE1,120,"['Fibromyalgia', 'Chronic Fatigue Syndrome', 'Multiple Sclerosis', 'Healthy']",Fibromyalgia,University of Alabama at Birmingham,[],['United States']
NCT07091630,A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP,"A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy",RECRUITING,2025-09-16,2027-10-07,2031-01-23,INTERVENTIONAL,PHASE3,160,"['Chronic Inflammatory Demyelinating Polyneuropathy', 'CIDP', 'Chronic Inflammatory Demyelinating Polyradiculoneuropathy']",Chronic Inflammatory Demyelinating Polyneuropathy,argenx,[],['United States']
NCT06881836,A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease,"A Phase II, 26-week, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of ONO-2020 in Patients With Mild to Moderate Alzheimer's Disease",RECRUITING,2025-04-24,2026-07,2026-08,INTERVENTIONAL,PHASE2,240,['Alzheimer Disease'],Alzheimer Disease,Ono Pharmaceutical Co. Ltd,[],"['Japan', 'United States']"
NCT04540497,A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease,"A Phase 3, Randomized, Double-blind, Multicenter, Placebo Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease",ACTIVE_NOT_RECRUITING,2020-12-04,2024-04-09,2028-10-31,INTERVENTIONAL,PHASE3,135,['IgG4 Related Disease'],IgG4 Related Disease,Amgen,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Israel', 'Hungary', 'France', 'Poland', 'India', 'Mexico', 'Spain', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07276477,Inspiratory Muscle Training After Stroke,"Effects of Inspiratory Muscle Training Via a Mobile Respiratory Trainer (AiroFit PRO™) on Pulmonary Function, Muscle Strength, and Quality of Life in Hemiplegic Individuals: A Randomized Controlled Study",RECRUITING,2025-12-11,2026-05-11,2026-06-11,INTERVENTIONAL,NA,54,"['Stroke', 'Exercise', 'Pulmonary']",Stroke,Uşak University,[],['Turkey (Türkiye)']
NCT05473429,Characterization of Nociception Phenotype in Individuals With Intellectual Disability,Characterization of the Nociception Phenotype in Individuals With Intellectual Disability,RECRUITING,2025-12-16,2026-10-06,2026-10-06,INTERVENTIONAL,NA,215,['Intellectual Disability'],Intellectual Disability,National Institutes of Health Clinical Center (CC),[],['United States']
NCT05632562,Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma,Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma,RECRUITING,2024-03-07,2028-02-01,2028-02-01,INTERVENTIONAL,EARLY_PHASE1,20,['High Grade Glioma'],High Grade Glioma,University of Alabama at Birmingham,[],['United States']
NCT05340270,PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma,"PD-1 Inhibitor Plus GP Chemotherapy as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II, Multicenter, Randomized Controlled Clinical Trial",ACTIVE_NOT_RECRUITING,2022-07-15,2026-03-29,2029-03-29,INTERVENTIONAL,PHASE2,150,"['Nasopharyngeal Carcinoma', 'Neoadjuvant Therapy', 'PD-1 Inhibitor']",Nasopharyngeal Carcinoma,Guangxi Medical University,"[""Hainan People's Hospital"", 'Wuzhou Red Cross Hospital', ""First People's Hospital of Yulin"", 'Fourth Affiliated Hospital of Guangxi Medical University', ""Guigang People's Hospital"", ""LiuZhou People's Hospital"", 'Afﬁliated Hospital of North Sichuan Medical College']",['China']
NCT07027839,Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B),Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B),RECRUITING,2025-12-16,2028-02-22,2029-02-22,INTERVENTIONAL,PHASE1,30,['Alcohol Use Disorder'],Alcohol Use Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT06606327,Diazoxide Suppression Test P&F Study,Human Models of Primary Hyperinsulinemia: Diazoxide Suppression Test (DzST) Pilot & Feasibility Study,RECRUITING,2024-10-23,2027-11,2028-01,INTERVENTIONAL,PHASE1,10,"['Insulin Resistance', 'Hyperinsulinemia', 'Obesity']",Insulin Resistance,Columbia University,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'University of Pisa']",['United States']
NCT06144840,INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP,"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria",ACTIVE_NOT_RECRUITING,2023-12-11,2026-04,2026-06,INTERVENTIONAL,PHASE3,165,"['Erythropoietic Protoporphyria (EPP)', 'X-Linked Protoporphyria (XLP)']",Erythropoietic Protoporphyria (EPP),"Tanabe Pharma America, Inc.",[],"['Bulgaria', 'Japan', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT05949580,Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis,Study to Evaluate the Usability of Introducing Integrated Digital Solutions Into Clinical Practice and the Value of Their Use in the Medical Care of Patients With Multiple Sclerosis (MS),RECRUITING,2024-10-21,2027-06-30,2028-03-31,OBSERVATIONAL,,500,['Relapsing Remitting Multiple Sclerosis'],Relapsing Remitting Multiple Sclerosis,Hoffmann-La Roche,['icometrix'],"['United States', 'Germany']"
NCT07204275,"A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)","A Phase 2b/3 Adaptive, Randomized, Active-controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy",RECRUITING,2025-09-30,2028-12-29,2028-12-29,INTERVENTIONAL,PHASE2,176,['Primary Membranous Nephropathy'],Primary Membranous Nephropathy,Vertex Pharmaceuticals Incorporated,[],['United States']
NCT02019706,"Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome","Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome",RECRUITING,2014-02-12,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE2,80,"['ACTH', ""Cushing's Syndrome""]",ACTH,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07272616,Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison,A Prospective Comparative Study of a Novel Gadolinium-Weighted MRI Sequence Versus Conventional T1-Weighted Imaging for the Detection of Brain Metastases,RECRUITING,2025-12-01,2026-12-31,2027-12-31,OBSERVATIONAL,,100,['Brain Neoplasms'],Brain Neoplasms,Region Stockholm,[],['Sweden']
NCT06707207,Predicting Future Errors During Skill Performance,Predicting Future Errors During Skill Performance,RECRUITING,2025-12-16,2029-04-01,2029-10-01,OBSERVATIONAL,,40,['Healthy'],Healthy,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07267598,Suitability of a 26 °C Indoor Environment for Mitigating Heat Strain in Young Adults,"Evaluating the Effectiveness of a 26 °C Indoor Temperature Limit to Mitigate Physiological Strain in Young, Habitually Active Adults",RECRUITING,2025-11-07,2026-03-30,2026-06-13,INTERVENTIONAL,NA,10,"['Heat Stress', 'Physiological Stress', 'Cognitive Change']",Heat Stress,University of Ottawa,[],['Canada']
NCT04752293,Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE),Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE): The Role of Angiotensin-(1-7) in Hypertension and Hypertension-Induced Heart and Kidney Damage,RECRUITING,2021-05-19,2026-12,2026-12,OBSERVATIONAL,,125,"['Hypertension', 'Left Ventricular Hypertrophy', 'Left Ventricular Dysfunction', 'Left Atrial Dilatation', 'Left Ventricular Diastolic Dysfunction', 'Kidney Diseases', 'Kidney Injury', 'Kidney Dysfunction', 'Sodium Urine High', 'Blood Pressure Disorders', 'Uric Acid Retention', 'Angiotensin Hypertension', 'Autonomic Dysfunction', 'Autonomic Imbalance', 'Pediatric Kidney Disease', 'Pediatric Obesity', 'Proteinuria', 'Albuminuria']",Hypertension,Wake Forest University Health Sciences,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07213674,A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer,"A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer",RECRUITING,2025-11-28,2028-08-29,2032-08-30,INTERVENTIONAL,PHASE3,750,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,Amgen,[],"['Singapore', 'Japan', 'Austria', 'United States', 'Switzerland', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Australia', 'Greece', 'Portugal', 'Germany']"
NCT06822790,Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia,A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia (SHASTA-10 Study),RECRUITING,2025-04-09,2028-07,2028-07,INTERVENTIONAL,PHASE3,869,['Hypertriglyceridemia'],Hypertriglyceridemia,Arrowhead Pharmaceuticals,[],"['United States', 'Canada']"
NCT07276659,The Contribution of Scenario Writing to Learning Stoma Care in Nursing Education: A Mixed-Methods Quasi-Experimental Intervention Study,The Contribution of Scenario Writing to Learning Stoma Care in Nursing Education: A Mixed-Methods Quasi-Experimental Intervention Study,RECRUITING,2025-10-27,2025-12-22,2025-12-22,INTERVENTIONAL,NA,60,['Stoma Care Education in Nursing Students'],Stoma Care Education in Nursing Students,hatice akaltun,[],['Turkey (Türkiye)']
NCT07278089,AF Screening in Patients With Abnormal Echocardiographic Parameters,"Screening of Atrial Fibrillation/Arrhythmia Events in Patients With Abnormal Echocardiographic Parameters: The Randomized, Prospective SAFE-ECHO Study Design and Rationale",RECRUITING,2025-03-17,2031-12-31,2032-12-31,INTERVENTIONAL,NA,3000,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),Tze-Fan Chao,[],['Taiwan']
NCT06170788,Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007),"A Randomized, Open-label, Phase 3 Study of MK-2870 in Combination With Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS Greater Than or Equal to 50% (TroFuse-007)",RECRUITING,2023-12-15,2028-01-25,2030-05-27,INTERVENTIONAL,PHASE3,614,['Non-small Cell Lung Cancer (NSCLC)'],Non-small Cell Lung Cancer (NSCLC),Merck Sharp & Dohme LLC,[],"['Japan', 'Netherlands', 'China', 'Australia', 'France', 'Chile', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Vietnam', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT05658562,A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL,A Phase I/II Open-Label Study of MT-2111 in Patients With Relapsed/Refractory DLBCL,ACTIVE_NOT_RECRUITING,2023-01-30,2025-12,2028-08,INTERVENTIONAL,PHASE1,46,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Tanabe Pharma Corporation,[],['Japan']
NCT05621291,A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...,A Pilot Trial to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following CAR T-cell Induced Remission in Pediatric Patients With B Lineage Acute Lymphoblastic Leukemia,RECRUITING,2025-12-16,2026-12-31,2027-12-31,INTERVENTIONAL,NA,60,"['B-All', 'Acute Lymphoblastic Leukemia']",B-All,National Cancer Institute (NCI),[],['United States']
NCT05567185,A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer,"A Phase 1 Study to Evaluate the Tolerability, Safety, and Pharmacokinetics of TAR-210 in Japanese Participants With Bladder Cancer and Selected FGFR Mutations or Fusions",ACTIVE_NOT_RECRUITING,2023-03-03,2026-10-16,2027-09-24,INTERVENTIONAL,PHASE1,5,"['Urinary Bladder Neoplasms', 'Receptors, Fibroblast Growth Factor']",Urinary Bladder Neoplasms,Janssen Pharmaceutical K.K.,[],['Japan']
NCT05458297,A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006),"A Multicenter, Open-label, Phase 2 Basket Study to Evaluate the Safety and Efficacy of MK-2140 as a Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (waveLINE-006)",RECRUITING,2022-07-21,2029-05-17,2029-05-17,INTERVENTIONAL,PHASE2,223,"['Chronic Lymphocytic Leukemia', 'Mantle Cell Lymphoma', 'Follicular Lymphoma', 'Richter Transformation Lymphoma']",Chronic Lymphocytic Leukemia,Merck Sharp & Dohme LLC,[],"['Japan', 'China', 'Israel', 'Estonia', 'Chile', 'Peru', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Spain', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy']"
NCT05330338,Genetics of Ventriculo-arterial Discordance,Genetics of Ventriculo-arterial Discordance: Towards a PRECIsion Medicine in PEDiatric Cardiology,ACTIVE_NOT_RECRUITING,2022-09-07,2025-06-24,2027-06-24,INTERVENTIONAL,NA,600,"['Heart Defects, Congenital']","Heart Defects, Congenital",Nantes University Hospital,"['Inserm UMR1087, CNRS UMR6291', 'Clinique des Données, CIC 1413, CHU Nantes', 'CIC-FEA, CIC 1413, CHU Nantes']",['France']
NCT07225491,Spine Oncology Registry,A Prospective Registry of Patients Undergoing Surgical Decompression Followed by Radiation Therapy for Spine Tumors,RECRUITING,2025-11-24,2035-12-31,2037-12-31,OBSERVATIONAL,,3000,"['Spine Tumor', 'Spine Metastases', 'Spine Cancer']",Spine Tumor,Ohio State University,"['Icotec Medical, Inc']",['United States']
NCT06940674,Adjunctive Cannabidiol for Recovery From Opioid Study,Adjunctive Cannabidiol for Recovery From Opioid Study (ACROS),RECRUITING,2025-06-13,2027-07-15,2027-08-15,INTERVENTIONAL,PHASE3,450,['Opioid Use Disorder (OUD)'],Opioid Use Disorder (OUD),Icahn School of Medicine at Mount Sinai,"['National Institute on Drug Abuse (NIDA)', 'International Center for Health Outcomes and Innovation Research', 'Brains Bioceutical']",['United States']
NCT07277608,Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea,Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea,RECRUITING,2023-08-07,2033-08-07,2033-08-07,OBSERVATIONAL,,500,['Obstructive Sleep Apnea'],Obstructive Sleep Apnea,Capital Medical University,[],['China']
NCT07092813,Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents,"A Phase 1, Multi-Center, Open-Label Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Sulopenem Etzadroxil + Probenecid in Adolescent Patients With Bacterial Infection",RECRUITING,2026-01,2026-07,2026-07,INTERVENTIONAL,PHASE1,12,['Pharmacokinetics After Oral Intake'],Pharmacokinetics After Oral Intake,"Iterum Therapeutics, International Limited",[],['United States']
NCT07275450,Comparative Study Between Ultrasound Guided Regional Anesthesia for Awake Tympanoplasty Surgery vs General Anesthesia,Safety and Efficacy of Regional Anesthesia for Awake Tympanoplasty Surgery: A Randomized Controlled Trial,RECRUITING,2025-12-10,2026-09-01,2026-10-01,INTERVENTIONAL,NA,128,"['Ultrasound Guided Nerve Block', 'Anesthesia , Analgesia']",Ultrasound Guided Nerve Block,Zagazig University,[],['Egypt']
NCT04086485,Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET),Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET),RECRUITING,2022-10-03,2027-07-01,2028-01-01,INTERVENTIONAL,PHASE1,56,"['Gastroenteropancreatico Tumors', 'Neuroendocrine Tumors', 'Neuroendocrine Neoplasms']",Gastroenteropancreatico Tumors,National Cancer Institute (NCI),[],['United States']
NCT03503331,UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy,UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy,RECRUITING,2018-04-20,2028-10,2028-10,INTERVENTIONAL,PHASE2,160,['Alzheimer Disease'],Alzheimer Disease,University of Alabama at Birmingham,['National Institute on Aging (NIA)'],['United States']
NCT07276386,Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma,Phase 2 Sequential Treatment With Melphalan/HDS Via Percutaneous Hepatic Perfusion Followed by Tebentafusp in the Treatment of Metastatic Uveal Melanoma,RECRUITING,2025-12,2030-12,2030-12,INTERVENTIONAL,PHASE2,18,['Metastatic Uveal Melanoma'],Metastatic Uveal Melanoma,H. Lee Moffitt Cancer Center and Research Institute,['Delcath Systems Inc.'],['United States']
NCT07262983,Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis,A Pilot Study to Evaluate the Safety and Tolerability of Baricitinib in Patients With Job s Syndrome With Lupus-like Disease and/or Atopic Dermatitis,RECRUITING,2025-12-16,2030-05-01,2030-10-01,INTERVENTIONAL,PHASE1,20,"['Hyper IgE Syndrome From STAT3 Mutation', 'Job s Syndrome', 'HIES', 'Lupus', 'Atopic Dermatitis']",Hyper IgE Syndrome From STAT3 Mutation,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT04165070,KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A),"KEYMAKER-U01 Substudy 01A: A Phase 1/2, Umbrella Study With Rolling Arms of Investigational Agents With Pembrolizumab With or Without Chemotherapy in Treatment-Naive Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",RECRUITING,2019-12-19,2032-02-13,2032-02-13,INTERVENTIONAL,PHASE1,450,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Hungary', 'United States', 'Spain', 'Italy', 'South Korea', 'Poland']"
NCT07276412,Study on the Effect of a Gamified Health Education Programme on Primary School Children,"Study on the Effect of a Health Education Programme Based on Gamification Strategies on Diet, Sedentary Behaviour and Daily Physical Activity in Primary School Children.",RECRUITING,2024-09-02,2026-07-24,2026-09-07,INTERVENTIONAL,NA,500,"['Gamification in Health Education', 'Health Education']",Gamification in Health Education,Universidad de Extremadura,['Diputación Provincial de Badajoz'],['Spain']
NCT07243639,Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis,"A Prospective Study on the Efficacy and Safety of a Novel Oral Drug, Etrasimod, in Elderly Patients With Ulcerative Colitis",RECRUITING,2025-10-01,2026-09-30,2026-09-30,INTERVENTIONAL,NA,30,['Ulcerative Colitis (Disorder)'],Ulcerative Colitis (Disorder),Showa Inan General Hospital,[],['Japan']
NCT06416696,Toripalimab for High-risk Locally Advanced Cervical Cancer,Toripalimab Combined With Chemoradiotherapy Followed by Toripalimab Maintenance Therapy for High-risk Locally Advanced Cervical Cancer: the Phase II Single-arm TorCH -CC Study,RECRUITING,2024-01-09,2026-05,2026-12,INTERVENTIONAL,PHASE2,130,['Cervical Cancers'],Cervical Cancers,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT07036523,A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment,"A Double-blind, Randomised, Placebo-controlled, Parallel Group, Phase IIa Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 765423 Administered Intravenously With or Without Standard of Care in Patients With Idiopathic Pulmonary Fibrosis",RECRUITING,2025-11-13,2027-04-28,2027-09-02,INTERVENTIONAL,PHASE2,71,['Idiopathic Pulmonary Fibrosis'],Idiopathic Pulmonary Fibrosis,Boehringer Ingelheim,[],"['Belgium', 'Japan', 'United States', 'Switzerland', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia', 'Germany']"
NCT04742621,Liver Transplantation for Unresectable Liver Limited Colorectal Metastases,Liver Transplantation for Unresectable Liver Limited Colorectal Metastases,RECRUITING,2020-09-30,2034-07-27,2035-07-27,OBSERVATIONAL,,20,['Unresectable Liver-limited Colorectal Metastases'],Unresectable Liver-limited Colorectal Metastases,Weill Medical College of Cornell University,[],['United States']
NCT06094816,Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study,Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study,RECRUITING,2024-03-05,2028-01,2028-07,INTERVENTIONAL,PHASE4,120,['Salt-Sensitivity of Blood Pressure'],Salt-Sensitivity of Blood Pressure,University of Delaware,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07189104,SAGA for Toddlers. Supporting Children's Linguistic and Socio-Emotional Development in Early Childhood Education and Care,SAGA for Toddlers. Supporting Children's Linguistic and Socio-Emotional Development in Early Childhood Education and Care,RECRUITING,2025-09-25,2027-04,2027-04,INTERVENTIONAL,NA,120,"['Social Emotional Competence', 'Language Development']",Social Emotional Competence,University of Helsinki,['Swedish Cultural Foundation in Finland'],['Finland']
NCT05525767,Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer,"Prospective, Multicenter, Single-arm Clinical Study of Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for Early or Locally Advanced HER2-negative Breast Cancer",RECRUITING,2022-03-31,2026-10-31,2028-12-31,INTERVENTIONAL,PHASE4,75,['Solid Tumor'],Solid Tumor,Hebei Medical University Fourth Hospital,[],['China']
NCT06848491,Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors,Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors (AYA Well),RECRUITING,2025-11-11,2027-10-31,2028-03-31,INTERVENTIONAL,NA,240,"['Obesity', 'Cancer', 'Physical Activity', 'Cancer Survivorship', 'Diet']",Obesity,UNC Lineberger Comprehensive Cancer Center,"['Virginia Commonwealth University', 'National Cancer Institute (NCI)']",['United States']
NCT06289582,Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging),Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging),RECRUITING,2024-08-14,2028-06,2028-06,INTERVENTIONAL,EARLY_PHASE1,60,['Parkinson Disease'],Parkinson Disease,University of Alabama at Birmingham,"[""Michael J. Fox Foundation for Parkinson's Research""]",['United States']
NCT07140874,Zinc as an Adjunctive Therapy for Cervical Dystonia,Evaluation of Supplemental Zinc as an Adjunct to Prolong the Duration of Benefit After Botulinum Toxin Injections in Subjects With Cervical Dystonia,RECRUITING,2025-09-17,2026-03-01,2026-06-01,INTERVENTIONAL,PHASE2,20,['Cervical Dystonia'],Cervical Dystonia,University of Florida,[],['United States']
NCT05605574,Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant,Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant,RECRUITING,2022-11-16,2026-12-31,2026-12-31,INTERVENTIONAL,NA,222,['Hematopoietic Stem Cell Transplantation'],Hematopoietic Stem Cell Transplantation,National Cancer Institute (NCI),[],['United States']
NCT04943913,Study of GC101 TIL in Brain Glioma (Soochow2),A Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) in Patients With Brain Glioma,RECRUITING,2021-05-06,2026-12-30,2027-05-31,INTERVENTIONAL,EARLY_PHASE1,50,['Glioma'],Glioma,Shanghai Juncell Therapeutics,['Second Affiliated Hospital of Soochow University'],['China']
NCT06312176,A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010),"An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer",RECRUITING,2024-04-14,2027-07-11,2031-04-12,INTERVENTIONAL,PHASE3,1200,['Breast Neoplasms'],Breast Neoplasms,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'India', 'Singapore', 'Costa Rica', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina', 'Philippines']"
NCT06819176,Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy,Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People Living With HIV Receiving Antiretroviral Therapy,RECRUITING,2025-12-16,2028-09-01,2029-01-24,INTERVENTIONAL,PHASE1,50,['Human Immunodeficiency Virus'],Human Immunodeficiency Virus,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT04087655,Microvascular Dysfunction in Obesity,NADPH Oxidase Activity and Muscle Microvascular Dysfunction in Obesity,RECRUITING,2019-11-20,2026-11-19,2027-05-31,INTERVENTIONAL,NA,25,"['Obesity', 'Endothelial Dysfunction']",Obesity,Florida State University,[],['United States']
NCT06370182,Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter,"A Prospective, Randomized, Dual-arm Multi-center Study to Assess the Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter in Combination With a Stent Retriever",RECRUITING,2024-09-09,2027-08,2027-12,INTERVENTIONAL,NA,327,['Acute Ischemic Stroke From Large Vessel Occlusion'],Acute Ischemic Stroke From Large Vessel Occlusion,Anaconda Biomed S.L.,[],"['Hungary', 'Turkey (Türkiye)', 'United States', 'France', 'Spain']"
NCT05091424,"A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia","A Phase IB Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia",RECRUITING,2022-03-07,2028-05-31,2030-02-28,INTERVENTIONAL,PHASE1,137,['Chronic Lymphocytic Leukemia'],Chronic Lymphocytic Leukemia,Hoffmann-La Roche,[],"['China', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT07276425,Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis,Early and Long-term Clinical Efficacy and Local Tissue and Peripheral Immune Changes Following Dupilumab Treatment in Prurigo Nodularis Patients,RECRUITING,2025-06-01,2028-06-01,2028-06-01,OBSERVATIONAL,,40,['Prurigo Nodularis (PN)'],Prurigo Nodularis (PN),UMC Utrecht,['Sanofi'],['Netherlands']
NCT05616026,Texts for Diabetes Control Among Homeless Persons,Short-messaging Services (SMS) Text for Uncontrolled Diabetes Among Persons Experiencing Homelessness,RECRUITING,2023-02-07,2026-11-15,2026-11-15,INTERVENTIONAL,NA,100,['Diabetes Mellitus'],Diabetes Mellitus,George Washington University,['NYU Langone Health'],['United States']
NCT06691932,At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN),At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN),RECRUITING,2024-11-12,2029-11-01,2029-11-01,OBSERVATIONAL,,240,"['Breast Feeding', 'Exclusive Breastfeeding']",Breast Feeding,University of Rochester,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT06259669,"Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population","A US-Prospective, Registry-Based, Observational, Exposure Cohort Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population",RECRUITING,2023-09-13,2032-08-01,2033-08-01,OBSERVATIONAL,,958,"['Pregnancy Related', 'Atopic Dermatitis']",Pregnancy Related,Incyte Corporation,[],['United States']
NCT06784323,Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC),A Culturally Tailored Anti-inflammatory Diet for American Patients With Ulcerative Colitis,RECRUITING,2025-03-05,2030-09-01,2030-09-01,INTERVENTIONAL,NA,122,['Ulcerative Colitis'],Ulcerative Colitis,University of Miami,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06528041,Impact of Native Chicory Inulin on Change and Persistence of Gut Microbiota,Effect of Native Chicory Inulin Supplementation on Rates of Microbial Change Between Individuals,RECRUITING,2024-08-01,2026-07-28,2026-07-30,INTERVENTIONAL,NA,52,['Healthy'],Healthy,Purdue University,[],['United States']
NCT06877598,Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners,Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners,RECRUITING,2025-06-01,2026-12,2027-12,OBSERVATIONAL,,575,"['Prostate Cancer', 'Sexual Dysfunction, Physiological', 'Sexual Dysfunction, Psychological', 'Sexual Dysfunction', 'Virtual Care', 'Virtual Clinic', 'Survivorship', 'Implementation of Evidence Based Programs', 'Implementation']",Prostate Cancer,"University Health Network, Toronto",[],['Canada']
NCT06790693,"A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer","A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer",RECRUITING,2025-04-09,2032-05-30,2032-05-30,INTERVENTIONAL,PHASE3,450,['Breast Cancer'],Breast Cancer,Hoffmann-La Roche,[],"['Brazil', 'South Africa', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Mexico', 'Puerto Rico', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT04898634,"A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer","A Phase 1 Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer",RECRUITING,2021-07-13,2026-02-13,2027-02-10,INTERVENTIONAL,PHASE1,216,['Prostatic Neoplasms'],Prostatic Neoplasms,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'United States', 'France', 'Spain']"
NCT05522660,Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer,"A Multicentre Randomised Open-label Phase III Study of Stereotactic Radiosurgery, in Addition to Standard Systemic Therapy for Patients With Metastatic Melanoma or Newly Diagnosed Metastatic NSCLC and Asymptomatic or Oligo-symptomatic Brain Metastases",RECRUITING,2022-11-30,2026-01,2026-12,INTERVENTIONAL,PHASE3,180,"['Non-Small Cell Lung Cancer', 'Melanoma']",Non-Small Cell Lung Cancer,ETOP IBCSG Partners Foundation,['USZ Foundation'],"['Netherlands', 'Switzerland', 'Spain', 'Italy', 'United Kingdom']"
NCT07278154,Proprioceptive Neuromuscular Facilitation Versus Music Therapy in Ataxic Cerebral Palsy,Proprioceptive Neuromuscular Facilitation Versus Music Therapy in Ataxic Cerebral Palsy,ACTIVE_NOT_RECRUITING,2025-09-25,2026-02-25,2026-03-20,INTERVENTIONAL,NA,29,['Cerebral Palsy (CP)'],Cerebral Palsy (CP),University of Lahore,[],['Pakistan']
NCT06283966,"A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease","A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)",RECRUITING,2024-02-21,2028-03-07,2028-03-07,INTERVENTIONAL,PHASE3,5000,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),AstraZeneca,[],"['Bulgaria', 'Japan', 'China', 'Slovakia', 'Serbia', 'Australia', 'Hungary', 'France', 'Chile', 'Finland', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT03755791,Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy,"A Randomized, Controlled Phase 3 Study of Cabozantinib (XL184) in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma Who Have Not Received Previous Systemic Anticancer Therapy",ACTIVE_NOT_RECRUITING,2018-06-10,2021-11-30,2026-07-31,INTERVENTIONAL,PHASE3,837,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,Exelixis,[],"['New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Singapore', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Philippines']"
NCT06732583,A Study to Evaluate the Safety and Immunogenicity of Ad5-105K in Adults Aged 18 to 49 Years,"A Phase I Randomized, Double-blind, Placebo-controlled and Dose Escalation Study to Evaluate the Safety and Immunogenicity of a Viral Vector-based Tuberculosis (TB) Vaccine Ad5-105K Against TB Disease in Adults Aged 18 to 49 Years",RECRUITING,2025-11-13,2026-08,2026-08,INTERVENTIONAL,PHASE1,36,['Tuberculosis'],Tuberculosis,CanSino Biologics Inc.,['PT Etana Biotechnologies Indonesia'],['Indonesia']
NCT05595642,A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease,"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease",RECRUITING,2022-12-29,2025-06-24,2027-03-11,INTERVENTIONAL,PHASE3,1290,['Chronic Obstructive Pulmonary Disease (COPD)'],Chronic Obstructive Pulmonary Disease (COPD),Hoffmann-La Roche,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Kenya', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'South Africa', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Latvia', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT05695196,Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant,Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant to Promote Colonization Resistance to Staphylococcus Aureus,ACTIVE_NOT_RECRUITING,2023-10-25,2025-05-06,2026-12-01,INTERVENTIONAL,PHASE1,34,"['Staphylococcus Aureus', 'Microbial Colonization', 'Neonatal Infection']",Staphylococcus Aureus,Johns Hopkins University,['National Institute of Allergy and Infectious Diseases (NIAID)'],['United States']
NCT06876142,Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma,A Phase 1b/2 Study of Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma (RRMM),RECRUITING,2025-12-16,2033-01-01,2033-01-01,INTERVENTIONAL,PHASE1,54,"['Multiple Myeloma', 'Relapsed and/or Refractory Multiple Myeloma (RRMM)']",Multiple Myeloma,National Cancer Institute (NCI),[],['United States']
NCT05325151,Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer,A Randomized Controlled Trial Comparing a Genetic Counseling Patient Preference Intervention vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer,ACTIVE_NOT_RECRUITING,2022-06-13,2026-03-30,2026-03-30,INTERVENTIONAL,NA,874,['Breast Carcinoma'],Breast Carcinoma,Ohio State University Comprehensive Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT07276867,Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity,"Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity: A Randomized, Comparative Study",RECRUITING,2025-10-20,2026-04-01,2026-04-01,INTERVENTIONAL,NA,58,"['Intrathecal', 'Dexmedetomidine', 'Fentanyl', 'Bupivacaine', 'Spinal Anesthesia', 'Above Knee Amputation', 'Sarcomas', 'Lower Extremity']",Intrathecal,"National Cancer Institute, Egypt",[],['Egypt']
NCT07277764,Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II),"Induction Therapy With High-Low Dose Radiotherapy Combined With Anti-PD-1 Monoclonal Antibody Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma: A Single-Arm, Single-Center Phase II Trial",RECRUITING,2025-10-10,2027-12-31,2029-12-31,INTERVENTIONAL,PHASE2,23,"['Nasopharyngeal Carcinoma (NPC)', 'Recurrent Nasopharyngeal Neoplasms']",Nasopharyngeal Carcinoma (NPC),Jiangxi Provincial Cancer Hospital,[],['China']
NCT06487481,Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma,A Phase I Dose-escalation Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma,RECRUITING,2025-12-16,2030-12-01,2040-12-01,INTERVENTIONAL,PHASE1,32,"['Adrenocortical Carcinoma (ACC)', 'Recurrent Adrenocortical Carcinoma (ACC)', 'Recurrent Abdominal Adrenocortical Carcinoma (ACC)', 'Carcinoma, Adrenocortical', 'Carcinoma, Adrenal Cortical']",Adrenocortical Carcinoma (ACC),National Cancer Institute (NCI),[],['United States']
NCT06643819,Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A,"A Randomized, Double-blind, Active-controlled, Multi-center, Therapeutic Confirmatory, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A",RECRUITING,2024-10-14,2026-03-31,2026-12-31,INTERVENTIONAL,PHASE3,324,['Essential Hypertension'],Essential Hypertension,Chong Kun Dang Pharmaceutical,[],['South Korea']
NCT06508164,International CRDS Registry,International Calcium Release Deficiency Syndrome Registry,RECRUITING,2024-11-21,2050-12-31,2050-12-31,OBSERVATIONAL,,500,['Calcium Release Deficiency Syndrome'],Calcium Release Deficiency Syndrome,Population Health Research Institute,['Canadian Institutes of Health Research (CIHR)'],"['Belgium', 'Israel', 'United States', 'France', 'Denmark', 'Canada', 'Australia']"
NCT06814145,Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023),"A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)",RECRUITING,2025-04-16,2029-03-30,2029-03-30,INTERVENTIONAL,PHASE2,130,"['Hypertension, Pulmonary']","Hypertension, Pulmonary",Merck Sharp & Dohme LLC,[],"['Belgium', 'Israel', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT06449222,"Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy","A Phase II, Multi-site, Randomized, Open-label Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT327 at Two Dose Levels in Combination With Chemotherapeutic Agents as First- and Second-line Treatment in Triple-negative Breast Cancer",RECRUITING,2024-08-26,2028-08,2029-06,INTERVENTIONAL,PHASE2,100,"['Locally Advanced Breast Cancer', 'Triple Negative Breast Cancer', 'Metastatic Triple Negative Breast Cancers']",Locally Advanced Breast Cancer,BioNTech SE,[],"['United Kingdom', 'United States', 'Turkey (Türkiye)', 'Australia']"
NCT07277166,The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function After Burn Injury,The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function After Burn Injury : Pilot Study,RECRUITING,2025-05-13,2026-11-15,2026-12-15,INTERVENTIONAL,NA,20,"['Burns', 'Gait Dysfunction', 'Robot Training']",Burns,Hangang Sacred Heart Hospital,[],['South Korea']
NCT05653466,Adaptive Trial Scheduling in Naming Treatment for Aphasia,Integrating Complementary Learning Principles in Aphasia Rehabilitation Via Adaptive Modeling (Sub-study 2: Adaptive Trial Scheduling),RECRUITING,2023-12-06,2027-01-31,2028-01-31,INTERVENTIONAL,PHASE2,32,"['Aphasia', 'Stroke']",Aphasia,University of Pittsburgh,"['University of Massachusetts, Amherst', 'National Institute on Deafness and Other Communication Disorders (NIDCD)']",['United States']
NCT07120659,Vacuum Massage vs Tactile Massage for the Treatment of Chronic Neck Pain,Vacuum Massage vs Tactile Massage for the Treatment of Chronic Neck Pain: A Randomized Controlled Pilot Study Investigating Pain Mechanisms.,RECRUITING,2025-10-27,2027-12-31,2030-12-31,INTERVENTIONAL,NA,60,['Chronic Neck Pain'],Chronic Neck Pain,University of Tromso,[],['Norway']
NCT07088263,Adaptive Chemotherapy for the Treatment of Advanced Breast Cancer,"A Prospective, Multicenter Phase Ⅲ Clinical Trial of Adaptive Chemotherapy for Advanced Breast Cancer After Standard Treatment",RECRUITING,2025-09-15,2027-07-24,2028-06-24,INTERVENTIONAL,PHASE3,192,['Breast Neoplasms'],Breast Neoplasms,Sun Yat-sen University,[],['China']
NCT07033494,A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004),"A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants With Early Alzheimer's Disease",RECRUITING,2025-07-16,2029-04-30,2029-04-30,INTERVENTIONAL,PHASE2,340,"[""Early Alzheimer's Disease""]",Early Alzheimer's Disease,Merck Sharp & Dohme LLC,[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'Spain', 'South Korea', 'United Kingdom', 'Argentina', 'Australia']"
NCT04929223,A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC),"A Phase I/Ib Global, Multicenter, Open-label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)",RECRUITING,2021-10-22,2027-08-09,2028-11-07,INTERVENTIONAL,PHASE1,542,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,Hoffmann-La Roche,[],"['United States', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT06744283,Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia,The Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia: an Ethnographic Study,RECRUITING,2025-12-16,2026-01-30,2026-01-30,OBSERVATIONAL,,20,['Fanconi Anemia'],Fanconi Anemia,National Cancer Institute (NCI),[],['United States']
NCT06811129,Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia,Long-Term Neurologic and Neurocognitive Sequelae Following Pediatric Ebola Virus in Liberia,RECRUITING,2025-12-16,2026-11-01,2026-11-01,OBSERVATIONAL,,410,"['Ebola', 'Post-Acute Ebola Syndrome']",Ebola,National Institute of Neurological Disorders and Stroke (NINDS),[],['Liberia']
NCT06011954,A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection,Use-result Surveillance for PADCEV Injection 20 mg and 30 mg (Enfortumab Vedotin) in South Korea,RECRUITING,2023-11-01,2027-07-31,2027-07-31,OBSERVATIONAL,,202,['Urothelial Cancer'],Urothelial Cancer,"Astellas Pharma Korea, Inc.",['Seagen Inc.'],['South Korea']
NCT05836987,The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation,REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation,RECRUITING,2023-07-13,2029-07-31,2029-07-31,INTERVENTIONAL,PHASE3,5350,['Atrial Fibrillation'],Atrial Fibrillation,Johns Hopkins University,"['National Heart, Lung, and Blood Institute (NHLBI)', 'Northwestern University']",['United States']
NCT06549374,Kinetics of INF-γ Production in Intensive Care Patients,Kinetics of INF-γ Production in Intensive Care Patients-Monitoring of INF-γ in Intensive Care,RECRUITING,2025-04-24,2026-04-24,2026-05-24,OBSERVATIONAL,,200,['Intensive Care'],Intensive Care,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06121297,RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus,"A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus",RECRUITING,2024-02-16,2029-12,2029-12,INTERVENTIONAL,PHASE1,28,"['Systemic Lupus Erythematosus', 'Lupus Nephritis']",Systemic Lupus Erythematosus,Cabaletta Bio,[],"['Spain', 'United States', 'Canada']"
NCT06774287,Evaluation of the Karman Line Memory Strategy Training,"Evaluation of the Karman Line Memory Strategy Training, a Combined Computerized and Face-to-face Compensatory Treatment Targeting Memory Complaints After Acquired Brain Injury, Using Single-case Experimental Design Methodology",RECRUITING,2025-01-21,2026-04-15,2026-05-15,INTERVENTIONAL,NA,6,['Acquired Brain Injury (Including Stroke)'],Acquired Brain Injury (Including Stroke),Klimmendaal Revalidatiespecialisten,[],['Netherlands']
NCT07276464,Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Health.,Characterization of the Gut Microbiota Metagenomic Signature According to Physical Fitness and Its Implications for Intestinal Health.,RECRUITING,2025-11-17,2026-04-01,2026-04-15,OBSERVATIONAL,,30,['Healthy'],Healthy,University of Rennes 2,[],['France']
NCT06142747,Tracking of Red Blood Cells Using Super Resolution Ultrasound in Persons With Healthy or Overuse Injured Tendons,SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Tendinopathic Tendons,RECRUITING,2024-02-08,2026-01,2026-01,OBSERVATIONAL,,135,['Tendinopathy'],Tendinopathy,University Hospital Bispebjerg and Frederiksberg,['Technical University of Denmark'],['Denmark']
NCT07219641,Radicle Clarity RPN: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes.,"Radicle Clarity RPN: A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes.",ACTIVE_NOT_RECRUITING,2025-11-05,2027-01-11,2027-01-11,INTERVENTIONAL,NA,750,['Cognitive Function'],Cognitive Function,Radicle Science,[],['United States']
NCT06947824,Time-of-Day Effects of Fasted Exercise on Energy Intake,Effects of Fasted Morning vs. Evening Exercise on Post-Exercise Energy Intake,RECRUITING,2025-04-01,2025-11-30,2025-12-31,INTERVENTIONAL,NA,35,"['Health', 'Energy Intake', 'Eating Behaviors', 'Appetite']",Health,Technical University of Munich,[],['Germany']
NCT06686654,Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older,"A Phase 1/2, Randomized, Observer-blind, Placebo-controlled Multi-arm Study to Evaluate the Safety and Immunogenicity of an hMPV/RSV mRNA Vaccine Candidate in Adult Participants Aged 60 Years and Older",ACTIVE_NOT_RECRUITING,2024-11-11,2027-01-18,2027-01-18,INTERVENTIONAL,PHASE1,1530,"['Human Metapneumovirus Immunization', 'Respiratory Syncytial Virus Immunization']",Human Metapneumovirus Immunization,"Sanofi Pasteur, a Sanofi Company",[],['United States']
NCT04958239,A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer,"An Open Label, Phase I Dose-finding and Expansion Study of BI 765179 as Monotherapy and in Combination With Ezabenlimab (BI 754091) in Patients With Advanced Solid Cancers, and BI 765179 in Combination With Pembrolizumab in First-line PD-L1-positive Metastatic or Incurable, Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)",RECRUITING,2021-10-18,2026-06-30,2028-05-23,INTERVENTIONAL,PHASE1,160,['Neoplasms'],Neoplasms,Boehringer Ingelheim,[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Germany', 'Mexico', 'Spain', 'Italy', 'South Korea', 'Czechia', 'Australia']"
NCT06728436,Testing the Effects of a Text Message Caregiver Support Intervention for Latinos,Testing the Effects of a Text Message Caregiver Support Intervention for Latinos,RECRUITING,2025-02-17,2029-05,2029-05,INTERVENTIONAL,NA,288,['Alzheimer Disease'],Alzheimer Disease,University of Kansas Medical Center,"['National Institute on Aging (NIA)', 'University of Puerto Rico', 'Icahn School of Medicine at Mount Sinai', 'University of Miami']",['United States']
NCT07254429,COMPASS - COpenhagen MenoPAuSe Study,Copenhagen Menopause Study (COMPASS): A Randomized Clinical Trial,RECRUITING,2025-10-02,2027-12,2028-05,INTERVENTIONAL,PHASE2,192,"['Menopausal Osteoporosis', 'Bone Markers']",Menopausal Osteoporosis,Martin Blomberg Jensen,[],['Denmark']
NCT04875429,Zenith® Fenestrated+ Clinical Study,Zenith® Fenestrated+ Endovascular Graft Clinical Study,ACTIVE_NOT_RECRUITING,2023-12-08,2026-08,2031-08,INTERVENTIONAL,NA,105,"['Aortic Aneurysm, Abdominal', 'Juxtarenal Aortic Aneurysm', 'Extent IV Thoracoabdominal', 'Pararenal Aneurysm']","Aortic Aneurysm, Abdominal",Cook Research Incorporated,[],"['United Kingdom', 'United States']"
NCT07229664,Vinpocetine in Patients With Parkinsonian Disease,Clinical Study to Evaluate Safety and Effectiveness of Vinpocetine in Patients With Parkinsonian Disease,RECRUITING,2025-11-10,2026-11-20,2027-11-20,INTERVENTIONAL,PHASE2,60,['Parkinson Disease'],Parkinson Disease,Tanta University,[],['Egypt']
NCT07274371,Effect of Brahmi-Gotukola Oil Foot Massage (Padabhyanga) on Sleep and Mood in Perimenopausal Women,"Effects of Brahmi-Gotu Kola Oil Padabhyanga (Foot Massage) on Sleep and Mood Disturbances in Perimenopausal Women: a Pragmatic, Single-blind, Pilot Randomized Controlled Comparative Trial",RECRUITING,2025-11-06,2026-03-30,2026-04-30,INTERVENTIONAL,NA,30,['Sleep Disturbances in Perimenopause'],Sleep Disturbances in Perimenopause,Saipriya Gowrishankar,['Maharishi International University'],['United States']
NCT07069738,Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure,Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure,RECRUITING,2025-10-22,2029-11,2029-11,INTERVENTIONAL,NA,850,['Heart Failure - NYHA II - IV'],Heart Failure - NYHA II - IV,Boston Scientific Corporation,[],['United States']
NCT02793999,Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia,Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia,RECRUITING,2015-05,2027-05,2028-05,OBSERVATIONAL,,125,"['Hypoxic Ischemic Brain Injury', 'Neonatal Encephalopathy']",Hypoxic Ischemic Brain Injury,Boston Children's Hospital,"[""Brigham and Women's Hospital"", 'Beth Israel Deaconess Medical Center', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT07176494,Revision of Deep Brain Stimulator in Patients With Parkinson's Disease,Revision of Deep Brain Stimulator in Patients With Parkinson's Disease: A Comparison of Perioperative Characteristics of Regional and General Anesthesia,RECRUITING,2025-09-20,2026-07-05,2026-07-20,INTERVENTIONAL,NA,50,"['Pain Management', 'Regional Anesthesia', 'Deep Brain Stimulation', 'Parkinsons Disease']",Pain Management,Ankara Etlik City Hospital,[],['Turkey (Türkiye)']
NCT07127302,Correlation of Ultrasonographic Findings With Clinical Parameters in Patients With Lateral Epicondylitis,"Evaluation and Clinical Correlation of Tendons With Power Doppler, SWE, Microvascular Flow (MV-Flow) Imaging and B-Mode Ultrasonography in Patients With Lateral Epicondylitis",RECRUITING,2025-09-30,2025-12-03,2025-12-25,OBSERVATIONAL,,50,"['Lateral Epicondylitis', 'Elastography', 'Ultrasonographic Diagnosis', 'Tennis Elbow']",Lateral Epicondylitis,Ahmet Yesildag,[],['Turkey (Türkiye)']
NCT06245356,Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer,TRIFLUOX-DP: Safety of Trifluridine/Tipiracil as Replacement of Fluoropyrimidines (5-fluorouracil and Capecitabine) Based Chemotherapy as First Line Metastatic Colorectal or Gastroesophageal Cancer Regimens in Patients With Dihydropyrimidine Dehydrogenase Deficiency: a Phase II Trial,RECRUITING,2025-03-21,2026-10-22,2028-10-21,INTERVENTIONAL,PHASE2,73,"['Metastatic Colorectal Cancer', 'Metastatic Gastroesophageal Adenocarcinoma', 'DPD Deficiency']",Metastatic Colorectal Cancer,UNICANCER,['Servier'],['France']
NCT06085209,Cryospray Therapy for Benign Airway Stenosis,Cryospray Therapy for Benign Airway Stenosis: a Pilot Study (Pilot-CRYOSTASIS),RECRUITING,2023-10-12,2026-12-30,2026-12-30,INTERVENTIONAL,PHASE1,12,['Stenosis Trachea'],Stenosis Trachea,Virginia Commonwealth University,['US Endoscopy Group Inc.'],['United States']
NCT06579443,"Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study","Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study",RECRUITING,2024-07-12,2026-05,2026-06,OBSERVATIONAL,,100,"['Inflammatory Bowel Diseases', 'Crohn Disease', 'Ulcerative Colitis']",Inflammatory Bowel Diseases,University Hospitals Coventry and Warwickshire NHS Trust,[],['United Kingdom']
NCT06581432,Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations,"Beamion PANTUMOR-1: A Phase II, Multicentre, Multicohort, Open-label Trial to Evaluate the Efficacy and Safety of Oral Zongertinib (BI 1810631) for the Treatment of Selected HER2-mutated or Overexpressed/Amplified Solid Tumours",RECRUITING,2024-10-11,2027-12-31,2028-12-29,INTERVENTIONAL,PHASE2,430,['Solid Tumours'],Solid Tumours,Boehringer Ingelheim,[],"['Belgium', 'Japan', 'Netherlands', 'Norway', 'China', 'United States', 'France', 'Germany', 'Puerto Rico', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia']"
NCT06929091,"Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)","Ready, Set, Nourish Study",RECRUITING,2025-11-07,2028-10-01,2029-12-01,INTERVENTIONAL,NA,240,"['Breastfeeding', 'Dietary Intervention', 'Milk Expression, Breast']",Breastfeeding,Arkansas Children's Hospital Research Institute,[],['United States']
NCT05547633,Detection and Management of Sinusitis in a Single-center Prospective Cohort of Patients With Exudative AMD (SINE),Detection and Management of Sinusitis in a Single-center Prospective Cohort of Patients With Exudative AMD (SINE),RECRUITING,2023-01-20,2027-01,2028-04,OBSERVATIONAL,,200,['AMD'],AMD,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT07274514,Virtual Reality on Balance of Parkinson's Disease,Effects of Immersive Virtual Reality on Balance of Parkinson's Disease,RECRUITING,2025-02-05,2026-02,2026-05,INTERVENTIONAL,NA,50,"['Parkinson Disease (PD)', 'Immersive Virtual Reality', 'Physical Therapy']",Parkinson Disease (PD),Instituto de Investigación Sanitaria Aragón,"['Universidad San Jorge', 'Universidad de Zaragoza']",['Spain']
NCT07257640,IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia,The Safety and Efficay Investigation of IL-5 CAR-T Cell Therapy for Patients With Refractory/Relapsed Eosinophilic Leukemia,RECRUITING,2025-11-30,2028-11-30,2028-11-30,INTERVENTIONAL,PHASE1,20,"['Hematologic Diseases', 'Neoplasms']",Hematologic Diseases,Zhejiang University,[],['China']
NCT06696313,Radiographic Migration Analysis of the Insignia Hip Stem,Radiographic Migration Analysis of the Insignia Hip Stem,ACTIVE_NOT_RECRUITING,2025-01-15,2027-04,2027-12,INTERVENTIONAL,NA,25,"['Hip Implant', 'Hip Replacement in Osteoarthritis Patients', 'Migration of Implant']",Hip Implant,Canadian Radiostereometric Analysis Network,['Orthopaedic Innovation Centre'],['Canada']
NCT05559580,A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms,"A Phase II, Randomised, Placebo-controlled, Double-blind, Parallel Group, Efficacy and Safety Study of at Least 48 Weeks of Oral BI 685509 Treatment in Adults With Progressive Systemic Sclerosis",ACTIVE_NOT_RECRUITING,2022-12-13,2025-10-22,2026-02-27,INTERVENTIONAL,PHASE2,214,"['Scleroderma, Systemic']","Scleroderma, Systemic",Boehringer Ingelheim,[],"['Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Finland', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07274462,DARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation),A Randomized Controlled Study of Daratumumab for Microvascular Inflammation (MVI) in Kidney Transplant Recipients With or Without Donor-Specific Antibodies,ACTIVE_NOT_RECRUITING,2025-11-01,2027-03-01,2027-09-30,INTERVENTIONAL,PHASE4,20,['Microvascular Inflammation - MVI in Kindey Transplant Recipients'],Microvascular Inflammation - MVI in Kindey Transplant Recipients,"University Hospital, Martin",[],['Slovakia']
NCT07275879,Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent,Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent. Randomized Clinical Trial.,RECRUITING,2025-12-28,2026-04-01,2026-04,INTERVENTIONAL,NA,40,"['Ureteral Double-J Stent', 'Urolithiasis', 'Quality of Life']",Ureteral Double-J Stent,"St. Luke's Clinical Hospital, Russia",[],['Russia']
NCT02693990,A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas,A Phase I Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas,ACTIVE_NOT_RECRUITING,2016-02,2027-08,2027-08,INTERVENTIONAL,NA,21,"['Meningioma', 'Brain Tumor']",Meningioma,Massachusetts General Hospital,['National Cancer Institute (NCI)'],['United States']
NCT04431024,"Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome","Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome",RECRUITING,2021-03-30,2038-06-30,2038-06-30,OBSERVATIONAL,,800,"['Familial Cancer', 'BRCA1-Associated Protein-1 (BAP1) Mutations', 'Tumor Predisposition Syndrome (TPDS)', 'Mesothelioma']",Familial Cancer,National Cancer Institute (NCI),[],['United States']
NCT07272525,Research Study for Single-Patient Treatment of Cree Leukoencephalopathy/Vanishing White Matter Disease,Research Study for Single-Patient Treatment of Cree Leukoencephalopathy/Vanishing White Matter Disease,ACTIVE_NOT_RECRUITING,2024-11-14,2027-11-30,2027-12-31,INTERVENTIONAL,EARLY_PHASE1,1,"['Cree Leukoencephalopathy', 'Vanishing White Matter']",Cree Leukoencephalopathy,Genevieve Bernard,[],['Canada']
NCT07050589,Group Recreation to Enhance Function Aging,A Community-Based Recreation Program to Improve Function and Quality of Life in Older Adults,RECRUITING,2025-09-15,2025-12-11,2026-01-15,INTERVENTIONAL,NA,80,"['Physical Functioning', 'Cognitive Functioning']",Physical Functioning,State University of New York at Buffalo,[],['United States']
NCT07083635,Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users,"Transdermal Ethinyl Estradiol and Norelgestromin for Treating Irregular Vaginal Bleeding in Contraceptive Implant Users: A Randomized, Double-Blind, Controlled Trial",RECRUITING,2025-07-29,2026-09,2026-12,INTERVENTIONAL,PHASE2,40,"['Menstruation Disturbances', 'Metrorrhagia', 'Uterine Hemorrhage', 'Contraception Behavior']",Menstruation Disturbances,Chulalongkorn University,[],['Thailand']
NCT06181435,A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2),"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallelgroup, 3-arm, Multinational, Multicenter Study to Evaluate the Efficacy and Safety of Amlitelimab Monotherapy by Subcutaneous Injection in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis",ACTIVE_NOT_RECRUITING,2023-12-21,2025-11-25,2026-03-18,INTERVENTIONAL,PHASE3,589,['Dermatitis Atopic'],Dermatitis Atopic,Sanofi,[],"['Bulgaria', 'Japan', 'South Africa', 'Turkey (Türkiye)', 'China', 'United States', 'Mexico', 'Chile', 'Denmark', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Portugal', 'Argentina', 'Sweden']"
NCT06697756,Resistance Training for the Improvement of Glycemic Control in Prediabetes,The Effect of Manipulating the Perception of Effort During Resistance Exercise Training on Glycemic Control and Psychological Responses in Individuals Living With Prediabetes: a Randomized-controlled Trial,ACTIVE_NOT_RECRUITING,2024-11-19,2027-12-31,2028-02-28,INTERVENTIONAL,NA,48,"['Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)']","Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)",University of New Mexico,[],['United States']
NCT07276074,Evaluation of the Relevance of Antithrombin Prescriptions at Strasbourg University Hospitals,Evaluation of the Relevance of Antithrombin Prescriptions at Strasbourg University Hospitals,RECRUITING,2024-12-18,2025-12-31,2025-12-31,OBSERVATIONAL,,160,['Antithrombinemia'],Antithrombinemia,"University Hospital, Strasbourg, France",[],['France']
NCT07275190,The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome,The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome,RECRUITING,2025-06-01,2026-09,2026-12,INTERVENTIONAL,NA,60,"['EGPA - Eosinophilic Granulomatosis With Polyangiitis', 'HES - Hypereosinophilic Syndrome']",EGPA - Eosinophilic Granulomatosis With Polyangiitis,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT04841447,Membrane Target Detection for Leukemia Treatment,Tumor Cell and DNA Detection in the Peripheral Blood of Patients With Hematological Malignancy,RECRUITING,2020-03-20,2027-03-20,2027-03-20,OBSERVATIONAL,,50,['Hematological Malignancy'],Hematological Malignancy,University of Missouri-Columbia,[],['United States']
NCT07275060,Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart,Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks Apart - A Multi-Center Non-Inferiority Placebo-Controlled Observer-Blinded Phase 2 Randomized Controlled Trial,RECRUITING,2025-10-14,2027-02-28,2027-09-30,INTERVENTIONAL,PHASE4,312,"['H5N1 Influenza', 'H5N1 Virus', 'Avian Influenza', 'Avian Influenza A Virus']",H5N1 Influenza,Canadian Immunization Research Network,"['Dalhousie University', 'IWK Health Centre', 'Public Health Agency of Canada (PHAC)', 'Canadian Center for Vaccinology', 'CHU de Quebec-Universite Laval', 'Vaccine Evaluation Center, Canada', 'McGill University Health Centre/Research Institute of the McGill University Health Centre']",['Canada']
NCT06456307,Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics,Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics,RECRUITING,2025-02-17,2028-03,2028-03,INTERVENTIONAL,NA,2970,"['Depression, Anxiety', 'Antenatal Depression', 'Postnatal Depression']","Depression, Anxiety",Kenyatta National Hospital,['National Institute of Mental Health (NIMH)'],['Kenya']
NCT02583646,Investigating the Impact of Obesity on Pubertal Development in Girls,Investigating the Impact of Obesity on Pubertal Development in Girls,RECRUITING,2015-12-15,2026-09-30,2026-09-30,OBSERVATIONAL,,150,"['Obesity', 'Puberty', 'Normal Physiology']",Obesity,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT07258693,Multimodal Treatment of Knee Osteoarthritis: Therapeutic Exercise and Noninvasive Neuromodulation (NESA) Versus Therapeutic Exercise and Transcutaneous Electrical Nerve Stimulation (TENS) in People Over 60 Years of Age.,"Multimodal Treatment of Knee Osteoarthritis: Comparison of the Combination of Therapeutic Exercise and Noninvasive Neuromodulation (NESA) Versus Therapeutic Exercise and Transcutaneous Electrical Nerve Stimulation (TENS) on Pain, Function, and Mental Health in People Over 60 Years of Age.",RECRUITING,2026-01-07,2026-01-12,2026-04-07,INTERVENTIONAL,NA,110,['Osteo Arthritis Knee'],Osteo Arthritis Knee,University of Jaén,[],['Spain']
NCT07274709,Emulation of the MONALEESA-2 Trial Using Specialty Oncology Electronic Health Records Databases,Emulation of the MONALEESA-2 Trial Using Specialty Oncology Electronic Health Records Databases,ACTIVE_NOT_RECRUITING,2025-09-07,2026-01,2026-01,OBSERVATIONAL,,2495,['Advanced Breast Cancer'],Advanced Breast Cancer,Shirley Vichy Wang,['Food and Drug Administration (FDA)'],['United States']
NCT05061862,Cardiac Implantable Electronic Device (CIED) Research Study,Cardiac Implantable Electronic Device (CIED) Research Study,ACTIVE_NOT_RECRUITING,2022-03-06,2025-10-31,2026-05-01,OBSERVATIONAL,,1000,"['Arrhythmias, Cardiac', 'Bradycardia', 'Tachycardia']","Arrhythmias, Cardiac",Medtronic Cardiac Rhythm and Heart Failure,[],"['Belgium', 'United States']"
NCT06552130,The Importance of Insulin Action in the Brain for the Immune System During Physical Activity,The Importance of Insulin Action in the Brain for the Immune System During Physical Activity,ACTIVE_NOT_RECRUITING,2024-12-15,2025-08-14,2026-09,INTERVENTIONAL,NA,20,['Insulin Sensitivity'],Insulin Sensitivity,University of Ulm,[],['Germany']
NCT01287000,Gulf Long-Term Follow-Up Study,Gulf STUDY: Gulf Long-Term Follow-Up Study,ACTIVE_NOT_RECRUITING,2011-03-24,,,OBSERVATIONAL,,32658,"['Cardiovascular Disease', 'Hematologic Diseases', 'Immunologic Disease', 'Cancer', 'Respiratory Function']",Cardiovascular Disease,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT03560752,CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant,CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients After Stem Cell Transplant,ACTIVE_NOT_RECRUITING,2018-08-20,2022-01-22,2026-07-29,INTERVENTIONAL,PHASE1,34,"['Accelerated Phase CML, BCR-ABL1 Positive', 'Acute Lymphoblastic Leukemia in Remission', 'Acute Myeloid Leukemia in Remission', 'Chronic Lymphocytic Leukemia', 'Chronic Phase CML, BCR-ABL1 Positive', 'Cytomegalovirus Positive', 'Donor', 'Hematopoietic Cell Transplant Recipient', 'Hodgkin Lymphoma', 'Myelodysplastic Syndrome', 'Myelodysplastic/Myeloproliferative Neoplasm', 'Non-Hodgkin Lymphoma', 'Myelofibrosis', 'Hematopoietic and Lymphoid Cell Neoplasm']","Accelerated Phase CML, BCR-ABL1 Positive",City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT01046825,Mature B-Cell Lymphoma And Leukemia Study III,Mature B-Cell Lymphoma And Leukemia Study III,ACTIVE_NOT_RECRUITING,2010-09-09,2023-08-31,2027-08,INTERVENTIONAL,PHASE2,128,['Mature B-Cell Lymphoma'],Mature B-Cell Lymphoma,St. Jude Children's Research Hospital,[],"['Singapore', 'Egypt', 'United States']"
NCT01668186,Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD),Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD),RECRUITING,2012-01,2030-01,2031-01,OBSERVATIONAL,,244,"['Peroxisome Biogenesis Disorder', 'Zellweger Spectrum Disorder', 'RCDP - Rhizomelic Chondrodysplasia Punctata', 'D-Bifunctional Protein Deficiency', 'Alpha-Methylacyl-CoA Racemase Deficiency', 'Peroxisomal Acyl-CoA Oxidase Deficiency', 'Peroxisomal Acyl-CoA Oxidase 2 Deficiency', 'ATP Binding Cassette Subfamily D Member 3 Gene Mutation', 'ACBD5 (AcylCoA Binding Domain 5) Deficiency', 'Adult Refsum Disease', 'Sterol Carrier Protein 2 Deficiency']",Peroxisome Biogenesis Disorder,McGill University Health Centre/Research Institute of the McGill University Health Centre,[],['Canada']
NCT05062031,Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops,Comparison of Defocus Incorporated Multiple Segments® (DIMS®) Lenses Alone Versus Monofocal Lenses + Atropine 0.05% Eyedrops on the Evolution of Ocular Axial Length at 2 Years in Myopia Control in Children: Single-centre Prospective Randomised Controlled 1:1 Open-label Non-inferiority Study,ACTIVE_NOT_RECRUITING,2021-10-19,2026-02,2026-02,INTERVENTIONAL,NA,242,['Myopia'],Myopia,Fondation Ophtalmologique Adolphe de Rothschild,"['Ecouter Voir', 'Hoya Lens France']",['France']
NCT07275541,Platelet Aggregation in the Diagnosis of Acute Graft Rejection,Platelet Aggregation in the Diagnosis of Acute Graft Rejection,RECRUITING,2024-11-26,2026-11-26,2027-11-26,OBSERVATIONAL,,60,"['Platelet Aggregation', 'Kidney Transplant Rejection']",Platelet Aggregation,"University Hospital, Martin",[],['Slovakia']
NCT05467657,Transcranial Magnetic Stimulation on Somtosensory Cortex Enhances Motor Learning in People With Stroke,Efficacy of Repetitive Transcranial Magnetic Stimulation of the Somatosensory Cortex on Motor Learning,ACTIVE_NOT_RECRUITING,2023-11-15,2025-11-22,2026-01-01,INTERVENTIONAL,NA,60,"['Transcranial Magnetic Stimulation', 'Stroke', 'Motor Learning']",Transcranial Magnetic Stimulation,"Neuron, Spain",['Centro Superior de Estudios Universitarios La Salle'],['Spain']
NCT07254520,The Effects of Reiki Therapy in Infants With Colic,"The Effect of Reiki Therapy on Colic Symptoms and Crying Duration in Infants With Infantile Colic, and on Maternal Fatigue and Quality of Life: A Double-Blind Randomized Controlled Trial",RECRUITING,2025-07-01,2026-01-01,2026-07-01,INTERVENTIONAL,NA,44,"['Reiki', 'Colic, Infantile']",Reiki,University of Yalova,[],['Turkey (Türkiye)']
NCT06557772,A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease,"A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Subcutaneous Amlitelimab in Adult Patients With Nonresponsive Celiac Disease as an Adjunct to a Gluten-free Diet",RECRUITING,2024-08-29,2026-08-04,2029-04-10,INTERVENTIONAL,PHASE2,204,"['Coeliac Disease', 'Celiac Disease']",Coeliac Disease,Sanofi,[],"['Netherlands', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Finland', 'Czechia', 'Poland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT05363631,Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab,Phase I/II Study of Seleno-L Methionine (SLM) in Sequential Combination With Fixed Doses and Schedules of Axitinib and Pembrolizumab (SAP) in Locally Advanced and Metastatic Clear Cell Renal Cell Carcinoma (ccRCC),ACTIVE_NOT_RECRUITING,2022-09-19,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,55,"['Clear Cell Renal Cell Carcinoma', 'Clear Cell Renal Cell Carcinoma Metastatic']",Clear Cell Renal Cell Carcinoma,Mohammed Milhem,['University of Iowa'],['United States']
NCT07261644,A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS),"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis (AS)",RECRUITING,2025-11-07,2027-01-14,2027-11-18,INTERVENTIONAL,PHASE3,500,['Ankylosing Spondylitis'],Ankylosing Spondylitis,"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.",[],['China']
NCT04811560,A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1),"A Phase 1/2, First-in-Human Study of the Menin-KMT2A (MLL1) Inhibitor Bleximenib in Participants With Acute Leukemia (cAMeLot-1)",RECRUITING,2021-05-19,2026-02-16,2028-05-26,INTERVENTIONAL,PHASE1,400,"['Acute Leukemias', 'Acute Myeloid Leukemia', 'Acute Lymphoblastic Leukemia']",Acute Leukemias,"Janssen Research & Development, LLC",[],"['Brazil', 'Israel', 'Japan', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT06483789,Efficacy and Safety of HB-1 for Panic Disorder,"Efficacy and Safety of HB-1 for Panic Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial",RECRUITING,2024-10-29,2027-01,2027-02,INTERVENTIONAL,PHASE2,240,"['Panic Disorder', 'Mental Illness']",Panic Disorder,Honeybrains Biotech LLC,[],['Australia']
NCT06965374,Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease,Foslevodopa/Foscarbidopa REal-world Evidence in Parkinson's Disease Quality of LIFE Outcomes,RECRUITING,2025-06-04,2027-06,2027-06,OBSERVATIONAL,,270,['Parkinson Disease'],Parkinson Disease,AbbVie,[],['Italy']
NCT07275333,Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine,Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine,RECRUITING,2025-04-01,2026-08-31,2026-08-31,INTERVENTIONAL,NA,1000,"['Cervical Cancer', 'Cervical Cancer Screening', 'Human Papillomavirus (HPV) Infection', 'Cervical Intraepithelial Neoplasia']",Cervical Cancer,Karolinska Institutet,"['Union for International Cancer Control', 'Zaporizhzhiya State Medical University', 'World Against Cancer Foundation']",['Ukraine']
NCT07274033,Effect of Manual Lymphatic Drainage on Muscle Fatigue in Female 11-a-side Football Players,Effect of Manual Lymphatic Drainage on Muscle Fatigue in Female 11-a-side Football Players,RECRUITING,2025-11-17,2026-02-28,2026-07-30,INTERVENTIONAL,NA,11,['Women'],Women,Camilo Jose Cela University,[],['Spain']
NCT07275866,Multi-strain Probiotic Effects on Self-Reported Constipation,A Pilot Study of a Multi-Strain Liquid Probiotic in Individuals Self-reporting Constipation in the General Population.,RECRUITING,2025-10-03,2026-04,2026-04,INTERVENTIONAL,NA,20,"['Constipation', 'Probiotic', 'Probiotic Intervention']",Constipation,Dr Anthony Hobson,[],['United Kingdom']
NCT03735667,ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement,ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR,ACTIVE_NOT_RECRUITING,2019-06-10,2024-06-14,2029-09,INTERVENTIONAL,NA,1948,['Aortic Stenosis'],Aortic Stenosis,Boston Scientific Corporation,[],"['United States', 'Canada']"
NCT06973655,Trial of Social Work Services in Fracture Clinic Setting,Social Worker Presence in Outpatient Fracture Clinics: A Batched Stepped-Wedge Cluster Randomized Trial,RECRUITING,2025-10-06,2028-06,2028-06,INTERVENTIONAL,NA,2000,"['Orthopaedic Fractures', 'Socioeconomic Factors']",Orthopaedic Fractures,Sheila Sprague,"['McMaster Surgical Associates', 'Orthopaedic Trauma Association']","['United States', 'Canada']"
NCT06898814,The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery,"The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture Surgery: a Multicentre, Parallel Group, Randomised Controlled Trial",RECRUITING,2025-06-09,2027-06-01,2027-09-14,INTERVENTIONAL,PHASE4,210,"['Hip Fracture', 'Anemia']",Hip Fracture,Soren Overgaard,"['University Hospital Bispebjerg and Frederiksberg', 'Copenhagen University Hospital at Herlev', 'Odense University Hospital', 'Musculoskeletal Statistics Unit, The Parker Institute', 'Svendborg Hospital']",['Denmark']
NCT06806852,A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone,A Phase Ib Open Label Randomised Clinical Trial to Evaluate Safety and Efficacy of BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Compared With Pembrolizumab Monotherapy for the First-line Treatment of Patients With Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC),RECRUITING,2025-05-14,2026-10-31,2027-07-31,INTERVENTIONAL,PHASE1,90,['Head and Neck Squamous Cell Carcinoma'],Head and Neck Squamous Cell Carcinoma,Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'Moldova', 'Australia', 'Hungary', 'France', 'South Korea', 'Thailand', 'Poland', 'Singapore', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT04983251,"Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity","Women's Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity",RECRUITING,2023-06-30,2026-09-30,2026-09-30,OBSERVATIONAL,,700,['Mental Health'],Mental Health,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT05977686,Hemoglobin Testing in Pregnant Patients,Point-of-Care Hemoglobin Testing in Pregnant Patients,RECRUITING,2025-12-03,2026-09,2026-12,OBSERVATIONAL,,200,"['Post Partum Hemorrhage', 'Anemia of Pregnancy']",Post Partum Hemorrhage,George Washington University,['Inova Health Care Services'],['United States']
NCT03975647,A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer,"Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)",ACTIVE_NOT_RECRUITING,2019-10-02,2023-06-29,2029-03-10,INTERVENTIONAL,PHASE3,466,['HER2-positive Breast Cancer'],HER2-positive Breast Cancer,"Seagen, a wholly owned subsidiary of Pfizer",[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Denmark', 'South Korea', 'Singapore', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Austria', 'United States', 'Italy']"
NCT07275918,SA1211 Injection Phase 1 Study,"A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SA1211 Injection in Healthy Participants and Participants With Chronic Hepatitis B",RECRUITING,2025-11-25,2027-03-30,2027-03-30,INTERVENTIONAL,PHASE1,80,['Chronic Hepatitis B'],Chronic Hepatitis B,"Suzhou Siran Biotechnology Co.,Ltd.","['Beijing Siran Biotechnology Co.,Ltd.']",['China']
NCT05597878,Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy,Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy: A Randomized Controlled Trial,RECRUITING,2023-04-18,2026-03,2026-03,INTERVENTIONAL,PHASE2,100,"['Pain Management', 'Opioid Use', 'Prostate Cancer']",Pain Management,Wake Forest University Health Sciences,[],['United States']
NCT06233474,Study of Intra-articular Allocetra in Knee Osteoarthritis,"A Phase 1/2a Randomized, Double-Blind Placebo-controlled Study of Intra-articular Allocetra in Knee Osteoarthritis",ACTIVE_NOT_RECRUITING,2024-01-26,2026-03-15,2026-05-15,INTERVENTIONAL,PHASE1,160,"['Osteoarthritis, Knee']","Osteoarthritis, Knee",Enlivex Therapeutics Ltd.,['Nordic Bioscience Clinical Development (NBCD)'],"['Israel', 'Denmark', 'Moldova']"
NCT07276126,"The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.","The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.",ACTIVE_NOT_RECRUITING,2025-11-28,2026-02-20,2026-04-20,INTERVENTIONAL,NA,1,"['Bonding', 'ERAS', 'Cesarean Section', 'Maternal Care', 'Father - Child Relations', 'Mother-Infant Interaction']",Bonding,Okan University,[],['Turkey (Türkiye)']
NCT07274215,Paragastric Block for Pain and PONV in Sleeve Gastrectomy,Impact of Intraoperative Paragastric Block on Visceral Pain and Postoperative Nausea and Vomiting After Sleeve Gastrectomy: A Randomized Controlled Trial,RECRUITING,2025-10-01,2025-12-30,2026-01-20,INTERVENTIONAL,NA,200,"['Postoperative Nausea and Vomiting', 'Postoperative Pain After Laparoscopic Sleeve Gastrectomy']",Postoperative Nausea and Vomiting,Umraniye Education and Research Hospital,[],['Turkey (Türkiye)']
NCT06148025,Antibiotics and Vaccine Immune Responses Study,A Human Experimental Medicine Study to Assess Whether the Gut Microbiota Regulates Specific and Non-specific Immune Responses to Vaccination,RECRUITING,2023-11-23,2027-10-01,2028-10-01,INTERVENTIONAL,PHASE4,348,['Vaccine Response Impaired'],Vaccine Response Impaired,South Australian Health and Medical Research Institute,"['Royal Adelaide Hospital', 'Flinders University', 'University of Sydney', 'Telethon Kids Institute', 'Centenary Institute']",['Australia']
NCT06254326,ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients,ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients,RECRUITING,2024-09-19,2027-12,2028-06,INTERVENTIONAL,PHASE1,12,"['Recurrent Oligodendroglioma', 'Progressive Oligodendroglioma']",Recurrent Oligodendroglioma,University of Florida,"['Oligo Nation, Inc']",['United States']
NCT03164278,Effectiveness of Web-Based Training (SERT),Studying the Effectiveness of Remote Training,ACTIVE_NOT_RECRUITING,2017-12-04,2026-12-01,2027-12-01,INTERVENTIONAL,NA,200,['Remote Transfer Training Program'],Remote Transfer Training Program,University of Pittsburgh,['Department of Health and Human Services'],['United States']
NCT07126613,Mobile Alcohol Use Intervention,Development of a Just-in-Time Adaptive Intervention to Reduce High-Intensity Drinking Among Young Adults,ACTIVE_NOT_RECRUITING,2025-09-29,2026-01,2026-01,INTERVENTIONAL,NA,40,['Alcohol Misuse'],Alcohol Misuse,"University of North Carolina, Chapel Hill",['National Institute on Alcohol Abuse and Alcoholism (NIAAA)'],['United States']
NCT07264933,Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation,"Effect of Immediate Postplacental Copper T380A Intrauterine Device Insertion Versus Postpartum Progesterone-only Pills on Uterine Niche Formation After Primary Cesarean Section: a Prospective, Open-label Randomized Controlled Trial",ACTIVE_NOT_RECRUITING,2025-02-12,2025-08-05,2026-02-05,INTERVENTIONAL,NA,750,"['Scar Niche', 'Myometrial Remodeling', 'Contraceptive Device; Complications', 'Cesarean Section Complications']",Scar Niche,Benha University,[],['Egypt']
NCT04931342,A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors,"A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors",ACTIVE_NOT_RECRUITING,2021-10-07,2028-02-28,2028-05-30,INTERVENTIONAL,PHASE2,176,['Ovarian Cancer'],Ovarian Cancer,Hoffmann-La Roche,"['GOG Foundation', 'European Network of Gynaecological Oncological Trial Groups (ENGOT)']","['Turkey (Türkiye)', 'Russia', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Czechia', 'South Korea', 'United Kingdom', 'Australia']"
NCT06205160,Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid ),The EpiGrid Study Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery,RECRUITING,2025-01-01,2027-03,2027-03,INTERVENTIONAL,NA,12,"['Focal Epilepsy', 'Intraoperative Monitoring']",Focal Epilepsy,Neurosoft Bioelectronics SA,"['UMC Utrecht', 'European Research Council']",['Netherlands']
NCT05732961,Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms,"A Phase 2, Single Arm Study of Luspatercept for the Treatment of Anemia in Lower Risk Myelodysplastic Syndromes (MDS) or Non-Proliferative Myelodysplastic Syndromes/ Myeloproliferative Neoplasms (MDS/MPN)",RECRUITING,2023-02-21,2026-06-20,2026-09,INTERVENTIONAL,PHASE2,70,"['Myelodysplastic Syndromes', 'Myeloproliferative Neoplasm', 'Anemia']",Myelodysplastic Syndromes,H. Lee Moffitt Cancer Center and Research Institute,['Bristol-Myers Squibb'],['United States']
NCT07005102,"A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer","A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer",RECRUITING,2025-08-03,2031-12,2031-12,INTERVENTIONAL,PHASE2,694,['Non-Squamous Non-Small Cell Lung Cancer'],Non-Squamous Non-Small Cell Lung Cancer,AbbVie,[],"['Singapore', 'Belgium', 'Israel', 'Japan', 'United States', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Portugal', 'Australia']"
NCT05765396,SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies,SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies,ACTIVE_NOT_RECRUITING,2023-05-15,2025-12-30,2026-03-30,OBSERVATIONAL,,300,"['COVID-19', 'SARS-CoV-2 Virus', 'COVID-19 Pneumonia', 'COVID-19 Respiratory Infection', 'COVID-19 Acute Respiratory Distress Syndrome', 'Corona Virus Infection', 'Influenza', 'RSV Infection']",COVID-19,The Geneva Foundation,"['Brooke Army Medical Center', 'Uniformed Services University of the Health Sciences', 'Level 42 AI, Inc.']",['United States']
NCT06926660,A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease,"A Phase II Randomised, Double-blind, Parallel-group, Multicentre, International Trial to Investigate the Safety and Efficacy of Vicadrostat and Empagliflozin Administered With Simultaneous vs Staggered Initiation in Participants With Chronic Kidney Disease at Risk of Kidney Disease Progression",RECRUITING,2025-07-18,2027-01-08,2027-01-08,INTERVENTIONAL,PHASE2,416,['Chronic Kidney Disease'],Chronic Kidney Disease,Boehringer Ingelheim,[],"['Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'Puerto Rico', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT06069622,Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment,The Role of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment of Overweight/Obese Individuals for Improving Adverse Cardiometabolic Phenotype Associated With CAV-1 Deficiency,RECRUITING,2023-11-01,2026-10-01,2026-11-30,OBSERVATIONAL,,30,['Overweight and Obesity'],Overweight and Obesity,Brigham and Women's Hospital,['Charles A. King Trust Postdoctoral Fellowship Program'],['United States']
NCT07155174,"A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer","A Phase 2 Randomized, Open Label, Multicenter Study to Evaluate the Optimal Dose, Safety, and Efficacy of ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Subjects With Previously Untreated Extensive Stage Small Cell Lung Cancer (ES-SCLC)",RECRUITING,2025-11-25,2029-05,2031-09,INTERVENTIONAL,PHASE2,180,['Small Cell Lung Cancer'],Small Cell Lung Cancer,AbbVie,[],['United States']
NCT06485960,Validation of the Experience Sampling Dietary Assessment Method,Validation of the Experience Sampling Dietary Assessment Method (ESDAM),RECRUITING,2025-10-09,2026-02,2026-03,OBSERVATIONAL,,115,['Validation Study'],Validation Study,KU Leuven,[],['Belgium']
NCT06680752,Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS,"A Phase 1/2, Open-label, Multicenter Trial to Assess the Safety and Efficacy of ARD103 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",RECRUITING,2025-05-20,2028-10,2028-12,INTERVENTIONAL,PHASE1,49,"['Acute Myeloid Leukemia, in Relapse', 'Acute Myeloid Leukemia Refractory', 'MDS (Myelodysplastic Syndrome)']","Acute Myeloid Leukemia, in Relapse","ARCE Therapeutics, Inc.",[],['United States']
NCT07275554,Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure,Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure,RECRUITING,2024-12-31,2026-12-31,2026-12-31,OBSERVATIONAL,,100,"['HBV Related Acute-on-chronic Liver Failure', 'HBV-related Liver Cirrhosis', 'HBV (Hepatitis B Virus)']",HBV Related Acute-on-chronic Liver Failure,Qilu Hospital of Shandong University,[],['China']
NCT05838092,Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III),"A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Trial to Investigate the Safety and Efficacy of ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) on Epidermolysis Bullosa (EB)",ACTIVE_NOT_RECRUITING,2023-10-18,2025-08-29,2026-07,INTERVENTIONAL,PHASE3,9,['Epidermolysis Bullosa'],Epidermolysis Bullosa,RHEACELL GmbH & Co. KG,[],['United States']
NCT06804369,Benchmarking and Change Mechanisms in Personality Disorder Treatment,Benchmarking and Mechanisms of Change During Intensive Psychodynamic Therapy for Personality Disorders: A Naturalistic Process-Outcome Study,ACTIVE_NOT_RECRUITING,2023-04-17,2026-04-17,2028-04-17,OBSERVATIONAL,,91,['Personality Disorders'],Personality Disorders,KU Leuven,['Universitaire Ziekenhuizen KU Leuven'],['Belgium']
NCT05079516,Neural Basis of Sensory Learning: Brain Regions,Neural Basis of Sensory Learning: Brain Regions,RECRUITING,2021-10-26,2026-12,2026-12,INTERVENTIONAL,NA,300,['Basic Science'],Basic Science,Indiana University,['National Institute of Neurological Disorders and Stroke (NINDS)'],['United States']
NCT07095075,A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases,"An Open-label Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases (r/r AID)",RECRUITING,2025-10-14,2029-12-31,2029-12-31,INTERVENTIONAL,EARLY_PHASE1,36,['Relapsed/Refractory Autoimmune Diseases'],Relapsed/Refractory Autoimmune Diseases,Nanjing Legend Biotech Co.,[],['China']
NCT05608681,A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).,"A Phase 1b/2 Trial Evaluating the Safety, Pharmacokinetics, and Efficacy of EP-104GI in Adults With Eosinophilic Esophagitis (RESOLVE)",RECRUITING,2023-03-31,2026-12,2026-12,INTERVENTIONAL,PHASE1,117,['Eosinophilic Esophagitis'],Eosinophilic Esophagitis,Eupraxia Pharmaceuticals Inc.,[],"['New Zealand', 'Netherlands', 'Switzerland', 'Canada', 'United Kingdom', 'Australia']"
NCT07256639,Evaluating Heart & Soil's Whole Package on Men's Health,Evaluating Heart & Soil's Whole Package on Men's Health,RECRUITING,2025-10-17,2026-10-17,2026-10-17,INTERVENTIONAL,NA,100,['Testosterone'],Testosterone,"Efforia, Inc",[],['United States']
NCT02738866,Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor,"Phase II Trial of Palbociclib With Fulvestrant in Individuals With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Who Have Progressed on Treatment With Palbociclib and an Aromatase Inhibitor",ACTIVE_NOT_RECRUITING,2016-10-25,2026-06,2026-06,INTERVENTIONAL,PHASE2,60,['Metastatic Breast Cancer'],Metastatic Breast Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Pfizer'],['United States']
NCT06153641,Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients,Cytokeratin 18 a Novel Non-invasive Biomarker for Rejection in Liver Transplant Patients,ACTIVE_NOT_RECRUITING,2019-04-16,2025-01-13,2026-03-31,OBSERVATIONAL,,70,"['Liver Transplant Rejection', 'Liver Transplant Failure and Rejection']",Liver Transplant Rejection,St. Louis University,['Mid-America Transplant'],['United States']
NCT06827626,Tailored Treatment of Insomnia in Social and Health Care Sector Shift Workers in Occupational Health Care,Tailored Treatment of Insomnia in Social and Health Care Sector Shift Workers in Occupational Health Care,RECRUITING,2025-02-17,2026-12-31,2027-01-29,INTERVENTIONAL,NA,84,"['Insomnia Chronic', 'Shift Work Sleep Disorder']",Insomnia Chronic,Finnish Institute of Occupational Health,"['Finnish Work Environment Fund', 'Terveystalo Oyj', 'Joint Authority HUS', 'The Wellbeing Services County of South Ostrobotnia and TT Botnia Oy']",['Finland']
NCT07075380,National Survey on Physical and Sports Activity of Adults With Epilepsy,National Survey on Physical and Sports Activity of Adults With Epilepsy,RECRUITING,2025-11-10,2027-05,2027-05,OBSERVATIONAL,,400,['Epilepsy'],Epilepsy,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT07275658,Timing and Dose of Fluid Deresuscitation in Critically Ill Patients: a Prospective Observational Multicenter Study,Timing and Dose of Fluid Deresuscitation in Critically Ill Patients: a Prospective Observational Multicenter Study,RECRUITING,2025-10-15,2027-01-31,2027-02-28,OBSERVATIONAL,,150,"['Fluid Overload', 'Critical Care, Intensive Care', 'Deresuscitation']",Fluid Overload,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),['OLVG'],['Netherlands']
NCT06173713,Emphasys Radiostereometric Analysis,"Multi-Center, Non-Controlled, Prospective Radiostereometric Analysis of Emphasys Hip Solutions",RECRUITING,2025-02-11,2027-08-31,2027-12-31,INTERVENTIONAL,NA,30,['Hip Osteoarthritis'],Hip Osteoarthritis,Canadian Radiostereometric Analysis Network,['Johnson & Johnson'],['Canada']
NCT03591510,"A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML","A Phase II, Open-label, Single Arm Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Twice Daily Midostaurin (PKC412) Combined With Standard Chemotherapy and as a Single Agent Post-consolidation Therapy in Children With Untreated FLT3-mutated AML",ACTIVE_NOT_RECRUITING,2019-03-13,2027-05-03,2029-09-02,INTERVENTIONAL,PHASE2,22,['FLT3-mutated Acute Myeloid Leukemia'],FLT3-mutated Acute Myeloid Leukemia,Novartis Pharmaceuticals,[],"['Japan', 'Turkey (Türkiye)', 'Russia', 'Slovenia', 'Italy', 'South Korea', 'Czechia', 'Jordan', 'Poland', 'Germany']"
NCT05587296,"A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer","A Double-blind, Randomized, Placebo-controlled Multicenter Study to Investigate Efficacy and Safety of Elinzanetant for the Treatment of Vasomotor Symptoms Induced by Adjuvant Endocrine Therapy, Over 52 Weeks and Optionally for an Additional up to 2.5 Years in Women With Hormone-receptor Positive Breast Cancer:",ACTIVE_NOT_RECRUITING,2022-10-14,2024-01-29,2028-06-05,INTERVENTIONAL,PHASE3,474,"['Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer', 'Hot Flashes']","Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer",Bayer,[],"['Belgium', 'Israel', 'Kazakhstan', 'Hungary', 'Austria', 'France', 'Finland', 'Ireland', 'Spain', 'Italy', 'Canada', 'Romania', 'United Kingdom', 'Poland', 'Portugal', 'Germany']"
NCT06895603,"The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)","The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)",RECRUITING,2025-10-28,2026-02,2026-06,OBSERVATIONAL,,75,"['ICU', 'Surgical Patients']",ICU,Philips Clinical & Medical Affairs Global,[],"['United States', 'Germany']"
NCT05612789,Improve Outcomes for Older Allogeneic Transplant Recipients,Intervening on Frailty to Improve Outcomes for Older Allogeneic Transplant Recipients,RECRUITING,2023-02-15,2030-06-01,2031-06-01,INTERVENTIONAL,NA,72,['Allogeneic Transplantation'],Allogeneic Transplantation,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT06546969,Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer,A Pilot Study of Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer,RECRUITING,2024-10-29,2027-12,2028-12,INTERVENTIONAL,PHASE1,15,"['Biliary Tract Cancer', 'Cholangiocarcinoma']",Biliary Tract Cancer,"University of Maryland, Baltimore",[],['United States']
NCT06191315,Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS),"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Longterm Safety of Dupilumab in Children 2 to <6 Years of Age With Uncontrolled Asthma and/or Recurrent Severe Asthmatic Wheeze",RECRUITING,2024-01-03,2028-12-21,2028-12-21,INTERVENTIONAL,PHASE3,90,"['Wheezing', 'Asthma']",Wheezing,Sanofi,['Regeneron Pharmaceuticals'],"['Brazil', 'Japan', 'Hungary', 'Netherlands', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Greece', 'Poland', 'Argentina', 'Germany']"
NCT07259148,Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial,Non-Inferiority Randomized Clinical Trial Comparing Behavioral Therapy Plus Pharmacotherapy Versus Pelvic Floor Muscle Training Plus Pharmacotherapy in Women With Urgency Urinary Incontinence,RECRUITING,2025-11-22,2026-03,2026-04,INTERVENTIONAL,NA,80,['Urgency Urinary Incontinence'],Urgency Urinary Incontinence,Emilio José Dávila Álvarez,"['Hospital Militar Escuela ""Dr. Alejandro Dávila Bolaños""']",['Nicaragua']
NCT06228066,Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER),A Phase II Study of Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER),RECRUITING,2024-06-13,2027-09-01,2028-09-01,INTERVENTIONAL,PHASE2,45,"['Small Cell Carcinoma of the Bladder', 'High Grade Neuroendocrine Tumors of the Urinary Tract']",Small Cell Carcinoma of the Bladder,National Cancer Institute (NCI),[],['United States']
NCT06842732,A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya,A Mixed Methods Randomized Controlled Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in Kenya,RECRUITING,2025-06-05,2027-05-05,2027-06-30,INTERVENTIONAL,NA,600,"['Malnutrition in Children', 'Children Exposed to HIV']",Malnutrition in Children,University of Washington,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['Kenya']
NCT07265271,A Cell-free tsRNA Signature for Early Detection of Hepatocellular Carcinoma,A Cell-Free tsRNA-Based Liquid Biopsy Signature for Early Detection of Hepatocellular Carcinoma,RECRUITING,2025-01-15,2026-06-18,2026-06-18,OBSERVATIONAL,,600,['Hepatocellular Carcinoma (HCC)'],Hepatocellular Carcinoma (HCC),City of Hope Medical Center,[],['United States']
NCT07020936,AIDANET Pediatrics,Safety and Feasibility Testing of AIDANET in Children Age 6-13 Years,RECRUITING,2025-07-21,2026-03-30,2026-03-30,INTERVENTIONAL,NA,36,['Type 1 Diabetes'],Type 1 Diabetes,"Mark D. DeBoer, MD, MSc., MCR","['Tandem Diabetes Care, Inc.', 'DexCom, Inc.']",['United States']
NCT07269587,A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19,"A Retrospective, Observational, and Multicenter Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19",ACTIVE_NOT_RECRUITING,2025-11-07,2027-11-30,2027-11-30,OBSERVATIONAL,,275,"['ALL (Acute B-Lymphoblastic Leukemia)', 'CAR-T Cell Therapy']",ALL (Acute B-Lymphoblastic Leukemia),Ruijin Hospital,[],['China']
NCT05987449,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A","A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A",RECRUITING,2023-09-21,2030-06-16,2030-06-16,INTERVENTIONAL,PHASE1,60,['Hemophilia A'],Hemophilia A,Hoffmann-La Roche,[],"['New Zealand', 'United States', 'Spain', 'Italy', 'Canada', 'Poland']"
NCT06310031,Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure,"Investigation of a Novel, magNetically Levitated VAD for the Treatment of refractOry Left Ventricular heArT failurE",RECRUITING,2024-10-28,2028-02,2028-12,INTERVENTIONAL,NA,780,"['Cardiovascular Diseases', 'Heart Diseases', 'Heart Failure']",Cardiovascular Diseases,"BrioHealth Solutions, Inc.",[],['United States']
NCT06335303,A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF),"A Randomised, Double-blind, Placebo-controlled, Dose-finding Study Evaluating Efficacy, Safety, and Tolerability of Different Oral Doses of BI 1819479 Over at Least 24 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)",ACTIVE_NOT_RECRUITING,2024-09-05,2025-11-25,2026-01-09,INTERVENTIONAL,PHASE2,322,['Idiopathic Pulmonary Fibrosis'],Idiopathic Pulmonary Fibrosis,Boehringer Ingelheim,[],"['Japan', 'New Zealand', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Finland', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT04578769,Assessment of Different Modified POEM for Achalasia,Comparison Study of Conventional Peroral Endoscopic Myotomy (POEM) and Different Modified Procedures of POEM for Achalasia,RECRUITING,2020-09-02,2025-12-30,2026-05-30,INTERVENTIONAL,NA,52,['Esophageal Achalasia'],Esophageal Achalasia,Peking Union Medical College Hospital,[],['China']
NCT04329494,"PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer","Safety and Efficacy of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian, Uterine, Appendiceal, Colorectal, and Gastric Cancer Patients With Peritoneal Carcinomatosis (PC)",RECRUITING,2020-08-21,2028-01-05,2028-01-05,INTERVENTIONAL,PHASE1,49,"['Clinical Stage IV Gastric Cancer AJCC v8', 'Clinical Stage IVA Gastric Cancer AJCC v8', 'Clinical Stage IVB Gastric Cancer AJCC v8', 'Malignant Uterine Neoplasm', 'Metastatic Appendix Carcinoma', 'Metastatic Colorectal Carcinoma', 'Metastatic Gastric Carcinoma', 'Metastatic Malignant Neoplasm in the Peritoneum', 'Metastatic Malignant Solid Neoplasm', 'Metastatic Ovarian Carcinoma', 'Pathologic Stage IV Gastric Cancer AJCC v8', 'Peritoneal Carcinomatosis', 'Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8', 'Stage IV Appendix Carcinoma AJCC v8', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IV Ovarian Cancer AJCC v8', 'Stage IV Uterine Corpus Cancer AJCC v8', 'Stage IVA Appendix Carcinoma AJCC v8', 'Stage IVA Colorectal Cancer AJCC v8', 'Stage IVA Ovarian Cancer AJCC v8', 'Stage IVA Uterine Corpus Cancer AJCC v8', 'Stage IVB Appendix Carcinoma AJCC v8', 'Stage IVB Colorectal Cancer AJCC v8', 'Stage IVB Ovarian Cancer AJCC v8', 'Stage IVB Uterine Corpus Cancer AJCC v8', 'Stage IVC Appendix Carcinoma AJCC v8', 'Stage IVC Colorectal Cancer AJCC v8']",Clinical Stage IV Gastric Cancer AJCC v8,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07276217,Phacoemulsification and Intraocular Lens Implantation: Patient Registry,Phacoemulsification and Intraocular Lens Implantation: Patient Registry,RECRUITING,2025-01-02,2026-07,2026-07,OBSERVATIONAL,,300,"['Cataract', 'Intraocular Lens']",Cataract,Sensor Cliniq,[],['Poland']
NCT05014256,System Interventions to Achieve Early and Equitable Transplants (STEPS) Study,System Interventions to Achieve Early and Equitable Transplants (STEPS) Study,ACTIVE_NOT_RECRUITING,2022-04-02,2025-12-31,2025-12-31,INTERVENTIONAL,NA,1168,['Chronic Kidney Diseases'],Chronic Kidney Diseases,Wake Forest University Health Sciences,"['Northwell Health', 'Geisinger Clinic', 'University of Mississippi Medical Center', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'Patient-Centered Outcomes Research Institute']",['United States']
NCT06798922,Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers,Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers: a De-escalation Randomized Phase III Trial,RECRUITING,2025-03-01,2031-03-01,2034-03-01,INTERVENTIONAL,PHASE3,348,"['Oral Cavity Carcinoma', 'Flap', 'Radiotherapy, Adjuvant', 'Reconstruction Surgery']",Oral Cavity Carcinoma,Centre Francois Baclesse,[],['France']
NCT07178873,Psychosocial Teleassistance Programme for Adults With Spina Bifida,Effects of a Psychosocial Teleassistance Programme for Adults With Spina Bifida,RECRUITING,2024-06-25,2027-01,2027-01,INTERVENTIONAL,NA,35,"['Spina Bifida', 'Self Esteem', 'Quality of Life (QOL)', 'Self Concept', 'Anxiety', 'Depression', 'Interpersonal Needs']",Spina Bifida,University of Deusto,[],['Spain']
NCT06265220,AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus,"A Phase 1 Study to Evaluate the Efficacy and Safety of AB-101, an Allogeneic Cord Blood- Derived NK-Cell Therapy in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus",ACTIVE_NOT_RECRUITING,2024-04-03,2027-08,2027-08,INTERVENTIONAL,PHASE1,51,"['Lupus Nephritis - WHO Class III', 'Lupus Nephritis - WHO Class IV', 'Refractory Systemic Lupus Erythematosus', 'SLE']",Lupus Nephritis - WHO Class III,"Artiva Biotherapeutics, Inc.",[],['United States']
NCT06402318,Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine,"A Prospective, Non-interventional, Observational Clinical Validation Study to Analytically Validate the A&M Breathalyzer PROTECT Kiosk Breath Capture System.",RECRUITING,2023-12-27,2025-12-31,2026-03-30,OBSERVATIONAL,,100,"['COVID-19', 'SARS CoV 2 Virus', 'COVID-19 Pneumonia', 'COVID-19 Respiratory Infection', 'COVID-19 Acute Respiratory Distress Syndrome']",COVID-19,The Geneva Foundation,"['Brooke Army Medical Center', 'Uniformed Services University of the Health Sciences', 'Level 42 AI, Inc.']",['United States']
NCT06721962,Treatment of Moderate to Severe Refractory Crohn's Disease,"A Phase 1/2a, Open Label, Dose Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX103 in Subjects With Moderate to Severe Treatment-Refractory Crohn's Disease",RECRUITING,2025-05-05,2026-01-30,2027-01-30,INTERVENTIONAL,PHASE1,39,['Crohns Disease'],Crohns Disease,"Tr1X, Inc.",[],['United States']
NCT05602363,AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma,A Phase 1b Study of Oral AS-1763 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma,RECRUITING,2023-08-01,2027-09,2027-09,INTERVENTIONAL,PHASE1,120,"['B-cell Malignancy', 'Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma', 'Waldenstrom Macroglobulinemia', 'Mantle Cell Lymphoma', 'Marginal Zone Lymphoma', 'Follicular Lymphoma', 'Non-Hodgkin Lymphoma']",B-cell Malignancy,"Carna Biosciences, Inc.",[],['United States']
NCT06909565,Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention,Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION),RECRUITING,2025-07-23,2029-10,2029-12,INTERVENTIONAL,PHASE4,6000,"['Percutaneous Coronary Intervention', 'Peripheral Endovascular Intervention']",Percutaneous Coronary Intervention,Duke University,"['Novartis Pharmaceuticals', 'Colorado Prevention Center', 'Mount Sinai Hospital, New York']",['United States']
NCT07275671,Microbiome and Premature Ovarian Insufficiency,A Case-Control Study of Gut and Vaginal Microbiota Differences Between Premature Ovarian Insufficiency Patients and Healthy Controls,RECRUITING,2025-05-13,2025-12-01,2026-01-30,OBSERVATIONAL,,40,"['Premature Ovarian Insufficiency', 'Reproductive Health']",Premature Ovarian Insufficiency,Westlake University,[],['China']
NCT05801809,Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System,Understanding the Effects of Non-invasive Transauricular Vagus Nerve Stimulation (taVNS) on Neural Networks and Autonomic Nervous System: a Randomized Double-blind Sham-control Mechanistic Trial in Healthy Participants,ACTIVE_NOT_RECRUITING,2023-04-26,2023-09-23,2026-03-01,INTERVENTIONAL,NA,44,['Healthy Volunteers'],Healthy Volunteers,Spaulding Rehabilitation Hospital,[],['United States']
NCT06770998,A Study of a Novel EEG Neurofeedback System for PTSD Treatment,A Prospective Randomized Study of a Novel EEG Neurofeedback System for the Treatment of PTSD Using Machine Learning-Based Amygdala Biomarkers,RECRUITING,2025-05-14,2027-06,2027-08,INTERVENTIONAL,NA,250,"['Stress Disorders, Post-Traumatic']","Stress Disorders, Post-Traumatic","Foundation for Atlanta Veterans Education and Research, Inc.","['GrayMatters Health Ltd.', 'Rochester Institute of Technology', 'NYU Langone Health', 'Atlanta VA Medical Center', 'Birmingham VA Health Care System', 'Ralph H. Johnson VA Medical Center', 'VA Boston Healthcare System', 'CTP Inc', 'BioStats Statistical Consulting Ltd', 'ShareCRF', 'United States Department of Defense']",['United States']
NCT07274501,The Effect of Music That the Individuals With Moderate Dental Anxiety Have Started Listening to While Waiting,The Evaluation of the Effect of Music That the Individuals With Moderate Dental Anxiety Have Started Listening to on Their Anxiety Levels While Waiting for Restorative Dental Treatments in the Patient Waiting Room,ACTIVE_NOT_RECRUITING,2025-04-17,2026-04-20,2026-06-15,INTERVENTIONAL,NA,90,['Dental Anxiety'],Dental Anxiety,Karadeniz Technical University,[],['Turkey (Türkiye)']
NCT05993923,Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer,Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer. Randomized Open-label Controlled Study,RECRUITING,2023-09-26,2028-10,2028-10,INTERVENTIONAL,NA,90,"['Colorectal Cancer', 'Surgery']",Colorectal Cancer,Centre Hospitalier Universitaire de Nīmes,[],['France']
NCT03340129,Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study),"A Phase II, Open Label, Randomised, Controlled Trial of Ipilimumab and Nivolumab With Concurrent Intracranial Stereotactic Radiotherapy Versus Ipilimumab and Nivolumab Alone in Patients With Melanoma Brain Metastases.",RECRUITING,2019-08-14,2026-08,2029-08,INTERVENTIONAL,PHASE2,218,['Melanoma Stage Iv'],Melanoma Stage Iv,Melanoma Institute Australia,['Bristol-Myers Squibb'],"['Sweden', 'Norway', 'Australia']"
NCT07209111,A Clinical Study of MK-1084 in People With Advanced Solid Tumors (MK-1084-014),"A Phase 2, Open-Label, Multicenter, Tumor-agnostic Study of MK-1084 as Monotherapy and in Combination With Cetuximab, in Participants With KRAS G12C-Mutant, Advanced Solid Tumors (KANDLELIT-014)",RECRUITING,2025-12-04,2032-04-09,2032-04-09,INTERVENTIONAL,PHASE2,150,['Neoplasm Malignant'],Neoplasm Malignant,Merck Sharp & Dohme LLC,[],"['Spain', 'United States', 'South Korea', 'Norway']"
NCT06935357,A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)",RECRUITING,2025-05-08,2027-05-31,2029-06-05,INTERVENTIONAL,PHASE3,454,['Immunoglobulin A Nephropathy (IgAN)'],Immunoglobulin A Nephropathy (IgAN),Biogen,"['Human Immunology Biosciences, Inc. (HI-Bio)']","['Bulgaria', 'Japan', 'China', 'Australia', 'Belgium', 'France', 'Puerto Rico', 'Croatia', 'South Korea', 'Colombia', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT07224334,Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.,Alpha to Beta Cell Communication in Health and Disease,RECRUITING,2025-12,2027-12,2027-12,INTERVENTIONAL,PHASE1,30,['Diabetes (DM)'],Diabetes (DM),"David D'Alessio, M.D.",['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT04452305,Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting,Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting,RECRUITING,2023-11-10,2027-07-01,2028-07-01,INTERVENTIONAL,NA,10,"['Infertility, Male', 'Cancer', 'Autoimmune Disorder']","Infertility, Male",University of Pittsburgh,[],['United States']
NCT05205499,A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease,"A Prospective, Multi-Center, Single-arm Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients With Coronary Artery Disease: IRONMAN-III",ACTIVE_NOT_RECRUITING,2022-03-10,2024-07-01,2028-08,INTERVENTIONAL,NA,1059,['Coronary Artery Disease'],Coronary Artery Disease,"Biotyx Medical (Shenzhen) Co., Ltd.",[],['China']
NCT06544499,A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia,"A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Arm Study Followed by an Open-Label Arm to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia",RECRUITING,2024-10-18,2028-06,2028-06,INTERVENTIONAL,PHASE3,69,['Primary Immune Thrombocytopenia (ITP)'],Primary Immune Thrombocytopenia (ITP),argenx,[],"['Bulgaria', 'Hungary', 'China', 'Austria', 'United States', 'France', 'Croatia', 'Ireland', 'Spain', 'Italy', 'Romania', 'United Kingdom', 'Poland', 'Portugal', 'Serbia', 'Germany']"
NCT07276087,Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls,Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls,RECRUITING,2025-09-11,2025-12-30,2026-01-30,OBSERVATIONAL,,30,"['Takayasu Arteritis', ""Behçet's Disease"", 'Healthy Controls']",Takayasu Arteritis,ÖZLEM NUR TOK YAMAN,"['Pamukkale University', 'Uşak University', 'Alanya Alaaddin Keykubat University']",['Turkey (Türkiye)']
NCT06465433,Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab,"An Open-Label, Multicenter, Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab",RECRUITING,2022-11-08,2027-08-29,2027-08-29,INTERVENTIONAL,PHASE2,25,['Hematologic Malignancies'],Hematologic Malignancies,Incyte Corporation,[],"['Hungary', 'Turkey (Türkiye)', 'Spain', 'South Korea', 'Italy']"
NCT04888923,Natural History of the Human Biological Response to Environmental Exposure and Injury,Natural History of The Human Biological Response to Environmental Exposure and Injury,RECRUITING,2021-11-16,2031-12-31,2031-12-31,OBSERVATIONAL,,2000,"['Inflammation', 'Normal Controls', 'Metabolic Disease']",Inflammation,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT06581900,Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA,"Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA , a Prospective Study at Reims University Hospital",RECRUITING,2024-11-27,2026-11-27,2026-12,OBSERVATIONAL,,29,['Sickle Cells Patients'],Sickle Cells Patients,CHU de Reims,[],['France']
NCT04824066,The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications,The Role of Wearable Devices in Cardiothoracic Surgery: Predicting and Detecting Early Postoperative Complications,RECRUITING,2021-07-10,2026-01-01,2027-06-30,OBSERVATIONAL,,1200,['Surgery--Complications'],Surgery--Complications,Massachusetts General Hospital,['Case Western Reserve University'],['United States']
NCT05514132,A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours,"A Phase I, Multi-centre, Open-label, Dose Exploration Study to Assess the Safety and Tolerability of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours",ACTIVE_NOT_RECRUITING,2022-09-23,2023-10-20,2026-03-31,INTERVENTIONAL,PHASE1,14,['Advanced Solid Tumours'],Advanced Solid Tumours,AstraZeneca,[],['China']
NCT07274007,Traumatic Injury of Spleen:Laparoscopic Splenectomy Vs Splenic Artery Embolization,Management of Grade III Traumatic Splenic Injury in Hemodynamically Stable Patients ; Laparoscopic Splenectomy Versus Splenic Artery Embolization by Interventional Radiology,ACTIVE_NOT_RECRUITING,2024-12-01,2025-05-31,2025-11-30,INTERVENTIONAL,NA,24,['Grade III Traumatic Splenic Injury in Hemodynamically Stable Patients'],Grade III Traumatic Splenic Injury in Hemodynamically Stable Patients,Zagazig University,[],['Egypt']
NCT06874361,Cooling to Alleviate Migraine #3,"A Prospective, Double-blind, Sham-controlled, Randomized Clinical Trial to Assess the Safety and Efficacy of the Mi-Helper Device for Acute Treatment of Migraine in an At Home Setting.",ACTIVE_NOT_RECRUITING,2025-03-24,2025-10-29,2025-12-15,INTERVENTIONAL,NA,156,"['Migraine With or Without Aura', 'Migraine', 'Migraine Headache']",Migraine With or Without Aura,"Mi-Helper, Inc.",[],['United States']
NCT06136559,A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011),"A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)",RECRUITING,2023-12-13,2032-09-07,2032-09-07,INTERVENTIONAL,PHASE3,1200,"['Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma']",Chronic Lymphocytic Leukemia,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Israel', 'Chile', 'Denmark', 'Peru', 'Thailand', 'Colombia', 'Czechia', 'Poland', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States']"
NCT07116876,Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers,An Open-Label Trial to Assess the Clinical Effectiveness of Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers,RECRUITING,2025-06-26,2026-05,2026-06,INTERVENTIONAL,NA,120,"['Diabetic Foot Ulcer (DFU)', 'Lower Extremity']",Diabetic Foot Ulcer (DFU),LifeNet Health,[],['United States']
NCT07274059,Allogeneic UCB-derived CAR-T for SLE,"Clinical Study on the Safety and Efficacy of Allogeneic, Umbilical Cord Blood Derived CAR T-cell Therapy for Refractory Systemic Lupus Erythematosus",RECRUITING,2025-03-26,2035-12-31,2037-12-31,INTERVENTIONAL,EARLY_PHASE1,48,['SLE - Systemic Lupus Erythematosus'],SLE - Systemic Lupus Erythematosus,"Chengdu Ucello Biotechnology Co., Ltd.","['The General Hospital of Western Theater Command', ""Yancheng Third People's Hospital""]",['China']
NCT06808997,Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates.,"Criteria and Reasons for Extubation and Non-extubation in Preterm Infants: A Mixed Methods Study Prospectively Exploring Extubation and Reintubation Practices in Extremely Preterm Infants, and Associated Respiratory Outcomes.",RECRUITING,2025-02-17,2025-12-22,2026-04-30,OBSERVATIONAL,,100,"['PreTerm Neonate', 'Extubation Readiness', 'Extubation Failure', 'Respiratory Morbidity', 'Bronchopulmonary Dysplasia', 'Mechanical Ventilation']",PreTerm Neonate,Centre Hospitalier Intercommunal Creteil,[],['France']
NCT07275502,Prospective Development and Validation of an Objective Classification for Difficult Facemask Ventilation: the MASCAN Score,Prospective Development and Validation of an Objective Classification for Difficult Facemask Ventilation: the MASCAN Score - Secondary Analysis of the Prospective Observational MASCAN Study,ACTIVE_NOT_RECRUITING,2022-11-07,2023-05-15,2025-11-30,OBSERVATIONAL,,423,"['Airway Management', 'Mask Ventilation', 'Noninvasive Ventilation']",Airway Management,Universitätsklinikum Hamburg-Eppendorf,[],['Germany']
NCT05327166,The Emergency Department Longitudinal Integrated Care,The Emergency Department Longitudinal Integrated Care Effectiveness Randomized Trial Targeting Opioid Use and Related Comorbidity From the ED,ACTIVE_NOT_RECRUITING,2022-04-12,2026-05-31,2026-12-31,INTERVENTIONAL,NA,500,['Opioid Use Disorder'],Opioid Use Disorder,University of Washington,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT06339138,"Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study","Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing in Blood and Urine",ACTIVE_NOT_RECRUITING,2018-06-27,2027-01-31,2027-01-31,OBSERVATIONAL,,589,"['Chromophobe Renal Cell Carcinoma', 'Clear Cell Papillary Renal Tumor', 'Clear Cell Renal Cell Carcinoma', 'Kidney Oncocytoma', 'Papillary Renal Cell Carcinoma', 'Urothelial Carcinoma']",Chromophobe Renal Cell Carcinoma,Mayo Clinic,[],['United States']
NCT07274085,A Phase 1 Study of HDM2017 in Advanced Solid Tumors,"A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Antitumor Efficacy of HDM2017 in Participants With Advanced Malignant Solid Tumors",RECRUITING,2025-11-18,2026-12-31,2027-07-01,INTERVENTIONAL,PHASE1,96,['Solid Tumors'],Solid Tumors,"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.",[],['China']
NCT02840448,Impact of Elastin Mediated Vascular Stiffness on End Organs,Impact of Elastin Mediated Vascular Stiffness on End Organs,RECRUITING,2016-12-02,2032-02-25,2032-02-25,OBSERVATIONAL,,218,"['Williams Syndrome', 'Supravalvular Aortic Stenosis', 'Cardiovascular Disease']",Williams Syndrome,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07159126,A Study of DS3610a in Participants With Advanced Solid Tumor,"A Phase 1, Open-label, Multicenter, First-in-Human Trial of DS3610a in Participants With Advanced Solid Tumor",RECRUITING,2025-10-09,2028-09-01,2031-02-01,INTERVENTIONAL,PHASE1,70,"['Solid Tumors', 'Metastatic Solid Tumors']",Solid Tumors,Daiichi Sankyo,[],['Japan']
NCT07274189,Periodontal Health and Sodium Bicarbonate Toothpaste,Maintenance of Periodontal Health With Daily Use of Sodium Bicarbonate Toothpaste,RECRUITING,2024-12-04,2026-10-20,2027-01-30,INTERVENTIONAL,NA,100,['Periodontal Diseases'],Periodontal Diseases,University of Plymouth,['HALEON'],['United Kingdom']
NCT05303519,Safusidenib Phase 2 Study in IDH1 Mutant Glioma,"A Phase 2, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Glioma",RECRUITING,2023-06-05,2027-12-01,2028-03-01,INTERVENTIONAL,PHASE2,125,"['Glioma', 'Astrocytoma, Grade IV', 'IDH1-mutant Glioma', 'Astrocytoma, IDH-Mutant, Grade 3', 'Astrocytoma, IDH-Mutant, Grade 4']",Glioma,Nuvation Bio Inc.,['AnHeart Therapeutics Inc.'],['United States']
NCT06532734,Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype,Presence of Barrett's Esophagitis in a Cohort of People With Eating Disorders Who Engage in Purging Behaviors: A Pilot Study,RECRUITING,2024-11-12,2026-11,2026-11,OBSERVATIONAL,,25,"['Barrett Esophagus', 'Anorexia Nervosa, Binge Eating/Purging Type', 'Rumination', 'Vomiting', 'Eating Disorders', 'Esophageal Adenocarcinoma']",Barrett Esophagus,Denver Health and Hospital Authority,"['Lucid Diagnostics, Inc.']",['United States']
NCT04099056,Brain Stimulation and Decision-making,Brain Stimulation Studies of Decision-making Using Repetitive Transcranial Magnetic Stimulation (rTMS) and Temporal Interference (TI),RECRUITING,2019-11-11,2028-03,2028-03,INTERVENTIONAL,NA,500,['Depression'],Depression,Emory University,['National Institute of Mental Health (NIMH)'],['United States']
NCT01558544,Cryopreservation of Ovarian Tissue,Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation,RECRUITING,1997-04,2029-10-31,2029-10-31,INTERVENTIONAL,NA,300,"['Cancer', 'Risk of Premature Ovarian Failure', 'Fertility Preservation']",Cancer,Weill Medical College of Cornell University,[],['United States']
NCT06127199,Contraceptive Efficacy Study of Ovaprene,"A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene",RECRUITING,2023-12-19,2026-06,2026-09,INTERVENTIONAL,NA,656,['Contraception'],Contraception,"Daré Bioscience, Inc.",['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT04805320,Association of Periodontal Inflammation on Immune Response in Wound Healing,Association of Periodontal Inflammation on Immune Response in Wound Healing,RECRUITING,2021-09-01,2026-06,2026-07,OBSERVATIONAL,,25,['Inflammation of Mouth'],Inflammation of Mouth,University of Nebraska,[],['United States']
NCT06882603,Efficacy of Corticosteroid Injection and Nerve Hydrodissection in Carpal Tunnel Syndrome,"Comparison of the Efficacy of Corticosteroid Injection and Saline Nerve Hydrodissection on Electrophysiological Study, Pain, Function and Sonographic Findings in the Treatment of Carpal Tunnel Syndrome: A Randomized Controlled Trial",RECRUITING,2025-10-14,2026-02-05,2026-05-05,INTERVENTIONAL,NA,90,['Carpal Tunnel Syndrome (CTS)'],Carpal Tunnel Syndrome (CTS),Kirsehir Ahi Evran Universitesi,[],['Turkey (Türkiye)']
NCT04504227,Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia,Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia,RECRUITING,2021-04-01,2026-08-31,2026-08-31,INTERVENTIONAL,NA,200,"['Dysphagia', 'Aspiration', 'Brief Resolved Unexplained Event (BRUE)', 'Apparent Life Threatening Event (ALTE)']",Dysphagia,Boston Children's Hospital,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT05782127,Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes,"A Phase I/II, Open-label, Single Arm, Multicenter Dose-finding Study Assess the Safety and Preliminary Efficacy of Oral Azacitidine CC-486 (ONUREG) in Combination With Venetoclax (VENCLYXTO) in Previously Untreated Higher-risk Myelodysplastic Syndromes Ineligible for Allogenic Transplantation",ACTIVE_NOT_RECRUITING,2023-12-06,2025-12,2028-11,INTERVENTIONAL,PHASE1,36,['Untreated Myelodysplastic Syndrome'],Untreated Myelodysplastic Syndrome,Groupe Francophone des Myelodysplasies,"['Bristol-Myers Squibb', 'AbbVie']",['France']
NCT07275567,Data-driven Development of a Core Dataset for Difficult Airway Alerts,Data-driven Development of a Core Dataset for Documentation of Difficult Airway Alerts - a Secondary Analysis of Pooled Database From Three Prospective Studies - the FingAIRprint Project,ACTIVE_NOT_RECRUITING,2019-04-01,2023-07-31,2025-11-30,OBSERVATIONAL,,1785,"['Airway Management', 'Intubation; Difficult or Failed', 'Airway Complication of Anesthesia']",Airway Management,Universitätsklinikum Hamburg-Eppendorf,[],['Germany']
NCT05304767,An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia,An Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia,RECRUITING,2022-03-07,2026-03-19,2026-03-19,INTERVENTIONAL,PHASE3,280,['Schizophrenia'],Schizophrenia,Karuna Therapeutics,[],"['Bulgaria', 'Japan', 'United States', 'Romania', 'Czechia', 'United Kingdom', 'Poland', 'Serbia', 'India']"
NCT06828471,Social Cognition Training in Individuals With Huntington's Disease,Social Cognition Training in Individuals With Huntington's Disease: A Feasibility Study,RECRUITING,2025-11-15,2027-12-15,2028-07-15,INTERVENTIONAL,NA,20,['Huntington&#39;s Disease (HD)'],Huntington&#39;s Disease (HD),Rush University Medical Center,[],['United States']
NCT07143019,The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms,"p48/64 MW HPC in Aneurysm Occlusion (PIANO): Prospective, Multicenter, Single-arm Clinical Trial to Determine Safety and Effectiveness of the Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms.",RECRUITING,2025-12,2027-05,2032-05,INTERVENTIONAL,NA,214,"['Hemorrhagic Stroke', 'Aneurysm, Intracranial', 'Saccular Aneurysm', 'Fusiform Aneurysm', 'Brain Aneurysm']",Hemorrhagic Stroke,phenox Inc.,['Phenox GmbH'],['United States']
NCT07185347,"A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene","A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene",RECRUITING,2025-10-21,2027-05-21,2027-05-21,INTERVENTIONAL,PHASE3,70,['Spinocerebellar Ataxia 27B (SCA27B)'],Spinocerebellar Ataxia 27B (SCA27B),Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06445738,Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE),"A Two-arm, Non-randomised, Prospective, Multicentre Study Using Magnetic Resonance Imaging (MRI) Findings and Pathology Features to Select Patients With Early Breast Cancer for Omission of Post-operative Radiotherapy",RECRUITING,2025-06-06,2032-06,2039-06,INTERVENTIONAL,NA,1400,"['Breast Cancer', 'Breast Cancer Female']",Breast Cancer,"Breast Cancer Trials, Australia and New Zealand",[],['Australia']
NCT05317858,Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets,A Randomized Pivotal Study Assessing the Safety and Efficacy of Targeted Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound During the Standard of Care Treatment of Brain Metastases of Non-small Cell Lung Cancer (NSCLC) Origin,RECRUITING,2022-08-12,2027-06-01,2027-12-01,INTERVENTIONAL,PHASE3,30,"['Brain Tumor', 'Non Small Cell Lung Cancer']",Brain Tumor,InSightec,[],"['United States', 'South Korea', 'Canada']"
NCT06136624,Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003),"A Phase 3 Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy (OMAHA-003)",RECRUITING,2023-12-31,2028-08-02,2028-08-02,INTERVENTIONAL,PHASE3,1310,['Prostate Cancer Metastatic'],Prostate Cancer Metastatic,Merck Sharp & Dohme LLC,"['Orion Corporation, Orion Pharma']","['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06892548,A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer,"A Phase Ib/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, Pharmacokinetics, and Recommended Combination Dose of BNT324 With BNT327 in Participants With Advanced Lung Cancer",RECRUITING,2025-05-02,2027-08,2031-06,INTERVENTIONAL,PHASE1,594,['Advanced Lung Cancer'],Advanced Lung Cancer,BioNTech SE,"['DualityBio Inc.', 'Biotheus Inc.']","['Turkey (Türkiye)', 'China', 'United States', 'United Kingdom', 'Australia']"
NCT04870255,Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS,"Modulating Probabilities: Prediction, Assessment, and Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS",ACTIVE_NOT_RECRUITING,2021-07-20,2026-12,2026-12,INTERVENTIONAL,NA,45,"['Depressive Disorder, Major', 'Borderline Personality Disorder']","Depressive Disorder, Major",Stanford University,[],['United States']
NCT00078078,Clinical and Laboratory Study of Methylmalonic Acidemia,Clinical and Basic Investigations of Methylmalonic Acidemia (MMA) and Related Disorders,RECRUITING,2004-06-07,,,OBSERVATIONAL,,2275,"['Organic Acidemia', 'Methylmalonic Acidemia', 'Inborn Errors of Metabolism']",Organic Acidemia,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06981065,The Scandinavian Displaced Lateral Clavicle Trial,"The Scandinavian Displaced Lateral Clavicle Trial (ScanDiLaC) - A Multicentre, Pragmatic, 12-Month, Non-inferiority, Randomized Controlled Trial",RECRUITING,2025-09-17,2028-12-31,2029-12-31,INTERVENTIONAL,NA,96,['Clavicle Fracture'],Clavicle Fracture,Uppsala University,[],"['Finland', 'Denmark', 'Sweden', 'Norway']"
NCT06878365,A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies,"Single-arm Open-label Trial to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BI 3000202 in Adult Patients With Selected Type 1 Interferonopathies",RECRUITING,2025-07-29,2026-12-06,2026-12-07,INTERVENTIONAL,PHASE1,18,['Type 1 Interferonopathies'],Type 1 Interferonopathies,Boehringer Ingelheim,[],"['Israel', 'Belgium', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Portugal', 'Germany']"
NCT06380101,Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC),"Prospective, Single Arm IIA Study to Evaluate the Feasibility of a Standardized Nonessential Amino Acid Restriction (NEAAR) Medical Food in Combination With Total Neoadjuvant Therapy (TNT) for Management of Locally Advanced Rectal Cancer (LARC) NEAAR-LARC",RECRUITING,2023-09-08,2026-12,2027-06,INTERVENTIONAL,NA,30,['Rectal Cancer'],Rectal Cancer,University of South Florida,[],['United States']
NCT04377594,Ablation of Fibrotic Areas in Patients With Persistent Atrial Fibrillation.,"Individually DEsigned Ablation of Low Voltage Areas in Patients With Persistent Atrial Fibrillation, a Randomized Controlled Multicenter Trial",ACTIVE_NOT_RECRUITING,2020-05-20,2026-04-11,2026-04-11,INTERVENTIONAL,NA,200,['Atrial Fibrillation'],Atrial Fibrillation,Karolinska University Hospital,[],['Sweden']
NCT07049575,Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa,A Maximal Use Trial of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa,RECRUITING,2025-11-03,2026-12-09,2026-12-09,INTERVENTIONAL,PHASE1,24,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,Incyte Corporation,[],['United States']
NCT06471829,A Trial of Lu AG13909 in Adult Participants With Cushing's Disease,"A Phase II, Multi-site, Open-label, Dose-titration Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Lu AG13909 in Adults With Cushing's Disease",RECRUITING,2024-06-19,2026-09-15,2027-11-30,INTERVENTIONAL,PHASE2,18,"[""Cushing's Disease""]",Cushing's Disease,H. Lundbeck A/S,[],"['Hungary', 'France', 'Georgia', 'Spain', 'Italy', 'Romania', 'United Kingdom']"
NCT05687266,"Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations","A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic NSCLC Without Actionable Genomic Alterations (D926NC00001; AVANZAR)",ACTIVE_NOT_RECRUITING,2022-12-29,2027-11-01,2027-11-01,INTERVENTIONAL,PHASE3,1350,['NSCLC'],NSCLC,AstraZeneca,[],"['Bulgaria', 'Japan', 'China', 'Hungary', 'France', 'Peru', 'South Korea', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Vietnam', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT07274072,Hospital at Home Versus Inpatient Care: Costs and Effectiveness,Hospital at Home Versus Inpatient Care: Costs and Effectiveness,RECRUITING,2025-09-01,2026-08-31,2026-08-31,OBSERVATIONAL,,200,"['Costs and Cost Analysis', 'Effectiveness', 'Patient Satisfaction']",Costs and Cost Analysis,Hospital at Home AG,"['Klinik Hirslanden, Zurich']",['Switzerland']
NCT01166893,Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential,Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential,RECRUITING,2010-03,2028-02,2030-02,OBSERVATIONAL,,200,['Skin Burn Multiple'],Skin Burn Multiple,"University of California, Irvine",['National Institute of General Medical Sciences (NIGMS)'],['United States']
NCT05780775,Lipid Balance in Adult Sickle Cell Patients,"Study of Lipid Balance in Adult Sickle Cell SS or SC Patients at Steady State and According to Clinical Phenotypes and During Acute Complications Acronym : ""HDL2""",ACTIVE_NOT_RECRUITING,2022-11-30,2027-11-30,2027-11-30,INTERVENTIONAL,NA,116,"['Sickle Cell Disease', 'Dyslipidemia', 'Complication']",Sickle Cell Disease,Centre Hospitalier Universitaire de la Guadeloupe,"[""Direction Générale de l'Offre de Soins""]",['Guadeloupe']
NCT07274449,Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors,Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors,ACTIVE_NOT_RECRUITING,2025-05-08,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE1,6,['Advanced Solid Cancers'],Advanced Solid Cancers,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,[],['China']
NCT06865417,A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis,"A Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Filgotinib, With Single Arm Induction and Maintenance, in Pediatric Subjects (8 to <18 Years of Age) With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2025-09-29,2028-06,2028-06,INTERVENTIONAL,PHASE3,80,['Ulcerative Colitis'],Ulcerative Colitis,Alfasigma S.p.A.,[],"['Belgium', 'Norway', 'France', 'Croatia', 'Ireland', 'Spain', 'Italy', 'Romania', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT05707806,Development and Validation of Learning and Decision-Making Tasks,Development and Validation of Learning and Decision-Making Tasks,RECRUITING,2023-03-29,2032-12-31,2032-12-31,OBSERVATIONAL,,550,['Normal Physiology'],Normal Physiology,National Institute on Drug Abuse (NIDA),[],['United States']
NCT05206084,A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease,"A Prospective, Multi-Center, Single-Blinded, Randomized Trial of the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System in Patients With Coronary Artery Disease: IRONMAN-II",ACTIVE_NOT_RECRUITING,2022-03-10,2024-12-29,2028-01,INTERVENTIONAL,NA,518,['Coronary Artery Disease'],Coronary Artery Disease,"Biotyx Medical (Shenzhen) Co., Ltd.",[],['China']
NCT03587038,OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma,Feasibility Pilot Study of OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma,ACTIVE_NOT_RECRUITING,2018-09-03,2020-12-23,2026-11,INTERVENTIONAL,PHASE1,27,['Glioblastoma'],Glioblastoma,University of Oklahoma,[],['United States']
NCT04128969,Causal Mechanisms in Adolescent Arterial Stiffness,Causal Mechanisms in Adolescent Arterial Stiffness,ACTIVE_NOT_RECRUITING,2020-02-01,2026-06-01,2026-08-31,INTERVENTIONAL,PHASE2,90,"['Lipid Disorder', 'Dyslipidemias', 'Aortic Stiffness', 'Insulin Resistance Syndrome', 'Metabolic Syndrome', 'Pediatric Obesity']",Lipid Disorder,Baylor College of Medicine,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT03320304,A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.,"A Global PRospective, Multi-cEnter, ObServational Post-markeT Study tO Assess shoRt, Mid and Long-term Effectiveness and Efficiency of VNS Therapy® as Adjunctive Therapy in reaL-world patIents With diFficult to Treat dEpression.",RECRUITING,2017-12-14,2029-12-01,2031-12-01,OBSERVATIONAL,,500,['Treatment Resistant Depression'],Treatment Resistant Depression,LivaNova,[],"['United Kingdom', 'Belgium', 'Austria', 'Germany']"
NCT06904807,A Phase I Study to Evaluate LIFE-001,"A Phase I, Single Ascending and Multiple Ascending Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LIFE-001",RECRUITING,2025-04-07,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE1,120,['Healthy Volunteers'],Healthy Volunteers,LifeMine Therapeutics,[],['Australia']
NCT05552547,Home BP Monitoring,Home BP Monitoring for Diagnosis of Hypertension in African American Adolescents,RECRUITING,2023-10-01,2026-09-30,2026-09-30,INTERVENTIONAL,NA,750,['High Blood Pressure'],High Blood Pressure,University Hospitals Cleveland Medical Center,[],['United States']
NCT06853626,One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care,Improved Management of Acute Chest Pain in Emergency Primary Care. The OUT-POC Study (One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care),RECRUITING,2025-06-27,2026-12-31,2029-12-31,INTERVENTIONAL,NA,2500,"['Acute Myocardial Infarction (AMI)', 'Chest Pain', 'Acute Coronary Syndromes (ACS)', 'Non-cardiac Chest Pain', 'Troponin', 'Point of Care Testing', 'Out-of-hours Medical Care', 'Primary Care']",Acute Myocardial Infarction (AMI),University of Oslo,"['Norwegian Health Association', 'Oslo University Hospital', 'QuidelOrtho', 'Vestre Viken Hospital Trust', 'The Dam Foundation', 'Amsterdam UMC', 'Sørlandet Hospital']",['Norway']
NCT07274306,"Incidence, Treatment and Outcome After Acute Mesenteric Ischemia in the Region of Västra Götaland, 2000-2023.","Incidence, Treatment of and Outcome of Acute Mesenteric Ischemia in the Region of Västra Götaland, 2000-2023 - a Retrospective Observational Study",ACTIVE_NOT_RECRUITING,2025-02-24,2025-12,2026-01,OBSERVATIONAL,,2446,['Mesenteric Artery Ischemia'],Mesenteric Artery Ischemia,Sahlgrenska University Hospital,"['Gothia Forum - Center for Clinical Trial', 'Göteborg University']",['Sweden']
NCT05464381,"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)","A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Trial to Investigate the Safety and Efficacy of ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) on Epidermolysis Bullosa (EB)",ACTIVE_NOT_RECRUITING,2023-06-13,2025-08-29,2027-01,INTERVENTIONAL,PHASE3,91,['Epidermolysis Bullosa'],Epidermolysis Bullosa,RHEACELL GmbH & Co. KG,[],"['Hungary', 'Austria', 'France', 'Chile', 'Spain', 'Taiwan', 'Italy', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Argentina']"
NCT07222072,Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study,Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study,RECRUITING,2025-12-01,2027-10,2028-10,INTERVENTIONAL,PHASE4,120,"['Post Operative Pain', 'Spinal Surgery']",Post Operative Pain,The Cleveland Clinic,[],['United States']
NCT06295692,A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis,"A Phase 3, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis",ACTIVE_NOT_RECRUITING,2024-02-09,2025-01-14,2027-10-14,INTERVENTIONAL,PHASE3,19,"['Generalized Pustular Psoriasis', 'Erythrodermic Psoriasis']",Generalized Pustular Psoriasis,Janssen Pharmaceutical K.K.,[],['Japan']
NCT02523040,Lenalidomide for Adult Histiocyte Disorders,A Phase II Study of Lenalidomide for Adult Histiocyte Disorders,ACTIVE_NOT_RECRUITING,2015-08,2024-02,2026-02,INTERVENTIONAL,PHASE2,12,"['Langerhans Cell Histiocytosis (LCH)', 'Histiocytoses Erdheim-chester Disease', 'Histiocytic Sarcoma (HS)']",Langerhans Cell Histiocytosis (LCH),Dana-Farber Cancer Institute,['Celgene'],['United States']
NCT07134231,Clinical Study to Evaluate the Anti-cavity Efficacy of Three Dentifrices: An In Situ Model,In Situ Evaluation of the Anti-cavity Efficacy of Three Dentifrices Using an Intra-oral Enamel Demineralization-Remineralization Model,ACTIVE_NOT_RECRUITING,2025-10-09,2025-12,2025-12,INTERVENTIONAL,PHASE3,36,"['Demineralization', 'Remineralization', 'Dental Cavity', 'Enamel Lesions']",Demineralization,Colgate Palmolive,['Federal University of Alagoas'],['Brazil']
NCT07274761,Neoadjuvant Sunvozertinib in Stage II-IIIB Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutation.,"A Phase II, Single-arm, Single-center Study of Neoadjuvant Sunvozertinib for Stage II-IIIB Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations.",ACTIVE_NOT_RECRUITING,2024-10-17,2030-05-01,2030-05-01,INTERVENTIONAL,PHASE2,24,"['Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer', 'Non Small Cell Lung Cancer']",Potentially Resectable EGFR Exon 20 Insertion Non-Small Cell Lung Cancer,"Shanghai Pulmonary Hospital, Shanghai, China",[],['China']
NCT06835569,A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations,A Phase 1/1b Multiple Cohort Trial of ALTA3263 in Patients With Advanced Solid Tumors With KRAS Mutations,RECRUITING,2025-03-05,2029-05,2029-08,INTERVENTIONAL,PHASE1,188,"['Cancer', 'PDAC - Pancreatic Ductal Adenocarcinoma', 'NSCLC (Non-small Cell Lung Cancer)', 'CRC (Colorectal Cancer)', 'Advanced Solid Tumors']",Cancer,"Alterome Therapeutics, Inc.",[],['United States']
NCT04820400,Reducing Pain and Anxiety During Dressing Changes After Burn Surgery Using Virtual Reality,BURN 360: Reducing Pain and Anxiety During Dressing Changes After Burn Surgery Using Virtual Reality,ACTIVE_NOT_RECRUITING,2021-03-24,2025-12,2025-12,INTERVENTIONAL,NA,80,"['Pain, Postoperative', 'Trauma', 'Burns']","Pain, Postoperative",Sunnybrook Health Sciences Centre,[],['Canada']
NCT07187531,SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes,"A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Parallel-Arm Dose Finding Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients With Stage 3 New Onset of Type 1 Diabetes (NOT1D)",RECRUITING,2025-11-25,2027-11,2028-12,INTERVENTIONAL,PHASE2,159,['Type 1 Diabetes'],Type 1 Diabetes,"SAb Biotherapeutics, Inc.",[],"['Belgium', 'New Zealand', 'Austria', 'United States', 'France', 'Germany', 'Slovenia', 'Finland', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Lithuania', 'Australia']"
NCT06892522,"A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; Carfilzomib","A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of Etentamig Monotherapy or Etentamig Combinations in Subjects With Multiple Myeloma",RECRUITING,2025-06-30,2036-02,2036-03,INTERVENTIONAL,PHASE1,440,['Multiple Myeloma'],Multiple Myeloma,AbbVie,[],"['Israel', 'Japan', 'United States', 'Australia']"
NCT07274267,Inspiratory Muscle Training in Patients With Inflammatory Myopathy,The Effect of Inspiratory Muscle Training on the Functional Status of Patients With Inflammatory Myopathy,RECRUITING,2024-08-12,2026-12,2026-12,INTERVENTIONAL,NA,33,['Inflammatory Myopathies'],Inflammatory Myopathies,Józef Piłsudski University of Physical Education,[],['Poland']
NCT07256652,How Does YES Bar Affect Blood Glucose Levels?,How Does YES Bar Affect Blood Glucose Levels?,RECRUITING,2025-08-25,2026-08-25,2026-08-25,INTERVENTIONAL,NA,100,['Blood Glucose Monitoring'],Blood Glucose Monitoring,"Efforia, Inc",[],['United States']
NCT07066241,"Virtual Reality on Stress, Pain Levels in Patients With Hyperthyroidism Undergoing Biopsy","Hospital, Interventional Radiology Unit",RECRUITING,2025-07-10,2025-12-10,2025-12-10,INTERVENTIONAL,NA,50,"['Virtual Reality', 'Hyperthyroidism']",Virtual Reality,Yuzuncu Yil University,[],['Turkey (Türkiye)']
NCT06243211,Spinal Decompression Plus Nerve Graft Implantation Following TSCI,Minimizing Secondary Injury in Patient With SCI Using Expansive Duroplasty,RECRUITING,2024-04-19,2026-12-31,2026-12-31,INTERVENTIONAL,NA,10,"['Spinal Cord Injuries', 'Acute Traumatic Spinal Cord Injury']",Spinal Cord Injuries,Francis Farhadi,['Spinal Cord and Brain Injury Research Center (SCOBIRC)'],['United States']
NCT06425016,Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy,Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy (EARLY): A Randomized Controlled Trial on Early Postoperative Pain,RECRUITING,2024-07-17,2026-09-01,2027-04-30,INTERVENTIONAL,NA,91,"['Post Operative Pain', 'Laparoscopic Sleeve Gastrectomy', 'Robotic Sleeve Gastrectomy', 'Obesity', 'Bariatric Surgery Candidate', 'Quality of Life']",Post Operative Pain,Ricard Corcelles,[],['United States']
NCT06999616,Physical Activity in Cancer Patients in an Oncology Day Clinic - Implementing a Person-centered Program Led by Nurses,Promoting Physical Activity in Individuals With Cancer in an Oncology Day Clinic - Testing the Feasibility of the Implementation of a Physical Activity Concept Within an Interprofessional Team Led by Nurses OnkoMoveNurse - Proof of Concept,RECRUITING,2025-08-01,2026-03-30,2026-08-31,OBSERVATIONAL,,50,"['Neoplasms', 'Motor Activity', 'Chemotherapy', 'Antitumor Drugs', 'Activity Level']",Neoplasms,St.Gallen University of Applied Sciences,['Kantonsspital Münsterlingen'],['Switzerland']
NCT07182500,The Effect of Bifidobacterium Probiotics on Gut Microbiota Changes in Healthy Adults During Short-term Travel Along the Silk Road,The Effect of Bifidobacterium Probiotics on Gut Microbiota Changes in Healthy Adults During Short-term Travel Along the Silk Road,RECRUITING,2025-10-16,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,75,['Healthy Adult Volunteer'],Healthy Adult Volunteer,Universiti Sains Malaysia,['Shanghai Jiao Tong University School of Medicine'],"['China', 'Malaysia']"
NCT06559241,Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）,"Safety and Efficacy of Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy (RECAST-MT): A Multicenter, Randomized, Controlled, Open-label, Blinded Endpoint Trial",RECRUITING,2024-09-23,2026-11,2027-02,INTERVENTIONAL,PHASE3,2105,"['Acute Ischemic Stroke', 'Anterior Circulation Brain Infarction']",Acute Ischemic Stroke,Capital Medical University,[],['China']
NCT05184556,Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders,Project HOME: Home-Based Treatment Options and Mechanisms for Eating Disorders,ACTIVE_NOT_RECRUITING,2022-08-01,2026-03-30,2026-04-30,INTERVENTIONAL,NA,77,"['Anorexia Nervosa', 'Eating Disorders']",Anorexia Nervosa,University of Pittsburgh,"['National Institute of Mental Health (NIMH)', 'Lifespan', 'Rhode Island College']",['United States']
NCT07220577,"Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis","A Multicenter, Randomized, Participant- and Investigator -Blinded, Placebo-controlled, Phase 2a Study to Assess the Efficacy, Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis",RECRUITING,2025-11-10,2027-05-24,2027-09-13,INTERVENTIONAL,PHASE2,84,['Atopic Dermatitis'],Atopic Dermatitis,Novartis Pharmaceuticals,[],"['Singapore', 'United States', 'Canada']"
NCT07059000,A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP),"A Phase III, Open-label, Single Arm, Prospective, Multicenter Study to Assess Efficacy and Safety of Kedrion Intravenous Human Normal Immunoglobulin (IVIg) 10% in Adult Patients With Chronic Immune Thrombocytopenia (ITP)",RECRUITING,2025-08-13,2026-08,2026-08,INTERVENTIONAL,PHASE3,40,['Chronic Primary Immune Thrombocytopenia (ITP)'],Chronic Primary Immune Thrombocytopenia (ITP),Kedrion S.p.A.,['ICON plc'],"['Turkey (Türkiye)', 'United States', 'Spain', 'Italy', 'Romania', 'Czechia', 'Serbia', 'Germany']"
NCT03024008,Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II,A Multicenter Study to Evaluate the Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II,RECRUITING,2017-07-27,2027-03,2027-06,INTERVENTIONAL,PHASE1,40,['Bone Fracture'],Bone Fracture,BonusBio Group Ltd,[],['Israel']
NCT05967299,Study of Intravenous ZMA001 in Healthy Subjects,"A Phase 1 Single-Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous ZMA001 in Healthy Subjects",RECRUITING,2023-11-27,2027-09-01,2027-11-30,INTERVENTIONAL,PHASE1,96,['Pulmonary Arterial Hypertension PAH'],Pulmonary Arterial Hypertension PAH,"National Heart, Lung, and Blood Institute (NHLBI)","['Zymedi, Co., Ltd.']",['United States']
NCT07259512,Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure,"Comparative Effects of Single Versus Twice-Daily Ramipril Dosing on Renal Function in Patients With Chronic Kidney Disease and Heart Failure With Reduced Ejection Fraction: Evaluation of Plasma Renin Activity, Malondialdehyde, Interleukin-6, Albuminuria, and Cystatin C",RECRUITING,2025-06-30,2025-12-31,2026-01-31,INTERVENTIONAL,PHASE4,80,"['Chronic Kidney Disease', 'Heart Failure With Reduced Ejection Fraction (HFrEF)']",Chronic Kidney Disease,Evi Liliek Wulandari,[],['Indonesia']
NCT06285604,Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia,Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia,ACTIVE_NOT_RECRUITING,2024-09-10,2025-12-30,2025-12-31,OBSERVATIONAL,,200,['Neonatal Anemia'],Neonatal Anemia,Women's Hospital School Of Medicine Zhejiang University,[],['China']
NCT07274735,Combined Effects of INF and OEP in Patients With Diabetic Peripheral Neuropathy,"Combined Effect Of Intraneural Facilitation Therapy And Otago Exercise On Pain, Balance And Quality Of Life In Patients With Diabetic Peripheral Neuropathy",RECRUITING,2024-10-17,2026-01-17,2026-01-17,INTERVENTIONAL,NA,65,['Diabetic Peripheral Neuropathy'],Diabetic Peripheral Neuropathy,Riphah International University,[],['Pakistan']
NCT07041008,Cognitive Stimulation in Older Adults With Alzheimer's Disease,Cognitive Stimulation in Older Adults With Alzheimer's Disease: Effects Across Multiple Domains and in Institutional and Sociogeographic Contexts,RECRUITING,2025-09-01,2025-09-13,2026-04-30,INTERVENTIONAL,NA,514,"['Dementia', 'Neurocognitive Disorders', 'Cognitive Impairment', 'Cognitive Dysfunction', 'Cognitive Decline']",Dementia,"Rsocialform - Geriatria, Lda",[],['Portugal']
NCT04144023,A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ,A Phase IB Trial of Neoadjuvant Multi-Epitope HER2 Peptide Vaccine in Patients With HER2-Expressing DCIS,RECRUITING,2019-06-27,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE1,43,['Breast Ductal Carcinoma In Situ'],Breast Ductal Carcinoma In Situ,Mayo Clinic,[],['United States']
NCT07204340,TLN-372 in Advanced KRAS Mutant Solid Tumors,"An Open-Label, Multicenter, Phase 1 Trial to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of TLN-372 as a Single Agent and in Combination With Other Anti-Tumor Agents, in Patients With Advanced KRAS Mutant Solid Tumors",RECRUITING,2025-09-29,2031-12-03,2032-04-01,INTERVENTIONAL,PHASE1,240,['KRAS Mutant Solid Tumors'],KRAS Mutant Solid Tumors,"Treeline Biosciences, Inc.",[],"['United States', 'Australia']"
NCT05323591,Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France,"A Prospective, Non-interventional Study in Patients With Moderate to Severe Active Rheumatoid Arthritis in France Receiving Filgotinib for 2 Years",ACTIVE_NOT_RECRUITING,2022-05-03,2026-07,2026-07,OBSERVATIONAL,,155,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Alfasigma S.p.A.,[],['France']
NCT02374242,Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases,A Phase II Study of Nivolumab and Nivolumab Combined With Ipilimumab in Patients With Melanoma Brain Metastases,ACTIVE_NOT_RECRUITING,2014-11-04,2017-09-04,2028-12,INTERVENTIONAL,PHASE2,76,"['Melanoma', 'Brain Metastases']",Melanoma,Melanoma Institute Australia,"['Melanoma and Skin Cancer Trials Limited', 'Bristol-Myers Squibb']",['Australia']
NCT07275749,Acetyl-leucine in Post-stroke Ataxia,The Safety and Efficacy of Acetyl-leucine in Post-stroke Ataxia: a Randomized Placebo-controlled Trial,RECRUITING,2025-12-01,2026-07-01,2026-07-20,INTERVENTIONAL,PHASE3,200,['Ischemic Stroke'],Ischemic Stroke,Kafrelsheikh University,[],['Egypt']
NCT05866536,Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years,Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years,RECRUITING,2023-05-04,2028-05,2028-05,INTERVENTIONAL,PHASE2,100,"['Diabetes Mellitus', 'Type 1 Diabetes', 'Diabetes type1', 'Autoimmune Diabetes']",Diabetes Mellitus,Massachusetts General Hospital,[],['United States']
NCT07123909,Studies on Adsorption International Learning Initiative Global,The Use of Sorption Technologies in Patients Receiving Program Hemodialysis With Inflammatory Syndrome,RECRUITING,2025-06-01,2026-03-31,2026-06-30,INTERVENTIONAL,NA,60,"['CKD (Chronic Kidney Disease) Stage 5D', 'Uremia; Chronic', 'Uremic; Toxemia', 'Inflammation Chronic', 'Hemodialysis', 'Inflammation Biomarkers', 'Dialysis Related Complication', 'Anemia Associated With End Stage Renal Disease']",CKD (Chronic Kidney Disease) Stage 5D,Botkin Hospital,[],['Russia']
NCT07053072,PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.,A Prospective，Single Arm Clinicial Trial Evaluating PD-1 mRNA LNP Vaccine for the Treatment of Advanced Primary Hepatocellular Carcinoma Failing Standard Therapy,RECRUITING,2025-10-23,2026-09-30,2026-12-30,INTERVENTIONAL,PHASE1,9,['Liver Cancer'],Liver Cancer,West China Hospital,[],['China']
NCT06056271,Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation,Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation,RECRUITING,2024-03-19,2027-12,2027-12,OBSERVATIONAL,,400,['Atrial Fibrillation'],Atrial Fibrillation,Volta Medical,"['Heart Rhythm Clinical and Research Solutions, LLC']",['United States']
NCT06208514,Brief Pain Exposure Therapy (BPET) For Nociplastic Pain,Brief Pain Exposure Therapy (BPET) For Nociplastic Pain,RECRUITING,2024-03-04,2026-04,2026-07,INTERVENTIONAL,NA,125,"['Fibromyalgia', 'Lupus Erythematosus, Systemic', 'Chronic Pelvic Pain', 'Chronic Low Back Pain (CLBP)']",Fibromyalgia,University of Michigan,[],['United States']
NCT05012111,Natural History of Acquired and Inherited Bone Marrow Failure Syndromes,The Natural History of Acquired and Inherited Bone Marrow Failure Syndromes,RECRUITING,2021-10-25,2041-02-04,2041-02-04,OBSERVATIONAL,,1000,"['Severe Aplastic Anemia', 'Telomere Biology Disorders', 'Inherited Bone Marrow Failure Syndromes']",Severe Aplastic Anemia,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT03514108,DANHEART (H-HeFT and Met-HeFT),"A Randomized, Double-blind, Placebo Controlled Study (DANHEART): Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) and Metformin in Patients With Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT)",RECRUITING,2018-03-01,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE4,1500,"['Heart Failure', 'Diabetes']",Heart Failure,Henrik Wiggers,"['Danish Heart Foundation', 'Danish Council for Independent Research', 'The Danish Regions: Foundation for Medical Research', 'The Novo Nordisk Foundation', 'The Aase og Ejnar Danielsen Foundation']",['Denmark']
NCT05458908,ProSPective Evaluation of Non-contrast sINe spiN Flat-dEtectoR CT for the Detection of Intracranial hemorrhageS,ProSPective Evaluation of the dIagnostic Accuracy of siNe spiN Noncontrast Flat-dEtectoR CT (FDCT) for the Detection of Intracranial Hemorrhage in Stroke Patients,ACTIVE_NOT_RECRUITING,2022-10-25,2025-12-31,2025-12-31,INTERVENTIONAL,NA,252,['Stroke'],Stroke,"University Hospital, Basel, Switzerland",['Siemens Healthineers AG'],"['United States', 'France', 'Finland', 'Switzerland', 'Spain']"
NCT04700527,The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study,LCCC2032: The Effects of Short Chain Fatty Acid Supplementation on the Quality of Life and Treatment-related Toxicities in Subjects Receiving Abdominopelvic Radiotherapy: A Randomized Controlled Study,RECRUITING,2023-12-15,2026-04-21,2030-05,INTERVENTIONAL,PHASE1,122,"['Toxicity', 'Radiation Toxicity']",Toxicity,UNC Lineberger Comprehensive Cancer Center,[],['United States']
NCT07275528,Effects of Task Oriented Circuit Training on Functional Mobility and Activity Participation in Cerebral Palsy,Effects of Task Oriented Circuit Training on Functional Mobility and Activity Participation in Cerebral Palsy,RECRUITING,2025-09-13,2025-12-10,2026-01-10,INTERVENTIONAL,NA,34,"['Cerebral Palsy (CP)', 'Functional Mobility']",Cerebral Palsy (CP),Foundation University Islamabad,[],['Pakistan']
NCT06555939,Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease,Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease,RECRUITING,2025-10-23,2029-09,2030-09,INTERVENTIONAL,NA,25,['Sickle Cell Disease'],Sickle Cell Disease,Boston Children's Hospital,['National Institutes of Health (NIH)'],['United States']
NCT07229560,A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants,"The Effect of Itraconazole on the Pharmacokinetics of Orally Administered HRS-8080 in Healthy Participants: A Single-Center, Single-Arm, Open-Label, Fixed-Sequence Study",ACTIVE_NOT_RECRUITING,2025-11-26,2025-12,2025-12,INTERVENTIONAL,PHASE1,16,['Breast Cancer'],Breast Cancer,"Shandong Suncadia Medicine Co., Ltd.",[],['China']
NCT05062291,Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP),"Prospective, Multicenter, Observational Study to Evaluate the Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion Within the Dialysis Outflow Circuit of an Arteriovenous (AVF) Fistula or AV Graft (AVG) (The WRAP Registry)",ACTIVE_NOT_RECRUITING,2022-06-23,2026-04-15,2027-10-15,OBSERVATIONAL,,500,"['Venous Stenosis', 'Venous Occlusion']",Venous Stenosis,"Merit Medical Systems, Inc.",[],"['Brazil', 'Israel', 'New Zealand', 'Netherlands', 'United Kingdom', 'Australia', 'Greece', 'Portugal', 'Germany']"
NCT07274813,"A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors","A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX37 (Recombinant Human Bispecific Antibodies Against PD-L1 and VEGF) in Patients With Advanced/Metastatic Solid Tumors",ACTIVE_NOT_RECRUITING,2025-11-28,2027-03-30,2028-12-30,INTERVENTIONAL,EARLY_PHASE1,254,"['Advanced/Metastatic Solid Tumors', 'NSCLC']",Advanced/Metastatic Solid Tumors,Shanghai Henlius Biotech,[],['China']
NCT04477460,Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event,Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event,RECRUITING,2021-04-01,2026-08-31,2026-08-31,OBSERVATIONAL,,250,"['Brief Resolved Unexplained Event', 'Apparent Life Threatening Event', 'Oropharyngeal Dysphagia']",Brief Resolved Unexplained Event,Boston Children's Hospital,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT07242586,PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas,PS-Trauma: Udvikling af Traumebehandling Til Psykiatriske Patienter Med Psykoselidelse - et Pilotstudie.,RECRUITING,2025-10-02,2026-05-31,2026-06-30,INTERVENTIONAL,NA,20,"['SCHIZOPHRENIA 1 (Disorder)', 'Schizotypal Disorder', 'Post Traumatic Stress Symptoms']",SCHIZOPHRENIA 1 (Disorder),Nikolai Albert,[],['Denmark']
NCT06063850,AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy,"A Multi-center, Phase 1/2a, First-in-human (FIH) Study Investigating the Safety, Tolerability, and Efficacy of AMT-260 in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy (MTLE) Administered Via Magnetic Resonance Imaging (MRI)-Guided Convection-enhanced Delivery (CED)",RECRUITING,2024-06-12,2026-11-30,2031-12,INTERVENTIONAL,PHASE1,12,['Mesial Temporal Lobe Epilepsy'],Mesial Temporal Lobe Epilepsy,UniQure Biopharma B.V.,[],['United States']
NCT03212170,FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer,[18F]Fluorofuranylnorprogesterone (FFNP) PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer,ACTIVE_NOT_RECRUITING,2017-12-13,2024-11-14,2026-01,INTERVENTIONAL,PHASE2,21,['Invasive Breast Cancer'],Invasive Breast Cancer,"University of Wisconsin, Madison",['National Center for Advancing Translational Sciences (NCATS)'],['United States']
NCT06782373,A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS),"PAXIS: A Randomized, Double-blind, Placebo-controlled Dose-finding Phase 2 Study (Part 1) Followed by an Open-label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients With VEXAS Syndrome",ACTIVE_NOT_RECRUITING,2025-05-28,2027-08,2027-08,INTERVENTIONAL,PHASE2,78,"['VEXAS', 'VEXAS Syndrome']",VEXAS,Swedish Orphan Biovitrum,['PSI CRO'],"['Japan', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT02327897,NHALES (Natural History of Asthma With Longitudinal Environmental Sampling),Natural History of Asthma With Longitudinal Environmental Sampling,RECRUITING,2015-09-10,2030-04-01,2030-04-01,OBSERVATIONAL,,400,['Asthma'],Asthma,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT07275983,"Total Knee Replacement Under Spinal Anesthesia, Comparison of Postoperative Recovery Versus General Anesthesia","Total Knee Replacement Under Spinal Anesthesia, Comparison of Postoperative Recovery Versus General Anesthesia: A Retrospective Single-Center Observational Comparative Superiority Study",RECRUITING,2024-05-03,2025-12-03,2025-12-03,OBSERVATIONAL,,500,['Total Knee Replacement'],Total Knee Replacement,"University Hospital, Strasbourg, France",[],['France']
NCT07263945,Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes,Influence of Prosthetic Foot Stiffness on Transtibial Osseointegrated Bone-Anchored Limb Outcomes,RECRUITING,2025-11-25,2030-05-31,2030-05-31,INTERVENTIONAL,PHASE1,60,"['Amputation', 'Transtibial Amputation - Unilateral', 'Bone Anchored Devices', 'Osseointegration']",Amputation,"University of Colorado, Denver",['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT07275957,Combined Nutrition and Exercise Interventions in Women With Breast Cancer History,"Study of the Effects of Implementing Dietary-nutritional Strategies and an Exercise Program at the Physical, Physiological, and Psychological Level in Women With a History of Breast Cancer.",ACTIVE_NOT_RECRUITING,2023-09-01,2025-12-31,2026-06-30,INTERVENTIONAL,NA,120,['Breast Cancer Survivors'],Breast Cancer Survivors,University of Alicante,[],['Spain']
NCT07274436,The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning,The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning,RECRUITING,2025-08-01,2026-08-01,2026-08-01,OBSERVATIONAL,,50,['Cardiac Disease'],Cardiac Disease,Lian Yang,[],['China']
NCT07224802,Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting,An Exosome-based Liquid Biopsy Signature for Preoperative Identification of Occult Liver Metastasis in Patients With Pancreatic Ductal Adenocarcinoma,RECRUITING,2024-06-21,2026-06-18,2026-06-18,OBSERVATIONAL,,400,['PDAC - Pancreatic Ductal Adenocarcinoma'],PDAC - Pancreatic Ductal Adenocarcinoma,City of Hope Medical Center,[],['United States']
NCT05013892,NTS-WBRT in Brain Metastases,Phase II Trial of Normal Tissue Sparing Whole Brain Radiation Therapy (NTS-WBRT) in Patients With Brain Metastases,RECRUITING,2022-02-08,2025-12-31,2027-12-31,INTERVENTIONAL,PHASE2,41,['Brain Metastases'],Brain Metastases,Massachusetts General Hospital,[],['United States']
NCT07225582,Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia,Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia: A Sub-study of the Reconnecting the Hand and Arm to the Brain (ReHAB) Clinical Trial,RECRUITING,2026-01-01,2030-09-01,2030-09-01,INTERVENTIONAL,NA,3,"['Spinal Cord Injury Cervical', 'Spinal Cord Injuries (Complete and Incomplete)']",Spinal Cord Injury Cervical,Case Western Reserve University,"['University Hospitals Cleveland Medical Center', 'Cleveland Clinic Lerner Research Institute']",['United States']
NCT06943859,Ketamine for Opioid Use Disorder,Ketamine for the Treatment of Opioid Use Disorder,RECRUITING,2025-12,2028-08-31,2029-08-31,INTERVENTIONAL,PHASE2,50,['Opioid Use Disorder'],Opioid Use Disorder,"University of Maryland, Baltimore",[],['United States']
NCT02553460,Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I,Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I,ACTIVE_NOT_RECRUITING,2016-01-29,2022-05-10,2031-10,INTERVENTIONAL,PHASE1,50,['Acute Lymphoblastic Leukemia'],Acute Lymphoblastic Leukemia,St. Jude Children's Research Hospital,"['Gateway for Cancer Research', 'Baylor College of Medicine']","['United States', 'Canada']"
NCT07239817,PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach,PENG 360°: PENG Block + LIA Nella Endoprotesi di Anca Con Accesso Anteriore.,RECRUITING,2025-12-01,2026-04-30,2026-04-30,INTERVENTIONAL,NA,100,"['Hip Fractures', 'Arthroplasty, Replacement, Hip', 'Pain, Postoperative', 'Anesthesia and Analgesia', 'Nerve Block', 'Local Anesthesia Infiltration']",Hip Fractures,ASST Gaetano Pini-CTO,[],['Italy']
NCT07275021,"Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates",The Vision Study: Cerebral/ Cortical Visual Impairment (CVI),RECRUITING,2025-07-07,2027-12-31,2028-12-31,OBSERVATIONAL,,60,"['Preterm Less Than 32wks With IVH, WMI/PVL', 'Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE']","Preterm Less Than 32wks With IVH, WMI/PVL",Brigham and Women's Hospital,"[""Boston Children's Hospital""]",['United States']
NCT06202989,Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty,Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty: A Blinded Randomized Controlled Trial,RECRUITING,2024-09-09,2026-02-01,2026-04-01,INTERVENTIONAL,PHASE3,288,['Postsurgical Pain'],Postsurgical Pain,KAZM Pharmaceuticals Inc.,['McMaster University'],['Canada']
NCT07239310,Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease,"A Prospective, Multicenter, Randomized, Double-Blind, Parallel-Group, Confirmatory Clinical Trial to Verify the Efficacy and Safety of the Cognitive Improvement Effect on Executive Function in Medication-Treated Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease Using the Neuclare Physical Device for Medical Use",RECRUITING,2025-11-20,2026-06,2026-07,INTERVENTIONAL,NA,138,"['Mild Cognitive Impairment', ""Alzheimer's Disease(AD)""]",Mild Cognitive Impairment,Deepsonbio,[],['South Korea']
NCT03754114,"Brain Oxygen Optimization in Severe TBI, Phase 3",Brain Oxygen Optimization in Severe TBI (BOOST3): A Comparative Effectiveness Study to Test the Efficacy of a Prescribed Treatment Protocol Based on Monitoring the Partial Pressure of Brain Tissue Oxygen.,RECRUITING,2019-08-28,2027-11-01,2027-11-01,INTERVENTIONAL,NA,1094,"['Brain Injuries, Traumatic']","Brain Injuries, Traumatic",University of Michigan,"['National Institute of Neurological Disorders and Stroke (NINDS)', 'University of Washington', 'University of Pennsylvania', 'University of Pittsburgh', 'Medical University of South Carolina']","['United States', 'Canada']"
NCT05991804,Upper Limb Spinal Cord Stimulation for Rehabilitation Enhancement,Upper Limb Spinal Cord Stimulation for Rehabilitation Enhancement,RECRUITING,2023-06-28,2028-04-16,2028-04-16,INTERVENTIONAL,NA,18,['Spinal Cord Injuries'],Spinal Cord Injuries,"University College, London",['Royal National Orthopaedic Hospital NHS Trust'],['United Kingdom']
NCT02081326,Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes,Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes,ACTIVE_NOT_RECRUITING,2015-06,2029-07,2031-07,INTERVENTIONAL,PHASE2,150,"['Diabetes Mellitus, Type One', 'Diabetes Mellitus, Type I', 'Autoimmune Diabetes', 'Covid19']","Diabetes Mellitus, Type One",Massachusetts General Hospital,[],['United States']
NCT04509700,Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465),"A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)",ACTIVE_NOT_RECRUITING,2020-08-03,2027-09-30,2027-09-30,INTERVENTIONAL,PHASE2,112,['B-Cell Malignancies'],B-Cell Malignancies,Incyte Corporation,[],"['Belgium', 'Israel', 'Japan', 'Hungary', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'South Korea', 'Czechia', 'United Kingdom', 'Poland', 'Sweden']"
NCT07255287,Behavioral Weight Loss and Sleep Health Intervention,Behavioral Weight Loss Plus Sleep Health Program (BWL+SLEEP) Feasibility Pilot Study,RECRUITING,2025-12,2027-01,2027-03,INTERVENTIONAL,NA,25,['Overweight and Obese Adults'],Overweight and Obese Adults,"University of Colorado, Denver","['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT03899155,Pan Tumor Rollover Study,Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies,RECRUITING,2019-08-09,2029-08-25,2029-08-25,INTERVENTIONAL,PHASE2,1500,['Cancer'],Cancer,Bristol-Myers Squibb,"['Exelixis', 'Novartis', 'Clovis Oncology, Inc.', 'Janssen Pharmaceuticals']","['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'Peru', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT01358058,Proton Radiation Therapy for Gliomas,Phase II Study of Proton Radiation Therapy for Low Grade and Favorable Grade 3 Gliomas,ACTIVE_NOT_RECRUITING,2011-05,2027-05,2027-11,INTERVENTIONAL,NA,63,"['Low Grade Glioma', 'WHO Grade 3 Glioma With IDH1 Mutation', 'WHO Grade 3 Glioma With 1p/19q Codeletion']",Low Grade Glioma,Massachusetts General Hospital,['National Cancer Institute (NCI)'],['United States']
NCT06882785,A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia,"A Phase 3, Randomized, Two-part Study With a 5-week Double-blind Part (Randomized, Parallelgroup, Placebo-controlled) Followed by a 52-week Open-label Extension Part to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Patients With Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) Schizophrenia",RECRUITING,2025-06-10,2028-09-23,2029-08-23,INTERVENTIONAL,PHASE3,250,['Schizophrenia'],Schizophrenia,Bristol-Myers Squibb,[],['Japan']
NCT07276048,Community Genetic Navigation Engagement Specialists to Increase Knowledge About Colorectal Cancer Genetics in Hispanic/Latino/a Communities,Community Genetic Navigation Engagement Specialists (CoGENES) Training Program,ACTIVE_NOT_RECRUITING,2023-06-23,2026-12-11,2027-12-11,INTERVENTIONAL,NA,20,['Colorectal Carcinoma'],Colorectal Carcinoma,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT05991388,A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma,A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma,RECRUITING,2024-05-02,2031-05-01,2033-05-01,INTERVENTIONAL,PHASE2,210,['B-cell Non Hodgkin Lymphoma'],B-cell Non Hodgkin Lymphoma,University of Birmingham,"['Cancer Research UK', 'Fight Kids Cancer', 'Regeneron Pharmaceuticals', 'ADC Therapeutics S.A.']","['Belgium', 'New Zealand', 'Netherlands', 'Austria', 'United Kingdom', 'Sweden', 'Australia']"
NCT07274423,Clinical Value of Deep Learning Reconstruction Technology in Ankle MRI,Clinical Value of Deep Learning Reconstruction Technology in Ankle MRI,RECRUITING,2025-08-01,2026-08-01,2026-08-01,OBSERVATIONAL,,120,['Ankle Trauma'],Ankle Trauma,Lian Yang,[],['China']
NCT07276061,Outpatient Total Knee Arthroscopy (TKA): Comparison of Postoperative Recovery Versus a Conventional Hospitalization,"Outpatient Total Knee Prosthesis, Comparison of Postoperative Recovery Versus Conventional Hospitalization: a Retrospective, Single-center, Observational, Comparative Study of Superiority",RECRUITING,2024-03-11,2025-12-31,2025-12-31,OBSERVATIONAL,,440,['Knee Arthroscopy'],Knee Arthroscopy,"University Hospital, Strasbourg, France",[],['France']
NCT05612100,Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients,Endocrine Therapy-Induced Alopecia Natural History Evaluation Among Female Breast Cancer Survivors,RECRUITING,2022-07-06,2028-06-30,2028-06-30,OBSERVATIONAL,,170,['Breast Carcinoma'],Breast Carcinoma,Mayo Clinic,[],['United States']
NCT01844986,Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.,"A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Following First Line Platinum Based Chemotherapy.",ACTIVE_NOT_RECRUITING,2013-08-26,2018-05-17,2028-08-29,INTERVENTIONAL,PHASE3,450,"['Newly Diagnosed', 'Advanced Ovarian Cancer', 'FIGO Stage III-IV', 'BRCA Mutation', 'Complete Response', 'Partial Response', 'First Line Platinum Chemotherapy']",Newly Diagnosed,AstraZeneca,"['GOG Foundation', 'Myriad Genetic Laboratories, Inc.', 'Merck Sharp & Dohme LLC']","['Brazil', 'Israel', 'Japan', 'Netherlands', 'China', 'Russia', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT01484730,A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion,A Pilot Study to Evaluate Multi-Spectral Imaging (MI) and Laser Speckle Imaging (LSI) and Multiphoton Microscopy (MPM) During Vascular Occlusion,RECRUITING,2011-11,2026-08,2028-08,OBSERVATIONAL,,150,['Abnormal Vascular Flow'],Abnormal Vascular Flow,"University of California, Irvine",['United States Department of Defense'],['United States']
NCT07059858,"Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities","Evaluation of Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities",RECRUITING,2025-09-28,2026-03-02,2026-12-02,OBSERVATIONAL,,100,"['Intellectual Disability', 'Healthy Subjects']",Intellectual Disability,Abant Izzet Baysal University,[],['Turkey (Türkiye)']
NCT07085533,Natural History Study of Inherited Retinal Diseases,"Color Vision Loss Progression in IRD Patients: Retinal Structural Changes Correlations, and a Novel Color Discrimination Test for Extreme Low Vision Patients",RECRUITING,2025-07-20,2027-06-04,2027-09-28,OBSERVATIONAL,,200,"['Retinal Dystrophies', 'Color Vision Defects', 'Vision Disorders', 'Macular Degeneration', 'Achromatopsia', 'Optical Coherence Tomography (OCT)', 'Visual Acuity', 'Genotype', 'Mutation', 'Phenotype']",Retinal Dystrophies,Zhongmou Therapeutics,"['Wuhan University', 'Renmin Hospital of Wuhan University']",['China']
NCT01555892,"Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE",Administration of Rapidly Generated EBV-Specific Cytotoxic T-Lymphocytes To Patients With EBV-Positive Lymphoma,RECRUITING,2013-01-14,2027-03-01,2027-07-01,INTERVENTIONAL,PHASE1,136,"[""Hodgkin's Disease"", ""Non-Hodgkin's Lymphoma"", 'Lymphoproliferative Disease', 'Lymphoma']",Hodgkin's Disease,Baylor College of Medicine,"['The Methodist Hospital Research Institute', 'Center for Cell and Gene Therapy, Baylor College of Medicine', 'National Institutes of Health (NIH)', 'National Cancer Institute (NCI)', 'Harris County Hospital District']",['United States']
NCT07216339,Gamification Effects on the 6-Minute Walk Test in Children,Effect of Gamification on 6-Minute Walk Test Performance and Engagement in Pediatric Neuromuscular Patients,RECRUITING,2025-12,2026-07-01,2026-07-01,INTERVENTIONAL,NA,20,['Neuromuscular Diseases in Children'],Neuromuscular Diseases in Children,David Toupin,[],['United States']
NCT06951698,A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder,"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-1)",RECRUITING,2025-06-11,2026-11-01,2026-11-01,INTERVENTIONAL,PHASE3,274,['Bipolar-I Disorder With Mania or Mania With Mixed Features'],Bipolar-I Disorder With Mania or Mania With Mixed Features,Bristol-Myers Squibb,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hungary', 'United States', 'Poland', 'Argentina', 'Australia']"
NCT04998188,Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis,Hydrolyzed Collagen Formulation Versus Placebo in the Treatment of Degenerative Knee Cartilage Injuries,RECRUITING,2022-02-16,2025-12,2025-12,INTERVENTIONAL,NA,204,['Knee Osteoarthritis'],Knee Osteoarthritis,Istituto Ortopedico Rizzoli,[],['Italy']
NCT07256041,Comparison of Gamification Approaches in Midwifery Education,Play to Learn: A Comparison of Puzzle-Based and Kahoot-Based Gamification in Midwifery Education,RECRUITING,2025-11-19,2026-01-01,2026-01-30,INTERVENTIONAL,NA,57,"['Education', 'Midwifery Education', 'Gameifaction']",Education,Agri Ibrahim Cecen University,[],['Turkey (Türkiye)']
NCT07025083,Adaptation of the Family Check-Up Online,Adaptation of Family Check-Up Online in the Latinx Community to Reduce Youth Substance Use,RECRUITING,2025-07-01,2026-12-31,2027-03-31,INTERVENTIONAL,NA,108,"['Substance Use (Drugs, Alcohol)']","Substance Use (Drugs, Alcohol)",University of Oregon,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT06052059,A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis",ACTIVE_NOT_RECRUITING,2023-10-25,2026-08-01,2029-08-01,INTERVENTIONAL,PHASE3,1020,['Ulcerative Colitis'],Ulcerative Colitis,Merck Sharp & Dohme LLC,"['PPD, Part of Thermo Fisher Scientific']","['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Slovakia', 'Dominican Republic', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Singapore', 'South Africa', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'Ukraine', 'Sweden', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT07274774,SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma,"Systemic Therapy Combined With Stereotactic Body Radiotherapy Versus Systemic Therapy Alone in BCLC Stage C Hepatocellular Carcinoma (SCRATCH): A Prospective, Multicenter, Phase II, Randomized Controlled Trial",RECRUITING,2025-11-30,2027-11-10,2028-11-10,INTERVENTIONAL,PHASE2,184,"['Hepatocellular Carcinoma', 'BCLC Stage C Hepatocellular Carcinoma']",Hepatocellular Carcinoma,Shandong Cancer Hospital and Institute,[],['China']
NCT03676010,Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1),Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) : Formal Consensus Method for the Development of Guidelines for Standardized Time-to-event Endpoints' Definitions in Cancer Clinical Trials,ACTIVE_NOT_RECRUITING,2009-09,2015-01,2026-12,OBSERVATIONAL,,265,['Cancer'],Cancer,Institut Bergonié,"['National Cancer Institute, France', ""Institut du Cancer de Montpellier - Val d'Aurelle"", 'Centre Georges Francois Leclerc']",['France']
NCT07275476,Pregnancy and Fibrin Clot Properties,Fibrin Clot Properties and Thrombin Generation in Pregnancy Women With and Without Obstetric Complications.,RECRUITING,2025-11-28,2026-01,2027-12,OBSERVATIONAL,,100,"['Fibrin Blood Clot', 'Pregnancy', 'Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode']",Fibrin Blood Clot,Jagiellonian University,[],['Poland']
NCT07274995,Machine Learning Prediction of Postoperative Pain in Pediatric Ambulatory Surgery,Prospective Evaluation of Machine Learning Algorithms to Predict Postoperative Pain in Pedaitric Ambulatory Surgical Procedures,ACTIVE_NOT_RECRUITING,2025-08-01,2026-11-30,2026-11-30,OBSERVATIONAL,,90,"['Pain, Acute Post-Operative', 'Ambulatory Surgical Procedures', 'Pediatric Pain', 'Pediatric Patient (1m-21y)']","Pain, Acute Post-Operative",Başakşehir Çam & Sakura City Hospital,[],['Turkey (Türkiye)']
NCT06736288,Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).,"Randomized, Double Blind, Placebo Controlled, Two-Arms, Multicenter, Post Authorization Efficacy and Safety Study (PAES) to Confirm and Collect More Clinical Data of Buccalin® Tablets In the Prophylaxis of Recurrent Lower Respiratory Tract Infections (RLRTIs).",RECRUITING,2025-10-21,2027-04,2029-04,INTERVENTIONAL,PHASE4,240,"['Respiratory Infection', 'Lower Respiratory Tract Infection (LRTI)']",Respiratory Infection,Laboratorio Farmaceutico SIT srl,[],"['North Macedonia', 'Italy']"
NCT06679140,A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease,"AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS",RECRUITING,2024-12-08,2026-12-06,2027-05-06,INTERVENTIONAL,PHASE3,2330,['COVID-19 SARS-CoV-2 Infection'],COVID-19 SARS-CoV-2 Infection,Pfizer,[],"['Brazil', 'Belgium', 'Bulgaria', 'Japan', 'South Africa', 'Turkey (Türkiye)', 'China', 'United States', 'Mexico', 'Finland', 'Slovakia', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Czechia', 'Argentina', 'Germany']"
NCT07274046,Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech Republic,Clinical and Public-Health Impact of Tick-Borne Encephalitis: A Prospective Multicenter Observational Study With 12-Month Follow-up and Cost-Effectiveness Analysis,RECRUITING,2023-04-01,2025-12,2026-12,OBSERVATIONAL,,209,['Tick Borne Encephalitis (TBE)'],Tick Borne Encephalitis (TBE),"Charles University, Czech Republic","['České Budějovice Hospital', 'University Hospital Ostrava', 'Hospital Pardubice', 'Bulovka Hospital']",['Czechia']
NCT04339036,CapTemY90 for Grade 2/3 NET Liver Metastases,UPCC 04219 Phase 2 Study of Capecitabine-Temozolomide(CapTem) With Yttrium-90 Radioembolization in the Treatment of Patients With Unresectable Metastatic Grade 2/3 Neuroendocrine Tumors,RECRUITING,2021-10-07,2026-05-01,2026-05-01,INTERVENTIONAL,PHASE2,70,"['Neuroendocrine Tumor Grade 2', 'Neuroendocrine Tumors']",Neuroendocrine Tumor Grade 2,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT07237516,Zymfentra (Infliximab-dyyb) REal World Cohort STudy,Zymfentra (Infliximab-dyyb) REal World Cohort STudy,RECRUITING,2025-11-20,2028-11-03,2028-11-03,OBSERVATIONAL,,200,"['Ulcerative Colitis (UC)', ""Crohn's Disease (CD)"", 'Indeterminate Colitis', 'Inflammatory Bowel Disease (IBD)']",Ulcerative Colitis (UC),"University of North Carolina, Chapel Hill",['Celltrion'],['United States']
NCT05819359,"Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD","A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene",ACTIVE_NOT_RECRUITING,2023-03-31,2026-03-31,2026-07-31,INTERVENTIONAL,PHASE2,237,"[""Parkinson's Disease""]",Parkinson's Disease,"Bial R&D Investments, S.A.",[],"['Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Portugal', 'Sweden', 'Germany']"
NCT07242833,Evaluation of the Effect of Seasonality on Biological Age in Adults,Evaluation of the Effect of Seasonality on Biological Age in Adults,RECRUITING,2025-11-24,2027-06,2027-08,OBSERVATIONAL,,60,"['Aging', 'Aging, Biological', 'Aging, Healthy', 'BIOLOGICAL CLOCKS', 'Biological Clock Disturbance']",Aging,Société des Produits Nestlé (SPN),[],['Switzerland']
NCT06222034,Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA),"An Open-label, Multiple Dose, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Filgotinib in Children and Adolescents From 8 to Less Than 18 Years of Age With Juvenile Idiopathic Arthritis",RECRUITING,2024-05-13,2026-03,2026-08,INTERVENTIONAL,PHASE1,10,['Juvenile Idiopathic Arthritis'],Juvenile Idiopathic Arthritis,Alfasigma S.p.A.,[],"['France', 'Spain', 'United Kingdom', 'Poland', 'Germany']"
NCT05743595,"Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma","A Pilot Study to Assess the Safety and Immunogenicity of a Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma",RECRUITING,2023-10-27,2027-04-30,2030-01-31,INTERVENTIONAL,PHASE1,27,['Unmethylated Glioblastoma'],Unmethylated Glioblastoma,Washington University School of Medicine,"['Incyte Corporation', 'PapiVax Biotech, Inc.', 'The Foundation for Barnes-Jewish Hospital']",['United States']
NCT06186648,Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome,"A Phase 2 Study Evaluating the Bispecific CD3xCD20 Antibody GLOfitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (CHOP) in Patients With RIchter Syndrome as Frontline therapY. A FILO Study",RECRUITING,2024-03-21,2026-03-01,2027-03-01,INTERVENTIONAL,PHASE2,40,['Richter Syndrome'],Richter Syndrome,French Innovative Leukemia Organisation,['Hoffmann-La Roche'],['France']
NCT02917993,An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer,An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer,ACTIVE_NOT_RECRUITING,2016-12-20,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE1,59,['Lung Cancer'],Lung Cancer,Incyte Corporation,['AstraZeneca'],"['Taiwan', 'Spain', 'United States', 'South Korea']"
NCT04701671,"Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids","Executive Functioning, Weight Trajectories, and Loss of Control Eating in Children With Overweight/Obesity: A Prospective Study",RECRUITING,2020-12-10,2028-05-09,2028-05-09,OBSERVATIONAL,,180,"['Pediatric Obesity', 'Binge-Eating Disorder']",Pediatric Obesity,University of Pittsburgh,"['Brown University', 'The Miriam Hospital', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']",['United States']
NCT04429087,A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3,"A First-In-human Phase I, Non-randomized, Open-label, Multi-center Dose Escalation Trial of BI 764532 Administered by Parenteral Route in Patients With Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3",RECRUITING,2020-07-29,2026-09-01,2027-02-15,INTERVENTIONAL,PHASE1,300,['Patients With Small Cell Lung Carcinoma and Other Neoplasms'],Patients With Small Cell Lung Carcinoma and Other Neoplasms,Boehringer Ingelheim,[],"['Japan', 'Spain', 'United States', 'Germany']"
NCT06982859,A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus,"A Phase 1, Investigator- and Participant-Blinded Study to Evaluate the Effect of Retatrutide on α- and β- Cell Function and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus",RECRUITING,2025-06-02,2026-11,2026-11,INTERVENTIONAL,PHASE1,95,"['Diabetes Mellitus', 'Insulin Sensitivity']",Diabetes Mellitus,Eli Lilly and Company,[],['Germany']
NCT04640025,A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib,"A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib (INCB039110)",ACTIVE_NOT_RECRUITING,2021-03-10,2026-06-22,2026-06-22,INTERVENTIONAL,PHASE2,18,"['Myelofibrosis', 'Postlung Transplant (Bronchiolitis Obliterans)', 'Chronic Graft Versus Host Disease']",Myelofibrosis,Incyte Corporation,[],"['Belgium', 'Israel', 'Austria', 'United States', 'Spain', 'Italy', 'Canada', 'Greece', 'Germany']"
NCT06988787,Multifaceted Intervention to Restore Resilience and Overcome Risk,Multifaceted Intervention to Restore Resilience and Overcome Risk,RECRUITING,2025-09-12,2028-08-01,2028-08-01,INTERVENTIONAL,NA,136,"['Military Sexual Trauma', 'Intimate Partner Violence', 'Brain Injury', 'Post Traumatic Stress Disorder']",Military Sexual Trauma,Icahn School of Medicine at Mount Sinai,['Baylor College of Medicine'],['United States']
NCT07275073,A Study of JMT106 Injection in the Treatment of Advanced Solid Tumors,"A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Antitumor Activity of JMT106 Injection in Patients With Advanced Solid Tumors",RECRUITING,2025-09-25,2026-11-05,2028-11-15,INTERVENTIONAL,PHASE1,200,"['Advanced Solid Tumor', 'Lung Squamous Cell Carcinoma', 'Hepatocellular Carcinoma']",Advanced Solid Tumor,Shanghai JMT-Bio Inc.,[],['China']
NCT05623111,Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities,"Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities: A Double-blind, Randomized, Placebo-controlled Study",RECRUITING,2023-08-01,2027-05-01,2027-12-01,INTERVENTIONAL,PHASE2,80,"['Diabetic Neuropathy, Painful']","Diabetic Neuropathy, Painful","Rigshospitalet, Denmark","['Merz Pharmaceuticals GmbH', 'Toyota Foundation Denmark', 'Steno Diabetes Center Zealand Region', 'Shipwright Per Henriksen, R., and wife Foundation', 'The GCP unit at Copenhagen University Hospital', 'Capital Region Pharmacy, Denmark']",['Denmark']
NCT03291522,Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration,Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration,ACTIVE_NOT_RECRUITING,2019-05-10,2027-01-01,2027-09-01,OBSERVATIONAL,,50,"['Azoospermia, Nonobstructive', 'Infertility, Male']","Azoospermia, Nonobstructive",University of Pittsburgh,"['Infertility and IVF Center, St. Louis, MO']",['United States']
NCT07242222,Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease,Evaluating the Safety and Efficacy of Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients,RECRUITING,2025-11-20,2026-11-20,2026-11-20,INTERVENTIONAL,PHASE1,50,['Fatty Liver'],Fatty Liver,Tanta University,[],['Egypt']
NCT06081426,Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD),Elucidating Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD): a Multidisciplinary Mechanistic Study,RECRUITING,2024-01-12,2027-01,2027-01,INTERVENTIONAL,NA,107,['Bipolar Disorder'],Bipolar Disorder,University of Pittsburgh,['Baszucki Brain Research Fund'],['United States']
NCT03973268,Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression,The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression,RECRUITING,2020-01-21,2026-02-01,2026-02-01,INTERVENTIONAL,PHASE1,70,"['Depression', 'Major Depressive Disorder', 'Major Depression']",Depression,National Institute of Mental Health (NIMH),[],['United States']
NCT05471908,Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial,The Follow-up Automatically vs. As-Needed Comparison Trial,RECRUITING,2022-08-22,2027-02,2028-02-28,INTERVENTIONAL,NA,2674,"['Pneumonia', 'Urinary Tract Infections', 'Soft Tissue Infections', 'Gastroenteritis']",Pneumonia,University of Utah,['Patient-Centered Outcomes Research Institute'],['United States']
NCT06727448,Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health,Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health,RECRUITING,2024-12-23,2026-06-23,2026-06-23,OBSERVATIONAL,,50,"['Chronic Insomnia Disorder', 'Circadian Rhythm Disorders']",Chronic Insomnia Disorder,"University Hospital, Bordeaux",[],['France']
NCT06631976,Conservative Treatment in Patients With Supraspinatus Tendon Injury.,"Comparison of Conservative Treatment Methods for Sleep Disorders, Pain, and Shoulder Function in Patients With Supraspinatus Tendon Injury.",RECRUITING,2024-06-04,2026-05-01,2026-09,INTERVENTIONAL,NA,40,"['Supraspinatus Injury', 'Sleep Disturbance']",Supraspinatus Injury,Medical University of Lodz,[],['Poland']
NCT04901884,PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation,"Exploratory Evaluation of Simultaneous Cardiac PET/MR, Metabolomic Markers and Circulating DNA as Possible Prognostic Markers in Identifying Patients Developing Transient or Permanent Cardiopulmonary Dysfunctions After Radiotherapy",RECRUITING,2021-06-01,2026-06-01,2026-06-01,INTERVENTIONAL,NA,40,['Pulmonary Hypertension'],Pulmonary Hypertension,"University Health Network, Toronto",[],['Canada']
NCT07273955,Alcohol Use Disorder Before and After Bariatric Surgery and the Impact of Considering This Surgery During Addiction Follow-up,Alcohol Use Disorder Before and After Bariatric Surgery and the Impact of Considering This Surgery During Addiction Follow-up,RECRUITING,2023-12-12,2025-12-12,2025-12-12,OBSERVATIONAL,,20,['Alcohol Use Disorder'],Alcohol Use Disorder,"University Hospital, Strasbourg, France",[],['France']
NCT07192133,Evaluation of CT-XPI,Evaluation of Computed Tomography X-ray-Pulsatility Index (CT-XPI),RECRUITING,2025-12,2026-11,2026-11,INTERVENTIONAL,PHASE2,30,"['CT Scan', 'Computed Tomography']",CT Scan,"University of Wisconsin, Madison",[],['United States']
NCT06427304,Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure,Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure,RECRUITING,2024-07-01,2027-07-02,2028-02-02,OBSERVATIONAL,,637,['Cardiac Amyloidosis'],Cardiac Amyloidosis,Gérond'if,[],['France']
NCT06194825,EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety in Chinese Subjects With Transthyretin Amyloid Cardiomyopathy,"A Phase 3, Randomized Study, With Initial 24-week, Double-Blind and Placebo-Controlled Treatment Phase, Followed by An 80-week Open-label Extension Treatment Phase to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-Term Safety in Chinese Participants With Transthyretin Amyloid Cardiomyopathy (EPIC-ATTR)",ACTIVE_NOT_RECRUITING,2023-12-01,2026-05-14,2027-01-05,INTERVENTIONAL,PHASE3,64,['Transthyretin Amyloid Cardiomyopathy'],Transthyretin Amyloid Cardiomyopathy,AstraZeneca,[],['China']
NCT07026383,Physiological and Psychological Profiles,Physiological and Psychological Profiles of the Athletic Women and the Risk of Sport Injuries in Saudi Arabia,RECRUITING,2025-01-25,2025-09-25,2025-12-30,OBSERVATIONAL,,60,"['Healthy Volunteer', 'Female']",Healthy Volunteer,Princess Nourah Bint Abdulrahman University,[],['Saudi Arabia']
NCT07209761,A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis,"A Phase 3, Randomized, Open-label, Multicenter Trial to Evaluate the Efficacy, Safety, and Tolerability of 4-month and 6-month Quabodepistat-containing Regimens for Rifampicin-resistant/Multidrug-resistant Pulmonary Tuberculosis",RECRUITING,2025-10-16,2027-05-28,2028-09-29,INTERVENTIONAL,PHASE3,532,['Pulmonary Tuberculosis'],Pulmonary Tuberculosis,"Otsuka Pharmaceutical Development & Commercialization, Inc.",[],"['Japan', 'South Africa', 'Moldova', 'China', 'Georgia', 'Peru', 'South Korea', 'Philippines']"
NCT05655182,A Study of BLB-201 RSV Vaccine in Infants and Children,"A Phase 1/2a Trial of the Safety, Tolerability and Immunogenicity of PIV5-vectored RSV Vaccine (BLB-201) in RSV Seronegative and Seropositive Infants and Children",RECRUITING,2023-03-09,2028-07-30,2028-07-30,INTERVENTIONAL,PHASE1,137,['Respiratory Syncytial Virus Infections'],Respiratory Syncytial Virus Infections,Blue Lake Biotechnology Inc.,[],['United States']
NCT05323864,Going to Altitude With Anxious-depressive Symptoms,Going to Altitude With Anxious-depressive Symptoms - a Randomised Cross Over Trial in Individuals With Mental Disorders and Healthy Controls,RECRUITING,2023-04-14,2025-07-15,2025-12,INTERVENTIONAL,NA,68,"['Hypoxia', 'Mental Disorder']",Hypoxia,Universitaet Innsbruck,['Medical University Innsbruck'],['Austria']
NCT04742452,Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears,Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears,RECRUITING,2020-11-24,2026-01-01,2026-01-01,INTERVENTIONAL,NA,105,['Rotator Cuff Tears'],Rotator Cuff Tears,University Hospitals Cleveland Medical Center,"['Lake Health', 'Midwest Orthopaedics at Rush']",['United States']
NCT07076147,Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer,Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer,RECRUITING,2025-06-02,2027-06-02,2028-06-02,OBSERVATIONAL,,150,['Breast Carcinoma'],Breast Carcinoma,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT06854328,The Prism Conformity Trial for Post-Traumatic Stress Disorder in Adolescents,"A Prospective, Single Arm, Open Label Trial, to Confirm Safety and Effectiveness of Prism, as an Adjunct to Standard of Care, in Adolescents With Post-Traumatic Stress Disorder (PTSD)",RECRUITING,2025-06-11,2026-08-01,2026-11-01,INTERVENTIONAL,NA,45,['Post-Traumatic Stress Disorder in Adolescence'],Post-Traumatic Stress Disorder in Adolescence,GrayMatters Health Ltd.,[],['United States']
NCT05782244,Sildenafil for Microvasculopathy in Chronic TBI,Phase 2 Randomized Controlled Trial of Sildenafil Citrate for Treatment of Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury,RECRUITING,2024-07-02,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE2,160,['Traumatic Brain Injury'],Traumatic Brain Injury,University of Pennsylvania,['Walter Reed National Military Medical Center'],['United States']
NCT05829681,Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCD,Individualized Neuroimaging Biomarkers for Predicting Repetitive Transcranial Magnetic Stimulation (rTMS) Response in Obsessive Compulsive Disorder (OCD),ACTIVE_NOT_RECRUITING,2022-03-14,2027-03-14,2029-03-14,INTERVENTIONAL,NA,212,['Obsessive-Compulsive Disorder'],Obsessive-Compulsive Disorder,Stanford University,"['Cornell University', 'Foundation for OCD Research']",['United States']
NCT06479239,Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer,Phase I/II Study of Anti-CD3 x Anti-EGFR Bispecific Antibody (EGFRBi) Armed Fresh Peripheral Blood Mononuclear Cells (EGFR FPBMC) in Metastatic or Unresectable Pancreatic Cancer,RECRUITING,2024-11-06,2027-12,2031-06,INTERVENTIONAL,PHASE1,23,"['Pancreas Cancer', 'Pancreatic Cancer']",Pancreas Cancer,University of Virginia,[],['United States']
NCT04661215,Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms,Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms,RECRUITING,2025-12-28,2027-04,2027-04,OBSERVATIONAL,,150,"['Gastroparesis', 'Idiopathic Gastric Motility Disorder', 'Diabetic Gastroparesis']",Gastroparesis,Johns Hopkins Bloomberg School of Public Health,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'Massachusetts General Hospital', 'Temple University', 'University of Louisville', 'Wake Forest University', 'Texas Tech University Health Sciences Center, El Paso', 'Mayo Clinic']",['United States']
NCT07112443,A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.,"A Phase 3 Randomized, Controlled Study to Assess the Efficacy and Safety of NVD003 Compared With Iliac Crest Bone Graft in Pediatric Participants Treated Surgically for Congenital Pseudarthrosis of the Tibia",RECRUITING,2025-09-02,2026-10,2027-07,INTERVENTIONAL,PHASE3,12,['Congenital Pseudarthrosis of Tibia'],Congenital Pseudarthrosis of Tibia,Novadip Biosciences,[],"['Belgium', 'United States']"
NCT07215624,"Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study",Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network (STOP-VTE),RECRUITING,2025-12-02,2026-12-01,2027-06-01,OBSERVATIONAL,,500,"['Malignant Digestive System Neoplasm', 'Malignant Female Reproductive System Neoplasm', 'Malignant Genitourinary System Neoplasm']",Malignant Digestive System Neoplasm,Wake Forest University Health Sciences,['National Cancer Institute (NCI)'],['United States']
NCT06936813,The PROMISE Survey,"Patients' and Physicians' Perspectives on the Management of Prolactinomas: Experiences, Treatment Preferences, and Related Outcomes - The PROMISE Survey",RECRUITING,2025-06-13,2026-03-30,2026-03-30,OBSERVATIONAL,,200,"['Prolactinoma', 'Pituitary Tumor']",Prolactinoma,"University Hospital, Basel, Switzerland",[],['Switzerland']
NCT04221542,Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer,"A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer",RECRUITING,2020-03-04,2030-03-22,2032-03-21,INTERVENTIONAL,PHASE1,479,['Prostate Cancer'],Prostate Cancer,Amgen,"['BeiGene', 'BeOne (China only)']","['Japan', 'China', 'United States', 'Switzerland', 'Spain', 'Taiwan', 'South Korea', 'Australia', 'Portugal', 'Germany']"
NCT06644196,Creation of a Database of Images of the Eye With the Holographic Doppler Laser,Creation of a Database of Images of the Eye With the Holographic Doppler Laser,RECRUITING,2024-11-08,2026-11-07,2026-11-07,OBSERVATIONAL,,123,['Vessels of the Eye Fundus'],Vessels of the Eye Fundus,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT06724848,A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population,"A Translational Study in Patients With COPD and Early COPD to Describe Patient Clinical Characteristics, Treatment Patterns, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes That May Support Future Development of Personalized Treatment Strategies in Chinese Population",RECRUITING,2024-09-19,2027-10-21,2027-10-21,OBSERVATIONAL,,850,['COPD'],COPD,AstraZeneca,[],['China']
NCT07274176,The Effect of Graded Forced Expiration on Intraocular Pressure,The Effect of Graded Forced Expiration on Intraocular Pressure: A Study Using the Airofit Device,RECRUITING,2025-11-30,2026-02-10,2026-02-25,INTERVENTIONAL,NA,60,['Intraocular Pressure'],Intraocular Pressure,Uşak University,[],['Turkey (Türkiye)']
NCT05843643,Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus,SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects With Moderately to Severely Active SLE,RECRUITING,2023-07-19,2026-12,2027-10,INTERVENTIONAL,PHASE3,1000,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,AbbVie,[],"['Bulgaria', 'Japan', 'New Zealand', 'China', 'Slovakia', 'Bosnia and Herzegovina', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Chile', 'Puerto Rico', 'Croatia', 'Guatemala', 'South Korea', 'Colombia', 'Poland', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Latvia', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT04745689,Study of AZD2811 + Durvalumab in ES-SCLC,"A Phase II Multicenter, Open-Label, Single Arm Study to Determine the Efficacy, Safety and Tolerability of AZD2811 and Durvalumab Combination as Maintenance Therapy After Induction With Platinum-Based Chemotherapy Combined With Durvalumab, for the First-Line Treatment of Patients With Extensive Stage Small-Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2021-02-23,2022-06-18,2026-12-01,INTERVENTIONAL,PHASE2,31,['Small-Cell Lung Cancer'],Small-Cell Lung Cancer,AstraZeneca,[],"['Poland', 'Spain', 'United States', 'South Korea']"
NCT06714240,Enhanced Protein Intake to Support Muscle Protein Synthesis in ICU,Increased Protein Amount as a Nutritional Strategy to Enhance Muscle Protein Synthesis in ICU Patients,RECRUITING,2025-09-01,2027-10,2028-09,INTERVENTIONAL,NA,26,"['Critical Illness', 'Muscle Protein Synthetic Response to Protein']",Critical Illness,Maastricht University Medical Center,['Danone Global Research & Innovation Center'],['Belgium']
NCT06369285,"A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer","A Phase 2 Study of Alisertib in Combination With Endocrine Therapy in Patients With HR+, HER2-negative Recurrent or Metastatic Breast Cancer",RECRUITING,2024-11-19,2027-06-30,2028-12-31,INTERVENTIONAL,PHASE2,150,"['Hormone Receptor Positive HER-2 Negative Breast Cancer', 'Metastatic Breast Cancer', 'Recurrent Breast Cancer']",Hormone Receptor Positive HER-2 Negative Breast Cancer,"Puma Biotechnology, Inc.",[],"['Spain', 'Portugal', 'United States']"
NCT03286335,"Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy","Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy",RECRUITING,2018-09-26,2027-09-30,2027-09-30,INTERVENTIONAL,NA,100,['Brain Tumor'],Brain Tumor,Massachusetts General Hospital,[],['United States']
NCT07251023,Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia,"Multicenter Randomized Double-blind Placebo-controlled Active Comparator-controlled Study to Assess the Efficacy and Safety of DMB-I (Dimebon®, INN: Latrepirdine) in Patients With Dementia Associated With Alzheimer's Disease",RECRUITING,2025-11-20,2027-05,2027-05,INTERVENTIONAL,PHASE3,450,['Alzheimer Type Dementia'],Alzheimer Type Dementia,Bigespas LTD,[],['Russia']
NCT06982846,A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia,"A Randomized, Placebo-Controlled, Parallel Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia",RECRUITING,2025-06-06,2026-05,2026-05,INTERVENTIONAL,PHASE1,78,['Type 2 Diabetes Mellitus'],Type 2 Diabetes Mellitus,Eli Lilly and Company,[],['Austria']
NCT00747396,The Bucharest Early Intervention Project,The Bucharest Early Intervention Project: Effects of Early Psychosocial Deprivation on Mental Health in Adolescence,ACTIVE_NOT_RECRUITING,2000-09,2027-03-31,2027-03-31,INTERVENTIONAL,NA,136,"['Cognitive Ability, General', 'Psychiatric and/or Mood Disorders', 'Brain Function', 'Social Cognition', 'Health Behavior', 'Risk-Taking', 'Executive Function']","Cognitive Ability, General",Charles Alexander Nelson III,"['Tulane University Health Sciences Center', 'University of Maryland', 'University of Minnesota', 'Temple University', 'Duke University', 'MacArthur Foundation', 'National Institute of Mental Health (NIMH)', 'Vanderbilt University', 'Harvard University', 'University of North Carolina, Chapel Hill', 'University of Toronto']",['Romania']
NCT06524180,Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension,Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension (TEACH)? a Randomised Controlled Trial and Cost-minimization Analysis,RECRUITING,2024-10-01,2027-09-30,2027-09-30,INTERVENTIONAL,NA,364,['Hypertension'],Hypertension,Chinese University of Hong Kong,[],['Hong Kong']
NCT05429268,Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND),"A Phase 3, Single-Arm, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",ACTIVE_NOT_RECRUITING,2022-12-23,2026-04-01,2027-04-01,INTERVENTIONAL,PHASE3,82,"['Large B-Cell Lymphoma', 'Diffuse Large B-Cell Lymphoma']",Large B-Cell Lymphoma,Incyte Corporation,[],"['Bulgaria', 'Israel', 'Hungary', 'Turkey (Türkiye)', 'Norway', 'Finland', 'Denmark', 'Croatia', 'Ireland', 'Romania', 'Czechia', 'United Kingdom', 'Poland', 'Serbia']"
NCT07273994,Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation,Multicenter Randomized Clinical Trial To Evaluate Two Different Amiodarone Regimens To Maintain Sinus Rhythm After Electrical Cardioversion In Persistent Atrial Fibrillation,RECRUITING,2025-11-01,2027-12,2028-04,INTERVENTIONAL,PHASE4,312,['Persistent Atrial Fibrillation'],Persistent Atrial Fibrillation,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,['Instituto de Salud Carlos III'],['Spain']
NCT07093437,Adhesive Devices Versus Elastic Devices for Urinary Catheter Securement in Critically Ill Patients Experimental Study,Dispositivos Adhesivos Frente a Dispositivos elásticos Para la sujeción de la Sonda Urinaria en el Paciente crítico Estudio Experimental,RECRUITING,2025-09-22,2026-09-30,2026-10-30,INTERVENTIONAL,NA,188,"['Pressure Injuries', 'Pain', 'Catheter-Associated Urinary Tract Infection', 'Medical Device Site Injury']",Pressure Injuries,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,['Hospital de la Santa creu i Sant Pau - Barcelona'],['Spain']
NCT06317051,Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART),A Phase III/IV Factorial Randomized Double-blind Trial to Compare the Addition of Dapagliflozin vs Placebo and Rosuvastatin/Ezetimibe Versus Pitavastatin in Patients With HIV on Integrase Strand Transfer Inhibitor-based Antiretrovirals With Elevated Metabolic Risk,ACTIVE_NOT_RECRUITING,2024-12-16,2026-07,2026-12,INTERVENTIONAL,PHASE3,300,"['HIV Infections', 'Weight Gain']",HIV Infections,Kirby Institute,[],"['South Africa', 'Uganda', 'Nigeria', 'Thailand', 'Malaysia', 'Australia', 'Argentina', 'Zimbabwe', 'India']"
NCT05849064,Concussion Treatment in Older Adults,Randomized Controlled Trial of Targeted Treatment in Older Adults Following Concussion,RECRUITING,2023-09-07,2026-03,2026-03,INTERVENTIONAL,NA,50,"['Concussion, Mild']","Concussion, Mild",University of Pittsburgh,[],['United States']
NCT05180591,Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes,Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes,RECRUITING,2022-03-22,2027-03,2027-03,INTERVENTIONAL,PHASE2,150,"['Diabetes Mellitus, Type 1', 'Diabetes type1', 'Autoimmune Diabetes']","Diabetes Mellitus, Type 1",Massachusetts General Hospital,[],['United States']
NCT04463771,Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.,An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204),ACTIVE_NOT_RECRUITING,2021-01-26,2026-04-14,2026-07-10,INTERVENTIONAL,PHASE2,206,['Endometrial Cancer'],Endometrial Cancer,Incyte Corporation,"['GOG Foundation', 'European Network of Gynaecological Oncological Trial Groups (ENGOT)']","['Belgium', 'United States', 'France', 'Georgia', 'Italy', 'Greece', 'Germany']"
NCT07274748,"Effects of High Intensity Interval Training Versus Intermittent Functional Training on Cardiovascular Fitness, Physical Function and Cognition in Stroke.","Effects of High Intensity Interval Training Versus Intermittent Functional Training on Cardiovascular Fitness, Physical Function and Cognition in Stroke",RECRUITING,2025-11-05,2026-05-30,2026-05-30,INTERVENTIONAL,NA,52,['Stroke'],Stroke,Riphah International University,[],['Pakistan']
NCT07242768,Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis,Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis: Three-year Follow-up of RESIST Trial,RECRUITING,2025-12-10,2028-11-30,2028-11-30,OBSERVATIONAL,,1300,"['Ischemic Stroke', 'Transient Ischemic Attack']",Ischemic Stroke,Capital Medical University,[],['China']
NCT03049462,The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists,The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists,RECRUITING,2017-03-13,2026-09-30,2026-09-30,INTERVENTIONAL,PHASE1,100,['Polycystic Ovary Syndrome'],Polycystic Ovary Syndrome,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT05888844,A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell Carcinoma,A Phase 2 Study Evaluating INCB099280 in Participants With Advanced Squamous Cell Carcinoma,ACTIVE_NOT_RECRUITING,2023-10-09,2025-12-31,2026-12-31,INTERVENTIONAL,PHASE2,63,['Cutaneous Squamous Cell Carcinoma'],Cutaneous Squamous Cell Carcinoma,Incyte Corporation,[],"['Brazil', 'New Zealand', 'Hungary', 'South Africa', 'Turkey (Türkiye)', 'North Macedonia', 'France', 'Chile', 'Croatia', 'Spain', 'South Korea', 'Canada', 'Romania', 'Montenegro', 'Australia']"
NCT07255560,DMAE Oleate for Facial Skin Firmness and Fine Lines in Healthy Adults,Clinical Evaluation of the Cosmetic Efficacy of the Product DMAE Oleate Aimed at Increasing Skin Firmness and Reducing Fine Lines and Wrinkles in Human Volunteers.,ACTIVE_NOT_RECRUITING,2025-09-09,2025-12-02,2025-12-23,INTERVENTIONAL,NA,30,"['Skin Aging of Face and Hands', 'Facial Wrinkles - Rough Texture - Hyperpigmentation', 'Skin Laxity']",Skin Aging of Face and Hands,Bionos Biotech S.L.,[],['Spain']
NCT07256340,Measuring Total Energy Expenditure in Critically Ill Patients Using the Doubly Labelled Water Method,Measuring Total Energy Expenditure in Critically Ill Patients Using the Doubly Labelled Water Method,RECRUITING,2025-12-01,2026-07,2026-09,INTERVENTIONAL,NA,50,['Critical Illness'],Critical Illness,Maastricht University Medical Center,[],['Belgium']
NCT06610682,Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib,Feasibility of CSF (Cerebrospinal Fluid) and Plasma ctDNA (Circulating Tumor Deoxyribonucleic) in BRAF (V-raf Murine Sarcoma Viral Oncogene Homolog B1)-Altered Glioma During Treatment With Plixorafenib,RECRUITING,2025-04-07,2026-06-30,2027-06-30,INTERVENTIONAL,EARLY_PHASE1,15,['BRAF V600E Mutation'],BRAF V600E Mutation,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Fore Biotherapeutics', 'Ivy Brain Tumor Foundation']",['United States']
NCT04802174,"Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers","A Phase I/II Trial of Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High Grade Neuroendocrine Cancers",RECRUITING,2021-06-01,2026-08-01,2027-12-01,INTERVENTIONAL,PHASE1,120,"['SCLC', 'Small Cell Cancer', 'Advanced Solid Tumor', 'High Grade Neuroendocrine Cancers']",SCLC,National Cancer Institute (NCI),[],['United States']
NCT06481163,Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).,"A Phase 2 Multicentre, Open-label Study to Evaluate the Efficacy, Safety and Tolerability, and Pharmacokinetics of 14 -28 Days Telacebec Treatment in Adult Participants With Buruli Ulcer.",RECRUITING,2024-07-09,2026-12,2026-12,INTERVENTIONAL,PHASE2,140,['Buruli Ulcer'],Buruli Ulcer,Barwon Health,['Global Alliance for TB Drug Development'],['Australia']
NCT05639413,A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer,"A Study to Collect Patients, Medical, and Biological Data From Patients Being Treated for Metastatic Colorectal Cancer With a Specific Genetic Mutation: BRAFV600E",RECRUITING,2023-07-24,2027-07,2028-07,INTERVENTIONAL,NA,400,"['Metastatic Colorectal Cancer', 'BRAF V600E Mutation Positive']",Metastatic Colorectal Cancer,UNICANCER,['Pierre Fabre Medicament'],['France']
NCT07275424,Study of Healthy Aging and Physical Function With Elamipretide,"Open-Label, Single-Arm Phase 2a Pilot Study to Evaluate the Safety and Tolerability of a Daily Subcutaneous Dose of Elamipretide in Older Adults",RECRUITING,2025-11-26,2026-03-15,2026-04-15,INTERVENTIONAL,PHASE2,30,"['Aging, Healthy']","Aging, Healthy",David Marcinek,['Stealth BioTherapeutics Inc.'],['United States']
NCT07275346,"Surgical Approaches for Medium-to-Large Ventral Hernias: Open, Laparoscopic, and Robotic-Assisted Techniques","Evaluating Surgical Approaches for Medium-to-Large Ventral Hernias: Open, Laparoscopic, and Robotic-Assisted Techniques",ACTIVE_NOT_RECRUITING,2018-01-01,2024-01-31,2026-12-31,OBSERVATIONAL,,750,['Ventral Hernia'],Ventral Hernia,Andreas Älgå,"['Danderyds Hospital, Stockholm, Sweden', 'Sodertalje Hospital', 'Ersta Hospital, Sweden', 'Stockholm South General Hospital']",['Sweden']
NCT07273786,"The Effects of Group Social Work Intervention on Children's Emotional Intelligence, Emotion Regulation Skills and Empathy Tendencies","The Effect of Group Social Work Intervention Based on Emotion-Focused Therapy on Emotion Regulation Skills, Emotional Intelligence and Empathic Tendency Levels of Children in Need of Protection",ACTIVE_NOT_RECRUITING,2025-03-05,2025-11-06,2026-02-25,INTERVENTIONAL,NA,38,"['Emotional Intelligence', 'Emotion Regulation', 'Empathy Skills']",Emotional Intelligence,Selcuk University,['aile ve sosyal hizmetler bakanlığı'],['Turkey (Türkiye)']
NCT06676735,Research on Intraoperative Hypothermia Risk Prediction Model and Temperature Management Strategy for Elderly Patients During Surgery Based on Dynamic Incremental Training,Research on Intraoperative Hypothermia Risk Prediction and Temperature Management Strategies in Elderly Patients: Construction of Intraoperative Hypothermia Prediction Model Based on Dynamic Incremental Training and Evaluation of Clinical Application Effectiveness,RECRUITING,2025-03-11,2025-11-30,2025-12-31,INTERVENTIONAL,NA,1200,['Intraoperative Hypothermia'],Intraoperative Hypothermia,First Affiliated Hospital of Chongqing Medical University,[],['China']
NCT07274163,Ambispective Registry of Patients Affected by Lung Cancer,Ambispective Registry of Patients Affected by Lung Cancer,RECRUITING,2019-01-01,2035-12,2035-12,OBSERVATIONAL,,1500,['Lung Cancer'],Lung Cancer,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT06967324,GRACE - Graduated Response for Advanced COPD With Enhanced Support,GRACE - Graduated Response for Advanced COPD With Enhanced Support,RECRUITING,2025-08-07,2026-12-31,2027-06-30,INTERVENTIONAL,NA,100,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),"Copenhagen University Hospital, Hvidovre",[],['Denmark']
NCT06670937,Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways,Role of BARriers in IgG-Pathogen Interactions at the Mucosal Surface in Human Airways,RECRUITING,2024-12-16,2026-06,2026-06,INTERVENTIONAL,NA,30,['Bronchiectasis Adult'],Bronchiectasis Adult,"University Hospital, Tours",[],['France']
NCT07276035,Brain-Stomach Circuits in Chronic Nausea,TMS Neuromodulation of Brain-to-Stomach Circuits in Chronic Nausea,RECRUITING,2025-12,2030-07,2031-07,INTERVENTIONAL,NA,219,['Chronic Nausea and Vomiting Syndrome'],Chronic Nausea and Vomiting Syndrome,David Levinthal,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06251076,Plan Development for Giving Teclistamab in the Outpatient Setting,"Outpatient-based Teclistamab Step-up Dosing in Patients With Relapsed/Refractory Multiple Myeloma: Process Development in Academic and Community Centres, and Evaluating Impact on Caregiver Burden",RECRUITING,2024-11-19,2026-06-15,2026-10,INTERVENTIONAL,PHASE4,15,"['Multiple Myeloma', 'Relapsed Cancer', 'Refractory Cancer']",Multiple Myeloma,"University Health Network, Toronto",['Janssen Inc.'],['Canada']
NCT06785818,Long-term Follow up Local Registry Study of Kymriah in South Korea,A Registry to Assess Long-Term Safety of Patients With B-Lymphocyte Malignancies Treated With Tisagenlecleucel in South Korea,RECRUITING,2025-03-12,2039-12-30,2039-12-30,OBSERVATIONAL,,179,"['B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma']","B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma",Novartis Pharmaceuticals,[],['South Korea']
NCT07274826,Diagnostic Creteria of Acid Sphingomyelinase Deficiency (ASMD),Intact Potential Symptoms and Biomarker Analysis in Diagnosis of Acid Sphingomyelinase Deficiency (ASMD),ACTIVE_NOT_RECRUITING,2025-11-20,2026-08-10,2026-09-10,OBSERVATIONAL,,7,['Acid Sphingomyelinase Deficiency (ASMD)'],Acid Sphingomyelinase Deficiency (ASMD),Sohag University,[],['Egypt']
NCT07274722,Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects,Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects,RECRUITING,2024-04-04,2026-04-03,2026-04-03,INTERVENTIONAL,NA,54,['Anorexia Nervosa'],Anorexia Nervosa,Centre Hospitalier Henri Laborit,"[""Centre de Recherches sur la Cognition et l'Apprentissage""]",['France']
NCT04534205,"A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1","An Open-label Phase II/III Randomized Trial of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Monotherapy as a First Line Therapy in Patients With Unresectable Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Which is Positive for Human Papilloma Virus 16 (HPV16+) and Expresses PD-L1",RECRUITING,2021-01-07,2029-04,2029-04,INTERVENTIONAL,PHASE2,350,"['Unresectable Head and Neck Squamous Cell Carcinoma', 'Metastatic Head and Neck Cancer', 'Recurrent Head and Neck Cancer']",Unresectable Head and Neck Squamous Cell Carcinoma,BioNTech SE,[],"['Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06645886,A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies,"A Phase 1/1b, Open-label, Multicenter, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of KQB198 as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hematologic Malignancies",RECRUITING,2024-12-09,2027-08,2028-02,INTERVENTIONAL,PHASE1,122,"['Hematologic Malignancies', 'Adult']",Hematologic Malignancies,Kumquat Biosciences Inc.,[],"['Netherlands', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Germany']"
NCT07073781,"Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation",A Double-blind Placebo-controlled Exploratory Trial to Assess the Impact of Daily Lab4P Probiotic Supplementation on Cognitive Performance and Metabolic Regulation in Overweight Young Adults With Impaired Glucose Regulation,RECRUITING,2025-08-15,2026-06-30,2026-08-20,INTERVENTIONAL,NA,70,"['Impaired Glucose Regulation', 'Impaired Glucose Tolerance (Prediabetes)', 'Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)', 'Overweight (BMI &gt; 25)', 'Cognitive Dysfunction', 'Neurovascular Coupling Mechanism and Cognitive Function']",Impaired Glucose Regulation,Leeds Beckett University,"['Cultech Ltd, Port Talbot, UK']",['United Kingdom']
NCT07231692,Comparison of BiFeS + ACB and IPACK + ACB Block Combinations for Postoperative Pain After Total Knee Arthroplasty,Comparative Evaluation of Biceps Femoris Short Head (BiFeS) and Adductor Canal Block and Interspace Between the Popliteal Artery and Capsule of the Knee (IPACK) and Adductor Canal Block Combinations for Postoperative Pain After Total Knee Arthroplasty,RECRUITING,2025-10-15,2026-01-15,2026-02-28,OBSERVATIONAL,,60,"['Pain After Total Knee Arthroplasty', 'Pain, Postoperative', 'Arthroplasty, Replacement, Knee']",Pain After Total Knee Arthroplasty,Karabuk University,[],['Turkey (Türkiye)']
NCT05865600,Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome,Perfusion Estimation for Optimal Revascularization and Medical Therapy in Chronic Coronary Syndrome - a Randomized Trial,RECRUITING,2023-05-23,2026-09-01,2027-09-01,INTERVENTIONAL,NA,570,"['Chronic Coronary Syndrome', 'Myocardial Ischemia', 'Stable Angina', 'Coronary Artery Disease']",Chronic Coronary Syndrome,Gødstrup Hospital,[],['Denmark']
NCT06113237,Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy,"Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant",RECRUITING,2025-08-05,2033-08-31,2033-08-31,OBSERVATIONAL,,50,"['Maternal Complications', 'Pregnancy Complication', 'Birth Outcomes, Adverse', 'Pregnancy']",Maternal Complications,Jazz Pharmaceuticals,[],['United States']
NCT06092892,IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases,IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Clinical T1-2N0 ER+ Her2- Breast Cancer With Ultrasound Detected Nodal Metastases,RECRUITING,2024-04-07,2031-04,2031-04,INTERVENTIONAL,PHASE2,45,"['Breast Cancer', 'Axillary Nodal Disease', 'Female Breast Cancer', 'Axilla; Breast', 'Mastectomy; Lymphedema', 'Tumor, Breast']",Breast Cancer,Alice Chung,[],['United States']
NCT07253753,"A Study to Evaluate Safety and Dosimetry of [18F]4-FDF, a New PET Imaging Agent for Inflammation",Phase 1 Evaluation of Novel Imaging Diagnostic Agent NeuCaVis in Healthy Volunteers,RECRUITING,2026-01-15,2026-06-15,2026-06-15,INTERVENTIONAL,PHASE1,12,['Healthy'],Healthy,Yellowbird Diagnostics Inc,[],['Canada']
NCT06653322,A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma,A Multi-centered，Randomized，Double-blind，Placebo-controlled Study to Evaluate the Efficacy and Safety of SHR-1703 in Eosinophilic Asthma,RECRUITING,2024-11-21,2027-09,2027-12,INTERVENTIONAL,PHASE3,400,['Asthma With Eosinophilic Phenotype'],Asthma With Eosinophilic Phenotype,"Guangdong Hengrui Pharmaceutical Co., Ltd",[],['China']
NCT06564857,Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation,Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation in Patients Undergoing General Anaesthesia - a Multicentre Randomised Controlled Trial -The ROCVIDEO Trial,RECRUITING,2025-11-17,2027-04-01,2027-04-08,INTERVENTIONAL,PHASE4,2648,"['Tracheal Intubation', 'Video Laryngoscopy', 'Remifentanil', 'Rocuronium']",Tracheal Intubation,Nordsjaellands Hospital,[],['Denmark']
NCT07162662,A Study on the Modulation of Gut Microbiota by Oral Sialic Acid in Healthy Subjects,Modulation of Gut Microbiota by Oral Sialic Acid: A Mechanistic Study,RECRUITING,2025-09-10,2026-08-01,2027-08-01,INTERVENTIONAL,NA,42,"['Taking Sialic Acid to Regulate the Gut Microbiota', 'Healthy']",Taking Sialic Acid to Regulate the Gut Microbiota,Xiaolong Li,[],['China']
NCT07220551,A Phase 1 Relative Bioavailability Study of UCB0022 Tablets in Healthy Participants,"An Open-Label, Single-Center, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability and Safety of Two UCB0022 Tablet Formulations in Healthy Participants",ACTIVE_NOT_RECRUITING,2025-10-23,2025-12-16,2025-12-16,INTERVENTIONAL,PHASE1,14,['Healthy Volunteers'],Healthy Volunteers,UCB Biopharma SRL,[],['United States']
NCT04715178,Beat Childhood Cancer Specimen Banking and Data Registry,Specimen Banking With Clinical and Genomic Data Registry With the Establishment of Tumor Models for Pediatric Cancers,RECRUITING,2021-02-02,2031-01,2032-01,OBSERVATIONAL,,1000,"['Pediatric Cancer', 'Survivorship']",Pediatric Cancer,Giselle Sholler,[],['United States']
NCT06206824,Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease,"Randomized, Double-Blind, Placebo-Controlled Phase 1 Study to Evaluate Safety, Tolerability, PK/PD of SAD, MAD and Food Effect of Leucettinib-21 in Healthy Male Subjects, and Single Dose in Subjects With Down Syndrome or Alzheimer's Disease",RECRUITING,2024-01-18,2026-06,2026-06,INTERVENTIONAL,PHASE1,164,"['Healthy Volunteers', 'Down Syndrome', ""Alzheimer's Disease""]",Healthy Volunteers,Perha Pharmaceuticals,"['France 2030 program', 'European Innovation Council', 'Fondation Jérôme Lejeune']",['France']
NCT06895590,"The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial","The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial",RECRUITING,2025-10-02,2026-02,2026-02,OBSERVATIONAL,,205,"['Cardiac Surgery, Non-Cardiac ICU']","Cardiac Surgery, Non-Cardiac ICU",Philips Clinical & Medical Affairs Global,[],"['United States', 'Germany']"
NCT06642246,Sleep Promotion and Pediatric Hypertension,Sleep Promotion Among Children Newly Diagnosed With Essential Hypertension,RECRUITING,2026-01,2026-06,2026-06,INTERVENTIONAL,NA,10,"['Insufficient Sleep', 'Hypertension']",Insufficient Sleep,Children's Hospital of Philadelphia,[],['United States']
NCT05620823,A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa,"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa",ACTIVE_NOT_RECRUITING,2022-12-19,2025-02-03,2026-01-30,INTERVENTIONAL,PHASE3,608,['Hidradenitis Suppurativa (HS)'],Hidradenitis Suppurativa (HS),Incyte Corporation,[],"['Belgium', 'Japan', 'Netherlands', 'Austria', 'United States', 'France', 'Spain', 'Canada', 'Czechia', 'Greece', 'Poland', 'Germany']"
NCT07276100,Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab,Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab,RECRUITING,2026-01-01,2027-01-01,2029-01-01,INTERVENTIONAL,PHASE2,15,['Hepato Cellular Carcinoma (HCC)'],Hepato Cellular Carcinoma (HCC),IRCCS Azienda Ospedaliero-Universitaria di Bologna,[],['Italy']
NCT07263321,Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.,"Optimising Treatment for Patients With Depressive Episodes in General Practice Through Algorithm-Based Treatment: A Randomised, Open-label Controlled Trial.",RECRUITING,2025-12,2027-06,2027-06,INTERVENTIONAL,NA,171,"['Depressive Disorder', 'Depression - Major Depressive Disorder', 'Depressive Disorder, Major Depressive Disorder', 'Depressive Disorders', 'Depression', 'Depressive Episodes', 'Depressive Episode']",Depressive Disorder,Aalborg University Hospital,[],['Denmark']
NCT07098936,Momelotinib in VEXAS Syndrome,A Single-arm Phase II With safety-run-in Multicenter Study of Momelotinib in Patients With VEXAS Syndrome With or Without Associated Myelodysplastic Syndrome,RECRUITING,2025-11-25,2028-06,2028-11,INTERVENTIONAL,PHASE2,57,"['VEXAS Syndome', 'Myelo Dysplastic Syndrome']",VEXAS Syndome,Groupe Francophone des Myelodysplasies,['GlaxoSmithKline'],['France']
NCT05468463,Promoting Increases in Living Donation Via Tele-navigation (PILOT),Promoting Increases in Living Donation Via Tele-navigation (PILOT),ACTIVE_NOT_RECRUITING,2023-04-12,2025-11-30,2026-02-28,INTERVENTIONAL,NA,347,['Kidney Diseases'],Kidney Diseases,University of Alabama at Birmingham,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06716580,EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations,EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations,RECRUITING,2025-04-01,2027-09-01,2030-09-01,INTERVENTIONAL,NA,1000,"['Lung Cancer', 'EGFR Gene Mutation']",Lung Cancer,Dana-Farber Cancer Institute,"['Beth Israel Deaconess Medical Center', 'Boston Medical Center', 'Massachusetts General Hospital']",['United States']
NCT05847283,DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT,Dydrogesterone Primed Ovarian Stimulation Versus Fixed Gonadotropin Releasing Hormone Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: A Randomized Controlled Trial,RECRUITING,2023-06-22,2027-05-31,2027-12-31,INTERVENTIONAL,NA,730,['Diminished Ovarian Reserve'],Diminished Ovarian Reserve,Tam Anh TP. Ho Chi Minh General Hospital,['Abbott'],['Vietnam']
NCT06812494,"A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV","A Randomized, Double Blind, Controlled, Phase 2 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Neutralization of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV",RECRUITING,2025-03-07,2027-01-15,2027-09-15,INTERVENTIONAL,PHASE2,200,['HIV'],HIV,National Institute of Allergy and Infectious Diseases (NIAID),"['National Institutes of Health (NIH)', 'Department of Health and Human Services', 'Dale and Betty Bumpers Vaccine Research Center (VRC)']","['Brazil', 'United States', 'Peru', 'South Africa']"
NCT07253688,Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus,Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus (RIFA-SNAP),RECRUITING,2025-11-10,2029-12,2030-07,INTERVENTIONAL,PHASE3,330,"['Staphylococcus Aureus Endocarditis', 'Prosthetic Valve Endocarditis']",Staphylococcus Aureus Endocarditis,Todd C. Lee MD MPH FIDSA,"['McGill University Health Centre/Research Institute of the McGill University Health Centre', 'Canadian Institutes of Health Research (CIHR)', 'University of Melbourne', 'The Peter Doherty Institute for Infection and Immunity']",['Canada']
NCT05372614,Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene,Phase I Trial of DS-8201a (Trastuzumab Deruxtecan) in Combination With Neratinib in Solid Tumors With HER2 Alterations,RECRUITING,2022-10-05,2025-12-01,2025-12-01,INTERVENTIONAL,PHASE1,30,"['Metastatic Malignant Solid Neoplasm', 'Unresectable Malignant Solid Neoplasm']",Metastatic Malignant Solid Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT06841562,Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis,Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis - Early Rheumatoid Arthritis Pilot Study,RECRUITING,2025-07-14,2026-09,2026-09,INTERVENTIONAL,NA,15,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Duke University,[],['United States']
NCT07271862,A Novel Laparoscopic Apical Promontofixation Technique With Simultaneous Perineal Reconstruction for Patients With Symptomatic Pelvic Organ Prolapse,A Novel Laparoscopic Apical Promontofixation Technique With Simultaneous Perineal Reconstruction for Patients With Symptomatic Pelvic Organ Prolapse,ACTIVE_NOT_RECRUITING,2024-08-29,2026-10-04,2027-12-31,INTERVENTIONAL,NA,60,"['Pelvic Organ Prolapse (POP)', 'Urinary Incontinence , Stress', 'Urinary Incontinence (UI)', 'Female Sexual Dysfunction (FSD)', 'Quality of Life']",Pelvic Organ Prolapse (POP),Riga East Clinical University Hospital,"['Pauls Stradins Clinical University Hospital', 'University of Latvia']",['Latvia']
NCT07112066,Multimodality Cardiac Imaging for Disease Progression in ATTR-CM,Natural History of Cardiac Transthyretin Amyloidosis - Mechanistic Insights by Multimodality Imaging,RECRUITING,2025-10-20,2027-06,2027-06,INTERVENTIONAL,NA,50,['Amyloidosis Cardiac'],Amyloidosis Cardiac,Dominik Benz,"['Olga Mayenfisch Stiftung, Zurich, Switzerland', 'University of Zurich']",['Switzerland']
NCT05642260,Effects of Fall Prevention Program on the Number of Falls Among Elderly Following Total Knee Replacement,The Short- and Long-term Effects of Fall Prevention Program on the Number of Falls Among Elderly Following Total Knee Replacement: a Pragmatic Single-blinded Randomized Controlled Trial.,RECRUITING,2023-01-08,2026-04,2026-09-08,INTERVENTIONAL,NA,90,"['Fall', 'Osteo Arthritis Knee', 'Total Knee Replacement']",Fall,"Ministry of Health, Kuwait",[],['Kuwait']
NCT04523493,Phase III Study of Toripalimab（JS001） Combined With Lenvatinib for Advanced HCC,"A Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter Phase III Study to Compare Toripalimab Combined With Lenvatinib Versus Placebo Combined With Lenvatinib as the 1st-line Therapy for Advanced HCC",ACTIVE_NOT_RECRUITING,2020-06-29,2025-12-31,2026-09-01,INTERVENTIONAL,PHASE3,530,['Advanced Hepatocellular Carcinoma (HCC)'],Advanced Hepatocellular Carcinoma (HCC),"Shanghai Junshi Bioscience Co., Ltd.",[],"['Singapore', 'China', 'Italy', 'Poland', 'Ukraine']"
NCT06482567,Promoting Improved Functioning Among People Experiencing Stressful Situations,Promoting Improved Functioning Among People Experiencing Stressful Situations,RECRUITING,2024-08-15,2027-03,2027-03,INTERVENTIONAL,NA,450,['Acute Stress Reaction'],Acute Stress Reaction,"University of North Carolina, Chapel Hill",['U.S. Army Medical Research Acquisition Activity'],['United States']
NCT07104565,Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders,"A Phase 2a, Open-Label, Multicenter Study of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders",RECRUITING,2025-12-10,2027-09-23,2028-03-09,INTERVENTIONAL,PHASE2,56,['Immune Thrombocytopenia'],Immune Thrombocytopenia,Incyte Corporation,[],"['Netherlands', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Australia']"
NCT07190430,"A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants","A Phase 1, Open-label, Fixed Sequence Study to Evaluate The Effect of Steady-State Dosing of PF-08049820 on the Single Dose Pharmacokinetics of Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants",ACTIVE_NOT_RECRUITING,2025-10-03,2025-12-15,2025-12-15,INTERVENTIONAL,PHASE1,16,['Atopic Dermatitis'],Atopic Dermatitis,Pfizer,[],['United States']
NCT06890598,Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer,"A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination With Standard of Care Immunotherapy in Participants With Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02",RECRUITING,2025-03-27,2029-05,2032-02,INTERVENTIONAL,PHASE3,700,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Eli Lilly and Company,['AstraZeneca'],"['Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'South Korea', 'Czechia', 'Poland', 'India', 'Switzerland', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy']"
NCT06105918,Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer,Phase 1 Trial to Determine Safety and Feasibility in Treating Biochemical Recurrence Post-Prostatectomy With PSMA PET Guided External Beam Radiotherapy Followed by Consolidative Radioligand Therapy,ACTIVE_NOT_RECRUITING,2023-11-29,2028-04-01,2029-04-01,INTERVENTIONAL,PHASE1,6,"['Biochemically Recurrent Prostate Carcinoma', 'Prostate Adenocarcinoma']",Biochemically Recurrent Prostate Carcinoma,Emory University,['National Cancer Institute (NCI)'],['United States']
NCT07271433,Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes,Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 Diabetes,ACTIVE_NOT_RECRUITING,2024-01-29,2024-11-12,2026-01-01,OBSERVATIONAL,,20,['Kidney Transplant'],Kidney Transplant,The Cleveland Clinic,['Abbott Medical Devices'],['United States']
NCT03981055,Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.,Parkinson's Disease: Enhancing Physical Therapy With Brain Stimulation for Treating Postural Instability.,ACTIVE_NOT_RECRUITING,2020-01-23,2024-04-30,2025-12-30,INTERVENTIONAL,NA,40,['Parkinson Disease'],Parkinson Disease,Spaulding Rehabilitation Hospital,"['Highland Instruments, Inc.', 'National Institute of Neurological Disorders and Stroke (NINDS)']",['United States']
NCT06058013,Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder,"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder",RECRUITING,2023-12-20,2026-05,2026-06,INTERVENTIONAL,PHASE3,332,['Major Depressive Disorder'],Major Depressive Disorder,"Neumora Therapeutics, Inc.",[],"['Brazil', 'Chile', 'United States', 'Canada']"
NCT04825379,Clinical Evaluation of a Bioactive Material,Clinical Evaluation of a Bioactive Material,ACTIVE_NOT_RECRUITING,2021-06-01,2021-09-01,2026-09-01,INTERVENTIONAL,NA,31,['Tooth Disease'],Tooth Disease,Hacettepe University,[],['Turkey (Türkiye)']
NCT05508789,A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5),Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease,RECRUITING,2022-10-10,2028-05,2028-07,INTERVENTIONAL,PHASE3,1500,"['Alzheimer Disease', 'Dementia', 'Brain Diseases', 'Central Nervous System Diseases', 'Nervous System Diseases', 'Tauopathies', 'Neurodegenerative Diseases', 'Neurocognitive Disorders', 'Mental Disorders']",Alzheimer Disease,Eli Lilly and Company,[],"['China', 'Spain', 'Taiwan', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT07221058,Adaptive Radiation Boost for Rectal Cancer,Adaptive Radiation BOost for Rectal Cancer: a Phase I Dose Escalation Study (ARBOR),RECRUITING,2025-10-24,2028-11-01,2029-11-01,INTERVENTIONAL,PHASE1,37,"['Rectum Cancer, Adenocarcinoma']","Rectum Cancer, Adenocarcinoma",Fox Chase Cancer Center,['Varian Medical Systems'],['United States']
NCT06637631,A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.,"A Phase 2, Multinational, Multicenter, Randomized, Doubleblind, Placebocontrolled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Crohn's Disease.",RECRUITING,2024-12-10,2027-07-21,2029-05-23,INTERVENTIONAL,PHASE2,260,"[""Crohn's Disease""]",Crohn's Disease,Sanofi,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Australia', 'Hungary', 'France', 'Chile', 'South Korea', 'Czechia', 'Poland', 'India', 'Mauritius', 'Georgia', 'Spain', 'Canada', 'Romania', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07215234,A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration,"A Phase 1/2, Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration",RECRUITING,2025-10-09,2027-10-13,2032-07-22,INTERVENTIONAL,PHASE1,104,['Geographic Atrophy'],Geographic Atrophy,Sanofi,[],['United States']
NCT05829655,Measuring Acute Drug Demand in Humans,Measuring Acute Drug Demand in Humans,RECRUITING,2023-08-08,2027-10-31,2027-10-31,INTERVENTIONAL,EARLY_PHASE1,75,"['Opioid Use Disorder', 'Opioid Dependence']",Opioid Use Disorder,Johns Hopkins University,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT07255755,Cereboost (American Ginseng Extract) and Brain Function,A Double Blind Randomised Clinical Study to Evaluate Attention Improvement in an Adult Population After Cereboost Intake,RECRUITING,2025-12-01,2027-01,2027-01,INTERVENTIONAL,NA,200,"['Attention', 'Cognition']",Attention,University of East Anglia,"['Givaudan France Naturals', 'Atlantia Food Clinical Trials']",['United Kingdom']
NCT07272213,"Thyroid-Stimulating Hormone Levels in Pregnancy and Their Association With Depression, Anxiety, and Sexual Function","Evaluation of the Effects of Thyroid-Stimulating Hormone (TSH) Levels in Pregnancy on Depression, Anxiety, and Sexual Function",RECRUITING,2025-11-01,2025-12-01,2025-12-01,OBSERVATIONAL,,180,"['Thyroid Disorders Complicating Pregnancy', 'Maternal Depression in Pregnancy, Unspecified Trimester', 'Anxiety Disorder, Unspecified', 'Sexual Dysfunction, Unspecified']",Thyroid Disorders Complicating Pregnancy,Gaziosmanpasa Research and Education Hospital,[],['Turkey (Türkiye)']
NCT06132113,DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers,"DAREON™-7: A Phase I, Open-label, Dose Escalation and Expansion Trial to Investigate Safety and Tolerability of BI 764532 Intravenous Infusions in Combination With Standard of Care (Platinum and Etoposide) in First-line Treatment of Patients With Neuroendocrine Carcinomas (NEC)",RECRUITING,2024-01-22,2027-02-09,2027-04-25,INTERVENTIONAL,PHASE1,55,['Neuroendocrine Neoplasms'],Neuroendocrine Neoplasms,Boehringer Ingelheim,[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Spain', 'Sweden', 'Germany']"
NCT07166094,Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer,"A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Endometrial Cancer After Platinum-Based Chemotherapy and PD(L)-1 Therapy",RECRUITING,2025-11-28,2028-11,2029-02,INTERVENTIONAL,PHASE3,544,"['Endometrial Cancer', 'Recurrent or Progressive Endometrial Cancer']",Endometrial Cancer,Genmab,[],"['Japan', 'United States']"
NCT05663216,Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome,Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome,RECRUITING,2023-05-31,2028-07-01,2028-07-01,OBSERVATIONAL,,180,['Systemic Inflammatory Response Syndrome'],Systemic Inflammatory Response Syndrome,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT01630850,"Islet Transplantation in Patients With ""Brittle"" Type I Diabetes","Islet Transplantation in Patients With ""Brittle"" Type I Diabetes",RECRUITING,2012-05,2030-06,2030-06,INTERVENTIONAL,NA,20,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1",University of Chicago,[],['United States']
NCT06246149,Adjuvant Tebentafusp in High Risk Ocular Melanoma,Adjuvant Tebentafusp (IMCgp100) Versus Observation in HLA-A*02:01 Positive Patients Following Definitive Treatment of High-risk Uveal Melanoma: an EORTC Randomized Phase III Study (ATOM Trial),RECRUITING,2024-11-11,2032-11,2032-11,INTERVENTIONAL,PHASE3,290,['Uveal Melanoma'],Uveal Melanoma,European Organisation for Research and Treatment of Cancer - EORTC,"['Northwell Health', 'Immunocore Ltd']","['Belgium', 'Netherlands', 'France', 'Spain', 'United Kingdom', 'Poland', 'Germany']"
NCT06925984,"Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)","The Oligopro-Breast Study: Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study",RECRUITING,2025-10-30,2028-05-01,2030-05-01,INTERVENTIONAL,NA,48,['OligoProgressive Metastatic Disease'],OligoProgressive Metastatic Disease,Jules Bordet Institute,[],['Belgium']
NCT07049276,The Multicentre Selective Lymphadenectomy Trial - 3,Randomized Controlled Trial of Selective Index Lymph Node Resection Versus Therapeutic Lymph Node Dissection After Neoadjuvant Immunotherapy for Stage IIIB-D Melanoma,RECRUITING,2025-10-01,2030-08,2040-08,INTERVENTIONAL,NA,1500,"['Cutaneous Melanoma, Stage III']","Cutaneous Melanoma, Stage III",Melanoma Institute Australia,[],"['New Zealand', 'United States', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT06820242,Open Pilot Trial of a Mind-Body Intervention for Patients With Chronic Hip Pain,Development and Feasibility of a Mind-Body Intervention to Improve Physical Activity for Patients With Chronic Hip Pain: Open Pilot (HIPS Study),RECRUITING,2025-04-04,2026-01,2026-06,INTERVENTIONAL,NA,5,"['Hip Pain', 'Hip Pain Chronic', 'Mind-Body Therapies']",Hip Pain,Massachusetts General Hospital,['National Center for Complementary and Integrative Health (NCCIH)'],['United States']
NCT04598893,Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension),"A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus",ACTIVE_NOT_RECRUITING,2020-10-26,2026-11,2026-11,OBSERVATIONAL,,188,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1","Provention Bio, a Sanofi Company",[],"['Belgium', 'United States', 'France', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT01723774,PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer,"A Phase II Trial of Neoadjuvant PD 0332991, a Cyclin-Dependent Kinase (Cdk) 4/6 Inhibitor, in Combination With Anastrozole in Women With Clinical Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer",ACTIVE_NOT_RECRUITING,2013-04-10,2021-04-13,2026-08-24,INTERVENTIONAL,PHASE2,84,['Breast Neoplasms'],Breast Neoplasms,Washington University School of Medicine,['Pfizer'],['United States']
NCT06788756,L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML,"A Pivotal Phase 2/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Adaptive Design Study of L Annamycin for Injection in Combination With Cytarabine Injection Versus Placebo in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed Acute Myeloid Leukemia",RECRUITING,2025-03-12,2029-08,2030-08,INTERVENTIONAL,PHASE2,312,['Acute Myeloid Leukaemia (AML)'],Acute Myeloid Leukaemia (AML),"Moleculin Biotech, Inc.",[],"['United States', 'Georgia', 'Spain', 'Italy', 'Romania', 'Ukraine', 'Poland', 'Lithuania']"
NCT06739122,A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS),"A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 mg and 4.5 mg in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes Mellitus",RECRUITING,2025-01-10,2026-06,2026-07,INTERVENTIONAL,PHASE3,55,['Type 2 Diabetes'],Type 2 Diabetes,Eli Lilly and Company,[],['United States']
NCT06665828,Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults,"A Phase 1, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of REGN9533, a Monoclonal Antibody Against Factor XII, in Healthy Adults",ACTIVE_NOT_RECRUITING,2025-03-04,2026-01-29,2026-01-29,INTERVENTIONAL,PHASE1,72,['Healthy Volunteer'],Healthy Volunteer,Regeneron Pharmaceuticals,[],['Belgium']
NCT04380441,Quality of Life Model for Older Patients With AML,Development of a Quality of Life Decision-Making Model for Older Patients With Acute Myeloid Leukemia,ACTIVE_NOT_RECRUITING,2020-07-08,2023-11-30,2026-03,OBSERVATIONAL,,206,"['AML, Adult', 'Acute Myeloid Leukemia']","AML, Adult",H. Lee Moffitt Cancer Center and Research Institute,['National Institute of Nursing Research (NINR)'],['United States']
NCT07257302,Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis,Exploratory Study on the Effects of Lung Insufflation Capacity Training Using the LIC Trainer in Patients With Amyotrophic Lateral Sclerosis: A Single-Center Prospective Interventional Study,RECRUITING,2025-11-01,2028-03-31,2030-03-31,INTERVENTIONAL,NA,15,['Amyotrophic Lateral Sclerosis (ALS)'],Amyotrophic Lateral Sclerosis (ALS),"National Center of Neurology and Psychiatry, Japan",[],['Japan']
NCT06269627,Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder,Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder,RECRUITING,2025-05-07,2025-12-31,2026-12-31,INTERVENTIONAL,PHASE4,48,['Alcohol Use Disorder'],Alcohol Use Disorder,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT07225751,"A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.","A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions",RECRUITING,2025-11-25,2028-10,2028-12,INTERVENTIONAL,NA,126,"['Ankle Arthrodesis or Arthroplasty', 'Hindfoot Fusion', 'Ankle Deformity', 'Ankle Disease', 'Hindfoot Arthrodesis', 'Hindfoot Pathologies']",Ankle Arthrodesis or Arthroplasty,Kuros Biosurgery AG,[],['United States']
NCT07267845,The Effect of α-GPC on Cognitive Function and Sports Performance,"A Randomised, Double-Blind, Placebo-Controlled Study on the Effects of Alpha-Glycerophosphocholine (α-GPC) on Cognitive Function and Sports Performance in Adults",RECRUITING,2025-10-21,2026-05-15,2026-07-05,INTERVENTIONAL,NA,80,['Healthy Participants'],Healthy Participants,"Nanjing Nutrabuilding Bio-tech Co., Ltd.",['Atlantia Food Clinical Trials'],['Ireland']
NCT07038369,A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations,"A Phase 1 Study of a Selective AKT1 E17K Allosteric Inhibitor, ATV-1601, in Patients With Advanced Solid Tumors",RECRUITING,2025-07-29,2028-08-31,2029-01-31,INTERVENTIONAL,PHASE1,134,"['Advanced Solid Tumors', 'Breast Cancer', 'Breast Carcinoma', 'Breast Neoplasms', 'ER Positive Breast Cancer', 'Cervical Cancers', 'Cervical Neoplasms', 'Cervical Carcinoma', 'Triple Negative Breast Cancer', 'Gynecologic Cancers', 'Gynecologic Neoplasm', 'Endometrial Cancer', 'Endometrial Neoplasm', 'Endometrial Carcinoma (EC)', 'Fallopian Cancer', 'Ovarian Carcinoma', 'Ovarian Cancer', 'Ovarian Neoplasms', 'Prostate Cancers', 'Prostate Carcinoma', 'Solid Tumors', 'Neoplasms', 'Neoplasms by Site', 'Breast Diseases', 'Uterine Neoplasms', 'Genital Neoplasms, Female', 'Urogenital Neoplasms']",Advanced Solid Tumors,"Atavistik Bio, Inc",[],"['Singapore', 'Spain', 'United States', 'France']"
NCT07273123,The Effect of Prolonged Sugar-Free Chewing Gum Mastication on Self-Reported Fatigue Levels and Changes of Static and Dynamic Surface Electromyography Parameters in Young Individuals With and Without Temporomandibular Joint Disorders.,Effect of Sugar-Free Chewing Gum Mastication on Fatigue of the Masticatory Muscles in Young Adults With and Without Temporomandibular Joint Disorders,RECRUITING,2025-12-01,2026-07-30,2026-07-30,OBSERVATIONAL,,30,['Temporomandibular Joint Disorder'],Temporomandibular Joint Disorder,University of Milan,[],['Italy']
NCT06533020,Long-term Outcomes of Complex Conversion Total Hip Arthroplasty,Long-term Outcomes of Complex Conversion Total Hip Arthroplasty,ACTIVE_NOT_RECRUITING,2024-10-06,2027-07-31,2027-07-31,OBSERVATIONAL,,210,['Arthroplasty Complications'],Arthroplasty Complications,"University of North Carolina, Chapel Hill",[],['United States']
NCT06965790,"Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations","Randomized Controlled Study on Sex-specific, Individualized Dose Calculation of Intravenously Administered Contrast Agent in CT Examinations in Portal Venous Phase to Achieve Equivalent Contrast in Men and Women",RECRUITING,2025-04-01,2026-03,2027-03,INTERVENTIONAL,NA,400,"['CT Scans', 'Contrast Media', 'Gender', 'Womens Health']",CT Scans,University Hospital Augsburg,[],['Germany']
NCT07224971,Impact of Circadian Rhythm on Immunotherapy,Assessing the Impact of Circadian Rhythm on Anti-PD-1/PD-L1 Immunotherapy,RECRUITING,2025-12-02,2027-05-01,2030-05-01,INTERVENTIONAL,PHASE2,350,['Advanced/Metastatic NSCLC'],Advanced/Metastatic NSCLC,"Liza Villaruz, MD",[],['United States']
NCT05444465,Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears,"Evaluation of Safety and Efficacy of a Resorbable Collagen Implant in Treatment of High Grade PArtial ThiCkness Tears; A Prospective, Multicenter, Randomized, Control Trial (IMPACT Study)",RECRUITING,2022-08-30,2026-08-15,2028-06-30,INTERVENTIONAL,NA,234,['Rotator Cuff Injuries'],Rotator Cuff Injuries,"Smith & Nephew, Inc.",[],"['United States', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT05500833,Multidimensional Characterization of Dyspnea in Children,Multidimensional Characterization of Dyspnea in Children,RECRUITING,2023-01-26,2028-02-26,2028-02-26,OBSERVATIONAL,,400,['Dyspnea and Respiratory Insufficiency in Children'],Dyspnea and Respiratory Insufficiency in Children,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06241456,"FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors","A Phase 1 Study of FT825/ONO-8250, an Off-the-Shelf CAR T-Cell Therapy, With or Without Monoclonal Antibodies, in HER2-Positive or Other Advanced Solid Tumors",RECRUITING,2024-01-05,2029-05-01,2044-05-01,INTERVENTIONAL,PHASE1,351,['Advanced Solid Tumor'],Advanced Solid Tumor,Fate Therapeutics,[],['United States']
NCT07233798,Presence of Dural Pulsation in Patients Diagnosed With Lumbar Spinal Stenosis,Correlation of the Presence of Dural Pulsation With Clinical and Radiological Parameters in Patients Diagnosed With Lumbar Spinal Stenosis,RECRUITING,2025-12-07,2026-12-20,2026-12-30,OBSERVATIONAL,,84,"['Lumbar Spinal Stenosis', 'Numerical Rating Scale', 'Disability Physical', 'Magnetic Resonance', 'Claudication']",Lumbar Spinal Stenosis,Marmara University,[],['Turkey (Türkiye)']
NCT07076407,A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3),"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder",RECRUITING,2025-07-08,2027-05,2027-07,INTERVENTIONAL,PHASE3,450,['Major Depressive Disorder'],Major Depressive Disorder,Xenon Pharmaceuticals Inc.,[],['United States']
NCT05721937,A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring,CIBINQO™ Pregnancy Registry: An Observational Study of the Safety of Abrocitinib Exposure in Pregnant Women and Their Offspring,RECRUITING,2023-07-25,2027-12-31,2027-12-31,OBSERVATIONAL,,400,['Atopic Dermatitis'],Atopic Dermatitis,Pfizer,"['PPD Development, LP']",['United States']
NCT05633875,Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis,Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis: Long Term Predictive Value (IMAGIN-DEAL in MS),RECRUITING,2023-04-25,2026-06-25,2026-06-25,OBSERVATIONAL,,80,['Multiple Sclerosis (MS)'],Multiple Sclerosis (MS),Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06254495,A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers,"A Phase 1, Open-label Study to Evaluate PF-08046044/SGN-35C in Adults With Advanced Malignancies.",ACTIVE_NOT_RECRUITING,2024-05-28,2028-04-18,2029-04-18,INTERVENTIONAL,PHASE1,57,"['Hodgkin Disease', 'Lymphoma, T-Cell, Peripheral', 'Lymphoma, Large B-Cell, Diffuse', 'Lymphoma, Large-Cell, Anaplastic']",Hodgkin Disease,"Seagen, a wholly owned subsidiary of Pfizer",[],"['United States', 'France', 'Denmark', 'Spain', 'Italy', 'United Kingdom']"
NCT05654922,Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant,"A Phase 3, Open-label, Randomized, Standard of Care-controlled, Parallel Study Arm Study to Demonstrate Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) Progression in Participants With a Bilateral Lung Transplant",RECRUITING,2023-04-10,2026-05,2026-11,INTERVENTIONAL,PHASE3,100,['Pre-Bronchiolitis Obliterans Syndrome'],Pre-Bronchiolitis Obliterans Syndrome,"Renovion, Inc.",[],['United States']
NCT06885177,TECTONIC CAD IVL IDE Study,TECTONIC CAD Intravascular Lithotripsy (IVL) IDE Study,RECRUITING,2025-04-01,2026-05,2028-06,INTERVENTIONAL,NA,335,"['Coronary Artery Calcification', 'Coronary Artery Disease', 'Stenotic Coronary Lesion']",Coronary Artery Calcification,Abbott Medical Devices,[],['United States']
NCT07020611,First-In-Human Study Evaluating Aneurysm Sac Lining in AAA Patients,Aneurysm SaC ManagemENt Device for Abdominal Aortic Aneurysms First-in-Human (ASCEND) Study,RECRUITING,2025-11-26,2026-09,2028-09,INTERVENTIONAL,NA,15,['Abdominal Aortic Aneurysm'],Abdominal Aortic Aneurysm,Life Seal Vascular Inc.,['Auckland City Hospital'],['New Zealand']
NCT05131022,A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies,"A Phase 1, Dose Escalation, and Cohort Expansion Study Evaluating NX-5948, a Bruton's Tyrosine Kinase (BTK) Degrader, in Adults With Relapsed/Refractory B-cell Malignancies",RECRUITING,2022-04-13,2027-01,2028-01,INTERVENTIONAL,PHASE1,572,"['Chronic Lymphocytic Leukemia (CLL)', 'Small Lymphocytic Lymphoma (SLL)', 'Diffuse Large B Cell Lymphoma (DLBCL)', 'Follicular Lymphoma (FL)', 'Mantle Cell Lymphoma (MCL)', 'Marginal Zone Lymphoma (MZL)', 'Waldenstrom Macroglobulinemia (WM)', 'Primary Central Nervous System Lymphoma (PCNSL)', 'Secondary Central Nervous System Lymphoma (SCNSL)']",Chronic Lymphocytic Leukemia (CLL),"Nurix Therapeutics, Inc.",[],"['Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'United Kingdom', 'Poland']"
NCT07273552,Root Torque Control in Cases Treated With Direct Printed Aligners,Efficacy of Root Torque Control in Adult Non-extraction Spacing Cases Treated With Directly 3D Printed Clear Aligners: a Cone Beam Computed Tomography Study,RECRUITING,2025-06-01,2026-06-01,2026-07-01,INTERVENTIONAL,NA,14,['Effect of Direct Printed Aligners on Root Torque'],Effect of Direct Printed Aligners on Root Torque,Suez Canal University,"['British University In Egypt', 'Beni-Suef University']",['Egypt']
NCT06237452,VE303 for Prevention of Recurrent Clostridioides Difficile Infection,"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection",RECRUITING,2024-05-20,2027-06,2027-10,INTERVENTIONAL,PHASE3,852,"['Clostridium Difficile', 'Clostridium Difficile Infections', 'Clostridium Difficile Infection Recurrence', 'Clostridioides Difficile Infection', 'Clostridioides Difficile Infection Recurrence', 'CDI', 'C. Diff Infection', 'Recurrent Clostridium Difficile Infection', 'C.Difficile Diarrhea', 'Diarrhea Infectious']",Clostridium Difficile,"Vedanta Biosciences, Inc.",[],"['Bulgaria', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Georgia', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'United States', 'Ireland', 'Italy']"
NCT00027274,Cancer in Inherited Bone Marrow Failure Syndromes,Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndromes: A Natural History Study,RECRUITING,2001-11-28,,,OBSERVATIONAL,,4000,"['Diamond Blackfan Anemia', 'Dyskeratosis Congenita', 'Fanconi Anemia', 'Shwachman Diamond Syndrome', 'Inherited Bone Marrow Failure Syndrome, Aplastic Anemia']",Diamond Blackfan Anemia,National Cancer Institute (NCI),[],['United States']
NCT06082037,A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction,"A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study, Followed by Open-label Extensions, to Evaluate the Efficacy of Oral Belumosudil in Adult Participants With Chronic Lung Allograft Dysfunction (CLAD) Following Bilateral Lung Transplantation",RECRUITING,2023-10-10,2026-09-17,2028-06-02,INTERVENTIONAL,PHASE3,180,['Lung Transplant Rejection'],Lung Transplant Rejection,Sanofi,[],"['Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Spain', 'Canada', 'Sweden', 'Germany', 'Norway', 'Austria', 'United States', 'Italy']"
NCT07115862,Effects of Pomegranate Juice on Ulcerative Colitis,"Effect of Pomegranate Juice on Gut Inflammation, Quality of Life and the Gut Microbiome in Patients With Ulcerative Colitis: A Pilot Study",RECRUITING,2025-10-15,2027-10-15,2027-10-15,INTERVENTIONAL,NA,30,['Ulcerative Colitis (Disorder)'],Ulcerative Colitis (Disorder),"University of California, Los Angeles","['National Institutes of Health (NIH)', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']",['United States']
NCT06214741,A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight,"A Phase III, Randomized, Double-blind, Parallel-group, Efficacy and Safety Study of BI 456906 Administered Subcutaneously Compared With Placebo in Chinese Participants With a BMI >=28 kg/m2 or BMI >=24 kg/m2 With at Least One Weight-related Complication",ACTIVE_NOT_RECRUITING,2024-02-06,2025-07-29,2026-01-30,INTERVENTIONAL,PHASE3,307,"['Obesity', 'Overweight']",Obesity,Boehringer Ingelheim,[],['China']
NCT06807268,A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema,"A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 6 TO LESS THAN 12 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS",RECRUITING,2025-07-24,2027-05-02,2027-05-02,INTERVENTIONAL,PHASE3,150,['Eczema'],Eczema,Pfizer,[],"['Japan', 'Hungary', 'China', 'United States', 'Mexico', 'Spain', 'Poland', 'Germany']"
NCT04772196,Temporal Profile of Serum Vitamin D Levels in Foot and Ankle Fusion Surgery,"Temporal Profile of Serum Vitamin D Levels and Outcomes After Total Ankle Arthroplasty, Ankle Arthrodesis and First Metatarsophalangeal Joint Arthrodesis",ACTIVE_NOT_RECRUITING,2020-12-21,2026-05,2026-05,INTERVENTIONAL,EARLY_PHASE1,90,"['Ankle Arthrodesis', 'MTP Arthrodesis']",Ankle Arthrodesis,Prisma Health-Midlands,['Medical University of South Carolina'],['United States']
NCT07073703,Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer.,"Effectiveness of a Personalized 6-month Programme on Frailty in Older Patients Treated for Bladder or Kidney Cancer - FRAGECO - Multicenter, Controlled, Randomized Study",RECRUITING,2025-12-03,2027-09,2028-03,INTERVENTIONAL,NA,106,"['Bladder (Urothelial, Transitional Cell) Cancer', 'Kidney (Renal Cell) Cancer']","Bladder (Urothelial, Transitional Cell) Cancer",Centre Hospitalier Universitaire de Saint Etienne,[],['France']
NCT05962879,Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness,Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness,RECRUITING,2024-03-22,2027-07-31,2027-07-31,INTERVENTIONAL,NA,70,"['Anxiety Disorders', 'Psychotic Disorders', 'Depressive Disorder', 'Psychosocial Functioning']",Anxiety Disorders,Massachusetts General Hospital,['National Institute of Mental Health (NIMH)'],['United States']
NCT06295809,A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007),"A Phase 2/3, Adaptive, Randomized, Open-label, Clinical Study to Evaluate Neoadjuvant and Adjuvant Intismeran Autogene (mRNA-4157) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care, and Pembrolizumab Monotherapy in Participants With Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma (LA cSCC) (INTerpath-007)",ACTIVE_NOT_RECRUITING,2024-04-18,2026-03-05,2026-03-05,INTERVENTIONAL,PHASE2,46,"['Carcinoma, Squamous Cell', 'Skin Neoplasms']","Carcinoma, Squamous Cell",Merck Sharp & Dohme LLC,"['ModernaTX, Inc.']","['New Zealand', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Colombia', 'Czechia', 'Poland', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Germany', 'Brazil', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT07271225,Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting,Effectiveness and Safety of Auricular Acupuncture for Nausea and Vomiting Side Effects Induced by Anti-Tuberculosis Drugs in Pulmonary TB Patients,RECRUITING,2025-11-05,2026-06-01,2026-06-30,INTERVENTIONAL,NA,58,"['Tuberculosis, Pulmonary']","Tuberculosis, Pulmonary",Indonesia University,[],['Indonesia']
NCT02003924,Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer,"PROSPER: A MULTINATIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER",ACTIVE_NOT_RECRUITING,2013-10-31,2017-06-28,2025-12-31,INTERVENTIONAL,PHASE3,1401,"['Nonmetastatic Castration-Resistant Prostate Cancer', 'Prostate Cancer', 'Cancer of the Prostate']",Nonmetastatic Castration-Resistant Prostate Cancer,Pfizer,"['Astellas Pharma Inc', 'Medivation LLC, a wholly owned subsidiary of Pfizer Inc.']","['New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Russia', 'France', 'Chile', 'Finland', 'Denmark', 'South Korea', 'Thailand', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT02504853,Natural History and Genetics of Food Allergy and Related Conditions,Natural History and Genetics of Food Allergy and Related Conditions,RECRUITING,2015-07-29,2026-06-15,2026-06-15,OBSERVATIONAL,,1800,"['Food Allergy', 'Loeys-Dietz Syndrome', 'Atopic Dermatitis', 'Eosinophilic Esophagitis']",Food Allergy,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06568562,XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer,PRO-XL: A Phase II Study of XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer After Progression on Lutetium-177 (177Lu)-PSMA-617,RECRUITING,2024-12-09,2026-12,2028-12,INTERVENTIONAL,PHASE2,32,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,University of Utah,['Exelixis'],['United States']
NCT06058039,Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder,"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder",RECRUITING,2023-12-21,2026-02,2026-03,INTERVENTIONAL,PHASE3,332,['Major Depressive Disorder'],Major Depressive Disorder,"Neumora Therapeutics, Inc.",[],"['Bulgaria', 'United States', 'France', 'Finland', 'Czechia', 'Poland', 'Sweden', 'Germany']"
NCT06834217,Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder,Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder,RECRUITING,2025-12-01,2029-04-01,2029-08-01,INTERVENTIONAL,NA,180,['Obsessive Compulsive Disorder (OCD)'],Obsessive Compulsive Disorder (OCD),Yale University,['National Institute of Mental Health (NIMH)'],['United States']
NCT07273435,Crown Movement in Cases Treated With Direct Printed Aligners,Comparison of Predicted and Achieved Crown Movements in Adult Spacing Cases Treated With 3D Direct-printed Aligners: A Prospective Clinical Trial,RECRUITING,2025-06-01,2026-06-01,2026-07-01,INTERVENTIONAL,NA,23,['Effect of Direct Printed Aligners on Crown Movement'],Effect of Direct Printed Aligners on Crown Movement,Suez Canal University,"['Beni-Suef University', 'British University In Egypt']",['Egypt']
NCT07273058,Effect of HIIT on Post-Stroke Fatigue,Effect of High-Intensity Interval Training Intervention on Post-Stroke Fatigue in Chronic Stroke Survivors: A Pilot Randomized Clinical Trial,RECRUITING,2025-10-15,2027-10-01,2027-10-01,INTERVENTIONAL,NA,60,['Stroke'],Stroke,The Hong Kong Polytechnic University,[],['Hong Kong']
NCT06170541,CORE-COMPARE Pilot Study,Ultra-High Resolution Computed Tomography (CT) vs. Conventional CT for Detecting Obstructive Coronary Artery Disease (CAD) The CORE-COMPARE Pilot Study,RECRUITING,2021-04-05,2026-04-05,2027-04-05,INTERVENTIONAL,NA,140,['Coronary Heart Disease (CHD)'],Coronary Heart Disease (CHD),Johns Hopkins University,"['Canon Medical Systems, USA']",['United States']
NCT06914908,Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study,"A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study",RECRUITING,2025-05-12,2031-01-29,2031-01-29,INTERVENTIONAL,PHASE2,64,['Chronic Rhinosinusitis With Nasal Polyps'],Chronic Rhinosinusitis With Nasal Polyps,Sanofi,[],"['Bulgaria', 'United States', 'United Kingdom', 'Poland', 'Argentina']"
NCT07273097,Effects of Ankle Evertor Fatigue on Perturbed Gait,Effects of Ankle Evertor Fatigue on Gait Perturbation Responses in Individuals With and Without Chronic Ankle Instability,RECRUITING,2025-05-05,2026-02,2026-04,OBSERVATIONAL,,40,"['Chronic Ankle Instability, CAI']","Chronic Ankle Instability, CAI",University of Ljubljana,[],['Slovenia']
NCT05252754,Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis,A Randomized Trial Comparing Rectal Indomethacin Alone Versus a Combination of Rectal Indomethacin and Oral Tacrolimus for Post-ERCP Pancreatitis Prophylaxis,RECRUITING,2023-01-18,2026-12,2026-12,INTERVENTIONAL,PHASE3,4874,['Post-ERCP Acute Pancreatitis'],Post-ERCP Acute Pancreatitis,Johns Hopkins University,[],"['Singapore', 'United States', 'India']"
NCT07272356,Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function,Investigation of the Efficacy of Local Minimally Invasive Ablative Therapy for Pulmonary Tumors and Its Impact on Respiratory Function,ACTIVE_NOT_RECRUITING,2022-11-22,2026-06-14,2026-06-14,INTERVENTIONAL,NA,68,"['Lung Cancer (Non-Small Cell)', 'Lung Metastases From Any Primary']",Lung Cancer (Non-Small Cell),Aurimas Macionis,[],['Lithuania']
NCT05026866,A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3),A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease,ACTIVE_NOT_RECRUITING,2021-08-27,2027-11,2027-11,INTERVENTIONAL,PHASE3,2996,['Alzheimer Disease'],Alzheimer Disease,Eli Lilly and Company,[],"['Puerto Rico', 'Japan', 'United States']"
NCT05395481,A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD),"A Single-Ascending and Repeated Subcutaneous Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Who Have the PNPLA3 I148M Genotype",RECRUITING,2022-06-08,2026-10,2026-10,INTERVENTIONAL,PHASE1,176,"['Metabolic Dysfunction-Associated Steatohepatitis (MASH)', 'Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)']",Metabolic Dysfunction-Associated Steatohepatitis (MASH),Eli Lilly and Company,[],"['Puerto Rico', 'Japan', 'United States']"
NCT05170412,Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease,Observational Study of Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease,RECRUITING,2022-05-26,2026-12-31,2026-12-31,OBSERVATIONAL,,80,['Sickle Cell Disease'],Sickle Cell Disease,National Institutes of Health Clinical Center (CC),"['National Human Genome Research Institute (NHGRI)', 'National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07271719,Fovea Sparing ILM Peeling in Diabetic Patients,Fovea Sparing ILM Peeling vs Complete ILM Peeling in Diabetic Patients With Proliferative Diabetic Retinopathy (PDR) Indicated for Pars Plana Vitrectomy (PPV).,ACTIVE_NOT_RECRUITING,2025-06-05,2025-12,2026-01,INTERVENTIONAL,NA,48,['Diabetes Mellitus'],Diabetes Mellitus,David Nashaat Shafik Fahmy,[],['Egypt']
NCT04798768,Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing,Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing,ACTIVE_NOT_RECRUITING,2021-07-20,2024-05-06,2030-12-31,INTERVENTIONAL,NA,297,"['Tachycardia, Ventricular', 'Arrhythmia, Ventricular']","Tachycardia, Ventricular",Boston Scientific Corporation,[],"['Netherlands', 'Austria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom']"
NCT07273383,Self-sampling for HPV Screening,Self-sampling for HPV Screening: a Population-based Feasibility Study,ACTIVE_NOT_RECRUITING,2025-06-01,2025-12-31,2026-02-01,INTERVENTIONAL,NA,1000,"['HPV', 'Cervical Cancers']",HPV,Université de Sherbrooke,[],['Canada']
NCT05199948,"Weight, Energy, Lipids, and the Liver (WELL) Study","Weight, Energy, Lipids, and the Liver (WELL) Study: Dietary Fat Quality and Ectopic Lipids in the Liver",ACTIVE_NOT_RECRUITING,2022-05-02,2025-09-01,2026-02-01,INTERVENTIONAL,NA,74,['Nonalcoholic Fatty Liver'],Nonalcoholic Fatty Liver,Ohio State University,[],['United States']
NCT07262424,Debriefing Styles and Clinical Judgment in Nursing Students,The Influence of Instructor-centered Versus Learner-centered Debriefing on Clinical Judgment in Nursing Students: A Mixed-methods Experimental Study Protocol.,RECRUITING,2025-10-10,2026-03,2026-05,INTERVENTIONAL,NA,110,"['Simulation Based Learning', 'Nursing Education', 'Debriefing Method']",Simulation Based Learning,Universitat Internacional de Catalunya,[],['Spain']
NCT05730257,Study Investigating Whether Robot-assisted Surgery Can Reduce Surgical Complications Following Kidney Transplantation,Open-label Randomized Clinical Trial Investigating Whether Robot-Assisted Kidney Transplantation Can Reduce Surgical Complications Compared to Open Kidney Transplantation; The ORAKTx Trial,ACTIVE_NOT_RECRUITING,2023-05-08,2025-10-26,2027-10-26,INTERVENTIONAL,NA,106,"['End Stage Renal Disease', 'Kidney Transplant; Complications']",End Stage Renal Disease,"Rigshospitalet, Denmark",[],['Denmark']
NCT06765980,A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration,"A Phase 1/2, First-in-Human, Multi-Arm, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of an Adeno-associated Virus Vector VV-14295 Administered Suprachoroidally With the Everads Injector In AdultS With GeographIc Atrophy Secondary to Age-related Macular DegeneratiON (the VISION Study)",RECRUITING,2025-05-28,2027-12-15,2027-12-15,INTERVENTIONAL,PHASE1,62,['Geographic Atrophy Secondary to Age-related Macular Degeneration'],Geographic Atrophy Secondary to Age-related Macular Degeneration,"Kriya Therapeutics, Inc.",[],"['New Zealand', 'Canada']"
NCT06574217,Evaluation of Stepping Stones,Evaluation of Stepping Stones,RECRUITING,2024-09-16,2028-03,2028-09-14,INTERVENTIONAL,NA,650,['Teen Pregnancy Prevention'],Teen Pregnancy Prevention,The Policy & Research Group,"['Department of Health and Human Services', 'Mathematica Policy Research, Inc.', 'Public Health - Seattle and King County', 'Reproductive Health National Training Center']",['United States']
NCT07222098,A Clinical Study of MK-1084 With Rosuvastatin and Metformin in Healthy People (MK-1084-016),"An Open-Label, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of MK-1084 on the Single-Dose Pharmacokinetics of Rosuvastatin and Metformin in Healthy Participants",ACTIVE_NOT_RECRUITING,2025-11-19,2025-12-14,2025-12-23,INTERVENTIONAL,PHASE1,16,['Healthy'],Healthy,Merck Sharp & Dohme LLC,[],['United States']
NCT04540380,Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH,Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH,ACTIVE_NOT_RECRUITING,2021-09-01,2027-01,2027-06,INTERVENTIONAL,PHASE1,20,['Renal Failure'],Renal Failure,Massachusetts General Hospital,[],['United States']
NCT05360056,Continuous Glucose Monitoring Following Hospital Discharge,Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes,ACTIVE_NOT_RECRUITING,2022-04-26,2024-08-31,2025-12,INTERVENTIONAL,NA,108,['Type 2 Diabetes'],Type 2 Diabetes,Kathleen Dungan,"['DexCom, Inc.']",['United States']
NCT04305431,Dietary Behavior Intervention in African Americans at Risk for Cardiovascular Disease,Exploring a Dietary Behavior Intervention in African-Americans at Risk for Cardiovascular Disease: A Community Acceptability and Feasibility Study,RECRUITING,2021-02-25,2026-12-19,2027-08-01,INTERVENTIONAL,NA,55,"['Diet', 'Cooking']",Diet,National Institutes of Health Clinical Center (CC),[],['United States']
NCT06105541,Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation,At-Home Transcutaneous Auricular Neuromodulation for Hypermobile Ehlers Danlos Syndrome,ACTIVE_NOT_RECRUITING,2023-07-05,2026-02-04,2026-02-04,INTERVENTIONAL,NA,25,"['Hypermobile Ehlers-Danlos Syndrome', 'Hypermobile Spectrum Disorder', 'Ehlers-Danlos Syndrome']",Hypermobile Ehlers-Danlos Syndrome,Medical University of South Carolina,[],['United States']
NCT05391061,A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis,Post Marketing Surveillance (PMS) Study for Cibinqo Tablet (Abrocitinib) in Patients With Moderate to Severe Atopic Dermatitis (AD) in Korea,RECRUITING,2023-01-07,2027-11-22,2027-11-22,OBSERVATIONAL,,1100,"['Dermatitis, Atopic']","Dermatitis, Atopic",Pfizer,[],['South Korea']
NCT07272772,Colon Cancer Diagnosis With FAPI-PET Imaging,Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients With Colon Cancer,RECRUITING,2024-10-09,2026-10,2026-10,INTERVENTIONAL,PHASE2,100,['Colon Cancer'],Colon Cancer,Turku University Hospital,[],['Finland']
NCT07097311,Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD),"A Phase II, Open Label Study to Evaluate the Safety of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)",RECRUITING,2026-02,2027-06,2027-12,INTERVENTIONAL,PHASE2,24,['Medium-chain Acyl-CoA Dehydrogenase Deficiency'],Medium-chain Acyl-CoA Dehydrogenase Deficiency,"Jerry Vockley, MD, PhD",['Ultragenyx Pharmaceutical Inc'],['United States']
NCT03983512,PULSTA Transcatheter Pulmonary Valve Pre-Approval Study,The PULSTA Transcatheter Pulmonary Valve (TPV) Pre-Approval Study,ACTIVE_NOT_RECRUITING,2019-10-07,2022-09-21,2026-12,INTERVENTIONAL,NA,58,"['Heart Diseases', 'Pulmonary Valve Regurgitation', 'Pulmonary Valve Stenosis', 'Tetralogy of Fallot']",Heart Diseases,"Taewoong Medical Co., Ltd.",['Avania'],"['Turkey (Türkiye)', 'Netherlands', 'Spain', 'South Korea', 'Italy', 'Germany']"
NCT07272434,Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell),"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) in Adults Aged 60 Aears and Above",RECRUITING,2025-10-22,2026-07-31,2028-12-31,INTERVENTIONAL,PHASE3,25000,['Respiratory Syncytial Virus (RSV)'],Respiratory Syncytial Virus (RSV),MAXVAX Biotechnology Limited Liability Company,"['Henan Center for Disease Control and Prevention', 'Hunan Provincial Center for Disease Control and Prevention', 'Hubei Provincial Center for Disease Control and Prevention', 'Shaanxi Provincial Center for Disease Control and Prevention', 'Guangdong Center for Disease Prevention and Control', 'Shandong Province Centers for Disease Control and Prevention', 'Sichuan Center for Disease Control and Prevention', 'Hebei CDC ,China']",['China']
NCT05479812,Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors,A Multicenter Phase I/Ib Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab in Patients With Selected Advanced or Metastatic Solid Tumors,RECRUITING,2022-05-20,2026-07-01,2026-07-31,INTERVENTIONAL,PHASE1,150,"['Metastatic Solid Tumor', 'Advanced Solid Tumor']",Metastatic Solid Tumor,"Werewolf Therapeutics, Inc.",['Merck Sharp & Dohme LLC'],['United States']
NCT06636383,Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program,GSDIa Disease Monitoring Program,RECRUITING,2024-11-04,2036-12,2036-12,OBSERVATIONAL,,140,['Glycogen Storage Disease Type Ia'],Glycogen Storage Disease Type Ia,Ultragenyx Pharmaceutical Inc,[],"['Brazil', 'Japan', 'Netherlands', 'United States', 'Denmark', 'Spain', 'Italy', 'Canada', 'Germany']"
NCT05630053,Cemented vs Cementless Persona Keel RCT,Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA,ACTIVE_NOT_RECRUITING,2023-07-25,2032-05,2032-12,INTERVENTIONAL,NA,300,"['Knee Pain Chronic', 'Rheumatoid Arthritis', 'Osteoarthritis', 'Traumatic Arthritis', 'Polyarthritis', 'Avascular Necrosis', 'Varus Deformity', 'Valgus Deformity', 'Flexion Deformity of Knee']",Knee Pain Chronic,Zimmer Biomet,[],['United States']
NCT07261254,Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children,Advancing Health Equity Via Basic Income + Early Childhood Systems Integration: An RCT of the Baby Bonus Program,RECRUITING,2025-04-07,2030-03,2030-03,INTERVENTIONAL,NA,2400,"['Income', 'Infant, Newborn', 'Mothers', 'Poverty', 'United States', 'Healthcare Disparities', 'Child Care', 'Child Health', 'Community Health Workers', 'Hispanic or Latino', 'Medicaid', 'Child Development', 'Social Services Utilization', 'Health Services Utilization']",Income,Stanford University,"['Health Plan of San Mateo', 'The Fidelity Charitable Trust', 'Silicon Valley Community Foundation', 'San Mateo County Health', 'First 5 San Mateo County', 'The Jackie Speier Foundation', 'Valhalla Foundation']",['United States']
NCT06576843,INDV-6001 Multiple-Dose Pharmacokinetic Study,"An Open-label, Multicentre Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Repeated Doses of INDV-6001 in Adults With Moderate to Severe Opioid Use Disorder",ACTIVE_NOT_RECRUITING,2024-09-17,2026-01,2026-01,INTERVENTIONAL,PHASE2,123,['Moderate to Severe Opioid Use Disorder'],Moderate to Severe Opioid Use Disorder,Indivior Inc.,[],['United States']
NCT05673408,NIBP Validation Study,Non-Invasive Blood Pressure Validation Study,RECRUITING,2023-06-23,2026-12-31,2026-12-31,OBSERVATIONAL,,189,['Critical Illness'],Critical Illness,Philips Clinical & Medical Affairs Global,[],['United States']
NCT07048249,Single Arm Romiplostim to Prevent CIT,Single Arm Evaluation of Romiplostim to Prevent Chemotherapy Induced Thrombocytopenia in Patients With Ewing Sarcoma,RECRUITING,2024-01-26,2027-01-01,2028-01-01,INTERVENTIONAL,EARLY_PHASE1,26,"['Ewings Sarcoma', 'Chemotherapy Induced Thrombocytopenia']",Ewings Sarcoma,"Children's Hospital Medical Center, Cincinnati",[],['United States']
NCT06614335,An Observational Cohort Study to Explore the Clinical Outcome of Congenital Strabismmus Based on Etiology and Timing of Surgery,An Observational Cohort Study to Explore the Clinical Outcome of Congenital Strabismmus Based on Etiology and Timing of Surgery,ACTIVE_NOT_RECRUITING,2024-03-26,2028-03-30,2028-03-30,OBSERVATIONAL,,300,['Congenital Esotropia'],Congenital Esotropia,Qiyu Bo,[],['China']
NCT07196605,Sodium Sivelestat With Mechanical Thrombectomy for Acute Stroke: A Pilot Study,Efficacy and Safety of Sodium Sivelestat as an Adjunct to Mechanical Thrombectomy in Acute Large Vessel Occlusion Stroke: A Prospective Single-Arm Exploratory Study,RECRUITING,2025-10-28,2026-03-01,2026-06-01,INTERVENTIONAL,NA,20,"['Acute Ischemic Stroke', 'Neutrophil Extracellular Traps Formation', 'Large Vessel Occlusion', 'Thrombectomy']",Acute Ischemic Stroke,"Xuanwu Hospital, Beijing",[],['China']
NCT07147894,Executive Function Training for Children and Adolescents,Understanding Mediating and Moderating Factors That Determine Transfer of Working Memory Training in Adolescents,RECRUITING,2025-12,2028-06-30,2028-06-30,INTERVENTIONAL,NA,780,['Cognitive Change'],Cognitive Change,Northeastern University,[],['United States']
NCT07272382,Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer,Effect of Omega-3 Fatty Acids on PD-1 Inhibitor Therapy in Advanced Esophageal Cancer (ESO-Shanghai28): A Phase II Randomized Controlled Trial,RECRUITING,2025-06-05,2027-06-05,2027-06-05,INTERVENTIONAL,NA,142,['Esophageal Neoplasms'],Esophageal Neoplasms,Fudan University,[],['China']
NCT07272720,PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones,"Post-Market Clinical Follow-Up Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones - A Confirmatory Parallel-Group, Randomized Controlled Trial",RECRUITING,2025-12-01,2026-09,2027-07,INTERVENTIONAL,NA,126,"['Kidney Stones', 'Urolithiasis']",Kidney Stones,Storz Medical AG,['Karolinska University Hospital'],['Sweden']
NCT07238283,"Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer","Irinotecan Hydrochloride Liposome Injection (II) in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate Versus Nab-paclitaxel in Combination With Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer: an Open, Randomized, Multicenter Phase III Trial.",RECRUITING,2025-12-02,2028-10,2028-12,INTERVENTIONAL,PHASE3,662,['First-line Treatment of Metastatic Pancreatic Cancer'],First-line Treatment of Metastatic Pancreatic Cancer,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT07231146,Interaction Between Dairy and Gut Hormone Response on Cognitive Performance in Children.,Interaction Between Milk and Yogurt and Gastrointestinal Hormone Response on Cognitive Performance in School-Aged Children,RECRUITING,2025-11-15,2027-10,2027-10,INTERVENTIONAL,NA,48,"['Children', 'Healthy']",Children,Toronto Metropolitan University,"['National Dairy Council', 'Dairy Management Inc.']",['Canada']
NCT06439277,A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2),"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)",RECRUITING,2024-06-03,2027-10,2030-12,INTERVENTIONAL,PHASE3,300,"['Obesity', 'Weight Gain']",Obesity,Eli Lilly and Company,[],"['Israel', 'United States', 'France', 'Germany', 'Mexico', 'Puerto Rico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Argentina', 'Australia']"
NCT05399992,Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD,VICTORION REAL: An International Prospective Real-world Study to Evaluate the LDL-C changE and Adherence to incLisiran in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia,ACTIVE_NOT_RECRUITING,2022-09-12,2026-10-05,2026-10-05,OBSERVATIONAL,,852,"['Primary Hypercholesterolemia', 'Mixed Dyslipidemia']",Primary Hypercholesterolemia,Novartis Pharmaceuticals,[],"['Israel', 'Saudi Arabia', 'China', 'Austria', 'Switzerland', 'United Arab Emirates', 'Malaysia', 'United Kingdom']"
NCT05456100,Chinese American Cancer Survivors Writing Study,A Randomized Controlled Trial Testing Expressive Helping for Chinese American Cancer Survivors,RECRUITING,2022-07-14,2026-06-30,2026-12-31,INTERVENTIONAL,NA,108,['Cancer'],Cancer,New York University,['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT07273695,Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders,Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders,RECRUITING,2025-09-19,2026-12,2026-12,OBSERVATIONAL,,80,"['Emotional Dysregulation', 'Externalizing Problems', 'Oppositional Defiant', 'Conduct Disorder', 'Disruptive Behaviours', 'Attention Deficit Hyerpactivity Disorder']",Emotional Dysregulation,IRCCS Eugenio Medea,[],['Italy']
NCT06890702,Clinical Evaluation of New Biomarkers for Ischemic Cerebrovascular Disease,A Prospective Observational Cohort Study of Predictive Biomarkers Related With Ischemic Cerebrovascular Disease,RECRUITING,2025-01-01,2035-12-27,2038-01-01,OBSERVATIONAL,,7000,"['Ischemic Stroke', 'Ischemic Cerebrovascular Disease']",Ischemic Stroke,Tongji Hospital,[],['China']
NCT07172477,Early Phase Study Using the 'Pivot Extend' System as a Treatment for Patients With Tricuspid Regurgitation,"Early Feasibility Study (EFS) of the 'Pivot Extend' for the Treatment of Tricuspid Regurgitation, Including High-Risk Patients (SPACER Study, Australia)",RECRUITING,2025-11-11,2026-04,2027-03,INTERVENTIONAL,NA,10,['Tricuspid Regurgitation'],Tricuspid Regurgitation,Tau Medical Australia Pty Ltd,"['Tau-MEDICAL Co., Ltd.']",['Australia']
NCT06815575,A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.,A Two-part Phase 1 Open-label Safety and Pharmacokinetic Study of Intravenous RC220 in Combination With Doxorubicin in Adult Patients With Solid Tumours.,RECRUITING,2025-04-02,2027-07-31,2029-01-31,INTERVENTIONAL,PHASE1,53,"['Solid Tumours', 'Advanced Solid Tumours']",Solid Tumours,Race Oncology Ltd,[],"['Hong Kong', 'Australia']"
NCT07256730,Computer-Guided Ridge Split and Expansion Using an Electromagnetic Mallet,Comparative Study Between Artificial Intelligence-Assisted/Computer-Guided Versus Conventional Ridge Splitting Utilizing Electromagnetic Mallet for Reconstruction of Horizontal Ridge Defects: A Randomized Controlled Clinical Study,RECRUITING,2024-08-27,2026-01-20,2026-03,INTERVENTIONAL,NA,22,['Reconstruction of Horizontal Ridge Defects'],Reconstruction of Horizontal Ridge Defects,Kafrelsheikh University,[],['Egypt']
NCT06668922,Irritable Bowel Syndrome and Control Volunteers: Diet Challenge,"Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbiota in Patients With Irritable Bowel Syndrome (IBS) and Control Volunteers: Diet Challenge",RECRUITING,2024-11-28,2029-12-31,2030-12-31,INTERVENTIONAL,NA,72,['Irritable Bowel Syndrome (IBS)'],Irritable Bowel Syndrome (IBS),"University of California, Los Angeles",[],['United States']
NCT06597448,Public Health Nurse-Peer Co-Led Group Cognitive Behavioral Therapy for Postpartum Depression,Public Health Nurse-Peer Co-Delivered Group Cognitive Behavioral Therapy for Postpartum Depression: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2024-09-16,2027-06-01,2028-01-01,INTERVENTIONAL,NA,170,['Postpartum Depression'],Postpartum Depression,McMaster University,['Niagara Region Public Health'],['Canada']
NCT07147296,ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury,ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury,RECRUITING,2025-10-17,2026-11,2029-03,INTERVENTIONAL,NA,60,"['Spinal Cord Injuries', 'Blood Pressure Disorders']",Spinal Cord Injuries,"ONWARD Medical, Inc.",[],['United States']
NCT04703192,"Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)","Single-arm, Phase 2 Study of Valemetostat Tosylate Monotherapy in Subjects With Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)",ACTIVE_NOT_RECRUITING,2021-06-03,2023-05-10,2027-02-19,INTERVENTIONAL,PHASE2,155,"['Relapsed/Refractory Peripheral T-Cell Lymphoma', 'Adult T Cell Leukemia/Lymphoma']",Relapsed/Refractory Peripheral T-Cell Lymphoma,Daiichi Sankyo,[],"['Japan', 'Netherlands', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'Australia', 'United Kingdom', 'Germany']"
NCT04389632,A Study of Sigvotatug Vedotin in Advanced Solid Tumors,A Phase 1 Study of Sigvotatug Vedotin in Advanced Solid Tumors,RECRUITING,2020-06-08,2027-06-16,2029-03-22,INTERVENTIONAL,PHASE1,1006,"['Carcinoma, Non-Small Cell Lung', 'Squamous Cell Carcinoma of Head and Neck', 'HER2 Negative Breast Neoplasms', 'Esophageal Squamous Cell Carcinoma', 'Esophageal Adenocarcinoma', 'Gastroesophageal Junction Adenocarcinoma', 'Ovarian Neoplasms', 'Cutaneous Squamous Cell Cancer', 'Exocrine Pancreatic Adenocarcinoma', 'Urinary Bladder Neoplasms', 'Uterine Cervical Neoplasms', 'Stomach Neoplasms']","Carcinoma, Non-Small Cell Lung","Seagen, a wholly owned subsidiary of Pfizer",[],"['United States', 'France', 'Switzerland', 'Spain', 'Taiwan', 'South Korea', 'United Kingdom']"
NCT07053423,A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Dupilumab on Airway Inflammation Through Assessments of Mucus Plugging and Other Lung Imaging Parameters in Patients With Chronic Obstructive Pulmonary Disease.",RECRUITING,2025-09-22,2028-12-23,2029-02-15,INTERVENTIONAL,PHASE4,218,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,Sanofi,['Regeneron Pharmaceuticals'],"['Hungary', 'United States', 'France', 'Denmark', 'Spain', 'Taiwan', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Sweden']"
NCT07222059,"Phase 3 Single Arm, Open Study on vYF in Adults","A Phase 3, Single Arm, Open Study to Assess the Immunogenicity and Safety of vYF in Adults Aged 18 Years and Over",ACTIVE_NOT_RECRUITING,2025-10-23,2025-12-05,2025-12-05,INTERVENTIONAL,PHASE3,254,['Yellow Fever'],Yellow Fever,"Sanofi Pasteur, a Sanofi Company",[],['Japan']
NCT04909138,Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy,Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy,RECRUITING,2022-10-15,2025-12,2026-12,INTERVENTIONAL,NA,30,"['CRPS (Complex Regional Pain Syndromes)', 'Radiculopathy', 'Peripheral Neuropathy']",CRPS (Complex Regional Pain Syndromes),Rush University Medical Center,[],['United States']
NCT07222293,Assessment of AI Program 'DRISTi' as a Screening Tool,Assessment of 'DRISTi' as an Automated Diabetic Retinopathy Screening Tool in Diabetic Populations,RECRUITING,2025-11-23,2026-03,2026-03,OBSERVATIONAL,,900,['Diabetic Retinopathy (DR)'],Diabetic Retinopathy (DR),Artelus AI,[],['United States']
NCT02900976,"Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder",A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes (LMP-TC) in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD),ACTIVE_NOT_RECRUITING,2017-03-22,2021-03-31,2025-12-31,INTERVENTIONAL,PHASE2,18,"['EBV-Related Post-Transplant Lymphoproliferative Disorder', 'Monomorphic Post-Transplant Lymphoproliferative Disorder', 'Polymorphic Post-Transplant Lymphoproliferative Disorder', 'Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder', 'Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder', 'Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder', 'Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder']",EBV-Related Post-Transplant Lymphoproliferative Disorder,Children's Oncology Group,['National Cancer Institute (NCI)'],['United States']
NCT07197450,Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism,Efficacy and Safety of mRNA Drug XH02 in the Treatment of Adult Hypoparathyroidism,RECRUITING,2025-05-20,2025-12-31,2026-03-31,INTERVENTIONAL,EARLY_PHASE1,6,['Hypoparathyroidism'],Hypoparathyroidism,Peking Union Medical College Hospital,[],['China']
NCT07272928,Comparison of the Resection Site Order in Simultaneous Approach of Colorectal Liver Metastasis,Comparison of the Resection Site Order in Simultaneous Approach of Colorectal Liver Metastasis. An International Multicentric Retrospective Trial.,RECRUITING,2025-02-27,2025-08-27,2026-08-27,OBSERVATIONAL,,500,['Colorectal Liver Metastasis'],Colorectal Liver Metastasis,Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria,[],['Italy']
NCT06916078,"A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function","A Phase 1, Multicenter, Sequential-Design, Single-Dose, Open-Label Study of Lepodisiran in Participants With Normal Hepatic Function and Participants With Mild, Moderate, or Severe Hepatic Impairment",RECRUITING,2025-04-23,2026-01,2026-01,INTERVENTIONAL,PHASE1,33,"['Liver Dysfunction', 'Healthy']",Liver Dysfunction,Eli Lilly and Company,[],"['United States', 'Hungary']"
NCT04004117,Effect of Sublingual Fentanyl on Breathlessness in COPD,Effect of Sublingual Fentanyl on Breathlessness in COPD : A Randomized Cross-over Trial,RECRUITING,2019-07-01,2019-12-31,2026-03,INTERVENTIONAL,PHASE2,40,['Copd'],Copd,McGill University Health Centre/Research Institute of the McGill University Health Centre,['Canadian Institutes of Health Research (CIHR)'],['Canada']
NCT07185230,Atosiban in Women With Previous Implantation Failure and Abnormal Uterine Contractions,"Atosiban in Women With Previous Implantation Failure and Abnormal Uterine Contractions Undergoing Single Blastocyst-Stage Embryo Transfer: A Randomised Triple-Blind, Placebo-Controlled Trial",RECRUITING,2025-12-06,2027-06-30,2027-09-30,INTERVENTIONAL,NA,792,['Infertility'],Infertility,"Northwest Women's and Children's Hospital, Xi'an, Shaanxi",[],['China']
NCT07166237,Group Cognitive Behavioural Therapy for Paternal Perinatal Depression,Group Cognitive Behavioural Therapy for Paternal Perinatal Depression: A Pilot Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-09-09,2026-09,2026-09,INTERVENTIONAL,NA,48,"['Perinatal Depression', 'Fathers']",Perinatal Depression,McMaster University,[],['Canada']
NCT07231211,A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors,"An Open-label, Multicenter Phase I/II Clinical Study of SHR-4610 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy",RECRUITING,2025-11-17,2026-10,2027-12,INTERVENTIONAL,PHASE1,258,['Solid Tumors'],Solid Tumors,"Shanghai Shengdi Pharmaceutical Co., Ltd",[],['China']
NCT07271771,The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity,The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity,RECRUITING,2024-05-21,2027-03-01,2027-03-01,INTERVENTIONAL,PHASE4,40,['Osteoporosis'],Osteoporosis,Aarhus University Hospital,[],['Denmark']
NCT06506344,Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems,Project 1 (Signature): Syncing Screening and Services for Suicide Prevention Across Health and Jail Systems,RECRUITING,2024-06-24,2027-07,2027-07,INTERVENTIONAL,NA,5250,['Suicide Prevention'],Suicide Prevention,Henry Ford Health System,"['National Institute of Mental Health (NIMH)', 'Michigan State University', 'HealthPartners Institute', 'Brown University']",['United States']
NCT06781801,Improving Heart and Metabolic Health in People With Severe Mental Illness Through a Long-term Clinical Trial,Longitudinal Approach to Generate Positive Cardiometabolic Health Outcomes in Severe Mental Illness,RECRUITING,2025-02-27,2029-12-31,2029-12-31,INTERVENTIONAL,NA,644,['Psychotic Disorders'],Psychotic Disorders,Vastra Gotaland Region,['The Swedish Society of Medicine'],['Sweden']
NCT07273747,Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms,"A Randomized Controlled Trial on the Effects of Oral Kelulut Honey Supplementation on Conjunctival Goblet Cell Density, Tear Film Stability, Dry Eye Disease Symptoms and Vision-Related Function in Patients With Allergic Conjunctivitis",RECRUITING,2025-09-17,2026-01-16,2026-09,INTERVENTIONAL,NA,72,"['Dry Eye Symptoms', 'Allergic Conjunctivitis of Both Eyes']",Dry Eye Symptoms,Universiti Sains Malaysia,[],['Malaysia']
NCT06876649,A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib,A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib,RECRUITING,2025-05-20,2030-05,2032-12,INTERVENTIONAL,PHASE4,787,"['Chronic Lymphocytic Leukemia', 'Non-Hodgkin Lymphoma']",Chronic Lymphocytic Leukemia,Eli Lilly and Company,[],"['Japan', 'United States', 'France', 'Italy', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT07271147,Effects of taVNS Combined With Dexmedetomidine on POVN,The Effect of Dexmedetomidine Combined With Percutaneous Auricular Vagus Nerve Stimulation on Postoperative Nausea and Vomiting in Female Laparoscopic Patients: A Randomized Controlled Trial,RECRUITING,2025-11-07,2026-12-01,2026-12-01,INTERVENTIONAL,NA,176,['Postoperative Nausea and Vomiting'],Postoperative Nausea and Vomiting,Affiliated Hospital of Nantong University,[],['China']
NCT05848258,An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis,"An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis",RECRUITING,2023-05-23,2026-02,2026-07,INTERVENTIONAL,PHASE2,380,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Eli Lilly and Company,['Rigel Pharmaceuticals'],"['Hungary', 'India', 'United States', 'France', 'Mexico', 'Czechia', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT05099666,Lurbinectedin + Doxorubicin In Leiomyosarcoma,A Phase 1b/2 Trial of Lurbinectedin Plus Doxorubicin in Leiomyosarcoma,ACTIVE_NOT_RECRUITING,2022-02-04,2026-07,2027-07,INTERVENTIONAL,PHASE1,62,"['Advanced Soft-tissue Sarcoma', 'Metastatic Soft-tissue Sarcoma', 'Advanced Leiomyosarcoma', 'Leiomyosarcoma Metastatic']",Advanced Soft-tissue Sarcoma,Massachusetts General Hospital,['Jazz Pharmaceuticals'],['United States']
NCT06890689,Effectiveness of Scaling and Root Planing in Deeper Pockets,Effectiveness of Scaling and Root Planing in Deeper Pockets,ACTIVE_NOT_RECRUITING,2025-01-01,2026-06-01,2026-08-01,OBSERVATIONAL,,110,"['Periodontal Disease', 'Periodontitis']",Periodontal Disease,Texas A&M University,[],['United States']
NCT06354088,"Human Models of Selective Insulin Resistance: Alpelisib, Part I","Human Models of Selective Insulin Resistance: Alpelisib, Part I",RECRUITING,2024-04-24,2026-05,2026-12,INTERVENTIONAL,PHASE1,32,"['Insulin Resistance', 'Prediabetic State', 'Overweight and Obesity', 'Non-Alcoholic Fatty Liver Disease']",Insulin Resistance,Columbia University,"['University of California, Berkeley', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'Stanford University']",['United States']
NCT06588478,A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"A Phase 2, Open-Label, Randomized Study Evaluating the Efficacy and Safety of 3 Doses of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Who Previously Received Treatment With a Covalent Bruton Tyrosine Kinase Inhibitor",RECRUITING,2025-01-03,2028-06,2028-12,INTERVENTIONAL,PHASE2,249,"['Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma']",Chronic Lymphocytic Leukemia,"Loxo Oncology, Inc.",['Eli Lilly and Company'],"['Belgium', 'Hungary', 'Turkey (Türkiye)', 'United Kingdom', 'United States', 'France', 'Germany', 'Slovakia', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'Romania', 'Greece', 'Poland', 'South Korea', 'Australia']"
NCT04421924,Periinterventional Coagulation Management of Patients Undergoing a TIPS,Optimizing Periinterventional Coagulation Management of Patients Undergoing a Transjugular Intrahepatic Portosystemic Shunt Implantation: A Prospective Randomized Cohort Study,RECRUITING,2020-05-27,2026-05,2027-05,INTERVENTIONAL,NA,39,['Liver Cirrhosis'],Liver Cirrhosis,Medical University of Graz,[],['Austria']
NCT04796792,Ultrasound to Facilitate Stone Passage,Ultrasound Technology to Fragment and Reposition Urinary Stones,RECRUITING,2023-04-01,2028-05-31,2028-10-31,INTERVENTIONAL,NA,140,"['Urinary Stone', 'Urinary Calculi']",Urinary Stone,University of Washington,"['Indiana University', 'VA Puget Sound Health Care System', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']",['United States']
NCT07012395,A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis,Phase 2 Platform Trial to Assess the Efficacy and Safety of Long-acting Antibodies as Single Agents and in Combinations for Moderately to Severely Active Ulcerative Colitis,RECRUITING,2025-05-27,2026-06,2028-03,INTERVENTIONAL,PHASE2,645,"['Ulcerative Colitis', 'Inflammatory Bowel Diseases', 'Colitis', 'Colitis, Ulcerative']",Ulcerative Colitis,"Spyre Therapeutics, Inc.",[],"['Moldova', 'United States', 'Georgia', 'Switzerland', 'Bosnia and Herzegovina', 'Taiwan', 'South Korea', 'Canada', 'Poland', 'Ukraine', 'Serbia']"
NCT05171075,A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE,"A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab vs. Dalteparin on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With GI/GU Associated VTE",RECRUITING,2022-09-27,2026-12-31,2027-02-28,INTERVENTIONAL,PHASE3,1020,"['Venous Thromboembolism', 'Deep Venous Thrombosis', 'Pulmonary Embolism']",Venous Thromboembolism,"Anthos Therapeutics, Inc.",['Novartis Pharmaceuticals'],"['Netherlands', 'China', 'Australia', 'Hungary', 'France', 'South Korea', 'Czechia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Latvia', 'Sweden', 'Germany', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy']"
NCT07155668,"A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)","A Randomized, Open-label Study Evaluating the Safety, Tolerability and Pharmacokinetics of VRDN-003 Administered Subcutaneously in Participants With Thyroid Eye Disease (TED)",RECRUITING,2025-07-01,2026-07,2026-11,INTERVENTIONAL,PHASE3,85,['Thyroid Eye Disease'],Thyroid Eye Disease,"Viridian Therapeutics, Inc.",[],['United States']
NCT07272343,The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes,A Study on the Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes Combined With Metabolic-associated Fatty Liver Disease and Its Molecular Mechanisms,RECRUITING,2023-02-10,2026-01-31,2026-06-01,INTERVENTIONAL,PHASE4,100,"['Type 2 Diabetes Mellitus (T2DM)', 'Semaglutide', 'Caloric Restriction']",Type 2 Diabetes Mellitus (T2DM),Second Affiliated Hospital of Nanchang University,[],['China']
NCT07180355,A Study of SGT-212 Gene Therapy in Friedreich's Ataxia,"A Phase 1b First-in-Human, Open-Label, Dose-Finding Trial to Evaluate the Safety and Tolerability of SGT-212 Delivered Via Dual Intradentate Nucleus (IDN) and Intravenous (IV) Administration to Participants With Friedreich's Ataxia (FA)",RECRUITING,2025-10-22,2028-03-21,2032-02-29,INTERVENTIONAL,PHASE1,10,"[""Friedreich's Ataxia (FA)""]",Friedreich's Ataxia (FA),Solid Biosciences Inc.,[],['United States']
NCT07271212,Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir,Evaluation of the Scalp Skin Care Effects of Premium Revitalizing Elixir,ACTIVE_NOT_RECRUITING,2025-11-01,2026-05,2026-05,INTERVENTIONAL,NA,60,"['Scalp Health', 'Hair Condition', 'Hair Loss', 'Alopecia', 'Sebum Production', 'Hair Health', 'Hair Thinning']",Scalp Health,Hungkuang University,['Schweitzer Biotech Company'],['Taiwan']
NCT02669251,"Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation","A Phase 1b/2 Study of Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation",ACTIVE_NOT_RECRUITING,2016-04-28,2027-12-01,2027-12-01,INTERVENTIONAL,PHASE1,14,"['Chronic Graft vs Host Disease', 'Chronic Graft-Versus-Host Disease', 'Bronchiolitis Obliterans Syndrome']",Chronic Graft vs Host Disease,National Cancer Institute (NCI),[],['United States']
NCT07166601,M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors,"An Open Label, Multicenter, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M0324, a Bispecific (MUC-1 x CD40) Antibody as Monotherapy, in Combination With Pembrolizumab, and in Combination With Chemotherapy, in Participants With Selected Advanced Solid Tumors",RECRUITING,2025-10-10,2029-02-23,2029-02-23,INTERVENTIONAL,PHASE1,77,['Advanced Solid Tumor'],Advanced Solid Tumor,"EMD Serono Research & Development Institute, Inc.","['Merck KGaA, Darmstadt, Germany']","['Japan', 'United States', 'Canada']"
NCT04610671,Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC,A Phase 1 Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With Muscle Invasive Bladder Cancer (MIBC),ACTIVE_NOT_RECRUITING,2020-10-26,2025-01-18,2026-01,INTERVENTIONAL,PHASE1,21,"['Muscle-Invasive Bladder Carcinoma', 'Bladder Cancer']",Muscle-Invasive Bladder Carcinoma,H. Lee Moffitt Cancer Center and Research Institute,"['CG Oncology, Inc.', 'Richard M. Shulze Family Foundation']",['United States']
NCT04745728,Different Immunosuppressive Treatment in iMN,Different Immunosuppressive Treatment in Idiopathic Membranous Nephropathy: a Prospective Cohort,RECRUITING,2021-04-14,2027-12,2029-12,INTERVENTIONAL,PHASE3,200,['Idiopathic Membranous Nephropathy'],Idiopathic Membranous Nephropathy,Peking Union Medical College Hospital,[],['China']
NCT06578845,HappyMums Mobile Application Study,HappyMums - Can Data Collected by a Mobile App be Used to Help Learn More About Mental Health Symptoms in Pregnant Women and Birthing People at Risk of Depression in Pregnancy?,RECRUITING,2025-02-18,2026-07-30,2026-10-31,OBSERVATIONAL,,1000,"['Pregnancy', 'Antenatal Depression']",Pregnancy,King's College London,"['University of Milan', 'Ospedale San Raffaele', 'Catholic University of Croatia', 'University of Helsinki', 'Charite University, Berlin, Germany', 'SWPS University of Social Sciences and Humanities', 'Ab.Acus', 'University of Barcelona']","['Finland', 'Croatia', 'Italy', 'United Kingdom', 'Poland', 'Germany']"
NCT06588634,The PERSEVERE Study,The PERSEVERE Study,RECRUITING,2024-12-16,2026-12-31,2027-08-31,INTERVENTIONAL,NA,200,"['Pulmonary Embolism', 'Pulmonary Thromboembolism']",Pulmonary Embolism,Inari Medical,[],"['United States', 'France', 'Switzerland', 'Spain', 'United Kingdom', 'Germany']"
NCT05018299,Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma,"A Randomized, Placebo Controlled, Double Blind Phase IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Multiple Intravenous Doses of FB704A in Adults With Severe Asthma",RECRUITING,2021-09-30,2026-02-13,2026-05-08,INTERVENTIONAL,PHASE2,20,['Severe Asthma'],Severe Asthma,"Oneness Biotech Co., Ltd.",[],['Taiwan']
NCT07068893,A 4-Anchor Construct With Internal Bracing Technique for Surgical Treatment of Perilunate Dislocations,A 4-Anchor Construct With Internal Bracing Technique for Surgical Treatment of Perilunate Dislocations: A Prospective Study,RECRUITING,2025-09-17,2028-01,2028-01,OBSERVATIONAL,,40,['Perilunate Dislocation'],Perilunate Dislocation,"Bryan D Brown,MD",[],['United States']
NCT02281747,Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries,Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries and Other Databases,ACTIVE_NOT_RECRUITING,2014-10-24,2029-05-30,2029-05-31,OBSERVATIONAL,,521292,"['Rheumatoid Arthritis', 'Ankylosing Spondylitis']",Rheumatoid Arthritis,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT03483012,Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis,A Phase II Study of Atezolizumab in Combination With Stereotactic Radiation for Patients With Triple-negative Breast Cancer and Brain Metastasis,ACTIVE_NOT_RECRUITING,2018-05-01,2019-11-21,2026-04-30,INTERVENTIONAL,PHASE2,6,['Breast Cancer'],Breast Cancer,Dana-Farber Cancer Institute,"['Genentech, Inc.']",['United States']
NCT07273266,Feeding Maturity in Preterm Infants,The Effect of Routine Versus Random Pacifier Administration Methods on Feeding Maturity in Preterm Infants,RECRUITING,2025-03-04,2026-07-30,2026-07-30,INTERVENTIONAL,NA,62,"['Preterm', 'Feeding', 'Non Nutritive Sucking']",Preterm,Acibadem University,[],['Turkey (Türkiye)']
NCT07271615,Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting,"Preoperative Stellate Ganglion Block Reduce the Incidence of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective, Randomized Controlled Pilot Trial",RECRUITING,2025-11-19,2026-05-31,2026-07-31,INTERVENTIONAL,NA,60,['Adult Patients Undergoing CABG'],Adult Patients Undergoing CABG,Xijing Hospital,[],['China']
NCT06398847,Virtual Reality (VR) Self-Hypnosis Software,An Open-label Study of Self-hypnosis Software for Virtual Reality for the Treatment of HIV-associated Chronic Pain - a Development and Usability Study,RECRUITING,2026-01-31,2026-06-30,2026-06-30,INTERVENTIONAL,NA,25,"['Musculoskeletal Pain', 'Neuropathic Pain', 'Neuralgia']",Musculoskeletal Pain,Icahn School of Medicine at Mount Sinai,[],['United States']
NCT06598943,A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis,"An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination With Mirikizumab for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2024-10-10,2027-12,2028-09,INTERVENTIONAL,PHASE2,140,"['Ulcerative Colitis', 'Ulcerative Colitis Chronic']",Ulcerative Colitis,Eli Lilly and Company,[],"['Japan', 'Belgium', 'Hungary', 'France', 'Croatia', 'Denmark', 'Colombia', 'Czechia', 'Poland', 'Spain', 'Canada', 'Romania', 'Latvia', 'Greece', 'Germany', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT03488394,"Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant","Phase I/II Study Evaluating Safety and Efficacy of Autologous Hematopoietic Stem and Progenitor Cells Genetically Modified With IDUA Lentiviral Vector Encoding for the Human α-L-iduronidase Gene for the Treatment of Patients Affected by Mucopolysaccharidosis Type I, Hurler Variant",ACTIVE_NOT_RECRUITING,2018-05-11,2028-01,2028-03,INTERVENTIONAL,PHASE1,8,['Mucopolysaccharidosis IH'],Mucopolysaccharidosis IH,Orchard Therapeutics,['Fondazione Telethon'],['Italy']
NCT06963723,Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer,Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer,RECRUITING,2025-07-01,2028-10-01,2029-04-01,INTERVENTIONAL,NA,1000,"['Advanced Cancer', 'Metastatic Cancer']",Advanced Cancer,"Alliance Foundation Trials, LLC.",['Memorial Sloan Kettering Cancer Center'],['United States']
NCT04981288,Lipids and Energy Study: Optimizing the Analysis of Lipids and Energy Metabolism in Blood Samples,Lipids and Energy Study: Optimizing the Analysis of Lipids and Energy Metabolism in Blood Samples,ACTIVE_NOT_RECRUITING,2021-07-02,2025-08-01,2027-12-01,OBSERVATIONAL,,24,['Healthy'],Healthy,Ohio State University,[],['United States']
NCT05503797,A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations,"A Phase 2 Master Protocol to Assess the Efficacy and Safety of FORE8394, an Inhibitor of BRAF Class 1 and Class 2 Alterations, in Participants With Cancer Harboring BRAF Alterations",RECRUITING,2023-02-21,2026-06-27,2026-12-28,INTERVENTIONAL,PHASE2,254,"['Cancer Harboring BRAF Alterations', 'HGG', 'LGG', 'Solid Tumors']",Cancer Harboring BRAF Alterations,Fore Biotherapeutics,[],"['Norway', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia', 'United Kingdom', 'Sweden', 'Germany']"
NCT06632977,"Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial",PREcision DIagnostics in Prostate Cancer Treatment (PREDICT),RECRUITING,2025-02-06,2030-04-11,2034-10-11,INTERVENTIONAL,PHASE2,474,"['Castration-Resistant Prostate Carcinoma', 'Stage IVB Prostate Cancer AJCC v8']",Castration-Resistant Prostate Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],['United States']
NCT03222531,Expanding the Pool in Orthotopic Heart Transplantation,Expanding the Pool in Orthotopic Heart Transplantation: The Use of Hepatitis C Positive Donor Hearts in Hepatitis C Negative Recipients,ACTIVE_NOT_RECRUITING,2017-08-01,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE2,20,"['Hepatitis C', 'Heart Transplant', 'Cardiac Transplant']",Hepatitis C,"Mary E. Keebler, MD",[],['United States']
NCT05788120,Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by ECMO-VA for Refractory Cardiogenic Shock,Incidence and Morbidity of Cardiac Rhythm Disorders in Patients Assisted by Extra Corporeal Membrane Oxygenation Veno-arterial (ECMO VA) for Refractory Cardiogenic Shock,RECRUITING,2023-04-28,2027-04-28,2027-04-28,OBSERVATIONAL,,600,['Cardiac Rhythm Disorder'],Cardiac Rhythm Disorder,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT05815927,Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer,Pembrolizumab and Radiotherapy for OLigometastatic Squamous Cell Carcinoma of the Head and Neck: a Randomized Phase III Study,RECRUITING,2025-05-23,2027-07-15,2030-03-30,INTERVENTIONAL,PHASE3,200,['Oligometastatic Squamous Cell Carcinoma of the Head and Neck'],Oligometastatic Squamous Cell Carcinoma of the Head and Neck,European Organisation for Research and Treatment of Cancer - EORTC,"['Swiss Cancer Institute', 'Merck Sharp & Dohme LLC']","['Switzerland', 'Belgium', 'Spain', 'Italy']"
NCT07152002,A Study of LY4064912 in Healthy Participants and With Overweight or Obesity,"A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4064912 in Healthy Participants and Participants With Overweight or Obesity",RECRUITING,2025-08-28,2026-10,2026-10,INTERVENTIONAL,PHASE1,144,"['Overweight or Obesity', 'Healthy']",Overweight or Obesity,Eli Lilly and Company,[],"['Singapore', 'United States']"
NCT06833983,To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A,"A Single-arm, Open-label, Multicenter Study Evaluating the Efficacy and Safety of GS1191-0445 Injection as a Single Dose in Chinese Subjects With Hemophilia A",RECRUITING,2025-03-31,2026-11-30,2030-11-30,INTERVENTIONAL,PHASE3,50,['Hemophilia A'],Hemophilia A,"Gritgen Therapeutics Co., Ltd.",[],['China']
NCT06756451,"This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.","A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of RJK-RT2831 Injection in Patients With Hematologic Malignancies.",RECRUITING,2025-03-25,2028-04-08,2028-07-14,INTERVENTIONAL,PHASE1,71,['Hematologic Malignancies'],Hematologic Malignancies,"Nanjing RegeneCore Biotech Co., Ltd.",[],['China']
NCT05571839,A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors,A Phase 1 Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors,ACTIVE_NOT_RECRUITING,2023-01-03,2026-06-06,2026-06-06,INTERVENTIONAL,PHASE1,41,"['Cutaneous Melanoma', 'Non-small Cell Lung Cancer', 'Colorectal Neoplasms', 'Pancreatic Neoplasms', 'Mesothelioma']",Cutaneous Melanoma,"Seagen, a wholly owned subsidiary of Pfizer",[],"['United States', 'France', 'Switzerland', 'Canada', 'United Kingdom', 'Germany']"
NCT06547619,"Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM","Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM",RECRUITING,2024-10-01,2026-05,2027-05,INTERVENTIONAL,EARLY_PHASE1,40,"['Gestational Diabetes', 'Endothelial Dysfunction', 'Physical Inactivity']",Gestational Diabetes,"Anna Stanhewicz, PhD",[],['United States']
NCT07130604,Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis",RECRUITING,2025-09-18,2027-07-28,2027-07-28,INTERVENTIONAL,PHASE3,390,['Plaque Psoriasis'],Plaque Psoriasis,"InventisBio Co., Ltd",[],['China']
NCT07272187,Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions,Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions - a Prospective Study,RECRUITING,2025-11-01,2040-12-31,2041-12-31,OBSERVATIONAL,,138,"['Insulinoma; Pancreas', 'MEN1', 'NETs', 'Radiofrequency Ablation', 'Endoscopic Ultrasound (EUS)', 'Conn Syndrome']",Insulinoma; Pancreas,Herlev Hospital,[],['Denmark']
NCT07154706,Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV),A Phase 3 Multicenter Double-blind Randomized Study of Taletrectinib Versus Placebo in Patients With ROS1-Fusion Positive Stage IB-IIIA Non-Small Cell Lung Cancer Who Have Undergone Complete Tumor Resection,RECRUITING,2025-08-21,2030-08-30,2033-08-30,INTERVENTIONAL,PHASE3,180,['Non-small Cell Lung Cancer (NSCLC)'],Non-small Cell Lung Cancer (NSCLC),Nuvation Bio Inc.,[],['United States']
NCT07250048,A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood,"A Randomised, Single-blind, Placebo-controlled Trial to Investigate Safety, Tolerability, and Pharmacokinetics of Single Rising Doses of BI 3009947 Administered Orally to Healthy Male Trial Participants, and a Randomised, Open-label, Single-dose, Three-way Cross-over Relative Bioavailability Comparison of Two Different Formulations for Oral Administration of BI 3009947 and the Effect of Food on One of These Formulations in Healthy Male Trial Participants",RECRUITING,2025-11-21,2026-05-13,2026-05-18,INTERVENTIONAL,PHASE1,68,['Healthy'],Healthy,Boehringer Ingelheim,[],['Germany']
NCT07271199,Eyelash Effect Evaluation for Premium Rejuvenation Eyelash Serum,Evaluation of the Eyelash Care Effects of Premium Rejuvenation Eyelash Serum,ACTIVE_NOT_RECRUITING,2025-11-01,2026-05,2026-05,INTERVENTIONAL,NA,30,"['Skin Condition', 'Eyelash Growth', 'Eyelashes', 'Skin Health', 'Hair Health']",Skin Condition,Hungkuang University,['Schweitzer Biotech Company'],['Taiwan']
NCT07272798,Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension,Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension,RECRUITING,2025-11-20,2026-11-20,2026-11-20,OBSERVATIONAL,,10,['Chronic Thromboembolic Pulmonary Hypertension'],Chronic Thromboembolic Pulmonary Hypertension,Damascus University,[],['Syria']
NCT07090499,A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors,A Phase 1 Open-label Study to Investigate PF-08046876 in Adult Participants With Advanced Solid Tumors.,RECRUITING,2025-08-20,2028-07-08,2029-07-08,INTERVENTIONAL,PHASE1,310,"['Advanced/Metastatic Solid Tumors', 'Bladder Cancer', 'Urothelial Carcinoma', 'Advanced Non-Small Cell Lung Cancer', 'Carcinoma, Non Small Cell Lung', 'Carcinoma, Squamous Cell of Head and Neck', 'Head and Neck Cancer', 'Esophageal Cancer', 'Gastroesophageal Junction Adenocarcinoma', 'Esophageal Squamous Cell Carcinoma', 'Esophageal Adenocarcinoma', 'Pancreatic Adenocarcinoma', 'Pancreatic Cancer']",Advanced/Metastatic Solid Tumors,Pfizer,[],"['Puerto Rico', 'United States', 'Canada']"
NCT07273084,Multidisciplinary Intervention for Non-Cancer Chronic Pain: Pilot Study,Multidisciplinary Intervention in Patients With Non-Cancer Chronic Pain in a Primary Care Center: Pilot Study,ACTIVE_NOT_RECRUITING,2025-07-01,2025-09-01,2026-03-01,INTERVENTIONAL,NA,12,"['Non-cancer Pain', 'Chronic Non-cancer Pain']",Non-cancer Pain,Victor Ortiz Mallasen,[],['Spain']
NCT05996016,Gut and Vaginal Microbiota Profile Study for HIV Women,A Cohort Study Among HIV Infected Women：Exploring the Regulatory Mechanism of Gut and Vaginal Microbiota in HPV Infection and Cervical Lesion,RECRUITING,2017-01-01,2029-01-01,2030-06-30,OBSERVATIONAL,,400,"['HPV', 'HIV Infections', 'Vaginal Microbiota']",HPV,Peking Union Medical College Hospital,[],['China']
NCT05912816,Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients,Perioperative Disitamab Vedotin and Tislelizumab Followed by Nephron-Sparing Surgery in High-Risk Upper Tract Urothelial Carcinoma: A Phase 2 Trial (DISTINCT-I),RECRUITING,2023-06-10,2025-11-03,2026-12-30,INTERVENTIONAL,PHASE2,20,"['Upper Urinary Tract Urothelial Carcinoma', 'Kidney Preservation', 'HER-2 ADC', 'PD-1antibody']",Upper Urinary Tract Urothelial Carcinoma,RenJi Hospital,"['Tianjin Medical University Second Hospital', 'Peking University First Hospital', 'West China Hospital']",['China']
NCT07188584,Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer,"A Multicenter, Phase III Non-Inferiority Clinical Trial: Locoregional Volume-Reduction Versus Conventional Definitive Target IMRT Following Full-Dose Chemotherapy for Treatment-Naïve Distant Metastatic Nasopharyngeal Carcinoma Undergoing Full-Course Immunotherapy",RECRUITING,2025-08-20,2030-12-01,2031-07-01,INTERVENTIONAL,PHASE3,166,['Nasopharyngeal Carcinoma (NPC)'],Nasopharyngeal Carcinoma (NPC),Ming-Yuan Chen,"['Fifth Affiliated Hospital, Sun Yat-Sen University', 'Cancer Hospital of Guangxi Medical University', 'Fujian Cancer Hospital', 'The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University', 'Sun Yat-sen University Cancer Center, Sun Yat-sen University', 'Affiliated Cancer Hospital & Institute of Guangzhou Medical University', 'Zhejiang Cancer Hospital', 'West China Hospital', 'Xiangya Hospital of Central South University', 'Affiliated Cancer Hospital of Shantou University Medical College', 'Yunnan Cancer Hospital', 'First Affiliated Hospital of Kunming Medical University', 'Wuzhou Red Cross Hospital', ""Zhongshan People's Hospital, Guangdong, China"", 'Southern Medical University, China']",['China']
NCT07237945,Quadro-Iliac Plane Block Versus Wound Infiltration for Postoperative Pain After Single-Level Lumbar Discectomy,Investigation of the Effects of Quadro-Iliac Plane Block and Wound Infiltration on Postoperative Acute Pain After Single-Level Lumbar Discectomy Surgery,RECRUITING,2025-12-01,2026-03-01,2026-04-01,OBSERVATIONAL,,60,"['Postoperative Pain Management', 'Lumbar Discectomy', 'Regional Anaesthesia']",Postoperative Pain Management,Elif Sarikaya Ozel,[],['Turkey (Türkiye)']
NCT07047872,A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction,Patient Reported Outcomes Post-Mastectomy and In-house 3D-printed Individualized External Breast Prostheses,RECRUITING,2024-11-05,2026-11-05,2026-11-05,INTERVENTIONAL,NA,50,['Breast Carcinoma'],Breast Carcinoma,Mayo Clinic,[],['United States']
NCT07273201,Isolated Versus Synergetic Muscle Facilitation on Upper Limb Functional Performance in Acute Stroke,Effect of Isolated Versus Synergetic Muscle Facilitation on Upper Limb Functional Performance in Patients With Acute Stroke,RECRUITING,2025-10-01,2026-04,2026-07,INTERVENTIONAL,NA,40,['Acute Stroke'],Acute Stroke,Cairo University,[],['Egypt']
NCT03716531,Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement,PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement,ACTIVE_NOT_RECRUITING,2019-03-19,2025-08-26,2027-12-31,INTERVENTIONAL,NA,199,['Pancreas Cancer'],Pancreas Cancer,Massachusetts General Hospital,['IntraOp/Mobetron'],['United States']
NCT05776667,Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma,Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma,ACTIVE_NOT_RECRUITING,2023-08-15,2025-11-18,2026-11-18,INTERVENTIONAL,NA,16,['Soft Tissue Sarcoma'],Soft Tissue Sarcoma,Medical University of South Carolina,[],['United States']
NCT07217795,"Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building",Developing a Telehealth Intervention for Alcohol and Trauma Among LGBTQ+ People,RECRUITING,2025-11-30,2026-11,2028-09,INTERVENTIONAL,NA,80,"['Alcohol Use Disorder (AUD)', 'PTSD']",Alcohol Use Disorder (AUD),University of Rhode Island,['Rhode Island Foundation'],['United States']
NCT07271121,Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL,A Phase II Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL,RECRUITING,2025-02-12,2028-03-30,2028-06-30,INTERVENTIONAL,PHASE2,26,['Non-Hodgkin Lymphoma Refractory/ Relapsed'],Non-Hodgkin Lymphoma Refractory/ Relapsed,King Hussein Cancer Center,[],['Jordan']
NCT06465069,A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors,"A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants With Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors",RECRUITING,2024-07-01,2027-05,2027-05,INTERVENTIONAL,PHASE1,420,"['Metastatic Solid Tumor', 'Recurrent Solid Tumor', 'Advanced Solid Tumor', 'Urinary Bladder Neoplasm', 'Triple Negative Breast Cancer', 'Non-small Cell Lung Cancer', 'Esophageal Cancer', 'Pancreatic Cancer', 'Ovarian Cancer', 'Cervical Cancer', 'Head and Neck Squamous Cell Carcinoma', 'Prostate Cancer', 'Renal Pelvis Cancer', 'Bladder Cancer']",Metastatic Solid Tumor,Eli Lilly and Company,[],"['Japan', 'United States', 'France', 'Spain', 'South Korea', 'United Kingdom', 'Australia']"
NCT05619653,Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19,Randomised Placebo Controlled Clinical Trial of Efficacy of MYOcardial Protection in Patients With Postacute inFLAMmatory Cardiac involvEment Due to COVID-19,ACTIVE_NOT_RECRUITING,2022-12-12,2025-08-08,2026-03-31,INTERVENTIONAL,PHASE3,279,"['COVID-19 Associated Cardiac Involvement', 'Remodeling, Left Ventricle', 'Remodeling, Vascular', 'Left Ventricular Dysfunction', 'Exercise Intolerance', 'Vascular Inflammation', 'Microvascular Angina', 'Long COVID', 'Myocarditis, Pericarditis']",COVID-19 Associated Cardiac Involvement,Valentina Puentmann,"['Bayer', 'Alcedis GmbH']","['Austria', 'Germany']"
NCT06980090,Neural Mechanisms of Interpersonal Expectations on Negative Affect,Neural Mechanisms of Interpersonal Expectations on Negative Affect,RECRUITING,2025-09-01,2026-08-31,2027-03-03,INTERVENTIONAL,NA,190,"['Negative Affectivity', 'Non-invasive Brain Stimulation', 'Placebo Effect', 'Expectations']",Negative Affectivity,Trustees of Dartmouth College,[],['United States']
NCT07273526,Adrenaline V/s Dopamine in Fuid Refractory Septic Shock,Comparison of the Efficacy of Renaline and Dopamine in the Treatment of Fluid Refractory Septic Shock in Children,RECRUITING,2025-06-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,90,"['Fluid Refractory Septic Shock', 'Septic Shock']",Fluid Refractory Septic Shock,Laiba Qamar,[],['Pakistan']
NCT06588738,A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001,"A Multicenter, Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 (ONWARD2)",ACTIVE_NOT_RECRUITING,2024-08-20,2025-09-23,2025-12,INTERVENTIONAL,PHASE3,840,['Plaque Psoriasis'],Plaque Psoriasis,Alumis Inc,[],"['Israel', 'Hungary', 'Estonia', 'Austria', 'United States', 'France', 'Puerto Rico', 'Spain', 'Canada', 'Latvia', 'Poland', 'Germany']"
NCT04921787,EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy,Exemplar Hospital Initiation Trial to Enhance Treatment Engagement - Implementation Trial of High Intensity Versus Low Intensity Strategy for Supporting Hospital-Based Opioid Use Disorder Treatment,ACTIVE_NOT_RECRUITING,2021-10-22,2025-12,2026-04,INTERVENTIONAL,NA,24,"['Substance Use Disorders', 'Opioid Use Disorder, Severe', 'Opioid Use Disorder, Moderate']",Substance Use Disorders,Gavin Bart,"['National Institute on Drug Abuse (NIDA)', 'The Emmes Company, LLC']",['United States']
NCT06297590,A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease,"A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3954068 in Patients With Early Symptomatic Alzheimer's Disease",RECRUITING,2024-08-15,2027-02,2027-02,INTERVENTIONAL,PHASE1,48,['Alzheimer Disease'],Alzheimer Disease,Eli Lilly and Company,[],"['United Kingdom', 'Japan', 'United States']"
NCT07240662,Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma,"Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma: A Multicenter, Prospective, Non-interventional Study in Germany",RECRUITING,2025-12,2031-11,2032-01,OBSERVATIONAL,,150,['Glioma'],Glioma,iOMEDICO AG,[],['Germany']
NCT06974734,A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies,AN OPEN-LABEL PHASE 1 STUDY TO EVALUATE PF-08046037 AS MONOTHERAPY AND PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED MALIGNANCIES,RECRUITING,2025-05-06,2028-09-30,2029-09-30,INTERVENTIONAL,PHASE1,399,"['Carcinoma, Non Small Cell Lung', 'Carcinoma, Pancreatic Ductal', 'Malignant Melanoma', 'Squamous Cell Carcinoma of the Head and Neck (SCCHN)']","Carcinoma, Non Small Cell Lung",Pfizer,[],"['Puerto Rico', 'United States']"
NCT05072314,Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial,Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial,RECRUITING,2022-07-27,2027-07,2028-07,INTERVENTIONAL,PHASE3,4300,"['Breast Cancer', 'Breast Cancer Female', 'Breast Conserving Surgery', 'Mastectomy']",Breast Cancer,Monash University,['Royal Perth Hospital'],"['United Kingdom', 'New Zealand', 'Hong Kong', 'Australia']"
NCT04784416,Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD),Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD),ACTIVE_NOT_RECRUITING,2021-04-27,2025-10-30,2026-01-31,INTERVENTIONAL,PHASE2,196,"['Mild Cognitive Impairment', 'Alzheimer Disease']",Mild Cognitive Impairment,NYU Langone Health,"['National Institutes of Health (NIH)', ""Alzheimer's Association"", 'LiteCure LLC']",['United States']
NCT05356364,Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE),Improving Negative Stressful Perseverations in Insomnia to Revitalize Expecting Moms (INSPIRE),ACTIVE_NOT_RECRUITING,2023-02-01,2026-04-30,2026-04-30,INTERVENTIONAL,NA,100,"['Insomnia', 'Depression']",Insomnia,Henry Ford Health System,[],['United States']
NCT06597864,Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study,Seven-step Phenomenological Psychotherapy for Self-disorder - a Pilot Study,RECRUITING,2024-10-17,2026-03-01,2026-03-01,INTERVENTIONAL,NA,8,['Psychosis;Schizophrenic'],Psychosis;Schizophrenic,Oslo University Hospital,"['University Hospital, Akershus', 'Vestre Viken Hospital Trust']",['Norway']
NCT06836063,Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients,"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial to Evaluate Efficacy and Safety of Ropanicant in Patients With Major Depressive Disorder",ACTIVE_NOT_RECRUITING,2025-07-15,2026-02-28,2026-02-28,INTERVENTIONAL,PHASE2,195,['Major Depressive Disorder (MDD)'],Major Depressive Disorder (MDD),Suven Life Sciences Limited,[],['United States']
NCT06059599,Active Informed Consent: a New Solution to Improve and Objectively Test the Patient Understanding of Complex Surgical Procedures Proposals,Active Informed Consent: a New Solution to Improve and Objectively Test the Patient Understanding of Complex Surgical Procedures Proposals,RECRUITING,2024-06-19,2026-09,2026-10,INTERVENTIONAL,NA,300,"['Spine Disease', 'Urologic Diseases']",Spine Disease,Istituto Ortopedico Rizzoli,[],['Italy']
NCT07236385,AI Training Program vs Standard Correction for Forward Head and Rounded Shoulder in Neck Pain,Artificial Intelligence Training Program Versus Standard Correction for Forward Head and Rounded Shoulder in Non-specific Neck Pain,ACTIVE_NOT_RECRUITING,2025-11-30,2026-08-01,2026-10-01,INTERVENTIONAL,NA,46,"['Forward Head Posture', 'Rounded Shoulder Posture', 'Upper Cross Syndrome']",Forward Head Posture,Cairo University,[],['Egypt']
NCT06754852,A Study Assessing HMB-002 in Participants With Von Willebrand Disease,"A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-002 in Participants With Von Willebrand Disease (Velora Pioneer)",RECRUITING,2025-02-06,2027-07,2027-07,INTERVENTIONAL,PHASE1,108,"['Von Willebrand Disease (VWD)', 'Von Willebrand Disease (VWD), Type 1', 'Von Willebrand Disease (VWD), Type 2']",Von Willebrand Disease (VWD),Hemab ApS,[],"['United Kingdom', 'Australia']"
NCT07246421,Glucagon Resistance in Patients With MASLD and T2DM,Mechanisms for Glucagon Resistance as Driver of Metabolic Associated Steatotic Liver Disease and Cardiovascular Disease in Humans With Type 2 Diabetes,RECRUITING,2026-01-01,2027-07-31,2028-07-31,INTERVENTIONAL,NA,24,"['Metabolic Associated Fatty Liver Disease', 'Type 2 Diabetes (T2DM)']",Metabolic Associated Fatty Liver Disease,University of Aarhus,['Novo Nordisk A/S'],['Denmark']
NCT06375876,Single Session Intervention to Promote Hope,Hope as a Path to Healing: Developing a Single-Session Intervention for Women Who Experience Intimate Partner Violence,RECRUITING,2024-05-07,2026-01,2026-01,INTERVENTIONAL,NA,65,['Domestic Violence'],Domestic Violence,Yale University,"['Office on Violence Against Women (OVW)', 'Center for Family Justice', 'Connecticut Coalition Against Domestic Violence']",['United States']
NCT05123274,Mobilizing Social Network Resources for HIV Care Support,"Mobilizing Social Network Resources for HIV Care Support: Development and Testing of an Intervention for HIV+ MSM in St. Petersburg, Russia",ACTIVE_NOT_RECRUITING,2021-01-15,2024-10-31,2026-06-30,INTERVENTIONAL,NA,100,['HIV Infections'],HIV Infections,Medical College of Wisconsin,[],['United States']
NCT06716606,A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE),An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD),RECRUITING,2024-12-12,2029-12-27,2029-12-27,INTERVENTIONAL,PHASE3,514,['Connective Tissue Diseases'],Connective Tissue Diseases,GlaxoSmithKline,['ICON plc'],"['Japan', 'China', 'United States', 'South Korea', 'United Kingdom', 'Greece', 'Argentina']"
NCT07003529,Role of Inferior Colliculi in Auditory Hallucinations,Rôle Des Colliculi inférieurs Dans Les Hallucinations Auditives : étude Pilote Par Neuroimagerie,RECRUITING,2025-09-12,2026-09,2026-09,INTERVENTIONAL,NA,40,"['Schizophrenia', 'Hallucinations, Auditory']",Schizophrenia,Centre Hospitalier Universitaire de Nīmes,[],['France']
NCT06722196,BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery,BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery,RECRUITING,2025-02-15,2027-01-15,2027-12-15,INTERVENTIONAL,PHASE3,500,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),Jilin Heart Hospital,['Cornell University'],['China']
NCT07272395,Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study,Monitoring Right Ventricular Function in Patients Undergoing Implantable Cardiac Electronic Device (CIED) Therapy: A Multimodal Imaging and Biomarker-Based Approach,RECRUITING,2025-08-15,2026-10-21,2026-11-25,OBSERVATIONAL,,40,['Right Ventricular Dysfunction'],Right Ventricular Dysfunction,Istanbul University - Cerrahpasa,[],['Turkey (Türkiye)']
NCT06230471,Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer,"A Phase II, Multicenter, Randomized Study of Pembrolizumab With or Without Chemotherapy or Lenvatinib in First-Line Treatment of Advanced Biliary Tract Cancer",RECRUITING,2023-01-09,2025-12-31,2026-04-30,INTERVENTIONAL,PHASE2,60,['Biliary Tract Neoplasms Immunotherapy'],Biliary Tract Neoplasms Immunotherapy,Peking Union Medical College Hospital,[],['China']
NCT06138639,A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE),"A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)",RECRUITING,2024-05-06,2027-05-06,2031-05-06,INTERVENTIONAL,PHASE1,60,['Duchenne Muscular Dystrophy'],Duchenne Muscular Dystrophy,Solid Biosciences Inc.,[],"['United Kingdom', 'United States', 'Italy', 'Canada']"
NCT05503771,Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record,"Health IT to Reduce Disparities in Risks for Sleep-related Infant Deaths, (SAFE Start 2.0 Project)",RECRUITING,2022-09-30,2026-07-01,2027-02-28,INTERVENTIONAL,NA,350,"['Sudden Infant Death', 'Sudden Unexplained Infant Death']",Sudden Infant Death,Johns Hopkins University,['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT05726786,The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial),The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy - A Multicenter Randomized Controlled Trial (INCyst Trial),RECRUITING,2023-04-10,2026-08,2026-10,INTERVENTIONAL,PHASE3,232,"['Bladder Cancer', 'Interstitial Cystitis', 'Painful Bladder Syndrome', 'Neurogenic Bladder', 'Hemorrhagic Cystitis', 'Endometriosis', 'Bladder Disease']",Bladder Cancer,Centre Hospitalier Universitaire Vaudois,"['Insel Gruppe AG, University Hospital Bern', 'Hôpital Riviera-Chablais, Vaud-Valais', 'University Hospital, Geneva']",['Switzerland']
NCT07273305,Effect of Cultural Competence Training on Nurses' Cultural Competence Levels and Patients' Perceptions of Culturally Competent Care,Effect of Cultural Competence Training on Nurses' Cultural Competence Levels and Patients' Perceptions of Culturally Competent Care,RECRUITING,2025-06-07,2026-03,2026-04,INTERVENTIONAL,NA,60,['Cultural Competence Training in Nursing'],Cultural Competence Training in Nursing,Oyku Ozturk,[],['Turkey (Türkiye)']
NCT07219511,"A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)","A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)",RECRUITING,2025-11-04,2026-06,2026-07,INTERVENTIONAL,PHASE1,42,"['Heart', 'Heart Failure With Preserved Ejection Fraction (HFPEF)']",Heart,Vasa Therapeutics,[],['United States']
NCT07217912,Daridorexant to Prevent Post-cardiotomy Delirium,"Randomized, Double-blind Trial of Daridorexant to Prevent Delirium After Heart Surgery",RECRUITING,2025-10-14,2027-11-01,2027-11-01,INTERVENTIONAL,PHASE2,80,"['Postoperative Cognitive Decline', 'Postoperative Delirium']",Postoperative Cognitive Decline,University of Rochester,[],['United States']
NCT07116200,Effectiveness of an Early Reading Intervention for Young Children With Intellectual Disabilities Who Need or Use Augmentative and Alternative Communication,Effectiveness of an Early Reading Intervention for Young Children With Intellectual Disabilities Who Need or Use Augmentative and Alternative Communication: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-08-15,2029-12,2029-12,INTERVENTIONAL,NA,120,['Education'],Education,Ostfold University College,"['University of Oslo', 'University of South-Eastern Norway', 'Karolinska Institutet', 'Heidelberg University', 'Penn State University']",['Norway']
NCT06246357,Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism,Phase 2 Study Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism,RECRUITING,2024-09-23,2027-12-01,2028-04-01,INTERVENTIONAL,PHASE2,80,"['Hyperaldosteronism', 'Hypercortisolism', 'Cushing s Syndrome']",Hyperaldosteronism,National Cancer Institute (NCI),[],['United States']
NCT00739362,Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment,The Effects of Transcranial Direct Current Stimulation (TDCS) on Food Intake and Weight Loss,RECRUITING,2009-01-19,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE2,148,"['Electric Stimulation Therapy', 'Obesity', 'Weight Loss', 'Eating']",Electric Stimulation Therapy,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07273617,Effects of Positive End-Expiratory Pressure (PEEP) and Prone Positioning in Healthy Volunteers on Venous Hemodynamics Including the Venous Excess Ultrasound (VExUS) Score,Effects of Positive End-Expiratory Pressure (PEEP) and Prone Positioning in Healthy Volunteers on Venous Hemodynamics Including the Venous Excess Ultrasound (VExUS) Score,RECRUITING,2025-09-25,2026-06,2026-06,INTERVENTIONAL,NA,40,['Venous Hemodynamics'],Venous Hemodynamics,"University Hospital, Basel, Switzerland",[],['Switzerland']
NCT07271680,Effects of Smartphone Addiction to Fetal Parameters in Pregnancy,"The Effect of Smartphone Addiction to Uterine Artery Blood Flow, Fetal Heart Rate, and Fetal Birth Weight in the Third Trimester of Pregnancy",RECRUITING,2025-08-01,2025-11-30,2025-12-15,OBSERVATIONAL,,128,"['Pregnancy', 'Smart Phone Addiction']",Pregnancy,Antalya Training and Research Hospital,[],['Turkey (Türkiye)']
NCT07181824,VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024,VAP Incidence and Adequation to SRLF 2017 Diagnostic Among an Intensive Care Medicine Service for the Period 2022 à 2024,RECRUITING,2025-08-25,2026-06-30,2026-06-30,OBSERVATIONAL,,100,['Pneumonia Ventilator Associated'],Pneumonia Ventilator Associated,Centre Hospitalier Sud Francilien,[],['France']
NCT07007559,ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies,"ASPEN-09: A Phase 1b/2, Multicenter, Multi Arm Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies",RECRUITING,2025-04-28,2027-06,2027-12,INTERVENTIONAL,PHASE1,80,"['Breast Cancer, Metastatic']","Breast Cancer, Metastatic",ALX Oncology Inc.,[],['United States']
NCT04014348,Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women,Pilot Study for Geospatial Analysis of Neighborhood Environmental Stress in Relation to Biological Markers of Cardiovascular Health and Health Behaviors in Women,RECRUITING,2021-10-20,2025-12-10,2025-12-26,OBSERVATIONAL,,250,['Cardiovascular (CV) Risk'],Cardiovascular (CV) Risk,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07273344,A Study on How the Immune System Responds to Sepsis and Its Long-term Effects,A Systems Immunology Approach to Characterize the Immune Response in Sepsis and Its Long-term Complications,RECRUITING,2025-11-03,2028-11-01,2028-12-01,OBSERVATIONAL,,400,['Sepsis'],Sepsis,Radboud University Medical Center,['Dutch Research Council'],['Netherlands']
NCT07247838,Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke,Investigation Into the Gut Microbiota-Immune-Inflammatory Interaction Network and Its Mechanisms in Patients With Ischemic Stroke,RECRUITING,2025-11-19,2026-12-31,2028-12-31,OBSERVATIONAL,,200,['Ischemic Stroke'],Ischemic Stroke,Affiliated Hospital of Nantong University,['Zhejiang University'],['China']
NCT05843188,Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer,"A Phase II Study of 5-FU, Irinotecan, Bevacizumab and Hydroxychloroquine in Drug-Tolerant Persister (DTP)-Selected Patients With Metastatic Colorectal Cancer",ACTIVE_NOT_RECRUITING,2023-08-09,2026-04-24,2026-10-24,INTERVENTIONAL,PHASE2,155,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,"University Health Network, Toronto",[],['Canada']
NCT06592183,Speech Rehabilitation Based on Mobile Applications,"Effect of Speech Rehabilitation Based on Mobile Application for People With Dysarthria After Stroke: A Single-Center, Investigator-Blinded, Randomized, Crossover Trial",RECRUITING,2024-05-15,2025-12-31,2025-12-31,INTERVENTIONAL,NA,36,"['Stroke', 'Motor Speech Disorder']",Stroke,Florida State University,[],['United States']
NCT03480633,Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure,Preserved vs. Reduced Ejection Fraction Biomarker Registry and Precision Medicine Database for Ambulatory Heart Failure Patients (PREFER-HF) Study,RECRUITING,2016-04-07,2026-04-06,2027-10-06,OBSERVATIONAL,,3000,"['Heart Failure With Normal Ejection Fraction', 'Heart Failure With Reduced Ejection Fraction', 'Heart Failure, Right Sided', 'Heart Failure With Mid Range Ejection Fraction', 'Cardiovascular Risk Factor']",Heart Failure With Normal Ejection Fraction,Massachusetts General Hospital,['Roche Diagnostics GmbH'],['United States']
NCT06185829,Evaluating the Benefit of Hypnoanalgesia Versus Neuroleptanalgesia During Hand Surgery,Evaluating the Benefit of Hypnoanalgesia Versus Neuroleptanalgesia During Hand Surgery,RECRUITING,2023-10-19,2026-11,2027-01,INTERVENTIONAL,NA,64,['Hand Surgery'],Hand Surgery,GCS Ramsay Santé pour l'Enseignement et la Recherche,['Vivactis M2Research'],['France']
NCT06305286,"Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)",A Pilot Study Assessing the Safety of Using a Monoclonal Antibody Against Cluster of Differentiation 40 (CD40) Ligand to Achieve a Calcineurin Inhibitor-free Immunosuppression Regimen in Patients With Type 1 Diabetes Mellitus (T1D) and Problematic Hypoglycemia Undergoing Islet Cell Transplantation,RECRUITING,2024-03-04,2029-03,2029-03,INTERVENTIONAL,PHASE1,70,['Diabetes Mellitus'],Diabetes Mellitus,University of Chicago,"['Juvenile Diabetes Research Foundation', 'Cure Alliance']",['United States']
NCT07162129,Online Transdiagnostic Group CBT for Postpartum Depression and Anxiety,Online Transdiagnostic Group Cognitive Behavioural Therapy (CBT) for Postpartum Depression and Anxiety: A Pilot Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-09-09,2026-09,2026-09,INTERVENTIONAL,NA,48,"['Postpartum Depression (PPD)', 'Postpartum Anxiety']",Postpartum Depression (PPD),McMaster University,[],['Canada']
NCT02290834,Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer,Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer,RECRUITING,2015-03,2026-01,2027-01,INTERVENTIONAL,NA,200,"['Impaired Cognition', 'Chemo-brain', 'Breast Cancer']",Impaired Cognition,Massachusetts General Hospital,[],['United States']
NCT07241221,Antenatal Myo-inositol Supplementation in Pre-existing Diabetes,Antenatal Myo-inositol Supplementation in Pre-existing Diabetes to Promote Normal Neonatal Outcomes,RECRUITING,2025-12,2028-08-31,2029-08-31,INTERVENTIONAL,NA,182,['Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM)'],Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM),"National University Hospital, Singapore",['National University of Singapore'],['Singapore']
NCT07271953,The Effect of Motivational Interviewing and Digital Game-Supported Counseling on Postpartum Relapse,The Effect of Motivational Interviewing and Digital Game-Supported Counseling on Postpartum Relapse in Pregnant Women Who Quit Smoking: A Randomized Controlled Trial,RECRUITING,2025-10-01,2026-06-30,2026-07-12,INTERVENTIONAL,NA,72,"['Postpartum Period', 'Smoking Relapse Behavior']",Postpartum Period,Lokman Hekim University,[],['Turkey (Türkiye)']
NCT06657157,Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma,"Peripheral Neuropathy in Patients Receiving Pembrolizumab and Enfortumab Vedotin as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma. An Investigator-Initiated, Prospective, Multicenter, Non-Interventional Trial.",RECRUITING,2025-01-22,2026-12,2027-02,OBSERVATIONAL,,80,['Urothelial Cancer'],Urothelial Cancer,LMU Klinikum,"['Department of Urology, LMU University Hospital Munich, Munich, Germany', 'Department of Urology, TUM Klinikum rechts der Isar, Munich, Germany']",['Germany']
NCT06436729,Impact of MINST With and Without Splinting in Periodontitis Patients With Mobile Anterior Teeth,Impact of MINST With and Without Splinting on Clinical Periodontal Parameters and OHRQoL in Periodontitis Patients With Mobile Anterior Teeth: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2024-06-01,2025-11-30,2025-12-31,INTERVENTIONAL,NA,50,"['Tooth Mobility', 'Periodontitis']",Tooth Mobility,Postgraduate Institute of Dental Sciences Rohtak,[],['India']
NCT03422822,Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis,"A PHASE 3 MULTI-CENTER, LONG-TERM EXTENSION STUDY INVESTIGATING THE EFFICACY AND SAFETY OF ABROCITINIB, WITH OR WITHOUT TOPICAL MEDICATIONS, ADMINISTERED TO SUBJECTS AGED 12 YEARS AND OLDER WITH MODERATE TO SEVERE ATOPIC DERMATITIS",ACTIVE_NOT_RECRUITING,2018-03-08,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE3,3166,"['Dermatitis, Atopic']","Dermatitis, Atopic",Pfizer,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'Chile', 'Finland', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Latvia', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT06548594,Out of State - tAN hEDS,"Out-of-State, At-Home, Transcutaneous Auricular Neuromodulation for Hypermobile Ehlers Danlos Syndrome",RECRUITING,2024-11-27,2026-04-01,2026-04-01,INTERVENTIONAL,NA,36,['Hypermobile EDS (hEDS)'],Hypermobile EDS (hEDS),Medical University of South Carolina,['MUSC Blue Sky initiative'],['United States']
NCT05746559,ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE,"ARTEMIS: RAvulizumab to PRotect PaTients With Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study",ACTIVE_NOT_RECRUITING,2023-04-06,2026-05-18,2027-02-17,INTERVENTIONAL,PHASE3,736,"['Chronic Kidney Disease', 'CKD', 'Cardiac Disease', 'Cardiopulmonary Bypass']",Chronic Kidney Disease,"Alexion Pharmaceuticals, Inc.",[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Israel', 'France', 'South Korea', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07159269,Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers,Cardiac Point-of-care Ultrasound Clinical Training Pathway Implementation and Impact Assessment for Advanced Practice Providers in the Emergency Department,RECRUITING,2025-11-13,2029-12-31,2030-06-30,INTERVENTIONAL,NA,75,"['Cardiovascular Disease Acute', 'Emergency Department Patient', 'Heart Failure Acute', 'Pulmonary Embolism (Diagnosis)', 'Point of Care Ultrasound (POCUS)', 'Cardiac Tamponade', 'Pericardial Effusion', 'Diagnostic Imaging', 'Medical Training', 'Implementation Science']",Cardiovascular Disease Acute,Duke University,[],['United States']
NCT05491213,TELESCOPE- TELEhealth Shared Decision-making COaching,TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary carE (TELESCOPE),RECRUITING,2023-02-14,2026-05-31,2027-01-31,INTERVENTIONAL,NA,594,['Lung Neoplasms'],Lung Neoplasms,"Rutgers, The State University of New Jersey","['National Institutes of Health (NIH)', 'National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06458335,Intervening on Opioid Use and Loneliness,Addressing Loneliness as a Therapy Target Among Individuals Using Opioids,RECRUITING,2024-09-19,2029-06-30,2029-06-30,INTERVENTIONAL,NA,300,"['Opioid Use Disorder', 'Loneliness', 'Social Isolation']",Opioid Use Disorder,University of Rochester,"['National Institute on Drug Abuse (NIDA)', 'Medical University of South Carolina', 'Ohio State University']",['United States']
NCT07166068,The Effect of Mobilization on Inflammatory Biomarkers in Patients With Knee Osteoarthritis.,The Effect of Mobilization With Movement Versus Sham Mobilization on Inflammatory Biomarkers in Patients With Knee Osteoarthritis.,RECRUITING,2025-09-20,2026-02-20,2026-04-20,INTERVENTIONAL,NA,40,['Knee Osteoarthritis'],Knee Osteoarthritis,University of Jazan,[],['Saudi Arabia']
NCT03828773,PTX3-targeted Antifungal Prophylaxis,PTX3 Genetically Stratified Randomized Double-blinded Allocation Event-driven Clinical Trial for Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia,RECRUITING,2019-02-11,2027-11-30,2027-11-30,INTERVENTIONAL,NA,410,"['Candidiasis', 'Fungal Infection', 'Acute Myeloid Leukemia', 'Genetic Predisposition', 'Aspergillosis']",Candidiasis,Bochud Pierre-Yves,['Swiss National Science Foundation'],"['Switzerland', 'Belgium', 'France']"
NCT06029439,Study to Assess the Safety and Effectiveness of NMRA-335140-501,Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants With Major Depressive Disorder,RECRUITING,2023-11-10,2027-06,2027-06,INTERVENTIONAL,PHASE3,1000,['Major Depressive Disorder'],Major Depressive Disorder,"Neumora Therapeutics, Inc.",[],"['Brazil', 'Bulgaria', 'United States', 'France', 'Chile', 'Finland', 'Canada', 'Czechia', 'Poland', 'Sweden', 'Germany']"
NCT06753331,"A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease","A Multicenter, Sham-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Clinical Responses Following Stereotactic Intracranial Implantation of DSP-1083 Into Subjects With Parkinson's Disease",RECRUITING,2024-12-18,2030-12-15,2030-12-15,INTERVENTIONAL,PHASE1,25,"[""Parkinson's Disease""]",Parkinson's Disease,"Sumitomo Pharma America, Inc.",[],['United States']
NCT07273669,Advanced Robotic Beds for the Early Rehabilitation of Cardiac Surgery Patients,Advanced Robotic Beds for the Early Rehabilitation of Cardiac Surgery Patients,ACTIVE_NOT_RECRUITING,2025-09-22,2026-05-01,2027-01,INTERVENTIONAL,NA,20,"['AORTIC VALVE DISEASES', 'Mitral Valve Failure']",AORTIC VALVE DISEASES,University of Salerno,[],['Italy']
NCT07272239,Effects of tVNS and mCIMT in Chronic Stroke,"Combined Effects of Transcutaneous Vagus Nerve Stimulation and Modified Constraint Induced Movement Therapy on Upper Extremity Function, Cognition and Quality of Life in Individual With Chronic Stroke",RECRUITING,2025-11-25,2026-05-05,2026-05-05,INTERVENTIONAL,NA,50,"['Stroke', 'Cerebrovascular Accident']",Stroke,Riphah International University,[],['Pakistan']
NCT03549754,iCaReMe Global Registry,"Real-world Multinational Registry to Determine Management and Quality of Care of Patients With Type 2 Diabetes, Hypertension, Heart Failure and/or Chronic Kidney Diseases",RECRUITING,2018-02-17,2025-12-31,2025-12-31,OBSERVATIONAL,,35000,"['Type 2 Diabetes', 'Hypertension', 'Chronic Kidney Disease', 'Heart Failure']",Type 2 Diabetes,AstraZeneca,[],"['Brazil', 'Kazakhstan', 'Côte d’Ivoire', 'Hong Kong', 'South Africa', 'Kenya', 'Mexico', 'Iraq', 'Chile', 'Nigeria', 'Taiwan', 'United Arab Emirates', 'Malaysia', 'Ukraine', 'India']"
NCT05920382,Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain.,Radiofrequency Ablation for the Treatment of Post-knee Arthroplasty Chronic Pain. A Randomized Double-blind Study. A Novel Approach.,RECRUITING,2023-09-25,2026-09-01,2027-12-01,INTERVENTIONAL,NA,86,"['Chronic Post-surgical Pain', 'Chronic Post Operative Pain', 'Chronic Knee Pain']",Chronic Post-surgical Pain,Consorci Sanitari de l'Alt Penedès i Garraf,[],['Spain']
NCT07272252,Narrative Nursing for Cesarean Mothers' Anxiety and Breastfeeding Confidence,Psychological Effects and Breastfeeding Self-Efficacy of a Structured Four-Step Narrative Nursing Intervention in Cesarean Mothers: A Randomized Controlled Mixed-Methods Study,RECRUITING,2025-10-01,2026-01-01,2026-03-01,INTERVENTIONAL,NA,160,"['Postpartum Anxiety', 'Postpartum Depression (PPD)', 'Breastfeeding Self-Efficacy', 'Cesarean Section Wound']",Postpartum Anxiety,Xi Huang,"['Xiamen University', ""Yilong People's Hospital""]",['China']
NCT07188558,A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy,"A Phase 3 Randomized Controlled Trial of Rondecabtagene Autoleucel , an Autologous, Dual-targeting CD19/CD20 CAR T-Cell Product Candidate, Vs. Investigator's Choice of CD19 CAR T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma in the Second-line Setting",RECRUITING,2026-01,2029-12,2032-01,INTERVENTIONAL,PHASE3,400,"['Large B-cell Lymphoma', 'Lymphoma, B-Cell', 'Relapsed Non-Hodgkin Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Non-Hodgkin Lymphoma', 'Non-Hodgkin Lymphoma Refractory/ Relapsed', 'Diffuse Large B Cell Lymphoma (DLBCL)', 'Diffuse Large B Cell Lymphoma Refractory', 'Diffuse Large B Cell Lymphoma Relapsed']",Large B-cell Lymphoma,"Lyell Immunopharma, Inc.",[],['United States']
NCT07135089,Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban,"Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban (INSIST-IT2): a Prospective, Randomized, Double Blinded, Multi-center Study",RECRUITING,2025-11-13,2027-09-30,2027-12-30,INTERVENTIONAL,PHASE3,870,"['Stroke, Ischemic']","Stroke, Ischemic",General Hospital of Shenyang Military Region,[],['China']
NCT05713890,Home-based Action Observation Treatment With Virtual-reality for Arm Rehabilitation in People With Multiple Sclerosis,An Integrated and Home-based Motor Rehabilitation Combining Virtual Reality and Action Observation Treatment in People With Multiple Sclerosis: a Clinical and Neuroimaging Study,RECRUITING,2023-11-02,2026-09,2026-12,INTERVENTIONAL,NA,60,['Multiple Sclerosis'],Multiple Sclerosis,IRCCS San Raffaele,['Istituto di Neuroscienze Consiglio Nazionale delle Ricerche'],['Italy']
NCT07272200,Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma,Understanding Gene ENvironment Interaction in ALcohol-related Hepatocellular Carcinoma,RECRUITING,2023-12-01,2026-12-31,2028-12-31,INTERVENTIONAL,NA,1000,"['HCC', 'Genetic Predisposition']",HCC,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",[],['Italy']
NCT06870487,A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers,An Open-Label Phase 1 Study to Evaluate PF-08046032 as Monotherapy and Part of Combination Therapy in Participants With Advanced Malignancies,ACTIVE_NOT_RECRUITING,2025-05-08,2026-02-27,2026-02-27,INTERVENTIONAL,PHASE1,6,"['Peripheral T Cell Lymphoma', 'Diffuse Large B-cell Lymphoma', 'Classical Hodgkin Lymphoma', 'Head and Neck Squamous Cell Carcinoma', 'Melanoma', 'Non-Small Cell Lung Cancer']",Peripheral T Cell Lymphoma,Pfizer,[],"['Spain', 'United States']"
NCT06623344,Brain Volume and Cardiac Function in Heart Failure,Brain Volume and Cardiac Function in Heart Failure,RECRUITING,2024-11-10,2026-10-01,2026-10-01,INTERVENTIONAL,NA,100,['Heart Failure'],Heart Failure,Johns Hopkins University,"['Canon Medical Systems, USA']",['United States']
NCT07272499,Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease,"A Prospective, Multicenter, Open-Label Clinical Study of Orelabrutinib Plus Lisaftoclax and Rituximab in Treatment-Naive, High-Risk Mantle Cell Lymphoma (MCL)",RECRUITING,2025-09-10,2028-09-10,2028-09-10,INTERVENTIONAL,PHASE2,25,['Mantle Cell Lymphoma (MCL)'],Mantle Cell Lymphoma (MCL),Ruijin Hospital,"['Fujian Medical University Union Hospital', 'First Affiliated Hospital of Wenzhou Medical University', 'The First Affiliated Hospital of Anhui Medical University', 'The Third Xiangya Hospital of Central South University', 'Qilu Hospital of Shandong University', 'Shanghai Minhang Central Hospital', 'Huadong Hospital', 'Yangpu District Central Hospital Affiliated to Tongji University']",['China']
NCT06586112,A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis,"A Multicenter, Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis (ONWARD1)",ACTIVE_NOT_RECRUITING,2024-07-25,2025-09-19,2025-12,INTERVENTIONAL,PHASE3,840,['Plaque Psoriasis'],Plaque Psoriasis,Alumis Inc,[],"['Bulgaria', 'Japan', 'United States', 'Germany', 'South Korea', 'Canada', 'Czechia', 'Poland', 'Portugal', 'Australia']"
NCT06002581,Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease,Clinical Study on the Efficacy and Safety of rTMS Regulating Slow-wave Sleep to Delay the Progression of Parkinson's Disease,RECRUITING,2023-09-03,2026-07-28,2026-07-28,INTERVENTIONAL,NA,56,"[""Parkinson's Disease""]",Parkinson's Disease,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",[],['China']
NCT07272993,Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes,The Effect of Golden Rice Cookies With Piper Crocatum on the Prevention of Diabetic Neuropathy in Patients With Diabetes Mellitus,ACTIVE_NOT_RECRUITING,2025-10-20,2025-11-30,2025-12-31,INTERVENTIONAL,NA,102,"['Diabetic Neuropathy', 'Diabetes Mellitus (DM)', 'Functional Food', 'Nutritional Intervention', 'Blood Glucose']",Diabetic Neuropathy,Hasanuddin University,[],['Indonesia']
NCT07271849,Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients,Effects of Different Administration Timings of Nalbuphine on Hemodynamics and Postoperative Analgesia in Elderly Patients Undergoing Total Knee Arthroplasty,RECRUITING,2025-10-28,2026-10-01,2026-10-31,INTERVENTIONAL,PHASE4,162,"['Postoperative Pain, Acute', 'Hemodynamics', 'Total Knee Arthroplasty (TKA)']","Postoperative Pain, Acute",Qianfoshan Hospital,[],['China']
NCT05914506,Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease,Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease,ACTIVE_NOT_RECRUITING,2023-10-05,2028-05-01,2028-05-01,OBSERVATIONAL,,30,['Progressive Fibrosing Interstitial Lung Disease'],Progressive Fibrosing Interstitial Lung Disease,University of Aarhus,['Aarhus University Hospital'],['Denmark']
NCT06413706,A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy,"A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Temozolomide Compared to Temozolomide Monotherapy in Children and Young Adults With Newly Diagnosed High-Grade Glioma Following Radiotherapy",RECRUITING,2024-10-25,2027-11,2028-02,INTERVENTIONAL,PHASE2,45,['Glioma'],Glioma,Eli Lilly and Company,[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Romania', 'Australia']"
NCT06884267,Hyperkalemia Quality Improvement Program (HK-QIP) Study,"A Prospective, Multicenter, Single Arm Study to Evaluate the Impact on the Implementation of Standardized Hyperkalemia Management in Chronic Kidney Disease Patients",RECRUITING,2025-06-25,2027-11-03,2027-11-03,INTERVENTIONAL,NA,1000,['Hyperkalemia'],Hyperkalemia,AstraZeneca,[],['China']
NCT06661720,Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer,Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE,RECRUITING,2025-03-14,2037-11,2037-11,INTERVENTIONAL,PHASE3,1040,"['Clear Cell Renal Cell Carcinoma', 'Renal Cell Carcinoma (RCC)', 'Stage II Renal Pelvis Cancer AJCC v8', 'Stage III Renal Pelvis Cancer AJCC v8']",Clear Cell Renal Cell Carcinoma,Alliance for Clinical Trials in Oncology,[],['United States']
NCT01443468,Clinical and Genetic Studies of Li-Fraumeni Syndrome,"Clinical, Epidemiologic, and Genetic Studies of Li-Fraumeni Syndrome",RECRUITING,2012-01-17,,,OBSERVATIONAL,,5000,"['Li-Fraumeni Syndrome', 'Neoplasms', 'Tp53 Mutations']",Li-Fraumeni Syndrome,National Cancer Institute (NCI),[],['United States']
NCT06957093,Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial,"Evaluation of the Therapeutic Efficacy and Safety of Artificial Intelligence-based Decision-making Technology in the Integrated Management of Diabetes Mellitus: a Longitudinal, Open-labeled, Randomized Controlled Trial",RECRUITING,2025-06-15,2026-12,2026-12,INTERVENTIONAL,NA,400,"['Diabetes Mellitus Type 2 (T2DM)', 'Artificial Intelligence (AI)']",Diabetes Mellitus Type 2 (T2DM),The First Hospital of Jilin University,[],['China']
NCT07237139,Pulmonary Volume Changes During Synchonized Noninvasive Positive Pressure Ventilation,Intrapulmonary Volume Changes During Synchronized Noninvasive Positive Pressure Ventilation In Preterm Infants,RECRUITING,2025-11-17,2026-12-31,2027-01-30,OBSERVATIONAL,,27,"['Infant, Preterm', 'Respiratory Distress Syndrome (Neonatal)', 'Chronic Lung Disease of Newborn', 'Respiratory Support', 'Synchronized Noninvasive Positive Pressure Ventilation (SNIPPV)', 'Lung Volume']","Infant, Preterm",University of Zurich,"['University Hospital, Zürich']",['Switzerland']
NCT06362265,A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus,A Single Dose Study to Evaluate the Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus,RECRUITING,2024-10-10,2026-11,2026-11,INTERVENTIONAL,PHASE1,22,['Type 2 Diabetes Mellitus'],Type 2 Diabetes Mellitus,Eli Lilly and Company,[],['United States']
NCT07271485,Propranolol for Misophonia,"Randomized, Placebo-Controlled Pilot Study of Propranolol for Treating Misophonia",RECRUITING,2025-12-19,2026-12-19,2026-12-19,INTERVENTIONAL,EARLY_PHASE1,20,"['Misophonia', 'Propanolol', 'Misophonia Treatment']",Misophonia,"Bloom Mental Health, LLC",[],['United States']
NCT07099443,Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL,Determinants of the Response to BTK Degraders (BTKd) in Double Refractory Chronic Lymphocytic Leukemia (CLL),RECRUITING,2025-10-09,2039-09-15,2039-09-15,OBSERVATIONAL,,60,"['Chronic Lymphocytic Leukemia', 'Refractory Chronic Lymphocytic Leukemia']",Chronic Lymphocytic Leukemia,Nantes University Hospital,[],['France']
NCT05613218,Oxygen Targets in Acute Heart Failure With Pulmonary Congestion,Restrictive Versus Liberal Oxygenation Targets in Patients With Acute Heart Failure and Pulmonary Congestion - a Randomized Clinical Pilot-trial,RECRUITING,2024-02-01,2026-02-28,2026-04-30,INTERVENTIONAL,PHASE2,122,"['Acute Heart Failure', 'Pulmonary Congestion', 'Hypoxemia']",Acute Heart Failure,"Copenhagen University Hospital, Hvidovre",['Bispebjerg Hospital'],['Denmark']
NCT05350748,Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS,Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS,RECRUITING,2022-08-18,2041-09-20,2042-05-01,OBSERVATIONAL,,1100,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,National Cancer Institute (NCI),[],['United States']
NCT06622044,Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia,Accommodation and Vergence Exercises Versus Prism Treatment for Small-angle Acute Acquired Concomitant Esotropia,RECRUITING,2024-09-07,2026-09-07,2026-12-07,INTERVENTIONAL,NA,100,['Esotropia'],Esotropia,Eye & ENT Hospital of Fudan University,[],['China']
NCT05417334,Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.,Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum: Randomised Prospective Trial,RECRUITING,2021-03-18,2025-12,2026-01,INTERVENTIONAL,NA,110,['Dyspareunia'],Dyspareunia,Hospital Clinic of Barcelona,[],['Spain']
NCT05050136,A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis",RECRUITING,2021-09-22,2027-04,2027-07,INTERVENTIONAL,PHASE2,260,"['Primary Biliary Cholangitis', 'PBC']",Primary Biliary Cholangitis,"Mirum Pharmaceuticals, Inc.",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Argentina', 'Germany']"
NCT07158658,Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers,Evaluation of the Efficacy of NeoThelium FT in the Healing of Chronic Pressure Ulcers: A Prospective Case Series,RECRUITING,2025-12-01,2026-03-01,2026-05-01,INTERVENTIONAL,NA,10,['Pressure Injury'],Pressure Injury,"NuScience Medical Biologics, LLC","['SygNola, LLC']",['United States']
NCT06767306,Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma,"A Phase II, Multicentre, Non-Comparative, Randomised Controlled Trial of Stereotactic Ablative Body Radiotherapy and Immunotherapy Versus Immunotherapy Alone in Patients With Treatment Naïve Oligometastatic Extracranial Melanoma",RECRUITING,2025-03-06,2033-04-01,2033-04-01,INTERVENTIONAL,NA,129,['Melanoma Metastatic'],Melanoma Metastatic,Melanoma Institute Australia,[],['Australia']
NCT05801029,A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations,"A Phase II, Open-label, Single-arm, Multi-centre Study to Evaluate the Safety and Efficacy of Osimertinib With Amivantamab as First-line Treatment in Participants With Epidermal Growth Factor Receptor Mutation-Positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer (OSTARA)",ACTIVE_NOT_RECRUITING,2023-07-18,2027-10-01,2027-10-01,INTERVENTIONAL,PHASE2,60,['Non-Small Cell Lung Cancer (NSCLC)'],Non-Small Cell Lung Cancer (NSCLC),AstraZeneca,['Parexel'],"['Singapore', 'Hong Kong', 'Taiwan', 'South Korea', 'Thailand', 'Malaysia']"
NCT06564233,Supportive Care Intervention for Outpatient Stem Cell Transplant Patients,A Randomized Controlled Trial of an Avatar-based Supportive Care Intervention for Patients Undergoing Outpatient Stem Cell Transplantation,RECRUITING,2024-10-21,2026-05-22,2026-06-30,INTERVENTIONAL,NA,90,"['Hematopoietic Stem Cell Transplantation', 'Cancer']",Hematopoietic Stem Cell Transplantation,Friendi.fi Corporation,"['Dana-Farber Cancer Institute', 'care.coach corporation']",['United States']
NCT07148258,Evaluating Georgia Part C Implementation Outcomes,Evaluating Georgia Part C Implementation Outcomes,RECRUITING,2025-09-03,2028-09,2028-09,INTERVENTIONAL,NA,80,"['Communication Disorder, Childhood', 'Autism']","Communication Disorder, Childhood",Emory University,"['National Institute of Mental Health (NIMH)', 'Georgia Department of Public Health']",['United States']
NCT05512754,Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen,Randomized Controlled Trial of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen,RECRUITING,2022-08-01,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE4,200,['Elevated Serum PSA'],Elevated Serum PSA,University of Chicago,[],['United States']
NCT06937086,Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study,"A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight",RECRUITING,2025-06-26,2028-04,2028-04,INTERVENTIONAL,PHASE3,350,"['Ulcerative Colitis', 'Obesity or Overweight']",Ulcerative Colitis,Eli Lilly and Company,[],"['Bulgaria', 'Netherlands', 'Slovakia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Denmark', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT05528510,A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab Subcutaneous Induction Therapy in Participants With Moderately to Severely Active Ulcerative Colitis",ACTIVE_NOT_RECRUITING,2022-09-13,2024-04-02,2028-10-06,INTERVENTIONAL,PHASE3,418,"['Colitis, Ulcerative']","Colitis, Ulcerative","Janssen Research & Development, LLC",[],"['Bulgaria', 'Japan', 'New Zealand', 'China', 'Slovakia', 'Jordan', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Argentina']"
NCT05646394,Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS,Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS,RECRUITING,2022-07-01,2029-07-31,2029-12-31,OBSERVATIONAL,,150,"['Antiphospholipid Syndrome', 'Arterial Thrombosis']",Antiphospholipid Syndrome,McMaster University,['International Society on Thrombosis and Haemostasis'],"['Argentina', 'Canada']"
NCT06205628,"Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension","A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ADX-850 in Participants With Hypertension",ACTIVE_NOT_RECRUITING,2024-03-21,2025-12-31,2026-09-30,INTERVENTIONAL,PHASE1,28,"['Hypertension', 'Hypertension,Essential']",Hypertension,"ADARx Pharmaceuticals, Inc.","['ADARx Australia Pty Ltd', 'Avance Clinical Pty Ltd.']",['Australia']
NCT06909773,"The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases","The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases -A Multi-center, Prospective, Interventional Study (PRECEDE)",RECRUITING,2025-11-28,2026-10-28,2026-12-31,INTERVENTIONAL,NA,3000,['Cardiovascular Diseases'],Cardiovascular Diseases,AstraZeneca,[],['China']
NCT07062003,"Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors, MBRT1 Trial",A Dose Finding Study of MiniBeam RadioTherapy for Skin and Superficial Soft Tissue Tumors (MBRT1),RECRUITING,2025-08-11,2028-08-01,2028-08-01,INTERVENTIONAL,NA,60,"['Metastatic Malignant Skin Neoplasm', 'Metastatic Malignant Soft Tissue Neoplasm', 'Recurrent Malignant Skin Neoplasm', 'Recurrent Malignant Soft Tissue Neoplasm', 'Skin Neoplasm', 'Soft Tissue Neoplasm']",Metastatic Malignant Skin Neoplasm,Mayo Clinic,[],['United States']
NCT07156565,Actinium Therapy for Late-stage Aggressive Sarcomas,"A Seamless Phase 1/2 Open-label Study to Evaluate the Safety, Determine the Maximum Tolerated Dose of Administered Activity, and Evaluate the Efficacy of the Therapeutic Radiopharmaceutical [Ac 225]-RTX-2358 in the Treatment of Relapsed or Refractory Sarcoma",RECRUITING,2025-11-12,2028-01,2032-01,INTERVENTIONAL,PHASE1,26,['Advanced Soft Tissue Sarcoma'],Advanced Soft Tissue Sarcoma,"Ratio Therapeutics, Inc.",[],['United States']
NCT06248606,Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases,Phase II Study of Adagrasib + Stereotactic Radiosurgery (SRS) for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases,RECRUITING,2024-08-06,2026-03,2028-08,INTERVENTIONAL,PHASE2,30,"['Non Small Cell Lung Cancer', 'NSCLC', 'KRAS G12C']",Non Small Cell Lung Cancer,"Ryan Gentzler, MD","['Mirati Therapeutics Inc.', 'University of Virginia']",['United States']
NCT07272044,Research on Anesthesia Depth Control Strategy Based on Continuous and Non-invasive Monitoring of Exhaled Breath,Research on Anesthesia Depth Control Strategy Based on Continuous and Non-invasive Monitoring of Exhaled Breath,RECRUITING,2024-03-16,2027-03-15,2029-03-15,OBSERVATIONAL,,500,['Anesthesia'],Anesthesia,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT07013032,Diagnostic and Prognostic Value of Reticulated Platelet Fraction in Ventilator-Associated Pneumonia (REPLAY-VAP),Diagnostic and Prognostic Value of Reticulated Platelet Fraction in Patients With Ventilator-Associated Pneumonia: A Prospective Observational Study,RECRUITING,2025-07-01,2025-12-01,2026-02-02,OBSERVATIONAL,,42,['Ventilator-Associated Pneumonia'],Ventilator-Associated Pneumonia,Konya City Hospital,[],['Turkey (Türkiye)']
NCT05992532,GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma,GammaGA: Study of the Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma,RECRUITING,2023-05-30,2025-12,2026-03,OBSERVATIONAL,,210,"['Gaucher Disease', 'Acid SphingoMyelinase Deficiency']",Gaucher Disease,Fundación Española de Hematología y Hemoterapía,[],['Spain']
NCT06547632,ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach,ClearPetra™ Vacuum-assisted Ureteral Access Sheath vs Traditional Approach in Retrograde Intrarenal Surgery. A Randomized Controlled Trial,RECRUITING,2025-07-31,2025-12,2025-12-01,INTERVENTIONAL,NA,150,"['Nephrolithiasis', 'Kidney Stone']",Nephrolithiasis,University of Kansas Medical Center,[],['United States']
NCT07087860,Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers,MC220503 Randomized Phase II Rescuing Cancer Immunotherapy With Plasma Exchange in Bladder Cancer 1 (ReCIPE-B1),RECRUITING,2025-08-01,2028-08-07,2028-08-07,INTERVENTIONAL,PHASE2,70,"['Metastatic Bladder Urothelial Carcinoma', 'Metastatic Renal Pelvis and Ureter Urothelial Carcinoma', 'Refractory Bladder Urothelial Carcinoma', 'Refractory Renal Pelvis and Ureter Urothelial Carcinoma', 'Stage IV Bladder Cancer AJCC v7', 'Stage IV Renal Pelvis and Ureter Cancer AJCC v7']",Metastatic Bladder Urothelial Carcinoma,Mayo Clinic,[],['United States']
NCT07272759,"Feasibility Study of Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program Among People With Stroke in Bang","Feasibility Study of Occupation-Based 'Remediation, Education, Adaptation, Promotion' (REAP) Program Among People With Stroke in Bang",ACTIVE_NOT_RECRUITING,2025-10-20,2025-12-20,2026-03-30,INTERVENTIONAL,NA,6,['Stroke'],Stroke,Tokyo Metropolitan University,"['Centre for the Rehabilitation of the Paralysed, Bangladesh']",['Bangladesh']
NCT05256290,Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations,"A Phase 1/2 Study to Assess BDTX-1535, an Oral EGFR Inhibitor, in Patients With Glioblastoma or Non-Small Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2022-03-31,2025-11-03,2026-06,INTERVENTIONAL,PHASE1,200,"['Non-Small Cell Lung Cancer', 'Advanced Non-Small Cell Squamous Lung Cancer', 'Metastatic Lung Non-Small Cell Carcinoma', 'Metastatic Lung Cancer', 'NSCLC', 'Advanced Lung Carcinoma', 'Epidermal Growth Factor Receptor C797S', 'Epidermal Growth Factor Receptor G719X', 'EGF-R Positive Non-Small Cell Lung Cancer', 'EGFR-TKI Resistant Mutation']",Non-Small Cell Lung Cancer,"Black Diamond Therapeutics, Inc.",[],['United States']
NCT05203510,A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension,"A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: ARTISAN (Afterload Reduction To Improve Right Ventricular Structure And FuNction)",ACTIVE_NOT_RECRUITING,2022-10-20,2026-04-30,2028-04-30,INTERVENTIONAL,PHASE4,52,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,United Therapeutics,['Lung Biotechnology PBC'],['United States']
NCT06882746,"A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas","A Phase I, Open-label, Non-randomised, Multi-center Dose Escalation Trial of BI 765049 Administered by Parenteral Route in Patients With Advanced, Unresectable, and/or Metastatic Colorectal Carcinoma (CRC), Gastric Carcinoma (GC), or Pancreatic Ductal Adenocarcinoma (PDAC) to Determine the MTD and the RP2D and to Determine the Dosing Regimen for Further Development of BI 765049",ACTIVE_NOT_RECRUITING,2025-03-28,2026-12-11,2027-05-12,INTERVENTIONAL,PHASE1,135,"['Colorectal Carcinoma', 'Gastric Carcinoma', 'Pancreatic Ductal Adenocarcinoma']",Colorectal Carcinoma,Boehringer Ingelheim,[],['United States']
NCT07124078,A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256),"A Phase 2, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)",RECRUITING,2025-12-15,2029-01-31,2029-07-31,INTERVENTIONAL,PHASE2,60,['Chronic Graft-versus-host-disease'],Chronic Graft-versus-host-disease,Incyte Corporation,[],"['Belgium', 'United States', 'Spain', 'Italy', 'United Kingdom', 'Germany']"
NCT07212543,Low-Flow Desflurane Anesthesia and Its Effects on BIS and Postoperative Cognitive Functions,The Effects of Different Low-Flow Desflurane Anesthesia Strategies on Bispectral Index and Postoperative Cognitive Functions in Patients Undergoing Major Abdominal Surgery,ACTIVE_NOT_RECRUITING,2025-05-15,2025-12-20,2025-12-21,OBSERVATIONAL,,72,['Major Abdominal Surgeries'],Major Abdominal Surgeries,Dolunay ARIK,[],['Turkey (Türkiye)']
NCT07272876,Kinesiophobia and Physical Function in Elderly With Musculoskeletal Pain,"Investigation of the Relationship Between Kinesiophobia, Pain Intensity, and Physical Performance in Elderly Individuals With Musculoskeletal Pain",ACTIVE_NOT_RECRUITING,2025-10-23,2025-12-30,2026-01-25,OBSERVATIONAL,,60,"['Musculoskeletal Pain', 'Physical Performance', 'Geriatrics', 'Kinesiophobia']",Musculoskeletal Pain,Istinye University,[],['Turkey (Türkiye)']
NCT07083089,"Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)",Phenotyping of Audition in Patients With Early Stage of Neurodegenerative Disorders (Alzheimer and Parkinson' Diseases),RECRUITING,2025-03-24,2026-12,2026-12,INTERVENTIONAL,NA,309,"['Mild Cognitive Impairment (MCI) Amnestic', 'Parkinson Disease (PD)', 'Healthy Participants']",Mild Cognitive Impairment (MCI) Amnestic,Cilcare SAS,[],['France']
NCT07273708,Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors,Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors,RECRUITING,2025-03-15,2026-07,2026-07,OBSERVATIONAL,,20,['Advanced HCC Treated by Systemic Immunotherapy'],Advanced HCC Treated by Systemic Immunotherapy,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT06332534,"Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease","A Phase 3 Multicenter Study to Evaluate Efficacy, Safety, and Pharmacokinetics of Upadacitinib With Open-Label Induction, Randomized, Double-Blind Maintenance and Open-Label Long-Term Extension in Pediatric Subjects With Moderately to Severely Active Crohn's Disease and Inadequate Response, Intolerance, or Medical Contraindications to Corticosteroids, Immunosuppressants, and/or Biologic Therapy",RECRUITING,2024-07-26,2027-06,2034-12,INTERVENTIONAL,PHASE3,110,"[""Crohn's Disease""]",Crohn's Disease,AbbVie,[],"['Brazil', 'Belgium', 'Bulgaria', 'Japan', 'New Zealand', 'China', 'United States', 'France', 'Puerto Rico', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Greece', 'Poland', 'Australia']"
NCT06636721,Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer,Lung Cancer and Aging (LuCA): Intervention Development for Addressing Aging-specific Concerns in Older Adults With Lung Cancer,RECRUITING,2025-02-25,2026-07,2026-07,INTERVENTIONAL,NA,46,['Lung Cancer'],Lung Cancer,Duke University,['National Institute on Aging (NIA)'],['United States']
NCT06510374,Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer,"A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer",RECRUITING,2024-10-01,2028-06-30,2031-06-30,INTERVENTIONAL,PHASE3,454,['Intermediate Risk Non-Muscle Invasive Bladder Cancer'],Intermediate Risk Non-Muscle Invasive Bladder Cancer,Ferring Pharmaceuticals,[],"['Japan', 'United States', 'Canada']"
NCT07271420,Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients,Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients,RECRUITING,2020-01-01,2026-12-31,2027-06-30,INTERVENTIONAL,PHASE4,40,"['Hypertension', 'Peritoneal Dialysis', 'End Stage Kidney Disease (ESRD)']",Hypertension,Chinese University of Hong Kong,[],['Hong Kong']
NCT06921590,A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects,"A Randomized, Balanced, Phase 1, Multiple-dose, Open-label, Two-treatment, Two-period, Two-sequence, Crossover, Relative Bioavailability Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects",ACTIVE_NOT_RECRUITING,2025-05-09,2025-12,2025-12,INTERVENTIONAL,PHASE1,6,"['Pharmacokinetics', 'Neurology']",Pharmacokinetics,"Alzamend Neuro, Inc.",['Massachusetts General Hospital'],['United States']
NCT05387980,A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.,Special Investigation for CIBINQO （Long Term）,ACTIVE_NOT_RECRUITING,2022-04-19,2028-08-02,2028-08-02,OBSERVATIONAL,,1128,['Atopic Dermatitis'],Atopic Dermatitis,Pfizer,[],['Japan']
NCT07273422,"Novel Self-charging, Medical-Grade Smart Insoles With AI/ML Edge Computing to Monitor Biometrics.",Evaluation of Self-powered Smart Insoles,RECRUITING,2026-06,2026-11,2027-02,OBSERVATIONAL,,150,['No Applicable Condition; Study of Physiologic Monitor Alarms'],No Applicable Condition; Study of Physiologic Monitor Alarms,Spectrum Ergonomics and Occupational Health Services,"['University of Utah', 'United States Air Force Research Laboratory']",['United States']
NCT06592261,Graded Insulin Suppression Test P&F,Human Models of Selective Insulin Resistance: Graded Insulin Suppression Test (GIST) Pilot & Feasibility Study,RECRUITING,2024-09-16,2026-08,2026-08,INTERVENTIONAL,PHASE1,15,"['Insulin Resistance', 'Hyperinsulinemia', 'Obesity', 'Healthy']",Insulin Resistance,Columbia University,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'University of Pisa']",['United States']
NCT03935295,Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis,Dysport ® (abobotulinumtoxinA) as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis,RECRUITING,2020-09-03,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE4,90,['Adolescent Idiopathic Scoliosis'],Adolescent Idiopathic Scoliosis,Johns Hopkins University,[],['United States']
NCT03742245,Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer,Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer,ACTIVE_NOT_RECRUITING,2019-06-11,2025-12-01,2026-03-01,INTERVENTIONAL,PHASE1,28,"['Breast Cancer Metastatic', 'Breast Cancer']",Breast Cancer Metastatic,The Methodist Hospital Research Institute,"['AstraZeneca', 'Merck Sharp & Dohme LLC']",['United States']
NCT06119581,A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer,"SUNRAY-01, A Global Pivotal Study in Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Comparing First-Line Treatment of LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Those With PD-L1 Expression ≥50% or LY3537982 and Pembrolizumab, Pemetrexed, Platinum vs Placebo and Pembrolizumab, Pemetrexed, Platinum Regardless of PD-L1 Expression",RECRUITING,2023-12-21,2026-10,2029-10,INTERVENTIONAL,PHASE3,1016,"['Carcinoma, Non-Small-Cell Lung', 'Neoplasm Metastasis']","Carcinoma, Non-Small-Cell Lung",Eli Lilly and Company,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy']"
NCT07259772,Anesthetic Effect of Ropivacaine on Local Infiltration Anesthesia in Arteriovenous Fistula Surgery,Anesthetic Effect of Ropivacaine on Local Infiltration Anesthesia in Arteriovenous Fistula Surgery: a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2019-04-10,2021-03-31,2026-06,INTERVENTIONAL,PHASE4,40,"['End Stage Renal Disease (ESRD)', 'Arteriovenous Fistula Patency', 'Chronic Kidney Disease 5D']",End Stage Renal Disease (ESRD),The First People's Hospital of Lianyungang,[],['China']
NCT05441709,Furthering Equity Through Infant Feeding EDucation and Support,Clinically Integrated Breastfeeding Peer Counseling to Promote Breastfeeding Equity,RECRUITING,2022-11-08,2026-12-31,2026-12-31,INTERVENTIONAL,NA,990,['Breastfeeding'],Breastfeeding,Endeavor Health,"['Patient-Centered Outcomes Research Institute', 'Northwestern University', 'University of Chicago', 'Rush University']",['United States']
NCT07273721,Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease,Efficacy and Safety of BT200 (Rondoraptivon Pegol) in Patients With Type 2B Von Willebrand Disease,RECRUITING,2025-08-14,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE2,6,"['Von Willebrand Disease (VWD), Type 2']","Von Willebrand Disease (VWD), Type 2",Medical University of Vienna,[],['Austria']
NCT07240922,The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study,The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study - a Randomized Controlled Trial,RECRUITING,2025-10-01,2030-10-01,2030-10-01,INTERVENTIONAL,PHASE4,600,['Influenza'],Influenza,The University of Hong Kong,[],['Hong Kong']
NCT07093788,Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions,Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions: a Randomized Controlled Trial (Shape),RECRUITING,2025-09-01,2026-09-01,2027-06-30,INTERVENTIONAL,NA,78,"['PCI', 'Coronary Arterial Disease (CAD)', 'Calcified Coronary Lesions']",PCI,"Nanjing First Hospital, Nanjing Medical University",[],['China']
NCT05363319,An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe,An Observational Study to Assess the Effectiveness and Safety of Cemiplimab Based Regimen in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe (CEMI-LUNG),RECRUITING,2022-10-26,2028-10-30,2028-10-30,OBSERVATIONAL,,500,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Regeneron Pharmaceuticals,[],"['Austria', 'France', 'Spain', 'Italy', 'Germany']"
NCT06029660,AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion,AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion,RECRUITING,2024-04-05,2027-06,2031-06,INTERVENTIONAL,NA,180,"['Aortic Aneurysm, Abdominal']","Aortic Aneurysm, Abdominal","Shape Memory Medical, Inc.",['NAMSA'],"['New Zealand', 'Netherlands', 'United States', 'France', 'United Kingdom']"
NCT05330923,Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease,Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease,RECRUITING,2022-05-01,2029-05-01,2029-06-01,OBSERVATIONAL,,200,"['Nonalcoholic Fatty Liver Disease', 'Nonalcoholic Steatohepatitis', 'Fibrosis', 'HIV/AIDS']",Nonalcoholic Fatty Liver Disease,Peking Union Medical College Hospital,['Wuxi Hisky Medical Technology Co Ltd'],['China']
NCT05595408,Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma,Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma(CURATE-UTUC): A Multicenter Prospective Longitudinal Cohort Study,RECRUITING,2022-02-01,2025-11-03,2026-12-31,OBSERVATIONAL,,84,['Muscle Invasive Upper Tract Urothelial Carcinoma'],Muscle Invasive Upper Tract Urothelial Carcinoma,RenJi Hospital,['West China Hospital'],['China']
NCT07045740,Physiotherapist Navigator Pilot Trial,Evaluation of a Novel Role Proposal for the Use of a Physiotherapist Navigator in an Acute Cancer Care Setting in Ontario: a Pilot Randomized Controlled Trial,RECRUITING,2025-11-21,2026-05-01,2026-05-01,INTERVENTIONAL,NA,26,['Cancer'],Cancer,McMaster University,[],['Canada']
NCT07273591,EFFECTS OF LOW-LEVEL LASER THERAPY ON SPASTICITY AND GAIT PARAMETERS IN CHRONIC STROKE PATIENTS WITH SPASTIC PLANTAR FLEXORS,EFFECTS OF LOW-LEVEL LASER THERAPY ON SPASTICITY AND GAIT PARAMETERS IN CHRONIC STROKE PATIENTS WITH SPASTIC PLANTAR FLEXORS,RECRUITING,2025-11-30,2025-12-30,2025-12-31,INTERVENTIONAL,NA,22,"['Stroke', 'Spasticity', 'Plantar Flexors']",Stroke,Montiha Azeem,[],['Pakistan']
NCT07021547,A Study of LY3867070 in Healthy Participants,A Single- and Multiple-Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of LY3867070 in Healthy Participants,RECRUITING,2025-05-27,2026-08,2026-08,INTERVENTIONAL,PHASE1,196,['Healthy'],Healthy,Eli Lilly and Company,[],['United States']
NCT04379414,YES Study - Newly Diagnosed/Metastatic Intervention,"Young, Empowered &Amp; Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Newly Diagnosed/Metastatic Intervention",ACTIVE_NOT_RECRUITING,2020-09-16,2027-03-01,2028-03-01,INTERVENTIONAL,NA,400,"['Breast Cancer', 'Symptom, Behavioral']",Breast Cancer,Dana-Farber Cancer Institute,['Breast Cancer Research Foundation'],['United States']
NCT05066217,An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome,"Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Clemizole HCl as Adjunctive Therapy in Patients With Lennox-Gastaut Syndrome",RECRUITING,2025-04-09,2026-11-01,2029-11-01,INTERVENTIONAL,PHASE3,260,['Lennox Gastaut Syndrome'],Lennox Gastaut Syndrome,Epygenix,"['Harmony Biosciences Management, Inc.']",['United States']
NCT05900401,Delayed Tolerance Through Mixed Chimerism,Delayed Tolerance Through Mixed Chimerism,ACTIVE_NOT_RECRUITING,2023-10-01,2028-12,2030-12,INTERVENTIONAL,PHASE1,20,"['Kidney Failure', 'Kidney Transplant; Complications', 'Chimera']",Kidney Failure,Massachusetts General Hospital,"['Ossium Health, Inc.', 'ITB-Med LLC']",['United States']
NCT06636318,Immune Status After Being on Call for 24 Hrs,Impact of a 24-hour Shift Call on the Immune Status of Surgery Residents,RECRUITING,2024-10-17,2027-12,2027-12,OBSERVATIONAL,,60,['Sleep Deprivation'],Sleep Deprivation,University of Chicago,[],['United States']
NCT03715933,Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas,"An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas",RECRUITING,2018-10-08,2026-06,2026-12,INTERVENTIONAL,PHASE1,321,['Ewing Sarcoma'],Ewing Sarcoma,"Inhibrx Biosciences, Inc",[],"['Netherlands', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom']"
NCT07272148,The Pilot of the Turku Outpatient Clinic for Functional and Fatigue Disorders,The Pilot of the Turku Outpatient Clinic for Functional and Fatigue Disorders in the Welbeing Services County of Southwest Finland,ACTIVE_NOT_RECRUITING,2023-08-01,2026-05,2027-05,OBSERVATIONAL,,125,"['Persistent Physical Symptoms (PPS)', 'Functional Disorder', 'Fatigue Syndrome, Chronic']",Persistent Physical Symptoms (PPS),Turku University Hospital,[],['Finland']
NCT04167033,Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP),Study of Ventricular Repolarization in Patients With Premature Ovarian Insufficiency and Influence of Estrogen-progestin Replacement Therapy,RECRUITING,2021-04-14,2027-04-13,2027-06-13,INTERVENTIONAL,NA,120,['Premature Ovarian Insufficiency'],Premature Ovarian Insufficiency,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06961955,5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer,FAST NOVEMBER: A Phase II Randomized Trial of a 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer,RECRUITING,2025-05-21,2030-05,2033-05,INTERVENTIONAL,PHASE2,144,"['Breast Cancer', 'Invasive Carcinoma of Breast', 'Ductal Breast Carcinoma in Situ']",Breast Cancer,University of Utah,[],['United States']
NCT06081829,A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation,"A Phase 2, Open-label, Multicenter Study of Orally Administered Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation",ACTIVE_NOT_RECRUITING,2023-10-10,2024-10-01,2027-05,INTERVENTIONAL,PHASE2,12,"['Cholangiocarcinoma Non-resectable', 'Cholangiocarcinoma Metastatic']",Cholangiocarcinoma Non-resectable,Servier,[],['Japan']
NCT06220669,A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis,"An Adaptive Phase 2a/2b, Randomized, Double-Blind, Parallel-Group Study to Investigate the Safety and Efficacy of LY3541860 Compared to Placebo in Slowing the Occurrence of New T1 Gadolinium-Enhancing Lesions in Adult Participants With Relapsing Multiple Sclerosis",RECRUITING,2024-03-19,2027-08,2028-08,INTERVENTIONAL,PHASE2,200,['Multiple Sclerosis'],Multiple Sclerosis,Eli Lilly and Company,[],"['Israel', 'United States', 'France', 'Slovakia', 'Italy', 'United Kingdom', 'Latvia', 'Poland', 'Lithuania', 'Germany']"
NCT06516198,Auricular Acupressure in Prehabilitation,A Pilot Study of the Utility of Auricular Acupressure in Enhancing Prehabilitation Benefits in Candidates for Thoracic Surgery.,RECRUITING,2025-07-21,2027-06-20,2027-06-20,INTERVENTIONAL,NA,40,"['Frailty', 'Thoracic', 'Prehabilitation', 'Lung Surgery', 'Wedge Resection', 'Segmentectomy', 'Lobectomy', 'Pneumonectomy; Status']",Frailty,University of Chicago,[],['United States']
NCT06948214,Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency,"A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)",RECRUITING,2025-12,2027-12,2028-01,INTERVENTIONAL,PHASE3,150,['Growth Hormone Deficiency (GHD)'],Growth Hormone Deficiency (GHD),Lumos Pharma,[],['United States']
NCT05338658,Study of PAT in Patients With Solid Tumor Cancers,Phase I Study of Peptide Alarm Therapy (PAT) Administered by Intratumoral Injection With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumor Cancers Who Have Failed 1 or More Prior Therapies,RECRUITING,2023-05-19,2027-01,2027-01,INTERVENTIONAL,PHASE1,21,"['Metastasis', 'Solid Tumor']",Metastasis,"Masonic Cancer Center, University of Minnesota",[],['United States']
NCT06641752,"Evaluation of CO Intoxication Rate, by CAPillary HbCO","Evaluation of the Accuracy of Capillary Versus Venous CO Measurement in Subjects With Suspected Carbon Monoxide Poisoning: a Prospective, Multicenter, Diagnostic, Controlled Study.",RECRUITING,2025-02-05,2027-02-05,2027-02-05,OBSERVATIONAL,,120,['Carbon Monoxide Intoxication'],Carbon Monoxide Intoxication,Nantes University Hospital,"['University Hospital, Angers']",['France']
NCT07111351,Multi-omics Studies of Primary Aldosteronism,Multi-omics Studies of Primary Aldosteronism,RECRUITING,2025-08-15,2029-04-01,2029-05-31,OBSERVATIONAL,,400,['Primary Aldosteronism'],Primary Aldosteronism,Peking University First Hospital,['Peking University'],['China']
NCT05458323,Cognitive Level Enhancement Through Vision Exams and Refraction,Cognitive Level Enhancement Through Vision Exams and Refraction: a Randomized Controlled Trial to Assess Impact of Near and Distance Spectacles on Reducing Rates of Cognitive Decline With Aging in Community Dwelling Older People in India,RECRUITING,2024-01-18,2027-11-30,2028-12-31,INTERVENTIONAL,NA,820,['Refractive Errors'],Refractive Errors,"Queen's University, Belfast","['L.V. Prasad Eye Institute', 'National Institute of Mental Health and Neuro Sciences, India', 'The George Institute', 'Johns Hopkins University', 'University of Michigan', 'Clearly', 'Belfast Health and Social Care Trust']",['India']
NCT07271576,Research on the Protective Effects of Phycocyanin Against Liver Fibrosis and Cirrhosis,"Research on the Role of Phycocyanin in the Prevention, Treatment, and Mechanism of Liver Fibrosis/Cirrhosis",RECRUITING,2025-06-04,2027-06-04,2027-06-04,INTERVENTIONAL,NA,10,"['Liver Fibrosis', 'Liver Cirrhosis']",Liver Fibrosis,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT04780568,Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer,A Phase Ib Study of AZD9291 (Osimertinib) and BC2059 (Tegavivint) as First-Line Therapy in Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC),RECRUITING,2022-01-18,2026-07-31,2029-07-31,INTERVENTIONAL,PHASE1,24,"['Metastatic Lung Non-Small Cell Carcinoma', 'Stage IV Lung Cancer AJCC v8', 'Stage IVA Lung Cancer AJCC v8', 'Stage IVB Lung Cancer AJCC v8']",Metastatic Lung Non-Small Cell Carcinoma,Ohio State University Comprehensive Cancer Center,[],['United States']
NCT05360446,Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events,"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (VICTORION-PLAQUE)",ACTIVE_NOT_RECRUITING,2022-07-08,2026-10-26,2026-10-26,INTERVENTIONAL,PHASE3,610,['Coronary Artery Disease'],Coronary Artery Disease,Novartis Pharmaceuticals,[],"['Brazil', 'Belgium', 'Japan', 'Hungary', 'China', 'India', 'United States', 'France', 'Chile', 'Switzerland', 'Ireland', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Argentina', 'Australia']"
NCT05131919,"Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers","Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers. The PUMA Study",ACTIVE_NOT_RECRUITING,2022-12-22,2030-07,2031-07,INTERVENTIONAL,PHASE2,25,['Colorectal Cancer'],Colorectal Cancer,The Netherlands Cancer Institute,['Merck Sharp & Dohme LLC'],['Netherlands']
NCT06674863,Addressing Health Literacy With a Tailored Survivorship Care Plan,Addressing Health Literacy With a Tailored Survivorship Care Plan to Improve Access in Underserved African American Prostate Cancer Patients,RECRUITING,2025-11-07,2029-12-31,2030-12-31,INTERVENTIONAL,NA,150,"['Localized Prostate Carcinoma', 'Oligometastatic Prostate Carcinoma', 'Stage IVB Prostate Cancer AJCC v8']",Localized Prostate Carcinoma,Emory University,"['National Cancer Institute (NCI)', 'United States Department of Defense']",['United States']
NCT04649229,Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3,Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3,ACTIVE_NOT_RECRUITING,2021-05-27,2025-05-22,2025-12-31,INTERVENTIONAL,PHASE4,80,['Heart Failure'],Heart Failure,Yale University,[],['United States']
NCT07271927,Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease,Evaluation Study of the Effects and Safety of Whole-Body Photobiomodulation Therapy on Motor and Cognitive Changes in Patients With Parkinson's Disease,RECRUITING,2025-02-12,2025-11-30,2025-12-31,INTERVENTIONAL,NA,15,['PARKINSON DISEASE (Disorder)'],PARKINSON DISEASE (Disorder),Pusan National University Yangsan Hospital,[],['South Korea']
NCT06959056,Evaluating the Impact of Cryo-analgesia on Recovery After Double Lung Transplantation,Evaluating the Impact of Cryo-analgesia on Recovery After Double Lung Transplantation: a Pilot Study,RECRUITING,2025-12-03,2026-05,2027-12,INTERVENTIONAL,NA,40,['Lung Transplant; Pain'],Lung Transplant; Pain,"University Hospital, Gasthuisberg",[],['Belgium']
NCT06535945,Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation,Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation,RECRUITING,2025-03-26,2028-04-26,2028-04-26,INTERVENTIONAL,PHASE4,400,"['Liver Transplantation', 'Acute Kidney Injury']",Liver Transplantation,Rennes University Hospital,"['Ministry of Health, France']",['France']
NCT05956041,"Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas","A Phase II Study of Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas",RECRUITING,2023-12-06,2025-12,2026-12,INTERVENTIONAL,PHASE2,23,"['Cutaneous T Cell Lymphoma', 'Fungoides Mycosis Sezary Syndrome']",Cutaneous T Cell Lymphoma,University of Michigan Rogel Cancer Center,"['Merck Sharp & Dohme LLC', 'Hoosier Cancer Research Network']",['United States']
NCT07273539,A Study to Evaluate the Effect of a Test (Sodium Bicarbonate) Toothpaste on the Oral Microbiome,"A Randomised, Controlled, Examiner Blind Study to Evaluate the Effect of a Sodium Bicarbonate Toothpaste on the Oral Microbiome",RECRUITING,2025-10-27,2026-02,2026-02,INTERVENTIONAL,NA,55,['Gingivitis'],Gingivitis,HALEON,[],['United Kingdom']
NCT05347134,"SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer","A Randomized, Controlled, Open-label, Multi-center Phase III Clinical Trial of SKB264 for Injection Versus Investigator Selected Regimens in Patients With Unresectable Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer Who Have Failed Second-line or Above Prior Standard of Care",ACTIVE_NOT_RECRUITING,2022-06-10,2023-11-30,2027-06-30,INTERVENTIONAL,PHASE3,254,['Triple Negative Breast Cancer'],Triple Negative Breast Cancer,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT05559359,A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis,"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Lebrikizumab Compared to Placebo in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis",RECRUITING,2022-10-18,2025-12,2026-12,INTERVENTIONAL,PHASE3,360,"['Atopic Dermatitis', 'Eczema']",Atopic Dermatitis,Eli Lilly and Company,"['Dermira, Inc.']","['Brazil', 'Japan', 'United States', 'Mexico', 'Germany', 'Spain', 'Taiwan', 'Canada', 'Czechia', 'Poland', 'Argentina', 'Australia']"
NCT07271823,Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer,Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer,ACTIVE_NOT_RECRUITING,2024-09-01,2026-12-31,2026-12-31,OBSERVATIONAL,,100,['Pancreatic Cancer Non-resectable'],Pancreatic Cancer Non-resectable,Zhejiang Cancer Hospital,[],['China']
NCT05510687,Transforming Households With Refraction and Innovative Financial Technology,A Randomised Controlled Trial on the Impact of Free Reading Glasses to Support Use of Smartphone Banking in Bangladesh Among Government Old Age Allowance and Widow Allowance Beneficiaries,ACTIVE_NOT_RECRUITING,2023-12-10,2025-09-08,2026-01,INTERVENTIONAL,NA,571,['Presbyopia'],Presbyopia,"Queen's University, Belfast","['L.V. Prasad Eye Institute', 'VisionSpring', 'MOMODa Foundation', 'Good Business Labs Foundation', 'Florida International University', 'Clearly', 'BRAC University']",['Bangladesh']
NCT06397118,Prevention of Malnutrition in Children With Sickle Cell Disease,Prevention of Malnutrition in Children With Sickle Cell Disease Living in Northern Nigeria,ACTIVE_NOT_RECRUITING,2024-11-06,2026-05-01,2027-05-31,INTERVENTIONAL,NA,148,"['Sickle Cell Disease', 'Malnutrition']",Sickle Cell Disease,Vanderbilt University Medical Center,"['Aminu Kano Teaching Hospital', 'Murtala Muhammed Specialist Hospital']",['United States']
NCT07197554,"A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies","A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies",RECRUITING,2025-12-01,2029-12-31,2029-12-31,INTERVENTIONAL,PHASE1,171,"['Advanced Solid Tumors', 'Ewing Sarcoma', 'Hepatocellular Carcinoma (HCC)', 'Biliary Tract Cancer (BTC)']",Advanced Solid Tumors,"SEED Therapeutics, Inc.",[],['United States']
NCT07107841,Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site),"Blinded, Randomized, Controlled, Trial to Evaluate the Efficacy and Safety of Autologous Hair Follicle Secretome for the Treatment of Androgenic Alopecia (Single Site)",RECRUITING,2025-10-16,2027-09-15,2027-09-15,INTERVENTIONAL,NA,60,"['Androgenic Alopecia', 'Alopecia', 'Baldness']",Androgenic Alopecia,Acorn Biolabs Inc.,[],['United States']
NCT07272473,"Effects of Cervical Mobilization on Dizziness, Balance, and Joint Position Sense in Patients With Meniere's Disease","Effects of Cervical Mobilization on Dizziness, Balance, and Joint Position Sense in Patients With Meniere's Disease",RECRUITING,2025-09-20,2026-03-30,2026-05-05,INTERVENTIONAL,NA,33,['Meniere Disease'],Meniere Disease,Abant Izzet Baysal University,[],['Turkey (Türkiye)']
NCT05614739,FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3,"FORAGER-1: A Phase 1, Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Locally Advanced or Metastatic Solid Tumors Including Urothelial Cancer With FGFR3 Alterations",RECRUITING,2023-01-12,2027-06,2027-06,INTERVENTIONAL,PHASE1,535,"['Urinary Bladder Neoplasms', 'Neoplasm Metastasis', 'Ureteral Neoplasms']",Urinary Bladder Neoplasms,Eli Lilly and Company,[],"['Israel', 'Japan', 'Netherlands', 'Norway', 'China', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT05571592,Cannabidiol as a Treatment for Social Anxiety Disorder (R61),Randomized Placebo-controlled Trial to Determine the Biological Signature of Cannabidiol as a Treatment for Social Anxiety Disorder (R61),ACTIVE_NOT_RECRUITING,2023-01-26,2025-12-01,2025-12-01,INTERVENTIONAL,PHASE2,60,['Social Anxiety Disorder'],Social Anxiety Disorder,NYU Langone Health,"['Ananda Scientific', 'National Center for Complementary and Integrative Health (NCCIH)']",['United States']
NCT07272811,Neurocognitive Assessment Platform 4 Alzheimer,Neurocognitive Assessment Platform 4 Alzheimer,RECRUITING,2021-12-15,2025-12,2025-12,OBSERVATIONAL,,100,"['MCI', 'MCI Conversion to Dementia', 'AMCI - Amnestic Mild Cognitive Impairment', 'Alzheimer Disease']",MCI,IRCCS San Raffaele,[],['Italy']
NCT06950775,The Neighborhood & Health Study,A Naturalistic Study of Residents of an Agriculturally Integrated Community,RECRUITING,2025-05-09,2026-08-01,2026-08-01,OBSERVATIONAL,,600,"['Healthy Eating', 'Cardiometabolic Health']",Healthy Eating,Texas A&M University,[],['United States']
NCT07051330,The Advancing Dynamic And Personalized Training Study,The Advancing Dynamic And Personalized Training Study,RECRUITING,2025-07-20,2027-06,2027-06,INTERVENTIONAL,NA,1500,"['Well-Being, Psychological']","Well-Being, Psychological","University of Wisconsin, Madison",['Templeton World Charity Foundation'],['United States']
NCT02863692,Registry of the German CLL Study Group,"Registry of the German CLL Study Group Long Term Follow-up of Patients With CLL, B-PLL, T-PLL, SLL,T or NK-LGL, HCL and Richter's Transformation",RECRUITING,2013-08,2026-12,2026-12,OBSERVATIONAL,,8000,"['CLL', 'SLL', 'HCL', 'Richter´s Transformation', 'Leukemia, Prolymphocytic, B-Cell', 'Leukemia, Prolymphocytic, T-Cell', 'T-LGL Leukemia', 'NK-LGL Leukemia']",CLL,German CLL Study Group,[],['Germany']
NCT06138236,Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides,Comparison of ESWT and Collagen Hydrolyzed Peptides in the Treatment of Plantar Fascitiis,RECRUITING,2023-07-01,2025-12-31,2025-12-31,INTERVENTIONAL,EARLY_PHASE1,84,['Plantar Fascitis'],Plantar Fascitis,Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari,[],['Italy']
NCT04316546,MK-7075 (Miransertib) in Proteus Syndrome,A Multi-Cohort Phase 2 Dose-Escalation Study of MK-7075 (Miransertib) in Proteus Syndrome,RECRUITING,2022-05-20,2026-07-01,2028-07-01,INTERVENTIONAL,PHASE2,45,['Proteus Syndrome'],Proteus Syndrome,National Human Genome Research Institute (NHGRI),[],['United States']
NCT05357482,Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia,Addition of JSP191 (C-kit Antibody) to Non-myeloablative Hematopoietic Cell Transplantation For Sickle Cell Disease and Beta-Thalassemia,ACTIVE_NOT_RECRUITING,2022-05-12,2026-01-31,2027-01-31,INTERVENTIONAL,PHASE1,40,"['Sickle Cell Anemia', 'Beta Thalassemia']",Sickle Cell Anemia,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07251452,Effectiveness of a Dual Program for Improving Sleep in Older Adults.,Effectiveness of a Dual Program of Physical Activity and Cognitive Intervention for Improving Sleep and Quality of Life in Older Adults.,ACTIVE_NOT_RECRUITING,2025-09-01,2025-09-15,2026-02-28,INTERVENTIONAL,PHASE1,66,"['Sleep', 'Gerontology', 'Physical Therapy', 'Cognitive']",Sleep,University of Castilla-La Mancha,[],['Spain']
NCT00060775,The Psychobiology of Childhood Temperament,The Psychobiology of Temperament: An fMRI Study,RECRUITING,2003-11-10,,,OBSERVATIONAL,,1410,['Developmental Psychology'],Developmental Psychology,National Institute of Mental Health (NIMH),"['University of Maryland, College Park']",['United States']
NCT06684483,The Impact of Heavy Alcohol Use on Saliva and Oral Health,"Quantifying Associations of Stress and Inflammation-Associated Oral Biomarkers With Oral Health, Oral Health Behaviors, Systemic Biomarkers and Clinical Phenotype in Individuals With Alcohol Use Disorder (AUD)",RECRUITING,2025-01-09,2026-12-01,2026-12-31,OBSERVATIONAL,,72,"['Alcohol Use Disorder', 'Alcohol Dependence']",Alcohol Use Disorder,National Institutes of Health Clinical Center (CC),[],['United States']
NCT03287193,Identification of the Molecular and/or Pathophysiological Bases of Rare Diseases of Genetic Origin (or Rare Forms of Frequent Diseases Suspected of Being of Genetic Origin).,Identification of the Molecular and/or Pathophysiological Bases of Rare Diseases of Genetic Origin (or Rare Forms of Frequent Diseases Suspected of Being of Genetic Origin).,RECRUITING,2017-03-13,2027-03,2027-12,OBSERVATIONAL,,850,"['Rare Diseases of Genetic Origin', 'Rare Forms of Common Diseases Suspected of Being Genetic in Origin']",Rare Diseases of Genetic Origin,Centre Hospitalier Universitaire Dijon,[],['France']
NCT07225647,A Study to Assess the Effect of Food on the Drug Levels of Admilparant,"An Open-Label, Randomized, Two-part Study in Healthy Participants to Assess the Food Effect on the Pharmacokinetics of Admilparant To-Be-Marketed Tablet Formulations",RECRUITING,2025-11-07,2025-12-28,2025-12-28,INTERVENTIONAL,PHASE1,56,['Healthy Participants'],Healthy Participants,Bristol-Myers Squibb,[],['United States']
NCT03641755,Olaparib + Sapacitabine in BRCA Mutant Breast Cancer,A Phase Ib/II Study of Olaparib With Sapacitabine in BRCA Mutant Breast Cancer,ACTIVE_NOT_RECRUITING,2018-10-01,2022-04-27,2026-10-22,INTERVENTIONAL,PHASE1,10,['Breast Cancer'],Breast Cancer,Dana-Farber Cancer Institute,"['AstraZeneca', 'Cyclacel Pharmaceuticals, Inc.']",['United States']
NCT05996185,Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma,Phase II Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma,RECRUITING,2024-10-09,2026-11,2027-11,INTERVENTIONAL,PHASE2,22,"['T Cell Lymphoma', 'T-cell Lymphoma']",T Cell Lymphoma,Yale University,"['Kyowa Kirin, Inc.']",['United States']
NCT01399385,New Heart Imaging Techniques to Evaluate Possible Heart Disease,"Magnetic Resonance of Body, Arterial Wall, and Angiography Imaging for Non- Invasive Assessment of Arterial Distensibility, Endothelial Dysfunction and Atherosclerotic Disease Using 1.5T and High Field (3T) MRI: A Technical Development Study of Cardiac and Body Imaging",RECRUITING,2011-07-06,2028-11-06,2030-11-05,INTERVENTIONAL,NA,4000,"['Healthy', 'Obesity', 'Diabetes', 'Healthy Volunteers', 'Atherosclerosis']",Healthy,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT03342144,Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting,"Observational Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting in Austria, Germany and Switzerland",RECRUITING,2017-12-04,2030-12,2030-12,OBSERVATIONAL,,500,['Chronic Lymphocytic Leukemia (CLL)'],Chronic Lymphocytic Leukemia (CLL),AbbVie,[],"['Switzerland', 'Austria', 'Germany']"
NCT03366168,Taste Bud-Derived Stem Cells in Humans,A Pilot Study of Taste Bud-Derived Stem Cells in Humans,RECRUITING,2017-12-18,2025-12-31,2025-12-31,OBSERVATIONAL,,250,['Diabetes'],Diabetes,National Institute on Aging (NIA),[],['United States']
NCT04727658,Linac FRACtionated Radiosurgical THALamotomie in Tremors (FRACTHAL),Linac FRACtionated Radiosurgical THALamotomy in Tremors : a Phase II Study,ACTIVE_NOT_RECRUITING,2021-07-01,2026-03,2027-03,INTERVENTIONAL,PHASE2,9,"['Essential Tremor', 'Parkinsonian Disorders']",Essential Tremor,Centre Hospitalier Universitaire de Nice,[],['Monaco']
NCT02014246,Genetic Characterization of Movement Disorders and Dementias,Genetic Characterization of Movement Disorders and Dementias,RECRUITING,2003-07-14,2059-12-31,2059-12-31,OBSERVATIONAL,,12000,"['Dementia', 'Movement Disorder']",Dementia,National Institute on Aging (NIA),[],['United States']
NCT02108080,Characterization Imaging Instruments in Alcoholics and Non-Alcoholics,Characterization Imaging Instruments for Addiction Neuroimaging Assessments,RECRUITING,2014-07-10,2025-12-31,2025-12-31,OBSERVATIONAL,,1000,"['Alcohol Dependence', 'Alcohol Drinking', 'Alcohol-Related Disorders', 'Alcoholism', 'Brain Mapping']",Alcohol Dependence,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT07231120,"A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia","A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia",RECRUITING,2025-11-17,2026-11-09,2026-12-30,INTERVENTIONAL,PHASE1,54,"['Cachexia-Anorexia Syndrome', 'Solid Tumor Malignancies']",Cachexia-Anorexia Syndrome,"Jiangsu Nutai Biologics Co., Ltd","['Jiangsu GQ Pharma Co., Ltd.']",['China']
NCT07270861,Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study,"A Multicenter, Non-interventional, Two-cohort Study to Describe Real-world Treatment Patterns and Outcomes in Patients With Peripheral T-cell Lymphoma",RECRUITING,2025-11-15,2030-12-31,2035-12-31,OBSERVATIONAL,,3000,['Peripheral T-Cell Lymphoma'],Peripheral T-Cell Lymphoma,Fudan University,[],['China']
NCT07269223,Oral Vitamin D3 Effect on Inflammatory Biomarkers in Ulcerative Colitis Patients,Effect Of Oral Vitamin D3 Supplementation On Inflammatory Biomarkers In Patients With Ulcerative Colitis,RECRUITING,2025-09-02,2025-12-15,2025-12-30,INTERVENTIONAL,NA,60,['Ulcerative Colitis (UC)'],Ulcerative Colitis (UC),"University of Veterinary and Animal Sciences, Lahore - Pakistan",[],['Pakistan']
NCT05369520,Non-invasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury,Non-invasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury: Moving From Mechanisms to Clinical Practice,RECRUITING,2023-10-03,2026-10,2027-10,INTERVENTIONAL,NA,30,"['Spinal Cord Injury', 'Autonomic Dysfunction', 'Sexual Dysfunction', 'Neurogenic Bladder Dysfunction', 'Neurogenic Bowel Dysfunction', 'Autonomic Dysreflexia', 'Orthostatic Hypotension']",Spinal Cord Injury,University of British Columbia,"['United States Department of Defense', 'Congressionally Directed Medical Research Programs']",['Canada']
NCT06214897,Choline to Prevent SAM in Children With MAM,"An Individually Randomized, Partially Blinded, Controlled Trial of Choline-containing Ready-to-use Supplementary Food (C-RUSF) for Children With Moderate Acute Malnutrition to Reduce Deterioration to Severe Acute Malnutrition Compared to Standard RUSF.",ACTIVE_NOT_RECRUITING,2024-03-18,2026-04,2026-04,INTERVENTIONAL,NA,1500,['Moderate Acute Malnutrition'],Moderate Acute Malnutrition,Washington University School of Medicine,"['Project Peanut Butter', 'Kamuzu University of Health Sciences', 'Balchem Corp']",['Malawi']
NCT05657743,A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer,A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer,RECRUITING,2023-08-16,2026-11,2027-11,INTERVENTIONAL,NA,15,"['Pancreatic Cancer', 'Unresectable Pancreatic Cancer', 'Metastatic Pancreatic Cancer', 'Pancreatic Adenocarcinoma']",Pancreatic Cancer,Alpha Tau Medical LTD.,[],['Israel']
NCT06616155,Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer,Study of JAK Inhibition in Stem-Like Prostate Cancer (JASPER): A Phase 1b/2a Multicenter Study of Ruxolitinib and Enzalutamide in Castration Resistant Prostate Cancer,RECRUITING,2026-01-30,2028-01-30,2030-01-30,INTERVENTIONAL,PHASE1,39,"['Castration-Resistant Prostate Carcinoma', 'Metastatic Prostate Adenocarcinoma', 'Stage IVB Prostate Cancer AJCC v8']",Castration-Resistant Prostate Carcinoma,University of Michigan Rogel Cancer Center,['Incyte Corporation'],['United States']
NCT07213791,A Study of LY4337713 in Participants With FAP-Positive Solid Tumors,"A Dose Escalation and Dose Optimization Phase 1a/1b Study to Evaluate Safety, Tolerability and Dosimetry of Radioligand Therapy With LY4337713 in Adults With FAP-Positive Solid Tumors (FiREBOLT)",RECRUITING,2025-10-22,2028-07,2033-03,INTERVENTIONAL,PHASE1,241,"['Ovarian Neoplasms', 'Breast Neoplasms', 'Pancreatic Intraductal Neoplasms', 'Colorectal Neoplasms', 'Esophageal Neoplasms', 'Stomach Neoplasms', 'Cholangiocarcinoma']",Ovarian Neoplasms,Eli Lilly and Company,[],"['United States', 'Netherlands']"
NCT00001174,Evaluation of the Genetics of Bipolar Disorder,Bipolar Genetics: A Collaborative Study,RECRUITING,1994-08-11,,,OBSERVATIONAL,,6000,['Bipolar Disorder'],Bipolar Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT03696784,Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma,A Phase I Study of Autologous Activated T-cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch in Subjects With Relapsed/Refractory B-cell Lymphoma,ACTIVE_NOT_RECRUITING,2019-03-12,2025-08-31,2040-07-31,INTERVENTIONAL,PHASE1,19,"['Lymphoma', 'Lymphoma, B-Cell', 'Immune System Diseases', 'Immunoproliferative Disorders', 'Lymphatic Diseases']",Lymphoma,UNC Lineberger Comprehensive Cancer Center,"['UNC Chapel Hill University Cancer Research Fund', 'The V Foundation', 'M.D. Anderson Cancer Center', 'National Cancer Institute (NCI)']",['United States']
NCT00092235,Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease,Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease,RECRUITING,2004-10-26,,,OBSERVATIONAL,,650,['Chronic Graft vs. Host Disease'],Chronic Graft vs. Host Disease,National Cancer Institute (NCI),"['Emory University, Department of Pediatrics']",['United States']
NCT06620276,ACT_for Alcohol Use Disorder and Depression,Acceptance and Commitment Therapy in Patients With Alcohol Use Disorder and Comorbid Treatment-Resistant Depression Who Are Undergoing Ketamine Intervention: A Feasibility Study,RECRUITING,2025-05-01,2026-08-01,2026-12-01,INTERVENTIONAL,NA,30,"['Depression - Major Depressive Disorder', 'Alcohol Use Disorder']",Depression - Major Depressive Disorder,Centre hospitalier de l'Université de Montréal (CHUM),[],['Canada']
NCT03037684,Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain,Selective Activation of Unmyelinated Skin Nerve Fibres Using Slow Depolarising Transcutaneous Electrical Stimulation in Patients With Neuropathic Pain or Chronic Postoperative Pain,RECRUITING,2017-03-27,2025-12-31,2025-12-31,OBSERVATIONAL,,75,['Neuropathy;Peripheral'],Neuropathy;Peripheral,"Swiss Paraplegic Research, Nottwil",[],['Switzerland']
NCT06156774,SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project,SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project,RECRUITING,2024-04-18,2026-07,2026-07,OBSERVATIONAL,,130,"['Non-hodgkin Lymphoma,B Cell']","Non-hodgkin Lymphoma,B Cell",Fondazione Italiana Linfomi - ETS,"['Kite, A Gilead Company']",['Italy']
NCT00867269,"Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia","Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia",RECRUITING,2009-07-13,,,OBSERVATIONAL,,950,"['Idiopathic CD4+ Lymphocytopenia', 'Cryptococcal Meningitis', 'Warts']",Idiopathic CD4+ Lymphocytopenia,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06361641,Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes,Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes-PHEMOP,RECRUITING,2024-05-29,2026-10-19,2028-10-19,INTERVENTIONAL,NA,70,"['Myeloproliferative Neoplasm', 'Polycythemia Vera', 'Essential Thrombocythemia', 'Primary Myelofibrosis']",Myeloproliferative Neoplasm,"University Hospital, Angers",[],['France']
NCT07083063,Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis,Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis: A Randomized Controlled Trial,RECRUITING,2025-09-15,2027-07-31,2027-07-31,INTERVENTIONAL,PHASE4,440,['Pancreatitis'],Pancreatitis,National Cheng-Kung University Hospital,[],['Taiwan']
NCT06448312,A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer,"A Randomized, Open-Label, Multicenter Phase III Clinical Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab as First-Line Treatment for PD-L1 Positive Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",RECRUITING,2024-06-07,2026-11,2026-11,INTERVENTIONAL,PHASE3,406,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT05492344,Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome,Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome,RECRUITING,2022-08-09,2027-08-01,2027-11-01,INTERVENTIONAL,NA,538,"['ARDS, Human', 'Lung Ultrasound', 'Mechanical Ventilation']","ARDS, Human",Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),[],"['Belgium', 'Netherlands', 'Denmark', 'Ireland', 'Italy', 'Greece', 'Poland']"
NCT06465199,"Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas","A Dose Escalation Study Using Eflornithine (DFMO) and AMXT 1501 Followed by a Randomized Controlled Trial of DFMO With or Without AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas",RECRUITING,2025-12-30,2033-02,2035-02,INTERVENTIONAL,PHASE1,289,"['Atypical Teratoid/Rhabdoid Tumor', 'Neuroblastoma Recurrent', 'Embryonal Tumor With Multilayered Rosettes', 'Ewing Sarcoma', 'Osteosarcoma Recurrent', 'Diffuse Intrinsic Pontine Glioma']",Atypical Teratoid/Rhabdoid Tumor,Milton S. Hershey Medical Center,"['Aminex Therapeutics, Inc.', 'Penn State University']",['United States']
NCT05827081,Phase IIIb Study of Ribociclib + ET in Early Breast Cancer,A Phase IIIb Study to Characterize the Efficacy and Safety of Adjuvant Ribociclib Plus Endocrine Therapy in a Close-to-clinical Practice Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER),RECRUITING,2024-02-28,2029-09-07,2030-09-20,INTERVENTIONAL,PHASE3,1400,['Early Breast Cancer'],Early Breast Cancer,Novartis Pharmaceuticals,[],"['Israel', 'Turkey (Türkiye)', 'Hong Kong', 'China', 'India', 'United States', 'Mexico', 'Taiwan', 'South Korea', 'Canada', 'Australia', 'Portugal', 'Germany']"
NCT06395168,Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination,IMPAC: Integrated Maternal Postpartum Appointment Combination in Mayo Clinic Health System Northwest Wisconsin,RECRUITING,2024-08-19,2026-10,2026-10,INTERVENTIONAL,NA,246,['Breast Feeding'],Breast Feeding,Mayo Clinic,[],['United States']
NCT06013579,Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV,Examining the Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV (HEALTH-Cog),RECRUITING,2023-08-01,2027-09,2028-03,INTERVENTIONAL,NA,110,"['HIV Infections', 'Cognitive Impairment']",HIV Infections,University of Alabama at Birmingham,"['University of Colorado, Denver', 'University of Washington', 'National Institute on Aging (NIA)']",['United States']
NCT01631617,Effects of Treatments on Atopic Dermatitis,Effects of Treatments on the Microbiome in Healthy Volunteers and Patients With Atopic Dermatitis,RECRUITING,2012-09-18,2027-01-01,2027-01-01,INTERVENTIONAL,PHASE2,130,"['Eczema', 'Dermatitis', 'Skin Diseases, Genetic', 'Dermatitis, Atopic', 'Skin Diseases']",Eczema,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT07268027,Constructivist Prenatal Education Effects,"The Effect of a Constructivist-Based Prenatal Education Program on Pregnant Women's Fear of Childbirth, Pain Beliefs, and Self-Efficacy for Normal Delivery: A Randomized Controlled Trial.",RECRUITING,2025-12-01,2026-05-01,2026-05-01,INTERVENTIONAL,NA,126,"['Fear of Childbirth', 'Self-Efficacy', 'Childbirth Education', 'Pain']",Fear of Childbirth,Selcuk University,[],['Turkey (Türkiye)']
NCT07196657,The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia,Comparing the Efficacy and Safety of Pregabalin Monotherapy Versus Other Neuromodulatory Drugs (Crisugabalin) in the Treatment of Fibromyalgia: A Multicenter Clinical Study,RECRUITING,2025-09-30,2027-06-30,2027-08-31,INTERVENTIONAL,NA,1116,"['Fibromyalgia', 'Pregabalin', 'Pain']",Fibromyalgia,Beijing Tiantan Hospital,"['China-Japan Friendship Hospital', 'The First Affiliated Hospital of Nanchang University', 'Peking University Third Hospital', 'The Fourth Affiliated Hospital of Harbin Medical University', 'Zhongnan Hospital', 'Xiangya Hospital of Central South University', 'The Affiliated Hospital of Yanbian University', 'The Second Hospital University of South China', 'First Affiliated Hospital of Lanzhou University']",['China']
NCT06063928,Confronting Cancer as a Community,Confronting Cancer as a Community,RECRUITING,2022-05-25,2027-05-25,2028-05-25,INTERVENTIONAL,NA,500,['Colorectal Carcinoma'],Colorectal Carcinoma,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT05206500,NextGen - Clinical Implication of Next Generation Sequencing,Clinical Implication of Next Generation Sequencing of Urinary Bacteria in Patients With Low Colony Forming Units of Bacteria in Traditional Urine Culture,RECRUITING,2022-05-17,2028-12,2028-12,INTERVENTIONAL,PHASE4,100,['Urinary Tract Infections'],Urinary Tract Infections,Wake Forest University Health Sciences,[],['United States']
NCT06049017,A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis,"A Phase 2b Multicenter, Randomized, Placebo- Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis",ACTIVE_NOT_RECRUITING,2023-10-09,2024-09-26,2026-01-16,INTERVENTIONAL,PHASE2,252,"['Colitis, Ulcerative']","Colitis, Ulcerative","Janssen Research & Development, LLC",[],"['Japan', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'South Korea', 'Czechia', 'Poland', 'India', 'Spain', 'Canada', 'Romania', 'Malaysia', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT03097185,Analysis of Graft Function Following Autologous Islet Transplantation,Analysis of Graft Function Following Autologous Islet Transplantation,RECRUITING,2010-06-03,2026-12,2026-12,OBSERVATIONAL,,100,['Chronic Pancreatitis'],Chronic Pancreatitis,Baylor Research Institute,[],['United States']
NCT07270835,Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma,The Study of Zanubrutinib Combined With Rituximab in the Treatment of Secondary Hemophagocytic Lymphohistiocytosis in B-cell Lymphoma,RECRUITING,2025-11-01,2027-04,2027-08,INTERVENTIONAL,PHASE4,40,"['Hemophagocytic Lymphohistiocytosis', 'B Cell Lymphoma']",Hemophagocytic Lymphohistiocytosis,The First Affiliated Hospital of Soochow University,[],['China']
NCT04698304,The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions,"Physician-initiated, Prospective, Multi-center，Observational Study: The Efficacy of Endovascular Treatment in Femoropopliteal Occlusive Disease (FPOD) With TransAtlantic InterSociety Consensus (TASC) C and D Lesions",ACTIVE_NOT_RECRUITING,2021-01-01,2025-12-31,2025-12-31,OBSERVATIONAL,,1000,['Femoropopliteal Occlusive Disease'],Femoropopliteal Occlusive Disease,RenJi Hospital,"['Xuanwu Hospital, Beijing', 'Second Affiliated Hospital of Suzhou University', 'Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology', 'Chengdu University of Traditional Chinese Medicine', 'First Affiliated Hospital of Zhejiang University', 'Xiamen Cardiovascular Hospital, Xiamen University', 'Shanghai Zhongshan Hospital', 'Huashan Hospital', 'Qingdao Haici Hospital', ""First People's Hospital of Hangzhou""]",['China']
NCT06851663,Trop2-targeted immunoPET Imaging of Solid Tumors,Trop2-targeted immunoPET Imaging of Solid Tumors,RECRUITING,2024-12-23,2027-12,2027-12,INTERVENTIONAL,PHASE2,400,"['Solid Tumor', 'Solid Carcinoma', 'Uroepithelial Carcinoma', 'Bladder Cancer', 'Prostate Cancer', 'Lung Cancer', 'Nasopharyngeal Cancer', 'Liver Cancer', 'Cholangiocarcinoma', 'Ovarian Cancer', 'Cervical Cancer', 'Endometrial Cancer', 'Thyroid Cancer', 'Head and Neck Cancer']",Solid Tumor,RenJi Hospital,[],['China']
NCT04936308,Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent,"A Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Who Had an Inadequate Response and/or Intolerance to One Prior Anti-Tumor Necrosis Factor Alpha Agent",ACTIVE_NOT_RECRUITING,2021-09-28,2024-10-28,2026-07-16,INTERVENTIONAL,PHASE3,453,"['Arthritis, Psoriatic']","Arthritis, Psoriatic","Janssen Research & Development, LLC",[],"['Bulgaria', 'Israel', 'Hungary', 'Turkey (Türkiye)', 'Russia', 'United States', 'Ukraine', 'Puerto Rico', 'Spain', 'Czechia', 'Poland', 'Argentina', 'Malaysia', 'Australia']"
NCT04670666,Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus,"National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus.",RECRUITING,2024-11-18,2026-07,2027-06,INTERVENTIONAL,PHASE3,270,['Type 2 Diabetes Mellitus'],Type 2 Diabetes Mellitus,EMS,[],['Brazil']
NCT03258567,Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas,Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas,RECRUITING,2018-04-26,2029-06-01,2031-06-01,INTERVENTIONAL,PHASE2,40,"['Epstein-Barr Virus Infections', 'Lymphoma', 'Lymphoproliferative Disorder', 'Disorders, Lymphoproliferative']",Epstein-Barr Virus Infections,National Cancer Institute (NCI),[],['United States']
NCT05556928,Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry,Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry,RECRUITING,2020-07-21,2027-12-31,2027-12-31,OBSERVATIONAL,,5000,"['Multiple Myeloma', 'Amyloidosis', 'Plasma Cell Leukemia']",Multiple Myeloma,University of Alabama at Birmingham,[],['United States']
NCT06915831,Type 1 Diabetes and Obstructive Sleep Apnea,Obstructive Sleep Apnea and Glycemic Dysregulation in Adults With Type 1 Diabetes,RECRUITING,2025-11-10,2029-08-31,2029-08-31,INTERVENTIONAL,NA,40,"['Sleep Apnea, Obstructive', 'Type 1 Diabetes (T1D)']","Sleep Apnea, Obstructive",University of Chicago,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07232732,A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity,"A Phase-1, Parallel-Design, Open-Label, Randomized, Multiple-Dose Escalation Study to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3549492 in Healthy Participants With Overweight or Obesity",RECRUITING,2025-10-27,2026-02,2026-02,INTERVENTIONAL,PHASE1,60,"['Healthy', 'Obesity', 'Overweight']",Healthy,Eli Lilly and Company,[],['United States']
NCT07269327,An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin,"A Phase 1, Open Label, Single Dose, Parallel-group Study to Investigate the Pharmacokinetics of the Fixed Combination of 900 IU r-hFSH and 450 IU r-hLH Given as Pergoveris®, Administered Subcutaneously in Pituitary-suppressed Healthy Premenopausal Female Participants of Japanese or Caucasian Origin",RECRUITING,2025-11-24,2026-03-09,2026-03-09,INTERVENTIONAL,PHASE1,24,['Fertility'],Fertility,"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","['Merck KGaA, Darmstadt, Germany']",['United Kingdom']
NCT06860737,A Randomized Clinical Trial on the Effectiveness of Novel Plano Spectacle Lenses on Myopia Prevention in Pre-myopic Children,A Randomized Clinical Trial on the Effectiveness of Novel Spectacle Lenses for Myopia Prevention in Pre-myopic Children,ACTIVE_NOT_RECRUITING,2025-03-15,2026-04,2026-06,INTERVENTIONAL,NA,388,['Myopic Children'],Myopic Children,Shanghai Eye Disease Prevention and Treatment Center,['Essilor International'],['China']
NCT07251270,Effect of Stress Ball During Chest Tube Removal After Open Heart Surgery,"Effect of Stress Ball on Pain, Anxiety Levels, and Hemodynamic Variables During Chest Tube Removal After Open Heart Surgery",RECRUITING,2025-11-27,2026-05-01,2026-06-20,INTERVENTIONAL,NA,46,"['Pain', 'Hemodynamic Changes', 'Anxiety']",Pain,Mersin University,"['Mersin University, School of Medicine']",['Turkey (Türkiye)']
NCT07270705,Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Gingivitis,Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Gingivitis,RECRUITING,2025-11-22,2026-05-31,2026-05-31,INTERVENTIONAL,NA,90,['Gingivitis'],Gingivitis,ENIKAM d.o.o.,[],['Slovenia']
NCT06616636,A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome),A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome),RECRUITING,2025-01-30,2027-08-27,2029-08-27,INTERVENTIONAL,PHASE1,24,"['Myelodysplastic Syndrome', 'Acute Myeloid Leukemia']",Myelodysplastic Syndrome,M.D. Anderson Cancer Center,"['Memorial Sloan Kettering Cancer Center (MSK)', 'PMV Pharmaceuticals, Inc']",['United States']
NCT07086521,Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD),"A Phase 1, Double-blinded, Randomized, Dose-repeating, Placebo-controlled, Cross-over Study to Assess the Safety and Preliminary Efficacy of Allogeneic ULSC on Disease Severity in Facioscapulohumeral Muscular Dystrophy (FSHD)",RECRUITING,2025-12-01,2028-09,2029-03,INTERVENTIONAL,PHASE1,16,['FSHD - Facioscapulohumeral Muscular Dystrophy'],FSHD - Facioscapulohumeral Muscular Dystrophy,"Restem, LLC.",['Solve FSHD'],['United States']
NCT05768711,Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR),Phase II Study With Safety run-in of Azacitidine (AZA) Combined With Venetoclax (VEN) in Patients With Higher-risk Chronic Myelomonocytic Leukemia (CMML),ACTIVE_NOT_RECRUITING,2023-10-04,2026-02,2028-10,INTERVENTIONAL,PHASE2,44,['Chronic Myeloid Leukemia'],Chronic Myeloid Leukemia,Groupe Francophone des Myelodysplasies,['AbbVie'],['France']
NCT01145196,"Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene",Genotype - Phenotype Study of Patients With Plaquenil-induced Retinal Toxicity,RECRUITING,2010-08-23,,,OBSERVATIONAL,,320,"['Genotype', 'Retinal Disease']",Genotype,National Eye Institute (NEI),[],['United States']
NCT06584227,Adebrelimab and Chidamide for Pancreatic Cancer,"A Single-Arm, Multicenter, Open, Phase II Clinical Study of Adebrelimab and Chidamide in Combination With Gemcitabine and S1 for the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer",RECRUITING,2024-09-10,2026-07-10,2027-05-10,INTERVENTIONAL,PHASE2,45,"['Pancreatic Cancer, Adult']","Pancreatic Cancer, Adult",Liu Xiufeng,[],['China']
NCT06910761,Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer,Phase II Trial of Photon Craniospinal Irradiation for Leptomeningeal Disease Secondary to Solid Tumor Malignancy,RECRUITING,2025-05-05,2028-10-02,2028-10-02,INTERVENTIONAL,PHASE2,35,"['Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic Breast Carcinoma', 'Metastatic Lung Non-Small Cell Carcinoma', 'Metastatic Malignant Neoplasm in the Leptomeninges', 'Stage IV Lung Cancer AJCC v8']",Anatomic Stage IV Breast Cancer AJCC v8,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07043569,Clinical-randomized Trial of the Effect of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Anterior Cruciate Ligament Reconstruction,Clinical-randomized Trial of the Effect of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Anterior Cruciate Ligament Reconstruction,RECRUITING,2025-06-20,2026-07-31,2026-12-31,INTERVENTIONAL,NA,30,['ACL - Anterior Cruciate Ligament Rupture'],ACL - Anterior Cruciate Ligament Rupture,"University Hospital, Bonn",[],['Germany']
NCT05564650,Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome,A Phase Ib/II Study Evaluating Navitoclax After Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome,ACTIVE_NOT_RECRUITING,2023-01-12,2024-05-03,2026-05-08,INTERVENTIONAL,PHASE1,6,"['Myelodysplastic Syndrome', 'Recurrent Myelodysplastic Syndrome', 'Refractory Myelodysplastic Syndrome']",Myelodysplastic Syndrome,Thomas Jefferson University,['AbbVie'],['United States']
NCT05123482,"A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies","A Phase I/IIa Multi-center, Open-label Master Protocol Dose Escalation and Expansion Study of AZD8205 as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors (BLUESTAR)",RECRUITING,2021-10-18,2027-09-29,2027-09-29,INTERVENTIONAL,PHASE1,460,"['Breast Cancer', 'Biliary Tract Carcinoma', 'Ovarian Cancer', 'Endometrial Cancer', 'Squamous Non-Small Cell Lung Cancer']",Breast Cancer,AstraZeneca,[],"['Belgium', 'Japan', 'Hungary', 'Netherlands', 'China', 'United States', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'Thailand', 'Poland', 'United Kingdom', 'Australia']"
NCT00594672,Age-Related Eye Disease Study (AREDS) Follow-Up,Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up,ACTIVE_NOT_RECRUITING,2008-06-02,,,OBSERVATIONAL,,110,"['Age-Related Macular Degeneration', 'Cataract']",Age-Related Macular Degeneration,National Eye Institute (NEI),[],['United States']
NCT03099434,Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media,Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media,ACTIVE_NOT_RECRUITING,2017-04-01,2026-12-07,2026-12-07,INTERVENTIONAL,NA,775,"['Kidney Failure', 'Kidney Diseases']",Kidney Failure,Johns Hopkins University,"['University of Alabama at Birmingham', 'Northwestern University', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']",['United States']
NCT05615844,Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy,A Randomized Controlled Trial Comparing Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy for the Management of Severe Open Tibia Fracture Wounds,RECRUITING,2023-11-05,2027-03-31,2027-10-01,INTERVENTIONAL,PHASE3,312,['Open tíbia Fracture'],Open tíbia Fracture,"University of Maryland, Baltimore",['McMaster University'],"['United States', 'Canada']"
NCT02840019,Advanced Fetal Imaging - Phase II,Advanced Fetal Imaging - Phase II,RECRUITING,2016-07,2027-06,2028-06,INTERVENTIONAL,NA,300,['Pregnancy'],Pregnancy,Boston Children's Hospital,"['Massachusetts Institute of Technology', 'Massachusetts General Hospital']",['United States']
NCT04750928,Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas,A Phase 0/I/II Study of the Cyclin-Dependent Kinase(CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type 1 (NF1) Related Atypical Neurofibromas,RECRUITING,2021-11-29,2028-12-31,2029-12-31,INTERVENTIONAL,PHASE1,55,['Neurofibromatosis 1'],Neurofibromatosis 1,National Cancer Institute (NCI),[],['United States']
NCT07269834,Workplace Exercise and Well-Being in Radiologic Technologists,"Effects of a Workplace Exercise Program on Stress, Burnout, and Quality of Life in Radiologic Technologists",ACTIVE_NOT_RECRUITING,2025-05-01,2025-10-30,2025-12,INTERVENTIONAL,NA,19,"['Occupational Stress or Workplace Stress', 'Burnout', 'Quality of Life', 'Exercise Training', 'Radiologists', 'Health Promotion']",Occupational Stress or Workplace Stress,Pedro Ramalho,['University of Beira Interior'],['Portugal']
NCT05367440,Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer,"A Multi-arm, Open-label Phase I/IIa Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of AZD5305 in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer (PETRANHA)",ACTIVE_NOT_RECRUITING,2022-06-02,2031-04-11,2031-04-11,INTERVENTIONAL,PHASE1,174,['Metastatic Prostate Cancer'],Metastatic Prostate Cancer,AstraZeneca,['Bayer'],"['United Kingdom', 'United States', 'Italy', 'Australia']"
NCT05922618,Pulsed Electromagnetic Fields (PEMFS) in Complex Regional Pain Syndrome Type i (CRPS-I) of the Foot (PeCFoA),PEMFS in Patients With CRPS-I of the Foot and Ankle: a Randomized Controlled Trial,RECRUITING,2023-08-01,2025-08-01,2025-12-01,INTERVENTIONAL,NA,28,"['Pain, Joint', 'Complex Regional Pain Syndromes', 'Ankle Disease', 'Foot Diseases']","Pain, Joint",Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari,[],['Italy']
NCT06952348,HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking,HYPERtension Reduction Through WALKing Stairs Versus Brisk Walking in Individuals With Increased Cardiometabolic Risk - The HYPERWALK Randomized Controlled Trial,RECRUITING,2025-11-27,2028-12,2029-05,INTERVENTIONAL,NA,450,"['Metabolic Disease', 'Cardiovascular Diseases', 'Hypertension', 'Obesity and Overweight']",Metabolic Disease,Karolinska Institutet,"['Södersjukhuset (Stockholm South General Hospital)', 'Ersta Cardiology Outpatient Clinic', 'Liljeholmens vårdcentral', 'Boo vårdcentral', 'Karolinska University Hospital', 'Sodertalje Hospital']",['Sweden']
NCT01087333,"Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment",A Study of Hairy Cell and Other Leukemias With a Focus on Recombinant Immunotoxins for Cancer Treatment,RECRUITING,2010-03-02,,,OBSERVATIONAL,,1263,"['Hairy Cell Leukemia (HCL)', 'Chronic Lymphocytic Leukemia (CLL)', 'Non-Hodgkins Lymphoma (NHL)', 'Cutaneous T Cell Lymphoma (CTCL)', 'Adult T Cell Lymphoma (ATL)']",Hairy Cell Leukemia (HCL),National Cancer Institute (NCI),[],['United States']
NCT06851533,Comparing Thoracolumbar Interfascial and Quadro Iliac Plane Blocks on Postoperative Opioid Use Following Lumbar Microsurgery,Comparison of the Effects of Thoracolumbar Interfascial Plane Block and Quadro Iliac Plane Block on Postoperative Opioid Consumption After Lumbar Microsurgery: A Randomized Controlled Trial,RECRUITING,2025-03-10,2026-03-10,2026-04-10,INTERVENTIONAL,NA,90,"['Lumbar Microdiscectomy', 'Nerve Block']",Lumbar Microdiscectomy,Medipol University,[],['Turkey (Türkiye)']
NCT07269964,At-Home tDCS as Maintenance Therapy,"At-home tDCS as Maintenance Therapy Following Successful Treatment With rTMS, ECT, and Esketamine - A Pilot Study",RECRUITING,2024-10-01,2026-08-29,2026-11-29,INTERVENTIONAL,NA,30,"['MDD', 'Severe Depression', 'Major Depressive Episode']",MDD,Technical University of Munich,[],['Germany']
NCT05691244,Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke,"A Multicentric, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke.",RECRUITING,2025-07-24,2026-09,2026-11,INTERVENTIONAL,PHASE3,514,"['Acute Ischemic Stroke', 'Cerebral Stroke']",Acute Ischemic Stroke,"Pharmazz, Inc.",[],"['United Kingdom', 'Spain', 'United States', 'Germany']"
NCT05545306,The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure,The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure,RECRUITING,2023-06-06,2027-02-02,2027-02-02,INTERVENTIONAL,NA,120,"['Obesity', 'Normal Physiology', 'Healthy Volunteers']",Obesity,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT00001352,Fungal Infection Susceptibility,Cryptococcosis in Previously Healthy Adults,RECRUITING,1993-04-01,,,OBSERVATIONAL,,800,"['Cryptococcal Infection', 'Cryptococcal Pneumonia', 'Pulmonary Cryptococcosis', 'Cryptococcal Meningitis', 'Cryptococcosis']",Cryptococcal Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07268833,Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy,Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy,RECRUITING,2024-10-24,2027-04,2027-04,OBSERVATIONAL,,400,"['Amyotrophic Lateral Sclerosis (ALS)', 'Peripheral Neuropathies']",Amyotrophic Lateral Sclerosis (ALS),Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,"['Azienda Ospedaliero Universitaria di Cagliari', 'IRCCS San Raffaele', 'Università di Napoli Federico II']",['Italy']
NCT07038343,Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001),"A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors",RECRUITING,2025-06-04,2030-06,2030-12,INTERVENTIONAL,PHASE1,430,"['Solid Tumor Cancer', 'Locally Advanced', 'Metastatic Solid Tumors', 'Lung Cancers', 'Epithelial Tumor']",Solid Tumor Cancer,"Avenzo Therapeutics, Inc.",[],['United States']
NCT04294810,A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer,"A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody, in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2020-03-04,2026-01-31,2026-01-31,INTERVENTIONAL,PHASE3,620,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Hoffmann-La Roche,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Hungary', 'Russia', 'Peru', 'South Korea', 'Thailand', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Greece', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Serbia']"
NCT01568697,Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis),Oral Microbial and Immunological Characterization of Patients With Immune Dysfunction,RECRUITING,2012-10-05,,,OBSERVATIONAL,,700,"['Immunosuppression', 'Periodontal Disease', 'Healthy Subjects', 'Healthy Volunteer']",Immunosuppression,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT05588167,"Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C","Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C",RECRUITING,2022-11-28,2026-09-30,2026-09-30,OBSERVATIONAL,,100,"['Niemann-Pick Disease, Type C']","Niemann-Pick Disease, Type C",Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT02544022,Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs),Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs),RECRUITING,2015-11-13,2026-06-30,2026-12-31,OBSERVATIONAL,,476,"['Neurofibromatosis 1', 'Plexiform Neurofibromas']",Neurofibromatosis 1,National Cancer Institute (NCI),[],['United States']
NCT00182858,Tissue Procurement for Biomedical Research,Tissue Procurement for Biomedical Research,RECRUITING,2003-06-26,2028-12-31,2028-12-31,OBSERVATIONAL,,5000,['Normal Volunteers'],Normal Volunteers,National Institute on Aging (NIA),[],['United States']
NCT07006792,A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden,"A Phase 4, Multicenter, Open-label, Single-arm Study to Investigate the Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate Atopic Dermatitis and High Itch Burden",RECRUITING,2025-06-16,2026-04,2026-09,INTERVENTIONAL,PHASE4,200,['Atopic Dermatitis'],Atopic Dermatitis,Eli Lilly and Company,[],"['Brazil', 'United States', 'Puerto Rico', 'Canada', 'Argentina']"
NCT06302439,PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency,A Prospective Observational Patient Registry to Evaluate Disease Progression in Patients With ENPP1 Deficiency and Infantile-Onset ABCC6 Deficiency (GACI Type 2),RECRUITING,2024-07-25,2034-05,2034-05,OBSERVATIONAL,,1000,"['Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency', 'ATP-Binding Cassette Subfamily C Member 6 Deficiency']",Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency,Inozyme Pharma,['GACI Global'],"['Japan', 'Oman', 'Turkey (Türkiye)', 'United States', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT04225507,Technology-Supported Treatment of Sleep Apnea in Prediabetes,Technology-Supported Treatment of Sleep Apnea in Prediabetes,ACTIVE_NOT_RECRUITING,2021-04-13,2026-07,2026-07,INTERVENTIONAL,NA,174,"['Sleep Apnea', 'PreDiabetes', 'Overweight or Obesity']",Sleep Apnea,University of Chicago,"['Northwestern University', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)']",['United States']
NCT05880173,SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population,SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population,RECRUITING,2023-10-20,2027-03,2027-03,INTERVENTIONAL,NA,502,"['Screening', 'Advanced Liver Fibrosis']",Screening,"University Hospital, Angers",[],['France']
NCT06969456,Managing Chronic Spinal Pain With Exercise and Neuromodulation,Patient-centered Management of Chronic Spinal Pain by Addressing the Peripheral and Central Component With Exercise and Non-invasive Neuromodulation: A Randomized Control Trial (RCT),RECRUITING,2025-10-27,2026-09-01,2027-01-01,INTERVENTIONAL,NA,42,"['Spinal Pain Syndrome', 'Chronic Pain (Back / Neck)']",Spinal Pain Syndrome,Fundación Universidad Católica de Valencia San Vicente Mártir,[],['Spain']
NCT07268742,Free Vitamin D and Steroid Metabolism in Endocrine Disorders,Free Fraction Vitamin D Measurements to Improve Understanding of Steroid Metabolism in Endocrine Disorders,RECRUITING,2024-06-01,2029-10,2029-10,OBSERVATIONAL,,930,"['Vitamin D', 'Vitamin D and Calcium Homeostasis']",Vitamin D,Universitaire Ziekenhuizen KU Leuven,['KU Leuven'],['Belgium']
NCT02911103,Deep Brain Stimulation Surgery for Focal Hand Dystonia,Deep Brain Stimulation Surgery for Treatment of Focal Hand Dystonia,ACTIVE_NOT_RECRUITING,2018-01-17,2029-02-02,2029-02-02,INTERVENTIONAL,PHASE1,5,"['Dystonia', 'Focal Dystonia', ""Musician's Dystonia""]",Dystonia,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06510556,Feasibility Study of the FARAFLEX Mapping and PFA System,Feasibility Study of the FARAFLEX Mapping and Pulsed Field Ablation (PFA) System in the Treatment of Persistent Atrial Fibrillation,RECRUITING,2025-02-17,2027-02-15,2027-09-15,INTERVENTIONAL,NA,250,"['Atrial Fibrillation', 'Persistent Atrial Fibrillation', 'Paroxysmal AF']",Atrial Fibrillation,Boston Scientific Corporation,[],"['Croatia', 'Italy', 'Czechia']"
NCT07186751,The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia,Comparing the Efficacy and Safety of Pregabalin Monotherapy With Pregabalin Combined Other Neuromodulatory Drugs (Venlafaxine) in the Treatment of Fibromyalgia: A Multicenter Clinical Study,RECRUITING,2025-09-20,2027-06-30,2027-08-31,INTERVENTIONAL,NA,750,"['Fibromyalgia', 'Pregabalin', 'Venlafaxine', 'Pain']",Fibromyalgia,Beijing Tiantan Hospital,"['China-Japan Friendship Hospital', 'First Affiliated Hospital of Army Medical University, PLA', 'Second Affiliated Hospital of Guangxi Medical University', 'The First Affiliated Hospital of Anhui Medical University', 'The First Affiliated Hospital of Nanchang University', 'Peking University Third Hospital']",['China']
NCT00001184,Immune Regulation in Ulcerative Colitis or Crohn s Disease,"A Natural History Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut",RECRUITING,1998-08-07,,,OBSERVATIONAL,,1000,"['Inflammatory Bowel Disease', 'Ulcerative Colitis', ""Chrohn's Disease""]",Inflammatory Bowel Disease,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT02275533,"Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial",Randomized Phase II Study to Assess the Role of Nivolumab as Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients After Chemotherapy (REMAIN TRIAL),ACTIVE_NOT_RECRUITING,2015-07-02,2025-07-28,2026-10-08,INTERVENTIONAL,PHASE2,82,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT05886439,LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer,"A Study of LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer to Evaluate the Safety, Tolerability and Preliminary Efficacy",RECRUITING,2023-05-11,2027-05-30,2028-05-30,INTERVENTIONAL,PHASE1,60,['Lung Cancer'],Lung Cancer,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT06736275,"A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors","A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2024-09-02,2026-02-28,2026-04-30,INTERVENTIONAL,EARLY_PHASE1,8,"['Advanced Cancer', 'Cachexia']",Advanced Cancer,"Jiangsu Nutai Biologics Co., Ltd",['Chinese Academy of Medical Sciences'],['China']
NCT06670287,The Use of Multiple Sensors to Track Sleep in Nightshift Workers,A Multi-Sensor Machine Learning Approach to Precision Sleep Tracking for Nightshift Workers,RECRUITING,2025-11-21,2029-11-30,2031-06-30,INTERVENTIONAL,NA,100,"['Sleep', 'Nightshift Work']",Sleep,Henry Ford Health System,['Michigan State University'],['United States']
NCT06434064,"Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer","A Pilot, Single-Arm, Phase II Trial of Tamoxifen Plus Pegylated Liposomal Doxorubicin in Patients With Metastatic Triple Negative Breast Cancer",RECRUITING,2026-01-15,2028-11-30,2028-11-30,INTERVENTIONAL,PHASE2,30,"['Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Locally Advanced Unresectable Triple-Negative Breast Carcinoma', 'Metastatic Triple-Negative Breast Carcinoma']",Anatomic Stage III Breast Cancer AJCC v8,Roswell Park Cancer Institute,[],['United States']
NCT07268963,Biofeedback for Dysfunctional Voiding and Giggle Incontinence,Biofeedback for Dysfunctional Voiding and Giggle Incontinence in Children,ACTIVE_NOT_RECRUITING,2022-09-01,2025-12,2026-04,OBSERVATIONAL,,60,"['Biofeedback Therapy', 'Dysfunctional Voiding', 'Giggle Incontinence']",Biofeedback Therapy,Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital,[],['Turkey (Türkiye)']
NCT07213726,Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System,"Quantification of Peripheral Hematopoietic Progenitor Cell Circulation Following Repeated Acute, Vascular Restriction Resistance Exercise Using the Delfi Tourniquet System",ACTIVE_NOT_RECRUITING,2022-08-16,2023-11-20,2026-11-20,INTERVENTIONAL,NA,15,['Blood Flow Restriction (BFR) Training Effects'],Blood Flow Restriction (BFR) Training Effects,Andrews Research & Education Foundation,['Florida'],['United States']
NCT06285643,A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD),"A Phase 2, Randomized, Double-blind, Sham Surgery-controlled Study of the Efficacy and Safety of Intraputaminal AAV2-GDNF in the Treatment of Adults With Moderate Stage Parkinson's Disease",RECRUITING,2024-06-11,2028-08-31,2028-08-31,INTERVENTIONAL,PHASE2,127,['Parkinson Disease'],Parkinson Disease,AskBio Inc,['Bayer'],"['United Kingdom', 'Poland', 'United States', 'Germany']"
NCT07174453,Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies,A Late Phase Randomized Open-Label Multi Cohort Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies,RECRUITING,2025-10-07,2027-10-01,2029-10-01,INTERVENTIONAL,PHASE3,192,['Solid Tumor Malignancies'],Solid Tumor Malignancies,University of Kansas Medical Center,[],['United States']
NCT06803693,Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL,A Study to Evaluate the Efficacy and Safety of Genotype-guided Targeted Agents in Combination With POLA-RCHP VERSUS POLA-RCHP in Patients With Previously Untreated Diffuse Large B-cell Lymphoma,RECRUITING,2025-04-01,2028-04-30,2028-12-31,INTERVENTIONAL,PHASE2,152,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Ruijin Hospital,[],['China']
NCT07202884,A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight,A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight,RECRUITING,2025-09-30,2028-03,2028-03,INTERVENTIONAL,PHASE3,1000,"['Urinary Incontinence,Stress']","Urinary Incontinence,Stress",Eli Lilly and Company,[],"['Japan', 'China', 'United States', 'Mexico', 'South Korea', 'Canada', 'Czechia', 'Romania', 'Poland', 'India']"
NCT06932406,Orofacial Pain Self-management: Personality Moderation Effect,Orofacial Pain Self-management: Personality Moderation Effect - Randomized Clinical Trial,RECRUITING,2025-11-28,2026-05-24,2026-05-24,INTERVENTIONAL,NA,98,"['Chronic Orofacial Pain', 'Temporomandibular Disorder (TMD)', 'Temporomandibular Disorders (TMD)', 'Temporomandibular Dysfunction (TMD)']",Chronic Orofacial Pain,Fundación Universidad Católica de Valencia San Vicente Mártir,[],['Spain']
NCT00004847,Diagnosis of Pheochromocytoma,"Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma",RECRUITING,2000-03-22,2048-11-30,2048-11-30,INTERVENTIONAL,PHASE1,3000,"['Pheochromocytoma', 'Endocrine Disease', 'Endocrine Diseases']",Pheochromocytoma,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT06828302,Internet-delivered Parent-Child Interaction for Parents of Children 2-7 Years With Disruptive Behaviors,Internet-delivered Parent-Child Interaction for Parents of Children 2-7 Years With Disruptive Behaviors,ACTIVE_NOT_RECRUITING,2025-03-10,2025-09-30,2026-06-15,INTERVENTIONAL,NA,20,['Disruptive Behavior'],Disruptive Behavior,Karolinska Institutet,[],['Sweden']
NCT05950802,Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta,Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving CAR T Cell Therapy With Yescarta/AxicabtageNeciloleucel (ODIN),RECRUITING,2023-07-14,2027-09,2027-09,INTERVENTIONAL,PHASE1,40,['DLBCL - Diffuse Large B Cell Lymphoma'],DLBCL - Diffuse Large B Cell Lymphoma,"University Health Network, Toronto",[],['Canada']
NCT00005917,Study of Chediak-Higashi Syndrome,Investigations Into Chediak-Higashi Syndrome and Related Disorders,RECRUITING,2002-09-10,,,OBSERVATIONAL,,60,['Chediak-Higashi Syndrome'],Chediak-Higashi Syndrome,National Human Genome Research Institute (NHGRI),[],['United States']
NCT07039305,Physical Capacity Building for Chronic Stroke,Modified Cardiac Rehabilitation to Enhance Post-Stroke Physical and Psychosocial Function: Does Depression Limit the Response?,RECRUITING,2025-08-05,2029-07,2029-08,INTERVENTIONAL,NA,76,"['Stroke', 'Post-stroke Depression']",Stroke,Medical University of South Carolina,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT04178005,Cladribine Tablets After Treatment With Natalizumab (CLADRINA),Cladribine Tablets After Treatment With Natalizumab (CLADRINA),ACTIVE_NOT_RECRUITING,2020-02-19,2026-08-30,2026-12,INTERVENTIONAL,PHASE4,40,['Multiple Sclerosis'],Multiple Sclerosis,University of Texas Southwestern Medical Center,['EMD Serono'],['United States']
NCT02108054,"Behavioral and Functional Task Development, Implementation, and Testing","Behavioral and Functional Task Development, Implementation, and Testing",RECRUITING,2014-05-28,2025-12-31,2025-12-31,INTERVENTIONAL,NA,400,"['Alcohol Dependence', 'Alcohol Drinking', 'Alcoholism', 'Alcohol Use Disorder', 'Addiction']",Alcohol Dependence,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT00006518,"Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer","Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer",RECRUITING,2000-12-06,,,OBSERVATIONAL,,1029,"['HIV', ""Kaposi's Sarcoma"", 'Lymphomas', ""Multicentric Castleman's Disease"", 'Primary Effusion Lymphoma']",HIV,National Cancer Institute (NCI),[],['United States']
NCT06095115,A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis,"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Retreatment",ACTIVE_NOT_RECRUITING,2023-10-12,2024-07-29,2027-04-06,INTERVENTIONAL,PHASE3,684,['Plaque Psoriasis'],Plaque Psoriasis,"Janssen Research & Development, LLC",[],"['Japan', 'Hungary', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT07087197,A Study of SKB107 in Advanced Solid Tumors With Bone Metastases,"A Multicenter, Open-label Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Dosimetry and Efficacy of SKB107 in Subjects With Advanced Solid Tumors With Bone Metastases",RECRUITING,2025-08-15,2027-10-01,2028-07-01,INTERVENTIONAL,PHASE1,90,['Metastatic Solid Tumors'],Metastatic Solid Tumors,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT07145489,Infrared Photobiomodulation in Humans With Epilepsy,An Open Label Pilot Study of Infrared Photobiomodulation in Humans With Epilepsy,RECRUITING,2025-11-25,2026-09-25,2027-09-25,INTERVENTIONAL,NA,13,['Drug Resistant Epilepsy'],Drug Resistant Epilepsy,Beth Israel Deaconess Medical Center,[],['United States']
NCT07215559,"A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes","A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Reduction With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and With Type 2 Diabetes",RECRUITING,2025-10-16,2027-03,2027-05,INTERVENTIONAL,PHASE2,200,"['Obesity', 'Overweight', 'Diabetes Mellitus, Type 2']",Obesity,Eli Lilly and Company,[],"['Argentina', 'Puerto Rico', 'United States', 'Australia']"
NCT03227146,Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents,"A Phase IIb, Prospective, Intra-patient Randomised Controlled, Multicentre Study to Evaluate the Safety and Efficacy of an Autologous Bio-engineered Dermo-epidermal Skin Substitute (EHSG-KF) for the Treatment of Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents in Comparison to Autologous Split-thickness Skin Grafts (STSG)",ACTIVE_NOT_RECRUITING,2017-10-25,2022-11-30,2025-12-31,INTERVENTIONAL,PHASE2,14,['Burns'],Burns,CUTISS AG,"['Wyss Zurich', 'Julius Clinical', 'Sintesi Research Srl', 'University Hospital, Zürich', 'University of Zurich']","['Switzerland', 'Italy', 'Netherlands']"
NCT05521048,Doxycycline in Cutaneous Schwannoma (NF2),Doxycycline Injection of Cutaneous Schwannoma in Neurofibromatosis Type 2,ACTIVE_NOT_RECRUITING,2022-09-19,2026-09-01,2026-12,INTERVENTIONAL,PHASE1,19,['Neurofibromatosis Type 2'],Neurofibromatosis Type 2,Massachusetts Eye and Ear Infirmary,[],['United States']
NCT07157631,Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial,"A Double-Blind, Randomized, Placebo-Controlled, Multi-Center Trial to Evaluate the Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation (ESTA Trial)",RECRUITING,2025-11-01,2027-11-01,2027-12-01,INTERVENTIONAL,NA,1546,"['Liver Transplantation', 'Tranexamic Acid', 'End-stage Liver Disease (ESLD)']",Liver Transplantation,RenJi Hospital,"['West China Hospital', 'The Affiliated Hospital of Qingdao University', 'The First Affiliated Hospital of Zhengzhou University', 'Huashan Hospital', 'Tianjin First Central Hospital', 'The First Hospital of Jilin University', 'Third Affiliated Hospital, Sun Yat-Sen University', 'First Affiliated Hospital, Sun Yat-Sen University', 'Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University', 'The First Affiliated Hospital with Nanjing Medical University', 'Tongji Hospital', ""People's Hospital of Guangxi Zhuang Autonomous Region"", 'The First Affiliated Hospital of University of Science and Technology of China', 'The First Affiliated Hospital of Anhui Medical University', 'Union Hospital, Tongji Medical College, Huazhong University of Science and Technology', ""First Affiliated Hospital Xi'an Jiaotong University"", 'Fujian Medical University Union Hospital', 'First Affiliated Hospital of Guangxi Medical University', 'Second Affiliated Hospital of Guangzhou Medical University', 'Zhejiang University', 'Hebei Medical University Third Hospital', 'Shandong First Medical University', 'Jinling Hospital, Medical School of Nanjing University']",['China']
NCT05588154,"Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies","Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies",RECRUITING,2023-01-11,2052-12-01,2052-12-01,OBSERVATIONAL,,1000,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,National Cancer Institute (NCI),[],['United States']
NCT07053956,Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma,Impact of Chewing Gum on FeNO Levels in Patients With Bronchial Asthma,RECRUITING,2025-08-01,2026-11-30,2026-12-30,INTERVENTIONAL,NA,40,"['Asthma Bronchiale', 'FeNO', 'Chewing Gum']",Asthma Bronchiale,RWTH Aachen University,[],['Germany']
NCT00442195,"Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers","Procurement and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers to Support Clinical and Translational Research Projects in the NHLBI",RECRUITING,2007-03-03,,,OBSERVATIONAL,,1000,['Healthy Volunteers'],Healthy Volunteers,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT02723734,Validation Study on the Impact of Decipher® Testing - VANDAAM Study,A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men With Prostate Cancer (VANDAAM Study),ACTIVE_NOT_RECRUITING,2016-04-13,2023-07-06,2026-09,OBSERVATIONAL,,240,['Prostate Cancer'],Prostate Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT03602599,Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls,Natural History of Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls,RECRUITING,2018-11-15,2026-03-03,2026-03-03,OBSERVATIONAL,,500,['Graft Versus Host Disease'],Graft Versus Host Disease,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT07019675,A Study of SKB518 in Patients With Lung Cancer,"A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of SKB518 in Patients With Lung Cancer",RECRUITING,2025-08-29,2027-02-20,2027-10-20,INTERVENTIONAL,PHASE2,192,['Lung Carcinoma'],Lung Carcinoma,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT03652064,"A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy","A Phase 3 Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy",ACTIVE_NOT_RECRUITING,2018-11-06,2024-05-07,2026-03-31,INTERVENTIONAL,PHASE3,395,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Brazil', 'Israel', 'Japan', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'France', 'Spain', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT06698614,MEMRI and Kidney Disease,Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) in Patients With Kidney Disease,RECRUITING,2024-11-07,2029-11-07,2029-11-07,OBSERVATIONAL,,120,"['Acute Kidney Injury', 'Kidney Transplant', 'Vasculitis', 'Chronic Kidney Disease(CKD)']",Acute Kidney Injury,University of Edinburgh,['NHS Lothian'],['United Kingdom']
NCT02257892,Novel Genetic Disorders of the Immune System,Novel Genetic Disorders of the Immune System,RECRUITING,2014-10-22,2026-08-30,2026-08-30,OBSERVATIONAL,,500,"['PI3KCD', 'CTLA4', 'STAT3GOF', 'MAGT1']",PI3KCD,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT04675593,Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders,Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders.,ACTIVE_NOT_RECRUITING,2021-03-15,2026-05-31,2026-06-01,INTERVENTIONAL,NA,176,"['Bipolar Disorder', 'Non-Adherence, Medication', 'Hypertension', 'Major Depressive Disorder']",Bipolar Disorder,Case Western Reserve University,"['University of California, San Diego', 'National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT03372733,Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults,Effect of Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults,RECRUITING,2018-07-31,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE2,110,['Cardiovascular Disease'],Cardiovascular Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT02390973,Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION),Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION),RECRUITING,2015-03,2027-03,2030-03,INTERVENTIONAL,NA,408,"['Bariatric Surgery Candidate', 'Diabetes']",Bariatric Surgery Candidate,Laval University,"['Johnson & Johnson Medical Products', 'Institut universitaire de cardiologie et de pneumologie de Québec, University Laval']",['Canada']
NCT05243797,Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation,Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4,RECRUITING,2022-09-08,2028-04,2032-04,INTERVENTIONAL,PHASE3,1594,['Multiple Myeloma'],Multiple Myeloma,European Myeloma Network B.V.,['Janssen Pharmaceutica'],"['Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Switzerland', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT00250159,Natural History Study of Patients With Excess Androgen,Natural History Study of Patients With Excess Androgen,RECRUITING,2006-01-02,,,OBSERVATIONAL,,3000,"['Congenital Adrenal Hyperplasia (CAH)', 'Familial Male-Limited Precocious Puberty (FMPP)']",Congenital Adrenal Hyperplasia (CAH),Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT05237986,Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy,Investigation of the Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy,RECRUITING,2025-06-23,2026-04-30,2027-04-30,OBSERVATIONAL,,60,"['Lymphoma', 'Leukemia']",Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT05567796,A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight,Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity,ACTIVE_NOT_RECRUITING,2022-11-01,2024-10-30,2026-10-19,INTERVENTIONAL,PHASE3,3400,['Obesity'],Obesity,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'Netherlands', 'Australia', 'Belgium', 'France', 'Finland', 'Denmark', 'South Korea', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT05770661,China Axial Length Study,Axial Length Study of Children and Adolescents in Ten Provinces of China,RECRUITING,2023-03-10,2026-12-31,2026-12-31,OBSERVATIONAL,,30000,"['Axial Length', 'Myopia', 'Child Development']",Axial Length,Shanghai Eye Disease Prevention and Treatment Center,"['Tongji Hospital', ""Sichuan Provincial People's Hospital"", 'Shandong University of Traditional Chinese Medicine', ""People's Hospital of Ningxia Hui Autonomous Region"", 'First Affiliated Hospital of Kunming Medical University', 'The First Affiliated Hospital of Guangxi Traditional Chinese Medical University', 'Affiliated Hospital of Inner Mongolia Minzu University', 'Xinjiang Hospital of Traditional Chinese Medicine']",['China']
NCT06600568,Novel Therapeutic Approach for Human T-cell Malignancies,Identification of Targetable Vulnerabilities in Redox Homeostasis Pathways as a Novel Therapeutic Approach for Human T-cell Malignancies,RECRUITING,2024-07-01,2026-07-01,2026-07-01,OBSERVATIONAL,,120,"['T-Cell Leukemia/Lymphoma, Adult']","T-Cell Leukemia/Lymphoma, Adult",Istituto Oncologico Veneto IRCCS,['Istituto Nazionale Tumori IRCSS-Fondazione G.Pascale'],['Italy']
NCT00001276,Diagnosing and Treating Low Blood Sugar Levels,Fasting Hypoglycemia: Diagnosis and Treatment,RECRUITING,1991-05-21,,,OBSERVATIONAL,,1500,"['Hypoglycemia', 'Insulinoma']",Hypoglycemia,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07269899,A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors,A Phase I Study Evaluating the Preliminary Efficacy and Safety of WTX212A Injection as Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors,RECRUITING,2025-11-25,2027-02-28,2027-08-30,INTERVENTIONAL,PHASE1,12,"['Solid Tumor Cancer', 'Cancer']",Solid Tumor Cancer,Sun Yat-sen University,['Westlake Therapeutics'],['China']
NCT06487858,A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors,A Multicenter Open-Label Phase 1a/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors,RECRUITING,2024-07-16,2027-12,2027-12,INTERVENTIONAL,PHASE1,75,['Solid Tumor'],Solid Tumor,BeOne Medicines,[],['China']
NCT07113561,Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance,Effects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance,RECRUITING,2025-09-16,2027-01,2027-12,INTERVENTIONAL,NA,60,['Obesity (Body Mass Index &gt;30 kg/m2)'],Obesity (Body Mass Index &gt;30 kg/m2),Norwegian University of Science and Technology,"['University of Alabama at Birmingham', 'University of Leeds, Appetite Control and Energy Balance Research', 'University of Copenhagen', 'St.Olavs Hospital, Trondheim University Hospital, Norway']",['Norway']
NCT00084305,Analysis of Specimens From Individuals With Pulmonary Fibrosis,Analysis of Specimens From Individuals With Pulmonary Fibrosis,ACTIVE_NOT_RECRUITING,2004-06-09,,,OBSERVATIONAL,,315,"['Pulmonary Fibrosis', 'Healthy Volunteers', 'Hermansky-Pudlak Syndrome (HPS)']",Pulmonary Fibrosis,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06975423,Walking Sensation Study,Somatosensory Feedback to Improve Neural Control of Walking in Older Adults,RECRUITING,2025-09-08,2027-03-31,2027-03-31,INTERVENTIONAL,NA,30,"['Aging', 'Sensory Deficit']",Aging,University of Florida,['The Claude D. Pepper Older Americans Independence Centers'],['United States']
NCT04932980,Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD,Study Comparing Early Extension of Aflibercept and Brolucizumab in Wet AMD (SPARROW),ACTIVE_NOT_RECRUITING,2022-05-09,2027-06,2028-03,INTERVENTIONAL,NA,80,['Wet Age-related Macular Degeneration'],Wet Age-related Macular Degeneration,Berner Augenklinik,['medignition AG'],['Switzerland']
NCT06983080,Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study),The Efficacy of Trazodone for the Treatment of Insomnia in Older Adults: A Randomized Controlled Trial (The TRADITION Study),RECRUITING,2025-11-10,2027-07,2027-12,INTERVENTIONAL,PHASE2,40,"['Insomnia Chronic', 'Older People', 'Drug Therapy']",Insomnia Chronic,Centre hospitalier de l'Université de Montréal (CHUM),[],['Canada']
NCT07269990,Evaluation of Bone Behavior in Maxillary Post-extractive Sites Treated With Guided Bone Regeneration (G.B.R.) Techniques in Alveolar Socket Preservation (A.S.P.) Procedures With Different Autologous and Heterologous Biomaterials.,Evaluation of Bone Behavior in Maxillary Post-extractive Sites Treated With Guided Bone Regeneration (G.B.R.) Techniques in Alveolar Socket Preservation (A.S.P.) Procedures With Different Autologous and Heterologous Biomaterials.,ACTIVE_NOT_RECRUITING,2023-07-03,2026-05,2026-05,INTERVENTIONAL,PHASE1,30,['Extracting Own Teeth'],Extracting Own Teeth,University of Foggia,[],['Italy']
NCT01212003,Training Protocol on the Natural History of Tuberculosis,Natural History of Tuberculosis,RECRUITING,2011-06-30,,,OBSERVATIONAL,,150,"['Mycobacterium Infections', 'Tuberculosis, Multidrug-Resistant', 'Latent Tuberculosis', 'Tuberculosis', 'Extensively Drug-Resistant Tuberculosis']",Mycobacterium Infections,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT04243005,Supramarginal Resection in Glioblastoma,Supramarginal Resection in Patients With Glioblastoma: A Randomised Controlled Trial,RECRUITING,2020-07-01,2026-03,2030-03,INTERVENTIONAL,NA,90,['Glioblastoma'],Glioblastoma,St. Olavs Hospital,"['Odense University Hospital', 'Sahlgrenska University Hospital', 'Turku University Hospital', 'Karolinska University Hospital', 'Norwegian University of Science and Technology', 'Uppsala University Hospital', 'University Hospital, Umeå', 'Haukeland University Hospital', 'Ullevaal University Hospital', 'Rikshospitalet University Hospital', 'Tampere University Hospital', 'Helsinki University Central Hospital', 'Kuopio University Hospital', 'Oulu University Hospital', 'Medical University of Vienna', 'Paracelsus Medical University', 'Medical Center Haaglanden, The Hague, The Netherlands', 'Erasmus Medical Center']","['Netherlands', 'Norway', 'Austria', 'Finland', 'Denmark', 'Sweden']"
NCT07270679,Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.,Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.,RECRUITING,2025-07-23,2026-10,2026-12-03,OBSERVATIONAL,,50,"['Breast Cancer', 'Hodgkin Lymphoma']",Breast Cancer,IRCCS Azienda Ospedaliero-Universitaria di Bologna,[],['Italy']
NCT06554353,Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea,Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea,RECRUITING,2024-10-29,2026-05-01,2026-06-30,OBSERVATIONAL,,50,"['Breathing, Mouth', 'Lung Function Decreased', 'Dyspnea', 'Shortness of Breath']","Breathing, Mouth",University of Rochester,[],['United States']
NCT07269483,A Study Assessing Adult Patients Referred to an NHS Sleep Service With Suspected Obstructive Sleep Apnoea. This Study Aims to Compare the Sunrise Wearable Diagnostic Device Performance and Potential Inclusion in a NHS Diagnostic Pathway With Oximetry and WatchPAT Which Are Currently Used.,Sunrise in Obstructive Sleep Apnoea Study (SOSA) A Comparison of the Sunrise Mandibular Movement Monitoring Device With Overnight Oximetry and WatchPAT in the Diagnosis and Management of Obstructive Sleep Apnoea.,RECRUITING,2025-07-28,2026-09-30,2026-09-30,INTERVENTIONAL,NA,100,['Obstructive Sleep Apnoea (OSA)'],Obstructive Sleep Apnoea (OSA),Virginia Hawkins,['University Hospitals Bristol and Weston NHS Foundation Trust'],['United Kingdom']
NCT07269418,Optimization of Conoid Anatomical Reconstruction During Ligamentoplasty for Acromioclavicular Disjunction,160 / 5 000 Evaluation of the Result of Conoid Ligament Reconstruction According to an Anatomical Index in the Arthroscopic Treatment of Acromioclavicular Disjunctions,ACTIVE_NOT_RECRUITING,2024-03-28,2028-03,2028-03,OBSERVATIONAL,,36,"['Acromioclavicular; Dislocation', 'Ligament Repair or Reconstruction']",Acromioclavicular; Dislocation,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT01805869,Oral Specimen and Data Acquisition Study of Subjects Requiring Third Molar Removal,Oral Specimen and Data Acquisition Study of Subjects Requiring Third Molar Removal,RECRUITING,2013-06-19,2029-12-31,,OBSERVATIONAL,,10000,"['Stomatognatic', 'Tooth Diseases', 'Diseases', 'Tooth', 'Tooth Impaction']",Stomatognatic,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT02721459,XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma,Phase I Study of Escalating Doses of XL888 With Vemurafenib Plus Cobimetinib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma,ACTIVE_NOT_RECRUITING,2016-09-07,2019-10-31,2026-11,INTERVENTIONAL,PHASE1,26,"['Melanoma', 'Skin Cancer']",Melanoma,H. Lee Moffitt Cancer Center and Research Institute,"['Exelixis', 'Genentech, Inc.']",['United States']
NCT07250724,C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.,"A Prospective, Observational Study to Evaluate C. Difficile Toxin Levels in Stool in Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.",RECRUITING,2025-12-01,2026-10-15,2026-10-15,OBSERVATIONAL,,60,['Clostridioides Difficile Infection Recurrence'],Clostridioides Difficile Infection Recurrence,Bactolife A/S,[],['United States']
NCT06727604,"A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease","A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease",RECRUITING,2024-12-17,2028-06,2028-06,INTERVENTIONAL,PHASE2,240,"[""Graves' Disease""]",Graves' Disease,Immunovant Sciences GmbH,[],"['Belgium', 'Hungary', 'United States', 'Georgia', 'Puerto Rico', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Germany']"
NCT04602754,Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.,"National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.",RECRUITING,2023-12-01,2026-05,2027-09,INTERVENTIONAL,PHASE3,228,['Dyslipidemia Associated With Type II Diabetes Mellitus'],Dyslipidemia Associated With Type II Diabetes Mellitus,EMS,[],['Brazil']
NCT05375812,NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH),NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH),RECRUITING,2023-04-16,2030-12-31,2030-12-31,OBSERVATIONAL,,85,['Gulf War Illness'],Gulf War Illness,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT05636579,Study to Assess Safety and Tolerability of Multiple Doses of EO2002,"Phase 1, Multiple Dose, Open-Label Study to Assess the Safety and Tolerability of EO2002 Intracameral Injections With or Without Topical Ripasudil in the Treatment of Corneal Edema",RECRUITING,2022-11-08,2025-12-09,2025-12-09,INTERVENTIONAL,PHASE1,12,"['Corneal Edema', 'Corneal Endothelial Dystrophy', 'Endothelial Dysfunction', 'Fuchs Dystrophy', ""Fuchs' Endothelial Dystrophy"", 'Bullous Keratopathy', 'Pseudophakic Bullous Keratopathy', 'Corneal Edema Pseudophakic']",Corneal Edema,Asociación para Evitar la Ceguera en México,['Emmecell'],['Mexico']
NCT00344188,Diagnosis and Treatment of Leishmania Infections,Host Response to Infection and Treatment in Leishmania Infection of Humans,RECRUITING,2001-11-30,,,OBSERVATIONAL,,289,"['Leishmaniasis', 'Skin Diseases, Parasitic', 'Euglenozoa Infections', 'Parasitic Diseases']",Leishmaniasis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT02450851,Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network,Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network,RECRUITING,2015-09-16,2028-12-31,2028-12-31,OBSERVATIONAL,,20000,['Genetic Disease'],Genetic Disease,National Human Genome Research Institute (NHGRI),[],['United States']
NCT01851395,Rapid Autopsy and Procurement of Cancer Tissue,"Inpatient Hospice With Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated With an Adoptive Cellular Therapy",RECRUITING,2013-12-30,2026-03-31,,OBSERVATIONAL,,275,"['Thymus Tumors', 'Adoptive Cellular Therapy', 'Mesothelioma', 'Genitourinary Cancers', 'Lung Cancers']",Thymus Tumors,National Cancer Institute (NCI),[],['United States']
NCT04609072,Connect for Cancer Prevention Study (Connect),Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US,RECRUITING,2021-07-26,2070-12-31,2070-12-31,OBSERVATIONAL,,200000,"['Cancer', 'General Research Use']",Cancer,National Cancer Institute (NCI),[],['United States']
NCT00055029,Clinical and Genetic Studies of X-Linked Juvenile Retinoschisis,X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies,ACTIVE_NOT_RECRUITING,2003-05-19,,,OBSERVATIONAL,,351,['Retinoschisis'],Retinoschisis,National Eye Institute (NEI),[],['United States']
NCT06090539,A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas,"A Phase 1/2, Multi-Center, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BMS-986458, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed/Refractory Non-Hodgkin Lymphomas (R/R NHL)",RECRUITING,2023-12-29,2027-10-28,2028-10-28,INTERVENTIONAL,PHASE1,308,['Relapsed/Refractory Non-Hodgkin Lymphoma'],Relapsed/Refractory Non-Hodgkin Lymphoma,Bristol-Myers Squibb,[],"['Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Germany']"
NCT06122831,A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF),A Phase Ib/II Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Intermediate- and High-risk Myelofibrosis,RECRUITING,2023-12-12,2026-12,2027-04,INTERVENTIONAL,PHASE1,92,['Myelofibrosis'],Myelofibrosis,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",[],['China']
NCT00044122,Study of Factors Regulating Mast Cell Proliferation,Regulation of the Proliferation and Survival of Normal and Neoplastic Human Mast Cells,RECRUITING,2002-09-18,,,OBSERVATIONAL,,600,"['Mastocytosis', 'Monoclonal', 'Bone Marrow', 'Tryptase']",Mastocytosis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05357378,Safety and Effectiveness of the HIT Reverse HRS,Safety and Effectiveness of the Hip Innovation Technology Reverse Hip Replacement System in Primary Total Hip Arthroplasty: A Pivotal Study,RECRUITING,2022-07-15,2026-07-15,2035-07-15,INTERVENTIONAL,NA,288,"['Degenerative Joint Disease', 'Osteoarthritis, Hip', 'Avascular Necrosis of Hip', 'Traumatic Arthropathy-Hip']",Degenerative Joint Disease,Hip Innovation Technology,[],['United States']
NCT01660984,Natural History Study of Children and Adults With Medullary Thyroid Cancer,Longitudinal Assessment and Natural History Study of Children and Adults With MEN2A or MEN2B With or Without Medullary Thyroid Carcinoma,RECRUITING,2012-07-30,,,OBSERVATIONAL,,259,['Medullary Thyroid Cancer'],Medullary Thyroid Cancer,National Cancer Institute (NCI),[],['United States']
NCT07270549,Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome,"GAIN-CTNNB1: A Phase I/II Open-Label Trial To Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intracerebroventricular Administration of an AAV9 Based Gene Replacement Therapy in Paediatric Patients With CTNNB1 Neurodevelopmental Syndrome",RECRUITING,2025-11-01,2032-12-31,2032-12-31,INTERVENTIONAL,PHASE1,12,['CTNNB1 Neurodevelopmental Syndrome'],CTNNB1 Neurodevelopmental Syndrome,CTNNB1 Foundation,['University Medical Centre Ljubljana'],['Slovenia']
NCT07269821,"Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota","Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota",ACTIVE_NOT_RECRUITING,2025-07-01,2025-10-31,2025-11-30,INTERVENTIONAL,NA,70,"['GLP-1', 'Weight Loss Trajectory', 'Emotional Disorder', 'Microbiota Balance']",GLP-1,University of Alicante,[],['Spain']
NCT06920459,Zimmer Biomet Shoulder Arthroplasty PMCF Study,Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study,RECRUITING,2025-04-29,2028-12-31,2036-12-31,OBSERVATIONAL,,40,"['Shoulder Fractures', 'Shoulder Arthritis Osteoarthritis', 'Shoulder Injury', 'Shoulder Pain', 'Degenerative Joint Disease', 'Arthritis Shoulder']",Shoulder Fractures,Zimmer Biomet,[],"['Netherlands', 'Germany']"
NCT07269340,Mandala Painting During Chemotherapy,"The Effect of Mandala Painting During Chemotherapy on Anxiety, Nausea, and Comfort Levels",RECRUITING,2025-09-09,2026-04,2026-05,INTERVENTIONAL,NA,120,"['Mandala Painting', 'Chemotherapy', 'Vomiting', 'Anxiety', 'Comfort', 'Nursing Care']",Mandala Painting,Uludag University,[],['Turkey (Türkiye)']
NCT07270770,BY002 IIT Study in R/R Acute Leukemia,"A Single-center, Open-label, Investigator-Initiated Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of Menin Inhibitor BY002 in Patients With Relapsed or Refractory Acute Leukemia",RECRUITING,2025-11-15,2026-06-30,2026-12-30,INTERVENTIONAL,PHASE1,24,"['Acute Leukemia', 'KMT2A Rearrangements or NPM1 Mutations Acute Leukemia']",Acute Leukemia,The First Affiliated Hospital of Soochow University,[],['China']
NCT05689671,Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma,Atezolizumab/Carboplatin/Nab-Paclitaxel vs. Pembrolizumab/Platinum/Pemetrexed in Metastatic TTF-1 Negative Lung Adenocarcinoma,RECRUITING,2023-12-06,2026-02,2026-10,INTERVENTIONAL,PHASE4,136,['Non-Small Cell Lung Cancer Metastatic'],Non-Small Cell Lung Cancer Metastatic,Nikolaj Frost MD,"['Roche Pharma AG', 'Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest']",['Germany']
NCT01581580,Deep Brain Stimulation Surgery for Movement Disorders,Deep Brain Stimulation Surgery for Movement Disorders,RECRUITING,2011-08-17,2029-12-01,2029-12-01,INTERVENTIONAL,NA,200,"[""Parkinson's Disease"", 'Essential Tremor', 'Dystonia']",Parkinson's Disease,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT04259359,Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure,Predominant Sensitizations to Single Bee Venom Allergens as a Risk Factor for Therapy Failure,RECRUITING,2019-05-02,2025-12,2026-03,OBSERVATIONAL,,266,['Bee Venom Allergy'],Bee Venom Allergy,Medical University of Graz,[],"['Spain', 'Austria', 'Germany']"
NCT01109420,Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer,Clinical and Genetic Studies in Familial Non-Medullary Thyroid Cancer,RECRUITING,2010-08-12,,,OBSERVATIONAL,,500,['Non-Medullary Thyroid Cancer'],Non-Medullary Thyroid Cancer,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT05181735,Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA,A Randomized Phase I/ II Multicenter Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA,RECRUITING,2022-05-18,2028-12-19,2029-06-19,INTERVENTIONAL,PHASE1,150,"['MDS', 'Myelodysplastic Syndromes']",MDS,Groupe Francophone des Myelodysplasies,['Celgene'],['France']
NCT00109174,MRS Measurement of Glutamate and GABA Metabolism in Brain,MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain,RECRUITING,2006-09-06,2030-01-11,2030-03-11,INTERVENTIONAL,NA,200,['Normal Physiology'],Normal Physiology,National Institute of Mental Health (NIMH),[],['United States']
NCT00924196,Natural History Study of Patients With Neurofibromatosis Type I,"Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults With Neurofibromatosis Type 1",ACTIVE_NOT_RECRUITING,2008-02-25,,,OBSERVATIONAL,,259,"['Neurofibromatosis Type 1', 'Malignant Peripheral Nerve Sheath Tumor', 'Plexiform Neurofibroma', 'Optic Glioma', 'Neurofibroma']",Neurofibromatosis Type 1,National Cancer Institute (NCI),[],['United States']
NCT07043127,Impact of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Elective Hip Replacement,Clinical Randomized Trial of the Influence of Rehabilitation Therapy Using Strength and Blood Flow Restriction Training on Muscular Fitness and Regeneration After Elective Hip Replacement,RECRUITING,2025-01-01,2026-07-31,2026-12-31,INTERVENTIONAL,NA,30,['Total Hip Arthroplasty (THA)'],Total Hip Arthroplasty (THA),"University Hospital, Bonn",[],['Germany']
NCT00050310,"Natural History of Anthrax: a Study of Primary Infected, Recovered, and Exposed Individuals (SPoRE); and Evaluation of AVA-Vaccinated Recipients","Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients",RECRUITING,2002-10-31,,,OBSERVATIONAL,,200,"['Anthrax', 'Bacillus Infections']",Anthrax,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06486168,Incidence of Diaphragmatic Dysfunction After Non-Intubated Video-Assisted Thoracoscopic Surgery,Incidence of Diaphragmatic Dysfunction After Non-Intubated Video-Assisted Thoracoscopic Surgery.,RECRUITING,2024-12-10,2025-12-31,2026-02,INTERVENTIONAL,NA,100,['Diaphragmatic Dysfunction'],Diaphragmatic Dysfunction,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT06044350,A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders,A Phase II/III Study to Evaluate the Efficacy and Safety of BAT4406F Injection in Patients With Neuromyelitis Optica Lineage Disease,ACTIVE_NOT_RECRUITING,2023-08-01,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE2,162,['Optic Neuromyelitis Spectrum Disease'],Optic Neuromyelitis Spectrum Disease,Bio-Thera Solutions,[],['China']
NCT07252674,Comparison of Laryngeal Mask Airway and Endotracheal Intubation on Mechanical Power in Pediatric Patients,Impact of Laryngeal Mask Airway Versus Endotracheal Intubation on Mechanical Power and Postoperative Respiratory Complications in Pediatric Patients: A Prospective Observational Study,RECRUITING,2025-11-30,2026-01-15,2026-01-30,OBSERVATIONAL,,100,['Mechanical Power'],Mechanical Power,Konya City Hospital,[],['Turkey (Türkiye)']
NCT07157774,Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event",RECRUITING,2025-09-02,2031-03,2031-03,INTERVENTIONAL,PHASE3,10450,"['Elevated Lp(a)', 'Atherosclerotic Cardiovascular Disease (ASCVD)']",Elevated Lp(a),Eli Lilly and Company,[],"['Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Hungary', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06708715,Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment,Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment,ACTIVE_NOT_RECRUITING,2023-05-05,2026-05-01,2026-05-01,INTERVENTIONAL,NA,150,"['Stress', 'Anxiety']",Stress,SuperPatch Limited LLC,['Clarity Science LLC'],['United States']
NCT06707688,Abbott Medical - VERITAS Study,Abbott Medical - VERITAS Study,ACTIVE_NOT_RECRUITING,2024-11-11,2025-11-04,2027-09,INTERVENTIONAL,NA,458,"['Atrial Fibrillation (AF)', 'Stoke']",Atrial Fibrillation (AF),Abbott Medical Devices,[],"['Belgium', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'Germany']"
NCT05704361,"A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis","A Multiple-center, Non-randomized, Open-label, Adaptive, Single-ascending Dose (Part 1 and Part 2) and Multiple-ascending Dose (Part 3) Parallel, Phase IB Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 Following Intravenous (Parts 1) and Subcutaneous Administration (Parts 2 and 3) in Participants With Multiple Sclerosis",RECRUITING,2021-08-11,2027-07-08,2027-07-08,INTERVENTIONAL,PHASE1,129,['Multiple Sclerosis'],Multiple Sclerosis,Hoffmann-La Roche,[],"['Belgium', 'Israel', 'Moldova', 'United States', 'Spain', 'Italy', 'Canada', 'Romania', 'Poland', 'Portugal', 'Serbia', 'Germany']"
NCT00001186,Psychological Benefits of a Normalized Camping Experience for Children With Cancer,Psychological Benefits of a Normalized Camping Experience for Children With Cancer,RECRUITING,1983-02-15,,,OBSERVATIONAL,,5000,['Pediatric Cancer'],Pediatric Cancer,National Cancer Institute (NCI),[],['United States']
NCT04986631,Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP,Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP,ACTIVE_NOT_RECRUITING,2022-04-04,2025-03-12,2026-03-12,INTERVENTIONAL,EARLY_PHASE1,65,"['Obesity, Childhood']","Obesity, Childhood",University of Minnesota,[],['United States']
NCT06735534,"Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System","The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters",RECRUITING,2025-06-03,2027-04,2028-01,INTERVENTIONAL,NA,407,['Persistent Atrial Fibrillation'],Persistent Atrial Fibrillation,Boston Scientific Corporation,[],"['Taiwan', 'United States']"
NCT04936607,ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions,"ImproviNg rEnal Outcomes Following Coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a Pragmatic, Adaptive, Patient-oriented Randomized Controlled Trial",RECRUITING,2021-06-28,2027-01-30,2027-07-31,INTERVENTIONAL,NA,1158,['Contrast-Induced Acute Kidney Injury'],Contrast-Induced Acute Kidney Injury,Montreal Heart Institute,"['Université de Montréal', 'Canadian Institutes of Health Research (CIHR)']",['Canada']
NCT07071584,Evaluation of a Multi-electrode Prosthesis Control System for Real-world Tasks Performance in Individuals With Upper Limb Transradial Amputation,Evaluation of a Multi-electrode Prosthesis Control System for Real-World Tasks Performance,RECRUITING,2025-08-15,2026-04,2026-06,INTERVENTIONAL,NA,25,['Upper Limb Amputation Below Elbow'],Upper Limb Amputation Below Elbow,Phantom Neuro Inc.,['Atlas Ambulatory Surgery Center'],['United States']
NCT06265558,Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery,Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery: a Prospective Randomized Controlled Trial,RECRUITING,2025-04-15,2027-05,2027-07,INTERVENTIONAL,NA,254,['Breast Cancer'],Breast Cancer,Institut du Cancer de Montpellier - Val d'Aurelle,[],['France']
NCT05666778,Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs,Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs Through Reduced Harmful Sexual and Menstrual Practices,ACTIVE_NOT_RECRUITING,2023-02-13,2025-12-01,2027-07-31,INTERVENTIONAL,PHASE2,408,"['Bacterial Vaginosis', 'Vaginal Microbiome', 'Chlamydia Trachomatis Infection', 'Neisseria Gonorrheae Infection', 'Trichomonas Vaginitis']",Bacterial Vaginosis,Rush University Medical Center,"['Nyanza Reproductive Health Society', 'Liverpool School of Tropical Medicine', 'University of Illinois at Chicago', 'National Institute of Allergy and Infectious Diseases (NIAID)']","['Kenya', 'United States']"
NCT06498349,Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl,A Randomized Controlled Trial of Bilateral Subthalamic Stimulation in Patients With Parkinson's Disease and Impulse Control Disorders,RECRUITING,2024-09-05,2027-07-15,2028-07-15,INTERVENTIONAL,NA,60,"['Parkinson Disease', 'Impulse Control Disorders']",Parkinson Disease,University of Kiel,"['Insel Gruppe AG, University Hospital Bern', 'Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)', 'Philipps University Marburg', 'University Hospital Schleswig-Holstein', 'Czech Technical University in Prague', 'University of Pennsylvania']","['Switzerland', 'Netherlands', 'Germany']"
NCT00271622,The Neurodevelopmental and Behavioral Phenotyping Screening Protocol,Neurodevelopmental and Behavioral Phenotyping Screening Protocol,RECRUITING,2006-02-27,,,OBSERVATIONAL,,5000,"['Neurologic Disorders', 'Autism', 'Neurodegenerative Disease', 'Neurobehavioral Manifestation']",Neurologic Disorders,National Institute of Mental Health (NIMH),[],['United States']
NCT07176390,A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014),"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Rheumatoid Arthritis",RECRUITING,2025-10-08,2027-03-08,2029-09-03,INTERVENTIONAL,PHASE2,182,"['Arthritis, Rheumatoid']","Arthritis, Rheumatoid",Merck Sharp & Dohme LLC,[],"['Japan', 'United States', 'Spain', 'Canada', 'Poland', 'Germany']"
NCT00846742,Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma,Reduced Duration Stanford V Chemotherapy With or Without Low-Dose Tailored-Field Radiation Therapy For Favorable Risk Pediatric Hodgkin Lymphoma,ACTIVE_NOT_RECRUITING,2009-06-05,2019-01-11,2028-10,INTERVENTIONAL,PHASE2,88,['Hodgkin Lymphoma'],Hodgkin Lymphoma,St. Jude Children's Research Hospital,[],['United States']
NCT03394066,Mechanism of Non-invasive Magnetic Stimulation,Understanding the Acute Modulation of Brain Activity by Transcranial Magnetic Stimulation,RECRUITING,2018-09-19,2026-12-31,2026-12-31,INTERVENTIONAL,NA,70,['Healthy Volunteers'],Healthy Volunteers,National Institute on Drug Abuse (NIDA),[],['United States']
NCT06541145,Bacterial Decolonization Within Dyads,Impact of Bacterial Decolonization on Bacterial Burden Within Maternal-infant Dyads,RECRUITING,2024-08-21,2026-04,2026-06,INTERVENTIONAL,NA,20,['Bacterial Colonization'],Bacterial Colonization,Duke University,['Bristol-Myers Squibb'],['United States']
NCT01426529,Caveolin-1 and Vascular Dysfunction,Caveolin-1 and Vascular Dysfunction,ACTIVE_NOT_RECRUITING,2010-10-01,2026-10-15,2026-10-15,INTERVENTIONAL,PHASE1,120,"['Hypertension', 'Insulin Resistance']",Hypertension,Brigham and Women's Hospital,"['National Heart, Lung, and Blood Institute (NHLBI)', 'National Institutes of Health (NIH)']",['United States']
NCT07113808,Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China,Clinical Medical Quality Control Management of Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China: A Multi-Center Study,RECRUITING,2024-09-10,2026-09-30,2026-09-30,OBSERVATIONAL,,108,"['Abdominal Neoplasm', 'Abdominal Injury', 'Ascites']",Abdominal Neoplasm,The Children's Hospital of Zhejiang University School of Medicine,"[""Shenzhen Children's Hospital"", ""Children's Hospital of Chongqing Medical University"", ""Tianjin Children's Hospital"", ""Kunming Children's Hospital"", 'Second Affiliated Hospital, School of Medicine, Zhejiang University', 'West China Hospital', ""Yuying Children's Hospital of Wenzhou Medical University"", ""Xian Children's Hospital""]",['China']
NCT04594018,Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia,"National, Multicentre, Randomized, Double-blind, Double-dummy Phase III Clinical Trial to Evaluate the Efficacy and Safety of Finlândia Hair Lotion Association in the Treatment of Androgenetic Alopecia.",RECRUITING,2023-02-02,2026-05,2027-09,INTERVENTIONAL,PHASE3,190,['Androgenetic Alopecia'],Androgenetic Alopecia,EMS,[],['Brazil']
NCT05470491,"Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...","A Phase I/II Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Transplantation Followed by GVHD Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living With HIV (PLWH)",RECRUITING,2023-01-26,2026-07-30,2027-07-30,INTERVENTIONAL,PHASE1,265,"['HIV', 'Hematologic Malignancies']",HIV,National Cancer Institute (NCI),[],['United States']
NCT06828861,ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial,"A Phase 3, Randomized, Double-blind, Placebo-controlled Study of ARD-101 for the Treatment of Hyperphagia in Patients With Prader-Willi Syndrome",RECRUITING,2024-12-20,2026-03,2026-04,INTERVENTIONAL,PHASE3,90,"['Hyperphagia', 'Prader-Willi Syndrome']",Hyperphagia,"Aardvark Therapeutics, Inc.",[],"['United States', 'France', 'Spain', 'Italy', 'Canada', 'Romania', 'South Korea', 'United Kingdom', 'Australia']"
NCT05587205,Safety and Tolerability of EO2002,"Phase 1, Randomized, Masked, Sham-Controlled Study to Assess the Safety and Tolerability of EO2002 in Subjects Undergoing Cataract Surgery",RECRUITING,2022-08-30,2026-10-06,2026-10-06,INTERVENTIONAL,PHASE1,32,"['Cataract', 'Endothelial Cell Loss, Corneal']",Cataract,Asociación para Evitar la Ceguera en México,['Emmecell'],['Mexico']
NCT06586151,Testing a Gender-inclusive HIV Prevention Program,Harnessing the Power of Technology to Develop a Population-based HIV Prevention Program for Trans Girls,RECRUITING,2024-09-01,2026-06-30,2026-06-30,INTERVENTIONAL,NA,200,['HIV Prevention'],HIV Prevention,Center for Innovative Public Health Research,"['University of Miami', 'Ann and Robert H Lurie Childrens Hospital of Chicago']",['United States']
NCT07241039,"A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors","A Phase 1 First-in-Human, Open-Label Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABBV-711 as a Monotherapy or in Combination With Budigalimab (ABBV-181) in Adult Subjects With Advanced Squamous Tumors",RECRUITING,2025-11-20,2029-04,2029-04,INTERVENTIONAL,PHASE1,220,['Advanced Squamous Tumors'],Advanced Squamous Tumors,AbbVie,[],"['Japan', 'United States']"
NCT01306019,Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID),Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency,RECRUITING,2012-09-25,2032-12-31,2032-12-31,INTERVENTIONAL,PHASE1,40,['X-linked Severe Combined Immunodeficiency (XSCID)'],X-linked Severe Combined Immunodeficiency (XSCID),National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06314633,Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children,Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children,RECRUITING,2024-01-29,2026-01,2026-06,INTERVENTIONAL,NA,140,['Healthy Volunteer Children'],Healthy Volunteer Children,Institut Cancerologie de l'Ouest,['ANSES'],['France']
NCT07269548,Evaluation of the Healing of the Pilonidal Cyst After 1940 nm Laser Treatment,Evaluation of the Healing of the Pilonidal Cyst After 1940 nm Laser Treatment,RECRUITING,2025-10-03,2026-06-30,2026-06-30,OBSERVATIONAL,,30,['Pilonidal Cyst/Fistula'],Pilonidal Cyst/Fistula,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT07223840,A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse,"A Phase 2, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for Reduction in Risk of Relapse to Cigarette Smoking in Adults (RENEW-Smk-1)",RECRUITING,2025-11-03,2027-02,2027-02,INTERVENTIONAL,PHASE2,222,['Smoking'],Smoking,Eli Lilly and Company,[],"['China', 'Japan', 'United States']"
NCT05701917,DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis,DEFIANCE - ClotTriever® Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis,RECRUITING,2023-01-06,2026-06-30,2027-01-15,INTERVENTIONAL,NA,300,"['Venous Thromboembolism', 'Deep Venous Thrombosis', 'Post-Thrombotic Syndrome']",Venous Thromboembolism,Inari Medical,[],"['United States', 'Finland', 'Switzerland', 'United Kingdom', 'Germany']"
NCT05220917,Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study,Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study,ACTIVE_NOT_RECRUITING,2021-08-01,2026-01-31,2026-07-01,OBSERVATIONAL,,781430,"['Cardiovascular Events', 'Type2 Diabetes', 'Renal Disease']",Cardiovascular Events,Brigham and Women's Hospital,"['Patient-Centered Outcomes Research Institute', 'VA Boston Healthcare System', 'McGill University']",['United States']
NCT05198557,A Study of MT-0551 in Patients With Systemic Sclerosis,Phase 3 Study of MT-0551 in Patients With Systemic Sclerosis (Placebo-Controlled Double-Blind Study),ACTIVE_NOT_RECRUITING,2022-07-20,2025-07-31,2026-08,INTERVENTIONAL,PHASE3,80,['Systemic Sclerosis'],Systemic Sclerosis,Tanabe Pharma Corporation,[],['Japan']
NCT00009243,Natural History of Stroke: Cause and Development,"Evaluation, Pathogenesis, and Treatment of Patients With or at Risk for Cerebrovascular Disease (A Natural History/Disease Pathogenesis Protocol)",RECRUITING,2001-01-26,,,OBSERVATIONAL,,4000,"['Brain Disease', 'Ischemic Attack, Transient', 'Cerebrovascular Accident', 'Cerebrovascular Disorder', 'Vascular Diseases']",Brain Disease,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07255664,"A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC","A FIH, Phase I/IIa, Open-label Trial Assessing Safety, Tolerability, and Feasibility of Repeated Administrations of a Novel Autologous TIL-based Immunotherapy in Patients With Metastatic Colorectal or Prostate Cancer",RECRUITING,2025-11-13,2027-04,2029-04,INTERVENTIONAL,PHASE1,12,"['Metastatic Colorectal Cancer', 'Prostate Cancer Metastatic', 'Prostate Cancer Locally Advanced']",Metastatic Colorectal Cancer,Curacell Holding AB,"['Zellwerk GmbH', 'Frankfurter Institut für Klinische Krebsforschung IKF GmbH', 'Krebsforschung Rhein-Main e.V.']",['Germany']
NCT01324206,Development of 3T Magnetic Resonance Research Methods for NIA Studies,Development of Magnetic Resonance Imaging and Spectroscopy Research Methods for NIA Studies,RECRUITING,2008-11-03,,,OBSERVATIONAL,,1000,['Normal Physiology'],Normal Physiology,National Institute on Aging (NIA),[],['United States']
NCT00369421,Diagnosis and Treatment of Patients With Inborn Errors of Metabolism,Diagnosis and Treatment of Patients With Inborn Errors of Metabolism or Other Genetic Disorders,RECRUITING,1978-09-12,,,OBSERVATIONAL,,4000,['Arterial Calcification Due to Deficiency of CD73'],Arterial Calcification Due to Deficiency of CD73,National Human Genome Research Institute (NHGRI),[],['United States']
NCT02908906,"A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers","A First-in-Human, Open-label, Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects With Advanced Cancers",ACTIVE_NOT_RECRUITING,2016-11-21,2023-11-17,2026-12-31,INTERVENTIONAL,PHASE1,413,['Neoplasms'],Neoplasms,"Janssen Research & Development, LLC",[],"['Moldova', 'Russia', 'United States', 'Spain', 'United Kingdom', 'Poland', 'Sweden']"
NCT03366116,5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors,Phase I Trial of 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in Patients With Advanced Solid Tumors,RECRUITING,2018-11-05,2026-09-30,2026-09-30,INTERVENTIONAL,PHASE1,65,"['Neoplasms', 'Solid Tumors']",Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT05768139,First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors,"First-in-Human Study of STX-478, a Mutant-Selective PI3Kα Inhibitor as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors",RECRUITING,2023-04-17,2030-07,2030-07,INTERVENTIONAL,PHASE1,720,"['Breast Cancer', 'Solid Tumors, Adult']",Breast Cancer,Eli Lilly and Company,[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Ireland', 'Spain', 'Italy', 'Germany']"
NCT05956821,Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age,Phase I/II Trial of Repeat Dosing of Super-Selective Intraarterial Infusion of Erbitux (Cetuximab) and Avastin (Bevacizumab) for Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age,RECRUITING,2025-06-19,2029-10-01,2029-12-01,INTERVENTIONAL,PHASE1,20,"['Glioblastoma Multiforme', 'Anaplastic Astrocytoma', 'Fibrillary Astrocytomas', 'Oligodendroglioma', 'Diffuse Intrinsic Brainstem Glioma', 'Diffuse Intrinsic Pontine Glioma', 'DIPG Brain Tumor', 'H3 K27M']",Glioblastoma Multiforme,University of Miami,[],['United States']
NCT00001406,Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia,Eosinophil Activation and Function in Parasitic Infections and Other Conditions With Increased Tissue or Peripheral Blood Eosinophilia in Humans,RECRUITING,1997-04-21,,,OBSERVATIONAL,,800,"['Immune System Diseases', 'Eosinophilia', 'Helminthiasis', 'Hypersensitivity', 'Parasitic Disease']",Immune System Diseases,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07100119,A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis,"A Multiple Ascending Dose Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis",RECRUITING,2025-08-05,2027-08,2027-09,INTERVENTIONAL,PHASE1,32,['ALS (Amyotrophic Lateral Sclerosis)'],ALS (Amyotrophic Lateral Sclerosis),Eli Lilly and Company,[],"['Belgium', 'Netherlands', 'Spain', 'Canada', 'Germany']"
NCT04411147,A Longitudinal Study of COVID-19 Sequelae and Immunity,A Longitudinal Study of COVID-19 Sequelae and Immunity,ACTIVE_NOT_RECRUITING,2020-06-17,2027-12-31,2027-12-31,OBSERVATIONAL,,583,['COVID-19'],COVID-19,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06230367,Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys,Harnessing the Power of Text Messaging to Reduce HIV Incidence in Adolescent Males Across the United States,RECRUITING,2024-01-15,2026-07-31,2026-07-31,INTERVENTIONAL,NA,5000,['HIV Infections'],HIV Infections,Center for Innovative Public Health Research,[],['United States']
NCT06847763,The Long Term Effects of Online Therapeutic Neuroscience Education in Patients With Chronic Low Back Pain,"The Effect of Online Therapeutic Neuroscience Education Added to Conventional Physiotherapy Program on Clinical Outcomes, Treatment Expectations and Satisfaction Levels in Patients With Chronic Low Back Pain",RECRUITING,2025-12-10,2026-08-01,2026-08-01,INTERVENTIONAL,NA,60,"['Low Back Pain, Mechanical', 'Chronic Pain']","Low Back Pain, Mechanical",Istanbul Bilgi University,['Marmara University'],['Turkey (Türkiye)']
NCT06092333,VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B,A Pilot Study of the Combination of VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B,RECRUITING,2025-01-31,2028-02-29,2028-08-31,INTERVENTIONAL,PHASE2,50,['Chronic Hepatitis B'],Chronic Hepatitis B,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06163534,A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC),TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC),RECRUITING,2024-08-01,2028-03-01,2028-03-01,OBSERVATIONAL,,500,['Head and Neck Squamous Cell Carcinoma'],Head and Neck Squamous Cell Carcinoma,Tempus AI,['AstraZeneca'],"['Puerto Rico', 'United States']"
NCT06933095,Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia,Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia,RECRUITING,2024-09-15,2029-09-15,2029-09-15,INTERVENTIONAL,NA,153,"['Eldery People', 'Cognitive Decline', 'Memory Decline', 'DHA CNS Delivery']",Eldery People,University of Cincinnati,[],['United States']
NCT07270172,The MICRON Study - A Steno 1 Substudy,Multifactorial Intervention to Reduce Cardiac and Renal Oxygen Need in Type 1 Diabetes (the MICRON Study) - A Steno 1 Substudy,RECRUITING,2025-10-27,2028-07,2028-12,OBSERVATIONAL,,40,['Type 1 Diabetes Mellitus'],Type 1 Diabetes Mellitus,University of Aarhus,[],['Denmark']
NCT01200680,Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes,Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes,ACTIVE_NOT_RECRUITING,2011-01-02,,,OBSERVATIONAL,,188,"['Genes', 'Sporadic Chordoma']",Genes,National Cancer Institute (NCI),[],['United States']
NCT01621594,Evaluating New Radiation Techniques for Cardiovascular Imaging,Prospective Evaluation of New Techniques in Radiation Reduction for Cardiovascular Computed Tomographic Angiography,RECRUITING,2012-06-21,2027-04-01,2027-04-01,INTERVENTIONAL,NA,5000,['Coronary Disease'],Coronary Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06970067,Co-Creating Active Middle School Communities to Increase Student Physical Activity,Co-Creating and Implementing Contextually Responsive Physical Activity Interventions With Middle School Adolescents,RECRUITING,2024-12-03,2028-08-31,2028-12-31,INTERVENTIONAL,NA,450,['Physical Activity'],Physical Activity,Deanna Hoelscher,"['University of Texas at Austin', 'National Institute on Minority Health and Health Disparities (NIMHD)']",['United States']
NCT07148193,Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+),"Understanding Long-Term Sarcoma Survivorship: Risk Profiles, Outcomes and Unmet Needs - A Joint Project of Research, Sarcoma Centres and Patient Experts (PROSa+)",RECRUITING,2025-11-28,2027-09,2027-09,OBSERVATIONAL,,1600,"['Sarcoma', 'Survivorship', 'Quality of Life (QOL)', 'Medical Care']",Sarcoma,Technische Universität Dresden,"['German Sarcoma Foundation (DSS)', 'German Cancer Research Center', 'Universitätsmedizin Mannheim', 'University Hospital, Essen', 'National Centre for Tumor Diseases Heidelberg']",['Germany']
NCT04844606,A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON),"A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the Long-term Efficacy and Safety of Mirikizumab in Children and Adolescents With Moderate-to-severe Ulcerative Colitis or Crohn's Disease",RECRUITING,2021-05-26,2030-12,2030-12,INTERVENTIONAL,PHASE3,150,"['Ulcerative Colitis', 'Ulcerative Colitis Chronic', 'Inflammatory Bowel Diseases', ""Crohn's Disease""]",Ulcerative Colitis,Eli Lilly and Company,[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'Austria', 'United States', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Portugal', 'Germany']"
NCT05526092,OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals,OAT-GUT-BRAIN: Comprehensive Health Effects of Long-term Consumption of Oats in Metabolically Challenged Volunteers - Gut-mediated Metabolomics and Vitality,ACTIVE_NOT_RECRUITING,2022-09-12,2025-12,2027-12,INTERVENTIONAL,NA,72,"['High Cholesterol/Hyperlipidemia', 'High Blood Pressure', 'Overweight and Obesity']",High Cholesterol/Hyperlipidemia,University of Turku,['University of Eastern Finland'],['Finland']
NCT06195540,RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing,RIVACAST : RIVAroxaban Versus Low-molecular Weight Heparinin Patients With Lower Limb Trauma Requiring Brace or CASTing,RECRUITING,2024-07-19,2026-11-19,2026-11-19,INTERVENTIONAL,PHASE3,1424,"['Venous Thromboembolism', 'Deep Vein Thrombosis', 'Pulmonary Embolism', 'Lower Limb Trauma', 'Thromboprophylaxis', 'Immobilisation']",Venous Thromboembolism,"University Hospital, Angers",[],['France']
NCT04227847,A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies,A Phase 1 Study of SEA-CD70 in Myeloid Malignancies,RECRUITING,2020-08-07,2027-07-04,2028-07-03,INTERVENTIONAL,PHASE1,178,"['Myelodysplastic Syndrome', 'Acute Myeloid Leukemia']",Myelodysplastic Syndrome,"Seagen, a wholly owned subsidiary of Pfizer",[],"['Japan', 'United States', 'Netherlands']"
NCT07268768,"PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE","Personological Structure, Cognitive Functions and Central Sensitization in Headache: Obstacles and Resources in the Treatment of Chronic and Episodic Headache.",RECRUITING,2025-11-20,2028-11-20,2028-11-20,OBSERVATIONAL,,64,"['Chronic and Episodic Headache', 'Headache Disorders']",Chronic and Episodic Headache,IRCCS Centro Neurolesi Bonino Pulejo,[],['Italy']
NCT07080125,A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis,Non-interventional Post-authorization Effectiveness Study to Assess Long-term Outcomes of Nintedanib Treatment in Patients With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD),ACTIVE_NOT_RECRUITING,2025-06-17,2033-12-31,2033-12-31,OBSERVATIONAL,,2000,"['Interstitial Lung Diseases', 'Systemic Sclerosis Associated Interstitial Lung Disease']",Interstitial Lung Diseases,Boehringer Ingelheim,[],['Switzerland']
NCT05208762,A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors,A Phase 1 Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors,RECRUITING,2022-10-25,2027-04-09,2028-04-08,INTERVENTIONAL,PHASE1,315,"['Carcinoma, Non-Small-Cell Lung', 'Squamous Cell Carcinoma of the Head and Neck', 'Esophageal Squamous Cell Carcinoma', 'Ovarian Neoplasms', 'Melanoma', 'Triple Negative Breast Neoplasms', 'Gastric Cancer']","Carcinoma, Non-Small-Cell Lung","Seagen, a wholly owned subsidiary of Pfizer",[],"['Belgium', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT05388669,A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer,"A Phase 3, Open-label, Randomized Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Patients With EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer After Progression on Osimertinib and Chemotherapy",ACTIVE_NOT_RECRUITING,2022-08-05,2024-01-03,2026-06-30,INTERVENTIONAL,PHASE3,418,['Advanced or Metastatic Non-small Cell Lung Cancer'],Advanced or Metastatic Non-small Cell Lung Cancer,"Janssen Research & Development, LLC",[],"['Japan', 'China', 'Australia', 'Israel', 'France', 'South Korea', 'Thailand', 'Poland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT04536805,Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin,Relapse in Previously Irradiated Prostate Bed : a Phase I/II Study of Stereotactic Ablative Reirradiation Potentiated by Metformin,RECRUITING,2020-11-17,2031-11,2031-11,INTERVENTIONAL,PHASE1,44,['Prostate Cancer'],Prostate Cancer,Institut Cancerologie de l'Ouest,[],['France']
NCT07268820,"Heartburn, Gastroesophageal Reflux Disease","A Multicenter, Double-blind, Randomized, Investigator-initiated Trial to Evaluate the Degree of Symptom Relief of Zastaprazan and Esomeprazole in Patients With Erosive Reflux Disease With Night-time Heartburn Symptoms",RECRUITING,2025-07-07,2026-05-29,2026-09-30,INTERVENTIONAL,PHASE4,160,['GERD'],GERD,Incheon St.Mary's Hospital,[],['South Korea']
NCT07268859,Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea,Effect of Fan Application in Preventing Ticagrelor-associated Dyspnea in Patients With Acute Coronary Syndrome.,RECRUITING,2025-03-15,2026-01-10,2026-01-30,INTERVENTIONAL,NA,110,"['Acute Coronary Syndromes', 'Ticagrelor', 'Dyspnea']",Acute Coronary Syndromes,Acibadem University,[],['Turkey (Türkiye)']
NCT03042962,Brain Networks in Dystonia,Brain Networks in Dystonia,RECRUITING,2015-08-01,2027-12-31,2027-12-31,OBSERVATIONAL,,141,"['Spasmodic Dysphonia', ""Singer's Dystonia"", ""Writer's Cramp"", ""Musician's Focal Hand Dystonia"", 'Craniofacial Dystonia', 'Blepharospasm Oromandibular Dystonia']",Spasmodic Dysphonia,Massachusetts Eye and Ear Infirmary,['National Institute of Dental and Craniofacial Research (NIDCR)'],['United States']
NCT01143454,Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System,Cardiovascular Disease Discovery Protocol,RECRUITING,2010-07-21,,,OBSERVATIONAL,,5000,"['Metabolic Disease', 'Obesity', 'Li-Fraumeni Syndrome', 'Cardiomyopathy', 'Atherosclerosis', 'Inflammatory Disease']",Metabolic Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT01036581,Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging,Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging,RECRUITING,2003-10-24,2029-12-31,2029-12-31,INTERVENTIONAL,NA,1000,"['Drug Abuse', 'Nicotine Dependence']",Drug Abuse,National Institute on Drug Abuse (NIDA),[],['United States']
NCT06884618,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)","A Phase I Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Clinical Activity of RO7673396 as a Single Agent and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors Harboring RAS Mutation(s)",RECRUITING,2025-04-30,2028-08-31,2029-05-25,INTERVENTIONAL,PHASE1,345,['Neoplasms'],Neoplasms,Hoffmann-La Roche,[],"['Singapore', 'New Zealand', 'Hong Kong', 'China', 'United States', 'Taiwan', 'Canada', 'Australia']"
NCT00342589,New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia,Studies of Human Pneumocystis Infection,RECRUITING,1999-09-28,,,OBSERVATIONAL,,1500,"['Pneumocystis Infection', 'Infection', 'Pneumonia, Pneumocystis', 'Lung Disease, Fungal', 'Mycoses']",Pneumocystis Infection,National Institute of Allergy and Infectious Diseases (NIAID),['National Institutes of Health Clinical Center (CC)'],['United States']
NCT05894382,Double Helix Design Defocus Lens Spectacle (RACE) for Myopia Control,"A Randomized Controlled Study on the Effectiveness, Safety and Adaptability of Double Helix Design Defocus Lens Spectacle Frames for Correction of Visual Acuity in Children and Adolescents, and Control of Myopia.",ACTIVE_NOT_RECRUITING,2023-06-03,2026-08-31,2026-12-31,INTERVENTIONAL,NA,236,"['Myopia, Progressive']","Myopia, Progressive",Shanghai Eye Disease Prevention and Treatment Center,[],['China']
NCT00090662,Collection of Data and Samples From Healthy Donors for Use in Translational Research,Collection of Data and Samples From Healthy Donors for Use in Translational Research,RECRUITING,2004-12-09,,,OBSERVATIONAL,,150,['Healthy Volunteer'],Healthy Volunteer,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05215327,High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients,Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients,RECRUITING,2022-11-08,2027-07-31,2027-12-31,INTERVENTIONAL,PHASE2,270,"['Immunization; Infection', 'Transplantation Infection', 'Influenza']",Immunization; Infection,Vanderbilt University Medical Center,"['Northwestern University Feinberg School of Medicine', 'University of Alabama at Birmingham', 'Duke University', 'University of Washington', 'Emory University', 'Baylor College of Medicine', 'NYU Langone Health']",['United States']
NCT06450951,A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals,A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals Among a Child-Bearing Age Cohort,ACTIVE_NOT_RECRUITING,2024-05-23,2025-12-31,2026-08-01,INTERVENTIONAL,NA,600,['Environmental Exposure'],Environmental Exposure,"Million Marker Wellness, Inc.","['Renown Health', 'University of Nevada, Reno']",['United States']
NCT00340405,"Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China","Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China",ACTIVE_NOT_RECRUITING,1992-04-30,2040-12-31,2040-12-31,OBSERVATIONAL,,9759,['Lung Cancer'],Lung Cancer,National Cancer Institute (NCI),[],['China']
NCT06667700,A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023),"A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression",RECRUITING,2024-12-02,2031-01-26,2031-01-26,INTERVENTIONAL,PHASE3,3082,['Coronavirus Disease (COVID-19)'],Coronavirus Disease (COVID-19),Merck Sharp & Dohme LLC,[],"['Bulgaria', 'Japan', 'New Zealand', 'France', 'Finland', 'Puerto Rico', 'Peru', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'Mexico', 'Georgia', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Ukraine', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT01386437,Natural History of Individuals With Immune System Problems That Lead to Fungal Infections,The Natural History and Pathogenesis of Human Fungal Infections,RECRUITING,2012-11-05,,,OBSERVATIONAL,,1200,"['Chronic Mucocutaneous Candidiasis', 'Invasive Aspergillosis', 'CARD9', 'APECED']",Chronic Mucocutaneous Candidiasis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07006649,CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum,CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum,RECRUITING,2025-11-28,2026-11,2026-11,INTERVENTIONAL,NA,60,"['Pseudoxanthoma Elasticum', 'Tomography, Optical Coherence', 'Retinal Disease']",Pseudoxanthoma Elasticum,"University Hospital, Angers",[],['France']
NCT05943535,Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF),"A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)",RECRUITING,2023-10-30,2027-11,2027-11,INTERVENTIONAL,PHASE3,698,"['Progressive Pulmonary Fibrosis', 'Interstitial Lung Disease']",Progressive Pulmonary Fibrosis,United Therapeutics,[],"['Belgium', 'Israel', 'New Zealand', 'United States', 'France', 'Germany', 'Chile', 'Peru', 'Italy', 'Canada', 'South Korea', 'Taiwan', 'United Kingdom', 'Argentina', 'Australia']"
NCT07101432,Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK),Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK),ACTIVE_NOT_RECRUITING,2025-10-04,2027-12-31,2029-12-31,INTERVENTIONAL,PHASE1,33,['Head and Neck Cancer'],Head and Neck Cancer,M.D. Anderson Cancer Center,[],['United States']
NCT04767555,Impact of ILM Peeling in RRD/ I-Peel,Impact of ILM Peeling on Functional and Anatomic Outcomes of Vitrectomy for Primary Rhegmatogenous Retinal Detachment - the I-Peel Study,ACTIVE_NOT_RECRUITING,2022-02-23,2026-04,2026-06,INTERVENTIONAL,NA,250,['Retinal Detachment'],Retinal Detachment,Berner Augenklinik,[],['Switzerland']
NCT07255378,Usage of Vasopressin in Septic Shock.,Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication,RECRUITING,2025-10-01,2027-10-31,2028-01-01,OBSERVATIONAL,,1200,['Septic Shock'],Septic Shock,Jamil Cedeño Mora,"['Fundación para la Investigación Biomédica del Hospital Gregorio Maranon', 'Hospital General Universitario Gregorio Marañon']",['Spain']
NCT07256548,Machine Learning for Predicting Spinal Anesthesia Duration,Comparative Evaluation of Machine Learning Algorithms for Predicting Spinal Anesthesia Termination Time,RECRUITING,2025-10-31,2026-02-14,2026-03-01,OBSERVATIONAL,,140,"['Spinal Anesthesia', 'Machine Learning', 'Knee Arthroplasty, Total', 'Spinal Anesthesia Duration', 'Postoperative Care', 'Postoperative Acute Pain']",Spinal Anesthesia,Kocaeli City Hospital,[],['Turkey (Türkiye)']
NCT07268911,Femoral Rami Obturator Nerve Trunk (FRONT) Block in Intramedullary Nail Surgery .,Femoral Rami Obturator Nerve Trunk (FRONT) Block in Intramedullary Nail Surgery .,RECRUITING,2025-11-01,2026-05,2026-06,INTERVENTIONAL,NA,20,['Anterior Hip Analgesia'],Anterior Hip Analgesia,South Valley University,[],['Egypt']
NCT00359684,Use of Cysteamine in the Treatment of Cystinosis,Use of Cysteamine in the Treatment of Cystinosis,RECRUITING,1979-01-04,,,OBSERVATIONAL,,330,['Cystinosis'],Cystinosis,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06182839,Canagliflozin in Advanced Renal Disease With MRI Endpoints,Canagliflozin in Advanced Renal Disease With MRI Endpoints,RECRUITING,2024-05-01,2028-03-30,2029-03-30,INTERVENTIONAL,PHASE2,92,"['ESRD, CKD Stage 4, CKD Stage 5']","ESRD, CKD Stage 4, CKD Stage 5",McGill University Health Centre/Research Institute of the McGill University Health Centre,['Heart and Stroke Foundation of Canada'],['Canada']
NCT07270601,Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis,Development and Diagnostic Evaluation of a Novel Quantifiable Ultrasound Based Multi-parametric Biomarker for Hepatic Steatosis in Patients With Suspected MASLD ( LYNX ),RECRUITING,2025-11-17,2026-10-31,2026-12-31,INTERVENTIONAL,NA,110,"['MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease', 'NAFLD - Non-Alcoholic Fatty Liver Disease']",MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease,ContextVision AB,['University of Washington'],['United States']
NCT07270666,A Study Using ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer,Pragmatic Pilot Study of ctDNA Informed Immune Checkpoint Inhibitor De-escalation in Advanced/Recurrent Mismatch Repair Deficient (MMR-D)/Microsatellite Instability High (MSI-H) Endometrial Cancer Using Standard of Care Treatments,RECRUITING,2025-11-25,2027-11,2027-11,INTERVENTIONAL,NA,30,['Endometrial Cancer'],Endometrial Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06977737,A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours,A Phase 1-2 Master Protocol to Study Intravenous ATTR-01 in Adult Participants With Select Epithelial Solid Tumours Under Multiple Sub-protocols,RECRUITING,2025-03-21,2029-12-31,2034-12-31,INTERVENTIONAL,PHASE1,72,"['Solid Tumor, Adult']","Solid Tumor, Adult",Accession Therapeutics Limited,[],"['United Kingdom', 'Spain']"
NCT07090824,Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes,Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes,RECRUITING,2025-10-28,2026-07,2026-10,INTERVENTIONAL,PHASE1,20,"['Diabetes Mellitus, Type 1', 'Type 1 Diabetes Mellitus']","Diabetes Mellitus, Type 1",Stanford University,[],['United States']
NCT06934525,Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings,Testing Delivery of Modalities in Community Health Settings: Developing Pathways to Health Equity,RECRUITING,2025-11-01,2029-02-01,2029-08-01,INTERVENTIONAL,NA,501,"['Obsessive Compulsive Disorder (OCD)', 'Pediatric Anxiety Disorders', 'Anxiety Disorder', 'Anxiety', 'OCD', 'Phobia', 'Agoraphobia', 'Generalized Anxiety', 'Generalized Anxiety Disorder', 'Selective Mutism', 'Separation Anxiety', 'Social Anxiety', 'Social Anxiety Disorder', 'Panic Disorder', 'Pediatric Disorders']",Obsessive Compulsive Disorder (OCD),Bradley Hospital,['Patient-Centered Outcomes Research Institute'],['United States']
NCT03230565,Continuous Infusions vs Scheduled Bolus Infusions,A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion,RECRUITING,2018-06-01,2026-12,2026-12,INTERVENTIONAL,PHASE4,240,"['Surgical Procedure, Unspecified', 'Pain, Postoperative']","Surgical Procedure, Unspecified",Stanford University,[],['United States']
NCT06979531,Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity,"A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity",RECRUITING,2025-06-30,2028-07,2028-07,INTERVENTIONAL,PHASE2,180,"[""Primary Sjögren's Syndrome""]",Primary Sjögren's Syndrome,Immunovant Sciences GmbH,[],"['Brazil', 'Hungary', 'United States', 'Mexico', 'Chile', 'Spain', 'Peru', 'Italy', 'Canada', 'Colombia', 'Romania', 'Greece', 'Poland', 'United Kingdom', 'Argentina', 'Germany']"
NCT06919445,Novel Mobile Resource for Food Insecurity,Novel Mobile Resource for Food Insecurity Randomized Controlled Trial,RECRUITING,2025-03-03,2026-03-02,2026-03-02,INTERVENTIONAL,NA,600,['Food Insecurity'],Food Insecurity,Vanderbilt University Medical Center,[],['United States']
NCT06925672,"Knowledge, Attitude and Perception of Pregnant Women Regarding Medications","Assessment Of Knowledge, Attitude and Perception of Pregnant Women Regarding Medications Use",ACTIVE_NOT_RECRUITING,2025-05-01,2025-10-12,2026-01,OBSERVATIONAL,,150,['Medications in Pregnancy'],Medications in Pregnancy,Rania Hassan Mostafa,[],['Egypt']
NCT07110987,The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia,"A Prospective Open-label Randomized Controlled Trial , Evaluating the Efficacy of Ursodeoxycholic Acid (UDCA) as an Adjuvant to Phototherapy in Neonates With Indirect Hyperbilirubinemia",RECRUITING,2025-06-26,2027-01-15,2027-03-01,INTERVENTIONAL,NA,70,"['Hyperbilirubinemia, Neonatal Indirect']","Hyperbilirubinemia, Neonatal Indirect",Tishreen University Hospital,[],['Syria']
NCT01174121,Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer,"A Phase II Study Using Short-Term Cultured, Autologous Tumor-Infiltrating Lymphocytes Following a Lymphodepleting Regimen in Metastatic Cancers Plus the Administration of Pembrolizumab",RECRUITING,2010-08-26,2028-12-27,2029-12-27,INTERVENTIONAL,PHASE2,332,"['Metastatic Colorectal Cancer', 'Metastatic Pancreatic Cancer', 'Metastatic Ovarian Cancer', 'Metastatic Breast Carcinoma', 'Metastatic Endocrine Tumors/ Neuroendocrine Tumors']",Metastatic Colorectal Cancer,National Cancer Institute (NCI),[],['United States']
NCT00024804,A Natural History Study of Bone and Mineral Disorders,A Natural History Study of Bone and Mineral Disorders,RECRUITING,2001-11-19,,,OBSERVATIONAL,,1000,"['Tumor Induced Osteomalcia', 'Osteomalacia', 'Familial Tumoral Calcinosis']",Tumor Induced Osteomalcia,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT07186101,LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:,"A Phase 2, Multicenter, Randomized, Double-Blind, Active-Controlled Study of LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2025-11-11,2027-05,2029-03,INTERVENTIONAL,PHASE2,252,['Ulcerative Colitis'],Ulcerative Colitis,Eli Lilly and Company,[],"['Brazil', 'Japan', 'Hungary', 'Turkey (Türkiye)', 'Netherlands', 'China', 'India', 'Austria', 'United States', 'Mexico', 'Denmark', 'Spain', 'Italy', 'Canada', 'Romania', 'Poland', 'Germany']"
NCT06602453,A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE),"A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events",RECRUITING,2025-01-17,2027-11-15,2027-11-15,INTERVENTIONAL,PHASE2,404,['Acute Kidney Injury'],Acute Kidney Injury,"Genentech, Inc.",[],"['Belgium', 'New Zealand', 'Netherlands', 'United States', 'France', 'Germany', 'Spain', 'South Korea', 'Canada', 'Czechia', 'United Kingdom', 'Australia']"
NCT04430452,Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma,Phase II Trial of Durvalumab (MEDI4736) With/Without Tremelimumab for Advanced Hepatocellular Carcinoma After Palliative Hypofractionated Radiotherapy,RECRUITING,2022-02-04,2028-07-31,2029-07-31,INTERVENTIONAL,PHASE2,21,"['Advanced Hepatocellular Carcinoma', 'Stage III Hepatocellular Carcinoma AJCC v8', 'Stage IIIA Hepatocellular Carcinoma AJCC v8', 'Stage IIIB Hepatocellular Carcinoma AJCC v8', 'Stage IV Hepatocellular Carcinoma AJCC v8', 'Stage IVA Hepatocellular Carcinoma AJCC v8', 'Stage IVB Hepatocellular Carcinoma AJCC v8']",Advanced Hepatocellular Carcinoma,"Mary Feng, MD",['AstraZeneca'],['United States']
NCT00557726,Diagnosis and Management of Inflammatory and Infectious Diseases,Diagnosis and Management of Inflammatory and Infectious Diseases,RECRUITING,1978-02-17,,,OBSERVATIONAL,,400,"['Infection', 'Inflammation']",Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07232108,Intrathecal Morphine Versus Trocar-Site and Intraperitoneal Bupivacaine for Quality of Recovery After Laparoscopic Hysterectomy,"Effects of Intrathecal Morphine Compared With Trocar-Site Infiltration and Intraperitoneal Bupivacaine on Postoperative Quality of Recovery and Inflammatory Markers After Laparoscopic Hysterectomy: A Prospective, Randomized, Double-Blind Controlled Trial",RECRUITING,2025-12-01,2026-06-01,2026-06-02,INTERVENTIONAL,NA,64,"['Postoperative Pain Management', 'Laparoscopic Hysterectomy', 'Postoperative Recovery']",Postoperative Pain Management,Ataturk University,[],['Turkey (Türkiye)']
NCT06706076,A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations,"A Phase 1/2 Open-Label, Multicenter, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of BH-30643 in Adult Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations (SOLARA)",RECRUITING,2025-01-09,2029-01-31,2029-07-31,INTERVENTIONAL,PHASE1,266,['NSCLC (Advanced Non-small Cell Lung Cancer)'],NSCLC (Advanced Non-small Cell Lung Cancer),BlossomHill Therapeutics,[],"['Singapore', 'Japan', 'Hong Kong', 'United States', 'Taiwan', 'Canada', 'Malaysia', 'Australia']"
NCT07269249,Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer,Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer,RECRUITING,2025-09-01,2027-01,2027-12,OBSERVATIONAL,,50,['Locally Advanced Rectal Cancer (LARC)'],Locally Advanced Rectal Cancer (LARC),"National Cancer Institute, Naples",[],['Italy']
NCT03065335,Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder,Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder,RECRUITING,2017-05-25,2026-01-01,2028-01-01,INTERVENTIONAL,PHASE1,150,"['Healthy Volunteer', 'Major Depressive Disorder', 'Depression']",Healthy Volunteer,National Institute of Mental Health (NIMH),[],['United States']
NCT06553625,Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS,Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System,RECRUITING,2024-01-29,2035-12,2035-12,OBSERVATIONAL,,200,"['Parkinson Disease', 'Dystonia', 'Essential Tremor', 'Movement Disorders']",Parkinson Disease,Boston Scientific Corporation,[],"['United Kingdom', 'Germany']"
NCT03909347,PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers,PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers,ACTIVE_NOT_RECRUITING,2021-04-20,2026-08-31,2026-08-31,INTERVENTIONAL,NA,288,['Dementia'],Dementia,Johns Hopkins University,"['National Institutes of Health (NIH)', 'NYU Langone Health', 'National Institute on Aging (NIA)']",['United States']
NCT06937476,Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole,Investigation of the Neurobiological Mechanisms Underlying Pathological Rumination and the Pharmacological Effects of Aripiprazole,RECRUITING,2025-05-08,2026-01,2026-03,INTERVENTIONAL,NA,60,"['Major Depressive Disorder (MDD)', 'Rumination']",Major Depressive Disorder (MDD),Central South University,"['Second Xiangya Hospital of Central South University', 'National Natural Science Foundation of China']",['China']
NCT05189925,NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD),NADPH Oxidase Correction in mRNA Transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD),RECRUITING,2022-07-22,2026-07-01,2026-07-01,INTERVENTIONAL,PHASE1,25,"['Chronic Granulomatous Disease', 'Infection']",Chronic Granulomatous Disease,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07231497,Cognitive Strategies in Early Psychosis 1,Cognitive Strategies in Early Psychosis 1,RECRUITING,2025-11-12,2030-04-30,2030-04-30,INTERVENTIONAL,PHASE3,103,"['Cognition', 'Healthy Participants']",Cognition,University of Minnesota,['National Institute of Mental Health (NIMH)'],['United States']
NCT06762444,Bump the Lump - Intervention for the Treatment of Globus Pharyngeus,Bump the Lump: Creation and Validation of Speech Language Pathology Intervention for the Treatment of Globus Pharyngeus,RECRUITING,2025-08-28,2026-08,2026-08,INTERVENTIONAL,NA,10,['Globus Pharyngeus'],Globus Pharyngeus,Wake Forest University Health Sciences,[],['United States']
NCT07269600,"Effects of Sarcopenia on Proprioception, Kinesiophobia, and Pressure Pain Threshold","The Effects of Sarcopenia on Cervical Proprioception, Kinesiophobia and Pressure Pain Threshold in Geriatric Nursing Home Residents",ACTIVE_NOT_RECRUITING,2025-04-01,2025-12-31,2026-01-30,OBSERVATIONAL,,31,['Sarcopenia in Elderly'],Sarcopenia in Elderly,Atılım University,[],['Turkey (Türkiye)']
NCT06733038,FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.,Phase III Randomized Study of FOLFOXIRI Plus Bevacizumab and Atezolizumab Versus FOLFOXIRI Plus Bevacizumab as First-Line Treatment of Unresectable pMMR and Immunoscore IC-High Metastatic Colorectal Cancer Patients,RECRUITING,2024-11-15,2028-04-01,2029-04-01,INTERVENTIONAL,PHASE3,238,['Colorectal Cancer'],Colorectal Cancer,Gruppo Oncologico del Nord-Ovest,['Hoffmann-La Roche'],['Italy']
NCT00017914,Adult and Juvenile Myositis,Studies in the Natural History and Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies,RECRUITING,1995-06-07,,,OBSERVATIONAL,,1200,"['Dermatomyositis', 'Polymyositis', 'Inclusion Body Myositis']",Dermatomyositis,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT07044297,A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011),"A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis",RECRUITING,2025-07-31,2027-07-22,2027-07-22,INTERVENTIONAL,PHASE3,4390,"['Human Immunodeficiency Virus (HIV)', 'HIV Pre-Exposure Prophylaxis']",Human Immunodeficiency Virus (HIV),Merck Sharp & Dohme LLC,[],"['South Africa', 'United States', 'France', 'Switzerland', 'Guatemala', 'Thailand', 'Malaysia', 'Dominican Republic', 'Argentina']"
NCT07269379,Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients,Intradialytic Exercise With Blood Flow Restriction by Vascular Occlusion: A New Strategy for Cardioprotection in Hemodialysis Patients,RECRUITING,2025-11-06,2028-05-06,2028-10-06,INTERVENTIONAL,NA,108,['Dialysis Patients'],Dialysis Patients,University of Avignon,"['Médipôle Lyon-Villeurbanne', ""Nouvel Hôpital Civil, 1 place de l'Hôpital 67091 Strasbourg cedex""]",['France']
NCT07007312,Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML,"Phase 3 Randomized, Double-blind, Placebo-controlled Studies Assessing Ziftomenib in Combination With Either Standard of Care Nonintensive (Venetoclax+Azacitidine) or Intensive (7+3) Therapy in Patients With Untreated NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia",RECRUITING,2025-09-26,2031-11,2031-11,INTERVENTIONAL,PHASE3,1300,['Acute Myeloid Leukemia (AML)'],Acute Myeloid Leukemia (AML),"Kura Oncology, Inc.",[],['United States']
NCT05487599,A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED),"An Open-label, Dose-Finding, Phase 1/2 Study to Evaluate the Safety and Tolerability of a Single Intravenous Dose of LY3884961 in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)",RECRUITING,2022-12-20,2031-11-30,2031-11-30,INTERVENTIONAL,PHASE1,15,"['Gaucher Disease', 'Gaucher Disease, Type 1']",Gaucher Disease,Prevail Therapeutics,['Eli Lilly and Company'],"['Brazil', 'United States', 'Spain', 'Australia', 'United Kingdom', 'Germany']"
NCT02543983,Neurobiology of Suicide,The Neurobiology of Suicide,RECRUITING,2015-12-01,2026-07-21,2026-07-21,INTERVENTIONAL,PHASE2,325,"['Healthy Volunteers', 'Depression']",Healthy Volunteers,National Institute of Mental Health (NIMH),[],['United States']
NCT06128863,Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial,"Phase II, Single-arm Clinical Trial Evaluating Efficacy and Safety of Pembrolizumab in Combination With a Soluble LAG-3 Protein, Eftilagimod Alpha, and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcomas (EFTISARC-NEO)",ACTIVE_NOT_RECRUITING,2023-07-17,2025-04-30,2027-04-30,INTERVENTIONAL,PHASE2,40,"['Neoadjuvant', 'Immunotherapy', 'Sarcoma,Soft Tissue', 'Radiation Therapy']",Neoadjuvant,Maria Sklodowska-Curie National Research Institute of Oncology,['Immutep S.A.S.'],['Poland']
NCT01352975,Study of Dark Adaptation in Age-Related Macular Degeneration,Longitudinal Investigation of Dark Adaptation in Participants With Age-Related Macular Degeneration,ACTIVE_NOT_RECRUITING,2011-05-16,,,OBSERVATIONAL,,217,['Age-Related Macular Degeneration'],Age-Related Macular Degeneration,National Eye Institute (NEI),[],['United States']
NCT07270744,Data Collection Using Eko Devices in a Clinical Setting,Data Collection Using Eko Digital Devices in a Clinical Setting,RECRUITING,2025-10-01,2026-10-01,2026-12-31,OBSERVATIONAL,,200,['Lung Diseases'],Lung Diseases,"Eko Devices, Inc.",[],['India']
NCT05521984,Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i),Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i),RECRUITING,2023-04-03,2026-08-31,2026-11-30,INTERVENTIONAL,PHASE1,20,"['Pediatric Brain Tumor', 'Pediatric Solid Tumor']",Pediatric Brain Tumor,Washington University School of Medicine,"[""Children's Discovery Institute""]",['United States']
NCT04870125,Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS),A Phase Ib Trial of Inhaled Carbon Monoxide for the Treatment of Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS),ACTIVE_NOT_RECRUITING,2023-12-06,2024-10-25,2026-03-31,INTERVENTIONAL,PHASE1,5,"['Acute Respiratory Distress Syndrome', 'Sepsis']",Acute Respiratory Distress Syndrome,Brigham and Women's Hospital,"['Weill Medical College of Cornell University', 'Massachusetts General Hospital', 'Duke University', 'National Heart, Lung, and Blood Institute (NHLBI)', 'Washington University School of Medicine']",['United States']
NCT05604534,Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects,Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects,RECRUITING,2023-02-02,2041-03-31,2041-03-31,OBSERVATIONAL,,200,['Normal Physiology'],Normal Physiology,National Institute of Neurological Disorders and Stroke (NINDS),['National Institute for Biomedical Imaging and Bioengineering (NIBIB)'],['United States']
NCT06583148,A Smoke-Free Home Intervention in Tribal Communities,Assessing the Effectiveness of a Smoke-Free Home Program in Tribal Communities,RECRUITING,2024-11-15,2028-01-31,2029-01-31,INTERVENTIONAL,NA,575,['Tobacco-Related Carcinoma'],Tobacco-Related Carcinoma,Emory University,"['National Cancer Institute (NCI)', 'National Institutes of Health (NIH)']",['United States']
NCT06341114,"A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors","A Multicenter, Open-label Phase Ib-II Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2024-04-12,2026-04-03,2026-07-28,INTERVENTIONAL,PHASE1,112,['Advanced Solid Tumors'],Advanced Solid Tumors,Bio-Thera Solutions,[],['China']
NCT03827343,Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer,Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer,ACTIVE_NOT_RECRUITING,2019-01-23,2025-12-31,2025-12-31,OBSERVATIONAL,,500,"['Macrophage Activation Syndrome', 'Primary Hemophagocytic Lymphohistiocytosis']",Macrophage Activation Syndrome,National Cancer Institute (NCI),[],['United States']
NCT05984979,The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes,The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and With Type 1 and 2 Diabetes: an Exploratory Study,RECRUITING,2023-08-07,2026-06-30,2026-06-30,OBSERVATIONAL,,60,['Diabetes Mellitus'],Diabetes Mellitus,University of Bern,"['Insel Gruppe AG, University Hospital Bern', 'DCB Research AG']",['Switzerland']
NCT06735560,"Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN","Prospective Pilot Study Assessing Imaging Performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in Patients With HepatoCellular Carcinoma, IntraHepatic CholangioCarcinoma or Gastro-Entero-Pancreatic Neuroendocrine Neoplasms",RECRUITING,2025-11-04,2027-05-04,2027-08-04,INTERVENTIONAL,NA,60,"['Hepatocellular Carcinoma (HCC)', 'Intrahepatic Cholangiocarcinoma (Icc)', 'Neuroendocrine Tumors']",Hepatocellular Carcinoma (HCC),Nantes University Hospital,[],['France']
NCT05028140,Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus,"National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus",RECRUITING,2024-10-08,2026-07,2027-09,INTERVENTIONAL,PHASE3,480,['Type II Diabetes'],Type II Diabetes,EMS,[],['Brazil']
NCT06212427,Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs),Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs): A Post-Market Study,RECRUITING,2023-11-20,2026-02-28,2026-02-28,INTERVENTIONAL,NA,188,"['Premature Infant', 'Low Birthweight Infant']",Premature Infant,Société des Produits Nestlé (SPN),[],"['Austria', 'Germany']"
NCT07270003,"A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis","A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis",RECRUITING,2025-10-01,2026-10-01,2026-10-01,INTERVENTIONAL,NA,60,['Palmoplantar Pustulosis (PPP)'],Palmoplantar Pustulosis (PPP),Xijing Hospital,[],['China']
NCT07223593,Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease,"A Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Peripheral Artery Disease: A Randomized, Double-Blind, Placebo Controlled Trial",RECRUITING,2025-10-31,2028-06,2028-06,INTERVENTIONAL,PHASE3,1205,['Peripheral Arterial Disease'],Peripheral Arterial Disease,Eli Lilly and Company,[],"['Brazil', 'Japan', 'Netherlands', 'China', 'India', 'United States', 'France', 'Slovakia', 'Puerto Rico', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT05983133,A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors,A Phase 1 Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors,RECRUITING,2023-11-14,2029-01-09,2030-01-09,INTERVENTIONAL,PHASE1,290,"['Colorectal Neoplasms', 'Carcinoma, Non-Small-Cell Lung', 'Squamous Cell Carcinoma of the Head and Neck', 'Pancreatic Ductal Adenocarcinoma']",Colorectal Neoplasms,"Seagen, a wholly owned subsidiary of Pfizer",[],"['United Kingdom', 'United States']"
NCT04944030,Clinico-biological Data Collection Study of Metastatic Lung Cancer,Prediction in Silico of Therapeutic Response in a Prospective Cohort Study of Metastatic Lung Cancer Patients,RECRUITING,2023-04-24,2031-10,2031-10,INTERVENTIONAL,NA,200,['Lung Cancer'],Lung Cancer,Institut Cancerologie de l'Ouest,[],['France']
NCT04235777,Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies,A Phase I Study of Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies,RECRUITING,2020-07-13,2027-12-01,2027-12-01,INTERVENTIONAL,PHASE1,100,"['Urothelial Cancer', 'Bladder Cancer', 'Genitourinary Cancer', 'Urogenital Neoplasms', 'Urogenital Cancer']",Urothelial Cancer,National Cancer Institute (NCI),[],['United States']
NCT06003231,A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2,"A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects With Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2",ACTIVE_NOT_RECRUITING,2023-11-14,2026-05-31,2028-05-31,INTERVENTIONAL,PHASE2,120,"['Carcinoma, Non-Small-Cell Lung', 'Ovarian Neoplasms', 'Endometrial Neoplasms', 'Head and Neck Neoplasms']","Carcinoma, Non-Small-Cell Lung","Seagen, a wholly owned subsidiary of Pfizer",[],"['United States', 'Spain', 'South Korea', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT06345729,A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004),"A Phase 3, Randomized, Double-blind, Multicenter Study of MK-1084 in Combination With Pembrolizumab Compared With Pembrolizumab Plus Placebo as Firstline Treatment of Participants With KRAS G12C-Mutant, Locally Advanced or Metastatic NSCLC With PD-L1 TPS ≥50% (KANDLELIT-004)",RECRUITING,2024-05-24,2029-02-19,2031-02-18,INTERVENTIONAL,PHASE3,600,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Merck Sharp & Dohme LLC,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'France', 'Chile', 'South Korea', 'Poland', 'Mexico', 'Georgia', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT00001853,Diabetes and Heart Disease Risk in Blacks,Diabetes and Heart Disease Risk in Blacks,RECRUITING,1998-10-21,,,OBSERVATIONAL,,2000,"['Cardiovascular Diseases', 'Diabetes', 'Obesity', 'Hypertension']",Cardiovascular Diseases,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07270419,Aneurysmal Subarachnoid Hemorrhage Multi-Omics Research Program,Aneurysmal Subarachnoid Hemorrhage Multi-Omics Research Program (aSAH-Omics) ：A Multicenter Clinical and Mechanistic Study,RECRUITING,2023-11-01,2026-12-01,2027-12-01,OBSERVATIONAL,,2000,['Aneurysmal Subarachnoid Hemorrhage'],Aneurysmal Subarachnoid Hemorrhage,"Xiaolin Chen, MD",['Peking Union Medical College'],['China']
NCT00005902,Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease,A Prospective Natural History Study of VHL Patients With CNS Hemangioblastomas,ACTIVE_NOT_RECRUITING,2001-02-15,,,OBSERVATIONAL,,250,"['Hemangioblastoma', 'Hippel Lindau Disease']",Hemangioblastoma,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT00339495,Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial,Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial,ACTIVE_NOT_RECRUITING,1998-05-01,2025-12-31,2025-12-31,OBSERVATIONAL,,154900,"['Cancer', 'Death']",Cancer,National Cancer Institute (NCI),[],['United States']
NCT06035939,SMYLS Multi-site Trial,Self-Management for Youth Living With Sickle Cell Disease: SMYLS Multi-site Trial,RECRUITING,2024-04-04,2027-07-31,2028-01-31,INTERVENTIONAL,NA,272,['Sickle Cell Disease'],Sickle Cell Disease,Medical University of South Carolina,['National Institute of Nursing Research (NINR)'],['United States']
NCT06736574,Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction,"A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients With Symptomatic Heart Failure With Severely Reduced Ejection Fraction (COMET-HF)",RECRUITING,2024-12-19,2027-09,2027-12,INTERVENTIONAL,PHASE3,1800,"['Heart Failure', 'Heart Failure With Reduced Ejection Fraction']",Heart Failure,Cytokinetics,[],"['United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Greece', 'Poland', 'Germany']"
NCT02089789,Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation,Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation and Deglycosylation,RECRUITING,2014-03-07,2030-12-01,2030-12-01,OBSERVATIONAL,,200,['Congenital Disorders of Glycosylation'],Congenital Disorders of Glycosylation,National Human Genome Research Institute (NHGRI),[],['United States']
NCT01629108,Normal Values in Hearing and Balance Testing,Normative Values in Audiovestibular Testing,RECRUITING,2012-09-21,,,OBSERVATIONAL,,500,['Healthy Volunteer'],Healthy Volunteer,National Institute on Deafness and Other Communication Disorders (NIDCD),[],['United States']
NCT00404560,Detection and Characterization of Infections and Infection Susceptibility,Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility,RECRUITING,2007-01-02,,,OBSERVATIONAL,,2000,['Immune Deficiencies'],Immune Deficiencies,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06858579,A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE),"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of DNTH103 In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)",RECRUITING,2025-02-10,2028-12-31,2030-12-31,INTERVENTIONAL,PHASE3,480,['Chronic Inflammatory Demyelinating Polyneuropathy'],Chronic Inflammatory Demyelinating Polyneuropathy,Dianthus Therapeutics,[],"['Bulgaria', 'China', 'United States', 'France', 'Georgia', 'Germany', 'Denmark', 'Spain', 'Italy', 'Romania', 'United Kingdom', 'Latvia', 'Poland', 'Serbia', 'Argentina', 'Australia']"
NCT07270497,The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight,The Effect of Pharmacotherapy With GLP-1 and GIP/GLP-1 Analogs on Changes in Qualitative and Quantitative Parameters of the Diet as Well as Metabolic and Behavioral Parameters in Patients With Excess Body Weight,RECRUITING,2025-08-15,2026-08-14,2026-08-14,OBSERVATIONAL,,100,"['GLP-1', 'Nutrition']",GLP-1,Medical University of Warsaw,[],['Poland']
NCT06106360,A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy,A Pilot Prospective Clinical Trial Using Remote Patient Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy,RECRUITING,2023-10-26,2025-11-01,2026-06-26,OBSERVATIONAL,,100,"['Solid Tumor', 'Hematological Malignancy']",Solid Tumor,Inova Health Care Services,[],['United States']
NCT07270978,Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS,Phase Ib Study of Anti-CD3 x Anti-CD33 Bispecific Antibody (CD33Bi) Armed Fresh Peripheral Blood Mononuclear Cells (CD33 FPBMC) in Patients With Measurable Residual Disease (MRD)+ Acute Myeloid Leukemia or Myelodysplastic Syndrome,RECRUITING,2025-12,2028-06,2031-05,INTERVENTIONAL,PHASE1,23,"['Acute Myeloid Leukemia', 'Myelodysplastic Syndromes', 'Myelodysplastic/Myeloproliferative Neoplasm']",Acute Myeloid Leukemia,University of Virginia,[],['United States']
NCT00001846,Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use,Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use,RECRUITING,2001-01-11,,,OBSERVATIONAL,,5000,"['Blood Donors', 'Research Subjects', 'Apheresis']",Blood Donors,National Institutes of Health Clinical Center (CC),[],['United States']
NCT07255261,Evaluation of Facial HA Dermal Fillers in Real-Life Conditions,Post-Marketing Clinical Follow Up On Hyaluronic Acid-Based Dermal Fillers Using COLD-X™ Technology By Symatese,RECRUITING,2025-07-02,2028-07,2028-07,INTERVENTIONAL,NA,460,"['Lips Enhancement', 'Perioral Wrinkles', 'Nasolabial Fold Wrinkles', 'Cheek Augmentation', 'Infraorbital Hollows']",Lips Enhancement,Symatese,[],['France']
NCT01200953,Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases,Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases,RECRUITING,2011-08-04,,,OBSERVATIONAL,,200,"['Occupational Accidents', 'Incubation Period, Infectious Disese']",Occupational Accidents,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT01950572,Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma,Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma and Other Mesothelin Expressing Cancers,RECRUITING,2013-09-09,2033-07-25,,OBSERVATIONAL,,1000,"['Mesothelioma', 'Thymoma', 'Pancreatic Neoplasms', 'Biliary Tract Neoplasms', 'Stomach Neoplasms']",Mesothelioma,National Cancer Institute (NCI),[],['United States']
NCT03773965,A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis,A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA),RECRUITING,2019-04-05,2031-07,2031-07,INTERVENTIONAL,PHASE3,190,['Juvenile Idiopathic Arthritis'],Juvenile Idiopathic Arthritis,Eli Lilly and Company,[],"['Japan', 'China', 'Australia', 'Belgium', 'Israel', 'Russia', 'France', 'Denmark', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'Italy', 'Argentina']"
NCT04657081,"Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)","A Single-Arm, Open-Label Pharmacokinetic, Safety, and Efficacy Study of ASTX727 in Combination With Venetoclax in Adult Patients With Acute Myeloid Leukemia",ACTIVE_NOT_RECRUITING,2021-02-09,2024-09-30,2026-12-31,INTERVENTIONAL,PHASE1,101,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,"Taiho Oncology, Inc.",[],"['Spain', 'United States', 'Canada']"
NCT05689151,A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.,Treating Atopic Dermatitis With Abrocitinib and Its Impact in Real Life: An Observational Cohort Study To Describe the Effectiveness of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis.,RECRUITING,2023-03-09,2026-06-05,2027-12-31,OBSERVATIONAL,,183,"['Atopic Dermatitis', 'Eczema']",Atopic Dermatitis,Pfizer,[],['France']
NCT07270757,Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Atrial Fibrillation Patients,Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Patients With Atrial Fibrillation: A Randomized Controlled Trial,RECRUITING,2025-02-01,2026-02,2026-03,INTERVENTIONAL,NA,100,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),Nanjing Medical University,[],['China']
NCT07215312,A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin,"A Phase 2, Randomized, Open-Label, Comparator-Controlled Trial to Evaluate the Efficacy and Safety of LY3938577 in Study Participants, With Type 2 Diabetes Previously Treated With Basal Insulin",RECRUITING,2025-10-13,2026-11,2026-12,INTERVENTIONAL,PHASE2,100,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",Eli Lilly and Company,[],"['Argentina', 'United States']"
NCT05866419,Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy,"Safety and Performance of the ThecaFlex DRx™ System Port and Catheter for Chronic Intrathecal Access, Cerebrospinal Fluid (CSF) Aspiration, and DElivery of Nusinersen in Spinal Muscular Atrophy (SMA) Patients Resistant to Lumbar PunctuRE Trial (PIERRE)",RECRUITING,2023-11-27,2026-05,2027-03,INTERVENTIONAL,NA,90,"['Spinal Muscular Atrophy', 'Spine Deformity', 'Scoliosis']",Spinal Muscular Atrophy,"Alcyone Therapeutics, Inc",['Biogen'],"['United States', 'Spain', 'Italy', 'Poland', 'Germany']"
NCT04034264,Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing,Characterization of Febrile Disease Landscape in Cambodia Via Metagenomic Pathogen Sequencing,RECRUITING,2019-07-23,2026-07-01,2026-07-01,OBSERVATIONAL,,6500,"['Vector-Borne Diseases', 'Emerging Pathogens']",Vector-Borne Diseases,National Institute of Allergy and Infectious Diseases (NIAID),[],['Cambodia']
NCT01900132,Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers,Electrical Impedance Myography: Natural History Studies in Neuromuscular Disorders and Healthy Volunteers,RECRUITING,2013-06-20,2026-06-01,2026-06-01,INTERVENTIONAL,NA,275,"['Neuromuscular Disease', 'Motor Neuron Disease', 'Inherited Neuromuscular Conditions', 'Inherited Neuropathies']",Neuromuscular Disease,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07270692,Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence,Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence,RECRUITING,2025-08-01,2026-08-01,2026-11-01,OBSERVATIONAL,,500,['Low Ejection Fraction'],Low Ejection Fraction,"Eko Devices, Inc.",[],['India']
NCT02682667,Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols,Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols,RECRUITING,2016-04-11,2030-12-01,2032-12-01,OBSERVATIONAL,,500,"['Multiple Myeloma', 'Lymphoma, Non-Hodgkin', 'Leukemia-Lymphoma, Adult T-Cell', 'Hodgkin Disease', 'Non-Small Cell Lung Cancer']",Multiple Myeloma,National Cancer Institute (NCI),[],['United States']
NCT02531880,Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy,Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy,RECRUITING,2024-11-19,2026-07-01,2026-07-01,INTERVENTIONAL,PHASE1,40,['Epilepsy'],Epilepsy,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06358040,Opioid Dispenser for Microdiscectomy/Laminectomy,Use of a Novel Device to Dispense Postoperative Opioids in Patients Undergoing Microdiscectomy/Laminectomy: A Pilot Study,RECRUITING,2026-10,2026-10,2026-12,INTERVENTIONAL,NA,30,"['Opioid Use', 'Pain, Postoperative', 'Medical Device', 'Laminectomy', 'Diskectomy']",Opioid Use,"Hospital for Special Surgery, New York",[],['United States']
NCT07017010,Optimizing Phonological Awareness Learning in Prekindergarten and Kindergarten to Improve Later Reading and Spelling,Optimizing Phonological Awareness Learning in Prekindergarten and Kindergarten to Improve Later Reading and Spelling,RECRUITING,2025-09-12,2029-07,2029-07,INTERVENTIONAL,NA,720,['Reading Difficulties'],Reading Difficulties,Ohio State University,"['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'Florida State University']",['United States']
NCT03301220,A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma,"A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects With High-Risk Smoldering Multiple Myeloma",ACTIVE_NOT_RECRUITING,2017-11-07,2024-05-01,2026-06-30,INTERVENTIONAL,PHASE3,390,['Smoldering Multiple Myeloma'],Smoldering Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Denmark', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT03388606,Characterization and Treatment of Adolescent Depression,Characterization and Treatment of Adolescent Depression,RECRUITING,2017-12-28,2026-07-01,2026-07-01,OBSERVATIONAL,,4100,['Depression'],Depression,National Institute of Mental Health (NIMH),[],['United States']
NCT00091871,A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression,A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression,RECRUITING,2005-06-08,,,OBSERVATIONAL,,50,"['Eosinophilia', 'Hypereosinophilic Syndrome']",Eosinophilia,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07271017,Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe,Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe,RECRUITING,2025-09-23,2030-05-31,2030-05-31,INTERVENTIONAL,PHASE1,60,['Prostate Cancer (Diagnosis)'],Prostate Cancer (Diagnosis),Johns Hopkins University,['National Cancer Institute (NCI)'],['United States']
NCT04145349,CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor,"A Randomized, Open-Label Phase 1/2 Study Evaluating Ramucirumab in Pediatric Patients and Young Adults With Relapsed, Recurrent, or Refractory Desmoplastic Small Round Cell Tumor",ACTIVE_NOT_RECRUITING,2020-01-22,2024-06-14,2026-10,INTERVENTIONAL,PHASE1,30,['Desmoplastic Small Round Cell Tumor'],Desmoplastic Small Round Cell Tumor,Eli Lilly and Company,[],"['Japan', 'United States', 'Spain', 'Italy', 'Australia', 'United Kingdom', 'Germany']"
NCT06192342,Ventilatory Parameters in Acute Neurological Injury,Baseline Ventilatory Parameters in Patients With Acute Neurological Injury,RECRUITING,2024-05-01,2026-05-30,2027-05-30,OBSERVATIONAL,,19,"['Neurologic Decompensation, Acute', 'Traumatic Brain Injury', 'Stroke', 'Subarachnoid Hemorrhage']","Neurologic Decompensation, Acute",Ramos Mejía Hospital,[],['Argentina']
NCT07269561,"Headache Registration and Followup Initiated by Tongji Hospital, HUST","Headache Registration and Followup Initiated by Tongji Hospital, HUST",RECRUITING,2024-01-01,2028-12-31,2028-12-31,OBSERVATIONAL,,50000,"['Headache', 'Comorbidities']",Headache,Tongji Hospital,[],['China']
NCT02872532,Testicular Tissue Cryopreservation in Children,Testicular Tissue Cryopreservation for Fertility Preservation in Males Facing Fertility Threatening Diagnoses or Treatment Regimens,RECRUITING,2016-08-16,2030-12,2030-12,INTERVENTIONAL,NA,200,"['Cancer', 'Cancer-Related Condition', 'Infertility']",Cancer,Mayo Clinic,[],['United States']
NCT07221890,A Trial of Academic Detailing to Promote Prescribing of Biosimilars,A Trial of Academic Detailing to Promote Prescribing of Biosimilars,ACTIVE_NOT_RECRUITING,2025-11-06,2026-12-31,2027-03-31,INTERVENTIONAL,NA,1325,"['Autoimmune Diseases', 'Rheumatoid Arthritis (RA)', 'Inflammatory Bowel Disease (IBD)', 'Psoriasis (PsO)']",Autoimmune Diseases,Brigham and Women's Hospital,"['Humana Healthcare Research, Inc.']",['United States']
NCT06356025,Botulinum Toxin Injection in the UES for R-CPD,"Botulinum Toxin Injection in the Upper Esophageal Sphincter for Retrograde-cricopharyngeus Dysfunction: a Prospective, Double Blind, Placebo-controlled Trial",ACTIVE_NOT_RECRUITING,2024-09-02,2025-12,2027-03,INTERVENTIONAL,PHASE4,50,['Retrograde Cricopharyngeus Dysfunction'],Retrograde Cricopharyngeus Dysfunction,AZ Delta,['KU Leuven'],['Belgium']
NCT07270614,Eight-week Sports Injury Prevention Program,Effects of an 8-Week Injury Prevention Program on Lower Limb Performance in Female Athletes: Quasi-Experimental Evidence,RECRUITING,2025-08-16,2025-12-30,2026-01-01,INTERVENTIONAL,NA,30,['Health Adult Subjects'],Health Adult Subjects,Princess Nourah Bint Abdulrahman University,[],['Saudi Arabia']
NCT07268755,Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection,"Multi-center, Real-world Study on the Treatment of Thoracic Aortic Dissection With a Straight-type Fenestrated Covered Stent System for Thoracic Aortic Aneurysms",ACTIVE_NOT_RECRUITING,2024-12-01,2027-11-30,2027-11-30,OBSERVATIONAL,,320,"['Thoracic Aortic Dissection', 'Thoracic Aortic Disease']",Thoracic Aortic Dissection,Qingyou Meng,[],['China']
NCT06991556,An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC),"A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)",RECRUITING,2025-07-07,2032-04-19,2035-11-07,INTERVENTIONAL,PHASE2,150,['Metastatic Hormone-sensitive Prostate Cancer'],Metastatic Hormone-sensitive Prostate Cancer,Novartis Pharmaceuticals,[],"['Singapore', 'Netherlands', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Czechia', 'Australia', 'Poland', 'Germany']"
NCT00077909,Study of Lung Proteins in Patients With Pneumonia,Biomarkers and Protein Mass Expression Profiles in Bronchoalveolar Lavage From Patients With Lung Infiltrates,RECRUITING,2004-02-20,,,OBSERVATIONAL,,750,"['Pneumonia', 'Pulmonary Disease', 'Lung Disease']",Pneumonia,National Institutes of Health Clinical Center (CC),[],['United States']
NCT07174726,A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa,A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa,RECRUITING,2025-09-10,2027-06-30,2030-12-15,INTERVENTIONAL,PHASE2,10,['X-Linked Retinitis Pigmentosa (XLRP)'],X-Linked Retinitis Pigmentosa (XLRP),Beacon Therapeutics,[],['United States']
NCT04923178,A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies,A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies,RECRUITING,2022-10-24,2041-12-01,2042-12-01,OBSERVATIONAL,,1100,"['Urothelial Cancer', 'Bladder Cancer', 'Genitourinary Cancer', 'Urogenital Neoplasms', 'Urogenital Cancer']",Urothelial Cancer,National Cancer Institute (NCI),[],['United States']
NCT07061704,Oncolytic Virus in Esophageal Squamous Cell Carcinoma,"Oncolytic Virus Combined With Chemotherapy and Immune Checkpoint Inhibitors in Patients With Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma：An Open-label, Single-arm Phase II Study",RECRUITING,2025-08-01,2027-08-01,2027-09-01,INTERVENTIONAL,PHASE1,40,['Esophageal Cancer'],Esophageal Cancer,Sichuan University,[],['China']
NCT04288635,Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study,Impact of Metabolite Supplementation to Restore Mitochondrial Dysfunction During Septic Shock: a Preclinical Study: MEFDASE Study,RECRUITING,2020-07-09,2026-07-09,2026-08-09,OBSERVATIONAL,,55,"['Septic Shock', 'Multiple Organ Failure']",Septic Shock,"University Hospital, Angers",[],['France']
NCT03579394,Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer,CHRONO - Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer,ACTIVE_NOT_RECRUITING,2018-10-19,2027-06,2028-07,INTERVENTIONAL,NA,211,"['Ovarian Cancer Stage IV', 'Ovarian Cancer Stage IIIC', 'Ovarian Cancer Stage IIIb']",Ovarian Cancer Stage IV,ARCAGY/ GINECO GROUP,[],['France']
NCT07268586,"Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention",RECRUITING,2025-08-01,2025-12,2025-12,INTERVENTIONAL,PHASE4,150,['Myocardial Infarction'],Myocardial Infarction,Ain Shams University,[],['Egypt']
NCT06529679,Michigan Split-belt Treadmill Training Program to Improve Acute Knee Biomechanics After ACL Reconstruction,Mi-SPA: Michigan Split-belt Adaptation Paradigm to Improve Knee Loading After Anterior Cruciate Ligament Reconstruction (Aim 2),RECRUITING,2024-10-29,2025-12-31,2025-12-31,INTERVENTIONAL,NA,30,"['ACL', 'ACL Injury']",ACL,University of Michigan,['National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)'],['United States']
NCT07219173,A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma,"A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma",RECRUITING,2025-10-22,2028-04,2028-06,INTERVENTIONAL,PHASE2,531,['Asthma'],Asthma,Eli Lilly and Company,[],"['Brazil', 'Japan', 'Netherlands', 'China', 'India', 'United States', 'France', 'Mexico', 'Canada', 'Poland', 'Argentina', 'Germany']"
NCT05882058,DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers,"DAREON™-5: An Open-label, Multi-center Phase II Dose Selection Trial of Intravenous BI 764532, a DLL3-targeting T Cell Engager, in Patients With Relapsed/Refractory Extensive-stage Small Cell Lung Cancer and in Patients With Other Relapsed/Refractory Neuroendocrine Carcinomas",RECRUITING,2023-10-13,2027-01-29,2027-07-30,INTERVENTIONAL,PHASE2,174,"['Small Cell Lung Carcinoma', 'Neuroendocrine Neoplasms', 'Extra-pulmonary Neuroendocrine Carcinoma']",Small Cell Lung Carcinoma,Boehringer Ingelheim,[],"['Belgium', 'Bulgaria', 'Japan', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'United Kingdom', 'Portugal', 'Germany']"
NCT05453058,Observational Study in Multiple System Atrophy,TALISMAN - Tracking Longitudinal Changes in MSA - International Natural History Study,ACTIVE_NOT_RECRUITING,2022-06-25,2024-03-12,2031-05-30,OBSERVATIONAL,,90,['Multiple System Atrophy'],Multiple System Atrophy,H. Lundbeck A/S,[],['China']
NCT06994845,"Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN","A Single-arm, Multicenter, Phase III Study to Assess Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients of 2 to <18 Years of Age With Primary Immunoglobulin A Nephropathy (IgAN)",RECRUITING,2025-11-27,2030-06-28,2030-06-30,INTERVENTIONAL,PHASE3,34,['Primary Immunoglobulin A Nephropathy (IgAN)'],Primary Immunoglobulin A Nephropathy (IgAN),Novartis Pharmaceuticals,[],"['China', 'Israel', 'Japan', 'United States']"
NCT07077616,Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.,"Clinical Study for the Therapeutic Efficacy and Safety of a Personalized and AI-Quantum Mechanics Based and Molecular Modeled Cancer Specific Neoantigenic Vaccine, the TamavaqTM NeoVaccine in Patients With Newly Diagnosed Glioma.",RECRUITING,2025-07-01,2027-12-01,2029-12-01,INTERVENTIONAL,EARLY_PHASE1,29,['Glioma'],Glioma,Biogenea Pharmaceuticals Ltd.,"['Naval Hospital, Athens']",['Greece']
NCT05640232,Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea,"A National, Multicenter, Randomized, Double-blind, Double-dummy, Phase III, Crossover Study to Assess the Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.",RECRUITING,2025-06-11,2026-06-28,2027-01-30,INTERVENTIONAL,PHASE3,238,['Primary Dysmenorrhea'],Primary Dysmenorrhea,EMS,[],['Brazil']
NCT06521229,Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study,An Ambispective Observational Multicenter Registry of Patients With Uncontrolled Asthma in the Population of the Russian Federation,RECRUITING,2024-06-27,2026-09-30,2026-09-30,OBSERVATIONAL,,10000,['Uncontrolled Asthma'],Uncontrolled Asthma,AstraZeneca,[],['Russia']
NCT04940936,Shared Decision Making on Radiation Dose for Lung Malignancies,Shared Decision Making on Radiation Dose for Stereotactic Body Radiotherapy of Malignancies Located Less Than 1 cm From the Thoracic Wall. A Randomized Trial,RECRUITING,2021-11-12,2026-03-31,2031-03-31,INTERVENTIONAL,NA,40,"['Decision Making, Shared', 'Stereotactic Body Radiation Therapy', 'Lung Cancer, Non-small Cell', 'Radiation Toxicity', 'Lung Metastases']","Decision Making, Shared",Vejle Hospital,[],['Denmark']
NCT07270887,The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks,"The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks (RICMO-ASCVD): a Prospective, Blinded Endpoint, Multi-center, Cohort Study",RECRUITING,2025-11-19,2027-12-30,2027-12-30,OBSERVATIONAL,,2800,['ASCVD'],ASCVD,General Hospital of Shenyang Military Region,[],['China']
NCT05091034,CAMP Air: Efficacy and Cost-effectiveness in Urban Adolescents,"The Efficacy of CAMP Air, a Web-based Asthma Intervention, Among Urban Adolescents With Uncontrolled Asthma",ACTIVE_NOT_RECRUITING,2021-11-08,2026-06-30,2027-06-30,INTERVENTIONAL,NA,374,['Asthma'],Asthma,Columbia University,"['3-C Institute for Social Development', 'National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07268781,Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients,The Effect of Golden Rice Cookies With Piper Crocatum Extract on Lipid Profile Control in Patients With Diabetes Mellitus,ACTIVE_NOT_RECRUITING,2025-10-20,2025-11-30,2025-12-31,INTERVENTIONAL,NA,102,"['Diabetes Mellitus (DM)', 'Dyslipidemia', 'Lipid Profile', 'Functional Food', 'Nutritional Intervention', 'Cardiovascular Risk Factor']",Diabetes Mellitus (DM),Hasanuddin University,[],['Indonesia']
NCT07219771,A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients,"A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis",RECRUITING,2025-10-14,2027-04,2027-10,INTERVENTIONAL,PHASE3,260,['Knee Osteoarthritis'],Knee Osteoarthritis,Doron Therapeutics Inc.,['Novotech (Australia) Pty Limited'],['Australia']
NCT06997588,"EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)","Study Assessing the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)",RECRUITING,2025-10-09,2028-08-02,2030-09-30,INTERVENTIONAL,PHASE2,104,['PIK3CA-related Overgrowth Spectrum (PROS)'],PIK3CA-related Overgrowth Spectrum (PROS),Novartis Pharmaceuticals,[],"['Austria', 'France', 'Germany', 'Australia']"
NCT00598351,Natural History Study of Patients With Neurofibromatosis Type 2,A Prospective Natural History Study of Patients With Neurofibromatosis Type 2 (NF2).,RECRUITING,2008-03-21,,,OBSERVATIONAL,,269,['Neurofibromatosis'],Neurofibromatosis,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT00001727,Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome,Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome,RECRUITING,1998-12-13,,,OBSERVATIONAL,,500,['McCune-Albright Syndrome'],McCune-Albright Syndrome,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT00001246,"Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers","Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers",RECRUITING,1990-06-19,,,OBSERVATIONAL,,6000,"['Attention Deficit Hyperactivity Disorder', 'Schizophrenia', 'Attention Deficit Disorder With Hyperactivity']",Attention Deficit Hyperactivity Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT06927388,Myopia Progression With Freeform Myopia Control Spectacles,Myopia Progression With Freeform Open Ring Myopia Control Spectacles Versus a Commercial Peripheral Plus Myopia Control Spectacle in Chinese Children,ACTIVE_NOT_RECRUITING,2025-05-17,2027-09-30,2027-09-30,INTERVENTIONAL,NA,180,"['Myopia, Progressive']","Myopia, Progressive",Shanghai Eye Disease Prevention and Treatment Center,[],['China']
NCT05242835,Management of Sleeve Gastrectomy Failure Using Single-anastomosis Metabolic Surgery,Management of Sleeve Gastrectomy Failure Using Single-anastomosis Metabolic Surgery,RECRUITING,2023-02-03,2027-01,2027-03,INTERVENTIONAL,NA,151,"['Obesity', 'Obesity, Morbid']",Obesity,Laval University,"['Institut universitaire de cardiologie et de pneumologie de Québec, University Laval']",['Canada']
NCT07219953,A Study of Brenipatide in Participants With Alcohol Use Disorder,"A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Alcohol Use Disorder (RENEW-ALC-2)",RECRUITING,2025-10-16,2028-04,2028-04,INTERVENTIONAL,PHASE3,1100,['Alcohol Use Disorder'],Alcohol Use Disorder,Eli Lilly and Company,[],"['Belgium', 'Japan', 'China', 'United States', 'Taiwan', 'South Korea', 'United Kingdom', 'Argentina', 'Germany']"
NCT05578742,V/Q Matching Variations With PEEP in ARDS According to Compliance-based Phenotypes (France),Effect of PEEP on Ventilartion/Perfusion Ratios According to Different Phenotypes in Patients With ARDS (France),RECRUITING,2024-02-08,2026-08,2026-09,INTERVENTIONAL,NA,50,['ARDS'],ARDS,"University Hospital, Angers",[],['France']
NCT06027996,Melodi Matrix™ in Breast Reconstruction,Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction With Infection Outcomes Assessment (ARIA),RECRUITING,2024-08-09,2027-12,2028-06,INTERVENTIONAL,NA,702,['Breast Reconstruction'],Breast Reconstruction,"Melodi Health, Inc.",[],['United States']
NCT02146170,"Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors","Tissue Procurement and Natural History Study of Patients With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors",RECRUITING,2014-05-28,2028-12-31,2029-12-31,OBSERVATIONAL,,2000,"['Non-Small Cell Lung Cancer', 'Small Cell Lung Cancer', 'Extrapulmonary Small Cell Cancer', 'Pulmonary Neuroendocrine Tumors', 'Thymic Epithelial Tumors']",Non-Small Cell Lung Cancer,National Cancer Institute (NCI),[],['United States']
NCT04826341,"A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors","A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors",RECRUITING,2021-09-20,2026-03-01,2027-03-01,INTERVENTIONAL,PHASE1,120,"['HRD Cancer', 'SCLC', 'Advanced Solid Tumors']",HRD Cancer,National Cancer Institute (NCI),[],['United States']
NCT07270588,MobACT: An Internet-Based Intervention for Chronic Pain Patients,MOBACT: An Internet-Based Guided Self-Help Intervention Based on Acceptance and Commitment Therapy for Chronic Pain,RECRUITING,2025-04-15,2026-04-01,2026-04-30,INTERVENTIONAL,NA,140,['Chronic Pain'],Chronic Pain,Catholic University of the Sacred Heart,"[""IRCCS Policlinico di Sant'Orsola, University Alma Mater Studiorum of Bologna, Italy"", 'Università degli studi di Verona', 'Linkoeping University']","['Sweden', 'Italy']"
NCT04165486,"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)","A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of ION464 Administered Intrathecally to Adults With Multiple System Atrophy",RECRUITING,2022-07-21,2027-09,2027-09,INTERVENTIONAL,PHASE1,40,['Multiple System Atrophy'],Multiple System Atrophy,"Ionis Pharmaceuticals, Inc.",[],"['Austria', 'France', 'United Kingdom', 'Portugal', 'Germany']"
NCT06026943,Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic Cancer,A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Advanced Pancreatic Cancer,RECRUITING,2025-12-04,2027-01,2028-01,INTERVENTIONAL,NA,15,"['Pancreatic Cancer', 'Unresectable Pancreatic Cancer', 'Pancreatic Adenocarcinoma']",Pancreatic Cancer,Alpha Tau Medical LTD.,[],['Italy']
NCT07133633,A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013),"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)",RECRUITING,2025-09-26,2027-06-15,2030-02-05,INTERVENTIONAL,PHASE2,315,['Radiographic Axial Spondyloarthritis'],Radiographic Axial Spondyloarthritis,Merck Sharp & Dohme LLC,[],"['United States', 'Taiwan', 'South Korea', 'Canada', 'Poland', 'Ukraine', 'Germany']"
NCT00001248,Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS),Evaluation of Progression in Multiple Sclerosis by Magnetic Resonance Imaging (MRI),RECRUITING,1992-07-23,,,OBSERVATIONAL,,3750,['Multiple Sclerosis'],Multiple Sclerosis,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07224880,"Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists","Safety and Outcomes of Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A Case Series",RECRUITING,2025-10-14,2026-01-30,2026-02-28,OBSERVATIONAL,,10,"['glp1 Agonist', 'Gene Expression', 'Skin Laxity']",glp1 Agonist,"Cytrellis Biosystems, Inc.",[],['United States']
NCT01780168,"The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism","The NIH Mini Study: Metabolism, INfection and Immunity in Inborn Errors of Mitochondrial Metabolism",RECRUITING,2012-12-31,2025-12-31,,OBSERVATIONAL,,400,"['Oxidative Phosphorylation Deficiencies', 'Electron Transport Chain Disorders, Mitochondrial', 'Mitochondrial Disorders', 'Leigh Disease']",Oxidative Phosphorylation Deficiencies,National Human Genome Research Institute (NHGRI),[],['United States']
NCT03358979,Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE),Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE),RECRUITING,2017-12-14,2026-12,2027-03,OBSERVATIONAL,,100,"['Conjunctival Diseases', 'Dry Eye Syndromes']",Conjunctival Diseases,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT04538742,A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer,"A Phase 1b/2 Multicentre, Open-label, Modular, Dose-finding and Dose-expansion Study to Explore the Safety, Tolerability, and Anti-tumour Activity of Trastuzumab Deruxtecan (T-DXd) in Combination With Other Anti-cancer Agents in Patients With HER2-positive Metastatic Breast Cancer (DESTINY-Breast07)",ACTIVE_NOT_RECRUITING,2020-12-28,2025-01-31,2030-01-31,INTERVENTIONAL,PHASE1,245,['Metastatic Breast Cancer'],Metastatic Breast Cancer,AstraZeneca,"['Daiichi Sankyo Company, Limited']","['Brazil', 'Turkey (Türkiye)', 'India', 'Russia', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT07270263,Efficacy and Safety of Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies: A Prospective Randomized Study,Efficacy and Safety of Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies: A Prospective Randomized Study,RECRUITING,2024-11-22,2026-04-30,2026-12-31,INTERVENTIONAL,NA,100,"['Lymphoma', 'Leukemia', 'Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma', 'Venous Thromboembolic Disease', 'VTE (Venous Thromboembolism)', 'PE - Pulmonary Embolism', 'Hematologic Malignacies']",Lymphoma,Medical University of Gdansk,[],['Poland']
NCT02262832,Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy,Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy,ACTIVE_NOT_RECRUITING,2014-10-09,2027-07-31,2027-07-31,INTERVENTIONAL,PHASE3,24,"['Lipodystrophy', 'Diabetes', 'Hyperlipidemia']",Lipodystrophy,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06615609,"""Smart Family Doctor"" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients","""Smart Family Doctor"" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients",RECRUITING,2025-09-24,2026-09-15,2026-11-15,INTERVENTIONAL,NA,536,"['Post Coronary Artery Bypass Grafting', 'Hypertension', 'Diabetes Mellitus', 'Hyperlipidemia', 'Post PCI']",Post Coronary Artery Bypass Grafting,China National Center for Cardiovascular Diseases,"['Chinese Academy of Medical Sciences, Fuwai Hospital']",['China']
NCT05400590,Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients,Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients,RECRUITING,2023-05-15,2026-05,2026-05,OBSERVATIONAL,,24,['Aniridia'],Aniridia,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT00040352,"Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma","Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma",RECRUITING,2002-07-01,,,OBSERVATIONAL,,3000,"['Melanoma', 'Dysplastic Nevus Syndrome']",Melanoma,National Cancer Institute (NCI),[],['United States']
NCT05256537,"Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil","IIT2021-11-PAQUETTE-OmitMMF: Fludarabine and Total Body Irradiation 800 cGy or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil",ACTIVE_NOT_RECRUITING,2022-04-26,2024-09-20,2026-03-07,INTERVENTIONAL,PHASE2,60,['Hematologic Neoplasms'],Hematologic Neoplasms,Ronald Paquette,[],['United States']
NCT00001177,Study of Premenstrual Syndrome and Premenstrual Dysphoria,The Evaluation of Women With Menstrually Regulated Mood and Behavioral Disorders,RECRUITING,1984-03-09,,,OBSERVATIONAL,,1600,['Mood Disorder'],Mood Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT00001595,An Investigation of Pituitary Tumors and Related Hypothalmic Disorders,A Clinical and Genetic Investigation of Pituitary and Hypothalamic Tumors and Related Disorders,RECRUITING,1997-04-21,,,OBSERVATIONAL,,2000,"['Panhypopituitarism', 'Gigantism/Acromegaly', 'Prolactinoma', 'Cushing Disease']",Panhypopituitarism,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT02481635,A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer,A Phase I/II Study Evaluating the Feasibility and Safety of Neoadjuvant Gemcitabine/Nab-paclitaxel (GA) and Concurrent Gemcitabine and Radiation Therapy Followed By Pancreatic Resection and Major Arterial Resection for Adenocarcinoma of the Pancreas (ARCAP) in Patients With Advanced Disease,ACTIVE_NOT_RECRUITING,2016-07,2024-12-10,2026-01,INTERVENTIONAL,PHASE1,30,['Pancreatic Cancer'],Pancreatic Cancer,"University Health Network, Toronto",[],['Canada']
NCT01241864,Islet Transplantation in Type 1 Diabetic Kidney Allograft,Islet Transplantation in Type 1 Diabetic Kidney Allograft,RECRUITING,2010-12,2026-12,2026-12,INTERVENTIONAL,PHASE2,10,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1",University of Chicago,[],['United States']
NCT00605878,Studies of Skin Microbes in Healthy People and in People With Skin Conditions,Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients,RECRUITING,2008-01-22,,,OBSERVATIONAL,,530,"['Eczema', 'Atopic Dermatitis']",Eczema,National Human Genome Research Institute (NHGRI),[],['United States']
NCT04639830,Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations,Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations,RECRUITING,2021-11-09,2027-04-15,2027-04-15,OBSERVATIONAL,,244,"['Healthy Children', 'Children With Neurodevelopmental Disorders', 'Children With Neuropsychiatric Disorders', 'Children With Behavioral Syndromes']",Healthy Children,National Institute of Mental Health (NIMH),[],['United States']
NCT05562492,Closed-loop for People Living With Cystic Fibrosis Related Diabetes,"An Open-label, Multi-centre, Randomised, Two Arm Single Period Parallel Study to Assess the Efficacy, Safety and Utility of Hybrid Closed-loop Glucose Control Compared to Standard Insulin Therapy Combined With Continuous Glucose Monitoring in Young People (≥16 Years) and Adults With Cystic Fibrosis Related Diabetes (CL4P-CF Study)",RECRUITING,2023-04-12,2026-03,2026-10,INTERVENTIONAL,NA,128,['Cystic Fibrosis-related Diabetes'],Cystic Fibrosis-related Diabetes,University of Cambridge,"['University of Oxford', 'University of Edinburgh']",['United Kingdom']
NCT04864886,Metabolic Profiling of Immune Responses in Immune-mediated Diseases,Metabolic Profiling of Immune Responses in Immune-Mediated Diseases,RECRUITING,2021-08-10,2027-06-30,2027-06-30,OBSERVATIONAL,,300,"['Primary Immunodeficiency', 'Psoriasis', 'Atopic Dermatitis', 'Immune-mediated Diseases']",Primary Immunodeficiency,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT02231840,NIAAA Natural History Protocol,NIAAA Natural History Protocol,RECRUITING,2015-01-21,2044-12-31,2044-12-31,OBSERVATIONAL,,7500,['Alcohol Use Disorder'],Alcohol Use Disorder,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT05648825,Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy,Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy,ACTIVE_NOT_RECRUITING,2022-11-15,2025-07-30,2026-12-30,INTERVENTIONAL,NA,100,['Nonobstructive Hypertrophic Cardiomyopathy'],Nonobstructive Hypertrophic Cardiomyopathy,Xiang Wei,[],['China']
NCT07190248,A Clinical Study of MK-1084 and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007),"A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)",RECRUITING,2025-10-08,2029-12-07,2032-08-06,INTERVENTIONAL,PHASE3,675,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Merck Sharp & Dohme LLC,[],"['Israel', 'Japan', 'United States', 'Taiwan', 'South Korea', 'Ukraine', 'Australia']"
NCT05928091,Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.,Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.,RECRUITING,2023-10-16,2026-12-31,2027-12-31,INTERVENTIONAL,NA,1000,['Hemorrhage'],Hemorrhage,"University Hospital, Clermont-Ferrand",[],['France']
NCT06904274,Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months,"A Multi-center, Open Label, Randomized Parallel Group Study Evaluating the Proportion of Women With Complete Resolution of Nonatypical Endometrial Hyperplasia Treated With Mirena or Oral Medroxyprogesterone Acetate for 6 Months",RECRUITING,2025-11-24,2027-05-03,2027-05-03,INTERVENTIONAL,PHASE3,207,['Endometrial Hyperplasia'],Endometrial Hyperplasia,Bayer,[],"['China', 'United States', 'Canada']"
NCT04708470,"A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers","A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers",ACTIVE_NOT_RECRUITING,2021-10-05,2025-12-01,2026-12-01,INTERVENTIONAL,PHASE1,55,"['Oropharyngeal Cancer', 'Neck Cancer', 'Human Papillomavirus', 'HPV', 'Anal Cancer', 'Cervical Cancer', 'Penile Cancer', 'Vulvar Cancer', 'Vaginal Cancer', 'Colon Cancer']",Oropharyngeal Cancer,National Cancer Institute (NCI),[],['United States']
NCT06091124,Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma,"A Prospective, Single-arm, Exploratory Study on the Efficacy and Safety of Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Patients With Neuroendocrine Bladder Carcinoma",RECRUITING,2023-11-16,2027-01-01,2027-12-31,INTERVENTIONAL,PHASE2,22,"['Neuroendocrine Carcinoma of the Bladder', 'Bladder Cancer']",Neuroendocrine Carcinoma of the Bladder,RenJi Hospital,[],['China']
NCT04561492,Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma,Exploratory Study Evaluating the Relevance of [68Ga]Ga -PentixaFor for Initial Staging and Therapeutic Evaluation of Symptomatic Multiple Myeloma Patients in First Line Treatment or in Relapse,RECRUITING,2021-09-21,2029-12-21,2030-05-21,INTERVENTIONAL,PHASE2,45,['Multiple Myeloma'],Multiple Myeloma,Nantes University Hospital,[],['France']
NCT05642884,Prehabilitation Feasibility Among Older Adults Undergoing Transplantation,Feasibility of a Prehabilitation Intervention Among Older Adults With Myeloma Receiving Autologous Stem Cell Transplant,RECRUITING,2023-07-10,2026-12-31,2026-12-31,INTERVENTIONAL,NA,30,['Multiple Myeloma'],Multiple Myeloma,Noha Mohamed Sharafeldin,[],['United States']
NCT06430801,A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderately to Severely Active Crohn's Disease",RECRUITING,2024-06-05,2028-10-30,2029-11-12,INTERVENTIONAL,PHASE3,1200,"[""Crohn's Disease""]",Crohn's Disease,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Singapore', 'South Africa', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'Ukraine', 'Sweden', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Serbia']"
NCT00029445,"Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors",Evaluation of Viral Factors and Immune Parameters to Study HIV-Specific Immunity,RECRUITING,2001-08-09,,,OBSERVATIONAL,,400,['HIV'],HIV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07011732,A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",RECRUITING,2025-07-10,2028-11-24,2028-12-08,INTERVENTIONAL,PHASE3,352,['Alzheimer Disease'],Alzheimer Disease,Bristol-Myers Squibb,[],"['Brazil', 'Bulgaria', 'Japan', 'China', 'United States', 'Mexico', 'Croatia', 'Spain', 'Taiwan', 'Canada', 'Romania', 'Greece', 'Portugal', 'Argentina', 'India']"
NCT06682169,Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease,"A Randomized, Open Label, Positive Controlled, Multicenter Phase III Clinical Trial Evaluating the Efficacy and Safety of the Selected Regimen of Rovadicitinib in Moderate to Severe Chronic Graft-versus-host Disease in Third Line and Beyond",RECRUITING,2024-11-20,2029-10,2030-12,INTERVENTIONAL,PHASE3,182,['Graft-versus-host Disease'],Graft-versus-host Disease,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",[],['China']
NCT06902077,A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients,Carb Control: Low-Carbohydrate Dietary Intervention for Pediatric Patients With Type 2 Diabetes,RECRUITING,2025-11-25,2027-08-31,2027-12-31,INTERVENTIONAL,NA,40,['Type 2 Diabetes'],Type 2 Diabetes,University of Alabama at Birmingham,"[""Children's of Alabama""]",['United States']
NCT06403475,Transcutaneous Vagus Nerve Stimulation in Aphasia After Stroke,Transcutaneous Vagus Nerve Stimulation for Language Recovery After Stroke: a Pilot Study,RECRUITING,2024-04-25,2026-06-03,2027-01-01,INTERVENTIONAL,NA,36,"['Aphasia', 'Chronic Stroke']",Aphasia,Sheffield Teaching Hospitals NHS Foundation Trust,[],['United Kingdom']
NCT05413018,An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Compare Efficacy and Safety of Oral Azacitidine (CC-486) Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Chinese Patients With Acute Myeloid Leukemia in Complete Remission",ACTIVE_NOT_RECRUITING,2022-08-19,2025-10-31,2026-03-01,INTERVENTIONAL,PHASE2,34,"['Leukemia, Myeloid, Acute']","Leukemia, Myeloid, Acute",Bristol-Myers Squibb,[],['China']
NCT06353906,Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer,A Phase 2 Clinical Study to Assess Efficacy of Induction Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer: PRIAM,RECRUITING,2024-08-13,2026-10-14,2028-01-14,INTERVENTIONAL,PHASE2,27,"['Urologic Neoplasms', 'Urogenital Neoplasms', 'Male Urogenital Diseases', 'Penile Cancer', 'Penile Squamous Cell Carcinoma', 'Locally Advanced Penile Carcinoma']",Urologic Neoplasms,The Netherlands Cancer Institute,['Merck Sharp & Dohme LLC'],"['Belgium', 'Netherlands']"
NCT02317328,Adaptive Optics Retinal Imaging,Adaptive Optics Retinal Imaging,RECRUITING,2015-02-20,2028-03-31,2028-03-31,OBSERVATIONAL,,1000,"['Eye Diseases', 'Healthy Volunteers']",Eye Diseases,National Eye Institute (NEI),[],['United States']
NCT06679608,Prospective Longitudinal Multicentric Study to Evaluate Syde® Digital Endpoints in Healthy Adults,Prospective Longitudinal Multicentric Study to Evaluate Syde® Digital Endpoints in Healthy Adults,ACTIVE_NOT_RECRUITING,2025-01-20,2027-12,2027-12,OBSERVATIONAL,,129,['Healthy Adults'],Healthy Adults,SYSNAV,[],['France']
NCT00007150,Treatment of Hemochromatosis,Studies of Phlebotomy Therapy in Hereditary Hemochromatosis,ACTIVE_NOT_RECRUITING,2001-01-01,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,622,['Hemochromatosis'],Hemochromatosis,National Institutes of Health Clinical Center (CC),[],['United States']
NCT07211958,Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Newly Diagnosed AML With an NPM1 Mutation",RECRUITING,2025-11-25,2029-06,2031-01,INTERVENTIONAL,PHASE3,468,['Acute Myeloid Leukemias'],Acute Myeloid Leukemias,Syndax Pharmaceuticals,[],['Georgia']
NCT03206099,NIAID Centralized Sequencing Protocol,NIAID Centralized Sequencing Protocol,RECRUITING,2017-07-31,2029-12-31,2029-12-31,OBSERVATIONAL,,20000,"['Atopy', 'Primary Immunodeficiency', 'Autoimmunity', 'Autoinflammation']",Atopy,National Institute of Allergy and Infectious Diseases (NIAID),['National Institute of Mental Health (NIMH)'],['United States']
NCT06022016,Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.,Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.,RECRUITING,2023-11-17,2030-01,2030-01,INTERVENTIONAL,NA,910,['DDX41 Gene Mutation'],DDX41 Gene Mutation,Institut Claudius Regaud,[],['France']
NCT00160732,Allogenic Islet Cell Transplantation,"Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy",ACTIVE_NOT_RECRUITING,2003-10,2030-10,2030-10,INTERVENTIONAL,PHASE1,50,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1",University of Chicago,[],['United States']
NCT01500447,Inherited Reproductive Disorders,The Molecular Basis of Inherited Reproductive Disorders,RECRUITING,2012-04-25,,,OBSERVATIONAL,,850,"['Genetic Disorder', 'Infertility', 'Hypogonadism', 'Amenorrhea']",Genetic Disorder,National Institute of Environmental Health Sciences (NIEHS),['Massachusetts General Hospital'],['United States']
NCT06953583,A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE),"A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled Study (Part 1) and Open-Label Extension (Part 2) to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omaveloxolone (BIIB141) in Participants With Friedreich's Ataxia Aged 2 to < 16 Years",RECRUITING,2025-06-09,2027-11-16,2029-11-22,INTERVENTIONAL,PHASE3,255,['Friedreich Ataxia'],Friedreich Ataxia,Biogen,[],"['Brazil', 'Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT00344331,"Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C","Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C",RECRUITING,2006-08-14,,,OBSERVATIONAL,,900,"['Niemann-Pick Disease, Type C']","Niemann-Pick Disease, Type C",Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT05184816,A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis,A Phase 1a/1b Trial of Intrathecal Deferoxamine for Leptomeningeal Metastases,RECRUITING,2021-12-22,2025-12,2025-12,INTERVENTIONAL,PHASE1,35,['Leptomeningeal Metastases'],Leptomeningeal Metastases,Memorial Sloan Kettering Cancer Center,"['Center for Experimental Therapeutics', 'F.M. KIRBY FOUNDATION']",['United States']
NCT07242755,Crossword Puzzle Activity on Students' Knowledge Level,The Effect of Crossword Puzzle Activity on Nursing Students' Knowledge Level Regarding Safe Medication Practices: A Randomized Controlled Trial,RECRUITING,2025-11-21,2026-01-02,2026-01-02,INTERVENTIONAL,NA,46,['Knowledge'],Knowledge,Necmettin Erbakan University,[],['Turkey (Türkiye)']
NCT06398626,An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis,"A Multi-Center, Prospective, Non-Interventional Study of Real-World Effectiveness of Etrasimod in Patients With Ulcerative Colitis (ENDEAVOUR-UC)",RECRUITING,2024-09-17,2027-10-01,2028-07-07,OBSERVATIONAL,,300,"['Colitis, Ulcerative']","Colitis, Ulcerative",Pfizer,[],['United States']
NCT02629120,High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease,High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease,ACTIVE_NOT_RECRUITING,2015-12-17,2027-12-30,2028-12-30,INTERVENTIONAL,PHASE1,45,['Chronic Granulomatous Disease Transplant'],Chronic Granulomatous Disease Transplant,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06569160,Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial,Impact du déploiement de Dispositifs d'Inactivation Des pathogènes de l'Air Par UVGI Dans la Lutte Contre Les Maladies Respiratoires Touchant Les résidents d'EHPAD,RECRUITING,2024-10-01,2026-06-01,2026-06-01,INTERVENTIONAL,NA,1200,['Acute Respiratory Infections'],Acute Respiratory Infections,Centre Hospitalier Emile Roux,['ANRS | French National Research Agency on Emerging Infectious Diseases'],['France']
NCT06077760,A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002),"A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer (INTerpath-002)",RECRUITING,2023-12-06,2030-06-25,2035-12-21,INTERVENTIONAL,PHASE3,868,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Merck Sharp & Dohme LLC,"['ModernaTX, Inc.']","['Japan', 'New Zealand', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Hungary', 'Estonia', 'France', 'Chile', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Costa Rica', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Greece', 'Latvia', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Ireland', 'Italy', 'Argentina', 'Philippines']"
NCT07270341,Evaluation of Cerebral Oxygenation During Orthopedic Surgeries Performed in the Beach Chair Position Under General Anesthesia,Evaluation of Cerebral Oxygenation During Orthopedic Surgeries Performed in the Beach Chair Position Under General Anesthesia,RECRUITING,2024-10-01,2026-05-30,2026-05-30,OBSERVATIONAL,,40,"['Cerebral Perfusion', 'Cerebral Oxygenation', 'Hemodynamic Monitoring', 'Semi-sitting Position', 'Orthopedic Surgical Procedures']",Cerebral Perfusion,Akdeniz University,[],['Turkey (Türkiye)']
NCT06095102,"A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)","A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas",ACTIVE_NOT_RECRUITING,2023-10-12,2024-06-19,2027-06-10,INTERVENTIONAL,PHASE3,311,['Plaque Psoriasis'],Plaque Psoriasis,"Janssen Research & Development, LLC",[],"['Hungary', 'Turkey (Türkiye)', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT05089370,Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma,Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab as a Strategy to Enhance the Efficacy of Immune Checkpoint Blockade in Unresectable or Metastatic Mucosal Melanoma,ACTIVE_NOT_RECRUITING,2022-06-20,2026-08-31,2026-10,INTERVENTIONAL,PHASE1,8,['Malignant Melanoma'],Malignant Melanoma,"University of Colorado, Denver","['National Comprehensive Cancer Network', 'Taiho Oncology, Inc.']",['United States']
NCT06602479,A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine,"A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of Migraine Headache Days Compared to Placebo in Adult Participants With Episodic Migraine",RECRUITING,2024-10-07,2026-12-18,2027-05-07,INTERVENTIONAL,PHASE2,408,['Migraine'],Migraine,AbbVie,['AstraZeneca'],"['Hungary', 'Netherlands', 'United States', 'Denmark', 'Spain', 'Italy', 'Czechia', 'Poland', 'Germany']"
NCT05909202,A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients,A Pilot Study of a Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients,RECRUITING,2024-06-05,2027-09-01,2029-09-01,INTERVENTIONAL,NA,218,"['Neoplasm', 'Caregivers']",Neoplasm,National Institutes of Health Clinical Center (CC),[],['United States']
NCT06564142,Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN),"A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)",ACTIVE_NOT_RECRUITING,2024-08-30,2028-09-30,2028-09-30,INTERVENTIONAL,PHASE3,605,['Immunoglobulin A Nephropathy'],Immunoglobulin A Nephropathy,"Alpine Immune Sciences Inc, A Subsidiary of Vertex",[],"['Japan', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Finland', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Latvia', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy']"
NCT00872495,Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer,Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney,RECRUITING,2002-09,2028-10,2028-11,OBSERVATIONAL,,500,"['Urothelial Cancer', 'Cancer', 'Bladder Neoplasms', 'Urinary Bladder Cancer']",Urothelial Cancer,Lahey Clinic,[],['United States']
NCT04175600,A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension,"A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged >=2 to <18 Years With Pulmonary Arterial Hypertension",ACTIVE_NOT_RECRUITING,2020-01-16,2024-10-11,2027-10-01,INTERVENTIONAL,PHASE3,138,"['Hypertension, Pulmonary']","Hypertension, Pulmonary",Actelion,[],"['Bulgaria', 'China', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Finland', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'Mexico', 'Switzerland', 'Belarus', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Vietnam', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Serbia']"
NCT01829724,Cerebral Palsy and the Study of Brain Activity During Motor Tasks,Near-infrared Spectroscopy and Electroencephalography to Assess and Train Cortical Activation During Motor Tasks,RECRUITING,2013-08-22,2026-10-15,,OBSERVATIONAL,,320,"['Cerebral Palsy', 'Children']",Cerebral Palsy,National Institutes of Health Clinical Center (CC),[],['United States']
NCT07260123,Medicolegal Aspects of Traumatic Hand Injuries,Medicolegal Aspects of Traumatic Hand Injuries in the Period From October 2025 to April 2026 in Sohag University Hospitals,ACTIVE_NOT_RECRUITING,2025-10-01,2026-04-01,2026-05-01,OBSERVATIONAL,,100,"['Traumatic Hand Injuries', 'Medicolegal Aspects']",Traumatic Hand Injuries,Sohag University,[],['Egypt']
NCT01778543,"Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma (MAC)","Pathogenesis and Genetics of Microphthalmia, Anophthalmia and Uveal Coloboma ( MAC)",RECRUITING,2013-01-08,2027-12-27,,OBSERVATIONAL,,600,"['Coloboma', 'Anophthalmia', 'Microphthalmia']",Coloboma,National Eye Institute (NEI),[],['United States']
NCT07010874,THE EFFECT OF REMOTE NURSING INTERVENTIONS BASED ON THE EMPOWERMENT PROCESS MODEL ON PEOPLE WITH DEMENTIA AND THEIR FAMILY CAREGIVERS,THE EFFECT OF REMOTE NURSING INTERVENTIONS BASED ON THE EMPOWERMENT PROCESS MODEL ON PEOPLE WITH DEMENTIA AND THEIR FAMILY CAREGIVERS: A MIXED METHODS STUDY,ACTIVE_NOT_RECRUITING,2025-06-01,2025-08-31,2025-12-31,INTERVENTIONAL,NA,60,['Dementia of Alzheimer Type'],Dementia of Alzheimer Type,Gazi University,[],['Turkey (Türkiye)']
NCT05703685,[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET,[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET,RECRUITING,2023-06-22,2028-10-03,2029-04-11,INTERVENTIONAL,PHASE1,108,['Depression'],Depression,National Institute of Mental Health (NIMH),[],['United States']
NCT01129297,A Biological Atlas of Severe Obesity (Biological Tissue Collection),Influence of the Glycemic and Ponderal Status on Tissues Gene Expression (Biological Tissue Collection),RECRUITING,2006-06-13,2027-06,2027-06,OBSERVATIONAL,,20000,"['Obesity', 'Glucose Intolerance', 'Diabetes']",Obesity,"University Hospital, Lille",[],['France']
NCT03374215,Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks,Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks,RECRUITING,2017-12-14,2025-12-31,2025-12-31,OBSERVATIONAL,,1150,"['Adrenal Gland Neoplasm', 'Hypertension', 'Bone Diseases, Metabolic', 'Cardiovascular Disease', 'Hyperinsulinemia']",Adrenal Gland Neoplasm,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT05570110,Enoxolone in Major Depression - Biomarker-outcome Relationship,"Double-blind Randomized Placebo Controlled Study on the Effect of Enoxolone ( 11-beta Hydroxysteroid-dehydrogenase Type 2 Inhibitor) on the RAAS, Autonomic and Imaging Biomarkers and the Outcome of Depression",RECRUITING,2022-09-23,2026-06,2026-06,INTERVENTIONAL,PHASE1,80,['Unipolar Depression'],Unipolar Depression,Philipps University Marburg,['Slovak Academy of Sciences'],['Germany']
NCT01087320,Genome Medical Sequencing for Gene Discovery,Genome Medical Sequencing for Gene Discovery,RECRUITING,2010-02-18,,,OBSERVATIONAL,,2000,"['Intellectual Disabilities', 'Congenital Anomaly', 'Rare Disorders']",Intellectual Disabilities,National Human Genome Research Institute (NHGRI),[],['United States']
NCT07235527,Real-Life Clinical Outcomes of Aflibercept Biosimilar MY-1701P in the Treatment of Exudative Age-Related Macular Degeneration,Real-World Outcomes of Aflibercept Biosimilar MY-1701P Treatment in Exudative Age-Related Macular Degeneration,RECRUITING,2025-11-20,2026-06-20,2026-08-20,OBSERVATIONAL,,54,"['Age Related Macular Degeneration', 'Exudative Age-Related Macular Degeneration', 'Anti Vascular Endothelial Growth Factor']",Age Related Macular Degeneration,Saglik Bilimleri Universitesi,[],['Turkey (Türkiye)']
NCT06425380,Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy,Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy,ACTIVE_NOT_RECRUITING,2024-07-12,2027-06-15,2027-06-15,INTERVENTIONAL,NA,11,"['Hepatic Encephalopathy', 'Cirrhosis']",Hepatic Encephalopathy,Mayo Clinic,[],['United States']
NCT03370276,Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma,A Phase I/II Study of Concurrent Cetuximab and Nivolumab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma,ACTIVE_NOT_RECRUITING,2017-12-20,2021-09-04,2025-12,INTERVENTIONAL,PHASE1,95,"['Squamous Cell Carcinoma of the Oropharynx', 'Squamous Cell Carcinoma of the Larynx', 'Squamous Cell Carcinoma of the Oral Cavity', 'Squamous Cell Carcinoma of the Hypopharynx', 'Squamous Cell Carcinoma of the Paranasal Sinus', 'Head and Neck Squamous Cell Carcinoma', 'Squamous Cell Cancer', 'Head and Neck Carcinoma']",Squamous Cell Carcinoma of the Oropharynx,H. Lee Moffitt Cancer Center and Research Institute,"['James and Esther King Biomedical Research Program', 'Eli Lilly and Company', 'Bristol-Myers Squibb']",['United States']
NCT04746950,ALICIA (Acalabrutinib in CLL Therapy),ALICIA (Observational Prospective Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Russia),ACTIVE_NOT_RECRUITING,2021-02-03,2026-02-28,2026-02-28,OBSERVATIONAL,,90,['Chronic Lymphocytic Leukemia'],Chronic Lymphocytic Leukemia,AstraZeneca,[],['Russia']
NCT06888388,Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer,Long-term Oncologic Safety of Nipple Sparing Mastectomy in Women With High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes,RECRUITING,2025-02-01,2027-02-01,2028-02-01,OBSERVATIONAL,,4700,['Breast Cancer Surgery'],Breast Cancer Surgery,Sir Mortimer B. Davis - Jewish General Hospital,"['Cancer Research Society', 'Quebec Breast Cancer Foundation']","['Belgium', 'United States', 'Canada', 'Portugal', 'Australia']"
NCT05753501,"Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies","First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants With B-cell Malignancies",RECRUITING,2023-06-09,2031-03,2031-03,INTERVENTIONAL,PHASE1,340,['Hematologic Cancer'],Hematologic Cancer,AbbVie,[],"['Israel', 'Japan', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT07270731,"A Research Study of a New Medicine, NNC9733-0001, in Healthy Participants and Participants With Type 2 Diabetes","Investigation of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics of Single Administrations of NNC9733-0001 in Healthy Participants and in Participants With Type 2 Diabetes",RECRUITING,2025-11-25,2027-08-30,2027-11-12,INTERVENTIONAL,PHASE1,72,"['Healthy Volunteer', 'Type 2 Diabetes']",Healthy Volunteer,Novo Nordisk A/S,[],['Germany']
NCT03602157,Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL,Phase I Study of the Administration of T Lymphocytes Co-Expressing the CD30 Chimeric Antigen Receptor (CAR) and CCR4 for Relapsed/Refractory CD30+ Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma,ACTIVE_NOT_RECRUITING,2018-12-12,2025-12-16,2039-11-04,INTERVENTIONAL,PHASE1,43,"['Lymphoma', 'Immune System Diseases', 'Immunoproliferative Disorders', 'Lymphatic Diseases', 'Lymphoproliferative Disorders', 'Neoplasms', 'Cutaneous Lymphoma', 'Cutaneous Anaplastic Large Cell Lymphoma', 'Mycosis Fungoides', 'Sezary Syndrome', 'Lymphomatoid Papulosis', 'Cutaneous T Cell Lymphoma', 'Gray Zone Lymphoma']",Lymphoma,UNC Lineberger Comprehensive Cancer Center,"['Stand Up To Cancer', 'National Cancer Institute (NCI)']",['United States']
NCT01130545,Imaging Techniques in MRI,Imaging Techniques in MRI,RECRUITING,2010-06-05,,,OBSERVATIONAL,,1000,"['Cardiac Risk Factors', 'Healthy', 'Healthy Volunteers']",Cardiac Risk Factors,National Institutes of Health Clinical Center (CC),[],['United States']
NCT05264818,Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma,Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma: a Prospective Single-center Cross-sectional Case-control Study,RECRUITING,2022-05-06,2026-05,2026-05,OBSERVATIONAL,,100,"['Primary Open-angle Glaucoma', 'Glaucoma']",Primary Open-angle Glaucoma,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT07255482,Mortality Benefit of Ultrasound for Thyroid Nodules Identified With PET Imaging: Non-Inferiority Emulated Target Trial,Mortality Benefit of Ultrasound for Incidental Thyroid Nodules Identified With PET Imaging: A Non-Inferiority Emulated Target Trial,ACTIVE_NOT_RECRUITING,2025-10-15,2025-11-30,2026-03-31,OBSERVATIONAL,,5000,"['Thyroid Nodule (Benign)', 'Thyroid Nodule (Diagnosis)', 'Thyroid Cancer']",Thyroid Nodule (Benign),Brigham and Women's Hospital,"['Harvard School of Public Health (HSPH)', 'Agency for Healthcare Research and Quality (AHRQ)']",['United States']
NCT04515446,Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza,Sequential Quantification of Viral Load in the Upper Respiratory Tract in Adult Patients Admitted for Influenza and Treated With Olsetamivir,ACTIVE_NOT_RECRUITING,2020-02-04,2023-03-10,2026-03-10,INTERVENTIONAL,NA,18,['Flu'],Flu,Centre Hospitalier Universitaire de Nice,['Centre Hospitalier Princesse Grace'],['Monaco']
NCT00001373,Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics,"An Exploratory Study of the Genetics, Pathophysiology, and Natural History of Autoinflammatory Diseases",RECRUITING,1994-03-10,,,OBSERVATIONAL,,5000,"['Familial Mediterranean Fever (FMF)', 'Autoinflammation', 'Periodic Fever', 'Fever', 'Genetic Diseases', 'ROSAH', 'ALPK1']",Familial Mediterranean Fever (FMF),National Human Genome Research Institute (NHGRI),"['University of Massachusetts, Worcester', 'Duke University', 'Merck Sharp & Dohme LLC']",['United States']
NCT06220604,A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2),"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis",ACTIVE_NOT_RECRUITING,2024-03-09,2024-11-15,2027-09-20,INTERVENTIONAL,PHASE3,731,['Plaque Psoriasis'],Plaque Psoriasis,"Janssen Research & Development, LLC",[],"['Brazil', 'Hungary', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Romania', 'Australia', 'Poland', 'Germany']"
NCT03610711,REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer,REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer,ACTIVE_NOT_RECRUITING,2019-03-06,2025-12,2025-12,INTERVENTIONAL,PHASE1,21,"['Gastroesophageal Cancer', 'Immune Checkpoint Inhibition']",Gastroesophageal Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Bristol-Myers Squibb'],['United States']
NCT07245264,Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH),Randomized Trial Comparing Adjuvant Tranexamic Acid Versus Surgery Alone For Chronic Subdural Hematoma,RECRUITING,2025-12-10,2028-11-01,2029-06-01,INTERVENTIONAL,PHASE2,274,['Chronic Subdural Hematoma'],Chronic Subdural Hematoma,St. Olavs Hospital,"['Post Graduate Institute of Medical Education and Research, Chandigarh']",['India']
NCT07244835,A Study of DEG6498 in Participants With Solid Tumors,"A First in Human Phase 1 Open-Label, Multicenter, Dose Escalation and Expansion Study of DEG6498 in Patients With Solid Tumors",RECRUITING,2025-11-13,2028-12,2028-12,INTERVENTIONAL,PHASE1,100,['Malignant Neoplasms'],Malignant Neoplasms,Degron Therapeutics Co.,[],['China']
NCT06107868,Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer,Phase I Study of the PKMYT1 Inhibitor RP-6306 in Combination With Carboplatin and Paclitaxel for the Treatment of Recurrent TP53 Ovarian and Uterine Cancer,ACTIVE_NOT_RECRUITING,2024-03-20,2025-10-31,2026-01-30,INTERVENTIONAL,PHASE1,6,"['Recurrent Ovarian Cancer', 'Recurrent Uterine Cancer', 'Metastatic Cancer', 'Advanced Cancer']",Recurrent Ovarian Cancer,"University Health Network, Toronto",[],['Canada']
NCT07071623,A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010),"A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women",RECRUITING,2025-11-10,2027-10-18,2027-10-18,INTERVENTIONAL,PHASE3,4580,"['Human Immunodeficiency Virus (HIV)', 'HIV Pre-Exposure Prophylaxis']",Human Immunodeficiency Virus (HIV),Merck Sharp & Dohme LLC,[],['South Africa']
NCT05685550,"Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phase II Clinical Study","Safety and Efficacy Analysis of Oral Etoposide Combined With Anlotinib and Envafolimab in First-line Treatment of Elderly Patients With Small Cell Lung Cancer/ Open-label, Single-arm, Exploratory Phase II Clinical Study",ACTIVE_NOT_RECRUITING,2023-04-12,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,30,['Progression Free Survival(PFS)'],Progression Free Survival(PFS),Tianjin Medical University Cancer Institute and Hospital,[],['China']
NCT05137925,Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum,Exploring Mechanisms of Change in a Pilot Randomized Trial of Mindfulness-Based Cognitive Therapy to Promote Well-being During Pregnancy and Postpartum Among At-risk Pregnant Women,ACTIVE_NOT_RECRUITING,2023-09-01,2026-01,2026-01,INTERVENTIONAL,NA,80,"['Psychological Distress', 'Pregnancy Related', 'Postpartum Blues', 'Postpartum Depression', 'Postpartum Anxiety', 'Postpartum Sadness']",Psychological Distress,University of Pittsburgh,"['American Psychological Foundation', 'The Pittsburgh Foundation']",['United States']
NCT07175038,A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY),"A Phase 2A, Open-Label Single Arm Multicenter Exploratory Study to Evaluate the Safety, Tolerability, and Efficacy of Oral Doses of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH).",RECRUITING,2025-10-01,2027-03,2029-03,INTERVENTIONAL,PHASE2,40,"['Pulmonary Arterial Hypertension (PAH)', 'Pulmonary Hypertension, Interstitial Lung Disease']",Pulmonary Arterial Hypertension (PAH),"AllRock Bio, Inc.",[],['United States']
NCT05173740,Rehabilitation for Survivors of Out-of-hospital Cardiac Arrest,The ROCK Trial. A Multidisciplinary Rehabilitation Intervention Targeted Return-to-work in Sudden Out-of-hospital Cardiac Arrest Survivors A Pragmatic Randomised Controlled Trial,RECRUITING,2022-02-01,2027-07-31,2028-07-31,INTERVENTIONAL,PHASE4,214,"['Cardiac Arrest', 'Heart Arrest', 'Cardiopulmonary Resuscitation', 'Return to Work', 'Return-to-work', 'Rehabilitation', 'Recovery of Function', 'Cardiac Rehabilitation']",Cardiac Arrest,"Rigshospitalet, Denmark","['Copenhagen University Hospital, Denmark']",['Denmark']
NCT07221435,Microlearning-Based Health Education for Ambulatory Surgery Patients,"Microlearning-Based Health Education to Enhance Ambulatory Surgery Patients' Knowledge Retention, Self-efficacy, and Quality of Postoperative Recovery",RECRUITING,2025-10-30,2026-01-31,2026-01-31,INTERVENTIONAL,NA,50,['Microlearning'],Microlearning,University Hospitals Cleveland Medical Center,['Case Western Reserve University'],['United States']
NCT04704674,"Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia","Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia",ACTIVE_NOT_RECRUITING,2021-09-30,2026-02-28,2026-02-28,OBSERVATIONAL,,396,['Malaria'],Malaria,National Institute of Allergy and Infectious Diseases (NIAID),[],['Liberia']
NCT07270718,"The Influence of Beetroot Powder at a Dose of 20 g on Blood Pressure, Microcirculation, and Biochemical Markers in Men With Arterial Hypertension.SVEKLA2025.","The Influence of Beetroot Powder at a Dose of 20 g on Blood Pressure, Microcirculation, and Biochemical Markers in Men With Arterial Hypertension.SVEKLA2025.",RECRUITING,2025-01-24,2026-08,2026-12,INTERVENTIONAL,NA,60,['Hypertensive Heart Disease Without (Congestive) Heart Failure'],Hypertensive Heart Disease Without (Congestive) Heart Failure,National Medical Research Center for Therapy and Preventive Medicine,['Saratov State Medical University'],['Russia']
NCT07256106,Occlusion and Dis-Occlusion Time in Mandibular Overdentures Supported by Conventional Versus Mini- Dental Implants,Evaluation of The Occlusion and Dis-Occlusion Time in Mandibular Single Overdentures Supported by Conventional Versus Mini- Dental Implants; A Parallel Blinded Randomized Clinical Trial,RECRUITING,2025-11-25,2026-03-31,2026-04-15,INTERVENTIONAL,NA,28,"['Dental Implant', 'Edentulous Mouth']",Dental Implant,Ain Shams University,[],['Egypt']
NCT03580629,Pilot Study of the Liver Live Donor Champion Program,Pilot Study of the Liver Live Donor Champion Program,ACTIVE_NOT_RECRUITING,2018-09-18,2026-12-28,2026-12-29,INTERVENTIONAL,NA,76,['End Stage Liver Disease'],End Stage Liver Disease,Johns Hopkins University,[],['United States']
NCT07269314,Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology,Introduzione Della Polymerase Chain Reaction (PCR) in Microbiologia e Parassitologia,RECRUITING,2023-09-01,2026-09-01,2026-12-01,OBSERVATIONAL,,200,"['Malaria, Pneumocystis, Leishmania']","Malaria, Pneumocystis, Leishmania",Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT00001238,"Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders","Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders",RECRUITING,1990-12-05,,,OBSERVATIONAL,,5000,"['Kidney Cancer', 'Urologic Malignant Disorders', 'Renal Cell Carcinoma', 'Familial Renal Cancer (FRC)', 'Clear Cell Renal Cancer']",Kidney Cancer,National Cancer Institute (NCI),[],['United States']
NCT00001205,Natural History of Treated Neurocysticercosis and Long-Term Outcomes,Natural History of Treated Neurocysticercosis and Long-Term Outcomes,RECRUITING,1985-10-07,,,OBSERVATIONAL,,500,"['Cysticercosis', 'Neurocysticercosis']",Cysticercosis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT03968822,Intralipid® 20% for Reversal of Local Anesthetics,The Use of Intralipid® 20% Solution to Reverse the Anesthetic Effect of Local Anesthetics: a Proof of Concept Study in Volunteers,ACTIVE_NOT_RECRUITING,2019-07-26,2026-10,2026-10,INTERVENTIONAL,PHASE4,18,"['Anesthesia, Local']","Anesthesia, Local","Hospital for Special Surgery, New York",[],['United States']
NCT07270510,The Effect of Collagen In Tooth Extraction Procedures,"Clinical and Volumetric Evaluation of Collagen Matrix Efficacy in Alveolar Socket Preservation, Randomized Clincal Trial",ACTIVE_NOT_RECRUITING,2025-07-01,2026-01-01,2026-02-20,INTERVENTIONAL,PHASE4,24,"['Extraction Socket Healing', 'Extraction, Tooth']",Extraction Socket Healing,Altinbas University,[],['Turkey (Türkiye)']
NCT00055172,Genetic Basis of Immunodeficiency,The Determination of Genetic Basis Of Immunodeficiency,RECRUITING,2004-04-05,,,OBSERVATIONAL,,100,['Severe Combined Immunodeficiency'],Severe Combined Immunodeficiency,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07153471,A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee,"A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial",RECRUITING,2025-09-15,2028-04,2028-05,INTERVENTIONAL,PHASE3,800,['Osteoarthritis'],Osteoarthritis,Eli Lilly and Company,[],"['Japan', 'China', 'United States', 'Mexico', 'Germany', 'Spain', 'Canada', 'India']"
NCT05782335,Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis,Analysis of T and B Cell Repertoire Changes and CTLA4 Genetics and Gene Expression to Understand the Mechanisms of Treatment Response to Orencia ® (Abatacept) in Rheumatoid Arthritis,RECRUITING,2022-11-01,2025-12,2025-12,OBSERVATIONAL,,72,['Rheumatoid Arthritis'],Rheumatoid Arthritis,"Hospital for Special Surgery, New York",[],['United States']
NCT00352924,Agriculture Health Study,The Main Agricultural Health Study - A Prospective Study of Cancer and Other Diseases Among Men and Women in Agriculture,ACTIVE_NOT_RECRUITING,1993-04-30,,,OBSERVATIONAL,,89655,"['Prostate Cancer', 'Pesticide Exposures', 'Lymphoma', 'Multiple Myeloma']",Prostate Cancer,National Cancer Institute (NCI),['Environmental Protection Agency (EPA)'],['United States']
NCT07100873,A Phase 1 Study of ADI-001 in Rheumatoid Arthritis,A Phase 1 Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (γδ) T Cells in Adults With Treatment-refractory Rheumatoid Arthritis,RECRUITING,2025-10-10,2027-03-30,2028-03-30,INTERVENTIONAL,PHASE1,25,['Rheumatoid Arthritis (RA)'],Rheumatoid Arthritis (RA),Adicet Therapeutics,[],['China']
NCT07269626,PULSAR in Systemic Therapy for Pancreatic Cancer,A Prospective Phase II Study of Systemic Therapy With Combined Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) in Pancreatic Cancer,RECRUITING,2025-11-14,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE2,47,"['Locally Advanced Pancreatic Ductal Adenocarcinoma', 'Borderline Resectable Pancreatic Ductal Adenocarcinoma', 'Oligometastatic Pancreatic Ductal Adenocarcinoma']",Locally Advanced Pancreatic Ductal Adenocarcinoma,Samsung Medical Center,[],['South Korea']
NCT05844254,Comparison of Root Coverage Outcomes by NORD Flap Versus Subepithelial Connective Tissue Graft in RT1 Gingival Recession,Patient Centered Outcomes and Stability of Root Coverage by Novel Overlapping Rotated Double (NORD) Flap as Compared to Sub Epithelial Connective Tissue Graft in Isolated Recession type1 Gingival Recession-A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2023-04-02,2025-11-01,2025-12,INTERVENTIONAL,NA,60,['Gingival Recession'],Gingival Recession,Postgraduate Institute of Dental Sciences Rohtak,[],['India']
NCT06203210,A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer,"A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)",ACTIVE_NOT_RECRUITING,2024-05-21,2027-04-30,2029-02-22,INTERVENTIONAL,PHASE3,540,['Small Cell Lung Cancer'],Small Cell Lung Cancer,Daiichi Sankyo,['Merck Sharp & Dohme LLC'],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'South Korea', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT05398783,A Natural History Study of Metabolic Sizing in Health and Disease,A Natural History Study of Metabolic Sizing in Health and Disease,RECRUITING,2022-10-25,2031-07-01,2031-07-01,OBSERVATIONAL,,2000,"['Metabolic Disorders', 'Cancer', 'Chronic Kidney Disease', 'Diabetes', 'Normal Physiology']",Metabolic Disorders,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07246941,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease","A Phase I, 2-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-ascending Doses of Intrathecally Administered RG6496 in a Randomized, Placebo-controlled, Investigator/Participant-blind Study With an Open-label Extension in Huntington's Disease Gene Expansion Carriers",RECRUITING,2025-11-19,2027-12-11,2029-03-05,INTERVENTIONAL,PHASE1,40,"[""Huntington's Disease""]",Huntington's Disease,Hoffmann-La Roche,[],['New Zealand']
NCT05977673,Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy,"Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy: a Phase II, Open-label Study",RECRUITING,2024-05-23,2027-11,2029-11,INTERVENTIONAL,PHASE2,28,['Hodgkin Lymphoma'],Hodgkin Lymphoma,Fondazione Italiana Linfomi - ETS,[],['Italy']
NCT05105919,Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes,Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes: APPEASED Study Phase 1,ACTIVE_NOT_RECRUITING,2021-08-26,2024-04-01,2025-12-01,INTERVENTIONAL,EARLY_PHASE1,50,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",Montreal Heart Institute,['Institut de Recherches Cliniques de Montreal'],['Canada']
NCT06782971,Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX,COSMOS-Avatar: Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX,RECRUITING,2025-06-06,2028-02,2030-03,OBSERVATIONAL,,25,['AML - Acute Myeloid Leukemia'],AML - Acute Myeloid Leukemia,Clinical Hub for Interventional Research (CHOIR),"['Cancer Institute NSW', 'The University of New South Wales', 'Australian National University']",['Australia']
NCT00542230,Blood Sampling for Research Related to Sickle Cell Disease,High Sensitivity Screening of Compound Libraries to Discover a Drug for the Treatment of Sickle Cell Disease,RECRUITING,2007-11-07,,,OBSERVATIONAL,,250,"['Sickle Cell Trait', 'Sickle Cell Disease', 'Sickle Cell Anemia']",Sickle Cell Trait,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07115836,"Standard Versus ""Single Loop"" Bypass After Parietal Gastrectomy","Standard Versus ""Single Loop"" Bypass After Parietal Gastrectomy: a Randomized Double-blind Study",ACTIVE_NOT_RECRUITING,2017-01-06,2025-01-06,2028-01-06,INTERVENTIONAL,NA,63,"['Obesity, Morbid', 'Obesity']","Obesity, Morbid",Laval University,"[""Fondation de l'Institut universitaire de cardiologie et pneumologie de Québec""]",['Canada']
NCT04210102,Community-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room Adults,Accuracy of Lung Ultrasound for the Diagnosis of Community-Acquired Pneumonia in Emergency Room Patients,ACTIVE_NOT_RECRUITING,2020-02-11,2025-01-28,2026-01-28,INTERVENTIONAL,NA,47,['Community-acquired Pneumonia'],Community-acquired Pneumonia,Centre Hospitalier Universitaire de Nice,['Centre Hospitalier Princesse Grace'],['Monaco']
NCT06196905,An Exploratory Study of MT-2990 in Patients With AAV,An Exploratory Study of MT-2990 in Patients With Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV),ACTIVE_NOT_RECRUITING,2024-06-24,2026-02,2026-02,INTERVENTIONAL,PHASE1,10,['Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV)'],Antineutrophil Cytoplasmic Antibody (ANCA) -Associated Vasculitis (AAV),Tanabe Pharma Corporation,[],['Japan']
NCT05853458,Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors,"HU-F-AIM - A Prospective, Interventional Study to Evaluate HU-resistance in Polycythemia Vera Patients Who Meet Predictive Parameters Identified in the Machine Learning Project PV-AIM",ACTIVE_NOT_RECRUITING,2023-07-28,2027-01-27,2027-01-27,INTERVENTIONAL,PHASE4,76,['Polycythemia Vera'],Polycythemia Vera,Novartis Pharmaceuticals,[],['Germany']
NCT06511674,Vulnerability and Risk of Neuropathic Pain in Cancer,Vulnerability and Risk of Neuropathic Pain in Cancer: Validation of a Predictive Tool to Optimize Treatment.,RECRUITING,2024-10-28,2027-05-31,2028-06-30,INTERVENTIONAL,NA,625,"['Neuropathic Pain', 'Cancer', 'Predictive']",Neuropathic Pain,"University Hospital, Clermont-Ferrand",[],['France']
NCT01362803,AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors,A Phase I/II Study of the Mitogen Activated Protein Kinase (MEK) 1 Inhibitor Selumetinib (AZD6244; Hydrogen Sulfate in Children With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN),ACTIVE_NOT_RECRUITING,2011-09-21,2027-01-01,2032-01-01,INTERVENTIONAL,PHASE1,99,"['Neurofibromatosis 1', 'Neurofibromatosis Type 1', 'NF1', 'Neurofibroma, Plexiform']",Neurofibromatosis 1,National Cancer Institute (NCI),[],['United States']
NCT03678389,Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery,Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery,RECRUITING,2019-05-09,2028-03-01,2028-12-01,INTERVENTIONAL,NA,70,['Pituitary Neoplasm'],Pituitary Neoplasm,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT04621279,Cool Prime Comparative Effectiveness Study for Mild HIE,COOLPRIME: Comparative Effectiveness for Cooling Prospectively Infants With Mild Encephalopathy,RECRUITING,2023-07-19,2026-10-31,2029-01-01,OBSERVATIONAL,,460,['Mild Hypoxic Ischemic Encephalopathy of Newborn'],Mild Hypoxic Ischemic Encephalopathy of Newborn,University of Texas Southwestern Medical Center,"['University of California, San Francisco', ""Children's National Research Institute"", ""Children's Hospital Los Angeles"", 'St. Louis University', 'Stanford University', 'University of Utah', 'University of Pittsburgh Medical Center', ""Children's Hospital Medical Center, Cincinnati"", 'University College Cork', ""The Children's Hospital of San Antonio"", 'Harvard University', 'Washington University School of Medicine', 'Sharp HealthCare', 'The Cleveland Clinic', 'University of Florida Health', 'Emory University', ""Nationwide Children's Hospital"", ""Children's Hospital of Orange County""]",['United States']
NCT06013462,DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery,DMEK Endothelial Keratoplasty in Patients With a History of Anterior or Posterior Segment Surgery : Serious Complication Rate and Visual Efficacy at 12 Months,RECRUITING,2024-03-15,2027-03-14,2028-04,OBSERVATIONAL,,80,['Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery'],Patients Undergoing DMEK With a History of Anterior or Posterior Segment Surgery,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT05502016,Family Model DSME in FBOs in the RMI,Family Model Diabetes Self-Management Education in Faith-Based Organizations in the Republic of the Marshall Islands,RECRUITING,2023-06-30,2027-01-31,2027-01-31,INTERVENTIONAL,NA,288,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",University of Arkansas,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT07243236,Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations,"""Assessment of the Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations in Ile-de-France Region in France""""",RECRUITING,2025-11-19,2027-05,2027-07,OBSERVATIONAL,,2920,"['Healthcare Providers', 'Postpartum']",Healthcare Providers,Assistance Publique - Hôpitaux de Paris,"['Agence régionale de santé Ile de France', 'Institut de Recherche en Santé Publique, France']",['France']
NCT04167683,Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant,"The Effect of Medical Treatment on Muscle Dysfunction and the Prognostic Role of Muscle Dysfunction at Critical Decision Points in Patients With Hematological Diseases Referred to Myeloablative Hematopoietic Stem Cell Transplant (HSCT), to Myeloablative HSCT With a ""Reduced Toxicity Conditioning"" Regime With Fludarabine and Treosulfane (FluTreo), or to Non-myeloablative HSCT. - A Prospective Observational Study.",ACTIVE_NOT_RECRUITING,2023-10-01,2026-11-01,2026-11-01,OBSERVATIONAL,,144,"['Hematologic Diseases', 'Chronic Myeloid Leukemia', 'Acute Myeloid Leukemia', 'Acute Lymphoid Leukemia', 'Myelodysplastic Syndromes', 'Non Hodgkin Lymphoma', 'Stem Cell Transplant Complications', 'Chronic Lymphocytic Leukemia']",Hematologic Diseases,"Rigshospitalet, Denmark",[],['Denmark']
NCT05782829,Perioperative Stress Management in Outpatient Surgery With L-tyrosine Supplementation (SPOT),Perioperative Stress Management in Outpatient Surgery With L-tyrosine Supplementation,RECRUITING,2023-11-14,2026-04,2026-05,INTERVENTIONAL,NA,150,['Stress'],Stress,Centre Hospitalier Universitaire de Nice,[],['Monaco']
NCT07270783,Healthy Volunteer Study,"A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of D-2570 Tablets in Healthy Subjects",RECRUITING,2025-12,2026-04,2026-06,INTERVENTIONAL,PHASE1,36,['Healthy Volunteer'],Healthy Volunteer,"InventisBio Co., Ltd",[],['United States']
NCT07268846,Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery,Randomized Clinical Trial on the Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery,RECRUITING,2025-06-01,2027-06-01,2027-06-01,INTERVENTIONAL,NA,164,"['Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)']","Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)",AC Camargo Cancer Center,[],['Brazil']
NCT07145229,Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare,"A Randomized, Double-blind, Multicenter, Colchicine and Placebo-controlled Study to Evaluate the Efficacy and Safety of ABP-745 in Subjects With an Acute Gout Flare",RECRUITING,2025-08-26,2026-05,2026-06,INTERVENTIONAL,PHASE2,380,"['Acute Gouty Arthritis', 'Gout Flare', 'Gout Flares', 'Acute Gout Flare']",Acute Gouty Arthritis,"Atom Therapeutics Co., Ltd",[],"['China', 'United States', 'Australia']"
NCT05784246,A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis,"A Multicenter, Phase 3, Open-Label Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2023-11-22,2026-05,2026-08,INTERVENTIONAL,PHASE3,60,['Ulcerative Colitis'],Ulcerative Colitis,Eli Lilly and Company,[],"['Belgium', 'Israel', 'Japan', 'Netherlands', 'United States', 'France', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Portugal', 'Germany']"
NCT06736327,"A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects With Advanced Solid Tumors","A Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 for Injection in Subjects With Advanced Solid Tumors",RECRUITING,2024-12-13,2027-07-31,2028-12-31,INTERVENTIONAL,PHASE1,180,['Advanced Solid Tumors'],Advanced Solid Tumors,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT06743165,New Generation Rehabilitation Approach in Children With Dysfunctional Voiding,"New Generation Rehabilitation Approach in Children With Dysfunctional Voiding: Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Training With Transabdominal Ultrasound, a Randomized Controlled Trial",RECRUITING,2025-02-01,2026-01-01,2026-06-01,INTERVENTIONAL,NA,38,"['Dysfunctional Voiding', 'Children', 'Pelvic Floor Muscle Training', 'Ultrasound', 'DNS']",Dysfunctional Voiding,Izmir University of Economics,['Health Institutes of Turkey'],['Turkey (Türkiye)']
NCT06984081,CAPA In-vitro Oocyte Maturation,CAPA In-vitro Oocyte Maturation,RECRUITING,2025-11-10,2030-05-31,2032-05-31,INTERVENTIONAL,NA,100,"['Infertility, Female']","Infertility, Female",Chinese University of Hong Kong,[],['Hong Kong']
NCT06941519,Addressing Social Needs to Improve Health in Adults With Multiple Chronic Conditions,Addressing Social Needs to Improve Health in Adults With Multiple Chronic Conditions,RECRUITING,2025-09-01,2029-09-15,2029-12-01,INTERVENTIONAL,NA,800,"['Multiple Chronic Conditions', 'Social Needs', 'Care Gaps', 'Navigation']",Multiple Chronic Conditions,Kaiser Permanente,[],['United States']
NCT06911502,A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4),"A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy",RECRUITING,2025-07-28,2028-04-24,2030-07-31,INTERVENTIONAL,PHASE3,400,['Follicular Lymphoma'],Follicular Lymphoma,Celgene,[],"['Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'France', 'Chile', 'Finland', 'South Korea', 'Poland', 'India', 'Spain', 'Canada', 'United Arab Emirates', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT02919592,Memory Gel and Shape Combined Cohort,"MemoryShape® and MemoryGel® Breast Implants Post Approval New Enrollment Study (""Glow Study"")",ACTIVE_NOT_RECRUITING,2016-09-01,2031-06-16,2031-06-16,INTERVENTIONAL,NA,3613,"['Primary Breast Augmentation', 'Primary Breast Reconstruction', 'Revision Breast Augmentation', 'Revision Breast Reconstruction']",Primary Breast Augmentation,"Mentor Worldwide, LLC",[],['United States']
NCT06533098,A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT),"Multicenter, Open-Label, Randomized Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)",RECRUITING,2025-02-10,2027-12-15,2029-12-05,INTERVENTIONAL,PHASE3,50,"['Thrombocytopenia, Neonatal Alloimmune']","Thrombocytopenia, Neonatal Alloimmune","Janssen Research & Development, LLC",[],"['Netherlands', 'Austria', 'United States', 'United Kingdom', 'Poland', 'Germany']"
NCT06944145,New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia,"A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)",RECRUITING,2025-12-03,2029-06-01,2030-08-31,INTERVENTIONAL,PHASE2,242,"['BPH (Benign Prostatic Hyperplasia)', 'Lower Urinary Track Symptoms']",BPH (Benign Prostatic Hyperplasia),Beth Israel Deaconess Medical Center,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT03153475,ATTUNE Revision System in the Revision Total Knee Arthroplasty Population,Multi-Center Clinical Evaluation of the ATTUNE® Revision System in Revision Total Knee Arthroplasty,ACTIVE_NOT_RECRUITING,2017-05-30,2029-03-31,2029-03-31,INTERVENTIONAL,NA,400,['Revision Total Knee Arthroplasty'],Revision Total Knee Arthroplasty,DePuy Orthopaedics,[],"['Belgium', 'New Zealand', 'Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Ireland', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT06502964,Study of ALTO-101 in Patients With Schizophrenia,"Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment",RECRUITING,2024-06-11,2026-02,2026-03,INTERVENTIONAL,PHASE2,82,"['Schizophrenia', 'Cognitive Impairment']",Schizophrenia,Alto Neuroscience,[],['United States']
NCT04696809,A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma,"A Phase 1/2 Study of JNJ-64007957, a Humanized BCMA * CD3 Bispecific Antibody in Japanese Patients With Relapsed or Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2021-02-22,2026-04-22,2026-04-22,INTERVENTIONAL,PHASE1,40,['Hematologic Malignancies'],Hematologic Malignancies,Janssen Pharmaceutical K.K.,[],['Japan']
NCT04640623,"A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy","Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin (BCG) Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy",ACTIVE_NOT_RECRUITING,2020-12-18,2025-07-03,2027-09-30,INTERVENTIONAL,PHASE2,220,['Urinary Bladder Neoplasms'],Urinary Bladder Neoplasms,"Janssen Research & Development, LLC",[],"['Belgium', 'Japan', 'Netherlands', 'Russia', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Australia']"
NCT07267403,Comparison of Modulations of Motor Brain Activity and SedLine After Median Nerve Stimulation in General Anesthesia,STIM-PSI: Comparison of Modulations of Motor Brain Activity and SedLine After Median Nerve Stimulation in General Anesthesia,RECRUITING,2025-10-27,2026-12-31,2026-12-31,INTERVENTIONAL,NA,48,['Accidental Awareness During General Anesthesia'],Accidental Awareness During General Anesthesia,Brugmann University Hospital,[],['Belgium']
NCT05780762,"Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies","Impact of an Intervention Integrating the MPHS Nursing Model of Care on the Partnership in Health, With the Patient Followed in Primary Care by an Advanced Practice Nurse (APN) for One or More Stabilized Chronic Pathologies",RECRUITING,2024-04-12,2028-02-28,2028-11-30,INTERVENTIONAL,NA,420,['Chronic Disease'],Chronic Disease,Centre Hospitalier Universitaire de Saint Etienne,"['Ministry of Health, France']",['France']
NCT06143514,A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk,A Post-marketing Study Evaluating the Presence and Concentration of BRIUMVI™ in Breast Milk (PROVIDE),RECRUITING,2024-03-26,2026-06-30,2026-06-30,OBSERVATIONAL,,16,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,"TG Therapeutics, Inc.",[],['United States']
NCT06105164,Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans,Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans,RECRUITING,2024-12-05,2029-08,2029-08,INTERVENTIONAL,NA,150,"['Appetitive Behavior', 'Obesity']",Appetitive Behavior,Brigham and Women's Hospital,"['Mclean Hospital', 'Beth Israel Deaconess Medical Center']",['United States']
NCT07266038,Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type 3 Supracondylar Fractures of Children,Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type # Supracondylar Fractures of Children : A Comparative Study,RECRUITING,2024-07-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,90,['Gartland Type 3 Supracondylar Fracture'],Gartland Type 3 Supracondylar Fracture,Laiba Qamar,['Bahawal Victoria Hospital Bahawalpur'],['Pakistan']
NCT03519464,Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia,"A Phase 2, Open-Label Study to Assess the Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in Patients With Idiopathic CD4 T Cell Lymphocytopenia",ACTIVE_NOT_RECRUITING,2019-02-04,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,54,['Idiopathic CD4 T Cell Lymphocytopenia'],Idiopathic CD4 T Cell Lymphocytopenia,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06218914,"Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors","Open-label, Phase 1, Multi-Center Master Protocol to Evaluate the Safety and Preliminary Anti-Tumor Activity of TCR-engineered T Cells Recognizing KRAS Mutations in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors",RECRUITING,2024-03-22,2027-08-30,2043-11-18,INTERVENTIONAL,PHASE1,24,"['Non-small Cell Lung Cancer', 'Colorectal Carcinoma', 'Pancreatic Ductal Adenocarcinoma', 'Endometrial Cancer', 'Solid Tumor, Adult', 'KRAS G12D']",Non-small Cell Lung Cancer,AstraZeneca,[],['United States']
NCT02754037,Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study,Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study,ACTIVE_NOT_RECRUITING,2016-04-30,2026-06-30,2026-06-30,OBSERVATIONAL,,120,"['Non-alcoholic Fatty Liver Disease (NAFLD)', 'Non-alcoholic Steatohepatitis (NASH)']",Non-alcoholic Fatty Liver Disease (NAFLD),"University of California, Davis",['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT04253392,RETHINK REFLUX Registry,Research to Further Inform Thinking About the Role of LINX for Reflux Disease,ACTIVE_NOT_RECRUITING,2020-07-08,2032-07-31,2032-07-31,OBSERVATIONAL,,500,['Gastroesophageal Reflux'],Gastroesophageal Reflux,Ethicon Endo-Surgery,[],"['Singapore', 'Austria', 'United States', 'Italy', 'United Kingdom', 'Germany']"
NCT06631638,EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)),Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Non-Invasive Navigation,RECRUITING,2025-10-24,2027-12-31,2027-12-31,INTERVENTIONAL,NA,118,"['Osteoarthritis', 'Traumatic Arthritis', 'Rheumatoid Arthritis', 'Congential Hip Dysplasia', 'Avascular Necrosis of the Femoral Head', 'Certain Cases of Ankylosis']",Osteoarthritis,DePuy Orthopaedics,[],['United States']
NCT04795843,Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia,MovetheHip-trial: The Effectiveness of Exercise and Patient Education Compared With Usual Care on Self-reported Pain in Patients With Hip Dysplasia,RECRUITING,2021-04-16,2027-07,2027-12,INTERVENTIONAL,NA,200,['Hip Dysplasia'],Hip Dysplasia,University of Aarhus,"['Research Unit for General Practice, Aarhus University', 'VIA University College', 'Copenhagen University Hospital, Hvidovre', 'Defactum, Central Denmark Region']",['Denmark']
NCT06926868,"A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)","A Randomized, Open-label, Inferentially Seamless Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Recurrent Inoperable,or Metastatic Triple-negative Breast Cancer (TNBC)or ER-low, HER2-negative BC Who Are Ineligible for Anti-PD1/PD-L1 Treatment",RECRUITING,2025-09-11,2028-03-13,2030-05-15,INTERVENTIONAL,PHASE2,500,['Breast Neoplasms'],Breast Neoplasms,Bristol-Myers Squibb,['SystImmune Inc.'],"['Japan', 'China', 'Australia', 'Israel', 'France', 'Chile', 'South Korea', 'Colombia', 'Poland', 'India', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Romania', 'United Arab Emirates', 'Greece', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07266909,Impact of Attentional Tunelling on a Population of French Practitioners,"Impact of Attentional Tunneling or the ""Tunnel Effect"" in Dentistry. Multi-centre Cross-sectional Study of a Population of French Practitioners.",RECRUITING,2025-11-21,2025-11-21,2026-11-30,OBSERVATIONAL,,160,"['Awareness', 'Attention']",Awareness,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06315127,The CanDo (Canadian Donor Milk) Trial,The CanDo (Canadian Donor Milk) Trial: Pasteurized Human Donor Milk Supplementation in the Well-baby Unit,ACTIVE_NOT_RECRUITING,2024-02-06,2026-01-30,2026-06-30,INTERVENTIONAL,NA,112,"['Small for Gestational Age at Delivery', 'Gestational Diabetes', 'type1diabetes', 'Type2diabetes', 'Late Preterm Infant']",Small for Gestational Age at Delivery,"Mount Sinai Hospital, Canada",['Mitacs'],['Canada']
NCT06741969,Nipocalimab in Moderate to Severe Sjogren's Disease,"A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 3 Protocol to Assess the Efficacy and Safety of Nipocalimab in Adults With Moderate to Severe Sjogren's Disease (SjD)",RECRUITING,2024-12-04,2028-01-01,2029-08-02,INTERVENTIONAL,PHASE3,600,['Sjogrens Syndrome'],Sjogrens Syndrome,"Janssen Research & Development, LLC",[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06646289,A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP),"An Open-label, Multicenter, Phase 2 Follow-on Study for Second Eye Treatment of Patients Previously Treated With a Recombinant Adeno-associated Virus Vector (AAV5 hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)",RECRUITING,2024-10-10,2030-10-24,2030-10-24,INTERVENTIONAL,PHASE2,42,['X-Linked Retinitis Pigmentosa'],X-Linked Retinitis Pigmentosa,"Janssen Research & Development, LLC",[],"['United Kingdom', 'United States']"
NCT05972291,Mechanisms of Gulf War Illness,Mechanisms of Gulf War Illness,RECRUITING,2023-10-16,2026-07-30,2027-07-31,INTERVENTIONAL,NA,80,"['Gulf War Illness', 'Irritable Bowel Syndrome', 'Gastrointestinal Symptoms']",Gulf War Illness,VA Office of Research and Development,[],['United States']
NCT07140913,"A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine","A Phase 3, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Individuals With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine",RECRUITING,2025-10-08,2027-06-28,2027-06-28,INTERVENTIONAL,PHASE3,424,"['Mania', 'Bipolar Disorder']",Mania,Bristol-Myers Squibb,[],"['Bulgaria', 'Israel', 'Japan', 'United States', 'France', 'Denmark', 'Italy', 'Romania', 'Ukraine', 'Poland', 'Argentina', 'India']"
NCT04658862,A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder,"A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder Who Are Not Receiving Radical Cystectomy",ACTIVE_NOT_RECRUITING,2020-12-07,2026-12-30,2028-12-31,INTERVENTIONAL,PHASE3,518,['Urinary Bladder Neoplasms'],Urinary Bladder Neoplasms,"Janssen Research & Development, LLC",[],"['Japan', 'China', 'Australia', 'Belgium', 'Hungary', 'Russia', 'France', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Greece', 'Portugal', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07121582,Modulation of Brain Rhythms in Stroke,Modulation of Beta Oscillatory Rhythms in Stroke to Promote Corticomuscular Circuit Function,RECRUITING,2025-12,2027-01,2027-01,INTERVENTIONAL,NA,20,['Stroke'],Stroke,"University of North Carolina, Chapel Hill",['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT03523442,A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer,A Phase 1 Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Subjects With Metastatic Castration-Resistant Prostate Cancer,ACTIVE_NOT_RECRUITING,2018-08-31,2019-07-09,2026-12-31,INTERVENTIONAL,PHASE1,19,['Prostatic Neoplasms'],Prostatic Neoplasms,"Janssen Research & Development, LLC",[],['China']
NCT07266480,Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.,"A Randomised, Controlled Clinical Study of Adebrelizumab for the Adjuvant Treatment of Esophageal Squamous Cell Cancer.",RECRUITING,2025-09-01,2027-09-01,2030-09-01,INTERVENTIONAL,PHASE2,142,['Squamous Oesophageal Cancer'],Squamous Oesophageal Cancer,Hebei Medical University Fourth Hospital,[],['China']
NCT06311578,"A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors","Phase 1 Study of Intratumoral Administration of JNJ-87704916, an Oncolytic Virus, as Monotherapy and in Combination for Advanced Solid Tumors",RECRUITING,2024-04-10,2028-11-08,2032-08-26,INTERVENTIONAL,PHASE1,96,['Advanced Solid Tumors'],Advanced Solid Tumors,Johnson & Johnson Enterprise Innovation Inc.,[],"['Spain', 'United States', 'France', 'Canada']"
NCT06206408,A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through Menopause,"A Phase 3, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Fezolinetant in Japanese Women Experiencing Vasomotor Symptoms (Hot Flashes) Associated With Menopause",ACTIVE_NOT_RECRUITING,2024-02-16,2025-10-22,2025-12-31,INTERVENTIONAL,PHASE3,410,['Hot Flashes'],Hot Flashes,Astellas Pharma Inc,[],['Japan']
NCT06440850,Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation,"A Pilot Clinical Trial of Vemurafenib and Cobimetinib as a Redifferentiation Strategy in High-Risk, Radioactive Iodine (RAI) Naïve, BRAFV600E Mutated Differentiated Thyroid Carcinoma Patients Undergoing Initial RAI Therapy",RECRUITING,2024-07-15,2026-11-22,2026-11-22,INTERVENTIONAL,PHASE2,21,"['Thyroid Gland Follicular Carcinoma', 'Thyroid Gland Oncocytic Carcinoma', 'Thyroid Gland Papillary Carcinoma']",Thyroid Gland Follicular Carcinoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07006818,Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function,Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function,RECRUITING,2025-09-15,2027-04-30,2028-04-30,INTERVENTIONAL,NA,50,['Stroke'],Stroke,University of Illinois at Chicago,[],['United States']
NCT05179876,A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option,"A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent Studies",RECRUITING,2022-05-04,2027-01-31,2029-09-28,INTERVENTIONAL,PHASE3,280,"['Hypertension, Pulmonary']","Hypertension, Pulmonary",Actelion,[],"['Belgium', 'Bulgaria', 'Hungary', 'South Africa', 'China', 'Russia', 'Vietnam', 'Belarus', 'Taiwan', 'South Korea', 'Thailand', 'Poland', 'Ukraine']"
NCT06832618,A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis,"A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis",RECRUITING,2025-06-17,2026-07-13,2028-05-18,INTERVENTIONAL,PHASE3,240,['Atopic Dermatitis'],Atopic Dermatitis,Incyte Corporation,[],"['Belgium', 'Hungary', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT06436690,Optimizing Antibiotics Prescription,Optimizing Antibiotics Prescription: A Stepped-Wedge Randomized Trial,ACTIVE_NOT_RECRUITING,2025-04-15,2025-11-28,2026-04-30,INTERVENTIONAL,NA,56,['Antimicrobial Resistance'],Antimicrobial Resistance,Penn State University,[],"['Nepal', 'United States']"
NCT02232191,Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients,Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients,RECRUITING,2014-12,2026-07,2026-07,INTERVENTIONAL,PHASE2,75,['Asplenia'],Asplenia,"University of California, Davis",[],['United States']
NCT05424822,"A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)","A Phase 1, First-in-human Study of JNJ-80948543, a T-cell Redirecting Antibody, in Participants With NHL and CLL",ACTIVE_NOT_RECRUITING,2022-08-18,2026-06-12,2027-07-30,INTERVENTIONAL,PHASE1,167,"['Lymphoma, Non-Hodgkin', 'Leukemia, Lymphocytic, Chronic, B-Cell']","Lymphoma, Non-Hodgkin","Janssen Research & Development, LLC",[],"['Israel', 'Japan', 'China', 'United States', 'France', 'Denmark', 'Poland', 'Australia']"
NCT07139769,Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer,The RAISE Study: Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer,RECRUITING,2025-10-22,2026-04-30,2026-08-31,INTERVENTIONAL,NA,48,['Caregiving for Cancer'],Caregiving for Cancer,"Zeba Ahmad, Ph.D.","['American Cancer Society, Inc.']",['United States']
NCT05818683,"A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer","A Phase 1b Study of JNJ-78278343, a T-cell Redirecting Agent Targeting Human Kallikrein 2 (KLK2), in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer",RECRUITING,2023-04-26,2026-06-30,2027-09-01,INTERVENTIONAL,PHASE1,185,"['Metastatic Castration-resistant Prostate Neoplasms', 'Metastatic Hormone-sensitive Prostate Cancer']",Metastatic Castration-resistant Prostate Neoplasms,"Janssen Research & Development, LLC",[],"['Spain', 'United States', 'Australia']"
NCT04986566,Perioperative Telemonitoring to Optimize Cancer Care and Outcomes,Perioperative Telemonitoring to Optimize Cancer Care and Outcomes,ACTIVE_NOT_RECRUITING,2021-10-19,2023-08-31,2026-02-07,INTERVENTIONAL,NA,134,['Malignant Digestive System Neoplasm'],Malignant Digestive System Neoplasm,City of Hope Medical Center,"['National Cancer Institute (NCI)', 'National Institute of Nursing Research (NINR)']",['United States']
NCT05784441,A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL),"A Phase 1b Multicenter, Open-Label, Study of JNJ-90009530, an Autologous Anti-CD20 CAR-T Cell Therapy in Adult Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma",RECRUITING,2023-11-06,2037-10-30,2040-01-03,INTERVENTIONAL,PHASE1,20,['Relapsed or Refractory B Cell Non-Hodgkin Lymphoma'],Relapsed or Refractory B Cell Non-Hodgkin Lymphoma,"Janssen Research & Development, LLC",[],"['United Kingdom', 'Israel', 'United States', 'Australia']"
NCT05643638,A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD,"A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination With Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease",RECRUITING,2024-03-04,2026-03,2027-12,INTERVENTIONAL,PHASE2,60,"['Graft Versus Host Disease, Acute']","Graft Versus Host Disease, Acute",Cynata Therapeutics Limited,[],"['Turkey (Türkiye)', 'United States', 'France', 'Spain', 'Italy', 'Lithuania', 'Australia']"
NCT06492785,Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer,"Use of Hyaluronic Acid-enriched Transfer Medium in Women Undergoing Single Blastocyst Transfer : a Multicenter, Randomized Controlled Trial",RECRUITING,2024-09-13,2025-12-31,2025-12-31,INTERVENTIONAL,NA,858,['Infertility'],Infertility,"Northwest Women's and Children's Hospital, Xi'an, Shaanxi","['Jiangxi Maternal and Child Health Hospital', 'Gansu Provincial Maternal and Child Health Care Hospital', 'Huazhong University of Science and Technology']",['China']
NCT04674462,Understanding Poor Vaccine Responses to Hepatitis B Vaccination,Understanding Poor Vaccine Responses to Hepatitis B Vaccination,ACTIVE_NOT_RECRUITING,2022-07-07,2026-07,2026-07,INTERVENTIONAL,PHASE4,101,['Vaccine Reaction'],Vaccine Reaction,NYU Langone Health,['National Institute of Allergy and Infectious Diseases (NIAID)'],['United States']
NCT07267221,"Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.","An Open-label, Randomized, Fed, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of ""DWJ1622"" and Co-administration of ""DWC202313"" and ""DWC202314"" in Healthy Volunteers",RECRUITING,2025-12-01,2026-01-30,2026-05-30,INTERVENTIONAL,PHASE1,36,['Healthy Volunteers'],Healthy Volunteers,Daewoong Pharmaceutical Co. LTD.,[],['South Korea']
NCT03847428,Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment,"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation",ACTIVE_NOT_RECRUITING,2019-04-29,2026-05-29,2027-05-31,INTERVENTIONAL,PHASE3,908,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,AstraZeneca,[],"['Japan', 'Hong Kong', 'China', 'Australia', 'Russia', 'France', 'Puerto Rico', 'Peru', 'South Korea', 'Thailand', 'Poland', 'India', 'Singapore', 'Taiwan', 'Canada', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Egypt', 'Philippines']"
NCT07267130,"A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects","Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects in China",RECRUITING,2025-11-25,2026-10,2026-12,INTERVENTIONAL,PHASE1,44,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,"Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.",[],['China']
NCT06663332,A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants,"A Phase 3, Multicenter, Open-label, Basket, LTE Study to Evaluate the Safety of Guselkumab in Pediatric Participants With Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis",RECRUITING,2024-10-29,2031-12-12,2031-12-12,INTERVENTIONAL,PHASE3,196,"['Crohns Disease', 'Colitis, Ulcerative', 'Arthritis, Psoriatic', 'Arthritis, Juvenile']",Crohns Disease,"Janssen Research & Development, LLC",[],"['Japan', 'Turkey (Türkiye)', 'China', 'United States', 'Spain', 'Poland', 'Argentina', 'Germany']"
NCT06888193,A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab),"A Multicenter Open-label, Prospective Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)",RECRUITING,2025-11-05,2027-05-03,2027-05-03,INTERVENTIONAL,PHASE1,20,"['Moderate to Severe Plaque Psoriasis', 'Psoriatic Arthritis', 'Axial Spondyloarthritis', 'Hidradenitis Suppurativa']",Moderate to Severe Plaque Psoriasis,UCB Biopharma SRL,[],"['Switzerland', 'United States', 'Canada']"
NCT06708897,"A Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas","Phase 1 Study of ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), and Select Low-grade Lymphomas",RECRUITING,2025-04-08,2026-03,2028-04,INTERVENTIONAL,PHASE1,66,"['CLL / SLL', 'CLL (Chronic Lymphocytic Leukemia)', 'SLL (Small Lymphocytic Lymphoma)']",CLL / SLL,"Lomond Therapeutics Holdings, Inc.",[],['United States']
NCT05453903,A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies,A Phase 1b Study of Bleximenib in Combination With AML-Directed Therapies for Participants With Acute Myeloid Leukemia Harboring KMT2A or NPM1 Alterations,RECRUITING,2022-10-04,2026-10-30,2027-03-19,INTERVENTIONAL,PHASE1,200,"['Leukemia, Myeloid, Acute']","Leukemia, Myeloid, Acute","Janssen Research & Development, LLC",[],"['United States', 'France', 'Spain', 'Italy', 'Canada', 'Australia', 'United Kingdom', 'Germany']"
NCT06675123,Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma,A Pilot Study of Pacritinib Combined With a BTK Inhibitor in Patients With Relapsed/Refractory Mantle Cell Lymphoma,RECRUITING,2026-02-01,2028-03-08,2028-03-08,INTERVENTIONAL,PHASE1,10,"['Recurrent Mantle Cell Lymphoma', 'Refractory Mantle Cell Lymphoma']",Recurrent Mantle Cell Lymphoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT04662580,ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer,"A Phase 1, Multicenter, Open-Label, Dose-Escalation, and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of ARX517 as Monotherapy and in Combination With Androgen Receptor Pathway Inhibitors in Subjects With Metastatic Prostate Cancer",RECRUITING,2024-12-09,2027-06-30,2028-12-29,INTERVENTIONAL,PHASE1,183,['Metastatic Prostate Cancer'],Metastatic Prostate Cancer,"Janssen Research & Development, LLC",[],['United States']
NCT05923073,A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease,"A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn's Disease",RECRUITING,2024-03-13,2027-10-27,2028-07-12,INTERVENTIONAL,PHASE3,120,"[""Crohn's Disease""]",Crohn's Disease,"Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'Norway', 'Austria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Portugal', 'Australia']"
NCT05739981,"Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer","Phase II Study Evaluating the Effect of IMNN-001 on Second Look Laparoscopy (SLL) in Combination With Bevacizumab (BEV) and Neoadjuvant Chemotherapy (NACT) in Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer",RECRUITING,2023-02-10,2026-08-30,2028-01-30,INTERVENTIONAL,PHASE1,50,"['Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']",Ovarian Cancer,Imunon,['Breakthrough Cancer Research'],['United States']
NCT05394675,A Study of DS-9606a in Patients With Advanced Solid Tumors,"A Phase 1, First-in-Human Study of DS-9606a in Patients With Tumor Types Known to Express Claudin-6 (CLDN6)",ACTIVE_NOT_RECRUITING,2022-05-31,2026-02-19,2026-02-19,INTERVENTIONAL,PHASE1,88,"['Advanced Cancer', 'Metastatic Cancer', 'Germ Cell Tumor']",Advanced Cancer,Daiichi Sankyo,[],"['United Kingdom', 'United States']"
NCT06449651,A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT),"Double-blind, Randomized, Placebo-controlled Study Evaluating the Safety and Efficacy of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) in At-risk Pregnancies",RECRUITING,2024-11-11,2029-12-05,2029-12-11,INTERVENTIONAL,PHASE3,39,"['Thrombocytopenia, Neonatal Alloimmune']","Thrombocytopenia, Neonatal Alloimmune","Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Israel', 'Hungary', 'Norway', 'Slovenia', 'France', 'Slovakia', 'Switzerland', 'Spain', 'Italy', 'Sweden']"
NCT06850038,"A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment",Prospective Registry-Based Study Evaluating the Effectiveness and Safety of Odevixibat in Participants With Alagille Syndrome (ALGS),RECRUITING,2025-04-22,2029-11,2029-11,OBSERVATIONAL,,30,['Alagille Syndrome'],Alagille Syndrome,Ipsen,[],['United States']
NCT06822738,A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma,"A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Subjects With Glaucoma",RECRUITING,2025-02-11,2028-11,2028-11,INTERVENTIONAL,PHASE3,130,['Primary Open Angle Glaucoma'],Primary Open Angle Glaucoma,AbbVie,[],['United States']
NCT06243848,Comparison of Ultrasound-Guided Injection With Median Nerve Decompression Surgery in Carpal Tunnel Syndrome,Comparison of Ultrasound-Guided Injection With Traditional Median Nerve Decompression Surgery in Patients With Carpal Tunnel Syndrome: Randomized Controlled Study,RECRUITING,2024-01-25,2025-11-24,2025-12-24,INTERVENTIONAL,NA,60,"['Musculoskeletal Diseases', 'Median Nerve Disease', 'Carpal Tunnel Syndrome', 'Ultrasound-Guided Injection', 'Surgery']",Musculoskeletal Diseases,Afyonkarahisar Health Sciences University,[],['Turkey (Türkiye)']
NCT06349148,The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients,"The Effects of Immunonutrition Therapy on the Nutritional Status, Immune Function, and Quality of Life of Locally Advanced Cervical Cancer Patients With Malnutrition: an Open-label Randomized Controlled Study",RECRUITING,2024-01-01,2026-08,2026-12,INTERVENTIONAL,NA,50,['Cervical Cancers'],Cervical Cancers,"SHUANG ZHENG JIA, PhD",[],['China']
NCT05438043,A Study of Daratumumab,"A Phase 3b, Multicenter, Open-label, Daratumumab Long-term Extension Study",RECRUITING,2022-12-15,2026-01-30,2029-01-31,INTERVENTIONAL,PHASE3,500,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Turkey (Türkiye)', 'China', 'Russia', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'South Korea', 'Czechia', 'United Kingdom', 'Greece', 'Poland', 'Ukraine', 'Germany']"
NCT07172035,The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis,Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Recompensation in Patients With Decompensated Cirrhosis: A Multicenter Prospective Cohort Study,RECRUITING,2025-08-01,2027-08-01,2027-08-01,OBSERVATIONAL,,250,"['Cirrhosis', 'Decompensation', 'Transjugular Intrahepatic Portosystemic Shunt (TIPS)', 'Survival Analysis']",Cirrhosis,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","['Zhongnan Hospital', ""Yichang Central People's Hospital"", 'Jingzhou Central Hospital', 'Xiangyang Central Hospital', ""Jiangxi Provincial People's Hopital"", 'The Central Hospital of Huanggang', 'Second Xiangya Hospital of Central South University', 'Shengjing Hospital', 'The First Affiliated Hospital with Nanjing Medical University', ""Shanxi Provincial People's Hospital"", 'The First Affiliated Hospital of Zhengzhou University', 'The Third Xiangya Hospital of Central South University', 'Fujian Medical University Union Hospital', 'Renmin Hospital of Wuhan University']",['China']
NCT02573415,Uterine Transplantation for the Treatment of Uterine Factor Infertility,Uterine Transplantation for the Treatment of Uterine Factor Infertility,ACTIVE_NOT_RECRUITING,2015-10,2026-12,2027-03,INTERVENTIONAL,NA,10,['Primary Uterine Infertility'],Primary Uterine Infertility,The Cleveland Clinic,[],['United States']
NCT06998966,Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support,Quality Improvement Initiative Leveraging Electronic Healthcare Records to Reduce Inappropriate Proton Pump Inhibitors (PPI) Prescribing at UCLA.,RECRUITING,2026-01,2026-11,2027-01,INTERVENTIONAL,NA,372,"['Prescribing Patterns, Physician', 'Physician&#39;s Practice Patterns', 'Drug Utilization Review']","Prescribing Patterns, Physician","University of California, Los Angeles",['National Institute on Aging (NIA)'],['United States']
NCT07219212,A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma,A Study of JNJ-90301900 in Combination With Concurrent Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma,RECRUITING,2025-12-11,2028-07-14,2028-07-14,INTERVENTIONAL,PHASE1,30,['Squamous Cell Carcinoma of Head and Neck'],Squamous Cell Carcinoma of Head and Neck,Johnson & Johnson Enterprise Innovation Inc.,[],['United States']
NCT07194070,A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry,Global Prospective Hemolytic Disease of the Fetus and Newborn Registry,RECRUITING,2025-11-28,2030-05-26,2030-09-30,OBSERVATIONAL,,175,['Hemolytic Disease of the Fetus and Newborn'],Hemolytic Disease of the Fetus and Newborn,"Janssen Research & Development, LLC",[],"['United States', 'Italy', 'Germany']"
NCT05168930,Zanubrutinib and Venetoclax in CLL (ZANU-VEN),A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients,RECRUITING,2022-02-18,2026-10-28,2028-10-28,INTERVENTIONAL,PHASE2,45,"['Chronic Lymphocytic Leukemia (CLL)', 'Small Lymphocytic Lymphoma (SLL)']",Chronic Lymphocytic Leukemia (CLL),Dana-Farber Cancer Institute,['BeiGene'],['United States']
NCT03809000,A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery,STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features,ACTIVE_NOT_RECRUITING,2019-04-15,2023-04-07,2029-09-15,INTERVENTIONAL,PHASE2,188,['Prostate Cancer'],Prostate Cancer,"RTOG Foundation, Inc.","['Pfizer', 'Astellas Pharma Inc']","['United States', 'Canada']"
NCT06550895,A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma,"A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma",ACTIVE_NOT_RECRUITING,2024-09-16,2026-08-31,2026-11-30,INTERVENTIONAL,PHASE2,11,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['United States', 'Australia']"
NCT06500156,Metabolic Cluster Analysis in Septic Shock Patients,Metabolic Cluster Analysis in Septic Shock Patients Undergoing Hemodynamic Resuscitation. A Multicenter Observational Study,RECRUITING,2024-05-01,2026-10-31,2026-10-31,OBSERVATIONAL,,120,['Septic Shock'],Septic Shock,Corporacion Parc Tauli,[],['Spain']
NCT07002723,Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality,Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality in Elderly Patients Undergoing Hip Surgery:A Superiority Randomized Controlled Trail,RECRUITING,2025-06-20,2026-06-30,2026-06-30,INTERVENTIONAL,NA,96,['Hip Fractures'],Hip Fractures,Peking University Shenzhen Hospital,[],['China']
NCT07192757,Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss,Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss,RECRUITING,2025-12-01,2026-07-30,2026-07-30,INTERVENTIONAL,NA,36,['Presbycusis'],Presbycusis,University of Florida,[],['United States']
NCT06788431,A Study Evaluating the Stability and Efficacy of IMC-001 for Injection on Atherosclerotic Plaques in Patients With ACS.,"A Randomized, Double-blind, Placebo-controlled, Multiple-dose Escalation IIT Clinical Study to Evaluate the Efficacy and Safety of Injectable IMC-001 in Patients With Recent Acute Coronary Syndrome (ACS) Who Are Receiving Optimal Medical Therapy After PCI Treatment",RECRUITING,2025-03-10,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE2,30,['Atherosclerosis'],Atherosclerosis,ImmuneOnco Biopharmaceuticals (Shanghai) Inc.,"['RenJi Hospital', 'ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.', 'The First Affiliated Hospital of Nanyang Medical College']",['China']
NCT07268495,The Impact of Intraperitoneal Spray Combined With Intravenous Lidocaine on Postoperative Pain After Myomectomy,The Impact of Intraperitoneal Spray Combined With Intravenous Lidocaine on Postoperative Pain After Myomectomy,RECRUITING,2024-08-01,2025-08-01,2025-12-20,INTERVENTIONAL,NA,100,['Postoperative Pain'],Postoperative Pain,General Hospital of Ningxia Medical University,[],['China']
NCT02808780,An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis,Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis,ACTIVE_NOT_RECRUITING,2016-12-16,2026-12-10,2027-03-11,OBSERVATIONAL,,537,['Ulcerative Colitis'],Ulcerative Colitis,"Janssen Biotech, Inc.",[],"['Austria', 'United States', 'France', 'Spain', 'South Korea', 'Canada', 'Czechia', 'Greece', 'Germany']"
NCT06359587,Re-Purposing the Ordering of Routine Laboratory Tests in Hospitals in British Columbia,Re-Purposing the Ordering of Routine Laboratory Testing in Hospitalized Medical Patients in British Columbia,RECRUITING,2024-05-06,2026-11-16,2026-11-16,INTERVENTIONAL,NA,700000,['Hospital Acquired Condition'],Hospital Acquired Condition,University of British Columbia,"['Providence Health & Services', 'Vancouver Coastal Health', 'Fraser Health', 'Interior Health', 'Northern Hospital, Australia', 'Canadian Institutes of Health Research (CIHR)', 'Island Health']",['Canada']
NCT06238921,Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases,Phase I/II Study of Stereotactic Radiation and Sacituzumab Govitecan With Zimberelimab in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases (TARGET-TNBC),RECRUITING,2024-12-19,2027-02,2027-02,INTERVENTIONAL,PHASE1,31,"['Breast Cancer', 'Triple Negative Breast Cancer']",Breast Cancer,H. Lee Moffitt Cancer Center and Research Institute,['Gilead Sciences'],['United States']
NCT04009499,"A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis",ACTIVE_NOT_RECRUITING,2019-08-13,2026-05-25,2026-05-25,INTERVENTIONAL,PHASE3,1131,['Psoriatic Arthritis'],Psoriatic Arthritis,UCB Biopharma SRL,[],"['Belgium', 'Japan', 'Hungary', 'Russia', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT05579366,"Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)",Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors,RECRUITING,2022-12-07,2027-07,2027-10,INTERVENTIONAL,PHASE1,764,"['High Grade Epithelial Ovarian Cancer', 'High Grade Serous Ovarian Cancer', 'Primary Peritoneal Carcinoma', 'Fallopian Tube Cancer', 'Endometrial Cancer', 'Non-small Cell Lung Cancer', 'Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)', 'Mesothelioma', 'Breast Adenocarcinoma', 'Triple Negative Breast Cancer', 'Hormone Receptor-positive/Her2 Negative Breast Cancer', 'Platinum-resistant Ovarian Cancer (PROC)', 'Platinum Sensitive Ovarian Cancer (PSOC)', 'Primary Refractory Ovarian Cancer', 'Uterine Cancer']",High Grade Epithelial Ovarian Cancer,Genmab,[],"['China', 'Japan', 'United States']"
NCT05714202,A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC),"A Phase 3, Open-Label, Multi-Center, Randomized Study Evaluating the Efficacy and Safety of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-Risk Non-Muscle Invasive Bladder Cancer",ACTIVE_NOT_RECRUITING,2023-03-23,2029-09-18,2029-09-18,INTERVENTIONAL,PHASE3,1135,['Bladder Cancer'],Bladder Cancer,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT06323980,INHANCE Stemless Reverse Shoulder IDE,"Randomized, Prospective, Multi-Center Study of the INHANCE Stemless Total Reverse Shoulder System",RECRUITING,2025-03-04,2027-11-10,2028-09-29,INTERVENTIONAL,NA,168,"['Arthroplasty', 'Replacement', 'Shoulder']",Arthroplasty,DePuy Orthopaedics,[],['United States']
NCT04497779,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,Evaluation of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,ACTIVE_NOT_RECRUITING,2020-07-13,2026-10-13,2026-10-13,OBSERVATIONAL,,95,"['Asymptomatic COVID-19 Infection Laboratory-Confirmed', 'Symptomatic COVID-19 Infection Laboratory-Confirmed']",Asymptomatic COVID-19 Infection Laboratory-Confirmed,City of Hope Medical Center,"['National Cancer Institute (NCI)', 'California Institute for Regenerative Medicine (CIRM)']",['United States']
NCT06552754,Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers,Cybersickness Prevention and Mitigation in Virtual Reality for Healthy Volunteers,RECRUITING,2025-09-26,2026-07-01,2026-07-01,INTERVENTIONAL,NA,150,"['Healthy Volunteers', 'Virtual Reality']",Healthy Volunteers,National Human Genome Research Institute (NHGRI),[],['United States']
NCT00706420,Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen,Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen,ACTIVE_NOT_RECRUITING,2004-04-07,2026-10-12,2026-10-12,INTERVENTIONAL,PHASE1,17,['Diabetes Mellitus'],Diabetes Mellitus,City of Hope Medical Center,['National Institutes of Health (NIH)'],['United States']
NCT06319820,A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer,"A Phase 3, Randomized Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Single Agent Intravesical Chemotherapy in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (IR-NMIBC) and Susceptible FGFR Alterations",RECRUITING,2024-04-18,2028-06-28,2028-06-28,INTERVENTIONAL,PHASE3,641,['Non-Muscle Invasive Bladder Cancer'],Non-Muscle Invasive Bladder Cancer,"Janssen Research & Development, LLC",[],"['Japan', 'Hong Kong', 'China', 'Belgium', 'Israel', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Spain', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT04661982,Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer,Long Term Follow Up After Breast Cancer,ACTIVE_NOT_RECRUITING,2010-07-06,2026-11-24,2026-11-24,OBSERVATIONAL,,500,['Breast Cancer'],Breast Cancer,City of Hope Medical Center,[],['United States']
NCT03420118,Study of Biomarkers in Gynecological Cancers,Molecular and Immunological Characterization of Gynecological Malignancies,RECRUITING,2017-12-21,2026-12-21,2027-12-21,INTERVENTIONAL,NA,1000,['Gynecologic Cancer'],Gynecologic Cancer,"University Health Network, Toronto",[],['Canada']
NCT06551285,"Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.","Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome",RECRUITING,2024-02-01,2026-01-31,2029-05-31,INTERVENTIONAL,NA,120,"['Polycystic Ovary Syndrome', 'Metabolic Syndrome']",Polycystic Ovary Syndrome,Celia Bañuls,[],['Spain']
NCT06979089,Implementation of DWM in Dutch SMEs,Improving the Mental Health of Working Adults in Dutch Small and Medium-Sized Enterprises (SMEs): A Cluster RCT of WHO's Doing What Matters in Times of Stress (DWM),RECRUITING,2025-05-19,2026-09,2026-09,INTERVENTIONAL,NA,518,"['Anxiety', 'Depression', 'Psychological Distress']",Anxiety,VU University of Amsterdam,"['World Health Organization', 'University of Copenhagen', 'University Hospital Heidelberg']",['Netherlands']
NCT04416191,Immune Cells During Disuse and Recovery,Muscle Immune Cells During Disuse and Recovery in Aging and Metabolic Disease,RECRUITING,2022-05-15,2027-04-30,2028-04-30,INTERVENTIONAL,NA,45,['Muscle Disuse'],Muscle Disuse,University of Utah,[],['United States']
NCT05039619,"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants","A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescent Patients With Active Class III or IV Lupus Nephritis, Including an Evaluation of Open Label Safety and PK in a Cohort of Pediatric Patients (Aged 5 to < 12)",RECRUITING,2022-05-12,2027-08-31,2029-09-28,INTERVENTIONAL,PHASE2,40,['Lupus Nephritis'],Lupus Nephritis,Hoffmann-La Roche,"['Genentech, Inc.']","['Brazil', 'South Africa', 'Russia', 'United States', 'France', 'Mexico', 'Spain', 'Peru', 'Italy', 'Canada', 'United Kingdom', 'Poland']"
NCT07266857,Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students,Pilot Observational Comparative Study Evaluating the Impact of the e-Bug Educational Programme on Parental Consent and HPV Vaccination Coverage During the National School-Based Vaccination Campaign in a Middle School in the Alpes-Maritimes,RECRUITING,2025-05-01,2025-06-30,2025-12-31,OBSERVATIONAL,,11000,"['Papillomavirus Infection', 'Papillomavirus Vaccines', 'Vaccination Coveage']",Papillomavirus Infection,Centre Hospitalier Universitaire de Nice,[],['France']
NCT07265999,Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES,Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES,RECRUITING,2021-07-16,2029-07-16,2029-07-16,OBSERVATIONAL,,10,['Dermatomyositis'],Dermatomyositis,Centre Hospitalier Universitaire de la Guadeloupe,[],['Guadeloupe']
NCT07267793,Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage,"Long-term Efficacy and Safety of CartiPRO Injection to Alleviate Knee Pain in Patients With Osteoarthritis and/or Diverse Cartilage Defects: a Multicenter, Single-blind, Randomized, Non-inferiority, Sponsor Initiated Trial",RECRUITING,2025-07-03,2026-02,2026-10,INTERVENTIONAL,NA,194,"['Osteoarthritis', 'Knee Pain Arthritis', 'Cartilage Defects of the Knee', 'Knee Osteoarthritis', 'Degenerative Joint Disease of Knee']",Osteoarthritis,"DALIM TISSEN Co., Ltd.",[],['South Korea']
NCT00508547,Psoriasis Longitudinal Assessment and Registry,"A Multicenter, Open Registry of Patients With Plaque Psoriasis Who Are Candidates for Systemic Therapy Including Biologics",ACTIVE_NOT_RECRUITING,2007-06-21,2029-12-31,2030-12-31,OBSERVATIONAL,,15842,['Psoriasis'],Psoriasis,"Janssen Scientific Affairs, LLC",[],"['Japan', 'Netherlands', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Slovenia', 'Chile', 'South Korea', 'Colombia', 'Czechia', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Greece', 'Portugal', 'Ukraine', 'Sweden', 'Austria', 'United States', 'Argentina']"
NCT07265778,Clinical Investigation for Evaluating the Safety and Efficacy of JTM102 to Mid Face Volume Deficiency,"Multicenter, Randomized, Subject & Independent Evaluator-blind, Split-face, Medical Device Pivotal Study to Evaluate the Efficacy and Safety of Injection With JTM102 as Compared to Juvederm VOLUMA With Lidocaine for Temporary Restoring the Mid-face Volume",ACTIVE_NOT_RECRUITING,2024-10-22,2026-04-30,2026-12-31,INTERVENTIONAL,NA,149,['Mid Face Volume Deficit'],Mid Face Volume Deficit,"Jetema Co., Ltd.",[],['South Korea']
NCT06392386,A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis,"An Open-label, Uncontrolled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Efgartigimod PH20 SC in Participants From 2 to Less Than 18 Years of Age With Generalized Myasthenia Gravis",RECRUITING,2024-06-28,2026-09-30,2026-09-30,INTERVENTIONAL,PHASE2,12,['Generalized Myasthenia Gravis'],Generalized Myasthenia Gravis,argenx,[],"['Belgium', 'Israel', 'Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07113405,Influence of Tea Extract on Maximal Voluntary Knee Contraction Following Downhill Jogging,"The Influence of Tea Extract on Maximal Voluntary Knee Contraction After 30 Minutes of Downhill Jogging: a Randomized, Double-blind, Placebo-controlled Study",RECRUITING,2025-12-01,2026-12-30,2026-12-30,INTERVENTIONAL,NA,60,['Muscle Recovery'],Muscle Recovery,University of Fribourg,[],['Switzerland']
NCT06930794,A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET Amplification.,"An Open-label, Randomized, Controlled, Multicenter Phase IIIb Clinical Study to Evaluate the Efficacy and Safety of Vebreltinib Enteric Capsule Combined With Platinum-based Doublet Chemotherapy Compared With Platinum-based Doublet Chemotherapy in Subjects With Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Who Have Not Received Previous Systemic Treatment and Carry MET Amplification.",RECRUITING,2025-07-07,2029-02,2030-02,INTERVENTIONAL,PHASE3,280,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Beijing Pearl Biotechnology Limited Liability Company,[],['China']
NCT06712407,Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy,An Open-label Study to Assess the Efficacy and Safety of Extended TARPEYO® (Delayed-release Budesonide Capsules) Treatment in Adult Patients With Primary IgA Nephropathy Who Have Completed 9 Months of TARPEYO® 16 mg Once Daily Treatment in Real-world Clinical Practice,RECRUITING,2024-12-17,2026-05-29,2027-11,INTERVENTIONAL,PHASE4,60,['IgA Nephropathy'],IgA Nephropathy,Calliditas Therapeutics AB,['Worldwide Clinical Trials'],"['Puerto Rico', 'United States']"
NCT06347432,Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy,Em-power: Maximizing Functional Independence for Children With Severe Cerebral Palsy,RECRUITING,2024-08-29,2027-03-31,2027-03-31,INTERVENTIONAL,NA,16,['Cerebral Palsy'],Cerebral Palsy,Grand Valley State University,[],['United States']
NCT05702034,A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE,"A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack",RECRUITING,2023-02-15,2026-11-11,2026-12-09,INTERVENTIONAL,PHASE3,15000,"['Ischemic Stroke; Ischemic Attack, Transient']","Ischemic Stroke; Ischemic Attack, Transient","Janssen Research & Development, LLC",['Bristol Myers Squibb Company (BMS)'],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'United Kingdom', 'Sweden', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07265544,Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease,Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease,RECRUITING,2023-03-01,2025-12-31,2026-02-12,OBSERVATIONAL,,240,"['Liver Neoplasm', 'HBV Infection', 'Non-alcoholic Fatty Liver Disease NAFLD', 'Liver Fibrosis']",Liver Neoplasm,"Nanfang Hospital, Southern Medical University","['Beijing Friendship Hospital', 'Beijing YouAn Hospital', 'Zhongnan Hospital', 'Guangzhou General Hospital of Guangzhou Military Command']",['China']
NCT07217587,Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis,"Efficacy and Safety of Nipocalimab vs Efgartigimod in a Randomized, Open-label, Phase 3b, Interventional Trial Including Within Class Switching From Efgartigimod to Nipocalimab",RECRUITING,2025-11-28,2027-09-28,2028-09-04,INTERVENTIONAL,PHASE3,115,['Myasthenia Gravis'],Myasthenia Gravis,"Janssen Research & Development, LLC",[],['United States']
NCT06428331,A Study of SKB518 in Patients With Advanced Solid Tumors,"A Phase 1, Multicenter, Open-label First-In-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of SKB518 in Subjects With Advanced Solid Tumors",RECRUITING,2024-07-04,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,150,['Advanced Solid Tumors'],Advanced Solid Tumors,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT06855771,A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9),"A Multicenter, Randomized, Open-label, Phase 2 Study Evaluating the Safety and Efficacy of BMS-986504 Monotherapy in Participants With Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion After Progression on Prior Therapies",RECRUITING,2025-09-09,2028-12-29,2031-12-30,INTERVENTIONAL,PHASE2,130,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Bristol-Myers Squibb,[],"['Japan', 'China', 'United States', 'France', 'Spain', 'Italy', 'Romania', 'Australia', 'Poland', 'United Kingdom', 'Sweden', 'Germany']"
NCT07231679,A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease,"A Randomized, Placebo-Controlled, Multicenter, Phase 1/2a Study to Investigate the Safety, Tolerability, and Pharmacokinetics of IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease",RECRUITING,2025-10-30,2026-10,2027-01,INTERVENTIONAL,PHASE1,94,"['Healthy Volunteers', 'Chronic Kidney Disease']",Healthy Volunteers,Ingenia Therapeutics INC,[],['Australia']
NCT05316129,Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer,A Phase I Clinical Trial of an Infusion of Autologous T Cells Genetically Engineered With a Chimeric Receptor to Target the Follicle-Stimulating Hormone Receptor in Patients With Recurrent Ovarian Cancer,RECRUITING,2022-04-28,2026-07,2029-05,INTERVENTIONAL,PHASE1,10,['Ovarian Cancer'],Ovarian Cancer,H. Lee Moffitt Cancer Center and Research Institute,"['Anixa Biosciences, Inc.']",['United States']
NCT04882098,A Study of Guselkumab in Participants With Active Psoriatic Arthritis,"A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants With Active Psoriatic Arthritis",ACTIVE_NOT_RECRUITING,2021-06-17,2024-12-30,2028-05-19,INTERVENTIONAL,PHASE3,1054,"['Arthritis, Psoriatic']","Arthritis, Psoriatic","Janssen Research & Development, LLC",[],"['Bulgaria', 'China', 'Slovakia', 'Bosnia and Herzegovina', 'Serbia', 'Lithuania', 'Australia', 'Israel', 'Hungary', 'Estonia', 'Russia', 'Slovenia', 'Croatia', 'South Korea', 'Czechia', 'Poland', 'Georgia', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Latvia', 'Greece', 'Ukraine', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Philippines']"
NCT07112638,The engAGE Project: Immersive Intergenerational Intervention to Improve Movement in Older Adults,Effects of an Immersive Technology-based Intergenerational Intervention to Improve Movement Patterns in Older Adults: Co-creation and a Randomised Controlled Trial (engAGE) Study Protocol.,ACTIVE_NOT_RECRUITING,2025-02-03,2026-06-01,2027-01-01,INTERVENTIONAL,NA,240,['Frailty at Older Adults'],Frailty at Older Adults,University Ramon Llull,[],['Spain']
NCT05967741,The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation,Randomized Controlled Clinical Trial to Gauge the Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation,RECRUITING,2023-07-20,2026-05-31,2026-06,INTERVENTIONAL,NA,24,"['Platelet Aggregation, Spontaneous', 'Vascular Thrombosis']","Platelet Aggregation, Spontaneous","University of California, Davis",[],['United States']
NCT06408935,Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients,"A Phase 3b, Open-label, Multicenter Study to Evaluate Transmural Healing and Disease Modifying Effect of Guselkumab in Crohn's Disease Patients",RECRUITING,2024-04-17,2027-06-08,2028-03-26,INTERVENTIONAL,PHASE3,112,"[""Crohn's Disease""]",Crohn's Disease,Janssen-Cilag Ltd.,[],"['Brazil', 'Belgium', 'Israel', 'United States', 'France', 'Germany', 'Slovakia', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'Poland', 'Australia']"
NCT07267117,"Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease","Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease (VALVE-COMPASS)",RECRUITING,2025-06-01,2027-12-31,2030-05-31,OBSERVATIONAL,,10000,"['Heart Valve Disease', 'Mitral Valve (MV) Regurgitation', 'Mitral Valve Disease', 'Mitral Valve Stenosis', 'Aortic Valve Disease', 'Aortic Valve Stenosis', 'Tricuspid Valve Disease', 'Tricuspid Valve Regurgitation', 'Aortic Valve Regurgitation', 'Pulmonary Valve Disease', 'Transcatheter Valve Replacement', 'Transcatheter Aortic Valve Replacement (TAVR)', 'Transcatheter Pulmonary Valve Replacement (TPVR)', 'Transcatheter Edge-to-edge Repair']",Heart Valve Disease,"Second Affiliated Hospital, School of Medicine, Zhejiang University","['Army Medical Center of PLA', 'Huaxi Hospital', 'Fuwai Yunnan Cardiovascular Hospital', ""People's Hospital of Xinjiang Uygur Autonomous Region"", 'Second Xiangya Hospital of Central South University', 'Xiangya Hospital of Central South University', 'The General Hospital of Northern Theater Command', 'Chinese Academy of Medical Sciences, Fuwai Hospital', 'Fujian Provincial Hospital', 'Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine', 'The Affiliated Hospital of Qingdao University', 'Renmin Hospital of Wuhan University', 'The First Affiliated Hospital of Air Force Medicial University', 'Navy General Hospital, Beijing']",['China']
NCT07254013,Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution,Left Bundle Branch Area Pacing (LBBAP) Monitoring Assistant: Evaluation of Portable ECG Solution,RECRUITING,2025-11-14,2026-02-28,2026-03-31,INTERVENTIONAL,NA,55,"['Bradycardia', 'Left Bundle Branch Area Pacing', 'Cardiac Resynchronisation Therapy (CRT)', 'ECG']",Bradycardia,MicroPort CRM,[],['France']
NCT06869889,Analgesia Following Lumbar Discectomy,"Fluoroscopy-Guided Retrolaminar Block Versus Local Wound Infiltration for Post Lumbar Discectomy Analgesia: A Double-Blinded, Randomized Trial",ACTIVE_NOT_RECRUITING,2025-03-12,2026-02,2026-03,INTERVENTIONAL,NA,130,"['Analgesia', 'Disk Herniated Lumbar', 'Local Infiltration']",Analgesia,Zagazig University,[],['Egypt']
NCT06782490,"A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity","A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of Three Doses of Orally Administered BMS-986368, a FAAH/MAGL Inhibitor, for the Treatment of Spasticity in Participants With Multiple Sclerosis (BALANCE-MSS-1)",RECRUITING,2025-06-05,2026-11-18,2027-01-27,INTERVENTIONAL,PHASE2,200,['Multiple Sclerosis Spasticity'],Multiple Sclerosis Spasticity,Celgene,[],"['United States', 'Puerto Rico', 'Canada', 'Czechia', 'Australia', 'Poland', 'Germany']"
NCT06773975,The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly,A 12-week Pilot Randomized Controlled Trial of an Oral Nutritional Supplement in Improving the Nutritional and Health Outcomes of the Elderly in Peri Urban Communities of the La Nkwantanang Madina Municipality in the Greater Accra Region,RECRUITING,2025-11-24,2026-04,2026-04,INTERVENTIONAL,PHASE1,80,"['Hypertension', 'Hand Grip Strength', 'Body Weight', 'Iron Deficiency', 'Anaemia', 'Total Cholesterol', 'Protein Deficiency']",Hypertension,University of Ghana,[],['Ghana']
NCT06465381,Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique,Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique: A Hybrid Effectiveness/Implementation Cluster Randomized Trial,RECRUITING,2025-09-01,2027-12-01,2028-12-01,INTERVENTIONAL,NA,2100,['Suicide Prevention'],Suicide Prevention,University of Washington,['National Institute of Mental Health (NIMH)'],['Mozambique']
NCT07267273,Betamethasone Phonophoresis For Vitiligo,Effect of Betamethasone Phonophoresis in Treatment of Vitiligo,RECRUITING,2025-11-10,2026-02-01,2026-02-10,INTERVENTIONAL,NA,60,['Vitiligo'],Vitiligo,Cairo University,[],['Egypt']
NCT07179380,Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD),"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease",RECRUITING,2026-01-15,2028-12-30,2028-12-30,INTERVENTIONAL,PHASE3,344,"['Pulmonary Hypertension', 'Interstitial Lung Disease']",Pulmonary Hypertension,Insmed Incorporated,[],"['Israel', 'Japan', 'United States']"
NCT03952299,Oxybutynin for Post-surgical Bladder Pain and Urgency,Oxybutynin for Post-surgical Bladder Pain and Urgency,RECRUITING,2021-09-01,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE3,100,"['Overactive Bladder Syndrome', 'Neuropathic Bladder']",Overactive Bladder Syndrome,"University of California, Davis",[],['United States']
NCT05429632,Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT,"Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study to Evaluate the Efficacy and Safety of Mocravimod as Adjunctive and Maintenance Treatment in Adult AML Patients Undergoing Allogeneic HCT",RECRUITING,2022-06-16,2027-05,2029-11,INTERVENTIONAL,PHASE3,366,['Adult Acute Myeloid Leukemia'],Adult Acute Myeloid Leukemia,Priothera SAS,[],"['Brazil', 'Israel', 'Japan', 'United States', 'France', 'Switzerland', 'Spain', 'Taiwan', 'Italy', 'Romania', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT05507164,Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects,Non-randomized Pilot Study to Characterize Temporo-masseteric Nerve Block (TMNB) in,RECRUITING,2022-10-10,2026-09,2026-12,INTERVENTIONAL,PHASE2,20,['Occlusion'],Occlusion,"Rutgers, The State University of New Jersey",[],['United States']
NCT07266948,Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work,Evaluating the Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work,RECRUITING,2025-11-01,2026-01-31,2026-03-01,INTERVENTIONAL,PHASE4,40,"['Dry Eye', 'Eye Diseases', 'Eyes Dry Chronic']",Dry Eye,Southern College of Optometry,[],['United States']
NCT05627648,Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar,"A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Confirmatory Study For Intracordal Administration Of KP-100LI In Patients With Vocal Fold Scar",RECRUITING,2022-12-01,2026-08-31,2027-02-28,INTERVENTIONAL,PHASE3,62,['Vocal Fold Scar'],Vocal Fold Scar,"Kringle Pharma, Inc.",[],['Japan']
NCT07265635,"Functional Proteomics of Uremic Retention Solutes Associated With Immunosenescence, Inflammation and Impaired Adaptive Stress Response","Functional Proteomics of Uremic Retention Solutes Associated With Immunosenescence, Inflammation and Impaired Adaptive Stress Response",ACTIVE_NOT_RECRUITING,2025-02-17,2027-02-17,2027-02-17,INTERVENTIONAL,NA,30,['Hemodialysis'],Hemodialysis,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT05945823,Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors,A Phase 2 Study of Futibatinib in Combination With PD-1 Antibody-based Standard of Care Therapy in Patients With Solid Tumors.,ACTIVE_NOT_RECRUITING,2023-07-13,2026-03,2027-01,INTERVENTIONAL,PHASE2,53,"['Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer', 'Esophageal Adenocarcinoma', 'Esophageal Squamous Cell Cancer', 'Siewert Type 1 GEJ Cancer', 'Pancreatic Cancer']",Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer,"Taiho Oncology, Inc.",[],"['Spain', 'United States', 'France', 'Germany']"
NCT05643027,A Novel Intervention for Patients With Cancer,A Novel Intervention for Avoidance-Related Opioid Misuse in Patients With Cancer,RECRUITING,2023-03-01,2026-06-10,2026-07-01,INTERVENTIONAL,NA,40,"['Substance Use', 'Cancer', 'Psychological']",Substance Use,Dana-Farber Cancer Institute,['National Cancer Institute (NCI)'],['United States']
NCT05236374,"Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc","Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet, on Cellular Zinc Status and Vascular Function in Older Adults",RECRUITING,2022-10-01,2025-12-31,2026-12-31,INTERVENTIONAL,NA,20,"['Zinc Deficiency', 'Inflammation', 'Metabolic Diseases', 'Vascular Diseases']",Zinc Deficiency,"University of California, Davis","[""National Cattlemen's Beef Association, a contractor to the Beef Checkoff""]",['United States']
NCT06678659,"A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer","A Phase 1 / 2, Open-Label Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer",RECRUITING,2024-11-21,2028-10-30,2028-10-30,INTERVENTIONAL,PHASE1,85,"['Unresectable', 'Locally Advanced', 'Metastatic Cancers', 'Relapsed/Refractory Lymphomas']",Unresectable,Recursion Pharmaceuticals Inc.,[],"['United States', 'Canada']"
NCT05083169,"A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma","A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2021-10-14,2028-12-08,2028-12-08,INTERVENTIONAL,PHASE3,587,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'Belgium', 'Russia', 'France', 'Denmark', 'South Korea', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06588556,Improving Needs Among Older Adults,Improving Needs Among Older Adults: the ICUconnect 2 Primary Palliative Care RCT,RECRUITING,2025-09-16,2028-08-31,2028-12-31,INTERVENTIONAL,NA,350,"['Critical Illness', 'Palliative Care', 'Older Adults', 'Informal Caregivers', 'Care Delivery Model']",Critical Illness,Duke University,['National Institute on Aging (NIA)'],['United States']
NCT03117751,Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma,Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma,ACTIVE_NOT_RECRUITING,2017-03-29,2026-09-30,2028-09-30,INTERVENTIONAL,PHASE2,790,"['Acute Lymphoblastic Leukemia', 'Acute Lymphoblastic Lymphoma']",Acute Lymphoblastic Leukemia,St. Jude Children's Research Hospital,"['Incyte Corporation', 'Amgen', 'Servier']","['United States', 'Australia']"
NCT07267442,"Turkish Translation , Validity and Reliability of the Hypertonia Assessment Tool in Children With Motor Disorders","Turkish Translation , Validity and Reliability of the Hypertonia Assessment Tool in Children With Motor Disorders",RECRUITING,2025-01-10,2026-01-10,2026-06-10,OBSERVATIONAL,,70,"['Motor Disorder', 'Reliability and Validity', 'Hypertonia']",Motor Disorder,Kastamonu University,['Gazi University'],['Turkey (Türkiye)']
NCT06635551,Comparison of Vascular Catheter-Related Thrombosis and Risk Factors After Oncologic and Non-Oncologic Major Surgery,Comparison of Vascular Catheter-Related Thrombosis and Risk Factors Using Daily Bedside Ultrasonography After Oncologic and Non-Oncologic Major Surgery,RECRUITING,2024-12-04,2026-02,2026-02,INTERVENTIONAL,NA,100,"['Catheter Related Complication', 'Thromboses, Venous', 'Surgery']",Catheter Related Complication,Mersin University,[],['Turkey (Türkiye)']
NCT05727176,Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement,Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusions or Rearrangements,RECRUITING,2023-07-05,2026-12,2026-12,INTERVENTIONAL,PHASE2,120,"['Advanced Cholangiocarcinoma', 'FGFR2 Fusions', 'Gene Rearrangement']",Advanced Cholangiocarcinoma,"Taiho Oncology, Inc.",[],"['Brazil', 'Japan', 'Hong Kong', 'China', 'United States', 'Spain', 'Italy', 'Canada', 'South Korea', 'Poland', 'Portugal', 'Argentina', 'Australia']"
NCT00001360,Studies of Blood Flow to the Brain During Thought,"Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory",RECRUITING,1993-09-17,,,OBSERVATIONAL,,4100,['Healthy Volunteer'],Healthy Volunteer,National Institute of Mental Health (NIMH),[],['United States']
NCT07112651,Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause,"The Effects of CL25216 on Vasomotor Symptoms in Women During Perimenopause: a Randomised, Double-blind, Placebo-controlled Study",RECRUITING,2025-11-24,2026-06-12,2026-06-12,INTERVENTIONAL,NA,80,['Vasomotor Symptoms'],Vasomotor Symptoms,ApexCPG LLC,[],['India']
NCT07007156,Is a Positive NECPAL in ICU Patients Associated With Higher Mortality,Is a Positive NECPAL in ICU Patients Associated With Higher Mortality,RECRUITING,2025-06-12,2027-01,2027-01,OBSERVATIONAL,,199,['Acute Disease'],Acute Disease,Consorci Sanitari de l'Alt Penedès i Garraf,[],['Spain']
NCT06100393,New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients.,"A Feasibility, Prospective, Repeated-measures Investigation of Hearing Outcomes With New Pre-processing Speech Enhancement Algorithms Compared to Standard-of-care Algorithms in Adult Cochlear Implant Recipients: a Master Umbrella Investigation",RECRUITING,2024-02-22,2026-10-31,2026-10-31,INTERVENTIONAL,NA,150,['Hearing Loss'],Hearing Loss,Cochlear,[],['Australia']
NCT06551506,"The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products","A Prospective, Randomized, Open-label Phase 4 Study of the Immunology and Safety of Maternal RSV Vaccination (ABRYSVO (TM)), Infant Nirsevimab (BEYFORTUS (TM)) Immunization, or Both Products During the First Year of Life",ACTIVE_NOT_RECRUITING,2024-09-19,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE4,181,['Respiratory Syncytial Virus Infection'],Respiratory Syncytial Virus Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT02609776,"Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer","A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Subjects With Advanced Non-Small Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2016-05-24,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,751,['Non-Small-Cell Lung Cancer'],Non-Small-Cell Lung Cancer,"Janssen Research & Development, LLC",[],"['Japan', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT06783140,Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer,Comparing Second-Line NABPLAGEM vs. Nab-paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma,RECRUITING,2025-06-10,2031-06-02,2031-06-02,INTERVENTIONAL,PHASE2,10,"['Pancreatic Cancer, Advanced or Metastatic', 'BRCA1/2 Mutation', 'PALB2 Gene Mutation']","Pancreatic Cancer, Advanced or Metastatic","University Health Network, Toronto",[],['Canada']
NCT00569127,"Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor","Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients",ACTIVE_NOT_RECRUITING,2007-12-01,2015-01-01,2026-01-31,INTERVENTIONAL,PHASE3,427,"['Colorectal Neuroendocrine Tumor G1', 'Gastric Neuroendocrine Tumor G1', 'Neuroendocrine Neoplasm', 'Neuroendocrine Tumor', 'Neuroendocrine Tumor G2']",Colorectal Neuroendocrine Tumor G1,National Cancer Institute (NCI),[],['United States']
NCT05272631,Depuy Synthes Lower Extremity Shaft Nail Registry,Depuy Synthes Lower Extremity Shaft Nail Registry (RFN-Advanced™ Retrograde Femoral Nailing System/ TN-Advanced™ Tibial Nailing System),ACTIVE_NOT_RECRUITING,2022-05-04,2025-12-31,2025-12-31,OBSERVATIONAL,,250,"['Femoral Fractures', 'Tibial Fractures']",Femoral Fractures,"DePuy Synthes Products, Inc.",[],['United States']
NCT05645003,Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients,Effect of Repetative Transcranial Magnetic Stimulation Therapy on Neuropathic Pain in Patients With Spinal Cord Injury,RECRUITING,2022-11-15,2025-12-31,2026-03-31,INTERVENTIONAL,NA,60,"['Spinal Cord Injuries', 'Neuropathic Pain', 'Neurological Diseases or Conditions']",Spinal Cord Injuries,Afyonkarahisar Health Sciences University,[],['Turkey (Türkiye)']
NCT07267819,Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents,The Efficacy of Xeomin as a Prophylactic Therapy for Migraine in Patients With Traumatic Brain Injuries (TBIs) Versus Anomalous Health Incidents (AHIs),RECRUITING,2025-08-05,2028-06-06,2028-06-06,OBSERVATIONAL,,60,"['Migraine', 'Traumatic Brain Injury', 'Anomalous Health Incidents']",Migraine,Uniformed Services University of the Health Sciences,[],['United States']
NCT05201781,A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel,Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel,RECRUITING,2022-03-09,2037-07-29,2037-10-30,INTERVENTIONAL,PHASE4,295,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Spain']"
NCT07266467,Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients,Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients,RECRUITING,2025-05-13,2026-11-30,2026-11-30,INTERVENTIONAL,PHASE4,290,['Kidney Transplant'],Kidney Transplant,First Affiliated Hospital Xi'an Jiaotong University,"[""Chinese People's Liberation Army Northern Theater Command General Hospital"", 'The First Hospital of Jilin University', 'The Affiliated Hospital of Qingdao University', 'Qianfo Mountain Hospital, Shandong Province', 'The First Affiliated Hospital of Anhui Medical University', 'Eastern Theater General Hospital', 'Shu lan Hospital', 'Shanghai Zhongshan Hospital', 'Tongji Hospital', 'The Second Xiangya Hospital, Central South University', 'The First Affiliated Hospital of Zhengzhou University', 'Second Affiliated Hospital of Guangzhou Medical University', 'First Affiliated Hospital, Sun Yat-Sen University', 'Beijing Chao Yang Hospital', 'RenJi Hospital', 'Nanfang Hospital, Southern Medical University', 'Tsinghua Changgeng Hospital, Beijing']",['China']
NCT06919965,A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer,"A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Investigator's Choice of Intravesical Chemotherapy in Participants With High-risk Non-muscle-invasive Bladder Cancer With Susceptible FGFR Alterations Who Had Received Intravesical Bacillus Calmette-Guérin (BCG)",RECRUITING,2025-09-10,2028-04-06,2032-03-16,INTERVENTIONAL,PHASE3,220,['Non-Muscle Invasive Bladder Neoplasms'],Non-Muscle Invasive Bladder Neoplasms,"Janssen Research & Development, LLC",[],"['Brazil', 'Israel', 'Japan', 'China', 'United States', 'South Korea', 'United Kingdom', 'Argentina']"
NCT03991819,Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer,"Phase I/Ib Study of Binimetinib, a MEK Inhibitor, in Combination With Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)",RECRUITING,2019-09-20,2026-08,2026-12,INTERVENTIONAL,PHASE1,40,['Non-small Cell Carcinoma'],Non-small Cell Carcinoma,"University Health Network, Toronto",[],['Canada']
NCT07007065,"Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)","A Randomized, Controlled, Partially Masked, Phase 3b Study to Assess the Injection Burden, Efficacy, Safety, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) in a Real-World Context in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)",RECRUITING,2025-11-05,2033-03,2033-03,INTERVENTIONAL,PHASE3,561,['Neovascular Age-related Macular Degeneration'],Neovascular Age-related Macular Degeneration,AbbVie,[],['United States']
NCT05398120,Skills Group for Youth at Clinical High-Risk for Psychosis,Testing the Feasibility of a Skills Group for Adolescents and Young Adults at Clinical High-risk for Psychosis,RECRUITING,2022-04-26,2026-01-01,2026-01-01,INTERVENTIONAL,NA,30,"['Clinical High-Risk', 'Psychological']",Clinical High-Risk,University of Pittsburgh,['Substance Abuse and Mental Health Services Administration (SAMHSA)'],['United States']
NCT07268274,Metabolic Trajectories and Protein Intake in Long-Stay Ventilated Intensive Care Unit (ICU) Patients,Metabolism and the Impact of Protein Intake in Chronic Critically Ill Adult Patients: Protocol for a Unicentric Prospective Cohort Study (MetaChronic Study),ACTIVE_NOT_RECRUITING,2024-03-15,2024-06-15,2025-12-31,OBSERVATIONAL,,100,['Adult ICU Patients'],Adult ICU Patients,Universidade do Algarve,[],['Portugal']
NCT07037758,A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311),"A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)",RECRUITING,2025-09-16,2028-03-18,2031-01-18,INTERVENTIONAL,PHASE1,380,['Extensive Stage Small Cell Lung Cancer'],Extensive Stage Small Cell Lung Cancer,Amgen,"['Asher Biotherapeutics, Inc.']","['United States', 'South Korea', 'Turkey (Türkiye)']"
NCT06866158,Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease,Single-arm Open-label Clinical Trial: Autologous Dendritic Cells and Lymphocytes in Type 2 Diabetes Mellitus With Albuminuria,ACTIVE_NOT_RECRUITING,2024-05-01,2024-08-05,2026-08-05,INTERVENTIONAL,PHASE1,80,['Diabetic Kidney Disease (DKD)'],Diabetic Kidney Disease (DKD),PT. JES Kasih Nusantara Sejahterah,"['Rumah Sakit Pusat Angkatan Darat Gatot Soebroto', 'Universitas Prima Indonesia', 'Universitas Pertahanan Indonesia']",['Indonesia']
NCT07265596,Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging),Early Longitudinal Imaging in the Parkinson's Progression Markers Initiative Using [18F] AV-133 (PPMI AV-133 Prodromal Imaging),RECRUITING,2023-10-30,2027-12,2027-12,INTERVENTIONAL,PHASE2,100,['Prodromal Parkinsons Disease'],Prodromal Parkinsons Disease,Michael J. Fox Foundation for Parkinson's Research,[],"['Israel', 'Netherlands', 'United States', 'Canada', 'United Kingdom', 'Germany']"
NCT02911805,Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation,Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation,ACTIVE_NOT_RECRUITING,2015-06-10,2022-06-14,2028-01-28,INTERVENTIONAL,NA,14,['Vision Disorders'],Vision Disorders,VA Office of Research and Development,[],['United States']
NCT05839379,Targeted Pediatric High-Grade Glioma Therapy,"Molecularly-Guided Phase II Umbrella Trial for Children, Adolescents, and Young Adults Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma",RECRUITING,2024-08-02,2029-08-28,2034-08-28,OBSERVATIONAL,,350,"['High Grade Glioma', 'Diffuse Intrinsic Pontine Glioma', 'Anaplastic Astrocytoma', 'Glioblastoma', 'Glioblastoma Multiforme', 'Diffuse Midline Glioma, H3 K27M-Mutant', 'Metastatic Brain Tumor', 'WHO Grade III Glioma', 'WHO Grade IV Glioma']",High Grade Glioma,Nationwide Children's Hospital,[],"['New Zealand', 'Netherlands', 'United States', 'Canada', 'Australia', 'United Kingdom', 'Germany']"
NCT07148089,A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT),"A Phase 1b, Multicenter, Open-Label, Dose Finding Study to Investigate the Safety and Tolerability of a Single Intravenous Dose of SGT-501 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia",RECRUITING,2025-12-01,2027-06,2031-05,INTERVENTIONAL,PHASE1,18,['Catecholaminergic Polymorphic Ventricular Tachycardia'],Catecholaminergic Polymorphic Ventricular Tachycardia,Solid Biosciences Inc.,[],"['United States', 'Canada']"
NCT07268313,Complete Remission After Treatment With Biologics for Nasal Polyps,English Title: Complete Remission Study Subtitle: Discontinuation of Mepolizumab or Dupilumab After at Least 12 Months Without Symptoms in Patients With Severe Chronic Rhinosinusitis With Polyps - a National Danish RCT Study,RECRUITING,2025-04-03,2027-06-01,2027-06-01,INTERVENTIONAL,PHASE4,66,['Nasal Polyps'],Nasal Polyps,"Rigshospitalet, Denmark",[],['Denmark']
NCT03921008,Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma,Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma,RECRUITING,2019-05-21,2028-08-31,2028-08-31,INTERVENTIONAL,PHASE1,19,['Cutaneous Angiosarcoma'],Cutaneous Angiosarcoma,Washington University School of Medicine,[],['United States']
NCT04557059,A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer,"A Randomized, Controlled, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer, Assessed by PSMA-PET With an Observational Cohort",ACTIVE_NOT_RECRUITING,2020-11-12,2029-08-27,2029-08-27,INTERVENTIONAL,PHASE3,694,['Prostatic Neoplasms'],Prostatic Neoplasms,"Janssen Pharmaceutica N.V., Belgium",[],"['Slovakia', 'Jordan', 'Australia', 'Belgium', 'Hungary', 'Russia', 'Finland', 'Denmark', 'Czechia', 'Poland', 'Lebanon', 'Mexico', 'Spain', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT07137546,Fundus-first Laparoscopic Cholecystectomy,Fundus-first Laparoscopic Cholecystectomy in Difficult Gallbladder,ACTIVE_NOT_RECRUITING,2024-05-01,2025-12-01,2026-01-01,INTERVENTIONAL,NA,174,"['Cholecystitis', 'Acute Cholecystitis', 'Pericholecystic Abscess']",Cholecystitis,Minia University,[],['Egypt']
NCT03459846,"A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)","A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Platinum-Ineligible Patients With Unresectable Stage IV Urothelial Cancer",ACTIVE_NOT_RECRUITING,2018-03-16,2020-10-15,2026-12-31,INTERVENTIONAL,PHASE2,154,['Urinary Bladder Neoplasms'],Urinary Bladder Neoplasms,AstraZeneca,[],"['Russia', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Vietnam']"
NCT06614491,SCOPE - Single-Point Classification Observational Peristomal Evaluation,"A Single-Time-Point, Observational Study to Evaluate Interrater Reliability of SACS 2.0 for the Assessment of Peristomal Skin Health in Ostomates",RECRUITING,2024-12-06,2025-12,2026-01,OBSERVATIONAL,,600,"['Ileostomy', 'Colostomy', 'Urostomy']",Ileostomy,ConvaTec Inc.,[],"['Brazil', 'Colombia']"
NCT06837480,Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema,Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors With Chronic Lymphedema,RECRUITING,2025-12-15,2029-08-30,2029-11-30,INTERVENTIONAL,NA,150,"['Head and Neck Cancer', 'Lymphedema of the Head and Neck']",Head and Neck Cancer,Abramson Cancer Center at Penn Medicine,['National Cancer Institute (NCI)'],['United States']
NCT05990946,Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer,"A Prospective, Randomized, Controlled Study to Evaluate the Impact of Remote Symptom Management Via Smartphone App Based on Electronic Patient-Reported Outcomes on Rehabilitation Exercise Adherence After Minimally Invasive Surgery in Lung Cancer Patients",RECRUITING,2023-06-01,2026-03-30,2026-06-30,INTERVENTIONAL,NA,736,"['Lung Neoplasms, Non-Small Cell Lung Cancer', 'Postoperative Complications', 'Patient Reported Outcome Measures', 'Telerehabilitation', 'Exercise Therapy']","Lung Neoplasms, Non-Small Cell Lung Cancer","Zhongshan People's Hospital, Guangdong, China",[],['China']
NCT05912517,A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN),"A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)",RECRUITING,2023-12-20,2027-08-05,2029-07-10,INTERVENTIONAL,PHASE3,120,['Hemolytic Disease of the Fetus and Newborn'],Hemolytic Disease of the Fetus and Newborn,"Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Argentina', 'Sweden', 'Australia']"
NCT01804686,A Long-term Extension Study of PCI-32765 (Ibrutinib),"A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study",RECRUITING,2013-09-09,2026-12-31,2027-01-29,INTERVENTIONAL,PHASE3,700,"['Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma', 'Mantle Cell Lymphoma', 'Follicular Lymphoma', 'Diffuse Large B-cell Lymphoma', 'Waldenstrom Macroglobulinemia', 'Chronic Graft Versus Host Disease']",Chronic Lymphocytic Leukemia,"Janssen Research & Development, LLC",['Pharmacyclics LLC.'],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Puerto Rico', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07218627,A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure,"A Randomised, Placebo-controlled, Double-blinded Phase 1b Study Investigating Safety, Tolerability, Pharmacokinetics and Effects on Biomarkers From Multiple Ascending Doses of NNC0537-1482 in Participants With Heart Failure",RECRUITING,2025-10-23,2027-01-15,2027-01-15,INTERVENTIONAL,PHASE1,36,['Heart Failure'],Heart Failure,Novo Nordisk A/S,[],['United Kingdom']
NCT05083182,A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis,"A Phase 3 Multicenter, Open-label Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)",RECRUITING,2022-08-30,2026-12-10,2027-08-09,INTERVENTIONAL,PHASE3,48,"['Arthritis, Juvenile']","Arthritis, Juvenile","Janssen Research & Development, LLC",[],"['Turkey (Türkiye)', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT07063745,A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion,A Randomized Phase 2/3 Study of BMS-986504 in Combination With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion,RECRUITING,2025-12-30,2031-08-12,2031-08-12,INTERVENTIONAL,PHASE2,590,['Metastatic Non-small Cell Lung Cancer With MTAP Deletion'],Metastatic Non-small Cell Lung Cancer With MTAP Deletion,Bristol-Myers Squibb,[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Romania', 'Malaysia', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05110742,Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances,Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances,ACTIVE_NOT_RECRUITING,2024-04-22,2027-12-30,2027-12-30,INTERVENTIONAL,PHASE1,11,['Hematological Malignancy'],Hematological Malignancy,M.D. Anderson Cancer Center,[],['United States']
NCT02146924,Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia,"Phase I Study to Evaluate Cellular Immunotherapy Using Memory-Enriched T Cells Lentivirally Transduced to Express a CD19-Specific, Hinge-Optimized, CD28-Costimulatory Chimeric Receptor and a Truncated EGFR Following Lymphodepleting Chemotherapy in Adult Patients With High-Risk CD19+ Acute Lymphoblastic Leukemia",ACTIVE_NOT_RECRUITING,2014-10-16,2026-07-15,2026-07-15,INTERVENTIONAL,PHASE1,71,"['B Acute Lymphoblastic Leukemia', 'Recurrent Acute Lymphoblastic Leukemia', 'Refractory Acute Lymphoblastic Leukemia']",B Acute Lymphoblastic Leukemia,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07249502,Scoliosis-Specific Exercises on Physical Fitness Parameters,The Effects of Scoliosis-Specific Corrective Exercises on Physical Fitness Parameters in Adolescents With Idiopathic Scoliosis,RECRUITING,2025-11-19,2026-05-15,2026-05-30,INTERVENTIONAL,NA,40,"['Scoliosis Idiopathic Adolescent', 'Scoliosis Idiopathic Adolescent Treatment']",Scoliosis Idiopathic Adolescent,Istinye University,[],['Turkey (Türkiye)']
NCT07180537,Creating Health Course Study for People With Rheumatological Conditions,Transforming Health Habits: Evaluating an Online Wellness Program for Individuals With Rheumatological Conditions,RECRUITING,2025-12-01,2027-12-31,2027-12-31,INTERVENTIONAL,NA,200,"['Rheumatoid Arthritis', ""Sjogren's Syndrome"", 'Systemic Lupus Erythematosus', 'Mixed Connective Tissue Disease', 'Psoriatic Arthritis']",Rheumatoid Arthritis,Terry L. Wahls,[],['United States']
NCT06115642,"A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors","A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced/Metastatic Solid Tumors",RECRUITING,2023-11-24,2026-06-30,2027-11-30,INTERVENTIONAL,PHASE1,340,['Advanced/Metastatic Malignant Solid Tumors'],Advanced/Metastatic Malignant Solid Tumors,Shanghai Henlius Biotech,[],['China']
NCT04108195,A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma,A Phase 1b Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Subjects With Multiple Myeloma,ACTIVE_NOT_RECRUITING,2020-02-21,2027-04-07,2027-04-07,INTERVENTIONAL,PHASE1,290,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Netherlands', 'United States', 'Spain', 'Canada', 'Germany']"
NCT05047172,Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis,Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA),RECRUITING,2022-08-02,2028-05-31,2028-05-31,INTERVENTIONAL,PHASE3,1683,"['Intracranial Arteriosclerosis', 'Stroke']",Intracranial Arteriosclerosis,University of Florida,"['National Institute of Neurological Disorders and Stroke (NINDS)', 'University of Cincinnati', 'Medical University of South Carolina', 'Janssen Scientific Affairs, LLC', 'AstraZeneca']","['United States', 'Canada']"
NCT07268365,Is Cap Assisted Endoscopy Useful in Acute Upper Gastrointestinal Bleeding ?,Is Cap Assisted Endoscopy Useful in Acute Upper Gastrointestinal Bleeding ?,RECRUITING,2025-10-16,2026-10,2026-11,INTERVENTIONAL,NA,72,"['Cap-assisted Endoscopy', 'Upper Gastro Intestinal Bleeding', 'Endoscopy']",Cap-assisted Endoscopy,"Centre Hospitalier Universitaire, Amiens",[],['France']
NCT05120271,BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors,"A First-in-Human, Phase 1/2, Dose Escalation Study of BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors",ACTIVE_NOT_RECRUITING,2022-10-26,2025-10-24,2042-12,INTERVENTIONAL,PHASE1,7,"['Hepatocellular Carcinoma', 'Squamous Cell Carcinoma of the Lung', 'Merkel Cell Carcinoma', 'Myxoid/Round Cell Liposarcoma']",Hepatocellular Carcinoma,Sotio Biotech Inc.,"['SOTIO Biotech a.s.', 'SOTIO Biotech AG']","['United Kingdom', 'United States']"
NCT06628167,Community Support Program for Lung Cancer Screening Volume II,Community Support Program for Lung Cancer Screening Volume II,RECRUITING,2024-10-01,2026-02-01,2026-02-01,INTERVENTIONAL,NA,100,['Lung Cancer'],Lung Cancer,Abramson Cancer Center at Penn Medicine,['University of Pennsylvania'],['United States']
NCT06455098,A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF),Assessment of Safety and Effectiveness in Treatment Management of Paroxysmal Atrial Fibrillation With the BWI Pulsed Field Ablation System With OMNYPULSE™ Catheter,RECRUITING,2024-06-28,2026-05-30,2026-06-30,INTERVENTIONAL,NA,440,['Atrial Fibrillation'],Atrial Fibrillation,"Biosense Webster, Inc.",[],"['United States', 'Australia']"
NCT06819007,Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01),"A Phase 3, Open-label, Multicenter, Randomized Trial of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy as First-line Maintenance Therapy in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01/ENGOT-ov89/GEICO144- O/GOG-3112)",RECRUITING,2025-03-19,2028-11-01,2032-01-31,INTERVENTIONAL,PHASE3,582,['Ovarian Cancer'],Ovarian Cancer,Daiichi Sankyo,[],"['Brazil', 'Belgium', 'Bulgaria', 'Israel', 'Japan', 'Singapore', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'Malaysia']"
NCT03799445,"Ipilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell Carcinoma","Phase 2 Study (With Safety Lead in) of the Safety, Tolerability and Efficacy of Anti-CTLA4 (Ipilimumab) and Anti-PD-1 (Nivolumab) in Combination With Radiation Therapy to 50-66 Gy in Low-Intermediate Volume, Local-Regionally Advanced HPV-Positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)",ACTIVE_NOT_RECRUITING,2019-07-25,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE2,37,"['Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma', 'Oropharyngeal Basaloid Carcinoma', 'Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8', 'Posterior Tongue Squamous Cell Carcinoma', 'Soft Palate Squamous Cell Carcinoma', 'Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Tonsillar Squamous Cell Carcinoma']",Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT06914609,REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome,Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults With Angelman Syndrome,RECRUITING,2025-06-10,2027-08,2030-04,INTERVENTIONAL,PHASE3,210,['Angelman Syndrome'],Angelman Syndrome,"Ionis Pharmaceuticals, Inc.",[],"['Japan', 'United States', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT05621044,Physical Activity Smartphone App for African American Men (FitBros) Ph II,Smartphone App to Increase and Maintain Physical Activity in African American Men (FitBrothers) Phase II,ACTIVE_NOT_RECRUITING,2024-05-01,2025-12-01,2026-03-15,INTERVENTIONAL,NA,100,"['Exercise', 'Health Behavior', 'Technology']",Exercise,"Klein Buendel, Inc.","['Pennington Biomedical Research Center', 'National Institute on Minority Health and Health Disparities (NIMHD)', 'Georgetown University']",['United States']
NCT05949684,ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions,"A Phase 3, Open-label, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) vs Epoetin Alfa for the Treatment of Anemia Due to Revised International Prognostic Scoring System (IPSS-R) Very Low, Low, or Intermediate-Risk Myelodysplastic Syndrome (MDS) in Erythropoiesis-Stimulating Agent (ESA)-Naive Participants Who Are Non-Transfusion Dependent (NTD): The ""ELEMENT-MDS"" Trial",RECRUITING,2023-10-24,2027-06-25,2030-03-11,INTERVENTIONAL,PHASE3,360,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,Bristol-Myers Squibb,[],"['Japan', 'Hong Kong', 'China', 'Australia', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Colombia', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Canada', 'Greece', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT02457338,Infant Microbiota and Probiotic Intake Study,Infant Supplementation With Probiotic Bifidobacterium Longum Subsp. Infantis Study,ACTIVE_NOT_RECRUITING,2014-11-01,2016-07-15,2027-06-07,INTERVENTIONAL,NA,120,['Healthy'],Healthy,"University of California, Davis","['Evolve BioSystems, Inc.']",['United States']
NCT06455592,Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years,Effect of Practicing Adapted Physical Activity (APA) on Sleep Quality in Children From 5 Years of Age and Adolescents up to 16 Years of Age Undergoing Treatment for a Hematologic Malignancy.,RECRUITING,2025-11-17,2027-11,2027-11,INTERVENTIONAL,NA,30,"['Child, Only', 'Blood Cancer', 'Adapted Physical Activity', 'Sleep']","Child, Only","University Hospital, Clermont-Ferrand",[],['France']
NCT07267052,Acute Effects of Transcutaneous Electrical Nerve Stimulation at Acupoints on Nociceptive Transmission: A Mechanism Study Using Pain-Related Evoked Potentials,Acute Effects of Transcutaneous Electrical Nerve Stimulation at Acupoints on Nociceptive Transmission: A Mechanism Study Using Pain-Related Evoked Potentials,RECRUITING,2025-11-25,2026-07,2026-07,INTERVENTIONAL,NA,35,['Pain Management'],Pain Management,China Medical University Hospital,[],['Taiwan']
NCT06336902,Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer,A Phase Ib Study of Botensilimab Plus Balstilimab and Fasting-Mimicking Diet (FMD) Plus Vitamin C in Patients With KRAS-Mutant Metastatic Colorectal Cancer,RECRUITING,2025-01-15,2027-01-15,2028-01-15,INTERVENTIONAL,PHASE1,15,"['Metastatic Colorectal Adenocarcinoma', 'Stage IV Colorectal Cancer AJCC v8']",Metastatic Colorectal Adenocarcinoma,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT06852222,"A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)","A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A Rearrangements or NPM1 Mutations Who Are Ineligible for Intensive Chemotherapy",RECRUITING,2025-06-04,2029-06-22,2029-08-15,INTERVENTIONAL,PHASE3,600,"['Leukemia, Myeloid, Acute']","Leukemia, Myeloid, Acute","Janssen Research & Development, LLC",[],"['Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT04613596,Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7,A Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation,RECRUITING,2020-12-02,2028-10-31,2029-10-31,INTERVENTIONAL,PHASE2,806,"['Advanced Non-Small Cell Lung Cancer', 'Metastatic Non-Small Cell Lung Cancer']",Advanced Non-Small Cell Lung Cancer,Mirati Therapeutics Inc.,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Serbia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Georgia', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Philippines']"
NCT06245772,"CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity","A National, Multicentre, Non-interventional, Prospective, Longitudinal Study to Assess CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity in Routine Clinical Practice.",RECRUITING,2023-11-16,2026-02-28,2027-02-28,OBSERVATIONAL,,113,['Upper Limb Injury'],Upper Limb Injury,Ipsen,[],['France']
NCT05903339,Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV,A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV,ACTIVE_NOT_RECRUITING,2023-08-29,2025-05-16,2025-12-21,INTERVENTIONAL,PHASE1,36,['Hiv'],Hiv,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05642572,Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial),"A Randomized Phase II Study of INC280 (Capmatinib) Plus Osimertinib With or Without Ramucirumab in Participants With EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)",RECRUITING,2023-05-05,2026-05-31,2027-05-31,INTERVENTIONAL,PHASE2,66,"['Recurrent Lung Non-Small Cell Carcinoma', 'Stage IV Lung Cancer AJCC v8']",Recurrent Lung Non-Small Cell Carcinoma,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],['United States']
NCT03153449,ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population,Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty,ACTIVE_NOT_RECRUITING,2017-09-19,2026-03-31,2028-06-30,INTERVENTIONAL,NA,400,['Primary Knee Arthroplasty'],Primary Knee Arthroplasty,DePuy Orthopaedics,[],"['New Zealand', 'Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Ireland', 'Canada', 'United Kingdom', 'Australia']"
NCT06055608,Advancing Transplantation Outcomes in Children,Advancing Transplantation Outcomes in Children (CTOT-41),RECRUITING,2024-05-22,2028-06-30,2028-06-30,INTERVENTIONAL,PHASE2,200,['Kidney Transplant'],Kidney Transplant,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06538246,Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors,Self-directed Mobile Adaptive Coping Skills Intervention to Improve Psychological Distress Symptoms Among Cardiorespiratory Failure Survivors: Blueprint 2,RECRUITING,2024-10-15,2027-11-15,2028-04-15,INTERVENTIONAL,NA,400,"['Depression', 'Anxiety', 'Post-traumatic Stress Disorder', 'Stress', 'Worries; Pain or Disability', 'Breath Shortness']",Depression,Duke University,"['Oregon Health and Science University', 'University of Colorado, Denver', 'University of California, Los Angeles']",['United States']
NCT07031323,"OnTrackCF: Engagement, Feasibility, and Acceptability Study","OnTrackCF: Engagement, Feasibility, and Acceptability Study",RECRUITING,2025-11-20,2026-09,2026-12,INTERVENTIONAL,NA,60,"['Cystic Fibrosis (CF)', 'Cystic Fibrosis - Complete']",Cystic Fibrosis (CF),Boston Children's Hospital,"['Cystic Fibrosis Foundation', 'Johns Hopkins University', 'University of Alabama at Birmingham']",['United States']
NCT07203833,Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock,Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock,ACTIVE_NOT_RECRUITING,2025-10-19,2027-04,2027-05,INTERVENTIONAL,NA,144,"['Vasorin', 'Septic Shock', 'Shock', 'Biomarker', 'Infection']",Vasorin,"Centre Hospitalier Universitaire, Amiens",[],['France']
NCT04923893,"A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy","A Phase 3 Randomized Study Comparing Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Ciltacabtagene Autoleucel, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy",ACTIVE_NOT_RECRUITING,2021-08-19,2029-02-14,2036-09-22,INTERVENTIONAL,PHASE3,743,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Argentina']"
NCT07250178,ONSD as an ICP Marker in vNOTES and TLH,Effect of Surgical Approach on Optic Nerve Sheath Diameter as a Surrogate Marker of Intracranial Pressure: A Comparison Between vNOTES and Total Laparoscopic Hysterectomy,RECRUITING,2025-11-27,2025-12-25,2025-12-30,INTERVENTIONAL,NA,56,"['Endometrial Cancer', 'Abnormal Uterine Bleeding', 'Myoma;Uterus']",Endometrial Cancer,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,[],['Turkey (Türkiye)']
NCT06240052,Use Electroencephalogram to Study Neural Dynamics of Fear Conditioning and Avoidance Learning Circuit in Humans,Use Electroencephalogram to Study Neural Dynamics of Fear Conditioning and Avoidance Learning Circuit in Humans,ACTIVE_NOT_RECRUITING,2024-02-08,2026-12-30,2026-12-30,INTERVENTIONAL,NA,150,['Neural Dynamics of the Acquisition and Retention of Fear Learning and Active Avoidance Learning'],Neural Dynamics of the Acquisition and Retention of Fear Learning and Active Avoidance Learning,"The University of Texas Health Science Center, Houston",[],['United States']
NCT07219550,A Study of MK-1084 in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017),A Clinical Study to Evaluate the Effect of Hepatic Impairment on the Single-Dose Pharmacokinetics of MK-1084,RECRUITING,2025-11-05,2026-06-30,2026-07-06,INTERVENTIONAL,PHASE1,58,"['Healthy', 'Hepatic Impairment']",Healthy,Merck Sharp & Dohme LLC,[],['United States']
NCT06472778,A Real-world Study in Participants With Smoldering Multiple Myeloma,"Smoldering Pathway Assessment Real-World Knowledge (SPARK) Study-Retrospective Observational, Non-interventional Chart Review Study in Smoldering Multiple Myeloma",RECRUITING,2024-05-31,2025-12-31,2026-02-20,OBSERVATIONAL,,450,['Smoldering Multiple Myeloma'],Smoldering Multiple Myeloma,Janssen-Cilag Ltd.,[],"['France', 'Spain', 'Italy', 'United Kingdom', 'Germany']"
NCT05022849,A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants,"A Phase 1, Dose Escalation Study of JNJ-75229414, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against KLK2 for Metastatic Castration-Resistant Prostate Cancer",ACTIVE_NOT_RECRUITING,2021-09-28,2037-10-30,2037-10-30,INTERVENTIONAL,PHASE1,15,['Prostatic Neoplasms'],Prostatic Neoplasms,"Janssen Research & Development, LLC",[],['United States']
NCT07023627,A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression,"A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression (MAESTRA 1)",RECRUITING,2025-11-12,2027-04-27,2027-10-24,INTERVENTIONAL,PHASE2,160,['Ovarian Cancer'],Ovarian Cancer,Incyte Corporation,"['ENGOT Foundation', 'GOG Foundation']","['Belgium', 'Japan', 'United States', 'Switzerland', 'Puerto Rico', 'Spain', 'United Kingdom', 'Australia']"
NCT06033196,Tocilizumab in Lung Transplantation,Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Tocilizumab (CTOT-45),RECRUITING,2024-02-13,2029-01-08,2029-01-08,INTERVENTIONAL,PHASE2,350,['Lung Transplant'],Lung Transplant,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06612203,Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer,Phase Ib/II Study to Evaluate Safety and Preliminary Efficacy of the Wee1 Inhibitor Debio 0123 in Combination With Sacituzumab Govitecan in Triple-negative or HR+/HER2- Advanced/ Metastatic Breast Cancer,ACTIVE_NOT_RECRUITING,2025-01-17,2027-02,2027-10,INTERVENTIONAL,PHASE1,76,['Advanced Breast Cancer'],Advanced Breast Cancer,MedSIR,"['Debiopharm International SA', 'Gilead Sciences']","['United Kingdom', 'Spain']"
NCT04929210,A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease,"A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease",RECRUITING,2021-08-30,2026-08-04,2027-04-13,INTERVENTIONAL,PHASE4,405,"['Arthritis, Psoriatic']","Arthritis, Psoriatic","Janssen Research & Development, LLC",[],"['Bulgaria', 'Hong Kong', 'Slovakia', 'Australia', 'Israel', 'Hungary', 'Russia', 'Denmark', 'Thailand', 'Czechia', 'Poland', 'Georgia', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT06315751,Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome,"A Double-blind, Placebo-controlled, Phase 2b, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients With Tourette Syndrome",ACTIVE_NOT_RECRUITING,2024-09-10,2026-02,2026-04,INTERVENTIONAL,PHASE2,164,['Tourette Syndrome'],Tourette Syndrome,Noema Pharma AG,[],"['Belgium', 'Hungary', 'United States', 'France', 'Spain', 'Poland', 'Germany']"
NCT05757869,A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation,"A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants With Atrial Fibrillation",ACTIVE_NOT_RECRUITING,2023-04-11,2026-10-31,2026-10-31,INTERVENTIONAL,PHASE3,20283,['Atrial Fibrillation'],Atrial Fibrillation,"Janssen Research & Development, LLC",['Bristol-Myers Squibb'],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Chile', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT03399799,Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma,"A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of Talquetamab, a Humanized GPRC5D x CD3 Bispecific Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2017-12-16,2022-07-07,2029-03-30,INTERVENTIONAL,PHASE1,279,['Hematological Malignancies'],Hematological Malignancies,"Janssen Research & Development, LLC",[],"['Belgium', 'Spain', 'United States', 'Netherlands']"
NCT05938543,Cerebellar TMS and Satiety in Prader-Willi Syndrome,Noninvasive Neuromodulation of a Novel Cerebellar Satiety Circuit in Prader-Willi Syndrome,RECRUITING,2023-09-01,2026-09,2026-10,INTERVENTIONAL,NA,20,['Prader-Willi Syndrome'],Prader-Willi Syndrome,Brigham and Women's Hospital,['Foundation for Prader-Willi Research'],['United States']
NCT05090891,"To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva","A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva",RECRUITING,2022-05-05,2027-07-30,2033-01-20,INTERVENTIONAL,PHASE2,98,['Fibrodysplasia Ossificans Progressiva (FOP)'],Fibrodysplasia Ossificans Progressiva (FOP),Incyte Corporation,[],"['Brazil', 'New Zealand', 'South Africa', 'Netherlands', 'China', 'United States', 'France', 'Germany', 'Mexico', 'Chile', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Argentina', 'Australia']"
NCT06362746,Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism,"Multicenter, Double-blind, Randomized, Placebo-controlled Trial of the Efficacy and Safety of a Single Bolus Administration of Non-immunogenic Recombinant Staphylokinase in Patients With Intermediate High-risk Pulmonary Embolism (FORPE-2)",RECRUITING,2024-05-23,2028-06-01,2028-12-01,INTERVENTIONAL,PHASE3,486,['Pulmonary Embolism'],Pulmonary Embolism,"Supergene, LLC",[],['Russia']
NCT04619420,A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study With a Long-Term Extension Treatment Period to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants With Early Alzheimer's Disease",ACTIVE_NOT_RECRUITING,2021-01-06,2025-10-17,2032-12-30,INTERVENTIONAL,PHASE2,523,"['Alzheimer Disease', 'Cognitive Dysfunction', 'Dementia']",Alzheimer Disease,"Janssen Research & Development, LLC",[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Spain', 'Canada', 'United Kingdom', 'Sweden', 'Australia']"
NCT06780111,Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06),"A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E",RECRUITING,2025-07-30,2032-01-04,2032-01-04,INTERVENTIONAL,PHASE1,228,['Esophageal Squamous Cell Carcinoma'],Esophageal Squamous Cell Carcinoma,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Brazil', 'Singapore', 'Japan', 'Norway', 'China', 'France', 'Chile', 'Switzerland', 'Taiwan', 'Italy', 'South Korea', 'Czechia', 'Thailand']"
NCT06726434,Evaluation of Percutaneous Cryoneurotomy Compared to Surgical Open Neurotomy for the Management of Equinovarus Foot Deformity in Patients With Refractory Lower Limb Spasticity After Stroke,"Evaluation of Percutaneous Cryoneurotomy Compared to Surgical Open Neurotomy for the Management of Equinovarus Foot Deformity in Patients With Refractory Lower Limb Spasticity After Stroke: a Multicenter, Randomized Controlled, Non-inferiority Trial",RECRUITING,2025-07-09,2029-04-09,2029-06-09,INTERVENTIONAL,NA,114,"['Stroke', 'Equinovarus Foot', 'Refractory Lower Limb Spasticity']",Stroke,Poitiers University Hospital,[],['France']
NCT06052332,Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer,"Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer: a Multicentre, Open-label, Randomised Pragmatic Clinical Trial",RECRUITING,2024-02-07,2029-12,2033-12,INTERVENTIONAL,NA,230,"['Locally Advanced Rectal Cancer', 'Older People']",Locally Advanced Rectal Cancer,Jules Bordet Institute,[],['Belgium']
NCT06926972,NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine Intervention,NOURISH: NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine Intervention,ACTIVE_NOT_RECRUITING,2025-04-04,2025-10-20,2026-04,INTERVENTIONAL,NA,11,"['Cancer, Nos']","Cancer, Nos",H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT05316311,A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic Stenosis,"Implantation of CERENOVUS ENTERPRISE 2 Intracranial Stent in Patients With Severe Symptomatic Intracranial Atherosclerotic Stenosis: A Multicenter, Prospective and Single-Arm Study in China",RECRUITING,2022-05-24,2026-02-10,2026-04-11,INTERVENTIONAL,NA,194,['Intracranial Atherosclerosis'],Intracranial Atherosclerosis,Medos International SARL,[],['China']
NCT07136012,OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events,"A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants With Elevated Lipoprotein(a)",RECRUITING,2025-08-22,2031-10-20,2031-10-20,INTERVENTIONAL,PHASE3,11000,['Cardiovascular Disease'],Cardiovascular Disease,Amgen,[],"['United States', 'Canada', 'Australia']"
NCT06048822,Enhancing Cancer Survivorship With Pickleball,Project Rally: Enhancing Cancer Survivorship With Pickleball,ACTIVE_NOT_RECRUITING,2023-09-11,2024-05-10,2026-03,INTERVENTIONAL,NA,28,['Cancer'],Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT07266675,Post-Acute Phase of Cardiogenic Shock,Post-Acute Phase of Cardiogenic Shock (PACS) Registry,RECRUITING,2024-07-19,2027-06-30,2028-06-30,OBSERVATIONAL,,350,['Cardiogenic Shock'],Cardiogenic Shock,Mackay Memorial Hospital,[],['Taiwan']
NCT06965192,Designing Visual Tools to Enhance Cancer Surgeon Decision-making,Designing Visual Tools to Enhance Cancer Surgeon Decision-making,RECRUITING,2025-04-24,2027-06-30,2028-01-30,INTERVENTIONAL,NA,220,"['Prostate Cancer', 'Kidney Cancer']",Prostate Cancer,UNC Lineberger Comprehensive Cancer Center,[],['United States']
NCT05538351,A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury,A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury,ACTIVE_NOT_RECRUITING,2022-09-09,2026-08-01,2026-08-01,OBSERVATIONAL,,120,['Acute Kidney Injury'],Acute Kidney Injury,University of Hertfordshire,['East and North Hertfordshire NHS Trust'],['United Kingdom']
NCT07256405,Metagenomic Next-Generation Sequencing for the Diagnosis of Fracture-related Infection,Contribution of Metagenomic Sequencing Using Nanopore Technology to the Management of Post-traumatic Bone and Joint Infections,ACTIVE_NOT_RECRUITING,2024-03-11,2025-12-31,2025-12-31,OBSERVATIONAL,,100,"['Infection', 'Fracture', 'Bone']",Infection,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,"['Military Teaching Hospital Sainte Anne, Toulon', 'Institut Hospitalo-Universitaire Méditerranée Infection']",['France']
NCT03486873,Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587),"A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab",RECRUITING,2018-08-21,2043-08-04,2043-08-04,INTERVENTIONAL,PHASE3,3500,"['Solid Tumors', 'Hematologic Malignancies']",Solid Tumors,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'Russia', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'Guatemala', 'Peru', 'Colombia', 'Czechia', 'South Korea', 'Thailand', 'Poland', 'Singapore', 'Costa Rica', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'Ukraine', 'Sweden', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Philippines']"
NCT05065554,ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy,Phase II Study on Acalabrutinib and Anti-CD20 Antibody in Patients With Predominantly Demyelinating Neuropathy With or Without Anti-MAG,ACTIVE_NOT_RECRUITING,2021-11-16,2026-12-01,2028-10-01,INTERVENTIONAL,PHASE2,12,"['IgM MGUS', 'Waldenstrom Macroglobulinemia', 'Neuropathy;Peripheral']",IgM MGUS,"Shayna Sarosiek, MD",['AstraZeneca'],['United States']
NCT06477653,Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents,A Pilot Phase 2 Study of the Safety and Efficacy of Dupilumab as Add-on Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents,RECRUITING,2025-02-05,2026-12-30,2027-03-30,INTERVENTIONAL,PHASE2,30,['Hypereosinophilic Syndrome'],Hypereosinophilic Syndrome,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07045142,Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients,"Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study",RECRUITING,2025-07-01,2027-12-31,2028-06-01,INTERVENTIONAL,PHASE3,400,['Schizophrenia'],Schizophrenia,Central South University,"[""Zhumadian Second People's Hospital"", 'The Third Hospital of Changsha County', ""The Second People's Hospital of Dali Bai Autonomous Prefecture"", 'Xiangshan County Traditional Chinese Medicine Hospital Medical and Health Group Three Hospitals Distric', 'Yueyang Rehabilitation Hospital']",['China']
NCT07241988,Virtual Reality and White Noise During Peripheral IV Catheterization in Adults,"The Effect of Virtual Reality Glasses and White Noise on Pain, Anxiety, and Satisfaction During Peripheral Intravenous Catheterization in Adults: A Randomized Controlled Trial",RECRUITING,2025-10-11,2026-01,2026-05,INTERVENTIONAL,NA,60,"['Peripheral Intravenous Catheterization', 'Pain', 'Anxiety', 'Patient Satisfaction']",Peripheral Intravenous Catheterization,Gizem Göktuna,[],['Turkey (Türkiye)']
NCT02932280,Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment,A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors,ACTIVE_NOT_RECRUITING,2016-10,2026-10,2026-10,INTERVENTIONAL,PHASE1,14,"['Solid Tumor', 'Central Nervous System Tumor', 'Lymphoma', 'Leukemia']",Solid Tumor,Memorial Sloan Kettering Cancer Center,"['Milton S. Hershey Medical Center', 'M.D. Anderson Cancer Center', 'Stanford University', ""Arkansas Children's Hospital Research Institute"", ""Alberta Children's Hospital"", ""Phoenix Children's Hospital"", 'University of Texas']","['United States', 'Canada']"
NCT03661866,A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC,A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions,RECRUITING,2018-12-21,2050-12,2050-12,OBSERVATIONAL,,15000,"['Atopic Dermatitis', 'Alopecia Areata', 'Hidradenitis Suppurativa', 'Vitiligo', 'Psoriasis', 'Chronic Spontaneous Urticaria']",Atopic Dermatitis,"Target PharmaSolutions, Inc.",[],"['Spain', 'United States', 'Canada', 'Germany']"
NCT05979311,"A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy","A Phase 3b, Multi-center, Randomized, Parallel-group, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Oral Dolutegravir/Lamivudine Once-daily as a First-line Regimen Compared to Oral Bictegravir/Emtricitabine/Tenofovir Alafenamide Once Daily for Virologic Suppression and Maintenance in Antiretroviral Therapy Naive Adults Living With HIV",ACTIVE_NOT_RECRUITING,2024-02-09,2026-03-24,2027-02-23,INTERVENTIONAL,PHASE3,473,"['HIV', 'HIV Infections']",HIV,ViiV Healthcare,[],"['Belgium', 'Israel', 'Japan', 'France', 'Mexico', 'Switzerland', 'Denmark', 'Ireland', 'Spain', 'Italy', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Argentina', 'Sweden', 'Germany']"
NCT05245500,Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion,A Phase 1 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With Homozygous MTAP Deletion,RECRUITING,2022-06-09,2027-12-10,2027-12-10,INTERVENTIONAL,PHASE1,336,"['Mesothelioma', 'Non Small Cell Lung Cancer', 'Malignant Peripheral Nerve Sheath Tumors', 'Solid Tumor', 'Pancreatic Adenocarcinoma', 'Advanced Solid Tumor']",Mesothelioma,Bristol-Myers Squibb,[],['United States']
NCT03865771,Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy.,Sleep Related Memory Consolidation in Children With Age Related Focal Epilepsy.,RECRUITING,2019-03-27,2027-09,2027-09,INTERVENTIONAL,NA,95,"['Benign Epilepsy With Centro Temporal Spikes (BECTS)', 'Atypical Benign Partial Epilepsy (ABPE)', 'Epileptic Encephalopathy With Continuous Spike and Waves During Sleep (ECSWS)']",Benign Epilepsy With Centro Temporal Spikes (BECTS),"University Hospital, Strasbourg, France",[],['France']
NCT06898957,Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC),"A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Tarlatamab in Combination With YL201 With or Without Anti-PD-L1 in Subjects With Extensive Stage Small Cell Lung Cancer",RECRUITING,2025-05-16,2031-04-23,2031-04-23,INTERVENTIONAL,PHASE1,200,['Small Cell Lung Cancer'],Small Cell Lung Cancer,Amgen,['MediLink'],"['Hungary', 'China', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'Greece']"
NCT04106349,Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC),REPLICA: Real Patient Life Treatment With Cabozantinib in Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic RCC: a Descriptive and Prospective Non Interventional Study.,ACTIVE_NOT_RECRUITING,2020-03-03,2027-03-31,2027-03-31,OBSERVATIONAL,,150,['Advanced or Metastatic Renal Cell Carcinoma'],Advanced or Metastatic Renal Cell Carcinoma,Ipsen,[],['Belgium']
NCT06979336,"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)","A Phase IIb, Multicenter, Double-blind, Placebo-controlled Induction Study With an Active Treatment Extension to Assess the Efficacy, Safety, and Pharmacokinetics of RO7837195 in Patients With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2025-09-29,2027-08-25,2028-10-31,INTERVENTIONAL,PHASE2,224,['Ulcerative Colitis'],Ulcerative Colitis,"Genentech, Inc.",[],"['Poland', 'United States']"
NCT04119050,Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia,"Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension",RECRUITING,2019-08-15,2025-02-02,2028-04-10,INTERVENTIONAL,PHASE2,111,['Warm Autoimmune Hemolytic Anemia'],Warm Autoimmune Hemolytic Anemia,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'Israel', 'Hungary', 'France', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Malaysia', 'United Kingdom', 'Greece', 'Ukraine', 'Germany', 'Brazil', 'United States', 'Italy', 'Egypt']"
NCT04113759,Blood Flow Restriction Following Hip Arthroscopy,Postoperative Blood Flow Restriction Training Following Hip Arthroscopy: A Randomized Clinical Trial,RECRUITING,2023-08-01,2027-11,2028-01,INTERVENTIONAL,NA,56,"['Labral Tear, Glenoid', 'Femoral Acetabular Impingement']","Labral Tear, Glenoid",Rush University Medical Center,[],['United States']
NCT07249424,Effective Myocardial Protection Time of Del Nido Cardioplegia in Adult Cardiac Surgery,Evaluation of the Effective Myocardial Protection Duration of Del Nido Cardioplegia: A Prospective Observational Study in Adult Patients Undergoing Cardiac Surgery,RECRUITING,2025-11-12,2026-03-01,2026-03-01,OBSERVATIONAL,,80,"['Heart Valve Diseases', 'Aortic Diseases', 'Myocardial Ischemia', 'Reperfusion Injury, Myocardial', 'Postoperative Complications (Cardiopulmonary)', 'Cardiopulmonary Bypass']",Heart Valve Diseases,"Muhammet Talha Ceran, MD",[],['Turkey (Türkiye)']
NCT04925609,"Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors","A Phase I/II Study of Brigatinib in Pediatric and Young Adult Patients With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors",RECRUITING,2022-08-18,2033-12,2033-12,INTERVENTIONAL,PHASE1,65,"['Anaplastic Large Cell Lymphoma, ALK-Positive', 'Inflammatory Myofibroblastic Tumor', 'Other Solid Tumor']","Anaplastic Large Cell Lymphoma, ALK-Positive",Princess Maxima Center for Pediatric Oncology,['Takeda'],"['France', 'Netherlands']"
NCT06735144,Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors,"A Multicenter, Open Label Phase I/II Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of FH-006 for Injection in Patients With Malignant Solid Tumors",RECRUITING,2024-12-23,2027-12,2027-12,INTERVENTIONAL,PHASE1,200,['Malignant Solid Tumor'],Malignant Solid Tumor,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT06559306,Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms,"A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-(Milligram) mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms",RECRUITING,2024-07-25,2026-12-30,2027-05-13,INTERVENTIONAL,PHASE3,752,"['Depressive Disorder, Major']","Depressive Disorder, Major","Janssen Research & Development, LLC",[],"['Brazil', 'Bulgaria', 'Turkey (Türkiye)', 'United States', 'Mexico', 'Slovakia', 'Spain', 'Italy', 'Romania', 'Czechia', 'Poland', 'Portugal', 'Argentina', 'Sweden', 'Serbia']"
NCT06920693,"Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants","A Phase 1, First in Human, Randomised, Double-Blind, Placebo-controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Study to Investigate the Safety, Tolerability and Pharmacokinetics of GB-7624 Administered Subcutaneously in Healthy Adult Participants",ACTIVE_NOT_RECRUITING,2025-03-27,2026-08-30,2026-12-30,INTERVENTIONAL,PHASE1,40,['Atopic Dermatitis (AD)'],Atopic Dermatitis (AD),Generate Biomedicines,[],['Australia']
NCT06532032,A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer,A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Docetaxel Combination Therapy in Metastatic Non-small Cell Lung Cancer,ACTIVE_NOT_RECRUITING,2024-07-23,2026-02-06,2026-06-09,INTERVENTIONAL,PHASE1,12,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung","Janssen Research & Development, LLC",[],"['United Kingdom', 'Taiwan', 'United States', 'Turkey (Türkiye)']"
NCT06260163,A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis,"A Phase 3 Randomized, Open-label Induction, Double-blind Maintenance, Parallel-group, Multicenter Protocol to Evaluate the Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2024-01-19,2028-05-22,2028-08-14,INTERVENTIONAL,PHASE3,120,"['Colitis, Ulcerative']","Colitis, Ulcerative","Janssen Research & Development, LLC",[],"['Belgium', 'Japan', 'Turkey (Türkiye)', 'Norway', 'China', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Poland', 'Portugal', 'Australia']"
NCT06476613,Permissive Hypotension After Cardiac Surgery,Pilot Study- Permissive Hypotension After Cardiac Surgery,ACTIVE_NOT_RECRUITING,2024-04-20,2025-07-01,2026-10-01,INTERVENTIONAL,NA,80,['Surgery'],Surgery,Massachusetts General Hospital,[],['United States']
NCT06116682,Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial),A Phase II Study of Amivantamab SC (Subcutaneous) in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY),RECRUITING,2024-11-19,2028-05-31,2028-05-31,INTERVENTIONAL,PHASE2,88,['Lung Non-Small Cell Carcinoma'],Lung Non-Small Cell Carcinoma,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],['United States']
NCT03050268,Familial Investigations of Childhood Cancer Predisposition,Familial Investigations of Childhood Cancer Predisposition,RECRUITING,2017-04-06,2037-03-31,2037-03-31,OBSERVATIONAL,,3000,"['Acute Leukemia', 'Adenomatous Polyposis', 'Adrenocortical Carcinoma', 'AML', 'BAP1 Tumor Predisposition Syndrome', 'Carney Complex', 'Choroid Plexus Carcinoma', 'Constitutional Mismatch Repair Deficiency Syndrome', 'Diamond-Blackfan Anemia', 'DICER1 Syndrome', 'Dyskeratosis Congenita', 'Emberger Syndrome', 'Familial Acute Myeloid Leukemia', 'Familial Adenomatous Polyposis', 'Fanconi Anemia', 'Familial Cancer', 'Familial Wilms Tumor', 'Familial Neuroblastoma', 'GIST', 'Hereditary Breast and Ovarian Cancer', 'Hereditary Paraganglioma-Pheochromocytoma Syndrome', 'Hodgkin Lymphoma', 'Juvenile Polyposis', 'Li-Fraumeni Syndrome', 'Lynch Syndrome', 'MDS', 'Melanoma Syndrome', 'Multiple Endocrine Neoplasia Type 1', 'Multiple Endocrine Neoplasia Type 2', 'Neuroblastoma', 'Neurofibromatosis Type 1', 'Neurofibromatosis Type II', 'Nevoid Basal Cell Carcinoma Syndrome', 'Non Hodgkin Lymphoma', 'Noonan Syndrome and Other Rasopathy', 'Overgrowth Syndromes', 'Pancreatic Cancer', 'Peutz-Jeghers Syndrome', 'Pheochromocytoma/Paraganglioma', 'PTEN Hamartoma Tumor Syndrome', 'Retinoblastoma', 'Rhabdoid Tumor Predisposition Syndrome', 'Rhabdomyosarcoma', 'Rothmund-Thomson Syndrome', 'Tuberous Sclerosis', 'Von Hippel-Lindau Disease']",Acute Leukemia,St. Jude Children's Research Hospital,[],['United States']
NCT06121843,"A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma","A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose for Each Add-on Investigational Component",RECRUITING,2024-02-22,2028-08-01,2028-08-01,INTERVENTIONAL,PHASE1,117,['Multiple Myeloma'],Multiple Myeloma,"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",[],"['United States', 'Canada']"
NCT06925750,A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION),An Open-label Extension Study to Evaluate Safety and Tolerability of Sotatercept (MK-7962) Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care,ACTIVE_NOT_RECRUITING,2025-05-12,2028-06-16,2028-06-16,INTERVENTIONAL,PHASE2,130,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,Merck Sharp & Dohme LLC,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Israel', 'Hungary', 'France', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'United States', 'Italy', 'Argentina']"
NCT05423262,A Study of TRK-950 in Patients With Advanced Solid Tumors,A Phase I/II Study of TRK-950 in Patients With Advanced Solid Tumors,RECRUITING,2022-07-06,2027-12,2027-12,INTERVENTIONAL,PHASE1,49,"['Solid Tumor', 'Melanoma']",Solid Tumor,"Toray Industries, Inc",[],['Japan']
NCT05811351,A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD),"A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)",ACTIVE_NOT_RECRUITING,2023-03-06,2026-02-26,2026-02-26,INTERVENTIONAL,PHASE2,305,['Geographic Atrophy'],Geographic Atrophy,"Janssen Research & Development, LLC",[],"['Belgium', 'Hungary', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'Germany', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Portugal', 'Sweden', 'Australia']"
NCT07129993,Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma,"A Randomized, Open-Label, Phase 2/3 Study of Datopotamab Deruxtecan (Dato-DXd) Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Who Progressed During or After Enfortumab Vedotin (EV) Plus Pembrolizumab Combination Treatment TROPION-Urothelial03 (TU03)",RECRUITING,2025-09-26,2029-06-01,2030-01-22,INTERVENTIONAL,PHASE2,630,"['Urothelial Cancer', 'Bladder Cancer']",Urothelial Cancer,Daiichi Sankyo,['AstraZeneca'],"['China', 'Japan', 'United States', 'France']"
NCT07267936,Interventions for Maximizing Patient And Family Smoking Cessation Together,Interventions for Maximizing Patient And Family Smoking Cessation Together,RECRUITING,2025-07-07,2026-01,2026-11,INTERVENTIONAL,NA,231,['Smoking Cessation'],Smoking Cessation,Papworth Hospital NHS Foundation Trust,[],['United Kingdom']
NCT05321134,Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery,Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery,RECRUITING,2022-04-28,2026-04,2028-04,INTERVENTIONAL,NA,25,"['Colo-rectal Cancer', 'Rectal Prolapse', 'Colostomy Stoma', 'Colorectal Disorders']",Colo-rectal Cancer,"University of California, Davis","['University of California, San Francisco', 'Yale University', 'Henry Ford Hospital', 'University of Massachusetts, Worcester']",['United States']
NCT01754363,Survivorship of Attune Primary Total Knee Prosthesis,"Short, Medium and Long Term Survivorship of Attune Primary Knee Prosthesis",ACTIVE_NOT_RECRUITING,2013-02-01,2030-02-01,2030-02-01,INTERVENTIONAL,NA,1542,['Noninflammatory Degenerative Joint Disease'],Noninflammatory Degenerative Joint Disease,DePuy International,[],"['Singapore', 'Belgium', 'New Zealand', 'Hong Kong', 'Austria', 'United States', 'Germany', 'South Korea', 'Canada', 'Malaysia', 'United Kingdom', 'Australia']"
NCT03969446,"Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory","Phase 1b Study of Pembrolizumab, Decitabine +/- Venetoclax Combination Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome",RECRUITING,2020-05-04,2026-02-10,2026-02-10,INTERVENTIONAL,PHASE1,54,"['Acute Myeloid Leukemia', 'Myelodysplastic Syndrome', 'Recurrent Acute Myeloid Leukemia', 'Recurrent Myelodysplastic Syndrome', 'Refractory Acute Myeloid Leukemia', 'Refractory Myelodysplastic Syndrome']",Acute Myeloid Leukemia,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT04350138,Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection,"A Phase II Randomized, Observer-Blind, Placebo-Controlled Study, to Assess the Efficacy of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) in Preventing Gonococcal Infection",ACTIVE_NOT_RECRUITING,2020-12-29,2026-02-26,2026-02-26,INTERVENTIONAL,PHASE2,2606,['Gonococcal Infection'],Gonococcal Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],"['United States', 'Thailand', 'Malawi']"
NCT04838249,"Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System","Investigation of the Effects of Testosterone and Estrogen on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System in Transsexual Patients Undergoing Cross-sex Hormone Therapy",RECRUITING,2021-05-05,2026-05,2026-05,OBSERVATIONAL,,80,"['Transsexualism', 'Transgenderism', 'Adiposity', 'Eating Behavior', 'Arterial Stiffness', 'Microangiopathy']",Transsexualism,University of Leipzig,['Göteborg University'],['Germany']
NCT04794101,Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene,Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene,ACTIVE_NOT_RECRUITING,2020-12-04,2029-09-20,2029-12-19,INTERVENTIONAL,PHASE3,97,['X-Linked Retinitis Pigmentosa'],X-Linked Retinitis Pigmentosa,"Janssen Research & Development, LLC",[],"['Belgium', 'Israel', 'Netherlands', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'United Kingdom']"
NCT07231029,A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment,An Open-label Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment,RECRUITING,2025-12,2026-10-26,2026-10-31,INTERVENTIONAL,PHASE1,24,['Patients With Mild or Moderate Hepatic Impairment'],Patients With Mild or Moderate Hepatic Impairment,"Taisho Pharmaceutical Co., Ltd.",[],['Japan']
NCT06351475,Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy,Evaluation de l'efficacité du Remplissage Vasculaire Par de l'ALBUmine Humaine 20% + Ringer Lactate comparé au Ringer Lactate Seul Chez Les Patients opérés Par cytoréduction Avec CHimiothérapie Intrapéritonéale hyPerthermique,RECRUITING,2025-09-03,2027-10,2027-10,INTERVENTIONAL,NA,140,"['Peritoneal Neoplasms', 'Hyperthermic Intraperitoneal Chemotherapy', 'Intraoperative Care', 'Fluid Therapy', 'Postoperative Complications']",Peritoneal Neoplasms,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06578247,Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML,"A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial Of Quizartinib Administered in Combination With Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients With Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia",RECRUITING,2024-11-19,2030-06-26,2030-06-26,INTERVENTIONAL,PHASE3,700,['Leukemia'],Leukemia,Daiichi Sankyo,[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Croatia', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Serbia']"
NCT06635148,A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD),Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies,RECRUITING,2024-09-19,2029-08-24,2030-06-27,INTERVENTIONAL,PHASE2,274,"['Geographic Atrophy', 'Macular Degeneration']",Geographic Atrophy,"Janssen Research & Development, LLC",[],"['Belgium', 'Hungary', 'Turkey (Türkiye)', 'Netherlands', 'China', 'United States', 'Germany', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Portugal', 'Sweden', 'Australia']"
NCT06878404,A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis,"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants With Active Psoriatic Arthritis",RECRUITING,2025-02-21,2026-05-27,2028-11-21,INTERVENTIONAL,PHASE3,540,"['Arthritis, Psoriatic']","Arthritis, Psoriatic","Janssen Research & Development, LLC",[],"['Bulgaria', 'Japan', 'Hungary', 'Hong Kong', 'China', 'India', 'United States', 'Germany', 'Denmark', 'Spain', 'Taiwan', 'Thailand', 'Czechia', 'Poland', 'Argentina', 'Australia']"
NCT06367192,School Readiness Intervention for Preschool Children With Sickle Cell Disease,School Readiness Intervention for Preschool Children With Sickle Cell Disease,RECRUITING,2024-05-14,2026-10,2028-10,INTERVENTIONAL,NA,36,['Sickle Cell Disease'],Sickle Cell Disease,St. Jude Children's Research Hospital,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06804811,A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo,"A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo",RECRUITING,2025-11-13,2027-04-30,2027-12-01,INTERVENTIONAL,PHASE3,250,['NonSegmental Vitiligo'],NonSegmental Vitiligo,Incyte Corporation,[],"['Belgium', 'Bulgaria', 'Hungary', 'Netherlands', 'Austria', 'France', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Portugal', 'Argentina', 'Germany']"
NCT06958211,Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2),"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa",RECRUITING,2025-06-12,2026-10-09,2027-07-11,INTERVENTIONAL,PHASE3,450,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,Incyte Corporation,[],"['Belgium', 'Bulgaria', 'Netherlands', 'United States', 'France', 'Spain', 'Canada', 'Poland', 'Germany']"
NCT06909942,Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients,Association of Sarcopenia With Rocuronium Use in Liver Transplant Recipients,RECRUITING,2025-04-01,2025-10-01,2026-02-01,INTERVENTIONAL,NA,3,"['Sarcopenia', 'Sarcopenia in Liver Cirrhosis', 'Liver Transplantation']",Sarcopenia,Inonu University,[],['Turkey (Türkiye)']
NCT06826040,SKB445 for Injection in Solid Tumors,"A Phase 1 Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of SKB445 for Injection in Patients With Advanced Solid Tumors",RECRUITING,2025-02-05,2026-12-31,2027-12-31,INTERVENTIONAL,PHASE1,126,['Advanced Solid Tumors'],Advanced Solid Tumors,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT06830746,ASCEND CSP IDE Study,A Stylet-Driven ICD Lead Intended for Conduction System Pacing IDE Study,RECRUITING,2025-04-11,2026-02,2028-05,INTERVENTIONAL,NA,414,"['Heart Failure', 'Ventricular Arrythmia']",Heart Failure,Abbott Medical Devices,[],"['Singapore', 'Hong Kong', 'India', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Australia']"
NCT06735209,First-in-Human PfSPZ-LARC2 Vaccination/CHMI,"A Randomized, Double-Blind, Placebo-Controlled Phase 1 Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of Sanaria(R) PfSPZ-LARC2 Vaccine, a Late-Arresting, Replication-Competent, Genetically Attenuated Plasmodium Falciparum Vaccine by Controlled Human Malaria Infection in Malaria-Naïve Healthy Adults",ACTIVE_NOT_RECRUITING,2025-07-23,2027-02-01,2027-03-30,INTERVENTIONAL,PHASE1,22,['Malaria'],Malaria,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05653349,Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP),"A Phase III, Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (VAYHIT1)",ACTIVE_NOT_RECRUITING,2023-03-06,2026-02-05,2028-09-29,INTERVENTIONAL,PHASE3,226,['Primary Immune Thrombocytopenia (ITP)'],Primary Immune Thrombocytopenia (ITP),Novartis Pharmaceuticals,[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Thailand', 'Czechia', 'India', 'Singapore', 'Mexico', 'Spain', 'Romania', 'Malaysia', 'United Kingdom', 'Vietnam', 'Germany', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07015242,A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma,The CAROLYN Trial: Lisocabtagene Maraleucelas First-Line Therapy for Primary Central Nervous System Lymphoma (PCNSL) in Transplant-Ineligible Patients,RECRUITING,2025-11-06,2028-01-09,2028-12-10,INTERVENTIONAL,PHASE2,65,['Lymphoma'],Lymphoma,"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",[],"['United States', 'France', 'Germany']"
NCT04926922,PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia,PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia,ACTIVE_NOT_RECRUITING,2021-07-27,2026-06-07,2026-06-07,OBSERVATIONAL,,200,"['Tuberculosis', 'HIV']",Tuberculosis,National Institute of Allergy and Infectious Diseases (NIAID),[],"['United States', 'Liberia']"
NCT06544616,A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease,"A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a Phosphorylated Tau Targeted Active Immunotherapy, in Participants With Preclinical Alzheimer's Disease",RECRUITING,2024-07-22,2031-07-17,2034-06-07,INTERVENTIONAL,PHASE2,498,"[""Preclinical Alzheimer's Disease""]",Preclinical Alzheimer's Disease,"Janssen Pharmaceutica N.V., Belgium",[],"['Belgium', 'Japan', 'United States', 'France', 'Spain', 'Australia', 'United Kingdom', 'Sweden', 'Germany']"
NCT04968990,Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation,Multi-Center Trial Sponsored by St. Jude Children's Research Hospital for the Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation,RECRUITING,2021-08-19,2026-12,2036-12,INTERVENTIONAL,PHASE2,95,['Wilms Tumor'],Wilms Tumor,St. Jude Children's Research Hospital,[],['United States']
NCT06997497,A Clinical Study of MK-1084 With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012),"A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 Versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)",RECRUITING,2025-07-16,2029-08-27,2030-10-27,INTERVENTIONAL,PHASE3,477,"['Colon Adenocarcinoma', 'Rectal Adenocarcinoma']",Colon Adenocarcinoma,Merck Sharp & Dohme LLC,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Israel', 'France', 'Finland', 'South Korea', 'Poland', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Ukraine', 'Germany', 'Brazil', 'United States', 'Argentina']"
NCT07174310,A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease,"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease",RECRUITING,2025-12-31,2029-07-27,2031-07-25,INTERVENTIONAL,PHASE3,900,"[""Parkinson's Disease""]",Parkinson's Disease,Hoffmann-La Roche,['Prothena Biosciences Limited'],"['United Kingdom', 'United States']"
NCT05978180,Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2),"Prospective, Multicenter, Randomized, Parallel Groups Study Comparing the Safety and the Efficacy of the Administration of One Intra-articular Injection of 4.8 ml (HO-1) or Three Intra-articular Injections of 2.2 ml (HS-3) of Pandora Gel to One Intra-articular Injection of 2.5 ml (SINOVIAL®ONE), in Symptomatic Gonarthrosis",ACTIVE_NOT_RECRUITING,2023-10-18,2026-01-06,2026-01-06,INTERVENTIONAL,NA,252,['Knee Osteoarthritis'],Knee Osteoarthritis,Labrha,['Statitec'],"['Monaco', 'France']"
NCT07246278,Celecoxib in Parkinson Disease as Adjuvant Therapy,Evaluating Safety and Efficacy of Celecoxib in Patients With PD.,RECRUITING,2025-11-20,2026-11-20,2026-11-28,INTERVENTIONAL,PHASE1,80,['Parkinson Disease'],Parkinson Disease,Tanta University,[],['Egypt']
NCT06624085,A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma,"A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",RECRUITING,2025-04-28,2030-03-31,2030-03-31,INTERVENTIONAL,PHASE1,50,['Lymphoma'],Lymphoma,Hoffmann-La Roche,[],['United States']
NCT06726265,Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004),"TACTI-004, a Double-Blinded, Randomized Phase 3 Trial in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Receiving Eftilagimod Alfa (MHC Class II Agonist) in Combination With Pembrolizumab (PD-1 Antagonist) and Chemotherapy.",RECRUITING,2025-03-21,2027-06,2029-09,INTERVENTIONAL,PHASE3,756,['Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)'],Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC),Immutep S.A.S.,['Merck Sharp & Dohme LLC'],"['Bulgaria', 'Lithuania', 'Australia', 'Belgium', 'Hungary', 'Chile', 'Croatia', 'Poland', 'India', 'Georgia', 'Spain', 'Canada', 'Malaysia', 'Romania', 'Latvia', 'Greece', 'Portugal', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'Ireland', 'Italy', 'Argentina']"
NCT07128927,Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors,Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors,RECRUITING,2025-12-01,2026-09-01,2026-09-01,INTERVENTIONAL,NA,40,['Insomnia'],Insomnia,Georgetown University,[],['United States']
NCT05316155,Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer,Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants With Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer,RECRUITING,2022-04-11,2028-03-30,2029-10-01,INTERVENTIONAL,PHASE1,262,"['Urinary Bladder Neoplasms', 'Receptors, Fibroblast Growth Factor']",Urinary Bladder Neoplasms,"Janssen Research & Development, LLC",[],"['Israel', 'Japan', 'Netherlands', 'United States', 'Spain', 'South Korea', 'Canada', 'Germany']"
NCT07146750,A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants,"An Open-label, Phase 1, Randomized, Parallel Design Study to Determine the Bioequivalence and Investigate the Safety and Tolerability of Subcutaneous Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants",ACTIVE_NOT_RECRUITING,2025-08-25,2026-03-25,2026-04-08,INTERVENTIONAL,PHASE1,212,['Healthy Volunteers'],Healthy Volunteers,Sanofi,[],['United States']
NCT07267364,Comparison of Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients,Comparison of Pelvic Floor Muscle Training and Dynamic Neuromuscular Stabilization Exercises in Pediatric Patients Diagnosed With Voiding Dysfunction: A Randomized Controlled Trial,RECRUITING,2025-11-11,2026-02-01,2026-02-28,INTERVENTIONAL,NA,48,"['Urology', 'Pediatric Disorder']",Urology,Necmettin Erbakan University,[],['Turkey (Türkiye)']
NCT07049887,A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria),A Multicenter Non-interventional Study for the Measurement of Scratch and Sleep Patterns Using the ADAM Sensor in Patients With Primary Biliary Cholangitis,RECRUITING,2025-07-16,2025-12-15,2025-12-15,OBSERVATIONAL,,30,['Primary Biliary Cholangitis'],Primary Biliary Cholangitis,Ipsen,[],['United States']
NCT07267858,Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach.,"Effect of a Clinical Pilates Programme on Individuals With Gold A COPD on Lung Function, Motor Performance, Chest Mobility, Sleep and Physical Activity, and Health-related Quality of Life: an Interactive Approach Between Rehabilitation Nursing and Sports Sciences.",ACTIVE_NOT_RECRUITING,2024-11-07,2025-11-11,2026-07-24,INTERVENTIONAL,NA,38,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),University of Trás-os-Montes and Alto Douro,"['Unidade Local de Saúde do Alto Ave, EPE']",['Portugal']
NCT07223125,A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors,"A Phase 1 Study of JNJ-89862175, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 Antibody Drug Conjugate, for Advanced Solid Tumors",RECRUITING,2025-10-10,2026-12-15,2028-08-15,INTERVENTIONAL,PHASE1,360,['Advanced-stage Solid Tumors'],Advanced-stage Solid Tumors,"Janssen Research & Development, LLC",[],['United States']
NCT07267078,Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer,Neoadjuvant Tuvonralimab and Iparomlimab With Gemcitabine-oxaliplatin for Biliary Tract Cancer,RECRUITING,2025-05-25,2028-01-25,2028-05-25,INTERVENTIONAL,PHASE2,45,['Biliary Tract Cancer'],Biliary Tract Cancer,Peking Union Medical College Hospital,[],['China']
NCT06709521,Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI),Optimization of Beta-lactam Dosing in Critically Ill Patients With Suspected or Documented Antimicrobial Resistant Gram-Negative Infections With Cystatin-C (OPTIMIZE-GNI),RECRUITING,2025-02-12,2026-06-30,2026-10-30,INTERVENTIONAL,PHASE4,150,['Bacterial Infection'],Bacterial Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06817733,Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging,Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging,RECRUITING,2025-02-15,2025-12-20,2025-12-31,INTERVENTIONAL,NA,30,['Benign Prostatic Hyperplasia (BPH)'],Benign Prostatic Hyperplasia (BPH),Chinese PLA General Hospital,[],['China']
NCT04833894,"Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis","Open-label Uncontrolled Trial to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Efgartigimod in Children From 2 to Less Than 18 Years of Age With Generalized Myasthenia Gravis",RECRUITING,2021-10-26,2027-03,2027-03,INTERVENTIONAL,PHASE2,12,['Generalized Myasthenia Gravis'],Generalized Myasthenia Gravis,argenx,[],"['Belgium', 'Netherlands', 'Austria', 'United States', 'France', 'Georgia', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT07196722,A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease,"A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease",RECRUITING,2025-10-03,2028-09-19,2032-10-06,INTERVENTIONAL,PHASE2,1092,['Crohn Disease'],Crohn Disease,"Janssen Research & Development, LLC",[],"['Israel', 'Japan', 'China', 'United States', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Poland', 'Australia']"
NCT07218029,A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038),An Open-label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH (MK-7962-038),RECRUITING,2025-11-11,2028-12-07,2028-12-07,INTERVENTIONAL,PHASE3,815,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,Merck Sharp & Dohme LLC,[],"['United Kingdom', 'United States']"
NCT06178614,A Study of JNJ-87890387 for Advanced Solid Tumors,"A Phase 1 Study of JNJ-87890387, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 (ENPP3) x CD3 Bispecific Antibody, for Advanced Solid Tumors",RECRUITING,2023-12-14,2027-03-16,2028-07-21,INTERVENTIONAL,PHASE1,200,['Advanced Solid Tumors'],Advanced Solid Tumors,"Janssen Research & Development, LLC",[],"['Spain', 'United States', 'France']"
NCT06516965,A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis",RECRUITING,2024-10-10,2026-10-19,2027-05-03,INTERVENTIONAL,PHASE3,330,['Prurigo Nodularis'],Prurigo Nodularis,Incyte Corporation,[],"['Belgium', 'Japan', 'United States', 'Germany', 'Chile', 'Spain', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT06798636,PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm,Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study,RECRUITING,2025-10-01,2026-08-31,2026-10-31,INTERVENTIONAL,EARLY_PHASE1,30,['Self Harm'],Self Harm,Imperial College London,[],['United Kingdom']
NCT06258902,Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation,"Odevixibat Pregnancy and Lactation Surveillance Program: A Post-marketing, Long-term, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Individuals Exposed to Odevixibat During Pregnancy and/or Lactation",RECRUITING,2023-09-28,2032-05-31,2032-05-31,OBSERVATIONAL,,20,['Pregnancy Related'],Pregnancy Related,Ipsen,[],['United States']
NCT05265273,A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis,"An Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis",RECRUITING,2022-07-20,2026-06-26,2026-06-26,INTERVENTIONAL,PHASE2,12,['Myasthenia Gravis'],Myasthenia Gravis,"Janssen Research & Development, LLC",[],"['Japan', 'Poland', 'United States', 'Netherlands']"
NCT07252180,Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA),A Prospective Study Comparing Patient Satisfaction and Efficacy of Two Different Methods of Ablation of Inlet Patches: Argon Plasma Coagulation Versus Radio Frequency Ablation,ACTIVE_NOT_RECRUITING,2025-11-01,2027-11-01,2027-11-01,INTERVENTIONAL,NA,72,"['GERD (Gastroesophageal Reflux Disease)', 'Throat Disorders']",GERD (Gastroesophageal Reflux Disease),Assaf-Harofeh Medical Center,[],['Israel']
NCT04586426,A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma,A Phase 1b/2 Dose Escalation and Expansion Study of the Combination of the Bispecific T Cell Redirection Antibodies Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma,ACTIVE_NOT_RECRUITING,2020-12-15,2025-03-18,2026-10-27,INTERVENTIONAL,PHASE1,228,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Israel', 'Japan', 'United States', 'Spain', 'South Korea', 'Canada', 'Australia']"
NCT05327114,Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),"Phase 2/3, Multistage, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel Group Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab Administered to Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",RECRUITING,2022-09-23,2027-05-14,2028-09-30,INTERVENTIONAL,PHASE2,201,"['Polyradiculoneuropathy, Chronic Inflammatory Demyelinating']","Polyradiculoneuropathy, Chronic Inflammatory Demyelinating","Janssen Research & Development, LLC",[],"['Japan', 'United Kingdom', 'China', 'United States', 'France', 'Germany', 'Mexico', 'Spain', 'Taiwan', 'Italy', 'Colombia', 'Czechia', 'South Korea', 'Greece', 'Poland', 'Portugal', 'Australia']"
NCT07184931,An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease,"A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease",RECRUITING,2025-10-01,2029-05-14,2029-05-14,INTERVENTIONAL,PHASE3,980,"[""Crohn's Disease""]",Crohn's Disease,Sanofi,['Teva Branded Pharmaceutical Products R&D LLC'],['United States']
NCT07267286,Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma （HNC-SYSU-005）,"Efficacy of Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma (cT1-2N0M0) Versus Standard Therapy: a Randomized Controlled, Single-center Exploratory Clinical Study",ACTIVE_NOT_RECRUITING,2024-12-15,2028-08-31,2032-08-31,INTERVENTIONAL,PHASE2,60,"['HNSCC', 'PD-1']",HNSCC,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT05322577,A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.,"A Phase 1b/2 Study Evaluating the Safety, Tolerability, Efficacy, and Pharmacokinetics of Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer (FORTITUDE-103).",ACTIVE_NOT_RECRUITING,2022-05-17,2025-11-21,2026-08-12,INTERVENTIONAL,PHASE1,72,"['Gastric Cancer', 'Gastroesophageal Junction Cancer']",Gastric Cancer,Amgen,[],"['Singapore', 'Japan', 'United States', 'Taiwan', 'South Korea']"
NCT07265531,A Comparative Study of Monopolar Versus Bipolar Electrocautery Post Tonsillectomy Outcomes.,A Comparative Study of Monopolar Versus Bipolar Electrocautery Post Tonsillectomy Outcomes.,ACTIVE_NOT_RECRUITING,2025-07-20,2026-05-01,2026-07-01,OBSERVATIONAL,,74,['Chronic Tonsillitis'],Chronic Tonsillitis,Indus Hospital and Health Network,[],['Pakistan']
NCT03145181,"Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma","A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of Teclistamab, a Humanized BCMA x CD3 Bispecific Antibody in Subjects With Relapsed or Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2017-05-16,2021-11-09,2027-05-28,INTERVENTIONAL,PHASE1,302,['Hematological Malignancies'],Hematological Malignancies,"Janssen Research & Development, LLC",[],"['Netherlands', 'United States', 'France', 'Spain', 'Sweden']"
NCT07267806,Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC,"Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy as First-Line Treatment for Advanced Hepatocellular Carcinoma (HCC): A Randomized, Controlled, Open-Label, Multicenter Phase III.",RECRUITING,2025-10-31,2029-10,2032-10,INTERVENTIONAL,PHASE3,326,"['Hepato Cellular Carcinoma (HCC)', 'Chemotherapy Effect']",Hepato Cellular Carcinoma (HCC),Linhui Peng,[],['China']
NCT03598309,Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers,"Phase II Trial of Investigational Agents to Modulate Intermediate Endpoint Biomarkers, Including Pulmonary Nodules, in Former and Current Smokers",ACTIVE_NOT_RECRUITING,2019-06-05,2025-03-04,2026-05,INTERVENTIONAL,PHASE2,19,"['Lung Diseases', 'Lung Cancer, Protection Against']",Lung Diseases,H. Lee Moffitt Cancer Center and Research Institute,['James and Esther King Biomedical Research Program'],['United States']
NCT04882904,Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.,Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects,RECRUITING,2020-09-25,2026-09,2026-12,INTERVENTIONAL,NA,45,['Amyotrophic Lateral Sclerosis'],Amyotrophic Lateral Sclerosis,Centre Hospitalier Universitaire de Liege,"['SYSNAV', 'Centre Hospitalier Régional de la Citadelle']",['Belgium']
NCT06659445,Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD,"A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)",RECRUITING,2025-10-28,2028-11,2028-11,INTERVENTIONAL,PHASE2,324,"['Geographic Atrophy (GA)', 'Age - Related Macular Degeneration (AMD)']",Geographic Atrophy (GA),ONL Therapeutics,[],"['United States', 'Canada']"
NCT07267507,Accessory Movements and Associated Factors During Active Cervical Range of Motion,Accessory Movements and Associated Factors During Active Cervical Range of Motion,ACTIVE_NOT_RECRUITING,2024-04-30,2025-12-31,2026-01-15,OBSERVATIONAL,,180,"['Asymptomatic Condition', 'Neck Pain']",Asymptomatic Condition,Atılım University,[],['Turkey (Türkiye)']
NCT07265622,First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors,"A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of 7MW4911 in Patients With Advanced Solid Tumors",RECRUITING,2025-11-12,2027-07,2028-12,INTERVENTIONAL,PHASE1,200,['Solid Tumors'],Solid Tumors,"Mabwell (Shanghai) Bioscience Co., Ltd.",[],['China']
NCT07176195,The Impact of Eating Habits on the Health of Employees in the Defense Sector,The Impact of Eating Habits on the Health of Employees in the Defense Sector,ACTIVE_NOT_RECRUITING,2025-09-22,2025-11-15,2026-06-15,OBSERVATIONAL,,125,['Health-Related Behavior'],Health-Related Behavior,University of Primorska,"['University of Ljubljana, Faculty of Social Sciences', 'Ministry of Defence, Slovenia']",['Slovenia']
NCT04652908,Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial,Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele,RECRUITING,2021-06-21,2026-03,2026-03,INTERVENTIONAL,PHASE1,55,['Myelomeningocele'],Myelomeningocele,"University of California, Davis",['California Institute for Regenerative Medicine (CIRM)'],['United States']
NCT07267585,Unravelling the Measles Paradox (MISIA),Unravelling the Measles Paradox: a Disease Associated With Both Immune Suppression and Immune Activation,RECRUITING,2025-07-03,2028-07-30,2028-07-30,OBSERVATIONAL,,300,['MEASLES DISEASE'],MEASLES DISEASE,Erasmus Medical Center,[],['Netherlands']
NCT06667076,"A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)","A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination With Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination With Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer",RECRUITING,2024-12-16,2029-05-23,2030-12-26,INTERVENTIONAL,PHASE2,480,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung","Janssen Research & Development, LLC",[],"['United Kingdom', 'Israel', 'Puerto Rico', 'United States']"
NCT07007091,A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult Participants,A Phase 1 Pharmacokinetic Study in Healthy Subjects to Evaluate the Bioavailability of Risankizumab Subcutaneous Administration With On-Body Injector Relative to Prefilled Syringe,ACTIVE_NOT_RECRUITING,2025-06-12,2025-12,2025-12,INTERVENTIONAL,PHASE1,260,['Healthy Volunteers'],Healthy Volunteers,AbbVie,[],['United States']
NCT06516952,A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis",RECRUITING,2024-10-10,2026-10-19,2027-05-03,INTERVENTIONAL,PHASE3,330,['Prurigo Nodularis'],Prurigo Nodularis,Incyte Corporation,[],"['Bulgaria', 'Netherlands', 'Austria', 'United States', 'France', 'Switzerland', 'Italy', 'Canada', 'South Korea', 'Poland', 'Argentina', 'Germany']"
NCT05957276,Global Patient Registry of Inherited Retinal Diseases,Global Patient Registry of Inherited Retinal Disease,ACTIVE_NOT_RECRUITING,2023-08-31,2026-07-03,2026-07-03,OBSERVATIONAL,,889,['Inherited Retinal Diseases'],Inherited Retinal Diseases,"Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'China', 'Austria', 'United States', 'France', 'Germany', 'Finland', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT05572515,"A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma","A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received 1 to 3 Prior Lines of Therapy, Including an Anti-CD38 Monoclonal Antibody and Lenalidomide",ACTIVE_NOT_RECRUITING,2023-03-29,2026-02-13,2031-08-31,INTERVENTIONAL,PHASE3,614,['Relapsed or Refractory Multiple Myeloma'],Relapsed or Refractory Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Denmark', 'Czechia', 'Poland', 'India', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT04141878,Dementia and Diabetes Prevention Program,Dementia and Diabetes Prevention Program (DDPP),RECRUITING,2021-05-26,2026-06-27,2026-06-27,INTERVENTIONAL,NA,400,"['Diabetes', 'Dementia']",Diabetes,"University of California, Davis","['East Oakland Sports Center', 'Tice Creek Fitness Center']",['United States']
NCT05549258,Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder,"An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder",RECRUITING,2023-07-03,2027-04-13,2027-04-13,INTERVENTIONAL,PHASE2,15,['Neuromyelitis Optica Spectrum Disorder'],Neuromyelitis Optica Spectrum Disorder,Amgen,[],"['Brazil', 'Netherlands', 'United States', 'France', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Argentina', 'Sweden', 'Serbia']"
NCT06797869,A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy,Efficacy and Safety of co Administered Cagrilintide and Semaglutide (CagriSema) Once Weekly Versus Placebo in Participants With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy,ACTIVE_NOT_RECRUITING,2025-01-29,2026-08-21,2026-08-21,INTERVENTIONAL,PHASE2,142,"['Diabetes Mellitus, Type 2', 'Diabetic Peripheral Neuropathy']","Diabetes Mellitus, Type 2",Novo Nordisk A/S,[],"['Norway', 'United States', 'France', 'Denmark', 'Spain', 'Canada', 'United Kingdom']"
NCT07173920,"Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localization) in Relieving Motor Symptoms of TD","A Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Study on the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation (rTMS) Under Precise Localization for Relieving Motor Symptoms of Tardive Dyskinesia",RECRUITING,2025-09-08,2027-12-30,2028-12-30,INTERVENTIONAL,NA,62,"['Tardive Dyskinesia', 'Repetitive Transcranial Magnetic Stimulation']",Tardive Dyskinesia,Peking University Sixth Hospital,[],['China']
NCT03149029,Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Melanoma,A Phase II Trial of Abbreviated MAPK Targeted Therapy Plus Pembrolizumab in Patients With Unresectable or Metastatic Melanoma,ACTIVE_NOT_RECRUITING,2017-11-27,2021-12-31,2025-12-31,INTERVENTIONAL,PHASE2,16,['Metastatic Melanoma'],Metastatic Melanoma,Massachusetts General Hospital,['Merck Sharp & Dohme LLC'],['United States']
NCT04047628,Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS),A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI),RECRUITING,2019-12-19,2026-10,2029-10,INTERVENTIONAL,PHASE3,156,"['Relapsing Multiple Sclerosis', 'Relapsing Remitting Multiple Sclerosis', 'Secondary Progressive Multiple Sclerosis']",Relapsing Multiple Sclerosis,National Institute of Allergy and Infectious Diseases (NIAID),"['Immune Tolerance Network (ITN)', 'Blood and Marrow Transplant Clinical Trials Network', 'PPD Development, LP', 'Rho Federal Systems Division, Inc.']",['United States']
NCT05207670,"A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies","An Open-Label, Multicenter, Phase II Trial Evaluating the Safety, Efficacy, and Pharmacokinetics of Subcutaneous Mosunetuzumab Monotherapy in Patients With Select B-Cell Malignancies",ACTIVE_NOT_RECRUITING,2022-02-01,2028-07-31,2028-07-31,INTERVENTIONAL,PHASE2,320,['Non-Hodgkin Lymphoma'],Non-Hodgkin Lymphoma,"Genentech, Inc.",[],['United States']
NCT06356129,Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma,"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy vs Placebo Plus R-CHOP Chemotherapy in Participants With Previously Untreated High-risk Large B-cell Lymphoma (GOLSEEK-1)",RECRUITING,2024-06-19,2028-08-14,2029-11-20,INTERVENTIONAL,PHASE3,850,['Large B-cell Lymphoma'],Large B-cell Lymphoma,Celgene,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Australia', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Puerto Rico', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06095089,A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer,A Phase 1 Study of JNJ-87189401 (PSMA-CD28 Bispecific Antibody) Combined With JNJ-78278343 (KLK2-CD3 Bispecific Antibody) for Advanced Prostate Cancer,RECRUITING,2023-11-01,2027-06-21,2027-10-27,INTERVENTIONAL,PHASE1,250,['Advanced Prostate Cancer'],Advanced Prostate Cancer,"Janssen Research & Development, LLC",[],"['United States', 'France']"
NCT06830473,KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection,KTRSensor Scotland Study: Investigating the Role of Biomarkers in Kidney Transplant Outcomes,RECRUITING,2025-05-16,2027-05-13,2027-05-13,OBSERVATIONAL,,200,"['Kidney Transplant', 'Kidney Disease, Chronic']",Kidney Transplant,University of Edinburgh,[],['United Kingdom']
NCT07267988,Additional Effects Of Brandt-Daroff Exercises With GANS Maneuver On Dizziness And Quality Of Life In Patients With BPPV,Additional Effects Of Brandt-Daroff Exercises With GANS Maneuver On Dizziness And Quality Of Life In Patients With BPPV,RECRUITING,2024-09-13,2025-12-10,2026-01-10,INTERVENTIONAL,NA,30,"['BPPV', 'Dizziness', 'Quality of Life']",BPPV,Foundation University Islamabad,[],['Pakistan']
NCT04924270,Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases,"Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatment-naïve Patients With Newly Diagnosed Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Pulmonary Sarcoidosis, Crohn's Disease, and Ulcerative Colitis: a 52-week, Double-blind, Randomised, Placebo-controlled, Exploratory Trial",RECRUITING,2023-12-13,2027-03-01,2027-12-31,INTERVENTIONAL,PHASE2,200,"['Rheumatoid Arthritis', 'Ankylosing Spondylitis', 'Psoriatic Arthritis', 'Crohn Disease', 'Ulcerative Colitis']",Rheumatoid Arthritis,Odense University Hospital,"['Region of Southern Denmark', 'University of Southern Denmark']",['Denmark']
NCT06863961,A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis,"A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Patients With Moderate to Severe Atopic Dermatitis",RECRUITING,2025-04-01,2026-07-13,2026-11-26,INTERVENTIONAL,PHASE2,160,['Atopic Dermatitis'],Atopic Dermatitis,Hoffmann-La Roche,[],"['Brazil', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Poland', 'Germany']"
NCT06798129,Effects of Extracorporeal Treatment in Patients With Acute Poisoning,"Effects of Extracorporeal Treatment in Patients With Acute Poisoning in Jiangsu Province, China: A Multi-center Target Trial Emulation",ACTIVE_NOT_RECRUITING,2015-01-01,2023-12-31,2026-12-31,OBSERVATIONAL,,5269,"['Poisoning', 'Extracorporeal Treatment']",Poisoning,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,[],['China']
NCT05318469,Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer,A Phase I/II Study Evaluating the Safety and Efficacy of Ivermectin in Combination With Immune Checkpoint Inhibitor in Patients With Metastatic Triple Negative Breast Cancer,RECRUITING,2023-10-13,2026-10,2026-10,INTERVENTIONAL,PHASE1,34,"['Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic Triple-Negative Breast Carcinoma']",Anatomic Stage IV Breast Cancer AJCC v8,Yuan Yuan,"['Agenus Inc.', 'Gateway for Cancer Research']",['United States']
NCT05869539,ACT-TIL and ANV419 for Advanced Melanoma.,A Phase I Trial of Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes and ANV419 in Patients With Advanced Melanoma. The BaseTIL-03M Trial,ACTIVE_NOT_RECRUITING,2023-06-21,2025-05-27,2026-06,INTERVENTIONAL,PHASE1,10,['Advanced Melanoma'],Advanced Melanoma,"University Hospital, Basel, Switzerland",['Anaveon AG'],['Switzerland']
NCT07265583,Early Prediction of Lung Injury in Preterm Infants Score,Electrical Impedance Tomography and Lung Ultrasound Score in Early Prediction of Bronchopulmonary Dysplasia in Preterm and Very Low Birth Weight Infants.,RECRUITING,2025-10-01,2026-07-01,2027-07-01,OBSERVATIONAL,,104,"['Respiratory Distress Syndrome RDS', 'Preterm Birth']",Respiratory Distress Syndrome RDS,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT07003919,Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers),"A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous Immunotherapy With DBV712 250 mcg in 1-through 3-year-old Children With Peanut Allergy",RECRUITING,2025-06-24,2026-11,2028-05,INTERVENTIONAL,PHASE3,480,"['Allergy', 'Peanut Allergy']",Allergy,DBV Technologies,[],"['Netherlands', 'United States', 'France', 'Ireland', 'Spain', 'Canada', 'United Kingdom', 'Australia']"
NCT05870319,A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients,"A Randomized, Open-Label, Multicenter Phase 3 Study to Evaluate SKB264 Monotherapy Versus Pemetrexed in Combination With Platinum in Patients With Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutation Who Have Failed to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Therapy",ACTIVE_NOT_RECRUITING,2023-06-26,2024-07-11,2026-09-30,INTERVENTIONAL,PHASE3,376,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT06962800,A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN),"An Open-Label, Multicenter, Randomized Phase 3 Study Evaluating the Efficacy and Safety of Felzartamab in Participants With Primary Membranous Nephropathy (PMN) [PROMINENT]",RECRUITING,2025-05-22,2028-12-29,2029-03-29,INTERVENTIONAL,PHASE3,180,['Primary Membranous Nephropathy'],Primary Membranous Nephropathy,Biogen,[],"['Brazil', 'China', 'United States', 'Taiwan', 'South Korea', 'Argentina', 'Australia']"
NCT07011706,ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis,"A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ATI-045 in Patients With Moderate-to-Severe Atopic Dermatitis",RECRUITING,2025-05-30,2026-08,2026-10,INTERVENTIONAL,PHASE2,96,"['Atopic Dermatitis', 'Atopic', 'Dermatitis', 'AD', 'Eczema']",Atopic Dermatitis,"Aclaris Therapeutics, Inc.",[],"['United States', 'Canada']"
NCT04634552,A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma,"A Phase 1/2, First-in-Human, Open-Label, Dose Escalation Study of Talquetamab, a Humanized GPRC5D x CD3 Bispecific Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma",RECRUITING,2021-02-01,2026-03-31,2029-03-30,INTERVENTIONAL,PHASE2,510,['Hematological Malignancies'],Hematological Malignancies,"Janssen Research & Development, LLC",[],"['Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Spain', 'South Korea', 'Poland', 'Germany']"
NCT05488314,A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer,A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer,ACTIVE_NOT_RECRUITING,2022-12-13,2026-06-09,2027-03-31,INTERVENTIONAL,PHASE1,57,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung","Janssen Research & Development, LLC",[],"['Brazil', 'Japan', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Germany']"
NCT06395948,A Study Evaluating APG777 in Atopic Dermatitis,"A Two-part, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of APG777 in Patients With Moderate-to-severe Atopic Dermatitis",RECRUITING,2024-04-29,2026-11,2028-06,INTERVENTIONAL,PHASE2,431,['Atopic Dermatitis'],Atopic Dermatitis,"Apogee Therapeutics, Inc.",[],"['Hungary', 'United States', 'France', 'Spain', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07267104,Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices,SAGE-NIV: Surveillance and Artificial Intelligence Guidance for Exacerbations in COPD Patients With Home Non-Invasive Ventilation,RECRUITING,2025-03-25,2025-04-19,2026-12,OBSERVATIONAL,,75,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),Corporacion Parc Tauli,[],['Spain']
NCT03767244,"A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy","A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy",ACTIVE_NOT_RECRUITING,2019-06-11,2026-02-10,2028-10-13,INTERVENTIONAL,PHASE3,2517,['Prostatic Neoplasms'],Prostatic Neoplasms,"Janssen Research & Development, LLC",[],"['Brazil', 'Israel', 'Japan', 'Netherlands', 'Russia', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Poland', 'United Kingdom', 'Argentina', 'Australia']"
NCT04133636,"A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma","A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma",ACTIVE_NOT_RECRUITING,2019-11-07,2026-08-04,2028-01-17,INTERVENTIONAL,PHASE2,210,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Israel', 'Belgium', 'Netherlands', 'Saudi Arabia', 'United States', 'France', 'Spain', 'Germany']"
NCT06032104,Feasibility and Colorectal Benefits of Pulses Supplementation,Feasibility of Pulses Supplementation in Healthy Adults: A Feeding Study,RECRUITING,2023-10-27,2026-09,2026-09,INTERVENTIONAL,NA,25,"['Colorectal Polyp', 'Obesity']",Colorectal Polyp,"University of California, Davis",[],['United States']
NCT06089616,A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP),An International Observational Registry Study to Further Describe Long-term Safety and Effectiveness of Palovarotene in Patients With Fibrodysplasia Ossificans Progressiva (FOP),RECRUITING,2024-12-05,2035-12-05,2035-12-05,OBSERVATIONAL,,100,['Fibrodysplasia Ossificans Progressiva'],Fibrodysplasia Ossificans Progressiva,Ipsen,[],"['United States', 'Canada']"
NCT06811909,Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC,"A Prospective, Multicenter, Randomized, Controlled Trial of Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC",RECRUITING,2025-02-14,2026-08,2026-10,INTERVENTIONAL,NA,60,"['Non-infected Venous Leg Ulcer', 'Venous Leg Ulcer', 'Venous Insufficiency', 'Venous Stasis', 'Venous Reflux']",Non-infected Venous Leg Ulcer,BioStem Technologies,[],['United States']
NCT05827016,A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma,"A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)",RECRUITING,2023-06-22,2029-03-15,2036-01-01,INTERVENTIONAL,PHASE3,1216,['Multiple Myeloma'],Multiple Myeloma,Bristol-Myers Squibb,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'India', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07266233,Toluidine Blue-Based Photodynamic Therapy for Antibacterial Activity and Postoperative Pain,Evaluation of the Antibacterial Activity and Postoperative Pain Outcomes of Photodynamic Therapy Using Toluidine Blue,ACTIVE_NOT_RECRUITING,2025-06-01,2025-11-07,2026-03,INTERVENTIONAL,NA,50,['Root Canal Infection'],Root Canal Infection,Ataturk University,[],['Turkey (Türkiye)']
NCT06758700,Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer,Phase II Clinical Study to Evaluate the Efficacy and Safety of Teniposide as a Post-Line Therapy for c-Myc-Driven Extensive-Stage Small Cell Lung Cancer,RECRUITING,2025-02-07,2026-06-30,2026-12-31,INTERVENTIONAL,PHASE2,15,"['Extensive-stage Small Cell Lung Cancer (ES-SCLC)', 'Thoracic Neoplasms', 'Lung Neoplasms', 'Lung Diseases']",Extensive-stage Small Cell Lung Cancer (ES-SCLC),"Shanghai Pulmonary Hospital, Shanghai, China","['CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD']",['China']
NCT06131398,A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors,"A Phase 1 First-in-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 355 as Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2024-03-07,2027-03-26,2028-03-25,INTERVENTIONAL,PHASE1,77,['Advanced Solid Tumors'],Advanced Solid Tumors,Amgen,[],"['Japan', 'Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Poland', 'Australia']"
NCT07059065,FIBERGRAFT Aeridyan Posterolateral Fusion Study,"A Post-market, Prospective, Controlled, Multicenter Clinical Study to Evaluate Radiographic Fusion of FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute in Subjects Who Undergo a Lumbar Posterolateral Fusion Surgery",RECRUITING,2025-08-15,2026-03-01,2028-12-29,INTERVENTIONAL,NA,316,['Degenerative Spine Disease'],Degenerative Spine Disease,"DePuy Synthes Products, Inc.",[],['United States']
NCT05849207,Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant,IIT2022-03-Paquette-GeriBMT: A Phase I Study of De-Escalation of Post-Transplant Cyclophosphamide Dosing in Patients Aged >/= 65 Years Undergoing Conditioning With Fludarabine and Total Body Irradiation 800 cGy,RECRUITING,2023-10-24,2027-07-01,2028-07-01,INTERVENTIONAL,PHASE1,26,['Hematologic Malignancies'],Hematologic Malignancies,Ronald Paquette,[],['United States']
NCT04532489,Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1),Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1),RECRUITING,2021-01-18,2026-12,2026-12,INTERVENTIONAL,EARLY_PHASE1,6,"['Radiotracer', 'Hypertension', 'Cholesterol']",Radiotracer,Benjamin Viglianti,[],['United States']
NCT05298748,The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants,Womb Recordings and Respiratory Control Maturation in Neonates,RECRUITING,2022-09-16,2026-10,2026-11,INTERVENTIONAL,NA,34,"['Apnea of Prematurity', 'Intermittent Hypoxemia', 'Bradycardia']",Apnea of Prematurity,Case Western Reserve University,[],['United States']
NCT06660563,A Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (R/R B-Cell NHL),A Phase 1b Study of JNJ-80948543 in Combination With Other CD3 T-Cell Engagers (TCEs) in Participants With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoid (R/R B-Cell NHL) Malignancies,ACTIVE_NOT_RECRUITING,2024-10-22,2026-09-21,2026-09-21,INTERVENTIONAL,PHASE1,19,"['Lymphoma, Non-Hodgkin']","Lymphoma, Non-Hodgkin","Janssen Research & Development, LLC",[],"['United Kingdom', 'Spain', 'Taiwan', 'Australia']"
NCT05379634,A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies,"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies",ACTIVE_NOT_RECRUITING,2022-07-05,2025-09-04,2026-09-16,INTERVENTIONAL,PHASE2,36,['Myositis'],Myositis,"Janssen Research & Development, LLC",[],"['Japan', 'Hungary', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Poland', 'United Kingdom', 'Germany']"
NCT02354014,Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB,"A Phase 2, Open-label, Multicenter, Single-arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Anti-mycobacterial Activity of TMC207 in Combination With a Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for the Treatment of Children and Adolescents 0 Months to <18 Years of Age Who Have Confirmed or Probable Pulmonary MDR-TB",RECRUITING,2016-05-03,2027-02-11,2027-02-11,INTERVENTIONAL,PHASE2,60,['Multidrug-Resistant Tuberculosis'],Multidrug-Resistant Tuberculosis,"Janssen Research & Development, LLC",[],"['South Africa', 'Russia', 'Uganda', 'Mozambique', 'Ukraine', 'Philippines']"
NCT05347095,"A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease","A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease",ACTIVE_NOT_RECRUITING,2022-09-27,2027-03-25,2027-03-25,INTERVENTIONAL,PHASE3,288,"['Fistulizing Crohns Disease', 'Perianal Crohns Disease']",Fistulizing Crohns Disease,Janssen-Cilag Ltd.,[],"['Japan', 'Netherlands', 'Saudi Arabia', 'Jordan', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Egypt']"
NCT04312672,Long-term Follow-up Gene Therapy Study for RPGR- XLRP,"Long-term Follow-up Study of Participants Following an Open Label, Multi-Centre, Phase I/II Dose Escalation Trial of a Recombinant Adeno-associated Virus Vector (AAV5- hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)",ACTIVE_NOT_RECRUITING,2017-07-31,2026-11-18,2026-11-18,OBSERVATIONAL,,42,['X-Linked Retinitis Pigmentosa'],X-Linked Retinitis Pigmentosa,"Janssen Research & Development, LLC",[],"['United Kingdom', 'United States']"
NCT05112445,"Retinal Ischemia Characterization in Diabetes - ""RICHARD""",Retinal Ischemia Characterization in Diabetes.,ACTIVE_NOT_RECRUITING,2022-03-30,2025-12,2025-12,OBSERVATIONAL,,60,['Diabetic Retinopathy'],Diabetic Retinopathy,Association for Innovation and Biomedical Research on Light and Image,['Boehringer Ingelheim'],['Portugal']
NCT06986174,A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia,A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia,RECRUITING,2025-11-21,2028-10-01,2032-10-01,INTERVENTIONAL,PHASE2,30,"['Waldenström Macroglobulinemia', 'Lymphoplasmacytic Lymphoma', 'B-Cell Lymphoproliferative Disorder', 'Indolent Lymphoma']",Waldenström Macroglobulinemia,"Shayna Sarosiek, MD","['Sobi, Inc.']",['United States']
NCT07090148,Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC,"Pilot Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP) and PD-1 Blockade, With Targeted Ablation of Resistant Lesions, in Patients With Non-Castrate Recurrent Oligometastatic Prostate Cancer",RECRUITING,2025-12,2030-09,2030-09,INTERVENTIONAL,PHASE1,14,"['Prostate Cancer Patients', 'Non-castrate Prostate Cancer', 'Recurrent Prostate Cancer', 'Oligometastatic Prostate Cancer (OMPC)']",Prostate Cancer Patients,"University of Wisconsin, Madison",['United States Department of Defense'],['United States']
NCT04546126,"Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)","Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)",RECRUITING,2021-11-01,2026-12,2026-12,INTERVENTIONAL,EARLY_PHASE1,24,"['Radiotracer', 'Hypertension', 'Cholesterol']",Radiotracer,Benjamin Viglianti,[],['United States']
NCT07225348,Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device,Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device,RECRUITING,2025-11-07,2026-06-01,2026-10-01,INTERVENTIONAL,PHASE4,26,['Perioral Wrinkles'],Perioral Wrinkles,Skincare Physicians of Chestnut Hill,['Galderma R&D'],['United States']
NCT05077904,A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures,"A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures",RECRUITING,2021-12-07,2026-04-06,2026-04-06,INTERVENTIONAL,PHASE3,350,['Stereotypical Prolonged Seizures'],Stereotypical Prolonged Seizures,UCB Biopharma SRL,[],"['Bulgaria', 'Japan', 'Hungary', 'China', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT04238637,Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC),"Phase II Study of Immunotherapy With Durvalumab (MEDI4736) or Durvalumab and Tremelimumab, Both Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)",ACTIVE_NOT_RECRUITING,2019-11-01,2026-08,2027-12,INTERVENTIONAL,PHASE2,50,['Intrahepatic Cholangiocarcinoma'],Intrahepatic Cholangiocarcinoma,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,['AstraZeneca'],['Germany']
NCT04585958,Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer,A Phase I Study of DS-8201a in Combination With Olaparib in HER2-Expressing Malignancies,RECRUITING,2021-05-21,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,55,"['Metastatic Malignant Solid Neoplasm', 'Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma', 'Unresectable Malignant Solid Neoplasm']",Metastatic Malignant Solid Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT06448026,Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).,Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC).,RECRUITING,2024-11-21,2027-05-15,2027-05-15,INTERVENTIONAL,PHASE2,17,['Locally Recurrent Oral Cavity Squamous Cell Carcinoma'],Locally Recurrent Oral Cavity Squamous Cell Carcinoma,M.D. Anderson Cancer Center,['Regeneron Pharmaceuticals'],['United States']
NCT03398135,A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis,"A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis",ACTIVE_NOT_RECRUITING,2018-08-28,2028-09,2029-02,INTERVENTIONAL,PHASE3,1242,['Ulcerative Colitis (UC)'],Ulcerative Colitis (UC),AbbVie,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Slovakia', 'Lithuania', 'Belgium', 'Israel', 'Russia', 'Slovenia', 'France', 'Chile', 'Puerto Rico', 'Croatia', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Latvia', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Egypt', 'Argentina', 'Serbia']"
NCT06564623,Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC),A Pilot Study of Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers,RECRUITING,2025-05-27,2029-05,2029-05,INTERVENTIONAL,PHASE1,25,['Biliary Tract Cancers'],Biliary Tract Cancers,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['AstraZeneca', 'Private Philanthropic Funds']",['United States']
NCT01424982,Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia,Phase II Study of Combination of Hyper-CVAD and Ponatinib in Patients With Philadelphia (PH) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL),ACTIVE_NOT_RECRUITING,2011-10-05,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE2,88,"['Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Acute Lymphoblastic Leukemia', 'Adult Acute Lymphoblastic Leukemia in Complete Remission', 'B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1', 'Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Philadelphia Chromosome Positive', 'Untreated Adult Acute Lymphoblastic Leukemia']","Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",M.D. Anderson Cancer Center,[],['United States']
NCT06832189,EVR and EPO for Liver Transplant Tolerance,Everolimus and Epoetin for Sustained Liver Transplant Tolerance (EVEREST)(ITN101ST),RECRUITING,2025-12-31,2030-06-01,2030-06-01,INTERVENTIONAL,PHASE1,20,['Liver Transplant'],Liver Transplant,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06769126,"Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study",PRISM: PRecIsion in SCLC Via a Multicohort Study: Randomized Phase II Studies Evaluating Maintenance Durvalumab With or Without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC),RECRUITING,2025-12-01,2028-12-31,2029-12-31,INTERVENTIONAL,PHASE2,900,"['Extensive Stage Lung Small Cell Carcinoma', 'Lung Small Cell Carcinoma, A Subtype', 'Lung Small Cell Carcinoma, I Subtype', 'Lung Small Cell Carcinoma, N Subtype', 'Lung Small Cell Carcinoma, P Subtype']",Extensive Stage Lung Small Cell Carcinoma,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],['United States']
NCT05711615,"Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma",A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil®) in Patients With Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas,RECRUITING,2024-02-06,2026-05-03,2026-05-03,INTERVENTIONAL,PHASE1,30,"['Metastatic Dedifferentiated Liposarcoma', 'Metastatic Leiomyosarcoma', 'Metastatic Myxofibrosarcoma', 'Metastatic Sarcoma', 'Metastatic Synovial Sarcoma', 'Metastatic Undifferentiated Pleomorphic Sarcoma', 'Unresectable Dedifferentiated Liposarcoma', 'Unresectable Leiomyosarcoma', 'Unresectable Myxofibrosarcoma', 'Unresectable Sarcoma', 'Unresectable Synovial Sarcoma', 'Unresectable Undifferentiated Pleomorphic Sarcoma']",Metastatic Dedifferentiated Liposarcoma,National Cancer Institute (NCI),[],['United States']
NCT06836752,Effects of Yoghurt Consumption on Glucose Metabolism in Prediabetic Subjects,"A Randomised, Open Label, Controlled, Parallel-group Study to Explore the Effects of 24 Weeks Intake of Yoghurt on Glucose Metabolism in Subjects at High Risk of Type 2 Diabetes Mellitus",RECRUITING,2025-09-16,2027-04,2027-04,INTERVENTIONAL,NA,60,['Prediabetes'],Prediabetes,Danone Global Research & Innovation Center,[],['France']
NCT03851445,Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer,LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study),RECRUITING,2019-02-06,2029-01-28,2029-01-28,INTERVENTIONAL,PHASE2,10000,['Previously Treated Non-Small Cell Lung Cancer'],Previously Treated Non-Small Cell Lung Cancer,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],['United States']
NCT06731894,Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors,A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy,RECRUITING,2025-10-03,2028-01-07,2028-01-07,INTERVENTIONAL,PHASE2,120,"['Breast Carcinoma', 'Chemotherapy-Induced Peripheral Neuropathy', 'Colon Carcinoma']",Breast Carcinoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT06910306,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma,A Study to Assess the Feasibility and Safety of Intratumoral Diffusing Alpha Emitters for the Treatment of Recurrent Glioblastoma,RECRUITING,2025-10-01,2026-11-01,2026-12-01,INTERVENTIONAL,NA,10,"['Recurrent Glioblastoma', 'Recurrent Gliomas']",Recurrent Glioblastoma,Alpha Tau Medical LTD.,[],['United States']
NCT07266987,Video Education and Patient Comfort in Thyroid Biopsy,"The Effect of Watching an Educational Video on Pain, Anxiety, and Comfort Levels in Patients Undergoing Thyroid Biopsy",RECRUITING,2025-08-20,2025-12-31,2025-12-31,INTERVENTIONAL,NA,68,['Pain'],Pain,Muş Alparslan University,[],['Turkey (Türkiye)']
NCT05676008,A Study of Positive Emotions With Long COVID-19,A Study of Positive Emotions With Long COVID (Post-Acute Sequelae of SARS CoV-2 Infection),ACTIVE_NOT_RECRUITING,2023-01-12,2026-04,2026-04,INTERVENTIONAL,NA,400,['Post-Acute COVID-19 Syndrome'],Post-Acute COVID-19 Syndrome,"University of California, Davis",[],['United States']
NCT07267949,Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation,Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation,RECRUITING,2025-10-22,2026-11,2026-12,INTERVENTIONAL,PHASE2,200,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),Acesion Pharma,[],"['Bulgaria', 'Hungary', 'Netherlands', 'Denmark', 'Italy', 'Poland', 'Germany']"
NCT03864068,Inositol Supplementation to Treat PCOS (INSUPP-PCOS),Inositol Supplementation to Treat Polycystic Ovary Syndrome: A Double Blind Dose Ranging RCT (INSUPP-PCOS),RECRUITING,2020-01-24,2025-12-10,2025-12-10,INTERVENTIONAL,PHASE2,154,"['Polycystic Ovary Syndrome', 'Anovulation', 'Hyperandrogenism', 'Insulin Resistance', 'Glucose Intolerance', 'Metabolic Complication']",Polycystic Ovary Syndrome,Milton S. Hershey Medical Center,['National Center for Complementary and Integrative Health (NCCIH)'],['United States']
NCT05836324,A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors,"A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors",RECRUITING,2023-07-24,2027-01-13,2027-01-13,INTERVENTIONAL,PHASE1,408,"['Solid Tumors', 'Advanced Solid Tumors', 'Metastatic Solid Tumors']",Solid Tumors,Incyte Corporation,[],"['Japan', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'United Kingdom']"
NCT06667908,A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC),"A Phase 2, Randomized, Open-Label, Active-Controlled Study of JNJ-90301900 in Combination With Chemoradiation Followed by Durvalumab in Locally Advanced and Unresectable Stage III NSCLC",RECRUITING,2024-12-06,2028-12-31,2028-12-31,INTERVENTIONAL,PHASE2,130,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Johnson & Johnson Enterprise Innovation Inc.,[],"['Brazil', 'Turkey (Türkiye)', 'Hong Kong', 'Netherlands', 'United States', 'France', 'Spain', 'United Kingdom', 'Australia']"
NCT07267390,Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts,MOVIE-TRACE Study: Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts,RECRUITING,2025-10-31,2026-01-31,2026-01-31,OBSERVATIONAL,,550,['Mpox (Monkeypox)'],Mpox (Monkeypox),"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","['University of Kinshasa', 'London School of Hygiene and Tropical Medicine']",['Democratic Republic of the Congo']
NCT05174650,Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements,"A Phase II Single-arm, Open-label Study of Atezolizumab and Derazantinib for Patients With Advanced Intrahepatic Cholangiocarcinoma With FGFR2",ACTIVE_NOT_RECRUITING,2022-04-20,2025-12,2026-08,INTERVENTIONAL,PHASE2,27,['Intrahepatic Cholangiocarcinoma'],Intrahepatic Cholangiocarcinoma,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,[],['Germany']
NCT07097077,Study of Functional Magnetic Resonance Signal Variations in Patients Undergoing Anterior Cruciate Ligament Reconstruction With the Application of a Dedicated Neuromotor Training,Study of Functional Magnetic Resonance Signal Variations in Patients Undergoing Anterior Cruciate Ligament Reconstruction With the Application of a Dedicated Neuromotor Training,RECRUITING,2025-12,2027-07,2027-07,INTERVENTIONAL,NA,12,"['fMRI', 'ACL Injury', 'Rehabilitation Exercise', 'Neuromuscular Control']",fMRI,Stefano Zaffagnini,"['IRCCS Istituto delle Scienze Neurologiche di Bologna', 'ISOKINETIC ER SRL']",['Italy']
NCT07220616,A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies,"A Phase 1/2, Multicenter, Open-Label, Multi-Cohort, First-in Human Trial of DS3790a, for Hematological Malignancies",RECRUITING,2025-11-12,2030-11-30,2030-11-30,INTERVENTIONAL,PHASE1,420,['Hematological Malignancies'],Hematological Malignancies,Daiichi Sankyo,[],['Japan']
NCT04901195,A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa,"A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa",ACTIVE_NOT_RECRUITING,2021-05-27,2026-07-28,2026-07-28,INTERVENTIONAL,PHASE3,658,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,UCB Biopharma SRL,[],"['Bulgaria', 'Japan', 'Netherlands', 'Australia', 'Belgium', 'Hungary', 'France', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy']"
NCT06663319,A Study of JNJ-89402638 for Metastatic Colorectal Cancer,A Phase I Study of JNJ-89402638 for Unresectable Metastatic Colorectal Cancer,RECRUITING,2024-10-15,2028-02-25,2028-07-19,INTERVENTIONAL,PHASE1,170,['Unresectable Metastatic Colorectal Cancer'],Unresectable Metastatic Colorectal Cancer,"Janssen Research & Development, LLC",[],"['Spain', 'United States']"
NCT04761328,Fear of Recurrence and Stopping Immunotherapy,Distress Associated With Stopping Immunotherapy of Cancer Patients,RECRUITING,2021-08-02,2027-12-31,2028-12-31,INTERVENTIONAL,NA,100,['Cognitive Behavioral Therapy'],Cognitive Behavioral Therapy,University of Pittsburgh,[],['United States']
NCT06734260,Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection,"Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection：a Multicenter, Prospective, Randomized Controlled Study",RECRUITING,2024-09-10,2025-11-10,2026-01-10,INTERVENTIONAL,PHASE3,477,['Helicobacter Pylori Eradication Rate'],Helicobacter Pylori Eradication Rate,"Eighth Affiliated Hospital, Sun Yat-sen University",[],['China']
NCT06269120,"SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary","SEMA-CardioDiab HUNGARY: A Multicentre, Prospective, Non-interventional Study to Evaluate Glycemic Control and Weight Changes in Patients With Type 2 Diabetes Initiating Treatment With Oral Semaglutide by Cardiologists or Diabetologists as Part of Local Clinical Practice in Hungary",RECRUITING,2024-09-30,2026-03-31,2026-03-31,OBSERVATIONAL,,470,['Type 2 Diabetes'],Type 2 Diabetes,Novo Nordisk A/S,[],['Hungary']
NCT06618807,Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI),"A Pilot Study Evaluating the Feasibility, Safety, and Efficacy of the Neuro RX Gamma (Version 2) for the Treatment of Mild Cognitive Impairment (MCI)",RECRUITING,2025-01-10,2027-08-01,2028-03-01,INTERVENTIONAL,NA,60,"[""Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease""]",Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease,Unity Health Toronto,[],['Canada']
NCT04069299,Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract,Somatostatin Receptor Expression in Poorly-Differentiated Neuroendocrine Carcinomas of the GI Tract: Analysis Using 68Ga-dotatate PET Scan,ACTIVE_NOT_RECRUITING,2019-09-25,2025-06-06,2026-01,OBSERVATIONAL,,30,['Neuroendocrine Carcinoma'],Neuroendocrine Carcinoma,H. Lee Moffitt Cancer Center and Research Institute,['Advanced Accelerator Applications'],['United States']
NCT07265921,A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors,"A Phase I First-in-Human, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors",RECRUITING,2025-11-07,2028-12,2029-06,INTERVENTIONAL,PHASE1,232,['Advanced Solid Cancer'],Advanced Solid Cancer,"Jiangsu Simcere Pharmaceutical Co., Ltd.","['Shanghai Xianwei Medical Technology Co., Ltd.']",['China']
NCT05242471,A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease,"A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease",ACTIVE_NOT_RECRUITING,2022-07-22,2025-05-23,2029-11-05,INTERVENTIONAL,PHASE2,703,"[""Crohn's Disease""]",Crohn's Disease,"Janssen Research & Development, LLC",[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Jordan', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'Slovenia', 'France', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy']"
NCT06221358,Pharmacogenomics of Stimulant Treatment Response,Pharmacogenomics of Stimulant Treatment Response in Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder,RECRUITING,2024-04-01,2028-08-31,2028-12-31,OBSERVATIONAL,,400,['Attention-Deficit/ Hyperactivity Disorder (ADHD)'],Attention-Deficit/ Hyperactivity Disorder (ADHD),University of Calgary,[],['Canada']
NCT06858111,Fertilo In Vitro Research Study and Trial,Phase III Randomized Control Trial to Investigate the Safety and Efficacy of Fertilo Versus Medicult In Vitro Maturation (IVM),RECRUITING,2025-04-17,2027-05,2028-01,INTERVENTIONAL,PHASE3,500,['In Vitro Maturation of Oocytes'],In Vitro Maturation of Oocytes,"Gameto, Inc.",[],['United States']
NCT06593639,Effect of Prehabilitation on Head and Neck Cancer Patients,"Does Prehabilitation be Able to Favorably Impact on the Pathway of Head and Neck Cancer Patients, Candidate to Surgery or Chemoradiotherapy as Primary Treatment? A Prospective Clinical Trial",RECRUITING,2024-09-09,2026-08,2026-08,INTERVENTIONAL,NA,60,['Head and Neck Cancer'],Head and Neck Cancer,Laura Deborah Locati,"['Fondazione IRCCS Policlinico San Matteo di Pavia', 'Azienda Ospedaliero Universitaria di Sassari', 'Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale', 'CNAO National Center of Oncological Hadrontherapy']",['Italy']
NCT07254871,Study of DM-101PX in Adults With Birch Pollen Allergy,"A Phase 2, Randomized, Double-Blind, Placebo-controlled Study to Investigate the Safety and Efficacy in Reducing Nasal Allergen Challenge Provoked Symptoms of Treatment With DM-101PX in Adults With Birch Pollen Allergic Rhinitis or Rhinoconjunctivitis",RECRUITING,2025-09-26,2026-04-30,2026-08-31,INTERVENTIONAL,PHASE2,100,['Birch Pollen Allergy'],Birch Pollen Allergy,Desentum Oy,[],['Canada']
NCT06194448,"To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations","A Phase II, Open-label, Single-arm Study of Osimertinib as Induction Therapy Prior to CRT and Maintenance Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive, Stage III, Unresectable Non-small Cell Lung Cancer (NEOLA)",ACTIVE_NOT_RECRUITING,2024-04-21,2026-07-07,2027-07-07,INTERVENTIONAL,PHASE2,76,['Lung Cancer'],Lung Cancer,AstraZeneca,[],"['Israel', 'Turkey (Türkiye)', 'China', 'United States', 'Spain', 'Taiwan', 'South Korea', 'Thailand', 'Vietnam']"
NCT00616317,Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study,Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study,RECRUITING,2006-09,2040-01,2040-01,OBSERVATIONAL,,50,['Antiphospholipid Syndrome'],Antiphospholipid Syndrome,"University of California, Davis","['Ministry of Higher Education, Science and Technology, Solvenia']",['United States']
NCT05049798,A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice,"Assessment of Guselkumab (Tremfya) and IL-17 Inhibitor Therapies in Patients With Psoriatic Arthritis in Routine Clinical Practice; A Prospective, Observational Cohort Study",ACTIVE_NOT_RECRUITING,2021-08-25,2027-08-01,2027-08-01,OBSERVATIONAL,,1314,"['Arthritis, Psoriatic']","Arthritis, Psoriatic","Janssen Pharmaceutica N.V., Belgium",[],"['Japan', 'Netherlands', 'Australia', 'Belgium', 'Russia', 'France', 'South Korea', 'Colombia', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Austria', 'Italy', 'Argentina']"
NCT05572047,Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation,Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation,ACTIVE_NOT_RECRUITING,2022-10-11,2026-04,2026-06,INTERVENTIONAL,NA,25,['Atrial Fibrillation'],Atrial Fibrillation,Arga Medtech SA,[],"['Croatia', 'Georgia']"
NCT05242484,A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis,"A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis",ACTIVE_NOT_RECRUITING,2022-09-19,2025-05-15,2029-03-27,INTERVENTIONAL,PHASE2,577,"['Colitis, Ulcerative']","Colitis, Ulcerative","Janssen Research & Development, LLC",[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Slovakia', 'Jordan', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'Slovenia', 'France', 'Chile', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'South Africa', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT04077463,A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer,"An Open-label Phase 1/1b Study to Evaluate the Safety and Pharmacokinetics of JNJ-73841937 (Lazertinib), a Third Generation EGFR-TKI, as Monotherapy or in Combinations With JNJ-61186372, a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non-Small Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2019-09-04,2026-06-03,2026-06-03,INTERVENTIONAL,PHASE1,701,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung","Janssen Research & Development, LLC",[],"['Japan', 'China', 'United States', 'France', 'Puerto Rico', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Germany']"
NCT06870201,Iron Absorption From Lipid-Based Nutrient Supplements,Dietary Iron Absorption From Lipid-Based Nutrient Supplements - A Pilot Study,ACTIVE_NOT_RECRUITING,2025-03-25,2026-03-01,2026-03-01,OBSERVATIONAL,,30,"['Undernutrition', 'Healthy']",Undernutrition,Pennington Biomedical Research Center,['Jomo Kenyatta University of Agriculture and Technology'],['Kenya']
NCT03698019,A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma,A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma,ACTIVE_NOT_RECRUITING,2019-02-15,2022-09-01,2026-10-30,INTERVENTIONAL,PHASE2,313,"['Acral Lentiginous Melanoma', 'Clinical Stage III Cutaneous Melanoma AJCC v8', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Mucosal Melanoma']",Acral Lentiginous Melanoma,National Cancer Institute (NCI),[],['United States']
NCT05024552,"Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML","A Phase 1 Study of Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated Acute Myeloid Leukemia",RECRUITING,2022-02-25,2027-02-15,2027-03,INTERVENTIONAL,PHASE1,22,['Acute Myeloid Leukemia With FLT3/ITD Mutation'],Acute Myeloid Leukemia With FLT3/ITD Mutation,H. Lee Moffitt Cancer Center and Research Institute,['Jazz Pharmaceuticals'],['United States']
NCT07134998,Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations,"A Phase I Study of HRS-6093 Evaluating Safety, Tolerability, and Pharmacokinetics in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations",RECRUITING,2025-09-16,2028-05,2028-12,INTERVENTIONAL,PHASE1,153,['Advanced KRAS G12D Mutant Solid Tumors'],Advanced KRAS G12D Mutant Solid Tumors,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT07176702,A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy,A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) in Combination With Trastuzumab and Chemotherapy for the First-Line Treatment of HER2-Positive Pancreatic Ductal Adenocarcinoma,ACTIVE_NOT_RECRUITING,2025-09-30,2027-03-05,2027-09-01,INTERVENTIONAL,PHASE2,45,"['Metastatic PDAC', 'HER2-positive Status']",Metastatic PDAC,Shanghai Zhongshan Hospital,['The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School'],['China']
NCT05023486,NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies,NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies,RECRUITING,2021-12-07,2025-12,2026-03,INTERVENTIONAL,PHASE1,140,['Advanced or Metastatic Solid Tumor Malignancies'],Advanced or Metastatic Solid Tumor Malignancies,"Novita Pharmaceuticals, Inc.",[],['United States']
NCT05414396,"Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities","Reducing Cancer and Chronic Disease Risk in Underserved Communities: Eat, Move, Live Program",ACTIVE_NOT_RECRUITING,2018-03-20,2026-10-12,2026-10-12,INTERVENTIONAL,NA,347,"['Diabetes Mellitus', 'Obesity-Related Malignant Neoplasm']",Diabetes Mellitus,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT04666610,"A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy","A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2 Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy",RECRUITING,2021-07-29,2027-02-25,2027-02-25,INTERVENTIONAL,PHASE3,160,"['Childhood Absence Epilepsy', 'Juvenile Absence Epilepsy']",Childhood Absence Epilepsy,UCB Biopharma SRL,[],"['Belgium', 'United States', 'Georgia', 'Slovakia', 'Spain', 'Italy', 'Romania', 'Poland', 'Ukraine', 'Australia']"
NCT06725160,Parent Encouragement And Coaching of Happiness in Youth,Maternal Positive Affect Socialization and Child Neural Reward Response,RECRUITING,2025-10-28,2029-02-01,2029-02-01,INTERVENTIONAL,NA,180,"['Depression', 'Parent-Child Relations']",Depression,University of Pittsburgh,['National Institute of Mental Health (NIMH)'],['United States']
NCT05250973,A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis,"A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis",ACTIVE_NOT_RECRUITING,2022-03-01,2025-05-30,2027-03-02,INTERVENTIONAL,PHASE2,151,['Amyloidosis'],Amyloidosis,"Janssen Research & Development, LLC",[],"['Netherlands', 'China', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Greece', 'Germany']"
NCT06664788,A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery,"A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of ETHIZIA™ Versus SURGICEL® Original in Controlling Minimal, Mild, or Moderate Soft Tissue Bleeding During Open Abdominal, Retroperitoneal, Pelvic, Thoracic (Non-cardiac) and Extremity Surgery",RECRUITING,2025-04-16,2026-01-30,2026-02-28,INTERVENTIONAL,NA,108,"['Hemostasis', 'Hemostatic Techniques']",Hemostasis,"Ethicon, Inc.",[],"['United States', 'Netherlands']"
NCT07205731,"Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma","PRODIGE 102 - FFCD 2201 - SAFE-ESO Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma",RECRUITING,2025-10-07,2029-10,2030-10,INTERVENTIONAL,PHASE2,95,['Esophageal Squamous Cell Carcinoma (ESCC)'],Esophageal Squamous Cell Carcinoma (ESCC),"University Hospital, Clermont-Ferrand","['BeiGene USA, Inc.', 'Federation Francophone de Cancerologie Digestive']",['France']
NCT04351256,Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy,Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy - Employing Optimized (Hypofractionated) Radiotherapy to Foster Durvalumab Efficacy,ACTIVE_NOT_RECRUITING,2020-05-20,2026-02-28,2026-06-30,INTERVENTIONAL,PHASE2,51,"['NSCLC, Stage III']","NSCLC, Stage III",Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,"['Thoraxklinik-Heidelberg gGmbH', 'AstraZeneca']",['Germany']
NCT04850846,Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma,A Randomized Placebo-Controlled Phase 2 Study of Metformin for the Prevention of Progression of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma,ACTIVE_NOT_RECRUITING,2021-04-27,2025-01-29,2027-07-31,INTERVENTIONAL,PHASE2,60,"['Monoclonal Gammopathy of Undetermined Significance', 'Smoldering Multiple Myeloma']",Monoclonal Gammopathy of Undetermined Significance,Dana-Farber Cancer Institute,['National Cancer Institute (NCI)'],['United States']
NCT07267637,Autogenous Tooth Bone Graft for Alveolar Socket Preservation,"""Autogenous Tooth Bone Graft for Alveolar Socket Preservation: A CBCT-Based Clinical Trial With 6-Month Follow-Up""",ACTIVE_NOT_RECRUITING,2024-07-14,2025-11-01,2026-08-31,INTERVENTIONAL,NA,20,"['Alveolar Bone Grafting', 'Bone Regeneration Following Wisdom Teeth Extraction', 'Tooth Extraction Site Healing']",Alveolar Bone Grafting,Haifaa Mohammed Al-hussini,[],['Yemen']
NCT07053345,A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression,"An Interventional, Open-label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of Esketamine Nasal Spray in Korean Participants With Treatment-Resistant Depression(TRD)",RECRUITING,2025-06-09,2027-06-25,2027-06-25,INTERVENTIONAL,PHASE4,47,"['Depressive Disorder, Treatment-Resistant']","Depressive Disorder, Treatment-Resistant","Janssen Korea, Ltd., Korea",[],['South Korea']
NCT05338775,A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma,A Phase 1b Study of Bispecific T Cell Redirection Antibodies in Combination With Checkpoint Inhibition for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma,ACTIVE_NOT_RECRUITING,2022-05-25,2025-05-22,2027-05-03,INTERVENTIONAL,PHASE1,74,['Relapsed/ Refractory Multiple Myeloma'],Relapsed/ Refractory Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Spain', 'United States', 'France', 'Germany']"
NCT07107230,A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors,A Phase 1 Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors,RECRUITING,2025-07-15,2027-11-18,2028-04-17,INTERVENTIONAL,PHASE1,380,['Colorectal Neoplasms'],Colorectal Neoplasms,"Janssen Research & Development, LLC",[],"['Spain', 'United States', 'South Korea']"
NCT05343741,Practice-Based Evidence in Psychotherapy in Ecuador,Practice-Based Evidence in Ecuador: Routine Outcome Monitoring in Psychotherapy for Common Mental Health Problems,ACTIVE_NOT_RECRUITING,2022-10-17,2025-07-20,2026-06,OBSERVATIONAL,,340,['Psychological Distress'],Psychological Distress,Universidad de las Americas - Quito,[],['Ecuador']
NCT04829357,Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System,A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT ABBREVO® Continence System for the Treatment of Stress Urinary Incontinence,RECRUITING,2021-09-09,2036-09-30,2037-02-27,OBSERVATIONAL,,195,['Stress Urinary Incontinence'],Stress Urinary Incontinence,"Ethicon, Inc.",[],"['Switzerland', 'Poland', 'United States', 'Italy']"
NCT04829175,Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry,A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) Registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse,RECRUITING,2022-04-13,2036-03-30,2036-08-30,OBSERVATIONAL,,1000,"['Stress Urinary Incontinence', 'Pelvic Organ Prolapse']",Stress Urinary Incontinence,"Ethicon, Inc.",[],"['Austria', 'United States', 'France', 'Denmark', 'Italy', 'Poland', 'Sweden', 'Germany']"
NCT07162753,Assesment of Ethnic Bias in an Artificial Intelligence Based Orthodontic Diagnosis System,Detection of Racial Bias in an Artificial Intelligence Based Orthodontic Diagnosis System,RECRUITING,2025-01-06,2026-06-15,2026-08-11,OBSERVATIONAL,,5000,"['Class I Malocclusion', 'Class II Div 1 Malocclusion', 'Class II Division 2 Malocclusion', 'Class III Malocclusion']",Class I Malocclusion,Bezmialem Vakif University,['PEBS DENTAL CLINIC'],['Turkey (Türkiye)']
NCT04829994,Post-Market Clinical Follow-Up onTVT EXACT® Continence System,A Long Term Prospective Post Market Clinical Follow-up (PMCF) of the GYNECARE TVT EXACT® Continence System for the Treatment of Stress Urinary Incontinence,ACTIVE_NOT_RECRUITING,2021-07-08,2035-09-30,2036-02-28,OBSERVATIONAL,,198,['Stress Urinary Incontinence'],Stress Urinary Incontinence,"Ethicon, Inc.",[],"['Austria', 'United States', 'France', 'Denmark', 'Sweden', 'Germany']"
NCT05754957,A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome",RECRUITING,2023-04-07,2026-09-07,2026-10-19,INTERVENTIONAL,PHASE3,16000,['Acute Coronary Syndrome'],Acute Coronary Syndrome,"Janssen Research & Development, LLC",['Bristol-Myers Squibb'],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'North Macedonia', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Croatia', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'United Kingdom', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07142265,Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients,Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients,RECRUITING,2025-09-30,2027-03-31,2027-03-31,OBSERVATIONAL,,300,['Myocardial Infarction'],Myocardial Infarction,Novartis Pharmaceuticals,[],['Russia']
NCT03248284,Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons,Stereological Quantification of Immune-Competent Cells in Biopsies From Painful Achilles Tendons of Psoriatic Arthritis Patients With Ultrasonic Verified Enthesitis: An Exploratory Prospective Cohort Study,RECRUITING,2017-08-21,2026-12-31,2027-03-31,OBSERVATIONAL,,30,"['Psoriatic Arthritis', 'Enthesitis']",Psoriatic Arthritis,Odense University Hospital,"['University of Southern Denmark', 'Odense Patient Data Explorative Network', 'The Danish Rheumatism Association', 'The Psoriasis Association, Denmark']",['Denmark']
NCT06855498,Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib,"A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib",RECRUITING,2025-02-28,2028-02-28,2028-02-28,INTERVENTIONAL,PHASE3,600,['Hidradenitis Suppurativa (HS)'],Hidradenitis Suppurativa (HS),Incyte Corporation,[],"['Bulgaria', 'Netherlands', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07266415,Study for Pregnant Women With Insomnia Using Sleep Inducing Digital Sound Application,"A 2-Week, Single-Center, Double-blind, Exploratory Study to Evaluate the Safety and Efficacy of the Sleep Inducing Digital Sound Application on Pregnant Women in Their 1st and 2nd Trimester With Insomnia",ACTIVE_NOT_RECRUITING,2025-06-24,2026-03-18,2026-05-18,INTERVENTIONAL,NA,30,"['Insomnia', 'Pregnancy, First Trimester', 'Pregnancy, Second Trimester']",Insomnia,Seoul National University Bundang Hospital,['BELL Therapeutics Inc.'],['South Korea']
NCT03502668,Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS,"A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects With Lower Risk (IPSS Low or Intermediate-1) Myelodysplastic Syndromes (MDS)",ACTIVE_NOT_RECRUITING,2018-07-27,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE1,160,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,"Taiho Oncology, Inc.",[],"['Belgium', 'United States', 'Spain', 'Italy', 'Canada', 'Germany']"
NCT06807424,A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis,"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced Participants With Active Psoriatic Arthritis",RECRUITING,2025-01-09,2027-02-10,2028-10-18,INTERVENTIONAL,PHASE3,750,"['Arthritis, Psoriatic']","Arthritis, Psoriatic","Janssen Research & Development, LLC",[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Australia', 'Hungary', 'Denmark', 'Thailand', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'Malaysia', 'United Kingdom', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT06290336,Pre-Operative Exercise Therapy and Patient Education Before Total Knee Replacement,"Pre-operative Exercise Therapy and Patient Education Before Total Knee Replacement - Effect on Subjective Knee Function, Patient Satisfaction and Enablement",RECRUITING,2024-02-26,2027-12-30,2027-12-30,INTERVENTIONAL,NA,110,['Knee Osteoarthritis'],Knee Osteoarthritis,Linkoeping University,"['Region Östergötland', 'Region Jönköping County']",['Sweden']
NCT07177430,Inspiratory Muscle Training in Children and Adolescents With Idiopathic Scoliosis Undergoing Schroth Therapy.,"The Effect of Inspiratory Muscle Training on Respiratory Function, Exercise Tolerance and Core Stability in Children and Adolescents With Idiopathic Scoliosis Undergoing Schroth Therapy.",RECRUITING,2025-10-13,2027-05,2027-07,INTERVENTIONAL,NA,56,['Scoliosis Idiopathic'],Scoliosis Idiopathic,Wroclaw University of Health and Sport Sciences,[],['Poland']
NCT04163432,"Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC","A Randomized, Phase II Study of Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed and Carboplatin (PC) for Metastatic Non-Squamous NSCLC",ACTIVE_NOT_RECRUITING,2020-06-16,2025-02-03,2026-12,INTERVENTIONAL,PHASE2,43,['Non-Small Cell Lung Cancer Metastatic'],Non-Small Cell Lung Cancer Metastatic,University of Utah,['AstraZeneca'],['United States']
NCT06921850,A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa,"A Multicenter, Open-Label Study to Assess The Pharmacokinetics And Safety of Bimekizumab in Pubertal Children And Adolescents With Moderate to Severe Hidradenitis Suppurativa",RECRUITING,2025-04-07,2027-03-19,2029-05-30,INTERVENTIONAL,PHASE3,40,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,UCB Biopharma SRL,[],"['Poland', 'United States', 'Germany']"
NCT07267546,"Heart-Lung Machine: Impact of the Priming Solution on Acid-Base Balance, Electrolytes and Outcome on Patients Undergoing Cardiac Surgery","Heart-Lung Machine: Impact of the Priming Solution on the Body's Acid-Base Balance, Electrolyte Composition and Clinical Outcome (PRIMEII)",RECRUITING,2025-09-01,2026-09-20,2026-11-01,INTERVENTIONAL,NA,80,"['Acid Base Imbalance', 'Osmolality Disturbance', 'Crystalloid Solutions', 'Electrolyte Changes', 'Cardiopulmonary Bypass']",Acid Base Imbalance,Region Skane,[],['Sweden']
NCT04864054,T-Cell Therapy (ECT204) in Adults With Advanced HCC,"An Open-Label, Dose Escalation, Multi-Center Phase I/II Clinical Trial of ECT204 T-Cell Therapy in Adults With Advanced Hepatocellular Carcinoma (HCC) (ARYA-3)",RECRUITING,2022-03-11,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE1,20,"['Hepatocellular Carcinoma', 'Liver Cancer, Adult', 'Liver Neoplasm', 'Metastatic Liver Cancer']",Hepatocellular Carcinoma,Eureka Therapeutics Inc.,[],"['Taiwan', 'United States']"
NCT06915025,"Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer","A Randomized Phase 3 Trial Evaluating the Safety & Efficacy of IP IMNN-001 Administered in Combination w/ Standard Neoadjuvant & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer",RECRUITING,2025-07-09,2032-10-31,2032-10-31,INTERVENTIONAL,PHASE3,500,"['Epithelial Ovarian Cancer', 'Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Carcinoma']",Epithelial Ovarian Cancer,Imunon,[],['United States']
NCT03759015,Evaluation of Health Education Theater,Evaluation of Health Education Theater,ACTIVE_NOT_RECRUITING,2019-04-03,2020-12-31,2026-06-30,INTERVENTIONAL,NA,10,['Community Health Education'],Community Health Education,"University of California, Davis",[],['United States']
NCT06480500,"i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial","Integrated Internet-Based Cognitive Behavioural Therapy (i-CBT) and Intravenous Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial",RECRUITING,2024-01-02,2026-03,2026-06,INTERVENTIONAL,PHASE2,110,"['Major Depressive Disorder', 'Suicide', 'Treatment Resistant Depression']",Major Depressive Disorder,"University Health Network, Toronto",['Ontario Shores Centre for Mental Health Sciences'],['Canada']
NCT06872164,Open Pilot Trial of Adapted Cognitive Processing Therapy for Comorbid PTSD and Opioid Use Disorder,Onsite PTSD Treatment to Improve MOUD Outcomes: Open Pilot Trial of Stakeholder-engaged Adapted Cognitive Processing Therapy,RECRUITING,2025-11-17,2026-08,2026-09,INTERVENTIONAL,NA,15,"['Posttraumatic Stress Disorder (PTSD)', 'Opioid Use Disorder']",Posttraumatic Stress Disorder (PTSD),The City College of New York,"['National Institute on Drug Abuse (NIDA)', 'Albert Einstein College of Medicine']",['United States']
NCT05060016,A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC),"A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Tarlatamab in Subjects With Relapsed/Refractory Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-301).",ACTIVE_NOT_RECRUITING,2021-12-01,2026-04-30,2027-04-30,INTERVENTIONAL,PHASE2,222,['Relapsed/Refractory Small Cell Lung Cancer'],Relapsed/Refractory Small Cell Lung Cancer,Amgen,[],"['Singapore', 'Belgium', 'Japan', 'Netherlands', 'Austria', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT06585787,A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease",RECRUITING,2024-09-26,2026-09-21,2026-10-19,INTERVENTIONAL,PHASE3,406,['Alzheimer Disease'],Alzheimer Disease,Karuna Therapeutics,[],"['Bulgaria', 'Japan', 'China', 'Slovakia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Croatia', 'South Korea', 'Poland', 'India', 'Spain', 'Romania', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT04557098,A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma,"A Phase 1/2, First-in-Human, Open-Label, Dose Escalation Study of Teclistamab, a Humanized BCMA x CD3 Bispecific Antibody, in Subjects With Relapsed or Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2020-09-17,2025-11-30,2027-05-28,INTERVENTIONAL,PHASE2,194,['Hematological Malignancies'],Hematological Malignancies,"Janssen Research & Development, LLC",[],"['Belgium', 'Netherlands', 'China', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Sweden', 'Germany']"
NCT06476184,Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery,A Pragmatic Randomized Phase III Trial to Assess the Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery,RECRUITING,2024-07-30,2027-06,2028-12,INTERVENTIONAL,PHASE3,250,['Ovarian Cancer'],Ovarian Cancer,ARCAGY/ GINECO GROUP,['Horizon 2020 - European Commission'],"['Italy', 'Japan', 'France']"
NCT06005285,Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism,Examining the Effectiveness of the Early Start Denver Model in Community Programs,RECRUITING,2024-03-01,2028-01-01,2028-06-01,INTERVENTIONAL,NA,600,['Autism'],Autism,"University of California, Davis",['National Institute of Mental Health (NIMH)'],['United States']
NCT07267455,"Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial","Efficacy Analysis of Personalized-Target Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Tinnitus: A Single-Center, Single-Blind Randomized Clinical Trial",RECRUITING,2025-08-01,2030-01,2030-08,INTERVENTIONAL,NA,116,['Chronic Tinnitus'],Chronic Tinnitus,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT07169578,A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease,"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease (MCI to Mild Dementia Due to AD)",RECRUITING,2025-09-17,2028-06-07,2028-06-07,INTERVENTIONAL,PHASE3,800,['Alzheimers Disease'],Alzheimers Disease,Hoffmann-La Roche,[],"['Japan', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT06934226,A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis,"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Ustekinumab Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis",ACTIVE_NOT_RECRUITING,2025-04-15,2026-03-30,2027-08-20,INTERVENTIONAL,PHASE3,752,['Plaque Psoriasis'],Plaque Psoriasis,"Janssen Research & Development, LLC",[],"['Belgium', 'Hungary', 'Austria', 'United States', 'Germany', 'Denmark', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Portugal', 'Argentina', 'Australia']"
NCT06616584,Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial),A Randomized Phase II/III Study of Docetaxel and Ramucirumab With or Without Cemiplimab for Participants Previously Treated With Platinum-Based Chemotherapy and Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Non-Matched Sub-Study),RECRUITING,2025-05-22,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE2,378,"['Recurrent Lung Non-Small Cell Carcinoma', 'Stage IV Lung Cancer AJCC v8']",Recurrent Lung Non-Small Cell Carcinoma,SWOG Cancer Research Network,"['Regeneron Pharmaceuticals', 'National Cancer Institute (NCI)']",['United States']
NCT06995833,Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance,Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance,RECRUITING,2025-09-19,2029-06-29,2029-06-29,OBSERVATIONAL,,50,['Endometrial Cancer'],Endometrial Cancer,AstraZeneca,[],['South Korea']
NCT06500884,A Study to Evaluate Preventive Treatments for Talquetamab-related Oral Toxicity,"A Phase 2, Open-label, Randomized Study to Evaluate Prophylactic Interventions on Talquetamab-related Oral Toxicity",RECRUITING,2024-08-26,2026-04-15,2027-10-18,INTERVENTIONAL,PHASE2,130,"['Relapse Multiple Myeloma', 'Refractory Multiple Myeloma']",Relapse Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Brazil', 'Netherlands', 'United States', 'Puerto Rico', 'Spain', 'South Korea', 'United Kingdom']"
NCT07164443,A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC),"A Phase 3 Randomized, Double-blind, Placebo-controlled Study of Pasritamig (JNJ-78278343), a T Cell Redirecting Agent Targeting Human Kallikrein 2, + Best Supportive Care Versus Best Supportive Care for Metastatic Castration-resistant Prostate Cancer",RECRUITING,2025-09-02,2028-05-30,2028-05-30,INTERVENTIONAL,PHASE3,663,['Metastatic Castration-resistant Prostate Neoplasms'],Metastatic Castration-resistant Prostate Neoplasms,"Janssen Research & Development, LLC",[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'Puerto Rico', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT06456411,Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer,"Real-Time Evaluation of Severity of Perceived Pain in Patients With Cancer by Using Functional Near-Infrared Spectroscopy (fNIRS), and Investigation of Pain Relief Utilizing Virtual Reality Technologies",RECRUITING,2022-07-12,2030-07-12,2030-07-12,INTERVENTIONAL,NA,410,"['Breast Carcinoma', 'Kidney Carcinoma', 'Carcinoma']",Breast Carcinoma,Roswell Park Cancer Institute,[],['United States']
NCT06769152,A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors,A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Recurrent/Metastatic Gynecological Malignant Tumors Failed or Intolerance to Standard First-Line Therapy,RECRUITING,2025-02-20,2026-10-31,2027-06-05,INTERVENTIONAL,PHASE2,130,"['Cervical Cancer', 'Ovarian Cancer']",Cervical Cancer,Shanghai Henlius Biotech,[],['China']
NCT04868526,Dietary Intervention to Mitigate Adverse Consequences of Night Work,Dietary Intervention to Mitigate Adverse Consequences of Night Work,RECRUITING,2023-03-29,2026-09-01,2026-09-01,INTERVENTIONAL,NA,24,['Dietary Habits'],Dietary Habits,Brigham and Women's Hospital,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06811116,"Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial",A Phase I/II Trial of Sapanisertib in Combination With Cabozantinib in β-catenin-mutated Hepatocellular Carcinoma (SAPHIRE),RECRUITING,2025-11-17,2027-08-31,2027-08-31,INTERVENTIONAL,PHASE1,92,"['Advanced Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma', 'Stage III Hepatocellular Carcinoma AJCC v8', 'Stage IV Hepatocellular Carcinoma AJCC v8']",Advanced Hepatocellular Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT03107884,Role of Metformin on Muscle Health of Older Adults,Metformin to Prevent Inactivity-induced Loss of Muscle Health During Aging,ACTIVE_NOT_RECRUITING,2019-08-01,2026-11-01,2026-11-01,INTERVENTIONAL,EARLY_PHASE1,64,"['Muscle Atrophy', 'Insulin Resistance']",Muscle Atrophy,University of Utah,[],['United States']
NCT06931509,Integration and Interactions Between Visual and Proprioceptive Feedbacks,Study of the Integration and Interactions Between Visual and Proprioceptive Feedbacks in Hemiplegic Patients,RECRUITING,2025-11-25,2028-04-30,2028-04-30,INTERVENTIONAL,NA,38,['Hemiparetic Stroke'],Hemiparetic Stroke,Centre Hospitalier Universitaire de Saint Etienne,[],['France']
NCT05552222,A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma,"A Phase 3 Randomized Study Comparing Teclistamab in Combination With Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab SC and Lenalidomide (Tal-DR) Versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma Who Are Either Ineligible or Not Intended for Autologous Stem Cell Transplant as Initial Therapy",RECRUITING,2022-10-25,2031-04-30,2033-10-28,INTERVENTIONAL,PHASE3,1590,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy']"
NCT07108153,"Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta","A Phase 2a Randomized, Double-blind, Placebo-controlled Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Physician-prescribed Trikafta® in People With Cystic Fibrosis Who Are Homozygous for the F508del Mutation",RECRUITING,2025-11-03,2026-07,2026-07,INTERVENTIONAL,PHASE2,16,['Cystic Fibrosis (CF)'],Cystic Fibrosis (CF),Sionna Therapeutics Inc.,[],"['United States', 'Australia']"
NCT06853405,Nutrition-based Interventions to Prevent Cognitive Decline,NUTRIMIND: Nutrition-based Interventions to Prevent Cognitive Decline,RECRUITING,2025-01-27,2026-05,2026-08,INTERVENTIONAL,NA,120,"['Cognitive Dysfunction', 'Cognition Disorder', 'Memory Disorders', 'Cognitive Impairment', 'Neurocognitive Disorders']",Cognitive Dysfunction,Instituto de Saude Publica da Universidade do Porto,[],['Portugal']
NCT06788912,Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01),KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC),RECRUITING,2025-03-20,2032-02-06,2032-02-06,INTERVENTIONAL,PHASE2,60,['Lung Neoplasm Malignant'],Lung Neoplasm Malignant,Merck Sharp & Dohme LLC,[],"['Hungary', 'Turkey (Türkiye)', 'United States', 'Chile', 'Spain', 'Italy', 'Greece', 'Poland', 'Ukraine']"
NCT06393296,A Study of Melatonin Concentration During Lactation,"Melatonin and Secretory Immunoglobulin A (sIgA) Concentration During Lactation, Maternal Determinants and Repercussions",ACTIVE_NOT_RECRUITING,2024-04-17,2025-10-24,2026-01-30,OBSERVATIONAL,,120,['Breastfeeding'],Breastfeeding,Mayo Clinic,"['Universidade Federal de Goias', 'University of Wisconsin, Eau Claire']",['United States']
NCT06558851,The Effect of Systematic Endurance Training in Treatment of Women With Lipedema,The Effect of Systematic Endurance Training in Treatment of Women With Lipedema - The LipidEx Study,ACTIVE_NOT_RECRUITING,2025-09-01,2026-07-31,2026-07-31,INTERVENTIONAL,NA,62,['Lipedema'],Lipedema,Norwegian University of Science and Technology,"['St.Olavs Hospital, Trondheim University Hospital, Norway']",['Norway']
NCT04577833,A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer,"An Open-label, Randomized Study to Assess the Relative Bioavailability (BA) and Bioequivalence (BE) of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer",ACTIVE_NOT_RECRUITING,2020-11-13,2021-10-15,2026-12-31,INTERVENTIONAL,PHASE1,136,['Prostatic Neoplasms'],Prostatic Neoplasms,"Janssen Research & Development, LLC",[],"['Belgium', 'Netherlands', 'Moldova', 'United States', 'France', 'Georgia', 'Spain', 'United Kingdom', 'Poland', 'Ukraine', 'Sweden']"
NCT05583721,Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET,An Evaluation of the Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET (Stress-Rest) Myocardial Perfusion Imaging (MYPERS),RECRUITING,2023-10-10,2027-09,2028-09,INTERVENTIONAL,PHASE2,40,['Sickle Cell Disease'],Sickle Cell Disease,St. Jude Children's Research Hospital,[],['United States']
NCT04225871,Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis,"A Phase 3, Multicenter, Open-Label Extension Study of Zilucoplan in Subjects With Generalized Myasthenia Gravis",ACTIVE_NOT_RECRUITING,2019-12-23,2026-06-02,2026-06-02,INTERVENTIONAL,PHASE3,200,['Generalized Myasthenia Gravis'],Generalized Myasthenia Gravis,UCB Biopharma SRL,[],"['Japan', 'Norway', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT06211764,A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG),"A Phase 3, Randomized, Open-label, Multi-center Study Evaluating the Efficacy and Safety of TAR-200 Versus Investigator's Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High-risk Non-muscle-invasive Bladder Cancer (HR-NMIBC) and Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy",ACTIVE_NOT_RECRUITING,2024-04-09,2030-11-27,2031-04-14,INTERVENTIONAL,PHASE3,272,['Non-Muscle Invasive Bladder Neoplasms'],Non-Muscle Invasive Bladder Neoplasms,"Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Japan', 'China', 'United States', 'France', 'Spain', 'Italy', 'Romania', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT04090528,"pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer","Phase II Trial of pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer",ACTIVE_NOT_RECRUITING,2019-10-21,2024-11-24,2026-10,INTERVENTIONAL,PHASE2,60,"['Castration-resistant Prostate Cancer', 'Metastatic Cancer', 'Prostate Cancer']",Castration-resistant Prostate Cancer,"University of Wisconsin, Madison","['Merck Sharp & Dohme LLC', 'Madison Vaccines Incorporated', 'Prostate Cancer Foundation']",['United States']
NCT03223766,Evaluation of Proton Therapy in Pediatric Cancer Patients,Phase IV Clinical Trial of Proton Therapy in Pediatric Cancer,ACTIVE_NOT_RECRUITING,2017-08-01,2037-07,2037-07,OBSERVATIONAL,,1000,['Tumor'],Tumor,St. Jude Children's Research Hospital,[],['United States']
NCT06576830,Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia,Single-Dose Intraoperative Methadone for Pain Management in Pediatric Tonsillectomy: A Randomized Double Blind Clinical Trial,RECRUITING,2024-11-21,2028-12-31,2029-06-01,INTERVENTIONAL,PHASE4,440,"['Pain, Postoperative', 'Tonsillar Hypertrophy', 'Tonsillitis', 'Pediatric Sleep Apnea', 'Sleep-Disordered Breathing']","Pain, Postoperative",Duke University,"['National Institutes of Health (NIH)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06866951,A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial,CIT Trial for Cervical Cancer Patients,ACTIVE_NOT_RECRUITING,2025-03-01,2028-12-31,2030-12-31,INTERVENTIONAL,PHASE2,440,['Cervical Cancers'],Cervical Cancers,Women's Hospital School Of Medicine Zhejiang University,[],['China']
NCT00760656,Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer,Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer,RECRUITING,2007-09-13,2025-12-31,2025-12-31,OBSERVATIONAL,,8000,['Cancer'],Cancer,St. Jude Children's Research Hospital,"['National Cancer Institute (NCI)', 'American Society of Clinical Oncology', 'Rally Foundation', 'Memorial Sloan Kettering Cancer Center', 'University of Minnesota', ""St. Baldrick's Foundation"", 'American Institute for Cancer Research', 'American Cancer Society, Inc.']",['United States']
NCT06849596,Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates,A Cluster Crossover Randomized Controlled Trial of Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates: The MVP Trial,RECRUITING,2025-12-01,2028-09-30,2029-01-01,INTERVENTIONAL,NA,780,"['Neonatal Resuscitation', 'Apnea Neonatal']",Neonatal Resuscitation,Michelle Baczynski,"['Royal Alexandra Hospital', 'Foothills Medical Centre', ""McMaster Children's Hospital"", ""St. Justine's Hospital"", 'Cedars-Sinai Medical Center', ""Montreal Children's Hospital of the MUHC"", 'Sunnybrook Health Sciences Centre', 'London Health Sciences Centre', ""BC Women's Hospital & Health Centre""]","['Denmark', 'United States', 'Canada']"
NCT05239741,Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66),A Phase 3 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer (MK-3475-C66),RECRUITING,2022-04-02,2028-09-19,2028-09-19,INTERVENTIONAL,PHASE3,100,['Colorectal Neoplasms'],Colorectal Neoplasms,Merck Sharp & Dohme LLC,[],['China']
NCT06874296,Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time,"Pilot, Open, Prospective, Randomized, Multicenter Trial On Quality Assessment Of Declined Liver Grafts By Normothermic Ex Vivo Machine Perfusion For Decreasing Time To Transplantation",RECRUITING,2025-06-02,2029-05-31,2030-12-31,INTERVENTIONAL,NA,186,"['Liver Transplantation', 'Liver Diseases', 'Surgery']",Liver Transplantation,"Charite University, Berlin, Germany",['German Research Foundation'],['Germany']
NCT07052396,"Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions","A Prospective, Non-interventional, Multicenter Observational Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With COPD Under Real-world Conditions",RECRUITING,2025-07-01,2029-07-01,2029-07-01,OBSERVATIONAL,,350,['Chronic Obstructive Pulmonary Disease (COPD)'],Chronic Obstructive Pulmonary Disease (COPD),Sanofi,['Regeneron Pharmaceuticals'],['Germany']
NCT06850805,Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps,"A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps",RECRUITING,2025-07-28,2028-03-31,2028-10-31,INTERVENTIONAL,PHASE3,84,['Chronic Rhinosinusitis Without Nasal Polyps'],Chronic Rhinosinusitis Without Nasal Polyps,Optinose US Inc.,[],['United States']
NCT07267156,Evaluation of a New Postoperative Dressing After Hallux Valgus Surgery,Evaluation of a New Postoperative Dressing After Hallux Valgus Surgery,RECRUITING,2025-11-30,2026-11-30,2027-04-15,INTERVENTIONAL,NA,40,['Hallux Valgus'],Hallux Valgus,Centre Assal for Foot Medicine and Surgery SA,[],['Switzerland']
NCT06136897,Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J),"MATCH Treatment Subprotocol J: Trastuzumab and Pertuzumab (HP) in Patients With Non-Breast, Non-Gastric/GEJ, and Non-Colorectal Cancers With HER2 Amplification",ACTIVE_NOT_RECRUITING,2017-03-23,2021-11-03,2025-12-31,INTERVENTIONAL,PHASE2,35,['Malignant Solid Neoplasm'],Malignant Solid Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT07267559,Dual Orexin Antagonism and Emotion and Affective Processing Study,An Investigation of the Effects of Dual Orexin Antagonism on Emotional Processing and Learning in Healthy Individuals,RECRUITING,2025-10-01,2026-09-01,2026-10-01,INTERVENTIONAL,PHASE4,62,"['Learning', 'Cognitive Functioning', 'Emotional Processing']",Learning,University of Oxford,[],['United Kingdom']
NCT05392582,MicroRNA Regulation of Chronic Inflammation During Aging,MicroRNA Regulation of Chronic Inflammation During Aging,RECRUITING,2024-11-12,2027-01-01,2028-01-01,OBSERVATIONAL,,40,['Chronic Inflammation'],Chronic Inflammation,University of Utah,[],['United States']
NCT05063162,A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD),"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD)",RECRUITING,2022-02-02,2027-05-06,2027-07-01,INTERVENTIONAL,PHASE3,104,['Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)'],Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD),UCB Biopharma SRL,[],"['Japan', 'Australia', 'Belgium', 'France', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT06979453,"A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis","A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis",RECRUITING,2025-12-03,2029-10-12,2034-08-12,INTERVENTIONAL,PHASE3,366,['Plaque Psoriasis'],Plaque Psoriasis,Bristol-Myers Squibb,[],"['Brazil', 'Belgium', 'Hungary', 'China', 'United States', 'Mexico', 'Puerto Rico', 'Spain', 'Taiwan', 'Canada', 'Colombia', 'Romania', 'Poland', 'Argentina', 'Germany']"
NCT00310180,Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial),Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment:The TAILORx Trial,ACTIVE_NOT_RECRUITING,2006-04-07,2018-03-02,2030-09-30,INTERVENTIONAL,PHASE3,10273,"['Breast Adenocarcinoma', 'Hormone Receptor Positive', 'Stage IA Breast Cancer AJCC v7', 'Stage IB Breast Cancer AJCC v7', 'Stage IIA Breast Cancer AJCC v6 and v7', 'Stage IIB Breast Cancer AJCC v6 and v7', 'Stage IIIB Breast Cancer AJCC v7']",Breast Adenocarcinoma,National Cancer Institute (NCI),"['American College of Surgeons', 'Cancer and Leukemia Group B', 'NSABP Foundation Inc', 'NCIC Clinical Trials Group', 'North Central Cancer Treatment Group', 'SWOG Cancer Research Network']","['New Zealand', 'United States', 'Puerto Rico', 'Ireland', 'Peru', 'Canada', 'United Kingdom', 'Australia']"
NCT04722146,A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma,A Multi-arm Phase 1b Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma,ACTIVE_NOT_RECRUITING,2021-03-12,2027-04-07,2027-10-05,INTERVENTIONAL,PHASE1,140,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Belgium', 'United States', 'France', 'United Kingdom', 'Australia']"
NCT06662786,A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer,"A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer",RECRUITING,2024-10-18,2028-12-15,2032-12-15,INTERVENTIONAL,PHASE3,1000,['Colorectal Neoplasms'],Colorectal Neoplasms,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'China', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'South Korea', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT06904027,A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders,"A Single-arm, Prospective, Multi-center Post-market Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders",RECRUITING,2025-12,2026-10,2031-07,OBSERVATIONAL,,40,['Urea Cycle Disorders'],Urea Cycle Disorders,Tongji Hospital,[],['China']
NCT05687123,Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors,A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors,RECRUITING,2024-08-14,2026-12-14,2026-12-14,INTERVENTIONAL,PHASE1,24,"['Metastatic Pancreatic Neuroendocrine Tumor', 'Pancreatic Neoplasm', 'Stage III Pancreatic Neuroendocrine Tumor AJCC v8', 'Stage IV Pancreatic Neuroendocrine Tumor AJCC v8', 'Unresectable Pancreatic Neuroendocrine Tumor']",Metastatic Pancreatic Neuroendocrine Tumor,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT05122546,CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer,Pilot Study to Evaluate the Biologic Effect of CBM588 in Combination With Cabozantinib/Nivolumab for Patients With Metastatic Renal Cell Carcinoma,ACTIVE_NOT_RECRUITING,2021-11-01,2026-01-27,2026-01-27,INTERVENTIONAL,PHASE1,31,"['Advanced Clear Cell Renal Cell Carcinoma', 'Advanced Papillary Renal Cell Carcinoma', 'Advanced Renal Cell Carcinoma', 'Advanced Sarcomatoid Renal Cell Carcinoma', 'Metastatic Clear Cell Renal Cell Carcinoma', 'Metastatic Papillary Renal Cell Carcinoma', 'Metastatic Renal Cell Carcinoma', 'Metastatic Sarcomatoid Renal Cell Carcinoma', 'Stage III Renal Cell Cancer AJCC v8', 'Stage IV Renal Cell Cancer AJCC v8', 'Unresectable Clear Cell Renal Cell Carcinoma', 'Unresectable Renal Cell Carcinoma']",Advanced Clear Cell Renal Cell Carcinoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07110532,pH1N1 Blinded Challenge Study,"A Double-Blinded, Randomized Influenza Virus Challenge Trial of Recombinant Influenza RG-A/Arkansas/08/2020 (pH1N1) in Healthy Adults to Assess Safety and Optimal Infectious Dose",RECRUITING,2025-09-10,2026-02-28,2026-04-30,INTERVENTIONAL,PHASE1,180,['Influenza'],Influenza,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07221578,Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder,"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Acute Anxiety in Patients With Social Anxiety Disorder",RECRUITING,2025-09-22,2026-12,2027-04,INTERVENTIONAL,PHASE3,500,['Social Anxiety Disorder (SAD)'],Social Anxiety Disorder (SAD),Vanda Pharmaceuticals,[],['United States']
NCT05901649,A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide,"Prospective, Multi-Country, Observational Study of Clinical Outcomes for Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With ADT Plus Apalutamide or Enzalutamide Under Routine Clinical Practice (ArtemisPRO)",ACTIVE_NOT_RECRUITING,2023-07-05,2026-06-05,2026-06-05,OBSERVATIONAL,,510,['Metastatic Hormone-sensitive Prostate Cancer'],Metastatic Hormone-sensitive Prostate Cancer,Janssen-Cilag Ltd.,[],"['Austria', 'France', 'Spain', 'United Kingdom', 'Greece', 'Germany']"
NCT04625647,Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial),A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY),ACTIVE_NOT_RECRUITING,2021-04-16,2026-12-31,2027-12-31,INTERVENTIONAL,PHASE2,116,"['Lung Adenocarcinoma', 'Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage IV Lung Cancer AJCC v8', 'Stage IVA Lung Cancer AJCC v8', 'Stage IVB Lung Cancer AJCC v8']",Lung Adenocarcinoma,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],"['Guam', 'United States']"
NCT05552976,A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2),"A Phase 3, Two-stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide (CC-92480/BMS-986348), Carfilzomib, and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM): SUCCESSOR-2",RECRUITING,2023-01-10,2026-02-04,2029-07-25,INTERVENTIONAL,PHASE3,525,['Relapsed or Refractory Multiple Myeloma'],Relapsed or Refractory Multiple Myeloma,Bristol-Myers Squibb,[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Israel', 'Hungary', 'Puerto Rico', 'Denmark', 'South Korea', 'Colombia', 'India', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05025176,Hypotension Prediction Index: Correlations Between Invasive and Non-invasive Pressure Points.,Hypotension Prediction Index: Correlations Between Invasive and Non-invasive Pressure Points,ACTIVE_NOT_RECRUITING,2021-08-20,2026-08-20,2026-08-20,OBSERVATIONAL,,50,['Hypotension'],Hypotension,"University of California, Davis",[],['United States']
NCT06430385,"ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)","A Phase 1-2, Double-Blind, Sham-Controlled Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Patients With MECP2 Duplication Syndrome",RECRUITING,2024-10-21,2027-09,2030-04,INTERVENTIONAL,PHASE1,48,['Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome'],Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome,"Ionis Pharmaceuticals, Inc.",[],"['Austria', 'United States', 'France']"
NCT06388083,A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease,"A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease",RECRUITING,2024-07-31,2027-12,2028-01,INTERVENTIONAL,PHASE2,60,"['STGD1', 'Stargardt Disease 1']",STGD1,"Belite Bio, Inc",[],"['United Kingdom', 'Japan', 'United States']"
NCT04677569,Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex,"ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects With Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium Avium Complex (MAC)",ACTIVE_NOT_RECRUITING,2021-04-01,2025-11-21,2026-01-15,INTERVENTIONAL,PHASE3,425,"['Mycobacterium Infections, Nontuberculous']","Mycobacterium Infections, Nontuberculous",Insmed Incorporated,[],"['Japan', 'New Zealand', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Denmark', 'South Korea', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05335070,Reducing Pain From Wisdom Molar Extractions,Non-randomized Prospective Pilot Study on Effect of Temporo-masseteric Nerve Block (TMNB) on Pain Reduction Following Wisdom Molar Extractions,RECRUITING,2022-09-13,2026-11,2026-12,INTERVENTIONAL,PHASE2,20,['Acute Pain'],Acute Pain,"Rutgers, The State University of New Jersey",[],['United States']
NCT05643469,Self-determination Plus Instant Messaging for Smokers With Cancer,Efficacy of a Self-determination Theory-based Smoking Cessation Intervention Plus Instant Messaging Via Mobile Application for Smokers With Cancer: A Pragmatic Randomized Controlled Trial,RECRUITING,2023-07-03,2026-05,2026-05,INTERVENTIONAL,NA,1448,"['Smoking', 'Cancer']",Smoking,Chinese University of Hong Kong,[],['Hong Kong']
NCT06148506,A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia,A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in the Russian Federation,ACTIVE_NOT_RECRUITING,2023-12-28,2027-06-30,2027-06-30,OBSERVATIONAL,,376,['HR+HER2- Advanced Breast Cancer'],HR+HER2- Advanced Breast Cancer,Novartis Pharmaceuticals,[],['Russia']
NCT05134935,Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Children Aged 6-12 Years.,Defocus Incorporated Multiple Segment (DIMS) Spectacle Lenses Versus Orthokeratology Lenses (OKL) for Slowing Myopia Progression In Children Aged 6-12 Years. A Non-inferiority Randomized Clinical Trial. The NISDO Study.,ACTIVE_NOT_RECRUITING,2022-06-29,2026-05,2026-05,INTERVENTIONAL,NA,90,['Myopia'],Myopia,Vejle Hospital,[],['Denmark']
NCT07268079,Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality,Validation Study of VIRADIA: A Virtual Reality Diagnostic Platform for the Assessment of Neurological and Cognitive Functions,RECRUITING,2025-12-01,2026-03-31,2026-05-01,OBSERVATIONAL,,200,"['Neurological Disorders', 'Cognitive Impairment', 'Motor Impairment', 'Neurodegenerative Diseases']",Neurological Disorders,Gametherapy,[],['Slovakia']
NCT07267416,Impact of Combined PSi + NIRS Monitoring in the Prevention of Postoperative Cognitive Disorders in Cardiac Surgery.,Prospective Randomized Controlled Study on the Impact of Combined PSi + NIRS Monitoring in the Prevention of Postoperative Cognitive Disorders in Cardiac Surgery.,RECRUITING,2025-05-13,2026-05-15,2026-05-15,INTERVENTIONAL,NA,80,['Postoperative Cognitive Disorders'],Postoperative Cognitive Disorders,Brugmann University Hospital,[],['Belgium']
NCT07195149,Optimal Antiplatelet Therapy in Patients After Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial),Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial),RECRUITING,2025-11-25,2030-04-30,2030-11-30,INTERVENTIONAL,PHASE3,1703,"['Chronic Coronary Syndrome', 'Stable Coronary Artery Disease CAD']",Chronic Coronary Syndrome,Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.,"['Medical Research Agency, Poland']",['Poland']
NCT07267039,Phenol Neurolysis Versus Local Anesthetic Plus Steroid Genicular Nerve Block in Knee Osteoarthritis,"Comparison of Phenol Neurolysis and Local Anesthetic Plus Steroid Genicular Nerve Block Under Ultrasound Guidance in Patients With Knee Osteoarthritis: Effects on Pain, Function, and Safety",ACTIVE_NOT_RECRUITING,2025-05-01,2025-09-01,2026-01-01,OBSERVATIONAL,,42,"['Knee Osteoarthritis', 'Genicular Nerve Block']",Knee Osteoarthritis,Salim Sencar,[],['Turkey (Türkiye)']
NCT06288009,Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds,Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds: a Randomized Evaluator-blinded Split-wound Comparative Effectiveness Trial,RECRUITING,2024-08-01,2026-08-01,2026-10-01,INTERVENTIONAL,NA,50,['Scarring'],Scarring,"University of California, Davis",[],['United States']
NCT01746836,"Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib","Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib",RECRUITING,2013-01-17,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE2,50,"['Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive', 'Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia', 'Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive']","Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive",M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT05908734,A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer,A Phase 1/2 Study Evaluating the Safety and Efficacy of Amivantamab and Cetrelimab Combination Therapy in Metastatic Non-small Cell Lung Cancer,ACTIVE_NOT_RECRUITING,2023-05-18,2026-01-30,2027-03-31,INTERVENTIONAL,PHASE1,71,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung","Janssen Research & Development, LLC",[],"['Brazil', 'Turkey (Türkiye)', 'United States', 'Spain', 'Italy', 'South Korea', 'Malaysia', 'United Kingdom', 'Poland']"
NCT06642675,nTMS for Negative Symptom in Schizophrenia,"Effectiveness of Navigated Transcranial Magnetic Stimulation (nTMS) of Left Supramarginal Gyrus for Negative Symptoms : A Double-blind, Randomized Controlled Trial",RECRUITING,2024-11-22,2026-02,2026-03,INTERVENTIONAL,NA,40,['Schizophrenia'],Schizophrenia,Central South University,[],['China']
NCT04497844,A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC),"A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)",ACTIVE_NOT_RECRUITING,2020-09-23,2025-01-07,2027-11-01,INTERVENTIONAL,PHASE3,696,['Metastatic Castration-sensitive Prostate Cancer'],Metastatic Castration-sensitive Prostate Cancer,"Janssen Research & Development, LLC",[],"['Bulgaria', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Puerto Rico', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'South Africa', 'Mexico', 'Belarus', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06798142,Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning,Risk Stratification and Heterogeneity for Organ Damage in Acute Diquat Poisoning: A Multi-Center Cohort Study,ACTIVE_NOT_RECRUITING,2022-02-01,2024-09-30,2026-12-31,OBSERVATIONAL,,193,"['Toxic Encephalopathy', 'Diquat Poisoning']",Toxic Encephalopathy,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,[],['China']
NCT03482986,Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C,Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C,ACTIVE_NOT_RECRUITING,2021-12-07,2028-06-30,2028-06-30,INTERVENTIONAL,NA,44,"['Bariatric Surgery', 'Sleeve Gastrectomy', 'Obesity']",Bariatric Surgery,Brigham and Women's Hospital,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07240610,Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma,Observational Study on the Abscopal Efect by Ultra-hypofractionated Radiation Therapyin Combination With Immune Checkpoint Inhibiters for Metastatic Renal Cell Carcinoma,RECRUITING,2025-11-10,2028-03-31,2029-09-30,OBSERVATIONAL,,145,['Renal Cell Cancer Metastatic'],Renal Cell Cancer Metastatic,Zhe Chen,['Participating institutions of the AURICRE Study Group'],['Japan']
NCT07265882,Bed Side Assessment in Patients With Acute Respiratory Failure Under Invasive Mechanical Ventilation,Bed Side Assessment in Patients With Acute Respiratory Failure Under Invasive Mechanical Ventilation,RECRUITING,2022-11-14,2026-07-01,2026-11-01,OBSERVATIONAL,,100,['Acute Respiratory Failure (ARF)'],Acute Respiratory Failure (ARF),Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT04829058,GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study,A Retrospective and Long-Term Prospective Post Market Clinical Follow-up (PMCF) Study of the GYNECARE GYNEMESH® PS Nonabsorbable PROLENE® Soft Mesh,RECRUITING,2021-11-24,2031-09-30,2032-03-31,OBSERVATIONAL,,100,['Pelvic Organ Prolapse'],Pelvic Organ Prolapse,"Ethicon, Inc.",[],"['United States', 'Germany']"
NCT04100148,SyncAV Post-Market Trial,SyncAV Post-Market Trial,ACTIVE_NOT_RECRUITING,2019-10-03,2025-12-31,2025-12-31,INTERVENTIONAL,NA,1686,['Congestive Heart Failure'],Congestive Heart Failure,Abbott Medical Devices,[],"['Japan', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Belgium', 'Russia', 'France', 'Finland', 'Puerto Rico', 'South Korea', 'Thailand', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Austria', 'United States', 'Italy', 'Serbia']"
NCT07255625,Effect of Stroboscopic Balance Training on Chronic Ankle Instability in Volleyball Players,Investigation of the Efficacy of Balance Training Program Applied With Stroboscopic Glasses in Female Volleyball Players With Chronic Ankle Instability,RECRUITING,2025-12-20,2026-02-20,2026-03-01,INTERVENTIONAL,NA,24,['Chronic Ankle Instability'],Chronic Ankle Instability,Biruni University,[],['Turkey (Türkiye)']
NCT07167927,Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis,Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis - Aims 2 and 3,RECRUITING,2025-10-21,2027-01-31,2027-03-31,INTERVENTIONAL,NA,110,"['Children With Medical Complexity (CMC)', 'Multiple Chronic Conditions', 'Neuromuscular Scoliosis', 'Shared Decision Making', 'Decision Support Systems, Clinical', 'Decision Aids']",Children With Medical Complexity (CMC),University of Utah,['National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)'],['United States']
NCT06959524,AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions,AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease,RECRUITING,2025-08-21,2028-03,2032-03,INTERVENTIONAL,NA,1616,"['Coronary Arterial Disease (CAD)', 'de Novo Lesions in Native Coronary Arteries']",Coronary Arterial Disease (CAD),Boston Scientific Corporation,[],['United States']
NCT06624228,A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis,"A Multicenter, Randomized, Double-Blind, Risankizumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis",ACTIVE_NOT_RECRUITING,2024-10-21,2026-02-03,2026-05-26,INTERVENTIONAL,PHASE3,684,['Psoriatic Arthritis'],Psoriatic Arthritis,UCB Biopharma SRL,[],"['Bulgaria', 'Japan', 'Hungary', 'United States', 'Germany', 'Spain', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT07266363,Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma,SYNERGY Study: Early Detection Through Integrated Evaluation of Cell-Free and Exosomal microRNAs for Biomarker-Guided Screening of Esophageal Squamous Cell Carcinoma,RECRUITING,2025-01-15,2026-06-18,2026-06-18,OBSERVATIONAL,,600,['ESCC'],ESCC,City of Hope Medical Center,[],['United States']
NCT02724371,A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction,A Study of the Safety and Effectiveness of the Mentor Smooth and Textured Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction,ACTIVE_NOT_RECRUITING,2016-04-01,2029-01-31,2029-01-31,INTERVENTIONAL,NA,400,"['Breast Reconstruction, Revision Breast Reconstruction']","Breast Reconstruction, Revision Breast Reconstruction","Mentor Worldwide, LLC",[],['United States']
NCT07117630,"An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy","An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy",RECRUITING,2025-09-25,2026-08,2027-08,INTERVENTIONAL,PHASE2,20,['Breast Cancer'],Breast Cancer,Fudan University,[],['China']
NCT04459507,"A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan","Registry of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan",ACTIVE_NOT_RECRUITING,2021-03-22,2025-12-29,2025-12-29,OBSERVATIONAL,,276,['Palmoplantar Pustulosis'],Palmoplantar Pustulosis,Janssen Pharmaceutical K.K.,[],['Japan']
NCT07266805,Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency,"A Phase 3, Randomized, Double-blind, Placebo-controlled, 3-Part Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-release (XR) Tablet for Prophylaxis and Deucrictibant Immediate-release (IR) Capsule for On-demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency",RECRUITING,2025-10-16,2027-06,2027-06,INTERVENTIONAL,PHASE3,32,['Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)'],Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH),Pharvaris Netherlands B.V.,[],['United States']
NCT06807437,Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula,A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula,RECRUITING,2025-05-09,2027-11-01,2027-11-01,INTERVENTIONAL,PHASE3,274,"['Pancreatic Carcinoma', 'Pancreatic Neoplasm']",Pancreatic Carcinoma,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],['United States']
NCT06333899,Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion,"A Pilot Study of Lorlatinib for Treatment of Children With Newly Diagnosed High-Grade Glioma With ROS-1 (ROS Proto-Oncogene 1, Receptor Tyrosine Kinase) or ALK (Anaplastic Lymphoma Kinase) Fusion",ACTIVE_NOT_RECRUITING,2025-08-03,2029-07-01,2035-06-01,INTERVENTIONAL,EARLY_PHASE1,15,"['High Grade Glioma', 'Diffuse Intrinsic Pontine Glioma', 'Anaplastic Astrocytoma', 'Infant Type Hemispheric Glioma', 'Glioblastoma', 'Glioblastoma Multiforme', 'WHO Grade III Glioma', 'WHO Grade IV Glioma', 'Diffuse Midline Glioma, H3K27-altered']",High Grade Glioma,Nationwide Children's Hospital,['Pfizer'],"['New Zealand', 'Netherlands', 'United States', 'Canada', 'Australia', 'Germany']"
NCT04570943,Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer,Phase II Study to Assess the Interest of a Sequential Treatment With Gemcitabine/Nab-paclitaxel (GEMBRAX) and Then FOLFIRINOX Followed by Stereotactic Magnetic Resonance-guided Adaptive Radiotherapy in Patients With Locally Advanced Pancreatic Cancer,RECRUITING,2021-06-16,2028-01,2030-06,INTERVENTIONAL,PHASE2,103,['Locally Advanced Pancreatic Adenocarcinoma'],Locally Advanced Pancreatic Adenocarcinoma,Institut du Cancer de Montpellier - Val d'Aurelle,[],['France']
NCT06018064,Investigating Fit and Satisfaction of the Prone Positioner,Investigating the Fit and Satisfaction of an Innovative Device - Prone to Excellence: A Tummy Time Device Prone Positioner for Infants With Medical Complexities Including Artificial Airways: A Design Pilot Study,RECRUITING,2023-09-21,2027-09,2028-09,INTERVENTIONAL,NA,30,['Infant Development'],Infant Development,Children's Mercy Hospital Kansas City,[],['United States']
NCT06889792,Prevent Non-communicable Diseases Through Screening and Educating Emergency Department Attendees to Adopt Healthy Lifestyles,A Proactive Approach to Prevent Non-communicable Diseases Through Screening and Educating Emergency Department Attendees to Adopt Healthy Lifestyles: A Randomised Clinical Trial,RECRUITING,2025-06-10,2027-06-30,2028-01-31,INTERVENTIONAL,NA,1172,"['Non Communicable Diseases', 'Health-risk Behaviours']",Non Communicable Diseases,Chinese University of Hong Kong,[],['Hong Kong']
NCT05245006,PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer,"A First-in-Human, Pilot PET Imaging Study of 89Zr-DFO-YS5, an immunoPET Agent for Detecting CD46 Positive Malignancy in Men With Prostate Cancer",ACTIVE_NOT_RECRUITING,2022-03-18,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE1,30,"['Prostate Cancer', 'Metastatic Castration-resistant Prostate Cancer']",Prostate Cancer,"Robert Flavell, MD, PhD","['United States Department of Defense', 'Fortis Therapeutics, Inc.']",['United States']
NCT06689111,Correlation of Typical LBBB Mechanical Activation Pattern by 2D Strain Echocardiography With Acute GWE Improvement in Patients Receiving LBBp or Conventional BiVp for Cardiac Resynchronization Therapy (Echo LBBp),"Investigation of Whether the Presence of the Typical LBBB- Mechanical Stimulation Pattern - Documented Through 2DSE (Two-dimensional Strain Echocardiography) - is Associated With Increased Rates of Acute Improvement in Global Myocardial Work Efficiency (GWE) Compared to the Absence of This Activation Pattern, in Patients in Need of Device Implantation for Cardiac Resynchronization Therapy in Whom LBBp is Chosen Compared to the Classic Biventricular Pacing Method",RECRUITING,2024-05-23,2026-09-30,2026-11-30,INTERVENTIONAL,NA,100,['Heart Failure With Reduced Ejection Fraction (HFrEF)'],Heart Failure With Reduced Ejection Fraction (HFrEF),University Hospital of Patras,"['University General Hospital of Heraklion', 'Ippokrateio General Hospital of Thessaloniki', 'Onassis Cardiac Surgery Centre', 'Alexandra Hospital, Athens, Greece', 'Korgialenio-Benakio Red Cross Hospital', 'Ippokration General Hospital']",['Greece']
NCT07188987,Prilocaine for Sphenopalatine Ganglion Block in Endoscopic Hypophysectomy,"Bilateral Sphenopalatine Ganglion Block Using Prilocaine Versus Lidocaine as Adjuvants to General Anesthesia During Endoscopic Hypophysectomy, Randomized Trial.",RECRUITING,2025-12-01,2026-02,2026-02,INTERVENTIONAL,NA,54,['Blood Pressure Control'],Blood Pressure Control,Kasr El Aini Hospital,[],['Egypt']
NCT03229863,"An Examination of Infants' Microbiome, Nutrition, and Development Study.","The Infant MiND Study: An Examination of Infants' Microbiome, Nutrition, and Development Study.",ACTIVE_NOT_RECRUITING,2017-04-18,2020-03-10,2027-03-10,INTERVENTIONAL,NA,102,"['Microbial Colonization', 'Infant Development']",Microbial Colonization,"University of California, Davis","['UC Davis Foods for Health Institute', 'Mengniu Dairy']",['United States']
NCT04256317,A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study),"A Multi-phase, Pharmacokinetics, Safety, and Efficacy Study of ASTX030 (Azacitidine and Cedazuridine) as Monotherapy in Subjects With Myeloid Neoplasm or in Combination With Venetoclax in Subjects With AML (AZTOUND Study)",RECRUITING,2020-05-21,2027-05-01,2028-05-01,INTERVENTIONAL,PHASE2,236,"['Myelodysplastic Syndromes', 'Acute Myeloid Leukemia', 'Myelodysplastic Syndrome/Neoplasm', 'Chronic Myelomonocytic Leukemia']",Myelodysplastic Syndromes,"Taiho Oncology, Inc.",[],"['Hungary', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT06421948,Linperlisib Combined With Chidamide in Patients With PTCL,"PI3Kδ Inhibitor Linperlisib Combined With HDAC Inhibitor Chidamide Versus CHOP in Patients With Peripheral T-cell Lymphoma: a Multicenter, Open Label, Phase Ib/II Study",RECRUITING,2024-05-25,2027-05-31,2027-12-31,INTERVENTIONAL,PHASE1,134,['Peripheral T-cell Lymphoma'],Peripheral T-cell Lymphoma,Yanyan Liu,[],['China']
NCT06025578,"A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis","A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis",RECRUITING,2023-10-25,2027-12-27,2027-12-27,INTERVENTIONAL,PHASE3,1092,['Progressive Pulmonary Fibrosis'],Progressive Pulmonary Fibrosis,Bristol-Myers Squibb,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07227376,Data Collection Using Eko Digital Devices in a Clinical Setting,Data Collection Using Eko Digital Devices in a Clinical Setting,RECRUITING,2025-09-14,2026-04-01,2026-07-01,OBSERVATIONAL,,250,['Lung Diseases'],Lung Diseases,"Eko Devices, Inc.",[],['United States']
NCT04372108,A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis,An Observational Study to Assess the Long-term Safety of Ustekinumab Versus Other Biologic Therapies Among Patients With Crohn's Disease and Ulcerative Colitis: A New-User Cohort Study Using the Department of Defense Electronic Health Records Database,RECRUITING,2021-06-24,2029-08-31,2030-08-30,OBSERVATIONAL,,1056,"['Crohn Disease', 'Colitis, Ulcerative']",Crohn Disease,"Janssen Scientific Affairs, LLC",[],['United States']
NCT06735833,MMA Embolization for Refractory Chronic Migraine,Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine,RECRUITING,2025-04-23,2028-12-25,2028-12-29,INTERVENTIONAL,NA,50,['Migraine'],Migraine,"Cerenovus, Part of DePuy Synthes Products, Inc.",[],['United States']
NCT04975152,Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma,Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma: Safety and Biomarker Analysis,ACTIVE_NOT_RECRUITING,2021-10-22,2028-03,2028-03,INTERVENTIONAL,PHASE1,36,"['Merkel Cell Carcinoma', 'Cutaneous Squamous Cell Carcinoma']",Merkel Cell Carcinoma,H. Lee Moffitt Cancer Center and Research Institute,"['Regeneron Pharmaceuticals', 'Sanofi-Synthelabo']",['United States']
NCT05092269,A Long-term Extension Study of Ustekinumab in Pediatric Participants,"A Phase 3, Multicenter, Open-label, Basket, Long-term Extension Study of Ustekinumab in Pediatric Clinical Study Participants (2 to <18 Years of Age)",RECRUITING,2021-10-18,2027-09-29,2027-09-29,INTERVENTIONAL,PHASE3,151,"['Crohn Disease', 'Colitis, Ulcerative', 'Arthritis, Psoriatic']",Crohn Disease,"Janssen Research & Development, LLC",[],"['Belgium', 'Israel', 'Japan', 'Hungary', 'Turkey (Türkiye)', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT04125095,Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images,Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images,ACTIVE_NOT_RECRUITING,2020-01-28,2027-10-31,2027-10-31,OBSERVATIONAL,,367,['Pediatric Cancer'],Pediatric Cancer,St. Jude Children's Research Hospital,[],['United States']
NCT05843253,"Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant","Phase 2 Study of Ribociclib-Containing Post-Radiotherapy Combinations in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma, Including Diffuse Intrinsic Pontine Glioma: Ribociclib and Everolimus for HGG/DIPG Which Harbor Alterations of the Cell Cycle and/or PI3K/mTOR Pathways AND Ribociclib and Temozolomide for DHG, H3G34-mutant",RECRUITING,2024-08-22,2029-08-31,2034-08-28,INTERVENTIONAL,PHASE2,120,"['High Grade Glioma', 'Diffuse Intrinsic Pontine Glioma', 'Anaplastic Astrocytoma', 'Glioblastoma', 'Glioblastoma Multiforme', 'Diffuse Midline Glioma, H3 K27M-Mutant', 'Metastatic Brain Tumor', 'WHO Grade III Glioma', 'WHO Grade IV Glioma', 'Diffuse Hemispheric Glioma, H3 G34-Mutant']",High Grade Glioma,Nationwide Children's Hospital,['Novartis'],"['New Zealand', 'Netherlands', 'United States', 'Canada', 'Australia', 'United Kingdom', 'Germany']"
NCT04606381,A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies,"An Open-label, Multicenter, Dose Escalation Phase 1b Study to Assess the Safety and Pharmacokinetics of Subcutaneous Delivery of Amivantamab, a Human Bispecific EGFR and cMet Antibody for the Treatment of Advanced Solid Malignancies",ACTIVE_NOT_RECRUITING,2020-11-10,2024-07-11,2026-12-31,INTERVENTIONAL,PHASE1,158,['Advanced Solid Malignancies'],Advanced Solid Malignancies,"Janssen Research & Development, LLC",[],"['United Kingdom', 'United States', 'South Korea', 'Canada']"
NCT03393884,Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2),"A Phase I/II Study Evaluating the Dosing, Safety, Efficacy, and Biological Activity of Intraperitoneal IMNN-001 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered in Combination With Neoadjuvant Chemotherapy (NACT) in Patients Newly Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer",ACTIVE_NOT_RECRUITING,2018-09-05,2024-07-25,2025-11-30,INTERVENTIONAL,PHASE1,130,"['Epithelial Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer']",Epithelial Ovarian Cancer,Imunon,[],"['United States', 'Canada']"
NCT06731478,"Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer","A Multicenter, Randomized, Open-Label, Phase 3 Trial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab Versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab as First-Line Treatment in Participants With Unresectable, Locally Advanced or Metastatic HER2-Positive Gastric Or Gastroesophageal Junction (GEJ) Cancer (Destiny-Gastric05)",RECRUITING,2025-02-27,2028-06-01,2030-02-01,INTERVENTIONAL,PHASE3,726,"['Gastric Cancer', 'Gastroesophageal Junction Cancer']",Gastric Cancer,Daiichi Sankyo,['Merck Sharp & Dohme LLC'],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'Chile', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Vietnam', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06915155,Swing-Mesh™ Study (SMS).,"Safety and Efficacy of the Swing-Mesh™ Implant (THT BioScience™, B. Braun™, France) in Laparoscopic-endoscopic Inguinal Hernia Repair - a Multicenter, Cohort, Prospective Observational Study.",ACTIVE_NOT_RECRUITING,2025-04-07,2025-08-30,2026-08-30,OBSERVATIONAL,,300,['Inguinal Hernia'],Inguinal Hernia,Swissmed Hospital,[],['Poland']
NCT06661915,A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs),A Randomized Phase 2 Trial of ASTX727 +/- Iadademstat in Accelerated/Blast-Phase Philadelphia Chromosome-Negative Myeloproliferative Neoplasms (MPNs),RECRUITING,2025-08-14,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE2,62,"['Accelerated Phase Myeloproliferative Neoplasm', 'Blast Phase Myeloproliferative Neoplasm', 'Essential Thrombocythemia', 'Myelodysplastic/Myeloproliferative Neoplasm', 'Myeloproliferative Neoplasm, Not Otherwise Specified', 'Polycythemia Vera', 'Primary Myelofibrosis', 'Secondary Myelofibrosis']",Accelerated Phase Myeloproliferative Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT04827862,RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy,RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy,ACTIVE_NOT_RECRUITING,2022-07-01,2026-06-01,2026-11,INTERVENTIONAL,PHASE2,6,['Non Hodgkin Lymphoma'],Non Hodgkin Lymphoma,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT02521103,Triathlon Tritanium Cone Augments Outcomes Study,"A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon TS Total Knee System With Triathlon Tritanium Cone Augments",ACTIVE_NOT_RECRUITING,2015-08,2025-03-31,2028-03-31,INTERVENTIONAL,NA,145,"['Arthroplasty', 'Replacement', 'Knee']",Arthroplasty,Stryker Orthopaedics,[],['United States']
NCT06730061,A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC),"A Phase III, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Elafibranor 80 mg in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)",RECRUITING,2025-01-16,2026-03-19,2032-04-08,INTERVENTIONAL,PHASE3,18,['Primary Biliary Cholangitis'],Primary Biliary Cholangitis,Ipsen,[],['Japan']
NCT04082429,Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors,Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B Without Inhibitors,ACTIVE_NOT_RECRUITING,2019-11-13,2022-07-12,2028-02-21,INTERVENTIONAL,PHASE3,156,"['Haemophilia A Without Inhibitors', 'Haemophilia B Without Inhibitors']",Haemophilia A Without Inhibitors,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'Slovakia', 'Bosnia and Herzegovina', 'Lithuania', 'Australia', 'Israel', 'Hungary', 'Estonia', 'Russia', 'France', 'Croatia', 'Denmark', 'South Korea', 'Algeria', 'Thailand', 'Poland', 'India', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Serbia']"
NCT07268222,Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS),Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS),RECRUITING,2025-12-01,2026-11-01,2027-11-25,INTERVENTIONAL,PHASE4,150,['Mild Autonomous Cortisol Secretion (MACS)'],Mild Autonomous Cortisol Secretion (MACS),"Laikο General Hospital, Athens",[],['Greece']
NCT05057403,UK Imaging Diabetes Study Seeing Diabetes Clearly,UK Imaging Diabetes Study Seeing Diabetes Clearly,RECRUITING,2022-05-30,2034-06,2034-06,OBSERVATIONAL,,1000,['Type2 Diabetes'],Type2 Diabetes,Perspectum,['Moorfields Eye Hospital NHS Foundation Trust'],['United Kingdom']
NCT06378996,Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring,Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm - A Pilot Study,RECRUITING,2024-05-01,2026-03,2026-03,INTERVENTIONAL,NA,60,"['Mitral Valve Prolapse', 'Ventricular Arrythmia']",Mitral Valve Prolapse,Universitaire Ziekenhuizen KU Leuven,[],['Belgium']
NCT07169318,"First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics","A First-in-Human, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VNT-101 Administered Orally to Healthy Adult Participants",RECRUITING,2025-09-16,2026-04-01,2026-04-01,INTERVENTIONAL,PHASE1,78,['Influenza'],Influenza,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06116786,A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer,"A Phase 1 Study of JNJ-86974680, an A2a Receptor Antagonist, Administered as Monotherapy and in Combination With Cetrelimab and Radiotherapy for Advanced Non-small Cell Lung Cancer",RECRUITING,2023-11-27,2027-04-14,2029-06-07,INTERVENTIONAL,PHASE1,126,"['Carcinoma, Non-small-Cell Lung']","Carcinoma, Non-small-Cell Lung",Johnson & Johnson Enterprise Innovation Inc.,[],"['Spain', 'United States', 'South Korea', 'Germany']"
NCT05455320,A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment,"A Phase 3 Randomized Study Comparing Talquetamab SC in Combination With Daratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination With Daratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone (DPd), in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy",ACTIVE_NOT_RECRUITING,2022-10-13,2026-02-06,2029-06-30,INTERVENTIONAL,PHASE3,864,['Relapsed or Refractory Multiple Myeloma'],Relapsed or Refractory Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Turkey (Türkiye)', 'Netherlands', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Czechia', 'United Kingdom', 'Greece', 'Poland', 'Germany']"
NCT03620903,Efficacy of First Line B-RI for Treatment Naive Waldenström's Macroglobulinemia,"Efficacy of First Line Bortezomib, Rituximab, Ibrutinib (B-RI) for Patients With Treatment Naive Waldenström's Macroglobulinemia",ACTIVE_NOT_RECRUITING,2019-09-11,2022-11-14,2027-02,INTERVENTIONAL,PHASE2,53,['Waldenstrom Macroglobulinemia'],Waldenstrom Macroglobulinemia,Christian Buske,"['University of Ulm', 'ClinAssess GmbH', 'Zentrum für Klinische Studien Ulm', 'Hoffmann-La Roche', 'Johnson & Johnson']","['Greece', 'Germany']"
NCT00684580,Protocol For Collecting Data On Patients With Childhood Cancer,Protocol For Collecting Data On Patients With Childhood Cancer,RECRUITING,2000-06-08,2045-05,2045-05,OBSERVATIONAL,,30000,['Childhood Cancer'],Childhood Cancer,St. Jude Children's Research Hospital,[],['United States']
NCT06634303,Hybernia Medical Post-Mechanical Thrombectomy Cerebral Cooling in Stroke,Hybernia Delta H (ΔH) Brain Cooling System for: Post-Mechanical Endovascular Cerebral Cooling,ACTIVE_NOT_RECRUITING,2025-06-01,2025-12,2025-12,INTERVENTIONAL,NA,10,['Acute Ischemic Stroke'],Acute Ischemic Stroke,Hybernia Medical,"[""Hospital Universitari Vall d'Hebron Research Institute""]",['Spain']
NCT07268261,Combined Method of Surgical Treatment of Anal Fissure,Combined Method of Surgical Treatment of Anal Fissure,RECRUITING,2023-09-01,2025-12-01,2026-09-01,INTERVENTIONAL,NA,122,['Chronic Anal Fissure'],Chronic Anal Fissure,"State Scientific Centre of Coloproctology, Russian Federation",[],['Russia']
NCT05072483,Natural History Study of CADASIL,Natural History Study of CADASIL,RECRUITING,2022-04-18,2034-06-01,2041-06-01,OBSERVATIONAL,,155,"['Cardiovascular Disease', 'Arterial Stiffness', 'Germline Mutation in the NOTCH 3 Gene', 'Pathogenesis of CADASIL', 'Clinical Phenotype of CADASIL']",Cardiovascular Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06750094,A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy,"A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Recurrent, Unresectable or Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy",RECRUITING,2024-12-12,2027-12-15,2029-04-13,INTERVENTIONAL,PHASE3,700,['Colorectal Neoplasms'],Colorectal Neoplasms,"Janssen Research & Development, LLC",[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'South Korea', 'Thailand', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Romania', 'Malaysia', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT06828848,"A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections","An Open-label, Multicentre, Single-Arm Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VaboremⓇ (Meropenem-Vaborbactam) in Paediatric Population With Suspected or Confirmed Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections",RECRUITING,2025-02-18,2026-07,2026-07,INTERVENTIONAL,PHASE2,44,['Gram Negative Infections'],Gram Negative Infections,Menarini Group,[],"['France', 'Spain', 'Italy', 'Czechia', 'Poland']"
NCT06745921,Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults,"A Phase 1 Trial to Evaluate the Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine, HydroVax-001B WNV in Healthy Adults",ACTIVE_NOT_RECRUITING,2025-02-24,2026-10-01,2027-11-01,INTERVENTIONAL,PHASE1,30,['West Nile Viral Infection'],West Nile Viral Infection,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07255365,Virtual Reality-Based 360° Clinic Walkthrough for Reducing Examination Anxiety in Preschool Children,VIRTUAL REALITY-BASED 360° CLINIC WALKTHROUGH: EFFECTS ON EXAMINATION ANXIETY AND PHYSICIAN EXAMINATION EASE IN CHILDREN,RECRUITING,2025-11-20,2025-12-20,2025-12-31,INTERVENTIONAL,NA,100,"['Anxiety', 'Stress, Psychological', 'Fear']",Anxiety,Berker Okay,[],['Turkey (Türkiye)']
NCT07091175,Dupilumab Therapy in Nephrotic Syndrome in Children,Singapore-Malaysian Renal Trials - Nephrotic Syndrome (SMART-NS): Dupilumab Maintenance Therapy for Steroid-dependent and Frequently Relapsing Nephrotic Syndrome,RECRUITING,2025-11-27,2028-02-28,2028-02-28,INTERVENTIONAL,PHASE2,66,"['Nephrotic Syndrome in Children', 'Nephrotic Syndrome Steroid-Dependent']",Nephrotic Syndrome in Children,"National University Hospital, Singapore","['National Medical Research Council (NMRC), Singapore', ""KK Women's and Children's Hospital"", 'National University of Singapore']",['Singapore']
NCT06959225,Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1),"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa",RECRUITING,2025-06-23,2026-10-09,2027-07-11,INTERVENTIONAL,PHASE3,400,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,Incyte Corporation,[],"['Bulgaria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT07265986,Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital,Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the Guadeloupe Archipelago Between the University Hospital of Guadeloupe and the Marie-Galante Hospital,RECRUITING,2025-11-30,2026-09-08,2026-09-08,INTERVENTIONAL,NA,50,"['Heart Failure', 'Remote Consultation, Teleconsultation', 'Echocardiography, Doppler']",Heart Failure,Centre Hospitalier Universitaire de la Guadeloupe,['GIRCI SOHO'],['Guadeloupe']
NCT06561685,A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors,"An Open-label, Multicenter Study of LY4050784, a Selective SMARCA2/BRM Inhibitor, in Advanced Solid Tumor Malignancies With SMARCA4/BRG1 Alterations",RECRUITING,2024-09-19,2027-10,2027-10,INTERVENTIONAL,PHASE1,340,"['Metastatic Solid Tumor', 'Advanced Solid Tumor', 'Non-small Cell Lung Cancer', 'SMARCA4-Deficient Tumor']",Metastatic Solid Tumor,Eli Lilly and Company,[],"['Japan', 'Spain', 'United States']"
NCT06522659,Evaluation of Clinical and Radiographic Outcomes of Surgically Treated Multiligamentous Knee Injuries,Evaluation of Clinical and Radiographic Outcomes of Surgically Treated Multiligamentous Knee Injuries,RECRUITING,2021-03-31,2025-12,2025-12,OBSERVATIONAL,,140,"['Knee Ligament Injury', 'PCL - Posterior Cruciate Ligament Rupture', 'PROMs']",Knee Ligament Injury,Istituto Ortopedico Rizzoli,[],['Italy']
NCT06649227,Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19,Prospective Non-randomized Phase I Study Investigating the Safety of CD19 CAR-T Cells in Patients With Refractory/Relapsed AML Expressing CD19.,RECRUITING,2025-07-10,2029-07-10,2030-07-10,INTERVENTIONAL,PHASE1,5,['Relapsed Adult AML'],Relapsed Adult AML,"University Hospital, Lille","['Ministry of Health, France', 'University Hospital, Rouen', 'Miltenyi']",['France']
NCT04340843,Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma,A Phase 2 Study of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma,ACTIVE_NOT_RECRUITING,2020-09-08,2024-02-22,2026-06-17,INTERVENTIONAL,PHASE2,19,"['Locally Advanced Unresectable Primary Central Chondrosarcoma', 'Metastatic Primary Central Chondrosarcoma', 'Unresectable Primary Central Chondrosarcoma']",Locally Advanced Unresectable Primary Central Chondrosarcoma,National Cancer Institute (NCI),[],['United States']
NCT06686485,cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia,cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia,RECRUITING,2025-03-18,2026-10-31,2029-10-31,OBSERVATIONAL,,433,"['Concomitant Procedures', 'Atrial Fibrillation', 'PFA', 'LAAC']",Concomitant Procedures,Boston Scientific Corporation,[],"['Singapore', 'Japan', 'Hong Kong', 'China', 'Taiwan', 'Malaysia']"
NCT04884035,Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma,"A Phase 1b, Open Label, Global, Multicenter, Dose Determination, Randomized Dose Expansion Study to Determine the Maximum Tolerated Dose, Assess the Safety and Tolerability, Pharmacokinetics and Preliminary Efficacy of Iberdomide (CC-220) in Combination With R-CHOP-21 and CC-99282 in Combination With R-CHOP-21 for Subjects With Previously Untreated Aggressive B-cell Lymphoma",RECRUITING,2021-09-15,2028-12-01,2028-12-01,INTERVENTIONAL,PHASE1,174,"['Lymphoma, B-Cell']","Lymphoma, B-Cell",Celgene,[],"['United States', 'Spain', 'Taiwan', 'South Korea', 'Greece', 'Poland', 'Australia']"
NCT06700343,Comparison Between ABP 692 and Ocrevus® (Ocrelizumab),"A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety Between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects With Relapsing-remitting Multiple Sclerosis",RECRUITING,2025-01-13,2027-01-15,2027-12-17,INTERVENTIONAL,PHASE3,444,['Relapsing-remitting Multiple Sclerosis (RRMS)'],Relapsing-remitting Multiple Sclerosis (RRMS),Amgen,[],"['Bulgaria', 'Slovakia', 'Lithuania', 'Belgium', 'France', 'Croatia', 'Denmark', 'Czechia', 'Poland', 'Georgia', 'Switzerland', 'Spain', 'Canada', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Serbia']"
NCT02627443,"Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","Phase 1 Dose Escalation and Expansion Cohort of Carboplatin and Gemcitabine With or Without M6620 (VX-970) in First or Second Recurrence Platinum-Sensitive Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer",ACTIVE_NOT_RECRUITING,2017-05-16,2024-10-04,2026-06-03,INTERVENTIONAL,PHASE1,35,"['Metastatic Fallopian Tube Carcinoma', 'Metastatic Ovarian Carcinoma', 'Metastatic Primary Peritoneal Carcinoma', 'Ovarian Endometrioid Tumor', 'Ovarian High Grade Serous Adenocarcinoma', 'Platinum-Sensitive Ovarian Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Stage IV Fallopian Tube Cancer AJCC v6 and v7', 'Stage IV Ovarian Cancer AJCC v6 and v7', 'Stage IV Primary Peritoneal Cancer AJCC v7']",Metastatic Fallopian Tube Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT07007013,Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study,Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study,ACTIVE_NOT_RECRUITING,2025-09-01,2025-11-19,2026-05-01,INTERVENTIONAL,NA,28,['Medically Unexplained Symptoms'],Medically Unexplained Symptoms,Consorci Sanitari de l'Alt Penedès i Garraf,[],['Spain']
NCT06608485,A Study of HARMONIC 700 Shears With Advanced Hemostasis in Pediatric and Adult Surgical Procedures,"A Prospective, Single-Arm Multi-Center Study of the HARMONIC™ 700, 5 mm Diameter Shears With Advanced Hemostasis in Pediatric Surgical Procedures (General) and Adult Surgical Procedures (General, Gynecological, Urological, and Thoracic)",RECRUITING,2025-01-23,2026-05-15,2026-08-15,OBSERVATIONAL,,165,"['Pediatric Surgical Procedures', 'Adult Surgical Procedures', 'Adult Gynecological Procedures', 'Adult Urological Procedures', 'Adult Thoracic Procedures']",Pediatric Surgical Procedures,Ethicon Endo-Surgery,[],"['United Kingdom', 'United States', 'Canada']"
NCT07046949,Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies,A Randomized Controlled Double-blinded Trial Evaluating the Efficacy of the Anterior Quadratus Lumborum Block as a Component of Multimodal Perioperative Analgesia for Abdominal Hysterectomies,RECRUITING,2025-07-07,2025-12,2025-12,INTERVENTIONAL,NA,56,"['Uterine Bleeding', 'Uterine Neoplasms', 'Uterine Diseases', 'Uterine Fibroids']",Uterine Bleeding,Yuri Semenyuk Rivne Regional Clinical Hospital,['Danylo Halytsky Lviv National Medical University'],['Ukraine']
NCT06447168,A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment,"Prospective Non-interventional, Phase IV Multicentre Study to Assess the Effectiveness, Safety and Tolerability of Elafibranor 80 mg/Day in Participants With Primary Biliary Cholangitis Receiving Treatment in a Real-world Setting.",RECRUITING,2024-10-14,2032-07-15,2032-07-15,OBSERVATIONAL,,424,['Primary Biliary Cholangitis'],Primary Biliary Cholangitis,Ipsen,[],"['Austria', 'United States', 'Italy', 'Canada', 'United Arab Emirates', 'United Kingdom', 'Greece', 'Germany']"
NCT06817525,Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC,"Nab-P+Cb+PD1 Inhibitor Neoadjuvant Therapy for Early TNBC: a Single Center, Non Blinded, Randomized Phase II Clinical Trial",RECRUITING,2024-11-06,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE2,64,['Triple-negative Breast Cancer'],Triple-negative Breast Cancer,Henan Cancer Hospital,[],['China']
NCT06185179,Metformin and Muscle Recovery,Use of Metformin to Improve Muscle Regrowth in Older Adults,RECRUITING,2024-09-01,2029-05-31,2030-05-31,INTERVENTIONAL,EARLY_PHASE1,50,['Muscle Atrophy or Weakness'],Muscle Atrophy or Weakness,University of Utah,[],['United States']
NCT04166825,Ovarian Hyperstimulation and Fibrin Clot Properties.,The Impact of Different Ovarian Hyperstimulation Protocols on Coagulation and Fibrinolysis.,RECRUITING,2019-11-18,2026-01,2026-01,INTERVENTIONAL,NA,300,"['Fibrin Blood Clot', 'Infertility, Female', 'Endometriosis']",Fibrin Blood Clot,Jagiellonian University,[],['Poland']
NCT07008118,A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms,"A Phase 1, Open-Label, Multicenter Study of INCA035784 in Participants With Myeloproliferative Neoplasms",RECRUITING,2025-10-01,2028-03-14,2029-12-14,INTERVENTIONAL,PHASE1,120,['Myeloproliferative Neoplasms'],Myeloproliferative Neoplasms,Incyte Corporation,[],"['United States', 'Australia']"
NCT06676527,Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma,An Observational Study of the Efficacy and Safety of Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma,RECRUITING,2024-09-01,2026-09-01,2026-09-01,OBSERVATIONAL,,39,"['Neoplasms', 'Kidney Neoplasms', 'Urologic Neoplasms', 'Urogenital Neoplasms', 'Female Urogenital Diseases', 'Male Urogenital Diseases', 'Urogenital Diseases', 'Kidney Diseases', 'Urologic Diseases', 'Carcinoma', 'Renal Cell Cancer', 'Carcinoma, Renal Cell', 'Antineoplastic Agents']",Neoplasms,"Jinling Hospital, China",[],['China']
NCT04468061,Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC,Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC),RECRUITING,2020-07-20,2026-04-01,2029-04-01,INTERVENTIONAL,PHASE2,110,"['Breast Cancer', 'Triple Negative Breast Cancer', 'PD-L1 Negative']",Breast Cancer,Dana-Farber Cancer Institute,"['Gilead Sciences', 'Merck Sharp & Dohme LLC']",['United States']
NCT05652335,A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis,"Phase 1, First-in-Human, Dose Escalation Study of JNJ-79635322, a Trispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated AL Amyloidosis",RECRUITING,2022-11-22,2027-04-19,2027-04-19,INTERVENTIONAL,PHASE1,180,"['Relapsed or Refractory Multiple Myeloma', 'Previously Treated Amyloid Light-chain (AL) Amyloidosis']",Relapsed or Refractory Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Spain', 'United Kingdom']"
NCT01503086,Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy,Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study,ACTIVE_NOT_RECRUITING,2014-07-30,2024-12-31,2026-03-31,INTERVENTIONAL,NA,45,"['Brain Neoplasm', 'Recurrent Brain Neoplasm']",Brain Neoplasm,Children's Oncology Group,['National Cancer Institute (NCI)'],"['United States', 'Canada']"
NCT07019883,A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults,A Phase 1 Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Antigenically Central (AC)-Anhui mRNA-LNP Vaccine in Healthy Adults,ACTIVE_NOT_RECRUITING,2025-06-12,2026-05-15,2026-05-15,INTERVENTIONAL,PHASE1,80,['Avian Influenza'],Avian Influenza,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06430866,Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab),"A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Participants With Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy",RECRUITING,2024-09-12,2026-12-14,2026-12-14,INTERVENTIONAL,PHASE3,154,['Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)'],Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC),Amgen,[],"['Bulgaria', 'Turkey (Türkiye)', 'France', 'Georgia', 'Mexico', 'Chile', 'Serbia', 'Spain', 'Italy', 'Romania', 'Malaysia', 'South Korea', 'Taiwan', 'Poland', 'Philippines', 'Argentina', 'Thailand', 'Germany']"
NCT07268066,Implementation of the Methylome in the Characterization of Solid Tumors,Implementation of the Methylome in the Characterization of Solid Tumors,RECRUITING,2024-05-21,2026-12-31,2026-12-31,OBSERVATIONAL,,180,['Solid Tumor Cancer'],Solid Tumor Cancer,IRCCS Azienda Ospedaliero-Universitaria di Bologna,[],['Italy']
NCT06671496,A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines,"A Multi-Center, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Stratified by Prior Biologic Use (LATITUDE-PsA-3002)",RECRUITING,2025-03-10,2027-05-18,2028-01-26,INTERVENTIONAL,PHASE3,600,['Psoriatic Arthritis'],Psoriatic Arthritis,Takeda,[],"['Brazil', 'Japan', 'China', 'United States', 'France', 'Germany', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT07115446,Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer,"A Phase Ib Study to Explore the Safety, Tolerability, and Pharmacokinetics of HS-20093 Combination With HRS-5041 in Patients With Advanced Prostate Cancer",RECRUITING,2025-08-19,2027-12,2028-12,INTERVENTIONAL,PHASE1,63,['Advanced Prostate Cancer'],Advanced Prostate Cancer,Hansoh BioMedical R&D Company,[],['China']
NCT04885322,"Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands","Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands",RECRUITING,2021-04-14,2027-06-30,2027-06-30,INTERVENTIONAL,NA,75,['Healthy'],Healthy,"University of California, Davis",[],['United States']
NCT04078295,A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor,An Open-Label Phase 1b/2 Study of E7389 Liposomal Formulation Plus Nivolumab in Subjects With Solid Tumor,ACTIVE_NOT_RECRUITING,2019-09-05,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE1,125,['Solid Neoplasms'],Solid Neoplasms,"Eisai Co., Ltd.",['Ono Pharmaceutical Co. Ltd'],['Japan']
NCT06449209,"Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy","A Phase II, Multi-site, Open-label, Parallel Group Trial of BNT327 in Combination With Chemotherapy for Participants With Untreated Extensive-stage Small-cell Lung Cancer and Participants With Previously Treated Small-cell Lung Cancer",ACTIVE_NOT_RECRUITING,2024-08-05,2027-06,2028-05,INTERVENTIONAL,PHASE2,110,"['Extensive-stage Small-cell Lung Cancer', 'Small-cell Lung Cancer']",Extensive-stage Small-cell Lung Cancer,BioNTech SE,[],"['Turkey (Türkiye)', 'United States', 'South Korea', 'United Kingdom', 'Australia']"
NCT05421663,A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma,"A Phase 1b/2, Multicenter, Open-label, Study of JNJ-90014496, an Autologous CD19/CD20 Bi-specific CAR-T Cell Therapy in Adult Participants With B-cell Non-Hodgkin Lymphoma",RECRUITING,2022-08-12,2028-12-29,2028-12-29,INTERVENTIONAL,PHASE1,385,"['Lymphoma, Non-Hodgkin', 'Lymphoma, B-Cell', 'Lymphoma, Large B-Cell, Diffuse']","Lymphoma, Non-Hodgkin","Janssen Research & Development, LLC",[],"['Netherlands', 'United States', 'Denmark', 'Spain', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT07265557,Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients,A Pilot Randomized Controlled Trial Comparing Two Post-Operative Pain Protocols at Discharge for Orthopaedic Patients: A Pilot Study,RECRUITING,2025-10-06,2025-12-10,2026-01-21,INTERVENTIONAL,PHASE4,100,"['Orthopaedic Related Pain (Musculoskeletal Pain)', 'Opioid', 'Pain', 'Pilot Study']",Orthopaedic Related Pain (Musculoskeletal Pain),Massachusetts General Hospital,['McMaster University'],['United States']
NCT05188092,Lung Ultrasound-Guided Fluid Deresuscitation in ICU Patients,Effect of Lung Ultrasound-Guided Fluid Deresuscitation on Duration of Ventilation in Intensive Care Unit Patients (CONFIDENCE),RECRUITING,2021-12-22,2026-04-01,2026-06-01,INTERVENTIONAL,NA,1000,"['Mechanical Ventilation', 'Fluid Overload', 'Deresuscitation', 'Ventilator-free Days']",Mechanical Ventilation,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),['ZonMw: The Netherlands Organisation for Health Research and Development'],['Netherlands']
NCT06181136,Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A),"A Phase 1/2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)",ACTIVE_NOT_RECRUITING,2023-12-07,2028-08,2028-08,INTERVENTIONAL,PHASE1,20,['Mucopolysaccharidosis Type IIIA'],Mucopolysaccharidosis Type IIIA,Denali Therapeutics Inc.,[],['United States']
NCT03501368,Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma,Phase 1 Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma,ACTIVE_NOT_RECRUITING,2018-06-27,2022-10-28,2026-01,INTERVENTIONAL,PHASE1,27,"['Melanoma', 'Unresectable Melanoma', 'Advanced Melanoma']",Melanoma,H. Lee Moffitt Cancer Center and Research Institute,['Novartis Pharmaceuticals'],['United States']
NCT03257761,"Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer","A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder Cancer",ACTIVE_NOT_RECRUITING,2018-02-07,2021-09-27,2026-07-31,INTERVENTIONAL,PHASE1,55,"['Extrahepatic Bile Duct Adenocarcinoma, Biliary Type', 'Gallbladder Adenocarcinoma, Biliary Type', 'Metastatic Pancreatic Adenocarcinoma', 'Recurrent Cholangiocarcinoma', 'Recurrent Gallbladder Carcinoma', 'Recurrent Hepatocellular Carcinoma', 'Recurrent Intrahepatic Cholangiocarcinoma', 'Recurrent Pancreatic Carcinoma', 'Stage III Gallbladder Cancer AJCC V7', 'Stage III Hepatocellular Carcinoma AJCC v7', 'Stage III Intrahepatic Cholangiocarcinoma AJCC v7', 'Stage III Pancreatic Cancer AJCC v6 and v7', 'Stage IIIA Gallbladder Cancer AJCC v7', 'Stage IIIA Hepatocellular Carcinoma AJCC v7', 'Stage IIIB Gallbladder Cancer AJCC v7', 'Stage IIIB Hepatocellular Carcinoma AJCC v7', 'Stage IIIC Hepatocellular Carcinoma AJCC v7', 'Stage IV Gallbladder Cancer AJCC v7', 'Stage IV Hepatocellular Carcinoma AJCC v7', 'Stage IV Pancreatic Cancer AJCC v6 and v7', 'Stage IVA Gallbladder Cancer AJCC v7', 'Stage IVA Hepatocellular Carcinoma AJCC v7', 'Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7', 'Stage IVB Gallbladder Cancer AJCC v7', 'Stage IVB Hepatocellular Carcinoma AJCC v7', 'Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7', 'Unresectable Gallbladder Carcinoma', 'Unresectable Pancreatic Carcinoma']","Extrahepatic Bile Duct Adenocarcinoma, Biliary Type",University of Southern California,"['National Cancer Institute (NCI)', 'Van Andel Research Institute']",['United States']
NCT07018869,Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors,A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention Called Current Together After Cancer (CTAC) to Promote Guideline-Concordant Colorectal Cancer Surveillance,RECRUITING,2025-10-15,2029-05-23,2029-06-06,INTERVENTIONAL,PHASE3,1057,"['Colorectal Cancer Stage II', 'Colorectal Cancer Stage III']",Colorectal Cancer Stage II,SWOG Cancer Research Network,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT07266259,Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women,Effects of Levocarnitine and Myoinositol in Comparison to Myoinositol Alone on Hormonal and Insulin ResistanceParameters in Subfertile Women With Insulin Resistant Polycystic Ovary Syndrome,RECRUITING,2025-09-19,2026-08-18,2027-03-01,INTERVENTIONAL,NA,72,['Polycystic Ovary Syndrome (PCOS)'],Polycystic Ovary Syndrome (PCOS),Mst.Sumyara Khatun,[],['Bangladesh']
NCT01802346,Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer,"A Randomized, Phase II Clinical Trial of a Controlled Diet Prior to Selected Chemotherapy Treatment in Breast and Prostate Cancer to Evaluate the Impact on Toxicity and Efficacy",ACTIVE_NOT_RECRUITING,2013-01-29,2026-06-29,2027-06-29,INTERVENTIONAL,NA,130,"['Breast Cancer', 'Hormone-resistant Prostate Cancer', 'Recurrent Prostate Cancer']",Breast Cancer,University of Southern California,"['National Cancer Institute (NCI)', 'Mayo Clinic']",['United States']
NCT04140487,"Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm","A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation",RECRUITING,2019-12-17,2028-09-01,2028-09-01,INTERVENTIONAL,PHASE1,97,"['Recurrent Acute Myeloid Leukemia', 'Recurrent Chronic Myelomonocytic Leukemia', 'Recurrent Myelodysplastic/Myeloproliferative Neoplasm', 'Refractory Acute Myeloid Leukemia', 'Refractory Chronic Myelomonocytic Leukemia', 'Refractory Myelodysplastic/Myeloproliferative Neoplasm']",Recurrent Acute Myeloid Leukemia,M.D. Anderson Cancer Center,[],['United States']
NCT06760819,A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2),A Phase 2 Open-label Basket Study to Evaluate the Efficacy and Safety of Orally Administered Reversible Tyrosine Kinase Inhibitor BAY 2927088 in Participants With Metastatic or Unresectable Solid Tumors With HER2-activating Mutations,RECRUITING,2025-02-13,2027-02-03,2027-10-25,INTERVENTIONAL,PHASE2,111,"['Advanced Solid Tumors', 'HER2 Mutation']",Advanced Solid Tumors,Bayer,[],"['Japan', 'China', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia']"
NCT03086421,Social Emotional Development in Young Children With Cancer,Social Emotional Development in Young Children With Cancer,ACTIVE_NOT_RECRUITING,2017-07-11,2026-12,2028-06,OBSERVATIONAL,,119,"['Solid Tumor, Childhood', 'Brain Tumor, Pediatric']","Solid Tumor, Childhood",St. Jude Children's Research Hospital,"['American Cancer Society, Inc.']",['United States']
NCT07151859,Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration,"A Pre-market, Two-stages, Monocentric, Interventional, Single-arm, Clinical Investigation to Evaluate the Safety and the Performance of PN30 (RDM16) for the Improvement of Skin Hydration",RECRUITING,2025-09-18,2026-12-31,2026-12-31,INTERVENTIONAL,NA,43,"['Aesthetic Improvement of the Skin', 'Skin Hydration in Healthy Volunteers', 'Skin Elasticity', 'Skin Turgor', 'Subject Satisfaction']",Aesthetic Improvement of the Skin,Mastelli S.r.l,['1Med'],['Italy']
NCT02839850,14022 ATTUNE Cementless RP Clinical Performance Evaluation,Multi-Center Clinical Evaluation of the ATTUNE Cementless Rotating Platform Total Knee Arthroplasty,ACTIVE_NOT_RECRUITING,2016-09-01,2027-09-01,2027-09-01,INTERVENTIONAL,NA,540,['Osteoarthritis'],Osteoarthritis,DePuy Orthopaedics,[],"['New Zealand', 'Netherlands', 'Austria', 'United States', 'France', 'Ireland', 'Canada', 'United Kingdom', 'Germany']"
NCT07266493,Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma,"A Single-arm, Open-label, Single-center Prospective Study of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma",RECRUITING,2023-12-01,2026-06-01,2026-12-01,INTERVENTIONAL,PHASE2,26,"['Esophageal Squamous Cell Carcinoma', 'Neoadjuvant Therapy']",Esophageal Squamous Cell Carcinoma,Shanghai Zhongshan Hospital,"['Jiangsu Simcere Pharmaceutical Co., Ltd.']",['China']
NCT03206060,Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma,Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma,RECRUITING,2017-10-10,2026-01-01,2027-01-01,INTERVENTIONAL,PHASE2,130,"['Pheochromocytoma', 'Paraganglioma', 'Neuroendocrine Tumors', 'Neuroendocrine Neoplasms']",Pheochromocytoma,National Cancer Institute (NCI),[],['United States']
NCT05574868,Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis (ERASE ED),Evaluation of the Rigicon Infla10® Three-Piece Inflatable Penile Prosthesis for the Treatment of Patients With Erectile Dysfunction,RECRUITING,2022-07-11,2026-05-21,2026-05-21,INTERVENTIONAL,NA,182,['Erectile Dysfunction'],Erectile Dysfunction,"Rigicon, Inc.",[],['Australia']
NCT06368518,Austrian Hypertrophic Cardiomyopathy Registry,Austrian Hypertrophic Cardiomyopathy Registry,RECRUITING,2024-03-08,2044-03,2044-03,OBSERVATIONAL,,1000,['Hypertrophic Cardiomyopathy'],Hypertrophic Cardiomyopathy,Medical University of Graz,[],['Austria']
NCT06425991,A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma,"A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants With Relapsed/Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2024-06-07,2027-02-28,2027-03-03,INTERVENTIONAL,PHASE1,108,['Relapsed or Refractory Multiple Myeloma'],Relapsed or Refractory Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Israel', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT05822089,Intraindividual Comparison of EMO IOLs,Comparison of Visual Outcomes of Enhanced Monofocal Intraocular Lenses,RECRUITING,2021-12-13,2026-12-31,2026-12-31,INTERVENTIONAL,NA,461,['Age Related Cataracts'],Age Related Cataracts,Medical University of Vienna,[],['Austria']
NCT07075640,"A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants","A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-Ascending Dose Safety, Tolerability, and Pharmacokinetic Study of AG-236 Administered as a Subcutaneous Dose in Healthy Male and Female Participants",RECRUITING,2025-07-07,2025-12-08,2026-01-13,INTERVENTIONAL,PHASE1,24,['Healthy Participants'],Healthy Participants,"Agios Pharmaceuticals, Inc.",[],['United States']
NCT05050097,A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma,A Multi-arm Phase 1b Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma,ACTIVE_NOT_RECRUITING,2021-09-22,2025-03-31,2027-04-07,INTERVENTIONAL,PHASE1,166,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Belgium', 'Netherlands', 'United States', 'France', 'United Kingdom', 'Australia']"
NCT06260891,Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial,Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial,RECRUITING,2025-12-01,2027-07-31,2027-12-31,INTERVENTIONAL,PHASE2,34,['Sickle Cell Disease'],Sickle Cell Disease,"University of California, San Francisco","[""Children's Hospital of Philadelphia"", 'University of Pennsylvania', ""Children's Hospital Medical Center, Cincinnati"", 'American Society of Hematology', 'Baylor College of Medicine', 'Thomas Jefferson University', 'Duke University']",['United States']
NCT04318938,Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping,Advancing Brigatinib Properties in Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer (ALK+ NSCLC) Patients,ACTIVE_NOT_RECRUITING,2020-03-30,2026-01-16,2026-01-16,INTERVENTIONAL,PHASE2,118,['NSCLC'],NSCLC,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,"['Thoraxklinik-Heidelberg gGmbH', 'Takeda']",['Germany']
NCT06208150,"A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide","A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants With Relapsed or Refractory Myeloma Who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide",RECRUITING,2024-01-22,2026-04-23,2028-03-31,INTERVENTIONAL,PHASE3,795,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06366789,"Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia","A Phase 1, Open-label, Dose Escalation and Dose Expansion, Multicenter Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)",RECRUITING,2024-05-29,2026-01,2027-12,INTERVENTIONAL,PHASE1,60,['AML With Gene Mutations'],AML With Gene Mutations,"Lomond Therapeutics Holdings, Inc.",[],['Australia']
NCT05375968,Splanchnic Venous Capacitance in Postural Tachycardia Syndrome,Mechanism of Glucose-dependent Insulinotropic Polypeptide (GIP) on Splanchnic Venous Capacitance in Postural Tachycardia Syndrome,RECRUITING,2023-02-25,2027-05-31,2028-06-01,INTERVENTIONAL,PHASE2,50,['Postural Tachycardia Syndrome (POTS)'],Postural Tachycardia Syndrome (POTS),Vanderbilt University Medical Center,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06548360,A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo,"A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo",RECRUITING,2025-01-24,2026-08-10,2027-03-13,INTERVENTIONAL,PHASE3,180,['NonSegmental Vitiligo'],NonSegmental Vitiligo,Incyte Corporation,[],"['United States', 'Canada']"
NCT06334120,An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea,Post-marketing Surveillance Study for Approved Darolutamide Use in Korean Patients,RECRUITING,2024-09-25,2028-03-31,2028-06-30,OBSERVATIONAL,,600,"['Non-metastatic Castration-resistant Prostate Cancer', 'Metastatic Hormone-sensitive Prostate Cancer']",Non-metastatic Castration-resistant Prostate Cancer,Bayer,[],['South Korea']
NCT06018558,Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy,A Phase 1/2 Study to Assess the Safety And Efficacy Of OCU410 For Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration,ACTIVE_NOT_RECRUITING,2023-02-23,2026-02-17,2026-05-29,INTERVENTIONAL,PHASE1,60,['Geographic Atrophy'],Geographic Atrophy,Ocugen,[],['United States']
NCT02531516,An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS,"ATLAS: A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects With High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment With Primary Radiation Therapy",ACTIVE_NOT_RECRUITING,2015-11-19,2026-06-30,2028-12-29,INTERVENTIONAL,PHASE3,1503,['Prostatic Neoplasms'],Prostatic Neoplasms,"Aragon Pharmaceuticals, Inc.",[],"['Netherlands', 'China', 'Belgium', 'Israel', 'Russia', 'France', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'Malaysia', 'United Kingdom', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Argentina']"
NCT06382948,"Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.","A Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Elacestrant Plus Everolimus Versus Elacestrant in Patients With ER+/HER2-, ESR1mut Advanced Breast Cancer Progressing to Endocrine Therapy and CDK4/6 Inhibitors",ACTIVE_NOT_RECRUITING,2024-12-05,2027-09,2028-04,INTERVENTIONAL,PHASE3,240,"['Advanced Breast Cancer', 'ER-positive Breast Cancer', 'HER2-negative Breast Cancer', 'ESR1 Gene Mutation']",Advanced Breast Cancer,MedSIR,"['Stemline Therapeutics, Inc.']","['Austria', 'France', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Greece', 'Germany']"
NCT04892173,JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC,A Phase 3 Study of NBTXR3 Activated by Investigator's Choice of Radiotherapy Alone or Radiotherapy in Combination With Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC,RECRUITING,2021-12-10,2026-06-30,2028-06-30,INTERVENTIONAL,PHASE3,500,"['Locally Advanced Head and Neck Squamous Cell Carcinoma', 'Aged']",Locally Advanced Head and Neck Squamous Cell Carcinoma,Johnson & Johnson Enterprise Innovation Inc.,[],"['Bulgaria', 'Japan', 'China', 'Serbia', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'Croatia', 'South Korea', 'Czechia', 'India', 'Georgia', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Austria', 'United States', 'Philippines']"
NCT06385080,A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer,"A Phase 1b/2, Open-label Study of Amivantamab Monotherapy and Amivantamab in Addition to Other Therapeutic Agents in Participants With Head and Neck Squamous Cell Carcinoma",RECRUITING,2024-04-22,2027-12-27,2032-12-27,INTERVENTIONAL,PHASE1,287,['Squamous Cell Carcinoma of Head and Neck'],Squamous Cell Carcinoma of Head and Neck,"Janssen Research & Development, LLC",[],"['Japan', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'Malaysia', 'United Kingdom', 'Poland', 'Germany']"
NCT04644770,"A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer","A Phase 1 Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer",RECRUITING,2020-11-12,2027-10-01,2027-10-01,INTERVENTIONAL,PHASE1,177,"['Prostatic Neoplasms', 'Adenocarcinoma']",Prostatic Neoplasms,"Janssen Research & Development, LLC",[],['United States']
NCT07265973,PREPARE: Perioperative REhabilitation Around Vaginal Prolapse RepAir Surgery for Recovery Enhancement,PREPARE: Perioperative REhabilitation Around Vaginal Prolapse RepAir Surgery for Recovery Enhancement,RECRUITING,2025-12-01,2027-06-25,2028-06-25,INTERVENTIONAL,NA,92,['Postoperative Physical Functioning'],Postoperative Physical Functioning,University of New Mexico,[],['United States']
NCT06961006,A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012),"A Phase 2, Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled Clinical Study of V940 (mRNA-4157) Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Participants With First-Line Advanced Melanoma (INTerpath-012)",RECRUITING,2025-05-29,2028-07-22,2031-09-05,INTERVENTIONAL,PHASE2,160,['Malignant Melanoma'],Malignant Melanoma,Merck Sharp & Dohme LLC,[],"['Israel', 'New Zealand', 'United States', 'France', 'Spain', 'Italy', 'Australia', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT06610760,Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia,"Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia: A Multicenter, Randomized, Placebo-Controlled Trial",RECRUITING,2024-11-12,2026-10-31,2026-10-31,INTERVENTIONAL,PHASE4,196,['Gastric Intestinal Metaplasia'],Gastric Intestinal Metaplasia,Yongquan Shi,[],['China']
NCT07188610,PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma,"PA3-17 Injection for the Treatment of Subjects With Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma: A Single-Arm, Open-Label Phase II Clinical Trial",RECRUITING,2025-09-25,2026-10-01,2027-10-01,INTERVENTIONAL,PHASE2,100,['CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma'],CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma,"PersonGen BioTherapeutics (Suzhou) Co., Ltd.",[],['China']
NCT02123758,A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer,"A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927 (ARN-509) and Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer",ACTIVE_NOT_RECRUITING,2014-07-09,2016-06-27,2027-12-31,INTERVENTIONAL,PHASE1,57,"['Prostatic Neoplasms', 'Metastatic Castration-Resistant Prostate Cancer']",Prostatic Neoplasms,"Aragon Pharmaceuticals, Inc.",[],"['United Kingdom', 'United States', 'Canada', 'Netherlands']"
NCT03851133,Florida Pancreas Collaborative Next Generation Biobank,The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer,ACTIVE_NOT_RECRUITING,2019-03-04,2022-08-06,2026-06-11,OBSERVATIONAL,,500,"['Pancreatic Cancer', 'Cancer Cachexia']",Pancreatic Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT00747851,NETs: Protection or Harm in Neonatal Inflammation or Infection,NETs: Protection or Harm in Neonatal Inflammation or Infection,RECRUITING,2003-10,2026-04-30,2026-04-30,OBSERVATIONAL,,388,['Necrotizing Enterocolitis (NEC)'],Necrotizing Enterocolitis (NEC),University of Utah,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT06309966,Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy,"A Phase 2/3 Multicenter, Randomization, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy",RECRUITING,2024-05-13,2026-05,2026-05,INTERVENTIONAL,PHASE2,390,['Focal Epilepsy'],Focal Epilepsy,Biohaven Therapeutics Ltd.,[],"['India', 'United States', 'Mexico', 'Finland', 'Slovakia', 'Denmark', 'Spain', 'Italy', 'Romania', 'United Kingdom', 'Australia', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT03683251,Extension Study for the Port Delivery System With Ranibizumab (Portal),"A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Portal)",RECRUITING,2018-09-20,2029-09-30,2029-09-30,INTERVENTIONAL,PHASE3,1000,['Neovascular Age-Related Macular Degeneration'],Neovascular Age-Related Macular Degeneration,Hoffmann-La Roche,[],"['Brazil', 'Belgium', 'Israel', 'Turkey (Türkiye)', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Taiwan', 'Italy', 'United Kingdom', 'Argentina', 'Australia']"
NCT03607890,Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor,Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor,RECRUITING,2018-11-16,2026-10,2026-10,INTERVENTIONAL,PHASE2,42,"['Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy', 'MSI-H Tumors']",Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Bristol-Myers Squibb', 'National Cancer Institute (NCI)']",['United States']
NCT07216027,A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema,"A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08049820 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS",RECRUITING,2025-11-20,2027-08-23,2027-08-23,INTERVENTIONAL,PHASE2,200,"['Atopic Dermatitis', 'Eczema, Atopic']",Atopic Dermatitis,Pfizer,[],['United States']
NCT06577025,"A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma","A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Combination With Daratumumab SC (Tal-D) and Teclistamab SC in Combination With Daratumumab SC (Tec-D) Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",ACTIVE_NOT_RECRUITING,2024-08-20,2030-07-31,2030-09-02,INTERVENTIONAL,PHASE2,43,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Brazil', 'United States', 'Spain', 'Australia', 'Germany']"
NCT04273945,Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension,"A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg",ACTIVE_NOT_RECRUITING,2020-06-30,2025-10-07,2029-02-20,INTERVENTIONAL,PHASE3,935,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,Actelion,[],"['Bulgaria', 'Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Belarus', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Vietnam', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT06942637,"Effectiveness of Integrated Network for Student Psychosocial Intervention, Resilience, and Education (INSPIRE) on Mental Health Outcomes Among Indonesian Adolescents in Bandung","Effectiveness of Integrated Network for Student Psychosocial Intervention, Resilience, and Education (INSPIRE) on Mental Health Outcomes Among Indonesian Adolescents in Bandung: A Randomised Controlled Trial and Process Evaluation",ACTIVE_NOT_RECRUITING,2025-09-12,2026-02-16,2026-03-31,INTERVENTIONAL,NA,680,"['Adolescents', 'Health Knowledge', 'Mental Health', 'Health Literacy', 'Resilience', 'Depression', 'Anxiety', 'Parents', 'School Intervention']",Adolescents,National University of Singapore,"['Indonesia Endowment Fund for Education (LPDP), Republic of Indonesia']",['Singapore']
NCT07237867,Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar Tendinopathy,Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Strength in Athletes With Patellar Tendinopathy: a Randomized Controlled Trial,RECRUITING,2025-09-20,2025-11-30,2025-12-15,INTERVENTIONAL,NA,19,['Patellar Tendinopathy / Jumpers Knee'],Patellar Tendinopathy / Jumpers Knee,Hospital Clinic of Barcelona,[],['Spain']
NCT06934967,"Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients","An Open-label, Single-arm, Multicenter, Phase 3 Study to Assess Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric PNH Patients 2 to <18 Years of Age",RECRUITING,2025-10-28,2031-11-19,2031-12-19,INTERVENTIONAL,PHASE3,12,['Paroxysmal Nocturnal Hemoglobinuria (PNH)'],Paroxysmal Nocturnal Hemoglobinuria (PNH),Novartis Pharmaceuticals,[],"['Brazil', 'Netherlands', 'United States', 'Italy', 'Colombia', 'Germany']"
NCT04919512,A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder,"A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Scheduled for Radical Cystectomy and Are Ineligible for or Refusing Platinum-Based Neoadjuvant Chemotherapy",ACTIVE_NOT_RECRUITING,2022-07-07,2025-01-31,2027-03-07,INTERVENTIONAL,PHASE2,163,['Urinary Bladder Neoplasms'],Urinary Bladder Neoplasms,"Janssen Research & Development, LLC",[],"['Israel', 'Belgium', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Germany']"
NCT07149857,A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel,A Phase 2 Multicohort Trial to Further Characterize the Efficacy and Safety of Ciltacabtagene Autoleucel,RECRUITING,2025-10-03,2028-01-03,2028-12-29,INTERVENTIONAL,PHASE2,60,['Multiple Myeloma'],Multiple Myeloma,"Janssen Research & Development, LLC",[],"['Spain', 'United States', 'Australia']"
NCT04955730,NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies,Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies,ACTIVE_NOT_RECRUITING,2021-08-05,2025-04-30,2026-03,INTERVENTIONAL,PHASE2,300,['Surgical Wound Infection'],Surgical Wound Infection,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT04799288,Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis,Phase I/II Study of Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis,RECRUITING,2021-09-24,2027-08-31,2027-08-31,INTERVENTIONAL,PHASE1,24,['HAM/TSP'],HAM/TSP,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06345157,"ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients","An ITAlian Observational, Multicenter, 12-month, Single-arm Study to Evaluate the Effectiveness and Safety of Treatment With Ofatumumab (Kesimpta®) in a pOpulation of RRMS Patients in a Real-world Setting - the ITAKOS Study",ACTIVE_NOT_RECRUITING,2024-07-30,2026-06-30,2026-06-30,OBSERVATIONAL,,376,"['Multiple Sclerosis, Relapsing-Remitting']","Multiple Sclerosis, Relapsing-Remitting",Novartis Pharmaceuticals,[],['Italy']
NCT05498428,A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer,"A Phase 2, Open-Label, Parallel Cohort Study of Subcutaneous Amivantamab in Multiple Regimens in Patients With Advanced or Metastatic Solid Tumors Including EGFR-mutated Non-Small Cell Lung Cancer",RECRUITING,2022-11-11,2027-08-17,2027-08-17,INTERVENTIONAL,PHASE2,520,"['Carcinoma, Non-small-Cell Lung']","Carcinoma, Non-small-Cell Lung","Janssen Research & Development, LLC",[],"['Brazil', 'Israel', 'Japan', 'China', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'Malaysia', 'United Kingdom', 'Germany']"
NCT06425302,A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma,"A Phase 2 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma",RECRUITING,2024-08-30,2026-11-23,2028-11-27,INTERVENTIONAL,PHASE2,90,"['Lymphoma, Follicular']","Lymphoma, Follicular",Celgene,[],"['Brazil', 'United States', 'France', 'Germany', 'Chile', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT07266246,Effectiveness of Aluminum Foil vs White Linen Reflectors in Phototherapy for Neonatal Hyperbilirubinemia,Research Assistant,RECRUITING,2024-12-30,2025-06-02,2025-12-01,INTERVENTIONAL,NA,27,"['Premature', 'Phototherapy', 'Neonatal Intensive Care Unit', 'Neonatal Hyperbilirubinemia', 'Nursing']",Premature,Baskent University,[],['Turkey (Türkiye)']
NCT06497556,A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer,"A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients With Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer",ACTIVE_NOT_RECRUITING,2024-09-23,2027-09-30,2029-11-30,INTERVENTIONAL,PHASE3,320,"['Non-Small Cell Lung Cancer', 'KRAS G12C Lung Cancer']",Non-Small Cell Lung Cancer,Hoffmann-La Roche,['Chugai Pharmaceutical'],"['Japan', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'France', 'Finland', 'Denmark', 'South Korea', 'Thailand', 'Poland', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT00606346,"A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease","A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease",ACTIVE_NOT_RECRUITING,2007-05-31,,2038-06-30,OBSERVATIONAL,,4970,"[""Crohn's Disease"", 'Ulcerative Colitis', 'Indeterminate Colitis', 'Inflammatory Bowel Diseases']",Crohn's Disease,"Janssen Biotech, Inc.",[],"['United States', 'Canada']"
NCT06093269,Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL),Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL),ACTIVE_NOT_RECRUITING,2023-11-20,2025-12,2025-12,INTERVENTIONAL,PHASE4,32,"['Hemodialysis Catheter Infection', 'Infection, Bacterial']",Hemodialysis Catheter Infection,"University Hospital, Tours",[],['France']
NCT02741986,"Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment","Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment (IDEALIST)",ACTIVE_NOT_RECRUITING,2016-10,2028-11,2028-11,OBSERVATIONAL,,200,['Postoperative Complications'],Postoperative Complications,University of Florida,['National Institute of General Medical Sciences (NIGMS)'],['United States']
NCT06782542,"Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy","Single-Arm Phase 2 Study of Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Eligible for Intensive Induction Chemotherapy",RECRUITING,2026-02-01,2029-02-01,2029-02-01,INTERVENTIONAL,PHASE2,16,"['Acute Myeloid Leukemia', 'IDH1 Mutation']",Acute Myeloid Leukemia,"Justin Watts, MD",['Rigel Pharmaceuticals'],['United States']
NCT04184050,Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001),"A Phase 1 Open-label, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients With Relapsed/Refractory Multiple Myeloma",ACTIVE_NOT_RECRUITING,2020-04-13,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,100,"['Multiple Myeloma in Relapse', 'Multiple Myeloma', 'Multiple Myeloma of Bone', 'Multiple Myeloma With Failed Remission']",Multiple Myeloma in Relapse,"Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)",[],"['Spain', 'United States', 'France']"
NCT06081959,"Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer","A Randomized, Open-label, Multicenter Phase 3 Study of SKB264 Versus Treatment of Physician's Choice (TPC) in Patients With Unresectable Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer Who Had Failed at Least One Line of Chemotherapy",RECRUITING,2023-10-31,2026-03-31,2027-12-31,INTERVENTIONAL,PHASE3,376,['Metastatic Breast Cancer'],Metastatic Breast Cancer,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT06287255,Feasibility and Acceptability of Incorporating Smartwatches Into an Exercise is Medicine Program in Older Individuals,Feasibility and Acceptability of Incorporating Fitbit Smartwatches Into a Health System Referral Based Exercise is Medicine Program in Older Individuals (EIM+),ACTIVE_NOT_RECRUITING,2024-03-15,2026-05-01,2026-05-01,INTERVENTIONAL,NA,150,"['Physical Inactivity', 'Obesity']",Physical Inactivity,Ohio State University,[],['United States']
NCT03346135,Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma,"A Multicenter, Open-Label, Single Arm, Phase II Study of Daratumumab as Consolidation/Maintenance Therapy After Autologous Stem Cell Transplantation in Patients With Multiple Myeloma",ACTIVE_NOT_RECRUITING,2019-07-17,2026-07-01,2026-07-01,INTERVENTIONAL,PHASE2,31,"['Plasma Cell Myeloma', 'Secondary Amyloidosis']",Plasma Cell Myeloma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT07267923,Investigation of the Acute Effects of Traditional and Functional IMT on Muscle Oxygenation in COPD,Investigation of the Acute Effects of Traditional and Functional Inspiratory Muscle Training on Muscle Oxygenation in Chronic Obstructive Pulmonary Disease,RECRUITING,2025-11-11,2025-12,2025-12,INTERVENTIONAL,NA,20,['Chronic Obstructive Pulmonary Disease (COPD)'],Chronic Obstructive Pulmonary Disease (COPD),Saglik Bilimleri Universitesi,[],['Turkey (Türkiye)']
NCT06670196,"A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer","A Randomized, Open-Label, Multicenter, Phase III Clinical Study of SKB264 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer",RECRUITING,2024-11-27,2027-05,2027-07,INTERVENTIONAL,PHASE3,420,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",[],['China']
NCT04873362,A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy,"A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy",ACTIVE_NOT_RECRUITING,2021-05-04,2028-08-31,2034-10-02,INTERVENTIONAL,PHASE3,1188,['Breast Cancer'],Breast Cancer,Hoffmann-La Roche,[],"['Bulgaria', 'New Zealand', 'Hong Kong', 'China', 'Kenya', 'Australia', 'Belgium', 'Hungary', 'Russia', 'France', 'Uganda', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT02872987,"GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial","Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult ALL Patients and Related Diseases Associated With a Prospective Collection of Biomaterial",RECRUITING,2009-02,2030-12,2035-12,OBSERVATIONAL,,10000,"['Acute Lymphoblastic Leukemia', 'Leukemia', ""Non-Hodgkin's Lymphoma""]",Acute Lymphoblastic Leukemia,Goethe University,[],"['Austria', 'Germany']"
NCT05884398,A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC,"A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide With Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) Following PSA Response in Participants With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)",ACTIVE_NOT_RECRUITING,2023-08-31,2026-10-12,2028-10-12,INTERVENTIONAL,PHASE3,420,['Metastatic Castrate-sensitive Prostate Cancer'],Metastatic Castrate-sensitive Prostate Cancer,"Janssen Research & Development, LLC",[],"['Brazil', 'China', 'United States', 'France', 'Germany', 'Mexico', 'Canada', 'Poland', 'Australia']"
NCT07267429,Resistance Training-induced Adaptations in Children,Resistance Training-induced Adaptations in Children,RECRUITING,2025-12-01,2026-02,2026-02,INTERVENTIONAL,NA,40,['Healthy Participants'],Healthy Participants,Brock University,[],['Canada']
NCT07171905,CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease,Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-hippel Lindau Disease,RECRUITING,2026-01-23,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,38,['VHL - Von Hippel-Lindau Syndrome'],VHL - Von Hippel-Lindau Syndrome,IRCCS Ospedale San Raffaele,[],['Italy']
NCT06970275,"To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.","A Multicentric, Observational, Post-marketing, Registry Study to Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.",RECRUITING,2025-11-19,2031-01-15,2031-01-15,OBSERVATIONAL,,850,"['Prostate Cancers', 'Breast Cancer', 'Head and Neck Cancer', 'Cancer']",Prostate Cancers,XEOS Medical,[],['Belgium']
NCT06388564,A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease,"A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease",RECRUITING,2024-10-11,2027-06-01,2029-12-01,INTERVENTIONAL,PHASE2,120,['Chronic Graft-versus-host-disease'],Chronic Graft-versus-host-disease,Incyte Corporation,[],"['Belgium', 'United States', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT06671483,A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines,"A Multi-Center, Randomized, Double-Blind, Placebo- and Active-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-Modifying Antirheumatic Drugs (LATITUDE-PsA-3001)",RECRUITING,2025-03-03,2027-05-18,2028-01-28,INTERVENTIONAL,PHASE3,1088,['Psoriatic Arthritis'],Psoriatic Arthritis,Takeda,[],"['Bulgaria', 'New Zealand', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'Chile', 'Puerto Rico', 'Croatia', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Latvia', 'Portugal', 'Germany', 'United States', 'Italy']"
NCT06969937,Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder,"Phase II, Randomised, Placebo-controlled, Double Blind, Parallel Group, Single Centre Study Investigating Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder",RECRUITING,2025-06-01,2026-12,2026-12,INTERVENTIONAL,PHASE2,75,"['Alcohol Abuse/Dependence', 'Alcohol Use Disorder (AUD)', 'Alcoholism']",Alcohol Abuse/Dependence,Dr. med. Marcus Herdener,['University of Zurich'],['Switzerland']
NCT06868264,C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV,"Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed-dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects With Chronic Hepatitis C Virus (HCV) Infection",ACTIVE_NOT_RECRUITING,2025-04-07,2026-09,2026-12,INTERVENTIONAL,PHASE3,880,['HEPATITIS C VIRUS CHRONIC INFECTION'],HEPATITIS C VIRUS CHRONIC INFECTION,"Atea Pharmaceuticals, Inc.",[],"['United States', 'Canada']"
NCT06930664,A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027),A Phase 1 Clinical Study in Healthy Females of Nonchildbearing Potential to Compare the Pharmacokinetics of Sotatercept (MK-7962) Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation,ACTIVE_NOT_RECRUITING,2025-05-16,2025-11-11,2025-11-25,INTERVENTIONAL,PHASE1,146,['Healthy'],Healthy,Merck Sharp & Dohme LLC,[],['United States']
NCT07266129,Virtual Biopsy of Prostate Cancer Using PSMA PET and AI,Prostate Cancer Malignancy Grading Using Prostate Specific Membrane Antigen (PSMA) PET and Machine Learning,RECRUITING,2024-06-03,2027-12,2027-12,OBSERVATIONAL,,220,['Prostate Cancer (Diagnosis)'],Prostate Cancer (Diagnosis),University Hospital of North Norway,[],['Norway']
NCT06785012,A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder,"A Randomized, Double-blind, Multicenter, Placebo-controlled, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-89495120 as Monotherapy in Adult Participants With Major Depressive Disorder (MDD)",RECRUITING,2024-12-26,2026-06-26,2026-06-26,INTERVENTIONAL,PHASE2,124,"['Depressive Disorder, Major']","Depressive Disorder, Major","Janssen Research & Development, LLC",[],['United States']
NCT07219966,A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder,"A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)",RECRUITING,2025-10-15,2028-04,2028-04,INTERVENTIONAL,PHASE3,1100,['Alcohol Use Disorder'],Alcohol Use Disorder,Eli Lilly and Company,[],"['Belgium', 'Japan', 'China', 'United States', 'Taiwan', 'South Korea', 'United Kingdom', 'Argentina', 'Germany']"
NCT06593353,Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail,Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail,RECRUITING,2024-11-21,2028-03-31,2028-06-30,INTERVENTIONAL,NA,4165,"['Opioid Use Disorder', 'Opioid Use Disorders']",Opioid Use Disorder,University of Washington,['National Institute of Nursing Research (NINR)'],['United States']
NCT07263971,Birth Experience of Women Giving Birth in Belgium,Birth Experiences of Women Giving Birth in French-speaking Belgium and Pathways to Choosing a Place of Birth,RECRUITING,2025-09-08,2028-12-31,2028-12-31,OBSERVATIONAL,,60,['Pregnancy Related'],Pregnancy Related,Université Catholique de Louvain,[],['Belgium']
NCT02530177,"Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer","A Prospective, Longitudinal Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast Cancer",ACTIVE_NOT_RECRUITING,2015-08-19,2026-08,2026-08,OBSERVATIONAL,,546,['Non-Metastatic Breast Cancer'],Non-Metastatic Breast Cancer,Memorial Sloan Kettering Cancer Center,"['University of Chicago', 'New York University']",['United States']
NCT02307630,PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study,PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study,ACTIVE_NOT_RECRUITING,2014-11,2026-11,2026-11,INTERVENTIONAL,NA,7,"['Melanoma', 'Neuroblastoma', 'Sarcoma']",Melanoma,Memorial Sloan Kettering Cancer Center,['Y-mAbs Therapeutics'],['United States']
NCT05916313,A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3,"A Phase Ib Open-label, Multi-center, Dose Escalation Trial of BI 764532 Given as Monotherapy Administered by Repeated Intravenous Infusions in Patients With Glioma Expressing DLL3",ACTIVE_NOT_RECRUITING,2024-01-30,2026-02-23,2026-03-30,INTERVENTIONAL,PHASE1,18,['Glioma'],Glioma,Boehringer Ingelheim,[],"['Netherlands', 'Austria', 'United States', 'Switzerland', 'Spain', 'Germany']"
NCT04324944,Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness,Improving Collaborative Decision Making in Veterans With Serious Mental Illness,ACTIVE_NOT_RECRUITING,2022-07-05,2025-01-31,2025-12-31,INTERVENTIONAL,NA,39,"['Schizophrenia', 'Schizoaffective Disorder', 'Delusional Disorder', 'Major Depressive Disorder With Psychotic Features']",Schizophrenia,VA Office of Research and Development,[],['United States']
NCT06311214,Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial),Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH),RECRUITING,2025-03-18,2028-03-31,2028-03-31,INTERVENTIONAL,PHASE2,500,"['Advanced Malignant Solid Neoplasm', 'Metastatic Malignant Solid Neoplasm']",Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT01736293,Natural History of Eye Diseases Related to ABCA4 Mutations,Natural History of ABCA4-Related Retinopathies,ACTIVE_NOT_RECRUITING,2012-10-09,,,OBSERVATIONAL,,68,"['Retinal Degeneration', 'ABCA4-Related Retinopathies']",Retinal Degeneration,National Eye Institute (NEI),[],['United States']
NCT07254819,Cotinus Coggygria Mouthwash and Halitosis and Oral Hygiene in Orthodontic Patients,The Effect of Cotinus Coggygria Mouthwash on Halitosis and Oral Hygiene in Orthodontic Patients: a Randomized Clinical Trial,RECRUITING,2025-12-03,2025-12-19,2025-12-19,INTERVENTIONAL,NA,30,"['Orthodontic Appliance Complication', 'Halitosis']",Orthodontic Appliance Complication,University of Athens,[],['Greece']
NCT03752892,Partitioned Training of Patients With Idiopathic Pulmonary Fibrosis,Randomized Controlled Trial of Partitioned Aerobic Exercise Training of Patients With Idiopathic Pulmonary Fibrosis,ACTIVE_NOT_RECRUITING,2019-03-01,2025-04-28,2026-05-31,INTERVENTIONAL,NA,50,"['Lung; Disease, Interstitial, With Fibrosis']","Lung; Disease, Interstitial, With Fibrosis",West Park Healthcare Centre,[],['Canada']
NCT05922748,Brain Injury and Cognitive Function,Brain Injury and Cognitive Function: Neuropsychology and Neuroimaging,RECRUITING,2014-02-05,2026-02-05,2027-02-05,INTERVENTIONAL,NA,1500,"['Cerebral Lesion', 'Cognitive Deficit Following Brain Lesions']",Cerebral Lesion,"Institut National de la Santé Et de la Recherche Médicale, France",[],['France']
NCT06780306,A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.,"A Phase 2 Randomized, Controlled, Multicenter, Dose Optimization Study of TTAX03 in the Treatment of Mild to Moderate Dry Eye Disease (DED)",ACTIVE_NOT_RECRUITING,2024-12-12,2026-01,2026-01,INTERVENTIONAL,PHASE2,72,"['Dry Eye', 'Dry Eye Disease (DED)', 'Dry Eye Disease With Severe Keratitis']",Dry Eye,"BioTissue Holdings, Inc",[],['United States']
NCT06133972,Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).,"A Randomized, Double-blind, Placebo-controlled Extension Study to Assess the Long-term Safety and Tolerability of Ianalumab in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE Extension)",RECRUITING,2024-05-21,2030-04-19,2032-04-16,INTERVENTIONAL,PHASE3,550,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,Novartis Pharmaceuticals,[],"['Bulgaria', 'Japan', 'China', 'Australia', 'Israel', 'Hungary', 'France', 'Chile', 'Guatemala', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Portugal', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT07112339,A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes,EFFectiveness of Once-weekly Insulin ICodec Versus Once-daily Basal Insulin Analogues in an Insulin-naïve Type 2 diabEtes Population in Real-world cliNical pracTice- The EFFICIENT Pragmatic Study Effectiveness of Insulin Icodec in Real-world Clinical Practice,RECRUITING,2025-08-15,2026-08-04,2028-08-31,INTERVENTIONAL,PHASE4,586,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",Novo Nordisk A/S,[],"['Italy', 'Canada', 'Germany']"
NCT06678841,ELEVATE-HFpEF Clinical Study,Randomized Trial of ELEVATEd Cardiac Pacing Rate for Personalized Treatment of Heart Failure With Preserved Ejection Fraction (ELEVATE-HFpEF),RECRUITING,2025-07-09,2028-08,2029-02,INTERVENTIONAL,NA,700,['Heart Failure With Preserved Ejection Fraction (HFpEF)'],Heart Failure With Preserved Ejection Fraction (HFpEF),Medtronic Cardiac Rhythm and Heart Failure,[],"['United States', 'Hong Kong', 'Australia']"
NCT00804154,Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer,A Phase I Study of the Intrathecal Administration of Resiniferatoxin for Treating Severe Refractory Pain Associated With Advanced Cancer,RECRUITING,2009-08-14,2026-02-07,2026-02-07,INTERVENTIONAL,PHASE1,45,"['Intractable Pain', 'Palliative Care']",Intractable Pain,National Institute of Dental and Craniofacial Research (NIDCR),"['National Institute of Neurological Disorders and Stroke (NINDS)', 'Sorrento Therapeutics, Inc.']",['United States']
NCT04524871,A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver),"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)",RECRUITING,2020-11-01,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,518,['Advanced Liver Cancers'],Advanced Liver Cancers,Hoffmann-La Roche,"['Adagene Inc', 'Tempest Therapeutics', 'NiKang Therapeutics, Inc.', 'Immune-Onc Therapeutics']","['Israel', 'New Zealand', 'China', 'United States', 'France', 'Taiwan', 'South Korea']"
NCT06824168,Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission,"A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia in Complete Remission",RECRUITING,2025-07-18,2028-06-06,2032-07-14,INTERVENTIONAL,PHASE2,130,"['Acute Myeloid Leukemia', 'Leukemia']",Acute Myeloid Leukemia,Daiichi Sankyo,[],"['Brazil', 'China', 'United States', 'South Korea', 'Australia']"
NCT07263425,Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis,Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab Via the Ommaya Reservoir in Breast Cancer With Leptomeningeal Metastasis: a Phase II Multicenter Clinical Trial,RECRUITING,2025-10-27,2027-10-27,2027-10-27,INTERVENTIONAL,PHASE2,26,['Leptomeningeal Metastasis of HER2-positive Breast Cancer'],Leptomeningeal Metastasis of HER2-positive Breast Cancer,The First Affiliated Hospital with Nanjing Medical University,['The Affiliated Brain Hospital of Nanjing Medical University'],['China']
NCT05226689,Porous Baseplate in Total Knee Replacement,"A Prospective, Multicenter, RSA Study of the Porous Tibia Baseplate W/Jrny Lock",ACTIVE_NOT_RECRUITING,2022-04-11,2025-04-08,2026-07,INTERVENTIONAL,NA,31,['Knee Osteoarthritis'],Knee Osteoarthritis,Canadian Radiostereometric Analysis Network,[],['Canada']
NCT01273168,Endoxifen in Adults With Hormone Receptor Positive Solid Tumors,"Phase I Trial of Z-Endoxifen in Adults With Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors",ACTIVE_NOT_RECRUITING,2011-03-01,2020-06-01,2026-06-01,INTERVENTIONAL,PHASE1,40,"['Hormone Receptor-Positive Breast', 'Gynecologic', 'Desmoid', 'Hormone Receptor-Positive Neoplasms']",Hormone Receptor-Positive Breast,National Cancer Institute (NCI),[],['United States']
NCT00029965,Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders,Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders,RECRUITING,2002-02-06,,,OBSERVATIONAL,,200,"['Neurological Regression', 'Myoclonus', 'Cherry Red Spot', 'Brain Atrophy']",Neurological Regression,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06236633,Safety & Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum,Evaluation of the Safety and Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Oncologic Surgery for Tumors of the Lower and Middle Rectum. Bicentric Exploratory Pilot Study,RECRUITING,2024-08-02,2026-08-01,2027-08-01,INTERVENTIONAL,NA,30,"['Cancer, Rectal']","Cancer, Rectal",Centre Hospitalier Universitaire de Nīmes,[],['France']
NCT07082543,A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis,"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",RECRUITING,2025-06-30,2027-11-04,2027-11-04,INTERVENTIONAL,PHASE3,75,"['Gangliosidoses, GM2', 'Gangliosidosis, GM1']","Gangliosidoses, GM2",Azafaros A.G.,[],"['Brazil', 'Turkey (Türkiye)', 'India', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Portugal', 'Argentina', 'Sweden', 'Australia']"
NCT04770779,A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT),"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE-T)",ACTIVE_NOT_RECRUITING,2021-11-30,2024-04-11,2029-06,INTERVENTIONAL,PHASE3,258,"['Transfusion-dependent Alpha-Thalassemia', 'Transfusion-dependent Beta-Thalassemia']",Transfusion-dependent Alpha-Thalassemia,"Agios Pharmaceuticals, Inc.",[],"['Bulgaria', 'Netherlands', 'Saudi Arabia', 'France', 'Denmark', 'Thailand', 'Lebanon', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Arab Emirates', 'Greece', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT06395103,Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01),LIGHTBEAM-U01 Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors,RECRUITING,2024-08-16,2029-03-31,2029-03-31,INTERVENTIONAL,PHASE1,90,"['B-cell Acute Lymphoblastic Leukemia', 'Diffuse Large B-cell Lymphoma', 'Burkitt Lymphoma', 'Neuroblastoma', 'Ewing Sarcoma']",B-cell Acute Lymphoblastic Leukemia,Merck Sharp & Dohme LLC,[],"['Netherlands', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT05465096,Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells.,Interventional Pilot Study on the Treatment of Osteoarthritis of the Hip Joint With Intra-articular Ultrasound-guided Infiltration of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells,ACTIVE_NOT_RECRUITING,2022-10-24,2025-12,2025-12,INTERVENTIONAL,NA,30,"['Hip Osteoarthritis', 'Hip Disease']",Hip Osteoarthritis,Istituto Ortopedico Rizzoli,[],['Italy']
NCT06876662,A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma,Long-Term Safety of Pirtobrutinib in Participants From Study LOXO-BTK-18001 With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma,RECRUITING,2025-05-20,2030-05,2032-12,INTERVENTIONAL,PHASE4,279,"['Chronic Lymphocytic Leukemia', 'Non-Hodgkin Lymphoma']",Chronic Lymphocytic Leukemia,Eli Lilly and Company,[],"['Japan', 'United States', 'France', 'Italy', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT02639325,Tumor Related Epilepsy,Tumor Related Epilepsy,RECRUITING,2016-01-26,2032-07-01,2032-07-01,OBSERVATIONAL,,100,"['Epilepsy', 'Cancer', 'Brain Neoplasm']",Epilepsy,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07003425,A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis,A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777,RECRUITING,2025-05-14,2029-12,2029-12,INTERVENTIONAL,PHASE2,350,['Atopic Dermatitis'],Atopic Dermatitis,"Apogee Therapeutics, Inc.",[],"['Poland', 'United States', 'Canada']"
NCT06948435,A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1,"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",RECRUITING,2025-04-30,2027-09,2027-09,INTERVENTIONAL,PHASE3,487,"['Hypertension', 'Overweight or Obesity']",Hypertension,Eli Lilly and Company,[],"['Japan', 'China', 'India', 'United States', 'Puerto Rico', 'Spain', 'Czechia', 'Greece', 'Poland', 'Argentina', 'Germany']"
NCT05648968,A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia,"A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versus Placebo in Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Who Failed at Least One Line of Treatment",RECRUITING,2022-12-30,2026-03-02,2029-05-02,INTERVENTIONAL,PHASE3,90,['Warm Autoimmune Hemolytic Anemia (wAIHA)'],Warm Autoimmune Hemolytic Anemia (wAIHA),Novartis Pharmaceuticals,[],"['Singapore', 'Israel', 'Japan', 'Hungary', 'China', 'India', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Romania', 'Malaysia', 'Thailand', 'United Kingdom', 'Argentina', 'Australia']"
NCT06797518,Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN,"A Multicenter, Single Arm, Open Label Biopsy Study to Evaluate Structural and Functional Changes in Kidneys of Adult Patients With IgA Nephropathy Receiving Iptacopan on Top of Supportive Care",RECRUITING,2025-02-21,2027-11-27,2027-11-27,INTERVENTIONAL,PHASE2,20,"['Glomerulonephritis, IGA', 'Immunoglobulin A Nephropathy']","Glomerulonephritis, IGA",Novartis Pharmaceuticals,[],"['Israel', 'United States', 'Malaysia']"
NCT02417324,International HIT-MED Registry (I-HIT-MED),"International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumours",RECRUITING,2015-01,2029-12,2029-12,OBSERVATIONAL,,500,['Childhood Brain Tumor'],Childhood Brain Tumor,Universitätsklinikum Hamburg-Eppendorf,[],['Germany']
NCT06333860,A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body),"A Phase 4 Multicenter, Randomized, Open-label, Efficacy Assessor Blinded Study of Risankizumab Compared to Deucravacitinib for the Treatment of Adult Subjects With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy",ACTIVE_NOT_RECRUITING,2024-05-10,2026-03,2026-03,INTERVENTIONAL,PHASE4,393,['Moderate Plaque Psoriasis'],Moderate Plaque Psoriasis,AbbVie,[],"['Belgium', 'Hungary', 'Netherlands', 'United States', 'Puerto Rico', 'Spain', 'Italy', 'Canada', 'Australia', 'Greece', 'United Kingdom', 'Germany']"
NCT06817356,A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder,"A Phase 2, Double-Blind, Proof of Concept Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder",RECRUITING,2025-02-06,2026-08,2026-08,INTERVENTIONAL,PHASE2,300,['Alcohol Use Disorder'],Alcohol Use Disorder,Eli Lilly and Company,[],['United States']
NCT05724108,"Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors",A Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated Somatostatin Receptor-Positive Neuroendocrine Tumors,RECRUITING,2023-08-30,2025-11-30,2025-11-30,INTERVENTIONAL,PHASE2,94,['Metastatic Neuroendocrine Tumor'],Metastatic Neuroendocrine Tumor,National Cancer Institute (NCI),[],['United States']
NCT05945212,Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.,Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients - a Multicentric Randomized Controlled Study,RECRUITING,2024-03-12,2027-01-07,2027-05-15,INTERVENTIONAL,NA,70,['Stroke Rehabilitation'],Stroke Rehabilitation,Centre Hospitalier Universitaire de Saint Etienne,"['Ministry of Health, France']",['France']
NCT02394769,ASPirin Intervention for the REDuction of Colorectal Cancer Risk,ASPIRED: ASPirin Intervention for the REDuction of Colorectal Cancer Risk,ACTIVE_NOT_RECRUITING,2015-07-06,2019-04-11,2029-07,INTERVENTIONAL,NA,180,['Colorectal Cancer'],Colorectal Cancer,Massachusetts General Hospital,['National Cancer Institute (NCI)'],['United States']
NCT05591677,D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT),"D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression: A Multi-Site, Randomised, Placebo-Controlled Trial (COGENT)",ACTIVE_NOT_RECRUITING,2023-04-21,2026-05-29,2026-05-29,INTERVENTIONAL,PHASE2,180,['Major Depressive Disorder'],Major Depressive Disorder,The Alfred,"['Blue Bell Health, Australia', 'Gold Coast Hospital and Health Service']",['Australia']
NCT04407611,Scalable Communication Modalities for Returning Genetic Research Results,Testing Scalable Communication Modalities for Returning Breast Cancer Genetic Research Results to African American Women,ACTIVE_NOT_RECRUITING,2023-03-06,2025-12,2025-12,INTERVENTIONAL,NA,932,"['Hereditary Breast and Ovarian Cancer', 'Lynch Syndrome']",Hereditary Breast and Ovarian Cancer,Boston University,"['University of Washington', 'MGH Institute of Health Professions', 'National Institute on Minority Health and Health Disparities (NIMHD)']",['United States']
NCT04275557,Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas,Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas and Uncover Hidden Biology,RECRUITING,2020-02-18,2026-06,2027-06,OBSERVATIONAL,,1174,"['Pancreatic Cancer', 'Pancreatic Cyst']",Pancreatic Cancer,H. Lee Moffitt Cancer Center and Research Institute,"['National Cancer Institute (NCI)', 'University of Florida', 'University of Miami']",['United States']
NCT06940375,Prevelence of Liver Disease-Related Outcomes in People With HIV,Construction of Prediction Models for Metabolic - Associated Fatty Liver Disease and Liver Fibrosis in HIV - Infected Individuals,RECRUITING,2025-07-01,2026-02-01,2026-07-01,OBSERVATIONAL,,320,"['MAFLD', 'Liver Fibrosis', 'MASH', 'HIV', 'Hepatic Steatosis', 'Metabolic Syndrome (MetS)']",MAFLD,Shanghai Public Health Clinical Center,[],['China']
NCT05020236,A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments,"AN OPEN-LABEL, 3-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) MONOTHERAPY AND ELRANATAMAB + DARATUMUMAB VERSUS DARATUMUMAB + POMALIDOMIDE + DEXAMETHASONE IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST 1 PRIOR LINE OF THERAPY INCLUDING LENALIDOMIDE AND A PROTEASOME INHIBITOR",RECRUITING,2021-10-04,2025-12-09,2027-05-31,INTERVENTIONAL,PHASE3,944,['Multiple Myeloma'],Multiple Myeloma,Pfizer,[],"['Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'Finland', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07264517,"Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).","A Phase 2, Double-masked, Randomized, Vehicle-controlled Study Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease",RECRUITING,2025-11-03,2026-06-15,2026-11-14,INTERVENTIONAL,PHASE2,100,['Dry Eye Disease'],Dry Eye Disease,"Instituto Grifols, S.A.",[],['United States']
NCT07263750,Effect of Haptonomy on Prenatal Attachment and Fear of Childbirth in Primiparous Couples,The Effect of Haptonomy Application for Primiparous Pregnant Women and Their Partners on Prenatal Attachment and Fear of Childbirth: A Randomized Controlled Study,RECRUITING,2024-08-01,2025-12-27,2026-03-01,INTERVENTIONAL,NA,144,"['Fear of Childbirth', 'Prenatal Attachment']",Fear of Childbirth,Nigde Omer Halisdemir University,[],['Turkey (Türkiye)']
NCT06708559,Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants,"Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants: A Prospective, Observational Study",ACTIVE_NOT_RECRUITING,2024-11-29,2026-01-30,2026-08-31,OBSERVATIONAL,,60,['Healthy'],Healthy,Société des Produits Nestlé (SPN),"['Asian Hospital and Medical Center, Muntinlupa City, Philippines']",['Philippines']
NCT06616974,A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study),"A Phase 2, Double-blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of TX000045 After 24 Weeks of Treatment in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (PH-HFpEF)",RECRUITING,2024-09-04,2026-10-09,2026-11-20,INTERVENTIONAL,PHASE2,180,"['Pulmonary Hypertension', 'Heart Failure With Preserved Ejection Fraction']",Pulmonary Hypertension,Tectonic Therapeutic,[],"['Belgium', 'Bulgaria', 'New Zealand', 'Moldova', 'United States', 'Georgia', 'Germany', 'Spain', 'Romania', 'Latvia', 'Poland', 'Portugal', 'Serbia', 'Armenia', 'Australia']"
NCT05001880,Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma,Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma,RECRUITING,2022-03-22,2026-08-20,2026-08-20,INTERVENTIONAL,PHASE2,66,['Peritoneal Malignant Mesothelioma'],Peritoneal Malignant Mesothelioma,National Cancer Institute (NCI),[],['United States']
NCT07183319,Circulating Tumor DNA Response In Urothelial Cancer,Circulating Tumor DNA Response Adapted Treatment De-escalation Metastatic Urothelial Carcinoma (CT-READ),RECRUITING,2025-12,2028-03,2029-03,INTERVENTIONAL,PHASE2,30,['Urothelial Carcinoma'],Urothelial Carcinoma,University of Oklahoma,"['Natera, Inc.']",['United States']
NCT06293365,Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease,"A Randomized, Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL Pre-filled Syringe With 1 mL Pre-filled Syringe in Adult Participants With Autoimmune Disease",ACTIVE_NOT_RECRUITING,2024-07-02,2025-06-05,2029-01-04,INTERVENTIONAL,PHASE2,155,"['Sjögrens Disease', 'Systemic Lupus Erythematosus', 'Rheumatoid Arthritis']",Sjögrens Disease,Novartis Pharmaceuticals,[],"['Hungary', 'United States', 'Spain', 'Italy', 'Canada', 'Czechia', 'Poland', 'Argentina']"
NCT06649981,Aging Resilience Through Microbiota Optimization and Regulation,"Intestinal Microbiota Transplant as a Strategy to Enhance the Resilience Capacity of the Elderly Aiming to Retain Muscular, Cognitive, and Metabolic Functions in a Stressful Environment.",RECRUITING,2025-01-10,2026-09-30,2027-09-30,INTERVENTIONAL,PHASE1,80,"['Resilience', 'Cognitive Function and Well-Being', 'Muscle Function, Handgrip Strength Test', 'Insulin Sensitivity']",Resilience,"Gonzalo Jorquera, PhD","['Universidad de los Andes, Chile']",['Chile']
NCT02568267,"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)","An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients With Locally Advanced or Metastatic Solid Tumors That Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements",ACTIVE_NOT_RECRUITING,2015-11-19,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,534,"['Breast Cancer', 'Cholangiocarcinoma', 'Colorectal Cancer', 'Head and Neck Neoplasms', 'Lymphoma, Large-Cell, Anaplastic', 'Melanoma', 'Neuroendocrine Tumors', 'Non-Small Cell Lung Cancer', 'Ovarian Cancer', 'Pancreatic Cancer', 'Papillary Thyroid Cancer', 'Primary Brain Tumors', 'Renal Cell Carcinoma', 'Sarcomas', 'Salivary Gland Cancers', 'Adult Solid Tumor']",Breast Cancer,Hoffmann-La Roche,[],"['Singapore', 'Belgium', 'Japan', 'Hong Kong', 'Netherlands', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT07212075,Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups,Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups,RECRUITING,2025-01-01,2027-08-31,2027-12-31,OBSERVATIONAL,,1809,"['Diabetes (DM)', 'Diabete Mellitus', 'Diabete Type 1', 'Diabete Type 2', 'Diabetes Distress', 'Diabetes Complications', 'Depression - Major Depressive Disorder', 'Depression Anxiety Disorder', 'Depression Bipolar', 'Depression Disorders', 'Anxiety Disorder (Panic Disorder or GAD)', 'Anxiety Disorder NOS', 'Eating Disorder Binge', 'Anorexia Nervosa', 'Bulimia Nervosa', 'Eating Disorder Not Otherwise Specified', 'Depressed Mood', 'Anxiety Symptoms', 'Disordered Eating Behaviors', 'Fear of Hypoglycemia']",Diabetes (DM),Forschungsinstitut der Diabetes Akademie Mergentheim,[],['Germany']
NCT07101458,The Eswatini PRISM Study on Adolescents Living With HIV,"Feasibility and Acceptability of the Promoting Resilience in Stress Management (PRISM) Intervention Among Adolescents (10 - 19 Years) Living With HIV in Eswatini: A Single Site, Single-Blind, Randomized Controlled Pilot Clinical Trial",RECRUITING,2025-12-30,2026-12-30,2026-12-30,INTERVENTIONAL,NA,140,"['Human Immunodeficiency Virus', 'Psychological Stress']",Human Immunodeficiency Virus,Eswatini Nazarene Health Institutions,"['Baylor Foundation Eswatini', 'Dana-Farber Cancer Institute', 'University of Eswatini']",['Eswatini']
NCT07264426,Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study,Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study,RECRUITING,2025-08-11,2029-10,2029-10,OBSERVATIONAL,,200,"['Chronic Inflammatory Demyelinating Polyradiculoneuropathy', 'CIDP', 'CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)']",Chronic Inflammatory Demyelinating Polyradiculoneuropathy,argenx,[],"['United States', 'Germany']"
NCT06717308,Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications.,Surgical Drape With an Atraumatic Acrylic Adhesive for Negative Pressure Wound Therapy,RECRUITING,2025-02-10,2026-08-31,2026-09-15,INTERVENTIONAL,NA,300,"['Frequency and Type of Medical Adhesive-Related Skin Injury', 'NPWT Drape Seal Effectiveness Rate (or Leak Incidence Rate)', 'Clinician Acceptability of New NPWT Drape', 'Patient Drop-out Rate From Prescribed NPWT Treatment', 'Pain Assessment During Medical Adhesive Drape Removal']",Frequency and Type of Medical Adhesive-Related Skin Injury,"Global Biomedical Technologies, LLC","['National Institute for Biomedical Imaging and Bioengineering (NIBIB)', 'Weill Medical College of Cornell University', 'Columbia University']",['United States']
NCT07262658,Cognitive Disparities in Parkinson's Disease,Disparities in Neurocognitive Impairment Among Hispanics/Latinos in the US With Parkinson's Disease: The Role of Cardiovascular Risk,RECRUITING,2022-09-30,2025-12-31,2025-12-31,OBSERVATIONAL,,120,['Parkinson Disease'],Parkinson Disease,Duke University,[],['United States']
NCT05337098,Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes,Non-Nutritive Sweetener Consumption (Aspartame and Sucralose) and Glucose Homeostasis in Older Adults With Prediabetes,RECRUITING,2023-04-18,2026-02-28,2026-02-28,INTERVENTIONAL,NA,30,"['Continuous Glucose Monitoring', 'Oral Glucose Tolerance', 'Insulin Sensitivity', 'Inflammatory Markers']",Continuous Glucose Monitoring,Virginia Polytechnic Institute and State University,[],['United States']
NCT07264673,A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.,A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.,RECRUITING,2025-04-17,2027-10,2029-10,INTERVENTIONAL,PHASE2,160,['NSCLC'],NSCLC,Fondazione Ricerca Traslazionale,[],['Italy']
NCT06807983,LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly,Impact of a Management Strategy for Acute Dyspnea in Elderly Subjects Based on the Use of Lung and Cardiac Ultrasonography,RECRUITING,2025-11-04,2027-05-01,2027-05-01,INTERVENTIONAL,NA,504,"['Dyspnea', 'Respiratory Distress Syndrome']",Dyspnea,"University Hospital, Toulouse",[],['France']
NCT07008820,Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan,Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (LR-MDS) or Unexplained Anemia In Japan,RECRUITING,2025-05-13,2026-02-28,2026-02-28,OBSERVATIONAL,,50,['Myelodysplastic Syndrome (MDS)'],Myelodysplastic Syndrome (MDS),Bristol-Myers Squibb,[],['Japan']
NCT06047457,A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults,"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Episodic Migraine in Adult Participants",ACTIVE_NOT_RECRUITING,2023-09-29,2026-06-22,2026-12-21,INTERVENTIONAL,PHASE3,714,['Episodic Migraine'],Episodic Migraine,Ipsen,[],"['United States', 'France', 'Georgia', 'Spain', 'Canada', 'Czechia', 'Poland', 'Germany']"
NCT06680128,"A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults","A 2-Stage, Phase I/II, Active-controlled, Randomized, Observer-blinded, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis mRNA Vaccines (GBP560) in Healthy Adults (Aged 18 Years and Older)",RECRUITING,2025-02-24,2026-06-26,2028-03-19,INTERVENTIONAL,PHASE1,402,['Japanese Encephalitis Virus Disease'],Japanese Encephalitis Virus Disease,"SK Bioscience Co., Ltd.",[],"['New Zealand', 'Australia']"
NCT05194397,Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors,Intensive Tailored Exercise Training With NAD+ Precursor Supplementation to Improve Muscle Mass and Fitness in Adolescent and Young Adult Hematopoietic Cell Transplant Survivors,RECRUITING,2023-02-23,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE2,80,"['Lymphoblastic Leukemia', 'Cancer Survivors', 'Aplastic Anemia', 'Myelodysplastic Syndromes', 'Myeloid Leukemia']",Lymphoblastic Leukemia,Children's Hospital of Philadelphia,"['National Institutes of Health (NIH)', 'City of Hope Medical Center', ""St. Jude Children's Research Hospital"", 'National Cancer Institute (NCI)', 'University of Pennsylvania']",['United States']
NCT07218601,Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer,Electronic Nose (E-nose) Technology to Assess Pathologic Response and Post- Treatment Progression for Non-small Cell Lung Cancer: a Phase II Study,RECRUITING,2025-10-10,2027-10,2027-10,INTERVENTIONAL,PHASE2,50,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06519357,"A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI)","A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI)",ACTIVE_NOT_RECRUITING,2024-10-28,2025-09-05,2026-03,INTERVENTIONAL,PHASE2,23,['Mild Cognitive Impairment'],Mild Cognitive Impairment,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",['IrsiCaixa'],['Spain']
NCT05081245,ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD),"A Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD).",ACTIVE_NOT_RECRUITING,2022-09-13,2026-10,2026-11,INTERVENTIONAL,PHASE2,150,['Autism Spectrum Disorder'],Autism Spectrum Disorder,MapLight Therapeutics,[],"['United States', 'Canada', 'Australia']"
NCT06843239,Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE),"A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis",RECRUITING,2025-02-06,2026-12,2027-05,INTERVENTIONAL,PHASE2,80,"['Systemic Sclerosis (SSc)', 'Scleroderma']",Systemic Sclerosis (SSc),Zura Bio Inc,[],"['United States', 'Mexico', 'Chile', 'United Kingdom', 'Argentina', 'Serbia']"
NCT05553041,18F-Fluciclovine PET-MRI in High-grade Glioma,Evaluation of 18F-Fluciclovine PET-MRI to Differentiate Tumor Progression From Post-treatment Changes in Pediatric High-grade Glioma (HGG),RECRUITING,2024-08-07,2026-12,2027-12,INTERVENTIONAL,EARLY_PHASE1,30,"['Glioma', 'High Grade Glioma', 'Glioma, Malignant', 'Glioma Intracranial', 'Diffuse Glioma']",Glioma,Children's Hospital of Philadelphia,"['Blue Earth Diagnostics', 'Dragon Master Foundation']",['United States']
NCT01011712,The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise,The Natural History of Severe Viral Infections and Characterization of Immune Defects,RECRUITING,2009-10-01,,,OBSERVATIONAL,,600,"['EBV', 'HSV', 'VZV', 'HPV', 'CMV']",EBV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07134192,Fluorescence-Guided Optimization of Sarcoma Margins,Fluorescence-Guided Optimization of Sarcoma Margins,RECRUITING,2025-09-01,2028-02-01,2028-03-01,INTERVENTIONAL,NA,90,"['Soft Tissue Sarcoma of the Trunk and Extremities', 'Sarcoma']",Soft Tissue Sarcoma of the Trunk and Extremities,University of Aarhus,[],['Denmark']
NCT07103499,Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH),Effects of Abdominal Endurance and Core Stabilization Exercises on Respiratory Functions in Overweight and Obese Women,RECRUITING,2025-12-15,2025-12-15,2026-01-15,INTERVENTIONAL,NA,48,"['Obesity', 'Overweight', 'Pulmonary Disease', 'Muscle Weakness']",Obesity,Ondokuz Mayıs University,[],['Turkey (Türkiye)']
NCT03971253,Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis,Japan Post-Marketing Surveillance - Specified Drug Use-results Survey for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis,RECRUITING,2019-09-02,2026-05-31,2026-05-31,OBSERVATIONAL,,3000,['Rheumatoid Arthritis (RA)'],Rheumatoid Arthritis (RA),Astellas Pharma Inc,[],['Japan']
NCT04576156,A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment,"A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat (GRN163L) Versus Best Available Therapy (BAT) in Patients With Intermediate-2 or High-risk Myelofibrosis (MF) Relapsed / Refractory (R/R) to Janus Kinase (JAK) Inhibitor",ACTIVE_NOT_RECRUITING,2021-04-12,2028-06-30,2028-06-30,INTERVENTIONAL,PHASE3,327,['Myelofibrosis'],Myelofibrosis,Geron Corporation,[],"['Bulgaria', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Denmark', 'South Korea', 'Colombia', 'Poland', 'India', 'Singapore', 'Georgia', 'Spain', 'Taiwan', 'Malaysia', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT04775082,SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity,"Effect and Safety of Liraglutide 3.0 mg on Weight Management in Children With Obesity Aged 6 to Below 12 Years: 56-week, Double-blind, Randomised, Placebo-controlled Trial",ACTIVE_NOT_RECRUITING,2021-03-04,2023-08-01,2027-01-15,INTERVENTIONAL,PHASE3,78,['Obesity'],Obesity,Novo Nordisk A/S,[],"['Belgium', 'Israel', 'Russia', 'United States', 'Mexico', 'Switzerland', 'Malaysia', 'Portugal', 'India']"
NCT02821741,Effects of External Ear Stimulation on Pain Perception and Mood,Effects of External Ear Stimulation on Pain Perception and Mood,RECRUITING,2016-10-18,2026-03-30,2026-03-30,INTERVENTIONAL,NA,76,['Pain in Healthy Participants'],Pain in Healthy Participants,National Center for Complementary and Integrative Health (NCCIH),[],['United States']
NCT02567422,"Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer","A Phase I Study of M6620 (VX-970, Berzosertib) in Combination With Cisplatin and XRT in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)",ACTIVE_NOT_RECRUITING,2017-04-17,2023-12-31,2026-05-14,INTERVENTIONAL,PHASE1,43,"['Head and Neck Carcinoma of Unknown Primary', 'Head and Neck Squamous Cell Carcinoma', 'Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7', 'Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7', 'Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7', 'Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7', 'Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7']",Head and Neck Carcinoma of Unknown Primary,National Cancer Institute (NCI),[],['United States']
NCT07265323,Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition,Effect of Physiologic Insulin Intervention on Insulin Sensitivity and Cognition,RECRUITING,2025-12,2027-05,2027-05,INTERVENTIONAL,NA,8,"['Alzheimer s Disease', 'Alzheimer Blood Biomarkers', 'Insulin Sensitivity']",Alzheimer s Disease,Pennington Biomedical Research Center,[],['United States']
NCT07046559,"A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants","A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants",RECRUITING,2025-05-13,2027-09,2027-09,INTERVENTIONAL,PHASE1,104,"['Healthy', 'Cancer']",Healthy,Eli Lilly and Company,[],['United Kingdom']
NCT06174376,Clinical Outcomes of the Gore Synthetic Cornea Device,"A Prospective, Multi-Center, Early Feasibility Study to Assess Clinical Outcomes of the GORE Synthetic Cornea Device in Patients With Loss of Corneal Clarity",RECRUITING,2024-08-19,2026-12-31,2030-12-31,INTERVENTIONAL,NA,10,['Corneal Opacity'],Corneal Opacity,W.L.Gore & Associates,[],['Mexico']
NCT04935840,Evaluation of the Effect of FertyBiotic Pregnancy in the Metabolic Profile in Pregnant Women,Clinical Study to Evaluate the Effect of a Food Supplement With Probiotics on the Metabolic Profile of Pregnant Women,ACTIVE_NOT_RECRUITING,2021-05-05,2025-11-01,2026-03-23,INTERVENTIONAL,NA,84,['Pregnancy Related'],Pregnancy Related,Fertypharm,[],['Spain']
NCT04345913,Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer,A Phase I/II Trial Evaluating the Safety and Efficacy of Eribulin in Combination With Copanlisib in Patients With Metastatic Triple Negative Breast Cancer,ACTIVE_NOT_RECRUITING,2021-03-01,2024-03-28,2026-05-07,INTERVENTIONAL,PHASE1,24,"['Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic Triple-Negative Breast Carcinoma', 'Unresectable Triple-Negative Breast Carcinoma']",Anatomic Stage III Breast Cancer AJCC v8,National Cancer Institute (NCI),[],['United States']
NCT06711887,Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension),An Open-label Extension Study to Assess the Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Adult Participants With Lupus Nephritis Who Have Completed Study Treatment in the CVAY736K12301 Core Study (SIRIUS-LN Extension),RECRUITING,2025-05-19,2030-07-18,2032-07-28,INTERVENTIONAL,PHASE3,316,['Lupus Nephritis'],Lupus Nephritis,Novartis Pharmaceuticals,[],"['Singapore', 'Hungary', 'China', 'Mexico', 'Taiwan', 'South Korea', 'Thailand']"
NCT05911893,the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children,the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children,RECRUITING,2024-06-17,2026-12-31,2027-06-30,INTERVENTIONAL,NA,200,"['Malnutrition, Child', 'Malnourishment', 'Nutritional Deficiency', 'Undernutrition']","Malnutrition, Child",Children's Hospital of Chongqing Medical University,"[""Anhui Provincial Children's Hospital"", 'Baoji Maternity and Child Healthcare Hospital', ""Chengdu Women's and Children's Central Hospital"", 'Guiyang Maternity and Child Health Care Hospital', ""Guangzhou Women and Children's Medical Center"", ""Hunan Children's Hospital"", 'Jiangxi Maternal and Child Health Hospital', ""Kunming Children's Hospital"", 'Nanjing Maternity and Child Health Care Hospital', ""Children's Hospital of The Capital Institute of Pediatrics"", ""Xianyang Children's Hospital"", 'Nestle Health Science', 'The First Hospital of Jilin University']",['China']
NCT05895981,Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.,An Exploratory Clinical Trial to Evaluate the Safety and Efficacy of Sacral Nerve Stimulation in Patients,RECRUITING,2023-07-20,2026-03-01,2027-12-01,INTERVENTIONAL,NA,15,['Ulcerative Colitis'],Ulcerative Colitis,Xijing Hospital,[],['China']
NCT03764852,"AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.","Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.",RECRUITING,2019-12-14,2026-09,2026-12,INTERVENTIONAL,NA,80,['Pelvic Organ Prolapse'],Pelvic Organ Prolapse,Centre Hospitalier Universitaire de Nice,[],['France']
NCT07209449,A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer,"Phase II Study of ELacestrant in Combination With Abemaciclib or Elacestrant Alone In p53 Wild Type, Estrogen Receptor-positive Advanced or recurrenT Endometrial Cancer (ELITE)",RECRUITING,2025-10-01,2028-10-01,2028-10-01,INTERVENTIONAL,PHASE2,75,['Endometrial Cancer'],Endometrial Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06383403,A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.,"A Phase IIIb Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Effect of Elafibranor 80 mg on Normalisation of Alkaline Phosphatase in Adult Participants With Primary Biliary Cholangitis (PBC) and Inadequate Response or Intolerance to Ursodeoxycholic Acid.",ACTIVE_NOT_RECRUITING,2024-07-09,2026-06-26,2026-06-26,INTERVENTIONAL,PHASE3,69,['Primary Biliary Cholangitis'],Primary Biliary Cholangitis,Ipsen,[],"['United States', 'France', 'Spain', 'Italy', 'Romania', 'Czechia', 'South Korea', 'Poland', 'United Kingdom', 'Germany']"
NCT01851447,Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy,Pilot Study to Assess Biomarkers of Changes in Barrier Function of Skeletal Muscle in Patients With a Fragile Sarcolemmal Muscular Dystrophy,ACTIVE_NOT_RECRUITING,2014-11-03,2025-12-31,,OBSERVATIONAL,,11,['Genetic Disorder'],Genetic Disorder,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),"['National Institute of Neurological Disorders and Stroke (NINDS)', 'National Institutes of Health Clinical Center (CC)', 'University of Massachusetts, Worcester']",['United States']
NCT05921552,Senior Adult Hepatobiliary Prehab Study,Feasibility of Exercise Prehabilitation Among Older Patients With Hepatobiliary Cancer Planning for Surgery,ACTIVE_NOT_RECRUITING,2023-06-26,2026-11-19,2026-11-19,INTERVENTIONAL,NA,25,"['Hepatobiliary Cancer', 'Cholangiocarcinoma', 'Liver Metastases']",Hepatobiliary Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT07264504,Experimentation of Formaldehyde Purification by Plants in the Anatomy and Cytology Department,Experimentation of Formaldehyde Purification by Plants in the Anatomy and Cytology Department,RECRUITING,2024-09-25,2024-12-31,2026-05,INTERVENTIONAL,NA,30,"['Formaldehyde', 'Pathological Anatomy and Cytology']",Formaldehyde,"Centre Hospitalier Universitaire, Amiens",[],['France']
NCT02741440,Natural History of Spinocerebellar Ataxia Type 7 (SCA7),Natural History of Spinocerebellar Ataxia Type 7 (SCA7),RECRUITING,2016-07-11,2028-12-31,2028-12-31,OBSERVATIONAL,,25,['Spinocerebellar Ataxia'],Spinocerebellar Ataxia,National Eye Institute (NEI),[],['United States']
NCT04790344,LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.,LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study (LUX-Dx TRENDS),ACTIVE_NOT_RECRUITING,2021-03-20,2026-05,2026-06,INTERVENTIONAL,NA,525,['Heart Failure'],Heart Failure,Boston Scientific Corporation,[],['United States']
NCT07263438,Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial,Open-label Phase II Clinical Trial to Test the Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma,RECRUITING,2025-11-03,2028-03-30,2030-12-31,INTERVENTIONAL,PHASE2,59,"['Glioblastoma', 'Recurrence Tumor']",Glioblastoma,Centre Hospitalier Universitaire Vaudois,[],['Switzerland']
NCT06961565,PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas,"A Phase 1/1b Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PAS-004, a MAPK/ERK Kinase 1/2 (MEK 1/2) Inhibitor, in Adult Participants With Neurofibromatosis Type 1 (NF1) With Symptomatic and Inoperable, Incompletely Resected, or Recurrent Plexiform Neurofibromas",RECRUITING,2025-05-30,2027-09,2027-12,INTERVENTIONAL,PHASE1,56,"['NF1 Mutation', 'Neurofibroma Plexiform', 'Neurofibroma, Plexiform', 'Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)', 'Neurofibromatosis Type 1 (NF1)']",NF1 Mutation,Pasithea Therapeutics Corp.,['Novotech (Australia) Pty Limited'],"['United States', 'South Korea', 'Australia']"
NCT05762107,A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes,"A Phase 2a Randomized, Double-blind, Placebo-controlled, Multiple-dose, Crossover Study of the Effect of ZT-01 on Frequency of Nocturnal Hypoglycemia in Type 1 Diabetes Mellitus",RECRUITING,2023-07-28,2026-12,2027-05,INTERVENTIONAL,PHASE2,186,['Type 1 Diabetes Mellitus With Hypoglycemia'],Type 1 Diabetes Mellitus With Hypoglycemia,Zucara Therapeutics Inc.,[],"['United States', 'Canada']"
NCT06057402,Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM),"ELRANATAMAB POST TRIAL ACCESS: AN OPEN-LABEL, SINGLE-ARM STUDY FOR PARTICIPANTS WITH MULTIPLE MYELOMA CONTINUING FROM PFIZER-SPONSORED ELRANATAMAB CLINICAL STUDIES",RECRUITING,2023-10-03,2032-02-22,2032-02-22,INTERVENTIONAL,PHASE4,80,['Multiple Myeloma'],Multiple Myeloma,Pfizer,[],"['Japan', 'China', 'United States', 'Taiwan', 'Canada']"
NCT04104412,The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain,The Safety/Efficacy Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Lumbar Discogenic Pain,RECRUITING,2019-08-15,2025-12-31,2026-06-30,INTERVENTIONAL,PHASE1,242,['Lumbar Discogenic Pain'],Lumbar Discogenic Pain,"Sclnow Biotechnology Co., Ltd.",[],['China']
NCT07214766,A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants,"A Phase 1, Randomized, Two-Part, Parallel-Group Study to Assess the Bioequivalence of Subcutaneously Administered Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Subjects",RECRUITING,2025-10-17,2026-04-15,2026-04-15,INTERVENTIONAL,PHASE1,312,['Healthy Participants'],Healthy Participants,"Genentech, Inc.",[],['United States']
NCT07264556,"Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery","Effect of Opioid-Free, Opioid-sparing Versus Opioid-based Anesthesia on Perioperative NETs and Cancer Cell Malignancy in Patients Undergoing Surgery for Colorectal Cancer: A Randomized, Controlled Trial",RECRUITING,2025-11-01,2025-11-30,2025-12-15,INTERVENTIONAL,NA,90,"['Colorectal Cancer', 'Opioid-free Anesthesia', 'NETs']",Colorectal Cancer,Fudan University,[],['China']
NCT06522204,Comparing the Gastric Emptying Times of Underweight and Healthy-weight School-aged Children,Comparing the Gastric Emptying Times of Underweight and Healthy-weight School-aged Children After Preoperative Precise Fluid Intake,RECRUITING,2024-07-30,2025-12-15,2025-12-15,INTERVENTIONAL,NA,60,['Preoperative Fasting'],Preoperative Fasting,Karaman Training and Research Hospital,[],['Turkey (Türkiye)']
NCT04130997,An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis,An Open Label Extension Study of Ublituximab in Subjects With Relapsing Multiple Sclerosis,ACTIVE_NOT_RECRUITING,2019-11-18,2030-02-01,2030-02-01,INTERVENTIONAL,PHASE3,1100,['Relapsing Multiple Sclerosis (RMS)'],Relapsing Multiple Sclerosis (RMS),"TG Therapeutics, Inc.",[],"['Russia', 'United States', 'Georgia', 'Croatia', 'Belarus', 'Poland', 'Ukraine', 'Serbia']"
NCT07102082,Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand,Ifluence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effect,RECRUITING,2025-09-25,2026-11-30,2026-11-30,INTERVENTIONAL,NA,160,['Smoking Behaviors'],Smoking Behaviors,Roswell Park Cancer Institute,['National Cancer Institute (NCI)'],['United States']
NCT04438681,Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients,INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients,ACTIVE_NOT_RECRUITING,2020-11-27,2026-11-09,2029-11-09,OBSERVATIONAL,,90,['Triple Negative Breast Cancer'],Triple Negative Breast Cancer,Centre Jean Perrin,[],['France']
NCT04871607,Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma,A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients With Primary Refractory or Relapsed Hodgkin Lymphoma,RECRUITING,2021-11-02,2029-10-02,2029-10-02,INTERVENTIONAL,PHASE2,33,"['Recurrent Hodgkin Lymphoma', 'Refractory Hodgkin Lymphoma']",Recurrent Hodgkin Lymphoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT06064136,Psoas Tenotomy Under Ultrasound,Psoas Tenotomy Under Ultrasound,RECRUITING,2025-12,2026-09,2026-09,INTERVENTIONAL,NA,15,['Hip Injuries'],Hip Injuries,Centre Hospitalier Universitaire de Nice,[],['France']
NCT00246857,Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death,Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death,RECRUITING,2007-02-12,,,OBSERVATIONAL,,5000,['Primary Immune Deficiency'],Primary Immune Deficiency,National Institute of Allergy and Infectious Diseases (NIAID),[],"['United States', 'Turkey (Türkiye)']"
NCT01174108,Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells,Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-Cells,RECRUITING,2010-12-10,2027-12-30,2028-06-30,INTERVENTIONAL,PHASE2,120,"['Severe Aplastic Anemia', 'MDS (Myelodysplastic Syndrome)']",Severe Aplastic Anemia,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT05636527,Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System,"A Non-Randomized, Prospective or Retrospective, Open-Label, Multi-Center, Observational Clinical Study With Two Arms to Further Evaluate Safety and Performance of the NEXUS® Aortic Arch Stent Graft System and the Custom-Made NEXUS Multibranch™ Aortic Arch Stent Graft System",RECRUITING,2022-11-09,2027-03,2030-07,OBSERVATIONAL,,70,['AAT9'],AAT9,Endospan Ltd.,[],"['Belgium', 'Netherlands', 'France', 'Switzerland', 'Spain', 'Cyprus', 'Italy', 'Greece', 'Poland', 'Germany']"
NCT04458922,Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma,A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Chondrosarcoma and Clear Cell Sarcoma,ACTIVE_NOT_RECRUITING,2020-10-05,2022-11-28,2025-12-13,INTERVENTIONAL,PHASE2,27,"['Central Chondrosarcoma, Grade 2', 'Central Chondrosarcoma, Grade 3', 'Dedifferentiated Chondrosarcoma', 'Metastatic Clear Cell Sarcoma of Soft Tissue', 'Metastatic Primary Central Chondrosarcoma', 'Unresectable Primary Central Chondrosarcoma']","Central Chondrosarcoma, Grade 2",National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT04863885,Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients,Phase I/II Study of Ipilimumab Plus Nivolumab (IPI-NIVO) Combined With Sacituzumab Govitecan (SG)as First-line Treatment for Cisplatin-ineligible Metastatic Urothelial Carcinoma,ACTIVE_NOT_RECRUITING,2021-04-30,2025-09-12,2027-10,INTERVENTIONAL,PHASE1,46,['Metastatic Urothelial Carcinoma'],Metastatic Urothelial Carcinoma,H. Lee Moffitt Cancer Center and Research Institute,"['Bristol-Myers Squibb', 'Gilead Sciences']",['United States']
NCT06133127,Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?,Is There an Association Between Quadriceps Strength and Different Markers of Fragility in Patients With Cirrhosis?,RECRUITING,2023-11-20,2026-05,2026-12,INTERVENTIONAL,NA,60,['Cirrhosis'],Cirrhosis,"University Hospital, Clermont-Ferrand",[],['France']
NCT05438927,Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer,Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer,ACTIVE_NOT_RECRUITING,2022-07-15,2024-10-16,2026-02,INTERVENTIONAL,NA,50,['Pancreatic Cancer'],Pancreatic Cancer,H. Lee Moffitt Cancer Center and Research Institute,['Canopy Cancer Collective'],['United States']
NCT02974582,Understanding How Cigarette Direct Mail Marketing Influences Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers,Understanding How Cigarette Direct Mail Marketing Influence Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers,RECRUITING,2026-10-17,2027-10-06,2027-10-06,INTERVENTIONAL,NA,530,['Nicotine Dependence'],Nicotine Dependence,National Institute on Minority Health and Health Disparities (NIMHD),[],['United States']
NCT07263841,Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation,Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigmentation,ACTIVE_NOT_RECRUITING,2025-06-01,2025-12-26,2026-03-26,INTERVENTIONAL,PHASE2,60,['Post Burn Facial Hyperpigmentation'],Post Burn Facial Hyperpigmentation,King Edward Medical University,[],['Pakistan']
NCT06760156,Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym,Phase 2 Study of Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lymphoma After Axicabtagene Ciloleucel,RECRUITING,2025-03-19,2027-01,2028-01,INTERVENTIONAL,PHASE2,28,['Large B-cell Lymphoma'],Large B-cell Lymphoma,H. Lee Moffitt Cancer Center and Research Institute,['Incyte Corporation'],['United States']
NCT07165860,Clinical Trial to Reduce Perinatal Intimate Partner Violence,Novel Doula Intervention to Leverage Clinic-community Connections to Support Perinatal Intimate Partner Violence Survivors,RECRUITING,2025-11-01,2028-10,2029-10,INTERVENTIONAL,NA,326,"['Domestic Violence', 'Perinatal Problems']",Domestic Violence,University of Pittsburgh,['National Institute of Nursing Research (NINR)'],['United States']
NCT05454150,Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST),Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis,ACTIVE_NOT_RECRUITING,2023-04-19,2025-10-29,2035-12-29,INTERVENTIONAL,NA,1960,['Aortic Valve Stenosis'],Aortic Valve Stenosis,"University Hospital, Lille","['Ministry of Health, France', 'Institut universitaire de cardiologie et de pneumologie de Québec, University Laval']",['France']
NCT06639360,Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke,Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke,RECRUITING,2025-08-02,2026-09-30,2026-12-31,INTERVENTIONAL,NA,60,"['Ischemic Stroke, Acute', 'Endovascular Thrombectomy']","Ischemic Stroke, Acute",Xijing Hospital,[],['China']
NCT00071045,Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members,"Collection of Blood, Bone Marrow, Urine, and/or Tissue Samples From Patients With Solid Tumors, Hematological Malignancies or Non-Malignant Hematologic Disorders or HLA Compatible Family Members",RECRUITING,2003-10-08,,,OBSERVATIONAL,,6000,"['Neoplasms', 'Hematologic Neoplasms', 'Healthy Volunteers']",Neoplasms,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT04603807,A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases,"Randomized, Open Label, Multicenter, Phase III Study of Entrectinib Versus Crizotinib in Patients With Locally-Advanced or Metastatic Non-Small Cell Lung Cancer Harboring ROS1 Gene Rearrangements With and Without Central Nervous System Metastases",RECRUITING,2021-09-30,2028-06-26,2028-06-26,INTERVENTIONAL,PHASE3,220,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Hoffmann-La Roche,[],"['Netherlands', 'China', 'Slovakia', 'Jordan', 'Russia', 'France', 'Croatia', 'Thailand', 'India', 'Lebanon', 'Mexico', 'Spain', 'Romania', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Italy']"
NCT06876714,ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab,ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade,RECRUITING,2025-09-17,2028-03-13,2037-03-13,INTERVENTIONAL,PHASE3,1524,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Early Stage Breast Carcinoma']",Anatomic Stage I Breast Cancer AJCC v8,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT07265414,DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy,DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy,ACTIVE_NOT_RECRUITING,2021-01-01,2026-01,2026-01,OBSERVATIONAL,,320,"['Prostate Cancer', 'Bladder Cancer']",Prostate Cancer,Istituto Clinico Humanitas,['Fondazione Humanitas per la Ricerca'],['Italy']
NCT07011043,A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE),"A Phase 1b Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Budoprutug (TNT119) in Adult Subjects With Systemic Lupus Erythematosus (SLE)",RECRUITING,2025-07-10,2027-04,2027-04,INTERVENTIONAL,PHASE1,30,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,"Climb Bio, Inc.",[],"['Bulgaria', 'United States', 'Puerto Rico', 'Spain', 'Romania', 'Greece', 'Ukraine']"
NCT07263217,Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury,Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury,RECRUITING,2025-10-01,2028-09-30,2028-09-30,INTERVENTIONAL,NA,30,['Cholangiocarcinoma'],Cholangiocarcinoma,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT07262840,Health Behavior Change in High-Risk Colorectal Cancer Individuals,Facilitating Health Behavior Change in High-Risk Individuals for Colorectal Cancer: A Randomized Controlled Trial,RECRUITING,2025-11-10,2026-02-10,2026-02-10,INTERVENTIONAL,NA,80,"['Health Behavior', 'Colorectal Neoplasms', 'Primary Prevention/Methods']",Health Behavior,"China Medical University, China",[],['China']
NCT03075696,"A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma","A Multicenter, Open-label, Phase I/II Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of Escalating Doses of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab Administered After a Fixed, Single Dose Pre-treatment of Obinutuzumab (Gazyva®/Gazyvaro™) in Patients With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma",RECRUITING,2017-02-21,2029-12-31,2029-12-31,INTERVENTIONAL,PHASE1,920,"[""Non-Hodgkin's Lymphoma""]",Non-Hodgkin's Lymphoma,Hoffmann-La Roche,[],"['Belgium', 'New Zealand', 'United States', 'France', 'Finland', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'Poland', 'Australia']"
NCT06809309,The Ventilation During In-hospital Cardiac Arrest Study,The Ventilation During In-Hospital Cardiac Arrest (VENT-IHCA) Study,RECRUITING,2025-02-01,2026-12,2027-01,OBSERVATIONAL,,900,"['Cardiac Arrest (CA)', 'In-Hospital Cardiac Arrest', 'Heart Arrest']",Cardiac Arrest (CA),University of Aarhus,[],"['Denmark', 'Norway']"
NCT05585229,Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication,Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study,RECRUITING,2025-10-27,2026-08-31,2026-08-31,INTERVENTIONAL,PHASE2,10,"['Opioid Dependence', 'Chronic Pain']",Opioid Dependence,University of British Columbia,['Etheridge Foundation'],['Canada']
NCT07159828,A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors,A Phase 1 Open-label Study to Assess AXN-2510 Monotherapy in Adult Patients With Advanced Solid Tumors,RECRUITING,2025-09-15,2026-07,2027-05-15,INTERVENTIONAL,PHASE1,52,"['Solid Tumor, Adult']","Solid Tumor, Adult","Axion Bio, Inc",['Instil Bio'],['United States']
NCT07180381,Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer,Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer,RECRUITING,2025-05-14,2031-01,2031-01,INTERVENTIONAL,NA,503,['Prostate Cancer'],Prostate Cancer,St. Antonius Hospital,[],['Netherlands']
NCT06526858,"Early Feasibility Study of ""HyperQureTM RDN System"", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension","A Prospective, Multicenter, Single Arm, Open-label, Early Feasibility Study to Evaluate Initial Safety and Device Design Concept of ""HyperQureTM RDN System"", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension on Three(3) or More Antihypertensive Medications",RECRUITING,2024-11-21,2026-06-18,2029-03-20,INTERVENTIONAL,NA,15,['Resistant Hypertension'],Resistant Hypertension,DeepQure Inc.,[],['United States']
NCT07262853,Dual Executive Function Training Package,Examining the Effectiveness of a Dual Executive Function Training Package: Protocol for a Randomised Controlled Trial,RECRUITING,2025-10-13,2026-06-30,2026-09-30,INTERVENTIONAL,NA,288,"['ADHD', 'Dyslexia', 'Autism']",ADHD,Education University of Hong Kong,[],['Hong Kong']
NCT01386424,Screening for LID Clinical Studies Unit Healthy Volunteer Protocols,Screening for LID Clinical Studies Unit Healthy Volunteer Protocols,RECRUITING,2011-07-20,,,OBSERVATIONAL,,5000,"['Zika', 'Influenza']",Zika,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT03523858,A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis,"An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients With Progressive Multiple Sclerosis",ACTIVE_NOT_RECRUITING,2018-05-28,2026-01-15,2026-12-04,INTERVENTIONAL,PHASE3,927,['Progressive Multiple Sclerosis (PMS)'],Progressive Multiple Sclerosis (PMS),Hoffmann-La Roche,[],"['Netherlands', 'Bosnia and Herzegovina', 'Hungary', 'Panama', 'Russia', 'France', 'Denmark', 'Guatemala', 'Colombia', 'Czechia', 'Poland', 'Costa Rica', 'Lebanon', 'Mexico', 'Spain', 'Canada', 'United Arab Emirates', 'Germany', 'Brazil', 'United States', 'Ireland', 'Italy', 'Morocco', 'Egypt']"
NCT06952049,Does Psychoeducation Improve the Pain Relief Derived From a Brief Intervention,Does Psychoeducation Improve the Pain Relief Derived From a Brief Mindfulness-Based Intervention Delivered in a Clinic Waiting Room,RECRUITING,2025-04-10,2026-02-01,2026-02-01,INTERVENTIONAL,NA,200,"['Pain', 'Acute Pain']",Pain,Florida State University,[],['United States']
NCT06777979,CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia,CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia (1922CAR),RECRUITING,2025-04-28,2030-01,2031-01,INTERVENTIONAL,PHASE1,30,"['Acute Lymphoblastic Leukemia', 'Recurrent Acute Lymphoblastic Leukemia', 'Recurrent B Acute Lymphoblastic Leukemia']",Acute Lymphoblastic Leukemia,St. Jude Children's Research Hospital,[],['United States']
NCT06141473,Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis,"Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis",RECRUITING,2023-12-13,2027-05-06,2027-05-06,INTERVENTIONAL,PHASE3,1600,['Multiple Sclerosis'],Multiple Sclerosis,Sanofi,[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Slovakia', 'Lithuania', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Croatia', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT00397280,Immune Cell Response to Stimuli,Innate Immunity Signal Transduction in Human Leukocytes,RECRUITING,2009-07-13,,,OBSERVATIONAL,,750,['Inflammation'],Inflammation,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT03223610,"Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma","Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma",RECRUITING,2018-02-09,2026-12-01,2027-12-01,INTERVENTIONAL,PHASE1,145,"['Lymphoma', 'Non-Hodgkin Lymphoma', 'Diffuse Large B-Cell Lymphoma', 'Burkitt Lymphoma']",Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT07018713,A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Chronic Migraine",RECRUITING,2025-08-21,2027-10,2028-03,INTERVENTIONAL,PHASE3,780,['Chronic Migraine'],Chronic Migraine,Merz Therapeutics GmbH,[],"['Austria', 'United States', 'Slovakia', 'Spain', 'Italy', 'Poland', 'Germany']"
NCT07102628,Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes: Victorion - RIDES",RECRUITING,2025-10-03,2027-02-15,2027-02-15,INTERVENTIONAL,PHASE3,300,['Acute Coronary Syndrome'],Acute Coronary Syndrome,Novartis Pharmaceuticals,[],['Japan']
NCT06305247,A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours,"An Open-label, Phase I/IIa First-in-human, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Antitumour Activity of ERK1/2 Inhibitor IPN01194 as Single Agent in Adult Participants With Advanced Solid Tumours",RECRUITING,2024-04-03,2028-03-20,2028-03-20,INTERVENTIONAL,PHASE1,220,"['Melanoma', 'Head and Neck Squamous Cell Carcinoma', 'Pancreatic Ductal Adenocarcinoma', 'Colorectal Cancer', 'Solid Tumor']",Melanoma,Ipsen,[],"['Spain', 'United States', 'France']"
NCT05894239,A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer,"A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo As Maintenance Therapy After First Line Induction Therapy in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer",RECRUITING,2023-09-08,2026-09-28,2032-12-28,INTERVENTIONAL,PHASE3,230,['Metastatic Breast Cancer'],Metastatic Breast Cancer,Hoffmann-La Roche,[],"['Hong Kong', 'China', 'Kenya', 'Jordan', 'Australia', 'Belgium', 'Oman', 'Tunisia', 'France', 'Uganda', 'Finland', 'South Korea', 'Colombia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06994377,Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy,The Impact of Emotional Distress on First Line Therapy in Patients With Metastatic Breast Cancer (EIRENE): a Prospective Observational Study,RECRUITING,2025-06-25,2029-06,2029-06,OBSERVATIONAL,,1000,['Metastatic Breast Cancer'],Metastatic Breast Cancer,European Institute of Oncology,[],['Italy']
NCT07237425,Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma,"A Safety, Efficacy and Pharmacokinetic Evaluation Study of Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma",RECRUITING,2025-11-14,2026-11-14,2027-01-14,INTERVENTIONAL,PHASE1,56,"['Lipoma', 'Submental Fullness']",Lipoma,"Glonova Pharma Co., Ltd","['T-TOP Clinical Research Co., Ltd.']",['Taiwan']
NCT00342927,Family Investigation of Nephropathy and Diabetes (F.I.N.D.),Family Investigation of Nephropathy and Diabetes (F.I.N.D.),RECRUITING,2001-03-07,,,OBSERVATIONAL,,100000,"['Diabetic Nephropathy', 'Diabetes Mellitus', 'Diabetic Kidney Disease', 'Albuminuria']",Diabetic Nephropathy,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07264803,A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers,A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Refractory Cancers,RECRUITING,2024-03-01,2027-12-30,2027-12-30,INTERVENTIONAL,PHASE2,35,"['Solid Tumor Malignancies', 'Solid Tumor Cancer']",Solid Tumor Malignancies,Qilu Hospital of Shandong University,[],['China']
NCT07263620,An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy,"A Single-center, Exploratory Study on Predicting Neoadjuvant Therapy Efficacy and Prognosis in Pan-gastrointestinal Cancer Patients Based on Intratumoral Microbiome Characteristics and Their Functional Targets.",RECRUITING,2025-10-01,2026-01-30,2026-03-01,OBSERVATIONAL,,90,['Digestive System Malignancies'],Digestive System Malignancies,Tianjin Medical University Cancer Institute and Hospital,[],['China']
NCT07058662,"A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.","A Phase 1/2, Open-label Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.",RECRUITING,2025-07-31,2027-06-30,2031-06-30,INTERVENTIONAL,PHASE1,9,['DMD'],DMD,"Belief BioMed (Beijing) Co., Ltd","['Shanghai Mianyi Biopharmaceutical Co., Ltd.', 'Shanghai Xinzhi BioMed Co., Ltd.', 'Belief BioMed Limited']",['China']
NCT07252336,A Multicenter Study of CAR-T Cells in Primary Ph+All,A Multicenter Study of CD19 CAR-T Cells in the Treatment of Adult Patients With Primary Ph Chromosome Positive Acute Lymphoblastic Leukemia,RECRUITING,2025-11-30,2027-11-30,2028-11-30,INTERVENTIONAL,PHASE2,50,['ALL'],ALL,Zhejiang University,['Yake Biotechnology Ltd.'],['China']
NCT06921785,Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma,"A Phase III, Randomised, Open-label, Sponsor-blinded, Multicentre Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma",RECRUITING,2025-05-06,2029-03-16,2030-03-14,INTERVENTIONAL,PHASE3,1220,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,AstraZeneca,[],"['Brazil', 'Japan', 'Turkey (Türkiye)', 'Hong Kong', 'Netherlands', 'China', 'India', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'Thailand', 'Vietnam', 'Australia']"
NCT06818643,A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002),A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors,RECRUITING,2025-03-25,2028-10-25,2031-03-25,INTERVENTIONAL,PHASE1,270,"['Advanced Solid Tumors', 'Malignant Neoplasm']",Advanced Solid Tumors,Merck Sharp & Dohme LLC,[],"['Israel', 'Japan', 'Turkey (Türkiye)', 'Netherlands', 'China', 'United States', 'France', 'Chile', 'Spain', 'Taiwan', 'South Korea']"
NCT05370183,Tenotomy of Biceps' Long Head by Mini-optics in Consultation (Hyperambulatory): What Advantage Compared to the Operating Room?,Tenotomy of Biceps' Long Head by Mini-optics in Consultation (Hyperambulatory): What Advantage Compared to the Operating Room?,ACTIVE_NOT_RECRUITING,2022-11-29,2025-05-05,2026-05-05,INTERVENTIONAL,NA,14,"['Shoulder Pain', 'Biceps Tendon Disorder']",Shoulder Pain,Centre Hospitalier Universitaire de Nice,[],['France']
NCT07039942,French Prospective Multicentric Study in Real World,Omnipod 5 - A French Prospective Multicentric Study in Real World,RECRUITING,2025-07-23,2027-04,2027-04,OBSERVATIONAL,,304,"['Diabetes', 'Diabetes Mellitus', 'Type 1 Diabetes']",Diabetes,Insulet Corporation,[],['France']
NCT07052292,User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes,DuraTouch® - Post-Market Clinical Follow-up (PMCF) Study in a Real-world Setting,ACTIVE_NOT_RECRUITING,2025-07-01,2026-01-02,2026-01-02,OBSERVATIONAL,,125,"['Diabetes Mellitus, Type 1', 'Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 1",Novo Nordisk A/S,[],['Poland']
NCT05558501,Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities,Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities,RECRUITING,2023-01-01,2026-12-31,2027-12-31,INTERVENTIONAL,PHASE1,60,['Obstructive Sleep Apnea'],Obstructive Sleep Apnea,VA Office of Research and Development,['John D. Dingell VA Medical Center'],['United States']
NCT03330821,"Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia","Phase 1B/II Study of Escalating Doses of Pevonedistat (TAK-924, Formerly MLN4924) Administered in Combination With Standard Induction Chemotherapy (Cytarabine and Idarubicin) in Newly Diagnosed High Risk Acute Myelogenous Leukemia (AML)",ACTIVE_NOT_RECRUITING,2018-04-18,2026-06-30,2026-12-31,INTERVENTIONAL,PHASE1,53,"['Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome', 'Acute Myeloid Leukemia With Myelodysplasia-Related Changes', 'Therapy-Related Acute Myeloid Leukemia']",Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT06450639,A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD),"A Phase II Multicenter, Open-label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Pediatric Patients With Duchenne Muscular Dystrophy (SHIELD DMD)",RECRUITING,2025-04-04,2026-09-30,2028-06-30,INTERVENTIONAL,PHASE2,50,['Duchenne Muscular Dystrophy'],Duchenne Muscular Dystrophy,Hoffmann-La Roche,[],"['United States', 'Denmark', 'Spain', 'Italy', 'Poland']"
NCT06341712,Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma,"A Phase II, Randomized, Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics (PK) of Maintenance Cabozantinib (XL184) Plus Best Supportive Care (BSC) Versus BSC in Children, Adolescents and Young Adults (AYA) With Unresectable Residual Osteosarcoma Either at Diagnosis or at First Relapse After Standard Treatment",RECRUITING,2024-11-22,2026-10-26,2028-06-15,INTERVENTIONAL,PHASE2,90,"['Osteosarcoma', 'Osteosarcoma in Children', 'Osteosarcoma in Adolescents and Young Adults']",Osteosarcoma,Ipsen,[],"['Belgium', 'Netherlands', 'Austria', 'United States', 'France', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT05786664,Breast Cancer Survivorship Biorepository,A Comprehensive Breast Cancer Survivorship Biorepository,RECRUITING,2022-04-11,2027-04-11,2028-04-11,OBSERVATIONAL,,1300,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8', 'Invasive Breast Carcinoma']",Anatomic Stage I Breast Cancer AJCC v8,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT05156398,Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects,"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age",RECRUITING,2022-02-28,2031-11-29,2032-11-27,INTERVENTIONAL,PHASE3,640,['Migraine'],Migraine,Pfizer,[],"['Japan', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Poland']"
NCT05317416,Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant,"A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION",RECRUITING,2022-03-25,2027-08-04,2029-10-31,INTERVENTIONAL,PHASE3,760,['Multiple Myeloma'],Multiple Myeloma,Pfizer,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'South Korea', 'Czechia', 'Poland', 'India', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy']"
NCT05267587,Preop fSRS for Resectable Brain Metastases,Pre-operative Hypofractionated Stereotactic Radiosurgery for Resectable Brain Metastases,ACTIVE_NOT_RECRUITING,2022-03-11,2025-05-29,2026-08-21,INTERVENTIONAL,PHASE2,49,"['Brain Metastases', 'Brain Lesion']",Brain Metastases,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT03331380,Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System,Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System,RECRUITING,2018-01-05,2026-05-31,2026-05-31,INTERVENTIONAL,NA,2950,['CAD'],CAD,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06885931,Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications),Exploratory Safety and Feasibility Study of Personalized Adaptive Pudendal Neuromodulation for Mixed Urinary Incontinence and Extended Indications Using an Implanted (Picostim IITM) System,RECRUITING,2025-06-24,2027-02,2029-08,INTERVENTIONAL,NA,56,"['Mixed Urinary Incontinence', 'Stress Urinary Incontinence (SUI)', 'Chronic Pelvic Pain']",Mixed Urinary Incontinence,Amber Therapeutics Ltd,[],"['United Kingdom', 'Belgium', 'Netherlands']"
NCT05132582,A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer,"A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)",ACTIVE_NOT_RECRUITING,2022-03-07,2025-09-05,2027-09-28,INTERVENTIONAL,PHASE3,654,['HER2 Positive Breast Cancer'],HER2 Positive Breast Cancer,"Seagen, a wholly owned subsidiary of Pfizer",[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'Chile', 'Finland', 'South Korea', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy']"
NCT06528431,Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study,Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study,RECRUITING,2024-12-19,2025-09-19,2026-12-19,INTERVENTIONAL,PHASE4,180,"['Arthritis, Rheumatoid']","Arthritis, Rheumatoid",Centre Hospitalier Universitaire de Saint Etienne,['AAP MESSIDOR'],['France']
NCT04908696,Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC),"Department of Otorhinolaryngology, Eye & ENT Hospital",RECRUITING,2025-12-01,2026-06-23,2027-12-01,OBSERVATIONAL,,1000,"['Glottic Carcinoma', 'Supraglottic Carcinoma', 'Subglottic Carcinoma', 'Pyriform Sinus Carcinoma', 'Postcricoid Carcinoma', 'Posterior Pharyngeal Wall Carcinoma']",Glottic Carcinoma,Eye & ENT Hospital of Fudan University,"['Changhai Hospital', 'Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine', 'Fudan University', 'Shanghai Changzheng Hospital', 'RenJi Hospital', ""Shanghai 6th People's Hospital"", 'Xinhua Hospital, Shanghai Jiao Tong University School of Medicine']",['China']
NCT07163403,First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers,First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers,RECRUITING,2025-09-04,2028-09-20,2028-09-20,INTERVENTIONAL,PHASE1,20,['Lynch Syndrome'],Lynch Syndrome,Fundacion Clinic per a la Recerca Biomédica,[],['Spain']
NCT07263581,Effect of Hybrid Functional Electrical Stimulation and Augmented Reality-Based Gait Training on Gait Parameters Among Incomplete Spinal Cord Injury Patients,Effect of Hybrid Functional Electrical Stimulation and Augmented Reality-Based Gait Training on Gait Parameters Among Incomplete Spinal Cord Injury Patients,RECRUITING,2025-12-10,2026-02-10,2026-03-10,INTERVENTIONAL,NA,70,"['Incomplete Spinal Cord Injury (SCI)', 'ASIA C and D Classification of SCI', 'Gait Dysfunction']",Incomplete Spinal Cord Injury (SCI),Lahore University of Biological and Applied Sciences,[],['Pakistan']
NCT06945419,"A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes","A Single-Dose and Multiple-Ascending Dose Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes",RECRUITING,2025-04-23,2026-04,2026-04,INTERVENTIONAL,PHASE1,186,"['Healthy', 'Overweight', 'Obesity', 'Type 2 Diabetes']",Healthy,Eli Lilly and Company,[],"['Singapore', 'United States']"
NCT06901531,A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer,"A Phase 3, Double-blind, Randomized Study of Zolbetuximab in Combination With Pembrolizumab and Chemotherapy (CAPOX or mFOLFOX6) in First-line Treatment of Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in Participants Whose Tumors Are HER2-negative, Claudin (CLDN) 18.2-positive and Programmed Death-ligand 1 (PD-L1)-Positive",RECRUITING,2025-05-22,2029-12-31,2029-12-31,INTERVENTIONAL,PHASE3,500,"['Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer', 'Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer', 'Metastatic Gastric Adenocarcinoma or Cancer', 'Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma']",Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,"Astellas Pharma Global Development, Inc.",[],"['Belgium', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Romania', 'South Korea', 'United Kingdom', 'Poland', 'Portugal', 'Lithuania', 'Australia']"
NCT06344130,Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma,A Phase I Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma,RECRUITING,2024-10-01,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE1,28,"['Astrocytoma', 'Glioma', 'Recurrent Glioblastoma']",Astrocytoma,National Cancer Institute (NCI),[],['United States']
NCT05835284,Clinical Data Collection On Advanced CT System,Clinical Data Collection On Advanced CT System,RECRUITING,2024-06-04,2026-03,2026-03,OBSERVATIONAL,,120,['CT Photon Counting'],CT Photon Counting,GE Healthcare,['Karolinska University Hospital'],['Sweden']
NCT07264569,"Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001","Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001 in the Treatment of Patients With Recurrent/Progressive Non-small Cell Lung Cancer",RECRUITING,2025-06-25,2027-12-30,2027-12-30,INTERVENTIONAL,PHASE1,42,['Meningeal Metastasis'],Meningeal Metastasis,Henan Cancer Hospital,[],['China']
NCT06049290,A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma,"A Multicenter, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LBL-034 in Patients With Relapsed/Refractory Multiple Myeloma",RECRUITING,2023-10-20,2026-10-20,2027-05-20,INTERVENTIONAL,PHASE1,342,['Relapsed/Refractory Multiple Myeloma'],Relapsed/Refractory Multiple Myeloma,"Nanjing Leads Biolabs Co.,Ltd",[],['China']
NCT04595760,Factors Influencing Fertility or Pregnancy Health,Factors Influencing Fertility or Pregnancy Health,ACTIVE_NOT_RECRUITING,2020-10-19,2030-12-31,2030-12-31,OBSERVATIONAL,,231,"['Menstrual Cycles', 'Conception', 'Early Pregnancy Loss', 'Pregnancy Outcomes']",Menstrual Cycles,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT04649242,Randomized Study in Children and Adolescents With Migraine: Acute Treatment,"Phase 3, Multicenter, Randomized, Double-blind, Group Sequential, Placebo-controlled Study to Assess Efficacy and Safety of Rimegepant for the Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age",RECRUITING,2021-01-15,2029-01-09,2029-01-09,INTERVENTIONAL,PHASE3,2100,['Pediatric Migraine'],Pediatric Migraine,Pfizer,[],"['Japan', 'China', 'United States', 'Mexico', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Sweden']"
NCT04728893,Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003),A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants With Hematologic Malignancies,RECRUITING,2021-04-05,2029-01-04,2029-01-04,INTERVENTIONAL,PHASE2,490,"['Hematologic Malignancies', 'Waldenstroms Macroglobulinaemia', 'Non-Hodgkins Lymphoma', 'Chronic Lymphocytic Leukaemia']",Hematologic Malignancies,Merck Sharp & Dohme LLC,[],"['China', 'Australia', 'Israel', 'Hungary', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT01247597,DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study,DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study,RECRUITING,2011-02-13,,,OBSERVATIONAL,,1500,"['Pleuropulmonary Blastoma', 'Cystic Nephroma', 'Ovarian Sertoli-Leydig Cell Tumors', 'Ocular Medulloepithelioma', 'Nasal Chondromesenchymal Hamartoma']",Pleuropulmonary Blastoma,National Cancer Institute (NCI),[],['United States']
NCT06120491,Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents,"A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of Saruparib (AZD5305) in Combination With Physician's Choice New Hormonal Agents in Patients With HRRm and Non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)",RECRUITING,2023-11-21,2028-01-11,2031-04-30,INTERVENTIONAL,PHASE3,1800,['Metastatic Castration-Sensitive Prostate Cancer'],Metastatic Castration-Sensitive Prostate Cancer,AstraZeneca,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Finland', 'Puerto Rico', 'Peru', 'South Korea', 'Thailand', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT07159061,Neurofeedback to Treat Depression - 2,Reducing Neural Perseveration Through Closed Loop Real Time fMRI Neurofeedback to Alleviate Depressive Symptoms,RECRUITING,2025-11-21,2028-11-21,2028-12-01,INTERVENTIONAL,NA,80,['Major Depressive Disorder (MDD)'],Major Depressive Disorder (MDD),University of Pennsylvania,[],['United States']
NCT07111546,A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)],"An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour[Substudy Number 02(BTC&HCC)]",RECRUITING,2025-10-20,2026-12-26,2026-12-26,INTERVENTIONAL,PHASE2,172,['Advanced Solid Tumour'],Advanced Solid Tumour,"Nanjing Leads Biolabs Co.,Ltd",['Shanghai Zhongshan Hospital'],['China']
NCT06500169,Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors,Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors Undergoing Hormone Therapy (GREENS),RECRUITING,2023-09-01,2026-09-01,2027-09-01,INTERVENTIONAL,NA,20,"['Localized Prostate Carcinoma', 'Locally Advanced Prostate Carcinoma', 'Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8', 'Stage II Prostate Cancer AJCC v8', 'Stage III Prostate Cancer AJCC v8']",Localized Prostate Carcinoma,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT05785624,A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease,"A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Idiopathic Pulmonary Fibrosis and in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease",RECRUITING,2023-05-26,2027-04-26,2027-08-10,INTERVENTIONAL,PHASE2,320,"['Idiopathic Pulmonary Fibrosis', 'Systemic Sclerosis With Lung Involvement']",Idiopathic Pulmonary Fibrosis,"Genentech, Inc.",[],"['New Zealand', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'South Korea', 'Poland', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Greece', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT06651489,Efficacy of Guselkumab in Treating Hailey Hailey Disease,"Efficacy of Guselkumab in the Treatment of Hailey Hailey Disease: An Open-label, Proof of Concept Study",RECRUITING,2025-03-13,2026-04,2026-04,INTERVENTIONAL,PHASE2,10,['Hailey Hailey Disease'],Hailey Hailey Disease,Yale University,"['Janssen Scientific Affairs, LLC']",['United States']
NCT07047703,EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1),"A Multi-part, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD0715 in Healthy Human Volunteers and Participants With Axial Spondyloarthritis",RECRUITING,2025-07-28,2028-04-30,2028-09-30,INTERVENTIONAL,PHASE1,141,['Axial Spondyloarthritis (AxSpA)'],Axial Spondyloarthritis (AxSpA),Grey Wolf Therapeutics,[],"['Netherlands', 'Belgium', 'Germany', 'Australia']"
NCT05986318,Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease,Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease: A 2x2 Factorial Randomized Phase II Trial Testing N-Acetyl Cysteine and Dexamethasone,RECRUITING,2025-01-07,2028-07-01,2032-12-31,INTERVENTIONAL,PHASE2,98,"['Lung Cancer', 'Interstitial Lung Disease']",Lung Cancer,David Palma,"['London Health Sciences Centre', ""Centre Hospitalier de l'Universite de Montreal (CHUM)""]",['Canada']
NCT05340582,Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants,Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants - The ACEDUCT Trial,RECRUITING,2022-12-12,2027-01,2027-04,INTERVENTIONAL,PHASE2,310,['Patent Ductus Arteriosus After Premature Birth'],Patent Ductus Arteriosus After Premature Birth,"Mount Sinai Hospital, Canada","['Sunnybrook Health Sciences Centre', ""McMaster Children's Hospital"", 'The Rotunda Hospital', 'John Hunter Hospital', 'Royal Alexandra Hospital', ""Centre Hospitalier de l'Universite Laval (CHUL)"", 'Royal North Shore Hospital', 'Prince of Wales Hospital, Shatin, Hong Kong']","['Ireland', 'Hong Kong', 'Canada', 'Australia']"
NCT02339012,Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT),The Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT),RECRUITING,2015-03-15,2099-12-31,2099-12-31,OBSERVATIONAL,,900,"['Healthy Volunteers', 'Non-Healthy/Non-Frail', 'Frail']",Healthy Volunteers,National Institute on Aging (NIA),[],['United States']
NCT02415621,Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer,A Pilot Study of Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer,ACTIVE_NOT_RECRUITING,2015-04-13,2019-08-12,2026-07,INTERVENTIONAL,EARLY_PHASE1,19,['Prostate Cancer'],Prostate Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT04008121,Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium,A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium,RECRUITING,2025-11-06,2026-05,2026-05,INTERVENTIONAL,EARLY_PHASE1,10,"['Retinopathy', 'Retinal Vein Occlusion', 'Diabetic Retinopathy', 'Macular Degeneration']",Retinopathy,MediBeacon,[],['United States']
NCT05763563,Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy,Feasibility Of Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy,ACTIVE_NOT_RECRUITING,2023-02-21,2025-01-19,2026-01-19,INTERVENTIONAL,NA,20,"['Lymphoma', 'Leukemia', 'Myeloma']",Lymphoma,H. Lee Moffitt Cancer Center and Research Institute,['Cancer and Aging Research Group'],['United States']
NCT05950464,Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer,A Phase 1B Study of Combination ATR (M1774) and BET Inhibition (ZEN00-3694) to Exploit ARID1A Loss in Recurrent Ovarian and Endometrial Cancer,RECRUITING,2023-12-18,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE1,60,"['Endometrial Carcinoma', 'Endometrial Clear Cell Adenocarcinoma', 'Endometrial Endometrioid Adenocarcinoma', 'Endometrial Low Grade Endometrioid Adenocarcinoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian High Grade Serous Adenocarcinoma', 'Ovarian Low Grade Endometrioid Adenocarcinoma', 'Platinum-Resistant Ovarian Carcinoma']",Endometrial Carcinoma,National Cancer Institute (NCI),['NRG Oncology'],['United States']
NCT05301283,"Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma",Phase 2 Clinical Trial of Radiomic Habitat-Directed Radiation Dose Escalation for High-Grade Soft Tissue Sarcoma,RECRUITING,2022-05-18,2026-08,2026-08,INTERVENTIONAL,PHASE2,43,['High Grade Sarcoma'],High Grade Sarcoma,H. Lee Moffitt Cancer Center and Research Institute,['Viewray Inc.'],['United States']
NCT05419375,Screening Study for Participants With Malignant Tumors,Master Screening Study to Determine Biomarker Status and Potential Trial Eligibility for Patients With Malignant Tumors,RECRUITING,2022-07-22,2032-08-21,2032-12-22,INTERVENTIONAL,PHASE2,15000,['Solid Tumors'],Solid Tumors,Hoffmann-La Roche,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Singapore', 'Costa Rica', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy', 'Serbia']"
NCT06937931,A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults,"A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants",RECRUITING,2025-06-30,2027-03-26,2027-11-05,INTERVENTIONAL,PHASE2,132,['Cervical Dystonia'],Cervical Dystonia,Ipsen,[],"['United States', 'France', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07099430,"A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma","An Open-label, Multicenter Phase Ib/II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 Monotherapy, LBL-024 in Combination With LBL-007 or Toripalimab in Patients With Advanced Melanoma",RECRUITING,2025-09-05,2027-10-30,2027-12-30,INTERVENTIONAL,PHASE1,200,['Advanced Melanoma'],Advanced Melanoma,"Nanjing Leads Biolabs Co.,Ltd",[],['China']
NCT01385176,Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF),Neural Cardiac Therapy for Heart Failure Study,ACTIVE_NOT_RECRUITING,2011-09-21,2014-05,2026-06-30,INTERVENTIONAL,NA,118,"['Heart Failure', 'Congestive Heart Failure']",Heart Failure,Boston Scientific Corporation,[],"['Belgium', 'Netherlands', 'France', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Germany']"
NCT06203873,A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine,A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine,RECRUITING,2024-03-01,2026-03-01,2026-03-01,INTERVENTIONAL,NA,400,"['PFO - Patent Foramen Ovale', 'Migraine', 'Migraine Headache', 'Migraine Headache, With or Without Aura']",PFO - Patent Foramen Ovale,"Chinese Academy of Medical Sciences, Fuwai Hospital",[],['China']
NCT01422694,Natural History and Development of Spondyloarthritis,Studies on the Natural History and Pathogenesis of Spondyloarthritis,RECRUITING,2011-08-12,,,OBSERVATIONAL,,2000,"['Arthritis', 'Spondylitis, Ankylosing']",Arthritis,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT07154251,Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery,Utilizing a Community Health Worker in the Role of a Diabetes Technology Coach for Black Children Using Automated Insulin Delivery and Not Meeting Glycemic Targets (CHWs AID Youth),RECRUITING,2025-11-06,2027-03-01,2027-03-01,INTERVENTIONAL,NA,16,['Type 1 Diabetes (T1D)'],Type 1 Diabetes (T1D),University Hospitals Cleveland Medical Center,[],['United States']
NCT07262801,Psychological and Physiological Impact of a Mindfulness-based Intervention on Anxiety Disorders During the Postpartum Period,Evaluating the Psychological and Physiological Impact of a Mindfulness-based Intervention on Anxiety Disorders During the Postpartum Period: A Proof of Concept Trial,RECRUITING,2025-12,2026-09,2026-09,INTERVENTIONAL,NA,50,"['Postpartum Anxiety', 'Anxiety Disorders']",Postpartum Anxiety,St. Joseph's Healthcare Hamilton,[],['Canada']
NCT06153836,Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction,Randomized Feasibility Study to Determine the Feasibility of Neurotization of the Nipple Areolar Complex at the Time of Nipple Sparing Mastectomy and Prosthetic Based Reconstruction,RECRUITING,2023-12-05,2026-11-10,2026-11-10,INTERVENTIONAL,PHASE2,20,"['Anatomic Stage 0 Breast Cancer AJCC v8', 'Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage IIA Breast Cancer AJCC v8']",Anatomic Stage 0 Breast Cancer AJCC v8,Mayo Clinic,[],['United States']
NCT07049081,A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases,"An Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases (r/r AID)",RECRUITING,2025-07-17,2028-04-30,2030-04-30,INTERVENTIONAL,PHASE1,42,['Relapsed/Refractory Autoimmune Diseases'],Relapsed/Refractory Autoimmune Diseases,Nanjing Legend Biotech Co.,[],['China']
NCT07048457,Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma,A Phase II Study of Consolidative Local Therapy in Patients With Locally Advanced or Oligo-metastatic Urothelial Carcinoma (la/mUC) Following Treatment Response to Systemic Therapy With or Without Metastasis-directed Radiotherapy,RECRUITING,2025-11-26,2028-11,2028-11,INTERVENTIONAL,PHASE2,32,"['Locally Advanced Urothelial Carcinoma', 'Oligo-metastaic Urothelial Carcinoma']",Locally Advanced Urothelial Carcinoma,Yale University,['Medical College of Virginia Foundation'],['United States']
NCT02504879,"Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease","Study of the Natural History, Pathogenesis and Outcome of Melorheostosis - a Rare Osteosclerotic Disease",RECRUITING,2015-08-16,2030-07-01,2030-07-01,OBSERVATIONAL,,350,['Rheumatic Disease'],Rheumatic Disease,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT06643741,Non-Invasive Preeclampsia Screening and Biobank,"Collection of Pregnancy Outcome Data and Whole Blood Samples From Women Undergoing Non-Invasive Screening for Early, Preterm, and Term Preeclampsia",RECRUITING,2025-02-02,2026-06-01,2026-07-01,OBSERVATIONAL,,6550,['Preeclampsia (PE)'],Preeclampsia (PE),"Sequenom, Inc.","['Rutgers Robert Wood Johnson Medical School', 'Laboratory Corporation of America']",['United States']
NCT06823037,Hormonal Contraception Access Through Pharmacist Prescribing Implementation,HAPPI (Hormonal Contraception Access Through Pharmacist Prescribing Implementation): Phase 2 (Aim 1),RECRUITING,2025-10-09,2026-08-31,2026-08-31,INTERVENTIONAL,NA,150,"['Contraception', 'Pharmaceutical Services', 'Access and Linkage to Healthcare', 'Technology Use']",Contraception,EMPOWERX INC,['Purdue University'],['United States']
NCT06118892,MISHA Post-Market Clinical Study,Post-Market Evaluation of the MISHA® Knee System for Symptom Relief in Subjects With Medial Knee Osteoarthritis,RECRUITING,2023-11-03,2030-06-30,2030-07-30,INTERVENTIONAL,NA,120,['Osteo Arthritis Knee'],Osteo Arthritis Knee,Moximed,[],['United States']
NCT05588843,Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis,"A Randomized, Double-blind, Placebo Controlled, Dose-finding Study to Assess the Efficacy and Safety of SAR443122 in Adult Patients With Moderate to Severe Ulcerative Colitis",RECRUITING,2022-11-25,2026-02-25,2026-12-16,INTERVENTIONAL,PHASE2,182,['Colitis Ulcerative'],Colitis Ulcerative,Sanofi,[],"['Japan', 'Netherlands', 'China', 'Slovakia', 'Hungary', 'France', 'Chile', 'Czechia', 'Poland', 'India', 'Mexico', 'Georgia', 'Spain', 'Romania', 'United Kingdom', 'Germany', 'United States', 'Italy', 'Argentina']"
NCT06164613,Use of Cinnamomum Verum for Induction of Labor. Double Blind Randomized Clinical Trial,Use of Cinnamomum Verum Extract Versus Placebo for Induction of Labor and Reduction of Physiological Phase 2-3 of Labor. Double-blind Randomized Clinical Trial. CINNALAB TRIAL,RECRUITING,2023-12-04,2026-12-30,2026-12-30,INTERVENTIONAL,PHASE2,70,"['Labor Onset and Length Abnormalities', 'First Birth']",Labor Onset and Length Abnormalities,Universidad Nacional Autonoma de Honduras,[],['Honduras']
NCT06111768,Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study,Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study,ACTIVE_NOT_RECRUITING,2024-05-30,2026-05,2026-05,INTERVENTIONAL,PHASE2,30,['Cardiorenal Syndrome'],Cardiorenal Syndrome,Yale University,['American Heart Association'],['United States']
NCT07264400,Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns,Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns,RECRUITING,2025-10-15,2029-04,2029-04,INTERVENTIONAL,NA,100,['Newborn Infant'],Newborn Infant,"University Hospital, Clermont-Ferrand",[],['France']
NCT07171684,Single vs Multi-Dose Insulin for Glycemic Control (SUGAR),Single vs Multi-Dose Insulin for Glycemic Control (SUGAR): A Randomized Noninferiority Trial,RECRUITING,2025-11-26,2026-10-01,2027-05-15,INTERVENTIONAL,NA,176,"['Diabetes in Pregnancy', 'Gestational Diabetes']",Diabetes in Pregnancy,"Rutgers, The State University of New Jersey",[],['United States']
NCT05201547,Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line,Randomized Phase III Trial in MMR Deficient Endometrial Cancer Patients Comparing Chemotherapy Alone Versus Dostarlimab in First Line Advanced/Metastatic Setting,ACTIVE_NOT_RECRUITING,2022-04-15,2026-04,2029-10,INTERVENTIONAL,PHASE3,260,['Endometrial Cancer'],Endometrial Cancer,ARCAGY/ GINECO GROUP,['GlaxoSmithKline'],"['Singapore', 'Japan', 'New Zealand', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT04319146,Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer,Pilot Feasibility Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer,ACTIVE_NOT_RECRUITING,2022-01-25,2025-12,2025-12,INTERVENTIONAL,NA,20,['Prostate Cancer'],Prostate Cancer,Centre Hospitalier Universitaire de Nice,[],['France']
NCT04752774,A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.,"An Integrated Phase I/II, Multicentre, Double-blind, Randomised, Dysport and Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity.",RECRUITING,2021-04-29,2027-10-30,2027-10-30,INTERVENTIONAL,PHASE1,240,['Spasticity'],Spasticity,Ipsen,[],"['Bulgaria', 'Japan', 'Hungary', 'Austria', 'United States', 'Russia', 'Spain', 'Czechia', 'Poland', 'Germany']"
NCT07016490,A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors,"A Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Anti-tumor Activity of SSGJ-709 in Patients With Advanced Malignant Tumors",RECRUITING,2025-06-12,2027-09-30,2027-12-30,INTERVENTIONAL,PHASE1,15,['Advanced Malignant Tumors'],Advanced Malignant Tumors,"Shenyang Sunshine Pharmaceutical Co., LTD.","['Macquarie University, Australia']",['Australia']
NCT06287762,A Natural History Study of RYR1-Related Disorders,A Single-Center Prospective Natural History Study of RYR1-Related Disorders,RECRUITING,2025-03-11,2031-04-30,2031-12-30,OBSERVATIONAL,,150,"['Ryanodine Receptor 1-Related Myopathy', 'Ryanodine Receptor 1 Related Disorders']",Ryanodine Receptor 1-Related Myopathy,National Institutes of Health Clinical Center (CC),[],['United States']
NCT06830720,A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence,"A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence to Evaluate Real-world Effectiveness, Safety Profile, Patient Compliance and Quality of Life",RECRUITING,2025-02-20,2030-06-30,2030-06-30,OBSERVATIONAL,,3250,['Breast Neoplasms'],Breast Neoplasms,Novartis Pharmaceuticals,[],"['Austria', 'Germany']"
NCT07181369,A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Cold Urticaria,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Tolerability, Pharmacokinetic, Pharmacodynamic, and Preliminary Efficacy Trial of GTX-B001 in Healthy Volunteers (Part A) and Patients With Cold Induced Urticaria (Part B)",RECRUITING,2025-10-06,2027-08,2027-08,INTERVENTIONAL,PHASE1,72,"['Healthy Subjects', 'Cold Urticaria']",Healthy Subjects,Granular Therapeutics Limited,[],['Germany']
NCT07046923,A Study of LY4175408 in Participants With Advanced Cancer,"A First-in-Human, Phase 1a/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4175408, an Antibody Drug Conjugate Targeting Protein Tyrosine Kinase 7-Expressing Tumor Cells, in Participants With Selected Advanced Solid Tumors",RECRUITING,2025-07-28,2030-07,2030-07,INTERVENTIONAL,PHASE1,240,"['Carcinoma, Non-Small-Cell Lung', 'Small Cell Lung Carcinoma', 'Endometrial Neoplasms', 'Neoplasm Metastasis', 'Triple Negative Breast Cancer']","Carcinoma, Non-Small-Cell Lung",Eli Lilly and Company,[],"['Japan', 'United States', 'France', 'Spain', 'South Korea']"
NCT05526989,Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma,A Phase 2 Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma Who Have Progressed Following Chemotherapy,RECRUITING,2022-12-28,2026-11,2027-11,INTERVENTIONAL,PHASE2,25,['Penile Carcinoma'],Penile Carcinoma,H. Lee Moffitt Cancer Center and Research Institute,['GlaxoSmithKline'],['United States']
NCT06137118,AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia,A Phase 1/2 Study to Evaluate the Safety and Efficacy of AZD0486 in Adolescent and Adult Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia,RECRUITING,2023-12-29,2026-11-13,2027-06-29,INTERVENTIONAL,PHASE1,142,['B-cell Acute Lymphoblastic Leukemia (B-ALL)'],B-cell Acute Lymphoblastic Leukemia (B-ALL),AstraZeneca,[],"['Brazil', 'Japan', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT04753879,Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.,"Multi-agent Low Dose Chemotherapy (Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, Irinotecan) Followed by Maintenance Olaparib and Pembrolizumab in Untreated Metastatic Pancreatic Ductal Adenocarcinoma.",RECRUITING,2021-09-29,2026-12-01,2029-12-01,INTERVENTIONAL,PHASE2,38,['Metastatic Pancreatic Cancer'],Metastatic Pancreatic Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Merck Sharp & Dohme LLC'],['United States']
NCT06899126,"Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer","A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)",RECRUITING,2025-10-24,2030-03-05,2032-07-05,INTERVENTIONAL,PHASE3,686,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Daiichi Sankyo,['Merck Sharp & Dohme LLC'],"['Brazil', 'Japan', 'China', 'United States', 'Taiwan', 'South Korea', 'Malaysia', 'United Kingdom']"
NCT00083512,Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme,Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence,RECRUITING,2004-06-22,,,OBSERVATIONAL,,200,['Glioblastoma Multiforme'],Glioblastoma Multiforme,National Cancer Institute (NCI),[],['United States']
NCT06868277,A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer,"A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)",RECRUITING,2025-04-10,2030-01-17,2030-12-02,INTERVENTIONAL,PHASE3,830,"['Carcinoma, Non-Small Cell Lung']","Carcinoma, Non-Small Cell Lung",AstraZeneca,[],"['Bulgaria', 'Japan', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'South Korea', 'Colombia', 'Costa Rica', 'Georgia', 'Switzerland', 'Spain', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT05987527,Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term),"Long-Term Follow-Up of Patients Who Have Received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg Therapy, TX200-TR101) in a Prior Clinical Study",ACTIVE_NOT_RECRUITING,2023-08-15,2039-06-11,2039-06-11,OBSERVATIONAL,,11,"['Kidney Transplant Rejection', 'End Stage Renal Disease']",Kidney Transplant Rejection,Sangamo Therapeutics,[],"['United Kingdom', 'Belgium', 'Netherlands']"
NCT00059748,"Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis","Studies of Natural History, Pathogenesis, and Outcomes in Autoimmune and Inflammatory Diseases Including Juvenile Dermatomyositis",RECRUITING,2003-05-09,,,OBSERVATIONAL,,5000,"['Autoinflammatory Disease', 'Juvenile Dermatomyositis']",Autoinflammatory Disease,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT06712797,Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center,Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center (PANTHER-PIC),RECRUITING,2025-02-19,2027-11,2027-11,INTERVENTIONAL,NA,24,"['Pancreatic Ductal Adenocarcinoma', 'Intraductal Papillary Mucinous Neoplasm']",Pancreatic Ductal Adenocarcinoma,H. Lee Moffitt Cancer Center and Research Institute,['Miles for Moffitt'],['United States']
NCT06809634,Large Linguistic Model for Clinical Reaoning of Physical Therapy Students,Feasibility of a Randomized Controlled Trial of Large Artificial Intelligence-Based Linguistic Models for Clinical Reasoning Training of Physical Therapy Students. A Randomized Controlled Trial,RECRUITING,2023-09-01,2026-06-30,2026-07-30,INTERVENTIONAL,PHASE2,60,"['Healthy', 'Artificial Intelligence (AI)']",Healthy,"Neuron, Spain",[],['Spain']
NCT06152575,MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide),"A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY",RECRUITING,2024-02-08,2026-08-30,2027-12-30,INTERVENTIONAL,PHASE3,492,['Multiple Myeloma'],Multiple Myeloma,Pfizer,[],"['Japan', 'Netherlands', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Slovenia', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT06963450,NeoSCB App for Screening Jaundice in Newborns,Clinical Investigation of the Smartphone App neoSCB to Perform Neonatal Jaundice Screening in Newborn Babies,RECRUITING,2025-09-23,2027-03-31,2027-03-31,OBSERVATIONAL,,405,['Neonatal Jaundice'],Neonatal Jaundice,"University College, London",['University College London Hospitals'],['United Kingdom']
NCT06539780,Imagery Rescripting as a Treatment for Early Psychosis,Imagery Rescripting for Early Psychosis: a Multiple-Baseline Single-Case Experimental Design.,ACTIVE_NOT_RECRUITING,2024-12-20,2025-12,2026-02,INTERVENTIONAL,NA,8,"['Psychosis', 'Psychotic Disorders', 'Schizophrenia', 'Psychoses, Traumatic']",Psychosis,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),[],['Netherlands']
NCT06904261,A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants,"An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12 Month Treatment With Migalastat in Pediatric Subjects (Aged 2 to < 12 Years) With Fabry Disease and Amenable GLA Variants",RECRUITING,2025-12,2027-12,2028-12,INTERVENTIONAL,PHASE3,8,['Fabry Disease'],Fabry Disease,Amicus Therapeutics,[],"['Belgium', 'United States', 'Spain', 'United Kingdom', 'Germany']"
NCT05568524,Resistance Training With Blood Flow Restriction in Hemophilia,"The Acute and Chronic Impact of Blood Flow Restriction Resistance Training on Physical and Neuromuscular Function, Pain, and Quality of Life in Patients With Moderate/Severe Hemophilia",ACTIVE_NOT_RECRUITING,2024-01-15,2025-11-30,2026-01-30,INTERVENTIONAL,NA,20,['Hemophilia'],Hemophilia,University of Valencia,[],['Spain']
NCT06256575,Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis,"Treatment of Digital Ulcers in Systemic Sclerosis With Diosmin: A Randomized, Double-blind, Placebo-controlled Multi-centre Pilot Study",RECRUITING,2025-05-02,2027-07-15,2027-08-15,INTERVENTIONAL,NA,45,"['Scleroderma, Systemic', 'Digital Ulcer']","Scleroderma, Systemic",Primus Pharmaceuticals,['KGK Science Inc.'],['Canada']
NCT04974671,Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma,Phase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma,RECRUITING,2023-12-22,2027-01-01,2028-04-01,INTERVENTIONAL,PHASE2,30,"['Renal Cell Carcinoma', 'Metastatic Renal Cell Carcinoma', 'Oligoprogressive', 'Progression']",Renal Cell Carcinoma,Yale University,[],['United States']
NCT07263412,Gestational Lifestyle & Outcomes Wellness,"A Multicenter Prospective Cohort Study to Identify Risk Factors and Develop a Diagnostic Prediction Model for Gestational Diabetes Mellitus, and to Evaluate the Effectiveness of Multidisciplinary Precision Health Interventions (GLOW Plan)",RECRUITING,2025-02-25,2026-11,2028-11,OBSERVATIONAL,,1000,['GDM'],GDM,The First Affiliated Hospital with Nanjing Medical University,[],['China']
NCT03805919,Men at High Genetic Risk for Prostate Cancer,Natural History Study of Men at High Genetic Risk for Prostate Cancer,RECRUITING,2019-03-27,2029-01-01,2039-01-01,OBSERVATIONAL,,500,['Prostatic Neoplasms'],Prostatic Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT07263789,Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values,"Randomized, Open-label, Parallel Group Study to Evaluate the Efficacy of Euglycem in Reducing Blood Glucose in Patients With Dysglycemia After Three Months of Treatment - EUGLYCARE Study",RECRUITING,2025-04-08,2025-12-31,2026-01-31,INTERVENTIONAL,NA,108,['Dysglycemia'],Dysglycemia,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT03419689,Study Looking at Biomarkers in Ovarian Cancer,Biomarker Discovery Project in High Grade Serous Ovarian Cancer,RECRUITING,2018-01-08,2028-06-08,2028-06-08,INTERVENTIONAL,NA,510,['Gynecologic Cancer'],Gynecologic Cancer,"University Health Network, Toronto",[],['Canada']
NCT05061004,Cephea Early Feasibility Study,Cephea Early Feasibility Study,RECRUITING,2022-04-28,2026-03-01,2031-03-01,INTERVENTIONAL,NA,50,['Mitral Regurgitation'],Mitral Regurgitation,Abbott Medical Devices,[],"['United States', 'Canada']"
NCT06470048,A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis,"A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis",RECRUITING,2024-10-09,2028-07-10,2030-07-15,INTERVENTIONAL,PHASE2,200,['Diffuse Cutaneous Systemic Sclerosis'],Diffuse Cutaneous Systemic Sclerosis,Novartis Pharmaceuticals,[],"['Japan', 'China', 'Belgium', 'Hungary', 'France', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Mexico', 'Spain', 'Taiwan', 'Malaysia', 'United Kingdom', 'Greece', 'Vietnam', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06946238,Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F),Accelerated Partial Breast Irradiation in One Fraction for Patients With Early-stage Disease and Favorable Histological Subtypes (Breast-1F).,RECRUITING,2025-07-25,2029-06-30,2035-06-30,INTERVENTIONAL,NA,311,['Breast Cancer'],Breast Cancer,IRCCS San Raffaele,[],['Italy']
NCT04340141,Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer,A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer,RECRUITING,2020-10-13,2026-01-01,2030-11-01,INTERVENTIONAL,PHASE3,352,"['Pancreatic Adenosquamous Carcinoma', 'Resectable Pancreatic Adenocarcinoma', 'Pancreatic Cancer']",Pancreatic Adenosquamous Carcinoma,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],"['United States', 'Canada']"
NCT00341237,Personalized Environment and Genes Study,Personalized Environment and Genes Study,RECRUITING,2010-05-26,,,OBSERVATIONAL,,25000,"['Diabetes', 'Heart Disease', 'Asthma']",Diabetes,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT05821517,METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX),METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation,RECRUITING,2023-12-30,2026-12-30,2027-03,INTERVENTIONAL,PHASE4,150,['Anterior Shoulder Dislocation'],Anterior Shoulder Dislocation,Centre Hospitalier Universitaire de Nice,[],['France']
NCT00001823,Evaluation for NCI Surgery Branch Clinical Research Protocols,Evaluation for NCI Surgery Branch Clinical Research Protocols,RECRUITING,1999-07-11,,,OBSERVATIONAL,,7000,"['Synovial Cell Cancer', 'Melanoma', 'Colorectal Cancer', 'Lung Cancer', 'Bladder Cancer']",Synovial Cell Cancer,National Cancer Institute (NCI),[],['United States']
NCT07264452,Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression,Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst Stimulation in Patients With Treatment-Resistant Depression,RECRUITING,2025-11-15,2026-11-15,2027-01-15,INTERVENTIONAL,NA,60,"['Treatment Resistant Depression (TRD)', 'Transcranial Magnetic Stimulation', 'Accelerated Protocol', 'Intermittent Theta Burst Stimulation', 'Continuous Theta Burst Stimulation', 'Unilateral rTMS']",Treatment Resistant Depression (TRD),Ataturk University,[],['Turkey (Türkiye)']
NCT07209904,Economic Evaluation of Mindline.sg,"Study on Understanding the Overall Effectiveness of Mindline.sg on Improving Mental Health Literacy, Quality of Life and Economic Outcomes",RECRUITING,2025-11-20,2026-01,2026-03,INTERVENTIONAL,NA,300,['Healthy'],Healthy,Centre for Evidence and Implementation Singapore Ltd,"['MOH Office for Healthcare Transformation (MOHT), Singapore', 'National University of Singapore, Behavioural and Implementation Science Interventions']",['Singapore']
NCT07035925,Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas,"Prospective Multi-Center, Single Arm, Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas",RECRUITING,2025-11-24,2027-02-24,2028-04-24,INTERVENTIONAL,NA,10,['Fistula in Ano'],Fistula in Ano,"ECM Therapeutics, Inc.",[],['United States']
NCT02543996,Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s),Human Biospecimen Procurement and Analysis to Support Translational Research to Identify Genetic Etiology and Disease Mechanism(s) in Rare Genetic Vascular/Cardiovascular Diseases,RECRUITING,2015-09-17,2040-06-04,2050-05-22,OBSERVATIONAL,,10000,"['Undiagnosed Diseases', 'Cardiovascular Disease']",Undiagnosed Diseases,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06923722,De-stressing the Brain: Can Eating Grapes During Periods of Mental Stress Protect Brain and Vascular Health in Young Adults,"A Placebo-controlled, Randomized, Double-masked, Cross-over Acute Intervention Study Investigating the Effects of Grape Polyphenols on Cerebral Oxygenation, Cognitive and Vascular Function in the Context of Mental Stress in Young Adults",RECRUITING,2025-04-01,2026-03-31,2026-03-31,INTERVENTIONAL,NA,44,['Healthy'],Healthy,University of Birmingham,['California Table Grape Commission'],['United Kingdom']
NCT06592001,Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study,Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study,ACTIVE_NOT_RECRUITING,2025-02-25,2025-10-27,2028-12-31,INTERVENTIONAL,NA,19,"['Ventricular Arrythmia', 'Ventricular Fibrillation', 'Ventricular Tachycardia']",Ventricular Arrythmia,"AtaCor Medical, Inc.",[],"['Croatia', 'New Zealand', 'Paraguay']"
NCT07262957,"Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA): an International Randomized Controlled Multicenter Trial","Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA): an International Randomized Controlled Multicenter Trial",RECRUITING,2025-09-01,2027-09-01,2027-12-01,INTERVENTIONAL,PHASE4,400,"['Pancreas Head Cancer', 'Pancreas Adenocarcinoma', 'IPMN, Pancreatic', 'Cholangio Carcinoma', 'Ampulla of Vater Adenocarcinoma', 'PDAC - Pancreatic Ductal Adenocarcinoma', 'Duodenal Carcinoma', 'Mucinous Cystic Neoplasm', 'Neuro Endocrine Tumours', 'Pancreatitis']",Pancreas Head Cancer,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),"['Erasmus Medical Center', 'UMC Utrecht', 'Medisch Spectrum Twente', 'Jeroen Bosch Ziekenhuis', 'Maastricht University Medical Center', 'Radboud University Medical Center', 'Isala', 'Catharina Ziekenhuis Eindhoven', 'Helsinki University Central Hospital', 'Oslo University Hospital', 'Karolinska University Hospital', 'Sahlgrenska University Hospital', 'University Hospital, Linkoeping', 'Lund University Hospital', 'Azienda Ospedaliera Universitaria Integrata Verona', 'Azienda Ospedaliera di Padova', 'San Raffaele University Hospital, Italy', 'Leiden University Medical Center', 'University Medical Center Groningen', 'Clinical Cancer Hospital, Kyiv', 'Rigshospitalet, Denmark', 'University Hospital, Antwerp']",['Netherlands']
NCT03815643,Avelumab Program Rollover Study,"An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies",ACTIVE_NOT_RECRUITING,2019-03-22,2027-02-19,2027-02-19,INTERVENTIONAL,PHASE3,205,['Solid Tumors'],Solid Tumors,"EMD Serono Research & Development Institute, Inc.","['Merck KGaA, Darmstadt, Germany']","['Bulgaria', 'Japan', 'Australia', 'Belgium', 'Hungary', 'Russia', 'France', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Romania', 'United Kingdom', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06974591,Postural Perturbations Tracing to the Stomatognathic System,Postural Perturbations Tracing to the Stomatognathic System,RECRUITING,2025-11-17,2027-06,2027-06,INTERVENTIONAL,NA,40,['Posture'],Posture,Boston University,[],['United States']
NCT07213817,"A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours","An Open-Label, Phase I/II First-in-Human, Dose Escalation, Dose Optimisation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 as Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumours.",RECRUITING,2025-11-05,2028-10-30,2028-10-30,INTERVENTIONAL,PHASE1,102,"['Locally Advanced Solid Tumor', 'Metastatic Solid Tumor']",Locally Advanced Solid Tumor,Ipsen,[],['United States']
NCT05649748,An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH),"An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension",ACTIVE_NOT_RECRUITING,2023-03-07,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,91,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,Insmed Incorporated,[],"['Brazil', 'Belgium', 'Japan', 'Austria', 'United States', 'Mexico', 'Denmark', 'Serbia', 'Spain', 'Italy', 'Malaysia', 'United Kingdom', 'Philippines', 'Argentina', 'Germany']"
NCT03952598,Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy,Studying the Biology of Higher-Grade Transformation in IDH-mutant Gliomas Via Longitudinal Observation of Tumor Metabolic Reprogramming Using Non-invasive Metabolic Imaging,RECRUITING,2019-10-16,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,270,"['Glioma', 'Gliomas', 'High Grade Glioma', 'Malignant Glioma', 'Low Grade Glioma']",Glioma,National Cancer Institute (NCI),[],['United States']
NCT05170204,"A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)","A Phase I-III, Multicenter Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Patients Selected According to Biomarker Status, With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer",RECRUITING,2022-11-01,2032-08-21,2033-09-01,INTERVENTIONAL,PHASE3,71,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Hoffmann-La Roche,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Singapore', 'Costa Rica', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy', 'Serbia']"
NCT07263906,Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia,Dose Escalation and Expansion Clinical Study of Targeted LILRA6 CAR-T for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia,RECRUITING,2025-12-01,2027-10-01,2028-10-01,INTERVENTIONAL,PHASE1,48,"['Refractory Acute Myeloid Leukemia', 'Recurrent Acute Myeloid Leukemia']",Refractory Acute Myeloid Leukemia,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT05366153,Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer,Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer (REDEEM-CAD),RECRUITING,2023-10-18,2026-05,2026-05,OBSERVATIONAL,,748,['Coronary Artery Disease'],Coronary Artery Disease,Baker Heart and Diabetes Institute,"['Western Health, Australia', 'Northern Hospital, Australia', 'Menzies Institute for Medical Research', 'Peter MacCallum Cancer Centre, Australia', 'The Alfred']",['Australia']
NCT07195396,To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake,"A Randomized, Double-blind, Moncentric, Cross-over Study to Collect Human Serum After Ingestion of Hydrolyzed Collagen Peptides.",RECRUITING,2025-10-22,2025-12-22,2026-04-16,INTERVENTIONAL,NA,3,['Healthy Women'],Healthy Women,Rousselot BVBA,['BioTeSys GmbH'],['Germany']
NCT06979596,A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015),"A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selected Solid Tumors (OMAHA-015)",RECRUITING,2025-08-11,2027-11-04,2027-11-04,INTERVENTIONAL,PHASE2,250,['Malignant Neoplasm'],Malignant Neoplasm,Merck Sharp & Dohme LLC,[],"['Brazil', 'United States', 'Chile', 'Spain', 'Peru', 'Taiwan', 'Malaysia', 'United Kingdom', 'Argentina']"
NCT06963905,Saci Nivo Rela for TNBC,Phase Ib Randomized Open-label Trial of Sacituzumab Govitecan Plus Nivolumab or Sacituzumab Govitecan Plus Nivolumab and Relatlimab as Second-line Therapy for PD-L1 Positive Metastatic Triple Negative Breast Cancer,RECRUITING,2025-12,2030-12,2030-12,INTERVENTIONAL,PHASE1,60,['Metastatic Triple-negative Breast Cancer'],Metastatic Triple-negative Breast Cancer,Yale University,['Bristol-Myers Squibb'],['United States']
NCT06806137,A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age,"A Phase 3a, Observer-blind, Randomized, Controlled, Study to Evaluate the Immunogenicity and Safety of an Investigational Varicella Vaccine Compared With Varivax, When Given as a Second Dose to Healthy Children, 3 Months After the Administration of a First Dose at 12 to 15 Months of Age",RECRUITING,2025-05-15,2026-12-14,2027-05-03,INTERVENTIONAL,PHASE3,600,['Chickenpox'],Chickenpox,GlaxoSmithKline,[],['Dominican Republic']
NCT06989463,Complementary Behavioral Interventions To Remediate Cognitive Impairment or Emotional Distress in Cancer Survivors,Complementary Behavioral Interventions To Remediate Cognitive Impairment or Emotional Distress in Cancer Survivors: A Pilot Study,ACTIVE_NOT_RECRUITING,2025-07-29,2025-12,2026-06,INTERVENTIONAL,NA,20,['Survivors of Childhood Cancer'],Survivors of Childhood Cancer,St. Jude Children's Research Hospital,[],['United States']
NCT01778504,"Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders","Diagnosis of Childhood-onset Behavioral Disorders, Neuropsychiatric Disorders and Neurodevelopmental Disorders",RECRUITING,2012-12-27,2029-02-20,,OBSERVATIONAL,,1000,"['Neuropsychiatric Disorder', 'Neurological Disorder', 'Neurodevelopmental Disorder', 'Sleep']",Neuropsychiatric Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT05028348,"A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma","A Phase 3 Randomized, Open-label Trial of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)",ACTIVE_NOT_RECRUITING,2022-04-19,2026-03,2029-03,INTERVENTIONAL,PHASE3,117,['Multiple Myeloma'],Multiple Myeloma,European Myeloma Network B.V.,['Karyopharm Therapeutics Inc'],"['Greece', 'Spain', 'France', 'Germany']"
NCT04477629,Belatacept in De Novo Heart Transplantation,Belatacept in De Novo Heart Transplantation - Pilot Study,RECRUITING,2020-08-06,2026-09,2026-09,INTERVENTIONAL,PHASE2,12,['Heart Transplantation'],Heart Transplantation,NYU Langone Health,['Bristol-Myers Squibb'],['United States']
NCT05189457,"First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer","A Phase IIA Study of Sequential (""First Strike, Second Strike"") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for High Risk Metastatic Castration Sensitive Prostate Cancer",ACTIVE_NOT_RECRUITING,2022-01-25,2027-07-15,2028-07,INTERVENTIONAL,PHASE2,32,"['Prostate Cancer', 'Stage IV Prostate Cancer']",Prostate Cancer,H. Lee Moffitt Cancer Center and Research Institute,['BeiGene'],['United States']
NCT07015905,REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults,"A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX)",RECRUITING,2025-06-25,2027-02-20,2027-05-12,INTERVENTIONAL,PHASE3,2000,['Venous Thromboembolism (VTE)'],Venous Thromboembolism (VTE),Regeneron Pharmaceuticals,[],"['Bulgaria', 'Japan', 'United States', 'Latvia', 'Lithuania']"
NCT07178119,Bridging Technique Validation for Nasolabial Folds JN-BRIDGE-1,A Prospective Clinical Evaluation of the Bridging Technique Using AILEENE Vol. 2 Dermal Filler for the Treatment of Nasolabial Folds,RECRUITING,2025-11-22,2026-05,2026-11,INTERVENTIONAL,NA,60,"['Nasolabial Fold Correction', 'Facial Aging', 'Skin Rejuvenation', 'Wrinkles Such as Nasolabial Folds']",Nasolabial Fold Correction,Dr. Joseph M Novoa Libermann,"['Cg Bio Co., Ltd.']",['United Kingdom']
NCT00092222,Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity,Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease With Laboratory and Clinical Correlates of Disease Activity,ACTIVE_NOT_RECRUITING,2004-10-28,2026-10-01,2026-10-01,INTERVENTIONAL,PHASE2,75,"['Lymphoproliferative Disorder', 'HHV-8', 'Malignancy', 'HIV']",Lymphoproliferative Disorder,National Cancer Institute (NCI),[],['United States']
NCT00001975,Study of Skin Tumors in Tuberous Sclerosis,Cutaneous Tumorigenesis in Patients With Tuberous Sclerosis,RECRUITING,2000-01-26,,,OBSERVATIONAL,,400,['Tuberous Sclerosis'],Tuberous Sclerosis,"National Heart, Lung, and Blood Institute (NHLBI)",['Uniformed Services University of the Health Sciences'],['United States']
NCT06520163,Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma,"A Prospective, Multicenter, Randomized Controlled Trial Comparing the Efficacy and Safety of Etoposide, Cytarabine, and PEG-rhG-CSF Combination Therapy vs. Disease-Specific Chemotherapy for Hematopoietic Stem Cell Mobilization in Lymphoma",RECRUITING,2024-08-01,2026-08,2026-08,INTERVENTIONAL,PHASE3,99,"[""Non-Hodgkin's Lymphoma"", 'Hematopoietic Stem Cell Mobilization']",Non-Hodgkin's Lymphoma,The Affiliated People's Hospital of Ningbo University,"['First Affiliated Hospital of Zhejiang University', 'First Affiliated Hospital of Wenzhou Medical University', 'Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University', ""Jinhua People's Hospital"", 'The Central Hospital of Lishui City', ""Shaoxing People's Hospital"", 'Shaoxing Second Hospital', 'Zhejiang Provincial Tongde Hospital', 'Taizhou Hospital', ""Dongyang People's Hospital"", 'Affiliated Hospital of Jiaxing University', 'Huzhou Central Hospital', 'Second Affiliated Hospital of Wenzhou Medical University', 'Ningbo Medical Center Lihuili Hospital', 'Jinhua Municipal Central Hospital']",['China']
NCT07159789,Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis,Non-Invasive Neuromodulation in MS Induced Spastic Paraparesis,RECRUITING,2025-10-15,2027-10,2028-03,INTERVENTIONAL,NA,60,['Multiple Sclerosis'],Multiple Sclerosis,Clinique Neuro-Outaouais,['University of Ottawa'],['Canada']
NCT06691035,Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer,Immunologic Targeting of Native and Mutated ESR1 Receptor for Treatment of Hormone Receptor Expressing Metastatic Breast Cancer,RECRUITING,2024-11-04,2026-11,2027-11,INTERVENTIONAL,PHASE1,18,"['Breast Cancer Metastatic Breast Cancer', 'HER2-negative Breast Cancer']",Breast Cancer Metastatic Breast Cancer,H. Lee Moffitt Cancer Center and Research Institute,['The V Foundation for Cancer Research'],['United States']
NCT05885555,A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies,A Phase 2 Study to Evaluate the Efficacy and Safety of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least a Corticosteroid and a Thrombopoietin Receptor Agonist (TPO-RA),ACTIVE_NOT_RECRUITING,2023-08-16,2025-02-05,2029-03-19,INTERVENTIONAL,PHASE2,41,['Primary Immune Thrombocytopenia (ITP)'],Primary Immune Thrombocytopenia (ITP),Novartis Pharmaceuticals,[],"['Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'South Korea', 'Malaysia', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT07264855,M-TAPA vs. Combined M-TAPA + EXOP for Postoperative Pain in Laparoscopic Gynecologic Surgery,Comparison of the Effects of M-TAPA Versus the Combination of M-TAPA and EXOP Blocks on Postoperative Pain in Laparoscopic Gynecologic Surgeries,RECRUITING,2025-10-06,2026-10,2026-10,OBSERVATIONAL,,86,"['Postoperative Pain', 'Laparoscopic Gynecologic Surgery']",Postoperative Pain,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,[],['Turkey (Türkiye)']
NCT07010289,Nurturing Outreach for Understanding and Reducing Inpatient Security of Health,NOURISH: Nurturing Outreach for Understanding and Reducing Inpatient Security of Health,RECRUITING,2025-07-07,2026-12,2026-12,INTERVENTIONAL,NA,30,['Food Insecurity'],Food Insecurity,Wake Forest University Health Sciences,[],['United States']
NCT05566483,Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity,"Physiological Underpinnings of Post-Acute Sequelae of SARS CoV-2 (""Long COVID"") and Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity",RECRUITING,2023-03-01,2027-10-31,2027-10-31,INTERVENTIONAL,NA,30,['Post-acute Sequelae of SARS-CoV-2 Infection'],Post-acute Sequelae of SARS-CoV-2 Infection,"University of Colorado, Denver",[],['United States']
NCT07056959,Efficacy of Collagen Matrix for Peri-implant Soft Tissue Phenotype Modification,Efficacy of Collagen Matrix for Peri-implant Soft Tissue Phenotype Modification: A Randomized Controlled Trial,RECRUITING,2025-11-01,2027-12,2028-06,INTERVENTIONAL,NA,30,"['Keratinized Mucosa', 'Keratinized Tissue']",Keratinized Mucosa,Mohammed Bin Rashid University of Medicine and Health Sciences,[],['United Arab Emirates']
NCT06686680,Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy,Treatment of Post Traumatic Knee Osteoarthritis With Extracorporeal Shockwave Therapy,RECRUITING,2025-04-01,2026-07,2026-09,INTERVENTIONAL,NA,70,"['Knee Osteoarthristis', 'ACL Injuries', 'Post-Traumatic']",Knee Osteoarthristis,Spaulding Rehabilitation Hospital,[],['United States']
NCT06972459,A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity,A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes,RECRUITING,2025-05-15,2027-01,2027-08,INTERVENTIONAL,PHASE3,600,"['Obesity', 'Overweight']",Obesity,Eli Lilly and Company,[],"['Japan', 'China', 'United States', 'Puerto Rico', 'Czechia', 'Argentina', 'Germany']"
NCT01212055,Apheresis of Patients With Immunodeficiency,"Apheresis and CD34+ Selection of Mobilized Peripheral Blood CD34+ Cells From Patients With DOCK8 Deficiency, LAD-1, and GATA2 Deficiency",RECRUITING,2010-11-08,,,OBSERVATIONAL,,7,"['LAD-1', 'DOCK8', 'GATA2 Deficancy']",LAD-1,National Cancer Institute (NCI),[],['United States']
NCT06339177,"Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study","Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study",RECRUITING,2024-07-02,2030-10-01,2031-04-01,OBSERVATIONAL,,300,"['Lymphohistiocytosis, Hemophagocytic', 'Secondary Hemophagocytic Lymphohistiocytosis', 'Macrophage Activation Syndrome', 'Hyperinflammatory Syndromes']","Lymphohistiocytosis, Hemophagocytic",National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07265037,Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management,Development of a New Integrated Strategy for Long-Distance and Full-Course Management of Diabetes Using Both Traditional Chinese and Western Medicine: A Combined Online and Offline Approach,RECRUITING,2025-11-01,2026-02-28,2026-05-31,INTERVENTIONAL,NA,10000,"['Diabetes Mellitus, Type 2', 'Integrated Traditional Chinese Medicine and Western Medicine', 'Telemedicine', 'Chronic Disease Management', 'Digital Health']","Diabetes Mellitus, Type 2",Shanxi Bethune Hospital,[],['China']
NCT07261085,A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.,A Real-world Study on the Effectiveness of Nirmatrelvir-ritonavir in Reducing Severe Outcomes From COVID-19,ACTIVE_NOT_RECRUITING,2025-10-27,2026-03-30,2026-03-30,OBSERVATIONAL,,99000,['COVID-19'],COVID-19,Pfizer,[],['United States']
NCT07114003,"Effects of Virtual Reality Application on Pain, Anxiety, and Patient Satisfaction in Dressing Patients With Pressure Sores","Effects of Virtual Reality Application on Pain, Anxiety, and Patient Satisfaction in Dressing Patients With Pressure Sores: A Randomized Controlled Trial",RECRUITING,2025-11-01,2026-05-01,2026-06-01,INTERVENTIONAL,NA,62,['Pressure Wounds'],Pressure Wounds,Cukurova University,['Toros University'],['Turkey (Türkiye)']
NCT06682988,"A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine","A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment",RECRUITING,2025-05-28,2028-03,2028-03,INTERVENTIONAL,PHASE2,110,"['Advanced High-Grade Epithelial Ovarian', 'Primary Peritoneal', 'Fallopian Tube Cancers', 'High Folate Receptor-Alpha Expression', 'Platinum Resistant']",Advanced High-Grade Epithelial Ovarian,AbbVie,[],"['United States', 'Spain', 'South Korea', 'United Kingdom', 'Australia']"
NCT04320888,"Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial",NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of LOXO-292 in Patients With Tumors Harboring RET Gene Alterations,ACTIVE_NOT_RECRUITING,2021-05-03,2024-09-30,2026-06-30,INTERVENTIONAL,PHASE2,1,"['Hematopoietic and Lymphatic System Neoplasm', 'Recurrent Ependymoma', 'Recurrent Ewing Sarcoma', 'Recurrent Hepatoblastoma', 'Recurrent Histiocytic and Dendritic Cell Neoplasm', 'Recurrent Langerhans Cell Histiocytosis', 'Recurrent Lymphoma', 'Recurrent Malignant Germ Cell Tumor', 'Recurrent Malignant Glioma', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Medulloblastoma', 'Recurrent Neuroblastoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Osteosarcoma', 'Recurrent Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Rhabdoid Tumor', 'Recurrent Rhabdomyosarcoma', 'Recurrent Soft Tissue Sarcoma', 'Recurrent WHO Grade 2 Glioma', 'Refractory Ependymoma', 'Refractory Ewing Sarcoma', 'Refractory Hepatoblastoma', 'Refractory Histiocytic and Dendritic Cell Neoplasm', 'Refractory Langerhans Cell Histiocytosis', 'Refractory Lymphoma', 'Refractory Malignant Germ Cell Tumor', 'Refractory Malignant Glioma', 'Refractory Malignant Solid Neoplasm', 'Refractory Medulloblastoma', 'Refractory Neuroblastoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Osteosarcoma', 'Refractory Peripheral Primitive Neuroectodermal Tumor', 'Refractory Rhabdoid Tumor', 'Refractory Rhabdomyosarcoma', 'Refractory Soft Tissue Sarcoma', 'Refractory WHO Grade 2 Glioma', 'Wilms Tumor']",Hematopoietic and Lymphatic System Neoplasm,National Cancer Institute (NCI),"[""Children's Oncology Group""]","['Puerto Rico', 'United States', 'Australia']"
NCT07119983,"Effect of Stress Ball Applied During Surgical Debridement/Dressing on Pain, Distress, and Physiological Parameters in Patients With Diabetic Foot Ulcers","Effect of Stress Ball Applied During Surgical Debridement/Dressing on Pain, Distress, and Physiological Parameters in Patients With Diabetic Foot Ulcers: A Randomized Controlled Trial",RECRUITING,2025-11-01,2026-07-01,2026-07-01,INTERVENTIONAL,NA,84,['Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus'],Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus,Cukurova University,[],['Turkey (Türkiye)']
NCT07165002,"A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment","A Phase 1, Multicenter, Parallel-Design, Single-Dose, Open-Label Study to Evaluate the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Hepatic Function and Participants With Mild, Moderate, or Severe Hepatic Impairment",RECRUITING,2025-10-20,2026-08,2026-08,INTERVENTIONAL,PHASE1,32,"['Healthy', 'Hepatic Insufficiency']",Healthy,Eli Lilly and Company,[],"['Slovakia', 'New Zealand', 'Hungary']"
NCT07264270,Study to Evaluate Safety of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy,"A Phase 1, Randomized, Double-Blind, Single Dose Escalation Study to Assess the Safety and Tolerability of Transforaminal Epidural Administration of C-1101 Versus Sterile Saline in Adults With Chronic Painful Lumbosacral Radiculopathy",RECRUITING,2025-12-15,2026-11-01,2026-12-01,INTERVENTIONAL,PHASE1,24,"['Lumbosacral Radicular Pain', 'Sciatic Radiculopathy', 'Sciatic Leg Pain', 'Sciatica', 'Lumbosacral Radicular Syndrome', 'Lumbosacral Radiculopathy']",Lumbosacral Radicular Pain,Consano Bio,[],['Australia']
NCT07041177,Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds,Evaluation of the Efficacy and Safety of NeoThelium FT Amnion Skin Graft in the Management of Chronic Open Wounds: A Prospective Case Series,RECRUITING,2025-08-25,2026-03-01,2026-04-01,INTERVENTIONAL,NA,10,['Open Wound'],Open Wound,"NuScience Medical Biologics, LLC","['SygNola, LLC']",['United States']
NCT07263269,Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in Adults With Obesity,Assessment of Dumping and Quality of Life 6 Months Following Sleeve Gastrectomy With and Without Transit Bipartition : Comparative Study,ACTIVE_NOT_RECRUITING,2024-04-06,2025-06-30,2026-03-30,INTERVENTIONAL,NA,200,"['Obesity', 'Morbid Obesity', 'Dumping Syndrome', 'Postgastrectomy Syndrome', 'Quality of Life', 'Bariatric Surgery', 'Metabolic Diseases', 'Gastrointestinal Function Disorders', 'Sleeve Gastrectomy', 'Gastrointestinal Transit', 'Nutritional Status', 'Patient-reported Outcome Measures']",Obesity,Mina Kamal Gergis Erian,['Kasr El Aini Hospital'],['Egypt']
NCT07264439,Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders With Behavioral Disturbances,Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders (ADRD) With Behavioral Disturbances,RECRUITING,2025-09-03,2027-04,2027-05,INTERVENTIONAL,NA,24,"['Effectiveness', 'Virtual Reality', 'Hypnotic Scenarios', 'Hygiene Care', ""Alzheimer's Disease and Related Disorders (ADRD)"", 'Behavioral Disturbances']",Effectiveness,"Centre Hospitalier Universitaire, Amiens",[],['France']
NCT06226883,A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 2 Active Dose Regimens of MORF-057 in Adults With Moderately to Severely Active Crohn's Disease (GARNET)",RECRUITING,2024-07-18,2026-11,2028-08,INTERVENTIONAL,PHASE2,210,"['Inflammatory Bowel Diseases', ""Crohn's Disease""]",Inflammatory Bowel Diseases,"Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)",[],"['Japan', 'Slovakia', 'Hungary', 'France', 'Croatia', 'Colombia', 'Czechia', 'Poland', 'India', 'Kazakhstan', 'Mexico', 'Georgia', 'Spain', 'Canada', 'Romania', 'Latvia', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Serbia']"
NCT07103941,IOA Preventing Occlusal Changes With MAD Use,Effectiveness of Interocclusal Aligner (IOA) on Preventing Occlusal Changes in Patients Treated With a Mandibular Advancement Device (MAD): A Preliminary Study,RECRUITING,2025-11-17,2026-03-28,2026-04-30,INTERVENTIONAL,NA,30,"['Sleep Related Breathing Disorder', 'Snoring', 'Obstructive Sleep Apnea (OSA)', 'Open Bite', 'Occlusal Changes', 'Tooth Migration', 'Posterior Open Bite']",Sleep Related Breathing Disorder,Isabel Moreno Hay,['American Academy of Orofacial Pain'],['United States']
NCT06930157,Multi-Center Clinical Trial of Shenling Baizhu Granules for Preventing Low-Risk Colorectal Adenoma Recurrence,"A Multi-Center, Randomized, Controlled Clinical Trial to Evaluate the Efficacy of Shenling Baizhu Granules in Preventing Recurrence of Low-Risk Colorectal Adenoma",RECRUITING,2025-11-21,2028-12-31,2028-12-31,INTERVENTIONAL,PHASE4,624,['Low-risk Colorectal Adenoma'],Low-risk Colorectal Adenoma,Shanghai Jiao Tong University School of Medicine,[],['China']
NCT03467906,Role of Dietary Habits in Efficacy of Bariatric Surgery - Study B,Role of Dietary Habits in Efficacy of Bariatric Surgery - Study B,ACTIVE_NOT_RECRUITING,2021-05-25,2028-06-30,2028-06-30,OBSERVATIONAL,,44,"['Bariatric Surgery', 'Sleeve Gastrectomy', 'Obesity']",Bariatric Surgery,Brigham and Women's Hospital,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06825871,Automated Inhaler Monitoring for Asthma Medication Usage,Automated Inhaler Monitoring for Asthma Medication Usage,RECRUITING,2025-12,2026-03,2026-06,INTERVENTIONAL,NA,26,['Asthma'],Asthma,Boston Children's Hospital,['Respiratory Analytics Ltd'],['United States']
NCT07263490,PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients),"PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) - Investigating Matching, Biomarkers and Outcomes.",RECRUITING,2024-10-21,2027-10-31,2028-06-01,OBSERVATIONAL,,462,"['Pre-eclampsia', 'Oocyte Donation', 'Pre-Eclampsia; Complicating Pregnancy', 'Pre-Eclampsia; Mild', 'Pre-Eclampsia, Severe', 'Pre-eclampsia or Eclampsia With Pre-existing Hypertension', 'ART', 'Neonatal Morbidity', 'Neonatal Mortality', 'Placental Abruption', 'Gestational Diabetes', 'Preterm Labor', 'Post-partum Hemorrhage (PPH)', 'Intrauterine Growth Restriction (IUGR)', 'Hypertensive Disorders of Pregnancy']",Pre-eclampsia,"Copenhagen University Hospital, Hvidovre","['Ferring Pharmaceuticals', 'Gedeon Richter Ltd.']",['Denmark']
NCT07220967,A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement,A Randomized Controlled Trial to Determine the Efficacy of Local Antibiotic Delivery in the Prevention of Breast Tissue Expander-Associated Infections,RECRUITING,2025-10-21,2027-10,2027-10,INTERVENTIONAL,PHASE4,392,['Breast Cancer'],Breast Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06109467,Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer,A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers,RECRUITING,2024-01-12,2028-04,2028-04,INTERVENTIONAL,PHASE2,36,"['GastroEsophageal Cancer', 'Gastric Cancer']",GastroEsophageal Cancer,H. Lee Moffitt Cancer Center and Research Institute,"['Puma Biotechnology, Inc.', 'National Comprehensive Cancer Network']",['United States']
NCT00471250,Collection of Lung Fluid and Tissue Samples for Research,Research Respiratory Tract Procedures,RECRUITING,2007-08-17,,,OBSERVATIONAL,,550,"['Leukocyte Disorders', 'Respiratory Tract Diseases', 'Bronchoscopy']",Leukocyte Disorders,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06138210,The Effect of GD-iExo-003 in Acute Ischemic Stroke,The Effect of Exosomes Derived From Human Induced Pluripotent Stem Cell (GD-iExo-003) in Acute Ischemic Stroke: an Exploratory Study.,RECRUITING,2024-06-05,2026-03-30,2026-03-30,INTERVENTIONAL,PHASE1,29,['Acute Ischemic Stroke'],Acute Ischemic Stroke,"Xuanwu Hospital, Beijing",['Guidon Pharmaceutics Ltd.'],['China']
NCT03867448,Study of Endocrine-Related Conditions and Physiology,The Evaluation and Management of Endocrine-Related Conditions and Physiology,RECRUITING,2019-03-27,2036-01-01,2036-01-01,OBSERVATIONAL,,1000,['Endocrine Disease'],Endocrine Disease,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT05562947,"A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)","A Phase III, Multicenter, Randomized, Visual Assessor-masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Chinese Patients With Neovascular Age-related Macular Degeneration",RECRUITING,2024-06-17,2027-07-27,2029-08-30,INTERVENTIONAL,PHASE3,68,"['Neovascular Age-related Macular Degeneration', 'nAMD']",Neovascular Age-related Macular Degeneration,Hoffmann-La Roche,[],['China']
NCT07264387,Predictive Factors for Return to Work After a First Stroke Treated at Clermont-Ferrand University Hospital in Puy de Dôme Between January 2020 and December 2024,Predictive Factors for Return to Work After a First Stroke Treated at Clermont-Ferrand University Hospital in Puy de Dôme Between January 2020 and December 2024,RECRUITING,2025-10-29,2026-11-01,2026-11-01,OBSERVATIONAL,,140,['Stroke'],Stroke,"University Hospital, Clermont-Ferrand",[],['France']
NCT04739800,Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents,"A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab",ACTIVE_NOT_RECRUITING,2021-06-10,2023-01-26,2026-06-14,INTERVENTIONAL,PHASE2,120,"['Fallopian Tube Mucinous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Platinum-Refractory Fallopian Tube Carcinoma', 'Platinum-Refractory Ovarian Carcinoma', 'Platinum-Refractory Primary Peritoneal Carcinoma', 'Recurrent Fallopian Tube Clear Cell Adenocarcinoma', 'Recurrent Fallopian Tube Endometrioid Adenocarcinoma', 'Recurrent Fallopian Tube High Grade Serous Adenocarcinoma', 'Recurrent Fallopian Tube Mucinous Adenocarcinoma', 'Recurrent Fallopian Tube Transitional Cell Carcinoma', 'Recurrent Fallopian Tube Undifferentiated Carcinoma', 'Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma', 'Recurrent Ovarian Clear Cell Adenocarcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma', 'Recurrent Ovarian High Grade Serous Adenocarcinoma', 'Recurrent Ovarian Low Grade Serous Adenocarcinoma', 'Recurrent Ovarian Mucinous Adenocarcinoma', 'Recurrent Ovarian Seromucinous Carcinoma', 'Recurrent Ovarian Transitional Cell Carcinoma', 'Recurrent Ovarian Undifferentiated Carcinoma', 'Recurrent Platinum-Resistant Fallopian Tube Carcinoma', 'Recurrent Platinum-Resistant Ovarian Carcinoma', 'Recurrent Platinum-Resistant Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Clear Cell Adenocarcinoma', 'Recurrent Primary Peritoneal Endometrioid Adenocarcinoma', 'Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma', 'Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma', 'Recurrent Primary Peritoneal Transitional Cell Carcinoma', 'Recurrent Primary Peritoneal Undifferentiated Carcinoma', 'Refractory Fallopian Tube Clear Cell Adenocarcinoma', 'Refractory Fallopian Tube Endometrioid Adenocarcinoma', 'Refractory Fallopian Tube High Grade Serous Adenocarcinoma', 'Refractory Fallopian Tube Mucinous Adenocarcinoma', 'Refractory Fallopian Tube Transitional Cell Carcinoma', 'Refractory Fallopian Tube Undifferentiated Carcinoma', 'Refractory Low Grade Fallopian Tube Serous Adenocarcinoma', 'Refractory Ovarian Clear Cell Adenocarcinoma', 'Refractory Ovarian Endometrioid Adenocarcinoma', 'Refractory Ovarian High Grade Serous Adenocarcinoma', 'Refractory Ovarian Low Grade Serous Adenocarcinoma', 'Refractory Ovarian Mucinous Adenocarcinoma', 'Refractory Ovarian Seromucinous Carcinoma', 'Refractory Ovarian Transitional Cell Carcinoma', 'Refractory Ovarian Undifferentiated Carcinoma', 'Refractory Primary Peritoneal Clear Cell Adenocarcinoma', 'Refractory Primary Peritoneal Endometrioid Adenocarcinoma', 'Refractory Primary Peritoneal High Grade Serous Adenocarcinoma', 'Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma', 'Refractory Primary Peritoneal Transitional Cell Carcinoma', 'Refractory Primary Peritoneal Undifferentiated Carcinoma']",Fallopian Tube Mucinous Adenocarcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['Puerto Rico', 'United States']"
NCT02771236,Clinical and Molecular Studies in Families With Inherited Eye Disease,Clinical and Molecular Studies in Families With Inherited Eye Disease,RECRUITING,2016-10-04,2032-01-01,2032-01-01,OBSERVATIONAL,,5000,['Inherited Eye Disease'],Inherited Eye Disease,National Eye Institute (NEI),[],"['Pakistan', 'China', 'United States', 'Italy', 'United Kingdom', 'Philippines', 'Ukraine', 'India']"
NCT03300492,Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS,"A Phase I/II Single Center Study to Assess the Safety, Tolerability and Feasibility of Pre-emptive Immunotherapy With in Vitro Expanded Natural Killer Cells in Patients Treated With Haplo-HSCT for AML/MDS",RECRUITING,2018-11-12,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,10,"['Acute Myeloid Leukemia', 'Myelodysplastic Syndromes']",Acute Myeloid Leukemia,"University Hospital, Basel, Switzerland",[],['Switzerland']
NCT07096843,A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy,"A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Budoprutug (TNT119) in Subjects With Primary Membranous Nephropathy (PMN)",RECRUITING,2025-08-25,2027-10,2027-10,INTERVENTIONAL,PHASE2,45,['Primary Membranous Nephropathy'],Primary Membranous Nephropathy,"Climb Bio, Inc.",[],"['United States', 'Ukraine']"
NCT03760575,Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM),Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM),RECRUITING,2023-01-10,2027-02-01,2027-02-01,INTERVENTIONAL,PHASE1,20,['Mesotheliomas Pleural'],Mesotheliomas Pleural,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT05769777,"Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis","An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis",RECRUITING,2023-04-03,2031-06-11,2031-06-11,INTERVENTIONAL,PHASE2,901,['Dermatitis Atopic'],Dermatitis Atopic,Sanofi,[],"['Japan', 'Netherlands', 'China', 'Australia', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06549595,A Study of AZD0486 Plus Rituximab in Previously Untreated Follicular Lymphoma Patients,"A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)",RECRUITING,2024-08-07,2031-11-26,2031-11-26,INTERVENTIONAL,PHASE3,1015,['Untreated Follicular Lymphoma'],Untreated Follicular Lymphoma,AstraZeneca,[],"['Brazil', 'Belgium', 'Japan', 'Hungary', 'Hong Kong', 'Turkey (Türkiye)', 'China', 'Finland', 'Spain', 'Taiwan', 'South Korea', 'Canada', 'Thailand', 'United Kingdom', 'Poland', 'Sweden', 'Australia']"
NCT00001645,"Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection","Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection",RECRUITING,1998-10-10,,,OBSERVATIONAL,,500,"['Malaria', 'Intestinal Worms', 'GI Protozoa', 'Echiniococcus', 'Strongyloides']",Malaria,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06456346,Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007),"A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study to Evaluate the Efficacy and Safety of Bomedemstat (MK-3543) Versus Hydroxyurea in Cytoreductive Therapy Naïve Essential Thrombocythemia Participants",RECRUITING,2024-07-16,2027-09-28,2028-03-24,INTERVENTIONAL,PHASE3,300,['Essential Thrombocythemia'],Essential Thrombocythemia,Merck Sharp & Dohme LLC,[],"['Japan', 'Hong Kong', 'Australia', 'Israel', 'Hungary', 'France', 'Chile', 'Denmark', 'Colombia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05483868,"A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer","A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) to Determine the Feasibility and Safety of Intratumoral Injection With or Without Intramural Injection in Subjects With Bladder Cancer",RECRUITING,2022-09-26,2027-03,2027-03,INTERVENTIONAL,PHASE1,55,"['Non-muscle-invasive Bladder Cancer', 'Non-Muscle Invasive Bladder Cancer (&Amp;#34;NMIBC&Amp;#34;) Unresponsive/Intolerant to BCG', 'NMIBC', 'Non-Muscle Invasive Bladder Carcinoma', 'Non-Muscle Invasive Bladder Neoplasms', 'Non-Muscle Invasive Bladder Urothelial Carcinoma', 'Urothelial Carcinoma Bladder']",Non-muscle-invasive Bladder Cancer,Aura Biosciences,[],"['United States', 'Australia']"
NCT07215585,AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL,"A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 Followed by AZD0486 Versus R-mini-CHOP x6 in Elderly or Unfit Participants With Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)",RECRUITING,2025-11-11,2030-06-27,2033-07-28,INTERVENTIONAL,PHASE3,420,['Large B-cell Lymphoma'],Large B-cell Lymphoma,AstraZeneca,[],"['Brazil', 'Belgium', 'Japan', 'Turkey (Türkiye)', 'Hong Kong', 'China', 'South Korea', 'Canada', 'United Kingdom', 'Poland', 'Australia']"
NCT06309576,Experimental Approach to Test Predictions of Body Weight Regulation Models,Experimental Approach to Test Predictions of Body Weight Regulation Models,RECRUITING,2025-01-17,2026-05-30,2026-06-30,INTERVENTIONAL,NA,12,"['Obesity', 'Underweight']",Obesity,Pennington Biomedical Research Center,['Tulane University'],['United States']
NCT02066220,International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma,"AN INTERNATIONAL PROSPECTIVE TRIAL ON MEDULLOBLASTOMA (MB) IN CHILDREN OLDER THAN 3 TO 5 YEARS WITH WNT BIOLOGICAL PROFILE (PNET 5 MB - LR and PNET 5 MB - WNT-HR), AVERAGE-RISK BIOLOGICAL PROFILE (PNET 5 MB -SR), OR TP53 MUTATION, AND REGISTRY FOR MB OCCURRING IN THE CONTEXT OF GENETIC PREDISPOSITION",ACTIVE_NOT_RECRUITING,2014-06,2026-12,2026-12,INTERVENTIONAL,PHASE2,360,['Brain Tumors'],Brain Tumors,Universitätsklinikum Hamburg-Eppendorf,['Deutsche Kinderkrebsstiftung'],"['Belgium', 'Netherlands', 'Norway', 'Austria', 'France', 'Switzerland', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Portugal', 'Sweden', 'Germany']"
NCT02979574,PEACE: Comparing Chronic Pain Treatment Options,Personalize Electro-acupuncture vs. Auricular-acupuncture Comparative Effectiveness,ACTIVE_NOT_RECRUITING,2016-11,2026-11,2026-11,INTERVENTIONAL,NA,360,"['Chronic Pain', 'Musculoskeletal Pain', 'Fibromyalgia', 'Pain Management']",Chronic Pain,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT05082025,"Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations","Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations",ACTIVE_NOT_RECRUITING,2022-09-27,2024-05-03,2027-02-02,INTERVENTIONAL,PHASE2,7,"['Endometrial Cancer', 'Ovarian Cancer']",Endometrial Cancer,M.D. Anderson Cancer Center,['Bayer'],['United States']
NCT03802695,A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies,"A Phase 1 Dose Escalation and Expansion Study of Orca-Q, an Engineered Donor Graft Derived From Mobilized Peripheral Blood, in Recipients Undergoing Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies",RECRUITING,2019-04-08,2027-12,2027-12,INTERVENTIONAL,PHASE1,300,"['Acute Myeloid Leukemia', 'Myelodysplastic Syndromes', 'Mixed Phenotype Acute Leukemia', 'Acute Lymphoblastic Leukemia']",Acute Myeloid Leukemia,"Orca Biosystems, Inc.",[],['United States']
NCT05955066,Effect of JAK Inhibitor on Erosion Healing in RA,Effect of JAK Inhibitor on Bone Erosion Repair in Rheumatoid Arthritis Assessed by HR-pQCT: a Randomized Placebo-controlled Study,RECRUITING,2023-12-01,2026-02,2026-06,INTERVENTIONAL,PHASE4,60,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Chinese University of Hong Kong,[],['Hong Kong']
NCT05840887,Knee Osteotomy Associated With Allograft Meniscus Transplantation,"Knee Osteotomy Associated With Allograft Meniscus Transplantation in Patients With Altered Mechanical Axis, Meniscectomy Outcomes, and Osteoarthritis: Clinical, Biomechanical, and Biological Evaluation",RECRUITING,2023-08-30,2026-06,2026-06,INTERVENTIONAL,NA,52,"['Malalignment, Bone', 'Osteoarthritis, Knee']","Malalignment, Bone",Istituto Ortopedico Rizzoli,[],['Italy']
NCT04077723,"A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma","An Open-Label, Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa (RO7227166, A CD19 Targeted 4-1BB Ligand) in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-treatment Dose of Obinutuzumab Administered in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma",RECRUITING,2019-08-13,2027-03-31,2027-03-31,INTERVENTIONAL,PHASE1,498,"['Lymphoma, Non-Hodgkin']","Lymphoma, Non-Hodgkin",Hoffmann-La Roche,[],"['Belgium', 'New Zealand', 'China', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT05438940,Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients,Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients,ACTIVE_NOT_RECRUITING,2022-07-15,2025-06-04,2026-06,INTERVENTIONAL,NA,23,['GastroEsophageal Cancer'],GastroEsophageal Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT03907488,Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma,"A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age &gt;/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma",ACTIVE_NOT_RECRUITING,2019-08-29,2024-03-31,2026-03-28,INTERVENTIONAL,PHASE3,994,"['Ann Arbor Stage III Hodgkin Lymphoma', 'Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma', 'Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma', 'Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma', 'Ann Arbor Stage IV Hodgkin Lymphoma', 'Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma', 'Ann Arbor Stage IV Mixed Cellularity Classic Hodgkin Lymphoma', 'Ann Arbor Stage IV Nodular Sclerosis Classic Hodgkin Lymphoma', 'Classic Hodgkin Lymphoma', 'Lymphocyte-Rich Classic Hodgkin Lymphoma']",Ann Arbor Stage III Hodgkin Lymphoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT07264712,"The Effect of Wound Care Education Given to Patients on Wound Care Knowledge, Self-Care Self-Efficacy, and Quality of Recovery","The Effect of Wound Care Education Given to Patients Undergoing Prosthetic Surgery on Wound Care Knowledge, Self-Care Self-Efficacy, and Quality of Recovery",ACTIVE_NOT_RECRUITING,2025-10-10,2026-02-20,2026-04-01,INTERVENTIONAL,NA,50,"['Prosthetic Treatment', 'Wound Care', 'Education']",Prosthetic Treatment,TC Erciyes University,[],['Turkey (Türkiye)']
NCT03955445,"Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN","An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis",RECRUITING,2019-10-03,2036-05-30,2036-05-30,INTERVENTIONAL,PHASE3,225,"['C3 Glomerulopathy', 'Immune-complex-membranoproliferative Glomerulonephritis']",C3 Glomerulopathy,Novartis Pharmaceuticals,[],"['Brazil', 'Israel', 'Japan', 'Turkey (Türkiye)', 'Netherlands', 'China', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Greece', 'Argentina', 'Germany']"
NCT06922630,WIN: a Feasibility Study of a Weight-Neutral Health Intervention,WIN: a Feasibility Study of a Weight-Neutral Health Intervention. Lighthouse Consortium on Obesity Management (LightCOM) Trial no 1.,ACTIVE_NOT_RECRUITING,2025-08-07,2026-12-31,2026-12-31,INTERVENTIONAL,NA,56,['Obesity'],Obesity,Carsten Dirksen,"['University of Copenhagen', 'Copenhagen Trial Unit, Center for Clinical Intervention Research']",['Denmark']
NCT03351764,Development of Non-Invasive Brain Stimulation Techniques,Development of Non-Invasive Brain Stimulation Techniques,RECRUITING,2018-01-11,2029-01-01,2029-03-01,INTERVENTIONAL,NA,180,['Normal Physiology'],Normal Physiology,National Institute of Mental Health (NIMH),[],['United States']
NCT05057507,Realistic Computational Electrophysiology Simulations for the Targetted Treatment of Atrial Fibrillation,Realistic Computational Electrophysiology Simulations for the Targetted Treatment of Atrial Fibrillation,ACTIVE_NOT_RECRUITING,2022-07-01,2024-10-15,2026-03-06,OBSERVATIONAL,,91,['Atrial Fibrillation'],Atrial Fibrillation,University of Edinburgh,"[""King's College London""]",['United Kingdom']
NCT06189872,Radiographic Migration Analysis of the ATTUNE Cementless CR Fixed-Bearing Total Knee Replacement,"Radiographic Migration Analysis of the ATTUNE Cementless CR Fixed-Bearing Total Knee Replacement: A Multi-Center, Non-Controlled, Prospective Study",ACTIVE_NOT_RECRUITING,2024-10-21,2026-12,2027-06,INTERVENTIONAL,NA,30,['Osteo Arthritis Knee'],Osteo Arthritis Knee,Canadian Radiostereometric Analysis Network,[],['Canada']
NCT00789009,Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection,Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection,RECRUITING,2008-11-20,,,OBSERVATIONAL,,600,['HIV'],HIV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05372263,Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study,Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study,RECRUITING,2021-08-26,2026-08-31,2026-12-31,OBSERVATIONAL,,700,['Pulmonary Hypertension'],Pulmonary Hypertension,China National Center for Cardiovascular Diseases,[],['China']
NCT05347563,Study on Ventilation Distribution With Electrical Impedance Tomography for Paediatric Respiratory Failure,Study on Ventilation Distribution With Electrical Impedance Tomography for Paediatric Respiratory Failure: Impact of Intervention,RECRUITING,2022-06-18,2027-06,2027-06,OBSERVATIONAL,,250,['Acute Respiratory Failure'],Acute Respiratory Failure,Hospices Civils de Lyon,[],['France']
NCT05418764,Effect of Validated Skills Simulation With the Miya Model,Effect of Validated Skills Simulation With the Miya Model on Operating Room Performance of Vaginal Hysterectomy,RECRUITING,2021-12-27,2025-12,2025-12,INTERVENTIONAL,NA,70,['Vaginal Hysterectomy'],Vaginal Hysterectomy,Wake Forest University Health Sciences,[],['United States']
NCT06730230,"Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients","Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients",RECRUITING,2025-02-10,2026-05-31,2027-05-31,INTERVENTIONAL,NA,300,['Hypertension'],Hypertension,NYU Langone Health,['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT05570825,SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer,A Phase 2 Trial of SX-682 and Pembrolizumab in Patients With Treatment Naive Stage IV or Recurrent Non-Small Cell Lung Cancer,RECRUITING,2023-04-06,2027-07-01,2028-07-01,INTERVENTIONAL,PHASE2,30,"['Metastatic Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage IIIC Lung Cancer AJCC v8', 'Stage IV Lung Cancer AJCC v8']",Metastatic Lung Non-Small Cell Carcinoma,University of Washington,"['National Cancer Institute (NCI)', 'Syntrix Biosystems, Inc.']",['United States']
NCT07263893,Inter Flex Three Dimensional Plate in Management of Mandibular Fracture RCT,Evaluation of the Efficacy of Custom-Made Inter-flex Three-Dimensional Plate in Treatment of Mandibular Fracture A Randomized Controlled Clinical Trial,RECRUITING,2025-12-02,2026-12-02,2026-12-03,INTERVENTIONAL,NA,20,['Mandibular Fracture Treatment'],Mandibular Fracture Treatment,Suez Canal University,[],['Egypt']
NCT06857955,A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients,"A Randomized, Double-blind, Placebo-controlled, Multicenter, 12 Months Treatment Duration, Dose Finding Study, to Evaluate Efficacy, Safety and Pharmacodynamics of QCZ484 in Mild to Moderate Hypertensive Patients",RECRUITING,2025-03-26,2026-12-31,2028-04-05,INTERVENTIONAL,PHASE2,380,['Hypertension'],Hypertension,Novartis Pharmaceuticals,[],"['Singapore', 'Japan', 'United States']"
NCT07264478,Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China,"Beijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China",ACTIVE_NOT_RECRUITING,2022-10-15,2025-12-12,2025-12-30,OBSERVATIONAL,,1100,"['RSV Infection', 'Disease Burden']",RSV Infection,Beijing Children's Hospital,[],['China']
NCT06136247,"Integrating Brain, Neurocognitive, and Computational Tools in OUD","Integrating Brain, Neurocognitive, and Computational Tools in Opioid Use Disorder (OUD) to Characterize Executive Function and to Predict Clinical Outcomes.",RECRUITING,2023-11-01,2027-01-31,2027-07-31,OBSERVATIONAL,,192,['Opioid Use Disorder'],Opioid Use Disorder,University of Pennsylvania,[],['United States']
NCT06807606,Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation,Optimized CBT for Pts With High-risk Hematologic Malignancies Who Have Relapsed After First ASCT,RECRUITING,2025-03-03,2027-11-30,2029-11-30,INTERVENTIONAL,PHASE2,35,['Hematologic Malignancies'],Hematologic Malignancies,M.D. Anderson Cancer Center,[],['United States']
NCT03992404,Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury,"Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Investigate the Efficacy and Safety of NT 201 in the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury in Adult Subjects, Followed by an Open Label Extension With or Without Combined Upper Limb Treatment",ACTIVE_NOT_RECRUITING,2019-09-16,2025-06-19,2027-04,INTERVENTIONAL,PHASE3,603,['Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury'],Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury,Merz Pharmaceuticals GmbH,[],"['Belgium', 'Hungary', 'Russia', 'United States', 'France', 'Slovakia', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Ukraine', 'Germany']"
NCT06866548,Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer,Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer,ACTIVE_NOT_RECRUITING,2025-03-10,2025-11-11,2028-11,INTERVENTIONAL,EARLY_PHASE1,7,['mCRPC'],mCRPC,Shanghai Changzheng Hospital,[],['China']
NCT06952504,A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29),"A Phase 3 Randomized, Open-label, Multicenter Study to Compare the Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-line Maintenance Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (TroFuse-033/GOG-3119/ENGOT-en29)",RECRUITING,2025-05-22,2032-05-24,2032-05-24,INTERVENTIONAL,PHASE3,1123,['Endometrial Cancer'],Endometrial Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Denmark', 'Puerto Rico', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT05398484,Psilocybin Therapy in Advanced Cancer,"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer",RECRUITING,2023-05-24,2027-01-01,2027-01-01,INTERVENTIONAL,PHASE2,200,['Advanced Cancer'],Advanced Cancer,NYU Langone Health,['National Cancer Institute (NCI)'],['United States']
NCT05464030,Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01),"A Phase I, Multicenter, Open-Label First in Human Study of Anti-CEACAM5 Antibody Drug Conjugate M9140 in Participants With Advanced Solid Tumors (PROCEADE-CRC-01)",RECRUITING,2022-08-04,2026-08-07,2026-08-07,INTERVENTIONAL,PHASE1,200,['Colorectal Cancer'],Colorectal Cancer,"EMD Serono Research & Development Institute, Inc.","['Merck KGaA, Darmstadt, Germany']","['Japan', 'United States', 'Spain', 'South Korea', 'Canada']"
NCT07161037,Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW),"A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VX-407 in Subjects With Autosomal Dominant Polycystic Kidney Disease Who Have a Subset of PKD1 Gene Variants",RECRUITING,2025-11-19,2027-07-22,2027-12-31,INTERVENTIONAL,PHASE2,24,['Autosomal Dominant Polycystic Kidney Disease (ADPKD)'],Autosomal Dominant Polycystic Kidney Disease (ADPKD),Vertex Pharmaceuticals Incorporated,[],['United States']
NCT07082725,A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC),"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",RECRUITING,2025-06-30,2027-11-04,2027-11-04,INTERVENTIONAL,PHASE3,72,['Niemann-Pick Type C Disease'],Niemann-Pick Type C Disease,Azafaros A.G.,[],"['Brazil', 'Turkey (Türkiye)', 'India', 'United States', 'Germany', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Portugal', 'Argentina', 'Australia']"
NCT05674617,PTSD Treatment for Veterans With Serious Mental Illness to Improve Functional Outcomes,PTSD Treatment for Veterans With Serious Mental Illness to Improve Functional Outcomes,RECRUITING,2023-12-01,2027-03-31,2028-03-31,INTERVENTIONAL,NA,48,"['Stress Disorders, Post-Traumatic; Mental Disorders']","Stress Disorders, Post-Traumatic; Mental Disorders",VA Office of Research and Development,[],['United States']
NCT03639753,Transportation Safety in Adolescence,Promoting Transportation Safety in Adolescence,ACTIVE_NOT_RECRUITING,2021-08-18,2026-02-01,2026-02-01,INTERVENTIONAL,NA,2216,['Automobile Accident'],Automobile Accident,University of Pennsylvania,"['University of Edinburgh', 'University of Alabama at Birmingham', ""Children's Hospital of Philadelphia"", 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'Wake Forest University Health Sciences']",['United States']
NCT07247695,Mechanisms Underlying the Placebo Effect in Both Histaminergic and Non-histaminergic Itch,"Pain and Itch Neuromodulation: Effects of Offset Analgesia, Placebo, and Nocebo and Topographical Distribution of Itch and Pain Receptors",RECRUITING,2025-11-03,2026-12-31,2028-12-31,INTERVENTIONAL,NA,30,['ITCH'],ITCH,Aalborg University,[],['Denmark']
NCT05457972,Postpartum Vaginal Estrogen for Breastfeeding Patients,Postpartum Vaginal Estrogen for Sexual Function in Breastfeeding Patients: A Randomized Controlled Trial,RECRUITING,2025-02-22,2026-03-30,2026-03-30,INTERVENTIONAL,PHASE4,100,"['Breastfeeding', 'Postpartum Sexual Dysfunction', 'Vaginal Atrophy']",Breastfeeding,University Hospitals Cleveland Medical Center,[],['United States']
NCT07262866,Evaluation of the Effects of Education and Counseling Provided to Patients Via Distance Nursing After Cataract Surgery on Regular Use of Medications and Patient Satisfaction. CAT-TELEMED (Cataract - Telemedicine) TNCat-25 (Tele-Nursing Cataract - 2025),Effect of Education and Counseling Provided Via Telenursing on Medication Compliance and Patient Satisfaction After Cataract Surgery,ACTIVE_NOT_RECRUITING,2025-01-16,2025-06-11,2025-12-28,INTERVENTIONAL,NA,128,"['Cataract Patients', 'Cataract After Surgery', 'Cataract Surgery']",Cataract Patients,Züleyha Sönmez,['Ataturk University'],['Turkey (Türkiye)']
NCT06522256,Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial,Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their Associations With the Presence of High-grade Lesions and/or Anal Cancer 10 Years After Inclusion in the ANRS IPERGAY Trial,RECRUITING,2025-03-20,2027-07-30,2027-07-30,INTERVENTIONAL,NA,100,"['HPV Infection', 'Anal Cancer']",HPV Infection,"ANRS, Emerging Infectious Diseases",['INSERM SC10-US19'],['France']
NCT07263529,Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years),Risk of Anemia Development and Clinical Effects of Oral Iron Therapy in Women (18-55 Years) With Non-Anemic Iron Deficiency,RECRUITING,2025-09-01,2026-01-01,2026-02-28,INTERVENTIONAL,NA,60,['Non-Anemic Iron Deficiency'],Non-Anemic Iron Deficiency,Istanbul University - Cerrahpasa,[],['Turkey (Türkiye)']
NCT06784895,Designing and Assessing a Women Only Cardiac Rehabilitation (CARE) Program,Designing and Assessing a Women Only Cardiac Rehabilitation Program,RECRUITING,2025-05-05,2027-03,2027-03,INTERVENTIONAL,NA,60,"['Cardiac Rehabilitation', 'Cardiovascular Diseases']",Cardiac Rehabilitation,University of Michigan,['University of Texas'],['United States']
NCT03914612,Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer,"A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer",ACTIVE_NOT_RECRUITING,2019-08-22,2022-12-16,2026-09-26,INTERVENTIONAL,PHASE3,813,"['Endometrial Clear Cell Adenocarcinoma', 'Endometrial Dedifferentiated Carcinoma', 'Endometrial Endometrioid Adenocarcinoma', 'Endometrial Mixed Cell Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Endometrial Undifferentiated Carcinoma', 'Recurrent Endometrial Adenocarcinoma', 'Recurrent Endometrial Carcinoma', 'Recurrent Endometrial Clear Cell Adenocarcinoma', 'Recurrent Endometrial Dedifferentiated Carcinoma', 'Recurrent Endometrial Endometrioid Adenocarcinoma', 'Recurrent Endometrial Mixed Cell Adenocarcinoma', 'Recurrent Endometrial Serous Adenocarcinoma', 'Recurrent Endometrial Undifferentiated Carcinoma', 'Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8', 'Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8']",Endometrial Clear Cell Adenocarcinoma,National Cancer Institute (NCI),"['Canadian Cancer Trials Group', 'NRG Oncology']","['Japan', 'United States', 'Puerto Rico', 'South Korea', 'Canada']"
NCT01730092,Natural History Study of Biomarkers in Pulmonary Arterial Hypertension,A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension,RECRUITING,2013-07-15,2030-12-31,,OBSERVATIONAL,,270,"['Pulmonary Disease', 'Pulmonary Hypertension']",Pulmonary Disease,National Institutes of Health Clinical Center (CC),[],['United States']
NCT04224493,"A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.","Symphony-1: A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study Of Tazemetostat Or Placebo In Combination With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma",RECRUITING,2020-06-11,2026-03-01,2029-03-01,INTERVENTIONAL,PHASE3,612,"['Relapsed/Refractory Follicular Lymphoma', 'Follicular Lymphoma', 'Refractory Follicular Lymphoma']",Relapsed/Refractory Follicular Lymphoma,"Epizyme, Inc.",[],"['Brazil', 'Belgium', 'Singapore', 'Hungary', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT05555550,Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG,Evaluation of 18F-Fluciclovine PET-MRI as a Biomarker of Response in Pediatric and Young Adult Patients With Low Grade Gliomas (LGG),RECRUITING,2025-12-29,2026-09,2027-09,INTERVENTIONAL,EARLY_PHASE1,30,"['Glioma', 'Low-grade Glioma', 'Low Grade Glioma of Brain', 'Glioma, Malignant', 'Glioma Intracranial']",Glioma,Children's Hospital of Philadelphia,"['Blue Earth Diagnostics', 'Dragon Master Foundation']",['United States']
NCT05992077,Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia,Pilot Therapeutic Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia,ACTIVE_NOT_RECRUITING,2023-08-07,2026-01-31,2026-01-31,INTERVENTIONAL,NA,21000,['HCV Infection'],HCV Infection,"ANRS, Emerging Infectious Diseases","['Institute Pasteur, Cambodia']",['Cambodia']
NCT06334263,Splenic Embolisation Decisions,Decision to Treat Acute Traumatic Splenic Artery Injury in the Context of Trauma,RECRUITING,2024-07-22,2026-06-02,2026-09-30,OBSERVATIONAL,,8000,"['Trauma', 'Spleen Injury']",Trauma,University Hospital Plymouth NHS Trust,[],['United Kingdom']
NCT06162221,Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC,A Platform Study of RAS(ON) Inhibitors in Patients With RAS-Mutated Non-Small Cell Lung Cancer (NSCLC),RECRUITING,2024-01-18,2027-06,2028-12,INTERVENTIONAL,PHASE1,616,"['Non-Small Cell Lung Cancer, NSCLC', 'KRAS, NRAS, HRAS-mutated NSCLC', 'KRAS G12C-mutated Solid Tumors, Lung Cancer', 'Lung Cancer Stage IV, Advanced Solid Tumor, Cancer', 'RAS G12D-mutated NSCLC']","Non-Small Cell Lung Cancer, NSCLC","Revolution Medicines, Inc.",[],"['Netherlands', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'Australia', 'Greece', 'Germany']"
NCT06880744,A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab,"Phase 3b, Multicenter, Randomized, Open-Label Study of Risankizumab Compared to Vedolizumab for the Treatment of Adult Subjects With Moderate to Severe Ulcerative Colitis Who Are Naïve to Targeted Therapies",RECRUITING,2025-06-17,2028-09,2028-09,INTERVENTIONAL,PHASE3,530,['Ulcerative Colitis'],Ulcerative Colitis,AbbVie,[],"['Bulgaria', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Lithuania', 'Israel', 'Hungary', 'Estonia', 'Slovenia', 'France', 'Finland', 'Puerto Rico', 'Croatia', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Arab Emirates', 'Latvia', 'United Kingdom', 'Sweden', 'Germany', 'Austria', 'United States', 'Ireland', 'Italy']"
NCT06764121,Impact of Canadian Haskap Berry Powder on Hypertension and Acuity in Women's Health,Impact of Haskalife(TM) Canadian Haskap Berry Powder Formulation on Hypertension and Acuity in Women's Health,ACTIVE_NOT_RECRUITING,2025-04-03,2026-03-26,2026-08-06,INTERVENTIONAL,NA,32,"['Hypertension', 'Alertness']",Hypertension,University of Manitoba,[],['Canada']
NCT07265427,Trust in AI and Digitalization in Healthcare Across Generational Groups: A Comparative Study of Barriers and Facilitators Toward Equitable Adoption.,"Acceptance and Perceived Benefits of Digitalization by Medical Assistants and Other Generational Groups (ANDI-MFA-2): ""Trust in AI and Digitalization in Healthcare Across Generational Groups: A Comparative Study of Barriers and Facilitators Toward Equitable Adoption""",RECRUITING,2025-11-24,2026-03-30,2026-12-30,OBSERVATIONAL,,250,"['Digital Health', 'Artificial Intelligence (AI)']",Digital Health,Jacobs University Bremen gGmbH,['Hamburg University of Applied Sciences/Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg)'],['Germany']
NCT05798780,The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors,The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors: A Randomized Clinical Trial,ACTIVE_NOT_RECRUITING,2023-04-06,2025-10-13,2026-07,INTERVENTIONAL,NA,40,"['Oral Cavity Cancer', 'Oropharynx Cancer', 'Hypopharynx Cancer', 'Larynx Cancer']",Oral Cavity Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT07199985,Assessment of Intrinsic Risk Factors for Ankle Injuries in Ballet Dancers,Assessment of Intrinsic Risk Factors for Ankle Injuries in Ballet Dancers,ACTIVE_NOT_RECRUITING,2025-09-22,2026-01,2026-04,OBSERVATIONAL,,45,['Healthy'],Healthy,Ege University,[],['Turkey (Türkiye)']
NCT06623240,HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis,"A Randomized, Double-Blind, Phase 2, Efficacy and Safety Cross-Over Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis",RECRUITING,2026-01,2027-12,2027-12,INTERVENTIONAL,PHASE2,66,['Juvenile Idiopathic Arthritis (JIA)'],Juvenile Idiopathic Arthritis (JIA),Hope Biosciences Research Foundation,[],['United States']
NCT07265336,Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant Women,Comparison of Base Excess in Arterial Blood Gases Between Patients With Severe Preeclampsia and Normotensive Pregnant Patients,RECRUITING,2025-08-15,2025-12-31,2026-01-31,INTERVENTIONAL,NA,100,"['Preeclampsia', 'Severe Preeclampsia']",Preeclampsia,"Saint Thomas Hospital, Panama",[],['Panama']
NCT02417714,Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR),Prospective Evaluation of Next Generation CT Reconstruction,RECRUITING,2014-09-08,2026-06-30,2026-07-01,OBSERVATIONAL,,215,['Healthy Subjects'],Healthy Subjects,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07264309,Combined Intravenous Tramadol and Paracetamol Versus Intramuscular Pethidine for Pain Relief During the First Stage of Labor. Compare the Efficacy and Adverse Effects,Combined Intravenous Tramadol and Paracetamol Versus Intramuscular Pethidine for Pain Relief During the First Stage of Labor,RECRUITING,2025-11-01,2026-12,2027-12,INTERVENTIONAL,NA,140,"['Pain Management', 'Birth']",Pain Management,Zohar Nachum,[],['Israel']
NCT07263126,Effect of Bicycle Ergometer Training on Fat Tissue Amount and Metabolism,Effect of Bicycle Ergometer Training in Thermoneutral and Lightly Cold Ambient Temperatures on Fat Tissue Amount and Metabolism in Overweight and Obese Women,RECRUITING,2025-05-27,2026-05-27,2026-05-27,INTERVENTIONAL,NA,36,['Endurance Training'],Endurance Training,Pamukkale University,[],['Turkey (Türkiye)']
NCT05786443,Safety and Efficacy of Empagliflozin in Hemodialysis,"A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Empagliflozin Among Patients Initiating Hemodialysis for the Treatment of End-Stage Kidney Disease",RECRUITING,2024-01-31,2026-12-30,2026-12-30,INTERVENTIONAL,PHASE2,60,['End Stage Renal Disease'],End Stage Renal Disease,NYU Langone Health,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'Boehringer Ingelheim']",['United States']
NCT06289985,StrokeNet Thrombectomy Endovascular Platform,STEP: StrokeNet Thrombectomy Endovascular Platform,RECRUITING,2025-01-31,2029-01-31,2030-01-31,INTERVENTIONAL,NA,1600,['Ischemic Stroke'],Ischemic Stroke,Medical University of South Carolina,"['National Institute of Neurological Disorders and Stroke (NINDS)', 'University of Cincinnati', 'University of Virginia', 'Berry Consultants', 'University of California, Los Angeles', 'MOUNT SINAI HOSPITAL', 'The Cooper Health System', 'University of Pittsburgh Medical Center', 'Stony Brook University', 'University at Buffalo']",['United States']
NCT07264322,Real-Time Dynamic Imaging Study of Normal Pharyngolaryngeal Structures During Barium Swallow (GLAM-III),Observational Imaging Study on Real-Time Dynamic Changes of Normal Pharyngolaryngeal Structures During Barium Swallow in Patients Undergoing Routine Barium Meal Examination,RECRUITING,2025-09-10,2025-12-30,2025-12-30,OBSERVATIONAL,,3,['Barium Meal Examination'],Barium Meal Examination,Zhejiang Cancer Hospital,[],['China']
NCT03485209,Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors,Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors,ACTIVE_NOT_RECRUITING,2018-06-25,2026-01-13,2026-09-13,INTERVENTIONAL,PHASE2,352,"['Colorectal Neoplasms', 'Carcinoma, Non-Small-Cell Lung', 'Exocrine Pancreatic Cancer', 'Carcinoma, Squamous Cell of Head and Neck']",Colorectal Neoplasms,"Seagen, a wholly owned subsidiary of Pfizer","['Genmab', 'Merck Sharp & Dohme LLC']","['United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT06792500,"A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)",Investigational Study of Glycerol Tributyrate in MELAS and LHON-Plus,RECRUITING,2025-12,2027-07,2027-07,INTERVENTIONAL,PHASE1,24,"['MELAS Syndrome', 'Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)']",MELAS Syndrome,George Washington University,"['National Center for Advancing Translational Sciences (NCATS)', ""Children's National Research Institute""]",['United States']
NCT07170904,"Dietary Patterns, Inflammation, Zinc Status, and Body Composition in Multi-Ethnic Women of Reproductive Age in Jakarta","The Relationship Between Dietary Patterns and Hair Zinc Levels With Body Composition, TNF-α, and Blood Pressure in Women of Reproductive Age (WRA) With Multi-Ethnicities in Jakarta: A Cross-Sectional Study",RECRUITING,2025-02-03,2025-12-30,2026-03-31,OBSERVATIONAL,,188,"['Body Composition', 'Zinc Status', 'Dietary Analysis', 'TNF Alpha', 'Blood Pressure']",Body Composition,Indonesia University,[],['Indonesia']
NCT06890338,"A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.","A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects With FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer",RECRUITING,2025-11-21,2030-02,2030-02,INTERVENTIONAL,PHASE2,140,"['Epithelial Ovarian Cancer', 'Fallopian Tube Cancer', 'Primary Peritoneal Cancer', 'Neoadjuvant']",Epithelial Ovarian Cancer,AbbVie,['GOG Foundation'],['United States']
NCT05768347,Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC,Phase 1 Clinical Trial of Intravesical Adoptive Cell Therapy {ACT) With Tumor Infiltrating Lymphocytes (TIL) for Patients With BCG Exposed High Grade Non-Muscle Invasive Bladder Cancer (NMIBC),ACTIVE_NOT_RECRUITING,2023-08-10,2025-10-10,2027-01,INTERVENTIONAL,PHASE1,9,"['Urothelial Carcinoma', 'Non-Invasive Bladder Urothelial Carcinoma']",Urothelial Carcinoma,H. Lee Moffitt Cancer Center and Research Institute,['United States Department of Defense'],['United States']
NCT03568266,Pharmacogenomics of Asparaginase Induced Hepatotoxicity,"Pharmacogenomics of Age-Specific, Asparaginase-Induced Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia",RECRUITING,2018-05-22,2026-06-30,2026-12-31,OBSERVATIONAL,,500,['Acute Lymphoblastic Leukemia'],Acute Lymphoblastic Leukemia,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT06874439,An Evaluation of the WHO QUAlityRights Program,An Evaluation of the WHO QUAlityRights Program,ACTIVE_NOT_RECRUITING,2024-06-17,2027-06,2027-10,INTERVENTIONAL,NA,1800,"['Recovery', 'Organization of Health Service', 'Mental Health Care', 'Mental Health Services']",Recovery,GCS-CCOMS,"['INSERM ECEVE 1123', ""L'Assistance Publique - Hopitaux de Paris (AP-HP)""]",['France']
NCT06314061,The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes.,"The Effect of Continuous Glucose Monitoring With Real-time Alerts on Glycaemic Control in Surgical Patients With Diabetes: A Randomised, Clinical Multicentre Trial",RECRUITING,2024-06-24,2026-04-01,2026-06-01,INTERVENTIONAL,PHASE4,200,"['Diabetes Mellitus', 'Dysglycemia', 'Perioperative Complication']",Diabetes Mellitus,Christian S. Meyhoff,"['Rigshospitalet, Denmark', 'Steno Diabetes Center Copenhagen', 'Zealand University Hospital']",['Denmark']
NCT06563895,Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant,"A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)",RECRUITING,2025-05-12,2031-10,2032-12,INTERVENTIONAL,PHASE3,582,"['Amyloidosis', 'Amyloid Cardiomyopathy', 'Transthyretin Amyloidosis', 'Cardiomyopathies', 'Heart Diseases', 'Polyneuropathies']",Amyloidosis,"Eidos Therapeutics, a BridgeBio company",[],"['Netherlands', 'Australia', 'France', 'Denmark', 'South Korea', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06430346,Exercise Prehabilitation for Locoregional Esophageal Cancer,Exercise Prehabilitation for Locoregional Esophageal Cancer: A Pilot Study,RECRUITING,2024-05-21,2027-05,2027-05,INTERVENTIONAL,NA,20,['Esophageal Cancer'],Esophageal Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT05326386,Gamification and Medication Adherence (GAME Adherence),Gamification and Social Incentives to Augment Medication Adherence,ACTIVE_NOT_RECRUITING,2022-09-12,2024-01-31,2026-05,INTERVENTIONAL,NA,84,['Hypertension and Hyperlipidemia'],Hypertension and Hyperlipidemia,University of Pennsylvania,[],['United States']
NCT03570892,Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma,"Tisagenlecleucel Versus Standard of Care in Adult Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma: A Randomized, Open Label, Phase III Trial (BELINDA)",ACTIVE_NOT_RECRUITING,2019-05-07,2021-05-06,2026-02-11,INTERVENTIONAL,PHASE3,331,['Non-Hodgkin Lymphoma'],Non-Hodgkin Lymphoma,Novartis Pharmaceuticals,[],"['Brazil', 'Belgium', 'Japan', 'Singapore', 'Hong Kong', 'Netherlands', 'Norway', 'China', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Taiwan', 'Italy', 'United Kingdom', 'Australia']"
NCT02098863,Sickle Cell Clinical Research and Intervention Program,Sickle Cell Clinical Research and Intervention Program,RECRUITING,2014-04-15,2044-12,2044-12,OBSERVATIONAL,,10000,['Sickle Cell Disease'],Sickle Cell Disease,St. Jude Children's Research Hospital,"['University of Memphis School of Public Health', ""Le Bonheur Children's Hospital"", 'University of Alabama at Birmingham', 'Washington University School of Medicine', 'UTHSC-ORNL Center in Biomedical Informatics', 'University of Washington', 'Medical College of Wisconsin', 'University of Tennessee', ""Children's Hospital of Philadelphia"", 'National Heart, Lung, and Blood Institute (NHLBI)', 'Vanderbilt University School of Medicine', 'Baylor College of Medicine']",['United States']
NCT06104644,A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany,"Deucravacitinib in Routine Clinical Practice: A 5-year, Multicenter, Prospective, Non-Interventional Cohort Study to Evaluate Effectiveness and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis in Germany (DELPHIN)",ACTIVE_NOT_RECRUITING,2023-04-13,2025-08-18,2030-05-31,OBSERVATIONAL,,550,['Plaque Psoriasis'],Plaque Psoriasis,Bristol-Myers Squibb,[],['Germany']
NCT07265349,A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure,A Phase I/II Clinical Trial to Evaluate the Safety and Efficacy of Intramyocardial Injection of Human Umbilical Cord Mesenchymal Stem Cells (HucMSCs) Combined With Coronary Artery Bypass Grafting in the Treatment of Chronic Heart Failure Caused by Chronic Ischemic Cardiomyopathy,RECRUITING,2025-12-01,2026-12-31,2027-08-01,INTERVENTIONAL,PHASE1,51,"['Coronary Artery Bypass Grafting (CABG)', 'Chronic Heart Failure', 'Chronic Ischemic Cardiomyopathy']",Coronary Artery Bypass Grafting (CABG),"Tasly Pharmaceutical Group Co., Ltd",[],['China']
NCT06244771,A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors,"An Open-Label, Phase 1/2 Dose Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, PK and Clinical Activity of FMC-376 in Participants With KRAS G12C Mutated Locally Advanced Unresectable or Metastatic Solid Tumors",RECRUITING,2024-02-12,2027-10,2028-04,INTERVENTIONAL,PHASE1,403,"['Advanced Solid Tumors With KRAS G12C Mutations', 'Solid Tumor, Adult', 'Unresectable Solid Tumor', 'Metastatic Solid Tumor', 'Non Small Cell Lung Cancer', 'Colorectal Cancer', 'KRAS G12C', 'Pancreatic Cancer']",Advanced Solid Tumors With KRAS G12C Mutations,Frontier Medicines Corporation,[],"['United States', 'South Korea', 'Australia']"
NCT06047444,A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults,"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Chronic Migraine in Adult Participants",ACTIVE_NOT_RECRUITING,2023-10-12,2026-06-22,2026-12-21,INTERVENTIONAL,PHASE3,720,['Chronic Migraine'],Chronic Migraine,Ipsen,[],"['United States', 'Georgia', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT06462430,PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry,Genotype-phenotype Correlations of Pediatric Patients With PTEN Hamartoma Tumor Syndrome (PHTS) and Creation of Patient Registry,RECRUITING,2022-11-01,2026-12-01,2026-12-01,OBSERVATIONAL,,100,"['PTEN Hamartoma Tumor Syndrome', 'Macrocephaly Autism Syndrome']",PTEN Hamartoma Tumor Syndrome,Yale University,"[""Boston Children's Hospital"", 'Ege University']",['Turkey (Türkiye)']
NCT07067463,A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis,"A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis",RECRUITING,2025-12,2030-06,2030-07,INTERVENTIONAL,PHASE3,705,['Multiple Sclerosis (MS) Primary Progressive'],Multiple Sclerosis (MS) Primary Progressive,"Zenas BioPharma (USA), LLC",[],['United States']
NCT05903573,Training Response Artificial Intelligence Network (TRAIN),Using Artificial Intelligence to Predict Cognitive Training Response in Amnestic Mild Cognitive Impairment,RECRUITING,2023-10-09,2028-04-30,2028-04-30,INTERVENTIONAL,NA,75,['Amnestic Mild Cognitive Impairment'],Amnestic Mild Cognitive Impairment,University of Florida,['National Institute on Aging (NIA)'],['United States']
NCT07264036,"Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study",Injectable Augmentation Outcomes in Post-Radiation Head and Neck Cancer Patients With Velopharyngeal Dysfunction,RECRUITING,2026-01-01,2027-01-01,2027-07-01,INTERVENTIONAL,NA,20,"['Velopharyngeal Insufficiency', 'Head and Neck Cancer', 'Survivorship', 'Dysphagia', 'Speech Disorder']",Velopharyngeal Insufficiency,Vanessa Torrecillas,[],['United States']
NCT05757219,Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy,"A Phase 2, Single-Arm, Open-Label Study Using Itacitinib as Pre-Modulation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Receiving CAR-T-Cell Therapy",RECRUITING,2023-05-19,2026-01,2027-01,INTERVENTIONAL,PHASE2,27,['Diffuse Large B Cell Lymphoma'],Diffuse Large B Cell Lymphoma,H. Lee Moffitt Cancer Center and Research Institute,['Incyte Corporation'],['United States']
NCT03460977,"A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma","A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF 06821497 (MEVROMETOSTAT) IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSED/REFRACTORY SMALL CELL LUNG CANCER (SCLC), CASTRATION RESISTANT PROSTATE CANCER (CRPC) AND FOLLICULAR LYMPHOMA (FL)",RECRUITING,2018-04-17,2028-05-01,2029-03-14,INTERVENTIONAL,PHASE1,433,"['Metastatic Castration Resistant Prostate Cancer (mCRPC)', 'Small Cell Lung Cancer (SCLC)', 'Follicular Lymphoma (FL)']",Metastatic Castration Resistant Prostate Cancer (mCRPC),Pfizer,[],"['Bulgaria', 'Japan', 'China', 'Russia', 'United States', 'Spain', 'South Korea', 'Poland']"
NCT06827470,Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis,"Open-label, Phase 1/2, Dose-escalation Clinical Trial to Establish a Controlled Human Infection Model by Determining and Confirming the Optimal and Safe J820 Bordetella Pertussis Dose Administered Intranasally to Healthy Adults 18-50 Years of Age That Induces Mild Symptomatic Infection and Detection of B. Pertussis in Nasal Samples",RECRUITING,2025-11-24,2026-12-31,2027-04-30,INTERVENTIONAL,PHASE1,60,['Pertussis (Whooping Cough)'],Pertussis (Whooping Cough),Dalhousie University,['Centers for Disease Control and Prevention'],['Canada']
NCT06952530,A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2,"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",RECRUITING,2025-04-30,2027-09,2027-09,INTERVENTIONAL,PHASE3,487,['Hypertension'],Hypertension,Eli Lilly and Company,[],"['Japan', 'China', 'India', 'United States', 'Puerto Rico', 'Spain', 'Czechia', 'Greece', 'Poland', 'Argentina', 'Germany']"
NCT07265466,"to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban","A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban in Healthy Volunteers.",RECRUITING,2025-11-17,2026-03-30,2026-03-30,INTERVENTIONAL,PHASE1,96,['Drug Drug Interaction (DDI)'],Drug Drug Interaction (DDI),Onconic Therapeutics Inc.,[],['South Korea']
NCT05410951,LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients,LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients,ACTIVE_NOT_RECRUITING,2022-05-16,2025-12-31,2026-05-16,OBSERVATIONAL,,800,"['Lobular Breast Carcinoma', 'Lobular in Situ Breast Carcinoma', 'BRCA1 Mutation', 'BRCA2 Mutation']",Lobular Breast Carcinoma,European Institute of Oncology,[],['Italy']
NCT02595957,Genomic Services Research Program,Genomic Services Research Program,RECRUITING,2014-09-16,2028-12-31,2028-12-31,OBSERVATIONAL,,5000,"['Colon Cancer', 'Breast Cancer']",Colon Cancer,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06545955,A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer,"A Phase 3, Randomised, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)",RECRUITING,2024-10-01,2028-06-30,2030-12-31,INTERVENTIONAL,PHASE3,250,['Non-muscle Invasive Bladder Cancer With Carcinoma in Situ'],Non-muscle Invasive Bladder Cancer With Carcinoma in Situ,Ferring Pharmaceuticals,[],"['United States', 'Spain', 'Canada', 'Czechia', 'Poland']"
NCT07265180,Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison,Oxytocin-Augmented Mindfulness-Based Group Psychotherapy for Patients With Schizophrenia Spectrum Disorders - an Oxytocin-dose Comparison (OXYMIND2.0),RECRUITING,2025-09-08,2026-11-30,2026-11-30,INTERVENTIONAL,NA,120,['Schizophrenia Spectrum Disorders (SSD)'],Schizophrenia Spectrum Disorders (SSD),"Charite University, Berlin, Germany",[],['Germany']
NCT06731179,"A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COVID, Lyme Disease and Myalic Encephalomyelitis / Chronic Fatigue Syndrome Using the Vira Immune Fluorospot T Cell Assay","STUDY TO EVALUATE THE ROLE OF T CELL-DYSFUNCTION IN SYMPTOMS ASSOCIATED WITH LONG COVID, LYME DISEASE AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME USING THE VIRAXIMMUNE FLUOROSPOT T CELL ASSAY",ACTIVE_NOT_RECRUITING,2024-12-10,2026-06-01,2026-06-01,OBSERVATIONAL,,160,"['Long COVID', 'PTLDs', 'Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)']",Long COVID,ViraxBio Labs,[],['United Kingdom']
NCT03212742,Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients,Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients,ACTIVE_NOT_RECRUITING,2017-09-04,2026-09-13,2026-12-31,INTERVENTIONAL,PHASE1,91,"['Malignant Gliomas', 'Radiotherapy', 'PARP Inhibitor']",Malignant Gliomas,Centre Francois Baclesse,"['National Cancer Institute, France']",['France']
NCT01991379,MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST),A Phase Ib/II Study of MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST),ACTIVE_NOT_RECRUITING,2013-11,2026-11,2026-11,INTERVENTIONAL,PHASE1,75,['Gastrointestinal Stromal Tumor (GIST)'],Gastrointestinal Stromal Tumor (GIST),Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07090785,A Study of LY4088044 in Healthy Participants,"A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4088044 in Healthy Participants.",RECRUITING,2025-07-24,2027-07,2027-07,INTERVENTIONAL,PHASE1,104,['Healthy'],Healthy,Eli Lilly and Company,[],"['Singapore', 'New Zealand', 'United States']"
NCT02570984,Preventing Asthma in High Risk Kids,Controlling and Preventing Asthma Progression and Severity in Kids,ACTIVE_NOT_RECRUITING,2018-11-27,2028-01-31,2028-03-31,INTERVENTIONAL,PHASE2,200,['Asthma'],Asthma,Boston Children's Hospital,['National Institute of Allergy and Infectious Diseases (NIAID)'],['United States']
NCT02417740,Natural History of Noncirrhotic Portal Hypertension,Natural History of Noncirrhotic Portal Hypertension,RECRUITING,2015-07-27,2029-09-04,2029-09-04,OBSERVATIONAL,,400,"['Cystic Fibrosis', 'Immunologic Deficiency Syndrome', 'Turner Syndrome', 'Congenital Hepatic Fibrosis', 'Idiopathic Non-Cirrhotic Portal Hypertension']",Cystic Fibrosis,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT00006150,"Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)","Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)",RECRUITING,2000-08-10,,,OBSERVATIONAL,,600,"['Infections', 'Pneumonia', 'Immune System Diseases', 'STAT3 Transcription Factor', 'Job Syndrome']",Infections,National Institute of Allergy and Infectious Diseases (NIAID),['Albert Einstein College of Medicine'],['United States']
NCT07264842,Triple Antibiotic Paste vs Simvastatin for Lesion Sterilization and Tissue Repair in Primary Molars.,Triple Antibiotic Paste Versus Simvastatin for LSTR Treatment of Primary Molars With Pulp Necrosis: A Randomized Controlled Trial,RECRUITING,2024-06-26,2026-04-30,2026-07-31,INTERVENTIONAL,PHASE2,60,['Pulpal Necrosis'],Pulpal Necrosis,Dow University of Health Sciences,[],['Pakistan']
NCT07263386,"A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer","A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer",RECRUITING,2025-10-23,2028-10,2030-10,INTERVENTIONAL,PHASE2,460,['Gastric Adenocarcinoma'],Gastric Adenocarcinoma,The First Affiliated Hospital with Nanjing Medical University,[],['China']
NCT01276470,Environmental Risk Factors for the Anti-synthetase Syndrome,Environmental Risk Factors for the Anti-Synthetase Syndrome,RECRUITING,2011-02-09,,,OBSERVATIONAL,,580,"['Myositis', 'Dermatomyositis', 'Polymyositis', 'Juvenile Dermatomyositis', 'Juvenile Polymyositis']",Myositis,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT07187973,"A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)","A Phase 1b Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-3405 in Participants With Sickle Cell Disease",RECRUITING,2025-12,2027-06,2027-10,INTERVENTIONAL,PHASE1,24,['Sickle Cell Disease'],Sickle Cell Disease,"Disc Medicine, Inc",[],['United States']
NCT07076264,Water Competency Intervention in Autism,Water Competency Intervention for Children on the Autism Spectrum: The AquOTic Hybrid Effectiveness Implementation Trial,RECRUITING,2025-09-19,2029-04,2029-04,INTERVENTIONAL,NA,108,['Autism Spectrum Disorders'],Autism Spectrum Disorders,Ohio State University,[],['United States']
NCT07262944,EOI Block in Otoplasty With Rib Cartilage Graft,Effect of Ultrasound-Guided External Oblique Intercostal Fascial Plane Block in Pediatric Patients Undergoing Otoplasty With Rib Cartilage Graft,RECRUITING,2026-12-01,2028-06-01,2028-08-30,INTERVENTIONAL,NA,60,"['Postoperative Pain, Acute']","Postoperative Pain, Acute",Seoul National University Hospital,[],['South Korea']
NCT07263178,A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.,"A Multi-center, Prospective, Observational Study to Assess the Treatment Patterns and Prognosis of Second and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer Who Failed First-line Palliative Chemotherapy",RECRUITING,2025-11-07,2029-12,2029-12,OBSERVATIONAL,,1000,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,"Boryung Pharmaceutical Co., Ltd",[],['South Korea']
NCT06121180,Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma,A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma,RECRUITING,2024-11-04,2030-10-31,2030-10-31,INTERVENTIONAL,PHASE2,32,['Metastatic Uveal Melanoma'],Metastatic Uveal Melanoma,H. Lee Moffitt Cancer Center and Research Institute,"['Genzyme, a Sanofi Company', 'Regeneron Pharmaceuticals']",['United States']
NCT07253636,"Social and Emotional Development Support Program for Adolescents: Effects on Belonging, Meaning in Life, Authenticity, Well-Being, and Resilience","An Examination of the Effects of the Social and Emotional Development Support Program on Adolescents' Sense of Belonging, Meaning in Life, Emotional Authenticity, Well-Being, and Psychological Resilience",ACTIVE_NOT_RECRUITING,2025-10-08,2025-12-22,2025-12-26,INTERVENTIONAL,NA,60,['Adolescent Social and Emotional Development'],Adolescent Social and Emotional Development,Hacettepe University,[],['Turkey (Türkiye)']
NCT06912633,"Safety of a Single, Intravitreal Injection of 8.8M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)","A Randomized, Masked, Sham-Controlled Phase 2 Trial of the Safety of a Single Intravitreal Injection of jCell (Famzeretcel) for the Treatment of Retinitis Pigmentosa (RP)",RECRUITING,2025-06-20,2026-09,2026-09,INTERVENTIONAL,PHASE2,60,['Retinitis Pigmentosa'],Retinitis Pigmentosa,"jCyte, Inc",[],['United States']
NCT07264647,Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC),Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC),RECRUITING,2025-03-27,2028-02-01,2030-02-01,INTERVENTIONAL,PHASE2,30,['Stage III NSCLC'],Stage III NSCLC,Fondazione Ricerca Traslazionale,[],['Italy']
NCT05495633,SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate,SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate,RECRUITING,2022-12-16,2031-12,2031-12,OBSERVATIONAL,,1000,['Benign Prostate Obstruction (BPO)'],Benign Prostate Obstruction (BPO),"University Hospital, Basel, Switzerland",['Boston Scientific Corporation'],"['Switzerland', 'Austria', 'Germany']"
NCT07059845,A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer,"A Phase 2, Open-Label, Randomized, Master Protocol Dose Optimization Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Mirvetuximab Soravtansine in Subjects With Ovarian Cancer",RECRUITING,2025-11-13,2029-01,2029-01,INTERVENTIONAL,PHASE2,320,['Ovarian Cancer'],Ovarian Cancer,AbbVie,[],"['South Korea', 'Australia']"
NCT06895044,Evolution of Ocular Growth in Myopic Children: A Prospective Cohort Study,Evolution of Ocular Growth in Myopic Children: A Prospective Cohort Study,RECRUITING,2025-04-30,2033-04-30,2033-04-30,OBSERVATIONAL,,1000,['Myopia'],Myopia,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT06402864,Evaluation Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma,Multicenter Randomized Phase III Trial Evaluating Contact X-ray Brachytherapy for Rectal Preservation in Intermediate Substage Rectal Adenocarcinoma,RECRUITING,2024-03-26,2029-06-15,2030-06-15,INTERVENTIONAL,PHASE3,212,['Adult With Intermediate Low or Mid Rectal Adenocarcinoma'],Adult With Intermediate Low or Mid Rectal Adenocarcinoma,"Gustave Roussy, Cancer Campus, Grand Paris",[],['France']
NCT03000244,Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation,Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation,RECRUITING,2017-04-26,2050-08-12,2050-08-12,OBSERVATIONAL,,2000,"['Hematopoietic Stem Cell Transplantation', 'Tissue Donors']",Hematopoietic Stem Cell Transplantation,National Cancer Institute (NCI),[],['United States']
NCT04770753,A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT),"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE)",ACTIVE_NOT_RECRUITING,2021-12-20,2023-11-13,2028-12,INTERVENTIONAL,PHASE3,194,"['Non-Transfusion-dependent Alpha-Thalassemia', 'Non-Transfusion-dependent Beta-Thalassemia']",Non-Transfusion-dependent Alpha-Thalassemia,"Agios Pharmaceuticals, Inc.",[],"['Brazil', 'Bulgaria', 'Lebanon', 'Turkey (Türkiye)', 'Netherlands', 'Saudi Arabia', 'United States', 'France', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Malaysia', 'Thailand', 'Greece', 'United Arab Emirates', 'United Kingdom']"
NCT06856863,Correlation Between Personnality Traits and Ability to Learn Oroesophageal Voice,Correlation Between Personnality Traits and Ability to Learn Oroesophageal Voice,RECRUITING,2025-10-14,2027-10-14,2028-10-14,INTERVENTIONAL,NA,40,"['Laryngectomy', 'Total Pharyngo-laryngectomy']",Laryngectomy,Assistance Publique Hopitaux De Marseille,[],['France']
NCT07265232,Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).,Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC).,RECRUITING,2025-10-15,2030-10-15,2030-10-15,INTERVENTIONAL,PHASE3,15,['Spinal Muscular Atrophy (SMA)'],Spinal Muscular Atrophy (SMA),Lantu Biopharma,[],['Indonesia']
NCT07206823,Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia,"An Open-label, Single-arm, Single-center Study to Evaluate the Efficacy and Safety of Romiplostim N01 in Combination With Rituximab in Patients With Primary Immune Thrombocytopenia Refractory to Oral TPO-RAs",RECRUITING,2025-09-01,2027-02-28,2027-07-31,INTERVENTIONAL,NA,30,['Primacy Immune Thrombocytopenia'],Primacy Immune Thrombocytopenia,The First Affiliated Hospital of Soochow University,[],['China']
NCT07264686,Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG - Second Trial,Ulcer Plants: Highly Accessible Plant Antiseptics for Use in Remote Areas of PNG- Second Trial,ACTIVE_NOT_RECRUITING,2025-11-03,2025-11-21,2026-03-30,INTERVENTIONAL,PHASE2,222,"['Cutaneous Ulcer Disease', 'Skin Sores']",Cutaneous Ulcer Disease,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","['The Royal Botanic Gardens, Kew']",['Papua New Guinea']
NCT06551662,DCB vs. DES in Bifurcation Coronary Lesions,Drug-coated Balloons vs. Drug Eluting Stents in Bifurcation Coronary Lesions: PICCOLETO V Study,RECRUITING,2025-08-01,2026-02-01,2028-02-01,INTERVENTIONAL,NA,321,"['Coronary Artery Disease', 'DCB']",Coronary Artery Disease,Fondazione Ricerca e Innovazione Cardiovascolare ETS,[],"['Singapore', 'Poland', 'Italy', 'Romania']"
NCT06154447,Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis,"A Phase 1, Study of VX-828 in Healthy Subjects and in Subjects With Cystic Fibrosis",RECRUITING,2023-12-12,2026-04-23,2026-04-23,INTERVENTIONAL,PHASE1,255,['Cystic Fibrosis'],Cystic Fibrosis,Vertex Pharmaceuticals Incorporated,[],['United States']
NCT07002320,Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer,"ASpiRE: A Proof-of-mechanism and Proof-of-concept Clinical Trial Evaluating the Safety, Tolerability, Biological and Anti-tumour Activity of Apalutamide With Dual CXCR1 and CXCR2 Blockade by SX-682 for Men Suffering From Metastatic Castration-resistant Prostate Cancer (mCRPC)",RECRUITING,2025-04-28,2029-10,2029-10,INTERVENTIONAL,PHASE1,78,['Metastatic Castrate-Resistant Prostate Cancer (mCRPC)'],Metastatic Castrate-Resistant Prostate Cancer (mCRPC),"Institute of Cancer Research, United Kingdom","['Prostate Cancer UK', 'Janssen Pharmaceutica N.V., Belgium', 'Oncology Institute of Southern Switzerland', 'Syntrix Biosystems, Inc.', 'Royal Marsden NHS Foundation Trust', 'Cambridge University Hospitals NHS Foundation Trust', 'Belfast Health and Social Care Trust', 'Institute of Oncology Research (IOR)']","['Switzerland', 'United Kingdom']"
NCT07262762,Spartina® (Tirzepatide) Effectiveness and Safety Evaluation,A Post-marketing Real-world Study for Evaluating Effectiveness and Safety of Spartina® (Tirzepatide Manufactured by CinnaGen) in Patients With Obesity and Overweight,RECRUITING,2025-11-11,2025-12,2026-04,OBSERVATIONAL,,175,['Obesity & Overweight'],Obesity & Overweight,Cinnagen,[],['Iran']
NCT07264491,Clinical Performance of Full Coverage Hybrid Ceramic Crowns in the Aesthetic Zone: A Randomized Clinical Trial,Clinical Performance of Full Coverage Hybrid Ceramic Crowns in the Aesthetic Zone: A Randomized Clinical Trial,RECRUITING,2025-09-20,2025-11-10,2026-05-10,INTERVENTIONAL,NA,54,"['Dental Restoration Failure of Marginal Integrity', 'Poor Aesthetic of Existing Restoration of Tooth']",Dental Restoration Failure of Marginal Integrity,Karim Ahmed Awadallah Osman,[],['Egypt']
NCT05761080,Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics,Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics,RECRUITING,2021-04-22,2027-11,2027-12,INTERVENTIONAL,PHASE4,158,"['Laparoscopic Appendectomy', 'Complicated Appendicitis', 'Periappendicular Abscess']",Laparoscopic Appendectomy,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,[],['Spain']
NCT02579967,Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies,Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies,RECRUITING,2015-11-19,2031-12-31,2036-12-31,INTERVENTIONAL,PHASE2,254,"['Primary T-cell Immunodeficiency Disorders', 'Common Variable Immunodeficiency', 'Immune System Diseases', 'Autoimmune Lymphoproliferative', 'Lymphoproliferative Disorders']",Primary T-cell Immunodeficiency Disorders,National Cancer Institute (NCI),[],['United States']
NCT07261007,Investigation of the Effectiveness of Flossing in Hemiplegic Patients With Shoulder Pain,Investigation of the Effectiveness of Flossing in Hemiplegic Patients With Shoulder Pain: Randomized Controlled Trial,RECRUITING,2025-12-03,2026-01-15,2026-02-01,INTERVENTIONAL,NA,40,"['Shoulder Pain', 'Hemiplegia']",Shoulder Pain,Uskudar University,[],['Turkey (Türkiye)']
NCT07134777,Mechanisms of Visual Restoration After Occipital Stroke,Mechanisms of Visual Restoration After Occipital Stroke (MOVROS),RECRUITING,2025-10-17,2029-08-01,2029-08-01,OBSERVATIONAL,,100,"['Cortical Blindness', 'Stroke Ischemic', 'Vision Loss Partial', 'Visual Fields Hemianopsia', 'Hemianopia', 'Hemianopia Homonymous', 'Occipital Lobe Infarct']",Cortical Blindness,University of Rochester,"['National Institutes of Health (NIH)', 'Research to Prevent Blindness', 'National Institute of Neurological Disorders and Stroke (NINDS)', 'National Institute of Mental Health (NIMH)', 'University of Texas at Austin']",['United States']
NCT05581030,CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL),"A Single-Arm, Open-Label Phase 1b Study of Hyper-CVAD + Calaspargase Pegol in Young Adults With Newly Diagnosed Acute Lymphoblastic Leukemia",ACTIVE_NOT_RECRUITING,2023-05-01,2025-06-29,2026-10,INTERVENTIONAL,PHASE1,7,['Acute Lymphoblastic Leukemia'],Acute Lymphoblastic Leukemia,H. Lee Moffitt Cancer Center and Research Institute,['Servier'],['United States']
NCT07069712,A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma,"A Master Protocol of an Open-Label, Multi-Drug, Multi-Center, Phase II Platform Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma (GEMINI-PeriOp GC)",RECRUITING,2025-07-17,2026-10-29,2028-09-06,INTERVENTIONAL,PHASE2,100,['Gastroesophageal Adenocarcinoma'],Gastroesophageal Adenocarcinoma,AstraZeneca,['Parexel'],"['Japan', 'Turkey (Türkiye)', 'China', 'United States', 'Georgia', 'Spain', 'Taiwan', 'Italy', 'Canada', 'United Kingdom', 'Poland']"
NCT06609928,FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia,A Phase 1 Study of FOLR1 CAR T for Pediatric Patients With Relapsed or Refractory AML,RECRUITING,2025-02-24,2027-10-01,2042-10-01,INTERVENTIONAL,PHASE1,12,"['Recurrent Childhood Acute Myeloid Leukemia', 'Refractory Childhood Acute Myeloid Leukemia']",Recurrent Childhood Acute Myeloid Leukemia,Fred Hutchinson Cancer Center,['Kuni Foundation'],['United States']
NCT03941730,"Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer",Therapeutic Targeting of ER Beta in Triple Negative Breast Cancer,ACTIVE_NOT_RECRUITING,2019-08-28,2024-07-29,2026-12-31,INTERVENTIONAL,PHASE2,5,"['Advanced Triple-Negative Breast Carcinoma', 'Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic Triple-Negative Breast Carcinoma', 'Recurrent Breast Carcinoma']",Advanced Triple-Negative Breast Carcinoma,Mayo Clinic,['National Cancer Institute (NCI)'],['United States']
NCT00033137,Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer,"Birt-Hogg-Dub(SqrRoot)(Copyright) Syndrome: Characterization of the FLCN Disease Gene and Predisposition to Renal Cancer, Cutaneous Fibrofolliculoma and Pulmonary Cysts",RECRUITING,2002-05-13,,,OBSERVATIONAL,,950,"['Kidney Neoplasms', 'Kidney Cancer', 'Pneumothorax', 'FLCN Protein, Human']",Kidney Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT07186595,A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance,"A Prospective, Open-Label Study to Evaluate Subject Satisfaction With Overall Facial Appearance After Treatment With JUVÉDERM® Products in Medical Weight Loss (MWL) Subjects",RECRUITING,2025-09-25,2026-08,2026-08,INTERVENTIONAL,PHASE4,94,['Mid Face Volume Deficit'],Mid Face Volume Deficit,AbbVie,[],['United States']
NCT05785611,A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis,"A Phase 3 Randomized, Placebo-controlled, Double-blind, Parallel-group Program to Evaluate Efficacy and Safety of Filgotinib in Adult Subjects With Active Axial Spondyloarthritis",ACTIVE_NOT_RECRUITING,2023-04-05,2024-09-04,2028-12,INTERVENTIONAL,PHASE3,495,['Axial Spondyloarthritis'],Axial Spondyloarthritis,Alfasigma S.p.A.,[],"['Belgium', 'Bulgaria', 'Hungary', 'South Africa', 'Netherlands', 'Estonia', 'United Kingdom', 'France', 'Spain', 'Taiwan', 'Italy', 'Romania', 'Czechia', 'South Korea', 'Poland', 'Philippines', 'Lithuania', 'Germany']"
NCT07054515,"A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis","18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis",RECRUITING,2025-06-30,2027-11-04,2027-11-04,INTERVENTIONAL,PHASE3,147,"['Niemann-Pick Type C Disease', 'GM1 Gangliosidosis', 'GM2 Gangliosidosis']",Niemann-Pick Type C Disease,Azafaros A.G.,[],"['Brazil', 'Turkey (Türkiye)', 'India', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Portugal', 'Argentina', 'Sweden', 'Australia']"
NCT06833008,A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours,"An Open-label, Phase I/II First-in-human, Dose Escalation and Confirmation Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic and Anti-tumour Activity of IPN01195 as Single Agent in Adult Participants With Advanced Solid Tumours",RECRUITING,2025-03-14,2028-10-03,2028-10-03,INTERVENTIONAL,PHASE1,85,['Advanced Solid Tumor'],Advanced Solid Tumor,Ipsen,[],"['Italy', 'Spain', 'United States', 'France']"
NCT05888974,Diagnostic Performance of the Mitral Annulus Velocity Variation Measured by Tissue Doppler to Evaluate the Fluid Responsiveness During the Initial Management of Shock in Patients Admitted to the Emergency Department,Diagnostic Performance of the Mitral Annulus Velocity Variation Measured by Tissue Doppler to Evaluate the Fluid Responsiveness During the Initial Management of Shock in Patients Admitted to the Emergency Department,RECRUITING,2023-08-01,2026-08-08,2026-12-31,OBSERVATIONAL,,187,['Shock'],Shock,Centre Hospitalier Universitaire de Nīmes,[],['France']
NCT06376474,To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage,"To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Mild, Moderate Liver Impairment and Normal Liver Function After a Single Oral Administration",RECRUITING,2024-04-28,2025-12-10,2025-12-31,INTERVENTIONAL,PHASE1,24,['Psoriasis'],Psoriasis,"Ganzhou Hemay Pharmaceutical Co., Ltd",[],['China']
NCT03976843,Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer,A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer,ACTIVE_NOT_RECRUITING,2019-12-04,2027-11-19,2027-11-19,INTERVENTIONAL,PHASE2,175,['Prostate Cancer'],Prostate Cancer,National Cancer Institute (NCI),['Lantheus'],['United States']
NCT07263191,A Study of Olanzapine in Participants With Bipolar Disorder.,"A Multicenter, Prospective Observational Study to Evaluate Treatment Patterns and Safety in Patients With Bipolar Disorder Taking Olanzapine",RECRUITING,2025-10-30,2027-09,2027-09,OBSERVATIONAL,,3000,['Bipolar Disorder'],Bipolar Disorder,"Boryung Pharmaceutical Co., Ltd",[],['South Korea']
NCT05911243,"Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer","A Randomized Controlled Trial Testing the Effects of an Acupressure Intervention on Appetite and Weight in Patients With Gastric, Esophageal, and Pancreatic Cancer: A Pilot and Feasibility Study",RECRUITING,2024-07-22,2026-09-01,2026-12-31,INTERVENTIONAL,NA,66,"['Clinical Stage II Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8', 'Clinical Stage II Gastric Cancer AJCC v8', 'Clinical Stage III Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8', 'Clinical Stage III Gastric Cancer AJCC v8', 'Clinical Stage IV Esophageal Adenocarcinoma AJCC v8', 'Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Stage II Pancreatic Cancer AJCC v8', 'Stage III Pancreatic Cancer AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8']",Clinical Stage II Esophageal Adenocarcinoma AJCC v8,University of Washington,"['National Center for Complementary and Integrative Health (NCCIH)', 'National Center for Advancing Translational Sciences (NCATS)']",['United States']
NCT03384914,Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer,A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer,ACTIVE_NOT_RECRUITING,2018-02-19,2025-12,2027-12,INTERVENTIONAL,PHASE2,119,"['Breast Cancer Female', 'Breast Cancer, Male', 'Breast Cancer Stage I', 'Breast Cancer Stage II', 'Breast Cancer Stage III', 'Residual Disease', 'HER2-positive Breast Cancer', 'HER2 Positive Breast Carcinoma']",Breast Cancer Female,H. Lee Moffitt Cancer Center and Research Institute,['United States Department of Defense'],['United States']
NCT06944522,A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease,exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease,RECRUITING,2025-06-17,2027-03,2032-03,INTERVENTIONAL,PHASE3,102,['Parkinsons Disease (PD)'],Parkinsons Disease (PD),BlueRock Therapeutics,['Bayer'],['United States']
NCT07018700,A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial With Extension Period to Evaluate the Efficacy and Safety of Xeomin® Injections for the Prevention of Episodic Migraine",RECRUITING,2025-08-21,2027-03,2027-10,INTERVENTIONAL,PHASE3,990,['Episodic Migraine'],Episodic Migraine,Merz Therapeutics GmbH,[],"['Austria', 'United States', 'Slovakia', 'Spain', 'Italy', 'Poland', 'Germany']"
NCT04172532,"Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer",A Phase 1/2 Study of M3814 (Peposertib) in Combination With Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma,RECRUITING,2021-01-11,2026-08-01,2026-08-01,INTERVENTIONAL,PHASE1,92,"['Locally Advanced Pancreatic Adenocarcinoma', 'Stage III Pancreatic Cancer AJCC v8']",Locally Advanced Pancreatic Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT06592794,A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis,"A Phase 3, Randomized, Observer-blinded, Placebo-controlled Study to Evaluate the Safety and Efficacy of mRNA-1403, a Multivalent Candidate Vaccine to Prevent Norovirus Acute Gastroenteritis in Adults ≥18 Years of Age",RECRUITING,2024-09-24,2027-02-15,2027-02-15,INTERVENTIONAL,PHASE3,28000,"['Acute Gastroenteritis', 'Norovirus Acute Gastroenteritis']",Acute Gastroenteritis,"ModernaTX, Inc.",[],"['Japan', 'Panama', 'United States', 'Puerto Rico', 'Canada', 'United Kingdom', 'Australia']"
NCT05515978,Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients,"A Randomized, Pragmatic, Adaptive Trial of Metformin for Glucose Intolerance or Increased Body Mass Index in Prostate Cancer Patients",RECRUITING,2022-10-10,2035-10-20,2036-11-06,INTERVENTIONAL,EARLY_PHASE1,100,['Prostate Cancer'],Prostate Cancer,"University of Colorado, Denver",[],['United States']
NCT01861106,Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations,Allogeneic Hematopoietic Stem Cell Transplant for Patients With Mutations in GATA2 or the MonoMAC Syndrome,RECRUITING,2013-07-24,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE2,144,"['GATA2', 'Immunodeficiency', 'MDS']",GATA2,National Cancer Institute (NCI),[],['United States']
NCT06855160,"A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age","A Phase 3a, Open-Label, Randomized, Controlled Study to Evaluate the Immunogenicity and Safety of Intramuscular Administration of an Investigational Varicella Vaccine and Priorix Compared With Subcutaneous Administration of Varivax and Priorix, When Given as a First Dose to Healthy Children 12 to 15 Months of Age",RECRUITING,2025-04-17,2026-09-10,2027-02-02,INTERVENTIONAL,PHASE3,900,['Chickenpox'],Chickenpox,GlaxoSmithKline,[],"['Belgium', 'United States']"
NCT01915225,Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer,"Tumor, Normal Tissue and Specimens From Patients Undergoing Evaluation or Surgical Resection of Solid Tumors",RECRUITING,2013-07-21,2029-06-30,,OBSERVATIONAL,,1800,"['Colorectal Neoplasms', 'Gastric Neoplasms', 'Cholangiocarcinoma', 'Bile Duct Cancer', 'Pancreas Cancer']",Colorectal Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT06527235,Meniscal INfiltration of Corticosteroid Guided With Ultra Sonography,"Efficacy of Ultrasound-monitored Meniscal Wall Betamethasone Infiltration on Pain in Relation to Degenerative Meniscal Injury: a Randomized, Double-blind, Placebo-controlled Multicenter Trial.",RECRUITING,2025-03-06,2028-06-01,2028-06-01,INTERVENTIONAL,PHASE3,152,['Meniscus Lesion'],Meniscus Lesion,"University Hospital, Toulouse",[],['France']
NCT05682378,Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies,"An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Have Completed the Adolescent ORION-16 or ORION-13 Studies (VICTORION-PEDS-OLE)",ACTIVE_NOT_RECRUITING,2023-02-10,2028-03-02,2028-03-02,INTERVENTIONAL,PHASE3,131,['Heterozygous or Homozygous Familial Hypercholesterolemia'],Heterozygous or Homozygous Familial Hypercholesterolemia,Novartis Pharmaceuticals,[],"['Netherlands', 'Slovakia', 'Jordan', 'Israel', 'Hungary', 'Russia', 'Slovenia', 'France', 'Czechia', 'Poland', 'Lebanon', 'South Africa', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT06448793,"Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments","Patient and Physician Preferences for Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer Treatments",RECRUITING,2024-11-25,2026-06-30,2026-06-30,OBSERVATIONAL,,55,['Non-small Cell Lung Cancer (NSCLC)'],Non-small Cell Lung Cancer (NSCLC),Bristol-Myers Squibb,[],['United Kingdom']
NCT05207098,A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy,Pilot Study of Radiation-Associated Neurocognitive Function Among Head and Neck Cancer Patients,ACTIVE_NOT_RECRUITING,2021-12-22,2026-12,2026-12,OBSERVATIONAL,,54,['Head and Neck Cancer'],Head and Neck Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07263984,Added Value of Three-dimensional Transvaginal Ultrasound (3D TVUS) and Gel Infusion Sonography (3D GIS) Compared With Magnetic Resonance Imaging (MRI) in the Diagnosis of Patients With Suspicion of a Uterine Septum.,SEPTUM-D Project: Diagnosis in Patients With a Uterine Septum,RECRUITING,2025-10-27,2028-10,2028-10,INTERVENTIONAL,NA,145,['Uterine Septum'],Uterine Septum,"University Hospital, Ghent",['Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)'],['Belgium']
NCT02443077,Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma,A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype,ACTIVE_NOT_RECRUITING,2016-10-12,2024-06-10,2025-12-24,INTERVENTIONAL,PHASE3,94,"['Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type', 'Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type']",Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type,National Cancer Institute (NCI),[],"['United States', 'Saudi Arabia']"
NCT03618537,Ixazomib Maintenance Study in Patients With AL Amyloidosis,Ixazomib Maintenance Following Initial Therapy in Patients With Immunoglobulin Light Chain (AL) Amyloidosis,ACTIVE_NOT_RECRUITING,2018-08-02,2026-08,2026-08,INTERVENTIONAL,PHASE2,17,['AL Amyloidosis'],AL Amyloidosis,Memorial Sloan Kettering Cancer Center,"['Tufts Medical Center', 'Vanderbilt University Medical Center']",['United States']
NCT06697275,Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia,Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia: Randomized Multicenter Trial,RECRUITING,2024-11-15,2027-10-01,2027-10-01,INTERVENTIONAL,NA,120,"['Virtual Reality', 'Children and Adolescents', 'Acute Leukemia', 'Anxiety and Fear']",Virtual Reality,"University Hospital, Clermont-Ferrand",[],['France']
NCT05253651,A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer,An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer,RECRUITING,2022-10-24,2026-04-03,2029-07-27,INTERVENTIONAL,PHASE3,400,['Colorectal Neoplasms'],Colorectal Neoplasms,"Seagen, a wholly owned subsidiary of Pfizer",[],"['Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'France', 'Chile', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07091084,A Study of Herbal Supplements in Cancer Survivors With Constipation,Herbal Formula Ma-Zi-Ren-Wan (MZRW) on Bowel Movement Function and Gut Microbiome Among Cancer Survivors With Constipation: A Double-blinded Randomized Controlled Trial (RELIEVE),RECRUITING,2025-07-15,2028-07-15,2028-07-15,INTERVENTIONAL,NA,70,"['Constipation', 'Cancer', 'Functional Constipation']",Constipation,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07264738,Oral Ondansetron to Improve Patient Experience of Unsedated Esophagogastroduodenoscopy Pilot Study,Oral Ondansetron to Improve Patient Experience of Unsedated Esophagogastroduodenoscopy: A Pilot Study,ACTIVE_NOT_RECRUITING,2025-07-01,2025-09-28,2025-12-10,INTERVENTIONAL,PHASE4,40,['Esophagogastroduodensocopy (EGD) Procedure'],Esophagogastroduodensocopy (EGD) Procedure,Peking Union Medical College Hospital,[],['China']
NCT07151248,Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome,ELECTRIG: Evaluating Effects of Cranial Electrical Stimulation Therapy With Responsive Imaging in Gulf War Illness Pain and Comorbid Symptoms,RECRUITING,2025-09-26,2029-09,2029-09,INTERVENTIONAL,NA,130,['Gulf War Syndrome'],Gulf War Syndrome,Emory University,['United States Department of Defense'],['United States']
NCT07218458,A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals,Enhancing Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals (Breathing Study-Burnout),RECRUITING,2025-10-27,2026-04-01,2026-06-01,INTERVENTIONAL,NA,40,"['Burnout, Healthcare Workers', 'Breathing Exercises']","Burnout, Healthcare Workers",Mayo Clinic,[],['United States']
NCT05627362,A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis.,"A Phase II, Multicenter, Double-Blind, Randomised, Placebo-Controlled Study and Open Label Long Term Extension to Evaluate the Safety and Efficacy of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis (PSC).",ACTIVE_NOT_RECRUITING,2022-12-29,2026-08-28,2026-08-28,INTERVENTIONAL,PHASE2,68,['Primary Sclerosing Cholangitis'],Primary Sclerosing Cholangitis,Ipsen,[],"['United States', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Portugal', 'Germany']"
NCT03506451,"PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study","PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study",ACTIVE_NOT_RECRUITING,2018-06-19,2021-11-29,2026-10-07,INTERVENTIONAL,NA,60,['Head and Neck Cancer'],Head and Neck Cancer,Duke University,[],['United States']
NCT07164105,LIFU Mechanisms for PTSD in Healthcare Workers,Mechanisms of Low Intensity Focused Ultrasound of the Ventral Anterior Cingulate Cortex for Post-Traumatic Stress Disorder in Frontline Healthcare Workers,RECRUITING,2025-12-29,2028-08,2028-08,INTERVENTIONAL,NA,66,['PTSD and Trauma-related Symptoms'],PTSD and Trauma-related Symptoms,"Laureate Institute for Brain Research, Inc.",[],['United States']
NCT04573231,Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer,"Evaluation of Prostate Specific Membrane Antigen (PSMA) in HER2-negative, Androgen Receptor (AR)-Positive Metastatic Breast Cancer With 18F-DCFPyL PSMA-based PET/CT",RECRUITING,2021-05-24,2025-12,2025-12,INTERVENTIONAL,PHASE2,13,"['Breast Cancer', 'HER2-negative Breast Cancer', 'Metastatic Breast Cancer']",Breast Cancer,"University of Wisconsin, Madison",[],['United States']
NCT06616194,A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine,"AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE",RECRUITING,2024-11-15,2026-10-08,2027-12-02,INTERVENTIONAL,PHASE3,200,['Migraine'],Migraine,Pfizer,[],"['Japan', 'Hungary', 'China', 'United States', 'Finland', 'Slovakia', 'Spain', 'Italy', 'Canada', 'Czechia', 'Poland', 'India']"
NCT06377254,Multi-organ Responses to CHronic Physical Activity and INactivity,"Concurrent Multi-organ Responses to CHronic Physical Activity and INactivity Intervention, to Increase Research Discovery in Human Health and Wellbeing",RECRUITING,2024-03-12,2027-12-17,2028-10-31,INTERVENTIONAL,NA,40,"['Sedentary Behavior', 'Metabolic Syndrome', 'Age-related Cognitive Decline', 'Age-Related Sarcopenia']",Sedentary Behavior,University of Nottingham,['Biotechnology and Biological Sciences Research Council'],['United Kingdom']
NCT03352765,A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients,A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients,ACTIVE_NOT_RECRUITING,2017-11-20,2026-11,2026-11,INTERVENTIONAL,PHASE1,28,['Lymphoma'],Lymphoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT01730131,Natural History Study of Progressive Multifocal Leukoencephalopathy (PML),Natural History Study of Progressive Multifocal Leukoencephalopathy (PML),RECRUITING,2012-11-08,2052-01-01,,OBSERVATIONAL,,700,['Progressive Multifocal Leukoencephalopathy'],Progressive Multifocal Leukoencephalopathy,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06390956,Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL),A Phase II Study of Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma,RECRUITING,2025-02-20,2031-12,2032-12,INTERVENTIONAL,PHASE2,23,['Marginal Zone Lymphoma'],Marginal Zone Lymphoma,University of Utah,['Eli Lilly and Company'],['United States']
NCT06941272,A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01),LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors,RECRUITING,2025-05-26,2030-12-30,2030-12-30,INTERVENTIONAL,PHASE1,50,['Malignant Neoplasm'],Malignant Neoplasm,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Belgium', 'Israel', 'Netherlands', 'United States', 'France', 'Slovakia', 'Denmark', 'Spain', 'Taiwan', 'South Korea', 'United Kingdom', 'Sweden']"
NCT06079879,A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006),"A Phase 3, Randomized, Open-label, Active-Comparator-Controlled Clinical Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543/IMG-7289) Versus Best Available Therapy (BAT) in Participants With Essential Thrombocythemia Who Have an Inadequate Response to or Are Intolerant of Hydroxyurea",RECRUITING,2023-12-31,2027-07-30,2028-08-18,INTERVENTIONAL,PHASE3,340,['Essential Thrombocythemia'],Essential Thrombocythemia,Merck Sharp & Dohme LLC,[],"['Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'South Korea', 'Colombia', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06049680,Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients,"A Single-arm Open-label Safety Study of SMOFlipid to Evaluate the Risk of Developing Essential Fatty Acid Deficiency (EFAD) and/or Parenteral Nutrition-associated Cholestasis (PNAC) in Pediatric Patients 1 Month to 17 Years of Age and in Adult Patients, Who Are Anticipated to Need 8 Weeks or Longer of Parenteral Nutrition Treatment",RECRUITING,2024-10-28,2026-03,2026-09,INTERVENTIONAL,PHASE4,100,"['Malnutrition, Child', 'Malnutrition', 'Essential Fatty Acid Deficiency (EFAD)', 'Parenteral Nutrition Associated Cholestasis']","Malnutrition, Child",Fresenius Kabi,[],['United States']
NCT02251821,JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis,JAK Inhibitor Prior to Allogeneic Stem Cell Transplant for Patients With Primary and Secondary Myelofibrosis: A Prospective Study,ACTIVE_NOT_RECRUITING,2014-10-20,2022-12-28,2025-12-28,INTERVENTIONAL,PHASE2,61,"['Primary Myelofibrosis', 'Secondary Myelofibrosis']",Primary Myelofibrosis,Fred Hutchinson Cancer Center,"['Incyte Corporation', 'National Cancer Institute (NCI)']",['United States']
NCT06811493,Comparison of the Efficacy of One Level and Tow Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial,Comparison of the Efficacy of One Level and Two Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial.,RECRUITING,2024-06-01,2025-12-01,2025-12-31,INTERVENTIONAL,NA,60,['Facial Plane Blocks'],Facial Plane Blocks,Kasr El Aini Hospital,[],['Egypt']
NCT07263711,Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction,A Prospective Real-World Study of Pathology Artificial Intelligence for Predicting Molecular Alterations in Gliomas,RECRUITING,2025-09-01,2030-09-01,2030-09-01,OBSERVATIONAL,,2000,['Glioma'],Glioma,"Nanfang Hospital, Southern Medical University",[],['China']
NCT06212063,Aim High: Readiness & Meeting the Standards in Military Pre-Recruits,Aim High: Readiness & Meeting the Standards in Military Pre-Recruits,RECRUITING,2024-09-17,2027-01-15,2027-01-15,INTERVENTIONAL,NA,100,['Health Behavior'],Health Behavior,Pennington Biomedical Research Center,[],['United States']
NCT07155421,Effects of Early Cardiopulmonary Rehabilitation in Patients With Acute Decompensated Heart Failure,Effects of Early Cardiopulmonary Rehabilitation in Patients With Acute Decompensated Heart Failure,RECRUITING,2025-11-10,2025-12,2025-12,INTERVENTIONAL,NA,40,['Heart Failure'],Heart Failure,Izmir Bakircay University,"['Istanbul University - Cerrahpasa', 'Saglik Bilimleri Universitesi', 'Yeditepe University']",['Turkey (Türkiye)']
NCT00719719,Cause of Unexplained Anaphylaxis,Studies in the Pathogenesis of Anaphylaxis,ACTIVE_NOT_RECRUITING,2008-11-05,,,OBSERVATIONAL,,115,"['Idiopathic Anaphylaxis', 'Drug Anaphylaxis', 'Venom Anaphylaxis', 'Food Anaphylaxis']",Idiopathic Anaphylaxis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05071300,"A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy","An Open-Label, Extension Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy",ACTIVE_NOT_RECRUITING,2022-01-04,2029-08,2029-08,INTERVENTIONAL,PHASE3,151,['Hereditary Transthyretin-Mediated Amyloid Polyneuropathy'],Hereditary Transthyretin-Mediated Amyloid Polyneuropathy,"Ionis Pharmaceuticals, Inc.",[],"['Brazil', 'Turkey (Türkiye)', 'United States', 'France', 'Spain', 'Cyprus', 'Italy', 'Canada', 'Taiwan', 'Portugal', 'Argentina', 'Sweden', 'Australia']"
NCT03288207,Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments,"Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments: A Multi-Level, Community-Based Physical Activity Intervention",RECRUITING,2018-06-21,2026-02-09,2026-03-28,INTERVENTIONAL,NA,325,['Obesity'],Obesity,"National Heart, Lung, and Blood Institute (NHLBI)",['George Washington University'],['United States']
NCT07071480,Noninvasive Therapy for Tinnitus,Noninvasive Therapeutic Hypothermia for Tinnitus,RECRUITING,2025-11-24,2026-11-30,2027-05-31,INTERVENTIONAL,NA,40,"['Tinnitus', 'Tinnitus, Subjective']",Tinnitus,Restorear Devices LLC,"['University of Miami', 'National Institute on Deafness and Other Communication Disorders (NIDCD)']",['United States']
NCT07265297,Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis,A Randomized Controlled Trial of Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis,RECRUITING,2025-08-12,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE3,210,"['Steatohepatitis, Nonalcoholic']","Steatohepatitis, Nonalcoholic",National Taiwan University Hospital,[],['Taiwan']
NCT04063540,Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura,Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura,RECRUITING,2020-08-11,2027-12,2027-12,INTERVENTIONAL,PHASE2,40,['Migraine With Aura'],Migraine With Aura,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06292650,Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients,"Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-02 in Retinitis Pigmentosa",RECRUITING,2024-02-25,2027-12-25,2028-12-25,INTERVENTIONAL,EARLY_PHASE1,12,['Retinitis Pigmentosa'],Retinitis Pigmentosa,Zhongmou Therapeutics,[],['China']
NCT04304768,"Opioid, HIV and Immune System",Immune Dysfunction in HIV+ Opioid Users,RECRUITING,2020-11-18,2026-03-31,2026-12-31,INTERVENTIONAL,PHASE4,400,['Immune Defect'],Immune Defect,University of Miami,[],['United States']
NCT06017960,Effects of Dry Needling on Electromyographic Activity and Ultrasonographic Characteristics in Post-Stroke Spasticity,Effects of Dry Needling on Electromyographic Activity and Ultrasonographic Characteristics in Post-Stroke Spasticity,RECRUITING,2023-09-15,2026-09-15,2026-09-15,INTERVENTIONAL,NA,28,['Spasticity as Sequela of Stroke'],Spasticity as Sequela of Stroke,Universidad de Zaragoza,['University of Alcala'],['Spain']
NCT06265285,Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program,"Pilot Single-Arm, Pragmatic Trial of In-Home Versus In-Clinic Subcutaneous Nivolumab Administration Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program",RECRUITING,2024-04-30,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,50,"['Advanced Esophageal Squamous Cell Carcinoma', 'Advanced Renal Cell Carcinoma', 'Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8', 'Clinical Stage IIB Cutaneous Melanoma AJCC v8', 'Clinical Stage IIC Cutaneous Melanoma AJCC v8', 'Clinical Stage III Cutaneous Melanoma AJCC v8', 'Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8', 'Clinical Stage IV Cutaneous Melanoma AJCC v8', 'Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8', 'Esophageal Carcinoma', 'Gastroesophageal Junction Adenocarcinoma', 'Hepatocellular Carcinoma', 'Locally Advanced Urothelial Carcinoma', 'Lung Non-Small Cell Carcinoma', 'Malignant Solid Neoplasm', 'Metastatic Colorectal Carcinoma', 'Metastatic Cutaneous Melanoma', 'Metastatic Esophageal Squamous Cell Carcinoma', 'Metastatic Head and Neck Squamous Cell Carcinoma', 'Metastatic Urothelial Carcinoma', 'Recurrent Esophageal Squamous Cell Carcinoma', 'Recurrent Head and Neck Squamous Cell Carcinoma', 'Renal Cell Carcinoma', 'Stage III Renal Cell Cancer AJCC v8', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8', 'Stage IV Renal Cell Cancer AJCC v8', 'Unresectable Cutaneous Melanoma', 'Unresectable Esophageal Squamous Cell Carcinoma', 'Urothelial Carcinoma', 'Unresectable Urothelial Carcinoma']",Advanced Esophageal Squamous Cell Carcinoma,Mayo Clinic,[],['United States']
NCT06112418,A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events,A Randomized Comparison of Cleerly Coronary Artery Disease Stage-Based Care Versus Risk Factor-Based Care for Primary Prevention of Cardiovascular Events,RECRUITING,2024-03-06,2029-03-05,2029-03-05,INTERVENTIONAL,NA,7500,"['Diabetes Mellitus, Type 2', 'PreDiabetes', 'Metabolic Syndrome']","Diabetes Mellitus, Type 2","Cleerly, Inc.",['CPC Clinical Research'],['United States']
NCT05174442,"ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices","A Registry-based, Multicenter, International, Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices:Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP), Occlutech Sizing Balloon (OSB) Used During to Implantation Procedures of Cardiac Implant Devices",RECRUITING,2021-10-14,2027-01-01,2027-01-01,OBSERVATIONAL,,685,['Heart Diseases'],Heart Diseases,Occlutech International AB,[],"['Turkey (Türkiye)', 'Germany']"
NCT07238413,Effect of Scapular Stabilization Exercises and ESWT in Patients With Lateral Epicondylitis,"Investigation of the Effect of Scapular Stabilization Exercises Applied in Addition to Extracorporeal Shock Wave Therapy on Pain, Muscle Strength, Functional Status, and Quality of Life in Patients With Lateral Epicondylitis",RECRUITING,2025-11-01,2026-01,2026-02,INTERVENTIONAL,NA,48,"['Lateral Epicondylitis', 'Tennis Elbow']",Lateral Epicondylitis,Saglik Bilimleri Universitesi,[],['Turkey (Türkiye)']
NCT06706661,Implementation of Nutritional Efforts on Discharged Older Patients,Implementation of Nutritional Treatment to Older Patients Discharged With the Liaison Team,RECRUITING,2025-01-06,2030-12-31,2030-12-31,INTERVENTIONAL,NA,2000,['Malnutrition'],Malnutrition,Herlev and Gentofte Hospital,[],['Denmark']
NCT07187388,"Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.","The Impact of Transcutaneous Electrical Stimulation on Facial Pain, Jaw Mobility, and Oral Health in Individuals With Motor Neuron Disease.",RECRUITING,2026-01-30,2026-08-13,2026-08-13,INTERVENTIONAL,NA,10,"['Amyotrophic Lateral Sclerosis (ALS)', 'Primary Lateral Sclerosis (PLS)', 'Motor Neuron Disease, Amyotrophic Lateral Sclerosis']",Amyotrophic Lateral Sclerosis (ALS),Nova Southeastern University,[],['United States']
NCT05962827,Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY,Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY,RECRUITING,2023-12-08,2026-08-11,2026-08-11,INTERVENTIONAL,NA,100,['Lymphedema'],Lymphedema,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06918561,Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds,"A Randomized Controlled Multisite Crossover Trial Evaluating the Efficacy of NeoThelium FT in the Treatment of ""Other"" Open Wounds",RECRUITING,2025-10-16,2026-08-01,2026-10-01,INTERVENTIONAL,NA,132,['Open Wound'],Open Wound,"NuScience Medical Biologics, LLC","['SygNola, LLC']",['United States']
NCT06827262,Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain,Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain,RECRUITING,2025-03-26,2034-07,2034-07,OBSERVATIONAL,,1500,"['Chronic Low-back Pain', 'Vertebrogenic Pain Syndrome']",Chronic Low-back Pain,Boston Scientific Corporation,[],['United States']
NCT07193446,"Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)","Optimising the Delivery of Diabetes Distress Informed Care for Its Prevention, Detection, and Management in Adults With Type 1 Diabetes: a Feasibility Study (D-stress Study)",RECRUITING,2025-10-31,2026-07-01,2026-09-01,INTERVENTIONAL,NA,110,['Diabetes Type 1'],Diabetes Type 1,Guy's and St Thomas' NHS Foundation Trust,[],['United Kingdom']
NCT07049861,Advancing Biopsychosocial Care Training Initiative,Increasing Access to USPSTF-Recommended Obesity Care for Youth and Adults Who Are Recipients of Medicaid: Evaluation of a Comprehensive Multidisciplinary Obesity Care Training Program in FQHCs,RECRUITING,2025-07-09,2029-07-31,2029-07-31,INTERVENTIONAL,NA,6200,"['Weight Management', 'Obesity Prevention', 'Obesity and Obesity-related Medical Conditions', 'Obesity and Overweight', 'Obesity']",Weight Management,Washington University School of Medicine,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', ""Children's Mercy Hospital Kansas City"", 'University of Missouri-Columbia', 'Missouri Institute of Mental Health', 'University of Missouri, Kansas City', 'The Missouri Department of Social Services, MO HealthNet Division, Office of Transformation']",['United States']
NCT07174141,Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study,Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study,RECRUITING,2025-11-28,2028-11,2028-11,OBSERVATIONAL,,100,"['Treatment With Second-generation Bruton&#39;s Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)']","Treatment With Second-generation Bruton&#39;s Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)",Centre Hospitalier Universitaire Dijon,[],['France']
NCT04432597,HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers,Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PD-L1/TGF-Beta Trap (M7824) in Subjects With HPV Positive Cancers,ACTIVE_NOT_RECRUITING,2020-08-11,2022-11-22,2026-01-30,INTERVENTIONAL,PHASE1,39,"['HPV Positive Cancer', 'Vulvar, Vaginal, Penile, Rectal Cancer', 'Anal Cancer', 'Oropharyngeal Cancer', 'Cervical Cancer']",HPV Positive Cancer,National Cancer Institute (NCI),[],['United States']
NCT05160012,Peer Comparison Feedback to Providers to Improve Hypertension Control,Peer Comparison Feedback to Providers to Improve Hypertension Control,ACTIVE_NOT_RECRUITING,2022-04-05,2022-10-06,2026-04,INTERVENTIONAL,NA,93,['Hypertension'],Hypertension,University of Pennsylvania,[],['United States']
NCT07187687,TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage,"TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage (TIME-ICH): A Prospective, Multi-center, Open-label, Adaptive, Randomized Controlled Trial",RECRUITING,2025-10-24,2027-09-01,2028-03-01,INTERVENTIONAL,NA,750,['Intracerebral Hemorrhage'],Intracerebral Hemorrhage,"Xuanwu Hospital, Beijing",[],['China']
NCT05008731,Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction,Effect of Botulinum Toxin on Hamstring Contracture and the Occurrence of Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction,ACTIVE_NOT_RECRUITING,2024-07-18,2025-11-30,2026-01,INTERVENTIONAL,PHASE3,132,['Hamstring Contractures'],Hamstring Contractures,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT05930418,Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis,Cardiovascular Magnetic Resonance Prognosticators In Pediatric Oncology Patients With Sepsis: A Priority Pilot Study,ACTIVE_NOT_RECRUITING,2023-05-20,2027-07-31,2027-12-31,INTERVENTIONAL,NA,7,"['Acute Respiratory Distress Syndrome', 'Sepsis', 'Cardiovascular Shock']",Acute Respiratory Distress Syndrome,St. Jude Children's Research Hospital,[],['United States']
NCT02133196,T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer,A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived From Patients With Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen,RECRUITING,2014-10-23,2027-10-23,2027-10-23,INTERVENTIONAL,PHASE2,85,"['Advanced Non-Small Cell Lung Cancer', 'Squamous Cell Carcinoma', 'Advanced NSCLC', 'Adenosquamous Carcinoma', 'Adenocarcinoma']",Advanced Non-Small Cell Lung Cancer,National Cancer Institute (NCI),[],['United States']
NCT06641466,A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine,"AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, PARALLEL GROUP STUDY TO INVESTIGATE INTERMITTENT PREVENTION OF MENSTRUAL MIGRAINE WITH RIMEGEPANT COMPARED WITH PLACEBO IN WOMEN PARTICIPANTS 18 TO 45 YEARS OF AGE",RECRUITING,2025-03-11,2026-11-29,2027-03-30,INTERVENTIONAL,PHASE3,723,['Menstrual Migraine'],Menstrual Migraine,Pfizer,[],"['Japan', 'Netherlands', 'China', 'India', 'United States', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT07204964,A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above,"A Phase 2a Randomized, Observer-Blind, Study to Evaluate the Immunogenicity and Safety of mRNA-Based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age and Older",RECRUITING,2025-10-07,2026-09-17,2026-09-17,INTERVENTIONAL,PHASE2,960,"['Influenza, Human']","Influenza, Human",GlaxoSmithKline,[],"['Belgium', 'United States']"
NCT05681780,"Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC",Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (CD40L TIL) for Patients With Oncogene-Driven Advanced Non-Small Cell Lung Cancer (NSCLC),ACTIVE_NOT_RECRUITING,2023-03-10,2025-12,2027-12,INTERVENTIONAL,PHASE1,13,"['Non Small Cell Lung Cancer', 'Stage IV Non-small Cell Lung Cancer', 'Recurrent Non Small Cell Lung Cancer']",Non Small Cell Lung Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT02193282,Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial),Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC),ACTIVE_NOT_RECRUITING,2015-02-11,2026-10-10,2026-10-10,INTERVENTIONAL,PHASE3,450,"['Lung Non-Squamous Non-Small Cell Carcinoma', 'Stage IB Lung Non-Small Cell Carcinoma AJCC v7', 'Stage II Lung Non-Small Cell Cancer AJCC v7', 'Stage IIA Lung Non-Small Cell Carcinoma AJCC v7', 'Stage IIB Lung Non-Small Cell Carcinoma AJCC v7', 'Stage IIIA Lung Non-Small Cell Cancer AJCC v7']",Lung Non-Squamous Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06641908,Anti-GD2 ADC M3554 in Advanced Solid Tumors,"A Phase 1, Two-Part, Multicenter, Open-Label First in Human Study of Anti-GD2 Antibody Drug Conjugate M3554 in Participants With Advanced Solid Tumors",RECRUITING,2024-11-08,2027-03-27,2028-03-27,INTERVENTIONAL,PHASE1,52,['Advanced Solid Tumor'],Advanced Solid Tumor,"EMD Serono Research & Development Institute, Inc.","['Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany']","['Belgium', 'Japan', 'United States', 'France', 'Switzerland', 'United Kingdom']"
NCT05886491,A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia,"A Phase 1/2a, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety and Efficacy of GDX012 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",ACTIVE_NOT_RECRUITING,2023-07-11,2025-08-20,2026-05-12,INTERVENTIONAL,PHASE1,14,['Leukemia'],Leukemia,Takeda,[],['United States']
NCT06530615,Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer,Investigation of Microplastic Pollution in the Human Respiratory System and Its Relationship to Lung Cancer,ACTIVE_NOT_RECRUITING,2024-02-05,2026-09-18,2026-09-18,OBSERVATIONAL,,119,['Lung Cancer'],Lung Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT04284774,"Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial",NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic Alterations,ACTIVE_NOT_RECRUITING,2020-10-13,2024-03-31,2027-09-30,INTERVENTIONAL,PHASE2,5,"['Malignant Solid Neoplasm', 'Recurrent Adrenal Gland Pheochromocytoma', 'Recurrent Ectomesenchymoma', 'Recurrent Ependymoma', 'Recurrent Ewing Sarcoma', 'Recurrent Hepatoblastoma', 'Recurrent Kidney Wilms Tumor', 'Recurrent Langerhans Cell Histiocytosis', 'Recurrent Malignant Germ Cell Tumor', 'Recurrent Malignant Glioma', 'Recurrent Medulloblastoma', 'Recurrent Melanoma', 'Recurrent Neuroblastoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Osteosarcoma', 'Recurrent Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Rhabdoid Tumor', 'Recurrent Rhabdoid Tumor of the Kidney', 'Recurrent Rhabdomyosarcoma', 'Recurrent Soft Tissue Sarcoma', 'Recurrent Thyroid Gland Carcinoma', 'Recurrent WHO Grade 2 Glioma', 'Refractory Adrenal Gland Pheochromocytoma', 'Refractory Ependymoma', 'Refractory Ewing Sarcoma', 'Refractory Hepatoblastoma', 'Refractory Langerhans Cell Histiocytosis', 'Refractory Malignant Germ Cell Tumor', 'Refractory Malignant Glioma', 'Refractory Medulloblastoma', 'Refractory Melanoma', 'Refractory Neuroblastoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Osteosarcoma', 'Refractory Peripheral Primitive Neuroectodermal Tumor', 'Refractory Rhabdoid Tumor', 'Refractory Rhabdoid Tumor of the Kidney', 'Refractory Rhabdomyosarcoma', 'Refractory Soft Tissue Sarcoma', 'Refractory Thyroid Gland Carcinoma', 'Refractory WHO Grade 2 Glioma']",Malignant Solid Neoplasm,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06202950,"Type 1 Diabetes,Mindfulness,Yoga,Stress,Health Quality,Glycemic İndex","The Effect of Mindfulness and Yoga on Stress Level, Quality of Life and Glycemic Control in Youth With Type 1 Diabetes",ACTIVE_NOT_RECRUITING,2023-03-15,2026-06-15,2026-07-15,INTERVENTIONAL,NA,90,"['Diabetes', 'Stress']",Diabetes,Hasan Kalyoncu University,[],['Turkey (Türkiye)']
NCT03306615,Peripheral Modulation of Muscle Stiffness and Spasticity,Peripheral Modulation of Muscle Stiffness and Spasticity,RECRUITING,2021-10-11,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE2,56,['Muscle Spasticity'],Muscle Spasticity,Johns Hopkins University,['Sheikh Khalifa Stroke Institute'],['United States']
NCT06743126,"SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma","A Prospective, Multicenter, Open-label, Randomized, Actively Controlled, Parallel-group Phase 3 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of IMA203 Versus Investigator's Choice of Treatment in Patients With Previously Treated, Unresectable or Metastatic Cutaneous Melanoma (ACTengine® IMA203-301)",RECRUITING,2025-01-14,2028-01,2031-10,INTERVENTIONAL,PHASE3,360,"['Melanoma, Cutaneous Malignant']","Melanoma, Cutaneous Malignant","Immatics US, Inc.",[],"['United States', 'Germany']"
NCT07263204,AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy,Precision Diagnosis and Prognostic Prediction of Hypertrophic Cardiomyopathy Using Artificial Intelligence: A Multicenter Study,RECRUITING,2025-01-01,2026-06-01,2026-12-31,OBSERVATIONAL,,15000,"['Hypertrophic Cardiomyopathy (HCM)', 'Left Ventricular Hypertrophy']",Hypertrophic Cardiomyopathy (HCM),"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT04989959,[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma,An Exploratory Study of [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma,RECRUITING,2021-08-18,2026-08-18,2027-08-18,INTERVENTIONAL,PHASE1,35,"['Renal Cell Carcinoma', 'Clear Cell Renal Cell Carcinoma']",Renal Cell Carcinoma,Orhan Kemal Oz,[],['United States']
NCT06721013,A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia,"A Phase 1/2, Dose-finding Study Investigating the Safety and Efficacy of Pirtobrutinib in Adults With Immune Thrombocytopenia",RECRUITING,2025-07-30,2026-12,2027-02,INTERVENTIONAL,PHASE1,58,['Immune Thrombocytopenia (ITP)'],Immune Thrombocytopenia (ITP),Eli Lilly and Company,[],"['Norway', 'China', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Poland']"
NCT03511196,Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer,A Phase 1b Study of Adaptive Androgen Deprivation Therapy for State IV Castration Sensitive Prostate Cancer,ACTIVE_NOT_RECRUITING,2018-09-17,2022-06-22,2026-09,INTERVENTIONAL,EARLY_PHASE1,17,"['Prostate Cancer', 'Stage IV Prostate Cancer', 'Advanced Prostate Cancer', 'Adenocarcinoma of the Prostate']",Prostate Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT07054840,Pain and Split-belt Motor Learning in Older Adults,Pain and Split-belt Motor Learning in Older Adults,RECRUITING,2025-08-26,2026-05-31,2026-05-31,INTERVENTIONAL,NA,34,"['Aging', 'Older Adults', 'Pain', 'Motor Learning']",Aging,University of Delaware,[],['United States']
NCT07115004,Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD),"A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)",RECRUITING,2025-10-15,2028-10,2028-10,INTERVENTIONAL,PHASE3,60,['Von Willebrand Disease (VWD)'],Von Willebrand Disease (VWD),"Vega Therapeutics, Inc",[],['United States']
NCT05706116,Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults,A Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults,RECRUITING,2025-09-10,2027-10-23,2028-04-30,INTERVENTIONAL,PHASE1,18,"['Whipworm', 'Trichuriasis', 'Controlled Human Infection']",Whipworm,George Washington University,['National Institute of Allergy and Infectious Diseases (NIAID)'],['United States']
NCT04261088,Assisted Suicide in Switzerland,Assisted Suicide in Switzerland,ACTIVE_NOT_RECRUITING,2020-02-03,2026-01-31,2026-01-31,OBSERVATIONAL,,25,['Assisted Suicide'],Assisted Suicide,National Institutes of Health Clinical Center (CC),[],['United States']
NCT04847063,"Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies","Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies",RECRUITING,2021-10-19,2030-12-30,2031-12-30,INTERVENTIONAL,PHASE1,60,"['Peritoneal Carcinomatosis', 'Peritoneal Mesothelioma', 'Ovarian Cancer', 'Gastrointestinal Cancer', 'Appendiceal Cancer']",Peritoneal Carcinomatosis,National Cancer Institute (NCI),[],['United States']
NCT07262671,Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer,Exosome Detection for Predicting Treatment Efficacy in Advanced NSCLC With Malignant Pleural Effusion,ACTIVE_NOT_RECRUITING,2025-10-16,2027-10-16,2030-10-16,OBSERVATIONAL,,100,['NSCLC (Advanced Non-small Cell Lung Cancer)'],NSCLC (Advanced Non-small Cell Lung Cancer),Fudan University,[],['China']
NCT07172516,A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression),"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Azetukalner in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)",RECRUITING,2025-08-08,2028-06,2028-08,INTERVENTIONAL,PHASE3,400,"['Bipolar Disorder', 'Bipolar Depression', 'Bipolar I Disorder', 'Bipolar II Disorder']",Bipolar Disorder,Xenon Pharmaceuticals Inc.,[],['United States']
NCT06985147,"A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)","A Phase 2, Open-Label Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DISC-3405 in Participants With Polycythemia Vera (PV)",RECRUITING,2025-08-12,2027-02,2029-02,INTERVENTIONAL,PHASE2,60,['Polycythemia Vera (PV)'],Polycythemia Vera (PV),"Disc Medicine, Inc",[],['United States']
NCT03003052,Assessing Current Clinical Concepts in Dental Practice,Assessing Current Clinical Concepts in Dental Practice,RECRUITING,2017-01,2026-07,2026-07,OBSERVATIONAL,,300,['Dental Implant'],Dental Implant,"The Campbell Clinic, UK",[],['United Kingdom']
NCT07264205,RT-310 Safety and Feasibility BPH Study,Safety and Feasibility Study of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH),RECRUITING,2025-03-13,2025-12,2026-06,INTERVENTIONAL,PHASE1,20,['BPH (Benign Prostatic Hyperplasia)'],BPH (Benign Prostatic Hyperplasia),Resurge Therapeutics Inc.,[],['Dominican Republic']
NCT01927783,Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention,Cardiovascular Health and Needs Assessment in Washington D.C. - Development of a Community-Based Behavioral Weight Loss Intervention,RECRUITING,2014-02-08,2026-10-20,,OBSERVATIONAL,,200,"['Cardiovascular Disease', 'Obesity']",Cardiovascular Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06752499,rTMS Combined With Motor Training for the Treatment of Upper Limb Motor Dysfunction in Stroke Patients,Individualized rTMS Concurrent With Motor Actions Promotes Post-stroke Upper Limb Recovery,RECRUITING,2023-02-20,2025-12,2025-12,INTERVENTIONAL,NA,60,"['Stroke', 'Upper Extremity Paresis']",Stroke,Ruijin Hospital,"['Changhai Hospital', 'Shanghai Yangzhi Rehabilitation Hospital', 'shanghai center for brain science and brain-inspired technology']",['China']
NCT00923221,Collection of Blood From Patients With Prostate Cancer,Collection of Blood From Patients With Prostate Cancer,RECRUITING,2007-02-28,,,OBSERVATIONAL,,1000,"['Cancer Of Prostate', 'Prostate Cancer', 'Prostatic Neoplasms', 'Metastatic Prostate Cancer', 'Prostate']",Cancer Of Prostate,National Cancer Institute (NCI),[],['United States']
NCT04996823,Axitinib + Ipilimumab in Advanced Melanoma,Phase 2 Study of Axitinib + Ipilimumab in Advanced Melanoma,RECRUITING,2021-08-04,2026-08-20,2027-03-29,INTERVENTIONAL,PHASE2,25,['Melanoma'],Melanoma,H. Lee Moffitt Cancer Center and Research Institute,['Pfizer'],['United States']
NCT05350761,Rare Tumors and Cancer Predisposition in Individuals and Families,Rare Tumors and Cancer Predisposition in Individuals and Families,RECRUITING,2023-03-10,2035-12-31,2035-12-31,OBSERVATIONAL,,500,"['Cancer', 'Hereditary Neoplasms', 'Genetic Predisposition to Cancer', 'Environment']",Cancer,National Cancer Institute (NCI),[],['United States']
NCT06216808,"A First-in-human Study of HyperQureTM"", Laparoscopic Renal Denervation Therapy in Patient With Resistant Hypertension","A Prospective, Multicenter, Single Arm, Open Label, First-in-human Study to Evaluate the Safety and Initial Efficacy of HyperQureTM, Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension on 3 or More Antihypertensive Medications",RECRUITING,2023-12-04,2026-03-06,2026-12-04,INTERVENTIONAL,NA,10,['Resistant Hypertension'],Resistant Hypertension,DeepQure Inc.,[],['South Korea']
NCT00001778,Evaluation of Patients With HAM/TSP,Immuno-Virological Evaluation of Human T Cell Leukemia Virus Type-1 Associated Myelopathy (HAM/TSP),RECRUITING,1998-04-06,,,OBSERVATIONAL,,750,"['HTLV-I Infection', 'Tropical Spastic Paraparesis']",HTLV-I Infection,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06877312,Longitudinal Study to Investigate Different Transcranial Electrical Stimulation,Longitudinal Study to Investigate Different Treatment Protocols of Transcranial Electrical Stimulation for Individuals With Dementia,RECRUITING,2024-10-09,2030-12-31,2033-12-31,INTERVENTIONAL,NA,200,"['Dementia; Degenerative, Dementia Mixed']","Dementia; Degenerative, Dementia Mixed",University of Manitoba,[],['Canada']
NCT07067788,B.Brilliant Revelation Comparision Study,"A Clinical Comparison of Siemens Mammomat B.Brilliant , A Novel Wide-Angel Digitial Breast Tomosynthesis System With Siemens Mammomat Revelation , A Standard Wide-Angle Digital Breast Tomosynthesis System",RECRUITING,2025-12-15,2026-07-30,2027-01-30,OBSERVATIONAL,,100,['Breast Cancer Screening'],Breast Cancer Screening,University of Pennsylvania,"['Siemens Corporation, Corporate Technology']",['United States']
NCT07012629,A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI),A EUROpean Pragmatic Multicenter Randomized Trial on Platelet Inhibition and/or Lipid Lowering Treatment in Covert Brain Infarction (CBI),RECRUITING,2025-11-26,2031-09-30,2040-01-01,INTERVENTIONAL,PHASE3,1652,['Covert Brain Infarction'],Covert Brain Infarction,Aarhus University Hospital,"['Rigshospitalet, Denmark', 'Bispebjerg Hospital', 'Herlev Hospital', 'Zealand University Hospital', 'Odense University Hospital', 'Aalborg University Hospital', 'Gødstrup Hospital', 'Oslo University Hospital', 'University Medical Center Hamburg-Eppendorf (UKE)', 'Insel Gruppe AG, University Hospital Bern', 'Lund University Hospital']","['Norway', 'Switzerland', 'Denmark', 'Sweden', 'Germany']"
NCT06993792,A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes,A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes,RECRUITING,2025-05-15,2027-01,2027-08,INTERVENTIONAL,PHASE3,1200,"['Obesity', 'Overweight', 'Type 2 Diabetes']",Obesity,Eli Lilly and Company,[],"['Japan', 'China', 'United States', 'Puerto Rico', 'Czechia', 'Argentina', 'Germany']"
NCT07162181,Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers,Long-Term Safety of Pirtobrutinib in Participants From Study J2N-MC-JZNJ With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma,RECRUITING,2025-08-07,2030-05,2030-05,INTERVENTIONAL,PHASE2,13,"['Lymphoma, Non-Hodgkin', 'Leukemia, Lymphocytic, Chronic, B-Cell', 'B-cell Lymphoma']","Lymphoma, Non-Hodgkin",Eli Lilly and Company,[],['China']
NCT05731128,A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab)),"A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Dupilumab Therapy in Patients With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype",RECRUITING,2023-01-12,2026-06-17,2027-03-24,INTERVENTIONAL,PHASE2,84,['Colitis Ulcerative'],Colitis Ulcerative,Sanofi,['Regeneron Pharmaceuticals'],"['Japan', 'South Africa', 'Turkey (Türkiye)', 'United States', 'Mexico', 'Chile', 'Puerto Rico', 'Taiwan', 'South Korea', 'Canada', 'Argentina']"
NCT07264972,Creation of a Biological Collection for Medical Research Purposes for Patients at the Reference Center for Rare Diseases of the Blood Vessels of the Brain and Eye at Lariboisière Hospital,Constitution d'Une Collection Biologique à Des Fins de Recherche médicale Pour Les Patients du Centre de référence Des Maladies Rares Des Vaisseaux du Cerveau et de l'Oeil à l'hôpital Lariboisière,ACTIVE_NOT_RECRUITING,2021-01-21,2027-07-31,2027-07-31,OBSERVATIONAL,,500,['Cerebrovascular Disease'],Cerebrovascular Disease,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT07014319,Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies,Maribavir Treatment of Cytomegalovirus for Lymphoid Malignancy Patients Undergoing Bispecific Antibodies,RECRUITING,2025-11-03,2027-10-31,2028-01-31,INTERVENTIONAL,PHASE2,20,['Cytomegalovirus (CMV)'],Cytomegalovirus (CMV),Seoul National University Hospital,[],['South Korea']
NCT03383081,The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis,A Clinical Research on the Safety/Efficacy of Human Umbilical Cord Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis,RECRUITING,2018-10-01,2026-06-30,2026-12-31,INTERVENTIONAL,PHASE2,60,"['Osteoarthritis, Knee']","Osteoarthritis, Knee","Sclnow Biotechnology Co., Ltd.",[],['China']
NCT07265154,Gait Training and Artificial Intelligence,Gait Training in Above Knee Amputation Patients Using Artificial Intelligence,RECRUITING,2025-12-01,2026-02-01,2026-03-01,INTERVENTIONAL,NA,40,"['Above Knee Amputation', 'Amputation']",Above Knee Amputation,South Valley University,"['Badr University', 'Benha University', 'Al Salam University']",['Egypt']
NCT06160102,Appropriate Medication Use for Individuals With Intellectual Disabilities - A Matter of Life,Appropriate Medication Use for Individuals With Intellectual Disabilities - A Matter of Life,ACTIVE_NOT_RECRUITING,2023-08-15,2027-07-31,2027-07-31,INTERVENTIONAL,NA,110,"['Disabilities, Intellectual', 'Disability, Developmental']","Disabilities, Intellectual",Vestvagoy Municipality,"['University of Oslo', 'University of Tromso']",['Norway']
NCT07165028,A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes),"A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes",RECRUITING,2025-10-15,2030-08,2032-08,INTERVENTIONAL,PHASE3,4500,['Metabolic Dysfunction-Associated Steatotic Liver Disease'],Metabolic Dysfunction-Associated Steatotic Liver Disease,Eli Lilly and Company,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT04743141,Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine,"Phase 3, Multicenter, Open-label Study to Assess the Long-term Safety and Tolerability of Rimegepant for the Acute Treatment of Migraine (With or Without Aura) in Children and Adolescents ≥ 6 to < 18 Years of Age",RECRUITING,2021-04-28,2030-07-31,2030-07-31,INTERVENTIONAL,PHASE3,600,['Acute Treatment of Migraine'],Acute Treatment of Migraine,Pfizer,[],"['Poland', 'Spain', 'United States']"
NCT06671912,"Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial","LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer",RECRUITING,2025-02-19,2030-11-30,2031-11-30,INTERVENTIONAL,PHASE3,1156,"['Anatomic Stage 0 Breast Cancer AJCC v8', 'Anatomic Stage 1 Breast Cancer AJCC v8', 'Anatomic Stage IIA Breast Cancer AJCC v8', 'Estrogen Receptor-Positive Breast Carcinoma', 'HER2-Negative Breast Carcinoma']",Anatomic Stage 0 Breast Cancer AJCC v8,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT04284969,PROADAPT-ovary/EWOC-2,"Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' Trajectories-ovary/Elderly Women With Ovarian Cancer-2, a GINECO Multicenter Randomized Study (PROADAPT-ovary/EWOC-2)",RECRUITING,2021-06-03,2027-06-03,2029-03-03,INTERVENTIONAL,NA,292,"['Ovarian Cancer', 'Surgery']",Ovarian Cancer,Hospices Civils de Lyon,[],['France']
NCT07127354,The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality,The Impact of GLP-1 Agonist and GIP Agonist on Bowel Preparation Quality: A Randomized Controlled Trial,RECRUITING,2025-08-01,2026-08,2026-08,INTERVENTIONAL,PHASE4,132,"['GLP - 1', 'Bowel Preparation for Colonoscopy']",GLP - 1,The Cleveland Clinic,[],['United States']
NCT07265388,SUCCESS Score Validation in Fuchs Dystrophy,Validation and Extension of the SUCCESS Score for Fuchs Dystrophy After Cataract Surgery,RECRUITING,2020-06-01,2026-07,2026-12,OBSERVATIONAL,,250,['Fuchs Endothelial Corneal Dystrophy'],Fuchs Endothelial Corneal Dystrophy,Instituto Ramón y Cajal de Investigación Sanitaria,[],['Spain']
NCT06353386,Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A),MK-5684-01A Substudy: A Phase 1/2 Umbrella Substudy of MK-5684-U01 Master Protocol to Evaluate the Safety and Efficacy of MK-5684-based Treatment Combinations or MK-5684 Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC),RECRUITING,2024-05-20,2029-01-15,2029-01-15,INTERVENTIONAL,PHASE1,220,"['Prostatic Neoplasms, Castration-Resistant']","Prostatic Neoplasms, Castration-Resistant",Merck Sharp & Dohme LLC,"['Orion Corporation, Orion Pharma']","['Japan', 'New Zealand', 'Australia', 'Israel', 'France', 'Chile', 'Finland', 'Denmark', 'South Korea', 'Colombia', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy']"
NCT06938685,Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers,Evaluation of the Efficacy of NeoThelium FT in the Healing of Chronic Diabetic Foot Ulcers: A Randomized Controlled Multicenter Crossover Trial,RECRUITING,2025-10-06,2026-09-01,2026-10-01,INTERVENTIONAL,NA,132,['Diabetic Foot Ulcer'],Diabetic Foot Ulcer,"NuScience Medical Biologics, LLC","['SygNola, LLC']",['United States']
NCT06409390,Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer,"A Pilot Study of Sequential (""First Strike, Second Strike"") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for Hormone Positive Metastatic Breast Cancer",RECRUITING,2024-08-14,2027-04,2027-04,INTERVENTIONAL,PHASE2,15,['Metastatic Breast Cancer'],Metastatic Breast Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT06625060,A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults,"A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults",RECRUITING,2024-10-10,2027-05-31,2027-06-15,INTERVENTIONAL,PHASE2,641,"['Episodic Migraine', 'Chronic Migraine']",Episodic Migraine,Ipsen,[],"['Brazil', 'Japan', 'New Zealand', 'United States', 'France', 'Georgia', 'Germany', 'Spain', 'South Korea', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT05552755,Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP),"A Phase 1b-2, Multicenter, Trial to Evaluate the Efficacy, Safety, Pharmacokintetics, and Pharmacodynamics of REC-4881 in Patients With Familial Adenomatous Polyposis (FAP)",RECRUITING,2023-07-10,2026-07,2026-07,INTERVENTIONAL,PHASE1,67,['Familial Adenomatous Polyposis'],Familial Adenomatous Polyposis,Recursion Pharmaceuticals Inc.,[],['United States']
NCT04638946,Exercise for Anxiety,Optimizing Exercise for the Treatment of Anxiety,ACTIVE_NOT_RECRUITING,2021-06-30,2026-01-31,2026-04-30,INTERVENTIONAL,NA,111,['Anxiety'],Anxiety,NYU Langone Health,[],['United States']
NCT07262788,A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes,A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes (ON LiMiT),RECRUITING,2025-09-30,2027-03,2027-03,INTERVENTIONAL,NA,24,['Type 2 Diabetes'],Type 2 Diabetes,Steno Diabetes Center Copenhagen,"['Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital', 'Steno Diabetes Center Odense', 'University of Copenhagen', 'The Novo Nordisk Foundation Center for Basic Metabolic Research', 'Bispebjerg Hospital']",['Denmark']
NCT04401774,Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy,Phase II Maintenance Trial of Nivolumab for Newly Diagnosed PCNSL Patients With Persistent Circulating Tumor DNA in the CSF After Completion of Methotrexate-Based First-Line Induction Chemotherapy,ACTIVE_NOT_RECRUITING,2020-05-22,2026-05-22,2026-05-22,INTERVENTIONAL,PHASE2,14,['Primary Central Nervous System Lymphoma (PCNSL)'],Primary Central Nervous System Lymphoma (PCNSL),Memorial Sloan Kettering Cancer Center,['Bristol-Myers Squibb'],['United States']
NCT07000734,"Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study","Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study",ACTIVE_NOT_RECRUITING,2025-07-28,2026-05,2026-05,INTERVENTIONAL,PHASE2,20,"['Aging', 'Cognitive Decline', 'Older Adults', 'Cardiovascular', 'Sedentary Behaviors', 'Immune Senescence', 'Motor Function']",Aging,Washington University School of Medicine,[],['United States']
NCT07201909,"CALM Study: Can A Prebiotic Fibre bLend Improve Stress, Mood, and Anxiety?","Can A Prebiotic Fibre bLend Improve Stress, Mood, and Anxiety? Assessing the Impact of a Daily Prebiotic Fibre Blend on Affect, Inflammation, and the Gut Microbiome: a 12-week Double-blind Placebo-controlled RCT",RECRUITING,2025-10-02,2026-09-30,2026-12-30,INTERVENTIONAL,NA,156,['Stress'],Stress,Myota GmbH,['University of Reading'],['United Kingdom']
NCT07089784,Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003),"A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of MK-2828 in Participants With Type 2 Diabetes",RECRUITING,2025-09-22,2026-03-25,2026-03-25,INTERVENTIONAL,PHASE1,64,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",Merck Sharp & Dohme LLC,[],['United States']
NCT04937998,PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT,THE USE OF FRESH PRP VS HA IN THE TREATMENT OF OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT Randomized Controlled Clinical Trial,RECRUITING,2022-10-26,2026-09,2026-09,INTERVENTIONAL,NA,166,['Patellofemoral Osteoarthritis'],Patellofemoral Osteoarthritis,Istituto Ortopedico Rizzoli,[],['Italy']
NCT05979051,A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）,"A Multicenter, Single-arm/Randomized, Double-blind, Active-controlled, Parallel-group Phase 2/3 Clinical Study to Evaluate the Efficacy and Safety of SHR-1703 for Patients With EGPA",RECRUITING,2023-11-16,2028-12,2028-12,INTERVENTIONAL,PHASE2,166,['Eosinophilic Granulomatosis With Polyangiitis'],Eosinophilic Granulomatosis With Polyangiitis,"Guangdong Hengrui Pharmaceutical Co., Ltd",[],['China']
NCT06311227,Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia,A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia,RECRUITING,2024-12-16,2027-05-20,2027-05-20,INTERVENTIONAL,PHASE2,20,"['Recurrent Hairy Cell Leukemia', 'Recurrent Hairy Cell Leukemia Variant']",Recurrent Hairy Cell Leukemia,National Cancer Institute (NCI),[],['United States']
NCT06318169,A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis),A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis,RECRUITING,2024-03-13,2029-02,2029-02,INTERVENTIONAL,PHASE3,1350,['Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis'],Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,"89bio, Inc.",[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'France', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Georgia', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT05689502,intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER),intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER),ACTIVE_NOT_RECRUITING,2023-03-20,2026-09-01,2026-12-31,INTERVENTIONAL,NA,9,['Chronic Stroke'],Chronic Stroke,"The University of Texas Health Science Center, Houston",[],['United States']
NCT06979375,A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy,"Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy",RECRUITING,2025-06-30,2027-05-16,2028-01-23,INTERVENTIONAL,PHASE2,200,['Heart Failure'],Heart Failure,Novo Nordisk A/S,[],"['Japan', 'Netherlands', 'Germany', 'Spain', 'South Korea', 'Czechia', 'Australia', 'Poland', 'United Kingdom', 'India']"
NCT01834001,Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy,Evaluation of Local Response of Prostate Cancer to Irradiation Using Multiparametric MRI and MR-Guided Biopsies,RECRUITING,2013-11-13,2027-02-25,,OBSERVATIONAL,,300,"['Prostatic Neoplasms', 'Prostate Cancer']",Prostatic Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT07262892,3D Evaluation of Maxillary Expansion Methods,Three-Dimensional Evaluation of the Effects of Different Maxillary Expansion Methods,RECRUITING,2025-11-20,2026-06,2026-06,INTERVENTIONAL,NA,60,['Maxillary Transverse Deficiency'],Maxillary Transverse Deficiency,Büşra Zeynep Yörük,['Centerdent Orthodontics & Aesthetic Dentistry Clinic'],['Turkey (Türkiye)']
NCT05537064,Centralized Prescribing for Statins,A Pilot Study of Strategies to Increase Use of Centralized Pharmacy Services for Management of Statin Therapy Among Patients With or at High Risk for Atherosclerotic Vascular Disease,ACTIVE_NOT_RECRUITING,2022-11-02,2023-06-13,2026-02,INTERVENTIONAL,NA,1950,['Hyperlipidemias'],Hyperlipidemias,University of Pennsylvania,[],['United States']
NCT07114601,A Study of LY4257496 in Participants With Cancer (OMNIRAY),"A Phase 1a/b Multicenter, Open-Label Trial to Evaluate Safety, Tolerability, and Dosimetry of LY4257496, a GRPR-Targeted Radioligand Therapy, in Adults With GRPR-Positive Advanced Solid Tumors (OMNIRAY)",RECRUITING,2025-08-06,2030-04,2035-04,INTERVENTIONAL,PHASE1,421,"['Breast Neoplasms', 'Colorectal Neoplasms', 'Prostate Neoplasm', 'Endometrial Neoplasms', 'Neoplasm Metastasis']",Breast Neoplasms,Eli Lilly and Company,[],"['United States', 'France', 'Spain', 'Canada', 'Germany']"
NCT07112053,"A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer",A Phase II Study of STEMVAC Vaccine Therapy for Patients With Hormone Receptor Positive Metastatic Breast Cancer,RECRUITING,2025-11-07,2028-07-31,2028-12-31,INTERVENTIONAL,PHASE2,40,"['Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic HER2-Negative Breast Carcinoma', 'Metastatic Hormone Receptor-Positive Breast Carcinoma']",Anatomic Stage IV Breast Cancer AJCC v8,University of Washington,[],['United States']
NCT06940739,A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel,"A Phase 1/2, Open-label Study of a Modified Interleukin-2 Fusion Protein (IOV-3001) in Participants With Previously Treated, Unresectable or Metastatic Melanoma Who Will Receive Lifileucel",RECRUITING,2025-03-11,2032-06,2032-07,INTERVENTIONAL,PHASE1,42,"['Unresectable Melanoma', 'Metastatic Melanoma', 'Ocular Melanoma']",Unresectable Melanoma,"Iovance Biotherapeutics, Inc.",[],"['United States', 'Australia']"
NCT06428409,A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A),A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers,RECRUITING,2024-06-20,2029-10-16,2029-10-16,INTERVENTIONAL,PHASE1,220,"['Colorectal Cancer', 'Pancreatic Ductal Adenocarcinoma', 'Biliary Tract Cancer']",Colorectal Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'Turkey (Türkiye)', 'China', 'United States', 'Chile', 'Switzerland', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT07019662,Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Standard Approach,Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Standard Approach,RECRUITING,2025-10-27,2027-02,2027-09,INTERVENTIONAL,NA,102,['VA-ECMO'],VA-ECMO,IHF GmbH - Institut für Herzinfarktforschung,[],['Germany']
NCT06366464,A Study of Pitolisant in Patients With Prader-Willi Syndrome,"A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients With Prader-Willi Syndrome",RECRUITING,2024-05-28,2026-07,2027-07,INTERVENTIONAL,PHASE3,134,['Prader-Willi Syndrome'],Prader-Willi Syndrome,"Harmony Biosciences Management, Inc.",[],"['Belgium', 'United States', 'France', 'Germany', 'Denmark', 'Spain', 'Italy', 'Canada', 'Romania', 'United Kingdom', 'Poland', 'Sweden', 'Australia']"
NCT06282055,Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes,Trajectories in Insulin Sensitivity Across Menstrual Cycles in Women With Type 1 Diabetes,RECRUITING,2025-11-20,2027-09-15,2027-09-15,OBSERVATIONAL,,350,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1",DCB Research AG,"['The Danish Diabetes Association', 'Heart and Diabetes Center North Rhine-Westphalia', 'University of Bristol', 'Emory University']",['Switzerland']
NCT06205836,Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer,Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer,RECRUITING,2024-06-13,2028-05,2028-05,INTERVENTIONAL,PHASE2,33,['Colorectal Cancer'],Colorectal Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Regeneron Pharmaceuticals'],['United States']
NCT06657716,Heidelberg Engineering ANTERION Software Comparison Study,The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study,ACTIVE_NOT_RECRUITING,2024-10-02,2026-05,2026-10,OBSERVATIONAL,,60,"['Eyes With Normal Anterior Segment', 'Eyes With Abnormal Anterior Segment']",Eyes With Normal Anterior Segment,Heidelberg Engineering GmbH,[],['United States']
NCT07115745,"A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases","A Phase 1, Multicenter, Open-label Study of BMS-986515, Healthy Donor Allogeneic CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Severe, Refractory Autoimmune Diseases",RECRUITING,2025-09-04,2029-02-13,2030-08-16,INTERVENTIONAL,PHASE1,125,['Refractory Autoimmune Diseases'],Refractory Autoimmune Diseases,"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",[],"['Brazil', 'Israel', 'United States', 'France', 'Germany', 'Spain', 'Romania', 'Czechia', 'Poland', 'Australia']"
NCT06920251,Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy,Optimal Infection Prophylaxis Strategy for Relapsed/Refractory Multiple Myeloma Patients Undergoing Elranatamab Therapy,RECRUITING,2025-09-11,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE2,40,['Relapsed Refractory Multiple Myeloma (RRMM)'],Relapsed Refractory Multiple Myeloma (RRMM),Seoul National University Hospital,[],['South Korea']
NCT06617312,Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity,Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-Reactivity,RECRUITING,2024-12-05,2026-12,2026-12,INTERVENTIONAL,PHASE2,64,"['Smoking Cessation', 'Tobacco Use Disorder']",Smoking Cessation,"University of California, Los Angeles",[],['United States']
NCT03481738,Pyruvate Kinase Deficiency Global Longitudinal Registry,Pyruvate Kinase Deficiency Global Longitudinal Registry,ACTIVE_NOT_RECRUITING,2018-04-23,2027-05-31,2027-05-31,OBSERVATIONAL,,500,['Pyruvate Kinase Deficiency'],Pyruvate Kinase Deficiency,"Agios Pharmaceuticals, Inc.",[],"['Turkey (Türkiye)', 'United Kingdom', 'Netherlands', 'United States', 'France', 'Switzerland', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Thailand', 'Portugal', 'Germany']"
NCT07224243,Impact of Intraoperative Oxygenation Practices on Patient Outcomes,Impact of Intraoperative Oxygenation Practices on Patient Outcomes,RECRUITING,2025-12-01,2028-02,2028-04,INTERVENTIONAL,NA,54000,['Surgeries Undergoing General Anesthesia'],Surgeries Undergoing General Anesthesia,Frederic T Billings IV,"['Multicenter Perioperative Outcomes Group', 'University of Michigan', 'The Association of University Anesthesiologists']",['United States']
NCT06544863,Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants,Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants at Pitié Salpêtrière University Hospital,RECRUITING,2025-03-19,2040-03-19,2040-03-19,OBSERVATIONAL,,1600,['Cirrhosis'],Cirrhosis,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT05377684,Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment,"Noninterventional, Multicentre, Prospective, Cohort Study Assessing the Quality of Life and Hormonal Levels in Premenopausal Patients With Hormone Receptor-positive and HER2-negative Early Breast Cancer in Italy - ROSE Study",ACTIVE_NOT_RECRUITING,2022-06-09,2026-06-05,2026-06-05,OBSERVATIONAL,,450,['Early-stage Breast Cancer'],Early-stage Breast Cancer,Ipsen,[],['Italy']
NCT07157007,Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19,"A Multicenter, Open-Label, Randomized Phase 2a Study to Evaluate Safety and Efficacy of Ratutrelvir and Standard of Care in Non-hospitalized Symptomatic Adult Participants With Mild to Moderate COVID-19",RECRUITING,2025-09-16,2025-12,2026-01,INTERVENTIONAL,PHASE2,90,['COVID - 19'],COVID - 19,"Traws Pharma, Inc.",[],"['Uzbekistan', 'Taiwan', 'South Korea', 'Australia']"
NCT06442930,EXtubation Related Complications - the EXTUBE Study (EXTUBE),EXtubation Related Complications - an International Observational Study To Understand the Impact and BEst Practices in the Operating Room and Intensive Care Unit - the EXTUBE Study,RECRUITING,2025-04-14,2026-12,2026-12,OBSERVATIONAL,,3000,['Extubation'],Extubation,"University Health Network, Toronto",[],"['Singapore', 'United States', 'Canada', 'Australia']"
NCT05965167,Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo,"A Phase 1b, Open-label, Partially Randomised Study to Assess Safety and Compare Pharmacokinetics of New Oral hPTH(1-34) Tablet Formulations vs. Oral EBP05 Tablets and Subcutaneous Forteo® Injection in Healthy Male Subjects",RECRUITING,2023-05-11,2026-05,2026-05,INTERVENTIONAL,PHASE1,45,"['Hypoparathyroidism', 'Osteoporosis', 'Fractures, Bone', 'Other Disease']",Hypoparathyroidism,Entera Bio Ltd.,[],['Israel']
NCT06209307,Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate,Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate,ACTIVE_NOT_RECRUITING,2024-02-08,2026-03-31,2026-05-31,INTERVENTIONAL,NA,72,"['Prostatic Hyperplasia', 'Stress Urinary Incontinence']",Prostatic Hyperplasia,"University of California, Irvine",[],['United States']
NCT03595124,A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC),A Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups,ACTIVE_NOT_RECRUITING,2019-01-08,2024-09-30,2026-11-13,INTERVENTIONAL,PHASE2,15,"['Metastatic Renal Cell Carcinoma', 'Stage III Renal Cell Cancer AJCC v8', 'Stage IV Renal Cell Cancer AJCC v8', 'TFE3-Rearranged Renal Cell Carcinoma', 'Unresectable Renal Cell Carcinoma']",Metastatic Renal Cell Carcinoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06808269,Prospective Comparative Multicenter Study of the Care Pathway After Shoulder Surgery,Prospective Comparative Multicenter Study of the Care Pathway After Shoulder Surgery,RECRUITING,2025-05-19,2026-06-30,2026-08-31,INTERVENTIONAL,NA,210,['Shoulder Injury'],Shoulder Injury,Clinique Victor Hugo,[],['France']
NCT07035886,A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea,Post-Marketing Surveillance (Usage Results Study) of Fruzaqla Capsule (Fruquintinib) for the Approved Indications in South Korea,RECRUITING,2025-09-29,2029-09-01,2031-03-01,OBSERVATIONAL,,600,['Colorectal Cancer'],Colorectal Cancer,Takeda,[],['South Korea']
NCT03697148,Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer,Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer,ACTIVE_NOT_RECRUITING,2019-02-11,2026-08-31,2026-08-31,INTERVENTIONAL,NA,852,['Prostate Carcinoma'],Prostate Carcinoma,ECOG-ACRIN Cancer Research Group,['National Cancer Institute (NCI)'],['United States']
NCT04793776,Manage Emotions to Reduce Aggression (MERA),Manage Emotions to Reduce Aggression - MERA: A Brief Aggression Treatment for Veterans With PTSD Symptoms,RECRUITING,2022-01-03,2026-06-01,2026-06-30,INTERVENTIONAL,NA,204,"['Stress Disorders, Post-Traumatic', 'Aggression', 'Emotion Regulation']","Stress Disorders, Post-Traumatic",VA Office of Research and Development,"['Michael E. DeBakey VA Medical Center', 'University of South Florida', 'VA Boston Healthcare System', 'University of Houston', 'Texas A&M University']",['United States']
NCT06297850,Accuracy of Continuous Glucose Monitoring in Patients With Diabetes. A Prospective Observational Study,Validation of the Accuracy of Continuous Glucose Monitoring Using the Dexcom G7 in Patients With Diabetes in Situations With Circulatory Impairment. A Prospective Observational Study,ACTIVE_NOT_RECRUITING,2024-04-01,2025-06-01,2025-12-01,OBSERVATIONAL,,60,"['Diabetes Mellitus', 'Dysglycemia', 'Perioperative Complication', 'Circulatory; Complications']",Diabetes Mellitus,University Hospital Bispebjerg and Frederiksberg,"['Rigshospitalet, Denmark', 'Steno Diabetes Center Copenhagen', 'Zealand University Hospital']",['Denmark']
NCT07219017,A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants,Mass Balance Study of [14C] ABBV-1354 (Icalcaprant) in Healthy Male Subjects Following Single Oral Dose Administration,ACTIVE_NOT_RECRUITING,2025-10-15,2025-12,2025-12,INTERVENTIONAL,PHASE1,8,['Healthy Volunteer'],Healthy Volunteer,AbbVie,[],['United States']
NCT07088068,A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes,"A Randomized, Double-blind, 2-arm, Phase 3 Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Newly Diagnosed Stage 3 Type 1 Diabetes (T1D)",RECRUITING,2025-08-06,2028-06-06,2028-12-12,INTERVENTIONAL,PHASE3,723,['Type 1 Diabetes Mellitus'],Type 1 Diabetes Mellitus,Sanofi,[],"['China', 'United Kingdom', 'United States', 'Netherlands']"
NCT04163315,Multimodal Connectome Study of Brain Tumor-operated Patients,Multimodal Connectome Study of Brain Tumor-operated Patients,ACTIVE_NOT_RECRUITING,2019-12-12,2020-01-12,2026-03-05,INTERVENTIONAL,NA,30,"['Tumor, Brain']","Tumor, Brain",Centre Hospitalier Universitaire de Nice,[],['France']
NCT05254743,A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL),"A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)",RECRUITING,2022-07-22,2025-06-10,2028-01,INTERVENTIONAL,PHASE3,662,"['Chronic Lymphocytic Leukemia', 'Leukemia, Lymphocytic', 'Leukemia, B-cell', 'Small Lymphocytic Lymphoma']",Chronic Lymphocytic Leukemia,"Loxo Oncology, Inc.",[],"['Japan', 'New Zealand', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'South Korea', 'Czechia', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT03647878,Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.,Prospective Non-interventional Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment,ACTIVE_NOT_RECRUITING,2018-09-24,2027-09-30,2027-09-30,OBSERVATIONAL,,224,"['Advanced Renal Cell Carcinoma', 'Metastatic Renal Cell Carcinoma']",Advanced Renal Cell Carcinoma,Ipsen,[],"['Austria', 'Germany']"
NCT04639635,CNGB1 and Allied Disorders,Study of CNGB1 Retinitis Pigmentosa and Allied Hereditary Disorders,RECRUITING,2019-03-14,2026-02,2026-02,OBSERVATIONAL,,20,['Retinitis Pigmentosa Associated With CNGB1 Mutations'],Retinitis Pigmentosa Associated With CNGB1 Mutations,Columbia University,"['Michigan State University', 'Moorfields Eye Hospital NHS Foundation Trust', 'Universität Tübingen', 'Wills Eye', 'La Fondation Voir et Entendre', 'Ludwig-Maximilians - University of Munich']","['United Kingdom', 'United States', 'France', 'Germany']"
NCT05169190,Stellate Ganglion Block for PTSD,Efficacy and Safety of Stellate Ganglion Block for Post-traumatic Stress Disorder in Veterans,ACTIVE_NOT_RECRUITING,2022-11-17,2025-09-30,2026-06-30,INTERVENTIONAL,NA,410,['Post-traumatic Stress Disorder'],Post-traumatic Stress Disorder,VA Office of Research and Development,"['Analydata, Inc.']",['United States']
NCT06047080,"An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma","A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma",RECRUITING,2023-09-18,2027-12-31,2030-12-31,INTERVENTIONAL,PHASE3,1130,['Large B-Cell Lymphoma'],Large B-Cell Lymphoma,Hoffmann-La Roche,[],"['Japan', 'China', 'Australia', 'Belgium', 'France', 'Puerto Rico', 'Denmark', 'South Korea', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06472973,ADDICTOlogical Intervention in LIVEr Transplantation Recipients,ADDICTOlogical Intervention in LIVEr Transplantation Recipients,RECRUITING,2024-11-21,2028-11-21,2030-11-21,INTERVENTIONAL,NA,720,"['Alcohol Associated Liver Disease', 'Liver Transplantation']",Alcohol Associated Liver Disease,"University Hospital, Montpellier",[],['France']
NCT05490446,A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS),"A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes",ACTIVE_NOT_RECRUITING,2022-11-07,2026-03,2029-03,INTERVENTIONAL,PHASE2,87,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,"Agios Pharmaceuticals, Inc.",[],"['Israel', 'Austria', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'South Korea', 'Czechia', 'United Kingdom', 'Greece', 'Poland', 'Australia']"
NCT07222384,A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19,"A PHASE 3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BNT162b2 (LP.8.1)-ADAPTED VACCINE IN CHILDREN 5 THROUGH 11 YEARS OF AGE CONSIDERED AT HIGH RISK FOR SEVERE COVID-19",RECRUITING,2025-10-30,2026-10-30,2026-10-30,INTERVENTIONAL,PHASE3,330,"['COVID-19', 'SARS-COV-2 Infection']",COVID-19,BioNTech SE,['Pfizer'],"['Puerto Rico', 'United States']"
NCT06854718,Pain With Dementia,Caregiver-assisted Pain Coping Skills Training for Dementia Pilot Study,RECRUITING,2025-08-13,2026-12-01,2026-12-01,INTERVENTIONAL,NA,60,"['Pain', 'Dementia, Mild', 'Dementia, Moderate']",Pain,Duke University,"['National Institute on Aging (NIA)', 'National Institutes of Health (NIH)']",['United States']
NCT05806606,Effect and Cost Effectiveness of a Dyadic Empowerment-based Heart Failure Management Program for Self-care,"The Effects and Cost-effectiveness of a Dyadic Empowerment-based Heart Failure Management Program (De-HF) on Self-care, HRQL and Hospital Readmission: A Randomized Controlled Trial",RECRUITING,2023-04-17,2025-09-01,2026-06-01,INTERVENTIONAL,NA,232,"['Heart Failure', 'Self Care', 'Empowerment', 'Transitional Care', 'Disease Management']",Heart Failure,The University of Hong Kong,"['Hospital Authority, Hong Kong']",['Hong Kong']
NCT05343286,"Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity","Biological & Fonctional Signatures for Muscle Failures, Aged People & Personalized Physical Activity : BioFaSt MAPPA",RECRUITING,2022-04-29,2027-04-15,2028-04-15,INTERVENTIONAL,NA,900,['Elderly'],Elderly,Centre Hospitalier Universitaire de Nice,[],['France']
NCT02312557,Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide,Addition of Pembrolizumab Upon Progression on Enzalutamide in Men With mCRPC,ACTIVE_NOT_RECRUITING,2014-11-18,2024-08-22,2026-06-30,INTERVENTIONAL,PHASE2,58,"['Castration-Resistant Prostate Carcinoma', 'Hormone-Resistant Prostate Cancer', 'PSA Progression', 'Recurrent Prostate Carcinoma', 'Stage IV Prostate Adenocarcinoma Cancer AJCC v8']",Castration-Resistant Prostate Carcinoma,OHSU Knight Cancer Institute,"['Merck Sharp & Dohme LLC', 'Collins Medical Trust', 'Oregon Health and Science University']",['United States']
NCT07074977,Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in Adults With Chronic Pruritus of Unknown Origin (CPUO),An Exploratory Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics (PK/PD) of Nemolizumab in Adult Participants With Chronic Pruritus of Unknown Origin (CPUO),RECRUITING,2025-10-20,2026-09,2027-01,INTERVENTIONAL,PHASE2,50,['Chronic Pruritus of Unknown Origin'],Chronic Pruritus of Unknown Origin,Galderma R&D,[],['United States']
NCT06658899,A Phase 2 Study of CRD-4730 in CPVT,"A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia",RECRUITING,2025-12,2027-04,2027-04,INTERVENTIONAL,PHASE2,12,['Catecholaminergic Polymorphic Ventricular Tachycardia'],Catecholaminergic Polymorphic Ventricular Tachycardia,"Cardurion Pharmaceuticals, Inc.",[],['United States']
NCT07261280,Testing a Biometric Identification System to Improve Malaria Vaccine Completion,Testing a Biometric Identification System to Improve Malaria Vaccine Completion,RECRUITING,2025-10-15,2027-12-31,2027-12-31,INTERVENTIONAL,NA,4715,['Vaccination'],Vaccination,University of Michigan,"['University of Ghana', 'Harvard School of Public Health (HSPH)']",['Ghana']
NCT06745882,Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC,Prospective Trial to Assess Real-world Outcomes and Predictive Biomarkers of Response to Pembrolizumab With or Without Chemotherapy in Black Patients With NSCLC,RECRUITING,2025-06-13,2030-01,2030-01,INTERVENTIONAL,PHASE2,318,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,H. Lee Moffitt Cancer Center and Research Institute,"['Merck Sharp & Dohme LLC', 'Foundation Medicine', 'Go-2 Lung']",['United States']
NCT03213704,"Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)",NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of LOXO-101 (Larotrectinib) in Patients With Tumors Harboring Actionable NTRK Fusions,ACTIVE_NOT_RECRUITING,2017-08-23,2024-09-30,2026-10-08,INTERVENTIONAL,PHASE2,9,"['Advanced Malignant Solid Neoplasm', 'Recurrent Ependymoma', 'Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Glioma', 'Recurrent Hepatoblastoma', 'Recurrent Kidney Wilms Tumor', 'Recurrent Langerhans Cell Histiocytosis', 'Recurrent Malignant Germ Cell Tumor', 'Recurrent Malignant Glioma', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Medulloblastoma', 'Recurrent Neuroblastoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Osteosarcoma', 'Recurrent Rhabdoid Tumor', 'Recurrent Rhabdomyosarcoma', 'Recurrent Soft Tissue Sarcoma', 'Refractory Ependymoma', 'Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor', 'Refractory Glioma', 'Refractory Hepatoblastoma', 'Refractory Langerhans Cell Histiocytosis', 'Refractory Malignant Germ Cell Tumor', 'Refractory Malignant Glioma', 'Refractory Malignant Solid Neoplasm', 'Refractory Medulloblastoma', 'Refractory Neuroblastoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Osteosarcoma', 'Refractory Primary Central Nervous System Neoplasm', 'Refractory Rhabdoid Tumor', 'Refractory Rhabdomyosarcoma', 'Refractory Soft Tissue Sarcoma']",Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT07253467,Load Dependent Modulation of Spinal Excitability: Linking H-Reflex Supression and Whole Body Vibration Induced Reflex Latency,Load Dependent Modulation of Spinal Excitability: Linking H-Reflex Supression and Whole Body Vibration Induced Reflex Latency,RECRUITING,2025-11-21,2025-12-08,2025-12-30,INTERVENTIONAL,NA,15,"['Vibration', 'H-reflex']",Vibration,Istanbul Physical Medicine Rehabilitation Training and Research Hospital,[],['Turkey (Türkiye)']
NCT06363357,"The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder","The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Neuromuscular Disorder",RECRUITING,2024-04-20,2025-12-31,2025-12-31,INTERVENTIONAL,NA,30,"['Muscular Dystrophy, Duchenne', 'Orthotic Devices', 'Upper Extremity', 'Neuromuscular Diseases (NMD)', 'Fascioscapulohumeral Muscular Dystrophy', 'Spinal Muscular Atrophy (SMA)', 'ALS (Amyotrophic Lateral Sclerosis)', 'LGMD', 'SCI - Spinal Cord Injury']","Muscular Dystrophy, Duchenne",Seoul National University Hospital,[],['South Korea']
NCT06860243,A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009),"An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MK-5684 in Male Participants With Moderate Hepatic Impairment",RECRUITING,2025-05-13,2025-12-11,2025-12-15,INTERVENTIONAL,PHASE1,16,"['Hepatic Impairment', 'Healthy Participants']",Hepatic Impairment,Merck Sharp & Dohme LLC,[],['United States']
NCT06910358,Study of Bitopertin in Participants With EPP or XLP (APOLLO),"APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)",RECRUITING,2025-04-04,2026-10,2026-11,INTERVENTIONAL,PHASE3,150,"['Erythropoietic Protoporphyria (EPP)', 'X-Linked Protoporphyria (XLP)']",Erythropoietic Protoporphyria (EPP),"Disc Medicine, Inc",[],"['Norway', 'United States', 'France', 'Canada', 'Australia']"
NCT07170033,The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis,A New Approach to Nutritional Therapy in Rheumatoid Arthritis: Evaluation of the Effect of the DASH Diet Through a Randomized Controlled Clinical Trial,ACTIVE_NOT_RECRUITING,2024-05-06,2025-10-06,2025-12,INTERVENTIONAL,NA,49,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Istanbul Health and Technology University,['The Scientific and Technological Research Council of Turkey'],['Turkey (Türkiye)']
NCT07261826,Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics,Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics,RECRUITING,2025-09-01,2028-06-30,2028-06-30,OBSERVATIONAL,,4000,"['Clostridium Difficile Infection Recurrence', 'Ulcerative Colitis (UC)', 'Crohn Disease (CD)', 'Irritable Bowel Syndrome (IBS)', 'Chronic Functional Constipation', 'Chemotherapy-Induced Colitis', 'PD-1 Associated Enteritis', 'Autism Spectrum Disorder', 'Incomplete Intestinal Obstruction']",Clostridium Difficile Infection Recurrence,Chen QiYi,[],['China']
NCT07260591,VSV-02 Compassionate Use in Advanced Solid Tumors,"A Single-Arm, Open-Label, Compassionate Use Study of VSV-02 Administered Intravenously and Intratumorally in Patients With Advanced Solid Tumors",RECRUITING,2025-09-22,2026-09-30,2027-09-30,INTERVENTIONAL,PHASE1,6,"['Advanced Solid Tumor', 'Melanoma', 'Breast Cancer', 'Lung Cancer', 'Cancer Treatment', 'Immunotherapy']",Advanced Solid Tumor,The First Affiliated Hospital of Xinxiang Medical College,[],['China']
NCT06053164,Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease,Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease,RECRUITING,2025-07-01,2026-09-01,2026-09-01,INTERVENTIONAL,PHASE2,60,['Fibrotic Interstitial Lung Disease'],Fibrotic Interstitial Lung Disease,University of Alberta,['Alberta Boehringer Ingelheim Collaboration'],['Canada']
NCT05061368,"Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD","The Effect of Oral Sildenafil on Exercise Capacity, Dyspnea and Cardiopulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)",RECRUITING,2022-03-01,2025-12,2025-12,INTERVENTIONAL,PHASE2,160,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,University of Alberta,['Canadian Institutes of Health Research (CIHR)'],['Canada']
NCT06831968,Clinical Validation of a Predictive Test for Postpartum Depression,Clinical Validation of a Predictive Test for Postpartum Depression,RECRUITING,2025-03-20,2026-11-30,2028-07-31,OBSERVATIONAL,,500,"['Postpartum Depression (PPD)', 'Pregnancy']",Postpartum Depression (PPD),University of Virginia,[],['United States']
NCT06735131,The Optimal Radioimmunotherapy Combinations for Advanced TNBC,"A Prospective, Multicenter Clinical Trial Exploring the Optimal Combination Strategies of Radiotherapy and Immunotherapy for Advanced Triple-Negative Breast Cancer",RECRUITING,2024-12-20,2026-07,2027-01,INTERVENTIONAL,PHASE2,60,['Triple-Negative Breast Cancer (TNBC)'],Triple-Negative Breast Cancer (TNBC),Sun Yat-sen University,"['West China Hospital', ""First Affiliated Hospital Xi'an Jiaotong University""]",['China']
NCT07187739,Effect of Mediterranean Diet on Nutrition in Parkinson's Disease Patients With Bilateral Subthalamic Deep Brain Stimulation,Investigation of the Effect of the Mediterranean Diet on Nutritional Status in Parkinson's Patients Undergoing Bilateral Subthalamic Nucleus Deep Brain Stimulation,RECRUITING,2025-09-25,2026-03,2026-03,INTERVENTIONAL,NA,24,"['Parkinson Disease', 'Deep Brain Stimulation', 'Deep Brain Stimulation Surgery']",Parkinson Disease,Ankara University,[],['Turkey (Türkiye)']
NCT07261501,An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds,An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds,RECRUITING,2025-11-01,2026-02-01,2026-11-01,INTERVENTIONAL,NA,30,"['Wound Heal', 'Wound Healing Delayed']",Wound Heal,Peking University Third Hospital,[],['China']
NCT06943430,The Effect of Laughter Yoga Applied to Nursing Students on Exam Anxiety and Spirituality,The Effect of Laughter Yoga Applied to Nursing Students on Exam Anxiety and Spirituality,ACTIVE_NOT_RECRUITING,2025-02-24,2026-04-27,2026-04-27,INTERVENTIONAL,NA,36,"['Exam Stress', 'Anxiety', 'Spirituality']",Exam Stress,Kırıkkale University,[],['Turkey (Türkiye)']
NCT07261553,Adherence to Home-Based Exercises in Musculoskeletal Disorders,Adherence to Home-Based Exercise Programs Among Patients With Musculoskeletal Disorders and Its Influencing Factors,RECRUITING,2024-07-18,2026-01-30,2026-02-28,OBSERVATIONAL,,252,"['Exercise Training', 'Adherence, Treatment', 'Musculoskeletal Disease', 'Rehabilitation Exercise', 'Adherence, Patient', 'Home Exercise Program']",Exercise Training,Konya Beyhekim Training and Research Hospital,[],['Turkey (Türkiye)']
NCT07248072,Effect of iPACK and BiFeS Blocks on Quality of Recovery After Total Knee Arthroplasty,"Effects of iPACK and Biceps Femoris Short Head (BiFeS) Blocks Combined With Adductor Canal Block on Quality of Recovery After Total Knee Arthroplasty: A Prospective, Randomized, Double-Blind Clinical Trial",RECRUITING,2025-12-01,2026-05-01,2026-05-02,INTERVENTIONAL,NA,74,"['Knee Osteoarthritis', 'Postoperative Pain Management', 'Total Knee Arthroplasty']",Knee Osteoarthritis,Ataturk University,[],['Turkey (Türkiye)']
NCT06319196,Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma,Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High Risk Melanoma,RECRUITING,2026-02-27,2027-02-15,2030-02-15,INTERVENTIONAL,PHASE2,54,"['Cutaneous Melanoma', 'Melanoma Stage IV', 'Mucosal Melanoma']",Cutaneous Melanoma,"University Health Network, Toronto",[],['Canada']
NCT05355701,A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.,"A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND ANTI TUMOR ACTIVITY OF PF-07799933 (ARRY-440) AS A SINGLE AGENT AND IN COMBINATION THERAPY IN PARTICIPANTS 16 YEARS AND OLDER WITH ADVANCED SOLID TUMORS WITH BRAF ALTERATIONS",RECRUITING,2022-07-05,2027-03-28,2028-09-28,INTERVENTIONAL,PHASE1,156,"['Melanoma', 'Non-Small-Cell Lung Cancer', 'Thyroid Cancer', 'Glioma', 'Advanced Colorectal Cancer (Part 1)']",Melanoma,Pfizer,[],"['Israel', 'United States', 'Canada']"
NCT03819712,Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections,Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections,ACTIVE_NOT_RECRUITING,2019-06-03,2023-12-03,2025-12-31,INTERVENTIONAL,NA,109,['Urinary Tract Infections'],Urinary Tract Infections,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06737562,Medico-economic Evaluation of Immediately Sequential Bilateral Cataract Surgery Compared With Delayed Sequential Cataract Surgery in France,Medico-economic Evaluation of Immediately Sequential Bilateral Cataract Surgery Compared With Delayed Sequential Cataract Surgery in France: a Multicenter Randomized Controlled Trial,RECRUITING,2025-07-03,2028-07,2029-07,INTERVENTIONAL,NA,242,"['Cataract Bilateral', 'Bilateral Cataracts', 'Bilateral Cataract']",Cataract Bilateral,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT06947083,Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma,Phase II Study of Elranatamab as Maintenance Therapy Post Ciltacabtagene-autoleucel(Cilta-cel) in Patients With Clinical High Risk Relapsed Myeloma,RECRUITING,2025-05-27,2029-04,2029-04,INTERVENTIONAL,PHASE2,39,['Myeloma'],Myeloma,H. Lee Moffitt Cancer Center and Research Institute,['Pfizer'],['United States']
NCT05533983,FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy,A Phase II Study of Fecal Microbiota Transplantation With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy,RECRUITING,2023-03-08,2026-08-19,2026-08-19,INTERVENTIONAL,NA,50,['Solid Carcinoma'],Solid Carcinoma,Asan Medical Center,[],['South Korea']
NCT07112378,A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis,A Randomized Study Evaluating 2 Dose Regimens of Dupilumab in Children ≥6 Months of Age Weighing ≥5 to <15 kg With Active Eosinophilic Esophagitis,RECRUITING,2026-01-13,2028-08-21,2028-12-11,INTERVENTIONAL,PHASE3,20,['Eosinophilic Esophagitis (EoE)'],Eosinophilic Esophagitis (EoE),Regeneron Pharmaceuticals,['Sanofi'],['United States']
NCT03375320,Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors,"Randomized, Double-Blinded Phase III Study of CABozantinib Versus Placebo IN Patients With Advanced NEuroendocrine Tumors After Progression on Prior Therapy (CABINET)",ACTIVE_NOT_RECRUITING,2018-10-26,2023-08-23,2026-08-19,INTERVENTIONAL,PHASE3,298,"['Functioning Pancreatic Neuroendocrine Tumor', 'Intermediate Grade Lung Neuroendocrine Neoplasm', 'Locally Advanced Digestive System Neuroendocrine Neoplasm', 'Locally Advanced Digestive System Neuroendocrine Tumor G1', 'Locally Advanced Lung Neuroendocrine Neoplasm', 'Locally Advanced Pancreatic Neuroendocrine Tumor', 'Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm', 'Low Grade Lung Neuroendocrine Neoplasm', 'Lung Neuroendocrine Tumor', 'Lung Neuroendocrine Tumor G2', 'Metastatic Digestive System Neuroendocrine Neoplasm', 'Metastatic Digestive System Neuroendocrine Tumor G1', 'Metastatic Lung Neuroendocrine Neoplasm', 'Metastatic Lung Neuroendocrine Tumor', 'Metastatic Pancreatic Neuroendocrine Neoplasm', 'Metastatic Pancreatic Neuroendocrine Tumor', 'Metastatic Thymus Neuroendocrine Neoplasm', 'Neuroendocrine Neoplasm', 'Neuroendocrine Tumor', 'Neuroendocrine Tumor G2', 'Non-Functioning Pancreatic Neuroendocrine Tumor', 'Pancreatic Serotonin-Producing Neuroendocrine Tumor', 'Thymus Neuroendocrine Tumor', 'Unresectable Digestive System Neuroendocrine Neoplasm', 'Unresectable Digestive System Neuroendocrine Tumor G1', 'Unresectable Lung Neuroendocrine Neoplasm', 'Unresectable Pancreatic Neuroendocrine Neoplasm', 'Unresectable Thymus Neuroendocrine Neoplasm']",Functioning Pancreatic Neuroendocrine Tumor,National Cancer Institute (NCI),[],['United States']
NCT06208657,Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer,Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer,RECRUITING,2024-07-10,2030-12,2035-12,INTERVENTIONAL,PHASE1,90,"['Childhood Cancer', 'Childhood Solid Tumor', 'Childhood Brain Tumor', 'Recurrent Cancer', 'Refractory Cancer']",Childhood Cancer,Australian & New Zealand Children's Haematology/Oncology Group,"['The Hospital for Sick Children', 'Medical Research Future Fund', 'Kazia Therapeutics Limited', 'C17 Council', 'Bristol-Myers Squibb', 'Stand Up To Cancer']","['Canada', 'Australia']"
NCT07251751,Forward Versus Backward Gait Training on Functional Abilities in Children With Spastic Cerebral Palsy,Forward Versus Backward Gait Training on Functional Abilities in Children With Spastic Cerebral Palsy,RECRUITING,2025-11-01,2026-02-01,2026-03-01,INTERVENTIONAL,NA,60,['Spastic Cerebral Palsy'],Spastic Cerebral Palsy,Cairo University,[],['Egypt']
NCT01920932,"Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma","Adcetris (Brentuximab Vedotin), Substituting Vincristine in the OEPA/COPDac Regimen [Treatment Group 3 (TG3) of Euro-Net C1] With Involved Node Radiation Therapy for High Risk Pediatric Hodgkin Lymphoma (HL)",ACTIVE_NOT_RECRUITING,2013-08-12,2020-11-16,2028-05,INTERVENTIONAL,PHASE2,77,"['Stage II Childhood Hodgkin Lymphoma', 'Stage III Childhood Hodgkin Lymphoma', 'Stage IV Childhood Hodgkin Lymphoma']",Stage II Childhood Hodgkin Lymphoma,St. Jude Children's Research Hospital,['Seagen Inc.'],['United States']
NCT05893940,Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients,Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients,RECRUITING,2023-08-14,2026-09-01,2026-09-01,INTERVENTIONAL,NA,75,['Hematopoietic and Lymphoid System Neoplasm'],Hematopoietic and Lymphoid System Neoplasm,Roswell Park Cancer Institute,[],['United States']
NCT05437250,National Acalabrutinib Observational Study,A French Multicentric Observational Study of Acalabrutinib in the Treatment of Chronic Lymphocytic Leukemia Patients,ACTIVE_NOT_RECRUITING,2022-09-13,2026-11-15,2026-11-15,OBSERVATIONAL,,350,['Chronic Lymphocytic Leukemia'],Chronic Lymphocytic Leukemia,AstraZeneca,[],['France']
NCT05609968,Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46),"An Open-label, Multicenter, Phase 3 Randomized, Active-Comparator-Controlled Clinical Study of Pembrolizumab (MK-3475) in Combination With Sacituzumab Govitecan Versus MK-3475 Monotherapy as First-line Treatment in Participants With PD L1 TPS Greater Than or Equal to 50% Metastatic Non-small Cell Lung Cancer (KEYNOTE D46/EVOKE-03)",ACTIVE_NOT_RECRUITING,2023-02-06,2027-01-12,2028-08-23,INTERVENTIONAL,PHASE3,614,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Merck Sharp & Dohme LLC,['Gilead Sciences'],"['Japan', 'China', 'Lithuania', 'Australia', 'Israel', 'Estonia', 'Chile', 'Peru', 'South Korea', 'Thailand', 'Poland', 'Mexico', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Latvia', 'Greece', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Philippines']"
NCT07260695,Odyssey Evaluation in Post LASIK Patients,Study Evaluating Visual Outcomes in Post-Myopic LASIK Patients After Implantation of the Odyssey Intraocular Lens,RECRUITING,2025-08-18,2026-08-18,2026-08-18,INTERVENTIONAL,PHASE4,30,['Cataract'],Cataract,Center For Sight,['Sengi Clinical'],['United States']
NCT07256873,Validity and Reliability of Face-to-Face and Tele-Assessment of Core Stability and Functional Capacity,Comparison of Validity and Reliability of Core Stability and Functional Capacity Assessments Using Face-to-Face and Tele-Assessment Methods in Individuals With Chronic Low Back Pain,RECRUITING,2025-11-30,2026-02-28,2026-03-30,OBSERVATIONAL,,36,['Chronic Low Back Pain (CLBP)'],Chronic Low Back Pain (CLBP),Istinye University,[],['Turkey (Türkiye)']
NCT05678894,Single-center Comparative Study of Variation in Acetabular Anteversion According to Pelvic Tilt in Patients With Femoro-acetabular Impingement and Healthy Volunteers.,Single-center Comparative Study of Variation in Acetabular Anteversion According to Pelvic Tilt in Patients With Femoro-acetabular Impingement and Healthy Volunteers.,RECRUITING,2023-09-28,2026-09-30,2027-09-30,INTERVENTIONAL,NA,140,['Femoro-acetabular Impingement'],Femoro-acetabular Impingement,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT05634369,"A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue","A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue",RECRUITING,2022-11-14,2026-12-01,2027-12-01,INTERVENTIONAL,PHASE1,50,"['Pediatric Sarcoma, Refractory', 'Pediatric Sarcoma, Relapsed']","Pediatric Sarcoma, Refractory",Nationwide Children's Hospital,['National Pediatric Cancer Foundation'],['United States']
NCT07261306,Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis,Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis,RECRUITING,2025-08-29,2025-12-10,2025-12-25,INTERVENTIONAL,EARLY_PHASE1,75,['Psoriasis'],Psoriasis,Lahore General Hospital,[],['Pakistan']
NCT07262307,Evaluation of PEEK Versus Titanium Bar Attachments With Implant Assisted Mandibular Complete Overdenture Fabricated by CAD/CAM Technology,Evaluation of PEEK Versus Titanium Bar Attachments With Implant Assisted Mandibular Complete Overdenture Fabricated by CAD/CAM Technology,ACTIVE_NOT_RECRUITING,2024-05-30,2026-09,2026-09,INTERVENTIONAL,NA,12,['Edentulism in Lower Jaw'],Edentulism in Lower Jaw,Tanta University,[],['Egypt']
NCT06432764,Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.,A Phase Ib Open Label Positron Emission Tomography Study to Assess Changes in Intestinal [11C]AZ14132516 Uptake Following Administration of Multiple Doses of AZD7798 to Patients With Crohn's Disease.,ACTIVE_NOT_RECRUITING,2024-10-16,2026-04-16,2026-04-16,INTERVENTIONAL,PHASE1,9,['Crohn Disease'],Crohn Disease,AstraZeneca,[],['Sweden']
NCT00912041,BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia,BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia,RECRUITING,2009-05,2038-09,2038-12,INTERVENTIONAL,NA,27,"['Tetraplegia', 'Spinal Cord Injuries', 'Amyotrophic Lateral Sclerosis', 'Brain Stem Infarctions', 'Locked in Syndrome', 'Muscular Dystrophy']",Tetraplegia,"Leigh R. Hochberg, MD, PhD.","['National Institute on Deafness and Other Communication Disorders (NIDCD)', 'US Department of Veterans Affairs', 'National Institute of Neurological Disorders and Stroke (NINDS)']",['United States']
NCT07002437,Hypoxia Pathways for Early Recovery After Spinal Cord Injury,Intermittent Hypoxia-Induced Motor Plasticity in Sub-Acute Spinal Cord Injury,RECRUITING,2025-11-20,2026-12,2027-07,INTERVENTIONAL,NA,18,['Spinal Cord Injuries (SCI)'],Spinal Cord Injuries (SCI),University of Florida,['Brooks Rehabilitation'],['United States']
NCT05796752,Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors,Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors,ACTIVE_NOT_RECRUITING,2023-08-02,2026-06,2026-06,INTERVENTIONAL,PHASE2,26,"['Skin-Picking', 'Trichotillomania (Hair-Pulling Disorder)']",Skin-Picking,University of Chicago,[],['United States']
NCT07260851,"Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions","An Open-label, Randomized, Fed, Single-dose, 2-sequence, 2-period, Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of ""DWJ1622"" and Co-administration of ""DWC202313"" and ""DWC202314"" in Healthy Volunteers",RECRUITING,2025-11-05,2026-01-30,2026-05-30,INTERVENTIONAL,PHASE1,40,['Healthy Volunteers'],Healthy Volunteers,Daewoong Pharmaceutical Co. LTD.,[],['South Korea']
NCT05166785,BRInging the Diabetes Prevention Program to GEriatric Populations,BRInging the Diabetes Prevention Program to GEriatric Populations,ACTIVE_NOT_RECRUITING,2022-10-05,2026-05,2026-11,INTERVENTIONAL,NA,238,['Pre Diabetes'],Pre Diabetes,NYU Langone Health,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06675448,In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm,In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm,RECRUITING,2021-01-28,2029-09-10,2030-09-10,OBSERVATIONAL,,50,"['Mitral Regurgitation', 'Valvular Heart Disease', 'Heart Failure']",Mitral Regurgitation,Inova Health Care Services,[],['United States']
NCT04608110,A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome,"A Phase 1, Multi-center, Open-label, Uncontrolled, Dose-escalation Study to Evaluate the Pharmacokinetics of ASTX030 in Patients With Myelodysplastic Syndrome (MDS)",RECRUITING,2020-10-30,2025-12,2026-01,INTERVENTIONAL,PHASE1,40,['Myelodysplastic Syndrome (MDS)'],Myelodysplastic Syndrome (MDS),"Taiho Pharmaceutical Co., Ltd.",[],['Japan']
NCT05039515,A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).,A Phase 2 Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva in Male and Female Paediatric and Adult Participants.,ACTIVE_NOT_RECRUITING,2021-12-01,2029-03-30,2029-03-30,INTERVENTIONAL,PHASE2,113,['Fibrodysplasia Ossificans Progressiva'],Fibrodysplasia Ossificans Progressiva,Clementia Pharmaceuticals Inc.,['Ipsen'],"['Belgium', 'Japan', 'China', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'South Korea', 'Portugal', 'Argentina', 'Sweden', 'Australia']"
NCT04192591,A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE),A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE),ACTIVE_NOT_RECRUITING,2020-01-30,2038-02,2041-02,INTERVENTIONAL,NA,166,['Lumbar Spinal Stenosis'],Lumbar Spinal Stenosis,Boston Scientific Corporation,[],['United States']
NCT04157322,Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis,5-hydroxymethylation Signatures in Plasma Circulating Cell-free DNA as Markers for Tumor Burden and Recurrence in Appendiceal and Colorectal Peritoneal Metastasis,ACTIVE_NOT_RECRUITING,2019-08-26,2027-10-31,2027-10-31,OBSERVATIONAL,,55,"['Colorectal Cancer Stage IV', 'Colorectal Cancer Metastatic', 'Colorectal Cancer, Genetics of', 'Appendix Cancer']",Colorectal Cancer Stage IV,University of Chicago,[],['United States']
NCT05828511,"A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment",Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma,RECRUITING,2023-12-19,2035-11-02,2035-11-02,INTERVENTIONAL,PHASE1,132,['Multiple Myeloma'],Multiple Myeloma,Regeneron Pharmaceuticals,[],"['Spain', 'United States', 'France']"
NCT06925581,A Trial of HRS-6768 in Patients With Advanced Solid Tumors,"A Phase I/II Clinical Trial to Evaluate the Pharmacokinetics, Radiation Dosimetry, Safety and Preliminary Efficacy of HRS-6768 in the Treatment of Patients With Advanced Solid Tumors",RECRUITING,2025-04-24,2026-04,2027-04,INTERVENTIONAL,PHASE1,84,['Advanced Solid Tumors'],Advanced Solid Tumors,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT07108062,Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis,Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis: Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-06-29,2026-03-29,2026-03-29,INTERVENTIONAL,NA,30,"['Enuresis Nocturnal', 'Urinary Incontinence']",Enuresis Nocturnal,Hungarian University of Sports Science,['Kafrelsheikh University'],['Egypt']
NCT06171386,Microneedling vs Dermabrasion for Early Facial Scar Resurfacing,Microneedling vs Dermabrasion for Early Facial Scar Resurfacing,RECRUITING,2024-04-01,2026-04,2026-04,INTERVENTIONAL,NA,30,['Scar'],Scar,Wake Forest University Health Sciences,[],['United States']
NCT05424068,Rehabilitation for People With Advanced Cancer,"Project 3 - Phase II, Preference Based, Randomized Controlled Trial of Group-Based, In Person Versus Virtual, Cancer Rehabilitation for People With Metastatic / Advanced Breast or Colorectal Cancers",ACTIVE_NOT_RECRUITING,2022-12-02,2025-07-30,2026-01-30,INTERVENTIONAL,NA,111,"['Advanced Breast Cancer', 'Advanced Colorectal Cancer', 'Cancer Rehabilitation']",Advanced Breast Cancer,"University Health Network, Toronto",[],['Canada']
NCT07260669,A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis,"A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Investigate the Efficacy and Safety of 2 Doses of Vipoglanstat in Patients With Moderate to Severe Endometriosis-related Pain - the NOVA Trial",RECRUITING,2025-10-15,2027-06,2027-06,INTERVENTIONAL,PHASE2,190,['Endometriosis'],Endometriosis,Gesynta Pharma AB,[],['United Kingdom']
NCT06698042,A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84),"A Phase 3 Randomized, Open-label Clinical Study to Evaluate the Pharmacokinetics and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Versus Intravenous Pembrolizumab, in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer With PD-L1 TPS 50% or Greater",ACTIVE_NOT_RECRUITING,2024-11-21,2026-06-22,2030-02-11,INTERVENTIONAL,PHASE3,160,"['Lung Cancer', 'Non-Small Cell Lung Cancer']",Lung Cancer,Merck Sharp & Dohme LLC,[],"['Japan', 'Turkey (Türkiye)', 'China', 'United States', 'Spain', 'Guatemala', 'Peru', 'Romania', 'South Korea', 'United Kingdom', 'Poland', 'Germany']"
NCT06847542,A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD,"A Phase IIIb, Multicenter, Single-arm Study Assessing the Effectiveness, Safety and Patient Reported Outcomes of a 36-week Refill Exchange Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration",RECRUITING,2025-11-27,2028-09-12,2028-10-12,INTERVENTIONAL,PHASE3,250,['Neovascular Age-related Macular Degeneration'],Neovascular Age-related Macular Degeneration,Hoffmann-La Roche,"['Genentech, Inc.']","['Austria', 'France', 'South Korea', 'Greece', 'Poland', 'Germany']"
NCT06956183,Effect of Vestibular Exercises on Post-Stroke Fatigue,"The Effect of Vestibular Exercise Program on Fatigue, Balance and Gait in Patients With Stroke",RECRUITING,2025-06-15,2026-02-26,2026-03-26,INTERVENTIONAL,NA,30,['Stroke'],Stroke,Hacettepe University,[],['Turkey (Türkiye)']
NCT07260305,A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients,"A Phase I , Open Label, Multi-center Study to Assess the Safety and Tolerability of KGX101 Mono and Combo Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients",RECRUITING,2024-11-27,2027-01-01,2027-03-30,INTERVENTIONAL,PHASE1,57,['Advanced or Metastatic Solid Tumors'],Advanced or Metastatic Solid Tumors,Kangabio AUSTRALIA LTD PTY,[],['China']
NCT06051578,Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation,Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation,ACTIVE_NOT_RECRUITING,2023-09-08,2025-05-22,2026-05-01,OBSERVATIONAL,,50,"['Hernia, Ventral', 'Hernia, Abdominal', 'Hernia Abdominal Wall']","Hernia, Ventral",The Cleveland Clinic,[],['United States']
NCT05878769,A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD),A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease,RECRUITING,2023-06-28,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE3,2000,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,Hoffmann-La Roche,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'China', 'Kenya', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'Peru', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Latvia', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT06963346,Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents,HERO Trial: Phase I Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents in Localized Bladder Cancer,RECRUITING,2025-06-24,2028-04,2028-04,INTERVENTIONAL,PHASE1,12,['Bladder Cancer'],Bladder Cancer,H. Lee Moffitt Cancer Center and Research Institute,['AstraZeneca'],['United States']
NCT05536908,Evaluating Supplementing Residential Substance Use Treatment With Written Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD) and Substance Use Disorders (SUD),Evaluating the Impact of Supplementing Residential Substance Use Treatment With Written Exposure Therapy for Veterans With Co-Occurring PTSD and Substance Use Disorders,RECRUITING,2023-06-22,2026-01-05,2026-01-15,INTERVENTIONAL,NA,70,"['PTSD', 'Substance Use Disorders']",PTSD,VA Office of Research and Development,"['VA Boston Healthcare System', 'Center for Biostatistics and Health Data Science']",['United States']
NCT07261878,Treatment of Intrabony Defect in Patient With Periodontitis Stage III by Using I-PRF and Xenograft,Injectable Platelet Rich Fibrin (I-PRF) With Xenograft in Intrabony Defects of Periodontitis Patient Stage III Versus Xenograft Alone,ACTIVE_NOT_RECRUITING,2025-02-17,2025-02-18,2026-12-17,INTERVENTIONAL,NA,20,"['Intrabony Defect', 'Intrabony Defects in Chronic Periodontitis']",Intrabony Defect,Al-Azhar University,[],['Egypt']
NCT06411691,KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer,Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Adenocarcinoma,RECRUITING,2025-06-24,2028-03-01,2029-07-01,INTERVENTIONAL,PHASE1,54,"['Colorectal Cancer', 'Pancreatic Cancer']",Colorectal Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Agenus Inc.', 'Private Philanthropic Funds', 'National Cancer Institute (NCI)', 'United States Department of Defense']",['United States']
NCT05165160,Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis,Local Undertaking of Resected Non-small Cell Lung Cancer by Generating a Residual Disease Outline Based on Circulating Cell-free DNA,ACTIVE_NOT_RECRUITING,2022-02-15,2025-07-15,2026-12-31,INTERVENTIONAL,NA,133,['Nsclc'],Nsclc,"University Hospital, Montpellier",[],['France']
NCT06574789,Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC),Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC),RECRUITING,2024-10-29,2028-06,2028-12,INTERVENTIONAL,PHASE2,232,['Cytomegalovirus Viraemia'],Cytomegalovirus Viraemia,Murdoch Childrens Research Institute,[],"['New Zealand', 'Australia']"
NCT06084936,A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma,"A Phase III, Open-Label, Multicenter Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma",RECRUITING,2023-10-22,2027-02-26,2027-09-30,INTERVENTIONAL,PHASE3,182,['Lymphoma'],Lymphoma,Hoffmann-La Roche,[],"['Brazil', 'China', 'United States', 'France', 'Puerto Rico', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Sweden', 'Australia']"
NCT06864364,Effect of Visualization of Functional Milk Efficacy on Perceived Benefits,Effect of Continuous Glucose Monitoring on Perceived Benefits of a Milk With Mulberry Leave Extract in Non-diabetic Adult Chinese Population,RECRUITING,2025-02-24,2025-09-15,2025-12-30,INTERVENTIONAL,NA,184,"['Healthy', 'Prediabetes', 'Asian', 'Adult']",Healthy,Société des Produits Nestlé (SPN),"['Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University', 'Sun Yat-sen University']",['China']
NCT03945552,Pediatric Parenting Support in Flint,Universal Strengths-Based Parenting Support in Pediatric Health Care for Families With Very Young Children Following the Flint Water Crisis,ACTIVE_NOT_RECRUITING,2019-07-23,2027-05-10,2027-05-10,INTERVENTIONAL,NA,486,"['Healthy', 'Family Research']",Healthy,NYU Langone Health,"['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'Michigan State University', 'University of Michigan', 'Northwestern University']",['United States']
NCT06957769,"Biological Impacts of Rising Temperatures on Maternal, Fetal, and Newborn Health: A Cohort Study (BIRTH Cohort)","Biological Impacts of Rising Temperatures on Maternal, Fetal, and Newborn Health: A Cohort Study (BIRTH Cohort)",RECRUITING,2025-05-07,2027-06-30,2028-06-30,OBSERVATIONAL,,6000,"['Low Birth Weight Baby', 'Small for Gestational Age (SGA)', 'Preterm Birth', 'Pregnancy Complications', 'Birth Outcome, Adverse', 'Heat Strain', 'Infant Morbidity', 'Infant Mortality', 'Neonatal Mortality']",Low Birth Weight Baby,Aga Khan University,[],['Pakistan']
NCT06908863,Correlations Between Fine Manual Motor Skills and Speech Articulation,Cortical Correlations Between Fine Manual Motor Skills and Speech Articulation : Pilot Study,RECRUITING,2025-10-13,2026-01-01,2026-05-01,INTERVENTIONAL,NA,20,['Correlations Between Cerebral Motor Control During a Manual Task and During an Articulatory Task'],Correlations Between Cerebral Motor Control During a Manual Task and During an Articulatory Task,Centre Hospitalier Universitaire de Nice,[],['France']
NCT05537740,"A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors","First-in-human Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the Anti-CCR8 Antibody BAY 3375968 as Monotherapy and in Combination With Pembrolizumab in Participants With Selected Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2022-10-11,2026-07-07,2027-05-04,INTERVENTIONAL,PHASE1,129,['Advanced Solid Tumors'],Advanced Solid Tumors,Bayer,[],"['Singapore', 'Belgium', 'China', 'United States', 'France', 'Spain', 'Canada', 'United Kingdom']"
NCT04626635,A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers,A Phase 1/2 Study of REGN7075 (EGFRxCD28 Costimulatory Bispecific Antibody) in Combination With Cemiplimab in Patients With Advanced Solid Tumors,RECRUITING,2020-12-21,2026-08-19,2026-12-12,INTERVENTIONAL,PHASE1,933,['Advanced Solid Tumors'],Advanced Solid Tumors,Regeneron Pharmaceuticals,[],"['Israel', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'France', 'Spain', 'Poland']"
NCT05132491,Benefits of Coding Training on Young Adults With Developmental Disabilities,Evaluation of a Technology Early Career Preparation Intervention (TECH-Prep) for African American Young Adults With Developmental Disabilities,ACTIVE_NOT_RECRUITING,2021-03-23,2025-06-30,2026-01,INTERVENTIONAL,NA,94,['Developmental Disability'],Developmental Disability,"University of Wisconsin, Madison",['Virginia Commonwealth University'],['United States']
NCT03564340,Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers,"A Phase 1/2 Study of REGN4018 (Ubamatamab), a MUC16×CD3 Bispecific Antibody, Administered Alone or in Combination With Cemiplimab in Patients With Recurrent Ovarian Cancer or Other Recurrent MUC16+ Cancers",RECRUITING,2018-05-21,2026-02-01,2027-01-31,INTERVENTIONAL,PHASE1,890,"['Recurrent Ovarian Cancer', 'Recurrent Fallopian Tube Cancer', 'Recurrent Primary Peritoneal Cancer', 'Recurrent Endometrial Cancer', 'Endometrial Cancer', 'Low-grade Serous Ovarian Cancer']",Recurrent Ovarian Cancer,Regeneron Pharmaceuticals,[],"['Israel', 'Belgium', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Australia']"
NCT07260578,Safety and Efficacy of Ellacor® Micro-coring® Following Best Practices on Technique and Post-Procedural Care,Safety and Efficacy of Ellacor Micro-coring Following Best Practices on Technique and Post-Procedural Care,RECRUITING,2025-12,2026-03,2026-03,INTERVENTIONAL,NA,24,"['Best Practices', 'Ellacor', 'Micro-coring Post Care', 'Ellacor Post Care']",Best Practices,"Cytrellis Biosystems, Inc.",[],['United States']
NCT05757791,Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD),"A Pilot, Phase II, Open-Label, Single-Center Study of Sodium-Glucose Cotransporter-2 Inhibitor Empagliflozin in Major Depressive Disorder",RECRUITING,2023-03-17,2026-04,2026-05,INTERVENTIONAL,PHASE2,16,['Major Depressive Disorder'],Major Depressive Disorder,NYU Langone Health,['American Society of Clinical Psychopharmacology'],['United States']
NCT06162676,Game-Based Intervention to Promote HPV Vaccination,Pilot Testing of a Game-Based Intervention to Promote HPV Vaccination in Families With Unvaccinated Children,ACTIVE_NOT_RECRUITING,2024-04-01,2025-07-30,2026-02-28,INTERVENTIONAL,NA,131,"['HPV Infection', 'Vaccine-Preventable Diseases']",HPV Infection,Michigan State University,['Arizona State University'],['United States']
NCT07214350,Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation,Sex Differences in Barriers and Participation in Physical Activity During and Following Cardiac Rehabilitation,RECRUITING,2025-12-02,2029-12,2030-08,OBSERVATIONAL,,150,"['Cardiac Rehabilitation', 'Heart Disease']",Cardiac Rehabilitation,Duke University,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07262190,NavSTAR Implementation Effectiveness Trial Across a Health System,Implementing a Patient Navigation Intervention Across a Health System to Improve Outcomes for Patients With Opioid Use Disorder,RECRUITING,2025-10-27,2029-01-01,2029-08-01,INTERVENTIONAL,NA,720,['Opioid Use Disorder'],Opioid Use Disorder,"Friends Research Institute, Inc.","['Thomas Jefferson University', 'National Institute on Drug Abuse (NIDA)']",['United States']
NCT07261722,Collaborative Opportunities for Reducing Alcohol and Sexual Violence Together,Harnessing the Power of Military Peers to Reduce Sexual Violence and Risky Drinking in Service Members,RECRUITING,2025-10-10,2026-03,2026-04,INTERVENTIONAL,NA,24,"['Sexual Violence', 'Behavior Change', 'Military Training']",Sexual Violence,State University of New York at Buffalo,[],['United States']
NCT07261956,Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia,Usefulness of Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia,RECRUITING,2025-08-25,2025-12-31,2026-01-31,INTERVENTIONAL,NA,202,"['Pulmonary Edema - Acute', 'Preeclampsia']",Pulmonary Edema - Acute,"Saint Thomas Hospital, Panama",[],['Panama']
NCT07043426,Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships,THRIVE-DM: Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships,RECRUITING,2025-12,2027-04,2027-04,INTERVENTIONAL,NA,900,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",Boston Medical Center,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT04835831,Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease,"Interest of APA in Fatty Liver Disease Evaluation of Efficacy and Adherence to an Adapted Physical Activity (APA) Program in Patients With Metabolic Fatty Liver Disease, Open-label, Multicenter, Multicenter Pilot Study",ACTIVE_NOT_RECRUITING,2021-09-15,2022-06-15,2026-01-09,INTERVENTIONAL,NA,115,['Non-Alcoholic Fatty Liver Disease (NAFLD'],Non-Alcoholic Fatty Liver Disease (NAFLD,Centre Hospitalier Universitaire de Nice,[],['France']
NCT05076682,Reverse Triple Negative Immune Resistant Breast Cancer,Reverse Triple Negative Immune Resistant Breast Cancer,RECRUITING,2022-06-30,2026-12-31,2027-03-31,INTERVENTIONAL,PHASE2,80,['Triple-negative Breast Cancer'],Triple-negative Breast Cancer,Fudan University,[],['China']
NCT07262450,Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms,Real-word Study to Assess Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms,RECRUITING,2025-08-27,2026-08,2026-08,INTERVENTIONAL,NA,1065,"['URTI', 'Bronchiolitis', 'COVID - 19', 'Allergic Rhinitis', 'Chronic Rhinosinusitis (CRS)', 'Post-surgery']",URTI,Laboratoire de la Mer,['EVAMED'],['France']
NCT07260513,"A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in Subjects With Advanced Solid Tumor.","A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in Subjects With Advanced Solid Tumor.",ACTIVE_NOT_RECRUITING,2025-03-27,2028-12-31,2030-12-31,INTERVENTIONAL,PHASE1,126,['Advanced Solid Tumor Cancer'],Advanced Solid Tumor Cancer,"Suzhou Genhouse Bio Co., Ltd.","['GCP ClinPlus Co., Ltd.', 'Jiaxing Yidixi Computer Technology Co., Ltd', 'Nanjing CR Medicon Technology Co., Ltd.', 'Nanjing Shihejiyin Technology, Inc.', 'Fudan University', 'Peking Union Medical College Hospital']",['China']
NCT06675097,Assessment of the Impact of Intestinal Gas Emission Quality on the Postoperative Course After Abdominal Surgery,Assessment of the Impact of Intestinal Gas Emission Quality on the Postoperative Course After Abdominal Surgery: Single-center Prospective Study - FLATQUAL- Abdominal Surgery and Gas Transit,RECRUITING,2025-01-31,2026-01,2026-10,OBSERVATIONAL,,200,"['Postoperative Complication', 'Recovery, Physiological']",Postoperative Complication,"University Hospital, Angers",[],['France']
NCT06935110,Feasibility of Tracheobronchial Defect Reconstruction Using Allogenic Aortic Patch,Feasibility of Tracheobronchial Defect Reconstruction Using Allogenic Aortic Patch,RECRUITING,2025-09-15,2029-07-31,2029-10,INTERVENTIONAL,NA,10,"['Trachea Diseases', 'Airway Remodeling', 'Reconstruction Surgery']",Trachea Diseases,National Taiwan University Hospital,[],['Taiwan']
NCT06621979,Evaluation of the Fundoplicature of the Excluded Stomach Post Omega Bypass,Evaluation of Post-Omega Bypass Excluded Stomach Fundoplication to Treat Disabling Gastroesophageal Reflux Disease Resistant to Medical Treatment and Requiring Surgery,RECRUITING,2025-11-24,2026-12-31,2026-12-31,INTERVENTIONAL,NA,17,"['Bypass, Gastric']","Bypass, Gastric",GCS Ramsay Santé pour l'Enseignement et la Recherche,['Euraxi Pharma'],['France']
NCT07073547,"A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma","A Modular, Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120, a Dual-targeting Autologous Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19 in Participants With Multiple Myeloma",RECRUITING,2025-07-31,2028-05-26,2028-05-26,INTERVENTIONAL,PHASE1,64,['Multiple Myeloma'],Multiple Myeloma,AstraZeneca,[],['United States']
NCT04982588,Evolut PRO China Clinical Study,Medtronic CoreValve™ Evolut™ PRO System China Clinical Study,ACTIVE_NOT_RECRUITING,2021-07-17,2023-03-17,2028-05-15,INTERVENTIONAL,NA,52,"['Severe, Symptomatic Aortic Stenosis']","Severe, Symptomatic Aortic Stenosis",Medtronic Cardiovascular,[],['China']
NCT07214961,Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC),"Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biodistribution and Antitumour Activity of the Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer",RECRUITING,2025-11-03,2027-11-03,2028-11-03,INTERVENTIONAL,PHASE1,80,"['Prostate Cancer (CRPC)', 'Metastatic Castrate Resistant Prostate Cancer (mCRPC)']",Prostate Cancer (CRPC),ARTBIO Inc.,[],['United States']
NCT06194929,"Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma","Phase 1b/2 Trial of Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma",RECRUITING,2024-03-20,2028-01-15,2030-01-15,INTERVENTIONAL,PHASE1,33,"['Cutaneous Melanoma', 'Brain Metastases']",Cutaneous Melanoma,University of Utah,"['Verastem, Inc.']",['United States']
NCT04071236,Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy,"A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, &Amp; Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)",RECRUITING,2020-10-14,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE1,90,"['Metastatic Castration-Resistant Prostate Carcinoma', 'Metastatic Malignant Neoplasm in the Bone', 'Metastatic Malignant Neoplasm in the Lymph Nodes', 'Stage IVB Prostate Cancer AJCC v8']",Metastatic Castration-Resistant Prostate Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT02886611,Limbal Stem Cell Deficiency of Genetic Origin: Genotype-phenotype Correlation,,RECRUITING,2015-12-15,2025-12,2026-12,OBSERVATIONAL,,60,['Limbus Corneae'],Limbus Corneae,Fondation Ophtalmologique Adolphe de Rothschild,[],['France']
NCT03897881,An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942),A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma (KEYNOTE- 942),ACTIVE_NOT_RECRUITING,2019-07-18,2032-11-30,2032-11-30,INTERVENTIONAL,PHASE2,267,['Melanoma'],Melanoma,"ModernaTX, Inc.",['Merck Sharp & Dohme LLC'],"['United States', 'Australia']"
NCT06815133,Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months,Multicenter Retrospective Study on the Short- and Medium-Term Efficacy and Tolerance of Zilucoplan Therapy in a Cohort of French Patients With Anti-AChR Myasthenia Gravis,RECRUITING,2025-03-01,2026-02-01,2026-03-03,OBSERVATIONAL,,55,['Myasthenia Gravis'],Myasthenia Gravis,Centre Hospitalier Universitaire de Nice,[],['France']
NCT07180212,Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer,"The Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer: An Open-Label, Randomized Controlled, Multicenter Clinical Study (Truce-LB02)",RECRUITING,2025-07-01,2027-07-01,2027-09-01,INTERVENTIONAL,NA,360,"['Bladder Cancer', 'Liquid Biopsy', 'Cystoscopy']",Bladder Cancer,Tianjin Medical University Second Hospital,[],['China']
NCT05590702,French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings,French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings. A FILO Study.,ACTIVE_NOT_RECRUITING,2022-11-11,2025-04-18,2032-12-01,OBSERVATIONAL,,1000,['CLL/SLL'],CLL/SLL,French Innovative Leukemia Organisation,"['AbbVie', 'AstraZeneca', 'BeiGene', 'Janssen-Cilag Ltd.']",['France']
NCT07260110,"A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States",TEPLIzumab: QUality of Life Evaluation During Stage Transition,RECRUITING,2025-10-31,2030-12-03,2030-12-03,OBSERVATIONAL,,550,['Type 1 Diabetes'],Type 1 Diabetes,Sanofi,[],['United States']
NCT04209686,"Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma","Phase 2 Study of Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma",ACTIVE_NOT_RECRUITING,2020-07-31,2028-09-01,2028-09-01,INTERVENTIONAL,PHASE2,36,['Advanced Gastric Adenocarcinoma'],Advanced Gastric Adenocarcinoma,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Merck Sharp & Dohme LLC'],['United States']
NCT07013929,Spyral InSight Study,Spyral InSight Early Clinical Feasibility Study,RECRUITING,2025-06-09,2027-02-28,2027-07-01,INTERVENTIONAL,NA,19,"['Hypertension', 'Vascular Diseases', 'Cardiovascular Diseases']",Hypertension,Medtronic Vascular,[],['Ireland']
NCT05331183,Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del,A Phase 3 Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes,ACTIVE_NOT_RECRUITING,2022-11-23,2027-04-06,2027-04-06,INTERVENTIONAL,PHASE3,297,['Cystic Fibrosis'],Cystic Fibrosis,Vertex Pharmaceuticals Incorporated,[],"['Belgium', 'Hungary', 'Netherlands', 'Norway', 'Austria', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Czechia', 'Poland', 'Portugal', 'Sweden', 'Germany']"
NCT04600973,Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection,The BASIC Trial: Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection,RECRUITING,2021-07-01,2026-06-30,2026-06-30,INTERVENTIONAL,NA,6000,['Infection'],Infection,Trustees of Dartmouth College,"['Mayo Clinic', 'Georgetown University']",['United States']
NCT05724173,Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia,Single Neuron Population Dynamics in Human Speech Motor Cortex for a Speech Prosthesis,RECRUITING,2023-10-18,2026-07,2026-12,INTERVENTIONAL,NA,3,"['Anarthria', 'Dysarthria', 'Tetraplegia', 'Spinal Cord Injuries', 'Amyotrophic Lateral Sclerosis', 'Brain Stem Infarctions', 'Locked in Syndrome', 'Muscular Dystrophies']",Anarthria,"Leigh R. Hochberg, MD, PhD.",['National Institute on Deafness and Other Communication Disorders (NIDCD)'],['United States']
NCT02562235,Riociguat in Children With Pulmonary Arterial Hypertension (PAH),"Open-label, Individual Dose Titration Study to Evaluate Safety, Tolerability and Pharmacokinetics of Riociguat in Children From 6 to Less Than 18 Years of Age With Pulmonary Arterial Hypertension (PAH)",ACTIVE_NOT_RECRUITING,2015-10-29,2020-03-07,2027-08-03,INTERVENTIONAL,PHASE3,24,"['Hypertension, Pulmonary']","Hypertension, Pulmonary",Bayer,['Merck Sharp & Dohme LLC'],"['Japan', 'Hungary', 'Turkey (Türkiye)', 'Mexico', 'Taiwan', 'Italy', 'Colombia', 'Poland', 'Germany']"
NCT06899607,Fibre and Mental Wellbeing Feasibility Trial,Bridging the Fibre Gap: A Pre-post Single-arm Feasibility Trial on Increased Fibre Intake and Mental Wellbeing,ACTIVE_NOT_RECRUITING,2025-05-01,2027-09-05,2027-09-05,INTERVENTIONAL,NA,40,"['Affect (Mental Function)', 'Sleep', 'Anxiety', 'Stress']",Affect (Mental Function),University of Reading,[],['United Kingdom']
NCT03991897,Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?,Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?,RECRUITING,2025-10-01,2028-02-01,2028-08-01,INTERVENTIONAL,NA,81,"['Lymphedema', 'Ketogenic Dieting', 'Ketone Ester Supplement']",Lymphedema,Universitaire Ziekenhuizen KU Leuven,[],['Belgium']
NCT06001788,Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia,Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-rearranged or NPM1-mutant Relapsed/Refractory Acute Myeloid Leukemia,RECRUITING,2024-02-22,2026-08,2027-08,INTERVENTIONAL,PHASE1,171,"['AML', 'AML With Mutated NPM1', 'Hematologic Malignancy', 'KMT2Ar', 'NPM1 Mutation', 'MLL Rearrangement', 'Leukemia', 'Acute Myeloid Leukemia', 'Leukemia, Myeloid', 'Leukemia, Myeloid, Acute', 'Acute Leukemia', 'Neoplasms by Histologic Type']",AML,"Kura Oncology, Inc.",[],"['Spain', 'United States', 'Italy']"
NCT05934305,Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders,Mitigating the Impact of Stigma and Shame as a Barrier to Viral Suppression Among People Living With HIV and Substance Use Disorders,RECRUITING,2025-03-20,2027-07,2028-07,INTERVENTIONAL,NA,256,"['Hiv', 'Substance Use Disorders']",Hiv,Boston University,"['National Institute on Drug Abuse (NIDA)', 'Florida International University']",['United States']
NCT06237803,European Myeloma Network (EMN) Sample Project,EMN Prospective Sample Collection Project,RECRUITING,2022-12-21,2037-12,2037-12,OBSERVATIONAL,,6000,"['Multiple Myeloma', 'Smoldering Multiple Myeloma', 'Plasma Cell Leukemia', 'Extramedullary Myeloma', 'MGUS']",Multiple Myeloma,European Myeloma Network B.V.,"['Janssen, LP']","['Belgium', 'Austria', 'Switzerland', 'Ireland', 'Italy', 'Czechia', 'Greece', 'Portugal', 'Serbia', 'Australia']"
NCT02869217,Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors,Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors,ACTIVE_NOT_RECRUITING,2016-09,2026-11,2026-11,INTERVENTIONAL,PHASE1,22,"['NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients', 'Synovial Sarcoma', 'Melanoma', 'Esophageal Cancer', 'Ovarian Cancer', 'Lung Cancer', 'Bladder Cancer', 'Liver Cancer']",NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients,"University Health Network, Toronto",['Takara Bio Inc.'],['Canada']
NCT06997822,Integrated Recovery Program for Critical Illness,Integrated Critical Illness Aftercare and Recovery Enhancement (I-CARE) Program,RECRUITING,2025-11-03,2028-07-31,2028-12-31,INTERVENTIONAL,NA,240,['ICU Survivors'],ICU Survivors,National Taiwan University Hospital,[],['Taiwan']
NCT04876131,Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children,CHOICE UTI - Clinical Efficacy of Single Dose (Daily) IV Antibiotics Followed by 2 Days Oral Antibiotics Compared to 3 Doses (Daily) IV Antibiotics for Children With Complicated Urinary Tract Infections: a Multicentre Randomised Trial,RECRUITING,2022-05-30,2028-05-16,2028-05-16,INTERVENTIONAL,PHASE4,452,"['Complicated Urinary Tract Infection', 'Infection', 'Pediatric Infectious Disease']",Complicated Urinary Tract Infection,Murdoch Childrens Research Institute,"[""Royal Children's Hospital""]","['New Zealand', 'Australia']"
NCT07121556,Treatment of Symptomatic Bilateral Knee Osteoarthritis: Intra-articular Injection of Autologous Microfragmented Adipose Tissue and Hyaluronic Acid vs Intra Articular Injection of Autologous Microfragmented Adipose Tissue,Randomized Double- Blind Study on the Treatment of Symptomatic Bilateral Knee Osteoarthritis: Intra-articular Injection of Autologous Microfragmented Adipose Tissue and Hyaluronic Acid vs Intra Articular Injection of Autologous Microfragmented Adipose Tissue. Double-Blind Randomized Controlled Clinical Trial,RECRUITING,2025-09-29,2030-09,2030-09,INTERVENTIONAL,NA,100,['Osteoarthritis Knees Both'],Osteoarthritis Knees Both,Istituto Ortopedico Rizzoli,[],['Italy']
NCT07090460,Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.,Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.,RECRUITING,2025-11-22,2026-08,2026-09,OBSERVATIONAL,,30,['Acute Respiratory Distress Syndrome (ARDS)'],Acute Respiratory Distress Syndrome (ARDS),Centre Hospitalier de la côte Basque,[],['France']
NCT02259621,"Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC","Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable Non-Small-Cell Lung Cancer.",ACTIVE_NOT_RECRUITING,2014-09,2022-10-14,2027-10,INTERVENTIONAL,PHASE2,39,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Bristol-Myers Squibb'],"['United States', 'Canada']"
NCT06600542,Inari VISION Registry,Inari VISION Registry,RECRUITING,2025-03-07,2029-12-31,2029-12-31,OBSERVATIONAL,,1000,['Pulmonary Embolism'],Pulmonary Embolism,Inari Medical,[],"['United Kingdom', 'Portugal']"
NCT03541720,18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma,18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma,ACTIVE_NOT_RECRUITING,2019-04-30,2027-01-01,2028-07-01,INTERVENTIONAL,EARLY_PHASE1,13,"['Neuroblastoma', 'Pheochromocytoma']",Neuroblastoma,St. Jude Children's Research Hospital,[],['United States']
NCT05576207,BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR),Balanced Energy and Protein (BEP) Supplementation Research in Bangladesh (JiVitA-BEP IR),ACTIVE_NOT_RECRUITING,2022-10-15,2025-04-23,2026-05-31,INTERVENTIONAL,NA,3390,"['Fetal Growth Retardation', 'Low Birth Weight', 'Preterm Birth', 'Gestational Weight Gain', 'Anemia of Pregnancy', 'Stunting', 'Pregnancy Complications']",Fetal Growth Retardation,Johns Hopkins Bloomberg School of Public Health,"['Bill and Melinda Gates Foundation', 'BRAC James P Grant School of Public Health, BRAC University']",['Bangladesh']
NCT06989112,"DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer","DESTINY-Endometrial01: An Open-Label, Sponsor-Blinded, Randomized, Controlled, Multicenter, Phase III Study of Trastuzumab Deruxtecan (T-DXd) Plus Rilvegostomig or Pembrolizumab vs Chemotherapy Plus Pembrolizumab as First-Line Therapy of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR), Primary Advanced or Recurrent Endometrial Cancer",RECRUITING,2025-03-27,2029-01-19,2031-02-19,INTERVENTIONAL,PHASE3,600,['Endometrial Cancer'],Endometrial Cancer,AstraZeneca,"['Daiichi Sankyo Co., Ltd.', 'Gynecologic Oncology Group (GOG) Foundation Inc.', 'European Network for Gynaecological Oncological Trial groups(ENGOT)']","['Japan', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Finland', 'Denmark', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy']"
NCT07181681,A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors,"A Phase 1a/b Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-C0902, an Antibody-Drug Conjugate Targeting Epidermal Growth Factor Receptor (EGFR) × Mesenchymal-Epithelial Transition (MET), Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors",RECRUITING,2025-11-10,2027-11-01,2027-11-01,INTERVENTIONAL,PHASE1,63,"['Solid Tumors', 'Advanced Solid Tumor']",Solid Tumors,BeiGene,[],"['United States', 'Australia']"
NCT07201194,Holistic Acupuncture for Patients With Chemotherapy Induced Nausea,HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea,RECRUITING,2025-11-17,2026-04,2026-12-31,INTERVENTIONAL,NA,90,"['Breast Cancer', 'Prostate Cancer', 'Lung Cancer', 'Gynaecologic Cancer', 'Colorectal Cancer', 'Pancreatic Cancer Metastatic']",Breast Cancer,Vejle Hospital,[],['Denmark']
NCT06644560,A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients,A Nutrition and Exercise Prehabilitation Intervention on Inflammatory Biomarkers in American Indian Cancer Patients,RECRUITING,2025-11-13,2027-12-31,2028-06-30,INTERVENTIONAL,NA,30,"['Cancer', 'Obesity']",Cancer,University of Arizona,['National Cancer Institute (NCI)'],['United States']
NCT06863142,"Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults","VRC 328: A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults",RECRUITING,2025-04-28,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE1,45,"['Influenza Prevention', 'Seasonal Influenza']",Influenza Prevention,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT03368742,Microdystrophin Gene Transfer Study in Adolescents and Children With DMD,"A Randomized, Controlled, Open-label, Single-ascending Dose, Phase I/II Study to Investigate the Safety and Tolerability, and Efficacy of Intravenous SGT-001 in Male Adolescents and Children With Duchenne Muscular Dystrophy",ACTIVE_NOT_RECRUITING,2017-12-06,2026-10-15,2026-10-15,INTERVENTIONAL,PHASE1,12,['Duchenne Muscular Dystrophy'],Duchenne Muscular Dystrophy,Solid Biosciences Inc.,[],['United States']
NCT03466151,RESOLUTE ONYX China RCT Study,A Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in Comparison With the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Subjects Eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) in China,ACTIVE_NOT_RECRUITING,2018-04-12,2021-02-12,2026-04-30,INTERVENTIONAL,NA,550,"['Ischemic Heart Disease', 'Stenotic Coronary Lesion', 'Cardiovascular Diseases', 'Arteriosclerosis', 'Coronary Artery Disease']",Ischemic Heart Disease,Medtronic Vascular,[],['China']
NCT06375837,Comparative Evaluation of an Alkasite-based Restorative Material and Two Different Resin Composites,Comparative Evaluation of an Alkasite-based Restorative Material and Two Different Resin Composites in Non-carious Cervical Lesions,ACTIVE_NOT_RECRUITING,2024-04-15,2024-06-15,2026-06-15,INTERVENTIONAL,NA,33,['Tooth Diseases'],Tooth Diseases,Hacettepe University,[],['Turkey (Türkiye)']
NCT06294795,Toric Intraocular Lens Implantation in Pediatric Cataract,A Prospective Randomized Controlled Trial of Toric Intraocular Lens Implantation in Pediatric Cataractous Eyes,ACTIVE_NOT_RECRUITING,2024-03-01,2025-02-05,2026-03-02,INTERVENTIONAL,NA,40,"['Cataract Congenital', 'Astigmatism', 'IOL']",Cataract Congenital,Kazakh Eye Research Institute,[],['Kazakhstan']
NCT05879419,Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases,"Efficacy, Immunogenicity and Safety of Recombinant Vaccine Against Herpes Zoster (RZV or SHINGRIX®) in Patients With Autoimmune Rheumatic Diseases",ACTIVE_NOT_RECRUITING,2023-05-23,2025-12-01,2032-06-30,INTERVENTIONAL,PHASE4,2005,"['Rheumatoid Arthritis', 'Spondylitis, Ankylosing', 'Spondyloarthritis', 'Systemic Lupus Erythematosus', ""Sjogren's Syndrome"", 'Systemic Sclerosis', 'Idiopathic Inflammatory Myopathies', 'Vasculitis, Systemic', 'Juvenile Idiopathic Arthritis', 'Dermatomyositis, Juvenile', 'Behçet Disease']",Rheumatoid Arthritis,University of Sao Paulo General Hospital,['GlaxoSmithKline'],['Brazil']
NCT06980701,Improving Oral and Systemic Health in Individuals With Prediabetes Through Personalized Oral Hygiene Advice Provided by Dentists or by AI,Improving Oral and Systemic Health in Individuals With Prediabetes Through Personalized Oral Hygiene Advice Provided by Dentists or by Artificial Intelligence: A Randomized Clinical Trial,RECRUITING,2025-04-12,2026-04-18,2026-04-18,INTERVENTIONAL,NA,148,"['Gum Disease', 'Prediabetes']",Gum Disease,The University of Hong Kong,[],['Hong Kong']
NCT06996665,Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study,Diaphragmatic Physiology Similarity Index May Titrate HFNC Flow Setting: A Prospective Observational Study,RECRUITING,2025-06-01,2025-12-30,2026-12-02,INTERVENTIONAL,NA,100,['Respiratory Failure'],Respiratory Failure,Sir Run Run Shaw Hospital,[],['China']
NCT07260136,Cervical Spine Abnormalities in Down Syndrome,A Study of Cervical Spine Abnormalities Associated With Down Syndrome in Children at Sohag University,ACTIVE_NOT_RECRUITING,2025-10-23,2026-12-23,2026-12-30,OBSERVATIONAL,,50,"['Down Syndrome', 'Cervical Spine Instability in Down Syndrome']",Down Syndrome,Sohag University,[],['Egypt']
NCT05812807,Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab,OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy,RECRUITING,2023-06-14,2033-05-31,2033-05-31,INTERVENTIONAL,PHASE3,1295,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8', 'Early Stage Triple-Negative Breast Carcinoma']",Anatomic Stage I Breast Cancer AJCC v8,Alliance for Clinical Trials in Oncology,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States', 'Canada']"
NCT06426693,Craving Network Neurofeedback,Connectome-based Neurofeedback of the Craving Network to Reduce Food Cue Reactivity,RECRUITING,2024-11-27,2027-03-31,2027-03-31,INTERVENTIONAL,NA,50,['Overweight or Obesity'],Overweight or Obesity,Yale University,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06697197,A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors,A Phase 1/2 Study of BMS-986482 as Monotherapy or Combination Therapy in Participants With Advanced Solid Tumors,RECRUITING,2025-02-17,2029-01-04,2029-01-05,INTERVENTIONAL,PHASE1,413,['Advanced Solid Tumors'],Advanced Solid Tumors,Bristol-Myers Squibb,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Greece', 'Sweden']"
NCT04829565,Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb,Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb,ACTIVE_NOT_RECRUITING,2021-09-09,2025-05-15,2026-05-15,INTERVENTIONAL,PHASE4,60,['Rhizarthrosis'],Rhizarthrosis,Centre Hospitalier Universitaire de Nice,[],['France']
NCT05106036,Preventing Cognitive Decline by Reducing BP Target Trial,Preventing Cognitive Decline by Reducing BP Target Trial,RECRUITING,2022-07-11,2026-08-31,2026-08-31,INTERVENTIONAL,NA,4000,"['Cognitive Decline', 'Blood Pressure', 'Hypertension']",Cognitive Decline,University of Texas Southwestern Medical Center,"['National Institute on Aging (NIA)', 'Duke University', 'Parkland Health and Hospital System']",['United States']
NCT07184411,Activities-based Locomotor Training in Children With Cerebral Palsy,Efficacy of Activities-based Locomotor Training in Children With Cerebral Palsy.,RECRUITING,2026-01-11,2028-05,2028-08-31,INTERVENTIONAL,NA,19,['Cerebral Palsy (CP)'],Cerebral Palsy (CP),Baylor University,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT04248569,DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma,A Pilot Study of a DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma,RECRUITING,2020-04-20,2029-03-01,2034-03-01,INTERVENTIONAL,PHASE1,56,['Fibrolamellar Hepatocellular Carcinoma (FLC)'],Fibrolamellar Hepatocellular Carcinoma (FLC),Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Fibrolamellar Cancer Foundation'],['United States']
NCT07110454,Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up,A Prospective Long-Term Follow-Up Study to Evaluate the Use of the Minder Device to Aid in Treatment After Actionable Event Identification in Patients Diagnosed With Epilepsy.,RECRUITING,2025-11-20,2029-01,2029-01,OBSERVATIONAL,,210,"['Epilepsy', 'Epilepsy (Treatment Refractory)']",Epilepsy,"Epiminder America, Inc.",[],['United States']
NCT06364280,Pediatric Prehospital Airway Resuscitation Trial,Pediatric Prehospital Airway Resuscitation Trial,RECRUITING,2024-05-20,2029-08-31,2029-09-30,INTERVENTIONAL,NA,3000,"['Heart Arrest, Out-Of-Hospital', 'Wounds and Injuries', 'Respiratory Insufficiency in Children', 'Child, Only', 'Critical Illness']","Heart Arrest, Out-Of-Hospital",Ohio State University,"['National Heart, Lung, and Blood Institute (NHLBI)', 'University of Utah']",['United States']
NCT06868160,Comparison of Different Non-invasive Electrical Stimulation Protocols to Facilitate Rehabilitation in Parkinson's Disease Subjects With Postural Instability and Gait Disorders,Neurotech PD Gait: Multisite Non-invasive Electrical Stimulation to Optimize Motor-cognitive Rehabilitation Response in Parkinson's Disease Subjects With Postural Instability and Gait Disorders,RECRUITING,2025-10-08,2028-10,2029-01,INTERVENTIONAL,NA,71,['Parkinson Disease'],Parkinson Disease,IRCCS San Raffaele,[],['Italy']
NCT05012982,Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction,Immunometabolic Mechanisms of Blood Flow Restriction Training After Anterior Cruciate Ligament Reconstruction,RECRUITING,2023-02-16,2026-05,2026-05,INTERVENTIONAL,NA,20,['Anterior Cruciate Ligament Reconstruction'],Anterior Cruciate Ligament Reconstruction,Yale University,[],['United States']
NCT02451982,Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas,A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients With Surgically Resectable Adenocarcinoma of the Pancreas,ACTIVE_NOT_RECRUITING,2016-03-28,2026-05-31,2026-05-31,INTERVENTIONAL,PHASE2,76,['Pancreatic Cancer'],Pancreatic Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['National Cancer Institute (NCI)', 'Bristol-Myers Squibb']",['United States']
NCT07260175,Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma,adIVO - A Phase II Trial of Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma,RECRUITING,2025-11-18,2030-12,2031-12,INTERVENTIONAL,PHASE2,40,"['Cholangiocarcinoma', 'IDH Mutation']",Cholangiocarcinoma,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,"['Servier Deutschland GmbH', 'Servier Affaires Médicales']",['Germany']
NCT07070518,Study of GV20-0251 in Participants With Solid Tumor Malignancies,An Open-Label Phase 1/2A Study of GV20-0251 in Participants With Advanced and/or Refractory Solid Tumor Malignancies,RECRUITING,2025-07-11,2027-07-16,2028-09-16,INTERVENTIONAL,PHASE1,350,"['Solid Tumor Cancer', 'Adult Refractory Cancer', 'Endometrial Carcinoma (EC)', 'Squamous Head and Neck Carcinoma', 'pMMR/MSS Adenocarcinoma of the Colon or Rectum', 'Non-Small Cell Lung Cancer', 'Melanoma', 'HCC - Hepatocellular Carcinoma', 'Small Cell Lung Cancer']",Solid Tumor Cancer,GV20 Therapeutics,[],['China']
NCT07254806,"A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease","A Prospective, Randomized, Double-Blinded, Sham-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of IDCT in Subjects With Single-Level, Symptomatic Mild to Moderate Lumbar Intervertebral Disc Degeneration",RECRUITING,2025-12-30,2027-11-24,2028-11-24,INTERVENTIONAL,PHASE3,162,['Degenerative Disc Disease'],Degenerative Disc Disease,"DiscGenics, Inc.",[],['United States']
NCT07171294,Reproducibility of Minimally Invasive Surgery for Grade III Hemorrhoids,Prospective Observational Study to Assess the Reproducibility of Minimally Invasive Surgery in the Treatment of Grade III Hemorrhoids: Phase 2A of the IDEAL Framework,ACTIVE_NOT_RECRUITING,2025-08-12,2026-01-31,2026-01-31,OBSERVATIONAL,,20,"['Hemorrhoidectomy', 'Minimal Invasive Surgery']",Hemorrhoidectomy,Hospital Son Llatzer,"[""Fundació d'investigació Sanitària de les Illes Balears""]",['Spain']
NCT05756413,Birth to Three - Cavity Free,Birth to Three - Cavity Free: Effectiveness of a Psychoeducational Intervention for ECC Prevention,ACTIVE_NOT_RECRUITING,2023-03-01,2027-03-31,2027-03-31,INTERVENTIONAL,NA,634,"['Caries,Dental']","Caries,Dental",University of Iowa,[],['United States']
NCT07261618,AI-Assisted 2D Fetal Brain Ultrasound for Intracranial Anomaly Detection,Evaluation of an Artificial Intelligence-Assisted Diagnostic Model for the Analysis of Archived 2D Fetal Brain Ultrasound Images to Improve Detection and Standardization of Intracranial Anomalies,ACTIVE_NOT_RECRUITING,2025-10-15,2025-11-30,2025-11-30,OBSERVATIONAL,,800,"['Intracranial Anomalies', 'Ultrasound Imaging', 'Artificial Intelligence']",Intracranial Anomalies,Sanliurfa Mehmet Akif Inan Education and Research Hospital,[],['Turkey (Türkiye)']
NCT05175300,Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject,Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject,RECRUITING,2023-03-24,2032-03,2032-03,INTERVENTIONAL,NA,100,['Hip Arthropathy'],Hip Arthropathy,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT06300528,Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas,PERFORM: A Phase II Study of Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas,RECRUITING,2025-10-03,2027-01,2030-12,INTERVENTIONAL,PHASE2,27,"['Relapsed or Refractory B-cell Non-Hodgkin Lymphoma', 'Mantle Cell Lymphoma', 'Marginal Zone Lymphoma']",Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,University of Utah,['Incyte Corporation'],['United States']
NCT07261228,The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding,THE DIFFERENCE IN CARBON FOOTPRINT BETWEEN DIAGNOSTIC UPPER GI ENDOSCOPY IN DYSPEPTIC PATIENTS VERSUS THERAPEUTIC UPPER GI BLEEDING,RECRUITING,2025-06-01,2025-08-31,2025-12-31,OBSERVATIONAL,,75,"['Carbon Footprint in Upper GI Endoscopy', 'Dyspepsia', 'Non-variceal Upper Gastrointestinal Bleeding']",Carbon Footprint in Upper GI Endoscopy,King Chulalongkorn Memorial Hospital,[],['Thailand']
NCT05069558,Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion,Prospective Randomized Multi-center Controlled Clinical Investigation Comparing Patent Foramen Ovale (PFO) Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion,ACTIVE_NOT_RECRUITING,2022-05-09,2025-11-30,2026-10-26,INTERVENTIONAL,NA,450,"['Stroke', 'Patent Foramen Ovale', 'PFO']",Stroke,Occlutech International AB,[],"['Netherlands', 'United States', 'France', 'Finland', 'Denmark', 'Canada', 'United Kingdom', 'Germany']"
NCT07038252,The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients,The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients,RECRUITING,2025-11-26,2027-02-26,2027-02-26,INTERVENTIONAL,NA,50,"['Hypertension', 'Obesity']",Hypertension,Assistance Publique - Hôpitaux de Paris,"['National Research Agency, France', 'The Company SOLUTEXGC, S.L']",['France']
NCT04815564,Clear Aligners for the Treatment of Dental Malocclusion in OI,Use of Clear Aligners for the Treatment of Dental Malocclusion in Individuals With Osteogenesis Imperfecta,ACTIVE_NOT_RECRUITING,2022-08-01,2027-08,2027-12,INTERVENTIONAL,NA,57,['Osteogenesis Imperfecta'],Osteogenesis Imperfecta,Baylor College of Medicine,"['University of California, Los Angeles', 'McGill University', 'National Institute of Dental and Craniofacial Research (NIDCR)']","['United States', 'Canada']"
NCT06899633,"Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.","Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in Routine Practice in Kazakhstan: a Registry Study With Retrospective and Prospective Components.",RECRUITING,2025-05-15,2027-02-28,2027-02-28,OBSERVATIONAL,,500,"['Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan', 'Description of the Course of SLE in Patients in the Republic of Kazakhstan', 'Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of Kazakhstan']",Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan,AstraZeneca,[],['Kazakhstan']
NCT06938347,Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt,"A Phase 3, Open-label, Multicenter, Randomized Crossover Trial Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt",RECRUITING,2025-11-05,2026-06,2026-06,INTERVENTIONAL,PHASE3,300,['Right-To-Left Shunt'],Right-To-Left Shunt,"Agitated Solutions, Inc.",['Bright Research Partners'],"['United States', 'Canada']"
NCT05802329,Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME),A Phase 1 Study To Assess The Safety And Efficacy Of OCU200 For Center-Involved Diabetic Macular Edema,RECRUITING,2024-01-13,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE1,24,"['Center Involved Diabetic Macular Edema', 'Diabetic Macular Edema']",Center Involved Diabetic Macular Edema,Ocugen,[],['United States']
NCT04008797,A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor,An Open-label Study of E7386 in Combination With Other Anticancer Drug(s) in Subjects With Solid Tumors,RECRUITING,2019-07-11,2027-08-31,2027-08-31,INTERVENTIONAL,PHASE1,301,"['Endometrial Neoplasms', 'Neoplasms', 'Carcinoma, Hepatocellular', 'Liver Neoplasms', 'Colorectal Neoplasms']",Endometrial Neoplasms,Eisai Inc.,[],"['Japan', 'China', 'United States', 'France', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea']"
NCT06864169,A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005),"A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers",RECRUITING,2025-04-01,2026-07-06,2029-01-04,INTERVENTIONAL,PHASE2,160,['Gastrointestinal Cancer'],Gastrointestinal Cancer,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Hong Kong', 'United States', 'France', 'Chile', 'Switzerland', 'Spain', 'Taiwan', 'Thailand', 'Canada', 'Argentina']"
NCT06246214,From Prevention to Treatment: How Biological Rhythms Can Maintain Perinatal Mental Health,Innovations in Biological Rhythms in the Context of Mental Health: Effectiveness of New Technologies and Exposure to Different Lighting Patterns in Women During the Postpartum Period,RECRUITING,2024-01-04,2027-05,2027-05,INTERVENTIONAL,NA,150,"['Depression, Postpartum', 'Anxiety State']","Depression, Postpartum",Hospital de Clinicas de Porto Alegre,['Federal University of Rio Grande do Sul'],['Brazil']
NCT07260890,Paired Comparison of SVV and PVI Accuracy,"Diagnostic Accuracy of Stroke Volume Variation (SVV) vs Pleth Variability Index (PVI) for Predicting Fluid Responsiveness in Laparoscopic Major Abdominal Surgery-A Prospective, Paired, Cohort Study",RECRUITING,2025-10-01,2025-10-22,2025-12-01,OBSERVATIONAL,,300,"['Perioperative Care', 'Fluid Therapy', 'Monitoring, Physiologic', 'Hemodynamics', 'Laparoscopy']",Perioperative Care,Wonkwang University Hospital,[],['South Korea']
NCT07262138,Active Surveillance in Older Women With ER+ Breast Cancer,"Protocol-Directed Active Surveillance for Older Women With Small, Screen-Detected, ER+/HER2- Breast Cancer",RECRUITING,2025-11-01,2028-11-01,2030-12-31,OBSERVATIONAL,,50,['Early Stage Estrogen Receptor (ER) Positive Breast Cancer'],Early Stage Estrogen Receptor (ER) Positive Breast Cancer,University of Pittsburgh,[],['United States']
NCT06230224,A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma,"A Phase 3, Randomized, Open Label Study Evaluating the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20 x Anti-CD3 Bispecific Antibody, Versus Standard of Care Therapy in Participants With Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma (OLYMPIA-4)",RECRUITING,2024-02-15,2027-05-14,2027-05-14,INTERVENTIONAL,PHASE3,216,['B-Cell Non-Hodgkin Lymphoma (B-NHL)'],B-Cell Non-Hodgkin Lymphoma (B-NHL),Regeneron Pharmaceuticals,[],"['Brazil', 'Singapore', 'Hungary', 'Turkey (Türkiye)', 'Netherlands', 'Chile', 'Spain', 'Taiwan', 'Italy', 'Colombia', 'Malaysia', 'Romania', 'South Korea', 'Thailand', 'Argentina', 'Australia']"
NCT06787612,Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer,Multi-arm Phase 2 Study of Ubamatamab (REGN4018; MUC16×CD3 Bispecific Antibody) With or Without Additional Agents in Platinum-Resistant Ovarian Cancer,RECRUITING,2025-05-28,2028-12-07,2028-12-07,INTERVENTIONAL,PHASE2,220,['Ovarian Cancer'],Ovarian Cancer,Regeneron Pharmaceuticals,[],"['Taiwan', 'United States', 'South Korea', 'Turkey (Türkiye)']"
NCT05263050,Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors,GU-187: Phase II Trial of Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors,RECRUITING,2022-01-21,2026-02,2027-02,INTERVENTIONAL,PHASE2,111,"['Metastatic Renal Cell Carcinoma', 'Clear-cell Metastatic Renal Cell Carcinoma', 'Neuroendocrine Tumors', 'Carcinoid Tumor']",Metastatic Renal Cell Carcinoma,Fox Chase Cancer Center,['Exelixis'],['United States']
NCT05591404,Investigating the Effects of Social Stress on Brain Imaging,Investigating the Effects of Social Stress on Brain Imaging,RECRUITING,2025-11-17,2026-09,2026-11,INTERVENTIONAL,NA,50,['Social Stress'],Social Stress,Massachusetts Institute of Technology,['Massachusetts General Hospital'],['United States']
NCT03660826,"Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone","A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer. A Multi-Arm Trial for Women With Recurrent or Persistent Endometrial Cancer",ACTIVE_NOT_RECRUITING,2018-09-27,2024-12-06,2026-01-24,INTERVENTIONAL,PHASE2,288,"['Endometrial Adenocarcinoma', 'Endometrial Mixed Cell Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Endometrial Undifferentiated Carcinoma', 'Endometrioid Adenocarcinoma', 'Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8']",Endometrial Adenocarcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['United States', 'Canada']"
NCT02112734,Can Vitamin D Supplementation in the First Year of Life Prevent Food Allergy in Infants? The VITALITY Trial: Parts 1&2,Can Vitamin D Supplementation Prevent Food Allergy in Infants? The VITALITY Trial,ACTIVE_NOT_RECRUITING,2014-12,2028-04,2028-12,INTERVENTIONAL,PHASE4,2739,['Food Allergy'],Food Allergy,Murdoch Childrens Research Institute,[],['Australia']
NCT05988138,Prevention of Anhedonia in Children,Reward Responsiveness as a Prevention Target in Youth At Risk for Anhedonia,ACTIVE_NOT_RECRUITING,2023-11-10,2026-01,2026-01,INTERVENTIONAL,NA,60,"['Anhedonia', 'Depression']",Anhedonia,Vanderbilt University,"[""Nationwide Children's Hospital""]",['United States']
NCT06216158,Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma,A Randomized Phase III Trial Assessing Iberdomide Versus Iberdomide Plus Isatuximab Maintenance Therapy Post Autologous Hematopoietic Stem-Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma,RECRUITING,2024-04-05,2028-12,2029-06,INTERVENTIONAL,PHASE3,411,['Multiple Myeloma'],Multiple Myeloma,University of Heidelberg Medical Center,"['KKS Netzwerk', 'Wuerzburg University Hospital', 'Sanofi', 'Bristol-Myers Squibb']","['Austria', 'Germany']"
NCT05867615,Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours:,Radiometabolic Therapy (RMT) With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours: a Basket Trial,ACTIVE_NOT_RECRUITING,2023-05-25,2026-08,2028-12,INTERVENTIONAL,PHASE2,83,['Cancer'],Cancer,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,[],['Italy']
NCT06789406,PMCF Study of the Axonics SNM System Model 5101 (R20),Post-Market Clinical Follow-up Study of the Axonics SNM System Model 5101 (R20),RECRUITING,2025-09-18,2027-01,2031-10,INTERVENTIONAL,NA,55,"['Urinary Urge Incontinence (UUI)', 'Urinary Frequency (UF)', 'Overactive Bladder (OAB)']",Urinary Urge Incontinence (UUI),"Axonics, Inc.",[],"['United Kingdom', 'United States']"
NCT07006987,HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women,Clinical Study for HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women of Ages 18-49 Years Considering Laparoscopy,RECRUITING,2025-10-14,2030-05-31,2037-06-01,INTERVENTIONAL,NA,100,['Endometriosis'],Endometriosis,Chinese University of Hong Kong,[],['China']
NCT06627764,"Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience Among Latino Families in the US","Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience Among Latino Families in the US",RECRUITING,2025-06-24,2028-10-31,2028-12-30,INTERVENTIONAL,NA,400,"['Substance Abuse', 'Intimate Partner Violence (IPV)', 'HIV Infections', 'Depression', 'Anxiety']",Substance Abuse,Duke University,['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT05860699,Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH,Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation in Patients With Severe Alcohol Use Disorder: A Phase II Trial,RECRUITING,2024-04-08,2026-05-23,2026-05-23,INTERVENTIONAL,PHASE2,210,['Severe Alcohol Use Disorder (DSM 5)'],Severe Alcohol Use Disorder (DSM 5),Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06438302,Effects of Nasal Ventilation on Cerebral and Pulmonary Function in Orally Intubated Patients,Effects of Nasal Ventilation on Cerebral and Pulmonary Function in Orally Intubated Patients,RECRUITING,2025-01-31,2028-02-01,2028-02-01,OBSERVATIONAL,,22,['Hypoxemic Acute Respiratory Failure'],Hypoxemic Acute Respiratory Failure,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06903819,"Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients","Ketamine's Impact on Opioid Use, Pain, and Mental Health in Polytraumatized Orthopedic Patients: A Randomized Controlled Trial (KOPM)",RECRUITING,2025-11-06,2027-05,2028-05,INTERVENTIONAL,PHASE4,90,"['Orthopedic Trauma Surgery Patients', 'Postoperative Pain', 'Opioid Use', 'Depression', 'Post-traumatic Stress Disorder (PTSD)']",Orthopedic Trauma Surgery Patients,Texas Tech University Health Sciences Center,[],['United States']
NCT06588686,A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.,"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial Evaluating the Efficacy and Safety of 2 Doses of Buloxibutid Over 52 Weeks in People With Idiopathic Pulmonary Fibrosis.",RECRUITING,2024-12-09,2027-05,2027-06,INTERVENTIONAL,PHASE2,360,['Idiopathic Pulmonary Fibrosis (IPF)'],Idiopathic Pulmonary Fibrosis (IPF),Vicore Pharma AB,['Population Services International'],"['Belgium', 'Austria', 'United States', 'Mexico', 'Germany', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Greece', 'Poland', 'Argentina', 'Australia']"
NCT06596044,Suicide Prevention After Community Care Discharge,Suicide Prevention In Department of Veterans Affairs Community Care Network Mental Health Settings,RECRUITING,2025-10-01,2028-06-30,2028-09-30,INTERVENTIONAL,NA,120,['Suicide Prevention'],Suicide Prevention,VA Office of Research and Development,['White River Junction Veterans Affairs Medical Center'],['United States']
NCT07025304,Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate Reduction in China,"A Prospective, Multi-center, Post-Market Clinical Study to Evaluate the Safety and Effectiveness of the REFLEX ULTRA 45 for the Coblation Inferior Turbinate Reduction in China",RECRUITING,2025-07-02,2026-09-30,2028-06-30,INTERVENTIONAL,NA,105,['Nasal Obstruction Due to Inferior Turbinate Hypertrophy'],Nasal Obstruction Due to Inferior Turbinate Hypertrophy,"Smith & Nephew, Inc.",[],['China']
NCT06159621,CD40 Agonist and PD-1 Inhibitor in HNSCC,Neoadjuvant/Phase 1 Study of CD40 Agonist (LVGN7409) and PD-1 Inhibitor (LVGN3616) in Patients With Resectable HPV-negative Mucosal Head/Neck Squamous Cell Carcinoma (HNSCC),ACTIVE_NOT_RECRUITING,2024-07-02,2028-03-01,2028-03-01,INTERVENTIONAL,PHASE1,27,['Head and Neck Squamous Cell Carcinoma'],Head and Neck Squamous Cell Carcinoma,University of Pennsylvania,[],['United States']
NCT06863337,Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring,Glucose Pattern in Infertile Women Receiving Assisted Reproduction: a Prospective Study Using Continuous Glucose Monitoring,RECRUITING,2025-03-26,2026-06-30,2027-04-30,INTERVENTIONAL,NA,100,['Infertility Female'],Infertility Female,Shanghai 6th People's Hospital,[],['China']
NCT05010005,A Study of Ruxolitinib and Duvelisib in People With Lymphoma,Phase I Multicenter Study of Ruxolitinib and Duvelisib in Relapsed or Refractory T- or NK-Cell Lymphomas,RECRUITING,2021-08-12,2027-08,2027-08,INTERVENTIONAL,PHASE1,70,"['T-cell Lymphomas', 'NK-Cell Lymphomas', 'T-cell Prolymphocytic Leukemia', 'T-cell Large Granular Lymphocyte Leukemia']",T-cell Lymphomas,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07262645,Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A),"A Multicenter, Randomized, Double-Blind, Sham-Controlled Study on The Efficacy And Safety of Near-Infrared Light Therapy Device in Participants With Mild-Moderate Alzheimer's Disease (NirsCure-03A)",RECRUITING,2025-12-15,2027-07-22,2027-07-22,INTERVENTIONAL,PHASE3,320,['Alzheimer s Disease'],Alzheimer s Disease,"Danyang Huichuang Medical Equipment Co., Ltd.",[],['China']
NCT05438719,MOTUS Total Joint Replacement Investigational Device Exemption Study,"An Interventional, Multi-center Investigation of the MOTUS Total Joint Replacement",ACTIVE_NOT_RECRUITING,2022-06-23,2026-06-13,2029-06-13,INTERVENTIONAL,NA,158,['Lumbar Spine Degeneration'],Lumbar Spine Degeneration,3Spine,[],['United States']
NCT06581328,A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting,A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting,RECRUITING,2025-03-27,2027-10-01,2028-06-01,INTERVENTIONAL,PHASE4,400,"['Ulcerative Colitis', ""Crohn's Disease""]",Ulcerative Colitis,Takeda,[],['United States']
NCT07016464,"A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.","A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of REM0045392 to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Food Effect in Healthy Male Participants and in a Panel of Healthy Elderly Participants (Both Sexes)",RECRUITING,2025-03-20,2026-06-03,2026-06-03,INTERVENTIONAL,PHASE1,72,['Healthy'],Healthy,reMYND,[],['Belgium']
NCT06680427,Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study,Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study,ACTIVE_NOT_RECRUITING,2025-03-26,2025-12,2025-12,INTERVENTIONAL,NA,30,['Aortic Stenosis Symptomatic'],Aortic Stenosis Symptomatic,MiRus,[],['United States']
NCT01840566,High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma,A Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma,ACTIVE_NOT_RECRUITING,2013-04,2026-04,2026-04,INTERVENTIONAL,PHASE1,17,"[""Non-Hodgkin's Lymphoma""]",Non-Hodgkin's Lymphoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06925776,"Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization","Community Health Workers in an Interdisciplinary Outpatient CKD Clinic to Optimize Social Care Navigation, Patient Engagement, and Home Dialysis Utilization- the CHOOSE Home Trial",RECRUITING,2025-12,2027-12,2027-12,INTERVENTIONAL,NA,106,['Kidney Replacement Therapy'],Kidney Replacement Therapy,Montefiore Medical Center,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'New York University']",['United States']
NCT06703489,Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS),Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia,RECRUITING,2025-03-18,2025-12,2026-06,INTERVENTIONAL,NA,40,['Ventricular Tachycardia (VT)'],Ventricular Tachycardia (VT),Medtronic Cardiac Ablation Solutions,[],['United States']
NCT07261891,Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders,Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders (JAKarta Study),RECRUITING,2024-11-21,2028-12-01,2030-12-01,INTERVENTIONAL,NA,20,['Primary Immunodeficiency Diseases (PID)'],Primary Immunodeficiency Diseases (PID),prof. dr. Rik Schrijvers,['Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)'],['Belgium']
NCT06607549,Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR),A Phase 1 Study of Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery (SRS) in Patients With Primary and Secondary Central Nervous System Lymphomas,RECRUITING,2025-03-18,2029-11,2030-11,INTERVENTIONAL,PHASE1,12,['Central Nervous System Lymphoma'],Central Nervous System Lymphoma,University of Utah,['ADC Therapeutics S.A.'],['United States']
NCT04204850,Cabozantinib to Treat Recurrent Liver Cancer Post Transplant,A Phase II Trial of Cabozantinib in the Treatment of Recurrent Hepatocellular Carcinoma Post Liver Transplant,RECRUITING,2020-08-07,2026-06-01,2026-06-30,INTERVENTIONAL,PHASE2,20,"['Hepatocellular Carcinoma', 'Recurrent Cancer', 'Liver Transplant']",Hepatocellular Carcinoma,"University Health Network, Toronto",['Ipsen'],['Canada']
NCT04324008,Clinical Comparison of Different Flowable Resin Composites,Clinical Comparison of Different Flowable Resin Composites,ACTIVE_NOT_RECRUITING,2017-11-01,2018-01-01,2026-11-01,INTERVENTIONAL,NA,28,['Tooth Diseases'],Tooth Diseases,Hacettepe University,[],['Turkey (Türkiye)']
NCT05139017,A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003),"A Phase 2/3 Multicenter, Open-label, Randomized, Active-Control Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (waveLINE-003)",RECRUITING,2022-01-14,2027-09-24,2027-09-24,INTERVENTIONAL,PHASE2,290,"['DLBCL', 'Diffuse Large B-Cell Lymphoma']",DLBCL,Merck Sharp & Dohme LLC,[],"['New Zealand', 'Hong Kong', 'China', 'Australia', 'Israel', 'France', 'Chile', 'Guatemala', 'Peru', 'Colombia', 'South Korea', 'Thailand', 'Poland', 'Costa Rica', 'Mexico', 'Canada', 'United Kingdom', 'Greece', 'Ukraine', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07076121,A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30),"A Randomized, Phase 2/3 Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion",RECRUITING,2025-10-23,2029-05-03,2029-05-03,INTERVENTIONAL,PHASE2,470,['Pancreatic Ductal Adenocarcinoma'],Pancreatic Ductal Adenocarcinoma,Bristol-Myers Squibb,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT07261189,Comparing Staples Versus Polypropylene Sutures for Mesh Fixation in Inguinal Hernia Repair in Terms of Postoperative Pain,Comparative Study of Staples Versus Polypropylene Sutures for Mesh Fixation in Lichenstein's Tension-free Inguinal Hernia Repair in Terms of Postoperative Pain,RECRUITING,2025-09-01,2026-03,2026-04,INTERVENTIONAL,NA,168,['Inguinal Hernia'],Inguinal Hernia,Jinnah Postgraduate Medical Centre,['College of Physicians and Surgeons Pakistan'],['Pakistan']
NCT04075526,Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty,Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty,ACTIVE_NOT_RECRUITING,2019-10-01,2024-01-01,2026-01-01,INTERVENTIONAL,PHASE1,2129,['Osteoarthritis'],Osteoarthritis,NYU Langone Health,[],['United States']
NCT06511141,Sacral Neuromodulation for Male Overactive Bladder (MOAB),Sacral Neuromodulation for Male Overactive Bladder,RECRUITING,2024-10-22,2027-12,2028-03,INTERVENTIONAL,NA,150,"['Overactive Bladder', 'Urinary Urgency Incontinence', 'Benign Prostatic Hyperplasia', 'Prostate Cancer', 'Prostatectomy', 'Urinary Frequency']",Overactive Bladder,"Axonics, Inc.",[],['United States']
NCT06972901,Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin,Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin,RECRUITING,2025-10-13,2027-03-01,2027-03-01,INTERVENTIONAL,NA,42,"['Crohn Disease (CD)', 'Ileocolic Resection', 'Post-endoscopic Operative Reccurence']",Crohn Disease (CD),"University Hospital, Clermont-Ferrand",[],['France']
NCT05893381,Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST),A Phase II Randomized Trial of Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Oligometastatic Prostate Cancer (LUST),RECRUITING,2023-06-27,2027-09,2032-04,INTERVENTIONAL,PHASE2,70,['Prostate Cancer'],Prostate Cancer,Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS,[],['Italy']
NCT06797895,Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units,Designing a Virtual Reality Intervention to Improve Physical and Psychological Health in Intensive Care Units,RECRUITING,2024-12-04,2027-03,2027-03,INTERVENTIONAL,NA,30,"['Mobility', 'ICU', 'Heart Surgery', 'Nursing']",Mobility,Duke University,[],['United States']
NCT07093450,Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients,Estudo de Implementação de Melhoria de Qualidade Para Redução do Uso de Antimicrobianos em Unidades de Terapia Intensiva,RECRUITING,2025-06-01,2026-04,2026-07,INTERVENTIONAL,NA,9000,"['Infection', 'Antimicrobial Stewardship', 'Critically Ill Intensive Care Unit Patients']",Infection,Hospital Sirio-Libanes,"['Hospital do Coracao', 'Hospital Israelita Albert Einstein', 'Beneficência Portuguesa de São Paulo']",['Brazil']
NCT07249060,Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients,"Interferon Signature in Cancer Patients Treated With Anti-CTLA-4 and Anti-PD-1/PD-L1 Therapies: A Multicenter, Prospective, Observational Cohort Study Comparing Cancer Patients and Non-Cancer Patients With Systemic Autoimmune Diseases",RECRUITING,2024-01-08,2026-12,2026-12,OBSERVATIONAL,,300,"['Immune-Related Adverse Events', 'Lupus Erythematosus, Systemic', 'Sjogren Syndrome', 'Systemic Sclerosis (SSc)', 'Inflammatory Myopathies', 'Solid Tumors']",Immune-Related Adverse Events,Hospital Universitario Araba,"['Hospital of Navarra', 'Hospital Galdakao-Usansolo', 'Hospital San Pedro de Logroño', 'Consorci Sanitari del Maresme. Hospital Universitari de Mataró', 'Hospital Donostia']",['Spain']
NCT05992883,NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis,"NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis: A Randomized, Controlled Trial",RECRUITING,2023-07-28,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE3,240,['Thumb Osteoarthritis'],Thumb Osteoarthritis,Mayo Clinic,[],['United States']
NCT06636656,A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis,"Phase IIa, Single-arm, Open-label, Multi-center Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Induction and Subcutaneous Maintenance Treatment With BI 3032950 in Patients With Moderate to Severe Ulcerative Colitis",ACTIVE_NOT_RECRUITING,2024-12-11,2026-01-19,2028-02-29,INTERVENTIONAL,PHASE2,45,['Ulcerative Colitis'],Ulcerative Colitis,Boehringer Ingelheim,[],"['Belgium', 'United States', 'Slovakia', 'Czechia', 'Poland', 'Serbia']"
NCT07253870,Comperative Effects of Transcutaneous Auricular and Cervical Vagus Nerve Stimulation in Subacute Stroke Patients,"Comparative Effects of Transcutaneous Auricular and Cervical Vagus Nerve Stimulation on Upper Limb Function, Cognition and Quality of Life in Subacute Stroke Patients",RECRUITING,2025-11-20,2026-05-20,2026-05-20,INTERVENTIONAL,NA,54,"['Stroke', 'Stroke, Acute']",Stroke,Lahore University of Biological and Applied Sciences,[],['Pakistan']
NCT07262177,Dance-Mindfulness Intervention for Well-Being in Recreational Adults,Mindful Embodied Movement: A 12-Week Modern Dance-Mindfulness Intervention and Mixed-Methods Randomized Controlled Trial in Recreational Adult Dancers,RECRUITING,2025-09-02,2025-11-30,2026-02-01,INTERVENTIONAL,NA,160,"['Healthy"" we Are Emphasizing the Wellness/Health Promotion Focus for Recreational, Non-clinical Population']","Healthy"" we Are Emphasizing the Wellness/Health Promotion Focus for Recreational, Non-clinical Population",University of Thessaly,['Aristotle University Of Thessaloniki'],['Greece']
NCT07196839,Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study,Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study,RECRUITING,2025-12,2026-12,2027-03,OBSERVATIONAL,,50,['Transthyretin (TTR) Amyloid Cardiomyopathy'],Transthyretin (TTR) Amyloid Cardiomyopathy,University of Texas Southwestern Medical Center,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT04685967,Clinical Evaluation of a Restorative Glass Ionomer and a Bulk-fill Composite Resin,Clinical Evaluation of a Restorative Glass Ionomer and a Bulk-fill Composite Resin,ACTIVE_NOT_RECRUITING,2021-03-15,2021-08-15,2026-08-15,INTERVENTIONAL,NA,23,['Tooth Disease'],Tooth Disease,Hacettepe University,[],['Turkey (Türkiye)']
NCT06658067,Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access,CGMs for All: Studying the Impact of Expanding CGM Access,RECRUITING,2024-11-12,2026-06,2026-06,INTERVENTIONAL,NA,17,"['Diabetes', 'Type 2 Diabetes', 'Type 2 Diabetes Mellitus - Poor Control']",Diabetes,Yale University,['Yale Office of Global Health'],['United States']
NCT04844528,Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers,Randomized Phase 2 Studying the Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC),RECRUITING,2022-02-25,2026-08,2028-08,INTERVENTIONAL,PHASE2,86,"['Chronic Lymphocytic Leukemia', 'Non-melanoma Skin Cancer (NMSC)']",Chronic Lymphocytic Leukemia,University of Utah,['Huntsman Cancer Institute'],['United States']
NCT04356612,Barriers to Efficient PACU Discharge at a Major Academic Orthopaedic Ambulatory Surgery Center,Barriers to Efficient PACU Discharge at a Major Academic Orthopaedic Ambulatory Surgery Center,ACTIVE_NOT_RECRUITING,2019-12-20,2025-12,2025-12,OBSERVATIONAL,,1000,"['Achilles Tendon Rupture', 'Database']",Achilles Tendon Rupture,"Hospital for Special Surgery, New York",[],['United States']
NCT06111781,The SUGAR Study; SBRT and Relugolix) for Prostate Cancer,The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer,RECRUITING,2024-04-15,2028-02,2028-02,INTERVENTIONAL,PHASE2,60,['Prostate Cancer'],Prostate Cancer,Yale University,['Pfizer'],['United States']
NCT04526665,Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC),"A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients With Primary Biliary Cholangitis With Inadequate Response or Intolerance to Ursodeoxycholic Acid",ACTIVE_NOT_RECRUITING,2020-09-24,2023-06-01,2028-12-01,INTERVENTIONAL,PHASE3,161,['Primary Biliary Cirrhosis'],Primary Biliary Cirrhosis,Ipsen,[],"['Brazil', 'Belgium', 'South Africa', 'Turkey (Türkiye)', 'United States', 'France', 'Chile', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Argentina', 'Germany']"
NCT07140484,Sotatercept in Pulmonary Arterial Hypertension,"A Single-arm, Open-label Phase IV Study to Evaluate the Effectiveness of Sotatercept in Improving Pulmonary Vascular Recruitment in Patients With Pulmonary Arterial Hypertension (PAH)",RECRUITING,2025-10-06,2029-01-01,2030-01-01,INTERVENTIONAL,PHASE4,27,['Pulmonary Artery Hypertension'],Pulmonary Artery Hypertension,University of Alberta,"['Merck Canada Inc.', 'Alberta Health services']",['Canada']
NCT06853158,MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease,MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease (MULTI-MUSIQOLS),RECRUITING,2025-04-02,2026-12-14,2027-01-31,INTERVENTIONAL,NA,90,['Sickle Cell Disease'],Sickle Cell Disease,"University of California, Irvine","['National Center for Complementary and Integrative Health (NCCIH)', 'University of California, San Francisco', 'Case Western Reserve University', 'Prisma Health-Upstate', 'University of Massachusetts Chan Medical School, Worcester']",['United States']
NCT03829371,STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA,"A RANDOMIZED, MULTICENTER, OPEN LABEL STUDY COMPARING TWO STANDARD TREATMENTS, BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) WITH OR WITHOUT DARATUMUMAB (Dara-VMP) VS LENALIDOMIDE-DEXAMETHASONE (Rd) WITH OR WITHOUT DARATUMUMAB (Dara-Rd) IN AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) INELIGIBLE COMMUNITY POPULATION AFFECTED BY MULTIPLE MYELOMA (MM)",ACTIVE_NOT_RECRUITING,2019-01-03,2027-01-03,2030-01-03,INTERVENTIONAL,PHASE4,450,['Multiple Myeloma'],Multiple Myeloma,"University of Turin, Italy",[],['Italy']
NCT03225144,Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia,Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia,RECRUITING,2017-10-11,2027-10-30,2027-10-30,OBSERVATIONAL,,360,"['Frontotemporal Dementia', 'Amyotrophic Lateral Sclerosis', 'Progressive Supranuclear Palsy']",Frontotemporal Dementia,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT06961357,Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma,Phase I/II Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (TIL) for Patients With Advanced Melanoma,RECRUITING,2026-01-01,2029-05,2030-05,INTERVENTIONAL,PHASE1,36,['Melanoma'],Melanoma,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT03880019,A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma,A Phase II Study of the PARP Inhibitor Olaparib in Combination With the DNA Damaging Agent Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma,ACTIVE_NOT_RECRUITING,2019-08-19,2020-08-01,2026-11-12,INTERVENTIONAL,PHASE2,23,"['Stage III Uterine Corpus Leiomyosarcoma AJCC v8', 'Stage IV Uterine Corpus Leiomyosarcoma AJCC v8', 'Uterine Corpus Leiomyosarcoma']",Stage III Uterine Corpus Leiomyosarcoma AJCC v8,National Cancer Institute (NCI),[],['United States']
NCT06914128,A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors,"A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of BAY 3713372, a Novel 2nd Generation PRMT5 Inhibitor, in Participants With MTAP-deleted Solid Tumors.",RECRUITING,2025-03-21,2029-06-17,2029-06-17,INTERVENTIONAL,PHASE1,370,['MTAP-deleted Solid Tumors'],MTAP-deleted Solid Tumors,Bayer,[],"['Singapore', 'Belgium', 'Japan', 'Netherlands', 'China', 'United States', 'Denmark', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Sweden', 'Australia']"
NCT06703177,A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors,"Phase IB/II Study of Safety, Tolerability and Efficacy of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors",RECRUITING,2025-02-18,2026-01-01,2027-07-01,INTERVENTIONAL,PHASE1,876,['Advanced Solid Tumors'],Advanced Solid Tumors,"Suzhou Suncadia Biopharmaceuticals Co., Ltd.",[],['China']
NCT06980116,Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies,"A Phase 1 Open-label, Multicenter, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of EXS73565 in Participants With Relapsed or Refractory B-cell Malignancies",RECRUITING,2025-03-31,2028-06,2028-12,INTERVENTIONAL,PHASE1,50,['Relapsed or Refractory B-cell Malignancies'],Relapsed or Refractory B-cell Malignancies,"Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.",[],"['United Kingdom', 'Spain']"
NCT06870591,Pivotal Study for the Cardiac Performance System (CPS),Pivotal Method-Comparison Study for the Cardiac Performance System (CPS) to Measure Hemodynamic Parameters,RECRUITING,2025-04-22,2026-01-31,2026-05-30,OBSERVATIONAL,,1000,['Cardiovascular Diseases'],Cardiovascular Diseases,Sensydia Corporation,[],['United States']
NCT06422078,"A Non-interventional, Prospective Study With Benralizumab","A Non-interventional, Prospective Study With Benralizumab to Investigate Clinical Outcome Based on Standard of Care Medication in Real-life",RECRUITING,2024-07-25,2027-07-31,2027-07-31,OBSERVATIONAL,,300,"['Asthma, Bronchial']","Asthma, Bronchial",AstraZeneca,[],['Germany']
NCT04944043,A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease,"A Single Group, Open-Label, Multicenter ,Phase Ib/II Clinical Trials of TQ05105 Tablet in Patients With Glucocorticoid Refractory and Dependent Moderate to Severe Chronic Graft Versus Host Disease (cGVHD).",ACTIVE_NOT_RECRUITING,2021-06-25,2023-06-30,2026-12-31,INTERVENTIONAL,PHASE1,45,['Chronic Graft Versus Host Disease'],Chronic Graft Versus Host Disease,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",[],['China']
NCT05035030,Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome,An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT-EXT),RECRUITING,2021-09-03,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE3,70,['Alagille Syndrome'],Alagille Syndrome,"Albireo, an Ipsen Company",[],"['Belgium', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'France', 'Italy', 'Malaysia', 'United Kingdom', 'Poland', 'Germany']"
NCT06434363,Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders,Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders,RECRUITING,2024-07-31,2028-12-31,2030-12-31,INTERVENTIONAL,PHASE1,47,"['Autoimmune Disorders', 'Systemic Sclerosis', 'Systemic Lupus Erythematosus', 'Lupus', 'Lupus Nephritis']",Autoimmune Disorders,M.D. Anderson Cancer Center,[],['United States']
NCT06725134,Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures,Impact of Therapy Dogs on Anxiety and Behavior of Pediatric Dental Patients During Local Anesthesia: A Randomized Controlled Trial,RECRUITING,2024-11-01,2026-11,2027-07,INTERVENTIONAL,NA,25,"['Situational Anxiety', 'Behavior']",Situational Anxiety,University of Michigan,[],['United States']
NCT06523634,Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.,Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.,RECRUITING,2024-12-10,2029-02-01,2032-02-01,INTERVENTIONAL,NA,284,['Prostate Cancer'],Prostate Cancer,Jules Bordet Institute,[],['Belgium']
NCT07144800,Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options),Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options),RECRUITING,2025-08-22,2030-07-31,2031-07-31,INTERVENTIONAL,NA,1330,"['Obesity', 'Child Obesity', 'Weight Loss']",Obesity,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT04658147,Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC),Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC),ACTIVE_NOT_RECRUITING,2021-05-28,2025-12-01,2026-12-01,INTERVENTIONAL,PHASE1,31,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Bristol-Myers Squibb'],['United States']
NCT05051384,Superb Microvascular Intraocular Tumor Imaging Study (SMITIS),Using the Superb Microvascular Imaging Method in the Diagnosis of Intraocular Tumors (SMITIS),ACTIVE_NOT_RECRUITING,2022-04-27,2023-04-27,2026-01-18,INTERVENTIONAL,NA,22,['Ocular Tumor'],Ocular Tumor,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06645678,Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma,Phase I/II Study of Mezigdomide and Elranatamab for Relapsed/Refractory Multiple Myeloma Patients,RECRUITING,2024-11-26,2026-10-01,2027-10-01,INTERVENTIONAL,PHASE1,75,['Relapsed Refractory Multiple Myeloma (RRMM)'],Relapsed Refractory Multiple Myeloma (RRMM),YOUNGIL KOH,[],"['Singapore', 'South Korea']"
NCT03698994,"Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)",NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of BVD-523FB (Ulixertinib) in Patients With Tumors Harboring Activating MAPK Pathway Mutations,ACTIVE_NOT_RECRUITING,2018-11-14,2022-03-31,2026-03-30,INTERVENTIONAL,PHASE2,20,"['Advanced Malignant Solid Neoplasm', 'Recurrent Ependymal Tumor', 'Recurrent Ewing Sarcoma', 'Recurrent Glioma', 'Recurrent Hepatoblastoma', 'Recurrent Histiocytic and Dendritic Cell Neoplasm', 'Recurrent Langerhans Cell Histiocytosis', 'Recurrent Malignant Germ Cell Tumor', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Medulloblastoma', 'Recurrent Neuroblastoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Osteosarcoma', 'Recurrent Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Primary Malignant Central Nervous System Neoplasm', 'Recurrent Rhabdoid Tumor', 'Recurrent Rhabdomyosarcoma', 'Recurrent Soft Tissue Sarcoma', 'Refractory Ependymoma', 'Refractory Ewing Sarcoma', 'Refractory Glioma', 'Refractory Hepatoblastoma', 'Refractory Histiocytic and Dendritic Cell Neoplasm', 'Refractory Langerhans Cell Histiocytosis', 'Refractory Malignant Germ Cell Tumor', 'Refractory Malignant Solid Neoplasm', 'Refractory Medulloblastoma', 'Refractory Neuroblastoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Osteosarcoma', 'Refractory Peripheral Primitive Neuroectodermal Tumor', 'Refractory Primary Malignant Central Nervous System Neoplasm', 'Refractory Rhabdoid Tumor', 'Refractory Rhabdomyosarcoma', 'Refractory Soft Tissue Sarcoma', 'Wilms Tumor']",Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06373601,SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective,Selution Sirolimus Coated Balloon (MedAlliance) Versus SeQuent Please Neo Paclitaxel Coated Balloon (Bbraun) for the Treatment of de Novo Coronary Artery Lesions in Medium-small Size Vessels.,RECRUITING,2024-09-05,2027-08-01,2027-08-01,INTERVENTIONAL,NA,140,"['Coronary Artery Disease', 'Stenosis Coronary', 'Coronary Artery Lesion', 'Percutaneous Coronary Intervention']",Coronary Artery Disease,Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS,[],['Italy']
NCT07176689,Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF),"A Single-Arm, Open-Label Phase 4 Study of Nirogacestat in Adult Premenopausal Females With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)",RECRUITING,2025-09-17,2031-02-28,2031-03-30,INTERVENTIONAL,PHASE4,50,"['Desmoid Tumor', 'Aggressive Fibromatosis']",Desmoid Tumor,"SpringWorks Therapeutics, Inc.",[],"['United Kingdom', 'Spain', 'Italy']"
NCT04916652,A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers,A First-ever Research Collaboration to Characterize MRI Measured Neural Flexibility Development in Chinese Toddlers,RECRUITING,2024-04-06,2026-08,2027-02,OBSERVATIONAL,,60,"['Growth & Development', 'Brain']",Growth & Development,Société des Produits Nestlé (SPN),[],['China']
NCT04464668,"Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health","Colorectal Cancer Awareness, Research and Education and Screening - Rural Expansion, Access and Capacity for Health",ACTIVE_NOT_RECRUITING,2020-06-25,2027-10-26,2027-12,OBSERVATIONAL,,49,['Colorectal Cancer'],Colorectal Cancer,H. Lee Moffitt Cancer Center and Research Institute,['National Cancer Institute (NCI)'],['United States']
NCT06174805,AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE,"A Prospective Multi-Center, Single-Arm Study of Endoscopic Ultrasound-Guided Gastroenterostomy With Lumen-Apposing Metal Stent for Gastric Outlet Obstruction From Malignant Unresectable Disease",RECRUITING,2025-02-11,2027-02,2027-03,INTERVENTIONAL,NA,67,['Gastric Outlet Obstruction'],Gastric Outlet Obstruction,Boston Scientific Corporation,[],"['Brazil', 'Belgium', 'China', 'United States', 'Canada', 'India']"
NCT05846516,"A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal Adenocarcinoma","A Phase 1b Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Heterologous Prime Boost Vaccination (ATP150/ATP152/ATP162, VSV-GP154) and Ezabenlimab (BI 754091) in Patients With Pancreatic Ductal Adenocarcinoma.",RECRUITING,2023-03-13,2028-06,2029-05,INTERVENTIONAL,PHASE1,94,['Pancreatic Ductal Adenocarcinoma'],Pancreatic Ductal Adenocarcinoma,Boehringer Ingelheim,[],"['Switzerland', 'Spain', 'United States', 'Germany']"
NCT07262216,Correlation Between Pain Threshold and Analgesic Consumption in Transvaginal Oocyte Aspiration Patients,Correlation Between Pain Threshold and Analgesic Consumption During Egg Collection in Patients,ACTIVE_NOT_RECRUITING,2025-04-28,2025-12-08,2025-12-10,OBSERVATIONAL,,30,"['Pain Threshold', 'Conscious Sedation', 'Oocyte Retrieval']",Pain Threshold,Burcu ayvazoğlu,[],['Turkey (Türkiye)']
NCT07260097,Choroidal Venous Congestion Following Scleral Buckling - An Imaging Study,Choroidal Venous Congestion Following Scleral Buckling - An Imaging Study,RECRUITING,2025-07-17,2028-07,2028-07,OBSERVATIONAL,,50,['Pachychoroid Disease'],Pachychoroid Disease,Singapore National Eye Centre,[],['Singapore']
NCT04080778,Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD),Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD),RECRUITING,2024-08-24,2027-12-30,2027-12-30,INTERVENTIONAL,NA,60,['Bipolar Disorder'],Bipolar Disorder,Joao L. DeQuevedo,[],['United States']
NCT07260240,Comparison of the Efficacy of Intravenous Fluid Administration Between Bolus and Continuous Infusion in Pregnant Women With Fetal Heart Rate Tracing Category II: A Randomized Controlled Trial,Comparison of the Efficacy of Intravenous Fluid Administration Between Bolus and Continuous Infusion in Pregnant Women With Fetal Heart Rate Tracing Category II: A Randomized Controlled Trial,RECRUITING,2025-12-05,2025-12-30,2026-03-30,INTERVENTIONAL,NA,60,['Fetal Non Reassuring'],Fetal Non Reassuring,"Queen Savang Vadhana Memorial Hospital, Thailand",[],['Thailand']
NCT06388668,Lipid Testing After Myocardial Infarction at the Montreal Heart Institute,Timing of Lipid Testing During Hospitalization for MI and Subsequent Management of Dyslipidemia An Observational Study to Reduce the Care Gaps in Dyslipidemia in Canada,RECRUITING,2024-06-01,2026-03,2026-05,OBSERVATIONAL,,100,"['Dyslipidemias', 'Lipid Testing', 'Myocardial Infarction']",Dyslipidemias,Montreal Heart Institute,['Novartis Pharmaceuticals'],['Canada']
NCT07136285,Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC,"PIb/II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of I.V. Olvi-Vec Combined With Platinum Plus Etoposide in Patients With Advanced SCLC Who Are Platinum-recurrent or Platinum-refractory",RECRUITING,2023-07-24,2026-12,2026-12,INTERVENTIONAL,PHASE1,27,"['SCLC, Extensive Stage']","SCLC, Extensive Stage","Newsoara HYK Biopharmaceutical (Shanghai) Co., Ltd.",['Genelux Corporation'],['China']
NCT07260435,Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer,Apa/Enza Short Study: Shortened 12 Months Duration of Androgen Receptor Signaling Agent in Combination With Androgen Deprivation Therapy in Patients With Low Volume Castration-sensitive Prostate Cancer: a Randomized Nationwide Study,RECRUITING,2024-02-20,2027-11-30,2027-12,INTERVENTIONAL,PHASE3,400,['Prostate Cancer'],Prostate Cancer,Nick Beije,['Stichting Treatmeds'],['Netherlands']
NCT07210463,A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU),"A Phase 3, Randomized, Parallel-group, Double-blind, Multicenter Study Investigating the Safety and Efficacy of NT 201 Compared With Placebo in Adult Participants With Moderate to Severe Platysma Prominence in Europe",RECRUITING,2025-10-01,2027-01,2027-11,INTERVENTIONAL,PHASE3,300,"['Neuromuscular Agents', 'Peripheral Nervous System Agents', 'Physiological Effects of Drugs', 'Acetylcholine Release Inhibitors', 'Membrane Transport Modulators', 'Molecular Mechanisms of Pharmacological Action', 'Cholinergic Agents', 'Neurotransmitter Agents', 'incobotulinumtoxinA', 'Botulinum Toxins, Type A']",Neuromuscular Agents,Merz Aesthetics GmbH,[],"['Poland', 'Spain', 'Germany']"
NCT03424850,"Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy","A Phase I/II Dose-escalation Study Evaluating the Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy",RECRUITING,2018-02-27,2029-02-28,2029-02-28,INTERVENTIONAL,PHASE1,30,"['Prostate Cancer', 'Prostate Neoplasm']",Prostate Cancer,Washington University School of Medicine,[],['United States']
NCT04024462,"A Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Participants With HER2-Positive Early Breast Cancer","A Phase III, Randomized, Multicenter, Open-Label, Two-Arm Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Chinese Patients With HER2-Positive Early Breast Cancer",ACTIVE_NOT_RECRUITING,2020-02-05,2021-12-13,2026-01-19,INTERVENTIONAL,PHASE3,200,['HER2-positive Early Breast Cancer'],HER2-positive Early Breast Cancer,Hoffmann-La Roche,[],['China']
NCT05218499,Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma,"Brightline-1: A Phase II/III, Randomized, Open-label, Multi-center Study of Brigimadlin (BI 907828) Compared to Doxorubicin as First Line Treatment of Patients With Advanced Dedifferentiated Liposarcoma",ACTIVE_NOT_RECRUITING,2022-03-31,2024-04-16,2025-11-28,INTERVENTIONAL,PHASE2,400,"['Liposarcoma, Dedifferentiated']","Liposarcoma, Dedifferentiated",Boehringer Ingelheim,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'France', 'Finland', 'Denmark', 'Czechia', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy']"
NCT06545721,Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome,The Effect and Mechanism Of Weight Cycling on Hyperandrogenemia And Insulin Resistance in Polycystic Ovary Syndrome,RECRUITING,2024-08-13,2026-03-01,2026-04-01,INTERVENTIONAL,NA,425,['Polycystic Ovary Syndrome'],Polycystic Ovary Syndrome,Peking Union Medical College Hospital,[],['China']
NCT06833593,Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia,Efficacy of Optimized Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia and Identification of Intestinal Microbiota Signature,RECRUITING,2021-02-06,2026-09-26,2026-09-26,OBSERVATIONAL,,510,"['Enterococcus Faecalis Infection', 'Blood Stream Infection', 'Gut Microbiomes']",Enterococcus Faecalis Infection,IRCCS Azienda Ospedaliero-Universitaria di Bologna,[],['Italy']
NCT07260188,Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy,Prospective Multicenter Study on the Collection of Tumor Biopsies and the Generation of Organoids Derived From Breast Cancer Patients Scheduled for Neoadjuvant Chemotherapy,RECRUITING,2025-09-23,2028-07,2028-07,OBSERVATIONAL,,240,['Invasive Breast Cancer'],Invasive Breast Cancer,Istituti Clinici Scientifici Maugeri SpA,"['ASST Fatebenefratelli Sacco', 'Università degli Studi di Brescia', ""Buzzi Children's Hospital"", 'The National Research Council, Italy']",['Italy']
NCT05317637,Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708,Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708,ACTIVE_NOT_RECRUITING,2022-08-01,2026-08,2026-09-01,OBSERVATIONAL,,18,['Osteogenesis Imperfecta'],Osteogenesis Imperfecta,Baylor College of Medicine,[],['United States']
NCT03625349,Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation,Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation,ACTIVE_NOT_RECRUITING,2015-09-01,2027-10-29,2027-10-29,OBSERVATIONAL,,130,"['Aging', 'Cardiovascular Disease']",Aging,VA Office of Research and Development,[],['United States']
NCT06444308,Community Health Worker-led Hypertension Management,"Assessing the Efficacy and Safety of Community Health Worker-led Hypertension Management Enabled by a Mobile Clinical Decision Support Application Compared to Physician Care: a Randomized, Controlled, Noninferiority Trial",RECRUITING,2024-09-09,2026-09,2026-09,INTERVENTIONAL,NA,460,['Hypertension'],Hypertension,"University of Wisconsin, Madison",['Fogarty International Center of the National Institute of Health'],['Guatemala']
NCT06496178,A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients,"A Phase 3 Open-label, Randomized Controlled Study to Evaluate the Efficacy and Safety of Petosemtamab Compared With Investigator's Choice Monotherapy Treatment in Previously Treated Patients With Incurable, Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma",RECRUITING,2024-06-25,2028-02,2029-03,INTERVENTIONAL,PHASE3,500,['Head and Neck Squamous Cell Carcinoma'],Head and Neck Squamous Cell Carcinoma,Merus N.V.,[],"['Japan', 'Netherlands', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT07249788,Resmiterom Efficacy & Safety in Patients With MASH,"Clinical Evaluation of Safety and Efficacy of Resmiterom in Patients With MASH (Metabolic Dysfunction-Associated Steato-Hepatitis) A Prospective, Open-label, Interventional Study",RECRUITING,2025-10-17,2026-10-16,2026-12-31,INTERVENTIONAL,PHASE4,165,['MASH - Metabolic Dysfunction-Associated Steatohepatitis'],MASH - Metabolic Dysfunction-Associated Steatohepatitis,Nabiqasim Industries (Pvt) Ltd,[],['Pakistan']
NCT06089473,Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates,Virtual Home-based Physical Pre-habilitation in Kidney Transplant Candidates: a Pilot RCT,RECRUITING,2024-11-02,2026-08,2027-02,INTERVENTIONAL,NA,30,"['Kidney Disease, End-Stage', 'Frailty', 'Transplant;Failure,Kidney']","Kidney Disease, End-Stage",McGill University Health Centre/Research Institute of the McGill University Health Centre,['The Kidney Foundation of Canada'],['Canada']
NCT07250906,Oral Health Related Quality of Life of Children With Amelogenesis Imperfecta,Evaluation of the Impact of Anterior Veneers on the Quality of Life of Children With Amelogenesis Imperfecta,ACTIVE_NOT_RECRUITING,2025-10-16,2026-05-16,2026-05-16,OBSERVATIONAL,,10,['Amelogenesis Imperfecta'],Amelogenesis Imperfecta,Istanbul University,[],['Turkey (Türkiye)']
NCT04159987,Monitoring to the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®,"A Multicenter, Interventional, Open-label Study to Monitor the Evolution of Motor Function in SMA Type II Adults Patients Treated With SPINRAZA®",ACTIVE_NOT_RECRUITING,2020-02-25,2024-07-19,2025-12-31,INTERVENTIONAL,NA,20,['Spinal Muscular Atrophy'],Spinal Muscular Atrophy,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06630884,Inflammatory Challenge and Fear,Inflammatory Challenge and Fear Extinction: A Model to Enhance Understanding of Posttraumatic Stress Disorder,RECRUITING,2025-03-28,2028-11,2028-11,INTERVENTIONAL,PHASE1,288,['Posttraumatic Stress Disorder (PTSD)'],Posttraumatic Stress Disorder (PTSD),"University of California, San Francisco","['National Institute of Mental Health (NIMH)', 'Northern California Institute of Research and Education', 'San Francisco Veterans Affairs Medical Center']",['United States']
NCT07092228,Evaluation of Exercise Capacity in Teenage Females Using Virtual Reality and Plyometric Workout,Evaluation of Exercise Capacity in Teenage Females With Abdominal Obesity Using Virtual Reality and Plyometric Workout: Randomized Clinical Trial,RECRUITING,2025-06-20,2025-09-25,2026-01-01,INTERVENTIONAL,NA,100,['Abdominal Obesity'],Abdominal Obesity,New Ismailia National University,[],['Egypt']
NCT05133531,A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment,"A Randomized, Open-Label, C5 Inhibitor-Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy",RECRUITING,2022-08-01,2027-01-28,2027-01-28,INTERVENTIONAL,PHASE3,190,['Paroxysmal Nocturnal Hemoglobinuria'],Paroxysmal Nocturnal Hemoglobinuria,Regeneron Pharmaceuticals,[],"['Japan', 'China', 'Jordan', 'Hungary', 'Peru', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'Malaysia', 'Greece', 'United Kingdom', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Philippines']"
NCT04821089,A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines,"A Phase Ib/II, Multicentre, Double-blind, Randomised, Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in Improving the Appearance of Moderate to Severe Upper Facial Lines in Adults",RECRUITING,2021-04-06,2026-08-31,2027-03-05,INTERVENTIONAL,PHASE1,727,['Moderate to Severe Upper Facial Lines'],Moderate to Severe Upper Facial Lines,Ipsen,[],"['France', 'Germany']"
NCT06713369,AZD5305 hADME in Patients With Advanced Solid Malignancies,"A Phase I, Open-label Study to Assess the Absolute Bioavailability of Saruparib (AZD5305) and Absorption, Distribution, Metabolism, and Excretion (ADME) of [14C]-Saruparib ([14C]-AZD5305) in Patients With Advanced Solid Malignancies",RECRUITING,2025-04-02,2026-10-02,2026-10-02,INTERVENTIONAL,PHASE1,8,['Locally Advanced or Metastatic Solid Tumor'],Locally Advanced or Metastatic Solid Tumor,AstraZeneca,['Fortrea'],['United Kingdom']
NCT03897270,Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects,Photoacoustic Imaging of Human Breast,RECRUITING,2018-10-25,2026-02-25,2026-02-25,INTERVENTIONAL,NA,400,"['Breast Carcinoma', 'Healthy Subject']",Breast Carcinoma,Roswell Park Cancer Institute,['Susan G. Komen Breast Cancer Foundation'],['United States']
NCT03811002,"Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)",Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab,ACTIVE_NOT_RECRUITING,2019-07-26,2024-04-21,2029-02-21,INTERVENTIONAL,PHASE3,544,"['Limited Stage Lung Small Cell Carcinoma', 'Stage I Lung Cancer AJCC v8', 'Stage II Lung Cancer AJCC v8', 'Stage III Lung Cancer AJCC v8']",Limited Stage Lung Small Cell Carcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['Japan', 'United States']"
NCT03265379,Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection,Improving Quality of Life for Patients With Breast Cancer Invading the Chest Wall: A Prospective Registry For Patients Undergoing Full Thickness Chest Wall Resection,RECRUITING,2017-08-22,2030-08-22,2030-08-22,OBSERVATIONAL,,104,['Breast Cancer'],Breast Cancer,"University Health Network, Toronto",[],['Canada']
NCT01733082,The Mycophenolate Pregnancy Registry,The Mycophenolate Pregnancy Registry,RECRUITING,2012-11-20,2026-10-31,2026-12-31,OBSERVATIONAL,,500,"['Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases']","Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases","Genentech, Inc.","['Accord Healthcare, Inc.', 'Alkem Laboratories Ltd', 'Ascend Laboratories, LLC', 'Amneal Pharmaceuticals, LLC', 'Amta labs Limited', 'Apotex Corporation', 'Avet Lifesciences Limited', 'Azurity Pharmaceuticals', 'Biocon Pharma Limited', 'Concord Biotech Limited', 'Endo Pharmaceuticals', 'Hetero Labs Limited, Unit-V', 'Hikma Pharmaceuticals USA Inc.', 'Hisun Pharmaceuticals', 'Jubilant Cadista Pharmaceuticals, Inc.', 'Lannett Company, Inc.', 'Meitheal Pharmaceuticals, Inc.', 'Mylan Pharmaceuticals Inc', 'Novartis Pharmaceuticals', 'Rising Pharma Holdings, Inc.', 'RK Pharma Inc.', 'Sandoz', 'Strides Pharma, Inc', 'Teva Pharmaceuticals USA', 'TWi Pharmaceuticals, Inc.', 'VistaPharm, Inc.', 'Wuxi Fortune Pharmaceutical Co., Ltd', 'Zydus Pharmaceuticals']",['United States']
NCT07029737,"A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain","The SOUND-MCL Study: A Single-arm, Open-label, Multicenter, Phase II Study of Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain",RECRUITING,2025-09-05,2027-06-15,2028-12-15,INTERVENTIONAL,PHASE2,55,['Mantle-cell Lymphoma'],Mantle-cell Lymphoma,AstraZeneca,['Apices Soluciones S.L.'],['Spain']
NCT06727942,Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes,Toward Healthy Living: Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes,RECRUITING,2022-05-10,2026-09,2026-09,INTERVENTIONAL,NA,60,['Adult ALL'],Adult ALL,The University of Texas at Arlington,[],['United States']
NCT06445231,Echocardiography in Nursing Home,Implementation and Effectiveness of Screening Echocardiography Performed in Nursing Home: ECHOGER,RECRUITING,2024-10-02,2028-01-01,2030-01-01,INTERVENTIONAL,NA,1050,"['Heart Diseases', 'Heart Failure', 'Heart Valve Diseases']",Heart Diseases,Nantes University Hospital,['Directorate of Health Care Supply'],['France']
NCT07261631,Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors,"A Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-DFC413 and Safety and Imaging Properties of [68Ga]Ga-NNS309 in Patients With Solid Tumors",RECRUITING,2025-11-24,2029-04-24,2029-04-24,INTERVENTIONAL,PHASE1,180,"['Pancreatic Ductal Adenocarcinoma', 'Non-Small Cell Lung Cancer', 'HR+/HER2- Ductal and Lobular Breast Cancer', 'Triple Negative Breast Cancer', 'Colorectal Cancer', 'Soft Tissue Sarcoma']",Pancreatic Ductal Adenocarcinoma,Novartis Pharmaceuticals,[],['Israel']
NCT05030428,Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease,"A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)",ACTIVE_NOT_RECRUITING,2021-11-23,2027-10-13,2027-10-13,INTERVENTIONAL,PHASE3,17004,['Atherosclerotic Cardiovascular Disease'],Atherosclerotic Cardiovascular Disease,Novartis Pharmaceuticals,[],"['Bulgaria', 'Japan', 'Iceland', 'New Zealand', 'Netherlands', 'China', 'Kenya', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'Russia', 'Slovenia', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Puerto Rico', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Mauritius', 'Singapore', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'Sweden', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07262073,Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy,Prospective Randomized Controlled Study Comparing Peak Expiratory Flow (PEF) Changes After Robot-Assisted and Open Radical Prostatectomy,ACTIVE_NOT_RECRUITING,2025-11-01,2025-12-30,2026-06-30,INTERVENTIONAL,NA,60,"['Prostate Cancer (CRPC)', 'Peak Expiratory Flow']",Prostate Cancer (CRPC),Ankara City Hospital Bilkent,[],['Turkey (Türkiye)']
NCT03974022,"Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)","A Phase I/II, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumor Efficacy of DZD9008 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With EGFR or HER2 Mutation",ACTIVE_NOT_RECRUITING,2019-07-09,2024-07-29,2025-12,INTERVENTIONAL,PHASE1,315,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Dizal Pharmaceuticals,[],"['Japan', 'China', 'United States', 'France', 'Chile', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Malaysia', 'South Korea', 'Argentina', 'Australia']"
NCT07090122,Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone,Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone,RECRUITING,2025-12-01,2028-01-13,2028-06-13,INTERVENTIONAL,NA,36,"['Spine Metastases', 'Bone Pain']",Spine Metastases,University of Minnesota,[],['United States']
NCT03072927,MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study,MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study,RECRUITING,2017-03-10,2026-12,2026-12,OBSERVATIONAL,,8000,['Lumbar Spinal Stenosis'],Lumbar Spinal Stenosis,Stryker Instruments,[],['United States']
NCT07262515,Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP,Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP,RECRUITING,2024-07-19,2025-12,2025-12,OBSERVATIONAL,,1400,['Acute Alcoholic Hepatitis'],Acute Alcoholic Hepatitis,Assistance Publique - Hôpitaux de Paris,"['URC-CIC Paris Descartes Necker Cochin', 'Ministry of Health, France']",['France']
NCT06502691,[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer,[18F]FTT Positron Emission Tomography (PET) in Patients With Metastatic Breast Cancer,RECRUITING,2026-01-01,2027-12-31,2030-12-31,INTERVENTIONAL,PHASE1,22,"['Anatomic Stage IV Breast Cancer AJCC v8', 'Metastatic Breast Carcinoma']",Anatomic Stage IV Breast Cancer AJCC v8,University of Washington,['Breast Cancer Research Foundation'],['United States']
NCT06055725,A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development,"A Prospective, Multicountry Study to Estimate the Incidence of and Provide a Best Practice Model for Monitoring the Development of Post-Stroke Spasticity",RECRUITING,2023-11-01,2027-11-30,2027-11-30,OBSERVATIONAL,,1051,['Spasticity as Sequela of Stroke'],Spasticity as Sequela of Stroke,Ipsen,[],"['United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Sweden', 'Germany']"
NCT05404048,PD-L1 PET-imaging During CAR T-cell Therapy,Programmed Death Ligand 1 (PD-L1)-PET Imaging in Patients With (Diffuse) Large B-cell Lymphoma Who Are Treated With CD19-directed CAR T-cell Therapy: a Pilot Study,ACTIVE_NOT_RECRUITING,2022-05-18,2025-12,2026-05,INTERVENTIONAL,PHASE2,20,['Large B-cell Lymphoma'],Large B-cell Lymphoma,University Medical Center Groningen,[],['Netherlands']
NCT06685757,A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR),"A Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase 3 Trial Evaluating the Efficacy and Safety of Felzartamab in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR)",RECRUITING,2024-12-03,2026-12-01,2027-06-01,INTERVENTIONAL,PHASE3,120,['Antibody-mediated Rejection'],Antibody-mediated Rejection,Biogen,[],"['Brazil', 'New Zealand', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Canada', 'Australia']"
NCT05443737,Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients,Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients: a Stepped Wedge Cluster Randomized Controlled Trial,RECRUITING,2022-01-01,2027-08-31,2027-08-31,INTERVENTIONAL,PHASE3,2800,"['Cancer', 'Fertility Preservation']",Cancer,"University of California, San Diego","[""Rady Children's Hospital, San Diego"", 'City of Hope Medical Center']",['United States']
NCT07021898,A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.,"A Phase 1 First-in-Human Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of ERAS-4001 Monotherapy and in Combination in Patients With Advanced Solid Tumors",RECRUITING,2025-08-06,2028-08,2028-12,INTERVENTIONAL,PHASE1,200,['Metastatic Solid Tumors'],Metastatic Solid Tumors,"Erasca, Inc.",[],['United States']
NCT06365216,ALS Phase II Study of NX210c,"A Double-blind, Randomized, Placebo-controlled, Multicentric, Phase II Study in Adult Patients With Amyotrophic Lateral Sclerosis (ALS) to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Multiple Intravenous Infusions of NX210c",ACTIVE_NOT_RECRUITING,2024-10-25,2026-02-01,2026-09-30,INTERVENTIONAL,PHASE2,80,['Amyotrophic Lateral Sclerosis'],Amyotrophic Lateral Sclerosis,Axoltis Pharma,['ACT4ALS network'],['France']
NCT05685199,Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding,Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding,RECRUITING,2024-05-10,2026-03,2030-03,OBSERVATIONAL,,150,"['Hypermobile Ehlers-Danlos Syndrome', 'Heavy Menstrual Bleeding', 'Hypermobility Syndrome (Disorder)']",Hypermobile Ehlers-Danlos Syndrome,St. Jude Children's Research Hospital,['Wallace H. Coulter Foundation'],['United States']
NCT06818916,Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma,Efficacy and Safety of Hetrombopag in Promoting Platelet Engraftment After Autologous Hematopoietic Stem Cell Transplantation in Children With Neuroblastoma,RECRUITING,2024-06-30,2027-04-30,2027-07-31,INTERVENTIONAL,NA,30,"['Delayed Platelet Engraftment', 'Neuroblastoma', 'Autologous Hematopoietic Stem Cell Transplantation']",Delayed Platelet Engraftment,Beijing Children's Hospital,[],['China']
NCT06016842,A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis,"A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants With Primary Biliary Cholangitis (PBC)",RECRUITING,2023-08-31,2029-05-31,2029-05-31,INTERVENTIONAL,PHASE3,276,['Primary Biliary Cholangitis (PBC)'],Primary Biliary Cholangitis (PBC),Ipsen,[],"['Bulgaria', 'New Zealand', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Canada', 'Romania', 'Greece', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT06758011,ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting,Feasibility Study for ivWatch® in Prevention of Extravasation of Vesicants in an Oncology Setting,RECRUITING,2023-05-17,2026-11-17,2026-11-17,INTERVENTIONAL,NA,2395,"['Oncology', 'Extravasation']",Oncology,Roswell Park Cancer Institute,[],['United States']
NCT07260747,"Comparison of the Effects of Virtual Reality-Based Interventions on Foot Function, Foot Pressure, and Balance in Sedentary Individuals","Comparison of the Effects of Virtual Reality-Based Interventions on Foot Function, Foot Pressure, and Balance in Sedentary Individuals",RECRUITING,2025-10-13,2025-11-15,2026-05-07,INTERVENTIONAL,NA,45,['Foot Diseases'],Foot Diseases,Istanbul Medipol University Hospital,[],['Turkey (Türkiye)']
NCT05624528,A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder,"A Double-Blind, Randomized, Placebo-Controlled Study of Tolcapone for OCD",RECRUITING,2023-06-22,2026-06,2026-06,INTERVENTIONAL,PHASE2,85,"['Obsessive-Compulsive Disorder', 'OCD']",Obsessive-Compulsive Disorder,University of Chicago,[],['United States']
NCT07163858,Postural Mobilization Compared to Noradrenaline Only in Off-Pump CABG Surgery,"Comparison of Hemodynamic Management by Postural Mobilization Versus Chemical Vasoconstriction Using Noradrenaline Exclusively in Off-pump Coronary Artery Bypass Graft Surgery: A Prospective, Randomized, Comparative, Single-center Study.",RECRUITING,2025-10-06,2027-07,2027-08,INTERVENTIONAL,NA,50,"['Coronary Artery Disease With Need for Bypass Surgery', 'Coronary Artery Disease(CAD)', 'Coronary Artery Bypass', 'Off Pump Coronary Artery Bypass Graft', 'Off Pump Coronary Artery Bypass Surgery', 'Hemodynamic Management', 'Hemodynamic Optimization', 'Noradrenaline']",Coronary Artery Disease With Need for Bypass Surgery,Infirmerie Protestante de Lyon,[],['France']
NCT06417814,A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer,"A Phase III, Open-label, Sponsor-blind, Randomized Study of Dato-DXd With or Without Osimertinib Versus Platinum-based Doublet Chemotherapy for Participants With EGFR-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Has Progressed on Prior Osimertinib Treatment (TROPION-Lung15)",ACTIVE_NOT_RECRUITING,2024-10-04,2026-09-30,2028-09-27,INTERVENTIONAL,PHASE3,744,['Metastatic Non-small Cell Lung Cancer'],Metastatic Non-small Cell Lung Cancer,AstraZeneca,['Daiichi Sankyo'],"['Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Israel', 'France', 'South Korea', 'Thailand', 'Poland', 'India', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Vietnam', 'Germany', 'Brazil', 'United States', 'Italy', 'Philippines']"
NCT06502483,PRISM for Depression and Anxiety in Young Adults With Cancer,Treatment Development Study of the Promoting Resilience in Stress Management (PRISM) Intervention for Depression and Anxiety in Young Adults With Cancer,ACTIVE_NOT_RECRUITING,2024-09-06,2026-02-01,2026-02-01,INTERVENTIONAL,NA,15,"['Cancer Diagnosis', 'Non-Metastatic Neoplasm', 'Anxiety', 'Anxiety Disorders', 'Depression', 'Depressive Disorder', 'Depression, Anxiety', 'Desmoid']",Cancer Diagnosis,Dana-Farber Cancer Institute,[],['United States']
NCT05755386,Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN,"A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Iptacopan (LNP023) in Idiopathic Immune-complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN)",RECRUITING,2023-10-02,2028-10-27,2029-05-31,INTERVENTIONAL,PHASE3,106,['IC-MPGN'],IC-MPGN,Novartis Pharmaceuticals,[],"['Japan', 'Netherlands', 'Slovakia', 'Israel', 'France', 'South Korea', 'Czechia', 'Poland', 'India', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT06639295,A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps,"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)",ACTIVE_NOT_RECRUITING,2024-11-22,2025-12,2026-08,INTERVENTIONAL,PHASE3,243,"['Sinusitis', 'Nasal Polyps']",Sinusitis,"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.",[],['China']
NCT07260877,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus","A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus",RECRUITING,2025-12,2026-07,2026-09,INTERVENTIONAL,PHASE2,24,"['Cutaneous Lupus Erythematosus (CLE)', 'Systemic Lupus Erythematosus', 'SLE', 'SLE (Systemic Lupus)', 'CLE']",Cutaneous Lupus Erythematosus (CLE),"Ventus Therapeutics U.S., Inc.",[],['United States']
NCT07261865,Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients,Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients and Assessing Their Impact on Organ Failure and Outcome.,RECRUITING,2024-05-01,2025-12-01,2025-12-01,OBSERVATIONAL,,4395,"['Diabetes (DM)', 'Critical Illness']",Diabetes (DM),University Medical Center Groningen,['Frisius Medisch Centrum'],['Netherlands']
NCT03348631,Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer,"A Phase II Study of Tazemetostat (EPZ-6438) in Recurrent or Persistent Endometrioid or Clear Cell Carcinoma of the Ovary, and Recurrent or Persistent Endometrioid Endometrial Adenocarcinoma",ACTIVE_NOT_RECRUITING,2019-05-01,2023-07-28,2026-02-12,INTERVENTIONAL,PHASE2,62,"['Recurrent Endometrial Endometrioid Adenocarcinoma', 'Recurrent Malignant Uterine Corpus Neoplasm', 'Recurrent Ovarian Carcinoma', 'Recurrent Ovarian Clear Cell Adenocarcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma']",Recurrent Endometrial Endometrioid Adenocarcinoma,National Cancer Institute (NCI),['NRG Oncology'],['United States']
NCT06185023,"Effects of High-intensity Exercise Training on Physical Fitness, Cognition, Language in Post-stroke Aphasia",Exercising Language: Behavioral and Neurophysiological Changes After High-intensity Exercise Training in Post-stroke Aphasia,ACTIVE_NOT_RECRUITING,2023-12-12,2025-09-12,2025-12,INTERVENTIONAL,NA,12,"['Aphasia, Acquired', 'Aphasia', 'Aphasia, Fluent', 'Aphasia Non Fluent']","Aphasia, Acquired","University of California, Berkeley","['University of California, San Francisco', 'University of San Francisco', 'California State University, East Bay']",['United States']
NCT06209567,A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors,An Investigator-Initiated Study to Evaluate PSMA Expression in Patients With High-Grade Gliomas or Brain Metastases With 68Ga-PSMA-11 PET,ACTIVE_NOT_RECRUITING,2024-01-05,2027-01-05,2027-01-05,INTERVENTIONAL,EARLY_PHASE1,11,"['High-grade Glioma', 'Brain Metastases', 'Brain Metastases, Adult']",High-grade Glioma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06563700,Novel Lenses for Myopia Progression Trial,"A Double Masked, Randomised, Longitudinal Comparative Study to Evaluate the Myopia Progression of Novel Spectacle Lenses Versus Single Vision Spectacle Lenses in Children With Myopia",ACTIVE_NOT_RECRUITING,2024-08-16,2027-07-31,2027-07-31,INTERVENTIONAL,NA,300,"['Myopia, Progressive']","Myopia, Progressive",Shanghai Eye Disease Prevention and Treatment Center,[],['China']
NCT07049939,A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023),"An Open-Label, Single-Dose Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of MK-3543",RECRUITING,2025-08-20,2026-03-16,2026-03-16,INTERVENTIONAL,PHASE1,24,['Hepatic Insufficiency'],Hepatic Insufficiency,Merck Sharp & Dohme LLC,[],['United States']
NCT07261969,CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan,CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan,RECRUITING,2024-12-18,2026-03-30,2027-04-30,INTERVENTIONAL,NA,1050,"['Respiratory Tract Infection Bacterial', 'Respiratory Tract Infection Viral', 'AMR', 'CRP', 'Inflammation']",Respiratory Tract Infection Bacterial,"Rigshospitalet, Denmark","['International Centre for Antimicrobial Resistance Solutions (ICARS)', 'University of Copenhagen']",['Kyrgyzstan']
NCT03857594,Integrative Sequencing In Germline and Hereditary Tumours,Integrative Sequencing In Germline and Hereditary Tumours,ACTIVE_NOT_RECRUITING,2018-10-02,2026-09,2026-09,OBSERVATIONAL,,10,"['Hereditary Cancer Syndrome', 'High-Risk', 'Mutation', 'Germline Mutation']",Hereditary Cancer Syndrome,"University Health Network, Toronto",[],['Canada']
NCT06955494,"ENACT Program on Auditory Perception and Function, Cognitive Function and Health-related Quality of Life","The Effect of the ""Empowerment Network for Auditory-Cognitive Training (ENACT) Program"" on Auditory Perception and Function, Cognitive Function and Health-related Quality of Life of Persons Living With Mild Cognitive Impairment",RECRUITING,2025-06-04,2026-09-30,2026-12-31,INTERVENTIONAL,NA,62,"['Hearing Loss', 'Cognitive Impairment, Mild']",Hearing Loss,The University of Hong Kong,[],['Hong Kong']
NCT07233473,Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections,"Prospective, Multicentric, Single Arm Clinical Investigation to Assess the Effectiveness and Safety of Multi-Gyn UT Protect Gel for Prevention of Recurrent Urinary Tract Infections",RECRUITING,2025-10-20,2026-12-31,2027-03-31,INTERVENTIONAL,NA,50,['Urinary Tract Infections (UTIs)'],Urinary Tract Infections (UTIs),Karo Pharma AB,[],['France']
NCT07162168,Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning,Development and Evaluation of a Deep Learning-Based Model for Automated Osteoporosis Assessment Using CT Images,RECRUITING,2024-09-01,2027-09-01,2027-12-01,OBSERVATIONAL,,3000,"['Bone Aging', 'Osteoporosis Diagnosis']",Bone Aging,Peking University People's Hospital,[],['China']
NCT07185815,"Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine","A Prospective, Dose Escalating, Open Label, Multi-center, Phase I/IIa Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine.",RECRUITING,2025-08-01,2026-12-31,2027-06-03,INTERVENTIONAL,PHASE1,24,"['Major Depressive Disorder (MDD)', 'Bipolar 1 Disorder', 'Schizophrenia']",Major Depressive Disorder (MDD),Mapi Pharma Ltd.,[],['Israel']
NCT03642795,Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology),Validation of the French Version of the CQR (Compliance Questionnaire Rheumatology): Specific Tool for Evaluation of Observance of Rheumatology Treatment,RECRUITING,2022-06-23,2029-03,2029-03,OBSERVATIONAL,,150,['Rheumatoid Polyarthritis'],Rheumatoid Polyarthritis,Centre Hospitalier Universitaire de Nīmes,[],['France']
NCT06172205,Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC,Infusional FOLFOX Plus Camrelizumab and Apatinib Versus HAIC-FOLFOX Plus Camrelizumab and Apatinib for Hepatocellular Carcinoma of BCLC C Stage: A Multi-center Randomized Phase III Trial,RECRUITING,2023-07-01,2028-07-31,2029-07-31,INTERVENTIONAL,PHASE3,262,"['BCLC Stage C Hepatocellular Carcinoma', 'Chemotherapy Effect']",BCLC Stage C Hepatocellular Carcinoma,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT04963946,STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia,STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia. A FILO Study.,ACTIVE_NOT_RECRUITING,2021-10-18,2025-08-01,2028-08-01,INTERVENTIONAL,PHASE2,160,['Untreated Chronic Lymphocytic Leukemia'],Untreated Chronic Lymphocytic Leukemia,French Innovative Leukemia Organisation,[],['France']
NCT07215299,"Temporal Interference Methods for Non-invasive Deep Brain Stimulation, Study 1.1",Temporal Interference Methods for Non-invasive Deep Brain Stimulation,RECRUITING,2025-11-12,2026-01-21,2026-01-21,INTERVENTIONAL,NA,30,['Healthy Volunteers'],Healthy Volunteers,Indiana University,['National Institute of Mental Health (NIMH)'],['United States']
NCT05322226,Addiction Intervention in Liver Transplantation Candidates,Evaluation of an Addiction Intervention in Candidates for Liver Transplantation,ACTIVE_NOT_RECRUITING,2022-07-27,2024-09-26,2026-12-31,INTERVENTIONAL,NA,64,"['Transplant; Failure, Liver', 'Addiction, Alcohol']","Transplant; Failure, Liver","University Hospital, Montpellier",[],['France']
NCT04117087,Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer,Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer,ACTIVE_NOT_RECRUITING,2020-05-28,2027-06-01,2027-06-01,INTERVENTIONAL,PHASE1,27,"['Colorectal Cancer', 'Pancreatic Cancer']",Colorectal Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Bristol-Myers Squibb', 'National Cancer Institute (NCI)', 'National Institutes of Health (NIH)']",['United States']
NCT07230418,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes","A Double-blind, Randomized, Dose-escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes",RECRUITING,2025-11-10,2026-02,2026-02,INTERVENTIONAL,PHASE1,66,['Chronic Spontaneous Urticaria'],Chronic Spontaneous Urticaria,"Chengdu Suncadia Medicine Co., Ltd.",[],['China']
NCT06333925,Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study,Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study,RECRUITING,2024-05-14,2026-11-30,2026-11-30,INTERVENTIONAL,NA,60,"['Misophonia', 'Emotion Dysregulation', 'Sensory Processing Disorder', 'Auditory Over Responsivity', 'Anxiety Disorder', 'Sound Sensitivity']",Misophonia,Duke University,['Misophonia Research Fund'],['United States']
NCT05711940,"Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD","A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression",ACTIVE_NOT_RECRUITING,2023-02-14,2026-02,2026-12,INTERVENTIONAL,PHASE3,572,['Treatment Resistant Depression'],Treatment Resistant Depression,COMPASS Pathways,[],"['Netherlands', 'United States', 'France', 'Denmark', 'Ireland', 'Spain', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT07215780,SORE Study: Sitz Baths After Urogynecologic Reconstruction,SORE Study: Sitz Baths After Urogynecologic Reconstruction,RECRUITING,2025-10-28,2027-03,2027-06,INTERVENTIONAL,NA,112,"['Pelvic Organ Prolapse', 'Postoperative Pain Management', 'Gynecologic Surgeries']",Pelvic Organ Prolapse,Yale University,['American Urogynecologic Society'],['United States']
NCT04077099,A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer,A Phase 1/2 Study of REGN5093 in Patients With MET-Altered Advanced Non-Small Cell Lung Cancer,RECRUITING,2020-01-07,2032-04-22,2032-04-22,INTERVENTIONAL,PHASE1,231,['NSCLC'],NSCLC,Regeneron Pharmaceuticals,[],"['South Korea', 'United States', 'France']"
NCT07261904,BIOCHROMADERM® PMCF STUDY,"Prospective, Observational, Multicentre, Single Group, Open-label Study to Confirm the Safety and Effectiveness of BIOCHROMADERM® Ink for the Reconstruction of the Nipple-areola Complex in Patients Undergoing Breast Reconstructive Surgery Following Mastectomy",RECRUITING,2025-11-12,2026-10-12,2027-06-12,OBSERVATIONAL,,115,['Reconstruction of the Nipple-areola Complex in Patients Undergoing Breast Reconstructive Surgery Following Mastectomy'],Reconstruction of the Nipple-areola Complex in Patients Undergoing Breast Reconstructive Surgery Following Mastectomy,Laboratoires BIOTIC Phocea,"['Clinical Research Consultants, Inc.']",['France']
NCT06753747,A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma,A Phase 1b/2 Trial of Afatinib Plus Palbociclib in Previously Treated Recurrent or Metastatic Esophageal Squamous Cell Carcinoma,RECRUITING,2025-09-10,2027-09,2028-09,INTERVENTIONAL,PHASE1,45,['Esophagus Cancer'],Esophagus Cancer,West China Hospital,[],['China']
NCT04449549,Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel,Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel,RECRUITING,2020-08-24,2026-04-02,2026-04-08,INTERVENTIONAL,PHASE2,82,['Neoplasms'],Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT04900792,A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma,A First-in-Human Clinical Trial of Pharmacologic Ascorbate and Ferumoxytol Combined With Concomitant Temozolomide and External Beam Radiation Therapy for Newly Diagnosed Glioblastoma,ACTIVE_NOT_RECRUITING,2023-02-28,2025-05-13,2026-12-31,INTERVENTIONAL,PHASE1,17,"['Glioblastoma', 'Glioblastoma Multiforme']",Glioblastoma,Bryan Allen,"['Holden Comprehensive Cancer Center', 'National Cancer Institute (NCI)']",['United States']
NCT05869058,DCNN Developed for Detection and Assessing the Perfusion of PTG,Development and Improvement of a Deep Convolutional Neural Network for Detection and Assessing the Perfusion of Parathyroid Gland During Endoscopic Thyroidectomy,RECRUITING,2023-06-13,2026-04,2026-10,OBSERVATIONAL,,300,['Thyroidectomy'],Thyroidectomy,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT05361434,A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults,A Prospective Observational International Study of Cabozantinib Tablets in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma in Adults,ACTIVE_NOT_RECRUITING,2022-09-26,2026-05-31,2026-11-30,OBSERVATIONAL,,311,['Advanced Renal Cell Carcinoma'],Advanced Renal Cell Carcinoma,Ipsen,[],"['Belgium', 'Norway', 'Saudi Arabia', 'France', 'Italy', 'South Korea', 'United Kingdom', 'Greece']"
NCT07260799,Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer,Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer,RECRUITING,2025-10-25,2026-02-28,2026-02-28,OBSERVATIONAL,,150,['Serum Analytes'],Serum Analytes,Tasso Inc.,['American Research Labs'],['United States']
NCT03867344,The Functional Neuroanatomy of the Human Physiological Stress Response,The Functional Neuroanatomy of the Human Physiological Stress Response,ACTIVE_NOT_RECRUITING,2019-10-01,2024-05-31,2026-09-01,INTERVENTIONAL,NA,44,"['Hypoglycemia', 'Physiological Stress']",Hypoglycemia,Brigham and Women's Hospital,"['Beth Israel Deaconess Medical Center', ""Boston Children's Hospital"", 'Mclean Hospital']",['United States']
NCT06489964,Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies,Addressing the Problem of Recommended But Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies,RECRUITING,2025-12,2026-03,2026-03,INTERVENTIONAL,NA,600,"['Preventable Disease, Vaccine']","Preventable Disease, Vaccine",Canadian Immunization Research Network,"['Dalhousie University', 'AstraZeneca', 'GlaxoSmithKline', 'Canadian Center for Vaccinology']",['Canada']
NCT06485076,Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma,Phase II Feasibility Study of Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma,RECRUITING,2024-07-18,2026-12,2027-06,INTERVENTIONAL,NA,144,"['Multiple Myeloma in Relapse', 'Multiple Myeloma, Refractory', 'Multiple Myeloma Stage III', 'Multiple Myeloma Progression', 'Multiple Myeloma', 'B Cell Lymphoma', 'Lymphoma, B-Cell', 'Aggressive Lymphoma']",Multiple Myeloma in Relapse,"University Health Network, Toronto","['Myeloma Canada', 'The Leukemia and Lymphoma Society of Canada']",['Canada']
NCT07261982,Analysis of the Efficacy of Pressure Pad vs Pressure Bandage Immobilisation for Snake Bite First Aid in Healthy Volunteers.,Efficacy of Pressure Pad vs Pressure Bandage Immobilisation for Snake Bite First Aid in Healthy Volunteers.,RECRUITING,2025-07-18,2026-12,2027-02,INTERVENTIONAL,NA,24,"['Snake Bites', 'Snakebite', 'Snake Envenomation', 'Snake Bite', 'First Aid']",Snake Bites,Townsville University Hospital,[],['Australia']
NCT07047118,A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC),"A Phase II, Randomized, Open-label, Multi-center Study of JSB462 (Luxdegalutamide) in Combination With Lutetium (177Lu) Vipivotide Tetraxetan in Adult Male Patients With PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC)",RECRUITING,2025-07-03,2028-01-07,2028-11-04,INTERVENTIONAL,PHASE2,130,"['Prostatic Cancer, Castration-Resistant']","Prostatic Cancer, Castration-Resistant",Novartis Pharmaceuticals,[],"['Singapore', 'Israel', 'Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Australia']"
NCT07261358,"The Effect of Three-Dimensional Exercises ( Schroth Method ) on Trunk Muscle Endurance, Sleep Quality, and Quality of Life in Adolescents With Hyperkyphosis","The Effect of Three-Dimensional Exercises ( Schroth Method ) on Trunk Muscle Endurance, Sleep Quality, and Quality of Life in Adolescents With Hyperkyphosis",RECRUITING,2025-10-06,2026-03-29,2026-05-01,OBSERVATIONAL,,42,"['Spine Deformity', 'Kyphosis', 'Adolescent', 'Sleep Quality', 'Trunk Muscle Endurance']",Spine Deformity,Gaziosmanpasa Research and Education Hospital,[],['Turkey (Türkiye)']
NCT05649059,Investigating the Effects of Cannabidiol on Social Anxiety Disorder,Investigating the Effects of Cannabidiol on Social Anxiety Disorder,RECRUITING,2025-07-10,2026-05,2026-09,INTERVENTIONAL,PHASE4,50,"['Phobia, Social']","Phobia, Social",Massachusetts Institute of Technology,['Massachusetts General Hospital'],['United States']
NCT06623578,Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC,Comparative Study of Transaxillary Robotic Thyroidectomy With Modified Radical Neck Dissection Versus Conventional Open Surgery in Patients With Papillary Thyroid Carcinoma and Lateral Neck Node Metastases: a Prospective Multicenter Randomized Controlled Study,RECRUITING,2024-09-23,2033-12-31,2033-12-31,INTERVENTIONAL,NA,876,"['Papillary Thyroid Carcinoma', 'Lymphatic Metastasis']",Papillary Thyroid Carcinoma,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT06431490,A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer,"A Study to Evaluate the Efficacy, Safety, and Immunogenicity of TQB2102 for Injection in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer",RECRUITING,2024-07-22,2027-05,2029-12,INTERVENTIONAL,PHASE1,103,['Biliary Tract Cancer'],Biliary Tract Cancer,"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.",[],['China']
NCT04774718,"A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors","A Phase I/II, Open-Label, Multicenter, Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors for Whom Prior Treatment Has Proven to be Ineffective or for Whom There is No Satisfactory Treatment Available",RECRUITING,2021-09-14,2032-02-28,2032-02-28,INTERVENTIONAL,PHASE1,42,['ALK Fusion-positive Solid or CNS Tumors'],ALK Fusion-positive Solid or CNS Tumors,Hoffmann-La Roche,[],"['Brazil', 'China', 'United States', 'France', 'Germany', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT07011745,A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease",RECRUITING,2025-07-16,2028-11-03,2028-11-13,INTERVENTIONAL,PHASE3,352,['Alzheimer Disease'],Alzheimer Disease,Bristol-Myers Squibb,[],"['Israel', 'Hungary', 'United States', 'France', 'Ukraine', 'Chile', 'Puerto Rico', 'Italy', 'South Korea', 'Czechia', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT06228365,Minimally Invasive Superficial Venous Insufficiency Surgery and Digital Sedation,Efficacy of Digital Sedation Compared With Neuroleptanalgesia in Percutaneous Outpatient Surgery for Superficial Venous Insufficiency,RECRUITING,2023-11-20,2026-05-31,2026-06-30,INTERVENTIONAL,NA,400,['Superficial Venous Insufficiency'],Superficial Venous Insufficiency,GCS Ramsay Santé pour l'Enseignement et la Recherche,['Vivactis M2Research'],['France']
NCT06186765,F15 Recharge Free Axonics SNM System Clinical Study,"Prospective, Non-randomized, Multicenter Clinical Evaluation of the Recharge Free Axonics SNM System (Model 4101)",RECRUITING,2023-12-08,2026-03,2027-03,INTERVENTIONAL,NA,150,"['Urinary Urge Incontinence (UUI)', 'Urinary Frequency (UF)', 'Fecal Incontinence (FI)']",Urinary Urge Incontinence (UUI),"Axonics, Inc.",[],"['United Kingdom', 'United States', 'Netherlands']"
NCT06302595,MRI Guided Prostate Biopsy,Magnetic Resonance Imaging Guided Prostate Biopsy,RECRUITING,2023-08-24,2026-06,2026-06,INTERVENTIONAL,NA,15,['Suspected Prostate Cancer'],Suspected Prostate Cancer,Brigham and Women's Hospital,"['National Cancer Institute (NCI)', 'Physical Sciences Inc.']",['United States']
NCT02915198,Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes,CSP #2002 - Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes (VA-IMPACT),RECRUITING,2023-04-03,2029-09-28,2029-09-28,INTERVENTIONAL,PHASE4,7410,"['Prediabetic State', 'Atherosclerosis', 'Metformin']",Prediabetic State,VA Office of Research and Development,[],['United States']
NCT06299839,PAS-004 in Patients With Advanced Solid Tumors,"A Phase 1 Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAS-004, a MEK (1/2) Inhibitor, in Patients With MAPK Pathway-driven Advanced Solid Tumors With a Documented RAS, NF1, or RAF Mutation or Patients Who Have Failed BRAF/MEK Inhibition",RECRUITING,2024-02-29,2026-02,2027-02,INTERVENTIONAL,PHASE1,48,"['RAS Mutation', 'NF1 Mutation', 'RAF Mutation', 'Advanced Solid Tumors']",RAS Mutation,Pasithea Therapeutics Corp.,[],"['Bulgaria', 'United States', 'Romania']"
NCT05141201,SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS),Saphnelo for Intravenous Infusion 300 mg Specific Use Result Study All Patient Investigation in Patients With Systemic Lupus Erythematosus,ACTIVE_NOT_RECRUITING,2021-12-21,2025-11-30,2025-11-30,OBSERVATIONAL,,1620,"['Lupus Erythematosus, Systemic']","Lupus Erythematosus, Systemic",AstraZeneca,[],['Japan']
NCT07256392,Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria,A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria Who Have Completed CDX0159-12 or CDX0159-13,RECRUITING,2025-11-25,2028-09,2028-09,INTERVENTIONAL,PHASE3,1370,['Chronic Spontaneous Urticaria'],Chronic Spontaneous Urticaria,Celldex Therapeutics,[],['United States']
NCT07236489,Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block,Prospective Multicenter Randomized Controlled Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block,RECRUITING,2025-11-25,2029-11,2029-11,INTERVENTIONAL,NA,266,"['Atrioventricular Block', 'Pacemaker']",Atrioventricular Block,Nantes University Hospital,[],['France']
NCT03692052,"A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia","A Phase 2, Open-label, Multicenter Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Subjects With Non-transfusion-dependent Thalassemia",ACTIVE_NOT_RECRUITING,2019-03-20,2020-08-20,2030-09-30,INTERVENTIONAL,PHASE2,20,['Thalassemia'],Thalassemia,"Agios Pharmaceuticals, Inc.",[],"['United Kingdom', 'United States', 'Canada']"
NCT00217737,"Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer","A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers",ACTIVE_NOT_RECRUITING,2005-09-06,2024-02-22,2026-04-11,INTERVENTIONAL,PHASE3,2431,"['Colon Adenocarcinoma', 'Stage IIA Colon Cancer AJCC v7', 'Stage IIB Colon Cancer AJCC v7', 'Stage IIC Colon Cancer AJCC v7']",Colon Adenocarcinoma,National Cancer Institute (NCI),[],"['South Africa', 'United States', 'Puerto Rico', 'Peru', 'Canada']"
NCT07070128,Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer,Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer (STAR-BREAST),RECRUITING,2025-08-20,2026-08-11,2026-08-11,OBSERVATIONAL,,800,['Breast Neoplasms'],Breast Neoplasms,AstraZeneca,[],['Brazil']
NCT04038138,Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study,Clinical Trial Readiness Network FSHD France: Prospective 24 Months MRI Study,ACTIVE_NOT_RECRUITING,2019-09-16,2025-09-03,2026-09-03,INTERVENTIONAL,NA,100,"['Muscular Dystrophy', 'Facioscapulohumeral']",Muscular Dystrophy,Centre Hospitalier Universitaire de Nice,[],['France']
NCT05006482,"Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial",Optimizing Functional Outcomes of Older Cancer Survivors: The GEM-S Study,RECRUITING,2023-07-18,2027-05-17,2027-05-17,INTERVENTIONAL,PHASE3,668,"['Lymphoma', 'Malignant Solid Neoplasm']",Lymphoma,University of Rochester,['National Cancer Institute (NCI)'],['United States']
NCT05702463,Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II,Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II,RECRUITING,2023-06-13,2027-06-01,2027-07-01,INTERVENTIONAL,PHASE1,30,"['Platelet Aggregation', 'Type 2 Diabetes', 'Aspirin', 'Diabetes Mellitus, Type 2', 'Platelet Aggregation Inhibitors']",Platelet Aggregation,Montreal Heart Institute,['Heart and Stroke Foundation of Canada'],['Canada']
NCT07261735,Clinical Evaluation of Customized Attachment Composites in Clear Aligner Therapy,Three-Dimensional Evaluation of Wear and Clinical Survival of Attachments Reproduced With Customized Composites for Clear Aligner Therapy: A Prospective Observational Clinical Study,RECRUITING,2025-08-25,2026-05,2026-08,OBSERVATIONAL,,24,['Clear Aligner Therapy - Attachment Wear and Bonding Performance'],Clear Aligner Therapy - Attachment Wear and Bonding Performance,Saglik Bilimleri Universitesi,[],['Turkey (Türkiye)']
NCT05428176,A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors,Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children With Cancer,ACTIVE_NOT_RECRUITING,2023-02-16,2026-05-12,2027-06-30,INTERVENTIONAL,NA,342,"['Acute Leukemia', 'Acute Lymphoblastic Leukemia', 'Acute Myeloid Leukemia', 'Lymphoblastic Lymphoma']",Acute Leukemia,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT06377852,The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study,Comparing Oral Drug Dosing Strategies in Older Patients With Metastatic Breast Cancer to Maximize Tolerance and Reduce Discontinuation: The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study,RECRUITING,2024-10-29,2028-08-31,2028-09-01,INTERVENTIONAL,PHASE3,500,['Metastatic Breast Cancer'],Metastatic Breast Cancer,American Society of Clinical Oncology,['Patient-Centered Outcomes Research Institute'],['United States']
NCT06505187,Celecoxib for ENT Pain Management,Celecoxib Pain Management Following Superficial Parotidectomy: Opioid Sparing Protocol,RECRUITING,2025-02-28,2026-09,2026-09,INTERVENTIONAL,PHASE2,84,['Parotidectomy'],Parotidectomy,"University of Wisconsin, Madison",[],['United States']
NCT06541704,A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy,"A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Tolerability of Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration",RECRUITING,2024-10-30,2027-11-29,2032-05-21,INTERVENTIONAL,PHASE3,975,"['Age-related Macular Degeneration (AMD)', 'Geographic Atrophy (GA)']",Age-related Macular Degeneration (AMD),Regeneron Pharmaceuticals,[],"['Hungary', 'Austria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT07260812,KSV01 Injection for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma,"A Phase I Clinical Study on the Safety, Tolerability, and Efficacy of KSV01 Injection in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma",RECRUITING,2025-05-07,2028-06-30,2028-12-31,INTERVENTIONAL,PHASE1,30,['Non-Hodgkin Lymphoma'],Non-Hodgkin Lymphoma,TCRx Therapeutics Co.Ltd,['Tongji Hospital'],['China']
NCT06941857,NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer,"A Phase 2 Study of NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Treatment-naïve, Metastatic Pancreatic Cancer",RECRUITING,2025-09-04,2030-09,2030-09,INTERVENTIONAL,PHASE2,20,['Pancreatic Cancer'],Pancreatic Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['NextCure, Inc.', 'Lustgarten Foundation']",['United States']
NCT06548165,Physiological Reaction After Food Intake,Physiological Reaction After Food Intake,ACTIVE_NOT_RECRUITING,2024-11-12,2025-08-14,2026-10,INTERVENTIONAL,NA,36,['Physiological Reactivity to Cues'],Physiological Reactivity to Cues,University of Ulm,[],['Germany']
NCT05922514,A Clinical Registry of Spontaneous Intracranial Hypotension,Spontaneous Intracranial Hypotension Registry,RECRUITING,2023-06-18,2026-07,2026-07,OBSERVATIONAL,,200,['Spontaneous Intracranial Hypotension'],Spontaneous Intracranial Hypotension,Mayo Clinic,[],['United States']
NCT05847855,Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors,A Prospective Study of Plasma Cell-free DNA Fragmentomics for Early Detection of Pancreatic Neuroendocrine Tumors and Differential Diagnosis of Solid Pancreatic Tumors,RECRUITING,2023-02-27,2025-12-31,2026-06-30,OBSERVATIONAL,,680,"['Pancreatic Neuroendocrine Tumor', 'Solid Pancreatic Neoplasms']",Pancreatic Neuroendocrine Tumor,Fudan University,[],['China']
NCT05786417,LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions,A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER,RECRUITING,2023-05-10,2027-05-30,2027-05-30,INTERVENTIONAL,PHASE4,741,"['Angina', 'Stable Ischemic Heart Disease']",Angina,Yale University,[],['United States']
NCT06835608,"Effects of Schroth-Based Exercise on Kyphosis Angle, Muscle Strength, Balance, Pain, and Quality of Life in Hyperkyphosis With Chronic Neck Pain","Effects of Schroth-Based Three-Dimensional Exercise Program on Angle of Kyphosis, Muscle Strength, Balance, Pain, and Quality of Life in Patients With Postural Hyperkyphosis With Chronic Neck Pain",RECRUITING,2025-02-25,2026-06,2026-08-23,INTERVENTIONAL,NA,52,"['Postural Kyphosis', 'Chronic Neck Pain']",Postural Kyphosis,Baskent University,['Baskent University Ankara Hospital'],['Turkey (Türkiye)']
NCT05996003,NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD),"A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089/NCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)",RECRUITING,2024-02-22,2026-09-11,2026-09-11,INTERVENTIONAL,PHASE2,20,"['Duchenne Muscular Dystrophy', 'Exon 44', 'DMD']",Duchenne Muscular Dystrophy,"NS Pharma, Inc.","['Nippon Shinyaku Co., Ltd.']","['Japan', 'New Zealand', 'Turkey (Türkiye)', 'United States', 'South Korea', 'Canada']"
NCT01189786,Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection,Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection (EXCESS),RECRUITING,2010-10,2026-10,2027-11,INTERVENTIONAL,NA,241,"['Stem Cell Transplant', 'Allogeneic']",Stem Cell Transplant,Baylor College of Medicine,"['Center for Cell and Gene Therapy, Baylor College of Medicine', 'The Methodist Hospital Research Institute']",['United States']
NCT06015893,Semaglutide Therapy for Alcohol Reduction (STAR),Semaglutide Therapy for Alcohol Reduction (STAR): A Proof-of-Concept Phase II Clinical Trial,RECRUITING,2023-10-17,2030-12-31,2030-12-31,INTERVENTIONAL,PHASE2,52,"['Addiction', 'Alcohol Use Disorder']",Addiction,National Institute on Drug Abuse (NIDA),[],['United States']
NCT06824701,Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,A Phase 1b Study of Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphomas (TARZAN Trial),RECRUITING,2025-09-12,2032-01,2033-01,INTERVENTIONAL,PHASE1,24,['Relapsed or Refractory B-cell Non-Hodgkin Lymphoma'],Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,University of Utah,['Ipsen'],['United States']
NCT06782932,Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer,A Pilot Study Comparing Neoadjuvant and Adjuvant GVAX vs a Mutated KRAS Peptide Vaccine Given With Anti-PD-1 and Anti-CD137 for the Treatment of Surgically Resectable Pancreatic Adenocarcinoma,RECRUITING,2025-05-27,2028-12,2028-12,INTERVENTIONAL,PHASE1,38,['Pancreatic Cancer'],Pancreatic Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Agenus Inc.', 'Lustgarten Foundation', 'Oncovir, Inc.']",['United States']
NCT07219420,A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study With Open-Label Extension to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis",RECRUITING,2025-11-14,2027-12-27,2029-10-29,INTERVENTIONAL,PHASE3,300,['Palmoplantar Pustulosis'],Palmoplantar Pustulosis,UCB Biopharma SRL,[],"['China', 'Canada']"
NCT07210723,A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy,"A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy",RECRUITING,2025-12,2027-09,2028-01,INTERVENTIONAL,PHASE2,332,['Symptomatic Genetic Dilated Cardiomyopathy'],Symptomatic Genetic Dilated Cardiomyopathy,"Kardigan, Inc.",[],['United States']
NCT07260903,Can Photobiomodulation Improve Balance and Cognition in Individuals Over 60: a Pilot Feasibility Placebo Randomized Controlled Trial.,Can Photobiomodulation Improve Balance and Cognition in Individuals Over 60: a Pilot Feasibility Placebo Randomized Controlled Trial.,RECRUITING,2025-06-01,2027-05-01,2027-07-10,INTERVENTIONAL,NA,60,['Age >60'],Age >60,University of Central Lancashire,[],['United Kingdom']
NCT04798924,Visual Rehabilitation After Occipital Stroke,Visual Rehabilitation After Occipital Stroke,ACTIVE_NOT_RECRUITING,2021-07-19,2025-09-26,2028-01,INTERVENTIONAL,NA,60,"['Stroke, Ischemic', 'Quadrantanopia', 'Vision Loss Partial', 'Visual Field Defect, Peripheral', 'Peripheral Visual Field Defect of Both Eyes', 'Peripheral Visual Field Defect', 'Hemianopsia', 'Hemianopia', 'Homonymous Hemianopia', 'Homonymous Hemianopsia', 'Visual Fields Hemianopsia', 'Occipital Lobe Infarct', 'Quadrantanopsia', 'Stroke Hemorrhagic']","Stroke, Ischemic",University of Rochester,['National Eye Institute (NEI)'],['United States']
NCT07039110,Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis,The Real-World Impact of Risankizumab on the Quality of Life and Cumulative Life Course Impairment (CLCI) in Patients With Moderate-to-Severe Plaque Psoriasis (DREAM),RECRUITING,2025-09-09,2028-03,2028-03,OBSERVATIONAL,,700,['Plaque Psoriasis'],Plaque Psoriasis,AbbVie,[],"['Greece', 'Japan', 'Canada', 'Czechia']"
NCT05859074,A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer,"A First-In-Human Phase I, Open Label, Safety and Tolerability Study of Escalating Multiple Doses of Intratumoral MQ710, a Multi-Transgene Expressing Modified Vaccinia Virus Ankara-Based Virotherapy, Alone and in Combination With the Systemic Checkpoint Inhibitor Pembrolizumab in Solid Tumors",RECRUITING,2023-05-04,2028-05-04,2028-05-04,INTERVENTIONAL,PHASE1,56,"['Cutaneous Squamous Cell Carcinoma', 'SCC - Squamous Cell Carcinoma', 'Basal Cell Carcinoma', 'BCC', 'BCC - Basal Cell Carcinoma', 'Melanoma', 'Merkel Cell Carcinoma', 'Sebaceous Carcinoma', 'Extramammary Paget Disease', 'Kaposi Sarcoma', 'Head and Neck Squamous Cell Carcinoma', 'HNSCC', 'Adnexal Carcinoma', 'Angiosarcoma', 'Cutaneous Neoplasm', 'Advanced Cancer', 'Metastatic Cancer', 'Refractory Cancer', 'Solid Tumor']",Cutaneous Squamous Cell Carcinoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07069517,"Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD","Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD: A Randomized Controlled Trial",RECRUITING,2025-12-02,2028-12-01,2028-12-01,INTERVENTIONAL,NA,160,"['Insomnia', 'PTSD - Post Traumatic Stress Disorder', 'Nightmares']",Insomnia,Palo Alto Veterans Institute for Research,"['The University of Texas Health Science Center at San Antonio', 'University of Arizona', 'NDRI-USA, Inc.']",['United States']
NCT05038735,"Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.","EPIK-B5: A Phase III, Randomized, Double-blind, Placebo-controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With HR-positive, HER2-negative Advanced Breast Cancer With a PIK3CA Mutation, Who Progressed on or After Aromatase Inhibitor and a CDK4/6 Inhibitor",ACTIVE_NOT_RECRUITING,2021-12-17,2026-09-15,2026-10-15,INTERVENTIONAL,PHASE3,212,['Breast Cancer'],Breast Cancer,Novartis Pharmaceuticals,[],"['Belgium', 'Bulgaria', 'Hungary', 'France', 'Finland', 'Slovakia', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Canada', 'Czechia', 'Romania', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT06950385,Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis,"A Phase 3, Multi-Site, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of eRapa to Improve Clinical Outcomes in Patients With Familial Adenomatous Polyposis",RECRUITING,2025-07-18,2030-07,2031-01,INTERVENTIONAL,PHASE3,168,['Familial Adenomatous Polyposis (FAP)'],Familial Adenomatous Polyposis (FAP),Rapamycin Holdings Inc.,['Biodexa Pharmaceuticals'],"['Netherlands', 'United States', 'Puerto Rico', 'Denmark', 'Spain', 'Germany']"
NCT04653064,"The Warmth, Anticipation, Sensation, Aversion, and Body-part Imaging Study",Placebo Effects on Anxiety and Pain,RECRUITING,2021-03-19,2025-12-26,2025-12-26,INTERVENTIONAL,NA,150,['Pain'],Pain,Trustees of Dartmouth College,[],['United States']
NCT05435690,Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty,Evaluation of a New Navigation System in Computer-assisted Total Knee Arthroplasty,ACTIVE_NOT_RECRUITING,2023-01-06,2026-05-31,2026-05-31,INTERVENTIONAL,NA,126,['Gonarthrosis'],Gonarthrosis,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT06145282,"Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function","Non-myeloablative Phase I/II Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function",ACTIVE_NOT_RECRUITING,2023-12-28,2025-11-26,2027-11-26,INTERVENTIONAL,PHASE1,6,['Sickle Cell Disease'],Sickle Cell Disease,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT07226778,Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations,"A Phase 1, Open-label, Randomized, Parallel-group Study to Assess the Relative Bioavailability of Maridebart Cafraglutide (AMG 133) as Two Subcutaneous Presentations in Participants Living With Overweight or Obesity",RECRUITING,2025-10-10,2026-05-12,2026-05-12,INTERVENTIONAL,PHASE1,340,"['Overweight', 'Obesity']",Overweight,Amgen,[],['United States']
NCT07260370,The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy,The Difference of microRNA Signature(S) and Circulating Tumor Cells in Blood Among Cancer Patients Before and Afte Immunotherapy,RECRUITING,2018-05-23,2025-12-27,2026-04-30,OBSERVATIONAL,,300,"['microRNA', 'Circulating Tumor Cells', 'Immunotherapy']",microRNA,Chang Gung Memorial Hospital,[],['Taiwan']
NCT06845839,Study to Evaluate CAY001 in Healthy Volunteers,"A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered CAY001 in Healthy Volunteer Subjects",RECRUITING,2025-12-02,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE1,24,['Healthy'],Healthy,"Cayuga Biotech, Inc.",[],['United States']
NCT05617677,A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)",ACTIVE_NOT_RECRUITING,2023-01-12,2026-10-19,2028-11-13,INTERVENTIONAL,PHASE3,516,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,Bristol-Myers Squibb,[],"['Bulgaria', 'Hong Kong', 'Moldova', 'China', 'Lithuania', 'France', 'Puerto Rico', 'Peru', 'South Korea', 'Colombia', 'Poland', 'India', 'Mexico', 'Canada', 'Romania', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06850688,Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery (CONTACT-GRECCAR 21),Impact of Ambulatory Continuous Monitoring Using Remote Monitoring Medicine Within Patient's Care Pathway Following Colorectal Surgery - A Multicenter Randomized Study,RECRUITING,2025-06-17,2026-10-17,2026-10-17,INTERVENTIONAL,NA,362,"['Colorectal Surgery', 'Readmission']",Colorectal Surgery,Nantes University Hospital,"['EPOCA U&I', 'Ministry of Health, France']",['France']
NCT06090097,Knee Biofeedback Rehabilitation Through Game Therapy,Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy,RECRUITING,2024-09-04,2026-11-01,2026-11-30,INTERVENTIONAL,NA,60,['Knee Osteoarthritis'],Knee Osteoarthritis,"Barron Associates, Inc.","['University of North Carolina, Chapel Hill']",['United States']
NCT02707029,Clinical and Scientific Assessment of Pain and Painful Disorders,Clinical and Scientific Assessment of Pain and Painful Disorders,RECRUITING,2016-07-22,2026-02-09,2026-02-09,OBSERVATIONAL,,10000,"['Normal Physiology', 'Pain']",Normal Physiology,National Center for Complementary and Integrative Health (NCCIH),[],['United States']
NCT07247487,Diet and Cardiometabolism in Rosario,"Comparative Analysis of Diet and Cardiometabolic Health in Individuals Following Vegan, Vegetarian, and Omnivorous Diets in the City of Rosario",RECRUITING,2025-12-01,2027-12-01,2027-12-01,OBSERVATIONAL,,105,"['Cardiovascular (CV) Risk', 'Nutrition', 'Cardiometabolic Health Indicators']",Cardiovascular (CV) Risk,Universidad del Centro Educativo Latinoamericano,['Universidad Nacional de Rosario'],['Argentina']
NCT04075903,Gout in the ED and Improving Research Participation,Improving Care for Gout in the Southeast Enhancing Gout Minority Patients Care and Participation in Gout Clinical Research,ACTIVE_NOT_RECRUITING,2021-06-01,2024-09-20,2026-02-01,INTERVENTIONAL,NA,200,['Gout'],Gout,University of Alabama at Birmingham,"['Massachusetts General Hospital', 'MetroHealth Medical Center', 'University of Iowa', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)']",['United States']
NCT06376097,Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.,"Implementation of a Lung Cancer Screening Program in a Public Service, Using Low-dose Tomography and Metabolomics Evaluation",RECRUITING,2023-04-19,2025-11-28,2025-11-28,OBSERVATIONAL,,1000,['Lung Cancer'],Lung Cancer,AstraZeneca,[],['Brazil']
NCT06183437,The STOP-MED CTRCD Trial,A Multi-Centre Non-Inferiority Randomized Controlled Trial of STOPping Cardiac MEDications in Patients With Normalized Cancer Therapy Related Cardiac Dysfunction: The STOP-MED CTRCD Trial,RECRUITING,2024-03-04,2027-12,2031-12,INTERVENTIONAL,PHASE4,335,"['Heart Failure', 'Cardiotoxicity', 'Cardiac Toxicity', 'Antineoplastics Toxicity', 'Cancer']",Heart Failure,"University Health Network, Toronto","['Unity Health Toronto', 'Hamilton Health Sciences Corporation', 'St. Boniface Hospital', 'Ottawa Heart Institute Research Corporation', 'University College London Hospitals', 'Alberta Health Services, Calgary', ""Brigham and Women's Hospital"", 'Baker Heart and Diabetes Institute']","['United Kingdom', 'United States', 'Canada', 'Australia']"
NCT06924970,"A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)","A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multicenter, Dose- Finding, Efficacy, and Safety Study of Tebapivat in Participants With Sickle Cell Disease",RECRUITING,2025-05-01,2026-05,2027-05,INTERVENTIONAL,PHASE2,56,['Sickle Cell Disease'],Sickle Cell Disease,"Agios Pharmaceuticals, Inc.",[],"['Belgium', 'Netherlands', 'United States', 'France', 'Ireland', 'Canada', 'United Kingdom']"
NCT07262606,"Salivary Mitofusin-1 Levels in Periodontitis: Associations With Disease Severity, Smoking, and Treatment Response","Salivary Mitofusin-1 Levels in Periodontitis: Associations With Disease Severity, Smoking, and Treatment Response",RECRUITING,2025-11-01,2026-02-15,2026-11-01,INTERVENTIONAL,NA,104,"['Periodontal Disease', 'Chronic Periodontitis (Disorder)']",Periodontal Disease,Ömer Faruk Okumuş,[],['Turkey (Türkiye)']
NCT06463587,Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)",RECRUITING,2024-06-25,2028-05-19,2030-08-19,INTERVENTIONAL,PHASE3,264,['Generalized Myasthenia Gravis'],Generalized Myasthenia Gravis,"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","['EMD Serono Research & Development Institute, Inc.']","['Japan', 'China', 'United States', 'Georgia', 'Taiwan', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT06360458,Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke,"Methylprednisolone as Adjunct to Endovascular Thrombectomy for Patients With Acute Ischemic Strokes With Large Infarct: a Multicenter, Randomized, Double-blind, Placebo-controlled Trial (MIRACLE)",ACTIVE_NOT_RECRUITING,2024-08-01,2025-09-30,2030-06-30,INTERVENTIONAL,PHASE3,928,"['Acute Ischemic Stroke', 'Large Infarct Core']",Acute Ischemic Stroke,Wan-Jin Chen,[],['China']
NCT06788964,Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL),A Phase 2 Study of Loncastuximab Tesirine and Rituximab as Bridging Therapy Prior to Standard-of-care CD19 CAR T-cell Therapy in Patients With Large B-cell Lymphoma,RECRUITING,2025-08-25,2027-03,2030-03,INTERVENTIONAL,PHASE2,29,['Relapsed or Refractory Large B-cell Lymphoma'],Relapsed or Refractory Large B-cell Lymphoma,University of Utah,['ADC Therapeutics S.A.'],['United States']
NCT07117318,Rectal NSAIDs With/Without PD Stent for PEP Prevention,"Rectal Non-steroid Anti-inflammatory Drugs With or Without Prophylactic Pancreatic Duct Stent for Prevention of Post-ERCP Pancreatitis: a Multicenter, Randomized, Non-inferiority Trial",RECRUITING,2025-07-01,2026-12-31,2028-06-01,INTERVENTIONAL,NA,1278,"['Post-ERCP Acute Pancreatitis', 'Non-steroid Anti-inflammatory Drugs', 'Pancreatic Duct Stent Placement']",Post-ERCP Acute Pancreatitis,"Air Force Military Medical University, China",[],['China']
NCT06379789,"A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B","A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B",RECRUITING,2024-09-11,2032-12-17,2032-12-17,INTERVENTIONAL,PHASE1,130,['Hemophilia B'],Hemophilia B,Regeneron Pharmaceuticals,['Intellia Therapeutics'],"['United States', 'France', 'Spain', 'Canada', 'Australia', 'United Kingdom', 'Germany']"
NCT03258580,Sociocultural & Biobehavioral Influences on Pain Expression and Assessment,Sociocultural & Biobehavioral Influences on Pain Expression and Assessment,RECRUITING,2018-05-09,2027-05-17,2027-05-30,INTERVENTIONAL,NA,700,"['Normal Physiology', 'Healthy Volunteers', 'Pain']",Normal Physiology,National Center for Complementary and Integrative Health (NCCIH),[],['United States']
NCT07261995,Comparison of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery in the Management of Renal Calculi,Comparison of Outcomes of Extracorporeal Shock Wave Lithotripsy Versus Retrograde Intrarenal Surgery in the Management of Renal Calculi Measuring 1 to 2 Centimeters,RECRUITING,2025-09-05,2026-02-05,2026-02-05,INTERVENTIONAL,NA,98,"['Nephrolithiasis', 'Renal Calculi']",Nephrolithiasis,Ziauddin Hospital,[],['Pakistan']
NCT06885697,Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma,Phase 1 Study With Dose Expansion of the Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma,RECRUITING,2025-07-08,2034-06-01,2044-06-01,INTERVENTIONAL,PHASE1,100,"['Mesothelioma', 'Neoplasms', 'Stomach Neoplasms', 'Pancreatic Neoplasms', 'Ovarian Neoplasms', 'Lung Neoplasms', 'Thymus Neoplasms', 'Colonic Neoplasms']",Mesothelioma,National Cancer Institute (NCI),[],['United States']
NCT07129252,A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors,A Phase 1/2 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants With Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Solid Tumors,RECRUITING,2025-11-26,2027-08,2029-08,INTERVENTIONAL,PHASE1,150,"['SST2-positive Neuroendocrine Neoplasms', 'Neuroendocrine Tumors', 'Neuroendocrine Neoplasm']",SST2-positive Neuroendocrine Neoplasms,Crinetics Pharmaceuticals Inc.,[],['United States']
NCT07260526,Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy,Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy,RECRUITING,2025-10-01,2026-10-01,2026-10-30,OBSERVATIONAL,,60,['Rectal Cancer'],Rectal Cancer,West China Hospital,[],['China']
NCT07186842,A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9,"First-in-human, Open-label, Multi-site, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT329 in Participants With Advanced Solid Tumors Known to Express CA19-9",RECRUITING,2025-11-18,2030-05,2030-05,INTERVENTIONAL,PHASE1,245,['Advanced Solid Cancers'],Advanced Solid Cancers,BioNTech SE,[],['United States']
NCT06768996,"Music, Social Attention, and Dementia",The Impact of a Caregiver-patient Music Intervention on Social Attention and Connectedness in Persons Living With bvFTD and AD,ACTIVE_NOT_RECRUITING,2025-01-10,2026-08-31,2026-12-01,INTERVENTIONAL,NA,80,"['Frontotemporal Dementia', 'Alzheimer Disease']",Frontotemporal Dementia,"University of California, San Francisco",['National Institute on Aging (NIA)'],['United States']
NCT04151342,CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS),CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS),RECRUITING,2020-01-17,2029-12,2029-12,OBSERVATIONAL,,5500,"['Cancer', 'Malignancies Multiple', 'Malignant Solid Tumor', 'Cancer, Therapy-Related', 'Molecular Sequence Variation', 'Genetic Alteration', 'Gene Fusion', 'Receptor Tyrosine Kinase Gene Mutation', 'RTK Family Gene Mutation', 'Ras (Kras or Nras) Gene Mutation']",Cancer,"University Health Network, Toronto","['Takeda Canada, Inc.', 'Applied Health Research Centre', 'Programs for Assessment of Technology in Health Research Institute', 'AstraZeneca', 'Amgen', 'Bayer', 'Nuvation Bio Inc.', 'IQVIA Solutions Canada Inc.']",['Canada']
NCT06654752,Streamlined Treatment of Pulmonary Exacerbations in Pediatrics,Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Randomized Controlled Trial (STOP PEDS RCT),RECRUITING,2024-12-01,2027-12-30,2029-02-28,INTERVENTIONAL,NA,430,['Cystic Fibrosis'],Cystic Fibrosis,"University of Washington, the Collaborative Health Studies Coordinating Center",['Cystic Fibrosis Foundation'],"['United States', 'Canada']"
NCT06001658,"Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers","Tumor Microenvironment Features of Response to Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers",RECRUITING,2024-07-08,2028-06,2028-06,INTERVENTIONAL,PHASE2,27,['Billiary Track Cancer'],Billiary Track Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Merck Sharp & Dohme LLC'],['United States']
NCT06721156,A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008),"A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia",RECRUITING,2024-12-16,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,350,"['Alzheimer Disease', 'Dementia']",Alzheimer Disease,Merck Sharp & Dohme LLC,[],"['Japan', 'Netherlands', 'United States', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Argentina']"
NCT06521723,Low Oxygen Therapy to Enhance Walking Recovery After SCI.,Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery for Aging Adults With Chronic SCI: The BO2ST-II Trial,RECRUITING,2025-06-06,2027-09-30,2028-09-30,INTERVENTIONAL,NA,60,['Spinal Cord Injuries'],Spinal Cord Injuries,Spaulding Rehabilitation Hospital,"['United States Department of Defense', 'Brooks Rehabilitation', 'Congressionally Directed Medical Research Programs']",['United States']
NCT07261683,"Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer",A Phase II Study Evaluating the Efficacy and Safety of Weekly Paclitaxel or Nab-Paclitaxel Combined With Pembrolizumab and Mirabegron in Patients With Recurrent Ovarian Cancer,RECRUITING,2025-12-01,2027-11-30,2028-11-30,INTERVENTIONAL,PHASE2,20,"['Ovarian Cancer', 'Immunotherapy', 'Pembrolizumab']",Ovarian Cancer,Obstetrics & Gynecology Hospital of Fudan University,[],['China']
NCT07262554,N-acetylcysteine for Root Canal Treatment of Necrotic Teeth With Apical Periodontitis,Evaluation of N-acetylcysteine as an Intracanal and Adjunctive Systemic Medication in Root Canal Treatment of Necrotic Mature Teeth With Apical Periodontitis: a Randomized Controlled Clinical Trial,RECRUITING,2025-11-15,2026-06,2026-06,INTERVENTIONAL,PHASE2,40,['Apical Periodontitis'],Apical Periodontitis,Alexandria University,[],['Egypt']
NCT06610201,A Study of Bleeding and Treatment in Participants With Von Willebrand Disease,"Velora Discover: A Prospective, Screening Study of Bleeding and Treatment in Participants With Von Willebrand Disease",RECRUITING,2024-08-30,2026-06,2026-06,OBSERVATIONAL,,200,"['Von Willebrand Disease (VWD)', 'Von Willebrand Disease (VWD), Type 1', 'Von Willebrand Disease (VWD), Type 2', 'Von Willebrand Disease (VWD), Type 3', 'Von Willebrand Disease, Type 2A', 'Von Willebrand Disease, Type 2M', 'Von Willebrand Disease, Type 2N']",Von Willebrand Disease (VWD),Hemab ApS,[],"['United Kingdom', 'United States', 'Australia']"
NCT06126757,"PelviSense, an Innovative, Non-invasive, Biofeedback Device for the Treatment of Stress Urinary Incontinence in Women","An Innovative, Non-invasive, Biofeedback Device for the Treatment of Stress Urinary Incontinence in Women: Evaluation and Mechanism Testing",ACTIVE_NOT_RECRUITING,2024-09-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,132,['Stress Urinary Incontinence'],Stress Urinary Incontinence,The Hong Kong Polytechnic University,[],['Hong Kong']
NCT06969573,Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD,The Impact of Inhaled Treprostinil on Dyspnea and Exercise Intolerance in Mild COPD; a Pilot and Feasibility Trial,RECRUITING,2025-06-05,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,20,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),University of Alberta,[],['Canada']
NCT06451341,IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas,IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas: Addressing Adherence Barriers Through Learning and Evidence-Informed Strategies (IM-CAPABLE),RECRUITING,2024-07-01,2027-04,2027-04,OBSERVATIONAL,,55,['HIV'],HIV,University of Nebraska,['ViiV Healthcare'],['United States']
NCT02743741,Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors,"A Prospective Single-Arm, Multi-Centre, Study of the Efficacy and Safety of Lutetium-177 Octreotate (Lu-DOTATATE) Treatment With Individualized Dosimetry in Patients With 68Ga-DOTATATE Identified Somatostatin Receptor Positive Neuroendocrine Tumors",ACTIVE_NOT_RECRUITING,2016-07-15,2026-06,2026-06,INTERVENTIONAL,NA,195,['Neuroendocrine Tumors'],Neuroendocrine Tumors,"University Health Network, Toronto","['Ozmosis Research Inc.', 'Cancer Care Ontario', 'Canadian Molecular Imaging Probe Consortium']",['Canada']
NCT07219719,Temporal Interference for Thalamocortical Activity and Network Modulation,Temporal Interference for Thalamocortical Activity and Network Modulation,RECRUITING,2025-12-01,2027-05,2027-11,INTERVENTIONAL,PHASE1,30,['Healthy Participants'],Healthy Participants,"University of Wisconsin, Madison",[],['United States']
NCT05415761,Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care,Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care,RECRUITING,2023-05-15,2027-06-30,2027-12-31,INTERVENTIONAL,NA,1332,['Tobacco Use Cessation'],Tobacco Use Cessation,University of Florida,['Patient-Centered Outcomes Research Institute'],['United States']
NCT05224973,Fine Motor Skills and Post-Stroke Swallowing,Effect of Fine Motor Training on Swallowing Skills After Stroke: Pilot Study,ACTIVE_NOT_RECRUITING,2022-11-23,2025-05-23,2026-06-06,INTERVENTIONAL,NA,30,['Stroke'],Stroke,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06732375,Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors,Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors,RECRUITING,2025-06-13,2026-04,2026-09,INTERVENTIONAL,NA,40,"['Cancer', 'Youth Cancer', 'Young Adult Cancer', 'Distress, Psychological']",Cancer,Duke University,[],['United States']
NCT07071441,Indomethacin vs Diclofenac for Preventing PEP,"Rectal Indomethacin Versus Diclofenac for Prevention of Post-ERCP Panceratitis (IDPPP2): A Multicenter, Double-blind, Randomized, Control Trial",RECRUITING,2025-06-01,2026-12-31,2026-12-31,INTERVENTIONAL,NA,4050,"['ERCP', 'Pancreatitis', 'Non-steroidal Anti-inflammatory (NSAID)', 'Indomethacin', 'Diclofenac']",ERCP,"Air Force Military Medical University, China",[],['China']
NCT07249294,Program to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease,Multidisciplinary Program to Avoid NSAIDs or Metamizole (HepatoAINEs Study) in Patients With Advanced Chronic Liver Disease Undergoing Major Surgery,ACTIVE_NOT_RECRUITING,2023-04-01,2025-12-31,2026-06-30,INTERVENTIONAL,NA,84,"['Advanced Chronic Liver Disease', 'Portal Hypertension Related to Cirrhosis']",Advanced Chronic Liver Disease,Parc de Salut Mar,[],['Spain']
NCT03945773,Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors,"A Phase II, Multicentre, Open-label Study of Cabozantinib as 2nd Line Treatment in Subjects With Unresectable, Locally Advanced or Metastatic Renal Cell Carcinoma With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors.",ACTIVE_NOT_RECRUITING,2020-01-08,2023-05-11,2030-12-30,INTERVENTIONAL,PHASE2,127,['Locally Advanced or Metastatic Renal Cell Carcinoma'],Locally Advanced or Metastatic Renal Cell Carcinoma,Ipsen,[],"['Netherlands', 'Austria', 'France', 'Switzerland', 'Spain', 'United Kingdom', 'Germany']"
NCT05667987,Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.,Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.,RECRUITING,2024-01-18,2026-01-18,2026-02-28,INTERVENTIONAL,NA,1800,['ERCP Surgery'],ERCP Surgery,GCS Ramsay Santé pour l'Enseignement et la Recherche,[],['France']
NCT07200206,A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea,"A Prospective, Single-arm, Non-interventional, Multi-center, Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea",RECRUITING,2025-10-02,2029-09-26,2029-09-26,OBSERVATIONAL,,3000,['Respiratory Syncytial Virus'],Respiratory Syncytial Virus,Sanofi,[],['South Korea']
NCT06579469,Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy,Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy (PROSPER),RECRUITING,2026-01,2027-03,2029-03,OBSERVATIONAL,,100,"['B-ALL', 'Hematologic Malignancy', 'Solid Tumor']",B-ALL,St. Jude Children's Research Hospital,['Rally Foundation for Childhood Cancer Research'],['United States']
NCT06394739,RevCore for In Stent Thrombosis,RevCore for In Stent Thrombosis (REVIT),RECRUITING,2024-09-09,2025-12,2026-12,OBSERVATIONAL,,100,['In-stent Thrombosis'],In-stent Thrombosis,Inari Medical,[],['United States']
NCT04829929,Evaluation of Safety and Performance of the Omega™ LAA (Left Atrial Appendage) Occluder and Omega™ Delivery System in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk,"Prospective, Single-arm Study to Assess the Safety and Performance of the Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation and High Bleeding Risk",ACTIVE_NOT_RECRUITING,2020-11-17,2025-02-19,2027-01-07,INTERVENTIONAL,NA,200,['Non-Valvular Atrial Fibrillation'],Non-Valvular Atrial Fibrillation,Eclipse Medical Ltd.,"['KCRI', 'Cardiovascular Research Institute Dublin']","['Denmark', 'Ireland', 'Spain', 'Italy', 'United Kingdom', 'Germany']"
NCT05898789,Virtual Rehabilitation for Cancer Survivors,Pragmatic Hybrid Type 1 Effectiveness-implementation (E-I) Trial of a Virtual Cancer Rehabilitation Program,RECRUITING,2023-07-07,2026-06-30,2026-11-30,INTERVENTIONAL,NA,388,"['Breast Cancer, Stage 0', 'Colorectal Cancer Stage I', 'Head and Neck Cancer Stage I', 'Lymphoma', 'Breast Cancer Stage I', 'Breast Cancer Stage II', 'Breast Cancer Stage III', 'Colorectal Cancer Stage II', 'Colorectal Cancer Stage III', 'Head and Neck Cancer Stage II', 'Head and Neck Cancer Stage III', 'Lymphoproliferative Disorders']","Breast Cancer, Stage 0","University Health Network, Toronto",[],['Canada']
NCT06705088,"Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SUVN-I6107 In Healthy Participants","A First-In-Human, Randomized, Double-Blind, Placebo-Controlled, Single And Multiple Ascending Oral Dose Study Of SUVN-I6107 To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics In Healthy Subjects",RECRUITING,2025-01-07,2025-12-19,2025-12-19,INTERVENTIONAL,PHASE1,64,['Healthy'],Healthy,Suven Life Sciences Limited,[],['United States']
NCT06957327,A Study of ERAS-601 in People With Chordoma,A Phase 1b/2 Study of ERAS-601 SHP2 Inhibitor as a Monotherapy in Patients With Advanced and Progressing Chordoma,RECRUITING,2025-04-25,2027-04,2027-04,INTERVENTIONAL,PHASE1,11,['Chordoma'],Chordoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT05013216,Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer,Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer,RECRUITING,2022-04-11,2027-10-01,2031-05-01,INTERVENTIONAL,PHASE1,37,"['High Risk Cancer', 'Pancreatic Cancer']",High Risk Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Stand Up To Cancer', 'National Cancer Institute (NCI)']",['United States']
NCT04074720,Prospective Breast Cancer Biospecimen Collection,Prospective Breast Cancer Biospecimen Collection,RECRUITING,2018-05-10,2028-07-01,2028-07-01,OBSERVATIONAL,,200,"['Breast Cancer', 'Invasive Breast Cancer', 'Carcinoma in Situ of the Breast']",Breast Cancer,Thomas Jefferson University,[],['United States']
NCT06483308,Shortened High-dose Palliative Radiotherapy for Lung Cancer,Shortened High-dose Palliative Radiotherapy for Lung Cancer (SHiP-Rt) Study,RECRUITING,2024-11-27,2026-03-31,2027-03-31,INTERVENTIONAL,NA,37,['Stage IV Lung Cancer'],Stage IV Lung Cancer,University Hospitals Coventry and Warwickshire NHS Trust,[],['United Kingdom']
NCT05914324,Outpatient Pediatric Pulse Oximeters in Africa,Evaluating Novel Pediatric Pulse Oximeters for Outpatient Child Pneumonia Care in Sub-Saharan Africa,RECRUITING,2024-11-04,2026-04-30,2026-12-31,INTERVENTIONAL,NA,1200,"['Child', 'Infant', 'Respiratory Tract Infections', 'Hypoxia']",Child,Johns Hopkins University,"['University of Stellenbosch', 'Karolinska Institutet', 'Baylor College of Medicine', 'Fogarty International Center of the National Institute of Health', 'Thrasher Research Fund']",['South Africa']
NCT07261579,Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis.,Composite Inflammatory Parameters Ratios Enforce the Role of CRP for Monitoring Ulcerative Colitis Disease Activity,ACTIVE_NOT_RECRUITING,2025-09-15,2025-11-25,2025-12-01,OBSERVATIONAL,,80,['Ulcerative Colitis'],Ulcerative Colitis,Benha University,[],['Egypt']
NCT05927571,"A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)","An Open-Label, Multicenter, Phase Ib Trial Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Patients With Relapsed or Refractory Multiple Myeloma",RECRUITING,2023-08-10,2027-07-31,2027-07-31,INTERVENTIONAL,PHASE1,120,['Relapsed or Refractory Multiple Myeloma'],Relapsed or Refractory Multiple Myeloma,"Genentech, Inc.",[],"['Israel', 'South Korea', 'Australia']"
NCT06372847,DISE-HNS Effect Study,Assessment of the Effect of Hypoglossal Nerve Stimulation Therapy on the Site of Collapse During DISE,RECRUITING,2025-10-21,2028-03-31,2028-03-31,INTERVENTIONAL,NA,58,['Obstructive Sleep Apnea'],Obstructive Sleep Apnea,"University Hospital, Antwerp",[],['Belgium']
NCT07037901,A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis,"A Phase 2b, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis",RECRUITING,2025-06-17,2026-11,2027-10,INTERVENTIONAL,PHASE2,220,"['Atopic Dermatitis', 'Atopic Dermatitis Eczema', 'Eczema']",Atopic Dermatitis,Inmagene LLC,[],"['United States', 'Canada']"
NCT05598333,Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure,"A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multi-center Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of AB-1002 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Failure and Non-ischemic Cardiomyopathy",ACTIVE_NOT_RECRUITING,2023-10-20,2026-10-31,2030-12-31,INTERVENTIONAL,PHASE2,150,['Congestive Heart Failure'],Congestive Heart Failure,AskBio Inc,[],"['Belgium', 'Bulgaria', 'Hungary', 'Netherlands', 'Austria', 'United States', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Poland', 'Germany']"
NCT06772831,Cognitive Reappraisal Training for Borderline Personality (BPD),Cognitive Reappraisal Training Targeting Emotion Circuits As a Therapeutic Intervention in Borderline Patients,RECRUITING,2024-11-15,2027-07-31,2027-07-31,INTERVENTIONAL,NA,130,['Borderline Personality Disorder'],Borderline Personality Disorder,Icahn School of Medicine at Mount Sinai,"['William Marsh Rice University', 'National Institute of Mental Health (NIMH)']",['United States']
NCT05653622,Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma,Simultaneous Integrated Boost FDOPA PET Guided in Patients With Partially- or Non-operated Glioblastoma,RECRUITING,2025-06-23,2028-07-01,2029-07-01,INTERVENTIONAL,PHASE2,75,"['Glioblastoma Multiforme, Adult']","Glioblastoma Multiforme, Adult",Institut de cancérologie Strasbourg Europe,[],['France']
NCT06693531,A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care,A U.S. Registry of Eosinophilic Esophagitis Patients Treated With DUPIXENT® As Standard of Care,RECRUITING,2024-11-22,2030-05-09,2030-05-09,OBSERVATIONAL,,300,['Eosinophilic Esophagitis (EoE)'],Eosinophilic Esophagitis (EoE),Regeneron Pharmaceuticals,['Sanofi'],['United States']
NCT07116031,A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK),"An Open-label, Phase 1/2, Multicenter Study of Belumosudil in Children Aged 1 to <18 Years Requiring Systemic Treatment for Active Moderate-to-severe Chronic Graft Versus Host Disease (cGVHD)",RECRUITING,2025-12-15,2031-02-28,2031-02-28,INTERVENTIONAL,PHASE2,37,['Chronic Graft Versus Host Disease'],Chronic Graft Versus Host Disease,Sanofi,[],"['Israel', 'United States', 'France', 'Spain', 'Germany']"
NCT06295640,Relative Contribution of Brain Insulin Action for Postprandial Metabolism,Relative Contribution of Brain Insulin Action for Postprandial Metabolism,ACTIVE_NOT_RECRUITING,2024-03-18,2025-09-05,2026-01,INTERVENTIONAL,NA,31,['Glucose Metabolism Disorders'],Glucose Metabolism Disorders,University of Ulm,[],['Germany']
NCT05444205,The Pittsburgh Study Early Childhood,The Pittsburgh Study Early Childhood Collaborative,ACTIVE_NOT_RECRUITING,2020-06-02,2030-12,2031-12,INTERVENTIONAL,NA,24000,"['Child Development', 'Child Language', 'Child Behavior Problem', 'Parenting', 'Parent Child Abuse']",Child Development,University of Pittsburgh,"['The Grable Foundation', 'The Shear Family Foundation', 'Heinz Endowments']",['United States']
NCT07262502,Evaluation of the Clinical Success of Hydrophilic Fissure Sealants,EVALUATION OF THE CLINICAL SUCCESS OF A HYDROPHILIC FISSURE SEALANT APPLIED TO LOWER PERMANENT MOLARS UNDER DRY AND WET CONDITIONS,ACTIVE_NOT_RECRUITING,2025-03-01,2026-03-01,2026-04-01,INTERVENTIONAL,NA,250,"['Pit and Fissure Caries (Disorder)', 'Pit and Fissure Sealants']",Pit and Fissure Caries (Disorder),Afyonkarahisar Health Sciences University,[],['Turkey (Türkiye)']
NCT04336722,Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD),"A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Odevixibat (A4250) in Children With Biliary Atresia Who Have Undergone a Kasai Hepatoportoenterostomy",ACTIVE_NOT_RECRUITING,2020-07-08,2026-06-26,2026-06-26,INTERVENTIONAL,PHASE3,254,['Biliary Atresia'],Biliary Atresia,"Albireo, an Ipsen Company",[],"['New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'South Korea', 'Poland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT07095946,Effectiveness of Intraligament vs IANB Anesthesia in Children Using Electronic Syringe,Comparing the Effectiveness of the Intraligament Anesthesia Technique With the Inferior Alveolar Nerve Block Technique Using the Electronic Syringe in Children: A Random Clinical Study,RECRUITING,2025-05-28,2025-09-20,2026-01-20,INTERVENTIONAL,NA,30,['Effectiveness of Anesthesia Using Electronic Syringe in Children in the Context of Endotopy Treatment'],Effectiveness of Anesthesia Using Electronic Syringe in Children in the Context of Endotopy Treatment,Tishreen University,[],['Syria']
NCT06027086,DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC),A Phase 1b/2 Study of Glutamine Antagonist DRP-104 in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Hepatocellular Carcinoma (FLC),RECRUITING,2024-02-12,2028-09-01,2033-09-01,INTERVENTIONAL,PHASE1,27,['Fibrolamellar Hepatocellular Carcinoma'],Fibrolamellar Hepatocellular Carcinoma,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,"['Dracen Pharmaceuticals, Inc.', 'Fibrolamellar Cancer Foundation']",['United States']
NCT07260500,"A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics","A Phase II, Multicenter, Randomized, Open-label, Active-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Polyethylene Glycol Recombinant Human Growth Hormone Injection in Short Children Born Small for Gestational Age (SGA)",RECRUITING,2025-11-11,2026-10-26,2027-01-31,INTERVENTIONAL,PHASE2,72,['Short Stature Children Born Small for Gestational Age (SGA)'],Short Stature Children Born Small for Gestational Age (SGA),"Changchun GeneScience Pharmaceutical Co., Ltd.",[],['China']
NCT00433511,"Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer",A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer,ACTIVE_NOT_RECRUITING,2007-11-02,2014-01-07,2026-02-22,INTERVENTIONAL,PHASE3,4994,['Breast Adenocarcinoma'],Breast Adenocarcinoma,National Cancer Institute (NCI),"['Cancer and Leukemia Group B', 'Eastern Cooperative Oncology Group', 'North Central Cancer Treatment Group']","['United States', 'Peru', 'South Africa']"
NCT07262437,Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles,Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles,ACTIVE_NOT_RECRUITING,2025-11-15,2026-02-28,2026-07-01,INTERVENTIONAL,NA,220,"['Uveitis Posterior Non-Infectious', 'Inflammation Eye', 'Uveitis', 'Uveitis, Anterior']",Uveitis Posterior Non-Infectious,University of Milan,['IRCCS San Raffaele'],['Italy']
NCT06713564,"A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer","A Phase 1b, Single Dose, Open-Label, Dose-escalation Study to Investigate the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer",ACTIVE_NOT_RECRUITING,2024-11-07,2026-03,2026-03,INTERVENTIONAL,PHASE1,24,['Lung Cancers'],Lung Cancers,Integro Theranostics,[],['United States']
NCT04373031,"Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer",Induction Immunotherapy to Promote Immunologic Priming and Enhanced Response to Neoadjuvant Pembrolizumab + Chemotherapy in Triple Negative Breast Cancer (TNBC),ACTIVE_NOT_RECRUITING,2020-12-30,2023-07-08,2025-12,INTERVENTIONAL,PHASE2,12,"['Breast Cancer', 'Breast Neoplasms']",Breast Cancer,Providence Health & Services,"['Merck Sharp & Dohme LLC', 'Brooklyn ImmunoTherapeutics, LLC']",['United States']
NCT06908954,A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose,"A Phase I, Open-label, Parallel-group Study to Evaluate the Single-dose Pharmacokinetics of Palovarotene in Male and Female Participants With Moderate and Severe Hepatic Impairment and Matched Participants With Normal Hepatic Function",RECRUITING,2025-03-14,2026-06-17,2026-06-17,INTERVENTIONAL,PHASE1,32,"['Hepatic Impairment', 'Healthy']",Hepatic Impairment,Ipsen,[],['United States']
NCT06979362,A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy,"Phase 2, Multicentre, Randomised, Double-blind, Placebo-controlled Safety and Efficacy Study of CDR132L on Reverse Cardiac Remodelling in Participants With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy",RECRUITING,2025-06-27,2027-05-16,2028-01-23,INTERVENTIONAL,PHASE2,200,['Heart Failure'],Heart Failure,Novo Nordisk A/S,[],"['Japan', 'United States', 'Germany', 'Spain', 'South Korea', 'Canada', 'United Kingdom', 'Poland', 'India']"
NCT04421365,Brain-Computer Interfaces in Laryngeal Dystonia,Adaptive Closed-loop Brain-computer Interface Therapeutic Intervention in Laryngeal Dystonia,RECRUITING,2022-04-18,2027-08-31,2027-08-31,INTERVENTIONAL,NA,40,['Laryngeal Dystonia'],Laryngeal Dystonia,Kristina Simonyan,[],['United States']
NCT07190300,"TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)","TulmiSTAR-02: A Two-part Phase I Dose Escalation Study of Tulmimetostat (DZR123) in Combination With Darolutamide or Abiraterone Followed by Open-label, Randomized, Phase II Dose Expansion Study to Assess the Safety and Efficacy of Tulmimetostat in Combination With Darolutamide Versus Darolutamide Alone in Patients With Metastatic Hormone-sensitive Prostate Cancer",RECRUITING,2025-11-24,2032-06-04,2032-06-04,INTERVENTIONAL,PHASE1,155,['Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)'],Metastatic Hormone-Sensitive Prostate Cancer (mHSPC),Novartis Pharmaceuticals,[],"['United States', 'South Korea']"
NCT05636748,The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke,The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke,RECRUITING,2023-02-28,2026-08-01,2026-08-01,OBSERVATIONAL,,120,"['Stroke', 'PET', 'Thrombosis']",Stroke,University of Edinburgh,['British Heart Foundation'],['United Kingdom']
NCT07217171,"A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas","A Phase 1 Dose-Escalation and Expansion Study Evaluating the Safety, Efficacy, and Pharmacokinetics of EVOLVE104 in Subjects With Advanced Urothelial and Squamous Cell Carcinomas",RECRUITING,2025-11-13,2029-01-29,2031-01-29,INTERVENTIONAL,PHASE1,160,"['Bladder Cancer', 'Squamous Cell Carcinoma of the Lung', 'Esophageal Squamous Cell Carcinoma', 'Tongue Squamous Cell Carcinoma', 'Cutaneous Squamous Cell Cancer', 'Penile Squamous Cell Carcinoma', 'Anal Squamous Cell Carcinoma', 'Vulvar Squamous Cell Carcinoma', 'Cervical Squamous Cell Carcinoma', 'Vaginal Squamous Cell Carcinoma', 'Urethral Squamous Cell Carcinoma']",Bladder Cancer,"EvolveImmune United, Inc",[],['United States']
NCT06843434,A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma,A Phase II Study of Neoadjuvant Botensilimab and Balstilimab Immunotherapy for Mismatch Repair Proficient Rectal Adenocarcinoma,RECRUITING,2025-02-20,2028-02-20,2028-02-20,INTERVENTIONAL,PHASE2,40,"['Microsatellite Stable Rectal Carcinoma', 'Locally Advanced Rectal Adenocarcinoma']",Microsatellite Stable Rectal Carcinoma,Memorial Sloan Kettering Cancer Center,['Agenus Inc.'],['United States']
NCT06878729,Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI,Antegrade Dissection and Re-entry Versus Retrograde Strategy in Chronic Total Occlusion Percutaneous Coronary Intervention,RECRUITING,2025-07-28,2028-03-31,2028-09-30,INTERVENTIONAL,NA,74,"['Coronary Artery Disease', 'Coronary Occlusion', 'Percutaneous Coronary Intervention']",Coronary Artery Disease,"National Institute of Cardiology, Warsaw, Poland","['Medical Research Agency, Poland']",['Poland']
NCT07227701,A Comparison of Satiety Effects Two Commercially Available Snack Bars,A Comparison of Satiety Effects of High Protein Snack Bars and High Carbohydrate Snack Bars,ACTIVE_NOT_RECRUITING,2025-02-27,2026-03-31,2026-03-31,INTERVENTIONAL,NA,150,['Satiety'],Satiety,Indiana University,[],['United States']
NCT07257653,The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer,The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer,RECRUITING,2025-10-21,2026-12-31,2027-12-31,INTERVENTIONAL,PHASE2,70,"['Colorectal Neoplasms', 'RAS', 'BRAF', 'Cetuximabβ', 'Fruquintinib']",Colorectal Neoplasms,Zhejiang University,[],['China']
NCT07260032,Determining the Benefits of Exercise on Cardiovascular Risk in PTSD,Using Advanced Imaging to Determine the Benefits of Exercise on Cardiovascular Risk in PTSD,RECRUITING,2025-02-01,2027-01-31,2027-01-31,INTERVENTIONAL,NA,10,"['PTSD', 'Cardiovascular Disease', 'Cardiovascular Disease Risk Factors']",PTSD,Massachusetts General Hospital,[],['United States']
NCT00001163,"Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer","Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer",ACTIVE_NOT_RECRUITING,1985-04-02,,,OBSERVATIONAL,,5201,"['Hereditary Neoplasms', 'Cancer', 'Genetic Predisposition to Cancer', 'Environment']",Hereditary Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT07222748,A Study of TLC590 for Postsurgical Pain Following Bunionectomy,"A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy",RECRUITING,2025-11-17,2026-04,2026-05,INTERVENTIONAL,PHASE3,300,['Postoperative Pain'],Postoperative Pain,"TLC Biopharmaceuticals, Inc.",[],['United States']
NCT04852887,"De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)","A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer",RECRUITING,2021-06-07,2026-01,2041-07,INTERVENTIONAL,PHASE3,1670,['Stage I Breast Cancer'],Stage I Breast Cancer,NRG Oncology,['National Cancer Institute (NCI)'],"['Japan', 'United States', 'Hong Kong', 'Canada']"
NCT06443281,Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury,Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury,RECRUITING,2024-04-17,2030-04-30,2030-04-30,OBSERVATIONAL,,300,"['Spinal Cord Injuries', 'Pain, Neuropathic', 'Nociceptive Pain', 'Neuropathy']",Spinal Cord Injuries,University of Zurich,['Swiss National Science Foundation'],['Switzerland']
NCT04820179,"Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer","Phase II Trial Evaluating the Safety and Efficacy of Atezolizumab in Combination With Cabozantinib for the Treatment of Metastatic, Refractory Pancreatic Cancer",RECRUITING,2021-10-12,2026-01-31,2026-01-31,INTERVENTIONAL,PHASE2,29,"['Pancreatic Cancer', 'Metastatic Pancreatic Cancer']",Pancreatic Cancer,University of Arizona,[],['United States']
NCT04293562,A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations,"A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations",RECRUITING,2020-07-21,2029-06-30,2029-06-30,INTERVENTIONAL,PHASE3,1186,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,Children's Oncology Group,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States', 'Canada', 'Australia']"
NCT07257913,Impact of Dairy Integration Into Canadian Food Guide on Gut Health,Impact of Dairy Integration Into Canadian Food Guide on Gut Health,RECRUITING,2025-10-06,2026-08-31,2026-08-31,INTERVENTIONAL,NA,20,"['Gut Epithelial Permeability', 'Gut Microbiota Composition and Diversity', 'Gut and Circulating Inflammatory Markers', 'Milk and Digestion']",Gut Epithelial Permeability,Laval University,[],['Canada']
NCT04649359,"MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb","MAGNETISMM-3 AN OPEN-LABEL, MULTICENTER, NON-RANDOMIZED PHASE 2 STUDY OF ELRANATAMAB (PF-06863135) MONOTHERAPY IN PARTICIPANTS WITH MULTIPLE MYELOMA WHO ARE REFRACTORY TO AT LEAST ONE PROTEASOME INHIBITOR, ONE IMMUNOMODULATORY DRUG AND ONE ANTI-CD38 ANTIBODY",ACTIVE_NOT_RECRUITING,2021-02-02,2022-06-17,2026-12-31,INTERVENTIONAL,PHASE2,187,['Multiple Myeloma'],Multiple Myeloma,Pfizer,[],"['Belgium', 'Japan', 'United States', 'France', 'Germany', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Australia']"
NCT06615479,A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2),"A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma",RECRUITING,2025-03-12,2027-12-30,2032-06-22,INTERVENTIONAL,PHASE3,440,['Relapsed or Refractory Multiple Myeloma (RRMM)'],Relapsed or Refractory Multiple Myeloma (RRMM),"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",['Celgene Corporation'],"['Japan', 'Netherlands', 'Saudi Arabia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06956235,Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012),"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Moderate to Severe Hidradenitis Suppurativa",ACTIVE_NOT_RECRUITING,2025-06-09,2026-11-16,2029-01-22,INTERVENTIONAL,PHASE2,147,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,Merck Sharp & Dohme LLC,[],"['Singapore', 'Japan', 'Netherlands', 'China', 'United States', 'France', 'Germany', 'Chile', 'Spain', 'Italy', 'Canada', 'Colombia', 'United Kingdom', 'Argentina', 'Australia']"
NCT06846450,Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC,Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC,RECRUITING,2025-04-01,2031-01-31,2031-01-31,INTERVENTIONAL,PHASE3,470,['Nasopharyngeal Cancinoma (NPC)'],Nasopharyngeal Cancinoma (NPC),"Lin Kong, MD",[],['China']
NCT03539692,Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site,Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site,RECRUITING,2018-06-10,2028-12,2028-12,OBSERVATIONAL,,1000,['Food Allergy'],Food Allergy,Stanford University,"['National Institute of Allergy and Infectious Diseases (NIAID)', 'National Institutes of Health (NIH)']",['United States']
NCT07193771,Altitude and Outcomes in Pediatric ARDS: A Multicenter Study,"Evaluation of Altitude as an Independent Risk Factor for Mortality in Pediatric Acute Respiratory Distress Syndrome: Influence of Oxygenation, Ventilation, and Hospital Structure in a Multicenter Observational Study.",RECRUITING,2025-11-01,2027-11,2028-03,OBSERVATIONAL,,1600,"['Respiratory Distress Syndrome, Pediatric', 'Altitude Hypoxia', 'High Altitude Effects']","Respiratory Distress Syndrome, Pediatric",Latin American Pediatric Collaborative Network,"['Universidad Nacional de Colombia', 'Fundación Universitaria de Ciencias de la Salud']","['Uruguay', 'Colombia']"
NCT04680026,A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF),"A Phase 2, Two-Stage, Serial Cohort Dose Escalation and Expansion Study of a Single Intravenous Infusion of HBI 3000 for the Conversion of Atrial Fibrillation (AF) of Recent Onset",ACTIVE_NOT_RECRUITING,2021-06-01,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,150,['Atrial Fibrillation'],Atrial Fibrillation,"HUYABIO International, LLC.",[],"['New Zealand', 'United States', 'Bosnia and Herzegovina', 'Canada', 'Serbia']"
NCT00001159,Natural History of Thyroid Function Disorders,Natural History of Thyroid Function Disorders,RECRUITING,1977-02-01,,,OBSERVATIONAL,,2500,"['Hyperthyroidism', 'Hypothyroidism', ""Grave's Disease""]",Hyperthyroidism,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07099391,A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma,ALTITUDE - ALTernating Induction Therapies to Achieve Undetectable Disease Endpoints: A Phase 1/2 Alternating Dara-RVd/Teclistamab-RVd in Transplant Eligible Standard-risk Newly Diagnosed Multiple Myeloma,RECRUITING,2025-07-24,2029-07-24,2029-07-24,INTERVENTIONAL,PHASE1,65,['Multiple Myeloma'],Multiple Myeloma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06414317,"An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers",A Comprehensive Education and Navigational Support Program for Advanced Bladder Cancer,RECRUITING,2024-01-12,2026-01-01,2026-01-01,INTERVENTIONAL,NA,160,"['Locally Advanced Bladder Carcinoma', 'Metastatic Bladder Carcinoma', 'Stage III Bladder Cancer AJCC v8', 'Stage IV Bladder Cancer AJCC v8', 'Unresectable Bladder Carcinoma']",Locally Advanced Bladder Carcinoma,Roswell Park Cancer Institute,[],['United States']
NCT05180474,GEN1047 for Solid Tumors - First in Human (FIH) Trial,"First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1047 in Subjects With Malignant Solid Tumors",ACTIVE_NOT_RECRUITING,2021-12-13,2026-03-26,2026-03-26,INTERVENTIONAL,PHASE1,179,"['Breast Cancer, Breast Neoplasms', 'Endometrial Cancer, Endometrial Neoplasm', 'Ovarian Cancer, Ovarian Neoplasms', 'Squamous Non Small Cell Lung Cancer (NSCLC-SCC)']","Breast Cancer, Breast Neoplasms",Genmab,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Poland']"
NCT05889182,A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy,"A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy",RECRUITING,2023-06-21,2028-03,2028-03,INTERVENTIONAL,PHASE3,1328,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,AbbVie,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'Saudi Arabia', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Croatia', 'Puerto Rico', 'South Korea', 'Colombia', 'Czechia', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT05612074,Methemoglobin Concentration in High Dose Inhaled Nitric Oxide,Kinetics of Methemoglobin Concentration in Healthy Subjects Exposed to High Dose Inhaled Nitric Oxide,ACTIVE_NOT_RECRUITING,2023-10-16,2026-11,2027-12,INTERVENTIONAL,EARLY_PHASE1,10,['Healthy Subjects'],Healthy Subjects,Massachusetts General Hospital,[],['United States']
NCT06553651,Necrosectomy With Cryotechnology for Accelerated Removal,Necrosectomy With Cryotechnology for Accelerated Removal,RECRUITING,2026-01,2026-12,2027-05,INTERVENTIONAL,NA,20,"['Pancreatic Necrosis', 'Acute Pancreatitis', 'Acute Pancreatic Necrosis', 'Necrosis', 'Necrosis Pancreas', 'Walled-Off Pancreatic Necrosis']",Pancreatic Necrosis,"Christopher C. Thompson, MD, MSc",['Erbe Elektromedizin GmbH'],['United States']
NCT06604000,Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury,Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury,RECRUITING,2023-09-26,2029-12-18,2030-01-01,INTERVENTIONAL,NA,116,"['Acquired Brain Injury', 'Executive Function Disorder']",Acquired Brain Injury,St. Olavs Hospital,['Norwegian University of Science and Technology'],['Norway']
NCT07107139,Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects,Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects,RECRUITING,2025-12-30,2027-03-01,2027-03-01,INTERVENTIONAL,NA,50,['Smokeless Tobacco'],Smokeless Tobacco,Roswell Park Cancer Institute,['National Cancer Institute (NCI)'],['United States']
NCT07258914,Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD),Feasibility and Efficacy of rTMS in Depression in Individuals With Autism Spectrum Disorder (ASD),RECRUITING,2024-12-19,2026-02-19,2026-02-19,INTERVENTIONAL,NA,25,"['Autism Spectrum Disorder', 'Depression', 'Major Depressive Episode (MDE)']",Autism Spectrum Disorder,Hospital Center Guillaume Régnier,[],['France']
NCT06501001,Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS),Time Restricted Eating and High-Intensity Interval Training to Improve Health in Patients With Metabolic Syndrome,ACTIVE_NOT_RECRUITING,2024-09-01,2026-02,2026-02,INTERVENTIONAL,NA,200,"['Metabolic Syndrome', 'Exercise', 'Weight Loss', 'Obesity', 'Cardiometabolic Syndrome', 'Time Restricted Eating']",Metabolic Syndrome,University of Castilla-La Mancha,[],['Spain']
NCT06554691,Understanding the Immune System's Role in Tree Nut and Peanut Allergies: Key Biomarkers for Diagnosis and Treatment Monitoring and Treatment Targets,Exploring the Immunological Basis in the Evolution of Tree Nut and Peanut Allergy During Treatment Care for Understanding Markers and Treatment Targets,ACTIVE_NOT_RECRUITING,2023-10-02,2026-12,2026-12,OBSERVATIONAL,,90,"['Food Allergy', 'Food Allergy in Children', 'Food Allergy Peanut', 'Tree Nut Allergies', 'Allergy;Food', 'Oral Immunotherapy for Food Allergy']",Food Allergy,Luxembourg Institute of Health,['Centre Hospitalier du Luxembourg'],['Luxembourg']
NCT06354491,An Imaging-based Quantitative Biomarker Assay for NAFLD in Children,An Imaging-based Quantitative Biomarker Assay for Non-alcoholic Fatty Liver Disease (NAFLD) in Children: a Feasibility Study,ACTIVE_NOT_RECRUITING,2024-04-01,2025-06-20,2028-07-01,INTERVENTIONAL,NA,24,"['NAFLD', 'NASH']",NAFLD,"University of Wisconsin, Madison",[],['United States']
NCT06854627,Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS,Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position on Mortality in ARDS Patients: A Multicenter Randomized Controlled Trial,RECRUITING,2025-04-07,2027-10,2028-01,INTERVENTIONAL,NA,780,['Acute Respiratory Distress Syndrome'],Acute Respiratory Distress Syndrome,Pontificia Universidad Catolica de Chile,"['Hospital do Coracao', 'Fundacion Clinica Valle del Lili', 'Fondo Nacional de Desarrollo Científico y Tecnológico, Chile']",['Chile']
NCT03834961,Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia,"Larotrectinib (LOXO-101, NSC# 788607) for Previously Untreated TRK Fusion Pediatric Solid Tumors and TRK Fusion Relapsed Pediatric Acute Leukemias",ACTIVE_NOT_RECRUITING,2019-10-25,2024-09-30,2027-07-25,INTERVENTIONAL,PHASE2,33,"['Central Nervous System Neoplasm', 'Infantile Fibrosarcoma', 'Recurrent Acute Leukemia', 'Refractory Acute Leukemia', 'Solid Neoplasm']",Central Nervous System Neoplasm,Children's Oncology Group,['National Cancer Institute (NCI)'],"['United States', 'Canada']"
NCT04396873,PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease,Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease,RECRUITING,2021-08-17,2029-04-11,2030-10-03,INTERVENTIONAL,PHASE1,184,"[""Parkinson's Disease"", 'Dementia', ""Alzheimer's Disease"", 'ALS', 'Mild Cognitive Impairment']",Parkinson's Disease,National Institute of Mental Health (NIMH),[],['United States']
NCT04010357,"Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC","Targeted Therapy With CDK4/6 Inhibitors in Chemo- Refractory/Relapsed, Rb Wild-type Extensive Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Lung Cancer, Extrapulmonary Small Cell Cancers and Other High Grade Neuroendocrine Cancers of the Lung, an Open Label Phase 2 Trial.",ACTIVE_NOT_RECRUITING,2020-01-13,2025-12,2025-12,INTERVENTIONAL,PHASE2,14,"['Small-cell Lung Cancer', 'Large Cell Neuroendocrine Carcinoma of the Lung', 'Extrapulmonary Small Cell Carcinoma']",Small-cell Lung Cancer,Case Comprehensive Cancer Center,[],['United States']
NCT07257081,Effect of Combining a Posterosuperior Humeral Notch Filling With a Coracoid Bone Block on the Rate of Return to Sport,Effect of Combining Filling of the Posterior Superior Notch of the Humerus With a Coracoid Stop on the Rate of Return to Sports at the Same Level: a Randomized Study,ACTIVE_NOT_RECRUITING,2025-11-01,2026-07-01,2027-07-31,INTERVENTIONAL,NA,120,['Shoulder Injuries'],Shoulder Injuries,"Clinique Saint Jean, France",[],['France']
NCT07257471,Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy,Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy,RECRUITING,2025-06-06,2028-06-30,2028-06-30,OBSERVATIONAL,,30,['Lung Cancer (NSCLC)'],Lung Cancer (NSCLC),Beijing Haidian Hospital,[],['China']
NCT05376267,Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP),Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP),RECRUITING,2022-08-05,2028-03-31,2028-03-31,INTERVENTIONAL,NA,900,"['Cardiac Arrest, Out-Of-Hospital', 'Hypothermia, Induced', 'Hypoxia-Ischemia, Brain']","Cardiac Arrest, Out-Of-Hospital",University of Michigan,"['National Heart, Lung, and Blood Institute (NHLBI)', 'Kennedy Krieger Institute, Baltimore, MD']","['New Zealand', 'United States', 'Canada', 'United Kingdom', 'Australia']"
NCT04735458,Investigating Inhibitory Control Networks in Parkinson's Disease,Investigating Inhibitory Control Networks in Parkinson's Disease,RECRUITING,2021-04-01,2027-03-31,2028-03-31,INTERVENTIONAL,NA,140,['Parkinson Disease'],Parkinson Disease,University of Alabama at Birmingham,['National Institute of Neurological Disorders and Stroke (NINDS)'],['United States']
NCT07257458,Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer,Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer,RECRUITING,2025-04-02,2028-06-30,2028-06-30,OBSERVATIONAL,,30,['Lung Cancer (NSCLC)'],Lung Cancer (NSCLC),Beijing Haidian Hospital,[],['China']
NCT05021835,"ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation","ZEUS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Participants With Established Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease and Systemic Inflammation",ACTIVE_NOT_RECRUITING,2021-08-30,2026-06-26,2026-06-26,INTERVENTIONAL,PHASE3,6200,"['Cardiovascular Risk', 'Chronic Kidney Disease', 'Inflammation']",Cardiovascular Risk,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'Croatia', 'Denmark', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Latvia', 'Greece', 'Portugal', 'Ukraine', 'Sweden', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT07259590,A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation,"A Multicenter, Open-Label, Phase Ib/II Clinical Study to Explore the Efficacy, Pharmacokinetics and Safety/Tolerability of GFH375 in Combination With Cetuximab or Chemotherapy in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutation",RECRUITING,2025-10-21,2027-07,2027-07,INTERVENTIONAL,PHASE1,126,"['Advanced Solid Tumors Cancer', 'PDAC', 'CRC (Colorectal Cancer)']",Advanced Solid Tumors Cancer,Genfleet Therapeutics (Shanghai) Inc.,[],['China']
NCT05632913,Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer,A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Recurrent Lung Cancer,RECRUITING,2023-07-01,2027-02,2027-02,INTERVENTIONAL,NA,10,"['Recurrent Lung Cancer', 'Lung Cancer']",Recurrent Lung Cancer,Alpha Tau Medical LTD.,[],['Israel']
NCT06942221,Digital Solutions in Heart Therapy (DIGNITY),Digital Solutions in Heart Therapy (DIGNITY) - a Randomized Controlled Trial Using Telemedicine for Heart Failure Treatment,RECRUITING,2025-07-17,2026-12-31,2026-12-31,INTERVENTIONAL,NA,140,['Heart Failure With Reduced Ejection Fraction'],Heart Failure With Reduced Ejection Fraction,"University Hospital, Basel, Switzerland",[],['Switzerland']
NCT03025035,Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer,"Open Label, Phase II Pilot Study of Immune Checkpoint Inhibition With Pembrolizumab in Combination With PARP Inhibition With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancers",ACTIVE_NOT_RECRUITING,2017-09-10,2024-10-08,2026-08-08,INTERVENTIONAL,PHASE2,14,['Breast Cancer'],Breast Cancer,Yuan Yuan,['Merck Sharp & Dohme LLC'],['United States']
NCT07178340,Perioperative Therapy for HER2-negative Hepatoid Adenocarcinoma of Stomach,"Prospective, Single-arm, Single-center Phase II Clinical Study of Perioperative Therapy for Locally Advanced HER2-negative Hepatoid Adenocarcinoma of Stomach",RECRUITING,2025-09-18,2027-09-20,2028-09-20,INTERVENTIONAL,PHASE2,30,['Hepatoid Adenocarcinoma of Stomach'],Hepatoid Adenocarcinoma of Stomach,Peking University Cancer Hospital & Institute,[],['China']
NCT07259928,Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion,"Open-label, Safety, Tolerability and Proof of Concept Study to Evaluate the Use of ANXV (Recombinant Human Annexin A5 Protein) in the Treatment of Patients With Either Diabetic Retinopathy or Recent Onset Retinal Vein Occlusion",RECRUITING,2025-11-07,2026-07,2026-07,INTERVENTIONAL,PHASE2,12,"['Non-Proliferative Diabetic Retinopathy', 'Retinal Vein Occlusion']",Non-Proliferative Diabetic Retinopathy,Annexin Pharmaceuticals AB,[],['United Kingdom']
NCT06778239,Childhood-Onset Essential Hypertension Natural History Study,Natural History Study to Determine Childhood-Onset Essential Hypertension Etiology,RECRUITING,2025-05-30,2034-12-09,2034-12-09,OBSERVATIONAL,,2300,"['Hypertension', 'Essential Hypertension']",Hypertension,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06998524,A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease,"A Phase III, Multicenter, Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Prophylaxis in Patients With Type 3 Von Willebrand Disease",RECRUITING,2025-06-27,2026-12-31,2028-12-31,INTERVENTIONAL,PHASE3,75,"['Von Willebrand Disease, Type 3']","Von Willebrand Disease, Type 3",Hoffmann-La Roche,[],"['Belgium', 'Japan', 'South Africa', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Colombia', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT05309954,Genetic Analysis to Predict the Development of Paget's Disease,Genetic Analysis to Predict the Development of Paget's Disease,RECRUITING,2022-01-01,2026-06-01,2027-06-01,OBSERVATIONAL,,950,"['Paget Disease', 'Paget Disease of Bone']",Paget Disease,University of Edinburgh,['European Research Council'],['United Kingdom']
NCT04933539,"Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma","A Phase 2 Adaptive Study of Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma",ACTIVE_NOT_RECRUITING,2022-10-31,2026-07-26,2032-10-31,INTERVENTIONAL,PHASE2,14,['Multiple Myeloma'],Multiple Myeloma,National Cancer Institute (NCI),"['Janssen Scientific Affairs, LLC']",['United States']
NCT06954337,MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial,MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial,RECRUITING,2025-05-01,2027-03-01,2027-05-01,INTERVENTIONAL,NA,1750,"['Breast Cancer', 'Prostate Cancer']",Breast Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT02839707,"Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer",ACTIVE_NOT_RECRUITING,2017-06-23,2023-05-09,2026-03-31,INTERVENTIONAL,PHASE2,444,"['Fallopian Tube High Grade Serous Adenocarcinoma', 'Ovarian High Grade Serous Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Primary Peritoneal High Grade Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Fallopian Tube Clear Cell Adenocarcinoma', 'Recurrent Fallopian Tube Endometrioid Adenocarcinoma', 'Recurrent Fallopian Tube Undifferentiated Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Ovarian Clear Cell Adenocarcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma', 'Recurrent Ovarian Undifferentiated Carcinoma', 'Recurrent Platinum-Resistant Fallopian Tube Carcinoma', 'Recurrent Platinum-Resistant Ovarian Carcinoma', 'Recurrent Platinum-Resistant Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Carcinoma', 'Recurrent Primary Peritoneal Clear Cell Adenocarcinoma', 'Recurrent Primary Peritoneal Endometrioid Adenocarcinoma', 'Recurrent Primary Peritoneal Undifferentiated Carcinoma']",Fallopian Tube High Grade Serous Adenocarcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['Puerto Rico', 'United States']"
NCT03625037,"First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma","A Phase 1/2, Open-label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma",ACTIVE_NOT_RECRUITING,2018-06-26,2029-01,2029-01,INTERVENTIONAL,PHASE1,666,"['DLBCL', 'High-grade B-cell Lymphoma (HGBCL)', 'Primary Mediastinal Large B-cell Lymphoma (PMBCL)', 'FL', 'MCL', 'Small Lymphocytic Lymphoma (SLL)', 'Marginal Zone Lymphoma (MZL)', 'Indolent B-cell Non-Hodgkin Lymphoma (iNHL)', 'Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)']",DLBCL,Genmab,['AbbVie'],"['Singapore', 'Netherlands', 'United States', 'France', 'Germany', 'Finland', 'Denmark', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Sweden', 'Australia']"
NCT04632953,Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program,Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program (LC-FAOD DMP),ACTIVE_NOT_RECRUITING,2021-11-30,2035-12,2035-12,OBSERVATIONAL,,150,['Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)'],Long-chain Fatty Acid Oxidation Disorders (LC-FAOD),Ultragenyx Pharmaceutical Inc,[],"['United States', 'Canada']"
NCT00326482,Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy,A Pilot Study of Hepatic Fibrosis in HIV/AIDS Patients With Chronically Elevated Transaminases on Antiretroviral Therapy,ACTIVE_NOT_RECRUITING,2006-07-31,,,OBSERVATIONAL,,127,"['Liver Fibrosis', 'Steatohepatitis', 'Elevated Transaminases']",Liver Fibrosis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT01150708,A Prospective Natural History Study of Patients With Syringomyelia,A Prospective Natural History Study of Patients With Syringomyelia,ACTIVE_NOT_RECRUITING,2010-08-03,,,OBSERVATIONAL,,180,"['Syringomyelia', 'Arnold Chiari Deformity']",Syringomyelia,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07233291,A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults,Evaluation of Efficacy and Safety of Oral Roflumilast in Treatment of Moderate to Severe Psoriasis: a Pilot Study,RECRUITING,2025-08-20,2026-02-28,2026-02-28,INTERVENTIONAL,PHASE2,36,['Psoriasis (PsO)'],Psoriasis (PsO),Ahmed Ibrahim,['Mansoura University Hospital'],['Egypt']
NCT06895720,THE MYOFASCIAL SYSTEM AND MINIMIZING THE RISK OS INJURY IN SPORT,"EFFECT OF SELF-MYOFASCİAL RELEASE ON MUSCLE MECHANİCAL PROPERTİES, PERFORMANCE, NEUROMUSCULAR FUNCTİON AND MİNİMİZATİON OF İNJURY RİSK İN YOUNG SOCCER PLAYERS",RECRUITING,2026-01-01,2026-02-26,2026-04-30,INTERVENTIONAL,NA,65,"['Sports Injuries', 'Flexibility', 'Balance', 'Jumping Performance', 'Muscle Tonus', 'Ranger of Motion', 'Reactive Strength Index', 'Muscle Stiffness', 'Muscle Elasticity']",Sports Injuries,Aveiro University,[],['Portugal']
NCT05618028,Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets,A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies,RECRUITING,2023-04-04,2029-07,2029-07,INTERVENTIONAL,PHASE1,150,"['Diffuse Large B-Cell Lymphoma', 'Chronic Lymphocytic Leukemia', 'B Cell Malignancies', ""Non-Hodgkin's Lymphoma""]",Diffuse Large B-Cell Lymphoma,AbbVie,[],"['Belgium', 'Israel', 'United States', 'France', 'Spain', 'South Korea', 'Australia', 'United Kingdom', 'Germany']"
NCT07208591,To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome,"Phase Ⅲ Randomized, Double-blind, Placebo-controlled Evaluation of the Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome",RECRUITING,2025-10-31,2026-07,2026-10,INTERVENTIONAL,PHASE3,406,['Acute Respiratory Distress Syndrome (ARDS)'],Acute Respiratory Distress Syndrome (ARDS),"Staidson (Beijing) Biopharmaceuticals Co., Ltd",[],['China']
NCT07258732,The Impact of Probiotics on Bariatric Treatment Outcomes,Study on the Impact of Probiotics on Postoperative Gastrointestinal Symptoms and Gut Microbiota After Sleeve Gastrectomy: A Randomized-Control Trial,ACTIVE_NOT_RECRUITING,2025-07-10,2026-07-10,2026-12-31,INTERVENTIONAL,NA,200,['Obesity &Amp; Overweight'],Obesity &Amp; Overweight,University of Warmia and Mazury in Olsztyn,[],['Poland']
NCT06658730,Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance,Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance,RECRUITING,2025-06-19,2038-08,2038-08,OBSERVATIONAL,,1500,"['Vascular Disease', 'Dissection', 'Dissection Aortic Aneurysm', 'Dissection of Aorta', 'Aneurysm Thoracic', 'Aneurysm Dissecting', 'Transection Aorta', 'Intramural Hematoma']",Vascular Disease,W.L.Gore & Associates,[],"['United States', 'France', 'Denmark', 'Spain', 'Greece', 'Sweden', 'Germany']"
NCT07259083,Psychological and Physiological Parameters for Return-to-sport After ACL Reconstruction,Long-term Correlation of Functional and Psychological Parameters for the Return-to-sport Decision After Anterior Cruciate Ligament Reconstruction,RECRUITING,2025-04-16,2025-09-01,2025-12,OBSERVATIONAL,,30,['ACL Reconstruction'],ACL Reconstruction,Johannes Kepler University of Linz,['University of Salzburg'],['Austria']
NCT05618327,Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma,Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma,ACTIVE_NOT_RECRUITING,2023-02-13,2026-12-30,2026-12-30,INTERVENTIONAL,PHASE1,104,"[""Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma""]",Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma,"Shanghai Junshi Bioscience Co., Ltd.",[],['China']
NCT04491383,Tocotrienols in Parkinson's Disease (PD),"Tocotrienols in Parkinson's Disease (PD): A Pilot, Randomised, Placebo-controlled Trial",ACTIVE_NOT_RECRUITING,2021-04-01,2026-07,2027-07-31,INTERVENTIONAL,PHASE2,100,"['Neuro-Degenerative Disease', 'Parkinson Disease']",Neuro-Degenerative Disease,National Neuroscience Institute,[],['Singapore']
NCT07160816,A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar,"A Real-world, Multi-centre, Prospective, Non-interventional, Single-arm Study Investigating Glycaemic Control, Treatment Satisfaction and Adherence Associated With the Use of Insulin Icodec in People Living With Type 1 Diabetes",RECRUITING,2025-08-28,2027-01-20,2027-01-20,OBSERVATIONAL,,245,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1",Novo Nordisk A/S,[],"['Italy', 'Germany']"
NCT06422715,PTLD: Multicentric Retrospective Study,Post-transplant Lymphoproliferative Disorders (PTLD): Multicentric Observational Retrospective Cohort Study,ACTIVE_NOT_RECRUITING,2024-10-30,2025-08-12,2026-01,OBSERVATIONAL,,241,['PTLD'],PTLD,Fondazione Italiana Linfomi - ETS,['Pierre Fabre Pharma AG'],['Italy']
NCT06579092,Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity,"A Phase IIb Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD5004 in Participants Living With Obesity or Overweight With Comorbidity",ACTIVE_NOT_RECRUITING,2024-10-08,2025-12-09,2025-12-09,INTERVENTIONAL,PHASE2,310,['Obesity or Overweight'],Obesity or Overweight,AstraZeneca,[],"['Japan', 'United States', 'Taiwan', 'Canada', 'Australia', 'United Kingdom', 'Germany']"
NCT07257263,Exploring How Health Care Support Workers Respond to Distressed Behaviour in People With Dementia,Exploring How Health Care Support Workers Respond to Distressed Behaviour in People With Dementia,ACTIVE_NOT_RECRUITING,2025-04-01,2025-12,2025-12,OBSERVATIONAL,,6,['Dementia'],Dementia,Royal Cornwall Hospitals Trust,[],['United Kingdom']
NCT06561919,STIMPulseControl Ancillary Speech Study,STIMPulseControl Ancillary Speech Study,RECRUITING,2024-09-05,2027-07-15,2028-07-15,INTERVENTIONAL,NA,60,"['Parkinson Disease', 'Impulse Control Disorder']",Parkinson Disease,Steffen Paschen,"['Czech Technical University in Prague', 'Insel Gruppe AG, University Hospital Bern', 'Philipps University Marburg', 'University Hospital Schleswig-Holstein', 'Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)']","['Switzerland', 'Netherlands', 'Germany']"
NCT03042975,Imaging Genetics of Laryngeal Dystonia,Imaging Genetics of Laryngeal Dystonia,RECRUITING,2017-01-23,2028-07-31,2028-07-31,OBSERVATIONAL,,410,"['Laryngeal Dystonia', 'Unaffected Relatives of Laryngeal Dystonia Patients', 'Voice Tremor', 'Muscle Tension Dysphonia']",Laryngeal Dystonia,Kristina Simonyan,['National Institute on Deafness and Other Communication Disorders (NIDCD)'],['United States']
NCT04174196,A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma,A Pilot Study Evaluating Lenalidomide and CC-486 in Combination With Radiotherapy For Patients With Plasmacytoma (LENAZART Study),ACTIVE_NOT_RECRUITING,2019-11-19,2026-11-19,2026-11-19,INTERVENTIONAL,PHASE2,21,"['Plasmacytoma', 'Plasmacytoma of Bone', 'Multiple Myeloma']",Plasmacytoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06897748,A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils,"A Phase II, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab in Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils (COMETA)",ACTIVE_NOT_RECRUITING,2025-04-12,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE2,98,['Chronic Obstructive Pulmonary Disease (COPD)'],Chronic Obstructive Pulmonary Disease (COPD),AstraZeneca,[],['Russia']
NCT03432806,"A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors",Development of Novel Imaging and Laboratory Biomarkers to Monitor the Liver Pre-metastatic Niche and Guide Treatment of Colon Cancer: A Pilot Study,ACTIVE_NOT_RECRUITING,2017-11-28,2026-11,2026-11,OBSERVATIONAL,,51,"['Colon Cancer', 'Liver Tumors']",Colon Cancer,Memorial Sloan Kettering Cancer Center,['Weill Medical College of Cornell University'],['United States']
NCT04220021,Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD,"A Single-Center, Open Label Study to Assess the Safety and Tolerability of Metformin in Subjects With C9orf72 Amyotrophic Lateral Sclerosis Over 24 Weeks of Treatment",ACTIVE_NOT_RECRUITING,2020-01-10,2024-08-26,2026-06-30,INTERVENTIONAL,PHASE2,41,"['C9orf72 Amyotrophic Lateral Sclerosis (ALS)', 'Frontotemporal Dementia']",C9orf72 Amyotrophic Lateral Sclerosis (ALS),University of Florida,"['ALS Association', 'United States Department of Defense']",['United States']
NCT06909214,A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG),"A Phase 4, Open-Label, Prospective, Single-Group, Multicenter Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adult Participants With New-Onset Generalized Myasthenia Gravis",RECRUITING,2025-04-17,2026-08,2027-05,INTERVENTIONAL,PHASE4,30,['New Onset Generalized Myasthenia Gravis (gMG)'],New Onset Generalized Myasthenia Gravis (gMG),argenx,[],['United States']
NCT07259304,"Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors","Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors: A Longitudinal Study",RECRUITING,2021-11-24,2026-12-31,2027-12-31,OBSERVATIONAL,,250,"['Anatomic Stage I Breast Cancer AJCC v8', 'Anatomic Stage IA Breast Cancer AJCC v8', 'Anatomic Stage IB Breast Cancer AJCC v8', 'Anatomic Stage II Breast Cancer AJCC v8', 'Anatomic Stage IIA Breast Cancer AJCC v8', 'Anatomic Stage IIB Breast Cancer AJCC v8', 'Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IIIA Breast Cancer AJCC v8', 'Anatomic Stage IIIB Breast Cancer AJCC v8', 'Anatomic Stage IIIC Breast Cancer AJCC v8', 'Central Nervous System Neoplasm', 'Clinical Stage I Cutaneous Melanoma AJCC v8', 'Clinical Stage IA Cutaneous Melanoma AJCC v8', 'Clinical Stage IB Cutaneous Melanoma AJCC v8', 'Clinical Stage II Cutaneous Melanoma AJCC v8', 'Clinical Stage IIA Cutaneous Melanoma AJCC v8', 'Clinical Stage IIB Cutaneous Melanoma AJCC v8', 'Clinical Stage IIC Cutaneous Melanoma AJCC v8', 'Clinical Stage III Cutaneous Melanoma AJCC v8', 'Hodgkin Lymphoma', 'Malignant Bone Neoplasm', 'Malignant Brain Neoplasm', 'Malignant Solid Neoplasm', 'Malignant Testicular Neoplasm', 'Non-Hodgkin Lymphoma', 'Pathologic Stage I Cutaneous Melanoma AJCC v8', 'Pathologic Stage IA Cutaneous Melanoma AJCC v8', 'Pathologic Stage IB Cutaneous Melanoma AJCC v8', 'Pathologic Stage II Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIA Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIB Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIC Cutaneous Melanoma AJCC v8', 'Pathologic Stage III Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIA Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIB Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIC Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIID Cutaneous Melanoma AJCC v8', 'Prognostic Stage I Breast Cancer AJCC v8', 'Prognostic Stage IA Breast Cancer AJCC v8', 'Prognostic Stage IB Breast Cancer AJCC v8', 'Prognostic Stage II Breast Cancer AJCC v8', 'Prognostic Stage IIA Breast Cancer AJCC v8', 'Prognostic Stage IIB Breast Cancer AJCC v8', 'Prognostic Stage III Breast Cancer AJCC v8', 'Prognostic Stage IIIA Breast Cancer AJCC v8', 'Prognostic Stage IIIB Breast Cancer AJCC v8', 'Prognostic Stage IIIC Breast Cancer AJCC v8', 'Stage I Cervical Cancer AJCC v8', 'Stage I Colorectal Cancer AJCC v8', 'Stage I Differentiated Thyroid Gland Carcinoma AJCC v8', 'Stage I Ovarian Cancer AJCC v8', 'Stage I Thyroid Gland Medullary Carcinoma AJCC v8', 'Stage I Uterine Corpus Cancer AJCC v8', 'Stage IA Cervical Cancer AJCC v8', 'Stage IA Ovarian Cancer AJCC v8', 'Stage IA Uterine Corpus Cancer AJCC v8', 'Stage IA1 Cervical Cancer AJCC v8', 'Stage IA2 Cervical Cancer AJCC v8', 'Stage IB Cervical Cancer AJCC v8', 'Stage IB Ovarian Cancer AJCC v8', 'Stage IB Uterine Corpus Cancer AJCC v8', 'Stage IB1 Cervical Cancer AJCC v8', 'Stage IB2 Cervical Cancer AJCC v8', 'Stage IC Ovarian Cancer AJCC v8', 'Stage II Cervical Cancer AJCC v8', 'Stage II Colorectal Cancer AJCC v8', 'Stage II Differentiated Thyroid Gland Carcinoma AJCC v8', 'Stage II Ovarian Cancer AJCC v8', 'Stage II Thyroid Gland Medullary Carcinoma AJCC v8', 'Stage II Uterine Corpus Cancer AJCC v8', 'Stage IIA Cervical Cancer AJCC v8', 'Stage IIA Colorectal Cancer AJCC v8', 'Stage IIA Ovarian Cancer AJCC v8', 'Stage IIA1 Cervical Cancer AJCC v8', 'Stage IIA2 Cervical Cancer AJCC v8', 'Stage IIB Cervical Cancer AJCC v8', 'Stage IIB Colorectal Cancer AJCC v8', 'Stage IIB Ovarian Cancer AJCC v8', 'Stage IIC Colorectal Cancer AJCC v8', 'Stage III Cervical Cancer AJCC v8', 'Stage III Colorectal Cancer AJCC v8', 'Stage III Differentiated Thyroid Gland Carcinoma AJCC v8', 'Stage III Ovarian Cancer AJCC v8', 'Stage III Thyroid Gland Medullary Carcinoma AJCC v8', 'Stage III Uterine Corpus Cancer AJCC v8', 'Stage IIIA Cervical Cancer AJCC v8', 'Stage IIIA Colorectal Cancer AJCC v8', 'Stage IIIA Ovarian Cancer AJCC v8', 'Stage IIIA Uterine Corpus Cancer AJCC v8', 'Stage IIIA1 Ovarian Cancer AJCC v8', 'Stage IIIA2 Ovarian Cancer AJCC v8', 'Stage IIIB Cervical Cancer AJCC v8', 'Stage IIIB Colorectal Cancer AJCC v8', 'Stage IIIB Ovarian Cancer AJCC v8', 'Stage IIIB Uterine Corpus Cancer AJCC v8', 'Stage IIIC Colorectal Cancer AJCC v8', 'Stage IIIC Ovarian Cancer AJCC v8', 'Stage IIIC Uterine Corpus Cancer AJCC v8', 'Stage IIIC1 Uterine Corpus Cancer AJCC v8', 'Stage IIIC2 Uterine Corpus Cancer AJCC v8']",Anatomic Stage I Breast Cancer AJCC v8,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT00107289,"Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma",Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors,RECRUITING,2006-05,2026-05,2026-05,INTERVENTIONAL,PHASE2,200,"['Neuroblastoma', 'Pheochromocytoma']",Neuroblastoma,Memorial Sloan Kettering Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT06634420,HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE),"HAELO: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2002 in Participants With Hereditary Angioedema (HAE)",ACTIVE_NOT_RECRUITING,2025-01-15,2026-04,2027-09,INTERVENTIONAL,PHASE3,60,['Hereditary Angioedema'],Hereditary Angioedema,Intellia Therapeutics,[],"['New Zealand', 'South Africa', 'Netherlands', 'United States', 'France', 'Canada', 'Australia', 'United Kingdom', 'Germany']"
NCT07259577,"Effects of Vagus Nerve Stimulation on Motor Function, Respiratory Muscle Strength, and Quality of Life in Stroke Patients","Effects of Vagus Nerve Stimulation on Motor Function, Respiratory Muscle Strength, and Quality of Life in Stroke Patients",RECRUITING,2025-10-06,2026-05-15,2026-06-01,INTERVENTIONAL,NA,30,"['Stroke', 'Stroke Treatment']",Stroke,Istanbul University - Cerrahpasa,[],['Turkey (Türkiye)']
NCT03610802,Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies,Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies,RECRUITING,2019-07-22,2038-03-31,2038-03-31,OBSERVATIONAL,,3000,['Primary Immunodeficiency'],Primary Immunodeficiency,National Institute of Allergy and Infectious Diseases (NIAID),[],"['United States', 'Italy', 'Turkey (Türkiye)']"
NCT05876078,DORAYA-HF OUS Assessment of the Doraya Catheter for the Treatment of ADHF Patients With Insufficient Response to Diuretics,DORAYA-HF EU: Assessment of the Doraya Catheter for the Treatment of Volume Overload in Acute Heart Failure Patients With Insufficient Response to Diuretics,RECRUITING,2024-07-01,2026-02-28,2026-04-30,INTERVENTIONAL,NA,35,['Acute Decompensated Heart Failure'],Acute Decompensated Heart Failure,Revamp Medical Ltd.,[],"['Hungary', 'Georgia', 'Slovakia', 'Spain', 'Italy', 'Czechia', 'Poland', 'Germany']"
NCT06827990,GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections,Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections,RECRUITING,2025-09-22,2030-09-01,2031-09-01,INTERVENTIONAL,NA,112,['Aortic Dissection'],Aortic Dissection,W.L.Gore & Associates,[],['United States']
NCT07257523,Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer,Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer: A Prospective Phase II Study,RECRUITING,2025-09-23,2027-07,2029-07,INTERVENTIONAL,PHASE2,33,['Pancreatic Neoplasm'],Pancreatic Neoplasm,Yonsei University,[],['South Korea']
NCT06541379,"Effect of Motor Imagery Ability on Functionality and Proprioception in Amputees Using Myoelectric Prostheses""",Investigation of the Effect of Motor Imagery Ability on Upper Extremity Functionality and Proprioception in Transradial Amputees Using Myoelectric Prostheses,RECRUITING,2025-06-01,2026-06-01,2026-06-01,OBSERVATIONAL,,30,"['Amputation of Upper Limb Below Elbow', 'Prosthesis User']",Amputation of Upper Limb Below Elbow,Medipol University,[],['Turkey (Türkiye)']
NCT07259785,SPSIPB vs CCB in Arthroscopic Shoulder Surgeries,Comparison of the Effects of Serratus Posterior Superior Intercostal Plane Block Versus Costoclavicular Brachial Plexus Block on Postoperative Pain and Hemidiaphragmatic Paralysis in Arthroscopic Shoulder Surgeries,ACTIVE_NOT_RECRUITING,2025-11-01,2026-02,2026-03,INTERVENTIONAL,NA,30,"['Postoperative Pain', 'Shoulder Arthoscopy']",Postoperative Pain,Cumhuriyet University,[],['Turkey (Türkiye)']
NCT07258563,The TASTY-steering Study,Taste Steering in Patients With Cancer Who Are Treated With Chemotherapy: a Multicentre Randomized Intervention Trial,RECRUITING,2025-06-06,2028-07,2028-07,INTERVENTIONAL,NA,201,"['Metastatic Triple Negative Breast Cancer or Metastatic Testicular Cancer, or Stage II-IV Diffuse Large B Cell Lymphoma']","Metastatic Triple Negative Breast Cancer or Metastatic Testicular Cancer, or Stage II-IV Diffuse Large B Cell Lymphoma",University Medical Center Groningen,[],['Netherlands']
NCT04964466,Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis,Growth Factor Availability and Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis,ACTIVE_NOT_RECRUITING,2021-08-31,2023-07-31,2026-12,OBSERVATIONAL,,5,['Bone Loss'],Bone Loss,University of Alabama at Birmingham,[],['United States']
NCT06472492,Cognitive Enhancement in Unipolar Depression With Yoga,A Randomized Control Trial Involving Yoga Intervention for Cognitive Enhancement in Persons With Remitted Unipolar Depression,RECRUITING,2024-05-17,2025-12-31,2026-03-31,INTERVENTIONAL,NA,76,['Unipolar Depression'],Unipolar Depression,University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', 'National Institute of Mental Health and Neuro Sciences, India']",['India']
NCT06138821,Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial,"Effect of Endoscopic Sleeve Gastroplasty on Patients With Obesity and Concomitant Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Multicenter, Open-label, Randomized Controlled Trial",RECRUITING,2025-06-24,2027-12,2028-06,INTERVENTIONAL,NA,132,"['Obesity', 'Liver Diseases', 'Liver Fibrosis', 'Liver Fat', 'Metabolic Dysfunction-Associated Steatotic Liver Disease', 'Metabolic Dysfunction-Associated Steatohepatitis', 'MASLD', 'MASH', 'Weight Loss', 'Insulin Resistance', 'Insulin Sensitivity', 'Insulin Sensitivity/Resistance', 'Metabolic Disease', 'Diabetes', 'Diabetes Mellitus, Type 2', 'NASH With Fibrosis', 'Non-Alcoholic Fatty Liver Disease', 'Non Alcoholic Fatty Liver', 'Non-alcoholic Steatohepatitis']",Obesity,"Pichamol Jirapinyo, MD, MPH","['Boston Scientific Corporation', 'Cook Group Incorporated']",['United States']
NCT07228676,INSPIRatory Efforts Estimation Under High-flow Nasal Oxygen,INSPIRatory Efforts Estimation Under High-flow Nasal Oxygen: a Pilot Study,RECRUITING,2025-11-29,2026-03-01,2026-04-01,INTERVENTIONAL,NA,20,"['Oxygen', 'Respiratory Insufficiency', 'Work of Breathing', 'Dyspnea']",Oxygen,Poitiers University Hospital,[],['France']
NCT05317390,Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia,Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia,RECRUITING,2022-06-01,2028-04-30,2028-04-30,INTERVENTIONAL,NA,1000,"['Dystonia', 'Drug Induced Dystonia', 'Parkinson Disease', 'Essential Tremor', 'Dyskinesias', 'Myoclonus', 'Tic Disorders', 'Torticollis', 'Ulnar Nerve Entrapment', 'Temporomandibular Joint Disorders', 'Dysphonia']",Dystonia,Massachusetts Eye and Ear Infirmary,[],['United States']
NCT07164885,RAPART in Locally Advanced Non-small Cell Lung Cancer Patients,Phase II/III Randomized Clinical Trial of Radiosensitivity-Assisted Personalized Adaptive RadioTherapy (RAPART) in Locally Advanced Non-small Cell Lung Cancer Patients,RECRUITING,2025-02-17,2027-12-30,2027-12-30,INTERVENTIONAL,NA,911,['Locally Advanced Non-small Cell Lung Cancer'],Locally Advanced Non-small Cell Lung Cancer,Capital Medical University,[],['China']
NCT04652882,Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD),"A Multicenter, Double-blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Participants With Delayed Sleep-Wake Phase Disorder (DSWPD)",RECRUITING,2020-12-09,2026-06,2026-06,INTERVENTIONAL,PHASE3,70,"['Sleep Wake Disorders', 'Sleep Disorders, Circadian Rhythm', 'Chronobiology Disorders']",Sleep Wake Disorders,Vanda Pharmaceuticals,[],"['Austria', 'United States', 'Germany']"
NCT04970888,"Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure","Comparing the Effects of Combining Cognitive and Physical Exercise Training on Cognition, and Cerebral Blood Flow Regulation in Men and Women With Chronic Heart Failure",RECRUITING,2021-09-01,2026-12-01,2026-12-01,INTERVENTIONAL,NA,216,"['Chronic Heart Failure', 'Aging']",Chronic Heart Failure,Montreal Heart Institute,"['Canadian Institutes of Health Research (CIHR)', 'The Montreal Health Innovations Coordinating Center (MHICC)']",['Canada']
NCT05344274,Retinal Blood Flow and Autoregulation,Direct Measures of Retinal Blood Flow and Autoregulation as Robust Biomarkers for Early Glaucoma,RECRUITING,2022-05-23,2027-09,2027-09,INTERVENTIONAL,PHASE4,90,['Glaucoma'],Glaucoma,"University of Maryland, Baltimore",[],['United States']
NCT04325217,Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan,Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan,ACTIVE_NOT_RECRUITING,2020-05-27,2026-06-30,2026-09-30,OBSERVATIONAL,,586,"['Lung Diseases, Interstitial']","Lung Diseases, Interstitial",Boehringer Ingelheim,[],['Japan']
NCT07227168,A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer,"A Phase 1 Open-Label Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-Tumor Activity of STRO-004 in Adults With Refractory/Recurrent Metastatic Solid Tumors",RECRUITING,2025-11-07,2027-12,2028-04,INTERVENTIONAL,PHASE1,200,"['Head and Neck Squamous Cell Carcinoma HNSCC', 'Non-Small Cell Lung Cancer NSCLC', 'Esophageal Cancer', 'Gastric Cancer', 'Colorectal Cancer', 'Pancreatic Ductal Adenocarcinoma (PDAC)', 'Cervical Cancer', 'Endometrial Cancer', 'Urothelial Cancer']",Head and Neck Squamous Cell Carcinoma HNSCC,"Sutro Biopharma, Inc.",[],['United States']
NCT06474260,"""One All"" to Get it RYT (Resilient Young Tribal Adults)","""One All"" to Get it RYT (Resilient Young Tribal Adults): A Multi Centric, Participatory,Feasibility and Effectiveness Study",RECRUITING,2024-04-22,2026-12-31,2026-12-31,INTERVENTIONAL,NA,240,"['Healthy Human Volunteers', 'Youth Resilience']",Healthy Human Volunteers,University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', 'Association for Health Welfare in the Nilgiris']",['India']
NCT05150106,Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor,Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor,RECRUITING,2022-11-07,2027-08-31,2027-08-31,OBSERVATIONAL,,165,"['Laryngeal Dystonia', 'Spasmodic Dysphonia', 'Tremor']",Laryngeal Dystonia,Massachusetts Eye and Ear Infirmary,['University of Utah'],['United States']
NCT05125809,Setrusumab vs Placebo for Osteogenesis Imperfecta,"An Operationally Seamless, Randomized Phase 2/3 Study Consisting of a Phase 2 Single-Blind, Dose-Evaluation Phase and a Phase 3 Double-Blind, Placebo-Controlled Phase to Assess the Efficacy and Safety of Setrusumab in Subjects With Osteogenesis Imperfecta",ACTIVE_NOT_RECRUITING,2022-02-21,2025-10-20,2027-04,INTERVENTIONAL,PHASE2,183,['Osteogenesis Imperfecta'],Osteogenesis Imperfecta,Ultragenyx Pharmaceutical Inc,['Mereo BioPharma'],"['Turkey (Türkiye)', 'Netherlands', 'United States', 'France', 'Italy', 'Canada', 'United Kingdom', 'Australia', 'Poland', 'Portugal', 'Germany']"
NCT06969274,Ultrasound-guided Sacral Erector Spinae Plane Block as a Sole Anesthetic Technique Versus Saddle Block in Hemorrhoidectomy,Ultrasound-guided Sacral Erector Spinae Plane Block as a Sole Anesthetic Technique Versus Saddle Block in Hemorrhoidectomy,RECRUITING,2025-05-29,2025-12,2025-12,INTERVENTIONAL,NA,50,['Hemorrhoids'],Hemorrhoids,Ain Shams University,[],['Egypt']
NCT04889417,COgnitive and Physical Exercise to Improve Outcomes After Surgery (COPE-iOS) Study,COgnitive and Physical Exercise to Improve Outcomes After Surgery (COPE-iOS) Study,ACTIVE_NOT_RECRUITING,2021-10-12,2026-10-31,2027-07-01,INTERVENTIONAL,NA,250,"['Cognitive Impairment', 'Disability Physical', 'Surgery']",Cognitive Impairment,Vanderbilt University Medical Center,['National Institute on Aging (NIA)'],['United States']
NCT05739383,A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.,"A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)",ACTIVE_NOT_RECRUITING,2023-03-09,2029-04-16,2029-04-16,INTERVENTIONAL,PHASE3,14082,['Primary Prevention of Atherosclerotic Cardiovascular Disease'],Primary Prevention of Atherosclerotic Cardiovascular Disease,Novartis Pharmaceuticals,[],"['Bulgaria', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Puerto Rico', 'Croatia', 'Denmark', 'Thailand', 'Colombia', 'Czechia', 'Poland', 'India', 'Singapore', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'Latvia', 'Portugal', 'United Kingdom', 'Sweden', 'Vietnam', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT05685602,CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer,A Phase I Clinical Trial of CA-4948 in Combination With Gemcitabine and Nab-Paclitaxel in Metastatic or Unresectable Pancreatic Ductal Carcinoma,RECRUITING,2023-06-12,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE1,36,"['Metastatic Pancreatic Ductal Adenocarcinoma', 'Stage III Pancreatic Cancer AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8', 'Unresectable Pancreatic Ductal Adenocarcinoma']",Metastatic Pancreatic Ductal Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT06733129,Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room,Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room: a 3-arm Randomized Trial,RECRUITING,2025-04-14,2027-04-14,2027-04-30,INTERVENTIONAL,PHASE3,1218,['Rapid Sequence Induction'],Rapid Sequence Induction,Nantes University Hospital,[],['France']
NCT04594902,The PANTHERS (Parents and iNfants Together in Home-based Early Remote Services) Project,The PANTHERS (Parents and iNfants Together in Home-based Early Remote Services) Project,ACTIVE_NOT_RECRUITING,2021-03-08,2026-09-07,2026-09-07,INTERVENTIONAL,NA,288,"['Early Childhood Development', 'Behavior Problems']",Early Childhood Development,Florida International University,"['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', ""Nicklaus Children's Hospital f/k/a Miami Children's Hospital""]",['United States']
NCT07090161,Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension",RECRUITING,2025-09-15,2026-10,2026-11,INTERVENTIONAL,PHASE2,240,"['Hypertension', 'Uncontrolled Hypertension']",Hypertension,Vanda Pharmaceuticals,[],['United States']
NCT02423070,Genome Transplant Dynamics,Genome Transplant Dynamics,RECRUITING,2015-06-25,2034-11-30,2034-11-30,OBSERVATIONAL,,991,['Thoracic Organ Transplantation'],Thoracic Organ Transplantation,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06869447,New York Better Breathing Study,Lung Cancer Better Breathing Study,RECRUITING,2025-12-15,2028-03-15,2028-03-15,INTERVENTIONAL,NA,100,"['Localized Lung Carcinoma', 'Stage I Lung Cancer AJCC v8', 'Stage II Lung Cancer AJCC v8', 'Stage III Lung Cancer AJCC v8']",Localized Lung Carcinoma,Roswell Park Cancer Institute,[],['United States']
NCT06474312,Reducing Suicide Ideation Among Young People,"A Randomized Controlled Trial to Examine the Feasibility, Relevance, and Effectiveness of the Tool ""Nae Disha for Life"" Module in Reducing Suicide Ideation Among Young People in Bundelkhand Region of Madhya Pradesh, India",ACTIVE_NOT_RECRUITING,2023-08-01,2025-02-26,2026-03-31,INTERVENTIONAL,NA,272,"['Suicidal Ideation', 'Suicide, Attempted']",Suicidal Ideation,University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', 'Christian Hospital Chhatarpur']",['India']
NCT05874726,Biological Sample Repository for Gastrointestinal Disorders,Biological Sample Repository for Gastrointestinal Disorders,ACTIVE_NOT_RECRUITING,2023-07-19,2028-07,2029-04,OBSERVATIONAL,,500,"['Obesity', 'Obesity, Morbid', 'Obesity, Primary', 'Gastro-Intestinal Disorder', 'Overweight and Obesity', 'Overweight', 'Overweight or Obesity', 'Diabetes Type 2', 'Diabetes Mellitus', 'Diabetes Mellitus, Type 2', 'Hypertension', 'Hyperlipidemias', 'Sleep Apnea', 'GERD', 'Gastroesophageal Reflux', 'Musculoskeletal Pain Disorder', 'Cancer']",Obesity,"Pichamol Jirapinyo, MD, MPH","['Tufts University', ""Boston Children's Hospital"", 'Mayo Clinic']",['United States']
NCT06408259,Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis,"A Phase 3, Multicenter, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod Compared to Oral Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis",RECRUITING,2025-04-08,2031-04-11,2036-07-13,INTERVENTIONAL,PHASE3,194,"['Multiple Sclerosis, Relapsing-Remitting']","Multiple Sclerosis, Relapsing-Remitting",Celgene,[],"['Turkey (Türkiye)', 'United States', 'Mexico', 'Spain', 'Taiwan', 'Italy', 'Romania', 'Poland', 'Portugal', 'Australia']"
NCT07028762,Evaluation of Catching Skills in Preschoolers With Motor Difficulties,Motor Coordination During Catching of a Moving Object in Preschool Children as the Indicator of Motor Development,RECRUITING,2025-03-31,2026-06-01,2026-12,OBSERVATIONAL,,40,"['Development Coordination Disorder', 'Motor Disabilities']",Development Coordination Disorder,Masaryk University,[],['Czechia']
NCT06474195,Cue-based Intervention in Prospective Memory and Medication Adherence.,Effectiveness of Cue-based Intervention in Improving Prospective Memory by Enhancing Medication Adherence in Patients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial,RECRUITING,2024-06-15,2025-12-31,2025-12-31,INTERVENTIONAL,NA,104,['Schizophrenia'],Schizophrenia,University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', ""St.John's Medical College and Hospital""]",['India']
NCT06003569,Reducing Asthma Attacks in Disadvantaged School Children With Asthma,Reducing Asthma Attacks in Disadvantaged School Children With Asthma,RECRUITING,2023-09-21,2027-05,2027-08,INTERVENTIONAL,NA,500,['Asthma in Children'],Asthma in Children,"University of Colorado, Denver","['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT03618550,Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma,Phase II Study of Second-line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma,RECRUITING,2018-08-01,2026-08,2026-08,INTERVENTIONAL,PHASE2,257,"['Hodgkin Lymphoma', 'Relapsed or Refractory Hodgkin Lymphoma']",Hodgkin Lymphoma,Memorial Sloan Kettering Cancer Center,['Merck Sharp & Dohme LLC'],['United States']
NCT06080191,Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL,"Phase I Clinical Trial on the Use of Fresh, Allogeneic, Second-generation CD19-CAR T Cells for Treatment of Children With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia",RECRUITING,2024-04-28,2026-06-30,2041-06-01,INTERVENTIONAL,PHASE1,24,['B-cell Acute Lymphoblastic Leukemia'],B-cell Acute Lymphoblastic Leukemia,Bambino Gesù Hospital and Research Institute,[],['Italy']
NCT07098182,Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique),Clinical Study Evaluating the Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique),RECRUITING,2025-11-27,2026-10,2026-10,INTERVENTIONAL,NA,50,"['Rectal Cancer', 'Colon Cancer', 'Ovarian Cancer']",Rectal Cancer,Institut du Cancer de Montpellier - Val d'Aurelle,[],['France']
NCT07257796,Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score,Artificial Intelligence in Assessing Gastric Intestinal Metaplasia Via the EGGIM Score,RECRUITING,2025-11-01,2027-05-31,2027-12-31,OBSERVATIONAL,,3000,"['Intestinal Metaplasia of Gastric Mucosa', 'Artificial Intelligence', 'Endoscopy']",Intestinal Metaplasia of Gastric Mucosa,Qilu Hospital of Shandong University,[],['China']
NCT02468024,JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer,"JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial",RECRUITING,2015-07,2028-12,2028-12,INTERVENTIONAL,PHASE3,272,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,University of Texas Southwestern Medical Center,[],"['United Kingdom', 'United States', 'Canada', 'Australia']"
NCT05882513,Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer,"A Prospective, Single-arm, Single-center, Exploratory Study of the Safety and Efficacy of Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer",ACTIVE_NOT_RECRUITING,2023-05-16,2025-12-31,2030-12-31,INTERVENTIONAL,PHASE2,36,"['NSCLC', 'Neoadjuvant Therapy']",NSCLC,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT06964815,"Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients","Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients: a Multicenter, Double-blind, Placebo-controlled, Randomized Study",RECRUITING,2025-11-12,2027-10,2027-10,INTERVENTIONAL,NA,110,"['Glioblastoma', 'IDH Wild-type and STAT3-positive Glioblastoma']",Glioblastoma,Istituto Oncologico Veneto IRCCS,[],['Italy']
NCT04158648,"A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors","A Multicenter, Open-Label Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Emicizumab in Patients With Mild or Moderate Hemophilia A Without FVIII Inhibitors",ACTIVE_NOT_RECRUITING,2020-02-10,2021-10-30,2025-12-31,INTERVENTIONAL,PHASE3,73,"['Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor', 'Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor', 'Hemophilia A']",Mild Hereditary Factor VIII Deficiency Disease Without Inhibitor,Hoffmann-La Roche,[],"['Belgium', 'South Africa', 'Netherlands', 'United States', 'France', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT05380453,Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission,"A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Trial to Investigate the Efficacy and Safety of Subcutaneously Administered Secukinumab in Patients With New-onset of Giant Cell Arteritis (GCA) Who Are in Clinical Remission and Eligible for Treatment With Glucocorticoid-monotherapy",ACTIVE_NOT_RECRUITING,2022-09-21,2026-02-11,2026-07-13,INTERVENTIONAL,PHASE3,151,['Giant Cell Arteritis'],Giant Cell Arteritis,Novartis Pharmaceuticals,[],['Germany']
NCT04971044,Competency Based Approaches for Community Health 2,COACH: Competency Based Approaches for Community Health 2,ACTIVE_NOT_RECRUITING,2021-11-18,2026-10,2026-10,INTERVENTIONAL,NA,301,['Obesity'],Obesity,Vanderbilt University Medical Center,"['National Institutes of Health (NIH)', 'University of North Carolina, Chapel Hill', 'Vanderbilt University', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06514521,Post Marketing Study on Pluvicto in Korea,"A Post Marketing Surveillance on PluvictoTM (Lutetium(177Lu) Vipivotide Tetraxetan) in South Korea; An Open-label, Non-interventional, Primary Data Collection, Multi-center, Non-comparative, Non-randomized Observational Study to Assess Safety and Effectiveness of Pluvicto in Real World Setting",RECRUITING,2025-04-18,2028-05-31,2028-05-31,OBSERVATIONAL,,278,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,Novartis Pharmaceuticals,[],['South Korea']
NCT06484088,Study Brain Mechanisms of Frustration With Magnetoencephalography in Healthy Volunteers,Characterizing the Brain Circuitry and Neural Activity Mediating Frustration,RECRUITING,2025-02-21,2027-08-31,2027-08-31,INTERVENTIONAL,EARLY_PHASE1,80,['Irritability'],Irritability,National Institute of Mental Health (NIMH),[],['United States']
NCT06967805,WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF),"A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)",RECRUITING,2025-05-05,2027-08,2027-08,INTERVENTIONAL,PHASE2,164,['Idiopathic Pulmonary Fibrosis'],Idiopathic Pulmonary Fibrosis,Mediar Therapeutics,[],"['United Kingdom', 'United States', 'Canada', 'Australia']"
NCT05574439,Young Adults With Early-onset Obesity Treated With Semaglutide,Young Adults With Early-onset Obesity Treated With Semaglutide -The RESETTLE Study,RECRUITING,2022-06-01,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE4,180,"['Obesity, Adolescent']","Obesity, Adolescent",Signe Torekov,"['University of Leeds', 'Karolinska Institutet', 'Holbaek Sygehus', 'Rigshospitalet, Denmark']",['Denmark']
NCT05660967,Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma,"Efficacy and Safety of Epcoritamab Monotherapy and in Combination With Lenalidomide as First-line Therapy for Anthracycline-ineligible Diffuse Large B-Cell Lymphoma Patients, an Open-label, Randomized, Multicenter, Global Phase 2 Trial",ACTIVE_NOT_RECRUITING,2023-03-06,2026-01-30,2027-07-31,INTERVENTIONAL,PHASE2,111,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Genmab,['AbbVie'],"['Belgium', 'Japan', 'Austria', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07013175,Wise Choices in the Intensive Care Unit,"WIse CHoices in the Intensive Care Unit, a Cluster Randomized Registry Based Clinical Trial",RECRUITING,2025-11-03,2026-12-31,2027-12-31,INTERVENTIONAL,NA,10000,"['Critical Illness', 'Ventilation', 'Outcome', 'Dialysis', 'Acute Kidney Injury']",Critical Illness,Karolinska Institutet,"['Uppsala-Örebro Regional Research Council', 'Vastra Gotaland Region', 'Region Jönköping County', 'Region Skane', 'Region Stockholm', 'Sormland County Council, Sweden']",['Sweden']
NCT06018519,Relevant Outcome Measures for Creatine Transporter Deficiency Patient,A Prospective Study in Creatine Transporter Deficiency (SLC6A8) Patients to Determine the Most Relevant Outcome Measures,RECRUITING,2023-03-13,2026-12-13,2026-12-13,INTERVENTIONAL,NA,197,['Creatine Transporter Defect'],Creatine Transporter Defect,Hospices Civils de Lyon,[],['France']
NCT04541030,Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies,UAB-NCI Collaborative Study on Integrating Genomic Prostate Score With MRI Targeted Prostate Biopsies,ACTIVE_NOT_RECRUITING,2020-09-02,2026-03-01,2026-03-01,OBSERVATIONAL,,241,['Prostate Cancer'],Prostate Cancer,National Cancer Institute (NCI),[],['United States']
NCT05630105,Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene,National Cohort of Patients With Cowden's Disease and With a Constitutional Alteration of the PTEN Gene for the Prospective Assessment of the Risk of Cancer.,RECRUITING,2023-06-12,2048-01,2048-01,OBSERVATIONAL,,430,['PTEN Gene Mutation'],PTEN Gene Mutation,Institut Bergonié,[],['France']
NCT07258459,Two Previous Cesarean and Vaginal Birth Before and After Starting Training and Protocols,Trial of Labor After Two CS Before and After Training a Protocol Introduction,RECRUITING,2016-01-01,2025-12-31,2026-01-01,OBSERVATIONAL,,2016,"['Cesarean Delivery Affecting Fetus or Newborn', 'Labor (Obstetrics)--Complications', 'Hemorrhagic Complications']",Cesarean Delivery Affecting Fetus or Newborn,G. d'Annunzio University,[],['Italy']
NCT05612048,A Study of Tooth Erosion in People With Esophagogastric Cancer,Pilot Study of Dental Erosion as a Non-invasive Biomarker of Esophagogastric Cancer,RECRUITING,2022-11-03,2026-11,2026-11,INTERVENTIONAL,NA,300,['Esophagogastric Cancer'],Esophagogastric Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06200961,Trans-nasal Endoscopy for Bariatric Patients,Use of Sedation-Free Transnasal Endoscopy to Improve Access and Lower Costs of Endoscopic Evaluations in a Bariatric Medical and Surgical Program,RECRUITING,2025-12,2026-12,2027-06,INTERVENTIONAL,NA,100,"['Obesity', 'Obesity, Morbid', 'Obese', 'GI Disorders', 'Gastrointestinal Diseases']",Obesity,"Christopher C. Thompson, MD, MSc","['EvoEndo, Inc.']",['United States']
NCT03831958,Long-Term Follow-Up of Survivors of Pediatric Cushing Disease,Long-Term Follow-UP of Survivors of Pediatric Cushing Disease,RECRUITING,2019-03-04,2040-01-03,2040-01-03,OBSERVATIONAL,,600,['Cushing Disease'],Cushing Disease,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT07259408,Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior,Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior,RECRUITING,2025-10-27,2026-05-01,2026-05-01,OBSERVATIONAL,,40,"['Suicide Prevention', 'Suicide', 'Suicidal Ideation']",Suicide Prevention,University Ghent,[],['Belgium']
NCT04530552,Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland,Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy,ACTIVE_NOT_RECRUITING,2021-07-23,2024-11-06,2027-01-31,INTERVENTIONAL,PHASE2,34,"['Localized Prostate Carcinoma', 'Prostate Adenocarcinoma', 'Stage I Prostate Cancer AJCC v8', 'Stage II Prostate Cancer AJCC v8']",Localized Prostate Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT00967785,A Phase I Study of Mozobil in the Treatment of Patients With WHIMS,A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS,RECRUITING,2010-01-06,2025-12-31,2026-04-30,INTERVENTIONAL,PHASE1,20,"['Leukopenia', 'Neutropenia', 'Infections', 'Warts', 'Myelokathexis']",Leukopenia,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07143643,The Effect of Escape Room Method in Nursing Process Teaching,"The Effect of Using Escape Room Method on Nursing Studentsˈ Self-Efficacy, Team Collaboration and Anxiety in Nursing Process Teaching",RECRUITING,2025-10-19,2025-12,2026-02,INTERVENTIONAL,NA,70,"['Nursing Education', 'ESCAPE ROOM', 'Nursing Students']",Nursing Education,Bezmialem Vakif University,[],['Turkey (Türkiye)']
NCT06251973,"A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer","A Phase II Study of agenT-797 (Invariant Natural Killer T Cells), Botensilimab, a Novel Fc-enhanced CTLA-4 Inhibitor, Plus Balstilimab (Anti-PD-1) With Ramucirumab and Paclitaxel for Patients With Previously Treated, Advanced Esophageal, Gastric, or Gastro-esophageal Junction Adenocarcinoma",RECRUITING,2024-02-01,2027-08-01,2027-08-01,INTERVENTIONAL,PHASE2,37,"['Metastatic Esophageal Carcinoma', 'Advanced Unresectable Gastric Adenocarcinoma', 'Metastatic Gastric Cancer', 'Metastatic Gastroesophageal Junction Adenocarcinoma', 'Metastatic Esophageal Cancer', 'Metastatic Esophageal Adenocarcinoma', 'Metastatic Gastric Adenocarcinoma', 'Metastatic Gastric Carcinoma', 'Unresectable Esophageal Cancer', 'Unresectable Esophageal Adenocarcinoma', 'Unresectable Gastric Carcinoma', 'Unresectable Gastric Adenocarcinoma', 'Unresectable Gastroesophageal Junction Adenocarcinoma']",Metastatic Esophageal Carcinoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07259226,Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers,International Multicenter Multicohort Open-label Phase II Trial Aiming to Define Optimal Methods for Predicting Response/Resistance to Antibody-drug Conjugates in Patients With Solid Tumors Treated According to Current Standard Indications.,RECRUITING,2025-11-14,2030-11-01,2030-11-01,INTERVENTIONAL,PHASE2,400,"['Advanced Breast Cancer', 'Advanced Gastric Cancer', 'Advanced Urothelial Cancer', 'Advanced Non Small Cell Lung Cancer (NSCLC)']",Advanced Breast Cancer,UNICANCER,[],['France']
NCT03148418,A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A),"An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study",ACTIVE_NOT_RECRUITING,2017-09-20,2030-03-06,2030-03-06,INTERVENTIONAL,PHASE3,382,['Cancer'],Cancer,Hoffmann-La Roche,[],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'Slovenia', 'France', 'Chile', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Portugal', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT05751018,Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer,Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer,RECRUITING,2021-12-08,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,18,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Peking Union Medical College Hospital,[],['China']
NCT06527846,Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease,Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients With Chronic Kidney Disease in Japan,RECRUITING,2024-10-22,2027-05-31,2027-05-31,OBSERVATIONAL,,1000,"['Kidney Disease, Chronic']","Kidney Disease, Chronic",Boehringer Ingelheim,[],['Japan']
NCT03260023,Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers,A Phase Ib/II Trial Evaluating the Combination of TG4001 and Avelumab in Patients With HPV-16 Positive Recurrent or Metastatic Malignancies.,ACTIVE_NOT_RECRUITING,2017-09-01,2024-09-18,2025-12,INTERVENTIONAL,PHASE1,143,"['HPV-Related Carcinoma', 'HPV-Related Cervical Carcinoma', 'HPV-Related Anal Squamous Cell Carcinoma', 'HPV-Related Penile Squamous Cell Carcinoma', 'HPV-Related Vulvar Squamous Cell Carcinoma']",HPV-Related Carcinoma,Transgene,"['Merck KGaA, Darmstadt, Germany', 'EMD Serono Research & Development Institute, Inc.', 'Pfizer']","['Spain', 'United States', 'France']"
NCT06926296,Moral Injury in French Healthcare Workers,Moral Injury in French Healthcare Workers,RECRUITING,2025-11-19,2026-05,2026-11,INTERVENTIONAL,NA,3073,['Moral Injury'],Moral Injury,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,[],['France']
NCT04246086,"A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma","A Phase Ib/II, Open-Label, Multicenter Study With a Non-Randomized Stage Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab Plus Lenalidomide (+Len), and a Randomized Stage Evaluating the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Patients With Follicular Lymphoma",RECRUITING,2020-08-12,2030-10-15,2030-10-15,INTERVENTIONAL,PHASE1,237,['Follicular Lymphoma'],Follicular Lymphoma,Hoffmann-La Roche,[],"['China', 'United States', 'France', 'Spain', 'United Kingdom']"
NCT07189195,"TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma",A Phase 1 Study of Bisaminoquinoline Derivative (TR-002) for Injection for Advanced Treatment-Refractory Solid Tumors,RECRUITING,2025-11-07,2029-11-07,2030-02-07,INTERVENTIONAL,PHASE1,52,"['Advanced Malignant Solid Neoplasm', 'Metastatic Malignant Solid Neoplasm', 'Metastatic Pancreatic Adenocarcinoma', 'Refractory Pancreatic Adenocarcinoma', 'Stage III Pancreatic Cancer AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8', 'Unresectable Malignant Solid Neoplasm', 'Unresectable Pancreatic Adenocarcinoma']",Advanced Malignant Solid Neoplasm,"University of California, Davis",['National Cancer Institute (NCI)'],['United States']
NCT06750146,Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis,French Prospective Study on Biliary Tract Drainage Guided by Endoscopic Ultrasound in Patients With Malignant Biliary Stenosis (RAINBOW),RECRUITING,2025-06-19,2027-05,2027-05,INTERVENTIONAL,NA,162,['Malignant Biliary Stenosis'],Malignant Biliary Stenosis,Boston Scientific Corporation,[],['France']
NCT06994897,A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults,"A PHASE 1, RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE DOSE-ESCALATION AND MULTIPLE DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF PF-07985631 IN HEALTHY ADULT PARTICIPANTS",RECRUITING,2025-08-13,2027-12-08,2027-12-08,INTERVENTIONAL,PHASE1,92,['Healthy'],Healthy,Pfizer,[],['Belgium']
NCT06685068,A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors,A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors,RECRUITING,2024-11-13,2028-05-29,2028-06-29,INTERVENTIONAL,PHASE1,260,['Advanced Solid Tumor'],Advanced Solid Tumor,Genmab,[],['United States']
NCT07257562,Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance,A Prospective Observational Study on the Effects of Concomitant Administration of Bacteroides Fragilis and Branched-Chain Amino Acids on HBsAg Clearance,RECRUITING,2025-06-01,2026-03-01,2026-12-01,OBSERVATIONAL,,40,['Chronic Hepatitis B'],Chronic Hepatitis B,First Affiliated Hospital of Fujian Medical University,[],['China']
NCT06571916,Brief Skills for Safer Living (Brief-SfSL),"Investigating the Efficacy of a Novel Therapy for Suicide Risk in Adults: A Randomized Controlled Trial of an Intensive Single Session of ""Brief Skills for Safer Living""",RECRUITING,2025-11-17,2028-10-01,2028-12-31,INTERVENTIONAL,NA,150,"['Suicide Prevention', 'Suicide', 'Suicide and Self-harm']",Suicide Prevention,Unity Health Toronto,[],['Canada']
NCT07230509,Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate,Efficacy of Pancreatic Parenchymal N-Butyl-2-Cyanoacrylate Injection in Pancreaticojejunostomy After Pancreaticoduodenectomy: A Randomized Controlled Trial,RECRUITING,2025-12-01,2027-12-01,2027-12-20,INTERVENTIONAL,PHASE2,90,"['Pancreaticoduodenectomy', 'Postoperative Pancreatic Fistula', 'Pancreas Cancer', 'Periampullary Cancer']",Pancreaticoduodenectomy,Minia University,[],['Egypt']
NCT07071298,AERA Pediatrics Registry,"A Real World, Observational Pediatric Registry of the Acclarent AERA® Eustachian Tube Balloon Dilation System",RECRUITING,2025-06-17,2030-10,2031-02,OBSERVATIONAL,,300,['Dysfunction of Eustachian Tube'],Dysfunction of Eustachian Tube,Integra LifeSciences Corporation,[],['United States']
NCT07042139,No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older,A Randomized Controlled Trial Comparing No Reduction to Closed Reduction for Distal Radius Fractures in Patients 65 Years and Older (DISCLOSE Trial): A Study Protocol,RECRUITING,2025-08-01,2029-07-01,2033-07-01,INTERVENTIONAL,NA,532,"['Distal Radius Fracture', 'Casting', 'Closed Reduction']",Distal Radius Fracture,Tampere University Hospital,"['Kuopio University Hospital', 'Viborg Regional Hospital', 'Karolinska University Hospital', 'Helsinki University Central Hospital', 'Tartu University Hospital', 'Pori Central Hospital', 'Oulu University Hospital']","['Finland', 'Denmark', 'Sweden', 'Estonia']"
NCT07242170,"Supplementary Nerve Blocks Added to the Adductor Canal Block for Postoperative Pain Management in Primary Total Knee Arthroplasty: A Randomized Controlled Comparison of Sciatic, BiFeS, and IPACK Techniques","Comparison of the Effectiveness of ""Sciatic Nerve"", ""Biceps Femoris Short Head (BiFeS)"" and ""Interspace Between the Popliteal Artery and the Capsule of the Posterior Knee (IPACK)"" Blocks Added to the Adductor Canal Block for Postoperative Pain Control in Patients Undergoing Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Clinical Trial",RECRUITING,2025-11-01,2026-11-01,2026-11-01,INTERVENTIONAL,NA,102,"['Post Operative Analgesia', 'Total Knee Arthroplasty']",Post Operative Analgesia,Erzincan University,[],['Turkey (Türkiye)']
NCT07258212,Safety and Normative Data With Neos™,"Safety and Normative Data With Neos™, in Healthy Volunteers, Children and Patient Populations With Ophthalmological or Neurological Disease",RECRUITING,2024-03-07,2026-06,2026-06,OBSERVATIONAL,,200,['Neuro-Ophthalmology'],Neuro-Ophthalmology,machineMD AG,[],['Switzerland']
NCT05768854,Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta,"An Open-label, Randomized, Active-Controlled, Phase 3 Study of Setrusumab Compared With Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Types I, III or IV",ACTIVE_NOT_RECRUITING,2023-06-14,2025-10-23,2027-04,INTERVENTIONAL,PHASE3,69,['Osteogenesis Imperfecta'],Osteogenesis Imperfecta,Ultragenyx Pharmaceutical Inc,[],"['Brazil', 'Netherlands', 'United States', 'France', 'Italy', 'Canada', 'Poland']"
NCT06801535,Efficacy of 3D-Printed Mouth Splints,Efficacy of 3D-Printed Mouth Splints in the Management of Microstomia in Burn Patients,RECRUITING,2025-02-21,2025-12,2026-12,INTERVENTIONAL,NA,10,['Microstomia'],Microstomia,Wake Forest University Health Sciences,[],['United States']
NCT06899061,Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib,"A Modular Phase I, Open-label Study to Assess the Safety, Pharmacokinetics, and Drug Interaction Potential and Relative Bioavailability of Saruparib in Patients With Advanced Solid Malignancies",RECRUITING,2025-03-25,2026-07-21,2026-11-19,INTERVENTIONAL,PHASE1,45,['Advanced Solid Malignancies'],Advanced Solid Malignancies,AstraZeneca,['Parexel'],"['Bulgaria', 'Romania', 'Moldova']"
NCT06749054,Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children,"A Phase 2, Open-label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Long-Acting Lenacapavir in Combination With an Optimized Background Regimen in Treatment-experienced Adolescents and Children With HIV-1",RECRUITING,2025-03-26,2026-10,2027-04,INTERVENTIONAL,PHASE2,12,['HIV-1-infection'],HIV-1-infection,Gilead Sciences,[],"['United States', 'South Africa']"
NCT05080673,Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps,Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps,RECRUITING,2022-02-09,2035-11-01,2065-11-01,INTERVENTIONAL,NA,9500,"['Adenocarcinoma of the Colon', 'Adenocarcinoma of the Rectum']",Adenocarcinoma of the Colon,NRG Oncology,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT05216770,Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor,Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor,RECRUITING,2022-03-24,2027-08-31,2027-08-31,INTERVENTIONAL,EARLY_PHASE1,165,"['Laryngeal Dystonia', 'Spasmodic Dysphonia', 'Tremor']",Laryngeal Dystonia,Massachusetts Eye and Ear Infirmary,"['University of California, San Francisco']",['United States']
NCT06769607,Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study,Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study,RECRUITING,2025-04-10,2025-12,2025-12,INTERVENTIONAL,NA,80,['Obstructive Sleep Apnea'],Obstructive Sleep Apnea,ResMed,[],['Australia']
NCT05926765,A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia,"A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia",RECRUITING,2023-06-13,2026-12,2026-12,INTERVENTIONAL,PHASE2,276,"['Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands']","Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands","MeiraGTx, LLC",[],"['United Kingdom', 'United States', 'Canada']"
NCT07257770,Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel,Evaluating the Effect of a Medical Device Based on Inositol in Improving Breast Pain,RECRUITING,2025-09-11,2026-01-11,2026-04-11,INTERVENTIONAL,NA,50,['Mastalgia'],Mastalgia,Lo.Li.Pharma s.r.l,[],['Italy']
NCT07073885,Effect of Ultra-Low Tidal Volume on Mechanical Power During Heart Bypass Surgery,The Effect of Ultra-Low Tidal Volume Ventilation on Mechanical Power in Coronary Artery Bypass Graft Surgery,RECRUITING,2025-10-10,2025-12-30,2026-01-15,INTERVENTIONAL,NA,60,['Coronary Artery Disease'],Coronary Artery Disease,Konya City Hospital,[],['Turkey (Türkiye)']
NCT07200310,Hearing/ET/Vestibular in Balloon Pilots,Hearing and Eustachian/Vestibular Functions in Hot Air Balloon Pilots: A Cross-sectional Matched-Control Study,RECRUITING,2025-09-04,2025-10-20,2025-11-30,OBSERVATIONAL,,90,"['Hearing Loss, Noise-Induced', 'Eustachian Tube Dysfunction', 'Vestibular Disorders', 'Occupational Exposure']","Hearing Loss, Noise-Induced",Gaziosmanpasa Research and Education Hospital,[],['Turkey (Türkiye)']
NCT02223208,Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas,Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study,ACTIVE_NOT_RECRUITING,2014-09,2020-10,2026-02,INTERVENTIONAL,PHASE1,89,"['Peripheral T-cell Lymphomas (PTCL)', 'PTCL-NOS', 'Angioimmunoblastic T-cell Lymphoma (AITL)', 'ALK- Anaplastic Large Cell Lymphoma (ALCL)', 'Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin']",Peripheral T-cell Lymphomas (PTCL),Fondazione Italiana Linfomi - ETS,[],['Italy']
NCT02821767,"Natural History, Pathogenesis, and Outcome of Ocular Disorders","Studies of the Natural History, Pathogenesis and Outcome of Ocular Disorders",RECRUITING,2016-08-03,2026-07-01,2026-07-01,OBSERVATIONAL,,1000,['Eye Disease'],Eye Disease,National Eye Institute (NEI),[],['United States']
NCT07257887,Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Periodontitis,Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Periodontitis,RECRUITING,2025-11-19,2026-05-31,2026-05-31,INTERVENTIONAL,NA,90,['Periodontal Disease'],Periodontal Disease,ENIKAM d.o.o.,[],['Slovenia']
NCT07260006,Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease,A Study on the Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease,RECRUITING,2024-10-01,2026-05-30,2026-05-30,INTERVENTIONAL,NA,80,"['Helicobacter Pylori Infection', 'Peptic Ulcer']",Helicobacter Pylori Infection,Can Tho University of Medicine and Pharmacy,[],['Vietnam']
NCT07208058,"A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])","An Open-label, Single-arm, Multicenter, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])",RECRUITING,2025-11-21,2026-12-20,2027-11-30,INTERVENTIONAL,PHASE3,30,['Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis'],Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis,"TJ Biopharma Co., Ltd.",[],['China']
NCT06508658,A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma,"A Phase 3, Multicenter, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared to Rituximab Plus Gemcitabine and Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma",RECRUITING,2024-08-13,2028-01,2028-01,INTERVENTIONAL,PHASE3,360,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Genmab,['AbbVie'],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Croatia', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'South Africa', 'Mexico', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Argentina', 'Serbia']"
NCT07160647,"The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)","The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT)",ACTIVE_NOT_RECRUITING,2025-08-20,2027-08-30,2030-08-30,INTERVENTIONAL,PHASE2,29,['dMMR/MSI-H-type Rectal Adenocarcinoma'],dMMR/MSI-H-type Rectal Adenocarcinoma,Sir Run Run Shaw Hospital,[],['China']
NCT06003816,"Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)","Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)",RECRUITING,2023-10-18,2026-11-30,2026-11-30,INTERVENTIONAL,NA,3140,"['Cholera', 'Diarrhea']",Cholera,Johns Hopkins Bloomberg School of Public Health,"['Research Training and Management International (RTMI)', 'International Centre for Diarrhoeal Disease Research, Bangladesh', 'National Institute of Allergy and Infectious Diseases (NIAID)']",['Bangladesh']
NCT06823596,"The T Cell Activator of Cell Killing (""TACK"") IT ON"" STUDY",Short-term Addition of Efavirenz to Induce CARD8-mediated Reduction of Persistent Nonsuppressible HIV Viremia in People With High Adherence to ART.,RECRUITING,2025-01-14,2026-01-01,2026-09-01,INTERVENTIONAL,NA,26,['Hiv'],Hiv,University of Toronto,"['Ontario HIV Treatment Network', 'Maple Leaf Research', 'Unity Health Toronto']",['Canada']
NCT06600698,Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA,Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial),RECRUITING,2025-05-07,2027-05-01,2028-05-01,INTERVENTIONAL,PHASE1,45,['Prostate Cancer'],Prostate Cancer,Milton S. Hershey Medical Center,[],['United States']
NCT04943562,"Actigraphy, Wearable EEG Band and Smartphone for Sleep Staging","Evaluation of the Viability of Actigraphy, Wearable EEG Band and Smartphone for Sleep Staging in Comparison With Polysomnography",RECRUITING,2021-09-09,2021-12-12,2026-12-01,OBSERVATIONAL,,96,"['Sleep', 'Insomnia', 'Sleep Apnea Syndrome, Obstructive']",Sleep,SleepUp Tecnologia em Saúde Ltda,[],['Brazil']
NCT07100080,Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01),"IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy",RECRUITING,2025-11-05,2028-09-15,2031-05-15,INTERVENTIONAL,PHASE2,596,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Bristol-Myers Squibb,[],"['Japan', 'Netherlands', 'China', 'Belgium', 'France', 'Chile', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'India', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT04589650,"Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum","EPIK-P2: A Phase II Double-blind Study With an Upfront, 16-week Randomized, Placebo-controlled Period, to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)",ACTIVE_NOT_RECRUITING,2021-04-19,2024-03-20,2031-01-17,INTERVENTIONAL,PHASE2,200,['PIK3CA-related Overgrowth Spectrum (PROS)'],PIK3CA-related Overgrowth Spectrum (PROS),Novartis Pharmaceuticals,[],"['Hong Kong', 'Netherlands', 'Norway', 'China', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT06192160,Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis,"A Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis",RECRUITING,2025-03-11,2026-11-11,2027-08-11,INTERVENTIONAL,PHASE2,315,['Pulmonary Tuberculosis'],Pulmonary Tuberculosis,National Institute of Allergy and Infectious Diseases (NIAID),['TB Alliance'],"['Brazil', 'South Africa', 'Haiti', 'Kenya', 'Botswana', 'Mexico', 'Uganda', 'Malawi', 'Peru', 'Thailand', 'Vietnam', 'Philippines', 'Zimbabwe', 'India']"
NCT07258524,PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis,PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis,RECRUITING,2026-01,2029-01,2029-01,OBSERVATIONAL,,120,['ANCA Associated Vasculitis (AAV)'],ANCA Associated Vasculitis (AAV),University of Edinburgh,[],['United Kingdom']
NCT07257679,Gentle Touch for Post-Mastectomy Lymphedema,"The Effects of 'Gentle Touch' in the Management of Lymphedema in Women Treated for Breast Cancer: A Preliminary Single-blind, Parallel-group Randomized Controlled Trial.",RECRUITING,2025-11-01,2027-01-15,2027-11-01,INTERVENTIONAL,PHASE4,36,"['Lymphedema, Breast Cancer']","Lymphedema, Breast Cancer",I.R.C.C.S. Fondazione Santa Lucia,['Comitato A.N.D.O.S. di Roma odv.'],['Italy']
NCT07136506,Gait Analysis Parameter and Upper Limb Evaluation in Control Participants,Gait Analysis Parameter and Upper Limb Evaluation in Control Participants,RECRUITING,2025-09-24,2028-09,2028-12,INTERVENTIONAL,NA,200,['Healthy Participants'],Healthy Participants,Centre Hospitalier Universitaire de Liege,"['Centre Hospitalier Régional de la Citadelle', 'SYSNAV']",['Belgium']
NCT07063901,Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer,Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer,RECRUITING,2025-06-01,2025-12-31,2026-05-31,OBSERVATIONAL,,200,['Esophagus Cancer'],Esophagus Cancer,Central South University,[],['China']
NCT04961840,A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy,Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Prucalopride During Pregnancy,ACTIVE_NOT_RECRUITING,2022-01-01,2026-12-31,2026-12-31,OBSERVATIONAL,,100,"['Constipation', 'Pregnancy']",Constipation,Takeda,[],['United States']
NCT06445335,Prevalence of NAFLD in T2DM Patients,"The Prevalence of Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients Followed at Ziekenhuis Oost-Limburg, Genk, Belgium",ACTIVE_NOT_RECRUITING,2019-03-01,2026-11-01,2026-11-01,INTERVENTIONAL,NA,385,"['NAFLD', 'T2D', 'Type 2 Diabetes', 'Fatty Liver, Nonalcoholic']",NAFLD,Ziekenhuis Oost-Limburg,[],['Belgium']
NCT07259343,"Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population",Effect of Glycomacropeptide on Clinical Manifestations of Atopic Dermatitis in Children: a Pilot Study,RECRUITING,2025-09-26,2026-01-31,2026-12-31,INTERVENTIONAL,NA,20,['Atopic Dermatitis (AD)'],Atopic Dermatitis (AD),Universidad Autónoma de Aguascalientes,[],['Mexico']
NCT06820957,Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body,Randomized Phase 2/3 Trial of Vincristine-Irinotecan-Regorafenib in Combination With Vincristine-Doxorubicin-Cyclophosphamide (VDC) and Ifosfamide-Etoposide (IE) in Patients With Newly Diagnosed Metastatic Ewing Sarcoma,ACTIVE_NOT_RECRUITING,2025-11-10,2032-07-15,2032-07-15,INTERVENTIONAL,PHASE2,437,"['CIC-Rearranged Sarcoma', 'Metastatic Ewing Sarcoma', 'Metastatic High Grade Sarcoma', 'Metastatic Undifferentiated Round Cell Sarcoma', 'Metastatic Undifferentiated Sarcoma, Not Otherwise Specified', 'Round Cell Sarcoma With EWSR1-non-ETS Fusion', 'Sarcoma With BCOR Genetic Alterations']",CIC-Rearranged Sarcoma,Children's Oncology Group,[],['United States']
NCT07139366,Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment,"Efficacy and Safety of Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment: A Prospective, Multicenter, Randomized Controlled Trial",RECRUITING,2025-10-28,2026-09,2026-09,INTERVENTIONAL,PHASE4,1248,"['Gastritis', 'Dyspepsia', 'Helicobacter Pylori Infection', 'Gastric Cancer', 'Peptic Ulcer']",Gastritis,Yongquan Shi,[],['China']
NCT06727903,Predictive Model for Mortality in Older People With Critical Illness,Development of a Predictive Model for Mortality in Patients Aged 75 or Older With Critical Illness,RECRUITING,2025-03-20,2026-12,2026-12,OBSERVATIONAL,,450,['Critical Illness'],Critical Illness,Consorci Sanitari de l'Alt Penedès i Garraf,[],['Spain']
NCT06773780,Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management,"Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management - A Randomized, Prospective Study",RECRUITING,2025-01-10,2026-06-01,2026-12-01,INTERVENTIONAL,NA,60,"['Aortic Valve Stenosis', 'Transcatheter Aortic Valve Implantation', 'Pericapsular Nerve Group Block', 'Fascia Iliaca Block']",Aortic Valve Stenosis,Medipol University,[],['Turkey (Türkiye)']
NCT06237842,Wearable Technologies for Sleep in Children and Adolescents,Evaluation of Wearable Technologies for Sleep Monitoring in Children and Adolescents,RECRUITING,2024-11-22,2026-12-01,2027-05-01,OBSERVATIONAL,,48,"['Sleep', 'Pediatric Sleep Apnea']",Sleep,SleepUp Tecnologia em Saúde Ltda,[],['Brazil']
NCT06651970,Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure,"A Multicentre, Open-label, Randomised Phase IV Study to Investigate Acalabrutinib Monotherapy Compared to Investigator's Choice of Treatment in Adults (> 18 Years) With Chronic Lymphocytic Leukaemia and Moderate to Severe Cardiac Impairment",RECRUITING,2025-02-04,2030-08-16,2030-08-16,INTERVENTIONAL,PHASE4,60,"['Chronic Lymphocytic Leukaemia', 'Heart Failure']",Chronic Lymphocytic Leukaemia,AstraZeneca,"['Fortrea', 'CALYX Inc.', 'eResearch Technology, Inc.', 'CISCRP']","['United States', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland']"
NCT04379596,Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03),"A Phase 1b/2 Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of Trastuzumab Deruxtecan (T-DXd) Monotherapy and Combinations in Adult Participants With HER2-expressing Gastric Cancer (DESTINY-Gastric-03)",RECRUITING,2020-06-03,2027-06-01,2027-06-01,INTERVENTIONAL,PHASE2,413,['Gastric Cancer'],Gastric Cancer,AstraZeneca,['Daiichi Sankyo'],"['Brazil', 'Japan', 'Netherlands', 'China', 'Russia', 'United States', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Germany']"
NCT05383742,"Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis","A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)",RECRUITING,2023-12-07,2028-04-30,2029-09-15,INTERVENTIONAL,PHASE2,330,['Tuberculous Meningitis'],Tuberculous Meningitis,National Institute of Allergy and Infectious Diseases (NIAID),[],"['Brazil', 'South Africa', 'Tanzania', 'Kenya', 'India', 'Mexico', 'Peru', 'Thailand', 'Vietnam', 'Philippines', 'Zimbabwe', 'Malawi']"
NCT07259395,Prospective Validation of the SWEET Tool for Pre-diction of Preintervention ERCP Procedure Time.,Prospective Validation of the SWEET Tool for Pre-diction of Preintervention ERCP Procedure Time.,RECRUITING,2025-12,2027-12,2027-12,OBSERVATIONAL,,363,['Endoscopic Retrograde Cholangio-Pancreatography'],Endoscopic Retrograde Cholangio-Pancreatography,Universitair Ziekenhuis Brussel,[],['Belgium']
NCT06092671,Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery,Effect of Family-centred Perioperative Care for Anaesthesia on Incidence of Emergency Delirium in Children After Surgery: a Protocol for a Randomised Controlled Trial,RECRUITING,2023-10-24,2026-09,2026-12,INTERVENTIONAL,NA,444,"['Postoperative Complications', 'Child', 'Family', 'Emergence Delirium', 'General Anaesthesia', 'Perioperative Care']",Postoperative Complications,Second Affiliated Hospital of Wenzhou Medical University,[],['China']
NCT07260071,Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease,Family Study of Early Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease,RECRUITING,2025-08-15,2028-03,2028-03,OBSERVATIONAL,,200,['Autosomal Dominant Polycystic Kidney Disease (ADPKD'],Autosomal Dominant Polycystic Kidney Disease (ADPKD,King's College London,"[""Guy's and St Thomas' NHS Foundation Trust""]",['United Kingdom']
NCT03889899,"Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.","A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia",RECRUITING,2020-10-21,2026-06,2026-09,INTERVENTIONAL,NA,30,"['Skin Cancer', 'Mucosal Neoplasm of Oral Cavity', 'Soft Tissue Neoplasm']",Skin Cancer,Alpha Tau Medical LTD.,[],['Israel']
NCT04656652,Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01),Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-LUNG01),ACTIVE_NOT_RECRUITING,2020-12-21,2024-05-10,2026-01-31,INTERVENTIONAL,PHASE3,605,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Daiichi Sankyo,['AstraZeneca'],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'Russia', 'France', 'Puerto Rico', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT06217822,First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC),"A Phase 1 Open-label, First-in-human, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of 225Ac-PSMA-Trillium in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)",RECRUITING,2024-03-07,2027-06-14,2031-05-24,INTERVENTIONAL,PHASE1,235,"['Advanced Metastatic Castration-resistant Prostate Cancer', 'Prostate Specific Membrane Antigen (PSMA) Expression']",Advanced Metastatic Castration-resistant Prostate Cancer,Bayer,[],"['Belgium', 'Netherlands', 'United States', 'Finland', 'Switzerland', 'Italy', 'Canada', 'United Kingdom', 'Sweden']"
NCT07211022,Precision of Digital Impressions in Complete-Arch Implant Rehabilitation: Evaluation of Two Digital Techniques,Clinical Evaluation of the Complete Arch Digital Impressions Precision Using Photogrammetry and Intraoral Scanning,RECRUITING,2025-10-25,2026-01-25,2026-03-25,INTERVENTIONAL,NA,12,['Complete Edentulism'],Complete Edentulism,Aldent University,[],['Albania']
NCT05323253,A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma,"A Prospective International Multicenter, Pivotal, Single Arm, Open Label Clinical Study to Assess the Efficacy and Safety of Intratumoral Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma",RECRUITING,2022-09-21,2025-12,2025-12,INTERVENTIONAL,NA,86,['Recurrent Squamous Cell Carcinoma'],Recurrent Squamous Cell Carcinoma,Alpha Tau Medical LTD.,[],"['Israel', 'United States', 'Canada']"
NCT06836739,At-Home Genital Nerve Stimulation for SCI Bowel,At-Home Feasibility Trial of Genital Nerve Stimulation to Modulate Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury,RECRUITING,2025-03-01,2026-09-30,2026-09-30,INTERVENTIONAL,NA,12,['Spinal Cord Injury'],Spinal Cord Injury,MetroHealth Medical Center,['Congressionally Directed Medical Research Programs'],['United States']
NCT06416657,General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter,General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter: an Exploratory Randomized Clinical Trial,RECRUITING,2024-06-01,2025-11-12,2026-06-01,INTERVENTIONAL,NA,188,['Intracranial Aneurysm'],Intracranial Aneurysm,Ming Lv,"['Beijing Chao Yang Hospital', 'Peking University International Hospital', 'Beijing Anzhen Hospital', 'The Affiliated Lianyungang Hospital of Xuzhou Medical University', 'Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University', 'The Third Medical Center of Chinese PLA General Hospital', 'The Second Artillery General Hospital']",['China']
NCT04276259,Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses,Neurocomputational Mechanisms of Mood Improvement,ACTIVE_NOT_RECRUITING,2020-10-19,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE4,120,"['Major Depressive Disorder', 'Depression']",Major Depressive Disorder,"Marta Peciña, MD PhD",[],['United States']
NCT05592990,"A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy","A Two Part, Randomized, Participant and Investigator-blinded, 2-arm, Parallel-design, Placebo-controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles on Tendon Regeneration in Patients With Achilles Tendinopathy",ACTIVE_NOT_RECRUITING,2023-06-14,2026-01-27,2026-01-27,INTERVENTIONAL,PHASE2,45,['Achilles Tendinopathy'],Achilles Tendinopathy,Novartis Pharmaceuticals,[],"['United States', 'France', 'Germany']"
NCT07257874,Intraoperative Pectoral Block vs IV Analgesia for Pain After Modified Radical Mastectomy,Comparison Between Intra-Operative Pectoral Block and Intravenous Analgesia for Post-Operative Pain Relief in Patients Undergoing Modified Radical Mastectomy,ACTIVE_NOT_RECRUITING,2025-07-01,2025-12-10,2025-12-15,INTERVENTIONAL,PHASE3,60,"['Mastectomy, Modified Radical']","Mastectomy, Modified Radical",Islamabad Medical and Dental College,[],['Pakistan']
NCT05534620,Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics,"An Open-label, Non-randomized, Prospective Trial to Evaluate the Effect of Renal Function Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics in Patients With AML or MDS Undergoing Allogeneic Hematopoietic Stem Cell Transplantation",RECRUITING,2024-02-01,2026-03,2026-12,INTERVENTIONAL,PHASE1,36,"['Acute Myeloid Leukaemia (AML)', 'Myelodysplastic Syndrome (MDS)', 'Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)']",Acute Myeloid Leukaemia (AML),medac GmbH,"['Synteract, Inc.']",['United States']
NCT04002479,Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer,A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer,ACTIVE_NOT_RECRUITING,2020-10-20,2026-10,2026-10,INTERVENTIONAL,NA,37,"['Pancreatic Cancer', 'Unresectable Pancreatic Cancer', 'Metastatic Pancreatic Cancer', 'Pancreatic Adenocarcinoma']",Pancreatic Cancer,Alpha Tau Medical LTD.,[],['Canada']
NCT07055451,Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV,A Phase 1b Study to Evaluate the Safety and Pharmacokinetics of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Neonates Exposed to HIV-1,RECRUITING,2025-08-12,2028-03,2028-03,INTERVENTIONAL,PHASE1,16,['HIV-1-infection'],HIV-1-infection,Gilead Sciences,[],"['United States', 'South Africa']"
NCT07259330,To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants,"A Phase 1, Single-Sequence, Two-Period Crossover, Open-Label Study to Determine the Potential Induction Effect of Multiple 100 mg BID Oral Doses of Nirogacestat on a Cocktail of CYP Probe Substrates CYP2B6 (Bupropion), CYP2C8 (Repaglinide), CYP2C9 (Flurbiprofen), CYP2C19 (Omeprazole), and CYP3A4 (Midazolam) in Healthy Males",RECRUITING,2025-11-17,2026-02,2026-10,INTERVENTIONAL,PHASE1,16,['Healthy'],Healthy,"SpringWorks Therapeutics, Inc.",[],['Netherlands']
NCT04657432,"Brief, High-dose rTMS for Depression",Accelerated Repetitive TMS for Affective Dysfunction: Establishing the Dose-Response Curve,ACTIVE_NOT_RECRUITING,2021-05-25,2026-01-30,2026-12-01,INTERVENTIONAL,NA,70,"['Depression', 'Anxiety']",Depression,Medical University of South Carolina,['National Alliance for Research on Schizophrenia and Depression'],['United States']
NCT06759649,A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies,"A First-in-Human, Phase 1 Dose Escalation and Dose Expansion Trial to Assess the Safety and Tolerability of COM503 as Monotherapy and in Combination Therapy in Participants With Advanced Solid Malignancies",RECRUITING,2025-01-07,2027-11-22,2027-11-22,INTERVENTIONAL,PHASE1,200,"['Neoplasm', 'Cancer, Malignant Tumors']",Neoplasm,Compugen Ltd,['Gilead Sciences'],"['Israel', 'United States']"
NCT04576104,Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer,Surgical Window of Opportunity Study of Megestrol Acetate Compared With Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia,ACTIVE_NOT_RECRUITING,2021-11-29,2025-12-15,2026-06-30,INTERVENTIONAL,PHASE2,51,"['Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia', 'Endometrial Carcinoma']",Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia,Northwestern University,['National Cancer Institute (NCI)'],['United States']
NCT06660433,Respiratory Outbreak Mitigation in Long-Term Care Using Point-of-Care Testing,imProving Respiratory Outbreak Mitigation Through Point-of-care Testing in Long Term Care (PROMPT-LTC): A Cluster Randomized Trial,RECRUITING,2024-11-11,2025-05-30,2026-03-31,INTERVENTIONAL,NA,24,['Outbreaks'],Outbreaks,Michael Garron Hospital,"['Sunnybrook Health Sciences Centre', 'Humber River Health']",['Canada']
NCT00114647,Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies,"Procedures to Obtain Plasma, Lymphocytes, or Other Specimens for Research Studies",RECRUITING,1984-01-09,,,OBSERVATIONAL,,3000,"['Healthy Volunteers', 'HIV']",Healthy Volunteers,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT04777409,A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus),A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE Plus),ACTIVE_NOT_RECRUITING,2021-05-18,2025-09-15,2026-10-06,INTERVENTIONAL,PHASE3,1840,['Early Alzheimer´s Disease'],Early Alzheimer´s Disease,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'Slovenia', 'France', 'Finland', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'South Africa', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT06976216,A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)",RECRUITING,2025-07-14,2028-09-11,2029-02-23,INTERVENTIONAL,PHASE3,586,"[""Alzheimer's Disease""]",Alzheimer's Disease,Bristol-Myers Squibb,[],"['Brazil', 'India', 'United States', 'Germany', 'Chile', 'Puerto Rico', 'Croatia', 'Spain', 'Italy', 'Canada', 'Czechia', 'Romania', 'Greece', 'Poland', 'South Korea', 'Argentina', 'Australia']"
NCT06871904,Fibrosis-Modulating Effects of Metformin and Pirfenidone in Oral Submucous Fibrosis,Exploring the Fibrosis-Modulating Potential of Metformin and Pirfenidone in Oral Submucous Fibrosis: Molecular Mechanisms to Clinical Applications,RECRUITING,2025-04-07,2025-12-01,2025-12-30,INTERVENTIONAL,PHASE1,45,['Oral Submucous Fibrosis'],Oral Submucous Fibrosis,Ziauddin University,['University of Karachi'],['Pakistan']
NCT05990244,Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion,Comprehensive Assessment of Tumor Stiffness and Adhesion in Glioma Using Magnetic Resonance Elastography: A Prospective Study,RECRUITING,2017-01-01,2026-07-01,2027-07-01,INTERVENTIONAL,NA,100,['Glioma'],Glioma,Shengjing Hospital,[],['China']
NCT06912087,Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC,A Phase I Study of Zanzalintinib With Pembrolizumab and Cetuximab in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck,RECRUITING,2025-09-29,2027-06-05,2027-06-05,INTERVENTIONAL,PHASE1,36,"['Head and Neck Neoplasms', 'Carcinoma, Squamous Cell', 'Neoplasm Recurrence, Local', 'Neoplasm Metastasis', 'Recurrent Squamous Cell Carcinoma', 'Metastatic Squamous Cell Carcinoma']",Head and Neck Neoplasms,University of Chicago,['Exelixis'],['United States']
NCT06128629,MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM),"MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)",ACTIVE_NOT_RECRUITING,2023-12-13,2027-12,2028-04,INTERVENTIONAL,PHASE3,1200,['Transthyretin Amyloidosis (ATTR) With Cardiomyopathy'],Transthyretin Amyloidosis (ATTR) With Cardiomyopathy,Intellia Therapeutics,['Regeneron Pharmaceuticals'],"['Japan', 'New Zealand', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Denmark', 'Czechia', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT02567136,Imaging Biomarkers in ALS,A Longitudinal Study of Imaging Biomarkers in Amyotrophic Lateral Sclerosis (ALS),RECRUITING,2015-09,2030-09-30,2031-09-30,OBSERVATIONAL,,30,"['Amyotrophic Lateral Sclerosis', 'Primary Lateral Sclerosis']",Amyotrophic Lateral Sclerosis,University of Minnesota,[],['United States']
NCT07259538,"A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray","A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray in Healthy Chinese Adult Subjects and Patients With Chronic Rhinosinusitis.",RECRUITING,2025-11-06,2026-07-30,2026-11-30,INTERVENTIONAL,PHASE1,60,['Chronic Rhinosinusitis (CRS)'],Chronic Rhinosinusitis (CRS),"VivaVision Biotech, Inc",[],['China']
NCT07116967,Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK),"A Phase 3b/4 Multi-center, Randomized, Open-label, Long-term Safety Study of Deucravacitinib in Comparison to Ustekinumab in Participants With Moderate-to-Severe Plaque Psoriasis",RECRUITING,2025-09-22,2031-01-16,2031-01-16,INTERVENTIONAL,PHASE3,3040,['Plaque Psoriasis'],Plaque Psoriasis,Bristol-Myers Squibb,[],"['Bulgaria', 'Japan', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT06100367,11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours,11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours,ACTIVE_NOT_RECRUITING,2019-12-30,2025-05-25,2025-12-31,INTERVENTIONAL,PHASE2,100,"['Primary Aldosteronism Due to Aldosterone Producing Adenoma', 'Primary Aldosteronism', 'Adrenal Tumors']",Primary Aldosteronism Due to Aldosterone Producing Adenoma,Changi General Hospital,"['National University Health System, Singapore', 'Clinical Imaging Research Centre', 'Singapore General Hospital', 'Tan Tock Seng Hospital', 'Khoo Teck Puat Hospital', 'Ng Teng Fong General Hospital', 'Sengkang General Hospital']",['Singapore']
NCT07162012,Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma,The Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection for Treating Relapsed/Refractory EBV-positive Lymphoma Patients With HLA-A11:01,RECRUITING,2025-09-20,2028-09,2029-09,INTERVENTIONAL,EARLY_PHASE1,24,"['NK/T-cell Lymphoma', 'Peripheral T-cell Lymphoma (PTCL)', 'DLBCL']",NK/T-cell Lymphoma,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",[],['China']
NCT07257510,Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma,"A Prospective, Multicenter Clinical Study of Pomalidomide Combined With Orelabrutinib and Zuberitamab in Treatment-Naive Mantle Cell Lymphoma",RECRUITING,2025-08-01,2028-08-01,2028-08-01,INTERVENTIONAL,NA,34,"['Mantle Cell Lymphoma (MCL)', 'POZ']",Mantle Cell Lymphoma (MCL),Peking University Third Hospital,[],['China']
NCT06855537,Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques,Randomized Controlled Study on the Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques,RECRUITING,2025-11-03,2027-09-01,2027-09-01,INTERVENTIONAL,PHASE4,2190,"['Coronary Arterial Disease (CAD)', 'Vulnerable Coronary Plaques', 'Thin-cap fIbroatheroma', 'Acute Coronary Syndromes (ACS)']",Coronary Arterial Disease (CAD),Beijing Anzhen Hospital,[],['China']
NCT04624659,A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS),"An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral Etavopivat, a Pyruvate Kinase Activator in Patients With Sickle Cell Disease (HIBISCUS)",ACTIVE_NOT_RECRUITING,2021-01-29,2026-02-20,2027-03-19,INTERVENTIONAL,PHASE3,450,['Sickle Cell Disease'],Sickle Cell Disease,"Forma Therapeutics, Inc.",['This study is currently undergoing a sponsor transition from Forma to Novo Nordisk. Sponsor field will be updated once the transition is complete.'],"['Lebanon', 'Oman', 'Turkey (Türkiye)', 'Saudi Arabia', 'India', 'Kenya', 'United States', 'France', 'Ghana', 'Nigeria', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Greece', 'Egypt', 'Germany']"
NCT04457895,Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.,"A Randomized, Open-labelled, Controlled Trial Evaluating the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.",RECRUITING,2021-02-11,2028-08,2028-08,INTERVENTIONAL,NA,108,['Breast Cancer'],Breast Cancer,Institut du Cancer de Montpellier - Val d'Aurelle,[],['France']
NCT04597580,Personalised Disease Monitoring in Metastatic Breast Cancer,Personalised Disease Monitoring During Treatment With an Aromatase Inhibitor + Cyclin Dependent Kinase (CDK) 4/6 Inhibitor as 1st Line Endocrine Therapy in Patients With ER-positive/HER2-negative Metastatic Breast Cancer,ACTIVE_NOT_RECRUITING,2019-05-08,2026-05-31,2030-01-31,OBSERVATIONAL,,97,"['Breast Cancer Metastatic', 'Estrogen Receptor-positive Breast Cancer']",Breast Cancer Metastatic,The Christie NHS Foundation Trust,['Sahlgrenska University Hospital'],"['United Kingdom', 'Sweden']"
NCT04406259,Atrioventricular Block and Cluster Headache (SEVA),Atrioventricular Block and Cluster Headache,ACTIVE_NOT_RECRUITING,2020-11-02,2025-09-05,2027-09-05,INTERVENTIONAL,PHASE4,60,['Cluster Headache'],Cluster Headache,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06332807,AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom),"An Open-Label, Multiple-Center, Phase I/II Dose Escalation Study for the Safety and Efficacy of NGGT002 in Adults With Classic Phenylketonuria",RECRUITING,2025-01-10,2030-12-30,2030-12-30,INTERVENTIONAL,PHASE1,12,['Phenylketonurias'],Phenylketonurias,NGGT INC.,[],['United States']
NCT05025826,Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy,"Randomized, Double-blind, Multicenter Placebo-controlled Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy",ACTIVE_NOT_RECRUITING,2022-04-01,2025-11,2026-03,INTERVENTIONAL,NA,110,['Metastatic Gastric Cancer'],Metastatic Gastric Cancer,Nantes University Hospital,['Algosource'],['France']
NCT07257848,Practice-Based Evidence in Psychotherapy: A Multicentric Study From Ecuador,Practice-Based Evidence in Ecuador: Routine Monitoring of Outcomes and Change in Psychotherapy for Common Mental Health Problems,RECRUITING,2025-02-21,2028-02-29,2028-08-31,OBSERVATIONAL,,340,['Psychological Distress'],Psychological Distress,Universidad de las Americas - Quito,[],['Ecuador']
NCT06984328,Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07),"Efficacy and Safety Study of Acasunlimab as Monotherapy and in Combination With Pembrolizumab in Subjects With Relapsed/Refractory, Unresectable Locally Advanced or Metastatic Cutaneous Melanoma That Progressed On or After Treatment With a Checkpoint Inhibitor (ABBIL1TY MELANOMA-07)",ACTIVE_NOT_RECRUITING,2025-07-25,2027-07-15,2029-07-15,INTERVENTIONAL,PHASE2,90,"['Cutaneous Melanoma', 'Relapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID)', 'Metastatic Cutaneous Melanoma (Stage IV)']",Cutaneous Melanoma,Genmab,[],"['Puerto Rico', 'United States']"
NCT04747041,Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis,Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis Preliminary Study,ACTIVE_NOT_RECRUITING,2021-05-18,2023-06-20,2026-01-23,INTERVENTIONAL,NA,15,['Cystitis Recurrent'],Cystitis Recurrent,Centre Hospitalier Universitaire de Nice,[],['France']
NCT04869111,The BrainHealth Project,"The BrainHealth Project, a Longitudinal Study in Generally Healthy Adults",RECRUITING,2020-08-01,2038-08-01,2038-08-01,INTERVENTIONAL,NA,100000,['Healthy'],Healthy,The University of Texas at Dallas,"['University of Iowa', 'University of California, Santa Barbara', 'University of Kansas Medical Center', 'Northeastern University', 'Georgia State University', 'University of Southern California', 'Inova Health Care Services', 'Methodist Healthcare']",['United States']
NCT07259239,SINGapore SoniCracker IntraVascular Lithotripsy (SING IVL) Study,SINGapore SoniCracker IntraVascular Lithotripsy (SING IVL) Study,RECRUITING,2025-09-30,2026-07,2026-07,INTERVENTIONAL,NA,40,['Cardiovascular Diseases'],Cardiovascular Diseases,National Heart Centre Singapore,['Biosensor Interventional Technologies Pte Ltd'],['Singapore']
NCT07258589,The TASTY-training Study,Taste and Smell Training in Patients With Cancer Who Are Treated With Tyrosine Kinase Inhibitors: a Multicentre Randomized Intervention Trial,RECRUITING,2025-11-10,2028-07,2028-07,INTERVENTIONAL,NA,90,['Patients Who Are Treated With Tyrosine Kinase Inhibitors'],Patients Who Are Treated With Tyrosine Kinase Inhibitors,University Medical Center Groningen,[],['Netherlands']
NCT07144189,AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography,Artificial Intelligence-Based Assessment of Low-Gradient Aortic Stenosis Severity Using Echocardiographic Images,RECRUITING,2025-08-20,2026-08-20,2026-08-20,OBSERVATIONAL,,300,"['Low-gradient Aortic Stenosis', 'Aortic Stenosis']",Low-gradient Aortic Stenosis,"National Institute of Cardiology, Warsaw, Poland","['The Institute of Bioorganic Chemistry, Polish Academy of Sciences']",['Poland']
NCT05781555,A Study of Diffusing Alpha Radiation Therapy for Target Treatments of Malignant Tumors,"A Prospective, Open Label, One Arm Study for a Compassionate Use of Diffusing Alpha Radiation Therapy",RECRUITING,2023-03-22,2026-04,2027-04,INTERVENTIONAL,NA,100,['Malignant Tumor'],Malignant Tumor,Alpha Tau Medical LTD.,[],['Israel']
NCT07257250,Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation,Effectiveness of Levothyroxine Treatment on In Vitro Fertilization and Pregnancy Outcome in Women With Subclinical Hypothyroidism and Infertility: A Target Trial Emulation,RECRUITING,2019-01-01,2024-12-30,2025-12-30,OBSERVATIONAL,,900,"['Subclinical Hypothyroidism', 'Infertility', 'Assisted Reproductive Technology', 'In Vitro Fertilization (IVF)', 'Intracytoplasmic Sperm Injection', 'Frozen Embryo Transfer (FET)']",Subclinical Hypothyroidism,Mỹ Đức Hospital,[],['Vietnam']
NCT03553420,Registry for Patients With Lipodystrophy,Osse Registry for Patients With Lipodystrophy Run by the European Consortium of Lipodystrophies (ECLip),RECRUITING,2017-12-16,2068-01,2068-01,OBSERVATIONAL,,5000,"['Lipodystrophy Acquired', 'Lipodystrophy Congenital']",Lipodystrophy Acquired,University of Ulm,"['Sorbonne University', 'University Hospital, Lille', 'University of Cambridge', 'Endocrinology Research Centre, Moscow', 'University of Leipzig', 'University of Amsterdam', 'Dokuz Eylul University', 'IRCCS Azienda Ospedaliero-Universitaria di Bologna', 'University of Rome Tor Vergata', 'University of Pisa', 'University of Santiago de Compostela', 'Università degli Studi del Piemonte Orientale Amedeo Avogadro', 'University Hospital Muenster', 'Szeged University', 'Centro Hospitalar do Porto', 'University Medical Centre Ljubljana', 'Medical University of Vienna', 'National and Kapodistrian University of Athens', 'Stoffwechselzentrum St. Gallen', 'National Taiwan University Hospital', 'Marmara University', 'University of Palermo', 'Attikon Hospital', 'Kinderkrankenhaus auf der Bult', 'Hopital Universitaire Robert-Debre', 'University of Milan', 'C.I. Parhon National Institute of Endocrinology']","['Hungary', 'Turkey (Türkiye)', 'Netherlands', 'Austria', 'Russia', 'France', 'Slovenia', 'Switzerland', 'Spain', 'Taiwan', 'Italy', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Germany']"
NCT06633380,Alternative Physical Activity Strategies for Breast Cancer Survivors,Alternative Physical Activity Strategies for Breast and Prostate Cancer Survivors,RECRUITING,2024-10-22,2026-04-30,2026-07-01,INTERVENTIONAL,NA,24,"['Breast Cancer', 'Insulin Resistance', 'Cardiometabolic Risk Factors']",Breast Cancer,University of Toronto,[],['Canada']
NCT04777331,A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease,"A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease",ACTIVE_NOT_RECRUITING,2021-05-05,2024-09-11,2026-12-30,INTERVENTIONAL,PHASE2,586,['Parkinsons Disease'],Parkinsons Disease,Hoffmann-La Roche,['Prothena Biosciences Limited'],"['Austria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Luxembourg']"
NCT00051857,MRI Study of Musculoskeletal Function,Virtual Function Anatomy (VFA),RECRUITING,2003-03-05,,,OBSERVATIONAL,,750,"['Abnormalities', 'Imaging', 'Patellofemoral Pain Syndrome']",Abnormalities,National Institutes of Health Clinical Center (CC),[],['United States']
NCT07116343,Intrapleural Ropivacaine Infusion in Cardiac Surgery,Intrapleural Ropivacaine Infusion in Cardiac Surgery: Randomized Double-blind Controlled Study,RECRUITING,2025-10-22,2027-09-25,2027-12-01,INTERVENTIONAL,PHASE4,116,"['Cardiac Surgery', 'Coronary Artery Disease', 'Valvular Diseases']",Cardiac Surgery,"Saint Petersburg State University, Russia",[],['Russia']
NCT07108283,A Study of Zasocitinib in Adults With Nonsegmental Vitiligo,"A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants With Nonsegmental Vitiligo",RECRUITING,2025-11-03,2027-10-12,2027-11-09,INTERVENTIONAL,PHASE2,200,['Nonsegmental Vitiligo'],Nonsegmental Vitiligo,Takeda,[],"['Japan', 'China', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'Poland']"
NCT06435429,"A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer","A Phase 3, Randomized, Open-label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combination With Physician's Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer Who Have Progressed on, or Are Intolerant to, Previous Trastuzumab Deruxtecan Treatment",RECRUITING,2024-08-13,2028-09-26,2031-11-26,INTERVENTIONAL,PHASE3,550,['Metastatic HER2-positive Breast Cancer'],Metastatic HER2-positive Breast Cancer,Jazz Pharmaceuticals,[],"['Brazil', 'Belgium', 'Japan', 'Austria', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Greece', 'Poland', 'Australia']"
NCT07258979,A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.,"A Multicenter, Open-label, Phase Ib/II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 Combined With Toripalimab, With or Without Cisplatin, in Subjects With Recurrent or Metastatic Nasopharyngeal Carcinoma.",RECRUITING,2025-11-05,2028-02,2028-05,INTERVENTIONAL,PHASE1,202,['Recurrent or Metastatic Nasopharyngeal Carcinoma'],Recurrent or Metastatic Nasopharyngeal Carcinoma,"MediLink Therapeutics (Suzhou) Co., Ltd.",[],['China']
NCT05327023,Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies,Phase I/II Study Using Prophylactic Donor Lymphocyte Infusion Early Post-Transplant After Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for High-Risk Hematologic Malignancies,RECRUITING,2022-05-23,2028-07-03,2029-07-02,INTERVENTIONAL,PHASE1,430,['Hematologic Neoplasms'],Hematologic Neoplasms,National Cancer Institute (NCI),[],['United States']
NCT07240012,Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes,Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes,RECRUITING,2025-12-01,2028-10,2028-10,INTERVENTIONAL,NA,305,"['Diabete Type 1', 'Pregnancy Complications']",Diabete Type 1,"Rigshospitalet, Denmark","['The Novo Nordic Foundation', 'Ypsomed Diabetes Care AG', 'Abbott']",['Denmark']
NCT05614102,"A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors","An Open-label, Phase 1, First-in-human, Dose Escalation and Expansion Study to Evaluate the Safety, Tolerability, Maximum Tolerated or Administered Dose, Pharmacokinetics, Pharmacodynamics, and Tumor Response Profile of the Diacylglycerol Kinase Zeta Inhibitor (DGKzi) BAY 2965501 as Monotherapy, and in Combination, in Participants With Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2022-11-04,2027-06-07,2027-09-09,INTERVENTIONAL,PHASE1,284,['Advanced Solid Tumors'],Advanced Solid Tumors,Bayer,[],"['Belgium', 'Japan', 'China', 'United States', 'Spain', 'South Korea', 'United Kingdom']"
NCT03729453,Intra-operative Pancreatoscopy in Patients With IPMN,Intra-operative Pancreatoscopy in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN),ACTIVE_NOT_RECRUITING,2019-03-20,2022-08-11,2027-05,OBSERVATIONAL,,100,['Intraductal Papillary Mucinous Neoplasm'],Intraductal Papillary Mucinous Neoplasm,Boston Scientific Corporation,[],"['Japan', 'Netherlands', 'China', 'United States', 'Sweden', 'India']"
NCT01838512,Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE),Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE),ACTIVE_NOT_RECRUITING,2012-06-13,2030-03-31,2030-03-31,OBSERVATIONAL,,2555,['Multiple Myeloma'],Multiple Myeloma,Bristol-Myers Squibb,[],"['United States', 'France', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT07258329,Screening for Intrapartum Fetal Compromise Using Placental Biomarkers,Screening Della Compromissione Fetale Intrapartum Mediante Utilizzo Dei Marcatori Placentari,RECRUITING,2025-03-28,2028-02-01,2028-10-01,OBSERVATIONAL,,428,['Pregnant Women'],Pregnant Women,IRCCS Azienda Ospedaliero-Universitaria di Bologna,[],['Italy']
NCT03703167,Ibrutinib With Rituximab and Lenalidomide for Patients With Recurrent/Refractory Primary or Secondary Central Nervous System Lymphoma (PCNSL/SCNSL),"Phase Ib Trial With Dose Expansion of the Bruton""s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination With Rituximab and Lenalidomide in Patients With Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)",ACTIVE_NOT_RECRUITING,2019-01-22,2026-11,2026-11,INTERVENTIONAL,PHASE1,25,"['Primary Central Nervous System Lymphoma (PCNSL)', 'Secondary Central Nervous System Lymphoma (SCNSL)']",Primary Central Nervous System Lymphoma (PCNSL),Memorial Sloan Kettering Cancer Center,['Pharmacyclics LLC.'],['United States']
NCT05760794,Barbed-suture Efficiency Study for Sacrocolpopexy,BEST: Barbed-suture Efficiency Study for Sacrocolpopexy,ACTIVE_NOT_RECRUITING,2023-06-21,2027-12,2027-12,INTERVENTIONAL,NA,52,['Prolapse; Female'],Prolapse; Female,Wake Forest University Health Sciences,[],['United States']
NCT02408822,Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS),"Superiority of Drug-eluting Balloon Angioplasty Versus Plain Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis : a Multicentre, Randomized, Controlled Trial",ACTIVE_NOT_RECRUITING,2015-09-29,2020-06-15,2026-06-15,INTERVENTIONAL,NA,52,['Dysfunction of Hemodialysis Vascular Access (Fistula and Graft)'],Dysfunction of Hemodialysis Vascular Access (Fistula and Graft),Centre Hospitalier Universitaire de Nice,[],['France']
NCT07257172,Sutureless Technique for Repositioning and Scleral Fixation of the Capsular Bag - Intraocular Lens Complex With Permanent Use of Iris Retractors,Sutureless Technique for Repositioning and Scleral Fixation of the Capsular Bag - Intraocular Lens Complex With Permanent Use of Iris Retractors,RECRUITING,2021-05-28,2026-01,2026-01,INTERVENTIONAL,NA,40,['Lens Subluxation'],Lens Subluxation,Military Institute od Medicine National Research Institute,[],['Poland']
NCT06734130,Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer,A Phase IIA Study of Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer,ACTIVE_NOT_RECRUITING,2025-01-10,2028-11,2028-11,INTERVENTIONAL,PHASE2,25,['Metastatic Castration Sensitive Prostate Cancer'],Metastatic Castration Sensitive Prostate Cancer,H. Lee Moffitt Cancer Center and Research Institute,[],['United States']
NCT05109728,A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.,A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Radiotherapy With or Without Temozolomide and in Recurrent Glioblastoma as Single Agent,RECRUITING,2022-05-10,2026-06-05,2026-07-31,INTERVENTIONAL,PHASE1,60,['Glioblastoma'],Glioblastoma,Novartis Pharmaceuticals,[],"['United States', 'France', 'Switzerland', 'Spain', 'Portugal']"
NCT06362993,Breast Cancer Screening in Ghana,Testing Approaches to Promote Breast Cancer Screening in Rural Ghana,ACTIVE_NOT_RECRUITING,2024-08-18,2025-03-15,2026-03,INTERVENTIONAL,NA,118,['Breast Cancer Female'],Breast Cancer Female,Penn State University,['University of Ghana'],['Ghana']
NCT05302999,Feasibility of Early Gabapentin as an Intervention for Neurorecovery,Feasibility of Early Gabapentin as an Intervention for Neurorecovery,RECRUITING,2022-03-14,2026-08-31,2026-08-31,INTERVENTIONAL,PHASE4,42,['Spinal Cord Injuries'],Spinal Cord Injuries,MetroHealth Medical Center,"['National Institute on Disability, Independent Living, and Rehabilitation Research']",['United States']
NCT04083599,GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors,"A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors",ACTIVE_NOT_RECRUITING,2019-09-17,2025-12,2026-11,INTERVENTIONAL,PHASE1,350,"['Malignant Solid Tumor', 'Non-Small Cell Lung Cancer (NSCLC)', 'Colorectal Cancer (CRC)', 'Melanoma', 'Head and Neck Squamous Cell Carcinoma (HNSCC)', 'Pancreatic Ductal Adenocarcinoma (PDAC)']",Malignant Solid Tumor,Genmab,['BioNTech SE'],"['Israel', 'Moldova', 'United States', 'France', 'Georgia', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'United Kingdom', 'Germany']"
NCT07110714,Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients,Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients: A Randomized Controlled Trial,RECRUITING,2025-12-01,2027-01-31,2027-10-31,INTERVENTIONAL,NA,30,"['Post COVID-19 Condition', 'Post COVID-19 Condition (PCC)', 'Post COVID-19', 'Post COVID-19 Syndrome', 'Long COVID-19 Syndrome']",Post COVID-19 Condition,Eggensberger OHG,['Bavarian Health and Food Safety Authority (LGL)'],['Germany']
NCT03210714,"Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)",NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Erdafitinib in Patients With Tumors Harboring FGFR1/2/3/4 Alterations,ACTIVE_NOT_RECRUITING,2018-06-05,2023-09-30,2025-12-31,INTERVENTIONAL,PHASE2,20,"['Advanced Malignant Solid Neoplasm', 'Recurrent Childhood Ependymoma', 'Recurrent Childhood Malignant Germ Cell Tumor', 'Recurrent Childhood Medulloblastoma', 'Recurrent Childhood Non-Hodgkin Lymphoma', 'Recurrent Childhood Osteosarcoma', 'Recurrent Childhood Rhabdomyosarcoma', 'Recurrent Childhood Soft Tissue Sarcoma', 'Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Hepatoblastoma', 'Recurrent Langerhans Cell Histiocytosis', 'Recurrent Malignant Glioma', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Neuroblastoma', 'Recurrent Primary Central Nervous System Neoplasm', 'Recurrent Rhabdoid Tumor', 'Refractory Childhood Malignant Germ Cell Tumor', 'Refractory Childhood Osteosarcoma', 'Refractory Childhood Rhabdomyosarcoma', 'Refractory Childhood Soft Tissue Sarcoma', 'Refractory Ependymoma', 'Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor', 'Refractory Hepatoblastoma', 'Refractory Langerhans Cell Histiocytosis', 'Refractory Malignant Glioma', 'Refractory Malignant Solid Neoplasm', 'Refractory Medulloblastoma', 'Refractory Neuroblastoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Primary Central Nervous System Neoplasm', 'Refractory Rhabdoid Tumor', 'Wilms Tumor']",Advanced Malignant Solid Neoplasm,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT06189209,Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC),"A Phase II, Multi-center, Single-arm, Open-label Study to Assess the Efficacy and Safety of Tenalisib, a PI3K δ/γ, and SIK3 Inhibitor, in Patients With Metastatic Triple Negative Breast Cancer (TNBC)",RECRUITING,2024-03-04,2026-12-31,2027-03-31,INTERVENTIONAL,PHASE2,40,['Triple Negative Breast Cancer (TNBC)'],Triple Negative Breast Cancer (TNBC),Rhizen Pharmaceuticals SA,['Incozen Therapeutics Pvt Ltd'],['India']
NCT04195399,"A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery","A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014), in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors",ACTIVE_NOT_RECRUITING,2020-10-07,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE2,35,"['Desmoid Fibromatosis', 'Recurrent Desmoid Fibromatosis', 'Unresectable Desmoid Fibromatosis']",Desmoid Fibromatosis,Children's Oncology Group,"['National Cancer Institute (NCI)', 'SpringWorks Therapeutics, Inc.']","['New Zealand', 'United States', 'Puerto Rico', 'Canada', 'Australia']"
NCT02789384,CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.,Prognostic Value of the CINSARC (Complexity Index in Sarcoma) Signature and Correlation With Chemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study. (NEOSarcomics ),RECRUITING,2016-06,2026-12,2027-12,INTERVENTIONAL,NA,205,['Soft-tissue Sarcomas'],Soft-tissue Sarcomas,Institut Bergonié,"['National Cancer Institute, France', 'Ministry of Health, France']",['France']
NCT06128564,A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD),"A Two-Part, Open-Label Systemic Gene Delivery Study to Evaluate the Safety and Expression of RO7494222 (SRP-9001) in Subjects Under the Age of Four With Duchenne Muscular Dystrophy",RECRUITING,2023-11-29,2034-01-30,2034-01-30,INTERVENTIONAL,PHASE2,21,['Duchenne Muscular Dystrophy'],Duchenne Muscular Dystrophy,Hoffmann-La Roche,"['Sarepta Therapeutics, Inc.']","['Belgium', 'France', 'Spain', 'Italy', 'United Kingdom', 'Germany']"
NCT04736199,Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer,"A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide in Addition to Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Men With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)",ACTIVE_NOT_RECRUITING,2021-02-23,2024-06-07,2026-01-30,INTERVENTIONAL,PHASE3,669,['Prostatic Neoplasms'],Prostatic Neoplasms,Bayer,"['Orion Corporation, Orion Pharma']","['Brazil', 'New Zealand', 'South Africa', 'China', 'India', 'Russia', 'Chile', 'Spain', 'Peru', 'Taiwan', 'Canada', 'Ukraine', 'Latvia', 'Lithuania', 'Australia']"
NCT02091245,"Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML","Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML.",ACTIVE_NOT_RECRUITING,2014-03,2018-02,2026-06,INTERVENTIONAL,PHASE1,16,"['Relapsed Acute Lymphoblastic Leukemia (ALL)', 'Refractory Acute Lymphoblastic Leukemia (ALL)', 'Relapsed Acute Myelogenous Leukemia (AML)', 'Refractory Acute Myelogenous Leukemia (AML)', 'Relapsed Mixed Lineage Leukemia', 'Refractory Mixed Lineage Leukemia', 'Relapsed Biphenotypic Leukemia', 'Refractory Biphenotypic Leukemia', 'Chronic Myelogenous Leukemia (CML) in Blast Crisis']",Relapsed Acute Lymphoblastic Leukemia (ALL),Dana-Farber Cancer Institute,"['William Lawrence and Blanche Hughes Foundation', 'Karyopharm Therapeutics Inc']",['United States']
NCT06965101,To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy Pathway,Rapid Response MRI-Guided Palliative Radiotherapy,RECRUITING,2025-11-04,2027-11-04,2028-11-04,INTERVENTIONAL,NA,72,['Metastatic Spinal Cord Compression'],Metastatic Spinal Cord Compression,The Christie NHS Foundation Trust,[],['United Kingdom']
NCT01425892,The Pathogenesis and Natural History of Sjogren's Disease,The Pathogenesis and Natural History of Sjogren's Disease,RECRUITING,2012-01-18,,,OBSERVATIONAL,,300,"[""Sjogren's Syndrome"", 'Salivary Gland', 'Pathogenesis']",Sjogren's Syndrome,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT01742143,Impact of ICCAN on Cancer Treatment Completion and Quality of Life,A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life,RECRUITING,2012-11,2026-11,2026-11,OBSERVATIONAL,,347,['Cancer Patients'],Cancer Patients,Memorial Sloan Kettering Cancer Center,"['National Cancer Institute (NCI)', 'The City College of New York', 'Ralph Lauren Center for Cancer Care and Prevention', 'Lincoln Medical and Mental Health Center', 'Lutheran Medical Center']",['United States']
NCT04798274,Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder,Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder,RECRUITING,2021-06-15,2027-06-30,2027-06-30,INTERVENTIONAL,NA,106,['Autism Spectrum Disorder'],Autism Spectrum Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT03334708,A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma,"Development of Biomarkers for the Early Detection, Surveillance and Monitoring of Pancreatic Ductal Adenocarcinoma",RECRUITING,2017-10-30,2026-10-30,2026-10-30,OBSERVATIONAL,,700,"['Pancreatic Cancer', 'Pancreatic Diseases', 'Pancreatitis', 'Pancreatic Cyst']",Pancreatic Cancer,Memorial Sloan Kettering Cancer Center,"['Sheba Medical Center', 'Weill Medical College of Cornell University', 'Weizmann Institute of Science']","['Israel', 'United States']"
NCT02341989,"Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer","A Randomized Phase III Study Comparing One Course of Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) and One Course of Carboplatin AUC7 in Clinical Stage I Seminomatous Testicular Cancer",ACTIVE_NOT_RECRUITING,2015-04-08,2027-05,2032-05,INTERVENTIONAL,PHASE3,348,"['Testicular Neoplasms', 'Seminoma']",Testicular Neoplasms,St. Olavs Hospital,"['Haukeland University Hospital', 'University Hospital of North Norway', 'Sahlgrenska University Hospital', 'Karolinska Institutet', 'Oslo University Hospital', 'Uppsala University Hospital', 'University Hospital, Linkoeping', 'Skane University Hospital', 'Norrlands University Hospital']",['Norway']
NCT06079281,Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa,"A Phase 3, Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN1850 (Recombinant Alkaline Phosphatase) Administered Subcutaneously in Adolescent (12 to < 18 Years of Age) and Adult Participants With Hypophosphatasia Who Have Not Previously Been Treated With Asfotase Alfa",ACTIVE_NOT_RECRUITING,2024-01-03,2025-07-09,2028-03-29,INTERVENTIONAL,PHASE3,124,['Hypophosphatasia'],Hypophosphatasia,"Alexion Pharmaceuticals, Inc.",[],"['Brazil', 'Israel', 'Japan', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Australia']"
NCT03917381,GEN1046 Safety Trial in Patients With Malignant Solid Tumors,"First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1046 in Subjects With Malignant Solid Tumors",ACTIVE_NOT_RECRUITING,2019-05-14,2025-04-01,2026-02,INTERVENTIONAL,PHASE1,429,"['Solid Tumors', 'Non-small Cell Lung Cancer', 'Urothelial Carcinoma', 'Endometrial Carcinoma', 'Triple Negative Breast Cancer', 'Squamous Cell Carcinoma of the Head and Neck', 'Cervical Cancer']",Solid Tumors,Genmab,[],"['Israel', 'Hungary', 'Turkey (Türkiye)', 'United States', 'Georgia', 'Spain', 'Italy', 'Czechia', 'Poland', 'Ukraine']"
NCT07257432,Electronic Anesthetic Efficacy Prof. Ali Rokia Ph.D. Al-Andalus University Prof . Mouetaz Kheirallah Ph.D ArabUST,a Spilt Mouth Clinical Comparative Evaluation of the Electronic Anesthetic Efficacy,ACTIVE_NOT_RECRUITING,2025-09-24,2025-09-24,2026-05-30,INTERVENTIONAL,NA,30,['Pain Perception'],Pain Perception,Mouetaz Kheirallah,[],['Syria']
NCT05147649,Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome,"Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome, With and Without CPAP, During Wakefulness - Impact on Cognitive Functions",RECRUITING,2023-03-02,2027-01-02,2027-07-02,INTERVENTIONAL,NA,70,['Obstructive Sleep Apnea Syndrome'],Obstructive Sleep Apnea Syndrome,CHU de Reims,[],['France']
NCT07245121,Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain.,Perineural Prolotherapy in Chronic Knee Osteoarthritis Pain: A Randomized Controlled Trial.,RECRUITING,2025-11-24,2026-12,2027-02,INTERVENTIONAL,NA,60,"['Chronic Pain', 'Perineural Analgesia', 'Prolotherapy', 'Knee Osteoarthritis']",Chronic Pain,National and Kapodistrian University of Athens,[],['Greece']
NCT07147816,Cervical Transcutaneous SCS for TBI,Effects of Transcutaneous Cervical Spinal Cord Stimulation on Upper Limb Motor Function After Traumatic Brain Injury,RECRUITING,2025-11-26,2029-11-01,2029-11-01,INTERVENTIONAL,NA,80,"['Traumatic Brain Injury', 'TBI (Traumatic Brain Injury)']",Traumatic Brain Injury,Roberto de Freitas,['Chuck Noll Foundation'],['United States']
NCT03631849,Epstein-Barr Virus Implication in Peri-implantitis: Towards an Innovative Etiopathogenic Model.,Epstein-Barr Virus Implication in Peri-implantitis: Towards an Innovative Etiopathogenic Model Involved in Implant-supported Prostheses Loss.,RECRUITING,2020-11-02,2026-05,2026-05,INTERVENTIONAL,NA,30,['Peri-Implantitis'],Peri-Implantitis,Centre Hospitalier Universitaire de Nice,[],['France']
NCT05707208,"A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain","A Randomized, Controlled Phase II Study of Repeat Dose ST-01 (Lidocaine Polymer Solution) vs Lidocaine for Spermatic Cord Block in Men With Chronic Scrotal Content Pain",ACTIVE_NOT_RECRUITING,2023-03-21,2025-12-04,2026-02-02,INTERVENTIONAL,PHASE2,63,['Chronic Pain'],Chronic Pain,Sustained Therapeutics Inc.,[],['Canada']
NCT07257835,Dupilumab Therapy for EGIDs,Dupilumab Therapy for Refractory Eosinophilic Gastrointestinal Disorders in Children,RECRUITING,2025-01-01,2027-01-01,2027-12-01,OBSERVATIONAL,,20,['Eosinophilic Gastrointestinal Disorders (EGIDs)'],Eosinophilic Gastrointestinal Disorders (EGIDs),Children's Hospital of Fudan University,[],['China']
NCT02390869,Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients,A Randomized Phase III Multicenter Trial Assessing Efficacy and Toxicity of a Combination of Rituximab and Lenalidomide (R2) vs Rituximab Alone as Maintenance After Chemoimmunotherapy With Rituximab-chemotherapy (R-CHT) for Relapsed/Refractory FL Patients Not Eligible for Autologous Transplantation (ASCT).,ACTIVE_NOT_RECRUITING,2014-05,2023-01-25,2027-08,INTERVENTIONAL,PHASE3,128,"['Lymphoma, Follicular']","Lymphoma, Follicular",Fondazione Italiana Linfomi - ETS,[],['Italy']
NCT05047094,A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC,A Safety and Efficacy Study of Intratumoral Diffusing Alpha Radiation Emitters in Recurrent Unresectable or Metastatic Head and Neck Squamous Cell Carcinoma,RECRUITING,2021-11-02,2026-12,2027-06,INTERVENTIONAL,NA,48,"['Head and Neck Squamous Cell Carcinoma', 'Skin Cancer', 'Metastatic Head-and-neck Squamous-cell Carcinoma']",Head and Neck Squamous Cell Carcinoma,Alpha Tau Medical LTD.,[],['Israel']
NCT07231289,Effect of Soundscapes on Emotional Distress in Fibromyalgia: a 4×4 Crossover Trial,"Effects of Soundscapes on the Mood States, Stress, and Anxiety in Individuals With Fibromyalgia Syndrome: A Randomized, Triple-Blind, Placebo-Controlled 4×4 Crossover Trial",RECRUITING,2025-11-24,2026-02,2026-02,INTERVENTIONAL,NA,72,['Fibromyalgia Syndrome'],Fibromyalgia Syndrome,Universidad de Granada,[],['Spain']
NCT07258368,Gong Mobilization Versus Spencer Technique for Diabetic Frozen Shoulder,Comparative Effect of Gong Mobilization and Spencer Technique in the Management of Frozen Shoulder Among Diabetic Patients,RECRUITING,2025-10-01,2026-01,2026-02,INTERVENTIONAL,NA,36,['Frozen Shoulder'],Frozen Shoulder,Riphah International University,[],['Pakistan']
NCT05682443,ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC,Randomized Study of ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Who Progressed on Androgen Receptor (AR) Pathway Inhibition,ACTIVE_NOT_RECRUITING,2023-12-11,2026-06-30,2027-06-30,INTERVENTIONAL,PHASE1,148,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,"OncoC4, Inc.",['Prostate Cancer Clinical Trials Consortium'],['United States']
NCT06878560,Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD,EXPAND: A Prospective Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With End-stage Renal Disease (ESRD),RECRUITING,2025-10-29,2028-10,2075-10,INTERVENTIONAL,PHASE1,50,"['ESRD (End-Stage Renal Disease)', 'Kidney Transplantation', 'Xenotransplantation']",ESRD (End-Stage Renal Disease),United Therapeutics,[],['United States']
NCT07165691,TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics,TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics,RECRUITING,2025-09-11,2027-06-30,2027-06-30,INTERVENTIONAL,NA,91,['Lung Neoplasms'],Lung Neoplasms,"Rutgers, The State University of New Jersey",['New Jersey Commission on Cancer Research'],['United States']
NCT05734768,"Impact of Preterm Birth on Symptoms of Anxiety and Depression in Parents, and on the Precursors of Cognition, Including Social Cognition in Their Child","Impact of Preterm Birth on Symptoms of Anxiety and Depression in Parents, and on the Precursors of Cognition, Including Social Cognition in Their Child",RECRUITING,2023-11-28,2027-02-28,2028-05-28,OBSERVATIONAL,,60,['Parental Anxiety Following Premature Birth'],Parental Anxiety Following Premature Birth,CHU de Reims,[],['France']
NCT00001350,Study of Autoimmune Lymphoproliferative Syndrome (ALPS),"Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated With an Expansion of CD4-8-/TCR Alpha/Beta+ T Cells",RECRUITING,1993-05-13,,,OBSERVATIONAL,,1200,['Benign Lymphoproliferative Disorder'],Benign Lymphoproliferative Disorder,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05940285,"Evaluation of the Diagnostic Performance of Dynamic Myocardial Perfusion Scintigraphy in Comparison With Invasive Intracoronary FFR Measurement, in the Assessment of Significant Residual Coronary Stenosis After Acute Coronary Syndrome: Dyna-MI Pilot Study.","Evaluation of the Diagnostic Performance of Dynamic Myocardial Perfusion Scintigraphy in Comparison With Invasive Intracoronary FFR Measurement, in the Assessment of Significant Residual Coronary Stenosis After Acute Coronary Syndrome: Dyna-MI Pilot Study.",RECRUITING,2023-10-20,2026-11-20,2027-10-20,INTERVENTIONAL,NA,60,['Myocardial Infarction'],Myocardial Infarction,Nantes University Hospital,[],['France']
NCT06785402,Ceftriaxone for Post-Treatment Lyme Disease,"Phase 1/2, Randomized, Double-Blind, Placebo-Controlled Trial of Pulse Dosed Ceftriaxone for Post-Treatment Lyme Disease",RECRUITING,2025-12-15,2026-12-01,2026-12-01,INTERVENTIONAL,PHASE1,20,['Post-Treatment Lyme Disease Syndrome'],Post-Treatment Lyme Disease Syndrome,Hackensack Meridian Health,['Columbia Clinical Trials Network for Lyme and Other Tick-Borne Diseases'],['United States']
NCT07226752,A Sub-study Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) in China,"A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma",ACTIVE_NOT_RECRUITING,2022-10-08,2025-10-13,2028-06-14,INTERVENTIONAL,PHASE3,72,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Genmab,['AbbVie'],['China']
NCT07258316,High Intensity Interval Training in Pre and Postmenopausal Women With Type II Diabetes.,Comparative Effects of High-Intensity Interval Training in Pre and Postmenopausal Women With Type II Diabetes Mellitus,RECRUITING,2025-09-25,2026-06,2026-07,INTERVENTIONAL,NA,45,"['Diabetes Mellitus, Type 2', 'Postmenopausal Symptoms']","Diabetes Mellitus, Type 2",Riphah International University,[],['Pakistan']
NCT07258784,RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis,RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis,RECRUITING,2025-09-11,2026-09-10,2026-12-31,OBSERVATIONAL,,10,"['Tracheal Stenosis', 'Subglottic Stenosis']",Tracheal Stenosis,"University of Maryland, Baltimore",[],['United States']
NCT07181278,Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon,Optimization of HPV-based Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon,RECRUITING,2025-04-28,2027-07-01,2028-08-01,INTERVENTIONAL,NA,1180,"['Cervical Cancer Screening', 'HIV']",Cervical Cancer Screening,Institut de Recherche pour le Developpement,"['International Agency for Research on Cancer', 'Institut National de la Santé Et de la Recherche Médicale, France', 'Centre Pasteur du Cameroun', 'Ecole Polytechnique Fédérale de Lausanne', 'Queen Mary University of London', ""Programme PACCI, Abidjan, Côte d'Ivoire"", 'RSD Institute, Cameroon', 'Centre Hospitalier Simone VEIL de BEAUVAIS']",['Cameroon']
NCT05057676,Autoimmune Intervention Mastery Course Study,Evaluation of an Online Course Designed to Support the Adoption of Healthier Diet and Self-Care Routines in Multiple Sclerosis Patients,RECRUITING,2021-12-01,2027-12-01,2027-12-01,INTERVENTIONAL,NA,400,"['Multiple Sclerosis', 'Clinically Isolated Syndrome', 'Fibromyalgia', 'Post Acute Sequelae of COVID-19', 'Cancer in Remission With Persisting Fatigue']",Multiple Sclerosis,Terry L. Wahls,[],['United States']
NCT00001160,Studies on Tumors of the Thyroid,Studies on Thyroid Nodules and Thyroid Cancer,RECRUITING,1977-06-01,,,OBSERVATIONAL,,2500,"['Hurthle Cell Thyroid Cancer', 'Tall Cell Variant Thyroid Cancer', 'Follicular Thyroid Cancer', 'Thyroid Cancer', 'Papillary Thyroid Cancer']",Hurthle Cell Thyroid Cancer,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT05150093,Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor,Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor,RECRUITING,2022-06-21,2027-08-31,2027-08-31,INTERVENTIONAL,NA,120,"['Laryngeal Dystonia', 'Spasmodic Dysphonia', 'Tremor', 'Dystonia']",Laryngeal Dystonia,Massachusetts Eye and Ear Infirmary,"['Massachusetts General Hospital', 'University of Utah', 'University of California, San Francisco', 'UMass Memorial Health', 'University of Iowa']",['United States']
NCT06527521,Prevalence of Amyloidosis in Trauma Patients,Prevalence of Amyloidosis in Trauma Patients Using Red Flags Tool,RECRUITING,2024-11-13,2026-08,2026-10,OBSERVATIONAL,,246,['Amyloidosis'],Amyloidosis,Consorci Sanitari de l'Alt Penedès i Garraf,[],['Spain']
NCT07224464,The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.,"Open Label Feasibility Dose Escalation Study to Evaluate the Safety of Sarah Nanotechnology System, With Alternating Magnetic Field (AMF) Application in Patients With Advanced Metastatic Solid Tumors.",RECRUITING,2025-12,2026-12,2030-12,INTERVENTIONAL,NA,9,"['Metastatic Solid Tumors', 'Stage 4 Cancer']",Metastatic Solid Tumors,New Phase Ltd.,[],['United States']
NCT03819803,Fecal Microbiota Transplantation in aGvHD After ASCT,Fecal Microbiota Transplantation in Patients With Acute Gastrointestinal Graft-versus-host-disease After Allogeneic Stem Cell Transplantation,RECRUITING,2017-03-01,2026-03-01,2026-12-31,INTERVENTIONAL,PHASE3,15,['Graft Versus Host Disease in GI Tract'],Graft Versus Host Disease in GI Tract,Medical University of Graz,[],['Austria']
NCT06040970,Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer,"A Single-Center, Open-Label, Single-Arm, Phase I Study With Dose Expansion Cohort of Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer",RECRUITING,2024-10-23,2026-07-01,2027-07-01,INTERVENTIONAL,PHASE1,54,"['Ovarian Cancer', 'Malignant Neoplasm of Uterus']",Ovarian Cancer,Icahn School of Medicine at Mount Sinai,[],['United States']
NCT02981628,Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia,A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL),RECRUITING,2017-06-19,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,80,"['Recurrent B Acute Lymphoblastic Leukemia', 'Recurrent B Lymphoblastic Lymphoma', 'Refractory B Acute Lymphoblastic Leukemia', 'Refractory B Lymphoblastic Lymphoma']",Recurrent B Acute Lymphoblastic Leukemia,Children's Oncology Group,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT03307304,Investigations of Juvenile Neuronal Ceroid Lipofuscinosis,Investigations of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3) and CLN3-Related Conditions,RECRUITING,2017-11-27,2050-12-31,2050-12-31,OBSERVATIONAL,,300,"['Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)', 'Batten Disease']",Juvenile Neuronal Ceroid Lipofuscinosis (CLN3),Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT05381649,Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder,"Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder - Prospective, Longitudinal, Cohort Study",ACTIVE_NOT_RECRUITING,2022-11-20,2026-03,2026-03,OBSERVATIONAL,,30,"['Emotionally Unstable Personality Disorder, Borderline Type']","Emotionally Unstable Personality Disorder, Borderline Type",University of Edinburgh,[],['United Kingdom']
NCT05169515,"A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma","A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Patients With B-Cell Non-Hodgkin Lymphoma",RECRUITING,2022-10-26,2029-09-15,2029-09-15,INTERVENTIONAL,PHASE1,121,['Non-Hodgkin Lymphoma'],Non-Hodgkin Lymphoma,Hoffmann-La Roche,[],"['Israel', 'United States', 'Spain', 'Italy', 'United Kingdom']"
NCT06902246,Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma,Regorafenib and Yttrium-90 Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma,RECRUITING,2026-01-05,2031-01-05,2031-01-05,INTERVENTIONAL,PHASE2,30,"['Unresectable Hepatocellular Carcinoma', 'Hepatocellular Carcinoma']",Unresectable Hepatocellular Carcinoma,University of Miami,['Bayer'],['United States']
NCT02642042,Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer,A Phase II Trial of Trametinib With Docetaxel in Patients With KRAS Mutation Positive Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease Following One or Two Prior Systemic Therapies,ACTIVE_NOT_RECRUITING,2016-07-18,2019-05-15,2026-03-19,INTERVENTIONAL,PHASE2,60,"['KRAS Gene Mutation', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage IV Lung Non-Small Cell Cancer AJCC v7']",KRAS Gene Mutation,National Cancer Institute (NCI),[],['United States']
NCT07042802,A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer,"An Open-label, Multicenter Phase Ib/Ⅱ Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Paclitaxel Injection in Patients With Platinum-resistant Ovarian Cancer",RECRUITING,2025-10-27,2027-12-25,2028-12-25,INTERVENTIONAL,PHASE1,110,['Ovarian Cancer'],Ovarian Cancer,"Nanjing Leads Biolabs Co.,Ltd",[],['China']
NCT07058428,FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma,Fractionated Stereotactic Radiotherapy Combines With Bevacizumab for the Treatment of Multiple Brain Metastases in Lung Adenocarcinoma: a Prospective Controlled Phase III Study,RECRUITING,2025-06-30,2028-12-30,2028-12-30,INTERVENTIONAL,PHASE3,258,['Multiple Brain Metastases in Lung Adenocarcinoma'],Multiple Brain Metastases in Lung Adenocarcinoma,Sun Yet-Sen University Cancer Center,[],['China']
NCT07237971,Cocreating Action to Improve Rationality in the Health System,Cocreating Action to Improve Rationality in the Health System,RECRUITING,2025-10-21,2029-04-01,2029-04-01,INTERVENTIONAL,NA,4000,"['Health-Related Quality-of-Life', 'Social Capital', 'Health Literacy', 'Community Based Participatory Research', 'Antibiotic Prescription', 'Mental Health Literacy', 'Cardio Vascular Disease', 'Antimicrobial Drug Resistance', 'Well-being', 'Health Equity']",Health-Related Quality-of-Life,Universidad Miguel Hernandez de Elche,[],['Spain']
NCT06818201,Effects of tDCS on Motor Cortex During ACL Recovery,Effects of Transcranial Direct Current Stimulation Over Motor Cortex During Recovery of ACL Patients,RECRUITING,2025-11-28,2027-12-27,2027-12-27,INTERVENTIONAL,NA,54,['Anterior Cruciate Ligament Reconstruction Rehabilitation'],Anterior Cruciate Ligament Reconstruction Rehabilitation,Fundación Universidad Católica de Valencia San Vicente Mártir,[],['Spain']
NCT07233980,Therapist-Guided Internet-Delivered CBT for Chronic Conditions: Predictors of Change,Therapist-Guided Internet-Delivered Cognitive Behaviour Therapy (CBT) for Chronic Conditions (Chronic Conditions Course; CCC): Single-Group Predictors of Change in Routine Care,RECRUITING,2025-10-08,2026-10,2026-12,INTERVENTIONAL,NA,260,['Chronic Physical Health Conditions'],Chronic Physical Health Conditions,University of Regina,"['Macquarie University, Australia', 'Government of Saskatchewan, Ministry of Health']",['Canada']
NCT06118281,ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack,ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction,RECRUITING,2024-06-25,2026-09-03,2026-09-03,INTERVENTIONAL,PHASE3,10000,"['Cardiovascular Risk', 'Acute Myocardial Infarction (AMI)']",Cardiovascular Risk,Novo Nordisk A/S,['Duke Clinical Research Institute'],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Australia', 'Israel', 'France', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Mexico', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07203599,A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes,A Randomized Controlled Clinical Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes,RECRUITING,2025-09-20,2026-10-01,2026-11-01,INTERVENTIONAL,PHASE1,59,['Androgenic Alopecia'],Androgenic Alopecia,Shenzhen People's Hospital,[],['China']
NCT05040204,The Effects of Dietary Supplementation on Serum Protein Glycosylation,The Effects of Dietary Supplementation on Serum Protein Glycosylation,RECRUITING,2022-06-23,2026-05-01,2026-09-01,INTERVENTIONAL,PHASE1,44,['Healthy'],Healthy,"University of California, Davis","['National Institutes of Health (NIH)', 'National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)']",['United States']
NCT06511193,"Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]","Chronicling the COPD Patient Journey and Change in Impact of a Single Inhaler Combination Therapy on COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF](CHRONICLES COPD)",ACTIVE_NOT_RECRUITING,2024-09-17,2026-03-31,2026-03-31,OBSERVATIONAL,,149,['Chronic Obstructive Pulmonary Disease (COPD)'],Chronic Obstructive Pulmonary Disease (COPD),AstraZeneca,"['Asthma Research Group Inc.', 'University Health Network, Toronto']",['Canada']
NCT07259733,Rapid Management of Resistant Hypertension in the Public Health System (Fast Control),Strategy for Rapid Control of Apparent Resistant Arterial Hypertension in the Public Health System (FAST Control),RECRUITING,2023-07-15,2026-12-31,2026-12-31,INTERVENTIONAL,NA,142,"['Apparent Resistant Hypertension', 'Hypertension', 'High Blood Pressure']",Apparent Resistant Hypertension,Instituto Dante Pazzanese de Cardiologia,['Servier'],['Brazil']
NCT02890342,"Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia","The Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic Acidemia",RECRUITING,2016-11-29,2036-08-31,2036-08-31,OBSERVATIONAL,,1045,"['Metabolic Disease', 'Propionic Acidemia', 'Organic Acidemia']",Metabolic Disease,National Human Genome Research Institute (NHGRI),[],['United States']
NCT07259889,Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors,A Phase I Clinical Study Evaluating the Safety and Tolerability of CEL001 Injection in the Treatment of Advanced Solid Tumors,RECRUITING,2025-06-16,2028-06-15,2028-06-15,INTERVENTIONAL,PHASE1,13,['Advanced Solid Tumors (Phase 1)'],Advanced Solid Tumors (Phase 1),"Guangzhou Xiling Biotechnology Co., Ltd.",[],['China']
NCT06683742,A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56,"A 2-year Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Wet AMD",ACTIVE_NOT_RECRUITING,2024-11-27,2026-10,2027-10,INTERVENTIONAL,PHASE3,400,"['Wet Age Related Macular Degeneration', 'wAMD']",Wet Age Related Macular Degeneration,"EyePoint Pharmaceuticals, Inc.",[],"['Brazil', 'Israel', 'Hungary', 'India', 'United States', 'Slovakia', 'Czechia', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT07257276,3D-CT-Based Prediction of Difficult Laryngoscopy in Infants With Pierre Robin Sequence,A 3D-CT-Based Dual-parameter Model for Predicting Difficult Laryngoscopy in Infants With Pierre Robin Sequence: Internal and Temporal External Validation,ACTIVE_NOT_RECRUITING,2023-01-01,2024-12-31,2025-12-31,OBSERVATIONAL,,294,"['Pierre Robin Sequence (PRS)', 'Difficult Laryngoscopy', 'Airway Management']",Pierre Robin Sequence (PRS),Nanjing Children's Hospital,[],['China']
NCT06965322,Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis,Prospective Observational Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis,RECRUITING,2024-11-11,2028-05-30,2029-09-30,OBSERVATIONAL,,800,"['Rheumatic Arthritis', 'Interstitial Lung Disease in Patients With Rheumatoid Arthritis']",Rheumatic Arthritis,Medical University Innsbruck,[],['Austria']
NCT04542824,Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL),"Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3×CD20) in Japanese Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - A Phase 1/2, Open-Label, Dose-Escalation Trial With Expansion Cohorts",ACTIVE_NOT_RECRUITING,2020-08-20,2027-09,2027-09,INTERVENTIONAL,PHASE1,78,"['Diffuse Large B Cell Lymphoma', 'High-grade B-cell Lymphoma', 'Primary Mediastinal Large B Cell Lymphoma', 'Follicular Lymphoma', 'Marginal Zone Lymphoma', 'Small Lymphocytic Lymphoma']",Diffuse Large B Cell Lymphoma,Genmab,['AbbVie'],['Japan']
NCT07180407,The Post-ICU Pain Study,"The Post-ICU Pain Study: a Multicenter, Prospective, Inception Cohort Study",RECRUITING,2025-09-23,2027-01,2027-06,OBSERVATIONAL,,800,"['Chronic Pain', 'Post Intensive Care Unit Syndrome', 'Quality of Life', 'Pain Disorder']",Chronic Pain,Zealand University Hospital,['Aalborg University Hospital'],['Denmark']
NCT06086145,Biomarker-estimated Flavanol Intake in Davis (FID),Flavanol Intake in Davis (FID) Study: Biomarker-estimated Habitual (-)-Epicatechin and Flavanol Intake in Adults,RECRUITING,2023-11-02,2026-06,2026-06,OBSERVATIONAL,,200,"['Healthy', 'Diet', 'Adults']",Healthy,"University of California, Davis","['Mars, Inc.']",['United States']
NCT06605807,Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions,Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions: Aim 3,RECRUITING,2025-11-13,2026-03,2026-06-30,INTERVENTIONAL,NA,150,"['Prescribing Decisions', 'Diabetes', 'Multimorbidity', 'Hypertension', 'Geriatrics']",Prescribing Decisions,University of Pittsburgh,['National Institute on Aging (NIA)'],['United States']
NCT06333314,Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI,Dostarlimab as First-line Treatment for Patients With dMMR/MSI (Non-colorectal/Non-endometrial) Locally Advanced or Metastatic Cancer: a Randomized Phase 2 Trial (Cohort Pan-MSI ACSE) With Crossover in the Standard Arm at Progression,RECRUITING,2024-07-23,2028-10,2030-09,INTERVENTIONAL,PHASE2,120,"['Pancreatic Adenocarcinoma', 'Ampulla of Vater Carcinoma', 'Adrenocortical Carcinoma', 'Neuroendocrine Carcinoma', 'Soft Tissue Sarcoma', 'Small Bowel Adenocarcinoma', 'Duodenum Adenocarcinoma', 'Gastric Adenocarcinoma']",Pancreatic Adenocarcinoma,UNICANCER,"['National Cancer Institute, France', 'GlaxoSmithKline']",['France']
NCT07196787,Exercise Therapy for Isotretinoin Users,Prophylactic Exercise Therapy for Musculoskeletal Side Effects in Isotretinoin Users: A Controlled Study,RECRUITING,2025-09-30,2026-02-06,2026-03-26,INTERVENTIONAL,NA,160,"['Isotretinoin', 'Isotretinoin Adverse Reaction']",Isotretinoin,Uşak University,[],['Turkey (Türkiye)']
NCT07235059,"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease","A Participant- and Investigator--Blinded, Placebo- Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease",RECRUITING,2025-11-20,2027-07-19,2027-07-19,INTERVENTIONAL,PHASE1,112,['Chronic Kidney Disease'],Chronic Kidney Disease,Novartis Pharmaceuticals,[],['United States']
NCT07224906,Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization,Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart,RECRUITING,2025-12-01,2026-03-06,2026-03-30,OBSERVATIONAL,,50,"['Pulmonary Hypertension', 'Congestive Heart Failure(CHF)', 'Valve Disease, Heart']",Pulmonary Hypertension,HemoCept Inc.,[],['United States']
NCT04787263,CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML,Phase I/II Study of Anti-CD19 Chimeric Antigen Receptor-Expressing T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia and Diffuse Large B Cell Lymphoma (DLBCL) or Primary Mediastinal B Cell Lymphoma (PML),ACTIVE_NOT_RECRUITING,2021-03-04,2027-03,2038-03-03,INTERVENTIONAL,PHASE1,32,"['Acute Lymphoblastic Leukemia', 'Diffuse Large B Cell Lymphoma', 'Primary Mediastinal Lymphoma']",Acute Lymphoblastic Leukemia,Bambino Gesù Hospital and Research Institute,[],['Italy']
NCT06211504,Sinus Tarsi Implant as an Adjuvant Procedure to Medial Displacement Calcaneal Osteotomy in the Treatment of Mobile Adult Acquired Flatfoot Deformity,Sinus Tarsi Implant as an Adjuvant Procedure to Medial Displacement Calcaneal Osteotomy in the Treatment of Mobile Adult Acquired Flatfoot Deformity: a Randomized Controlled Trial,RECRUITING,2024-07-31,2027-12-31,2029-12-31,INTERVENTIONAL,PHASE4,130,"['Acquired Adult Flatfoot Deformity', 'Flat Foot', 'Flexible Flatfoot']",Acquired Adult Flatfoot Deformity,Region Skane,[],['Sweden']
NCT04192773,An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus,An fMRI Investigation of the Effects of IV Lidocaine on Tinnitus,RECRUITING,2021-04-28,2027-12-31,2027-12-31,INTERVENTIONAL,EARLY_PHASE1,40,['Tinnitus'],Tinnitus,"D. Bradley Welling, MD, PhD",[],['United States']
NCT06064903,CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL,Phase I/II Study of Anti-CD7 Chimeric Antigen Receptor-Expressing T Cells in Pediatric Patients Affected by Relapsed/Refractory CD7+ T-cell Acute Lymphoblastic Leukemia/Lymphoma,RECRUITING,2024-04-21,2028-09-30,2040-09-30,INTERVENTIONAL,PHASE1,26,['T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma'],T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma,Bambino Gesù Hospital and Research Institute,[],['Italy']
NCT06788990,"FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC","A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",RECRUITING,2025-01-28,2028-04,2029-07,INTERVENTIONAL,PHASE2,650,"['Metastatic Head and Neck Squamous Cell Carcinoma', 'Recurrent Head and Neck Squamous Cell Carcinoma']",Metastatic Head and Neck Squamous Cell Carcinoma,Bicara Therapeutics,[],"['New Zealand', 'United States', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Portugal', 'Australia']"
NCT07109726,A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations,A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations,RECRUITING,2025-09-23,2028-12-30,2029-02-28,INTERVENTIONAL,PHASE1,205,"['Breast Cancer', 'Endometrial Cancer', 'Ovarian Cancer', 'Lung Squamous Cell Carcinoma', 'Head and Neck Squamous Cell Carcinoma', 'Esophageal Squamous Cell Carcinoma', 'Solid Tumor', 'Cervical Cancer']",Breast Cancer,Terremoto Biosciences Inc.,[],"['Puerto Rico', 'United States']"
NCT06801067,A Study of SER-155 to Treat Diarrhea in People on Immunotherapy,"A Single-Arm, Open-Label, Phase 1 Study to Assess Safety and Preliminary Efficacy of Cultivated Multi-Strain Live Bacterial Therapeutic SER-155 for First-Line Treatment of Immunotherapy-Related Enterocolitis",RECRUITING,2025-01-24,2027-01-24,2027-01-24,INTERVENTIONAL,PHASE1,15,"['Diarrhea', 'Enterocolitis']",Diarrhea,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT05588128,Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL,A Study of Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18F-DCFPyL,RECRUITING,2023-03-21,2026-12-31,2027-12-31,OBSERVATIONAL,,350,"['Prostate Cancer', 'Biochemically Recurrent']",Prostate Cancer,National Cancer Institute (NCI),[],['United States']
NCT04241328,Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery,SYMBIOSIS Post-Market Registry,RECRUITING,2020-01-09,2026-12-31,2026-12-31,OBSERVATIONAL,,5000,['Cardiovascular Diseases'],Cardiovascular Diseases,Medtronic Cardiac Surgery,[],"['Belgium', 'Netherlands', 'Norway', 'Austria', 'France', 'Spain', 'Greece', 'Germany']"
NCT06405087,A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD),A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease,RECRUITING,2025-10-27,2032-01-26,2032-01-26,INTERVENTIONAL,PHASE3,70,"['Ulcerative Colitis', ""Crohn's Disease""]",Ulcerative Colitis,Takeda,[],['Japan']
NCT06896916,Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma,Phase 1/2 Study of Etentamig in Combination With a CELMoD Agent for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma,RECRUITING,2025-08-07,2036-03,2036-03,INTERVENTIONAL,PHASE1,135,['Multiple Myeloma'],Multiple Myeloma,AbbVie,[],"['Japan', 'Netherlands', 'Norway', 'United States', 'France', 'Canada', 'Australia']"
NCT06769347,Circulating Vascular Regenerative Cell Exhaustion in Individuals Without Type 2 Diabetes Who Are of South Asian or European Origins,Circulating Vascular Regenerative Cell Exhaustion in Individuals Without Type 2 Diabetes Who Are of South Asian or European Origins,RECRUITING,2025-01-30,2029-01,2029-01,OBSERVATIONAL,,120,['Cardiovascular Diseases Risk'],Cardiovascular Diseases Risk,Canadian Medical and Surgical Knowledge Translation Research Group,"['Unity Health Toronto', 'Western University, Canada']",['Canada']
NCT06698458,Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer,A Study to Assess the Safety of Intratumoral Diffusing Alpha Radiation Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer,RECRUITING,2025-06-17,2026-10,2026-12,INTERVENTIONAL,NA,30,"['Pancreatic Cancer', 'Pancreatic Adenocarcinoma', 'Metastatic Pancreatic Cancer']",Pancreatic Cancer,Alpha Tau Medical LTD.,[],"['Israel', 'United States', 'Canada']"
NCT07259005,Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety,Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety,RECRUITING,2025-04-10,2027-04-10,2028-04-10,INTERVENTIONAL,NA,96,['Social Anxiety'],Social Anxiety,Maastricht University,[],['Netherlands']
NCT00071526,Urinary Vitamin C Loss in Diabetic Subjects,Urinary Vitamin C Loss in Subjects With and Without Diabetes,RECRUITING,2006-04-11,,,OBSERVATIONAL,,5000,['Diabetes'],Diabetes,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT04452955,A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors,"An Open Label, Multicenter, Safety and Efficacy Phase 2 Study of PRL3-Zumab in Solid Tumors",ACTIVE_NOT_RECRUITING,2020-12-12,2026-03-01,2026-03-01,INTERVENTIONAL,PHASE2,51,['Solid Tumor'],Solid Tumor,Intra-IMMUSG Pte Ltd,['Parexel'],['United States']
NCT06488404,Implementation Science to Improve School Ethos for Mental Health,Improving School Ethos Towards Mental Health Through Whole School Mental Health Interventions: Implementation Science Approach,ACTIVE_NOT_RECRUITING,2024-06-01,2025-04-30,2025-12-31,OBSERVATIONAL,,50,['Mental Health Issue'],Mental Health Issue,University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', 'Schizophrenia Research Foundation (SCARF India), Chennai, India']",['India']
NCT05626816,Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury,Short-term Genital Nerve Stimulation to Modulate Anorectal Reflex Activity in Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury,RECRUITING,2023-03-21,2025-12-31,2025-12-31,INTERVENTIONAL,NA,52,['Fecal Incontinence'],Fecal Incontinence,MetroHealth Medical Center,"['VA of Northeast Ohio Health System', 'Congressionally Directed Medical Research Programs']",['United States']
NCT00024635,Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers,The Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers,RECRUITING,2001-02-02,,,OBSERVATIONAL,,16000,"['Mood Disorders', 'Anxiety Disorders', 'Healthy Volunteers', 'Bipolar Disorder', 'Depression']",Mood Disorders,National Institute of Mental Health (NIMH),['Suburban Hospital'],['United States']
NCT05527184,First in Human Study of IMGN151 in Recurrent Gynaecological Cancers,"A Phase 1, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGN151 (Anti-FRα Antibody-drug Conjugate) in Adult Patients With Recurrent Gynaecological Cancers",RECRUITING,2023-01-11,2027-02,2027-02,INTERVENTIONAL,PHASE1,423,"['Endometrial Cancer', 'High Grade Serous Adenocarcinoma of Ovary', 'Primary Peritoneal Carcinoma', 'Fallopian Tube Cancer', 'Cervical Cancer']",Endometrial Cancer,AbbVie,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Germany', 'Ireland', 'Spain', 'Italy', 'Canada', 'Australia']"
NCT07259278,Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients,Artificial Intelligence-enhanced Stratified Management Platform Guiding Home-based Exercise Rehabilitation for Coronary Heart Disease Patients: a Randomized Control Trial,RECRUITING,2025-12-01,2026-11-30,2026-11-30,INTERVENTIONAL,NA,200,['Secondary Prevention of Coronary Heart Disease'],Secondary Prevention of Coronary Heart Disease,China National Center for Cardiovascular Diseases,['Chinese Academy of Medical Sciences'],['China']
NCT00104325,Cytapheresis of Volunteer Donors,Cytapheresis of Volunteer Donors,RECRUITING,2003-01-30,,,OBSERVATIONAL,,10000,['Healthy Volunteers'],Healthy Volunteers,National Institute on Aging (NIA),[],['United States']
NCT00001979,Immune System Related Kidney Disease,Studies of Immunologically-Mediated Kidney Diseases,RECRUITING,1992-06-25,,,OBSERVATIONAL,,2000,"['Kidney Disease', 'Nephrotic Syndrome']",Kidney Disease,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT02535702,Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction,Development of Neuroimaging Methods to Assess the Neurobiology of Addiction,RECRUITING,2016-06-28,2025-12-31,2026-12-31,INTERVENTIONAL,NA,192,['Normal Physiology'],Normal Physiology,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT07001475,A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder,"A Phase Ib, Multicentre, Randomised, Double Blind, Placebo Controlled, 2 Sequence Crossover Trial to Evaluate the Effects of BI 3031185 on Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder",RECRUITING,2025-08-12,2026-04-27,2026-05-27,INTERVENTIONAL,PHASE1,96,"['Borderline Personality Disorder', 'Attention Deficit Hyperactivity Disorder']",Borderline Personality Disorder,Boehringer Ingelheim,[],['Germany']
NCT06907134,"The Purpose of the Study is to Investigate if a Smartphone App Combined With Internet Based Cognitive Behavioural Therapy (ICBT) Leads to Improved Symtoms in Depressive Adults on Antidepressive Medicine, Compared to a Wait-list Control Condition",A Controlled Trial of Smartphone-delivered Cognitive Behavioral Therapy for Adults Treated With Medication for Depressive Symptoms,ACTIVE_NOT_RECRUITING,2024-11-02,2026-06-01,2028-09-01,INTERVENTIONAL,NA,150,['Depressive Symptoms'],Depressive Symptoms,Linkoeping University,[],['Sweden']
NCT04278651,Early Antenatal Support for Iron Deficiency Anemia,Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy,RECRUITING,2021-09-29,2026-08-30,2026-12-30,INTERVENTIONAL,PHASE4,80,"['Pregnancy Related', 'Anemia, Iron Deficiency', 'Anemia of Pregnancy']",Pregnancy Related,Thomas Jefferson University,['Auerbach Hematology and Oncology'],['United States']
NCT04611516,The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD),The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD),RECRUITING,2020-03-02,2030-12,2040-12,OBSERVATIONAL,,1000,"['Primary Ciliary Dyskinesia', 'Kartagener Syndrome']",Primary Ciliary Dyskinesia,University of Bern,"['Bicetre Hospital', 'Centre Hospitalier Intercommunal Creteil', 'University Hospital Southampton NHS Foundation Trust', 'Universitaire Ziekenhuizen KU Leuven', 'Amsterdam UMC, location VUmc', 'University of Cyprus', 'Hacettepe University', 'Marmara University', 'Hospital Universitario La Fe', 'Insel Gruppe AG, University Hospital Bern']",['Switzerland']
NCT06102434,Safety Profile of Psilocybin for Cocaine Use Disorder,Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder,RECRUITING,2025-12-01,2026-05,2026-06,INTERVENTIONAL,EARLY_PHASE1,10,['Cocaine Use Disorder'],Cocaine Use Disorder,"University of California, Los Angeles",[],['United States']
NCT06840821,"Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors","A Phase I/II, Multicenter, Open-label, Single-arm, Dose-escalation and Dose-expansion Study Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 Sequential Therapy in Adult Subjects With Advanced Solid Tumors (Including Gastroenteropancreatic Neuroendocrine Neoplasms, Small Cell Lung Cancer or Triple Negative Breast Cancer)",RECRUITING,2025-05-08,2028-07-04,2028-07-04,INTERVENTIONAL,PHASE1,156,['Advanced Solid Tumors'],Advanced Solid Tumors,"Mainline Biosciences (Shanghai) Co., Ltd",[],['China']
NCT07085767,Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer,"A Phase 3 Randomized, Double-Blind, Active-Controlled Study of Palazestrant With Ribociclib Versus Letrozole With Ribociclib for the First-Line Treatment of ER+, HER2- Advanced Breast Cancer (OPERA-02)",RECRUITING,2025-11-03,2028-12,2032-01,INTERVENTIONAL,PHASE3,1000,"['Breast Cancer', 'Locally Advanced Breast Cancer', 'Metastatic Breast Cancer', 'ER Positive Breast Cancer', 'HER2 Negative Breast Carcinoma']",Breast Cancer,"Olema Pharmaceuticals, Inc.",['Novartis Pharmaceuticals'],"['United States', 'Australia']"
NCT06191744,Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma,"A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)",RECRUITING,2024-02-05,2037-11,2037-11,INTERVENTIONAL,PHASE3,1095,['Follicular Lymphoma (FL)'],Follicular Lymphoma (FL),Genmab,['AbbVie'],"['Bulgaria', 'Japan', 'New Zealand', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Croatia', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'South Africa', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Serbia']"
NCT05664412,Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion Syndrome,Using Transcranial Alternating Current Stimulation With Starstim Home Device to Improve Executive Function in Youths With 22q11.2 Deletion Syndrome: A Randomized Double-blind Sham-controlled Study,RECRUITING,2023-10-20,2026-12-31,2026-12-31,INTERVENTIONAL,NA,40,"['22Q11 Deletion Syndrome', 'tACS']",22Q11 Deletion Syndrome,Stephan Eliez,[],['Switzerland']
NCT07258628,Comparison of Fentanyl and Magnesium to Control Reflex Hemodynamics in Patients Aged 50 and Older,Magnesium and Fentanyl in Preventing Reflex Hemodynamic Response to Endotracheal Intubation in Patients Aged 50 Years and Older,RECRUITING,2025-10-10,2026-01-10,2026-01-30,INTERVENTIONAL,NA,75,"['Hypertension', 'Tachycardia']",Hypertension,Ankara City Hospital Bilkent,[],['Turkey (Türkiye)']
NCT06853431,Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia,Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia,RECRUITING,2025-03-01,2025-11-30,2025-11-30,INTERVENTIONAL,PHASE4,80,"['Preoperative Anxiety', 'Preoperative Sedation', 'Children', 'Dexmedetomidine', 'Esketamine', 'ED95', 'ED50', 'Preoperative Sedation of Children']",Preoperative Anxiety,Second Affiliated Hospital of Wenzhou Medical University,[],['China']
NCT07114419,The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE）,"A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Efsubaglutide Alfa Injection in Subjects With Overweight or Obesity",RECRUITING,2025-08-25,2026-06-01,2026-08-01,INTERVENTIONAL,PHASE2,200,['Obesity and Overweight'],Obesity and Overweight,"Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.",[],['Australia']
NCT07258030,Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting,Development of a Decision Algorithm for Vital Sign Assessment in the Outpatient Physical Therapy Setting: An e-Delphi Study,RECRUITING,2025-11-21,2026-03-31,2026-04,OBSERVATIONAL,,100,['Healthy'],Healthy,Youngstown State University,[],['United States']
NCT06249269,Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study,Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study,RECRUITING,2024-05-01,2026-12,2027-03,OBSERVATIONAL,,198,"['Atrial Fibrillation, Paroxysmal or Persistent']","Atrial Fibrillation, Paroxysmal or Persistent",Ratika Parkash,['Nova Scotia Health Research Fund'],['Canada']
NCT05642819,REVOLUTION Surgery (REVOLUTION Surgery),Routine Evaluation of People Living With Cancer - Surgery,RECRUITING,2023-10-01,2027-12,2027-12,OBSERVATIONAL,,200,"['Cachexia', 'Oesophageal Cancer', 'Gastric Cancer', 'Pancreatic Cancer', 'Colorectal Cancer']",Cachexia,University of Edinburgh,['NHS Lothian'],['United Kingdom']
NCT05329129,"OssDsign® Spine Registry Study (""Propel"")",PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE,RECRUITING,2022-03-23,2027-03-23,2027-04-01,OBSERVATIONAL,,450,"['Degenerative Disc Disease', 'Spinal Stenosis']",Degenerative Disc Disease,OssDsign,[],['United States']
NCT05738824,Natural History of Inflammatory Muscle Diseases,Natural History of Inflammatory Muscle Diseases,RECRUITING,2023-06-01,2032-02-25,2032-02-25,OBSERVATIONAL,,500,['Inflammation In Skeletal Muscle'],Inflammation In Skeletal Muscle,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT04255303,Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support,Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Implementation of Nurse Driven Clinical Decision Support,ACTIVE_NOT_RECRUITING,2022-02-23,2025-06-15,2025-12-15,INTERVENTIONAL,NA,347,['Acute Respiratory Infection'],Acute Respiratory Infection,NYU Langone Health,['National Institute of Allergy and Infectious Diseases (NIAID)'],['United States']
NCT07173088,Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture,Efficacy and Clinical Feasibility of the Ankle Muscle Power (AMP) Program for Return to Duty After an Ankle Fracture,RECRUITING,2025-11-13,2028-03,2028-03,INTERVENTIONAL,NA,60,['Ankle Fractures'],Ankle Fractures,Brian W. Noehren,[],['United States']
NCT07200375,An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma,"Evaluating Effectiveness and Safety of Glofitamab Based Second-Line Therapy in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter, Cohort Study",RECRUITING,2025-09-29,2029-09-29,2029-09-29,OBSERVATIONAL,,300,['Diffuse Large B-Cell Lymphoma'],Diffuse Large B-Cell Lymphoma,Hoffmann-La Roche,[],['China']
NCT06973161,ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors,External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors (ESPERANZA),RECRUITING,2025-06-10,2026-04-30,2026-04-30,OBSERVATIONAL,,384,"['Bladder Cancer', 'Biliary Tract Cancer', 'Cervical Cancer', 'Endometrial Cancer', 'Ovarian Cancer', 'Pancreatic Cancer', 'Colorectal Cancer', 'Lung Cancer', 'Other Tumors']",Bladder Cancer,AstraZeneca,"['Daiichi Sankyo', 'Iqvia Pty Ltd']","['Belgium', 'Austria', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Portugal', 'Germany']"
NCT03999229,S-Nitrosylation (SNO) Therapy During Autologous Blood Transfusion,Phase 1 Study of S-Nitrosylation Therapy to Improve Tissue Oxygenation During Autologous Blood Transfusion in Healthy Volunteer,RECRUITING,2019-07-25,2028-02-29,2028-02-29,INTERVENTIONAL,PHASE1,35,['Transfusion Related Complication'],Transfusion Related Complication,James Reynolds,"['Case Western Reserve University', 'National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06985953,Evaluating the Communication Between Patients and Providers in Cancer Clinics,Evaluating the Impact of TrialTalkTM; to Foster Equitable Cancer Care,RECRUITING,2025-12,2026-06,2026-06,INTERVENTIONAL,NA,30,['Cancer'],Cancer,"University of Wisconsin, Madison",['Alliance for Clinical Trials in Oncology'],['United States']
NCT06110975,Deprescribing dRrugs for Overactive Bladder in General Practice (DROP),Deprescribing dRugs for Overactive Bladder in the Elderly in General Practice - a Randomized Controlled Trial With a Nested Mixed Methods Study,ACTIVE_NOT_RECRUITING,2023-12-01,2025-12-01,2026-12-01,INTERVENTIONAL,NA,72,"['Overactive Bladder', 'Deprescribing', 'PIMS']",Overactive Bladder,Anne Estrup Olesen,['University College of Northern Denmark'],['Denmark']
NCT06748222,E-Mindfulness Approaches for Living After Breast Cancer,Harnessing E-Mindfulness Approaches for Living After Breast Cancer-HEAL-ABC,RECRUITING,2025-06-12,2029-02-28,2030-02-28,INTERVENTIONAL,PHASE3,402,"['Breast Cancer', 'Depression']",Breast Cancer,NRG Oncology,['National Cancer Institute (NCI)'],"['Puerto Rico', 'United States']"
NCT01712620,Spironolactone for Pulmonary Arterial Hypertension,A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension,RECRUITING,2014-01-10,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,70,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,National Institutes of Health Clinical Center (CC),"['National Heart, Lung, and Blood Institute (NHLBI)', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'University of Pennsylvania', 'University of Maryland, Baltimore', 'Medstar Health Research Institute', 'New England Medical Center, Tufts University School of Medicine']",['United States']
NCT01470105,Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases,Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases,ACTIVE_NOT_RECRUITING,2011-11,2026-11,2026-11,OBSERVATIONAL,,230,['Bone Metastases'],Bone Metastases,Memorial Sloan Kettering Cancer Center,['Montefiore Medical Center'],['United States']
NCT06588868,Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma,Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma: an Observational Retrospective Multicenter Study,RECRUITING,2025-02-27,2026-07,2026-07,OBSERVATIONAL,,400,"['Cutaneous T Cell Lymphoma', 'Cutaneous T-Cell Lymphoma/Mycosis Fungoides', 'Cutaneous T-Cell Lymphoma/Sezary Syndrome']",Cutaneous T Cell Lymphoma,Fondazione Italiana Linfomi - ETS,['Takeda'],['Italy']
NCT06953960,A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM),"A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of the BCL-2 Inhibitor ABBV-453 Given as Monotherapy or in Combination With Antimyeloma Regimens in Subjects With Multiple Myeloma",RECRUITING,2025-07-23,2030-12,2030-12,INTERVENTIONAL,PHASE1,130,['Multiple Myeloma'],Multiple Myeloma,AbbVie,[],"['Belgium', 'Japan', 'Israel', 'United States', 'Portugal', 'Australia']"
NCT05114746,Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan,"A Prospective, Open Label, Multicenter, Single Arm, Phase 2 Study of 177Lu-PSMA-617 in the Treatment of Participants With Progressive PSMA- Positive Metastatic Castration-resistant Prostate Cancer (mCRPC) in Japan",RECRUITING,2022-01-25,2023-12-08,2026-04-30,INTERVENTIONAL,PHASE2,110,['Prostate Cancer'],Prostate Cancer,Novartis Pharmaceuticals,['Eckert & Ziegler Radiopharma GmbH'],['Japan']
NCT07259174,Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease,Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease,RECRUITING,2025-10-14,2026-10,2026-12,OBSERVATIONAL,,186,['COPD'],COPD,Isala,[],['Netherlands']
NCT07175077,"7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)","7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)",RECRUITING,2025-11-01,2027-09,2027-09,OBSERVATIONAL,,20,"['Small-cell Lung Cancer', 'Brain Metastases']",Small-cell Lung Cancer,University of Missouri-Columbia,['Siemens Medical Solutions'],['United States']
NCT06934889,Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma,Phase Ib Trial of ABBV-637 or ABBV-155 in Combination With ERAS-801 for Glioblastoma With Amplification of the Epidermal Growth Factor Receptor,RECRUITING,2025-04-07,2028-04,2028-04,INTERVENTIONAL,PHASE1,60,"['Glioblastoma', 'Gliosarcoma']",Glioblastoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT02728817,Evaluation of the Radial Artery Deviation And Reimplantation Technique for Primary Hemodialysis Access Creation,Evaluation of the Radial Artery Deviation And Reimplantation Technique for Primary Hemodialysis Access Creation: a Multicenter Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2017-04-12,2018-04-12,2026-09-09,INTERVENTIONAL,NA,200,['End-stage Renal Disease'],End-stage Renal Disease,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06619236,Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer,"A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer",RECRUITING,2025-02-07,2027-02,2028-05-23,INTERVENTIONAL,PHASE3,530,['Platinum-resistant Ovarian Cancer'],Platinum-resistant Ovarian Cancer,Genmab,[],"['Belgium', 'Japan', 'Netherlands', 'Norway', 'Austria', 'United States', 'France', 'Germany', 'Puerto Rico', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'Greece', 'Poland', 'Australia']"
NCT05786716,"DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations","DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations.",RECRUITING,2023-03-07,2029-10,2029-10,INTERVENTIONAL,PHASE2,30,"['Haematological Malignancy', 'Colorectal Neoplasms', 'Urinary Bladder Neoplasm', 'Gallbladder Neoplasms', 'Salivary Gland Neoplasm', 'Lung Neoplasm', 'Pancreatic Neoplasm', 'Ovarian Neoplasms', 'Prostatic Neoplasm', 'Skin Neoplasm', 'Solid Tumour']",Haematological Malignancy,Cancer Research UK,"['University of Manchester', 'University of Birmingham', 'Royal Marsden NHS Foundation Trust', 'Hoffmann-La Roche']",['United Kingdom']
NCT05659251,Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma,"A Prospective, Single-arm, Single-center, Exploratory Study of the Safety and Efficacy of Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma",ACTIVE_NOT_RECRUITING,2022-12-01,2024-10-31,2029-12-31,INTERVENTIONAL,PHASE2,48,"['Esophageal Squamous Cell Carcinoma', 'Neoadjuvant Therapy']",Esophageal Squamous Cell Carcinoma,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT07042165,Treatment of Bile Acid Diarrhoea With Atorvastatin,"Treatment of Bile Acid Diarrhoea With Atorvastatin (BASTA): A Randomised, Double-Blind, Placebo-Controlled, Crossover, Investigator-Initiated Trial",RECRUITING,2025-10-15,2026-12,2026-12,INTERVENTIONAL,PHASE4,20,"['Bile Acid Diarrhea', 'Bile Acid Malabsorption']",Bile Acid Diarrhea,"Asger Lund, MD","['Fonden til Lægevidenskabens Fremme', 'Prosektor Axel Søeborg Ohlsens Mindelegat', ""Læge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat"", 'Aase and Ejnar Danielsens Foundation']",['Denmark']
NCT04063501,Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer,Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer,RECRUITING,2021-02-09,2026-12,2027-02,OBSERVATIONAL,,48,['Lung Cancer'],Lung Cancer,NYU Langone Health,['National Cancer Institute (NCI)'],['United States']
NCT07257809,Herombopag Treated T-DM1 Induced Platelet Reduction,"A Multicenter, Single-arm Exploratory Clinical Study Evaluating the Efficacy and Safety of T-DM1 in Patients With Breast Cancer Who Developed Thrombocytopenia.",RECRUITING,2025-10-13,2026-09-26,2027-09-26,INTERVENTIONAL,PHASE2,56,['Thrombocytopenia'],Thrombocytopenia,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT06066138,A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing,A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing,RECRUITING,2025-11-04,2026-01-31,2027-01-31,INTERVENTIONAL,PHASE1,40,"['Locally Advanced Alveolar Soft Part Sarcoma', 'Metastatic Alveolar Soft Part Sarcoma', 'Locally Advanced Non Small Cell Lung Cancer', 'Metastatic Non Small Cell Lung Cancer', 'Locally Advanced Small Cell Lung Cancer', 'Metastatic Small Cell Lung Cancer', 'Locally Advanced Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma', 'Locally Advanced Melanoma', 'Metastatic Melanoma']",Locally Advanced Alveolar Soft Part Sarcoma,National Cancer Institute (NCI),[],['United States']
NCT06202248,A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer,A Feasibility and Safety Study of Focal Interstitial Radiotherapy Using Diffusing Alpha Emitters Radiation Therapy (DaRT) Seeds in Men With Non-metastatic Locally Recurrent Prostate Cancer.,RECRUITING,2024-03-12,2027-06,2027-06,INTERVENTIONAL,NA,10,"['Non-metastatic Prostate Cancer', 'Locally Recurrent Prostate Cancer']",Non-metastatic Prostate Cancer,Alpha Tau Medical LTD.,[],['Israel']
NCT05696626,Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation,"An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation",RECRUITING,2023-10-31,2027-04,2028-04,INTERVENTIONAL,PHASE3,500,['Metastatic Breast Cancer'],Metastatic Breast Cancer,Sermonix Pharmaceuticals Inc.,[],"['Singapore', 'Belgium', 'Israel', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Romania', 'South Korea', 'Poland', 'United Kingdom', 'Australia']"
NCT04663347,Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL),"A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Combination With Other Agents in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)",ACTIVE_NOT_RECRUITING,2020-11-03,2028-09-30,2028-09-30,INTERVENTIONAL,PHASE1,543,"['Diffuse Large B-Cell Lymphoma', 'Follicular Lymphoma']",Diffuse Large B-Cell Lymphoma,Genmab,['AbbVie'],"['Belgium', 'Netherlands', 'Norway', 'United States', 'France', 'Finland', 'Denmark', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Sweden', 'Australia']"
NCT06700616,A Study in Patients With Myasthenia Gravis in China,"A Multicenter, Prospective Cohort Study in Patients With Myasthenia Gravis in China",ACTIVE_NOT_RECRUITING,2024-09-26,2027-12-30,2027-12-30,OBSERVATIONAL,,1199,['Myasthenia Gravis'],Myasthenia Gravis,AstraZeneca,[],['China']
NCT07247448,The Analgesic Efficacy of Pecto-Intercostal Fascial Block Combined With Pectoral Nerve Block II Versus Serratus Plane Block in Modified Radical Mastectomy,The Analgesic Efficacy of Pecto-Intercostal Fascial Block Combined With Pectoral Nerve Block II Versus Serratus Plane Block in Modified Radical Mastectomy,ACTIVE_NOT_RECRUITING,2025-10-15,2026-11,2026-11,INTERVENTIONAL,NA,70,['Pain Management'],Pain Management,Assiut University,[],['Egypt']
NCT06852963,"A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001","A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 (30 μg and 75 μg) Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 in the PLATYPUS Study (Protocol # VP001-101) or WALLABY Study (Protocol # VP001-102) for a Minimum of 8 Weeks",RECRUITING,2025-06-01,2028-01-30,2028-03-03,INTERVENTIONAL,PHASE1,16,"['Retinitis Pigmentosa 11', 'Retinal Degeneration', 'Retinal Disease', 'Eye Diseases Hereditary', 'Retinal Dystrophies']",Retinitis Pigmentosa 11,PYC Therapeutics,[],['United States']
NCT06525987,Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD),Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD): a Randomized Clinical Trial,RECRUITING,2025-05-02,2026-12-31,2026-12-31,INTERVENTIONAL,NA,60,"['Lacunar Stroke', 'Small Vessel Cerebrovascular Disease']",Lacunar Stroke,University of L'Aquila,['Fondazione Policlinico Universitario Agostino Gemelli IRCCS'],['Italy']
NCT04950309,Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array,Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array,RECRUITING,2022-05-12,2026-08-01,2026-08-01,INTERVENTIONAL,NA,75,['Normal Physiology'],Normal Physiology,National Institute of Mental Health (NIMH),[],['United States']
NCT06785909,"Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain.","The Role of Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain in Pregnant Women.",RECRUITING,2025-03-03,2028-09-01,2028-12-31,INTERVENTIONAL,NA,211,"['Low Back Pain', 'Lumbopelvic Pain', 'Pelvic Girdle Pain']",Low Back Pain,Hasselt University,['KU Leuven'],['Belgium']
NCT07140016,A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC),A Phase 1b Study of Gilteritinib in Participants With Locally Advanced or Metastatic NSCLC With ALK Rearrangement After Prior Treatment With an ALK Inhibitor,RECRUITING,2025-09-22,2029-12-31,2029-12-31,INTERVENTIONAL,PHASE1,40,"['Non-small Cell Lung Cancer (NSCLC)', 'Anaplastic Lymphoma Kinase (ALK) Positive']",Non-small Cell Lung Cancer (NSCLC),"Astellas Pharma Global Development, Inc.",[],['United States']
NCT00044304,Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome,Efficacy of Tyrosine Kinase Inhibition in Reducing Eosinophilia in Patients With Myeloid and/or Steroid-Refractory Hypereosinophilic Syndrome,RECRUITING,2002-09-26,2026-01-01,2026-01-01,INTERVENTIONAL,PHASE2,60,"['Eosinophilic Myeloid Neoplasm', 'Hypereosinophilic Syndrome']",Eosinophilic Myeloid Neoplasm,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06699134,Hi-Fatigue G Bone Cement Retrospective Study,Evaluation of Hi-Fatigue G Bone Cement With Gentamicin A Retrospective Data Collection,RECRUITING,2024-11-19,2026-10,2026-10,OBSERVATIONAL,,90,['Total Hip and Knee Arthroplasties'],Total Hip and Knee Arthroplasties,Zimmer Biomet,[],['Germany']
NCT00001281,Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV,Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV,RECRUITING,1993-03-09,,,OBSERVATIONAL,,2419,"['HIV', 'Immunodeficiencies', 'Infectious Diseases']",HIV,National Institute of Allergy and Infectious Diseases (NIAID),['Medstar Health Research Institute'],['United States']
NCT06199999,Erector Spinae Plane Block vs Local Infiltration Following Fusion Surgery,"A Randomized Controlled Trial Comparing the Effect of Erector Spinae Plane Blocks Versus High Volume Local Infiltration Analgesia on Pain, Inflammation and Cognitive Outcomes Following Thoraco-Lumbar Fusion Surgery",ACTIVE_NOT_RECRUITING,2024-05-15,2026-01-01,2026-12-30,INTERVENTIONAL,PHASE2,120,"['Postoperative Delirium', 'Pain, Postoperative', 'Degenerative Disc Disease']",Postoperative Delirium,Rashmi Mueller,[],['United States']
NCT06467344,Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR),"ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy",RECRUITING,2024-06-11,2030-08-01,2030-12-01,INTERVENTIONAL,PHASE1,15,"['Stargardt Disease', 'Cone Rod Dystrophy', 'Juvenile Macular Degeneration', 'Stargardt Disease 1']",Stargardt Disease,"Ascidian Therapeutics, Inc",[],['United States']
NCT07001332,ELEVATE High-Risk PCI Pivotal Study,ELEVATE High-Risk PCI Pivotal Study,RECRUITING,2025-07-25,2027-03-16,2027-09-16,INTERVENTIONAL,NA,290,['High-Risk Percutaneous Coronary Intervention (High-risk PCI)'],High-Risk Percutaneous Coronary Intervention (High-risk PCI),Magenta Medical Ltd.,[],['United States']
NCT07066813,Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces,T-Staging Strategies and Their Prognostic and Therapeutic Significance in Lung Cancer With Cystic Airspaces: A Retrospective Cohort Study,RECRUITING,2025-06-01,2025-12-31,2026-07-01,OBSERVATIONAL,,500,['Lung Cancer Associated With Cystic Airspaces'],Lung Cancer Associated With Cystic Airspaces,Central South University,[],['China']
NCT05069688,Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin,Mind the Gaps: Pharmacokinetic Research to Advance Pediatric HIV/TB Cotreatment and TB Prevention,RECRUITING,2023-07-07,2026-12,2026-12,INTERVENTIONAL,PHASE1,20,"['Pediatric HIV Infection', 'Tuberculosis Infection']",Pediatric HIV Infection,Brigham and Women's Hospital,"['APIN Public Health Initiatives', 'University of Cape Town']",['Nigeria']
NCT06488443,Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals,Randomized Control Study to Study the Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals Who Want to Quit Tobacco Use,RECRUITING,2024-11-01,2026-05-31,2026-12-31,INTERVENTIONAL,NA,96,['Tobacco Dependence'],Tobacco Dependence,University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', ""St.John's Medical College and Hospital""]",['India']
NCT06975878,Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age,"A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2-arm Study to Investigate the Safety and Immunogenicity of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers",RECRUITING,2025-05-22,2027-08-18,2027-08-18,INTERVENTIONAL,PHASE3,1080,"['Pneumococcal Immunization', 'Healthy Volunteers']",Pneumococcal Immunization,Sanofi,[],"['Belgium', 'Estonia', 'Finland', 'Italy', 'Czechia', 'Greece', 'Poland', 'Germany']"
NCT06576973,Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma,"A Prospective, Single-arm, Single-center, Exploratory Study of the Safety and Efficacy of Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma",RECRUITING,2024-08-08,2026-12,2031-12,INTERVENTIONAL,PHASE2,35,"['Esophageal Squamous Cell Carcinoma', 'Neoadjuvant Treatment']",Esophageal Squamous Cell Carcinoma,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT05387863,Decision Aid (DA) for Renal Patients,Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors,RECRUITING,2022-09-12,2026-06,2026-09,INTERVENTIONAL,NA,40,"['Kidney Tumor', 'Renal Cancer']",Kidney Tumor,NYU Langone Health,[],['United States']
NCT04802356,Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients,"An Open Label, Multicenter, Phase II Study of Belantamab Mafodotin in Combination With VRd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients",ACTIVE_NOT_RECRUITING,2021-04-07,2025-03-31,2025-12,INTERVENTIONAL,PHASE2,50,['Multiple Myeloma'],Multiple Myeloma,PETHEMA Foundation,['GlaxoSmithKline'],['Spain']
NCT07257822,The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes,The Digital Diabetes Patient Reminder (DIPAR) Tool to Improve Clinical Outcomes and Process of Management in Adults With Type 2 Diabetes: A Proof-of-Concept Randomized Controlled Trial,RECRUITING,2025-10-06,2027-06,2027-06,INTERVENTIONAL,NA,200,['Type 2 Diabetes Mellitus (T2DM)'],Type 2 Diabetes Mellitus (T2DM),KU Leuven,"['Regionaal Ziekenhuis Heilig Hart Tienen', 'Universitaire Ziekenhuizen KU Leuven']",['Belgium']
NCT07259499,Predictors of Emergency Department Use in Frail Patients,"Towards an Integrated Care System for the Assistance of Patients With Chronic Diseases, Multimorbidity, Frailty, and Polypharmacy",RECRUITING,2023-11-19,2025-12-31,2025-12-31,OBSERVATIONAL,,110,"['Alzheimer s Disease', 'Vascular Dementia', 'Frailty', 'Elderly', 'Emergency Department Visits', 'Autonomy']",Alzheimer s Disease,University of Pisa,"['Azienda Ospedaliero, Universitaria Pisana']",['Italy']
NCT04602481,Living With Primary Ciliary Dyskinesia (Living With PCD),Living With Primary Ciliary Dyskinesia (Formerly COVID-PCD),RECRUITING,2020-05-31,2030-05-31,2030-05-31,OBSERVATIONAL,,1500,['Primary Ciliary Dyskinesia'],Primary Ciliary Dyskinesia,University of Bern,"['Selbsthilfegruppe Kartagener Syndrom und Primäre Ciliäre Dyskinesie', 'Verein Kartagener Syndrom und PCD', 'PCD Support UK', 'PCD Foundation', 'PCD Australia', 'European Lung Foundation', 'University of Southampton', 'Universität Luzern', 'Associazione Italiana Discinesia Ciliare Primaria Sindrome di Kargagener APS', 'Asociación Nacional de Pacientes con Discinesia Ciliar Primaria', 'Association Dyskinésie Ciliaire Primitive ADCP']",['Switzerland']
NCT06989164,Post Prandial Individual Responses to Different Foods,"Quantifying Differential Individual Responses to OGTT, Starchy Foods, and Mitigators and Its Association With Metabolic Subphenotypes",RECRUITING,2025-10-01,2028-11-30,2028-11-30,INTERVENTIONAL,NA,100,"['PreDiabetes', 'Diabetes Mellitus, Type 2', 'Healthy']",PreDiabetes,Stanford University,[],['United States']
NCT06730126,Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients,A Phase 2a Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients,RECRUITING,2025-03-10,2026-03-01,2026-12-01,INTERVENTIONAL,PHASE2,15,['Autoimmune Lymphoproliferative Syndrome'],Autoimmune Lymphoproliferative Syndrome,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07259200,Impact of Atrial Fibrillation Ablation on Sleep Parameters.,Assessment of Sleep Parameters Using Polygraphy in Patients With Paroxysmal Atrial Fibrillation Qualified for Pulmonary Vein Isolation - A Prospective Observational Study (AAHI Study),RECRUITING,2025-03-20,2026-02-01,2026-02-28,OBSERVATIONAL,,100,"['Atrial Fibrillation (AF)', 'OSA - Obstructive Sleep Apnea', 'Pulmonary Vein Isolation']",Atrial Fibrillation (AF),Primula Clinics,[],['Poland']
NCT07257107,Effect of Transcutaneous Auricular Vagus Nerve Stimulation Combined With Upper Extremity Robot-Assisted Training on Upper Extremity Motor Functions in Stroke Patients,Effect of Transcutaneous Auricular Vagus Nerve Stimulation Combined With Upper Extremity Robot-Assisted Training on Upper Extremity Motor Functions in Stroke Patients,RECRUITING,2025-10-01,2027-03-01,2027-06-01,INTERVENTIONAL,NA,30,"['Stroke Treatment', 'Stroke']",Stroke Treatment,Istanbul University - Cerrahpasa,[],['Turkey (Türkiye)']
NCT06515314,HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors,"A Phase 1, Single-arm, Open-label, Dose-escalation Study of AFP Specific T Cell Receptor Transduced T Cells Injection（HRYZ-T102）in Patients With AFP Positive Advanced Hepatocellular Carcinoma and Other Solid Tumors",RECRUITING,2024-10-17,2026-08-10,2027-08-10,INTERVENTIONAL,PHASE1,12,['Hepatic Cell Carcinoma'],Hepatic Cell Carcinoma,"Shanghai Ruiliyuan Biotechnology Co., Ltd.",[],['China']
NCT00005909,Study of Alkaptonuria,"Clinical, Biochemical, and Molecular Investigations Into Alkaptonuria",RECRUITING,2000-06-21,,,OBSERVATIONAL,,300,['Alkaptonuria'],Alkaptonuria,National Human Genome Research Institute (NHGRI),[],['United States']
NCT07142291,PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS,"A Phase IIB Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Study to Evaluate the Effects of PHENOGENE-1A (Cromolyn) as an Adjuvant Treatment in Subjects With Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)",RECRUITING,2025-11-25,2027-11,2028-03,INTERVENTIONAL,PHASE2,105,['Amyotrophic Lateral Sclerosis (ALS)'],Amyotrophic Lateral Sclerosis (ALS),"PhenoNet, Inc.",[],['United States']
NCT06360406,Real-World Treatment Study of Koselugo (Selumetinib),Real-World Treatment Study of Koselugo (Selumetinib),RECRUITING,2024-06-15,2031-09-30,2031-09-30,OBSERVATIONAL,,150,"['Neurofibromatosis 1', 'Neurofibroma, Plexiform']",Neurofibromatosis 1,AstraZeneca,[],['South Korea']
NCT06057038,A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors,"A Phase 1 Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GEN1042 Monotherapy and in Combination With Pembrolizumab ± Chemotherapy in Japanese Subjects With Malignant Solid Tumors",ACTIVE_NOT_RECRUITING,2023-11-24,2026-03-26,2026-12-26,INTERVENTIONAL,PHASE1,42,['Malignant Solid Tumor'],Malignant Solid Tumor,Genmab,['BioNTech SE'],['Japan']
NCT06259435,Modulating Energy Density in Time-Restricted Eating,Modulating Energy Density in Time-Restricted Eating,ACTIVE_NOT_RECRUITING,2024-05-29,2026-04,2026-04,INTERVENTIONAL,NA,40,"['Insulin Resistance', 'Body Weight']",Insulin Resistance,Pennington Biomedical Research Center,[],['United States']
NCT06585033,Placebo Effect In Spinal Cord Electrical Stimulation for Pain,"Spinal Cord Stimulation for the Treatment of Therapy-Resistant Neuropathic Pain After Lumbar Spinal Surgery - A Randomized, Double-Blind, Sham-Controlled, Cross-over Study",RECRUITING,2024-11-15,2027-06-30,2027-06-30,INTERVENTIONAL,NA,50,['Chronic Postoperative Pain'],Chronic Postoperative Pain,Sahlgrenska University Hospital,['Rijnstate Hospital'],"['Norway', 'Sweden', 'Netherlands']"
NCT04940052,"Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer","A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer (DTC)",ACTIVE_NOT_RECRUITING,2021-11-15,2025-01-22,2027-06-04,INTERVENTIONAL,PHASE3,153,['Differentiated Thyroid Cancer (DTC)'],Differentiated Thyroid Cancer (DTC),Novartis Pharmaceuticals,[],"['Brazil', 'Turkey (Türkiye)', 'China', 'United States', 'Taiwan', 'South Korea', 'Canada', 'Malaysia', 'Vietnam', 'Argentina', 'India']"
NCT05433116,Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC,Combined Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC in PD-L1 Positive Patients (CPS≥1),ACTIVE_NOT_RECRUITING,2023-05-25,2026-01,2027-01,INTERVENTIONAL,PHASE2,50,['Head and Neck Squamous Cell Carcinoma'],Head and Neck Squamous Cell Carcinoma,Universität des Saarlandes,[],['Germany']
NCT05222529,"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma","A Phase II, Double-blind, Randomized, Multiple Dose, Cross Over, Three-treatment, Three-period, Six Sequence Placebo Controlled Trial to Evaluate Efficacy, Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety and Tolerability of Glycopyrronium (Bromide) in Children From 6 to Less Than 12 Years of Age With Asthma.",RECRUITING,2022-08-29,2027-07-30,2027-08-30,INTERVENTIONAL,PHASE2,42,['Asthma'],Asthma,Novartis Pharmaceuticals,[],"['Bulgaria', 'Hungary', 'South Africa', 'Spain', 'Guatemala', 'Colombia', 'United Kingdom', 'Poland']"
NCT04777396,A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE),A Randomised Double-blind Placebo-controlled Clinical Trial Investigating the Effect and Safety of Oral Semaglutide in Subjects With Early Alzheimer´s Disease (EVOKE),ACTIVE_NOT_RECRUITING,2021-05-18,2025-09-16,2026-10-23,INTERVENTIONAL,PHASE3,1840,"[""Early Alzheimer's Disease""]",Early Alzheimer's Disease,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'Netherlands', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'Slovenia', 'France', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Portugal', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT07071883,Group Activities to Support Addiction Recovery,Group Activities to Support Addiction Recovery,RECRUITING,2025-08-27,2026-03-14,2026-03-14,INTERVENTIONAL,NA,100,"['Addiction', 'Substance Use Disorders (SUD)']",Addiction,University of Nebraska,[],['United States']
NCT07190794,RESCUE: Discontinuation of GLP-1,Evaluation of Endoscopic Sleeve Gastroplasty (ESG) as an Alternative Weight Loss Strategy for Patients With Obesity Discontinuing GLP-1 Receptor Agonists Due to Intolerance or Ineffectiveness: A Retrospective Study,RECRUITING,2025-12,2026-06,2026-06,OBSERVATIONAL,,150,['Obesity'],Obesity,Boston Scientific Corporation,[],['United States']
NCT06781359,Study on Plasmablastic Lymphoma Patients,An International Multicenter Observational Retrospective Study on Plasmablastic Lymphoma Patients,RECRUITING,2025-02-14,2028-02-01,2028-02-01,OBSERVATIONAL,,200,['Plasmablastic Lymphoma'],Plasmablastic Lymphoma,Fondazione Italiana Linfomi - ETS,"['AIL Roma - Italia', 'AIL Cuneo - Italia']",['Italy']
NCT05307094,Optimizing Intervention Options for Toddlers With Early Social Communication Delays,Optimizing Intervention Options for Toddlers With Early Social Communication Delays,ACTIVE_NOT_RECRUITING,2022-01-15,2025-05-31,2025-12-31,INTERVENTIONAL,NA,44,['Autism Sibling'],Autism Sibling,University of Texas at Austin,[],['United States']
NCT06776094,Physical Activity and Insulin Sensitivity Dynamics,The Significance of Physical Activity for Insulin Signaling Dynamics and Insulin Sensitivity,RECRUITING,2025-05-05,2025-08-26,2027-01,INTERVENTIONAL,NA,8,['Insulin Sensitivity'],Insulin Sensitivity,University of Copenhagen,[],['Denmark']
NCT06333483,"Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus","A Single-Arm, Open-Label, Phase I Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patients With Severe, Refractory Systemic Lupus Erythematosus",RECRUITING,2024-02-02,2025-12,2026-12,INTERVENTIONAL,PHASE1,18,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,Autolus Limited,[],"['United Kingdom', 'Spain']"
NCT06125951,Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease,"A Phase 2b/3, Double-Blind, Placebo-Controlled, Parallel-Group, 36-Week, 2-Arm Trial to Assess the Safety, Tolerability, and Efficacy of Xanamem® 10 mg Daily in Patients With Mild or Moderate Dementia Due to Alzheimer's Disease",ACTIVE_NOT_RECRUITING,2024-04-12,2026-10,2026-10,INTERVENTIONAL,PHASE2,220,"['Dementia Moderate', 'Dementia, Mild', 'Alzheimer Disease']",Dementia Moderate,Actinogen Medical,[],"['United States', 'Australia']"
NCT07205341,Detecting Changes in Arterial Blood Volume and Cardiac Efficiency,"A Pilot Clinical Study to Assess Correlation Between Arterial Blood Volume Status and Cardiac Efficiency, and HemoCept Device Data in Trans-Aortic Valve Replacement (TAVR} Surgery",RECRUITING,2025-04-29,2026-03,2026-03,OBSERVATIONAL,,20,['Aortic Valve Stenosis'],Aortic Valve Stenosis,HemoCept Inc.,[],['United States']
NCT06941194,Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery,Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery a Randomized Clinical Trial,RECRUITING,2025-09-15,2027-11,2027-11,INTERVENTIONAL,NA,48,"['Sarcoma', 'Sarcoma,Soft Tissue']",Sarcoma,Istituto Oncologico Veneto IRCCS,[],['Italy']
NCT00001405,"Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes","Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes",RECRUITING,1994-02-27,,,OBSERVATIONAL,,850,"['Granuloma', 'Granulomatous Disease, Chronic', 'Leukocyte Disease', 'Genetic Disease, X-Linked', 'Genetic Disease, Inborn']",Granuloma,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06391775,Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy,"First-In-Human, Open-Label, Dose Escalation Trial With Expansion Cohorts to Evaluate the Safety and Preliminary Efficacy of GEN1055 as Monotherapy and as Combination Therapy in Subjects With Malignant Solid Tumors",ACTIVE_NOT_RECRUITING,2024-05-14,2028-05,2028-05,INTERVENTIONAL,PHASE1,21,['Malignant Solid Tumor'],Malignant Solid Tumor,Genmab,['BioNTech SE'],"['Spain', 'United States']"
NCT07259811,Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration,Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration,ACTIVE_NOT_RECRUITING,2023-09-18,2026-05-14,2026-05-14,INTERVENTIONAL,NA,10,['Vertebral Compression Fracture'],Vertebral Compression Fracture,Amber Implants B.V.,['Avania B.V.'],['Germany']
NCT04820036,A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG),A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG): Effects of ESG on Non-Alcoholic Steatohepatitis (NASH) and Portal Pressure Gradient in Patients With Obesity and NASH With Advanced Fibrosis,ACTIVE_NOT_RECRUITING,2021-05-06,2026-12-24,2027-12-24,INTERVENTIONAL,NA,20,"['Non-alcoholic Steatohepatitis (NASH)', 'Endoscopic Sleeve Gastroplasty', 'Non-alcoholic Fatty Liver Disease (NAFLD)', 'Endoscopic Ultrasound', 'Liver Function', 'Obesity', 'Liver Fibroses']",Non-alcoholic Steatohepatitis (NASH),Brigham and Women's Hospital,"['American Society for Gastrointestinal Endoscopy', 'Boston Scientific Corporation']",['United States']
NCT06084884,A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma,"A Phase I/II Open-Label Study to Evaluate the Safety, Cellular Kinetics and Efficacy of AZD5851, a Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Directed Against GPC3 in Adult Participants With Advanced/Recurrent Hepatocellular Carcinoma: ATHENA",ACTIVE_NOT_RECRUITING,2023-12-14,2027-12-13,2027-12-13,INTERVENTIONAL,PHASE1,94,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,AstraZeneca,[],"['Japan', 'United States', 'South Korea']"
NCT07163221,At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study],At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study],RECRUITING,2025-11-03,2026-08,2026-11,INTERVENTIONAL,NA,60,['Rheumatoid Arthritis (RA)'],Rheumatoid Arthritis (RA),SecondWave Systems Inc.,[],['United States']
NCT07258875,"Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery","Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery",RECRUITING,2024-11-27,2028-11-01,2029-11-01,INTERVENTIONAL,NA,230,"['Thoracic Surgery With One-lung Ventilation', 'VExUS', 'Fluid Management', 'Acute Kidney Injury', 'Postoperative Pulmonary Complications (PPCs)']",Thoracic Surgery With One-lung Ventilation,University of Crete,[],['Greece']
NCT00353782,Causes and Natural History of Dyslipidemias,Disease Pathogenesis and Natural History of Lipid Disorders,RECRUITING,2003-10-14,,,OBSERVATIONAL,,2000,"['Hypercholesterolemia', 'Atherosclerosis']",Hypercholesterolemia,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT06839482,Robotic Rehabilitation of the Upper Limb in Subacute Stroke,Efficacy of Robotic Rehabilitation for Neuro Recovery of the Upper Limb in Subacute Stroke Survivors: An International Multicenter Randomized Controlled Trial,RECRUITING,2025-02-06,2026-02-28,2028-01-31,INTERVENTIONAL,NA,130,['Stroke'],Stroke,IRCCS San Raffaele Roma,[],"['Russia', 'United States', 'Spain', 'Italy', 'Thailand', 'Czechia']"
NCT06581146,"A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition","A Non-interventional, Epidemiologic Study of XLMTM and Clinical Expression in the Liver",RECRUITING,2025-05-19,2027-05-31,2027-05-31,OBSERVATIONAL,,50,['X-Linked Myotubular Myopathy'],X-Linked Myotubular Myopathy,Astellas Gene Therapies,[],['United States']
NCT05037968,MagnetOs Flex Matrix Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented Posterolateral Fusion,"A Prospective, Randomized, Multi-center Study to Assess the Performance of MagnEtOs Flex Matrix Mixed With Local Autograft Compared to Trinity Elite Mixed With Local Autograft in Patients Undergoing up to Four-level Instrumented poSterolatEral Lumbar/Thoraco-lumbar Fusion (PLF)",RECRUITING,2024-06-10,2026-12,2026-12,INTERVENTIONAL,NA,100,"['Degenerative Disc Disease', 'Spine Fusion', 'Leg Pain and/or Back Pain']",Degenerative Disc Disease,Kuros Biosurgery AG,['Kuros BioSciences B.V.'],['United States']
NCT07258043,Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia,Efficacy on Progression Free Overall Survival of a Dose-Adjusted Regimen in Frail Adult Patients With Acute Lymphoblastic Leukemia,RECRUITING,2025-07-23,2026-07-23,2026-07-26,OBSERVATIONAL,,45,"['Acute Lymphobkastic Leukemia', 'Leukemia', 'Overall Survival']",Acute Lymphobkastic Leukemia,Hospital General de Mexico,[],['Mexico']
NCT07232810,Prognostic Outcomes of Total Mesopancreas Excision for Pancreatic Head Cancer,Prognostic Outcomes of Total Mesopancreas Excision During Pancreaticoduodenectomy for Pancreatic Head Cancer,RECRUITING,2025-12-01,2027-12-01,2027-12-20,INTERVENTIONAL,NA,90,"['Pancreatic Head Cancer', 'Pancreatic Ductal Adenocarcinoma']",Pancreatic Head Cancer,Minia University,[],['Egypt']
NCT06764485,A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer,"A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 Versus Investigator's Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge",RECRUITING,2025-03-13,2027-09-12,2029-01-19,INTERVENTIONAL,PHASE3,960,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,Celgene,[],"['Japan', 'China', 'Slovakia', 'Australia', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Romania', 'United Kingdom', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT06920004,A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP,"A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Intravenous Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy",RECRUITING,2025-08-22,2027-09,2030-09,INTERVENTIONAL,PHASE3,218,"['Chronic Inflammatory Demyelinating Polyneuropathy', 'CIDP', 'CIDP - Chronic Inflammatory Demyelinating Polyneuropathy']",Chronic Inflammatory Demyelinating Polyneuropathy,argenx,[],['United States']
NCT07258082,TaVNS for Delirium,Transauricular Vagus Nerve Stimulation (taVNS) for Delirium,RECRUITING,2025-09-26,2028-10,2028-10,INTERVENTIONAL,NA,10,"['Delirium Treatment', 'Delirium']",Delirium Treatment,Stony Brook University,[],['United States']
NCT05803382,"Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers",Phase I Trial of ZEN003694 (ZEN-3694) in Combination With Capecitabine in Patients With Solid Tumors,RECRUITING,2023-11-08,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE1,30,"['Metastatic Colorectal Carcinoma', 'Metastatic Malignant Solid Neoplasm', 'Stage IV Colorectal Cancer AJCC v8', 'Unresectable Colorectal Carcinoma', 'Unresectable Malignant Solid Neoplasm']",Metastatic Colorectal Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06248554,Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation,Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation: a Prospective Cohort Study,RECRUITING,2019-12-01,2024-12-31,2025-12-31,INTERVENTIONAL,NA,200,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,Chen Xiaoping,[],['China']
NCT06929273,A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3),"A Phase 3, Open-label Extension Study to Assess the Long-term Safety of KarXT for the Treatment of Mania or Mania With Mixed Features in Bipolar-I Disorder (BALSAM-3)",RECRUITING,2025-07-18,2028-06-13,2028-06-13,INTERVENTIONAL,PHASE3,450,['Bipolar Disorder Type I With Mania'],Bipolar Disorder Type I With Mania,Bristol-Myers Squibb,[],"['Bulgaria', 'Israel', 'Japan', 'Hungary', 'New Zealand', 'India', 'United States', 'Slovakia', 'Croatia', 'Denmark', 'Spain', 'Italy', 'Romania', 'Ukraine', 'Poland', 'Argentina', 'Sweden', 'Australia']"
NCT04623541,Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome,"A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3xCD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome",RECRUITING,2020-11-25,2029-06,2029-08,INTERVENTIONAL,PHASE1,424,"['Relapsed/Refractory Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma', ""Richter's Syndrome"", 'Treatment-naïve High Risk Chronic Lymphocytic Leukemia']",Relapsed/Refractory Chronic Lymphocytic Leukemia,Genmab,"['AbbVie', 'Eli Lilly and Company']","['Belgium', 'Israel', 'Netherlands', 'United States', 'France', 'Germany', 'Denmark', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT06976203,A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 2)",RECRUITING,2025-07-21,2028-09-11,2029-02-23,INTERVENTIONAL,PHASE3,586,"[""Alzheimer's Disease""]",Alzheimer's Disease,Bristol-Myers Squibb,[],"['Brazil', 'Japan', 'Netherlands', 'United States', 'France', 'Germany', 'Finland', 'Puerto Rico', 'Spain', 'Italy', 'Romania', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Argentina', 'Australia']"
NCT05224102,"A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema","A Phase IV, Multicenter, Open-Label, Single-Arm Study to Investigate Faricimab (RO6867461) Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema",ACTIVE_NOT_RECRUITING,2022-02-28,2027-01-26,2027-01-26,INTERVENTIONAL,PHASE4,218,['Diabetic Macular Edema'],Diabetic Macular Edema,"Genentech, Inc.",[],"['Kenya', 'Puerto Rico', 'United States', 'India']"
NCT02690545,Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL,Phase Ib/II Study of the Administration of T Lymphocytes Expressing the CD30 Chimeric Antigen Receptor (CAR) for Relapsed/Refractory CD30+ Hodgkin's Lymphoma and CD30+ Non-Hodgkin's Lymphoma,ACTIVE_NOT_RECRUITING,2016-08-26,2025-12-16,2039-11-04,INTERVENTIONAL,PHASE1,38,"['Lymphoma', 'Lymphoma, Non-Hodgkin', 'Immune System Diseases', 'Immunoproliferative Disorders', 'Lymphatic Diseases', 'Lymphoproliferative Disorders', 'Neoplasms', 'Neoplasms by Histologic Type']",Lymphoma,UNC Lineberger Comprehensive Cancer Center,[],['United States']
NCT06442436,A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015),A Study to Evaluate the Pharmacokinetics of Nemtabrutinib in Participants With Moderate Hepatic Impairment,RECRUITING,2024-07-24,2026-09-14,2026-09-14,INTERVENTIONAL,PHASE1,16,['Hepatic Impairment (HI)'],Hepatic Impairment (HI),Merck Sharp & Dohme LLC,[],['United States']
NCT06784466,Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation,Coherent Sine Burst Electroporation (CSE) Ablation System US Investigational Device Exemption (IDE) Study for Patients With Atrial Fibrillation,RECRUITING,2025-09-10,2027-06,2027-08,INTERVENTIONAL,NA,360,"['Atrial Fibrillation (AF)', 'Persistant Atrial Fibrillation', 'Paroxysmal AF']",Atrial Fibrillation (AF),Arga Medtech SA,[],"['Croatia', 'United States', 'Lithuania', 'Czechia']"
NCT05742776,The Relationship Between Ultrasonographic Findings and Sleep Quality in Carpal Tunnel Syndrome,The Relationship Between Ultrasonographic Findings and Sleep Quality in Patients With Carpal Tunnel Syndrome,RECRUITING,2023-02-23,2025-12-31,2026-03-01,OBSERVATIONAL,,120,"['Musculoskeletal Diseases', 'Median Nerve Disease', 'Carpal Tunnel Syndrome', 'Ultrasound', 'Sleep Quality']",Musculoskeletal Diseases,Afyonkarahisar Health Sciences University,[],['Turkey (Türkiye)']
NCT06687304,Light in Healthcare Environment (Ljus i sjukhusmiljö),Benefits of Light in the Radiographic Environment,RECRUITING,2024-11-15,2027-03-31,2027-03-31,INTERVENTIONAL,NA,18,"['Sleep Quality', 'Well-being', 'Melatonin', 'Cortisol', 'Energy Levels']",Sleep Quality,Lund University,['AFA Insurance'],['Sweden']
NCT03647358,Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma,Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma,RECRUITING,2018-08-21,2026-08,2026-08,INTERVENTIONAL,PHASE1,60,"['Thyroid Carcinoma', 'Metastatic Thyroid Carcinoma']",Thyroid Carcinoma,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06716814,Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa,"A Multinational, Prospective, Open-label, Roll-over Study (LIBERTY) to Provide Post-trial Access to Treatment for Patients With Severe Haemophilia A Who Have Completed a Previous Trial With Efanesoctocog Alfa",RECRUITING,2025-03-06,2027-03,2027-03,INTERVENTIONAL,PHASE3,104,['Severe Haemophilia A'],Severe Haemophilia A,Swedish Orphan Biovitrum,['PSI CRO'],"['Bulgaria', 'Norway', 'France', 'Spain', 'Italy', 'Greece', 'Sweden']"
NCT00034216,Collection of Blood From Patients With Cancer,Biospecimen Acquisition From Human Subjects,RECRUITING,2002-07-16,,,OBSERVATIONAL,,1750,"['Prostate Cancer', 'Breast Cancer', 'Colon Cancer', 'Lung Cancer', 'Liver Cancer']",Prostate Cancer,National Cancer Institute (NCI),[],['United States']
NCT00028080,"Evaluation, Treatment, and Follow-up of Patients With Lyme Disease","Evaluation, Treatment, and Follow-up of Patients With Lyme Disease",RECRUITING,2002-01-16,,,OBSERVATIONAL,,500,['Lyme Disease'],Lyme Disease,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06760897,Effect of Gastrogenic Microbiota in FD,The Clinical Efficacy Study of Selective Gastrogenic Microbiota Transplantation in the Treatment of Functional Dyspepsia,ACTIVE_NOT_RECRUITING,2024-12-31,2025-11-28,2025-12-30,INTERVENTIONAL,NA,74,"['Dyspepsia', 'Dysbiosis']",Dyspepsia,"Nanfang Hospital, Southern Medical University",[],['China']
NCT05851976,Duloxetine for LBP,Duloxetine for Patients With Low Back Pain Who Fail to Improve With Oral NSAIDs. A Randomized Placebo-controlled Exploratory Study,RECRUITING,2023-10-04,2027-05,2027-05,INTERVENTIONAL,PHASE4,120,"['Back Pain, Low']","Back Pain, Low",Montefiore Medical Center,[],['United States']
NCT07026474,Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC,Randomized Phase III Trial of Sequential Re-Radiochemotherapy and Pembrolizumab Versus Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive HNSCC (CPS≥1),RECRUITING,2025-10-30,2032-12,2032-12-31,INTERVENTIONAL,PHASE3,214,['Recurrent Head and Neck Squamous Cell Carcinoma'],Recurrent Head and Neck Squamous Cell Carcinoma,Universität des Saarlandes,[],['Germany']
NCT06474221,Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters,A Multi-centric Trial to Evaluate the Efficacy of Electronic-Based Psychosocial Interventions on Future Suicide Risk Among Adolescent Suicide Attempters,RECRUITING,2024-08-31,2025-12-31,2026-05-30,INTERVENTIONAL,NA,168,"['Suicide, Attempted']","Suicide, Attempted",University of Pittsburgh,"['Fogarty International Center of the National Institute of Health', ""St.John's Medical College and Hospital""]",['India']
NCT06898047,Consistency of Response With Rimegepant in Acute Treatment of Migraine,CORRELATE-UK: COnsistency of Response With RimegEpant Oral Lyophilisate in Acute Treatment of migrainE in the United Kingdom,ACTIVE_NOT_RECRUITING,2025-11-15,2026-06-30,2026-06-30,OBSERVATIONAL,,250,['Migraine'],Migraine,Pfizer,[],['United Kingdom']
NCT03055013,Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy,A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC),ACTIVE_NOT_RECRUITING,2017-04-28,2023-05-24,2031-06-09,INTERVENTIONAL,PHASE3,819,"['Metastatic Renal Cell Carcinoma', 'Sarcomatoid Renal Cell Carcinoma', 'Stage II Renal Cell Cancer AJCC v7', 'Stage III Renal Cell Cancer AJCC v7', 'Unclassified Renal Cell Carcinoma']",Metastatic Renal Cell Carcinoma,National Cancer Institute (NCI),['Canadian Cancer Trials Group'],"['Israel', 'United States', 'Canada']"
NCT04046523,Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy,Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy,RECRUITING,2023-01-31,2029-07-31,2030-07-31,INTERVENTIONAL,NA,90,['Intracranial Pressure Increase'],Intracranial Pressure Increase,University of Minnesota,"['Hennepin County Medical Center, Minneapolis', 'Minnesota Office of Higher Education']",['United States']
NCT04550481,"Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study",Role of Lisinopril in Preventing The Progression of Non-Alcoholic Fatty Liver Disease (NAFLD): Relief-NAFLD,ACTIVE_NOT_RECRUITING,2021-05-11,2025-12-15,2026-09-30,INTERVENTIONAL,PHASE2,45,"['Hepatocellular Carcinoma', 'Nonalcoholic Steatohepatitis']",Hepatocellular Carcinoma,Northwestern University,['National Cancer Institute (NCI)'],['United States']
NCT02390752,"Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...","Phase I Trial of TURALIO (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor (TGCT)",RECRUITING,2015-04-29,2026-12-31,2028-12-31,INTERVENTIONAL,PHASE1,54,"['Neurofibroma, Plexiform', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma', 'Leukemia, Promyelocytic, Acute', 'Sarcoma']","Neurofibroma, Plexiform",National Cancer Institute (NCI),[],['United States']
NCT07258342,Evaluation of Lower Extremity Interventions in Individuals With Chronic Stroke,Evaluation of the Effects of Closed Kinetic Chain Exercises and Kinesio Taping on the Lower Extremity in Individuals With Chronic Stroke,ACTIVE_NOT_RECRUITING,2025-05-30,2025-08-30,2025-12-30,INTERVENTIONAL,NA,30,"['Chronic Stroke Patients', 'Lower Extremity', 'Knee Proprioception', 'Closed Kinetic Chain Exercises', 'Kinesiotape', 'Physiomaster']",Chronic Stroke Patients,Medipol University,[],['Turkey (Türkiye)']
NCT06574269,A Study on TLC590 for Managing Postsurgical Pain,"A Phase 2, Open-label, Dose-escalation Study to Evaluate Pharmacokinetics, Pharmacodynamics, Bioavailability, Safety, and Tolerability of TLC590 in Multiple Surgical Models",RECRUITING,2024-09-30,2026-07,2026-08,INTERVENTIONAL,PHASE2,120,['Postsurgical Pain Management'],Postsurgical Pain Management,"TLC Biopharmaceuticals, Inc.",[],['United States']
NCT07161388,Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China,"Durvalumab Consolidation After Chemoradiation Therapy (CRT) for Patients With Limited Stage Small-Cell Lung Cancer in China: A Multicentre, Observational Study (DREAM)",RECRUITING,2025-11-17,2028-09-30,2028-09-30,OBSERVATIONAL,,200,['Limited Stage Small-Cell Lung Cancer'],Limited Stage Small-Cell Lung Cancer,AstraZeneca,[],['China']
NCT06879561,Pressure Wire Guidance for Infrapopliteal Artery Interventions,Impact of Pressure Wire-guidance Versus Angiography-guidance for Infrapopliteal Artery Interventions on Post-procedural Perfusion Status and Wound Healing in Patients With Chronic Limb Threatening Ischemia (PERFECT-CLI),RECRUITING,2025-10-02,2027-12-29,2028-08-29,INTERVENTIONAL,NA,100,['Chronic Limb-Threatening Ischemia'],Chronic Limb-Threatening Ischemia,Yonsei University,[],['South Korea']
NCT07259759,JURA Study - Observational First-in-human Feasibility Study,JURA Study - Observational First-in-human Feasibility Study,RECRUITING,2025-10-31,2025-12-31,2025-12-31,OBSERVATIONAL,,20,['Imaging'],Imaging,Intuitive Surgical,[],['Netherlands']
NCT07160725,"A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors","A Phase 1/2a, First-in-human, Open-label Study of BMS-986517 as Monotherapy in Adult Participants With Advanced Solid Tumors",RECRUITING,2025-10-15,2028-07-31,2028-08-01,INTERVENTIONAL,PHASE1,315,['Solid Tumours'],Solid Tumours,Bristol-Myers Squibb,[],"['Denmark', 'Japan', 'United States', 'Spain']"
NCT06717269,Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets,"A Phase 1, Open-Label Study in Healthy Volunteers to Evaluate the Relative Bioavailability of NX-5948 Tablets Compared to Capsules, and the Effect of Food and an Acid-reducing Agent on the Pharmacokinetics of NX-5948",RECRUITING,2024-11-30,2025-11-30,2025-12-31,INTERVENTIONAL,PHASE1,18,['Healthy Volunteer'],Healthy Volunteer,"Nurix Therapeutics, Inc.",[],['United States']
NCT06503913,Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder,Cognitive Muscular Therapy for Patients With Long-COVID (Post COVID-19) and Breathing Pattern Disorder,ACTIVE_NOT_RECRUITING,2024-08-01,2026-03-01,2026-04-01,INTERVENTIONAL,NA,20,"['Long COVID', 'Respiratory Disease']",Long COVID,University of Salford,[],['United Kingdom']
NCT06946797,A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC),"A Phase 2, Open-label, Randomized Trial to Evaluate Two Dosing Regimens of Subcutaneous Formulation of Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent NSCLC",RECRUITING,2025-09-19,2027-02-05,2028-10-25,INTERVENTIONAL,PHASE2,76,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Bristol-Myers Squibb,[],"['Brazil', 'South Africa', 'Turkey (Türkiye)', 'United States', 'France', 'Mexico', 'Chile', 'Italy', 'Romania', 'Greece', 'Poland']"
NCT05748197,A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia,A Phase I Study of ADCLEC.syn1 CAR T Cells in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia,RECRUITING,2024-04-18,2028-04-18,2028-04-18,INTERVENTIONAL,PHASE1,40,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,Memorial Sloan Kettering Cancer Center,['Takeda'],['United States']
NCT07258056,GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies,GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies (GUIDE PSMA PET/MRI),RECRUITING,2025-11-03,2028-12,2038-12,INTERVENTIONAL,NA,100,['Prostate Cancer'],Prostate Cancer,Mads Ryo Jochumsen,[],['Denmark']
NCT07258225,Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen,Clinical Effectiveness of a Once-daily Regimen of Tigecycline Compared to the Standard Regimen in Critically Ill Patients,ACTIVE_NOT_RECRUITING,2024-04-01,2026-02-01,2026-04-30,INTERVENTIONAL,PHASE4,86,['Multi Drug Resistant Infections'],Multi Drug Resistant Infections,"Air Force Specialized Hospital, Cairo, Egypt",[],['Egypt']
NCT07008378,"A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis","A Phase I, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Patients With Multiple Sclerosis",RECRUITING,2025-10-15,2032-08-31,2032-08-31,INTERVENTIONAL,PHASE1,60,['Multiple Sclerosis'],Multiple Sclerosis,"Genentech, Inc.","['Poseida Therapeutics, Inc., a member of the Roche Group']",['United States']
NCT05879926,"Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25","A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)",RECRUITING,2023-08-31,2032-01,2034-07,INTERVENTIONAL,PHASE3,3960,['Breast Cancer'],Breast Cancer,NRG Oncology,['National Cancer Institute (NCI)'],"['Japan', 'Uruguay', 'United States', 'Mexico', 'Puerto Rico', 'Peru', 'Colombia', 'Canada']"
NCT07258576,Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise,The Effect of Menstrual Cycle Phase and Oral Contraceptive Use on Muscle Protein Metabolism Post-Resistance Training,RECRUITING,2025-07-20,2026-09-01,2026-09-01,INTERVENTIONAL,NA,20,"['Female Sex Hormones', 'Menstrual Cycle', 'Oral Contraceptives', 'Protein Metabolism']",Female Sex Hormones,University of Toronto,[],['Canada']
NCT05174169,Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease,Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease,RECRUITING,2022-03-10,2029-03-10,2030-03-10,INTERVENTIONAL,PHASE2,1912,['Stage III Colon Cancer'],Stage III Colon Cancer,NRG Oncology,"['Natera, Inc.', 'National Cancer Institute (NCI)']","['Puerto Rico', 'United States', 'Canada']"
NCT06422507,A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema,"Multi-Center, Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of 8 mg Aflibercept in Chinese Participants With Diabetic Macular Edema",ACTIVE_NOT_RECRUITING,2024-05-29,2025-12-30,2026-03-22,INTERVENTIONAL,PHASE3,333,['Diabetic Macular Edema'],Diabetic Macular Edema,Bayer,['Regeneron Pharmaceuticals'],"['China', 'Hong Kong']"
NCT04052022,Paradoxical Tuberculosis Reactions in Patients Without HIV Infection,Paradoxical Tuberculosis Reactions in Patients Without HIV Infection,RECRUITING,2019-12-20,2029-04-30,2029-04-30,OBSERVATIONAL,,140,['Tuberculosis'],Tuberculosis,National Institute of Allergy and Infectious Diseases (NIAID),[],"['United States', 'Mexico']"
NCT04106102,Study of the Effectiveness of Transcranial Direct Current Stimulation on Obsessive Compulsive Disorder,Study of the Effectiveness of Transcranial Direct Current Stimulation on Obsessive Compulsive Disorder,ACTIVE_NOT_RECRUITING,2019-09-20,2025-09-09,2026-09-09,INTERVENTIONAL,NA,43,['Obsessive-Compulsive Disorder'],Obsessive-Compulsive Disorder,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06220201,"A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)","A Phase 1, Multicenter, Single-arm, Dose-escalation Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, Evaluating Safety and Tolerability in Participants With Autoimmune Neurological Diseases: Relapsing Forms of Multiple Sclerosis (RMS), Progressive Forms of Multiple Sclerosis (PMS), or Refractory Myasthenia Gravis (MG).",RECRUITING,2024-03-28,2027-07-15,2027-07-15,INTERVENTIONAL,PHASE1,120,"['Multiple Sclerosis', 'Myasthenia Gravis']",Multiple Sclerosis,"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",['Celgene Corporation'],"['Belgium', 'United States', 'France', 'Spain', 'United Kingdom', 'Germany']"
NCT02775851,Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery,A Phase II and Pilot Trial of PD-1 Blockade With Pembrolizumab (MK-3475) in Patients With Resectable or Unresectable Desmoplastic Melanoma (DM),ACTIVE_NOT_RECRUITING,2017-02-06,2023-04-14,2026-05-15,INTERVENTIONAL,PHASE2,57,['Desmoplastic Melanoma'],Desmoplastic Melanoma,National Cancer Institute (NCI),[],['United States']
NCT05723601,Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream,Addressing Preference as a Patient-centered Outcome to Prevent Recurrent Urinary Tract Infection (rUTI) in Post-menopausal Women: a Cross-over Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2024-01-12,2027-01,2027-01,INTERVENTIONAL,PHASE4,21,['Recurrent Urinary Tract Infection'],Recurrent Urinary Tract Infection,Wake Forest University Health Sciences,[],['United States']
NCT04628494,A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL),"A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)",ACTIVE_NOT_RECRUITING,2021-01-13,2025-10-13,2028-04,INTERVENTIONAL,PHASE3,484,['Diffuse Large B-cell Lymphoma'],Diffuse Large B-cell Lymphoma,Genmab,['AbbVie'],"['Japan', 'Netherlands', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Finland', 'Denmark', 'South Korea', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Italy']"
NCT04901702,Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma,A Randomized Phase I/II Study of Talazoparib or Temozolomide in Combination With Onivyde in Children With Recurrent Solid Malignancies and Ewing Sarcoma,RECRUITING,2021-06-09,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE1,90,"['Recurrent Solid Tumor', 'Recurrent Ewing Sarcoma', 'Recurrent Hepatoblastoma', 'Recurrent Malignant Germ Cell Tumor', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Neuroblastoma', 'Recurrent Osteosarcoma', 'Recurrent Peripheral Primitive Neuroectodermal Tumor', 'Recurrent Rhabdoid Tumor', 'Recurrent Rhabdomyosarcoma', 'Recurrent Soft Tissue Sarcoma', 'Recurrent Wilms Tumor', 'Refractory Ewing Sarcoma', 'Refractory Hepatoblastoma', 'Refractory Malignant Germ Cell Tumor', 'Refractory Malignant Solid Neoplasm', 'Refractory Neuroblastoma', 'Refractory Osteosarcoma', 'Refractory Peripheral Primitive Neuroectodermal Tumor', 'Refractory Rhabdoid Tumor', 'Refractory Rhabdomyosarcoma', 'Refractory Soft Tissue Sarcoma']",Recurrent Solid Tumor,St. Jude Children's Research Hospital,"['Pfizer', 'Ipsen']","['United States', 'Canada']"
NCT05104502,Immunomodulatory Effects of Fasting in Healthy Adults,Immunomodulatory Effects of Fasting in Healthy Adults,RECRUITING,2022-03-25,2026-06,2026-06,INTERVENTIONAL,NA,4,['Fasting'],Fasting,"University of California, Davis",[],['United States']
NCT06035120,An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema,An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema: The CONVERT II Trial,RECRUITING,2024-02-22,2027-06-30,2028-03-31,INTERVENTIONAL,NA,200,"['Emphysema, Pulmonary', 'Emphysema or COPD']","Emphysema, Pulmonary",Pulmonx Corporation,[],"['Netherlands', 'Austria', 'United States', 'France', 'Germany', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Australia']"
NCT03190941,Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients,A Phase I/II Study Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients,RECRUITING,2017-09-21,2027-06-29,2028-06-29,INTERVENTIONAL,PHASE1,110,"['Pancreatic Cancer', 'Gastric Cancer', 'Gastrointestinal Cancer', 'Colon Cancer', 'Rectal Cancer']",Pancreatic Cancer,National Cancer Institute (NCI),[],['United States']
NCT02214836,Ultrasound Imaging of Kidney Stones and Lithotripsy,Ultrasound Imaging of Kidney Stones and Lithotripsy,ACTIVE_NOT_RECRUITING,2015-01-01,2026-12-31,2027-12-31,INTERVENTIONAL,NA,370,"['Kidney Stones', 'Nephrolithiasis', 'Urolithiasis', 'Ureter Stones']",Kidney Stones,University of Washington,"['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', 'Congressionally Directed Medical Research Programs']",['United States']
NCT06465810,Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis,"A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients With Transthyretin (ATTR) Amyloidosis",RECRUITING,2024-06-25,2031-12-29,2031-12-29,OBSERVATIONAL,,1850,"['Transthyretin Amyloidosis', 'ATTR-CM', 'ATTRv-PN', 'ATTR', 'ATTR-Mixed', 'hATTR']",Transthyretin Amyloidosis,AstraZeneca,['ICON plc'],"['United Kingdom', 'United States', 'Canada', 'Germany']"
NCT05463224,Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients,"Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients: A Single-arm, Phase II Single-center Trial",ACTIVE_NOT_RECRUITING,2023-01-02,2026-03-31,2026-12-31,INTERVENTIONAL,PHASE2,150,['NSCLC'],NSCLC,Myung-Ju Ahn,[],['South Korea']
NCT06692361,Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder,"Assessment of the Effectiveness and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder Who Do Not Show Early Improvement Following Antidepressant Treatment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study",RECRUITING,2025-01-01,2026-06,2026-12,INTERVENTIONAL,NA,214,"['Major Depressive Disorder (MDD)', 'Depression - Major Depressive Disorder']",Major Depressive Disorder (MDD),Gang Wang,"['Shandong Daizhuang Hospital', 'Tianjin Anding Hospital', 'The First Affiliated Hospital, Zhejiang University', 'The First Hospital of Hebei Medical University', 'West China Hospital', ""Wuhu Fourth People's Hospital""]",['China']
NCT07259746,Study of Student Flourishing,A Multi-Institutional Longitudinal Randomized Controlled Trial of Student Well-Being Using the Flourish App,RECRUITING,2025-09-22,2026-05,2026-05,INTERVENTIONAL,NA,2500,['Healthy'],Healthy,"Flourish Science, Inc.",[],"['New Zealand', 'United States', 'Canada']"
NCT07216703,A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22),"A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab With or Without Bevacizumab Compared With Standard of Care as Firstline Maintenance Treatment for Participants With Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer With PD-L1 CPS Greater Than or Equal to 1 (TroFuse-036/GOG-3123/ENGOT-cx22)",RECRUITING,2025-12-12,2031-10-29,2031-10-29,INTERVENTIONAL,PHASE3,1023,['Cervical Cancer'],Cervical Cancer,Merck Sharp & Dohme LLC,[],['United States']
NCT07015983,"A Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)","A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Active SLE (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants",RECRUITING,2025-07-14,2028-05-17,2032-06-15,INTERVENTIONAL,PHASE2,89,"['Lupus Erythematosus, Systemic', 'Lupus Nephritis']","Lupus Erythematosus, Systemic","Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'Austria', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Portugal', 'Argentina', 'Germany']"
NCT07233005,The Effect of Quadriceps Sets Exercise on Knee Joint Biomechanics and Functional Outcomes of Post-Total Knee Arthroplasty Patients,The Effect of Quadriceps Sets Exercise on Knee Joint Biomechanics and Functional Outcomes of Post-Total Knee Arthroplasty Patients,RECRUITING,2025-12-01,2026-02-01,2026-02-01,INTERVENTIONAL,NA,40,['Total Knee Arthroplasty'],Total Knee Arthroplasty,Cairo University,[],['Saudi Arabia']
NCT07258186,Generation of Endometrial Carcinoma Organoids,Feasibility Study of the Generation of Endometrial Carcinoma Organoids From Tumor Samples Transferred From Extramural Facilities,RECRUITING,2025-03-23,2028-09-23,2028-09-23,OBSERVATIONAL,,20,['Endometrial Cancer'],Endometrial Cancer,Regina Elena Cancer Institute,['Azienda Ospedaliera Universitaria Integrata Verona'],['Italy']
NCT05416125,Vyvanse in Children Aged 6 to 12 Years,Lisdexamfetamine for the Treatment of Severe Obesity in Children Aged 6 to 12 Years,RECRUITING,2023-12-20,2026-07-31,2027-07-31,INTERVENTIONAL,EARLY_PHASE1,40,"['Obesity, Childhood']","Obesity, Childhood",University of Minnesota,[],['United States']
NCT05307835,Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection,Clinical Study of a Personalized Neoantigen Vaccine in Esophagus Cancer Patients Who Have Completed Adjuvant Therapy Following Neoadjuvant Therapy and Surgical Resection,ACTIVE_NOT_RECRUITING,2021-12-02,2026-06-30,2026-12-31,INTERVENTIONAL,PHASE1,27,['Resectable Esophageal Cancer'],Resectable Esophageal Cancer,"Second Affiliated Hospital, School of Medicine, Zhejiang University","['Hangzhou Neoantigen Therapeutics Co., Ltd.']",['China']
NCT05820711,Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy,A Phase I Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Xerostomia After Radiation Therapy for Head and Neck Cancer,ACTIVE_NOT_RECRUITING,2023-07-17,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE1,23,"['Head and Neck Cancer', 'Xerostomia']",Head and Neck Cancer,"University of Wisconsin, Madison",['National Institute of Dental and Craniofacial Research (NIDCR)'],['United States']
NCT07224763,Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD,EXTEND: A Prospective Study to Evaluate the Safety and Efficacy of GGTA1 KO Thymokidney XenoTransplantation in Patients With End-stage Renal Disease (ESRD),RECRUITING,2026-03,2029-03,2076-03,INTERVENTIONAL,PHASE1,50,"['ESRD (End-Stage Renal Disease)', 'Kidney Transplantation', 'Xenotransplantation']",ESRD (End-Stage Renal Disease),United Therapeutics,[],['United States']
NCT07257367,Pressure Sensing Sheath Blood Pressure Monitoring Compared to Traditional Methods in Interventional Procedures,"Accuracy and Safety Assessment of Pressure Sensing Sheath Blood Pressure Monitoring Compared to Traditional Invasive and Non-invasive Blood Pressure Monitoring in Interventional Procedures: A Prospective, Single-Center, Self-Controlled Randomized Study",RECRUITING,2025-08-01,2026-12-31,2027-05-31,OBSERVATIONAL,,50,"['Blood Pressure Monitoring', 'Neuroendovascular Procedures']",Blood Pressure Monitoring,Shanghai Fourth People's Hospital Tongji University,[],['China']
NCT07259447,Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer,Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer,RECRUITING,2024-06-21,2026-08-01,2026-12-31,INTERVENTIONAL,NA,30,"['NSCLC (Advanced Non-small Cell Lung Cancer)', 'Adaptive Radiotherapy']",NSCLC (Advanced Non-small Cell Lung Cancer),Universitaire Ziekenhuizen KU Leuven,[],['Belgium']
NCT05620407,A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)",ACTIVE_NOT_RECRUITING,2023-01-12,2026-10-19,2028-11-13,INTERVENTIONAL,PHASE3,513,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,Bristol-Myers Squibb,[],"['Bulgaria', 'Japan', 'Australia', 'Hungary', 'Chile', 'Puerto Rico', 'Peru', 'Thailand', 'Czechia', 'Poland', 'India', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'United Kingdom', 'Greece', 'Portugal', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Argentina']"
NCT07257744,"Comparison of IV Analgesia, Thoracic Epidural Analgesia, and ESP Block for Chronic Pain After Open Heart Surgery","A Comparative Evaluation of Intravenous Analgesia, Thoracic Epidural Analgesia, and Erector Spinae Plane Block on Chronic Postoperative Pain Following Open Heart Surgery",RECRUITING,2025-02-15,2025-12-20,2026-04-20,OBSERVATIONAL,,90,"['Chronic Postoperative Pain', 'Open Heart Surgery', 'Postoperative Analgesia', 'Analgesia']",Chronic Postoperative Pain,Karadeniz Technical University,[],['Turkey (Türkiye)']
NCT00001971,Evaluation of Patients With Liver Disease,Evaluation of Patients With Liver Disease,RECRUITING,1992-05-27,,,OBSERVATIONAL,,8050,"['Hepatitis D', 'Hepatitis C', 'Hepatitis B', 'Liver Disease']",Hepatitis D,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06732414,A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up,A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-up,RECRUITING,2025-01-28,2044-11-01,2045-11-01,OBSERVATIONAL,,10000,"['Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a']","Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a",National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT02867592,"Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors","Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults With Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors",ACTIVE_NOT_RECRUITING,2017-05-18,2021-06-30,2026-06-27,INTERVENTIONAL,PHASE2,109,"['Adrenal Cortical Carcinoma', 'Alveolar Soft Part Sarcoma', 'Central Nervous System Neoplasm', 'Childhood Clear Cell Sarcoma of Soft Tissue', 'Clear Cell Sarcoma of Soft Tissue', 'Ewing Sarcoma', 'Hepatoblastoma', 'Hepatocellular Carcinoma', 'Osteosarcoma', 'Recurrent Adrenal Cortical Carcinoma', 'Recurrent Alveolar Soft Part Sarcoma', 'Recurrent Clear Cell Sarcoma of Soft Tissue', 'Recurrent Ewing Sarcoma', 'Recurrent Hepatoblastoma', 'Recurrent Hepatocellular Carcinoma', 'Recurrent Kidney Wilms Tumor', 'Recurrent Malignant Solid Neoplasm', 'Recurrent Osteosarcoma', 'Recurrent Primary Malignant Central Nervous System Neoplasm', 'Recurrent Renal Cell Carcinoma', 'Recurrent Rhabdomyosarcoma', 'Recurrent Soft Tissue Sarcoma', 'Recurrent Thyroid Gland Medullary Carcinoma', 'Refractory Adrenal Cortical Carcinoma', 'Refractory Alveolar Soft Part Sarcoma', 'Refractory Clear Cell Sarcoma of Soft Tissue', 'Refractory Ewing Sarcoma', 'Refractory Hepatoblastoma', 'Refractory Hepatocellular Carcinoma', 'Refractory Malignant Solid Neoplasm', 'Refractory Osteosarcoma', 'Refractory Primary Central Nervous System Neoplasm', 'Refractory Primary Malignant Central Nervous System Neoplasm', 'Refractory Renal Cell Carcinoma', 'Refractory Rhabdomyosarcoma', 'Refractory Soft Tissue Sarcoma', 'Refractory Thyroid Gland Medullary Carcinoma', 'Refractory Wilms Tumor', 'Renal Cell Carcinoma', 'Rhabdomyosarcoma', 'Soft Tissue Sarcoma', 'Solid Neoplasm', 'Thyroid Gland Medullary Carcinoma', 'Wilms Tumor']",Adrenal Cortical Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06668064,A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56,"A 2-year Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Wet AMD",ACTIVE_NOT_RECRUITING,2024-10-22,2026-08,2027-08,INTERVENTIONAL,PHASE3,400,"['Wet Age Related Macular Degeneration', 'wAMD']",Wet Age Related Macular Degeneration,"EyePoint Pharmaceuticals, Inc.",[],['United States']
NCT06382051,Modifying PEST for Psoriatic Arthritis Screening,"A Multicenter, Prospective, Study to Evaluate the Impact of Modifying the Validated Psoriasis Epidemiology Screening Tool (PEST) on the Potential Diagnosis of Psoriatic Arthritis in Adult Patients With Moderate-to-severe Plaque Psoriasis in Canada (""ScreenX"")",RECRUITING,2025-01-23,2025-12-31,2026-08-31,INTERVENTIONAL,NA,502,"['Plaque Psoriasis', 'Psoriatic Arthritis']",Plaque Psoriasis,Novartis Pharmaceuticals,[],['Canada']
NCT07119541,Testing an Alliance-Focused Dialectical Behaviour Therapy Training for Borderline Personality Disorder,A Pilot Randomized Controlled Trial Evaluating an Alliance-Focused Dialectical Behaviour Therapy Training Intervention for Borderline Personality Disorder,ACTIVE_NOT_RECRUITING,2025-08-01,2025-11-28,2026-01-31,INTERVENTIONAL,NA,80,"['Borderline Personality Disorder', 'Emotion Dysregulation']",Borderline Personality Disorder,York University,[],['Canada']
NCT07259629,Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients,Fasting Induced Hypoglycaemia in Anaesthetised Paediatric Patients,RECRUITING,2025-05-12,2026-03-30,2027-01-12,OBSERVATIONAL,,6580,"['Hypoglycemia; Iatrogenic', 'Anesthesia', 'Pediatrics']",Hypoglycemia; Iatrogenic,Guy's and St Thomas' NHS Foundation Trust,"[""Evelina London Children's Charity"", 'Nova Biomedical', 'Kings Health Partners']",['United Kingdom']
NCT07169851,A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer,"A Phase 2, Double-blind, Placebo-Controlled Study to Evaluate LY3537021 for the Treatment of Chemotherapy-Induced Nausea and Vomiting in Adult Participants With Malignant Disease",RECRUITING,2025-11-28,2026-09,2026-09,INTERVENTIONAL,PHASE2,204,"['Nausea', 'Vomiting', 'Drug-Related Side Effects and Adverse Reactions', 'Neoplasms']",Nausea,Eli Lilly and Company,[],"['Japan', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'Romania', 'Australia']"
NCT07257575,A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally Advanced Gastric Adenocarcinoma,A Phase II Randomized Controlled Clinical Study of Serplulimab Combined With Chemotherapy in the Treatment of Patients With Locally Advanced Gastric Adenocarcinoma,ACTIVE_NOT_RECRUITING,2025-01-05,2027-01-31,2031-06-30,INTERVENTIONAL,PHASE2,138,['Gastric Cancer Stage III'],Gastric Cancer Stage III,Guangdong Provincial People's Hospital,['Shanghai Henlius Biotech'],['China']
NCT07092501,An Experimental Evaluation of Menthol-Flavored Tobacco Accessories,An Experimental Evaluation of Menthol-Flavored Tobacco Accessories: Subjective Effects and Purchasing Behavior,RECRUITING,2025-09-01,2025-12-20,2025-12-23,INTERVENTIONAL,NA,23,"['Cigarette', 'Smoking Behaviors', 'Cigarette Smoking Behavior']",Cigarette,Virginia Polytechnic Institute and State University,[],['United States']
NCT06561386,A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%,"A Phase 3, Randomized, Open-label Study of Nivolumab + Relatlimab Fixed-dose Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy as First-line Treatment for Participants With Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer and With Tumor Cell PD-L1 Expression ≥ 1%",RECRUITING,2024-10-07,2030-07-30,2032-08-04,INTERVENTIONAL,PHASE3,1000,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Bristol-Myers Squibb,[],"['Japan', 'New Zealand', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'Belgium', 'France', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Poland', 'India', 'South Africa', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Romania', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT04685200,"Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach","Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach",RECRUITING,2023-03-31,2026-10-31,2026-10-31,OBSERVATIONAL,,143,['Primary Sclerosing Cholangitis'],Primary Sclerosing Cholangitis,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06689800,Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy,Let's Get REAL: A Pilot Trial of a Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy,RECRUITING,2024-11-26,2026-05-31,2026-05-31,INTERVENTIONAL,NA,60,"['Hematologic Malignancy', 'Solid Tumor', 'Sickle Cell Disease', 'Aplastic Anemia', 'Immune Deficiency', 'Metabolic Disorder']",Hematologic Malignancy,Washington University School of Medicine,['National Cancer Institute (NCI)'],['United States']
NCT06498128,"Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®",QUVIVIQ® Pregnancy Registry,RECRUITING,2024-11-21,2033-03,2033-03,OBSERVATIONAL,,785,['Insomnia'],Insomnia,Idorsia Pharmaceuticals Ltd.,['Iqvia Pty Ltd'],"['United States', 'France', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT06226571,A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias,"A Phase 1, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Newly Diagnosed Acute Myeloid Leukemias Harboring Alterations in Lysine-specific Methyltransferase 2A (KMT2A/MLL), Nucleophosmin 1 (NPM1), and Nucleoporin 98 (NUP98) Genes",RECRUITING,2024-05-21,2027-02,2027-02,INTERVENTIONAL,PHASE1,76,['Acute Myeloid Leukemias'],Acute Myeloid Leukemias,Syndax Pharmaceuticals,[],"['Netherlands', 'United States', 'Spain', 'Canada', 'United Kingdom', 'Australia']"
NCT05800665,"A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer","A Phase 1, Open-Label, Multicenter, Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 in Patients With Advanced or Metastatic Prostate Cancer",RECRUITING,2023-05-02,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE1,210,"['Advanced Prostate Cancer', 'Metastatic Prostate Cancer']",Advanced Prostate Cancer,"Genentech, Inc.",[],"['United States', 'France', 'Spain', 'South Korea', 'Canada', 'United Kingdom', 'Australia']"
NCT05109975,A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors,"A Phase 1, Dose-finding Study of Debio 0123 as Monotherapy in Adult Patients With Advanced Solid Tumors, Followed by an Expansion Part to Assess Safety and Preliminary Anti-tumor Activity",ACTIVE_NOT_RECRUITING,2021-11-05,2026-01,2027-06,INTERVENTIONAL,PHASE1,155,['Advanced Solid Tumors'],Advanced Solid Tumors,Debiopharm International SA,[],"['Switzerland', 'Spain', 'United States']"
NCT06511934,Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01),"Intuitive, Complete Neural Control of Tablet Computers for Communication",RECRUITING,2024-07-22,2026-07-30,2027-07-30,INTERVENTIONAL,NA,2,"['Brainstem Stroke', 'ALS', 'Tetraplegia', 'Spinal Cord Injuries', 'Cervical Spinal Cord Injury']",Brainstem Stroke,"Leigh R. Hochberg, MD, PhD.","['Brown University', 'Stanford University', 'National Institute on Deafness and Other Communication Disorders (NIDCD)']",['United States']
NCT06659588,Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency,Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency,RECRUITING,2024-10-10,2026-10-10,2026-10-10,OBSERVATIONAL,,120,"['Humoral Primary Immunodeficiencies (PIDs)', 'Secondary Form of Humoral Immunodeficiencies', 'Combined Immunodeficiency (CID)', 'Severe Combined Immunodeficiency (SCID)']",Humoral Primary Immunodeficiencies (PIDs),Assistance Publique - Hôpitaux de Paris,['URC-CIC Paris Descartes Necker Cochin'],['France']
NCT07115160,The Leksand Hockey Trial on Grip Strength,The Leksand Hockey Trial on Grip Strength,RECRUITING,2025-11-05,2026-04-30,2026-11-30,INTERVENTIONAL,NA,40,"['Grip Strength', 'Performance', 'Injuries']",Grip Strength,"Dalarna County Council, Sweden",[],['Sweden']
NCT07211542,A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis,"A Randomized, Double-blind, Placebo-controlled Phase IIa Study to Evaluate the Efficacy and Safety of SHR-1905 Injection in Patients With Moderate to Severe Atopic Dermatitis",RECRUITING,2025-11-07,2026-09,2027-02,INTERVENTIONAL,PHASE2,70,['Moderate-to-severe Atopic Dermatitis'],Moderate-to-severe Atopic Dermatitis,"Guangdong Hengrui Pharmaceutical Co., Ltd",[],['China']
NCT04399941,Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis,Role of Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis,RECRUITING,2021-08-03,2026-09,2026-09,INTERVENTIONAL,NA,50,['End Stage Renal Disease'],End Stage Renal Disease,Boston Medical Center,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT03976063,Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation,Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation: a Double-blinded Randomized Controlled Trial,RECRUITING,2019-10-07,2026-11,2031-11,INTERVENTIONAL,PHASE3,850,['Preterm Premature Rupture of Membrane'],Preterm Premature Rupture of Membrane,Assistance Publique - Hôpitaux de Paris,"['Institut National de la Santé Et de la Recherche Médicale, France', 'Ministry of Health, France', 'Groupe de Recherche en Obstétrique et Gynécologie', 'URC-CIC Paris Descartes Necker Cochin']",['France']
NCT05975307,Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation,"A Single-arm, Phase II Clinical Trial to Treat Muscle-invasive Bladder Cancer With Neoadjuvant Chemotherapy Plus Anti-PD-1 Therapy Followed by Radiotherapy Plus Concurrent Anti-PD-1 Therapy",ACTIVE_NOT_RECRUITING,2023-12-01,2025-12-31,2029-12-31,INTERVENTIONAL,PHASE2,71,"['Muscle-Invasive Bladder Carcinoma', 'Programmed Cell Death Protein 1 Inhibitor', 'Radiotherapy']",Muscle-Invasive Bladder Carcinoma,Sun Yat-sen University,[],['China']
NCT07255352,Effect of Kinesio Taping Applied to the Suprahyoid Muscles on Swallowing Safety in Patients With Post-Stroke Dysphagia,Investigation of the Effects of Suprahyoid Kinesio Taping on Swallowing Safety and Hyolaryngeal Elevation in Patients With Post-Stroke Dysphagia,RECRUITING,2025-04-01,2026-04-01,2026-10-01,INTERVENTIONAL,NA,25,"['Stroke', 'Dysphagia', 'Swallowing Disorder']",Stroke,Harran University,[],['Turkey (Türkiye)']
NCT06781996,A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer,Phase III Randomized Controlled Open Label Clinical Trial to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer,RECRUITING,2025-09-09,2026-03-15,2026-12-15,INTERVENTIONAL,PHASE3,180,"['Breast Cancer', 'Breast Cancer Early Stage Breast Cancer (Stage 1-3)']",Breast Cancer,"Gustave Roussy, Cancer Campus, Grand Paris","['Resilience', 'WeShare', 'National Cancer Institute, France']",['France']
NCT05554302,Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis,Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis,RECRUITING,2023-01-10,2030-01,2030-01,INTERVENTIONAL,PHASE2,20,"['Brain Metastases', 'Brain Cancer']",Brain Metastases,Baptist Health South Florida,['Blue Earth Diagnostics'],['United States']
NCT06766214,Attexis and tDCS for the Treatment of ADHD,Augmentation Von Online-Psychotherapie Mit tDCS Bei Der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS),ACTIVE_NOT_RECRUITING,2024-09-01,2025-11-21,2026-02-28,INTERVENTIONAL,NA,30,['ADHD'],ADHD,University of Regensburg,"['Sooma Medical', 'Gaia AG']",['Germany']
NCT06321458,Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity,Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity: the LightWAY Randomised Trial: Lighthouse Consortium on Obesity Management (LightCOM) Trial no 3,RECRUITING,2024-04-29,2028-03,2048-12,INTERVENTIONAL,NA,600,['Obesity'],Obesity,Carsten Dirksen,"['University of Copenhagen', 'University of Southern Denmark', 'University of Oxford', 'Copenhagen Trial Unit, Center for Clinical Intervention Research']","['United Kingdom', 'Denmark']"
NCT04823663,BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES),BoStOn SCientific Rhythm MAnagemenT REgiStry,RECRUITING,2021-03-31,2030-12-31,2030-12-31,OBSERVATIONAL,,12500,['Cardiac Disease'],Cardiac Disease,Boston Scientific Corporation,[],"['Belgium', 'Israel', 'France', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Greece', 'Germany']"
NCT06561308,Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer,"A Single-arm, Multicenter Phase II Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer in Clinical Efficacy",RECRUITING,2025-09-01,2026-12-01,2031-12-01,INTERVENTIONAL,PHASE2,39,['Endometrioid Endometrial Cancer'],Endometrioid Endometrial Cancer,Women's Hospital School Of Medicine Zhejiang University,"['Xiangya Hospital of Central South University', 'Tongji Hospital', 'Qilu Hospital of Shandong University', 'Anhui Provincial Cancer Hospital', 'Sichuan Cancer Hospital and Research Institute', ""Henan Provincial People's Hospital"", 'Hunan Cancer Hospital', 'Zhejiang Cancer Hospital', 'First Affiliated Hospital of Wenzhou Medical University', 'Ningbo No. 1 Hospital', 'The First Affiliated Hospital of Zhengzhou University']",['China']
NCT07179640,"A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1","A Randomised, Placebo Controlled, Double-Blind, Single-Ascending Dose And Multiple-Ascending Dose First-In-Human Study To Investigate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Orally Administered ALE1 With Or Without Food In Healthy Adult Subjects And Adult Patients With Hypophosphatasia",RECRUITING,2025-09-30,2027-01,2027-01,INTERVENTIONAL,PHASE1,120,['Hypophosphatasia (HPP)'],Hypophosphatasia (HPP),Alesta Therapeutics,[],['New Zealand']
NCT06687967,A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1),"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults",RECRUITING,2024-11-28,2027-04-12,2027-07-05,INTERVENTIONAL,PHASE3,136,['Lichen Simplex Chronicus'],Lichen Simplex Chronicus,Sanofi,['Regeneron Pharmaceuticals'],"['Japan', 'Hungary', 'Turkey (Türkiye)', 'China', 'United States', 'Mexico', 'Chile', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Greece', 'Portugal', 'Argentina', 'Germany']"
NCT04597710,Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing,Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing,ACTIVE_NOT_RECRUITING,2021-02-18,2025-12-31,2025-12-31,OBSERVATIONAL,,200,"['Liver Cancer', 'Liver Metastasis Colon Cancer']",Liver Cancer,Perspectum,[],['United Kingdom']
NCT06425549,A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis,"A Multicenter, Randomized, Parallel-Group, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis",RECRUITING,2024-06-25,2028-08-21,2030-11-08,INTERVENTIONAL,PHASE3,168,['Moderate to Severe Plaque Psoriasis'],Moderate to Severe Plaque Psoriasis,UCB Biopharma SRL,[],"['Belgium', 'Japan', 'Hungary', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Czechia', 'Poland', 'Germany']"
NCT06373159,An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan,A Study for the Disseminated Intravascular Coagulation Among Patients With Sepsis in Japan: A Hospital-based Cohort Study,ACTIVE_NOT_RECRUITING,2024-03-22,2025-12-31,2025-12-31,OBSERVATIONAL,,5740,"['Sepsis', 'Disseminated Intravascular Coagulation']",Sepsis,Bayer,[],['Japan']
NCT07255859,CRYSTALSIGHT Cohort 2.0,CRYSTALSIGHT: Clinical Evaluation of OCCUTRACK's CRYSTALSIGHT Device Through Remote Monitoring for Disease Recurrence of Wet Aged-Related Macular Degeneration Using Eye Gaze Tracking (Cohort 2.0).,RECRUITING,2025-06-16,2026-07-31,2027-07-31,INTERVENTIONAL,NA,60,['Maculopathy'],Maculopathy,Tan Tock Seng Hospital,[],['Singapore']
NCT07251413,Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma,Phase Ib/II Study Of The Combination Of Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma,RECRUITING,2025-10-22,2028-12,2028-12,INTERVENTIONAL,PHASE1,18,['Cutaneous Basal Cell Carcinoma'],Cutaneous Basal Cell Carcinoma,Instituto Oncológico Dr Rosell,['Regeneron Pharmaceuticals'],['Spain']
NCT07226882,A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults,"A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF DIFFERENT VACCINATION SCHEDULES OF 6-VALENT OSPA-BASED LYME DISEASE VACCINE, VLA15, IN HEALTHY ADULT PARTICIPANTS",RECRUITING,2025-11-19,2028-02-14,2028-02-14,INTERVENTIONAL,PHASE3,200,['Lyme Borreliosis'],Lyme Borreliosis,Pfizer,[],['United States']
NCT01696734,Domperidone in Treating Patients With Gastrointestinal Disorders,Treatment Protocol for the Compassionate Use of Domperidone,RECRUITING,2012-10-23,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE3,200,"['Digestive System Disorder', 'Dyspepsia', 'Esophagitis', 'Gastroesophageal Reflux Disease', 'Gastroparesis', 'Heartburn', 'Nausea and Vomiting']",Digestive System Disorder,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT06942533,Effect of Visual Feedback From the SpiroGym Mobile Application,The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease,RECRUITING,2025-05-01,2026-05-01,2026-07-01,INTERVENTIONAL,NA,30,"['Parkinson Disease', 'Breathing Exercises', 'Telemedicine']",Parkinson Disease,"General University Hospital, Prague",[],['Czechia']
NCT06190717,Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial,Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial,RECRUITING,2024-02-21,2026-02-01,2026-02-01,INTERVENTIONAL,NA,304,"['Diabetes', 'End Stage Renal Disease']",Diabetes,"Sonavex, Inc.",[],['United States']
NCT06464926,Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE),A Prospective Randomized Controlled Trial of Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System,RECRUITING,2025-06-23,2030-06,2030-06,INTERVENTIONAL,NA,148,"['Nausea', 'Vomiting']",Nausea,"Enterra Medical, Inc.",['Bright Research Partners'],"['Sweden', 'Belgium', 'United States', 'France']"
NCT05911360,"A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF","A Phase 3b, Multicenter, Single-arm, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to DTG/3TC Single Tablet Regimen Administered Once Daily From a Bictegravir/Emtricitabine/Tenofovir Alafenamide Single Tablet Regimen in People Living With HIV of at Least 50 Years of Age Who Are Virologically Suppressed",ACTIVE_NOT_RECRUITING,2023-01-31,2025-02-24,2026-01-13,INTERVENTIONAL,PHASE3,205,"['HIV', 'HIV Infections']",HIV,ViiV Healthcare,[],"['Belgium', 'Netherlands', 'Austria', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Portugal', 'Germany']"
NCT06995820,"A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.","A Phase I Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of AZD1613 Following Single and Multiple Dose Administration in Healthy Participants",RECRUITING,2025-06-06,2026-10-12,2026-10-12,INTERVENTIONAL,PHASE1,136,['Healthy'],Healthy,AstraZeneca,['Parexel'],['United States']
NCT07256704,"Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)",Hypnosis and Attention in Patients With a Neurological Disease,RECRUITING,2025-11-18,2029-07-31,2029-07-31,INTERVENTIONAL,NA,48,"['Stroke', 'Traumatic Brain Injury', 'Multiple Sclerosis']",Stroke,Luzerner Kantonsspital,[],['Switzerland']
NCT06161025,"A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","A Phase 2/3, Multicenter, Randomized Study of Raludotatug Deruxtecan (R-DXd), a CDH6-directed Antibody-drug Conjugate, in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer",RECRUITING,2024-02-27,2027-12-31,2029-12-31,INTERVENTIONAL,PHASE2,710,['Solid Cancer'],Solid Cancer,Daiichi Sankyo,['Merck Sharp & Dohme LLC'],"['Japan', 'United Kingdom', 'China', 'United States', 'France', 'Germany', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Poland', 'Portugal', 'Australia']"
NCT06935890,Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation,Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation,RECRUITING,2025-11-25,2029-10,2029-10,INTERVENTIONAL,PHASE4,100,"['Allergy', 'Immunotherapy', 'Venom Allergy']",Allergy,Murdoch Childrens Research Institute,[],['Australia']
NCT07256483,Influence of the Menstrual Cycle on the Maximal Strength of the External and Internal Rotators of the Shoulder in High-level Sports Women.,Influence of the Menstrual Cycle on the Maximal Strength of the External and Internal Rotators of the Shoulder in High-level Sports Women From Montpellier Hérault Rugby.,RECRUITING,2025-09-01,2025-12-20,2025-12-20,INTERVENTIONAL,NA,30,['Shoulder Injuries'],Shoulder Injuries,"Clinique Saint Jean, France",[],['France']
NCT07256522,"Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger","Comparative Evaluation of Finger Splint, Paraffin, and Peloidotherapy Interventions in the Management of Trigger Finger. A Prospective, Randomized, Controlled Study",RECRUITING,2025-11-03,2026-12-30,2026-12-30,INTERVENTIONAL,NA,60,"['Trigger Finger', 'Splint Therapy', 'Paraffin Bath', 'Peloidotherapy', 'Efficacy and Safety', 'Randomised Clinical Trial']",Trigger Finger,Konya Beyhekim Training and Research Hospital,[],['Turkey (Türkiye)']
NCT07256951,Gen 2 Battrode Wear Study,Gen 2 Battrode Wear Study,RECRUITING,2025-11-12,2025-12-19,2026-05-15,INTERVENTIONAL,NA,30,['Adhesive Wear Time'],Adhesive Wear Time,Baxter Healthcare Corporation,[],['United States']
NCT07241923,"A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection","A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SYH2070 Injection in Healthy Subjects",RECRUITING,2025-11-15,2026-11-01,2027-11-01,INTERVENTIONAL,PHASE1,48,['Healthy Subjects (HS)'],Healthy Subjects (HS),"CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.",[],['China']
NCT05183646,A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB,"A Pivotal Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of DMX-200 in Patients With Focal Segmental Glomerulosclerosis (FSGS) Who Are Receiving an Angiotensin II Receptor Blocker (ARB)",RECRUITING,2022-05-30,2029-12,2029-12,INTERVENTIONAL,PHASE3,286,['FSGS'],FSGS,Dimerix Bioscience Pty Ltd,[],"['Japan', 'New Zealand', 'Hong Kong', 'China', 'Australia', 'France', 'Denmark', 'Thailand', 'Czechia', 'Mexico', 'Spain', 'Taiwan', 'Malaysia', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07161895,Kinesiophobia and Its Impact on Pain and Function in Knee Osteoarthritis,Prevalence of Kinesiophobia and Its Effects on Functional Capacity and Pain Severity in Patients With Primary Knee Osteoarthritis,ACTIVE_NOT_RECRUITING,2025-05-01,2025-11-01,2025-12-01,OBSERVATIONAL,,84,"['Knee Osteoarthritis (Knee OA)', 'OA', 'Kinesiophobia']",Knee Osteoarthritis (Knee OA),Ankara Training and Research Hospital,[],['Turkey (Türkiye)']
NCT07208136,A Study of JMKX005425 in Patients With MSI-H/dMMR Advanced Solid Tumors,"An Open-label, Multi-center Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of JMKX005425 Tablets in Subjects With Microsatellite Instability-High or Mismatch Repair Deficient Advanced Solid Tumors",RECRUITING,2025-10-22,2027-12,2028-12,INTERVENTIONAL,PHASE1,102,['Advanced Solid Tumors'],Advanced Solid Tumors,Jemincare,[],['China']
NCT07248176,Universal CAR-T Cell Therapy for MM,A Clinical Study on the Safety and Efficacy of Allogeneic CAR T Cells Targeting BCMA in the Treatment of Adult r/r Multiple Myeloma,RECRUITING,2025-04-10,2027-03-15,2028-04-18,INTERVENTIONAL,NA,6,"['Multiple Myeloma', 'Multiple Myeloma in Relapse', 'Multiple Myeloma, Refractory']",Multiple Myeloma,Bioray Laboratories,['Shanghai Tongji Hospital (Tongji Hospital of Tongji University)'],['China']
NCT07139496,Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation,Combined Injury-site & Lumbosacral Epidural Stimulation for Spinal Cord Injury - a Pilot Study.,RECRUITING,2025-09-01,2028-09-01,2029-03-01,INTERVENTIONAL,NA,5,['Spinal Cord Injuries (SCI)'],Spinal Cord Injuries (SCI),The University of Hong Kong,[],['Hong Kong']
NCT07023289,A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease,"A Phase 2, Randomized, Open-Label Study Comparing Telisotuzumab Adizutecan (ABBV-400) Monotherapy to the Current Standard of Care in Subjects With Post Adjuvant ctDNA Positive Colorectal Cancer and No Radiographic Evidence of Disease (NED)",RECRUITING,2025-08-07,2029-11,2029-11,INTERVENTIONAL,PHASE2,140,['Colorectal Cancer'],Colorectal Cancer,AbbVie,[],"['Japan', 'United States', 'Denmark', 'Spain', 'Taiwan', 'South Korea', 'Italy']"
NCT06062238,Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Clinical Trial to Assess the Prophylactic Efficacy, Safety, and Immunogenicity of the Investigational M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine When Administered Intramuscularly on a 0,1-month Schedule to Adolescents and Adults",ACTIVE_NOT_RECRUITING,2024-03-05,2028-04,2028-04,INTERVENTIONAL,PHASE3,20081,['Tuberculosis'],Tuberculosis,Gates Medical Research Institute,"['Wellcome Trust', 'Bill and Melinda Gates Foundation']","['South Africa', 'Kenya', 'Indonesia', 'Zambia', 'Malawi']"
NCT06803992,Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter,Induction of Labor in Women With Unfavorable Cervix at Term - Comparison of Propess Versus Prostaglandin E2 Vaginal Gel and Extra-amniotic Balloon Catheter,RECRUITING,2025-04-06,2027-01-29,2027-01-29,INTERVENTIONAL,PHASE4,140,['Induction of Labor'],Induction of Labor,"HaEmek Medical Center, Israel",[],['Israel']
NCT05732311,Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression,Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression,RECRUITING,2023-04-25,2026-01-31,2026-02-28,INTERVENTIONAL,NA,60,['Depression'],Depression,"Berthold Langguth, MD, Ph.D.",[],['Germany']
NCT06253130,"A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors","A First-in-human, Phase 1/2, Open-label, Multi-center, Dose-escalation, Dose-optimization, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of PARP1 Selective Inhibitor, IMP1734, as Monotherapy in Patients With Advanced Solid Tumors",RECRUITING,2023-12-11,2026-02-01,2026-12-01,INTERVENTIONAL,PHASE1,70,['Advanced Solid Tumor'],Advanced Solid Tumor,Eikon Therapeutics,"['Impact Therapeutics, Inc.']","['China', 'United States', 'France', 'Denmark', 'Spain', 'South Korea', 'Canada', 'Australia']"
NCT06664177,Analgesic Efficacy of Quadratus Lumborum vs. Transversalis Fascia Block in Inguinal Hernia Surgery,Comparison of the Postoperative Analgesic Efficacy of Quadratus Lumborum Block and Transversalis Fascia Block in Inguinal Hernia Surgery,RECRUITING,2024-11-01,2026-06-01,2026-06-10,INTERVENTIONAL,NA,60,"['Pain, Postoperative']","Pain, Postoperative",Gaziosmanpasa Research and Education Hospital,[],['Turkey (Türkiye)']
NCT06588153,A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China,A Phase 4 Single-arm Open-label Study for the Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China,RECRUITING,2025-05-24,2027-05-24,2027-05-24,INTERVENTIONAL,PHASE4,100,['Glucocorticoid-induced Osteoporosis'],Glucocorticoid-induced Osteoporosis,Amgen,[],['China']
NCT06029972,Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis,"A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Ranging Study Evaluating the Efficacy and Safety of GS-5290 in Participants With Moderately to Severely Active Ulcerative Colitis",RECRUITING,2023-12-05,2026-04,2027-05,INTERVENTIONAL,PHASE2,176,['Ulcerative Colitis'],Ulcerative Colitis,Gilead Sciences,[],"['Belgium', 'Japan', 'Hungary', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Australia']"
NCT05636514,Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS,A Phase I Study of Oral Decitabine and Cedazuridine (ASTX727) In Combination With Defactinib (VS-6063) as Therapy of Myelodysplastic Syndromes and Low-blast Acute Myeloid Leukaemia,RECRUITING,2022-12-14,2025-12-30,2027-12-30,INTERVENTIONAL,PHASE1,12,"['Myelodysplastic Syndromes', 'Chronic Myelomonocytic Leukemia', 'Acute Myeloid Leukemia']",Myelodysplastic Syndromes,Clinical Hub for Interventional Research (CHOIR),"['The University of New South Wales', 'Australian National University']",['Australia']
NCT06847854,"A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)","A Phase I, Multipart, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7497372 Following Intravitreal Administration in Participants With Diabetic Macular Edema (Part 1 Non-Randomized, Open-Label, Multiple Ascending Dose; Part 2 Randomized, Double-Masked)",RECRUITING,2022-12-08,2027-02-28,2027-04-30,INTERVENTIONAL,PHASE1,176,['Diabetic Macular Edema'],Diabetic Macular Edema,"Genentech, Inc.",[],"['Puerto Rico', 'United States']"
NCT06439888,Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer,Pan-lesions SBRT Combined With Lymphocyte Support Through ATRA-driven Blockade of MDSC in Patients With Oligo-metastatic Solid Cancer,RECRUITING,2024-07-11,2026-09,2027-01,INTERVENTIONAL,PHASE1,58,"['Oligometastatic Disease', 'Solid Tumor, Adult']",Oligometastatic Disease,"Gustave Roussy, Cancer Campus, Grand Paris",[],['France']
NCT05948943,Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.,"A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.",RECRUITING,2023-11-24,2028-05-31,2033-05-02,INTERVENTIONAL,PHASE2,232,['Lymphatic Malformations'],Lymphatic Malformations,Novartis Pharmaceuticals,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Australia', 'Germany']"
NCT04114682,Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes,Longitudinal Assessment of Multiple Organs in Patients With Type 2 Diabetes,ACTIVE_NOT_RECRUITING,2020-01-27,2025-03-31,2026-09-30,OBSERVATIONAL,,135,['Type 2 Diabetes'],Type 2 Diabetes,Perspectum,"['University of Liverpool', 'Liverpool University Hospitals NHS Foundation Trust', 'Oxford University Hospitals NHS Trust', 'Royal Free Hospital NHS Foundation Trust']",['United Kingdom']
NCT07255937,PMCF Study of Debridement Pad,"Post Market Clinical Follow up Study to Confirm the Ongoing Safety and Performance of a Debridement Pad in Superficial, Chronic and Acute Wounds",RECRUITING,2025-11-20,2026-07-10,2026-07-10,INTERVENTIONAL,NA,184,"['Diabetic Ulcers', 'Venous Leg Ulcer', 'Arterial Leg Ulcer', 'Pressure Ulcer', 'Postoperative Wound Healing', 'Traumatic Wounds', 'Surgical Wounds', 'Burns and Scalds']",Diabetic Ulcers,Advanced Medical Solutions Ltd.,[],['Spain']
NCT02670408,Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation,"Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation, a Multicenter Study (INTERHEART)",RECRUITING,2016-01,2026-12,2027-07,OBSERVATIONAL,,900,['Cardiac Transplant Disorder'],Cardiac Transplant Disorder,University of Alberta,[],"['Austria', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Czechia', 'Australia']"
NCT07220538,A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment,"Pragmatic Open-label, Parallel-group Clinical Trial on the Effectiveness of Extract of Ginkgo Biloba Leaves Tablets as add-on to Standard of Care in Participants With Cognitive Impairment After an Acute Ischemic Stroke (GiCIIS)",RECRUITING,2025-11-28,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE4,400,"['Ischemic Stroke Hospitalized', 'Impairment, Cognitive']",Ischemic Stroke Hospitalized,Dr. Willmar Schwabe GmbH & Co. KG,['Beijing Tiantan Hospital'],['China']
NCT06931691,"A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China","A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan on Disease Management, Treatment-Related Outcomes and Healthcare Resource Utilization for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria in China",RECRUITING,2025-06-10,2027-04-20,2027-04-20,OBSERVATIONAL,,80,['Paroxysmal Nocturnal Hemoglobinuria'],Paroxysmal Nocturnal Hemoglobinuria,Novartis Pharmaceuticals,[],['China']
NCT06795022,First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours,"A Modular Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD9793, a T Cell-engaging Antibody Targeting Glypican-3 (GPC3) in Adult Participants With Advanced or Metastatic Solid Tumours (RHEA-1)",RECRUITING,2025-03-27,2028-02-25,2028-07-25,INTERVENTIONAL,PHASE1,304,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,AstraZeneca,[],"['Japan', 'Hong Kong', 'China', 'United States', 'Spain', 'Taiwan', 'South Korea']"
NCT06094205,Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02),Understanding and Restoring Speech Production Using an Intracortical Brain-computer Interface,RECRUITING,2023-10-16,2027-08-31,2027-08-31,INTERVENTIONAL,NA,2,"['Anarthria', 'Dysarthria', 'Tetraplegia', 'Spinal Cord Injuries', 'Amyotrophic Lateral Sclerosis', 'Brain Stem Infarctions', 'Locked-in Syndrome', 'Muscular Dystrophies']",Anarthria,"Leigh R. Hochberg, MD, PhD.",['National Institute on Deafness and Other Communication Disorders (NIDCD)'],['United States']
NCT06253494,"Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer","Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer",RECRUITING,2024-05-14,2026-12-31,2028-12-31,INTERVENTIONAL,PHASE1,60,"['Endometrial Cancer', 'Cancer of Endometrium', 'Carcinoma of Endometrium', 'Endometrial Carcinoma']",Endometrial Cancer,National Cancer Institute (NCI),[],['United States']
NCT06987253,Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery,Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery,RECRUITING,2025-11-06,2026-05-31,2026-05-31,INTERVENTIONAL,NA,60,"['Tooth Extrusion', 'Wound Healing']",Tooth Extrusion,ENIKAM d.o.o.,[],['Slovenia']
NCT06706414,NT-NOA - Novel Treatment of Some Men With Non-Obstructive Azoospermia,Novel Treatment of Some Men With Non-Obstructive Azoospermia (NT-NOA): A Clinical Interventional Study,ACTIVE_NOT_RECRUITING,2025-03-01,2026-08,2026-08,INTERVENTIONAL,PHASE1,16,"['Infertility, Male']","Infertility, Male",Martin Blomberg Jensen,[],['Denmark']
NCT06981143,Oncologists' Perceptions on Physical Activity and Exercise,"""Investigation of Knowledge and Perceptions of Physical Activity and Exercise of Greek Specialists and Residents in Pathological Oncology""",ACTIVE_NOT_RECRUITING,2025-07-15,2025-10-31,2026-02,OBSERVATIONAL,,606,['Perceptions on Physical Activity and Exercise'],Perceptions on Physical Activity and Exercise,University of Thessaly,[],['Greece']
NCT01698489,The Very Large Database of Lipids,The Very Large Database of Lipids (VLDL): A Clinical Laboratory Big Data Project,ACTIVE_NOT_RECRUITING,2006-04,2026-04,2026-04,OBSERVATIONAL,,5051467,['Lipid Disorders and Lipid Measurement'],Lipid Disorders and Lipid Measurement,Johns Hopkins University,['VAP Diagnostics Lab'],['United States']
NCT05065216,Treatment of Acute Ischemic Stroke (ReMEDy2 Trial),"Phase 2/3 Adaptive Design, Randomized Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of DM199 for the Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)",RECRUITING,2021-11-07,2026-12,2026-12,INTERVENTIONAL,PHASE2,728,"['Acute Stroke', 'Ischemic Stroke', 'Stroke']",Acute Stroke,DiaMedica Therapeutics Inc,[],"['Georgia', 'United States', 'Canada']"
NCT05285904,Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study,Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study (KOSMOS),ACTIVE_NOT_RECRUITING,2022-05-12,2026-03-31,2026-03-31,OBSERVATIONAL,,107,['Multiple Sclerosis'],Multiple Sclerosis,Novartis Pharmaceuticals,[],['Switzerland']
NCT06723158,Oral Surgery Virtual Reality Glasses Study,Investigating the Impact of Virtual Reality Glasses on Sedation Requirement and Patient Experience in Patients Undergoing Oral Surgery,RECRUITING,2025-11-18,2026-03,2026-03,INTERVENTIONAL,NA,80,"['Procedural Anxiety', 'Procedural Pain']",Procedural Anxiety,Boston University,[],['United States']
NCT05767047,A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis,"A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet's Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis",RECRUITING,2023-03-23,2036-03-17,2036-03-17,INTERVENTIONAL,PHASE3,48,"[""Behçet's Disease"", 'Juvenile Psoriatic Arthritis']",Behçet's Disease,Amgen,[],"['Greece', 'Spain', 'Turkey (Türkiye)', 'Israel']"
NCT03448042,A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers,"A Phase Ia/Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Runimotamab Administered Intravenously as a Single Agent and in Combination With Trastuzumab in Patients With Locally Advanced or Metastatic HER2-Expressing Cancers",ACTIVE_NOT_RECRUITING,2018-06-06,2026-05-30,2026-05-30,INTERVENTIONAL,PHASE1,123,['Solid Tumors'],Solid Tumors,"Genentech, Inc.",[],"['Singapore', 'Belgium', 'Japan', 'Netherlands', 'United States', 'France', 'Denmark', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Australia']"
NCT07112924,CCM OPEN HF Registry,CCM Technologies OPEN HF Registry: Observational Patient EvaluatioN of CCM® Therapy for Heart Failure,RECRUITING,2025-11-01,2035-08-15,2036-08-01,OBSERVATIONAL,,5500,['Heart Failure'],Heart Failure,Impulse Dynamics,[],['United States']
NCT07255742,Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.,Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.,ACTIVE_NOT_RECRUITING,2025-08-01,2025-12,2025-12,INTERVENTIONAL,NA,50,['Ventilator Associated Pneumonia'],Ventilator Associated Pneumonia,Dalia Mohamed Salah,[],['Egypt']
NCT06201234,Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer,"Phase II Study Evaluating the Addition of Elacestrant, an Oral Selective Estrogen Receptor Degrader (SERD), to Standard-of-care Olaparib in Patients With Hormone Receptor (HR)-Positive, HER2-negative Locally Advanced or Metastatic Breast Cancer With gBRCA1/2 Mutations",RECRUITING,2024-12-13,2028-12-31,2028-12-31,INTERVENTIONAL,PHASE2,176,"['Hormone Receptor Positive HER-2 Negative Breast Cancer', 'Advanced or Metastatic Breast Cancer', 'BRCA1 Mutation', 'BRCA2 Mutation']",Hormone Receptor Positive HER-2 Negative Breast Cancer,GBG Forschungs GmbH,"['Stemline Therapeutics, Inc.']",['Germany']
NCT07091721,Using Mentalization Based Therapy to Support Children and Adolescents Referred to Specialist Mental Health Services in the NHS for Aggressive and/or Violent Behaviour,The Mentalization Intervention for Children and Adolescents (MICA) Study: A Randomised Controlled Trial of Support for Aggressive and Violent Behaviour Via Forensic Child and Adolescent Mental Health Services (FCAMHS),RECRUITING,2025-11,2027-06,2027-06,INTERVENTIONAL,NA,632,"['Conduct Disorder', 'Mentalization Based Therapy', 'Violent Behavior', 'Aggressive Behaviour', 'Adolescent Behavior', 'Children Behavior']",Conduct Disorder,Anna Freud,['University of Hertfordshire'],['United Kingdom']
NCT05735834,Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients,"Phase 3, Interventional, Multicentre, Open-label, Randomized Study Comparing Rituximab Plus Zanubrutinib to Rituximab Monotherapy in Previously Untreated, Symptomatic Splenic Marginal Zone Lymphoma (RITZ)",RECRUITING,2024-05-21,2029-05,2029-05,INTERVENTIONAL,PHASE3,120,['Splenic Marginal Zone Lymphoma'],Splenic Marginal Zone Lymphoma,International Extranodal Lymphoma Study Group (IELSG),[],"['Norway', 'Austria', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Sweden']"
NCT07111078,Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults,"VRC 329: A Phase I Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (STEMos1) With and Without ALFQ Adjuvant in Healthy Adults",RECRUITING,2025-08-27,2027-08-18,2027-08-18,INTERVENTIONAL,PHASE1,56,"['Influenza Prevention', 'Pandemic Influenza Prevention']",Influenza Prevention,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06883240,An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment,A Multicenter Non-Interventional Study Evaluating Bleeds and Health-Related Quality Of Life in Patients With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment,RECRUITING,2025-04-29,2026-11-01,2026-11-01,OBSERVATIONAL,,40,"['Von Willebrand Disease, Type 3']","Von Willebrand Disease, Type 3",Hoffmann-La Roche,[],"['Belgium', 'Japan', 'South Africa', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Colombia', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT06427876,Fasenra Pediatric Japan Post-Marketing Study(PMS),FASENRA® Subcutaneous Injection 30 mg / 10mg Syringe Protocol of Specific Drug Use Result Study for Pediatric Patients,RECRUITING,2024-07-16,2027-03-17,2027-03-17,OBSERVATIONAL,,40,['Bronchial Asthma'],Bronchial Asthma,AstraZeneca,[],['Japan']
NCT06567470,A Study With CIT-013 in RA Patients,"A Phase IIa Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Trial To Investigate The Effects Of Three Dose Levels Of CIT-013 On Disease Activity In Patients With Moderately Active Rheumatoid Arthritis.",RECRUITING,2025-07-29,2027-04,2027-07,INTERVENTIONAL,PHASE2,88,['Rheumatoid Arthritis'],Rheumatoid Arthritis,Citryll BV,[],"['Belgium', 'Netherlands', 'Spain', 'Poland', 'Germany']"
NCT06504394,A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65),"A Phase 2 Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)",RECRUITING,2024-10-14,2028-11-08,2028-11-08,INTERVENTIONAL,PHASE2,66,"['Classical Hodgkin Lymphoma Recurrent', 'Classical Hodgkin Lymphoma Refractory', 'Primary Mediastinal Large B-cell Lymphoma Recurrent', 'Primary Mediastinal Large B-cell Lymphoma Refractory']",Classical Hodgkin Lymphoma Recurrent,Merck Sharp & Dohme LLC,[],"['New Zealand', 'Turkey (Türkiye)', 'United States', 'Mexico', 'Chile', 'Spain', 'South Korea', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT06905522,A PAN-USR TB Multi-Center Trial,A Pan-Ultrashort Regimen for Drug-susceptible and Drug-resistant Pulmonary Tuberculosis: A Multi-Center Randomized Controlled Trial,RECRUITING,2025-06-18,2029-01,2029-12,INTERVENTIONAL,PHASE3,610,['Pulmonary Tuberculosis'],Pulmonary Tuberculosis,Shenzhen Third People's Hospital,"['First Affiliated Hospital of Zhejiang University', 'Beijing Chest Hospital of Capital Medical University', ""Shenyang Tenth People's Hospital"", ""The Sixth People's Hospital of the Xinjiang Uygur Autonomous Region"", 'The Fourth Hospital of Inner Mongolia Autonomous Region', 'Guizhou Aerospace Hospital']",['China']
NCT05698732,Coroflex® ISAR NEO PMCF Study,Coroflex® ISAR NEO Coronary Stent System Post-Market Clinical Follow-up Study,RECRUITING,2023-08-04,2027-02-01,2027-02-01,OBSERVATIONAL,,3000,"['Coronary Artery Disease (CAD)', 'Ischemic Heart Disease']",Coronary Artery Disease (CAD),Fundación EPIC,[],"['Spain', 'France']"
NCT06311721,A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer,"A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer",RECRUITING,2024-09-09,2028-02-14,2028-05-29,INTERVENTIONAL,PHASE3,927,['Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer'],Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer,Amgen,[],"['Bulgaria', 'Japan', 'France', 'Chile', 'Peru', 'South Korea', 'Thailand', 'Poland', 'South Africa', 'Georgia', 'Spain', 'Taiwan', 'Malaysia', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Philippines', 'Argentina', 'Serbia']"
NCT05428969,"A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies","A Phase I/II Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of the Clever-1 Antibody Bexmarilimab in Combination With Standard of Care Therapy in Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia",ACTIVE_NOT_RECRUITING,2022-06-02,2026-04,2026-04,INTERVENTIONAL,PHASE1,181,"['Acute Myeloid Leukemia', 'Chronic Myelomonocytic Leukemia', 'Myelodysplastic Syndromes', 'Relapsed/Refractory AML']",Acute Myeloid Leukemia,Faron Pharmaceuticals Ltd,[],"['Finland', 'United Kingdom', 'United States']"
NCT02101853,Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia,Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL),ACTIVE_NOT_RECRUITING,2014-12-17,2021-06-30,2026-09-16,INTERVENTIONAL,PHASE3,669,['Recurrent B Acute Lymphoblastic Leukemia'],Recurrent B Acute Lymphoblastic Leukemia,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Puerto Rico', 'Canada', 'Australia']"
NCT06624670,A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum,"A Multi-centre, Randomised, Placebo-controlled, Double-blind, Parallel-group Trial to Evaluate Safety and Efficacy of Spesolimab (BI 655130) in Adult Patients With Ulcerative Pyoderma Gangrenosum (PG) Who Require Systemic Therapy",RECRUITING,2025-02-04,2027-04-12,2028-02-01,INTERVENTIONAL,PHASE3,90,['Pyoderma Gangrenosum'],Pyoderma Gangrenosum,Boehringer Ingelheim,[],"['Japan', 'China', 'Australia', 'Belgium', 'France', 'Finland', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07256210,Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation,Phase I/II Clinical Trial of mbIL21 ex Vivo-expanded Donor-derived NK-cell Infusions With Hematopoietic Stem Cell Transplantation for Disease Relapse Prophylaxis in Pediatric and Young Adult Patients With Chemorefractory or Minimal Residual Disease Positive Acute Leukemia,RECRUITING,2025-05-09,2026-10,2027-10,INTERVENTIONAL,PHASE2,15,"['Acute Myeloid Leukemia', 'Acute Lymphoblastic T-cell Leukemia', 'Mixed Phenotype Acute Leukemia']",Acute Myeloid Leukemia,"Federal Research Institute of Pediatric Hematology, Oncology and Immunology",[],['Russia']
NCT07229430,Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue,"A Prospective, Multi-center, Randomized Controlled, Non-inferiority Study to Evaluate the Safety and Effectiveness of ULTRAFORMER MPT PLUS Treatment to Lift Lax Submental (Beneath the Chin) and Neck Tissue",RECRUITING,2025-10-16,2026-11-26,2026-11-26,INTERVENTIONAL,NA,273,"['Skin Laxity (Submental and Neck)', 'Facial Skin Laxity', 'Submental Tissue Laxity']",Skin Laxity (Submental and Neck),CLASSYS Inc.,[],['United States']
NCT05110248,Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application,Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application (RADIUS),RECRUITING,2021-11-15,2025-12-15,2026-01-15,OBSERVATIONAL,,200,['Multiple'],Multiple,Perspectum,[],['United Kingdom']
NCT05372718,Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial,"Multicenter, Open-label, Randomized Clinical Trial of Efficacy and Safety of the Thrombolysis With Recombinant Non-immunogenic Staphylokinase (Fortelyzin®) in Patients With ALI vs Surgery",RECRUITING,2022-12-26,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE3,170,['Acute Limb Ischemia'],Acute Limb Ischemia,"Supergene, LLC",[],['Russia']
NCT06964113,A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice,"A Multi-center, Open-Label, Single-Arm, Phase 4 Study to Evaluate the Efficacy and Safety of Filgotinib 200 mg in Korean Patients With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice",RECRUITING,2025-06-11,2027-11-30,2027-11-30,INTERVENTIONAL,PHASE4,94,['Ulcerative Colitis'],Ulcerative Colitis,Eisai Korea Inc.,['Gilead Sciences'],['South Korea']
NCT02166463,"Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma",A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults,ACTIVE_NOT_RECRUITING,2015-03-19,2021-12-31,2026-10-03,INTERVENTIONAL,PHASE3,600,"['Ann Arbor Stage IIB Hodgkin Lymphoma', 'Ann Arbor Stage IIIB Hodgkin Lymphoma', 'Ann Arbor Stage IVA Hodgkin Lymphoma', 'Ann Arbor Stage IVB Hodgkin Lymphoma', 'Childhood Hodgkin Lymphoma', 'Classic Hodgkin Lymphoma']",Ann Arbor Stage IIB Hodgkin Lymphoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT03190954,Brain Dopaminergic Signaling in Opioid Use Disorders,Brain Dopaminergic Signaling in Opioid Use Disorders (OUD),ACTIVE_NOT_RECRUITING,2017-08-17,2025-12-31,2026-12-31,INTERVENTIONAL,EARLY_PHASE1,153,"['Normal Physiology', 'Opioid Use Disorders']",Normal Physiology,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT07054346,Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617,Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 in a Prostatectomy Model (LUTACT Trial),RECRUITING,2025-07-08,2027-04-30,2028-04-30,INTERVENTIONAL,PHASE1,45,"['Prostate Cancer', 'Prostate Cancer (Diagnosis)', 'High-risk Prostate Cancer', 'Localized Prostate Carcinoma', 'Very High Risk Prostate Carcinoma']",Prostate Cancer,Thomas Hope,['Novartis'],['United States']
NCT06911112,NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD),"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)",RECRUITING,2025-03-31,2027-07,2027-07,INTERVENTIONAL,PHASE3,200,['Major Depressive Disorder'],Major Depressive Disorder,Neurocrine Biosciences,[],['United States']
NCT05186740,ProVee Urethral Expander System IDE Study (ProVIDE),The ProVee Urethral Expander System Clinical Study,ACTIVE_NOT_RECRUITING,2022-06-09,2024-03-15,2028-12,INTERVENTIONAL,NA,221,['Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms'],Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms,ProVerum Medical,[],"['Ireland', 'United States', 'Canada']"
NCT06946524,A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult Participants,A Phase 1 Pharmacokinetic Study in Healthy Subjects to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to Prefilled Syringe,ACTIVE_NOT_RECRUITING,2025-05-08,2026-01,2026-01,INTERVENTIONAL,PHASE1,59,['Healthy Volunteers'],Healthy Volunteers,AbbVie,[],['United States']
NCT03003117,The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL),"Effectiveness of an Early Intervention Aiming at Promoting Healthy Diet, Lifestyle and Growth of Children Living in Situation of Social Disadvantage : the prEgnanCy and eArly Childhood nutrItion triaL (ECAIL)",ACTIVE_NOT_RECRUITING,2017-04-03,2026-06,2026-06,INTERVENTIONAL,NA,800,"['Diet', 'Growth', 'Infant', 'Physical Activity', 'Sedentary Behavior']",Diet,French Red Cross,"['Institut National de la Santé Et de la Recherche Médicale, France', 'University Hospital, Lille', 'Association Programme MALIN', 'Société Française de Pédiatrie', 'Association Française de Pédiatrie Ambulatoire']",['France']
NCT05454787,Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation),Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation),RECRUITING,2022-06-02,2026-08-31,2026-08-31,OBSERVATIONAL,,300,"['Life Threatening Bleeding', 'Factor Xa Inhibitor']",Life Threatening Bleeding,AstraZeneca,[],['Japan']
NCT07159451,"A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer","A Short-term Preoperative, Window-of-opportunity Study, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer",RECRUITING,2025-10-06,2027-01-29,2027-05-29,INTERVENTIONAL,PHASE2,140,['Breast Cancer'],Breast Cancer,"Gustave Roussy, Cancer Campus, Grand Paris",['Menarini Group'],['France']
NCT07008183,Perinatal Thymic DYsregulation: Characterization of Perinatal Mood Episodes,Perinatal Thymic Dysregulation: Characterization of Perinatal Mood Episodes,RECRUITING,2025-10-13,2026-07-31,2026-12-31,INTERVENTIONAL,NA,200,['Perinatal Mental Health'],Perinatal Mental Health,"Centre Hospitalier Charles Perrens, Bordeaux",[],['France']
NCT06661876,Cardiac RadiothErapy For hEart faiLure,Cardiac RadiothErapy For hEart faiLure,RECRUITING,2025-01-01,2026-12-31,2027-06-30,INTERVENTIONAL,NA,40,"['Heart Failure', 'Non-ischemic Cardiomyopathy', 'Ischemic Cardiomyopathy']",Heart Failure,Universitaire Ziekenhuizen KU Leuven,[],['Belgium']
NCT06297161,A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).,Post Marketing Surveillance Study to Observe Safety and Effectiveness of BOSULIF,ACTIVE_NOT_RECRUITING,2025-01-20,2028-06-01,2028-06-01,OBSERVATIONAL,,600,['Chronic Leukemia Myelogenous'],Chronic Leukemia Myelogenous,Pfizer,[],['United States']
NCT00025935,Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder,Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth,RECRUITING,2002-01-01,,,OBSERVATIONAL,,2350,['Mood Disorder'],Mood Disorder,National Institute of Mental Health (NIMH),[],['United States']
NCT06357754,Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy,Protocol for Transgene Assay Service,RECRUITING,2023-10-06,2038-10-06,2038-10-06,OBSERVATIONAL,,50,"['Non-Hodgkin Lymphoma', 'Chronic Lymphocytic Leukaemia', 'Multiple Myeloma']",Non-Hodgkin Lymphoma,Bristol-Myers Squibb,[],"['Switzerland', 'Japan', 'United States', 'Germany']"
NCT06321601,"Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.","A Phase 3, Open-label, Uncontrolled Single-arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Avacopan in Combination With a Rituximab or a Cyclophosphamide-containing Regimen in Children From 6 Years to < 18 Years of Age With Active ANCA-associated Vasculitis (AAV)",RECRUITING,2024-10-22,2030-07-20,2030-07-20,INTERVENTIONAL,PHASE3,20,['Vasculitis'],Vasculitis,Amgen,[],"['Belgium', 'Hungary', 'United States', 'France', 'Slovakia', 'Spain', 'Canada', 'Czechia', 'Poland']"
NCT06263946,Essilor® Stellest® Lenses Multicentre European Study (SLOMES),"Post Market Clinical Follow-up Study to Demonstrate the Efficacy, Safety, Acceptability and Quality of Life Implications of Essilor® Stellest® Spectacle Lenses in Slowing Myopia Progression in Children and Adolescents.",ACTIVE_NOT_RECRUITING,2024-03-22,2027-04-23,2027-04-30,INTERVENTIONAL,NA,150,['Myopia'],Myopia,Essilor International,[],"['Ireland', 'France', 'Netherlands']"
NCT06850103,SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases,A Phase II Exploratory Multicenter Randomized Controlled Clinical Trial to Evaluate the Effectiveness of Neoadjuvant Short-Course Radiotherapy (SCRT) Followed by CAPEOX Chemotherapy and Serplulimab in Microsatellite Stable (MSS) or Proficient Mismatch Repair (pMMR) Rectal Cancer With Synchronous Oligometastases,RECRUITING,2025-04-22,2027-12-31,2032-12,INTERVENTIONAL,PHASE2,102,"['Colorectal Carcinoma', 'Oligometastases', 'pMMR', 'MSS', 'iTNT']",Colorectal Carcinoma,First Affiliated Hospital of Zhejiang University,"['Ningbo No.2 Hospital', 'Ningbo Medical Center Lihuili Hospital', 'Second Affiliated Hospital of Wenzhou Medical University', 'Ningbo No. 1 Hospital', 'Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University', ""The Affiliated People's Hospital of Ningbo University""]",['China']
NCT06851754,Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency,Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency,RECRUITING,2025-07-17,2031-12-01,2031-12-31,INTERVENTIONAL,EARLY_PHASE1,185,['Premature Ovarian Insufficiency'],Premature Ovarian Insufficiency,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT06081881,Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism,Predictors for Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism Episode,RECRUITING,2025-01-01,2026-10-01,2026-12-01,OBSERVATIONAL,,100,['Chronic Thromboembolic Pulmonary Hypertension'],Chronic Thromboembolic Pulmonary Hypertension,Ester Ashraf Faried Beshay,[],['Egypt']
NCT05649800,"Vascular mEchanisms in, Stroke, dePression, dementiA, and deliRum: The VESPAR Project",Evaluating the Feasibility of Remote Haemodynamic Monitoring in a Cohort of Multi-ethnic Chronic Stroke Patients Using a Novel User Interface and Artificial Intelligence Algorithms,RECRUITING,2023-03-17,2025-11-26,2026-08-26,OBSERVATIONAL,,140,"['Cognitive Dysfunction', 'Stroke', 'Dementia', 'Depression', 'Delirium']",Cognitive Dysfunction,University of Leicester,[],['United Kingdom']
NCT07102771,Efficacy of Hyaluronidase Added to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block in Percutaneous Nephrolithotomy.,The Efficacy of Hyaluronidase as an Adjuvant to Bupivacaine in Ultrasound-guided Erector Spinae Plane Block in Percutaneous Nephrolithotomy. Randomized Double-blind Controlled Study,ACTIVE_NOT_RECRUITING,2025-01-01,2025-10-30,2025-12-30,INTERVENTIONAL,NA,100,"['Erector Spinae Plane Block, Nephrolithotomy, Hyaluronidase']","Erector Spinae Plane Block, Nephrolithotomy, Hyaluronidase",Kasr El Aini Hospital,[],['Egypt']
NCT06380751,"Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer","A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)",RECRUITING,2024-08-01,2029-03-30,2030-10-18,INTERVENTIONAL,PHASE3,500,['Advanced Breast Cancer'],Advanced Breast Cancer,AstraZeneca,[],"['Bulgaria', 'Japan', 'Hong Kong', 'China', 'Australia', 'Israel', 'Hungary', 'France', 'Chile', 'Puerto Rico', 'Peru', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07099898,A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC),"Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)",RECRUITING,2025-08-11,2026-09-02,2028-09-11,INTERVENTIONAL,PHASE3,300,"['Neoplasms, Lung']","Neoplasms, Lung",GlaxoSmithKline,[],"['Brazil', 'Japan', 'Turkey (Türkiye)', 'Mexico', 'South Korea', 'Canada', 'United Kingdom', 'Argentina', 'Australia']"
NCT07256015,Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy,"""DEMOS"" - Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy",RECRUITING,2025-08-05,2027-07-05,2027-08-05,OBSERVATIONAL,,200,['Psoriasis'],Psoriasis,Bristol-Myers Squibb,[],['Italy']
NCT00898235,Collection of Samples and Clinical Data From Patients With Amyloid Diseases,"Data, Tissue, Blood, and Urine Repository for Amyloid Diseases",RECRUITING,2000-01,2040-12,2040-12,OBSERVATIONAL,,10000,['Multiple Myeloma'],Multiple Myeloma,Boston Medical Center,[],['United States']
NCT05724121,Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax,Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax,RECRUITING,2023-03-01,2027-04-08,2027-04-08,OBSERVATIONAL,,135,"['Chronic Lymphocytic Leukemia (CLL)', 'Waldenstr(SqrRoot)(Delta)m s Macroglobulinemia', 'Mantle Cell Lymphoma', 'Sudden Cardiac Death', 'Cardiac Arrhythmias', 'Hematologic Malignancies']",Chronic Lymphocytic Leukemia (CLL),"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT05398809,Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata,A Phase 2 Open-Label Study to Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata,RECRUITING,2023-01-18,2027-12-01,2027-12-01,INTERVENTIONAL,PHASE2,70,"['Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)', 'Alopecia Areata']",Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced),National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07255716,Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation,Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation,ACTIVE_NOT_RECRUITING,2020-06-01,2025-11-15,2026-10-01,OBSERVATIONAL,,120,"['Infection', 'Driveline Heart-assisted Device Related Infection', 'Pneumonia', 'Sepsis']",Infection,China National Center for Cardiovascular Diseases,"['Chinese Academy of Medical Sciences, Fuwai Hospital']",['China']
NCT07255950,Accuracy Between Transthoracal Needle Aspiration (TTNA) Techniques in Suspected Lung Cancer Patients,"Accuracy Between Jabbing-then-suction, Suction-with-jabbing, and Suction-only Transthoracal Needle Aspiration (TTNA) Techniques in Suspected Lung Cancer Patients",RECRUITING,2025-07-15,2025-12,2026-02,INTERVENTIONAL,NA,54,"['Lung Cancer (Diagnosis)', 'Biopsy, Fine-Needle/Methods']",Lung Cancer (Diagnosis),Gadjah Mada University,[],['Indonesia']
NCT02269592,"Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome",Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome,RECRUITING,2014-08,2025-12,2030-09,OBSERVATIONAL,,10000,"['Monoclonal Gammopathy of Undetermined Significance (MGUS)', 'Myelodysplastic Syndromes', 'Hematological Malignancies', 'B-cell Malignancy, Low-grade', 'Myelodysplastic Syndrome With Low-grade Lesions', 'IgG Monoclonal Gammopathy of Uncertain Significance', 'Smoldering Multiple Myeloma', 'Waldenstrom Macroglobulinemia']",Monoclonal Gammopathy of Undetermined Significance (MGUS),Dana-Farber Cancer Institute,['The Leukemia and Lymphoma Society'],['United States']
NCT04732871,"Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above","A Phase 3, Randomized, Open-label, Multi-country Study to Evaluate the Immunogenicity, Safety, Reactogenicity and Persistence of a Single Dose of the RSVPreF3 OA Investigational Vaccine and Different Revaccination Schedules in Adults Aged 60 Years and Above",ACTIVE_NOT_RECRUITING,2021-02-15,2022-06-06,2027-02-15,INTERVENTIONAL,PHASE3,1720,['Respiratory Syncytial Virus Infections'],Respiratory Syncytial Virus Infections,GlaxoSmithKline,[],"['Japan', 'United States', 'Finland', 'Taiwan', 'Germany']"
NCT05061550,Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer,"A Phase II, Open-label, Multicentre, Randomised Study of Neoadjuvant and Adjuvant Treatment in Patients With Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer (NeoCOAST-2)",RECRUITING,2022-04-14,2030-05-09,2030-05-09,INTERVENTIONAL,PHASE2,630,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,AstraZeneca,['Parexel'],"['Belgium', 'Hungary', 'Turkey (Türkiye)', 'United States', 'France', 'Ireland', 'Spain', 'Italy', 'Canada', 'South Korea', 'Taiwan', 'Portugal']"
NCT06198010,A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors (ASCENT),"Advancing Safe, Comprehensive, Digitally-Enabled Cancer Pain Management (ASCENT) Clinical Trial - Main",RECRUITING,2024-02-07,2027-01-31,2027-08-31,INTERVENTIONAL,NA,660,"['Hematopoietic and Lymphoid System Neoplasm', 'Malignant Solid Neoplasm', 'Hematopoietic and Lymphatic System Neoplasm']",Hematopoietic and Lymphoid System Neoplasm,Mayo Clinic,['National Cancer Institute (NCI)'],['United States']
NCT06550674,Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma,Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma,ACTIVE_NOT_RECRUITING,2024-10-29,2026-10,2027-10,INTERVENTIONAL,NA,50,['Uveal Melanoma'],Uveal Melanoma,Centre Jean Perrin,"[""Association Nationale des Patients atteints de cancers de l'oeil (A.N.P.A.C.O.)""]",['France']
NCT06848777,"The Effect of Mobilising Patients Using Nature Sounds on Anxiety, Pain and Stress Levels","The Effect of Mobilising Patients Using Nature Sounds on Anxiety, Pain and Stress Levels of Patients After Laparoscopic Cholecystectomy Surgery",RECRUITING,2025-03-01,2025-11-28,2025-12-28,INTERVENTIONAL,NA,92,"['Anxiety', 'Pain', 'Stress', 'Laparoscopic Colecctomy', 'Mobilization', 'Nature Sound']",Anxiety,Akdeniz University,[],['Turkey (Türkiye)']
NCT05103605,Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations,"Positioning, Utilization and Effectiveness of Osimertinib in First Line in Real-life Therapeutic Strategy in France Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations",ACTIVE_NOT_RECRUITING,2021-05-12,2026-01-15,2026-01-15,OBSERVATIONAL,,274,['Non Small Cell Lung Cancer'],Non Small Cell Lung Cancer,AstraZeneca,[],['France']
NCT05816382,A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions,A Long-term Extension Study to Evaluate the Safety and Tolerability of TAK-861 in Participants With Selected Central Hypersomnia Conditions,RECRUITING,2023-04-05,2028-02-28,2028-02-28,INTERVENTIONAL,PHASE2,500,['Narcolepsy Type 1'],Narcolepsy Type 1,Takeda,[],"['Japan', 'Netherlands', 'Norway', 'United States', 'France', 'Finland', 'Switzerland', 'Spain', 'Italy', 'Australia', 'Sweden', 'Germany']"
NCT07157969,ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC,Immune Checkpoint Inhibitors and Anti-Vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without Interventional Therapy for Advanced HCC,RECRUITING,2025-02-19,2026-06-01,2027-06-30,INTERVENTIONAL,PHASE2,300,['HCC - Hepatocellular Carcinoma'],HCC - Hepatocellular Carcinoma,Peking Union Medical College Hospital,[],['China']
NCT07136857,Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531),Study To Assess Response to Eptacog Beta iN Patients With Glanzmann THromboasthenia (STRENGTH ),RECRUITING,2025-10-02,2026-12,2026-12,INTERVENTIONAL,PHASE2,6,['Glanzmann Thrombasthenia'],Glanzmann Thrombasthenia,Emory University,['Laboratoire Français du Fractionnement et des Biotechnologies (LFB BIOTECHNOLOGIES)'],['United States']
NCT02306161,Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma,"Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma",ACTIVE_NOT_RECRUITING,2014-12-12,2021-03-31,2026-09-17,INTERVENTIONAL,PHASE3,312,"['Metastatic Ewing Sarcoma', 'Metastatic Malignant Neoplasm in the Bone', 'Metastatic Malignant Neoplasm in the Bone Marrow', 'Metastatic Malignant Neoplasm in the Lung', 'Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone', 'Peripheral Primitive Neuroectodermal Tumor of Soft Tissues']",Metastatic Ewing Sarcoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT04090723,Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum,Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum,ACTIVE_NOT_RECRUITING,2021-09-14,2024-01-25,2026-11-01,INTERVENTIONAL,NA,12,"['HIV', 'Alcohol; Harmful Use', 'Mental Health Disorder']",HIV,Johns Hopkins University,['National Institute on Alcohol Abuse and Alcoholism (NIAAA)'],['United States']
NCT06928142,A Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's,"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Participants With Sjögren's",RECRUITING,2025-04-23,2027-03-13,2027-06-04,INTERVENTIONAL,PHASE2,80,['Sjogren Disease'],Sjogren Disease,"Otsuka Pharmaceutical Development & Commercialization, Inc.",[],"['Bulgaria', 'United States', 'Mexico', 'Spain', 'Romania', 'Greece', 'Poland', 'Argentina', 'Germany']"
NCT06800885,Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants,Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants During Current Respiratory Season,ACTIVE_NOT_RECRUITING,2024-10-22,2026-02-02,2026-02-02,OBSERVATIONAL,,5000,['Influenza Immunization'],Influenza Immunization,"Sanofi Pasteur, a Sanofi Company",[],['Germany']
NCT06965751,A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19,"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of PDI204 as Intravenous Infusion or Intramuscular Injection in Healthy Participants",ACTIVE_NOT_RECRUITING,2025-06-27,2026-02-13,2026-05-31,INTERVENTIONAL,PHASE1,32,['COVID-19 Infection'],COVID-19 Infection,University of Melbourne,"['Nucleus Network Ltd', 'Syneos Heath']",['Australia']
NCT05731141,A Prospective Natural History Study of Lymphatic Anomalies,A Prospective Natural History Study of Lymphatic Anomalies,RECRUITING,2023-03-20,2026-12-31,2028-12-31,OBSERVATIONAL,,1200,"['Lymphatic Diseases', 'Lymphatic Abnormalities']",Lymphatic Diseases,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT06838910,Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma,"Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma: An Open-label, Single-centre, Phase 2 Study",RECRUITING,2025-03-31,2026-12,2026-12-30,INTERVENTIONAL,PHASE2,20,"['Thymic Carcinoma', 'Thymoma']",Thymic Carcinoma,The First Affiliated Hospital with Nanjing Medical University,[],['China']
NCT04528082,Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease,"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study, Followed by an Active Treatment Phase to Evaluate the Efficacy and Safety of Apremilast in Children From 2 to Less Than 18 Years of Age With Active Oral Ulcers Associated With Behçet's Disease (BEAN)",RECRUITING,2021-09-09,2030-02-07,2030-12-17,INTERVENTIONAL,PHASE3,60,['Behçet Disease'],Behçet Disease,Amgen,[],"['Israel', 'Turkey (Türkiye)', 'France', 'Switzerland', 'Spain', 'Italy', 'United Kingdom', 'Greece']"
NCT02483312,A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML),Phase I Study of Autologous Acute Myelogenous Leukemia (AML) Cells Containing Lentivirus Engineering Expression of IL-12,ACTIVE_NOT_RECRUITING,2015-09,2026-08,2026-08,INTERVENTIONAL,PHASE1,9,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,"University Health Network, Toronto",['Ozmosis Research Inc.'],['Canada']
NCT06098755,The Sequestration of Holistic Stress Management Techniques for Adults,Transcendence Research: Holistic Education For Colonized Countries Primarily English Speaking,RECRUITING,2026-01-26,2028-12,2028-12,INTERVENTIONAL,NA,100,"['Stress, Job', 'PTSD', 'Hypervigilance', 'Hyperthyroidism', 'Migraine', 'Migraine With Aura', 'Immunodeficiency', 'Sickle Cell Trait', 'Sickle Cell Disease', 'Anemia, Sickle Cell', 'Anemia', 'Fatigue', 'Anxiety', 'Depression', 'Flat Feet', 'Lordosis', 'TBI (Traumatic Brain Injury)', 'Rheumatoid Arthritis', 'Arthritis', 'Masturbation', 'Priapism', 'Erectile Dysfunction', 'Flight Reaction', 'Hypertension', 'Sexual Arousal Disorder', 'Hemorrhoids', 'Fibroid']","Stress, Job",Goddess Zena I. Jones,[],['United States']
NCT06598306,Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308),"A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of Subcutaneous Tarlatamab in Subjects With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)",RECRUITING,2024-10-07,2027-02-01,2030-03-27,INTERVENTIONAL,PHASE1,220,['Extensive Stage Small Cell Lung Cancer'],Extensive Stage Small Cell Lung Cancer,Amgen,['BeOne Medicines'],"['Belgium', 'Japan', 'Turkey (Türkiye)', 'China', 'United States', 'Switzerland', 'Spain', 'Australia', 'Poland', 'Germany']"
NCT05312255,Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma,Improving Host Factors in Patients With Monoclonal Gammopathies and Other Hematologic Disorders,RECRUITING,2022-06-28,2027-06-28,2027-06-28,INTERVENTIONAL,NA,175,"['Plasma Cell Myeloma', 'Recurrent Plasma Cell Myeloma', 'Refractory Plasma Cell Myeloma', 'Smoldering Plasma Cell Myeloma']",Plasma Cell Myeloma,Roswell Park Cancer Institute,[],['United States']
NCT03225677,Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis,Multiple Tracer Using Single Muscle Biopsy Technique in Evaluating Protein Synthesis and Break Down in Muscles of Cirrhotic Patients,RECRUITING,2017-08-03,2027-09-30,2027-09-30,OBSERVATIONAL,,20,['Cirrhosis'],Cirrhosis,The Cleveland Clinic,[],['United States']
NCT05470504,Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance,Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance,RECRUITING,2023-01-23,2028-01-31,2028-01-31,INTERVENTIONAL,PHASE2,25,"['Insulin Receptor Mutation', 'Partial Lipodystrophy']",Insulin Receptor Mutation,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07256002,Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy,Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy:A Real World Multicenter Retrospective Study,ACTIVE_NOT_RECRUITING,2020-01-01,2023-12-01,2027-12-01,OBSERVATIONAL,,10000,['Lung Cancer (NSCLC)'],Lung Cancer (NSCLC),"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT05739162,A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis,Endoscopic Sleeve Gastroplasty (ESG) as a Treatment Option for Obesity in Ulcerative Colitis (UC) Patients Undergoing Colectomy With Ileal Pouch Anal Anastomosis (IPAA),RECRUITING,2023-09-20,2026-06,2027-01,INTERVENTIONAL,NA,12,"['Obesity', 'Ulcerative Colitis']",Obesity,Mayo Clinic,[],['United States']
NCT07248527,PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery,PAN-ICIS: Prospective Observational Study Evaluating the Intensive Care Infection Score for Early Detection of Infectious Complications After Pancreatic Resections,ACTIVE_NOT_RECRUITING,2025-11-01,2027-12-31,2028-03-31,OBSERVATIONAL,,400,"['Pancreatectomy', 'Pancreatic Surgery', 'Intensive Care (ICU)', 'Inflamatory Markers', 'Postoperative Care', 'Postoperative Pancreatic Fistula', 'Surgical Site Infection After Major Surgery', 'Postoperative Complications']",Pancreatectomy,"Charles University, Czech Republic",[],['Czechia']
NCT07256561,Antimicrobial and Anti-inflammatory Effects of Simvastatin as an Intracanal Medication,"Antimicrobial and Anti-inflammatory Effects of Simvastatin as an Intracanal Medication in Endodontically Retreated Teeth With Periapical Radiolucency, Randomized Controlled Clinical Trial",RECRUITING,2025-08-10,2026-08-01,2026-08-10,INTERVENTIONAL,NA,54,"['Endodontically Retard Teeth', 'Periapical Radiolucency']",Endodontically Retard Teeth,Hadeer Maher Mostafa Mohamed,[],['Egypt']
NCT06506916,A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis,A Phase 3b Exploratory Multicenter Open-Label Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis,RECRUITING,2024-07-29,2027-03-09,2028-03-14,INTERVENTIONAL,PHASE3,90,"['Moderate to Severe Plaque Psoriasis', 'Psoriatic Arthritis']",Moderate to Severe Plaque Psoriasis,UCB Biopharma SRL,[],"['Poland', 'United States', 'Germany']"
NCT05083481,"A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors",A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination With Pembrolizumab and/or Standard Therapies Including Chemotherapy and/or Immunotherapy in Participants With Locally Advanced or Metastatic Solid Tumors,RECRUITING,2021-10-19,2028-05-31,2028-05-31,INTERVENTIONAL,PHASE1,366,['Advanced Solid Tumors'],Advanced Solid Tumors,"Astellas Pharma Global Development, Inc.",['Merck Sharp & Dohme LLC'],"['Japan', 'China', 'United States', 'France', 'Puerto Rico', 'Spain', 'South Korea']"
NCT06860971,A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma,"A Randomized, Double-Blind, Multicenter Phase III Clinical Trial Evaluating AL2846 Capsule Versus Placebo in Patients With Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma Who Failed Prior VEGFR-Targeted Therapy",RECRUITING,2025-04-18,2027-01,2028-01,INTERVENTIONAL,PHASE3,144,['Thyroid Cancer'],Thyroid Cancer,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",[],['China']
NCT06637371,"A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma","A Phase 1, Randomized, Double-blind, Placebo-controlled, Integrated Single Ascending Dose, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma",RECRUITING,2024-10-16,2027-06-07,2027-06-07,INTERVENTIONAL,PHASE1,124,['Asthma'],Asthma,Amgen,[],"['Belgium', 'United States', 'Canada', 'United Kingdom', 'Australia']"
NCT05520567,"A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia","A Phase 1/2, Multicenter, Open-Label, Randomized Dose Ranging and Expansion Study of the Combination of Gilteritinib, Venetoclax and Azacitidine in Patients With Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AML) Not Eligible for Intensive Induction Chemotherapy",RECRUITING,2023-01-31,2028-07-31,2028-07-31,INTERVENTIONAL,PHASE1,70,"['Acute Myeloid Leukemia (AML)', 'FLT3-mutated Acute Myeloid Leukemia']",Acute Myeloid Leukemia (AML),"Astellas Pharma Global Development, Inc.",[],['United States']
NCT02945800,Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma,Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults,ACTIVE_NOT_RECRUITING,2016-10-25,2024-11-19,2026-02,INTERVENTIONAL,PHASE2,59,"['Osteosarcoma', 'Ewing Sarcoma', 'Rhabdomyosarcoma', 'Soft Tissue Sarcoma']",Osteosarcoma,H. Lee Moffitt Cancer Center and Research Institute,['National Pediatric Cancer Foundation'],['United States']
NCT06987539,"A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)","A Phase 2 Open-label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age With Generalized Myasthenia Gravis (gMG)",RECRUITING,2026-04-30,2030-03-13,2030-03-13,INTERVENTIONAL,PHASE2,15,['Generalized Myasthenia Gravis'],Generalized Myasthenia Gravis,Amgen,[],['United States']
NCT06920043,A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH,"A Phase 2, Randomized, Double-blinded, Placebo-controlled Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)",RECRUITING,2025-04-09,2027-11,2027-12,INTERVENTIONAL,PHASE2,42,['Metabolic Dysfunction-Associated Steatohepatitis'],Metabolic Dysfunction-Associated Steatohepatitis,Boston Pharmaceuticals,['GlaxoSmithKline'],['United States']
NCT06457451,Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial,Impact d'un Programme coordonné diététique-activité Physique adaptée Sur le Pourcentage de Masse Maigre d'Adultes Atteints de Mucoviscidose traités Par Elexacaftor-Tezacaftor-Ivacaftor : Essai contrôlé randomisé Multicentrique,RECRUITING,2024-11-25,2027-11,2027-11,INTERVENTIONAL,NA,100,['Cystic Fibrosis'],Cystic Fibrosis,"University Hospital, Tours",['Fondation Ildys'],['France']
NCT07025967,Using Mölkky for Community-dwelling Older Adults,Using Mölkky for Community-dwelling Older Adults - A Pilot Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2024-08-01,2026-02,2026-05,INTERVENTIONAL,NA,50,['Older Adults Without Any Specific Clinical Condition'],Older Adults Without Any Specific Clinical Condition,The Hong Kong Polytechnic University,[],['Hong Kong']
NCT07062952,Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery,Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery: a Single-center Randomized Controlled Study(KISS Study),RECRUITING,2025-04-24,2027-07-01,2027-12-31,INTERVENTIONAL,NA,200,"['Kidney Tumors', 'CKD', 'Salt Substitute', 'Nephrectomy', 'eGFR']",Kidney Tumors,"Jinling Hospital, China",[],['China']
NCT06722365,Characterization of Fetal Lung With Quantitative Ultrasound,Characterization of Fetal Lung With Quantitative Ultrasound,RECRUITING,2024-12-17,2026-06,2026-06,OBSERVATIONAL,,12,"['Respiratory Complication', 'Fetal Lung Imaging']",Respiratory Complication,"University of Wisconsin, Madison",[],['United States']
NCT07229729,A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer,"A Randomized, Open-label, Multicenter Phase II Clinical Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer",RECRUITING,2025-11-24,2026-10,2029-10,INTERVENTIONAL,PHASE2,300,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,"Shanghai Hengrui Pharmaceutical Co., Ltd.",[],['China']
NCT07239505,"A Randomized Controlled Trial Evaluating Whether Pre-operative Trinase Reduces Post-operative Pain in Patients With Symptomatic Irreversible Pulpitis Compared to Placebo, Using VAS Scores and Analgesic Intake Over 48 Hours.",The Role Of Trinase In Reducing Post-Operative Pain For Patients With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial,RECRUITING,2025-08-01,2025-12-15,2025-12-15,INTERVENTIONAL,NA,182,"['Symptomatic Irreversible Pulpitis (SIP)', 'Postoperative Pain After Endodontic Treatment', 'Endodontic Disease', 'Dental Pain']",Symptomatic Irreversible Pulpitis (SIP),Fayoum University,[],['Egypt']
NCT07101094,Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU),Real-world Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU),RECRUITING,2025-09-22,2029-01-31,2029-05-14,OBSERVATIONAL,,300,['Schizophrenia'],Schizophrenia,Bristol-Myers Squibb,[],['United States']
NCT06857487,Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke,Efficacy and Safety of Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Patients With Acute Ischemic Stroke : A Randomized Double-blind Placebo-controlled Pilot Trial,RECRUITING,2025-06-13,2026-10-24,2026-10-29,INTERVENTIONAL,PHASE1,72,['Acute Ischemic Stroke'],Acute Ischemic Stroke,"Dongzhimen Hospital, Beijing",[],['China']
NCT07255885,"CRYSTALSIGHT: ''Cohort 1.5"" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking","CRYSTALSIGHT: ''Cohort 1.5"" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking",ACTIVE_NOT_RECRUITING,2025-05-08,2025-05-31,2026-03-13,OBSERVATIONAL,,20,"['Maculopathy', 'Maculopathy, Age Related', 'Macular Degeneration, Age-Related', 'Diabetic Retinopathy', 'Wet Age Related Macular Degeneration', 'Aged-related Macular Degeneration']",Maculopathy,Tan Tock Seng Hospital,"['Occutrack Medical Solutions Pte Ltd', 'Agency for Science, Technology and Research', 'National Healthcare Group, Singapore']",['Singapore']
NCT06425406,Application of HFNC for the Prevention of Hypoxemia During Perioperative Anesthetic-induced Intubation in Children: A Randomized Controlled Clinical Trial,Application of HFNC for the Prevention of Hypoxemia During Perioperative Anesthetic-induced Intubation in Children: A Randomized Controlled Clinical Trial,RECRUITING,2024-06-15,2025-11-30,2025-11-30,INTERVENTIONAL,NA,48,"['High-flow Nasal Cannula', 'Children', 'Pre-oxygenation']",High-flow Nasal Cannula,Henan Provincial People's Hospital,[],['China']
NCT07232654,Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC,"A Clinical Study to Evaluate the Safety and Efficacy of Iparomlimab/Tuvonralimab Injection (QL1706, a Bifunctional Mabpair Product of Anti-PD-1 and Anti-CTLA-4 Antibodies) in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer",RECRUITING,2025-11-11,2027-11-30,2028-02-28,INTERVENTIONAL,PHASE2,30,['LOCALLY ADVANCED CERVICAL CANCERS'],LOCALLY ADVANCED CERVICAL CANCERS,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT06639451,"A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)","A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis",ACTIVE_NOT_RECRUITING,2024-12-13,2026-04-30,2026-12-31,INTERVENTIONAL,NA,186,"['Arteriovenous Fistula Stenosis', 'Arteriovenous Fistula', 'Vascular Access']",Arteriovenous Fistula Stenosis,Boston Scientific Corporation,[],['Japan']
NCT07160257,A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus,"A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus",RECRUITING,2025-08-05,2026-08-26,2026-12-13,INTERVENTIONAL,PHASE1,70,['Type 2 Diabetes Mellitus'],Type 2 Diabetes Mellitus,Amgen,[],['United States']
NCT04289142,Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients,Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients: CODEX Trial,RECRUITING,2019-12-01,2028-07,2029-03,INTERVENTIONAL,PHASE4,2400,"['Delirium', 'Cognitive Dysfunction', 'Cognition Disorder', 'Neurocognitive Disorders', 'Mental Disorders', 'Confusion', 'Neurobehavioral Manifestations', 'Neurologic Manifestations', 'Nervous System Diseases', 'Signs and Symptoms', 'Dexmedetomidine', 'Hypnotics and Sedatives', 'Central Nervous System Depressants', 'Physiological Effects of Drugs', 'Analgesics, Non-Narcotic', 'Analgesics', 'Molecular Mechanisms of Pharmacological Action']",Delirium,Sunnybrook Health Sciences Centre,"['London Health Sciences Centre', 'University Health Network, Toronto', 'McMaster University', 'Canadian Institutes of Health Research (CIHR)', 'The Dana Foundation', 'Brain Canada', ""Alzheimer's Association"", 'Hamilton Health Sciences Corporation', 'University of Saskatchewan', 'Fraser Health', 'Providence Health & Services']",['Canada']
NCT07101770,A Prediction Model in Pregnant Women With Aplastic Anemia,Development and Validation of a Prediction Model for Adverse Pregnancy Outcomes in Women With Aplastic Anemia,RECRUITING,2025-11-27,2030-06-30,2030-12-31,OBSERVATIONAL,,300,"['Aplastic Anemia', 'Pregnancy', 'Prediction Model']",Aplastic Anemia,Peking University People's Hospital,"['Tianjin Medical University General Hospital', 'Lanzhou University Second Hospital', 'The Affiliated Hospital of Inner Mongolia Medical University', 'General Hospital of Ningxia Medical University', 'Peking Union Medical College Hospital', 'Peking University Third Hospital', 'The First Affiliated Hospital of Anhui Medical University', 'Wuhan TongJi Hospital', 'Peking University First Hospital', 'Chinese PLA General Hospital', 'Second Xiangya Hospital of Central South University', 'The First Affiliated Hospital of Soochow University', 'Qilu Hospital of Shandong University', ""Shanxi Provincial People's Hospital"", 'The First Affiliated Hospital of Zhengzhou University', 'Shandong Provincial Hospital', 'Shanxi Bethune Hospital', 'Yantai Yuhuangding Hospital', 'First Affiliated Hospital of Harbin Medical University', 'The Third Affiliated Hospital of Guangzhou Medical University', 'First Affiliated Hospital of Zhejiang University', 'Union Hospital, Tongji Medical College, Huazhong University of Science and Technology']",['China']
NCT07255469,Metabolic Fluid Responsiveness in Children,Parameters Associated With Metabolic Response to Volume Expansion in Children Post-operative of Cardiac Surgery,RECRUITING,2025-03-21,2027-03-21,2027-04-18,OBSERVATIONAL,,110,"['Circulatory Failure / Shock State', 'Fluid Therapy']",Circulatory Failure / Shock State,"University Hospital, Bordeaux",[],['France']
NCT05649722,An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD),"An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease",ACTIVE_NOT_RECRUITING,2023-05-11,2026-03-14,2026-03-14,INTERVENTIONAL,PHASE2,31,"['Pulmonary Hypertension', 'Interstitial Lung Disease']",Pulmonary Hypertension,Insmed Incorporated,[],"['Belgium', 'Spain', 'Italy', 'Australia', 'United Kingdom', 'Argentina', 'Germany']"
NCT06529419,A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations,"A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Dose Range-Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults With Uncontrolled Asthma at Risk of Exacerbations (LEVANTE)",ACTIVE_NOT_RECRUITING,2024-08-30,2026-02-04,2026-02-04,INTERVENTIONAL,PHASE2,534,['Asthma'],Asthma,AstraZeneca,[],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Slovakia', 'Belgium', 'Israel', 'France', 'Chile', 'Denmark', 'South Korea', 'Czechia', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'United Kingdom', 'Ukraine', 'Germany', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07241572,Evaluation of Perioperative Myocardial Injury in Patients Undergoing Below-Knee Lower Extremity Surgery,Evaluation of Perioperative Myocardial Injury in Patients Undergoing Below-knee Lower Extremity Surgery With Peripheral Nerve Block,RECRUITING,2025-09-01,2025-12-31,2026-01-10,OBSERVATIONAL,,54,"['Myocardial Ischemia', 'Diabetes Complication']",Myocardial Ischemia,Ankara City Hospital Bilkent,[],['Turkey (Türkiye)']
NCT06980428,"A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels","A Phase I, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4954 Following Single and Multiple Ascending Dose Administration to Healthy Participants With or Without Elevated Lp(a) Levels",RECRUITING,2025-05-27,2026-12-04,2026-12-04,INTERVENTIONAL,PHASE1,120,['Healthy Participants'],Healthy Participants,AstraZeneca,[],['United States']
NCT04104672,A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies,A Phase 1 Study to Evaluate the Safety and Tolerability of AB680 Combination Therapy in Participants With Gastrointestinal Malignancies,ACTIVE_NOT_RECRUITING,2019-11-06,2027-05,2027-05,INTERVENTIONAL,PHASE1,196,['Advanced Pancreatic Cancer'],Advanced Pancreatic Cancer,"Arcus Biosciences, Inc.",[],['United States']
NCT05568212,Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab,"Phase II, Two-cohorts, Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab (MEDI4736)",RECRUITING,2022-05-02,2026-05,2027-05,INTERVENTIONAL,PHASE2,176,['Non-small-cell Lung Cancer Patients'],Non-small-cell Lung Cancer Patients,Fondazione Ricerca Traslazionale,[],['Italy']
NCT07255599,Evaluation of BH4 Responsiveness in Our PKU Patients,Tetrahydrobiopterin Responsiveness in Phenylketonuria Prediction With the 48-hour Loading Test and Genotype,ACTIVE_NOT_RECRUITING,2025-09-01,2026-01-01,2026-09-01,INTERVENTIONAL,PHASE1,20,['Phenylketonuria (PKU)'],Phenylketonuria (PKU),Sohag University,[],['Egypt']
NCT06574984,Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients,Descriptive Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients - An Observational Retrospective Study,RECRUITING,2024-11-10,2025-12-01,2025-12-01,OBSERVATIONAL,,900,"['Congenital Bleeding Disorder', 'Haemophilia A']",Congenital Bleeding Disorder,Novo Nordisk A/S,[],['Iraq']
NCT06778863,A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation,GUARDIAN-101: A Phase 1 Dose Escalation and Expansion Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation,RECRUITING,2025-02-28,2027-12,2028-06,INTERVENTIONAL,PHASE1,90,"['Advanced Solid Tumor', 'Unresectable Solid Tumor', 'Metastatic Solid Tumor', 'Colorectal Adenocarcinoma', 'Pancreatic Adenocarcinoma', 'Lung Cancer', 'Ovarian Cancer', 'Breast Cancer', 'Head and Neck Squamous Cell Carcinoma', 'Prostate Cancer', 'Bladder Cancer']",Advanced Solid Tumor,"Clasp Therapeutics, Inc.",[],['United States']
NCT07076199,"A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes","A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes",RECRUITING,2025-08-11,2026-11-23,2026-12-28,INTERVENTIONAL,PHASE3,877,"['Diabetes Mellitus, Type 1']","Diabetes Mellitus, Type 1",Novo Nordisk A/S,[],"['United States', 'Slovakia', 'Puerto Rico', 'Canada', 'Romania', 'Australia', 'Poland', 'Germany']"
NCT06792799,Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease,An Exploratory Clinical Study on the Safety and Efficacy of CD19/BCMA Chimeric Antigen Receptor NK Cells in the Treatment of B Cell-related Autoimmune Diseases in Children,RECRUITING,2025-01-30,2028-06-30,2029-06-30,INTERVENTIONAL,EARLY_PHASE1,36,"['Autoimmune Diseases', 'Systemic Lupus Erthematosus', 'Multi-Drug Resistant Nephrotic Syndrome', 'IgAN - IgA Nephropathy']",Autoimmune Diseases,The Children's Hospital of Zhejiang University School of Medicine,[],['China']
NCT04843111,"Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)",The MenQuadfi® Pregnancy Registry: A Surveillance Registry to Assess the Safety of MenQuadfi® Among Exposed Pregnant Women and Their Offspring,RECRUITING,2021-03-05,2028-05-18,2028-05-18,OBSERVATIONAL,,50,['Meningococcal Infection'],Meningococcal Infection,"Sanofi Pasteur, a Sanofi Company",[],['United States']
NCT07097298,Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers,Empathy and (Self-)Compassion to Improve the Quality of Life of Parkinson's Disease Patients and Caregivers: an Exploratory Study,RECRUITING,2025-11-06,2027-07,2027-07,INTERVENTIONAL,NA,30,['Parkinson Disease(PD)'],Parkinson Disease(PD),Alain Kaelin,['CTU-EOC Clinical Trial Unit Ente Ospedaliero Cantonale'],['Switzerland']
NCT05765812,A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma,A Phase 1/2 Open-label Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma,RECRUITING,2023-05-15,2028-09,2028-09,INTERVENTIONAL,PHASE1,116,"['Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype', 'Astrocytoma, Grade III']",Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,Debiopharm International SA,[],"['Switzerland', 'Spain', 'United States']"
NCT04804553,Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis,"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)",RECRUITING,2022-03-17,2028-03-21,2028-12-29,INTERVENTIONAL,PHASE3,60,['Active Juvenile Psoriatic Arthritis'],Active Juvenile Psoriatic Arthritis,Amgen,[],"['Belgium', 'South Africa', 'Turkey (Türkiye)', 'Netherlands', 'Austria', 'France', 'Spain', 'Italy', 'Romania', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Lithuania', 'Germany']"
NCT06496568,A Study Evaluating Single-agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers,A Phase I/Ib Study Evaluating Single-Agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers,RECRUITING,2023-12-11,2026-09-30,2026-09-30,INTERVENTIONAL,PHASE1,40,['PIK3CA-Mutated Cancers'],PIK3CA-Mutated Cancers,Hoffmann-La Roche,[],"['United States', 'South Korea', 'Canada']"
NCT02502266,Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer,"A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)",ACTIVE_NOT_RECRUITING,2016-05-03,2023-06-12,2026-07-16,INTERVENTIONAL,PHASE2,582,"['Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Endometrioid Adenocarcinoma', 'Fallopian Tube Serous Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Adenocarcinoma', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Adenocarcinoma', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Primary Peritoneal Serous Adenocarcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Primary Peritoneal Carcinoma']",Fallopian Tube Clear Cell Adenocarcinoma,National Cancer Institute (NCI),"['Canadian Cancer Trials Group', 'NRG Oncology']","['Japan', 'United States', 'Puerto Rico', 'South Korea', 'Canada']"
NCT02932150,Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection,"A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects With Chronic Hepatitis B Virus Infection",ACTIVE_NOT_RECRUITING,2016-11,2026-09,2029-10,INTERVENTIONAL,PHASE2,150,['Chronic Hepatitis B'],Chronic Hepatitis B,Gilead Sciences,[],"['Belgium', 'Hong Kong', 'Russia', 'United States', 'Taiwan', 'South Korea', 'Romania', 'India']"
NCT03633708,A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis,"Phase 3, Randomized, Open-label, Controlled, Multiple Dose, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Etelcalcetide in Pediatric Subjects 28 Days to < 18 Years of Age With Secondary Hyperparathyroidism and Chronic Kidney Disease Receiving Maintenance Hemodialysis",RECRUITING,2019-04-29,2029-01-31,2029-01-31,INTERVENTIONAL,PHASE3,56,"['Secondary Hyperparathyroidism', 'Chronic Kidney Disease']",Secondary Hyperparathyroidism,Amgen,[],"['Singapore', 'Turkey (Türkiye)', 'Russia', 'United States', 'Ukraine', 'Taiwan', 'South Korea', 'Malaysia', 'Argentina', 'India']"
NCT07028385,"Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1","Exploratory Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Impact on HIV-1 Reservoir of Baricitinib in Virologically Suppressed People With HIV-1",RECRUITING,2025-09-22,2026-03,2026-04,INTERVENTIONAL,PHASE2,30,['HIV'],HIV,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","['IrsiCaixa', 'University of Turin, Italy', 'Instituto de Salud Carlos III', 'Germans Trias i Pujol Hospital']",['Spain']
NCT07256743,Efficacy of SALI-10 Oral Probiotics in Experimental Gingivitis,"A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy SALI-10 Oral Probiotics in Experimental Gingivitis",RECRUITING,2025-09-01,2025-12-31,2026-06-01,INTERVENTIONAL,PHASE2,60,['Gingivitis'],Gingivitis,Ostia Sciences,['University of Toronto'],['Canada']
NCT07245017,JN002 for the Treatment of Dry Eye Disease,"Randomized, Double-Blind, Placebo-Controlled, Single Center Clinical Trial to Evaluate the Safety and Preliminary Efficacy of JN002 Ophthalmic Solution in Adult Patients With Dry Eye Disease",RECRUITING,2025-11-24,2026-03,2026-03,INTERVENTIONAL,EARLY_PHASE1,30,['Dry Eye'],Dry Eye,Eye & ENT Hospital of Fudan University,[],['China']
NCT07139210,"EFFECT OF PERCEPTUAL-MOTOR TRAINING ON COGNITIVE FUNCTIONS, MOTOR ABILITIES AND QUALITY OF LIFE IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVE DISORDER","EFFECT OF PERCEPTUAL-MOTOR TRAINING ON COGNITIVE FUNCTIONS, MOTOR ABILITIES AND QUALITY OF LIFE IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVE DISORDER",ACTIVE_NOT_RECRUITING,2025-06-01,2025-08-31,2025-11-30,INTERVENTIONAL,NA,30,"['Cognitive Function', 'Quality of Life', 'ADHD - Attention Deficit Disorder With Hyperactivity', 'Motor Abilities']",Cognitive Function,Cairo University,[],['Egypt']
NCT02567435,Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma,"A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)",ACTIVE_NOT_RECRUITING,2016-06-01,2023-06-30,2026-10-27,INTERVENTIONAL,PHASE3,325,"['Alveolar Rhabdomyosarcoma', 'Botryoid-Type Embryonal Rhabdomyosarcoma', 'Embryonal Rhabdomyosarcoma', 'Rhabdomyosarcoma', 'Sclerosing Rhabdomyosarcoma', 'Spindle Cell Rhabdomyosarcoma']",Alveolar Rhabdomyosarcoma,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Puerto Rico', 'Canada', 'Australia']"
NCT04116996,Globus Pallidus Stimulation to Treat Insomnia,Stimulation of the External Pallidal Segment for Insomnia in Patients With Parkinson's Disease,RECRUITING,2019-01-01,2029-01-01,2029-01-01,INTERVENTIONAL,NA,10,['Parkinson Disease'],Parkinson Disease,Mayo Clinic,[],['United States']
NCT05291091,Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON),"A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of EDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults and Adolescents With Becker Muscular Dystrophy",ACTIVE_NOT_RECRUITING,2022-11-10,2026-09,2026-09,INTERVENTIONAL,PHASE2,175,['Becker Muscular Dystrophy'],Becker Muscular Dystrophy,"Edgewise Therapeutics, Inc.","['Medpace, Inc.', 'ImagingNMD', 'SYSNAV']","['Belgium', 'Israel', 'New Zealand', 'Netherlands', 'United States', 'France', 'Germany', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Australia']"
NCT06569264,Evaluation of Dentin Graft and I-PRF With and Without Vitamin C for Post-extraction Socket Preservation,Evaluation of Dentin Graft and I-PRF With and Without Vitamin C for Post-extraction Socket Preservation. A Randomized Controlled Clinical Trial,RECRUITING,2025-11-04,2026-02-15,2026-02-28,INTERVENTIONAL,NA,26,['Socket Preservation'],Socket Preservation,Cairo University,[],['Egypt']
NCT02180867,Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery,Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754),ACTIVE_NOT_RECRUITING,2014-07-11,2019-06-30,2025-12-23,INTERVENTIONAL,PHASE2,140,"['Alveolar Soft Part Sarcoma', 'Angiomatoid Fibrous Histiocytoma', 'Atypical Fibroxanthoma', 'Clear Cell Sarcoma of Soft Tissue', 'Epithelioid Malignant Peripheral Nerve Sheath Tumor', 'Epithelioid Sarcoma', 'Extraskeletal Myxoid Chondrosarcoma', 'Extraskeletal Osteosarcoma', 'Fibrohistiocytic Neoplasm', 'Fibrosarcoma', 'Inflammatory Myofibroblastic Tumor', 'Intimal Sarcoma', 'Leiomyosarcoma', 'Liposarcoma', 'Liver Embryonal Sarcoma', 'Low Grade Fibromyxoid Sarcoma', 'Low Grade Myofibroblastic Sarcoma', 'Malignant Peripheral Nerve Sheath Tumor', 'Malignant Skin Granular Cell Tumor', 'Malignant Triton Tumor', 'Mesenchymal Chondrosarcoma', 'Myxofibrosarcoma', 'Myxoid Chondrosarcoma', 'Myxoinflammatory Fibroblastic Sarcoma', 'Nerve Sheath Neoplasm', 'PEComa', 'Pericytic Neoplasm', 'Plexiform Fibrohistiocytic Tumor', 'Sclerosing Epithelioid Fibrosarcoma', 'Skin Glomus Tumor', 'Stage IB Soft Tissue Sarcoma AJCC v7', 'Stage IIB Soft Tissue Sarcoma AJCC v7', 'Stage III Soft Tissue Sarcoma AJCC v7', 'Stage IV Soft Tissue Sarcoma AJCC v7', 'Synovial Sarcoma', 'Undifferentiated High Grade Pleomorphic Sarcoma of Bone']",Alveolar Soft Part Sarcoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States', 'Canada']"
NCT06691984,Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute),"A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Chemotherapy",RECRUITING,2024-12-09,2029-01-02,2029-07-30,INTERVENTIONAL,PHASE3,675,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,Amgen,[],"['Japan', 'Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'France', 'Denmark', 'South Korea', 'Poland', 'Singapore', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT06556563,EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma,"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Optune® (TTFields, 200 kHz) Concomitant With Maintenance Temozolomide and Pembrolizumab Versus Optune® Concomitant With Maintenance Temozolomide and Placebo for the Treatment of Newly Diagnosed Glioblastoma (EF-41/KEYNOTE D58).",RECRUITING,2025-02-03,2029-04,2029-04,INTERVENTIONAL,PHASE3,741,['Glioblastoma'],Glioblastoma,NovoCure GmbH,['Merck Sharp & Dohme LLC'],"['Israel', 'Japan', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT06077864,A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT),"A Phase 3, Randomised, Double-blind, Parallel-group, Event-driven, Cardiovascular Safety Study With BI 456906 Administered Subcutaneously Compared With Placebo in Participants With Overweight or Obesity With Established Cardiovascular Disease (CVD) or Chronic Kidney Disease, and/or at Least Two Weight-related Complications or Risk Factors for CVD",ACTIVE_NOT_RECRUITING,2023-11-20,2026-04-06,2026-06-29,INTERVENTIONAL,PHASE3,5533,['Obesity'],Obesity,Boehringer Ingelheim,[],"['Bulgaria', 'Japan', 'New Zealand', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Australia', 'Belgium', 'Hungary', 'Finland', 'Puerto Rico', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'India', 'Kazakhstan', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'Austria', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT02438904,Compassionate Access of the Miltenyi Device for CD34+ Cell Selection,Compassionate Access of the Miltenyi Device for CD34+ Cell Selection,RECRUITING,2015-05-06,2027-05-01,2027-05-01,INTERVENTIONAL,NA,200,['Blood And Marrow Transplantation'],Blood And Marrow Transplantation,M.D. Anderson Cancer Center,[],['United States']
NCT07185035,An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules,An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules,RECRUITING,2025-09-20,2026-09-20,2027-09-20,INTERVENTIONAL,EARLY_PHASE1,24,"['Pulmonary Nodules, Solitary', 'Pulmonary Nodules, Multiple']","Pulmonary Nodules, Solitary",The First Affiliated Hospital with Nanjing Medical University,"['Rui Therapeutics Co., Ltd']",['China']
NCT07204457,Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old,"Multicenter, Randomized, Subject/Evaluator Blind, Active Control, Phase II/III Clinical Trial to Assess Immunogenicity and Safety of EG-MCV4 Meningococcal (Groups A, C, W-135, and Y) Conjugated Vaccines",RECRUITING,2025-10-15,2026-09,2027-06,INTERVENTIONAL,PHASE2,1123,['Meningococcal Infections'],Meningococcal Infections,EyeGene Inc.,['BMI Korea'],['South Korea']
NCT05673018,Galleri® in the Medicare Population.,REACH Study: Galleri® in the Medicare Population.,RECRUITING,2024-07-12,2030-09,2030-09,INTERVENTIONAL,NA,50000,['Cancer'],Cancer,"GRAIL, Inc.",[],['United States']
NCT07083947,"Effect of Herbal Compositions on Body Weight, Body Composition and Metabolic Health in Overweight Subjects","A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Effect of Herbal Compositions CL19183 and CL24212 on Body Weight, Body Composition and Metabolic Health in Overweight Subjects",ACTIVE_NOT_RECRUITING,2025-07-16,2026-01-25,2026-01-25,INTERVENTIONAL,NA,150,['Healthy Participants'],Healthy Participants,ApexCPG LLC,[],['India']
NCT06520787,DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions,DAta-driven personaLIzation of a digitAl Health Solution to Support Family Caregivers of Children With Chronic Conditions,RECRUITING,2025-03-11,2026-04,2026-05,OBSERVATIONAL,,40,"['Obesity, Childhood']","Obesity, Childhood","Adhera Health, Inc.","['Hospital Universitario Miguel Servet, Zaragoza', 'University of Valencia', 'University of Seville']",['Spain']
NCT07145658,Multivitamin for Health and Cognition,"A Randomised Placebo-controlled Trial Assessing the Effect of Daily Supplementation of a 20-ingrediant Multivitamin, on Markers of Health, Wellbeing and Cognitive Function in Healthy Volunteers",ACTIVE_NOT_RECRUITING,2025-07-07,2025-12,2025-12,INTERVENTIONAL,NA,36,"['Healthy', 'Cognition', 'Health']",Healthy,Dr Anthony Hobson,['Heights'],['United Kingdom']
NCT07239063,Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer,"Validation of a High-Throughput, Large-Format, Tissue-Specific Preprocessing Protocol for Lung and Colorectal Cancer",RECRUITING,2024-10-01,2025-12,2027-12,OBSERVATIONAL,,1000,"['CRC (Colorectal Cancer)', 'Lung Cancer (Diagnosis)']",CRC (Colorectal Cancer),"Nanfang Hospital, Southern Medical University",[],['China']
NCT04640779,"Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma","Phase Ib Trial of Low-Dose Selinexor (KPT-330) in Combination With Choline Salicylate (CS) for the Treatment of Patients With Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasms, or Multiple Myeloma",ACTIVE_NOT_RECRUITING,2021-02-08,2026-08-15,2027-08-15,INTERVENTIONAL,PHASE1,22,"['Recurrent Histiocytic and Dendritic Cell Neoplasm', 'Recurrent Hodgkin Lymphoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Plasma Cell Myeloma', 'Refractory Histiocytic and Dendritic Cell Neoplasm', 'Refractory Hodgkin Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Plasma Cell Myeloma']",Recurrent Histiocytic and Dendritic Cell Neoplasm,Mayo Clinic,['National Cancer Institute (NCI)'],['United States']
NCT07002203,Personalized Neoantigen Peptide Vaccines for Solid Tumors,A Phase Ib Clinical Study of Personalized Neoantigen Peptide Vaccines for Solid Tumors,RECRUITING,2024-03-01,2027-08,2027-08,INTERVENTIONAL,PHASE1,10,"['Solid Tumors', 'Advanced Cancer', 'Recurrent Cancer', 'Neoantigen-Specific Immunotherapy', 'Personalized Cancer Vaccine']",Solid Tumors,"Seqker Biosciences, Inc.",['Bumrungrad International Hospital'],['Thailand']
NCT07229742,A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis,"A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-2173 Injection in Patients With Active Lupus Nephritis",RECRUITING,2025-11-22,2027-06,2028-03,INTERVENTIONAL,PHASE2,51,['Active Lupus Nephritis'],Active Lupus Nephritis,"Guangdong Hengrui Pharmaceutical Co., Ltd",[],['China']
NCT06969430,"A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)","A Phase 1/2, First-in-human, Multicenter, Open-label Trial Evaluating the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)",RECRUITING,2025-05-30,2031-11,2031-11,INTERVENTIONAL,PHASE1,134,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,Debiopharm International SA,[],['United States']
NCT05645172,Retention Rate of Acalabrutinib in a Non-interventional Setting,Retention Rate of Acalabrutinib in a Non-interventional Setting,ACTIVE_NOT_RECRUITING,2022-12-12,2026-10-15,2026-10-15,OBSERVATIONAL,,137,['Chronic Lymphocytic Leukaemia (CLL)'],Chronic Lymphocytic Leukaemia (CLL),AstraZeneca,[],['Germany']
NCT07256301,"A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)","A Multicenter, Open-Label, Phase Ib Clinical Trial to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Multiple Doses of the Humanized Monoclonal Antibody EA5 in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)",RECRUITING,2024-01-03,2026-03-01,2026-05-01,INTERVENTIONAL,PHASE1,24,['PNH - Paroxysmal Nocturnal Hemoglobinuria'],PNH - Paroxysmal Nocturnal Hemoglobinuria,"Shanghai Lanyi Therapeutics Co., Ltd.",[],['China']
NCT04949633,Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening,Oxytocine Versus Prostaglandines Pour le déclenchement du Travail Des Femmes Dont le Col Est défavorable après 24 Heures de Maturation Cervicale : Essai Multicentrique randomisé de Non infériorité,RECRUITING,2021-09-28,2026-09,2026-11,INTERVENTIONAL,PHASE3,1494,"['Cervical Ripening', 'Unfavorable Cervix']",Cervical Ripening,"University Hospital, Tours",[],['France']
NCT05732298,Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment,Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant,ACTIVE_NOT_RECRUITING,2023-02-27,2025-12-31,2026-03-31,INTERVENTIONAL,NA,72,['Depression'],Depression,University of Regensburg,[],['Germany']
NCT05383963,Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome,Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome (QUICK-SEPSIS),RECRUITING,2022-07-15,2026-09,2027-12,OBSERVATIONAL,,10000,"['Sepsis', 'Septic Shock']",Sepsis,"Charite University, Berlin, Germany",[],['Germany']
NCT05000242,West Hertfordshire Inflammatory Bowel Disease Technology Study,West Hertfordshire Inflammatory Bowel Disease Technology Study,ACTIVE_NOT_RECRUITING,2022-01-31,2026-01-31,2026-03-01,OBSERVATIONAL,,200,['Inflammatory Bowel Diseases'],Inflammatory Bowel Diseases,Perspectum,['West Hertfordshire Hospitals NHS Trust'],['United Kingdom']
NCT05006196,Contrast-Free Magnetic Resonance Imaging for Breast Disease,Contrast-Free Magnetic Resonance Imaging for Breast Disease,ACTIVE_NOT_RECRUITING,2021-07-06,2025-12-30,2025-12-30,OBSERVATIONAL,,1030,"['Breast Cancer', 'Breast Diseases']",Breast Cancer,Perspectum,[],['United Kingdom']
NCT05921994,Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.,"Long Term observAtional, Prospective, Multicenter Study to Collect iN a Real-world populatIon Data on the treatMent Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (ANIMA)",ACTIVE_NOT_RECRUITING,2023-08-10,2027-03-31,2027-03-31,OBSERVATIONAL,,425,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,Novartis Pharmaceuticals,[],['Germany']
NCT06395753,A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer,"A Phase 2, Randomized, Open-Label, Dose-Finding Study of Debio 4228, an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Advanced Prostate Cancer",RECRUITING,2024-05-23,2026-12,2027-01,INTERVENTIONAL,PHASE2,66,['Prostate Cancer'],Prostate Cancer,Debiopharm International SA,[],"['Belgium', 'Spain', 'United States', 'France']"
NCT06009809,Blood Velocity Variation in Right Renal and Superior Mesenteric Arteries During Cardio-pulmonary Bypass,Blood Velocity Variation in Right Renal and Superior Mesenteric Arteries During Cardio-pulmonary Bypass,RECRUITING,2022-02-15,2025-12-31,2025-12-31,OBSERVATIONAL,,92,['Heart Surgical Procedure'],Heart Surgical Procedure,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,[],['Italy']
NCT07255534,Efficacy and Safety of Digital Therapeutics for Improving Shoulder Function After Rotator Cuff Repair,"Efficacy and Safety of Digital Therapeutics for Improving Shoulder Function After Rotator Cuff Repair: A Prospective, Randomized, Parallel-Group, Evaluator-Blinded Study",RECRUITING,2025-10-20,2026-12-31,2026-12-31,INTERVENTIONAL,NA,70,"['Rotator Cuff Tear Arthropathy', 'Repair of a Cuff Tear']",Rotator Cuff Tear Arthropathy,Samsung Medical Center,[],['South Korea']
NCT06613100,Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer,"A Phase 1b, Open-Label, Multicenter Study Evaluating the Safety, Tolerability, and Feasibility of Neoadjuvant Xaluritamig Therapy Prior to Radical Prostatectomy in Subjects With Newly Diagnosed Localized Intermediate or High-Risk Prostate Cancer",RECRUITING,2024-11-25,2027-01-22,2030-01-23,INTERVENTIONAL,PHASE1,40,['Prostate Cancer'],Prostate Cancer,Amgen,[],"['United States', 'Germany']"
NCT06914492,"Real-time Smoking Cessation Instant Messaging Support Using a Large Language Model (LLM)-Based Chatbot Via ""Quit to Win"" 2025 (QTW2025)","Building Capacity and Promoting Smoking Cessation in the Community Via ""Quit to Win"" Contest 2025: Real-time Smoking Cessation Instant Messaging Support Using a Large Language Model (LLM)-Based Chatbot",ACTIVE_NOT_RECRUITING,2025-06-21,2026-06-30,2027-06-30,INTERVENTIONAL,NA,1094,['Smoking Cessation'],Smoking Cessation,The University of Hong Kong,[],['Hong Kong']
NCT07079631,"A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer","A Phase I/II, Randomized, Multi-site Trial to Investigate the Efficacy and Safety of BNT314 in Combination With BNT327 and Chemotherapy in Participants With Metastatic Colorectal Cancer",RECRUITING,2025-07-18,2030-12,2031-05,INTERVENTIONAL,PHASE1,482,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,BioNTech SE,['Genmab'],"['United Kingdom', 'Spain', 'United States']"
NCT06995807,EL-SHIN Therapy for Depressive Symptoms,Enhancing the Efficacy of Depression and Low Mood Treatment: A Novel Adjunctive Approach,RECRUITING,2025-06-01,2026-07,2027-05,INTERVENTIONAL,NA,80,['Depressive Disorder'],Depressive Disorder,Monash University Malaysia,[],['Malaysia']
NCT07255274,Overweight and Obesity in Adolescents - Sleep Behavioral Intervention,Treatment of Overweight and Obesity in Adolescents - Impact of a Sleep Behavioral Intervention - SLEEP-OB,RECRUITING,2025-06-03,2026-06,2026-12,INTERVENTIONAL,NA,126,"['Obesity and Overweight', 'Sleep Disorder']",Obesity and Overweight,University of Beira Interior,[],['Portugal']
NCT06440993,Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma,"The CLEAN-DUCT / TRITICC-3 Trial - Phase IIa, Prospective, Single Arm, Open Label, Non-randomized, Multi-center Pilot Study of Durvalumab (MEDI4736) + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma",RECRUITING,2024-08-23,2027-01,2028-04,INTERVENTIONAL,PHASE2,42,"['Extrahepatic Cholangiocarcinoma', 'Unresectable Perihilar or Ductal CCA']",Extrahepatic Cholangiocarcinoma,Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest,"['Universitätsklinikum Düsseldorf, Germany', 'Universitätsklinikum Köln', 'AstraZeneca']",['Germany']
NCT05192434,Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs,"Efficacy of a Trauma Intervention for Affect Regulation, Adherence, and Substance Use to Optimize PrEP for Women Who Inject Drugs",ACTIVE_NOT_RECRUITING,2022-06-17,2026-12-31,2026-12-31,INTERVENTIONAL,NA,240,"['HIV Infections', 'Opioid Use', 'Trauma, Psychological']",HIV Infections,Drexel University,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT07235709,Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study,Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR Study (ESCAPE-FABRY Trial),RECRUITING,2025-11-12,2029-06,2029-11,OBSERVATIONAL,,25,['Fabry Disease'],Fabry Disease,Yonsei University,[],['South Korea']
NCT05588141,A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations,A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations,RECRUITING,2023-05-16,2028-08-01,2032-08-02,INTERVENTIONAL,PHASE1,96,"['Brain Tumor', 'Cancer']",Brain Tumor,National Cancer Institute (NCI),[],['United States']
NCT07036718,NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice,"A Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of Iptacopan in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) in Routine Clinical Practice in the Russian Federation",RECRUITING,2025-07-28,2028-01-31,2028-01-31,OBSERVATIONAL,,100,['Paroxysmal Nocturnal Hemoglobinuria'],Paroxysmal Nocturnal Hemoglobinuria,Novartis Pharmaceuticals,[],['Russia']
NCT05836584,Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer,A Randomized Phase II Study of Perioperative Atezolizumab +/- Chemotherapy in Resectable MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer,ACTIVE_NOT_RECRUITING,2023-12-06,2027-10-31,2027-10-31,INTERVENTIONAL,PHASE2,240,"['Clinical Stage I Gastric Cancer AJCC v8', 'Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Clinical Stage II Gastric Cancer AJCC v8', 'Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Clinical Stage III Gastric Cancer AJCC v8', 'Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Clinical Stage IVA Gastric Cancer AJCC v8', 'Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Gastric Adenocarcinoma', 'Gastroesophageal Junction Adenocarcinoma']",Clinical Stage I Gastric Cancer AJCC v8,National Cancer Institute (NCI),[],['United States']
NCT05363397,Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke,Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke,RECRUITING,2023-09-27,2026-02-01,2026-05-01,INTERVENTIONAL,PHASE2,80,['Acute Ischemic Stroke'],Acute Ischemic Stroke,The Florey Institute of Neuroscience and Mental Health,['Neuroscience Trials Australia'],['Australia']
NCT06484075,Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms,Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms,RECRUITING,2024-11-21,2028-12-31,2029-12-31,INTERVENTIONAL,PHASE1,180,"['Healthy Volunteers', 'Alcohol Use Disorder (AUD)']",Healthy Volunteers,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT00231400,Pompe Disease Registry Protocol,Pompe Disease Registry,RECRUITING,2004-09-15,2034-01-31,2034-01-31,OBSERVATIONAL,,2000,"['Glycogen Storage Disease Type II', 'Pompe Disease']",Glycogen Storage Disease Type II,"Genzyme, a Sanofi Company",[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'Pakistan', 'China', 'Saudi Arabia', 'Slovakia', 'Jordan', 'Serbia', 'Kuwait', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Chile', 'Croatia', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Singapore', 'Lebanon', 'Indonesia', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Arab Emirates', 'Portugal', 'United Kingdom', 'Vietnam', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT05496556,Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV,Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV,ACTIVE_NOT_RECRUITING,2023-11-01,2026-10-01,2026-10-01,INTERVENTIONAL,NA,190,['Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations'],Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations,Centre Georges Francois Leclerc,[],['France']
NCT07035769,"A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults","A Phase 1, First-in-human, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Debio 1453P in Healthy Adults",RECRUITING,2025-06-18,2026-04,2026-05,INTERVENTIONAL,PHASE1,88,['Healthy Participants'],Healthy Participants,Debiopharm International SA,"['Biomedical Advanced Research and Development Authority', 'Wellcome Trust', ""Germany's Federal Ministry of Research, Technology and Space (BMFTR)"", 'Global Antimicrobial Resistance Innovation Fund-(GAMRIF)', 'Novo Nordisk Foundation (NNF)']",['Belgium']
NCT02945579,Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy,Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy,RECRUITING,2017-01-20,2026-01-31,2026-01-31,INTERVENTIONAL,NA,120,"['Estrogen Receptor Negative', 'HER2 Positive Breast Carcinoma', 'HER2/Neu Negative', 'Invasive Breast Carcinoma', 'Progesterone Receptor Negative', 'Stage I Breast Cancer AJCC v7', 'Stage IA Breast Cancer AJCC v7', 'Stage IB Breast Cancer AJCC v7', 'Stage II Breast Cancer AJCC v6 and v7', 'Stage IIA Breast Cancer AJCC v6 and v7', 'Stage IIB Breast Cancer AJCC v6 and v7', 'Triple-Negative Breast Carcinoma']",Estrogen Receptor Negative,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT06472245,Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor,"A Randomised, Open-label, Phase 3 Trial Comparing the Efficacy and Safety of OSE2101 Versus Docetaxel in HLA-A2 Positive Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) With Secondary Resistance to Immune Checkpoint Inhibitor",RECRUITING,2024-12-03,2027-12-15,2028-12-15,INTERVENTIONAL,PHASE3,363,['Patients With Non-Small Cell Lung Cancer'],Patients With Non-Small Cell Lung Cancer,OSE Immunotherapeutics,"['Exystat', 'Genome Diagnostics (GenDx)']","['Belgium', 'Hungary', 'Netherlands', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Poland', 'Portugal', 'Germany']"
NCT05677763,OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness,"A Randomised, Placebo-Controlled, 3-Arm, Double-Blind, Multicentre, Phase 4 Study to Assess the Efficacy of OM-85 (Broncho-Vaxom) Short- and Long-Term Treatment vs. Placebo in the Prevention of Respiratory Tract Infections in Children Aged Between 6 Months and 5 Years With Wheezing Lower Respiratory Illness",ACTIVE_NOT_RECRUITING,2022-12-12,2026-03-23,2026-09-16,INTERVENTIONAL,PHASE4,525,"['Respiratory Tract Infections', 'Wheezing Lower Respiratory Illness']",Respiratory Tract Infections,OM Pharma SA,[],"['Hungary', 'Switzerland', 'Italy', 'United Kingdom', 'Poland', 'Germany']"
NCT07255963,"Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL","A Prospective Study of Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)",RECRUITING,2025-11-30,2028-09-30,2030-09-30,INTERVENTIONAL,PHASE2,29,['DLBCL - Diffuse Large B Cell Lymphoma'],DLBCL - Diffuse Large B Cell Lymphoma,The First Affiliated Hospital of Soochow University,[],['China']
NCT07221981,Study of Patient With Frequent COPD Exacerbations,Clinical and dEmographic chaRacteristics of Patients With Frequent COPD Exacerbations and Evaluation of Therapeutic Approaches in Treatment in RussiA,RECRUITING,2024-12-16,2026-06-30,2026-06-30,OBSERVATIONAL,,2000,['Chronic Obstructive Pulmonary Disease (COPD)'],Chronic Obstructive Pulmonary Disease (COPD),AstraZeneca,[],['Russia']
NCT00233272,Baltimore Longitudinal Study of Aging,The Baltimore Longitudinal Study of Aging (BLSA),RECRUITING,2014-02-03,,,OBSERVATIONAL,,10000,['Aging'],Aging,National Institute on Aging (NIA),[],['United States']
NCT07011719,Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma,"A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma",RECRUITING,2025-09-08,2028-04,2030-12,INTERVENTIONAL,PHASE3,720,"['Metastatic Clear Cell Renal Cell Carcinoma', 'Advanced Clear Cell Renal Cell Carcinoma']",Metastatic Clear Cell Renal Cell Carcinoma,"Arcus Biosciences, Inc.",[],['United States']
NCT06918041,FiberLocker® System Augmentation of Rotator Cuff Repairs,FiberLocker® System Augmentation of Rotator Cuff Repairs,RECRUITING,2025-08-05,2026-10-01,2028-04-01,INTERVENTIONAL,NA,60,"['Rotator Cuff Tear', 'Rotator Cuff Tears', 'Rotator Cuff Tears of the Shoulder']",Rotator Cuff Tear,ZuriMED Technologies Inc.,[],['United States']
NCT07045922,"Motor-Cognitive Training , Cognitive Performance and Balance",Effects of Motor-Cognitive Training on Cognitive Performance and Balance in Preschool Children,ACTIVE_NOT_RECRUITING,2025-06-30,2025-11-30,2025-12-01,INTERVENTIONAL,NA,50,"['Coordination Impairment', 'Children', 'Balance']",Coordination Impairment,Princess Nourah Bint Abdulrahman University,[],['Turkey (Türkiye)']
NCT03937154,"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer","PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer",RECRUITING,2020-02-26,2026-05-20,2027-05-20,INTERVENTIONAL,PHASE3,162,['Chemotherapy-induced Thrombocytopenia'],Chemotherapy-induced Thrombocytopenia,Amgen,[],"['Brazil', 'Bulgaria', 'Hungary', 'Turkey (Türkiye)', 'Austria', 'United States', 'Mexico', 'Russia', 'Ukraine', 'Chile', 'Spain', 'Peru', 'Colombia', 'Romania', 'Greece', 'Poland', 'Portugal', 'Argentina']"
NCT03641092,CenteringParenting Clinical Intervention on Kindergarten Readiness in Early Childhood,Evaluation of the Impact of the CenteringParenting Clinical Intervention on Kindergarten Readiness in Early Childhood,RECRUITING,2019-02-19,2026-09,2026-09,INTERVENTIONAL,NA,1200,"['Parent-Child Relations', 'Parenting', 'Child Development', 'Child Behavior']",Parent-Child Relations,Boston Medical Center,"['Centering Healthcare Institute', 'Overdeck Family foundation', 'Valhalla Foundation']",['United States']
NCT02890355,FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer,Randomized Phase II Study of 2nd Line FOLFIRI Versus Modified FOLFIRI With PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer,ACTIVE_NOT_RECRUITING,2016-09-01,2019-05-01,2026-03-17,INTERVENTIONAL,PHASE2,123,"['Metastatic Pancreatic Adenocarcinoma', 'Recurrent Pancreatic Carcinoma', 'Stage IV Pancreatic Cancer AJCC v6 and v7']",Metastatic Pancreatic Adenocarcinoma,National Cancer Institute (NCI),[],['United States']
NCT05055297,SELUTION4BTK Trial,SELUTION SLR™ 014 BTK: A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI),RECRUITING,2022-05-19,2027-06-01,2032-07-30,INTERVENTIONAL,NA,376,"['Peripheral Arterial Disease', 'Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities']",Peripheral Arterial Disease,M.A. Med Alliance S.A.,"['NAMSA', 'Cordis US Corp.']","['Singapore', 'New Zealand', 'Hong Kong', 'Netherlands', 'Austria', 'United States', 'France', 'Switzerland', 'Italy', 'Germany']"
NCT02446600,"Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer",ACTIVE_NOT_RECRUITING,2016-03-28,2020-02-23,2026-08-23,INTERVENTIONAL,PHASE3,579,"['Fallopian Tube Clear Cell Adenocarcinoma', 'Fallopian Tube Transitional Cell Carcinoma', 'Fallopian Tube Undifferentiated Carcinoma', 'Ovarian Clear Cell Adenocarcinoma', 'Ovarian Endometrioid Tumor', 'Ovarian Seromucinous Carcinoma', 'Ovarian Serous Tumor', 'Ovarian Transitional Cell Carcinoma', 'Ovarian Undifferentiated Carcinoma', 'Recurrent Fallopian Tube Carcinoma', 'Recurrent Ovarian Carcinoma', 'Recurrent Ovarian Endometrioid Adenocarcinoma', 'Recurrent Primary Peritoneal Carcinoma']",Fallopian Tube Clear Cell Adenocarcinoma,National Cancer Institute (NCI),"['AstraZeneca', 'NRG Oncology']","['Japan', 'United States', 'South Korea', 'Canada']"
NCT07247552,Personalized Treatment by rTMS in Chronic Pain - Study2,Personalized Pain Treatment by Transcranial Magnetic Stimulation in Patients With Chronic Pain: A Prospective Interventional Study With Embedded Predictive Biomarker Evaluation,RECRUITING,2025-04-01,2026-03,2026-06,INTERVENTIONAL,NA,90,['Chronic Pain'],Chronic Pain,Aalborg University,[],['Denmark']
NCT07178847,cDNA and Residual Disease After Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinomas,Evaluation of Circulating DNA as a Biomarker of Residual Disease After Chemoradiotherapy for Locally Advanced Head and Necksquamous Cell Carcinoma,RECRUITING,2025-10-13,2029-04,2031-07,INTERVENTIONAL,NA,59,['Locally Advanced Head and Neck Carcinoma'],Locally Advanced Head and Neck Carcinoma,Centre Jean Perrin,[],['France']
NCT06619509,A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine,"A Phase II, Single-arm, Open-label, Long-term Safety Rollover Trial of Oral Brigimadlin in Patients With Solid Tumours",RECRUITING,2024-12-30,2030-12-30,2030-12-30,INTERVENTIONAL,PHASE2,90,['Solid Tumours'],Solid Tumours,Boehringer Ingelheim,[],"['Japan', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Denmark', 'Czechia', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Sweden', 'Germany', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT05419011,Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome,A Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccines (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome,ACTIVE_NOT_RECRUITING,2023-05-08,2027-07-01,2028-01-01,INTERVENTIONAL,PHASE2,186,"['Colorectal Carcinoma', 'Colorectal Neoplasm', 'Lynch Syndrome']",Colorectal Carcinoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT07208097,Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage,Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage,RECRUITING,2025-10-25,2027-12-31,2028-06-30,INTERVENTIONAL,NA,768,"['Intracerebral Haemorrhage', 'Minimally Invasive Treatment']",Intracerebral Haemorrhage,Tongji Hospital,[],['China']
NCT01676805,Tissue Collection for Studies of Lymph Cancer,Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol,RECRUITING,2012-09-21,,,OBSERVATIONAL,,1095,"['Hodgkin Disease', 'Lymphoma, Non-Hodgkin', 'Multiple Myeloma', 'Lymphomatoid Granulomatosis', 'Leukemia-Lymphoma, Adult T-Cell']",Hodgkin Disease,National Cancer Institute (NCI),[],"['Jamaica', 'United States']"
NCT07096102,Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome,Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome,RECRUITING,2025-08-31,2026-12-30,2026-12-30,INTERVENTIONAL,NA,310,['Metabolic Syndrome (MetS)'],Metabolic Syndrome (MetS),Meihua Ji,['The Luhe Teaching Hospital of the Capital Medical University'],['China']
NCT05568095,"A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body","A Randomized, Open-Label, Multicenter Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma",ACTIVE_NOT_RECRUITING,2022-11-21,2026-06,2026-06,INTERVENTIONAL,PHASE3,1040,['Advanced Upper Gastrointestinal Tract Adenocarcinoma'],Advanced Upper Gastrointestinal Tract Adenocarcinoma,"Arcus Biosciences, Inc.","['Gilead Sciences', 'Taiho Pharmaceutical Co., Ltd.']","['Japan', 'Hong Kong', 'China', 'Serbia', 'Lithuania', 'Australia', 'Israel', 'Hungary', 'France', 'Chile', 'Guatemala', 'Peru', 'South Korea', 'Thailand', 'Poland', 'Mexico', 'Georgia', 'Spain', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Portugal', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07236229,The Effects of Immersive Virtual Reality in Patients With Grade 1-2 Adhesive Capsulitis,"The Effects of Immersive Virtual Reality-Based Exercise Therapy on Pain, Functionality, Sleep, and Cognitive Functions in Patients With Grade 1-2 Adhesive Capsulitis",RECRUITING,2025-11-28,2026-01-11,2026-02-27,INTERVENTIONAL,NA,36,"['Adhesive Capsulitis', 'Virtual Reality', 'Sleep', 'Pain', 'Cognition']",Adhesive Capsulitis,Bahçeşehir University,[],['Turkey (Türkiye)']
NCT06517732,Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation,"Prospective, Observational, Multicenter Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation (ANIMA-R)",RECRUITING,2024-07-26,2026-08-31,2026-08-31,OBSERVATIONAL,,300,['Hidradenitis Suppurativa'],Hidradenitis Suppurativa,Novartis Pharmaceuticals,[],['Russia']
NCT04339764,Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration,A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration,RECRUITING,2020-09-23,2029-05-31,2029-05-31,INTERVENTIONAL,PHASE1,20,"['Dry Age-Related Macular Degeneration', 'Geographic Atrophy']",Dry Age-Related Macular Degeneration,National Eye Institute (NEI),[],['United States']
NCT07255300,Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging,"Follow up Study of the Effects of the Longevity and the Fasting Mimicking Diet on Body Composition, Age-related Risk Factors and Biomarkers of Aging in a Randomized Study 1 and 2",RECRUITING,2025-05-02,2027-05-02,2027-06-02,INTERVENTIONAL,NA,135,"['Fat Mass', 'Risk Factors Cardiovascular Disease', 'Epigenetic Aging', 'Metabolism Changes', 'Overweight (BMI &gt; 25)', 'Risk Behavior', 'Obesity (Disorder)']",Fat Mass,Fondazione Valter Longo,"['Universita degli Studi di Palermo', 'University of Calabria', 'Regione Calabria / Comune Varapodio', 'European Longevity Institute']",['Italy']
NCT05198934,Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation,"A Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib and Panitumumab Versus Investigator's Choice (Trifluridine and Tipiracil, or Regorafenib) for the Treatment of Previously Treated Metastatic Colorectal Cancer Subjects With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation",ACTIVE_NOT_RECRUITING,2022-04-19,2025-07-16,2026-01-31,INTERVENTIONAL,PHASE3,160,['Colorectal Cancer (CRC)'],Colorectal Cancer (CRC),Amgen,[],"['Japan', 'United States', 'France', 'Mexico', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Australia', 'Greece', 'United Kingdom', 'Germany']"
NCT06227000,Living Longer and Stronger With Spinal Cord Injury (SCI),Living Longer and Stronger With Spinal Cord Injury: An Online Program for Promoting Healthy Aging,ACTIVE_NOT_RECRUITING,2024-02-13,2026-07-01,2026-07-01,INTERVENTIONAL,NA,180,['Spinal Cord Injuries'],Spinal Cord Injuries,"The University of Texas Health Science Center, Houston","['National Institute on Disability, Independent Living, and Rehabilitation Research']",['United States']
NCT02112916,Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma,A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy),ACTIVE_NOT_RECRUITING,2014-10-04,2020-03-31,2026-09-16,INTERVENTIONAL,PHASE3,847,"['Adult T Acute Lymphoblastic Leukemia', 'Ann Arbor Stage II Adult Lymphoblastic Lymphoma', 'Ann Arbor Stage II Childhood Lymphoblastic Lymphoma', 'Ann Arbor Stage III Adult Lymphoblastic Lymphoma', 'Ann Arbor Stage III Childhood Lymphoblastic Lymphoma', 'Ann Arbor Stage IV Adult Lymphoblastic Lymphoma', 'Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma', 'Childhood T Acute Lymphoblastic Leukemia']",Adult T Acute Lymphoblastic Leukemia,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Canada', 'Australia']"
NCT01299168,Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation,Multi-centric Observational Study to Analyse the Diagnostic Molecular Features in the Clinical Setting of Kidney Allograft Biopsies,RECRUITING,2011-05,2026-12,2027-06,OBSERVATIONAL,,500,"['Validation Study of Molecular Diagnostic System', 'Development of Reporting System for Molecular Diagnosis', 'Incorporate Molecular Diagnosis Into Diagnostic Standards']",Validation Study of Molecular Diagnostic System,University of Alberta,[],"['Austria', 'United States', 'France', 'Slovenia', 'Switzerland', 'Croatia', 'Ireland', 'Spain', 'South Korea', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Germany']"
NCT07120893,Pilot Study of Brief Culturally Adapted Behavioral Activation for Adults With Depression in Primary Care Setting,"Pilot Study Assessing Acceptability, Feasibility, and Appropriateness of Brief Culturally Adapted Behavioral Activation for Adults With Depression in Primary Care Setting",RECRUITING,2025-09-22,2025-12-06,2025-12-13,INTERVENTIONAL,NA,12,['Depression in Adults'],Depression in Adults,Gadjah Mada University,[],['Indonesia']
NCT06007092,Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer,Multicentric Randomized Phase I/IIa Trial of the Safety and Immunogenicity of a Therapeutic Anti-HPV DC Targeting Vaccine in Patients With Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer,RECRUITING,2023-07-31,2025-11,2026-08,INTERVENTIONAL,PHASE1,24,"['Head and Neck Carcinoma', 'Adult Disease']",Head and Neck Carcinoma,"Gustave Roussy, Cancer Campus, Grand Paris",['LinKinVax'],['France']
NCT07201649,"Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications","Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications",RECRUITING,2025-11-24,2028-11-24,2029-11-24,INTERVENTIONAL,NA,95,['Liver Cirrhosis'],Liver Cirrhosis,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06309238,Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial,Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial. Lighthouse Consortium on Obesity Management (LightCOM) Trial no 4,RECRUITING,2024-05-08,2027-12,2048-12,INTERVENTIONAL,NA,500,['Obesity'],Obesity,Carsten Dirksen,"['University of Copenhagen', 'University of Southern Denmark', 'University of Oxford', 'Copenhagen Trial Unit, Center for Clinical Intervention Research']","['United Kingdom', 'Denmark']"
NCT07013487,A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1),"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Immunogenicity, and Efficacy of V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age",RECRUITING,2025-06-11,2032-02-02,2032-02-02,INTERVENTIONAL,PHASE3,12000,['Healthy'],Healthy,Merck Sharp & Dohme LLC,[],"['Singapore', 'Indonesia', 'Thailand', 'Malaysia', 'Philippines']"
NCT06930625,A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs,"A Phase 3 Randomized 3-arm Trial (Double-blind Debio 4126, Placebo Control, and Open-label Debio 4126), to Assess the Efficacy and Safety of Debio 4126, a 12-week Octreotide Formulation, in Patients With Acromegaly Previously Treated With Somatostatin Analogs",RECRUITING,2025-11-26,2028-06,2029-03,INTERVENTIONAL,PHASE3,119,['Acromegaly'],Acromegaly,Debiopharm International SA,[],"['Bulgaria', 'Slovakia', 'Lithuania', 'Belgium', 'Israel', 'Hungary', 'Estonia', 'France', 'Denmark', 'Poland', 'Spain', 'Romania', 'United Kingdom', 'Latvia', 'Sweden', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Serbia']"
NCT01875588,Thinking and Memory Problems in People With HIV,An Evaluation of HIV-associated Neurocognitive Disorders (HAND) in Virologically Controlled Patients,RECRUITING,2013-07-08,2037-02-22,,OBSERVATIONAL,,1150,['HIV Positive'],HIV Positive,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07256769,"Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis","Synergic Role of Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis in Breast Cancer Patients Treated With Aromatase Inhibitors",RECRUITING,2025-09-29,2027-09-29,2028-03-31,OBSERVATIONAL,,134,"['Osteoporosis Secondary', 'Breast Cancer Females']",Osteoporosis Secondary,Regina Elena Cancer Institute,[],['Italy']
NCT05918302,Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.,"Efficacy, Safety and Patient-reported Outcomes of Peptide Receptor Radionuclide Therapy With 177Lu-edotreotide Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.",RECRUITING,2023-10-27,2028-03,2028-07,INTERVENTIONAL,PHASE3,120,"['Neuroendocrine Tumors', 'Lung Neuroendocrine Neoplasm', 'Thymus Neoplasms']",Neuroendocrine Tumors,Grupo Espanol de Tumores Neuroendocrinos,"['ITM Oncologics GmbH', 'MFAR']","['Belgium', 'Spain', 'Italy', 'France']"
NCT04499248,AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension,A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension,RECRUITING,2020-11-16,2029-02,2029-02,INTERVENTIONAL,PHASE1,96,"['Open-angle Glaucoma', 'Ocular Hypertension']",Open-angle Glaucoma,AbbVie,[],"['Japan', 'United States']"
NCT07255547,PRP vs AD-SVF in Addition to Marrow Stimulation for Knee Chondral Lesion,"Arthrosocpic Treatment of Knee Chondral Lesions: Clinical, MRI and Histologic Comparison Between the Use of PRP vs ADSCs in Addition to Marrow Stimulation Techniques",ACTIVE_NOT_RECRUITING,2019-05-01,2026-05,2026-05,INTERVENTIONAL,PHASE4,80,['Knee Chondral Lesion'],Knee Chondral Lesion,Università degli Studi dell'Aquila,['Arthrex GmbH'],['Italy']
NCT05689567,Focus-out Glasses on Emmetropization in Chinese Children,Effect of Peripheral Focus-out Glasses on Emmetropization in Chinese Children Aged 6-8 Years: 2 Years Randomized Clinical Trial.,ACTIVE_NOT_RECRUITING,2023-03-23,2026-03-31,2026-03-31,INTERVENTIONAL,NA,160,"['Emmetropization', 'Myopia', 'Hyperopia']",Emmetropization,Children's Hospital of Fudan University,[],['China']
NCT06644157,Treatment and Prevention of Melasma Relapses by Using 1064nm 650 Microsecond Laser,Treatment and Prevention of Melasma Relapses by Using 1064nm 650 Microsecond Laser: a Prospective Randomized Intra-individual Study,ACTIVE_NOT_RECRUITING,2024-12-10,2026-03-01,2026-09-01,INTERVENTIONAL,NA,30,['Melasma'],Melasma,Centre Hospitalier Universitaire de Nice,[],['France']
NCT07255911,Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS,Cabergoline and Letrozole Compared to Letrozole Alone for Ovulation Induction in Infertile Women With Polycystic Ovary Syndrome,RECRUITING,2025-02-07,2026-01-06,2026-06-30,INTERVENTIONAL,NA,72,['PCOS'],PCOS,Mst.Sumyara Khatun,[],['Bangladesh']
NCT07115953,Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension,Sub-study of SPYRAL AFFIRM: Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT),RECRUITING,2025-09-22,2027-06-30,2029-12-31,INTERVENTIONAL,NA,130,"['Hypertension', 'Vascular Diseases', 'Cardiovascular Diseases', 'Chronic Kidney Diseases', 'Diabetes Mellitus']",Hypertension,Medtronic Vascular,[],"['Belgium', 'Netherlands', 'Ireland', 'Australia', 'United Kingdom', 'Germany']"
NCT05336565,PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics,Incidence of Prescribing Potentially Inappropriate Medications to Older Cardiovascular Patients During COVID-19 Pandemics According to Medical Information System BARS,RECRUITING,2022-07-01,2027-08-31,2027-12-31,OBSERVATIONAL,,1000,['Potentially Inappropriate Medications'],Potentially Inappropriate Medications,Tomsk National Research Medical Center of the Russian Academy of Sciences,[],['Russia']
NCT06389136,A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab,"A Phase 3b/4 Randomized, Open-label, Efficacy Assessor-Blinded Study, to Evaluate the Efficacy and Safety of Upadacitinib for the Treatment of Adult Subjects With Moderate to Severe Atopic Dermatitis and Inadequate Response to Dupilumab (SWITCH-UP)",RECRUITING,2024-06-12,2026-08,2027-03,INTERVENTIONAL,PHASE3,200,['Atopic Dermatitis'],Atopic Dermatitis,AbbVie,[],"['Japan', 'United States', 'Puerto Rico', 'South Korea', 'Colombia', 'Canada']"
NCT02466971,"Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers","A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer",ACTIVE_NOT_RECRUITING,2016-05-10,2023-01-26,2026-07-14,INTERVENTIONAL,PHASE3,450,"['Advanced Vaginal Adenocarcinoma', 'Advanced Vaginal Adenosquamous Carcinoma', 'Advanced Vaginal Squamous Cell Carcinoma', 'Cervical Adenocarcinoma', 'Cervical Adenosquamous Carcinoma', 'Cervical Squamous Cell Carcinoma', 'Stage IB2 Cervical Cancer AJCC v6 and v7', 'Stage II Cervical Cancer AJCC v7', 'Stage II Vaginal Cancer AJCC v6 and v7', 'Stage IIA Cervical Cancer AJCC v7', 'Stage IIB Cervical Cancer AJCC v6 and v7', 'Stage III Vaginal Cancer AJCC v6 and v7', 'Stage IIIB Cervical Cancer AJCC v6 and v7', 'Stage IV Vaginal Cancer AJCC v6 and v7', 'Stage IVA Cervical Cancer AJCC v6 and v7', 'Stage IVA Vaginal Cancer AJCC v6 and v7', 'Unresectable Vaginal Carcinoma', 'Vaginal Adenocarcinoma', 'Vaginal Adenosquamous Carcinoma', 'Vaginal Carcinoma', 'Vaginal Squamous Cell Carcinoma, Not Otherwise Specified']",Advanced Vaginal Adenocarcinoma,National Cancer Institute (NCI),['NRG Oncology'],"['Puerto Rico', 'United States', 'Canada']"
NCT06539182,DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8),"A Phase 2, Open-label, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of DZD8586 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma",RECRUITING,2024-04-29,2027-09,2028-03,INTERVENTIONAL,PHASE2,155,['Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma'],Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Dizal Pharmaceuticals,[],['China']
NCT02115282,Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic,A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer,ACTIVE_NOT_RECRUITING,2014-03-29,2020-05-05,2026-06-02,INTERVENTIONAL,PHASE3,608,"['Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Breast Adenocarcinoma', 'HER2/Neu Negative', 'Locally Advanced Breast Carcinoma', 'Metastatic Breast Carcinoma', 'Recurrent Breast Carcinoma']",Anatomic Stage III Breast Cancer AJCC v8,National Cancer Institute (NCI),[],"['United States', 'South Africa']"
NCT04054310,Non-Invasive Quantification of Liver Health in NASH (N-QUAN),Non-Invasive Quantification of Liver Health in NASH (N-QUAN): A Prospective Diagnostic Accuracy Study,RECRUITING,2020-08-05,2026-02-01,2026-02-01,INTERVENTIONAL,NA,225,['NASH - Nonalcoholic Steatohepatitis'],NASH - Nonalcoholic Steatohepatitis,Perspectum,[],['United States']
NCT04636190,Triathlon All-Polyethylene Tibia Outcomes Study,"A Retrospectively Enrolled and Prospectively Followed, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon All-Polyethylene Tibia",ACTIVE_NOT_RECRUITING,2021-07-02,2033-10,2033-10,INTERVENTIONAL,NA,204,"['Arthropathy of Knee', 'Replacement', 'Knee Arthritis']",Arthropathy of Knee,Stryker Orthopaedics,[],['United States']
NCT07156240,Impact of Two Short Behavioral Theory-Driven Professional Training Programs Targeting Attendance in Fitness Centers,Impact of Two Short Behavioral Theory-Driven Professional Training Programs Targeting Attendance in Fitness Centers: Protocol for a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-09-03,2026-08-31,2026-09,INTERVENTIONAL,NA,174,['Exercise Frequency'],Exercise Frequency,Grupo Lusófona,[],['Portugal']
NCT06608927,Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma,"A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma",ACTIVE_NOT_RECRUITING,2024-12-13,2030-11-30,2030-11-30,INTERVENTIONAL,PHASE3,610,['Metastatic Pancreatic Ductal Adenocarcinoma'],Metastatic Pancreatic Ductal Adenocarcinoma,"Arcus Biosciences, Inc.","['Taiho Pharmaceutical Co., Ltd.']","['Belgium', 'Japan', 'Austria', 'United States', 'France', 'Germany', 'Spain', 'Italy', 'Canada', 'Czechia', 'South Korea', 'United Kingdom', 'Australia']"
NCT07256613,Non-surgical Periodontal Therapy and Kidney Outcomes in Type 2 Diabetes Mellitus,Outcomes of Non-surgical Periodontal Therapy on Urea and Creatinine Levels in Type-2 Diabetes Mellitus Patients,RECRUITING,2025-08-15,2026-01-15,2026-04-15,INTERVENTIONAL,NA,46,"['Type 2 Diabetes Mellitus MeSH:D003924', 'Periodontitis MeSH:D010518', 'Diabetic Nephropathies MeSH:D003928']",Type 2 Diabetes Mellitus MeSH:D003924,Dow University of Health Sciences,[],['Pakistan']
NCT07246902,Mobilization and Outcomes After Venous Closure,MOVE - Mobilization and Outcomes After VEnous Closure - A Prospective Registry of Real-World Outcomes/Usage/Evidence for the MYNX CONTROL™ VENOUS Vascular Closure Device 6F-12F,RECRUITING,2025-11-24,2026-08,2026-08,OBSERVATIONAL,,300,"['Venous Vascular Closure', 'Electrophysiology Study']",Venous Vascular Closure,Cordis US Corp.,['NAMSA'],['United States']
NCT05681351,CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG),An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG),ACTIVE_NOT_RECRUITING,2022-12-13,2027-03,2027-03,INTERVENTIONAL,PHASE3,885,['Severe Hypertriglyceridemia'],Severe Hypertriglyceridemia,"Ionis Pharmaceuticals, Inc.",[],"['Bulgaria', 'New Zealand', 'Netherlands', 'Slovakia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'Denmark', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy', 'Argentina']"
NCT06129539,"A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)","LIBELULA™: An Open-label, Single-arm, Multi-center, Phase 3 Study on the Efficacy, Safety, and Pharmacokinetics of Debio 4326, a Triptorelin 12-month Formulation, in Pediatric Participants With Central Precocious Puberty",ACTIVE_NOT_RECRUITING,2024-07-31,2026-10,2028-02,INTERVENTIONAL,PHASE3,56,['Central Precocious Puberty'],Central Precocious Puberty,Debiopharm International SA,[],"['Brazil', 'United States', 'Mexico', 'Chile', 'Argentina']"
NCT07256145,Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia,Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia,RECRUITING,2025-08-01,2026-02-01,2026-03-01,INTERVENTIONAL,NA,60,['Post-Herpetic Neuralgia'],Post-Herpetic Neuralgia,Alexandria University,[],['Egypt']
NCT06324357,Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread,"Beamion BCGC-1: A Phase Ib Dose Escalation and Phase II Dose Optimization, Randomized, Open-label, Multicenter Trial of Oral Zongertinib (BI 1810631) Alone or in Combination With Other Agents for the Treatment of Patients With Advanced HER2+ Metastatic Breast Cancer (mBC) and Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (mGEAC)",RECRUITING,2024-06-03,2029-09-28,2029-09-28,INTERVENTIONAL,PHASE1,582,"['Metastatic Breast Cancer', 'Metastatic Gastric Adenocarcinoma', 'Gastroesophageal Junction Adenocarcinoma', 'Esophageal Adenocarcinoma']",Metastatic Breast Cancer,Boehringer Ingelheim,[],"['Belgium', 'Japan', 'China', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Germany']"
NCT07255729,An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer,Machine Learning-Based Exosomal microRNA Signature for Preoperative Staging and Chemotherapy Eligibility in Colon Cancer,RECRUITING,2025-01-15,2026-06-18,2026-06-18,OBSERVATIONAL,,400,['Colon Cancer'],Colon Cancer,City of Hope Medical Center,[],['United States']
NCT06307652,Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function,"A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared With Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients With Heart Failure and Impaired Kidney Function",RECRUITING,2024-04-12,2027-06-11,2027-06-11,INTERVENTIONAL,PHASE3,4800,['Heart Failure and Impaired Kidney Function'],Heart Failure and Impaired Kidney Function,AstraZeneca,[],"['Bulgaria', 'Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Australia', 'Israel', 'Hungary', 'France', 'Chile', 'Finland', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Vietnam', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT06461897,A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis,"A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis",RECRUITING,2024-08-19,2030-07,2030-07,INTERVENTIONAL,PHASE3,675,['Atopic Dermatitis'],Atopic Dermatitis,AbbVie,[],"['Bulgaria', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Croatia', 'South Korea', 'Poland', 'Singapore', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06499974,POASAC Study (Preoperative Anemia Severity and Classification Study),Impact of Preoperative Anemia Severity and Classification on Perioperative Oxygen Supply-Demand Imbalance-Related Complications--A Prospective Observational Multi-center Cohort Study,RECRUITING,2024-08-02,2026-12-31,2027-12-31,OBSERVATIONAL,,1000,['Anemia'],Anemia,Peking Union Medical College Hospital,[],['China']
NCT06606314,Specified Drug-use Surveillance of Fabhalta Capsules,"Specified Drug-use Surveillance of Fabhalta Capsules (Paroxysmal Nocturnal Hemoglobinuria, CLNP023C11401)",RECRUITING,2024-09-18,2028-09-30,2028-09-30,OBSERVATIONAL,,100,['Paroxysmal Nocturnal Hemoglobinuria'],Paroxysmal Nocturnal Hemoglobinuria,Novartis Pharmaceuticals,[],['Japan']
NCT06664333,Experiences Reported by Siblings of Children Hospitalized in the PICU,Experiences Reported by Siblings of Children Hospitalized in the PICU,RECRUITING,2025-01-21,2027-12-21,2027-12-21,OBSERVATIONAL,,20,['Intensive Care Pediatric'],Intensive Care Pediatric,Assistance Publique - Hôpitaux de Paris,['URC-CIC Paris Descartes Necker Cochin'],['France']
NCT03047213,Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations,"An Open Label, Multicenter, Single Arm Phase II Study to Evaluate the Activity and Tolerability of the Novel mTOR Inhibitor, MLN0128 (TAK-228), in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract Whose Tumors Harbor a TSC1 and/or a TSC2 Mutation",ACTIVE_NOT_RECRUITING,2017-08-24,2020-10-06,2026-11-12,INTERVENTIONAL,PHASE2,17,"['Locally Advanced Bladder Urothelial Carcinoma', 'Metastatic Transitional Cell Carcinoma', 'Metastatic Urothelial Carcinoma', 'Recurrent Bladder Carcinoma', 'Stage III Bladder Urothelial Carcinoma AJCC v6 and v7', 'Stage IV Bladder Urothelial Carcinoma AJCC v7']",Locally Advanced Bladder Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05663515,A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs,EXCEED - A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs,RECRUITING,2024-09-30,2026-03-02,2026-03-02,OBSERVATIONAL,,24000,['Pancreatic Cancer'],Pancreatic Cancer,AstraZeneca,['IQVIA Pvt. Ltd'],"['Norway', 'France', 'Finland', 'Denmark', 'Spain', 'United Kingdom', 'Sweden']"
NCT06617325,A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus",RECRUITING,2024-11-21,2028-05-31,2028-05-31,INTERVENTIONAL,PHASE3,450,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,UCB Biopharma SRL,[],"['Japan', 'Netherlands', 'China', 'Belgium', 'France', 'Chile', 'Puerto Rico', 'Denmark', 'Peru', 'South Korea', 'Poland', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Greece', 'Germany', 'United States', 'Italy', 'Argentina', 'Serbia']"
NCT06241118,A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, 3-arm, Multinational, Multicenter Study to Evaluate the Efficacy and Safety of Amlitelimab by Subcutaneous Injection in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (AD) Who Are on Background Topical Corticosteroids and Have Had an Inadequate Response to Prior Biologic Therapy or Oral Janus Kinase (JAK) Inhibitor Treatment",RECRUITING,2024-02-29,2026-05-25,2026-09-14,INTERVENTIONAL,PHASE3,330,['Dermatitis Atopic'],Dermatitis Atopic,Sanofi,[],"['Japan', 'Netherlands', 'Saudi Arabia', 'China', 'Australia', 'Israel', 'France', 'Chile', 'South Korea', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Arab Emirates', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Reunion', 'United States', 'Italy', 'Argentina']"
NCT02531087,Urinary Biomarkers of OI Pathobiology,Cross-Linked Collagen Peptides as a Urinary Biomarker of OI Pathobiology,ACTIVE_NOT_RECRUITING,2015-08-17,2019-08-31,2026-08-31,OBSERVATIONAL,,25,['Osteogenesis Imperfecta'],Osteogenesis Imperfecta,Baylor College of Medicine,"['Shriners Hospitals for Children', 'University of Nebraska', 'University of Washington']","['United States', 'Canada']"
NCT07255326,Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes,Role of Omega-3 Fatty Acids in Modulating Retinal Microvascular Changes in Type 1 Diabetes,RECRUITING,2025-10-01,2026-03-01,2026-07-30,INTERVENTIONAL,NA,80,"['Diabetic Retinopathy', 'Type 1 Diabetes', 'Omega 3 Fatty Acids']",Diabetic Retinopathy,University of Faisalabad,[],['Pakistan']
NCT07136714,Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity,Is the GLP-1 Receptor Agonist Semaglutide Able to Alleviate Mood in Patients With Major Depressive Disorder and Overweight or Obesity,RECRUITING,2025-09-11,2027-09,2027-09,INTERVENTIONAL,PHASE4,116,['Major Depressive Disorder'],Major Depressive Disorder,Maj Vinberg,[],['Denmark']
NCT07159022,High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy,High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy: A Randomized Controlled Trial.,RECRUITING,2025-08-31,2026-06-30,2026-07-31,INTERVENTIONAL,NA,200,"['High Flow Nasal Cannula', 'Body Roundness Index']",High Flow Nasal Cannula,Shanghai Zhongshan Hospital,[],['China']
NCT07246083,Study On Let's Talk,Study on Let's Talk,RECRUITING,2025-11,2026-01,2026-03,INTERVENTIONAL,NA,170,['Mental Health Help-Seeking'],Mental Health Help-Seeking,Centre for Evidence and Implementation Singapore Ltd,"['MOH Office for Healthcare Transformation (MOHT), Singapore']",['Singapore']
NCT05732727,Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease,"Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease: an Open Label, a Cluster Randomized Controlled, Phase 3 Trial",RECRUITING,2023-03-28,2029-03,2029-03,INTERVENTIONAL,PHASE3,720,"['Chronic Kidney Disease(CKD)', 'Uncontrolled Hypertension']",Chronic Kidney Disease(CKD),"University Hospital, Tours",[],['France']
NCT07205718,A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors,"An Open-label, Dose Escalation and Expansion, Phase 1/2 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TAK- 188, an Anti-CCR8 Antibody-Drug- Conjugate, as a Single Agent in Adult Participants With Locally Advanced or Metastatic Solid Tumors",RECRUITING,2025-11-19,2028-12-26,2029-12-21,INTERVENTIONAL,PHASE1,223,['Advanced or Metastatic Solid Tumors'],Advanced or Metastatic Solid Tumors,Takeda,[],['United States']
NCT07256782,A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors,"A Phase Ib/II, Open-label, Multi-center Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administration of QLC5508 in Combination With Other Anti-tumor Agents in Patients With Advanced Solid Tumors",RECRUITING,2025-10-24,2026-10,2028-05,INTERVENTIONAL,PHASE1,444,['Advanced Solid Tumor'],Advanced Solid Tumor,"Qilu Pharmaceutical Co., Ltd.",[],['China']
NCT05572632,Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD,Community-based Pulmonary Rehabilitation (COPD Wellness) and Social Navigation (Health Advocates) to Improve Outcomes in Vulnerable Patients With COPD,RECRUITING,2023-01-19,2026-12-31,2027-06-30,INTERVENTIONAL,NA,387,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),"University of California, San Francisco","['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06813911,Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD,"A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Atherosclerotic Cardiovascular Disease (ASCVD), and Elevated LDL-C and Lp(a)",RECRUITING,2025-04-30,2027-11-05,2027-12-01,INTERVENTIONAL,PHASE3,340,['Atherosclerotic Cardiovascular Disease (ASCVD)'],Atherosclerotic Cardiovascular Disease (ASCVD),Novartis Pharmaceuticals,[],"['Hong Kong', 'China', 'United States', 'Puerto Rico', 'Taiwan', 'United Kingdom']"
NCT03224949,"Comparison of ALD, NASH, and Healthy Control Patients","Comparison of ALD, NASH, and Healthy Control Patients",RECRUITING,2017-06-19,2027-09-30,2028-09-30,OBSERVATIONAL,,500,['ALD - Alcoholic Liver Disease'],ALD - Alcoholic Liver Disease,The Cleveland Clinic,[],['United States']
NCT00907868,Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS),A Multicentric Phase III Trial Evaluating the Impact of a Radiation Boost (16Gy) After Breast Conserving Surgery and a Whole Breast Irradiation (50Gy) for DCIS,ACTIVE_NOT_RECRUITING,2008-11,2011-05,2029-10,INTERVENTIONAL,NA,2004,['Breast Cancer'],Breast Cancer,Institut du Cancer de Montpellier - Val d'Aurelle,[],['France']
NCT05908110,Evidence-based Pediatric Obstructive Sleep Apnea Detection,The Role of Health Communication Messaging in Evidence-based Pediatric Obstructive Sleep Apnea Detection,ACTIVE_NOT_RECRUITING,2023-06-21,2026-11-14,2026-11-14,INTERVENTIONAL,NA,200,['Obstructive Sleep Apnea of Child'],Obstructive Sleep Apnea of Child,Indiana University,"['National Heart, Lung, and Blood Institute (NHLBI)', 'Eskenazi Health']",['United States']
NCT00196742,Fabry Disease Registry & Pregnancy Sub-registry,Fabry Disease Registry Protocol,RECRUITING,2001-07-31,2034-01-31,2034-01-31,OBSERVATIONAL,,9000,['Fabry Disease'],Fabry Disease,"Genzyme, a Sanofi Company",[],"['Bulgaria', 'Japan', 'Hong Kong', 'Netherlands', 'Saudi Arabia', 'China', 'Slovakia', 'Serbia', 'Lithuania', 'Australia', 'Belgium', 'Hungary', 'Estonia', 'Russia', 'Slovenia', 'France', 'Chile', 'Finland', 'Croatia', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'Poland', 'India', 'Singapore', 'Indonesia', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Vietnam', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Norway', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT07186556,Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention,Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention,RECRUITING,2025-09-09,2029-12-31,2031-12-31,INTERVENTIONAL,NA,75,"['Cancer', 'Fatigue', 'Brain Tumor Adult']",Cancer,M.D. Anderson Cancer Center,['Cancer Prevention Research Institute of Texas'],['United States']
NCT06963827,A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition,"A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate Efficacy and Safety of Mezagitamab (TAK-079) in Study Participants With Primary IgA Nephropathy in Combination With Stable Background Therapy",RECRUITING,2025-07-15,2028-09-07,2030-01-14,INTERVENTIONAL,PHASE3,347,['Kidney Disease'],Kidney Disease,Takeda,[],"['Japan', 'Hong Kong', 'China', 'United States', 'Switzerland', 'United Kingdom']"
NCT05815160,Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy,A Phase 1 Dose-Escalation and Expansion Study to Assess Safety and Preliminary Antitumor Activity of Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy,ACTIVE_NOT_RECRUITING,2023-05-02,2026-01,2026-02,INTERVENTIONAL,PHASE1,34,['Small Cell Lung Cancer Recurrent'],Small Cell Lung Cancer Recurrent,Debiopharm International SA,[],"['Spain', 'United States']"
NCT07229677,Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort.,The AEVI-Fiji Cohort Study: a Longitudinal Study Assessing the Transmission Risk and Dynamics of Mosquito-borne and Respiratory Viruses in Fiji.,RECRUITING,2025-10-23,2025-12-31,2028-12-31,OBSERVATIONAL,,910,"['Arbovirus Infections', 'Respiratory Infection Virus']",Arbovirus Infections,Fiji National University,"['Institut Louis Malardé', 'Institut Pasteur', 'Institut Hospitalo-Universitaire Méditerranée Infection', 'Ministry of Health, Fiji', 'London School of Hygiene and Tropical Medicine']",['Fiji']
NCT07032675,Cartilage Remodeling Using Low-Temperature Radiofrequency for Nasal Airway Reconstruction,Cartilage Remodeling Using Low-Temperature Radiofrequency for Facial Reconstruction,RECRUITING,2025-10-14,2027-06-01,2027-06,INTERVENTIONAL,NA,20,"['Nasal Valve Collapse', 'Nose Enhancement']",Nasal Valve Collapse,Indiana University,[],['United States']
NCT07006727,Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors,"A Phase I, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors",RECRUITING,2025-10-16,2031-06-17,2031-06-17,INTERVENTIONAL,PHASE1,96,"['Small Cell Lung Carcinoma', 'Large Cell Neuroendocrine Carcinoma of the Lung', 'Neuroendocrine Prostate Cancer', 'Gastroenteropancreatic Neuroendocrine Carcinoma']",Small Cell Lung Carcinoma,Novartis Pharmaceuticals,[],"['United States', 'South Korea', 'Canada']"
NCT04647409,Screening for NAFLD in Flanders,"Screening for Non-Alcoholic Fatty Liver Disease (NAFLD) in a General Practitioner Population, in Flanders, Belgium.",ACTIVE_NOT_RECRUITING,2020-10-26,2025-04-30,2026-12-31,INTERVENTIONAL,NA,10000,['Non-Alcoholic Fatty Liver Disease'],Non-Alcoholic Fatty Liver Disease,Hasselt University,[],['Belgium']
NCT07234994,Comparison of the Effect of Ozonized Gel to That of Photobiomodulation Therapy on Wound Healing Following Surgical Gingivectomy,Effect of Ozonized Gel Compared to Photobiomodulation Therapy on Wound Healing Following Surgical Gingivectomy : A Randomized Controlled Clinical Trial,RECRUITING,2025-11-16,2025-12-25,2025-12-30,INTERVENTIONAL,NA,48,['Gingival Enlargement'],Gingival Enlargement,Mennatullah osama ahmed zaki wahba,[],['Egypt']
NCT01222741,Studies of Disorders With Increased Susceptibility to Fungal Infections,Studies of Disorders With Increased Susceptibility to Fungal Infections,RECRUITING,2011-01-07,,,OBSERVATIONAL,,850,"['Fungal Infections', 'Primary Immune Deficiencies']",Fungal Infections,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07255976,Comparison of Effectiveness of Gingival Displacement Using Retraction Cord and Aluminum Chloride Gel,Comparison of Effectiveness of Gingival Displacement Using Retraction Cord and Aluminum Chloride Gel,RECRUITING,2024-09-11,2025-12-15,2025-12-30,INTERVENTIONAL,PHASE4,66,"['Gingival Bleeding', 'Prosthesis Failure, Dental', 'Tissue Injury']",Gingival Bleeding,Dow University of Health Sciences,[],['Pakistan']
NCT07062523,Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT,Application of [68Ga]Ga-FAPI-04 PET/CT in the Assessment of Inflammatory Activity in Sjögren's Syndrome,RECRUITING,2024-07-01,2025-09-01,2025-12-01,INTERVENTIONAL,PHASE1,60,"[""Sjogren's Syndrome""]",Sjogren's Syndrome,Peking Union Medical College Hospital,[],['China']
NCT07010159,Phase 2/3 Study of KPL-387 in Recurrent Pericarditis,A Phase 2/3 Efficacy and Safety Study of KPL-387 Treatment in Participants With Recurrent Pericarditis,RECRUITING,2025-07-25,2027-12-31,2029-12-31,INTERVENTIONAL,PHASE2,165,"['Pericarditis', 'Pericarditis Acute', 'Recurrent Pericarditis']",Pericarditis,"Kiniksa Pharmaceuticals International, plc","['Kiniksa Pharmaceuticals, GmbH']","['United States', 'Italy']"
NCT05714085,"Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)","A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Systemic Left Ventricular Systolic Dysfunction (VALOR)",RECRUITING,2023-05-31,2032-04-15,2032-04-15,INTERVENTIONAL,PHASE2,342,"['Heart Failure', 'Left Ventricular Systolic Dysfunction']",Heart Failure,Merck Sharp & Dohme LLC,[],"['New Zealand', 'Netherlands', 'Belgium', 'Hungary', 'France', 'Finland', 'Denmark', 'Peru', 'South Korea', 'Colombia', 'Thailand', 'Poland', 'Singapore', 'South Africa', 'Mexico', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy']"
NCT07141277,GRANITE: Airsupra Effectiveness in the Real World,"GRANITE: Airsupra Effectiveness in the Real World A Retrospective Prevalent New-user Cohort Study to Describe Characteristics and Compare Effectiveness of Airsupra vs Albuterol, in Patients With Asthma Requiring Use of Rescue Therapy in a Real-world Setting in the United States",RECRUITING,2025-07-09,2026-03-31,2026-03-31,OBSERVATIONAL,,2000,['Asthma'],Asthma,AstraZeneca,[],['United States']
NCT04394871,Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing,"An Observational Study to Assess Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4, Other Inherited Neurological Disorders With RNA Processing Defects, and Other Neurological Diseases With a Gain of Function Mechanism.",RECRUITING,2020-12-14,2030-12-25,2030-12-31,OBSERVATIONAL,,330,"['Amyotrophic Lateral Sclerosis Type 4', 'Inherited Neurological Disorders of RNA Processing']",Amyotrophic Lateral Sclerosis Type 4,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07156175,A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission,"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of SAR444336 in Participants With Microscopic Colitis in Clinical Remission With Budesonide",RECRUITING,2025-10-14,2027-04-08,2027-05-06,INTERVENTIONAL,PHASE2,54,['Microscopic Colitis'],Microscopic Colitis,Sanofi,[],"['Hungary', 'France', 'Denmark', 'Italy', 'United Kingdom', 'Sweden', 'Germany']"
NCT05330182,LMN-201 for Prevention of C. Difficile Infection Recurrence,"A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence",RECRUITING,2024-08-29,2025-12-01,2026-04-01,INTERVENTIONAL,PHASE2,375,['Clostridioides Difficile Infection'],Clostridioides Difficile Infection,"Lumen Bioscience, Inc.",['Congressionally Directed Medical Research Programs'],['United States']
NCT06355934,"OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis","OverTTuRe: An Observational Multi-Country Study Collecting Real-World Secondary Data on the Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis",RECRUITING,2023-08-21,2026-09-30,2026-09-30,OBSERVATIONAL,,55000,['ATTR Amyloidosis'],ATTR Amyloidosis,AstraZeneca,[],"['Japan', 'China', 'United States', 'Denmark', 'Spain', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany']"
NCT07252921,Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults,"A Phase II, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of HRS-9190 for Injection as a Neuromuscular Blocking Agent for Tracheal Intubation During General Anesthesia Induction in Adult Patients Undergoing Elective Surgery",RECRUITING,2025-10-30,2026-03,2026-03,INTERVENTIONAL,PHASE2,66,['Neuromuscular Blockade'],Neuromuscular Blockade,"Jiangsu HengRui Medicine Co., Ltd.",[],['China']
NCT06165653,Guided Meditation During Radiation Therapy for Brain Tumors,An Interventional Trial Using Guided Meditation During Radiation Therapy for Brain Tumors,RECRUITING,2024-02-29,2026-01-15,2028-01-15,INTERVENTIONAL,NA,30,['Brain Neoplasms'],Brain Neoplasms,University of Utah,[],['United States']
NCT06834230,Effect of Dotinurad in Hyperuricemia With Hypertension,Effect of Dotinurad in Hyperuricemia With Hypertension: a Randomized Study With Febuxostat (DIANA-NEXT),RECRUITING,2025-03-28,2027-07-31,2030-03-31,INTERVENTIONAL,PHASE4,360,"['Hyperuricemia or Gout', 'Hypertension']",Hyperuricemia or Gout,Saga University,[],['Japan']
NCT06167655,A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM,"A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM IN RELIEVING, INTERRUPTING, AND PREVENTING CHRONIC MIGRAINE (RELIEV-CM2)",RECRUITING,2024-05-29,2026-08-30,2026-08-30,INTERVENTIONAL,NA,250,['Headache Migraine Chronic'],Headache Migraine Chronic,ShiraTronics,[],"['United States', 'Australia']"
NCT06750289,Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment,"BRISOTE: A Multicentre, Randomised, Double-Blind, Parallel Group, Active-Controlled, Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium-Dose Inhaled Corticosteroid Plus Long-acting β2-Agonist.",RECRUITING,2025-03-28,2027-11-02,2027-11-02,INTERVENTIONAL,PHASE3,400,['Eosinophilic Asthma'],Eosinophilic Asthma,AstraZeneca,[],"['Bulgaria', 'Hong Kong', 'Norway', 'China', 'United States', 'France', 'Switzerland', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT05877963,"Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab","Evaluating Safety, Efficacy and Pharmacokinetics of a Modified Regimen of Ublituximab (ENHANCE )",RECRUITING,2023-06-13,2026-09-01,2026-09-01,INTERVENTIONAL,PHASE3,800,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,"TG Therapeutics, Inc.",[],"['Poland', 'United States']"
NCT07131813,Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus,Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus: A Randomized Clinical Trial,RECRUITING,2025-10-10,2027-01-01,2027-06-01,INTERVENTIONAL,PHASE4,60,['Oral Lichen Planus'],Oral Lichen Planus,"All India Institute of Medical Sciences, Bhubaneswar",[],['India']
NCT07254468,Effect of Cardiovascular Autonomic Neuropathy on AKI and Outcomes in Isolated CABG Surgery,Effects of Cardiovascular Autonomic Neuropathy (CAN) on Acute Kidney Injury and Clinical Outcomes in Patients Undergoing Isolated Coronary Artery Bypass Surgery,ACTIVE_NOT_RECRUITING,2021-11-04,2025-01-10,2025-12-23,OBSERVATIONAL,,884,"['Acute Kidney Injury (AKI)', 'Coronary Artery Bypass Graft (CABG)', 'Cardiovascular Autonomic Neuropathy (CAN)', 'Postoperative Outcomes']",Acute Kidney Injury (AKI),Akdeniz University,[],['Turkey (Türkiye)']
NCT04654208,Swedish Ibrance Registries Insights (SIRI),Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI),ACTIVE_NOT_RECRUITING,2020-12-15,2025-12-31,2025-12-31,OBSERVATIONAL,,1500,['Malignant Neoplasm of Breast'],Malignant Neoplasm of Breast,Pfizer,[],['Sweden']
NCT07254117,The Role of Granulation Tissue in Periodontal Regeneration,The Role of Biochemical and Microbiological Properties of Granulation Tissue in Periodontal Regeneration,RECRUITING,2025-05-29,2026-09,2026-09,OBSERVATIONAL,,46,"['Periodontal Bone Loss', 'Periodontitis', 'Periodontal Disease', 'Periodontal Diseases', 'Periodontal Regeneration', 'Periodontal Granulation Tissue', 'Vertical Periodontal Bone Defects', 'Periodontal Healing']",Periodontal Bone Loss,Riga Stradins University,['University of Turku'],['Latvia']
NCT05492903,COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP),Translating an Intervention to Address Chronic Pain Among Home Care Workers,ACTIVE_NOT_RECRUITING,2023-08-21,2025-04-11,2026-09,INTERVENTIONAL,NA,140,"['Pain Management', 'Ergonomics', 'Wounds and Injuries']",Pain Management,Oregon Health and Science University,[],['United States']
NCT02003222,Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia,A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults,ACTIVE_NOT_RECRUITING,2014-05-19,2023-06-23,2026-03-25,INTERVENTIONAL,PHASE3,488,"['Acute Lymphoblastic Leukemia', 'B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative']",Acute Lymphoblastic Leukemia,National Cancer Institute (NCI),['Canadian Cancer Trials Group'],"['Israel', 'Puerto Rico', 'United States', 'Canada']"
NCT04927416,The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer,The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer,RECRUITING,2021-10-25,2030-11-30,2030-11-30,INTERVENTIONAL,PHASE2,54,['Metastic Thyroid Cancer'],Metastic Thyroid Cancer,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07200518,Effect of Probiotics After Neurosurgery,The Multistrain Probiotic OMNi-BiOTiC® Hetox for Treatment After Neurosurgery (ProSURG),RECRUITING,2025-11-03,2026-12-31,2027-06-01,INTERVENTIONAL,NA,110,['Healing'],Healing,University Maribor,['University Medical Centre Maribor'],['Slovenia']
NCT07082478,External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia,External Carotid Blood Flow Dynamics in Individuals With Post-Bariatric Hypoglycemia (PBH): Pilot Study,RECRUITING,2025-07-28,2026-09-15,2026-09-15,OBSERVATIONAL,,5,"['Hypoglycemia', 'Cerebral Blood Flow']",Hypoglycemia,Joslin Diabetes Center,[],['United States']
NCT05031780,A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP),"A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Mitapivat in Subjects With Sickle Cell Disease",ACTIVE_NOT_RECRUITING,2022-02-11,2025-10-30,2030-02,INTERVENTIONAL,PHASE2,286,['Sickle Cell Disease'],Sickle Cell Disease,"Agios Pharmaceuticals, Inc.",[],"['Brazil', 'Belgium', 'Israel', 'Lebanon', 'Oman', 'Turkey (Türkiye)', 'Netherlands', 'Saudi Arabia', 'Kenya', 'United States', 'France', 'Nigeria', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT04954274,"Improvement of Live Babies Rates After ICSI, Using cpFT","Improvement of Live Babies Rates After ICSI, Using cpFT: Multicenter Prospective Randomized Clinical Trial",ACTIVE_NOT_RECRUITING,2021-07-29,2026-07-29,2027-07-29,INTERVENTIONAL,PHASE3,366,"['Infertility', 'Oocyte', 'Pregnancy']",Infertility,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT07254286,Food Effect Study in Healthy Volunteers,"A Phase 1 Open-Label, Randomized, Crossover Food Effect and Formulation Assessment for Icovamenib Capsule in Healthy Volunteers",RECRUITING,2025-09-11,2026-01,2026-01,INTERVENTIONAL,PHASE1,60,['Healthy Volunteer'],Healthy Volunteer,Biomea Fusion Inc.,[],['United States']
NCT06029998,Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion,A Phase II Study of Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion,RECRUITING,2024-03-11,2026-12,2028-12,INTERVENTIONAL,PHASE2,22,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,University of Utah,[],['United States']
NCT07092124,Validation of a Virtual Reality Test for the Assessment of Visually Impaired Patients Undergoing Low Vision Rehabilitation,Validation of a Virtual Reality Test for the Assessment of Visually Impaired Patients Undergoing Low Vision Rehabilitation,RECRUITING,2025-10-30,2027-02,2027-02,INTERVENTIONAL,NA,60,['Low Vision'],Low Vision,Fondation Ophtalmologique Adolphe de Rothschild,['Streetlab'],['France']
NCT06687980,A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2),"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Dupilumab for the Treatment of Pruritus of Lichen Simplex Chronicus (LSC) in Adults",RECRUITING,2024-11-25,2027-04-12,2027-07-05,INTERVENTIONAL,PHASE3,136,['Lichen Simplex Chronicus'],Lichen Simplex Chronicus,Sanofi,['Regeneron Pharmaceuticals'],"['Belgium', 'Hungary', 'Turkey (Türkiye)', 'China', 'United States', 'Mexico', 'Chile', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Greece', 'United Kingdom', 'Argentina', 'Germany']"
NCT06594068,"Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users","PRIMULA Lac (Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users): The AstraZeneca Lactation Study for Anifrolumab",RECRUITING,2026-01-30,2027-08-31,2027-08-31,INTERVENTIONAL,PHASE4,16,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,AstraZeneca,"['PPD Development, LP']",['United States']
NCT04576182,Supportive-Expressive and Emotion-Focused Treatment for Depression,Investigating Mechanisms of Change in Supportive-Expressive vs. Emotion-Focused Treatment of Depression Using a Personalized Treatment Approach: The Case of the Theories of Weakness vs. Strength,RECRUITING,2020-11-29,2025-12-31,2025-12-31,INTERVENTIONAL,NA,124,['Major Depressive Disorder'],Major Depressive Disorder,University of Haifa,['Israel Science Foundation'],['Israel']
NCT06559189,CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL,Phase I Dose Escalation and Preliminary Efficacy Study of Bispecific CD19 and CD22 Chimeric Antigen Receptor Co-Expressing T Cells (CD19x22 CAR T) in Pediatric Patients With Relapsed and/or Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL),RECRUITING,2024-09-27,2028-12,2029-12,INTERVENTIONAL,PHASE1,53,['B-cell Acute Lymphoblastic Leukemia'],B-cell Acute Lymphoblastic Leukemia,"University of Colorado, Denver",[],['United States']
NCT05995717,Evaluation of PKU UP,"An Acceptability Study to Evaluate the Compliance, Gastrointestinal Tolerance, Palatability and Metabolic Control of Children With Phenylketonuria (PKU) When Using PKU UP (a Food for Special Medical Purposes) as Part of Dietary Management.",ACTIVE_NOT_RECRUITING,2024-01-11,2026-05-31,2026-05-31,INTERVENTIONAL,NA,16,['PKU'],PKU,"Vitaflo International, Ltd","[""Birmingham Women's and Children's NHS Foundation Trust""]",['United Kingdom']
NCT06577467,Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection,Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection,RECRUITING,2025-03-27,2026-09-01,2027-09-01,OBSERVATIONAL,,12,['PASC Post Acute Sequelae of COVID-19'],PASC Post Acute Sequelae of COVID-19,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT03424005,A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer,"A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic Breast Cancer (Morpheus-panBC)",RECRUITING,2018-03-30,2030-09-30,2030-09-30,INTERVENTIONAL,PHASE1,792,['Metastatic Breast Cancer'],Metastatic Breast Cancer,Hoffmann-La Roche,"['Gilead Sciences', 'Pfizer']","['Israel', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'Australia', 'United Kingdom', 'Germany']"
NCT06638294,Study in Patients With Breast Cancer Leptomeningeal Metastasis,A Translational Observational Biorepository and Management Study in Patients With Breast Cancer Leptomeningeal Metastasis: The BioLept Study,RECRUITING,2024-11-25,2026-12,2028-12,OBSERVATIONAL,,30,['Leptomeningeal Metastasis of Breast Cancer'],Leptomeningeal Metastasis of Breast Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Avon Foundation'],['United States']
NCT06651294,Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments,Efficacy and Safety of Neorenal Forte as Adjuvant Treatment for the Complete Elimination of Residual Fragments After Flexible Ureterorenoscopy With Laser Lithotripsy for Renal Calculi.,RECRUITING,2025-04-01,2026-10-30,2026-11-30,INTERVENTIONAL,NA,120,['Urolithiasis'],Urolithiasis,Neopharm Bulgaria Ltd.,[],['Bulgaria']
NCT00001372,Study of Systemic Lupus Erythematosus,Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE),RECRUITING,1994-02-10,,,OBSERVATIONAL,,2250,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT07119528,Application-Based Integrated Care in Patients After Pulse Field Ablation,Application-Based Integrated Care Approach for Enhancing the Effect of FARAPULSE™ Pulse Field Ablation in Patients With Atrial Fibrillation: Randomized Control Trial,RECRUITING,2025-07-21,2029-12-31,2029-12-31,INTERVENTIONAL,NA,500,['Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System'],Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System,Yonsei University,[],['South Korea']
NCT03937830,"Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma","A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinoma (BTC)",ACTIVE_NOT_RECRUITING,2021-03-10,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,27,"['Hepatocellular Cancer', 'Hepatocellular Carcinoma', 'Metastatic Hepatocellular Carcinoma']",Hepatocellular Cancer,National Cancer Institute (NCI),[],['United States']
NCT03983954,"Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.","Phase 1B, Open-Label, Dose Escalation and Cohort Expansions Trial of Naptumomab Estafenatox (NAP, ABR-217620) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced or Metastatic Solid Tumors",ACTIVE_NOT_RECRUITING,2019-10-10,2027-03-01,2027-03-01,INTERVENTIONAL,PHASE1,120,"['ER+ Breast Cancer', 'Ovarian Cancer', 'Cervical Squamous Cell Carcinoma', 'Pancreatic Adenocarcinoma', 'Endometrial Cancer', 'Renal Cell Carcinoma', 'Urothelial Cancer', 'Head and Neck Squamous Cell Carcinoma', 'Mesothelioma', 'Melanoma', 'Hepatocellular Carcinoma', 'Prostate Cancer', 'NSCLC', 'HER2-negative Breast Cancer', 'Triple Negative Breast Cancer', 'Bladder Cancer', 'Colorectal Cancer Metastatic', 'GastroEsophageal Cancer', 'NSCL2 Gene Mutation', 'Esophageal Cancer']",ER+ Breast Cancer,NeoTX Therapeutics Ltd.,['AstraZeneca'],"['Israel', 'India']"
NCT03313778,"Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors","A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors",ACTIVE_NOT_RECRUITING,2017-08-14,2027-08-01,2027-08-01,INTERVENTIONAL,PHASE1,242,['Solid Tumors'],Solid Tumors,"ModernaTX, Inc.",['Merck Sharp & Dohme LLC'],"['United Kingdom', 'Japan', 'United States', 'Australia']"
NCT06717594,PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE,PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to Carbapenem-resistant Enterobacterales (CRE),RECRUITING,2023-12-01,2026-04-30,2026-04-30,OBSERVATIONAL,,60,"['Gram Negative Infections', 'Antimicrobial Resistance (AMR)']",Gram Negative Infections,IRCCS Azienda Ospedaliero-Universitaria di Bologna,[],"['Spain', 'Italy']"
NCT07253363,Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension,Investigation of Circulating ACTIvin-A and FSTL3 as Prognostic and Predictive BIOmarkers in Precapillary Pulmonary Hypertension,ACTIVE_NOT_RECRUITING,2024-03-01,2026-04,2028-04,INTERVENTIONAL,NA,550,['Pulmonary Hypertension'],Pulmonary Hypertension,Assistance Publique - Hôpitaux de Paris,[],['France']
NCT06784336,Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation,Phase II Multi-center Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation,RECRUITING,2025-10-15,2028-10,2029-10,INTERVENTIONAL,PHASE2,50,['Allogeneic Stem Cell Transplant'],Allogeneic Stem Cell Transplant,University of Michigan Rogel Cancer Center,[],['United States']
NCT04692675,Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer,Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer,RECRUITING,2022-11-18,2029-09-01,2031-09-01,INTERVENTIONAL,NA,508,['Prostate Cancer'],Prostate Cancer,National Cancer Institute (NCI),[],['United States']
NCT04823377,Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.,Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.,ACTIVE_NOT_RECRUITING,2021-09-24,2026-09-23,2027-09-23,INTERVENTIONAL,NA,364,"['Carcinoma, Non-Small-Cell Lung', 'Advanced Cancer']","Carcinoma, Non-Small-Cell Lung",Institut Curie,[],['France']
NCT04232085,Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures,Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures,RECRUITING,2020-02-12,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE2,27,"['Primary Immune Deficiency Disorder', 'Immune Deficiency Disease', 'Bone Marrow Failure', 'Short Telomere Length', 'Fanconi Anemia', 'Non Fanconi DNA-DSB Repair Disorder', 'Hoyeraal-Hreidarsson Syndrome', 'Dyskeratosis Congenita', 'Telomere Biology Disorder', 'Short Telomere Syndrome']",Primary Immune Deficiency Disorder,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,['Maryland Stem Cell Research Fund'],['United States']
NCT00039689,Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants,Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants,RECRUITING,2002-07-12,,,OBSERVATIONAL,,750,['HIV'],HIV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT04816604,Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH),An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH),ACTIVE_NOT_RECRUITING,2021-04-05,2027-12,2027-12,INTERVENTIONAL,PHASE2,74,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,"GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.",[],"['United States', 'France', 'Spain', 'Czechia', 'Australia', 'United Kingdom', 'Germany']"
NCT06343974,Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics,Noninvasive Evaluation of Fetal Hyperinsulinemia With Ultrasound Radiomics,RECRUITING,2024-10-11,2026-03-31,2026-06-01,OBSERVATIONAL,,60,"['Pregnancy in Diabetic', 'Diabetes Mellitus, Type 1']",Pregnancy in Diabetic,Turku University Hospital,[],['Finland']
NCT05615415,Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI,Assessment of Immunological and Vascular Dysfunction in Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO PET and MRI,ACTIVE_NOT_RECRUITING,2022-02-15,2026-12-31,2026-12-31,OBSERVATIONAL,,30,['Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection'],Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection,NYU Langone Health,[],['United States']
NCT05179863,Swiss Rare Disease Registry (SRDR),Swiss Rare Disease Registry,RECRUITING,2018-01-01,2071-01,2071-01,OBSERVATIONAL,,500000,['Rare Diseases'],Rare Diseases,University of Bern,"['Federal Office of Public Health, Switzerland', 'Universitäts-Kinderspital Zürich', ""University Children's Hospital Basel"", 'Insel Gruppe AG, University Hospital Bern', 'University Hospital, Zürich', 'Centre Hospitalier Universitaire Vaudois', 'University Hospital, Geneva', 'Proraris Allianz seltener Krankheiten', 'Kosek National Coordination Rare Diseases Switzerland', 'Orphanet Suisse', 'University of Zurich', 'Kantonsspital Aarau', 'Ente Ospedaliero Cantonale, Bellinzona', 'Cantonal Hospital of St. Gallen', 'Ostschweizer Kinderspital', 'University Hospital, Basel, Switzerland', 'Balgrist University Hospital', 'Centro Malattie Rare della Svizzera Italiana']",['Switzerland']
NCT07241325,"Psychological Well-Being, Depression, and Health-Related Quality of Life in Adults With Type 2 Diabetes: A Cross-Sectional Study","A Cross-Sectional Observational Study to Evaluate Psychological Well-Being, Depression, and Health-Related Quality of Life and Their Demographic and Clinical Correlates in Adults With Type 2 Diabetes Attending an Outpatient Metabolic Clinic",ACTIVE_NOT_RECRUITING,2025-09-09,2026-06-30,2026-10-01,OBSERVATIONAL,,350,"['Type 2 Diabetes Mellitus (T2DM)', 'Health-related Quality of Life', 'Depressive Symptoms', 'Psychological Well-being', 'Spiritual Well-being']",Type 2 Diabetes Mellitus (T2DM),National Taiwan University Hospital,[],['Taiwan']
NCT07252830,"Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid and Coronary Explorations, Compared to Simple Risk Calculation Using the European ""SCORE 2"" Algorithm. (IDEA-CVR)","Identification of Asymptomatic Patients at Very High Cardiovascular Risk: Contribution of a Strategy Based on Carotid and Coronary Explorations, Compared to Simple Risk Calculation Using the European ""SCORE 2"" Algorithm.",RECRUITING,2021-09-12,2025-12-20,2026-01-20,OBSERVATIONAL,,1000,"['Myocardial Infarction', 'Atheroma', 'Cholesterol', 'Cardiovascular (CV) Risk']",Myocardial Infarction,Elsan,['Polyclinique Poitiers'],['France']
NCT07102875,Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases,"Pilot Study ""Ready to Sail 2"": Evaluation of the Feasibility and Safety of Sail-Assisted Telerehabilitation in Patients With Rare Skeletal Diseases - Assessment of Motor, Psychosocial, and Quality of Life Outcomes",RECRUITING,2025-07-16,2026-03,2026-03,INTERVENTIONAL,NA,24,['Rare Bone Disorders'],Rare Bone Disorders,Istituto Ortopedico Rizzoli,[],['Italy']
NCT07072351,Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma,A Phase Ib/II Study of Hypofractionated Radiotherapy Combined With Immunochemotherapy as Conversion Therapy for Locally Advanced Gastroesophageal Junction Adenocarcinoma,RECRUITING,2025-09-15,2028-05-14,2028-05-14,INTERVENTIONAL,PHASE1,88,"['Gastroesophageal Junction Adenocarcinoma', 'Hypofractionated Radiotherapy', 'Immunotherapy', 'Chemotherapy']",Gastroesophageal Junction Adenocarcinoma,West China Hospital,[],['China']
NCT07037277,C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV,"An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study",RECRUITING,2025-06-02,2026-12,2027-03,INTERVENTIONAL,PHASE3,880,"['HEPATITIS C VIRUS CHRONIC INFECTION', 'Hepatitis C, Chronic', 'Hepatitis C Virus Infection', 'Hepatitis C']",HEPATITIS C VIRUS CHRONIC INFECTION,"Atea Pharmaceuticals, Inc.",[],"['South Africa', 'Pakistan', 'Moldova', 'France', 'Germany', 'Spain', 'South Korea', 'Romania', 'Malaysia', 'Thailand', 'Poland', 'India']"
NCT06054828,Modified Hospital Elder Life Program at Intensive Care Unit,Modified Hospital Elder Life Program at Intensive Care Unit: A Stepped-Wedge Cluster Randomized Controlled Trial,RECRUITING,2023-09-05,2026-07-31,2026-07-31,INTERVENTIONAL,NA,266,['ICU Delirium'],ICU Delirium,National Taiwan University Hospital,[],['Taiwan']
NCT06195709,ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients,ECLECTIC: EstroTEP and Circulating Biomarkers to Determine the Optimal Second Line Therapy for ER-positive HER2-negative Metastatic Breast Cancer Patients,RECRUITING,2024-05-27,2028-09-27,2029-09-27,INTERVENTIONAL,PHASE3,300,['Breast Carcinoma'],Breast Carcinoma,Institut Curie,['Zionexa'],['France']
NCT06789107,Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus,Clinical Trial of Blinatumomab in Refractory/Active Systemic Lupus Erythematosus in Children,RECRUITING,2024-12-08,2027-12-07,2027-12-07,INTERVENTIONAL,PHASE1,6,"['Systemic Lupus Erythematosus (SLE)', 'Children', 'Blinatumomab']",Systemic Lupus Erythematosus (SLE),Mao Jianhua,[],['China']
NCT07253805,Plasma and Tissue Concentration of Cefazolin in Preoperative Prophylaxis in Patients Undergoing Bariatric Surgery,Plasma and Tissue Concentration of Cefazolin in Preoperative Prophylaxis in Patients Undergoing Bariatric Surgery,ACTIVE_NOT_RECRUITING,2019-04-11,2022-02-16,2026-02-01,OBSERVATIONAL,,70,"['Bariatric Sleeve Gastrectomy', 'Cefazolin']",Bariatric Sleeve Gastrectomy,Laval University,['Fondation IUCPQ'],['Canada']
NCT07253246,ENX-205 SAD/PET Study in Healthy Adults,"A Two-Part, Single Ascending Dose and Positron Emission Tomography Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Receptor Occupancy After Single Oral Dose Administration of ENX-205 in Healthy Adult Participants",RECRUITING,2025-05-23,2026-03,2026-03,INTERVENTIONAL,PHASE1,40,['Healthy Volunteer'],Healthy Volunteer,Engrail Therapeutics INC,[],['United Kingdom']
NCT06830278,The Efficacy of the SUN Program in Adolescents,The Efficacy of a New Sexual Violence Primary Prevention Program for Adolescents: A Cluster Randomized Trial of the Stand Up Now Against Sexual Violence (SUN) Program,ACTIVE_NOT_RECRUITING,2024-06-01,2025-12,2025-12,INTERVENTIONAL,NA,231,['Sexual Violence'],Sexual Violence,Universidade do Porto,"['University of Coimbra', 'Aveiro University', 'Faculty of Medicine of the University of Porto', 'Foundation for Science and Technology, Portugal', 'Center for Psychology at the University of Porto, Portugal']",['Portugal']
NCT07243171,"A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity","A Multicenter, Multiple-dose Escalation, Randomized, Double-blind, Placebo-controlled Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity",RECRUITING,2025-11-18,2026-08-03,2026-11-22,INTERVENTIONAL,PHASE1,84,"['Overweight and/or Obesity', 'Weight Management']",Overweight and/or Obesity,"Hangzhou Sciwind Biosciences Co., Ltd.",[],['China']
NCT06971276,Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening,Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening,ACTIVE_NOT_RECRUITING,2024-04-03,2026-01-31,2026-01-31,OBSERVATIONAL,,101,['Anal Dysplasia'],Anal Dysplasia,Massachusetts Eye and Ear Infirmary,[],['United States']
NCT02379520,"HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA",HPV-16/18 E6/E7-Specific T Lymphocytes in Patients With Relapsed HPV-Associated Cancers,ACTIVE_NOT_RECRUITING,2015-09,2026-01,2033-10,INTERVENTIONAL,PHASE1,32,"['Human Papillomavirus-Related Carcinoma', 'Human Papillomavirus Positive Oropharyngeal Carcinoma', 'Human Papillomavirus Positive Cervical Carcinoma', 'Human Papillomavirus Positive Anal Carcinoma', 'Human Papillomavirus Positive Vulvar Carcinoma', 'Human Papillomavirus Positive Penile Carcinoma']",Human Papillomavirus-Related Carcinoma,Baylor College of Medicine,"['Center for Cell and Gene Therapy, Baylor College of Medicine', 'The Methodist Hospital Research Institute']",['United States']
NCT00903110,Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).,Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).,RECRUITING,2008-12-09,2027-12-31,2027-12-31,OBSERVATIONAL,,500,['IGF1 Deficiency'],IGF1 Deficiency,Ipsen,[],"['French Guiana', 'Austria', 'United States', 'France', 'Spain', 'Italy', 'Martinique', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT07040475,"Effects of the Clinical Application of Traditional, Complementary and Integrative Medicine (TCIM) Procedures During Inpatient Stays in Germany",Effects of the Clinical Application of TCIM Procedures During Inpatient Stays in Germany - a Multicenter Observational Study,RECRUITING,2025-07-01,2026-12-31,2027-12-31,OBSERVATIONAL,,2500,['Chronic Disease'],Chronic Disease,"Charite University, Berlin, Germany","['Universität Tübingen', 'Universität Duisburg-Essen', 'Sozialstiftung Bamberg']",['Germany']
NCT07167056,Artificial Intelligence-Powered Support For Quality Of Life Improvement In Participants With Cancer,Artificial Intelligence-Powered Support For Quality Of Life Improvement In Patients With Cancer,RECRUITING,2025-11-17,2026-04-15,2027-01-15,INTERVENTIONAL,NA,60,['Cancer'],Cancer,Case Comprehensive Cancer Center,['Florida Department of Health (Casey DeSantis Florida Cancer Innovation Fund)'],['United States']
NCT05579548,"A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding","A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding",RECRUITING,2022-11-22,2032-10-04,2032-10-04,OBSERVATIONAL,,50,"['Phenylketonuria, Maternal']","Phenylketonuria, Maternal",BioMarin Pharmaceutical,['Syneos Health'],"['United States', 'Italy', 'Canada', 'Germany']"
NCT07129915,Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial,Effect of Nudge-Based Shared Decision Making on Self-Management Among Patients With Type 2 Diabetes: A Randomized Controlled Trial,RECRUITING,2025-11-01,2026-05-31,2026-06,INTERVENTIONAL,NA,250,"['Diabetes Mellitus, Type 2', 'Physician-Patient Relations', 'Self-management']","Diabetes Mellitus, Type 2",Yunxuan Li,[],['China']
NCT07072273,A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic Dermatitis,Open-label Clinical Trial Evaluating an Emollient With Lactobacillus Reuteri for the Treatment of Pediatric Atopic Dermatitis,RECRUITING,2025-11-17,2026-05,2026-05,INTERVENTIONAL,NA,40,['Atopic Dermatitis'],Atopic Dermatitis,Biogaia New Sciences AB,['Bioithas SL'],['Spain']
NCT07159841,A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH),"A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension",RECRUITING,2025-11-30,2030-03,2030-03,INTERVENTIONAL,PHASE2,153,"['Congenital Adrenal Hyperplasia', 'Classic Congenital Adrenal Hyperplasia']",Congenital Adrenal Hyperplasia,Crinetics Pharmaceuticals Inc.,[],"['United States', 'Australia']"
NCT06492616,"A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence","Elacestrant Versus Standard Endocrine Therapy in Women and Men With Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer With High Risk of Recurrence-A Global, Multicenter, Randomized, Open-label Phase 3 Study",RECRUITING,2024-09-27,2029-08,2032-10,INTERVENTIONAL,PHASE3,4220,['Breast Cancer'],Breast Cancer,"Stemline Therapeutics, Inc.",[],"['Hong Kong', 'Netherlands', 'Australia', 'Belgium', 'Hungary', 'France', 'Finland', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Singapore', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07253129,"Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)","Allogeneic Hematopoietic Stem Cell Transplantation Versus Autologous Hematopoietic Stem Cell Transplantation for Peripheral T-cell Lymphoma Patients With Partial Remission After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study(T-START-PR)",RECRUITING,2025-11,2029-05-30,2029-09-30,OBSERVATIONAL,,88,['Peripheral T Cell Lymphoma'],Peripheral T Cell Lymphoma,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",[],['China']
NCT00001456,Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome,Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome,RECRUITING,1995-11-06,,,OBSERVATIONAL,,600,['Hermansky-Pudlak Syndrome (HPS)'],Hermansky-Pudlak Syndrome (HPS),National Human Genome Research Institute (NHGRI),[],['United States']
NCT07148687,ChatGPT and DeepSeek-Assisted Rehabilitation in Subacromial Pain,Effect of ChatGPT and DeepSeek-Guided Rehabilitation on Clinical Outcomes in Individuals With Subacromial Pain Syndrome,RECRUITING,2025-09-25,2025-12-01,2025-12-20,INTERVENTIONAL,NA,60,['Subacromial Pain Syndrome'],Subacromial Pain Syndrome,Kirsehir Ahi Evran Universitesi,[],['Turkey (Türkiye)']
NCT06925516,A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC,"Efficacy and Safety of Apatinib Combined With Adebrelimab and GEMOX Regimen Chemotherapy as the First-line Treatment for Unresectable Intrahepatic Cholangiocarcinoma (ICC): A Single-arm, Multicenter, Phase II Study",RECRUITING,2025-01-22,2026-06-01,2027-10-01,INTERVENTIONAL,PHASE2,38,['Intrahepatic Cholangiocarcinoma (Icc)'],Intrahepatic Cholangiocarcinoma (Icc),Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,"['Jiangsu HengRui Medicine Co., Ltd.']",['China']
NCT02763033,Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients,Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients,RECRUITING,2017-04-26,2026-04,2026-04,INTERVENTIONAL,PHASE2,125,['Hematopoietic Stem Cell Transplantation'],Hematopoietic Stem Cell Transplantation,University of Michigan Rogel Cancer Center,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT06541106,Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China,Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China,RECRUITING,2011-01-01,2031-01-01,2032-01-01,OBSERVATIONAL,,2000,['Dissecting Aneurysm of Cerebral Artery'],Dissecting Aneurysm of Cerebral Artery,Beijing Tiantan Hospital,"['Beijing Chao Yang Hospital', 'Peking University International Hospital', ""The First People's Hospital of Lianyungang"", 'Chinese PLA General Hospital', 'Union Hospital, Tongji Medical College, Huazhong University of Science and Technology', ""Yichang Central People's Hospital"", 'Taihe Hospital', ""Liaocheng People's Hospital"", ""Binzhou People's Hospital"", 'The First Affiliated Hospital of Shanxi Medical University', 'Beijing Aerospace General Hospital', 'The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture', 'The Second Hospital of Hebei Medical University', 'Dalian Municipal Central Hospital', 'Shijiazhuang Third Hospital', 'Affiliated Hospital of Chengde Medical University', ""Xingtai People's Hospital"", 'Taian City Central Hospital', 'Wuhan Brain Hospital']",['China']
NCT06587256,Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.,Mouth Tape for Snoring and Sleep Apnea (MTASSA),RECRUITING,2026-06-01,2029-10,2029-10,INTERVENTIONAL,PHASE2,100,"['Mild Obstructive Sleep Apnea', 'Snoring']",Mild Obstructive Sleep Apnea,Johns Hopkins University,[],['United States']
NCT07188090,Mozobil for Autologous Hematopoietic Stem Cell Transplantation,A Prospective Trial Evaluating Plerixafor-based Mobilization and Risk of Engraftment Syndrome After Autologous Hematopoietic Stem Cell Transplantation,RECRUITING,2025-10-16,2027-12,2028-06,INTERVENTIONAL,PHASE2,100,"['Multiple Myeloma', 'Hodgkin Lymphoma', 'Non-hodgkin Lymphoma']",Multiple Myeloma,Thomas Jefferson University,[],['United States']
NCT07198854,Risk Factors Affecting MSC Efficacy in ACLF Patients,Analysis of Risk Factors Affecting Mesenchymal Stem Cells Efficacy in Hepatitis B Related Acute-on-chronic Liver Failure,RECRUITING,2025-10-20,2025-12-30,2026-06-30,OBSERVATIONAL,,446,['Acute-On-Chronic Liver Failure'],Acute-On-Chronic Liver Failure,Sun Yat-sen University,[],['China']
NCT02991469,A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS),"An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered With Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, With Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extension Phase",RECRUITING,2018-08-09,2026-04-01,2029-02-19,INTERVENTIONAL,PHASE2,51,['Juvenile Idiopathic Arthritis'],Juvenile Idiopathic Arthritis,Sanofi,['Regeneron Pharmaceuticals'],"['Bulgaria', 'Russia', 'France', 'Finland', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Argentina', 'Germany']"
NCT01568658,Genetic and Physical Study of Childhood Nerve and Muscle Disorders,Clinical and Molecular Manifestations of Neuromuscular and Neurogenetic Disorders of Childhood,RECRUITING,2012-03-20,,,OBSERVATIONAL,,9300,"['Muscular Dystrophies', 'Muscle Myopathies', 'Hereditary Spastic Paraplegias', 'Inherited Neuropathies', 'Inherited Neuromuscular Conditions']",Muscular Dystrophies,National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT07190196,A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease,"A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease",RECRUITING,2025-09-26,2028-06-28,2030-12-25,INTERVENTIONAL,PHASE3,124,['Immunoglobulin G4 Related Disease'],Immunoglobulin G4 Related Disease,Sanofi,[],"['Israel', 'United States', 'Chile', 'Italy', 'Canada', 'South Korea', 'Poland']"
NCT06791291,Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes,"Efficacy and Safety of Teplizumab in the Treatment of Japanese Pediatric and Adult Participants Aged 8 to 34 Years With Stage 2 Type 1 Diabetes: A Multicenter, Randomized, Open-label, Controlled Study.",RECRUITING,2025-07-25,2028-03-06,2028-03-06,INTERVENTIONAL,PHASE2,10,['Type 1 Diabetes Mellitus'],Type 1 Diabetes Mellitus,Sanofi,[],['Japan']
NCT03854318,Longitudinal Studies of Patient With FPDMM,Longitudinal Studies of Patients and Families With Familial Platelet Disorders With Associated Myeloid Malignancy (FPDMM) Caused by RUNX1 Germline Variants or FPDMM-Like Conditions,RECRUITING,2019-03-28,2028-12-31,2028-12-31,OBSERVATIONAL,,1000,"['Inherited Hematological Diseases', 'Rare Diseases', 'FPDMM']",Inherited Hematological Diseases,National Human Genome Research Institute (NHGRI),[],['United States']
NCT06517017,"Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma","Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma: A Phase 2 Multicenter Study",RECRUITING,2025-10-09,2026-11,2027-11,INTERVENTIONAL,PHASE2,40,"['Multiple Myeloma', 'Plasma Cell Leukemia']",Multiple Myeloma,University of Utah,['Sanofi'],['United States']
NCT07087054,Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen,"A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors",RECRUITING,2025-11-19,2027-08,2030-01,INTERVENTIONAL,PHASE3,141,"['Carcinoid Syndrome', 'Carcinoid', 'Carcinoid Tumor', 'Carcinoid Tumor of Ileum', 'Carcinoid Tumor of Cecum', 'Carcinoid Tumor of Liver', 'Carcinoid Tumor of Pancreas', 'Carcinoid Syndrome Diarrhea', 'Carcinoid Intestine Tumor']",Carcinoid Syndrome,Crinetics Pharmaceuticals Inc.,[],"['Brazil', 'United States', 'France', 'Spain', 'Argentina']"
NCT07052890,"Curcumin, Vitamin D and Green Tea in IBS-D","Role of a Food Supplement Containing Curcumin, Green Tea and Vitamin D on Symptom Control in Diarrhoea Predominant Irritable Bowel Syndrome (IBS-D)",ACTIVE_NOT_RECRUITING,2024-09-19,2025-12,2025-12,INTERVENTIONAL,NA,78,"['Irritable Bowel Syndrome (IBS)', 'Irritable Bowel Syndrome With Diarrhea (IBS-D)']",Irritable Bowel Syndrome (IBS),Dr Anthony Hobson,[],['United Kingdom']
NCT07253948,Distribution Characteristics of Helicobacter Pylori,Distribution Characteristics of Helicobacter Pylori in Different Gastritis and Early Gastric Cancer States Using Immunohistochemical Staining,RECRUITING,2025-10-22,2025-12-31,2025-12-31,OBSERVATIONAL,,231,"['Helicobacter Pylori', 'Early Gastric Cancer']",Helicobacter Pylori,Jilin University,[],['China']
NCT06441617,Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis,Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis,RECRUITING,2024-12-05,2027-02-15,2027-09-14,INTERVENTIONAL,NA,2000,"['Multiple Sclerosis', 'Fatigue']",Multiple Sclerosis,Accelerated Cure Project for Multiple Sclerosis,"['Congressionally Directed Medical Research Programs', 'United States Department of Defense', 'Charite University, Berlin, Germany', 'University Medical Center Goettingen', 'US Department of Veterans Affairs']",['United States']
NCT07159880,Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS),Extended Therapy Versus Traditional Therapy With Letrozole for Ovulation Induction in Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial,RECRUITING,2025-09-01,2026-07-30,2026-07-30,INTERVENTIONAL,NA,20,"['PCOS (Polycystic Ovary Syndrome)', 'Infertility', 'Anovulation']",PCOS (Polycystic Ovary Syndrome),GABRIEL MONTEIRO PINHEIRO,[],['Brazil']
NCT06526546,ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study,ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression (ADVENT LTO Study),RECRUITING,2024-10-31,2025-12,2026-02,OBSERVATIONAL,,356,['Paroxysmal Atrial Fibrillation'],Paroxysmal Atrial Fibrillation,Boston Scientific Corporation,[],['United States']
NCT05561647,"A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using GATTEX","Quantitative Testing of Patient and Prescriber Knowledge, Attitudes, and Behavior About GATTEX (Teduglutide) for Injection Safety and Use Information",RECRUITING,2013-08-01,2026-12-31,2026-12-31,OBSERVATIONAL,,600,['Short Bowel Syndrome (SBS)'],Short Bowel Syndrome (SBS),Takeda,[],['United States']
NCT07253259,A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD),A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD),RECRUITING,2025-12,2027-11-30,2028-12-31,INTERVENTIONAL,EARLY_PHASE1,36,['cGVHD'],cGVHD,Grit Biotechnology,"['Institute of Hematology & Blood Diseases Hospital, China']",['China']
NCT07111208,Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN),Noise and/or Ultrafine Particulate Matter Induced Cerebral and Cardiovascular Damage: Experimental and Epidemiological Studies (MARKOPOLO) and Lifestyle Intervention to Attenuate Cardiovascular Health Risk (METSGREEN),RECRUITING,2025-10-24,2026-07,2028-12,INTERVENTIONAL,NA,180,"['Cardiovascular Diseases (CVD)', 'Metabolic Syndrome', 'Air Pollution Exposure', 'Environmental Exposure', 'Health Behavior Change']",Cardiovascular Diseases (CVD),Regina Grazuleviciene,['Lithuanian University of Health Sciences'],['Lithuania']
NCT06906562,"A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations","A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR2 Gene Fusions or Other FGFR Genetic Alterations",RECRUITING,2025-08-26,2026-12-31,2028-12-31,INTERVENTIONAL,PHASE2,40,"['Advanced Pancreatic Carcinoma', 'Metastatic Pancreatic Carcinoma', 'Stage II Pancreatic Cancer AJCC v8', 'Stage III Pancreatic Cancer AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8']",Advanced Pancreatic Carcinoma,Sameek Roychowdhury,['Incyte Corporation'],['United States']
NCT07235761,Preventing Home Accidents With Simulation Based Training,The Effect of Simulation Based Nursing Interventions on Mothers Prevention and Intervention of Home Accidents: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-07-01,2025-12-10,2026-03-10,INTERVENTIONAL,NA,48,"['Accident at Home', 'First Aid Training', 'Simulation Training']",Accident at Home,Selcuk University,['The Scientific and Technological Research Council of Turkey'],['Turkey (Türkiye)']
NCT06641115,Integrated Treatment for Opioid Use Disorder and PTSD,Integrated Treatment for Co-Occurring Opioid Use Disorder and Posttraumatic Stress Disorder,RECRUITING,2025-03-01,2027-08,2027-08,INTERVENTIONAL,NA,76,"['Opioid Use Disorder', 'Posttraumatic Stress Disorder (PTSD)']",Opioid Use Disorder,Medical University of South Carolina,"['National Institute on Drug Abuse (NIDA)', 'National Institutes of Health (NIH)']",['United States']
NCT05915988,U011 - Wireless Ultra Long-Term EEG Recordings in Epilepsy,Wireless Ultra Long-Term EEG Recordings in Epilepsy - A Prospective Long-term Clinical Evaluation Using the UNEEG EpiSight Solution,ACTIVE_NOT_RECRUITING,2023-12-04,2025-12,2026-12,INTERVENTIONAL,NA,19,['Epilepsy'],Epilepsy,UNEEG Medical A/S,[],"['Denmark', 'Ireland']"
NCT06287970,TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS,"Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Moderate to Severe Chronic Prostatitis/Chronic Pelvic Pain Syndrome (TASC-P Trial): a Randomized, Sham Controlled Trial.",RECRUITING,2024-03-15,2026-12-31,2027-02-18,INTERVENTIONAL,NA,68,['Chronic Prostatitis'],Chronic Prostatitis,Jiani Wu,[],['China']
NCT05303467,A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM,FRONTIER: A Feasibility Study to Evaluate the Safety of the TheRaSphere GliOblastoma (GBM) Device iN PaTIEnts With Recurrent GBM,RECRUITING,2022-07-30,2026-03-31,2026-06-01,INTERVENTIONAL,PHASE1,36,"['Glioblastoma Multiforme', 'Recurrent Glioblastoma']",Glioblastoma Multiforme,Boston Scientific Corporation,[],['United States']
NCT06835972,A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC),A Phase 1b/2 Study of Abemaciclib Plus Cabozantinib in Immune Checkpoint Blockade-pretreated Metastatic Clear Cell Renal Cell Carcinoma,RECRUITING,2025-02-14,2027-02,2027-02,INTERVENTIONAL,PHASE1,43,"['Metastatic Renal Cell Carcinoma', 'Translocation Renal Cell Carcinoma']",Metastatic Renal Cell Carcinoma,Memorial Sloan Kettering Cancer Center,"['Eli Lilly and Company', 'Exelixis']",['United States']
NCT05897775,Coordinated Reset Deep Brain Stimulation for Essential Tremor,Coordinated Reset Deep Brain Stimulation for Essential Tremor,RECRUITING,2023-09-11,2028-06-30,2028-12-31,INTERVENTIONAL,PHASE1,23,"['Essential Tremor', 'Upper Extremity Essential Tremor']",Essential Tremor,University of Minnesota,[],['United States']
NCT06602193,Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD),"A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)",RECRUITING,2024-10-24,2026-04-30,2028-02-28,INTERVENTIONAL,PHASE2,50,['Parkinson Disease'],Parkinson Disease,Denali Therapeutics Inc.,['Biogen'],"['Spain', 'United States', 'Germany']"
NCT07253493,Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship,The Effect of Mechanical Loading and Bone Loss on the Relationship Between Motor Neuron Pool Activity and H-Reflex Amplitude,RECRUITING,2025-11-18,2026-03,2026-04,INTERVENTIONAL,NA,24,['Osteoporosis Postmenopausal'],Osteoporosis Postmenopausal,Istanbul Physical Medicine Rehabilitation Training and Research Hospital,[],['Turkey (Türkiye)']
NCT07147023,Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication,Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication,RECRUITING,2025-09-15,2026-03-31,2026-10-31,INTERVENTIONAL,NA,60,"['Advanced Cancer', 'Cancer', 'End of Life']",Advanced Cancer,Dana-Farber Cancer Institute,[],['United States']
NCT07037082,Understanding Cycles to Improve Women's Health,Understanding Socio-ecological Variation in Menstrual Cycles to Advance Female Health,RECRUITING,2025-09-01,2029-07-01,2029-07-01,OBSERVATIONAL,,320,"['Woman of Reproductive Age', 'Socioeconomic Factors']",Woman of Reproductive Age,"University Hospital, Montpellier","['National Research Agency, France', 'Institut National de la Santé Et de la Recherche Médicale, France', 'Centre National de la Recherche Scientifique, France', 'Institute of Evolutionary Science of Montpellier', 'Université Montpellier']",['France']
NCT02152982,Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme,A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation,ACTIVE_NOT_RECRUITING,2014-12-15,2021-12-01,2025-12-26,INTERVENTIONAL,PHASE2,447,"['Glioblastoma', 'Gliosarcoma']",Glioblastoma,National Cancer Institute (NCI),[],"['Puerto Rico', 'United States']"
NCT07255222,Effects of a Multimodal Exercise Program on Physical Performance and Muscle Function in Middle-aged Patients With T2DM,The Effects of a Multimodal Exercise Program on Physical Performance and Muscle Function in Middle-Aged Patients With Type 2 Diabetes: A Multicenter Randomized Controlled Trial,RECRUITING,2025-08-18,2025-12-31,2025-12-31,INTERVENTIONAL,NA,66,['Type 2 Diabetes Mellitus (T2DM)'],Type 2 Diabetes Mellitus (T2DM),yueh chu wu,[],['Taiwan']
NCT06180356,Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression,Phase II Study to Assess the Efficacy of Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (The ANALLISA Study),RECRUITING,2024-12-03,2028-01,2028-01,INTERVENTIONAL,PHASE2,30,"['Ovarian Cancer', 'Oligometastatic Disease', 'Serous Ovarian Tumor']",Ovarian Cancer,MedSIR,[],['Spain']
NCT06472622,Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort,Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort,RECRUITING,2025-04-09,2034-06-30,2034-06-30,INTERVENTIONAL,EARLY_PHASE1,47,"['Fatigue Syndrome, Chronic']","Fatigue Syndrome, Chronic",National Institute of Neurological Disorders and Stroke (NINDS),[],['United States']
NCT05593094,A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors,"A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of ZN-A-1041 Enteric Capsules as a Single Agent or in Combination in Patients With HER2-Positive Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2020-09-03,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE1,210,"['Advanced Solid Tumors', 'HER2-positive Breast Cancer']",Advanced Solid Tumors,Hoffmann-La Roche,[],"['New Zealand', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Australia']"
NCT06935838,Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV,Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV,RECRUITING,2025-11-12,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE2,12,"['Obesity and Overweight', 'HIV', 'Chronic Inflammation']",Obesity and Overweight,University of Hawaii,[],['United States']
NCT03191149,Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change,Phase II Study of Osimertinib (AZD9291) in Advanced NSCLC Patients With Exon 20 Insertion Mutations in EGFR,RECRUITING,2018-04-25,2027-06-30,2027-06-30,INTERVENTIONAL,PHASE2,46,"['Advanced Lung Non-Small Cell Carcinoma', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage IIIB Lung Non-Small Cell Cancer AJCC v7', 'Stage IV Lung Non-Small Cell Cancer AJCC v7']",Advanced Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT03986021,Reproductive Axis Maturation in the Early Post-Menarchal Years,Reproductive Axis Maturation in the Early Post-Menarchal Years: A Pilot Study,RECRUITING,2019-12-19,2029-07-01,2029-07-01,OBSERVATIONAL,,400,"['Reproductive Physiological Processes', 'Pediatrics', 'Adolescent Health', 'Adolescent Development']",Reproductive Physiological Processes,National Institute of Environmental Health Sciences (NIEHS),[],['United States']
NCT06581809,Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds (Tumoss),Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds,RECRUITING,2025-03-27,2026-06-30,2026-12-30,INTERVENTIONAL,NA,108,['Malignant Wound'],Malignant Wound,Institut Curie,[],['France']
NCT03537586,"A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction","A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction",ACTIVE_NOT_RECRUITING,2018-06-29,2025-06-30,2026-06-30,INTERVENTIONAL,NA,206,"['Coronary Microvascular Disease', 'Ischemic Heart Disease', 'Myocardial Ischemia']",Coronary Microvascular Disease,NYU Langone Health,[],['United States']
NCT03510442,"Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions","Investigation of the Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease and Related Inflammatory Conditions",RECRUITING,2018-05-21,2050-01-01,2050-01-01,OBSERVATIONAL,,2000,"[""Still's Disease, Adult-Onset"", 'Systemic Inflammation', 'Arthritis', 'Autoinflammatory Syndrome']","Still's Disease, Adult-Onset",National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT05452642,The Supporting Understanding of PCOS Education and Research (SUPER) Study,Supporting Understanding of PCOS Education and Research. Official Title: Glycemic Reduction Approaches in Polycystic Ovary Syndrome: a Comparative Effectiveness Study,ACTIVE_NOT_RECRUITING,2022-08-15,2026-07-15,2026-07-15,INTERVENTIONAL,NA,214,['Polycystic Ovary'],Polycystic Ovary,University of Michigan,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT06970223,A Study to Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV,"Phase 1, Open-Label, Randomised Crossover Study Assessing the Tolerability and Acceptability of Long Acting Cabotegravir Intramuscular and Lenacapavir Subcutaneous Injections Over Time in Healthy Adults Without HIV",ACTIVE_NOT_RECRUITING,2025-04-22,2025-07-15,2026-07-10,INTERVENTIONAL,PHASE1,65,['HIV Infections'],HIV Infections,ViiV Healthcare,[],['United States']
NCT00001355,Detection and Characterization of Host Defense Defects,Detection and Characterization of Host Defense Defects,RECRUITING,1993-09-01,,,OBSERVATIONAL,,3600,['Immune Defects'],Immune Defects,National Institute of Allergy and Infectious Diseases (NIAID),"['University of Miami', 'University of South Florida']",['United States']
NCT06451770,Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia,A Phase 1b Single Ascending Dose Study to Evaluate the Safety of VERVE-201 in Patients With Refractory Hyperlipidemia,RECRUITING,2024-10-30,2027-12,2027-12,INTERVENTIONAL,PHASE1,36,"['Hypercholesterolemia', 'Hypertriglyceridemia', 'Refractory Hyperlipidemia']",Hypercholesterolemia,"Verve Therapeutics, Inc.",[],"['United Kingdom', 'South Africa', 'Canada', 'Australia']"
NCT06977724,"A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)","A Phase1b, Multiple Ascending Dose, Open-label, Non-randomized Study Evaluating the Pharmacokinetics, Safety, and Efficacy of ABBV-319 in Subjects With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)",RECRUITING,2025-08-26,2029-03,2029-03,INTERVENTIONAL,PHASE1,36,"['Dry Eye Syndrome', 'Systemic Lupus Erythematosus']",Dry Eye Syndrome,AbbVie,[],"['United States', 'Netherlands']"
NCT06911346,"Plant-Based Foods and (Poly)Phenol Supplementation in Gut Microbiota Modulation, Body Weight, and Cardiometabolic Risk",Exploring the Role of Native Plant-Based Foods and (Poly)Phenol Supplementation in Modifying Gut-Microbiota Metabolism: A Strategy for Reducing Body Weight and Cardiometabolic Risk,ACTIVE_NOT_RECRUITING,2025-07-21,2026-06-03,2026-06-03,INTERVENTIONAL,NA,99,['Obesity and Overweight'],Obesity and Overweight,Universidad Catolica de Temuco,['Agencia Nacional de Investigación y Desarrollo'],['Chile']
NCT00655096,Screening for Research Participants,Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants,RECRUITING,2008-08-20,,,OBSERVATIONAL,,10000,['Eye Diseases'],Eye Diseases,National Eye Institute (NEI),[],['United States']
NCT00900198,Collection of Tissue Samples for Cancer Research,"Tissue Procurement Protocol for the Developmental Therapeutics Clinic, National Cancer Institute (NCI)",RECRUITING,2006-07-06,,,OBSERVATIONAL,,5000,"['Neoplasms', 'Lymphomas', 'Multiple Myeloma', 'Myelodysplastic Syndrome']",Neoplasms,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT01553214,Improving White Blood Cell Collection From Healthy Donors,Collection of Granulocytes by Apheresis of Healthy Donors Stimulated With Filgrastim (G-CSF) and Dexamethasone,RECRUITING,2012-12-31,2032-01-01,2032-01-01,INTERVENTIONAL,PHASE4,1000,['Allogeneic Granulocyte Donation'],Allogeneic Granulocyte Donation,National Institutes of Health Clinical Center (CC),[],['United States']
NCT07253987,Cancer Survivors Program,Cancer Survivors Program: Effectiveness of Monitoring Adverse Events After Completion of Curative Treatment for Breast and Prostate Cancer,RECRUITING,2025-05-05,2025-12-12,2025-12-31,INTERVENTIONAL,NA,200,"['Prostate Cancer Patients', 'Breast Cancer Patients']",Prostate Cancer Patients,Masaryk Memorial Cancer Institute,[],['Czechia']
NCT05725902,Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease,A Pilot Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease,ACTIVE_NOT_RECRUITING,2024-03-25,2025-12-08,2026-02-26,INTERVENTIONAL,PHASE2,12,['Sickle Cell Disease'],Sickle Cell Disease,Novo Nordisk A/S,[],['United States']
NCT07253428,Emergence Agitation,IMPACT OF SUGAMADEX ON AGITATION UPON EMERGENCE FOLLOWING ADULT NASAL SURGERIES.,ACTIVE_NOT_RECRUITING,2025-10-30,2025-12-31,2026-01-31,INTERVENTIONAL,NA,486,"['Emergence Agitation', 'Nasal Surgery']",Emergence Agitation,Ain Shams University,[],['Saudi Arabia']
NCT05499975,Comprehensive Health Assessment for my Cancer Treatment Plan,Comprehensive Health Assessment for my Cancer Treatment Plan: Field Validation of a Geriatric Assessment Tool for Cancer Patients,ACTIVE_NOT_RECRUITING,2023-07-24,2025-04-30,2026-06-30,INTERVENTIONAL,NA,180,"['Cancer', 'Older Adults']",Cancer,"University Health Network, Toronto",[],['Canada']
NCT05626894,Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors,A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life of Chronic Stroke Survivors,RECRUITING,2025-03-20,2026-06-30,2026-09-30,INTERVENTIONAL,PHASE2,32,"['Stroke', 'Stroke Sequelae', 'Hemiparesis;Poststroke/CVA']",Stroke,Spaulding Rehabilitation Hospital,"['BioSensics', 'MGH Institute of Health Professions', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06318273,"A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer","A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-969 in Adult Subjects With Metastatic Castration-Resistant Prostate Cancer",RECRUITING,2024-03-08,2027-05,2027-05,INTERVENTIONAL,PHASE1,140,['Metastatic Castration-Resistant Prostate Cancer'],Metastatic Castration-Resistant Prostate Cancer,AbbVie,[],"['Israel', 'Japan', 'United States', 'France', 'Spain', 'Canada', 'Australia']"
NCT05051657,Evaluation of the Express Plus Range,"A Study To Evaluate The Acceptability Of the Express Plus Range, Foods For Special Medical Purposes (FSMP), In Children And Adults With Inborn Errors of Metabolism (IEM)",ACTIVE_NOT_RECRUITING,2021-06-14,2025-09-30,2025-12-31,INTERVENTIONAL,NA,28,"['Phenylketonurias', 'PKU', 'Homocystinuria', 'Maple Syrup Urine Disease', 'Hereditary Tyrosinemia', 'Glutaric Acidemia I']",Phenylketonurias,"Vitaflo International, Ltd",[],['United Kingdom']
NCT04602377,Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT,Multicentric Non-randomized Phase II of Pembrolizumab in Combination With Etoposide-cisplatin-based Chemotherapy in First-line Small Cell Ovarian Carcinoma of Hypercalcemic Type,RECRUITING,2021-08-04,2026-06,2030-02,INTERVENTIONAL,PHASE2,27,['Small Cell Ovarian Carcinoma'],Small Cell Ovarian Carcinoma,ARCAGY/ GINECO GROUP,['Merck Sharp & Dohme LLC'],['France']
NCT06361719,Efficacy of Two HMOs in Chinese Infants,"Efficacy of a Ready to Feed (RTF) Starter Liquid Infant Formula Containing 2'FL and LNnT in Chinese Infants: A Double-blind, Randomized Controlled Trial Including a Breastfed Reference Group",RECRUITING,2024-07-29,2026-11,2027-06,INTERVENTIONAL,NA,262,['Healthy Infants'],Healthy Infants,Société des Produits Nestlé (SPN),[],['China']
NCT04422652,Combination of Novel Therapies for CKD Comorbid Depression,Combination of Novel Therapies for CKD Comorbid Depression (CONCORD),RECRUITING,2020-09-24,2027-04-01,2027-04-01,INTERVENTIONAL,PHASE2,201,"['Chronic Kidney Diseases', 'Major Depressive Disorder', 'End Stage Kidney Disease (ESRD)']",Chronic Kidney Diseases,Stony Brook University,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT05150925,Immediate Mobilization Versus 2 Weeks Cast Immobilization After Distal Radius Fracture Treated With Volar Locking Plate,"Immediate Mobilization Versus 2 Weeks Cast Immobilization After Distal Radius Fracture Treated With Volar Locking Plate - a Study Protocol for a Prospective, Randomized, Controlled Trial",RECRUITING,2021-12-01,2025-12-31,2026-12-31,INTERVENTIONAL,NA,240,['Distal Radius Fracture'],Distal Radius Fracture,Tampere University Hospital,"['Kuopio University Hospital', 'Jyväskylä Central Hospital', 'Sundsvall Hospital', 'Danderyd Hospital']","['Finland', 'Sweden']"
NCT04681417,Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome,Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018,RECRUITING,2021-03-25,2035-01-20,2036-01-20,INTERVENTIONAL,PHASE2,225,['Retinoblastoma'],Retinoblastoma,Institut Curie,['Fondation Rothschild Paris'],['France']
NCT06726148,Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors,"An Open-label, Multi-center, Phase I/II Study of ECI830 as a Single Agent and in Combination With Ribociclib and Endocrine Therapy in Patients With Advanced Hormone Receptor Positive, HER2-negative Breast Cancer and Advanced Solid Tumors",RECRUITING,2025-04-03,2028-09-25,2028-09-25,INTERVENTIONAL,PHASE1,280,"['Advanced HR+/HER2- Breast Cancer', 'Advanced CCNE1-amplified Solid Tumors']",Advanced HR+/HER2- Breast Cancer,Novartis Pharmaceuticals,[],"['Singapore', 'Israel', 'Japan', 'United States', 'France', 'Germany', 'Denmark', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Australia']"
NCT06073587,The CARDIO-TTRansform Scintigraphy Sub-study,CARDIO-TTRansform ION-682884-CS2-Scintigraphy Sub-study,ACTIVE_NOT_RECRUITING,2023-04-04,2026-03,2026-03,OBSERVATIONAL,,150,['Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)'],Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM),"Ionis Pharmaceuticals, Inc.",['AstraZeneca'],"['Spain', 'United States']"
NCT07192068,Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.,Widening Treatment Options Among Adult Patients With HER2-overexpressing or Mutant Solid Cancers.,ACTIVE_NOT_RECRUITING,2025-10-30,2028-03-13,2030-06-24,INTERVENTIONAL,PHASE2,105,"['Non-Small Cell Lung Cancer', 'Sarcoma', 'Head &Amp; Neck Cancer', 'Colorectal Carcinoma', 'Endometrial']",Non-Small Cell Lung Cancer,UNICANCER,"['National Cancer Institute, France', 'Jazz Pharmaceuticals']",['France']
NCT07253324,ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD),"A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ENX-104 in Participants With Major Depressive Disorder With Anhedonia",RECRUITING,2025-02-17,2025-12,2025-12,INTERVENTIONAL,PHASE1,42,['Major Depressive Disorder'],Major Depressive Disorder,Engrail Therapeutics INC,[],['United Kingdom']
NCT03249220,Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device in Brain-injured Patients,"Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device That Allows the Measurement of Regional Cerebral Blood Flow (rCBF), Intracranial Pressure (ICP), Brain Temperature Monitoring and Ventricular Cerebrospinal Fluid (CSF) Drainage in Brain-injured Patients",ACTIVE_NOT_RECRUITING,2020-09-01,2027-06-30,2027-09-30,INTERVENTIONAL,NA,1,['Brain Injuries'],Brain Injuries,Carag AG,[],['Switzerland']
NCT07133568,Fun Exercise Intervention for Older Adults to Improve Intrinsic Capacity and Motivation,"Design, Development, and Validation of a Recreational Exercise Intervention in Older Adults to Improve Intrinsic Capacity and Motivation: A Randomized Clinical Trial",RECRUITING,2025-09-04,2025-12-19,2025-12-31,INTERVENTIONAL,NA,120,"['Sarcopenia', 'Frailty Syndrome']",Sarcopenia,Cardenal Herrera University,[],['Spain']
NCT06870045,Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA,Investigation of Validity and Reliability of Dynamic Walking Index in Childhood Rheumatic Diseases,RECRUITING,2025-02-01,2026-03,2026-06,OBSERVATIONAL,,52,"['Juvenile Idiopathic Arthritis', 'Childhood Rheumatic Disease']",Juvenile Idiopathic Arthritis,Istanbul University - Cerrahpasa,"['Medipol University', 'Istanbul Medeniyet University']",['Turkey (Türkiye)']
NCT07241481,Using Two Different Attachments (Equator Vs Ball and Sockets) Retaining Mandibular Implant Overdenture in Order to See Bone Changes and Occlusal Force Distribution,Comparing Two Different Attachments Retaining Mandibular Implant Overdenture Regarding Bone Changes and Occlusal Force Distribution (Randomized Clinical Trial),ACTIVE_NOT_RECRUITING,2024-07-01,2025-11-01,2025-12-01,INTERVENTIONAL,NA,24,"['Edentulous Alveolar Ridge In Mandible', 'Complete Edentulism', 'Dental Implant', 'Attachments', 'Implant Retained Overdenture', 'Edentulous Jaw']",Edentulous Alveolar Ridge In Mandible,Al-Azhar University,[],['Egypt']
NCT06695845,A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors,"A Phase 2, Open-label, Multicenter Study to Evaluate Efficacy and Safety of Zanidatamab for the Treatment of Participants With Previously Treated HER2-expressing Solid Tumors (DiscovHER PAN-206)",RECRUITING,2025-01-14,2026-12-31,2027-12-31,INTERVENTIONAL,PHASE2,200,"['Breast Cancer', 'Gastric Cancer', 'Esophageal Cancer', 'Gastroesophageal Cancer', 'Colorectal Cancer', 'Endometrial Cancer', 'Non-small Cell Lung Cancer', 'Ovarian Cancer', 'Urothelial Carcinoma', 'Salivary Gland Cancer', 'Pancreatic Cancer', 'HER-2 Protein Overexpression']",Breast Cancer,Jazz Pharmaceuticals,['Jazz Pharmaceuticals Ireland Limited'],"['United States', 'South Korea']"
NCT03436654,Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma,Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma,ACTIVE_NOT_RECRUITING,2018-06-21,2026-02-14,2026-02-14,INTERVENTIONAL,PHASE2,102,['Prostate Cancer'],Prostate Cancer,Memorial Sloan Kettering Cancer Center,['Dana-Farber Cancer Institute'],['United States']
NCT06904677,Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer,Predicting and Evaluating the Efficacy of Neoadjuvant Therapy in Colorectal Cancer Based on 4D Deep Urinary Proteomics Technology,RECRUITING,2025-05-01,2027-05-01,2029-05-01,OBSERVATIONAL,,400,"['Colorectal Cancer (CRC)', 'Neoadjuvant Therapy', 'Proteomics']",Colorectal Cancer (CRC),"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT06429956,Combining Treatment Components in Transdiagnostic Therapy for Anxiety and Depression,Combining Treatment Components in Transdiagnostic Therapy for Anxiety and Depression: A Randomized Controlled Trial,RECRUITING,2024-06-28,2026-06,2026-06,INTERVENTIONAL,NA,93,"['Depression', 'Anxiety']",Depression,University of Aarhus,[],['Denmark']
NCT06168019,Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India,Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE) Study in India,RECRUITING,2023-12-26,2028-06,2028-06,OBSERVATIONAL,,10000,"['Influenza', 'COVID-19', 'SARS-COV-2 Infection', 'Other Respiratory Viruses', 'Perinatal Morbidity', 'Infant Morbidity']",Influenza,Boston University,"['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'Lata Medical Research Foundation, Nagpur']","['United States', 'India']"
NCT03730792,Success & Health Impacts For Transit Drivers During Onboarding,SHIFT Onboard: Protecting New Transit Operators Against Safety and Health Hazards,ACTIVE_NOT_RECRUITING,2020-03-22,2024-10-23,2026-07,INTERVENTIONAL,NA,284,['Obesity'],Obesity,Oregon Health and Science University,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT04877977,Long-term Observation of Participants With Mood Disorders,Long-term Observation of Participants With Mood Disorders,RECRUITING,2021-08-17,2028-10-01,2028-10-01,OBSERVATIONAL,,1000,"['Depression', 'Suicide Risk']",Depression,National Institute of Mental Health (NIMH),[],['United States']
NCT00098475,Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma,A Randomized Phase III Study of CC-5013 Plus Dexamethasone Versus CC-5013 Plus Low Dose Dexamethasone in Multiple Myeloma With Thalidomide Plus Dexamethasone Salvage Therapy for Non-Responders,ACTIVE_NOT_RECRUITING,2004-11-03,2008-11-30,2026-10-23,INTERVENTIONAL,PHASE3,452,"['DS Stage I Multiple Myeloma', 'DS Stage II Multiple Myeloma', 'DS Stage III Multiple Myeloma']",DS Stage I Multiple Myeloma,National Cancer Institute (NCI),[],['United States']
NCT07182227,PS-002 for the Treatment of IgA Nephropathy in Adults,"A Phase 1/2 Multicenter, Open Label, Two-part Study (Single Ascending Dose [Part 1], and Dose Expansion [Part 2]) to Evaluate Safety, Tolerability and Efficacy of PS-002, a Gene Therapy for the Treatment of Adult Participants With Primary IgA Nephropathy",RECRUITING,2025-11,2028-09,2029-09,INTERVENTIONAL,PHASE1,32,['Immunoglobulin A (IgA) Nephropathy'],Immunoglobulin A (IgA) Nephropathy,Purespring Therapeutics Limited,[],"['United Kingdom', 'United States']"
NCT06212323,Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial,Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial,RECRUITING,2024-01-11,2026-01,2029-01,OBSERVATIONAL,,100,['Smoldering Multiple Myeloma'],Smoldering Multiple Myeloma,University of Utah,[],['United States']
NCT07229157,Effect of Maridebart Cafraglutide on the Heart's Electrical Activity,"A Phase 1, Randomized, Double-blind, Placebo- and Positive-controlled, Parallel Group Study With Nested Crossover Comparison to Assess the Effect of Maridebart Cafraglutide on QT/QTc Intervals in Participants Living With Overweight or Obesity",RECRUITING,2025-10-22,2026-08-23,2026-08-23,INTERVENTIONAL,PHASE1,82,"['Overweight', 'Obesity']",Overweight,Amgen,[],['United States']
NCT07252700,Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care,Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care,RECRUITING,2025-09-02,2027-12-31,2028-03-31,INTERVENTIONAL,NA,6000,"['Pre Diabetes', 'Diabetes (DM)']",Pre Diabetes,Lynette Goh,"['National University Health System, Singapore', 'National University of Singapore']",['Singapore']
NCT07210281,Osteogenon in Orthopedics and Traumatology,The Use of Ossein-hydroxyapatite Complex as an Adjunctive Treatment in Orthopedics and Traumatology,RECRUITING,2024-11-01,2027-02-02,2027-12-30,INTERVENTIONAL,PHASE4,150,['Patients With Fractures'],Patients With Fractures,University of Opole,[],['Poland']
NCT01125228,Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV,A Phase III Study With Long-Term Follow-Up of Zidovudine Versus Zidovudine and Alpha-Interferon Versus Alpha-Interferon in Patients With Early HIV Infection,ACTIVE_NOT_RECRUITING,1988-10-19,,,OBSERVATIONAL,,180,['HIV'],HIV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06991517,A Study of Transcatheter Aortic Valve Replacement Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm,A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing Using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve,RECRUITING,2025-05-13,2026-12,2027-12,OBSERVATIONAL,,290,['Aortic Stenosis'],Aortic Stenosis,World Health Research Inc.,['Edwards Lifesciences'],"['Singapore', 'Costa Rica', 'New Zealand', 'Mexico', 'Thailand', 'Colombia', 'Canada', 'Australia']"
NCT01708954,Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer,"A Randomized Phase II Trial of Erlotinib, Cabozantinib, or Erlotinib Plus Cabozantinib as 2nd or 3rd Line Therapy in Patients With EGFR Wild-Type NSCLC",ACTIVE_NOT_RECRUITING,2013-02-13,2015-08-14,2026-03-18,INTERVENTIONAL,PHASE2,125,"['Recurrent Lung Non-Small Cell Carcinoma', 'Stage IV Lung Non-Small Cell Cancer AJCC v7']",Recurrent Lung Non-Small Cell Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT05720039,Robotic vs. Open NSM for Early Stage Breast Cancer,"A Prospective, Multicenter Randomized Controlled Trial(RCT) of the da Vinci® SP™ Surgical System vs Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures",RECRUITING,2023-05-08,2025-12,2030-12,INTERVENTIONAL,NA,204,"['Breast Cancer Female', 'Breast Cancer', 'Breast Cancer, Early-Onset', 'Breast Disease', 'Breast']",Breast Cancer Female,Intuitive Surgical,[],['United States']
NCT03952624,Patient-Centered Assessment of Symptoms and Outcomes,Patient-Centered Assessment of Symptoms and Outcomes,RECRUITING,2019-09-13,2026-06-01,2026-07-01,OBSERVATIONAL,,692,"['Fatigue', 'Cancer', 'CFS', 'ME/CFS', 'Myalgic Encephalomyelitis/Chronic Fatigue Syndrome', 'Lupus', 'Systemic Lupus Erthematosus', 'Sjogrens']",Fatigue,National Center for Complementary and Integrative Health (NCCIH),[],['United States']
NCT07253610,Effect of Bilateral Rectointercostal Fascial Plane Block on Postoperative Pain After Laparoscopic Sleeve Gastrectomy,Investigation of the Effects of Bilateral Rectointercostal Fascial Plane Block on Postoperative Acute Pain in Patients Undergoing Laparoscopic Sleeve Gastrectomy,RECRUITING,2025-11-01,2025-12-31,2026-01-05,INTERVENTIONAL,NA,50,"['Pain, Postoperative', 'Obesity, Morbid', 'Laparoscopic Sleeve Gastrectomy (LSG)', 'Opioid Use']","Pain, Postoperative",Samsun University,[],['Turkey (Türkiye)']
NCT06976112,Impact of Lean Pork on Endothelial Function in Perimenopause,Effects of Lean Pork Intake on Endothelial Function and Vasomotor Symptoms in Perimenopausal Women,RECRUITING,2025-08-01,2026-12-31,2027-05,INTERVENTIONAL,NA,30,"['Cardiovascular Outcome', 'Overweight and Obese Women', 'Perimenopausal Women', 'Vasomotor Symptoms (VMS)']",Cardiovascular Outcome,Pennington Biomedical Research Center,[],['United States']
NCT05149573,Investigation of PEMF Therapy for Female Patients With IC/BPS,Investigation of Non-Invasive Pulsed Electromagnetic Field (PEMF) Therapy for Female Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS),RECRUITING,2022-08-29,2026-04,2026-04,INTERVENTIONAL,NA,75,"['Interstitial Cystitis', 'Chronic Interstitial Cystitis', 'Bladder Pain Syndrome']",Interstitial Cystitis,Wake Forest University Health Sciences,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT07128329,Acute Effects of Oral Nicotine Pouches,The Acute Effects of Oral Nicotine Pouches Among Infrequent and Frequent Nicotine/Tobacco Users,RECRUITING,2025-11-21,2027-04-01,2027-04-01,INTERVENTIONAL,PHASE1,120,"['Nicotine Pouch Self-Administration', 'Nicotine Pharmacokinetic Study', 'Nicotine Pharmacodynamic Study']",Nicotine Pouch Self-Administration,Johns Hopkins University,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT07254312,Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.,Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.,RECRUITING,2024-10-21,2026-04,2026-04,OBSERVATIONAL,,14,['AML (Acute Myelogenous Leukemia'],AML (Acute Myelogenous Leukemia,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT05389449,A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH,A Long-term Extension (LTE) Study to Characterize the Safety and Efficacy of Danicopan as an Add-on Therapy to a Complement Component 5 Inhibitor (C5i) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Previously Treated With Danicopan in an Alexion-sponsored Clinical Study,ACTIVE_NOT_RECRUITING,2022-10-28,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE3,80,['Paroxysmal Nocturnal Hemoglobinuria'],Paroxysmal Nocturnal Hemoglobinuria,"Alexion Pharmaceuticals, Inc.",[],"['Brazil', 'Israel', 'Japan', 'United Kingdom', 'United States', 'France', 'Spain', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Greece', 'Poland', 'Thailand', 'Malaysia']"
NCT07160738,A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060,"AN INTERVENTIONAL, PHASE 1, OPEN-LABEL, TWO-COHORT, TWO-PERIOD, FIXED SEQUENCE STUDY TO ESTIMATE THE EFFECT OF MULTIPLE DOSES OF ITRACONAZOLE AND PROBENECID ON THE PHARMACOKINETICS OF SINGLE DOSE PF-07220060 ADMINISTERED UNDER THE FED CONDITION TO HEALTHY PARTICIPANTS",RECRUITING,2025-09-22,2025-12-18,2026-01-09,INTERVENTIONAL,PHASE1,28,['Healthy Adults'],Healthy Adults,Pfizer,[],['United States']
NCT03999710,Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer,Durvalumab With Thoracic Radiation Therapy Without Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (DART),ACTIVE_NOT_RECRUITING,2019-07-19,2026-07,2026-07,INTERVENTIONAL,PHASE2,61,"['Non Small Cell Lung Cancer', 'Lung Cancer', 'Nsclc', 'NSCLC Stage II', 'NSCLC, Stage III']",Non Small Cell Lung Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT05516914,A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors,"A Multicenter Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LBL-007 in Combination With Tislelizumab in the Treatment of Malignancies",RECRUITING,2022-09-01,2026-05-01,2026-07-30,INTERVENTIONAL,PHASE1,490,['Malignant Tumors'],Malignant Tumors,"Nanjing Leads Biolabs Co.,Ltd",[],['China']
NCT07206498,A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC,"A Phase I/II Study to Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU in Combination With Osimertinib for Patients With Locally Advanced or Metastatic Non- Small Cell Lung Cancer",RECRUITING,2025-10-17,2028-10-14,2029-10-14,INTERVENTIONAL,PHASE1,48,['Non Small Cell Lung Cancer (NSCLC)'],Non Small Cell Lung Cancer (NSCLC),"Wayshine Biopharm, Inc.",[],['China']
NCT06909825,FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC),"A Phase 2, Open-label, Multi-centre Study of FPI-2265 (225Ac-PSMA-I&T) and Olaparib in Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)",ACTIVE_NOT_RECRUITING,2025-02-26,2030-01-29,2030-08-12,INTERVENTIONAL,PHASE2,85,['Metastatic Castration-resistant Prostate Cancer'],Metastatic Castration-resistant Prostate Cancer,Fusion Pharmaceuticals Inc.,[],['Australia']
NCT05099471,Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia,Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia,RECRUITING,2025-03-21,2028-03,2033-03,INTERVENTIONAL,PHASE2,80,"['Waldenstrom Macroglobulinemia', 'Treatment Naive']",Waldenstrom Macroglobulinemia,Christian Buske,"['Ludwig-Maximilians - University of Munich', 'Zentrum für Klinische Studien Ulm', 'AbbVie', 'Pfizer', 'University of Ulm', 'University Hospital Schleswig-Holstein']","['Greece', 'Germany']"
NCT04624477,Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer,Active Surveillance or Surgery for Primary Management of Very Low Risk Papillary Thyroid Cancer: How Often Are the Long-term Disease Management Goals Achieved?,ACTIVE_NOT_RECRUITING,2021-02-03,2034-12-31,2034-12-31,OBSERVATIONAL,,450,"['Papillary Thyroid Cancer', 'Papillary Thyroid Carcinoma', 'Papillary Microcarcinoma of the Thyroid']",Papillary Thyroid Cancer,"University Health Network, Toronto","['University of British Columbia', 'University of Calgary', ""London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's"", 'McMaster University', 'CHU de Quebec-Universite Laval', 'Dalhousie University', 'Canadian Cancer Society (CCS)', 'Canadian Institutes of Health Research (CIHR)', ""Centre hospitalier de l'Université de Montréal (CHUM)""]",['Canada']
NCT07253974,"PEARL: IMPROVING RECOVERY: AFTER STROKE, A NEW SCREENING TOOL FOR SELECTING REHABILITATION PROGRAMS","IMPROVING RECOVERY: A NEW SCREENING TOOL FOR SELECTING HIGH-INTENSITY AND MODERATE-INTENSITY ATRIAL FIBRILLATION RELATED STROKE REHABILITATION PROGRAMS (PEARL), an Observational Cohort Study Protocol",RECRUITING,2024-11-11,2026-11-11,2027-12-01,OBSERVATIONAL,,213,"['STROKE', 'Rehabilitation Outcome', 'Brain Disease', 'Cardiovascular Disease Acute', 'Hemiplegia and/or Hemiparesis Following Stroke', 'Disability Physical']",STROKE,Parc de Salut Mar,[],['Spain']
NCT06433765,A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS),BRIUMVI® Pregnancy Registry: A Prospective Study of Pregnancy and Infant Outcomes in Patients Treated With BRIUMVI®,RECRUITING,2024-06-01,2035-03-31,2035-03-31,OBSERVATIONAL,,728,['Multiple Sclerosis'],Multiple Sclerosis,"TG Therapeutics, Inc.",[],['United States']
NCT07186309,A Study of a Test for Postpartum Depression at Home,A Prospective Validation of the Enlighten Device in Predicting Postpartum Depression Using At-Home Sample Collection in Both Blood and Saliva,RECRUITING,2025-11-20,2029-08,2030-08,OBSERVATIONAL,,1000,"['Postpartum Depression (PPD)', 'Pregnancy']",Postpartum Depression (PPD),University of Virginia,"['Mayo Clinic', 'Dionysus Health']",['United States']
NCT07109492,The Role of Mandala Painting Before Surgery,The Role of Mandala Painting Before Surgery on Anxiety and Stress,RECRUITING,2025-07-01,2026-07-01,2026-12-01,INTERVENTIONAL,NA,60,"['Mandala Painting', 'Surgery', ""Nurse's Role""]",Mandala Painting,Niran Çoban,[],['Turkey (Türkiye)']
NCT04549207,Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer,A Randomised Trial Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer (REaCT-Hold BMA),ACTIVE_NOT_RECRUITING,2020-10-09,2025-04-17,2026-06,INTERVENTIONAL,PHASE4,240,"['Breast Cancer', 'Castration-resistant Prostate Cancer']",Breast Cancer,Ottawa Hospital Research Institute,[],['Canada']
NCT07041307,Microvascular Profiling of Nodules in the Thyroid Gland,Microvascular Profiling of Nodules in the Thyroid Gland,RECRUITING,2025-08-15,2028-12-01,2028-12-31,OBSERVATIONAL,,50,['Thyroid Nodular Disease'],Thyroid Nodular Disease,"Rigshospitalet, Denmark","['University of Copenhagen', 'Technical University of Denmark']",['Denmark']
NCT06637917,Pulse Oximetry Performance Comparison in Newborns,Pulse Oximetry Performance Comparison in Newborns,ACTIVE_NOT_RECRUITING,2024-09-10,2025-09-18,2026-01,OBSERVATIONAL,,120,"['Newborn', 'Birth, Preterm']",Newborn,Medtronic - MITG,[],['United States']
NCT04091126,Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma,"A Phase 1, Randomized, Dose and Schedule Evaluation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Belantamab Mafodotin Administered in Combination With Standard of Care in Participants With Newly Diagnosed Multiple Myeloma",ACTIVE_NOT_RECRUITING,2019-12-18,2025-06-02,2026-12-31,INTERVENTIONAL,PHASE1,118,['Multiple Myeloma'],Multiple Myeloma,GlaxoSmithKline,[],"['United States', 'France', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT06911632,Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension,MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion),RECRUITING,2025-07-23,2028-05,2028-07,INTERVENTIONAL,NA,1000,"['Pulmonary Hypertension', 'Interstitial Lung Disease (ILD)']",Pulmonary Hypertension,Tempus AI,['United Therapeutics'],['United States']
NCT01798407,DBS of the Lateral Habenula in Treatment-Resistant Depression,A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression,ACTIVE_NOT_RECRUITING,2013-02,2026-08,2026-08,INTERVENTIONAL,NA,6,['Treatment Resistant Major Depressive Disorder'],Treatment Resistant Major Depressive Disorder,Wayne Goodman MD,[],['United States']
NCT01856192,Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma,"Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma",ACTIVE_NOT_RECRUITING,2013-08-27,2020-03-26,2025-12-31,INTERVENTIONAL,PHASE2,349,"['Ann Arbor Stage II Diffuse Large B-Cell Lymphoma', 'Ann Arbor Stage III Diffuse Large B-Cell Lymphoma', 'Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma']",Ann Arbor Stage II Diffuse Large B-Cell Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT06130553,"A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors","PRIMROSE: A Modular Phase I/IIa, Multi-centre, Dose Escalation, and Expansion Study of AZD3470, a MTA Cooperative PRMT5 Inhibitor, as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumors That Are MTAP Deficient",RECRUITING,2024-01-18,2026-02-26,2026-02-26,INTERVENTIONAL,PHASE1,234,['Advanced Solid Tumors That Are MTAP Deficient'],Advanced Solid Tumors That Are MTAP Deficient,AstraZeneca,[],"['Japan', 'Netherlands', 'China', 'United States', 'France', 'Spain', 'South Korea', 'Australia']"
NCT06193980,ICU Combined Assessment of Cardio-Respiratory Exercise,Exercise Testing in ICU Survivors to Evaluate ICU-acquired Weakness,RECRUITING,2023-12-15,2028-07,2028-07,OBSERVATIONAL,,50,"['ICU Acquired Weakness', 'Sepsis', 'Shock', 'Critical Illness', 'Microcirculation']",ICU Acquired Weakness,University of Manitoba,[],['Canada']
NCT07065214,Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy,Argon Plasma Treatment for Ovarian Endometrioma Compared to Standard Cystectomy: A Prospective Controlled Randomized Pilot Study,RECRUITING,2025-11-26,2027-03-01,2027-09-30,INTERVENTIONAL,NA,72,['Endometriosis'],Endometriosis,Erbe Elektromedizin GmbH,[],['Germany']
NCT07055516,Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus,"A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes",ACTIVE_NOT_RECRUITING,2025-05-08,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE2,162,['Obesity and Type 2 Diabetes'],Obesity and Type 2 Diabetes,NodThera Limited,[],['United States']
NCT06672978,"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis","A Multi-Center, Open-Label, Single-Arm, Phase 2 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Vabomere (Meropenem-Vaborbactam) In The Treatment Of Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis",RECRUITING,2025-06-03,2027-01,2027-07,INTERVENTIONAL,PHASE2,66,"['Acute Pyelonephritis', 'Complicated Urinary Tract Infection']",Acute Pyelonephritis,"Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)",['Biomedical Advanced Research and Development Authority'],"['Bulgaria', 'United States', 'Georgia', 'Croatia', 'Greece', 'Poland']"
NCT06072482,A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis,"A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis",RECRUITING,2024-02-07,2036-12-31,2036-12-31,INTERVENTIONAL,PHASE4,300,['Antineutrophil Cytoplasmic Antibody-associated Vasculitis'],Antineutrophil Cytoplasmic Antibody-associated Vasculitis,Amgen,[],"['Hungary', 'United States', 'Romania', 'Czechia', 'Poland']"
NCT06545331,Study of XB010 in Subjects With Solid Tumors,A Dose-Escalation and Expansion Study of XB010 as a Single Agent and Combination Therapy in Subjects With Locally Advanced or Metastatic Solid Tumors,RECRUITING,2024-08-06,2026-11-23,2027-10-20,INTERVENTIONAL,PHASE1,396,"['Locally Advanced or Metastatic Solid Tumors', 'Esophageal Squamous Cell Cancer', 'Head and Neck Squamous Cell Cancer', 'NSCLC (Non-small Cell Lung Cancer)', 'Hormone-receptor-positive Breast Cancer', 'Triple Negative Breast Cancer (TNBC)']",Locally Advanced or Metastatic Solid Tumors,Exelixis,[],['United States']
NCT06975722,A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis,"A Phase 2b, Multi-national, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Followed by a Long-term Extension to Evaluate the Efficacy and Safety of SAR442970 in Adult Participants With Moderate to Severe Ulcerative Colitis",RECRUITING,2025-07-07,2026-12-17,2029-10-17,INTERVENTIONAL,PHASE2,99,['Ulcerative Colitis'],Ulcerative Colitis,Sanofi,[],"['Japan', 'Hungary', 'Moldova', 'United States', 'France', 'Spain', 'Czechia', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT07253896,Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab,Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab as Second-line Treatment in MSS Type Metastatic Colorectal Cancer Based on RAS Gene Status,RECRUITING,2024-01-03,2026-01-03,2027-01-03,INTERVENTIONAL,PHASE2,40,['Safety'],Safety,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT06613841,"Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma","Pilot Study to Evaluate Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI Methods at 7Tesla Metabolic Profiling of Glioblastoma",RECRUITING,2025-05-01,2026-10-01,2026-12-31,INTERVENTIONAL,EARLY_PHASE1,15,"['Glioblastoma', 'Recurrent Glioblastoma', 'Glioblastoma Multiforme of Brain']",Glioblastoma,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT03481829,Early Tracking of Childhood Health Determinants (ETCHED) Study,Early Tracking of Childhood Health Determinants Study,RECRUITING,2022-04-14,2041-12-31,2041-12-31,OBSERVATIONAL,,1500,"['Diabetes Mellitus', 'Obesity', 'Fatty Liver']",Diabetes Mellitus,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06460961,A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001),"A Phase 1 Open-label, Multicenter Study of MK-6837 as Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors",ACTIVE_NOT_RECRUITING,2024-07-14,2029-07-13,2029-07-13,INTERVENTIONAL,PHASE1,168,['Neoplasm Metastasis'],Neoplasm Metastasis,Merck Sharp & Dohme LLC,[],"['Israel', 'United States', 'Canada', 'Australia']"
NCT05175105,"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, Followed by a 5-Year Extension Period","A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Subjects With Pyruvate Kinase Deficiency Who Are Not Regularly Transfused, Followed by a 5-Year Open-label Extension Period",ACTIVE_NOT_RECRUITING,2022-06-06,2024-12-13,2030-01,INTERVENTIONAL,PHASE3,30,"['Pediatric Pyruvate Kinase Deficiency', 'Pediatric Hemolytic Anemia']",Pediatric Pyruvate Kinase Deficiency,"Agios Pharmaceuticals, Inc.",[],"['Netherlands', 'United States', 'France', 'Switzerland', 'Spain', 'Canada', 'Germany']"
NCT07095595,The Effect of Education-based Patient Safety on Nursing Leaders' and Educators' Perceptions of Patient Safety Culture in Saudi Arabia,The Effect of Education-based Patient Safety on Nursing Leaders' and Educators' Perceptions of Patient Safety Culture in Saudi Arabia,ACTIVE_NOT_RECRUITING,2025-09-01,2026-01-28,2026-01-28,INTERVENTIONAL,NA,102,['Healthy Participants'],Healthy Participants,Universiti Putra Malaysia,[],['Saudi Arabia']
NCT05462951,Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer,Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer,ACTIVE_NOT_RECRUITING,2023-01-03,2026-06-01,2026-06-01,OBSERVATIONAL,,19,['Uterine Cervix Cancer'],Uterine Cervix Cancer,Denise Fabian,['UK Radiopharma Alliance'],['United States']
NCT07253337,Analysis of Bite Force Distribution After Premolars Extraction by Using T-scan Analysis System,Effect of First Premolars Extraction During Orthodontic Treatment on Distribution of Bite Force During the Mandibular Excursive Movements: A Prospective Clinical Trial Using T-scan Occlusal Analysis System.,ACTIVE_NOT_RECRUITING,2025-01-01,2026-06-01,2026-07-01,INTERVENTIONAL,NA,16,['Effect of Premolars Extraction on Bite Force'],Effect of Premolars Extraction on Bite Force,Suez Canal University,[],['Egypt']
NCT05815745,"""Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment"" (PROTECT-HF)",Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment,RECRUITING,2023-06-05,2029-12-04,2029-12-04,INTERVENTIONAL,NA,2600,"['Bradycardia', 'Pacing', 'Right Ventricular Pacing', 'His Bundle Pacing', 'Left Bundle Branch Area Pacing']",Bradycardia,Imperial College London,['British Heart Foundation'],"['United Kingdom', 'Ireland', 'Slovenia']"
NCT06714006,Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003,"A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered PYC-003, a Peptide-phosphorodiamidate Morpholino Oligonucleotide Conjugate, in Healthy Adult Participants and Adult Participants With Confirmed PKD1 Mutation-associated Autosomal Dominant Polycystic Kidney Disease",RECRUITING,2025-04-07,2026-01,2026-01,INTERVENTIONAL,PHASE1,56,['Autosomal Dominant Polycystic Kidney Disease (ADPKD)'],Autosomal Dominant Polycystic Kidney Disease (ADPKD),PYC Therapeutics,[],['Australia']
NCT07039149,Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents,Dual Antiplatelet Agents Therapy in the Emergency Department for Acute Coronary Syndrome (The DATES Study).,RECRUITING,2025-08-01,2026-08-01,2026-11-01,OBSERVATIONAL,,200,"['Major Bleeding', 'Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)']",Major Bleeding,Jordan Collaborating Cardiology Group,[],['Jordan']
NCT06975865,The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease,"A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Group Sequential Study to Evaluate the Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease",RECRUITING,2025-08-12,2027-07-23,2028-12-29,INTERVENTIONAL,PHASE3,192,['Sickle Cell Disease'],Sickle Cell Disease,Sanofi,[],"['Brazil', 'Belgium', 'Israel', 'Turkey (Türkiye)', 'Netherlands', 'Tanzania', 'United States', 'Ghana', 'France', 'Spain', 'Italy', 'United Kingdom', 'Greece']"
NCT05659901,Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease,Integrated Prospective and Retrospective Observational Study to Characterize Biomarkers and Disease Progression in Patients With Pelizaeus-Merzbacher Disease,RECRUITING,2022-10-03,2029-03,2029-03,OBSERVATIONAL,,32,['Pelizaeus-Merzbacher Disease'],Pelizaeus-Merzbacher Disease,"Ionis Pharmaceuticals, Inc.",[],"['Israel', 'France', 'Netherlands', 'Germany']"
NCT07211386,The Erector Spinae Plane Block For Gastrointestinal Malignancy Pain Treatment (EGIPT),Efficacy of the Erector Spinae Plane Block for Abdominal Pain From Gastrointestinal Malignancies,RECRUITING,2025-12-11,2027-05-15,2027-06-15,INTERVENTIONAL,NA,25,"['Gastrointestinal Malignancy', 'Pain Control']",Gastrointestinal Malignancy,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT07245667,Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study,Clinical Study to Assess Tolnaftate 1% With a Novel Vehicle for the Treatment of Tinea Pedis,RECRUITING,2024-12-30,2026-02,2026-02,INTERVENTIONAL,PHASE2,150,['Tinea Pedis'],Tinea Pedis,"Propedix, Inc.",[],['United States']
NCT05626608,Continuous Electrical Neuromodulation of the Globus Pallidus Intern in Parkinson's Disease by the Directional Electrode CARTESIA™,Neuromodulation électrique Continue du Globus Pallidus Dans la Maladie de Parkinson Par l'électrode Directionnelle CARTESIA™,RECRUITING,2023-04-28,2026-10-28,2026-10-28,INTERVENTIONAL,NA,10,['Parkinson Disease'],Parkinson Disease,"University Hospital, Montpellier",[],['France']
NCT07190950,Effects of Low-level Laser Therapy on Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Extraction,Effects of Low-level Laser Therapy on Soft and Hard Tissue Healing After Impacted Mandibular Third Molar Extraction,RECRUITING,2024-08-30,2025-08-30,2025-12-31,INTERVENTIONAL,NA,22,"['Third Molars Extraction', 'Low Level Laser Therapy', 'Bone Healing']",Third Molars Extraction,University of Medicine and Pharmacy at Ho Chi Minh City,[],['Vietnam']
NCT06524882,Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age,A Randomized Trial of Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age,RECRUITING,2024-10-22,2027-07-01,2027-11-01,INTERVENTIONAL,PHASE3,252,['Amblyopia'],Amblyopia,Jaeb Center for Health Research,"['National Eye Institute (NEI)', 'Pediatric Eye Disease Investigator Group']",['United States']
NCT07151690,BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis,A Single-arm Single-center Trial of BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis,RECRUITING,2025-09-04,2026-12-01,2027-12-01,INTERVENTIONAL,PHASE2,21,['Systemic Light Chain Amyloidosis'],Systemic Light Chain Amyloidosis,"Institute of Hematology & Blood Diseases Hospital, China",[],['China']
NCT06519565,Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP),Clinical Study on the Safety and Efficacy of PRG-1801 for the Treatment of Recurrent/Refractory Primary Immune Thrombocytopenia (ITP),RECRUITING,2024-08-20,2026-12-15,2027-08-15,INTERVENTIONAL,EARLY_PHASE1,6,['Immune Thrombocytopenia'],Immune Thrombocytopenia,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","['Shenzhen Pregene Biopharma Co., Ltd.']",['China']
NCT06028126,Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial,Efficacy of Intermittent Superficial Parasternal Intercostal Plane Block on Postoperative Pain Control in Patients Undergoing Cardiac Surgery With Median Sternotomy - EPOCH Randomized Clinical Trial,RECRUITING,2023-09-08,2026-01,2026-01,INTERVENTIONAL,NA,340,"['Post-operative Pain', 'Post-operative Delirium', 'Post-cardiac Surgery', 'Chronic Pain', 'Opioid Use Disorder', 'Anesthesia, Local']",Post-operative Pain,Unity Health Toronto,"['Queen Elizabeth II Health Sciences Centre', 'Foothills Medical Centre']",['Canada']
NCT06817278,Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health Services: Pilot Study,Internet-delivered Emotion Regulation Individual Therapy or Adolescents (IERITA) With Self-injury Within Child and Adolescent Mental Health Services: Pilot Study,RECRUITING,2025-01-15,2026-06,2026-12,INTERVENTIONAL,NA,100,"['Nonsuicidal Self-Injury', 'Self-Harm']",Nonsuicidal Self-Injury,Karolinska Institutet,"['Region Stockholm', 'Region Skane', 'Vastra Gotaland Region']",['Sweden']
NCT06980103,Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer,Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer: The Radiance Trial,RECRUITING,2025-08-01,2030-05-15,2032-05-15,INTERVENTIONAL,NA,408,['Thyroid Cancer'],Thyroid Cancer,Georgetown University,"['National Institutes of Health (NIH)', 'National Institute of Dental and Craniofacial Research (NIDCR)']",['United States']
NCT07255170,RED BEAN AND TOMATO SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS,"DEVELOPMENT OF ""GLYCEMIC CONTROL BAR WITH BEANS AND TOMATO FOR DIABETIC EATING"" (GLYCOBITE) SNACK BAR FORMULATIONS AS A HEALTHY SNACK FOR DIABETES MELLITUS PATIENTS",ACTIVE_NOT_RECRUITING,2025-08-15,2025-11-20,2025-11-22,INTERVENTIONAL,NA,100,['Diabetes Mellitus'],Diabetes Mellitus,University Ngudi Waluyo,[],['Indonesia']
NCT07252778,Effect of a Short-term Multi-strain Probiotic Supplementation in Endurance Athletes,Effect of a Short-term Multi-strain Probiotic Supplementation on the Exercise- Associated Gastrointestinal Disturbances in Trained Female Athletes Under Controlled Conditions During Professional Training Cycle,RECRUITING,2025-11-20,2027-06-01,2027-06-30,INTERVENTIONAL,PHASE2,30,"['Sports Nutrition', 'Biochemical Markers', 'Exercise Performance', 'Aerobic Capacity', 'Supplementation']",Sports Nutrition,Krzysztof Durkalec-Michalski,"['Institute of Human Genetics, Polish Academy of Sciences']",['Poland']
NCT01607008,MRI for Assessing Prostate Cancer Response,Multiparametric MRI for Assessing Radiotherapy Treatment Response of Prostate Cancer,ACTIVE_NOT_RECRUITING,2012-11-16,2027-12,2028-12,INTERVENTIONAL,NA,38,['Prostate Cancer'],Prostate Cancer,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,[],['United States']
NCT05440617,Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy,Biorepository in Participants Who Undergo OTC for Gonadotoxic Therapy,RECRUITING,2022-07-22,2041-09-21,2041-09-21,OBSERVATIONAL,,100,"['Acute Ovarian Failure', 'Infertility', 'Early Menopause And Infertility In Females After Treatment For Childhood Cancer']",Acute Ovarian Failure,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT07229131,Effect of an Oral Acerola Juice Powder on Skin Beauty Parameters in Women Exposed to Environmental Stresses,"Effect of an Oral Acerola Juice Powder on Skin Beauty Parameters in Women Exposed to Environmental Stresses: A Double-blind, Randomised, Placebo-controlled Study.",ACTIVE_NOT_RECRUITING,2025-11-03,2026-02-13,2026-02-13,INTERVENTIONAL,NA,108,['Pollution; Exposure'],Pollution; Exposure,Diana SAS,['Eurofins Dermscan Pharmascan'],['China']
NCT07193147,Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment,"A Single Dose Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function",ACTIVE_NOT_RECRUITING,2025-10-20,2026-07-14,2026-11-04,INTERVENTIONAL,PHASE1,36,['Diabetes'],Diabetes,Gan & Lee Pharmaceuticals.,[],['China']
NCT00001316,Viral Load in Blood and Lymph Tissues in People Living With HIV,A Study of Viral Burden in Peripheral Blood Versus Lymphoid and Bone Marrow Tissue in People Living With HIV,RECRUITING,1992-08-26,,,OBSERVATIONAL,,400,['HIV'],HIV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT03405155,Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery,Phase II Study of Adjuvant Nivolumab in Patients With Resected Stage IIB/IIC Melanoma,ACTIVE_NOT_RECRUITING,2018-01-17,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,26,['Melanoma (Skin)'],Melanoma (Skin),Sidney Kimmel Cancer Center at Thomas Jefferson University,['Bristol-Myers Squibb'],['United States']
NCT06220318,Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid Tumors,"A Phase I/II Clinical Study on the Safety, Tolerability and Preliminary Efficacy of C019199 in Combination With Sintilimab in Patients With Advanced Solid Tumors",ACTIVE_NOT_RECRUITING,2023-07-19,2026-08-30,2026-08-30,INTERVENTIONAL,PHASE1,155,['Solid Tumor'],Solid Tumor,"Fujian Haixi Pharmaceuticals Co., Ltd.",[],['China']
NCT07069725,"The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.","A Phase 1, Open-label Positron Emission Tomography Trial to Assess Changes in Liver Uptake of [68Ga]Ga-FAPI-46 Following Oral Administration of Single Doses of AZD2389 to Patients With Advanced Liver Fibrosis (PECHORA).",RECRUITING,2025-05-26,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE1,12,"['Liver Fibrosis', 'Hepatic Cirrhosis']",Liver Fibrosis,AstraZeneca,"['CTC Clinical Trial Consultants AB', 'Karolinska Institutet']",['Sweden']
NCT04662710,Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015),"Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy Compared With Standard of Care Therapy as First-line Intervention in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (LEAP-015)",ACTIVE_NOT_RECRUITING,2020-12-30,2024-10-29,2026-03-31,INTERVENTIONAL,PHASE3,895,['Advanced/Metastatic Gastroesophageal Adenocarcinoma'],Advanced/Metastatic Gastroesophageal Adenocarcinoma,Merck Sharp & Dohme LLC,['Eisai Inc.'],"['Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Israel', 'Russia', 'France', 'Chile', 'Guatemala', 'South Korea', 'Colombia', 'Poland', 'Costa Rica', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina']"
NCT03792659,The EXPLORE MG Registry for Myasthenia Gravis,Exploring Outcomes and Characteristics of Myasthenia Gravis: The EXPLORE MG Registry,RECRUITING,2016-03-30,2026-09-30,2026-10-30,OBSERVATIONAL,,800,['Myasthenia Gravis'],Myasthenia Gravis,Yale University,[],['United States']
NCT05135091,Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)),A Study of Inhibitory Interneurons (NRTX-1001) in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (MTLE),RECRUITING,2022-06-16,2029-02,2043-09,INTERVENTIONAL,PHASE3,88,['Mesial Temporal Lobe Epilepsy'],Mesial Temporal Lobe Epilepsy,Neurona Therapeutics,['California Institute for Regenerative Medicine (CIRM)'],['United States']
NCT07253389,Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis,A Multicenter Randomized Controlled Trial: Comparison of Underdilated Versus Standard Transjugular Intrahepatic Portosystemic Shunt in Preventing Rebleeding From Esophagogastric Varices in Patients With Cirrhosis,RECRUITING,2025-10-21,2028-03-31,2028-03-31,INTERVENTIONAL,NA,170,"['Liver Cirrhosis', 'Gastroesophageal Varices Bleeding']",Liver Cirrhosis,"Air Force Military Medical University, China",[],['China']
NCT07254481,"VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population","A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Food Effects, and QT/QTc Interval Impact of VB19055 Tablets in Healthy Chinese Adult Subjects",RECRUITING,2025-10-05,2026-07,2026-07,INTERVENTIONAL,PHASE1,86,['Hypertension'],Hypertension,"Zhejiang Yangli Pharmaceutical Technology Co., Ltd.",[],['China']
NCT07254065,Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT,Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT,RECRUITING,2025-11-14,2027-12-31,2028-06-30,INTERVENTIONAL,NA,130,"['Feasibility and Acceptability', 'Prevention Childhood Obesity']",Feasibility and Acceptability,Northwell Health,"['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07042412,Ta'am Mustadam Intervention to Promote Sustainable Food Choices,Ta'am Mustadam Intervention: Promoting Sustainable Food Choices Among Young Adults in the UAEU Community,ACTIVE_NOT_RECRUITING,2025-10-22,2025-12-15,2026-01-20,INTERVENTIONAL,NA,80,"['Food Preferences', 'Health Behaviour', 'Choice Behavior', 'Feeding Behaviors', 'Sustainable Healthy Eating Behaviour']",Food Preferences,United Arab Emirates University,[],['United Arab Emirates']
NCT06873581,Pivotal Study of Voro Urologic Scaffold,A Pivotal Study of Voro Urologic Scaffold for the Treatment of Post Prostatectomy Stress Urinary Incontinence (ARID II),RECRUITING,2025-04-18,2027-02-01,2028-02-01,INTERVENTIONAL,PHASE3,266,"['Radical Prostatectomy', 'Stress Urinary Incontinence (SUI)']",Radical Prostatectomy,"Levee Medical, Inc.",[],['United States']
NCT05877599,"A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation","An Open-label, Phase 1, Multicenter Study to Evaluate the Safety and Preliminary Anti-tumor Activity of NT-175 in Human Leukocyte Antigen-A*02:01-Positive Adult Subjects With Unresectable, Advanced and/or Metastatic Solid Tumors That Are Positive for the TP53 R175H Mutation",RECRUITING,2023-07-12,2028-09-01,2039-08-01,INTERVENTIONAL,PHASE1,162,"['Non-small Cell Lung Cancer', 'Head and Neck Squamous Cell Carcinoma', 'Colorectal Carcinoma', 'Pancreatic Adenocarcinoma', 'Breast Cancer', 'Other Solid Tumors', 'Ovarian Cancer']",Non-small Cell Lung Cancer,AstraZeneca,[],['United States']
NCT03233399,Modulating Movement Intention Via Cortical Stimulation,Modulating Movement Intention Via Cortical Stimulation in Healthy Subjects and Patients With Psychogenic Movement Disorders and Non-epileptic Seizures,RECRUITING,2017-07-20,2027-05,2027-05,INTERVENTIONAL,NA,30,"['Seizures', 'Seizure Disorder', 'Psychogenic Movement Disorder']",Seizures,NYU Langone Health,[],['United States']
NCT05237687,The Role of Sirolimus in Preventing Functional Decline in Older Adults,Sirolimus in Older Adults- Randomized Trial Assessing the Improvement in Phenotypic/Functional Biomarkers of Aging,RECRUITING,2026-01,2027-09,2027-11,INTERVENTIONAL,PHASE2,10,['Aging'],Aging,Irina Timofte,[],['United States']
NCT04715685,Mind Body Balance for Pediatric Migraine,Mind Body Balance for Pediatric Migraine,RECRUITING,2021-03-09,2026-05-01,2026-05-31,INTERVENTIONAL,NA,260,"['Headache', 'Headache Disorders', 'Headache, Migraine', 'Migraine', 'Migraine Disorders', 'Migraine With Aura', 'Migraine Without Aura', 'Chronic Migraine']",Headache,"Children's Hospital Medical Center, Cincinnati",['National Center for Complementary and Integrative Health (NCCIH)'],['United States']
NCT07253025,Comparison of Post Operative Pain in Resin-Based and Bioceramic Based Root Canal Sealers in Patient Presenting at Peshawar Dental College.,Comparison of Post Operative Pain in Resin-Based and Bio Ceramic Based Root Canal Sealer in Patient Presenting at Peshawar Dental College,RECRUITING,2025-11-30,2026-04-02,2026-04-02,INTERVENTIONAL,NA,180,['Post Operative Pain'],Post Operative Pain,Prime Foundation,[],['Pakistan']
NCT04178018,Transvaginal Ultrasound and Photoacoustic Imaging of Ovary,Transvaginal Ultrasound and Photoacoustic Imaging of the Ovary,RECRUITING,2020-02-09,2027-01-31,2027-01-31,INTERVENTIONAL,NA,310,['Ovary; Anomaly'],Ovary; Anomaly,Washington University School of Medicine,['National Cancer Institute (NCI)'],['United States']
NCT00410241,ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study,ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study,ACTIVE_NOT_RECRUITING,2007-01-05,,,OBSERVATIONAL,,1665,"['Healthy Volunteers', 'Atherosclerotic Heart Disease']",Healthy Volunteers,National Human Genome Research Institute (NHGRI),[],['United States']
NCT07254663,GEL & MEDication Dysphagia,Influence of Swallow Gel and Semi-solid Consistency on Medication Dysphagia: A Multicenter Observational Study,RECRUITING,2025-09-15,2027-09-15,2027-09-15,OBSERVATIONAL,,500,"['Neurological Diseases or Conditions', 'Healthy Participants']",Neurological Diseases or Conditions,"Heinrich-Heine University, Duesseldorf",[],['Germany']
NCT07255131,The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program,The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers in Comparison to Control Groups by the Hellenic Cystic Fibrosis Association A Randomized Controlled Trial,RECRUITING,2025-09-26,2028-12-20,2028-12-20,INTERVENTIONAL,NA,52,"['Depression - Major Depressive Disorder', 'Anxiety Chronic', 'Anxiety', 'Functional Outcome', 'Recovery', 'Obsessive Compulsive Disorders', 'Assertiveness']",Depression - Major Depressive Disorder,"Rakitzi, Stavroula",[],['Greece']
NCT07254988,Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders,Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders,RECRUITING,2023-03-24,2026-12,2026-12,INTERVENTIONAL,NA,8,"['Spinal Muscular Atrophy (SMA)', 'Cerebral Palsy (CP)', 'Duchenne Muscular Dystrophy (DMD)']",Spinal Muscular Atrophy (SMA),University of Copenhagen,[],['Denmark']
NCT07230197,The Efficacy and Safety of Pregabalin Combined With Dexmedetomidine in Patients With Fibromyalgia,Comparing the Efficacy and Safety of Pregabalin Monotherapy With Pregabalin Combined Dexmedetomidine in the Treatment of Fibromyalgia: A Multicenter Clinical Study,RECRUITING,2025-09-30,2027-06-30,2027-08-31,INTERVENTIONAL,NA,400,"['Fibromyalgia', 'Pregabalin', 'Dexmedetomidine']",Fibromyalgia,Beijing Tiantan Hospital,[],['China']
NCT05034627,Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer,"A Phase I, Open-Label, Dose Finding Study of Calaspargase Pegol-Mnkl in Combination With Cobimetinib in Locally-Advanced or Metastatic Pancreatic Cancer",ACTIVE_NOT_RECRUITING,2022-08-09,2025-12-16,2026-10-01,INTERVENTIONAL,PHASE1,15,"['Locally Advanced Pancreatic Adenocarcinoma', 'Metastatic Pancreatic Adenocarcinoma', 'Stage II Pancreatic Cancer AJCC v8', 'Stage IIA Pancreatic Cancer AJCC v8', 'Stage IIB Pancreatic Cancer AJCC v8', 'Stage III Pancreatic Cancer AJCC v8', 'Stage IV Pancreatic Cancer AJCC v8']",Locally Advanced Pancreatic Adenocarcinoma,OHSU Knight Cancer Institute,"['Oregon Health and Science University', 'Genentech, Inc.', 'Servier Pharmaceuticals, LLC']",['United States']
NCT06090669,Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency,Phase Ib Study of Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency,RECRUITING,2023-12-19,2026-10-30,2027-10-30,INTERVENTIONAL,PHASE1,75,"['Inherited Bone Marrow Failure Syndrome', 'Familial Platelet Disorder With Predisposition to Myeloid Malignancies']",Inherited Bone Marrow Failure Syndrome,National Cancer Institute (NCI),[],['United States']
NCT04849741,A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD),"A Phase 1-3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients With Alexander Disease",ACTIVE_NOT_RECRUITING,2021-06-01,2025-08-22,2029-09,INTERVENTIONAL,PHASE3,54,['Alexander Disease'],Alexander Disease,"Ionis Pharmaceuticals, Inc.",[],"['Israel', 'Japan', 'Netherlands', 'United States', 'Italy', 'Canada', 'United Kingdom', 'Australia']"
NCT06405607,Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial,Psilocybin vs Ketamine for Alcohol Use Disorder,RECRUITING,2025-06-12,2028-04,2028-04,INTERVENTIONAL,PHASE2,80,"['Alcohol Use Disorder', 'Alcohol Dependence', 'Alcohol Abuse']",Alcohol Use Disorder,University of Iowa,[],['United States']
NCT00397111,Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders,Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders,RECRUITING,2006-12-06,,,OBSERVATIONAL,,340,"['Mood Disorders', 'Anxiety Disorders']",Mood Disorders,National Institute of Mental Health (NIMH),[],['United States']
NCT06874452,"An Extension Test of Whether to Use Oral Anti-anxiety Drugs (XANAX) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction","Pain, Anxiety and Anesthetic Satisfaction for Patient With Different State Anxiety Underwent Cataract Surgery With Topical Anesthesia. An Extension Test of Whether to Use Oral Anti-anxiety Drugs (XANAX) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain Satisfaction",RECRUITING,2025-03-25,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE4,250,"['Ophthalmology', 'Cataract Surgery Anesthesia', 'Oral Anxiolytic', 'Satisfaction Survey']",Ophthalmology,National Taiwan University Hospital,[],['Taiwan']
NCT05946616,Spectral Characteristics of Memory Transformation,Probing Mechanisms of Procedural Memory Transformation With Cross-frequency Transcranial Alternating Current Stimulation (Cf-tACS) as an Avenue to Sculpt Sensorimotor Behavior,RECRUITING,2023-07-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,30,['Healthy'],Healthy,Medical University of South Carolina,[],['United States']
NCT06958536,A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease,"A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR442970 in Adults With Moderate to Severe Crohn's Disease",RECRUITING,2025-06-03,2026-12-17,2029-10-17,INTERVENTIONAL,PHASE2,99,"[""Crohn's Disease""]",Crohn's Disease,Sanofi,[],"['Belgium', 'Japan', 'China', 'United States', 'France', 'Germany', 'Spain', 'Czechia', 'United Kingdom', 'Poland', 'Australia']"
NCT07032493,Identifying the Limits of Survivability in Heat-exposed Older Females,Identifying the Upper Environmental Limits of Thermal Compensation in Older Human Females Using a Rapid Humidity Ramp Protocol,RECRUITING,2025-07-16,2026-01-31,2026-01-31,INTERVENTIONAL,NA,12,"['Heat Stress', 'Temperature Change, Body', 'Aging', 'Thermoregulation', 'Heat Exposure']",Heat Stress,University of Ottawa,[],['Canada']
NCT07254390,Effects of Trans-Auricular Vagal Stimulation on Neuromotor Recovery in Subacute Stroke During Technological and Traditional Training,Effects of Trans-Auricular Vagal Stimulation on Neuromotor Recovery Post-Stroke in the Subacute Phase During Training With the Khymeia Technological Device and Traditional Rehabilitation,RECRUITING,2025-01-08,2026-12-20,2027-04-03,INTERVENTIONAL,NA,48,['Stroke'],Stroke,Istituti Clinici Scientifici Maugeri SpA,[],['Italy']
NCT06401317,Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA),Comparison of the Efficacy of Intra-Articular Corticosteroid Injections Versus Saline Solution for Thumb Osteoarthritis: Double-Blind Pragmatic Randomized Pilot Study,RECRUITING,2025-11-04,2027-12-31,2028-12-31,INTERVENTIONAL,PHASE2,40,['Trapeziometacarpal Osteoarthritis'],Trapeziometacarpal Osteoarthritis,Université du Québec à Trois-Rivières,"[""Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal"", 'McGill University', 'Université de Montréal', ""Centre hospitalier de l'Université de Montréal (CHUM)"", ""Centre de Recherche du Centre Hospitalier de l'Université de Montréal""]",['Canada']
NCT07226960,Deprescribing in Outpatient Internal Medicine Practices,Deprescribing in Outpatient Internal Medicine Practices,RECRUITING,2025-11-12,2026-04,2026-04,INTERVENTIONAL,NA,100,['Deprescribing'],Deprescribing,Wake Forest University Health Sciences,[],['United States']
NCT06764160,"Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG","An Open-label, Single-arm, Multi-center Study to Evaluate the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Participants With Refractory Generalized Myasthenia Gravis (gMG)",ACTIVE_NOT_RECRUITING,2025-01-06,2025-12-19,2025-12-19,INTERVENTIONAL,PHASE3,15,"['Generalized Myasthenia Gravis (gMG)', 'Refractory gMG']",Generalized Myasthenia Gravis (gMG),"Alexion Pharmaceuticals, Inc.",[],['China']
NCT04557969,"Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis","Prospective Study of Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis",RECRUITING,2020-12-18,2040-12-30,2040-12-30,OBSERVATIONAL,,400,"['Gastric Cancer', 'Gastric Neoplasm', 'Gastrointestinal Stromal Sarcoma', 'Gastrointestinal Stromal Neoplasm', 'Gastrointestinal Stromal Tumor (GIST)']",Gastric Cancer,National Cancer Institute (NCI),[],['United States']
NCT07254247,A Unique Body-Powered Terminal Device With Enhanced Grasping Capabilities for Individuals With Upper Limb Loss,A Unique Body-Powered Terminal Device With Enhanced Grasping Capabilities for Individuals With Upper Limb Loss,RECRUITING,2025-11-20,2026-01,2026-01,INTERVENTIONAL,NA,8,['Amputation'],Amputation,"Little Room Innovations, LLC",['University of Michigan'],['United States']
NCT07211633,"A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)","A Phase 3, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab Versus Intravenous Ublituximab in Patients With Multiple Sclerosis",RECRUITING,2025-07-09,2026-12-31,2028-12-31,INTERVENTIONAL,PHASE3,360,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,"TG Therapeutics, Inc.",[],"['Bulgaria', 'Hungary', 'North Macedonia', 'Georgia', 'Croatia', 'Bosnia and Herzegovina', 'Czechia', 'Ukraine']"
NCT05063565,TheraSphere With Durvalumab and Tremelimumab for HCC,"An Open-Label, Prospective, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of TheraSphere™ Followed by Durvalumab (Imfinzi®) With Tremelimumab (Imjudo®) for Hepatocellular Carcinoma (HCC)",ACTIVE_NOT_RECRUITING,2023-11-03,2027-06,2027-06,INTERVENTIONAL,PHASE2,100,['Hepatocellular Carcinoma'],Hepatocellular Carcinoma,Boston Scientific Corporation,['Biocompatibles UK Ltd'],"['United States', 'France', 'Switzerland', 'Spain', 'Italy']"
NCT06472934,Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement (B-TAVR),Impact of Beta-blocker Administration on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement B-TAVR,RECRUITING,2024-07-04,2028-05,2028-05,INTERVENTIONAL,NA,498,['Aortic Stenosis'],Aortic Stenosis,"University Hospital, Basel, Switzerland",[],"['Switzerland', 'Austria', 'Germany']"
NCT07189507,Suitability of the 26 °C Indoor Temperature Upper Limit for Older Adults: Impacts of Clothing and Daily Activity,Evaluation of the 26 °C Indoor Temperature Upper Limit Considering Clothing Insulation and Daily Activity in Older Adults,RECRUITING,2025-09-23,2026-09-30,2027-03-31,INTERVENTIONAL,NA,10,"['Heat Stress', 'Physiological Stress']",Heat Stress,University of Ottawa,[],['Canada']
NCT05326399,Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment,"Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment: a Single-center, Prospective Cohort Study",RECRUITING,2022-06-01,2027-05-31,2030-12-31,OBSERVATIONAL,,369,"['Liver Transplantation', 'Renal Insufficiency, Chronic']",Liver Transplantation,RenJi Hospital,[],['China']
NCT07228858,Uterine Scar Resection During Repeat Cesarean Delivery to Prevent Uterine Niche Formation,Uterine Scar Resection During Repeat Cesarean Delivery in a Simple Modification to Prevent Uterine Niche Formation: Results of a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-02-09,2025-05-30,2025-11-30,INTERVENTIONAL,NA,170,"['Cesarean Section Complications', 'Scar Niche', 'Scarred Uterus']",Cesarean Section Complications,Benha University,[],['Egypt']
NCT00001471,Tissue Biopsy and Imaging Studies in HIV-Infected Patients,"Virologic and Immunologic Evaluation of Lymph Node, Tonsillar and Intestinal Biopsies, and Bronchoalveolar Lavage Fluid",RECRUITING,1994-11-30,,,OBSERVATIONAL,,635,"['HIV', 'ICL', 'Healthy Volunteers']",HIV,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07172204,Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML,"The Efficacy and Safety of VA Alternating With Low-dose CHA in the Treatment of Newly Diagnosed Unfit AML: a Prospective, Multi-centers, Single Arm Phase II Study",RECRUITING,2025-09-16,2027-07-31,2029-07-31,INTERVENTIONAL,PHASE2,25,"['Intensive Chemotherapy Unfit', 'Newly Diagnosed Acute Myeloid Leukemia (AML)', 'Age ≥60']",Intensive Chemotherapy Unfit,First Affiliated Hospital of Zhejiang University,['AbbVie'],['China']
NCT07254715,Effect of Itopride on Semaglutide Gastroparesis,Does Itopride Improve Semaglutide Induced Gastroparesis Ultrasound Before Anesthesia? Randomized Controlled Trial,RECRUITING,2025-12,2026-04,2026-04,INTERVENTIONAL,PHASE4,60,"['Semaglutide-Induced Gastric Motility', 'Anesthesia']",Semaglutide-Induced Gastric Motility,Ain Shams University,[],['Egypt']
NCT07255105,Epidemiological Investigation of Central Venous Catheter-related Bloodstream Infections in Icus in China,The First Phase of the Closed-loop Improvement Project for Preventing CLABSI,RECRUITING,2025-06-08,2026-01-31,2026-09-30,OBSERVATIONAL,,1846,['CLABSI - Central Line Associated Bloodstream Infection'],CLABSI - Central Line Associated Bloodstream Infection,Jianfeng Xie,[],['China']
NCT04461639,Study to Learn More About the Safety of Drug Jivi Over a Long Period of Time in Previously Treated Patients With Hemophilia A (Bleeding Disorder Resulting From a Lack of FVIII) Who Are Receiving Jivi Regularly at Their Treating Doctors to Prevent Bleeding,Observational Study Evaluating Long-term Safety of Real-world Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A,ACTIVE_NOT_RECRUITING,2021-05-14,2028-06-30,2028-06-30,OBSERVATIONAL,,62,['Hemophilia A'],Hemophilia A,Bayer,[],"['Slovenia', 'Austria', 'Spain', 'Italy', 'Greece', 'Germany']"
NCT07253051,BRCA Mutation Carriers' Platform a Multicenter Study,"BRCA Mutation Carriers' Platform, a Multicenter Study",RECRUITING,2025-04-05,2045-04-01,2045-12-31,OBSERVATIONAL,,10000,"['BRCA1 Mutation', 'BRCA2 Mutation']",BRCA1 Mutation,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,[],['Italy']
NCT07254403,Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method,Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method,RECRUITING,2025-10-31,2026-12,2026-12,INTERVENTIONAL,NA,60,['Protein Metabolism'],Protein Metabolism,Texas A&M University,[],['United States']
NCT03799354,Study on Impact of Maximal Strength Training in Patients With COPD,Study on Impact of Maximal Strength Training in Patients With COPD: Physiological and Clinical Implications,RECRUITING,2019-09-18,2025-12-30,2026-03-30,INTERVENTIONAL,NA,20,['Chronic Obstructive Pulmonary Disease'],Chronic Obstructive Pulmonary Disease,Istituti Clinici Scientifici Maugeri SpA,['Universita di Verona'],['Italy']
NCT05935995,Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination,Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination (Pilot Study),ACTIVE_NOT_RECRUITING,2023-11-28,2025-06-21,2026-03,INTERVENTIONAL,NA,42,"['Squamous Cell Carcinoma of Head and Neck', 'Basal Cell Carcinoma of Skin']",Squamous Cell Carcinoma of Head and Neck,Institut de Cancérologie de Lorraine,[],['France']
NCT01737619,PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer,Prospective Evaluation of Lymph Node Metastasis at the Time of Surgical Staging for High Risk Endometrial Cancer,ACTIVE_NOT_RECRUITING,2013-04-03,2025-04-30,2025-12-31,INTERVENTIONAL,NA,101,"['Endometrial Clear Cell Adenocarcinoma', 'Endometrial Mixed Adenocarcinoma', 'Endometrial Serous Adenocarcinoma', 'Grade 3 Endometrial Endometrioid Adenocarcinoma', 'Malignant Mixed Mesodermal (Mullerian) Tumor']",Endometrial Clear Cell Adenocarcinoma,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT06551038,Evaluating Primary Suicide Prevention in Adolescents With Risk Factors,Evaluating Primary Suicide Prevention in Adolescents With Risk Factors,RECRUITING,2025-03-11,2027-05-30,2028-09-30,INTERVENTIONAL,NA,240,['Suicide Prevention'],Suicide Prevention,Stephanie Baggio,[],['Switzerland']
NCT07254000,Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants,Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants,RECRUITING,2025-06-27,2026-06,2026-12,INTERVENTIONAL,PHASE2,24,"['Premature Infants', 'Very Premature Infants', 'Inflammation']",Premature Infants,Monash Medical Centre,"['Monash University', 'Hudson Institute of Medical Research', 'Liggins Institute', ""Starship Children's Hospital of New Zealand""]","['New Zealand', 'Australia']"
NCT05936034,Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.,Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.,RECRUITING,2024-01-04,2027-09-04,2028-07-04,INTERVENTIONAL,NA,52,"['Cancer', 'Ototoxicity, Drug-Induced', 'Quality of Life', 'Hearing Disorders']",Cancer,Institut de Cancérologie de Lorraine,[],['France']
NCT06274801,Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT),An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Seralutinib Orally Inhaled for the Treatment of Pulmonary Arterial Hypertension (PAH),RECRUITING,2024-09-03,2026-12,2026-12,INTERVENTIONAL,PHASE3,300,['Pulmonary Arterial Hypertension'],Pulmonary Arterial Hypertension,"GB002, Inc.",[],"['Japan', 'Netherlands', 'Saudi Arabia', 'Lithuania', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Denmark', 'South Korea', 'Colombia', 'Czechia', 'Poland', 'Singapore', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Latvia', 'Greece', 'Portugal', 'Germany', 'Brazil', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT05660642,"An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression","An Open-Label, Phase 2a Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression",RECRUITING,2023-02-10,2026-11,2026-11,INTERVENTIONAL,PHASE2,64,['Treatment Resistant Depression'],Treatment Resistant Depression,Beckley Psytech Limited,[],['United Kingdom']
NCT05232929,Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA),Long-term Follow-up Study of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment,ACTIVE_NOT_RECRUITING,2022-03-29,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE4,402,['Spinal Muscular Atrophy'],Spinal Muscular Atrophy,"Genentech, Inc.",[],"['Puerto Rico', 'United States']"
NCT07241429,Kinesiophobia and Balance in Stroke Patients,"Kinesiophobia, Balance Performance, Fear of Falling, and Related Factors in Stroke Patients",RECRUITING,2025-11-15,2025-12-15,2025-12-31,OBSERVATIONAL,,138,['Stroke'],Stroke,Istanbul Physical Medicine Rehabilitation Training and Research Hospital,[],['Turkey (Türkiye)']
NCT05826535,Study of LYL314 in Aggressive Large B-Cell Lymphoma,"A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of LYL314, a CD19/CD20 Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy in Participants With Aggressive B-Cell Non-Hodgkin Lymphoma",RECRUITING,2023-05-09,2028-12-31,2031-06-30,INTERVENTIONAL,PHASE1,270,"['Relapsed Non-Hodgkin Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Non-Hodgkin Lymphoma', 'Large B-cell Lymphoma']",Relapsed Non-Hodgkin Lymphoma,"Lyell Immunopharma, Inc.",[],['United States']
NCT05776888,Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years,Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years- A Non-interventional Observational Study,ACTIVE_NOT_RECRUITING,2023-07-10,2027-03-31,2027-03-31,OBSERVATIONAL,,106,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,Novartis Pharmaceuticals,[],['Austria']
NCT05789082,"A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation","A Phase Ib/II, Open-Label, Multicenter Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients With Previously Untreated Advanced Or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation",RECRUITING,2023-06-20,2032-01-29,2032-01-29,INTERVENTIONAL,PHASE1,320,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Hoffmann-La Roche,[],"['Brazil', 'Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'United States', 'Switzerland', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Sweden', 'Australia']"
NCT05331625,Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care,Understanding Quality of Life Among Patients With Cancer Receiving Palliative Care,ACTIVE_NOT_RECRUITING,2022-11-03,2026-08,2026-08,INTERVENTIONAL,NA,208,['Cancer'],Cancer,Abramson Cancer Center at Penn Medicine,[],['United States']
NCT07243262,Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2),Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2),RECRUITING,2025-10-21,2028-08-01,2028-08-01,OBSERVATIONAL,,6079,"['Pancreatic Cancer', 'PDAC - Pancreatic Ductal Adenocarcinoma']",Pancreatic Cancer,Imperial College London,"['Pancreatic Cancer UK', 'Imperial College Healthcare NHS Trust', 'Royal Free Hospital NHS Foundation Trust', 'Liverpool University Hospitals NHS Foundation Trust', 'Newcastle-upon-Tyne Hospitals NHS Trust', 'University Hospital Southampton NHS Foundation Trust', 'Sherwood Forest Hospitals NHS Foundation Trust', 'Dorset County Hospital NHS Foundation Trust', 'Buckinghamshire Healthcare NHS Trust']",['United Kingdom']
NCT06659705,Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI),Cutting Edge Imaging for Earlier Pancreatic Cancer Diagnosis: Evaluation of Positron Emission Tomography (PET) With the Fibroblast Activation Protein Inhibitor (FAPI),RECRUITING,2025-10-17,2029-01-30,2030-01-30,INTERVENTIONAL,PHASE2,35,['Pancreatic Ductal Adenocarcinoma (PDAC)'],Pancreatic Ductal Adenocarcinoma (PDAC),Institut Curie,[],['France']
NCT06895343,"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous or Intravenous Doses of ABBV-701 in Healthy Adult Western and Asian Participants","A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Doses of ABBV-701 in Healthy Adult Western and Asian Subjects",RECRUITING,2025-04-03,2026-10,2026-10,INTERVENTIONAL,PHASE1,100,['Healthy Volunteer'],Healthy Volunteer,AbbVie,[],['United States']
NCT05891171,Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers,A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies,ACTIVE_NOT_RECRUITING,2023-10-13,2026-03,2026-03,INTERVENTIONAL,PHASE1,40,"['Advanced Cancer', 'Advanced Malignancies', 'Bladder Cancer', 'Cervical Cancer', 'Esophageal Cancer', 'Gastric Cancer', 'Gastroesophageal-junction Cancer (GEJ)', 'Head and Neck Squamous Cell Carcinoma (HNSCC)', 'Non-Small Cell Lung Cancer (NSCLC)', 'Ovarian Cancer', 'Renal Cell Carcinoma (RCC)', 'Triple Negative Breast Cancer (TNBC)']",Advanced Cancer,"Arcus Biosciences, Inc.",[],"['Taiwan', 'United States', 'Australia']"
NCT04570423,A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy,"A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy",RECRUITING,2021-05-20,2027-10,2027-10,INTERVENTIONAL,PHASE2,40,"['Solid Tumors', 'Lymphoma']",Solid Tumors,"Spectrum Pharmaceuticals, Inc",[],['United States']
NCT05381597,5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer,Combination of 5-Fluorouracil and Calcipotriene in the Treatment of Superficial Basal Cell Carcinomas and Squamous Cell Carcinomas in Situ,RECRUITING,2022-10-15,2027-06,2027-06,INTERVENTIONAL,PHASE2,200,"['Superficial Basal Cell Carcinoma', 'Squamous Cell Carcinoma in Situ']",Superficial Basal Cell Carcinoma,Boston University,[],['United States']
NCT06136819,RT-310 Dose Escalation BPH Study,Safety and Feasibility Dose Escalation Study for Evaluation of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH),ACTIVE_NOT_RECRUITING,2024-04-19,2025-12,2027-12,INTERVENTIONAL,PHASE1,20,"['BPH (Benign Prostatic Hyperplasia)', 'Lower Urinary Tract Symptoms']",BPH (Benign Prostatic Hyperplasia),Resurge Therapeutics Inc.,[],"['New Zealand', 'Australia']"
NCT00018057,Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders,Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders,RECRUITING,2001-10-02,2029-01-01,2029-01-01,INTERVENTIONAL,PHASE2,2530,"['Anxiety Disorders', 'Major Depressive Disorder']",Anxiety Disorders,National Institute of Mental Health (NIMH),"['University of Minnesota', 'University of Oregon', 'University of Maryland']",['United States']
NCT06663787,Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Who Achieved Durable Response by Anti-HER2 Treatment (HER2 CR),Personalized Detection of ctDNA for Patients With HER2-Positive Metastatic Breast Cancer Who Achieved Durable Response by Anti-HER2 Treatment (HER2 CR),ACTIVE_NOT_RECRUITING,2024-04-01,2025-12-31,2025-12-31,OBSERVATIONAL,,50,"['Breast Cancer, Metastatic', 'HER2 + Breast Cancer']","Breast Cancer, Metastatic",Nagoya City University,[],"['Japan', 'United States']"
NCT07226219,Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease,Pilot Trial of Stimulant Treatment to Address Attention and Executive Deficits Among Children With Sickle Cell Disease,RECRUITING,2025-11-25,2027-07,2028-08,INTERVENTIONAL,PHASE1,72,"['Sickle Cell Disease', 'Executive Dysfunction', 'Cognitive Impairment', 'Attention Deficit/Hyperactivity Disorder (ADHD)']",Sickle Cell Disease,St. Jude Children's Research Hospital,[],['United States']
NCT05883644,Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC),"A Phase IIIb Single Arm, Open-label, Multicentre Study of Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (SIERRA)",ACTIVE_NOT_RECRUITING,2023-06-27,2025-12-31,2026-03-31,INTERVENTIONAL,PHASE3,111,['Advanced Hepatocellular Carcinoma'],Advanced Hepatocellular Carcinoma,AstraZeneca,[],"['Singapore', 'Japan', 'Hong Kong', 'United States', 'France', 'Spain', 'Italy', 'South Korea', 'Vietnam', 'Germany']"
NCT07253064,Study Comparing Eye Growth Over Time in Children Using Two Myopia Control Lenses,"A Monocentre, Randomized, Contralateral Trial to Study the Effect of Temporal Changes in Ocular Biometry of Two Myopia Control Lenses",RECRUITING,2025-11-11,2026-09,2026-09,INTERVENTIONAL,NA,20,['Myopia'],Myopia,Essilor International,[],['Singapore']
NCT06238700,Study on Allopregnanolone and Depression in Women Across the Menopause Transition,Targeting Allopregnanolone to Probe Behavioral and Neurobiological Mechanisms That Underlie Depression in Women Across the Menopause Transition,RECRUITING,2024-05-14,2027-07-31,2027-08-31,INTERVENTIONAL,NA,80,['Depression'],Depression,Brigham and Women's Hospital,[],['United States']
NCT06626516,Tebentafusp-tebn With LDT in Metastatic UM,A Phase I/II Study of Tebentafusp-tebn in Combination With Liver-Directed Therapies for the Treatment of Metastatic Uveal Melanoma,RECRUITING,2025-10-15,2030-10,2032-08,INTERVENTIONAL,PHASE1,109,['Metastatic Uveal Melanoma'],Metastatic Uveal Melanoma,Thomas Jefferson University,['Sidney Kimmel Cancer Center at Thomas Jefferson University'],['United States']
NCT06018181,Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice,Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice: A Patient Registry,RECRUITING,2023-09-28,2025-12-31,2025-12-31,OBSERVATIONAL,,2008,"['Ischemic Stroke, Acute']","Ischemic Stroke, Acute","Dongzhimen Hospital, Beijing",[],['China']
NCT05411614,Hybrid Ablation of Atrial Fibrillation in Heart Failure,A Randomised Controlled Trial Comparing Convergent Hybrid Ablation to Catheter Ablation in Patients With Persistent Atrial Fibrillation and Heart Failure,RECRUITING,2022-06-25,2026-05,2027-10,INTERVENTIONAL,NA,120,"['Persistent Atrial Fibrillation', 'Atrial Fibrillation, Persistent', 'Atrial Arrhythmia', 'Atrial Fibrillation', 'Heart Failure', 'Left Ventricular (LV) Systolic Dysfunction']",Persistent Atrial Fibrillation,"St. George's Hospital, London",[],['United Kingdom']
NCT06517979,Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis,Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis,RECRUITING,2024-07-26,2027-06-30,2027-06-30,OBSERVATIONAL,,10000,"['Cancer', 'Lymphatic Metastasis']",Cancer,Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University,[],['China']
NCT07101874,A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients,A Retrospective Study of Biliary Complications and Treatment Duration in Patients With Biliary Tract Cancer Receiving Systemic Therapy in Japan,RECRUITING,2025-08-22,2026-02-28,2026-02-28,OBSERVATIONAL,,1000,['Biliary Tract Cancer'],Biliary Tract Cancer,AstraZeneca,['Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)'],['Japan']
NCT07253090,EUS-PPG Alteration After Ligation and Sclerotherapy in Esophageal Varices,The Comparative Study on the Alteration of Endoscopic Ultrasound Guided Portal Pressure Gradient in Esophageal Varices After Ligation and Sclerotherapy,RECRUITING,2025-08-18,2026-12-31,2026-12-31,INTERVENTIONAL,NA,70,['Esophagogastric Varices'],Esophagogastric Varices,"Second Affiliated Hospital, School of Medicine, Zhejiang University",[],['China']
NCT06111586,FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS),"A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2b Study With a 52-week Blinded Extension and an Optional Open-label Extension - Assessing Safety and Efficacy of Frexalimab, a CD40L-antagonist Monoclonal Antibody, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Newly Diagnosed Type 1 Diabetes on Insulin Therapy",RECRUITING,2023-12-11,2027-04-30,2031-08-11,INTERVENTIONAL,PHASE2,192,['Type 1 Diabetes Mellitus'],Type 1 Diabetes Mellitus,Sanofi,[],"['Belgium', 'Hungary', 'Austria', 'United States', 'France', 'Slovenia', 'Finland', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT02815891,A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD),A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD),RECRUITING,2016-07,2036-07,2036-07,OBSERVATIONAL,,15000,"['Nonalcoholic Fatty Liver', 'Nonalcoholic Steatohepatitis']",Nonalcoholic Fatty Liver,"Target PharmaSolutions, Inc.",[],"['Spain', 'United States', 'Germany']"
NCT07254572,Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes,"A Randomized, Open-label, Clinical Trial Evaluating the Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes",RECRUITING,2025-07-10,2029-08-01,2029-08-01,INTERVENTIONAL,PHASE4,300,"['Coronary Artery Disease', 'PreDiabetes']",Coronary Artery Disease,"National Institute of Cardiology, Warsaw, Poland","['Medical Research Agency, Poland']",['Poland']
NCT06168851,Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP),"A Prospective, One-arm and Open Clinical Study to Assess Safety and Efficacy of Anti-CD38 Antibody in the Treatment of Pediatric Primary Immune Thrombocytopenia",RECRUITING,2023-12-28,2025-12,2030-12,INTERVENTIONAL,PHASE2,60,"['Immune Thrombocytopenia', 'Treatment']",Immune Thrombocytopenia,"Institute of Hematology & Blood Diseases Hospital, China","[""Beijing Children's Hospital"", ""Tianjin Children's Hospital""]",['China']
NCT05513300,HIIT vs. MICT Training Study,Physiological and Molecular Effects of High-intensity Interval Training (HIIT) vs. Moderate-intensity Continuous Training (MICT),ACTIVE_NOT_RECRUITING,2023-01-10,2025-08-11,2026-08,INTERVENTIONAL,NA,135,"['Lifestyle', 'Sedentary']",Lifestyle,Stanford University,[],['United States']
NCT07253402,Microbiota-guided Radiotherapy for Head and Neck Cancer,MIcrobiota-Guided RAdiotherapy for Head and Neck Cancer. (MIGRHAN),RECRUITING,2025-10-15,2031-10-30,2031-10-30,OBSERVATIONAL,,100,['Head and Neck Cancer'],Head and Neck Cancer,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",[],['Italy']
NCT05723107,EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC),Phase I Pilot Study of Endoscopic Ultrasound Guided RFA in Advanced Pancreatic Cancer,RECRUITING,2023-03-31,2027-11,2028-03,INTERVENTIONAL,PHASE1,15,['Pancreatic Cancer'],Pancreatic Cancer,NYU Langone Health,['Taewoong Medical'],['United States']
NCT07241936,A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors,A Phase Ib/II Clinical Trial on the Safety and Efficacy of Sirolimus (Albumin-bound) Combined With Different ADCs in Patients With Advanced Solid Tumors,RECRUITING,2025-11-13,2027-10-30,2028-10-30,INTERVENTIONAL,PHASE1,444,['Advanced Solid Tumors'],Advanced Solid Tumors,"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",[],['China']
NCT07083271,Financial Toxicity and Quality of Life in Hospitalized Cancer Patients: A Multicenter Study,"Evaluation of Financial Toxicity, Caregiver Burden, and Quality of Life in Hospitalized Cancer Patients: A Multicenter Cross-Sectional Observational Study",RECRUITING,2025-08-01,2025-10-22,2026-01-15,OBSERVATIONAL,,130,"['Financial Toxicity', 'Cancer Patients']",Financial Toxicity,Ankara Etlik City Hospital,"['Gazi University', 'Kocaeli University']",['Turkey (Türkiye)']
NCT02048813,"Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)",ACTIVE_NOT_RECRUITING,2014-03-10,2018-10-24,2026-10-09,INTERVENTIONAL,PHASE3,529,"['Anemia', 'Chronic Lymphocytic Leukemia', 'Small Lymphocytic Lymphoma']",Anemia,National Cancer Institute (NCI),[],['United States']
NCT07215078,Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Participants,"A PHASE 1, OPEN-LABEL, TWO-PERIOD, CROSS-OVER STUDY TO EVALUATE DOSE PROPORTIONALITY OF ATIRMOCICLIB (PF-07220060) PHARMACOKINETICS WHEN ADMINISTERED UNDER FED CONDITIONS TO HEALTHY PARTICIPANTS",RECRUITING,2025-10-08,2026-06-03,2026-06-26,INTERVENTIONAL,PHASE1,72,['Healthy Volunteer'],Healthy Volunteer,Pfizer,[],['United States']
NCT07123155,Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD),"A Phase 2, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Investigate the Safety, Pharmacodynamics, and Preliminary Efficacy of S-606001 as an Add-on to Enzyme Replacement Therapy in Patients With Late-onset Pompe Disease",RECRUITING,2025-10-30,2027-08-08,2027-08-08,INTERVENTIONAL,PHASE2,45,['Pompe Disease'],Pompe Disease,Shionogi,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'United Kingdom', 'Germany']"
NCT04250155,An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors,"A Phase Ia/Ib, Open-Label, Multicenter, Global, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of XmAb24306 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors",ACTIVE_NOT_RECRUITING,2020-03-09,2026-12-15,2026-12-15,INTERVENTIONAL,PHASE1,195,['Solid Tumors'],Solid Tumors,"Genentech, Inc.",[],"['Brazil', 'Belgium', 'Netherlands', 'United States', 'Spain', 'Italy', 'Canada', 'South Korea', 'Australia']"
NCT06861244,Embryonal Tumor With Multilayered Rosettes,PNOC031: Protocol for Embryonal Tumor With Multilayered Rosettes (ETMR),RECRUITING,2025-03-06,2030-09-30,2032-03-31,INTERVENTIONAL,PHASE2,70,"['Embryonal Tumor With Multilayered Rosettes', 'Embryonal Tumor With Multilayered Rosettes, Nos']",Embryonal Tumor With Multilayered Rosettes,"University of California, San Francisco","['Pediatric Neuro-Oncology Consortium', ""Solving Kids' Cancer""]",['United States']
NCT05098132,Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers,A Phase 1/2 Study to Evaluate STK-012 as a Single Agent and in Combination Therapy in Subjects With Front-line Advanced NSCLC and Other Selected Indications,RECRUITING,2022-01-25,2029-01,2029-01,INTERVENTIONAL,PHASE1,364,"['Advanced Solid Tumor', 'Non Small Cell Lung Cancer', 'Untreated Advanced NSCLC', '1st Line NSCLC']",Advanced Solid Tumor,Synthekine,[],['United States']
NCT06356831,National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis,National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis,RECRUITING,2024-06-15,2027-07-31,2028-01-31,OBSERVATIONAL,,300,"['Endometriosis', 'Cryotherapy Effect', 'Surgical', 'Radiology']",Endometriosis,Centre Hospitalier Intercommunal Creteil,[],['France']
NCT06742931,Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2,Discontinuation of Antiplatelet Agent After Drug-Coated Balloon Angioplasty in Stabilized Patients With High Bleeding Risk and Coronary Artery Disease,RECRUITING,2025-04-07,2029-12-31,2031-12-31,INTERVENTIONAL,NA,1200,['Chronic Coronary Syndrome'],Chronic Coronary Syndrome,Samsung Medical Center,['Chonnam National University Hospital'],['South Korea']
NCT07253701,EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE,EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE,RECRUITING,2024-02-27,2028-03,2028-03,OBSERVATIONAL,,1500,"['Epilepsy', 'Microbiota', 'Proteomics', 'Metabolomics', 'Biomarker Discovery']",Epilepsy,Karolinska Institutet,[],['Sweden']
NCT05751434,A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer,Phase 2 Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer,ACTIVE_NOT_RECRUITING,2023-02-10,2027-02-10,2027-02-10,INTERVENTIONAL,PHASE2,36,"['Prostate Cancer', 'Prostate Adenocarcinoma', 'Localized Prostate Carcinoma']",Prostate Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT04566991,Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH),Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (DISH),RECRUITING,2022-03-20,2027-10,2027-10,INTERVENTIONAL,PHASE2,120,['Aneurysmal Subarachnoid Hemorrhage'],Aneurysmal Subarachnoid Hemorrhage,"Aditya S. Pandey, MD",[],['United States']
NCT07105059,A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma,Teclistamab and Mezigdomide for Relapsed/Refractory Multiple Myeloma,RECRUITING,2025-08-08,2028-08-08,2028-08-08,INTERVENTIONAL,PHASE1,18,['Multiple Myeloma'],Multiple Myeloma,Memorial Sloan Kettering Cancer Center,"['Bristol-Myers Squibb', 'Johnson & Johnson']",['United States']
NCT05144256,"A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Regularly Transfused, Followed by a 5-Year Extension Period","A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Subjects With Pyruvate Kinase Deficiency Who Are Regularly Transfused, Followed by a 5-Year Open-label Extension Period",ACTIVE_NOT_RECRUITING,2022-06-08,2024-05-03,2029-06,INTERVENTIONAL,PHASE3,49,"['Pediatric Pyruvate Kinase Deficiency', 'Pediatric Hemolytic Anemia']",Pediatric Pyruvate Kinase Deficiency,"Agios Pharmaceuticals, Inc.",[],"['Turkey (Türkiye)', 'Netherlands', 'United States', 'Switzerland', 'Denmark', 'Spain', 'Canada', 'Czechia', 'United Kingdom', 'Germany']"
NCT05084196,Melatonin for Prevention of Kidney Injury,Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury,RECRUITING,2023-06-05,2027-06-01,2027-12-31,INTERVENTIONAL,PHASE3,300,"['Acute Kidney Injury', 'Adverse Drug Event']",Acute Kidney Injury,"Rutgers, The State University of New Jersey",[],['United States']
NCT06766656,Comparison of Transverse and Longitudinal Incisions for Venous Access Port Placement,Comparison of Transverse and Longitudinal Incisions for Venous Access Port Placement,RECRUITING,2025-02-01,2025-12-31,2026-01,INTERVENTIONAL,NA,200,"['Central Venous Access Devices', 'Implantable Venous Access Port']",Central Venous Access Devices,Jagiellonian University,[],['Poland']
NCT07254754,Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma,"LATE-R Trial. A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma",RECRUITING,2024-11-20,2027-01-31,2031-12-31,INTERVENTIONAL,PHASE2,45,['DIFFUSE LARGE B-CELL LYMPHOMA'],DIFFUSE LARGE B-CELL LYMPHOMA,Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea,"['Kite, A Gilead Company', 'Evidenze Health España (CRO)']",['Spain']
NCT01005654,Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms,Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms,RECRUITING,2009-10-07,,,OBSERVATIONAL,,2415,"['Endocrine Tumors', 'Thyroid Neoplasms', 'Parathyroid Neoplasms', 'Adrenal Neoplasm', 'Neuroblastoma']",Endocrine Tumors,National Cancer Institute (NCI),[],['United States']
NCT07254494,Guided Bone Regeneration in Lower Posterior Edentulous Arch Using Resorbable or Non Resorbable Membrane.,Comparative Evaluation of Resorbable (Pericardium) Versus Non Resorbable (Polytetrafluoroethylene) Membrane for Horizontal Bone Augmentation of Posterior Atrophic Mandible,RECRUITING,2026-05,2026-12,2026-12,INTERVENTIONAL,NA,30,"['Horizontal Alveolar Bone Defect', 'Guided Bone Regeneration']",Horizontal Alveolar Bone Defect,Beirut Arab University,[],['Lebanon']
NCT04584983,Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration,Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration,ACTIVE_NOT_RECRUITING,2021-02-11,2024-03-14,2026-06-14,INTERVENTIONAL,PHASE2,134,['Bilirubin Encephalopathy'],Bilirubin Encephalopathy,"The University of Texas Health Science Center, Houston",['National Center for Advancing Translational Sciences (NCATS)'],['United States']
NCT06762496,A New Tool to Promote Patient's Engagement in Their Healthcare Process,Development and Testing of a Patient's Decision Aid for Early Breast Cancer: a New Tool to Promote Patient's Engagement in Their Healthcare Process,RECRUITING,2025-01-22,2027-01,2027-01,OBSERVATIONAL,,180,"['Breast Carcinoma', 'Breast Cancer Stage I', 'Breast Cancer Stage II']",Breast Carcinoma,European Institute of Oncology,[],['Italy']
NCT07252999,Comparison of Outcomes of Hernia Sac Transection and Sac Reduction in Open Pediatric Inguinal Hernia Repair in Ramathibodi Hospital,Transection Versus Reduction of Hernia Sac in Open Pediatric Inguinal Hernia Repair: A Randomized Controlled Trial Study,RECRUITING,2025-10-31,2027-05-31,2027-12-31,INTERVENTIONAL,NA,40,['Inguinal Hernia Repair'],Inguinal Hernia Repair,Piyanuch Lormuangthong,['Ramathibodi Hospital'],['Thailand']
NCT06073574,CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study,The CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study,ACTIVE_NOT_RECRUITING,2021-03-31,2026-03,2026-04,OBSERVATIONAL,,150,['Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)'],Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM),"Ionis Pharmaceuticals, Inc.",['AstraZeneca'],"['United Kingdom', 'Spain', 'United States', 'Italy']"
NCT06528691,Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors,PHASE 2 Study of Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors (GLOBOTRK),RECRUITING,2026-01,2027-11,2032-11,INTERVENTIONAL,PHASE2,52,"['High Grade Glioma', 'CNS Tumor']",High Grade Glioma,St. Jude Children's Research Hospital,['Hoffmann-La Roche'],['United States']
NCT07233889,Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for the Treatment of Hypophosphatemia.,A Prospective Clinical Study Evaluating the Effectiveness and Safety of Enteral Supplementation With Sodium Dihydrogen Phosphate and Disodium Hydrogen Phosphate Granules for Varying Degrees of Hypophosphatemia,RECRUITING,2025-11-21,2026-05-31,2026-06-30,INTERVENTIONAL,NA,60,['Hypophosphatemia'],Hypophosphatemia,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",[],['China']
NCT06946550,Non-Ablative Laser to Treat Scarring Alopecia With Hair Follicle Gene Expression Analysis,1470 nm Non-Ablative Laser for the Treatment of Scarring Alopecia: A Clinical and Mechanistic Study,RECRUITING,2025-12,2027-12,2027-12,INTERVENTIONAL,NA,5,['Scarring Alopecia'],Scarring Alopecia,Montefiore Medical Center,"['Sciton', 'American Society for Laser Surgery and Medicine']",['United States']
NCT06767735,A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM),A Phase III Clinical Study Comparing the Efficacy and Safety of GZR4 QW Versus Insulin Glargine U100 QD+ Non-Insulin Antidiabetic Agents in Insulin-naive Subjects With Type 2 Diabetes Mellitus,ACTIVE_NOT_RECRUITING,2025-02-17,2026-08-01,2026-08-17,INTERVENTIONAL,PHASE3,580,['Diabetes'],Diabetes,Gan & Lee Pharmaceuticals.,[],['China']
NCT07199803,OBS-QoR-10 in Patients With and Without Postpartum Hemorrhage,Comparing the Obstetric Quality of Recovery-10 (OBS-QoR-10) in Patients With and Without Postpartum Hemorrhage: A Matched Case-control Study,RECRUITING,2025-10-03,2026-07,2026-07,OBSERVATIONAL,,152,['Postpartum Hemorrhage (Primary)'],Postpartum Hemorrhage (Primary),"Samuel Lunenfeld Research Institute, Mount Sinai Hospital",[],['Canada']
NCT04318717,Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma,Adjuvant Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma,RECRUITING,2020-05-29,2030-07-31,2032-07-31,INTERVENTIONAL,PHASE2,19,['Mucosal Melanoma of the Head and Neck'],Mucosal Melanoma of the Head and Neck,Washington University School of Medicine,[],['United States']
NCT06764940,A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases,A Pivotal Phase II Clinical Trial of Utidelone Injection (UTD1) Plus Capecitabine (CAP) in HER2-negative Breast Cancer Patients With Brain Metastases,RECRUITING,2025-07-14,2027-01-15,2027-07-15,INTERVENTIONAL,PHASE2,120,['HER2-negative Breast Cancer Patients With Brain Metastases'],HER2-negative Breast Cancer Patients With Brain Metastases,"Biostar Pharma, Inc.",[],['United States']
NCT06879574,Identifying the Best Tools for Recording Diet in Free-living UK Adults (SODIAT-2 Study),Investigating a Data-driven Standardized and Objective Dietary Intake Assessment Tool in Free-living Individuals - SODIAT-2 Study,RECRUITING,2025-08-25,2026-07,2026-07,OBSERVATIONAL,,133,"['Dietary Intake Assessment', 'Food Intake Measurement']",Dietary Intake Assessment,University of Reading,"['Aberystwyth University', 'University of Cambridge', 'Imperial College London']",['United Kingdom']
NCT02979873,Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy,A Randomized Trial of Sirolimus (Rapamune(R)) for Relapse Prevention in Patients With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy,ACTIVE_NOT_RECRUITING,2016-12-19,2026-09-03,2030-06-30,INTERVENTIONAL,PHASE2,84,['Severe Aplastic Anemia'],Severe Aplastic Anemia,"National Heart, Lung, and Blood Institute (NHLBI)",[],['United States']
NCT01886872,"Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia",A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (≥ 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL),ACTIVE_NOT_RECRUITING,2014-01-15,2018-08-07,2026-06-07,INTERVENTIONAL,PHASE3,547,"['Stage I Chronic Lymphocytic Leukemia', 'Stage II Chronic Lymphocytic Leukemia', 'Stage III Chronic Lymphocytic Leukemia', 'Stage IV Chronic Lymphocytic Leukemia']",Stage I Chronic Lymphocytic Leukemia,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT04874064,TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence,Triple Negative Breast Cancer Markers in Liquid Biopsies Using Artificial Intelligence (TRICIA Study),RECRUITING,2019-12-05,2027-12,2027-12,OBSERVATIONAL,,130,['Breast Cancer'],Breast Cancer,Jewish General Hospital,['Exactis Innovation'],['Canada']
NCT06660199,Text-based Support for Parents of Adolescents Following an Emergency Department Visits,Effectiveness of Text-based Support for Parents of Suicidal Adolescents Following Emergency Department Visits,RECRUITING,2025-11-20,2028-07,2028-07,INTERVENTIONAL,NA,420,['Suicide'],Suicide,University of Michigan,['National Institute of Mental Health (NIMH)'],['United States']
NCT04378790,A Randomized Trial to Evaluate Sequential vs Simultaneous Patching,A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles Plus Patching for Amblyopia in Children 3 to <13 Years Old,RECRUITING,2020-12-08,2028-05-01,2028-05-01,INTERVENTIONAL,PHASE3,544,['Amblyopia'],Amblyopia,Jaeb Center for Health Research,"['National Eye Institute (NEI)', 'Pediatric Eye Disease Investigator Group']",['United States']
NCT00001529,Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives,Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections From Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation,RECRUITING,1996-03-18,,,OBSERVATIONAL,,500,"['Graft-Versus-Host Disease', 'Graft-versus-leukemia', 'Donor Apheresis']",Graft-Versus-Host Disease,"National Heart, Lung, and Blood Institute (NHLBI)",['New York University and New York Genome Center'],['United States']
NCT00353483,"Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells","Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells",RECRUITING,2005-09-14,2026-08-31,2026-08-31,OBSERVATIONAL,,300,['Breast Neoplasms'],Breast Neoplasms,Washington University School of Medicine,[],['United States']
NCT07244952,Effects of Vojta Therapy on Posture and Trunk Control,Effects of Vojta Therapy on Posture and Trunk Control in Patients With Sub-acute Stroke,RECRUITING,2025-11-15,2026-08-15,2026-08-30,INTERVENTIONAL,NA,62,"['Stroke', 'Stroke Ischemic']",Stroke,University of Lahore,[],['Pakistan']
NCT07236671,Progression Patterns of Choroidal Venous Alterations,"International Multi-centre, Prospective, Longitudinal Cohort to Evaluate the Progression Pattern of Choroidal Venous Alterations",RECRUITING,2025-03-04,2029-06,2029-08,OBSERVATIONAL,,250,['Pachychoroid Disease'],Pachychoroid Disease,Singapore National Eye Centre,"['National University Hospital, Singapore', 'University of Malaya', 'Hong Kong University']","['Singapore', 'Hong Kong', 'Malaysia']"
NCT06734559,Assessment of Masseter Muscle With Ultrasonography,Evaluation of the Effect of Acute Apical Periodontitis on Masseter Muscle With Elastography: A Case-control Study,ACTIVE_NOT_RECRUITING,2025-01-30,2025-11-01,2025-11-20,INTERVENTIONAL,NA,60,['Acute Apical Periodontitis of Pulpal Origin'],Acute Apical Periodontitis of Pulpal Origin,Harran University,[],['Turkey (Türkiye)']
NCT05773274,"Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial",NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus or Sunitinib or Cabozantinib in Metastatic/Unresectable Gastroenteropancreatic Neuroendocrine Tumours,RECRUITING,2024-01-12,2026-04-30,2026-04-30,INTERVENTIONAL,PHASE2,100,"['Metastatic Digestive System Neuroendocrine Tumor G1', 'Metastatic Digestive System Neuroendocrine Tumor G2', 'Unresectable Digestive System Neuroendocrine Tumor G1', 'Unresectable Digestive System Neuroendocrine Tumor G2']",Metastatic Digestive System Neuroendocrine Tumor G1,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT06449313,Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement,A Phase 2 Single-Arm Study of Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advance Non-Small Cell Lung Cancer (NSCLC) With N3 Lymph Node Involvement,RECRUITING,2025-12,2027-12,2032-09,INTERVENTIONAL,PHASE2,21,['Non-small Cell Lung Cancer Stage III'],Non-small Cell Lung Cancer Stage III,Georgetown University,['Regeneron Pharmaceuticals'],['United States']
NCT05512390,"A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)","A First In Human Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-319 in B-cell Malignancies",RECRUITING,2023-04-26,2027-02,2027-02,INTERVENTIONAL,PHASE1,154,"['Diffuse Large B-Cell Lymphoma', 'Chronic Lymphocytic Leukemia', 'Follicular Lymphoma']",Diffuse Large B-Cell Lymphoma,AbbVie,[],"['Israel', 'United States', 'Spain', 'South Korea', 'Canada', 'Australia']"
NCT05113017,The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE),"To Evaluate the Effectiveness and Safety of Stereotactic Radiotherapy (SBRT) in the Treatment of Patients With Residual Malignant Pulmonary Nodules After Lung Cancer Surgery: A Multi-center, Prospective Clinical Trial (SMILE)",RECRUITING,2021-07-01,2026-12-31,2026-12-31,OBSERVATIONAL,,40,['The Efficacy and Safety of SBRT in MPLC'],The Efficacy and Safety of SBRT in MPLC,Fang Wu,"['Xiangya Hospital of Central South University', 'The Third Xiangya Hospital of Central South University', 'Hunan Cancer Hospital']",['China']
NCT07255183,Glucose and Motivation States,Impact of Blood Glucose on Motivation States: A Double-Blind Placebo-Controlled Study,RECRUITING,2025-10-30,2026-08,2026-08,INTERVENTIONAL,NA,40,['Motivation'],Motivation,University of South Florida,[],['United States']
NCT06233942,Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors,"Phase 1a/1b Study of BG-C9074, an Antibody Drug Conjugate Targeting B7H4, as Monotherapy and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors",RECRUITING,2024-04-12,2027-09-28,2028-05-15,INTERVENTIONAL,PHASE1,308,['Advanced Solid Tumor'],Advanced Solid Tumor,BeOne Medicines,[],"['China', 'United States', 'Australia']"
NCT06834347,"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps",RECRUITING,2025-02-12,2027-01-08,2027-12-13,INTERVENTIONAL,PHASE3,210,['Chronic Rhinosinusitis With Nasal Polyps'],Chronic Rhinosinusitis With Nasal Polyps,Sanofi,['Regeneron Pharmaceuticals'],"['Japan', 'Netherlands', 'Israel', 'Hungary', 'Chile', 'Finland', 'South Korea', 'Poland', 'Spain', 'Canada', 'United Kingdom', 'Portugal', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT06154538,Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer,"Comparison of Immune Checkpint Inhibitors Combined With Chemotherapy Versus Chemotherapy Alone in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer: a Randomized, Open-label, Single-center Phase II Clinical Study",RECRUITING,2023-11-01,2026-11-01,2028-11-01,INTERVENTIONAL,PHASE2,170,['Locally Advanced Colorectal Carcinoma'],Locally Advanced Colorectal Carcinoma,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences",[],['China']
NCT07254026,Precision Health and Smart Telerehabilitation in OSA,Developing a Precision Health Approach for Obstructive Sleep Apnea: Treatment Responses Analysis and Smart Telerehabilitation Systems,RECRUITING,2025-10-15,2029-12-31,2029-12-31,INTERVENTIONAL,NA,300,['Obstructive Sleep Apnea'],Obstructive Sleep Apnea,National Cheng-Kung University Hospital,[],['Taiwan']
NCT07229222,A Two-Layered Simple Interrupted Myometrial Suturing Reduces Uterine Niche Formation After Primary Cesarean Section,Decidual-Sparing Two-Layered Simple Interrupted Myometrial Suturing With Visceral Peritoneal Closure Reduces Uterine Niche Formation After Primary Cesarean Section: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-02-13,2025-06-15,2025-12,INTERVENTIONAL,NA,380,"['Cesarean Section Complications', 'Scar Niche', 'Myometrial Remodeling', 'Suture Techniques']",Cesarean Section Complications,Benha University,[],['Egypt']
NCT07104292,Pelvic Floor Muscle Training During Pregnancy,"PFMT During Pregnancy - Its Implementation and Effects on Pelvic Floor Disorders, Sexual Function and Obstetric Outcomes: a Hybrid Type 1 Design Randomised Controlled Trial",RECRUITING,2025-10-27,2027-08-01,2028-08-01,INTERVENTIONAL,NA,734,"['Pelvic Floor', 'Urinary Incontinence', 'Anal Incontinence', 'Pelvic Organ Prolapse', 'Sexual Dysfunction']",Pelvic Floor,University of Southern Denmark,[],['Denmark']
NCT06834360,"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps",RECRUITING,2025-02-06,2027-01-08,2027-12-13,INTERVENTIONAL,PHASE3,210,['Chronic Rhinosinusitis With Nasal Polyps'],Chronic Rhinosinusitis With Nasal Polyps,Sanofi,['Regeneron Pharmaceuticals'],"['Netherlands', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Chile', 'Denmark', 'Czechia', 'Poland', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina']"
NCT07089888,A Study of Dotinurad Versus Allopurinol in Tophaceous Gout,"A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Tophaceous Gout",RECRUITING,2025-08-04,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE3,250,['Tophaceous Gout'],Tophaceous Gout,Crystalys Therapeutics,[],['United States']
NCT05731427,Research on the Mechanism Affecting Progression of Bronchiectasis,Research on the Mechanism Affecting Progression of Bronchiectasis Based on Omics Method,RECRUITING,2021-02-01,2026-02-01,2026-02-01,OBSERVATIONAL,,150,['Bronchiectasis'],Bronchiectasis,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",[],['China']
NCT06455527,Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS),HRV-Guided tDCS: Integrating A Biomarker For Clinical Utility,RECRUITING,2025-01-02,2027-11-01,2027-11-01,INTERVENTIONAL,NA,100,['Depression'],Depression,NYU Langone Health,['National Institute for Biomedical Imaging and Bioengineering (NIBIB)'],['United States']
NCT06008795,BLOCK-SAH - PPF-Block for Post-SAH Headache,Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for Acute Headache in Spontaneous Subarachnoid Hemorrhage,RECRUITING,2023-12-17,2027-01-15,2027-02-28,INTERVENTIONAL,PHASE2,195,"['Subarachnoid Hemorrhage, Aneurysmal', 'Headache']","Subarachnoid Hemorrhage, Aneurysmal",University of Florida,"['National Institute of Neurological Disorders and Stroke (NINDS)', 'New York University', 'Massachusetts General Hospital']",['United States']
NCT07089875,A Study of Dotinurad Versus Allopurinol in Participants With Gout,"A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout",RECRUITING,2025-08-01,2027-11-29,2027-11-29,INTERVENTIONAL,PHASE3,500,['Gout'],Gout,Crystalys Therapeutics,[],['United States']
NCT07254364,Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring,Advancing Precision Nutrition: Wearable Technology for Noninvasive Insulin Monitoring,RECRUITING,2025-09-11,2026-12,2026-12,INTERVENTIONAL,NA,32,['Insulin Response'],Insulin Response,Texas A&M University,[],['United States']
NCT07255144,Ultrafast Ultrasound Imaging in Pediatric Cardiology,Ultrafast Ultrasound Imaging: Application in Pediatric Cardiology: Cardiac Ultrafast,RECRUITING,2025-03-11,2028-03-11,2028-03-11,OBSERVATIONAL,,300,['CHD - Congenital Heart Disease'],CHD - Congenital Heart Disease,"University Hospital, Bordeaux",[],['France']
NCT05538000,Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog),"Evaluation of the Feasibility of Personalized and Preventive Support for COGnitive Complaints, by a Paramedical Caregiver in Women Suffering From Non-Metastatic Breast Cancer, Requiring Chemotherapy (EFACog).",ACTIVE_NOT_RECRUITING,2024-08-01,2026-06-17,2027-06-17,INTERVENTIONAL,NA,50,['No Metastatic Breast Cancer'],No Metastatic Breast Cancer,Institut de Cancérologie de Lorraine,[],['France']
NCT06850766,The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma,"A Randomized, Multicentre Pilot Trial Evaluating the Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma",RECRUITING,2025-05-08,2026-11,2031-05,INTERVENTIONAL,NA,50,"['IDH-Wildtype Glioblastoma', 'Glioblastoma (GBM)']",IDH-Wildtype Glioblastoma,Ottawa Hospital Research Institute,['The Ottawa Hospital'],['Canada']
NCT06579105,"Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.","A Phase IIb, Randomized, Double-blind, Placebo-controlled and Open-label Active Comparator Study to Evaluate the Efficacy, Safety, and Tolerability of AZD5004 in Adults With Type 2 Diabetes Mellitus.",ACTIVE_NOT_RECRUITING,2024-10-08,2025-12-19,2025-12-19,INTERVENTIONAL,PHASE2,406,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",AstraZeneca,[],"['Japan', 'Hungary', 'United States', 'Slovakia', 'Spain', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT06587841,Noninvasive Spinal Cord Stimulation for Early SCI,Noninvasive Spinal Cord Neuromodulation to Improve Lower Urinary Tract Function After Spinal Cord Injury in Ukrainian War Veterans,RECRUITING,2024-10-01,2027-10-01,2027-10-01,INTERVENTIONAL,NA,60,"['Spinal Cord Injuries', 'Bowel Dysfunction', 'Sexual Dysfunction', 'Autonomic Dysfunction', 'Urologic Disorders']",Spinal Cord Injuries,University of British Columbia,"['United States Department of Defense', 'Rivne Regional War Veterans Hospital, Spinal Cord Injury Rehabilitation Center', 'Congressionally Directed Medical Research Programs']",['Canada']
NCT06797154,A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors,A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life of Subacute Stroke Survivors,RECRUITING,2025-08-08,2026-06-30,2026-08-31,INTERVENTIONAL,NA,88,"['Stroke', 'Stroke Sequelae', 'Hemiparesis;Poststroke/CVA']",Stroke,Spaulding Rehabilitation Hospital,"['BioSensics', 'MGH Institute of Health Professions', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06285422,Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID),"A Phase 1 Study Evaluating SC262, a Hypoimmune, Allogeneic CD22-directed CAR T Cell Therapy, in Relapsed and/or Refractory Non-Hodgkin's Lymphoma (VIVID)",ACTIVE_NOT_RECRUITING,2024-04-18,2025-12,2029-03,INTERVENTIONAL,PHASE1,6,"[""Non Hodgkin's Lymphoma"", 'Large B-cell Lymphoma']",Non Hodgkin's Lymphoma,Sana Biotechnology,[],['United States']
NCT07136181,"Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma","A Multicenter Phase Ib/II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma",RECRUITING,2025-11-20,2028-03-28,2029-08-30,INTERVENTIONAL,PHASE1,36,"['Metastatic Uveal Melanoma', 'Uveal Melanoma, Metastatic', 'Uveal Melanoma, Recurrent', 'Eye Cancer, Intraocular Melanoma', 'Eye Cancer']",Metastatic Uveal Melanoma,Novelwise Pharmaceutical Corporation,[],['United States']
NCT06100224,Piloting a Healthy Aging Cohort in Manitoba,Piloting a Healthy Aging Cohort in Manitoba - PACMan,RECRUITING,2024-04-01,2026-05,2026-05,OBSERVATIONAL,,100,['Healthy Aging'],Healthy Aging,University of Manitoba,"['Seven Oaks Hospital Chronic Disease Innovation Centre', 'The Wellness Institute Powered by Seven Oaks General Hospital', 'Medical Fitness Association']",['Canada']
NCT06846346,Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma,Phase II Study Evaluating Ivonescimab in Combination With Chemotherapy for First- and Second-line Treatment of Advanced or Metastatic Gastric and Gastroesophageal Adenocarcinoma Patients,RECRUITING,2025-11-20,2027-09,2028-09,INTERVENTIONAL,PHASE2,88,"['Metastatic Esophageal Adenocarcinoma', 'Advanced Esophageal Adenocarcinoma', 'Metastatic Gastric Adenocarcinoma', 'Advanced Gastric Adenocarcinoma']",Metastatic Esophageal Adenocarcinoma,UNICANCER,['Summit Therapeutics'],['France']
NCT05669755,REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels,The Cardiovascular Safety and Efficacy of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) Once-weekly in Participants With Established Cardiovascular Disease,ACTIVE_NOT_RECRUITING,2023-03-01,2027-09-01,2027-10-13,INTERVENTIONAL,PHASE3,7101,['Cardiovascular Disease'],Cardiovascular Disease,Novo Nordisk A/S,[],"['Bulgaria', 'Japan', 'Netherlands', 'Australia', 'France', 'Puerto Rico', 'Denmark', 'Thailand', 'Colombia', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Canada', 'Malaysia', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Ireland', 'Italy', 'Argentina', 'Serbia']"
NCT07073846,"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","Efficacy of Lidocaine-Dexmedetomidine Combination Therapy in Reducing Post-Operative Pain, Inflammatory Response, and Oxidative Stress in Patients Undergoing Bariatric Surgery",RECRUITING,2025-10-06,2027-05-01,2027-07-01,INTERVENTIONAL,PHASE4,104,"['Morbid Obesity Requiring Bariatric Surgery', 'Postoperative Pain', 'Postoperative Pain Management', 'Postoperative Analgesia', 'Postoperative Adjuvant Treatment', 'Postoperative Inflammatory Markers', 'Postoperative Inflammatory Response']",Morbid Obesity Requiring Bariatric Surgery,Instituto Mexicano del Seguro Social,[],['Mexico']
NCT05424562,A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada,Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax (LIVEN),ACTIVE_NOT_RECRUITING,2022-09-07,2027-03,2027-03,OBSERVATIONAL,,210,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,AbbVie,[],['Canada']
NCT05340465,Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants,Trial of Darbepoetin Plus Slow-release Intravenous Iron to Decrease Transfusions and Improve Iron Status and Neurodevelopment in Preterm Infants,RECRUITING,2022-11-27,2026-10-30,2027-06-30,INTERVENTIONAL,PHASE2,120,"['Prematurity', 'Iron-deficiency', 'Iron Deficiency Anemia', 'Iron Malabsorption']",Prematurity,University of Washington,['Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'],['United States']
NCT01841736,Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors,Prospective Randomized Phase II Trial of Pazopanib (NSC #737754) Versus Placebo in Patients With Progressive Carcinoid Tumors,ACTIVE_NOT_RECRUITING,2013-09-20,2019-03-05,2026-09-10,INTERVENTIONAL,PHASE2,171,"['Foregut Neuroendocrine Tumor', 'Hindgut Neuroendocrine Tumor', 'Metastatic Digestive System Neuroendocrine Tumor G1', 'Metastatic Neuroendocrine Tumor', 'Midgut Neuroendocrine Tumor G1', 'Neuroendocrine Tumor G2', 'Recurrent Digestive System Neuroendocrine Tumor G1', 'Regional Digestive System Neuroendocrine Tumor G1']",Foregut Neuroendocrine Tumor,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT05756244,PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism,A Prospective Cohort Study Evaluating Peripartum Anticoagulation Management Among Pregnant Women With Venous Thromboembolism and Its Impact on Patient Outcomes,RECRUITING,2023-04-04,2029-06-30,2029-12-31,OBSERVATIONAL,,825,"['Pregnancy Related', 'Venous Thromboembolism']",Pregnancy Related,University of Calgary,[],"['United States', 'France', 'Switzerland', 'Denmark', 'Canada']"
NCT07234071,Manual Therapy Combined With Functional Magnetic Stimulation for Lumbar Radiculopathy,The Effectiveness of Manual Therapy Combined With Functional Magnetic Stimulation in Individuals With Lumbar Radiculopathy Due to Lumbar Disc Herniation: A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-11-04,2025-12-10,2025-12-10,INTERVENTIONAL,NA,40,['Lumbar Disc Herniation With Radiculopathy'],Lumbar Disc Herniation With Radiculopathy,International Hellenic University,[],['Greece']
NCT06165341,Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis),"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Fazirsiran in the Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease With METAVIR Stage F1 Fibrosis",RECRUITING,2024-03-01,2028-08-26,2028-08-26,INTERVENTIONAL,PHASE3,50,['Alpha1-Antitrypsin Deficiency'],Alpha1-Antitrypsin Deficiency,Takeda,[],"['Belgium', 'Austria', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Portugal', 'Sweden', 'Germany']"
NCT06486883,Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype,A Randomized Phase II Study to Evaluate the Safety and Efficacy of Trastuzumab Deruxtecan Versus CDK4/6 Inhibitor-based Endocrine Therapy as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype According to Gene Expression Profiling.,RECRUITING,2025-06-30,2027-01,2028-01,INTERVENTIONAL,PHASE2,200,"['Advanced Breast Cancer', 'Advanced Breast Carcinoma', 'Hormone Receptor Positive Breast Carcinoma']",Advanced Breast Cancer,MedSIR,[],"['Spain', 'Portugal', 'Italy']"
NCT07220629,Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2),"A Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide Plus a Reduced Calorie Diet and Increased Physical Activity in Participants With Obesity",RECRUITING,2025-10-02,2026-06-01,2026-06-01,INTERVENTIONAL,PHASE2,80,['Obesity'],Obesity,NodThera Limited,[],['United States']
NCT06731244,Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER ),Prognosis Improvement of Unprovoked vEnous THromboEmbolism With the Use of a Shared Decision-making Process Including a Time-dependent Multicomponent Risk Prediction Scores inteRvention.,RECRUITING,2025-10-30,2035-10,2035-10,INTERVENTIONAL,NA,2400,['Venous Thromboembolism'],Venous Thromboembolism,"University Hospital, Brest","['European Commission', 'European Clinical Research Infrastructure Network']",['France']
NCT06622902,Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.,Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.,RECRUITING,2023-08-16,2026-12-01,2026-12-31,INTERVENTIONAL,NA,45,"['Respiratory Distress Syndrome', 'Prematurity', 'Non Invasive Ventilation']",Respiratory Distress Syndrome,Rambam Health Care Campus,[],['Israel']
NCT03862911,Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer,Phase III Randomized Controlled Trial and Economic Evaluation of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer (SABR-COMET-3),ACTIVE_NOT_RECRUITING,2019-11-01,2030-11-24,2030-12-31,INTERVENTIONAL,NA,330,['Metastatic Tumors'],Metastatic Tumors,British Columbia Cancer Agency,"['London Regional Cancer Program, Canada', 'The Alfred', 'Beacon Hospital, Ireland', 'Cancer Trials Ireland', 'Cancer Research UK Edinburgh Centre', 'Bon Secours Cork Cancer Centre', 'UPMC Hillman Cancer Centre', 'Beatson West of Scotland Cancer Centre', 'Tom Baker Cancer Centre', 'Walker Family Cancer Centre', 'Riverina Cancer Care Centre', 'Aberdeen Royal Infirmary']","['United Kingdom', 'Ireland', 'Canada', 'Australia']"
NCT07197034,The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial,"A Phase 3, Multicenter, Open-Label Extension Study to Assess the Safety and Efficacy of ARD-101 in Patients With Prader-Willi Syndrome",RECRUITING,2024-07-23,2027-03,2027-04,INTERVENTIONAL,PHASE3,90,"['Hyperphagia', 'Prader-Willi Syndrome', 'Hyperphagia in Prader-Willi Syndrome']",Hyperphagia,"Aardvark Therapeutics, Inc.",[],"['United States', 'France', 'Spain', 'Italy', 'Canada', 'Romania', 'South Korea', 'United Kingdom', 'Australia']"
NCT04302272,STRIVE Post-Market Registry Study,The Spiration® Valve System (SVS) Post-Market Registry Study for Severe Emphysema,RECRUITING,2021-10-09,2026-12,2028-04,OBSERVATIONAL,,150,['Emphysema'],Emphysema,Olympus Corporation of the Americas,[],['United States']
NCT02263014,Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM),Treatment Decisions and Breast Cancer: Psychosocial Outcomes,ACTIVE_NOT_RECRUITING,2014-02-24,2016-10,2028-04-30,OBSERVATIONAL,,345,['Breast Cancer'],Breast Cancer,M.D. Anderson Cancer Center,['Patient-Centered Outcomes Research Institute'],['United States']
NCT07250607,Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications,Extreme Phenotypes to Identify the Patients With Type 2 Diabetes Who Are Susceptible or Resistant to Complications and to Reveal the Mechanisms,ACTIVE_NOT_RECRUITING,2024-05-01,2025-11-30,2026-07-31,OBSERVATIONAL,,1000,"['Diabete Type 2', 'Diabetes Complications']",Diabete Type 2,"Azienda Ospedaliero, Universitaria Pisana",[],['Italy']
NCT05525507,Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants,"A Single-armed, Unblinded, Non-randomized Feasibility Study of Hematopoietic Stem Cell Infusion Following a Conditioning Regimen of Total Lymphoid Irradiation (TLI) and Anti-thymocyte Globulin (ATG) in Patients With a Pre-existing, Well-functioning HLA-matched Kidney Transplant",RECRUITING,2022-12-21,2026-12,2026-12,INTERVENTIONAL,PHASE1,10,"['End Stage Kidney Disease', 'Immunological Tolerance', 'Kidney Transplant Failure and Rejection', 'Chronic Kidney Diseases']",End Stage Kidney Disease,"University of California, Los Angeles",[],['United States']
NCT07251296,Impact of Funcional Exercise and Supplementation in Perimenopausal Women's Health,"Effects of a Nutritional Supplement and Physical Exercise on the Psycho-emotional, Cognitive, Functional, and Neuroendocrine Health of Perimenopausal Women.",RECRUITING,2025-12-15,2026-07,2026-07,INTERVENTIONAL,NA,90,"['Perimenopause', 'Aging']",Perimenopause,University of Valencia,[],['Spain']
NCT07063446,sTMS Combined With CIMT and taVNS In Infants With Hemiplegia,Integrating Corticospinal Tract Assessment Via sTMS And taVNS-Augmented CIMT In Infants With Hemiplegia,RECRUITING,2025-11-07,2026-10-31,2026-12-31,INTERVENTIONAL,NA,10,"['Hemiplegia', 'Perinatal Brain Injury']",Hemiplegia,Medical University of South Carolina,[],['United States']
NCT07251140,Dysphagia Study Using Novel Microphone Device,Novel Acoustic Biopatch for the Investigation of Dysphagia,RECRUITING,2025-10-12,2026-09-30,2026-09-30,INTERVENTIONAL,NA,50,"['Dysphagia', 'Stroke']",Dysphagia,Emory University,[],['United States']
NCT07179822,Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI),Can MEP Conditioning Improve Corticospinal Recruitment of Motoneurons in Chronic Cervical SCI?,RECRUITING,2025-11-03,2027-09-30,2027-09-30,INTERVENTIONAL,NA,15,"['Spinal Cord Injuries and Disorders (SCI/D)', 'Spinal Cord Injury']",Spinal Cord Injuries and Disorders (SCI/D),Medical University of South Carolina,"['Northwestern University', 'National Institutes of Health (NIH)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06084234,National Liver Cancer Screening Trial,National Liver Cancer Screening Trial,RECRUITING,2023-12-26,2029-12-31,2034-12-31,INTERVENTIONAL,PHASE4,5500,"['Carcinoma, Hepatocellular', 'Liver Cancer', 'Liver Cirrhosis', 'Hepatitis B']","Carcinoma, Hepatocellular",University of Texas Southwestern Medical Center,"['National Cancer Institute (NCI)', 'University of Pennsylvania', 'University of Michigan', 'Dana-Farber Cancer Institute', 'Baylor College of Medicine', 'Fred Hutchinson Cancer Center']",['United States']
NCT06640387,CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools,CARE-ID: Dynamics of Respiratory Infections in Children and Transmission in Households and Schools,RECRUITING,2024-10-10,2026-05-31,2026-12-31,OBSERVATIONAL,,500,"['SARS CoV 2 Infection', 'RSV Infection', 'Influenza', 'Mycoplasma Pneumoniae', 'Bordetella Pertussis, Whooping Cough']",SARS CoV 2 Infection,The Hospital for Sick Children,[],['Canada']
NCT07049926,Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03),A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (KEYMAKER-U03): Substudy 03C in Participants With Recurrent Disease During or After Anti-PD-(L)1 Adjuvant Therapy,RECRUITING,2025-07-20,2031-10-26,2031-10-26,INTERVENTIONAL,PHASE1,140,['Renal Cell Carcinoma'],Renal Cell Carcinoma,Merck Sharp & Dohme LLC,['Exelixis'],"['Israel', 'United States', 'France', 'Spain', 'South Korea', 'United Kingdom', 'Poland']"
NCT05982678,Basket Study for Oligo-metastatic Breast Cancer,Basket Study for Oligo-metastatic Breast Cancer Part 1: Trastuzumab-deruxtecan for HER2-positive Oligo-metastatic Breast Cancer,RECRUITING,2024-05-02,2027-10-01,2034-10-01,INTERVENTIONAL,PHASE2,72,['HER2-positive Breast Cancer'],HER2-positive Breast Cancer,The Netherlands Cancer Institute,"['Daiichi Sankyo', 'AstraZeneca']",['Netherlands']
NCT04587128,Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC,Phase II Trial of Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With Metastatic Colorectal Cancer,ACTIVE_NOT_RECRUITING,2020-10-19,2029-10,2029-10,INTERVENTIONAL,PHASE2,34,['Metastatic Colorectal Cancer'],Metastatic Colorectal Cancer,"University of Wisconsin, Madison",['Doris Duke Charitable Foundation'],['United States']
NCT02598661,Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS),A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment,ACTIVE_NOT_RECRUITING,2016-01-12,2023-10-13,2026-10-13,INTERVENTIONAL,PHASE2,289,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,Geron Corporation,[],"['Belgium', 'Israel', 'Turkey (Türkiye)', 'Netherlands', 'Russia', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Czechia', 'South Korea', 'Poland', 'United Kingdom', 'Ukraine', 'Germany']"
NCT07000123,A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event,"A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Elevated Low Density Lipoprotein Cholesterol and Clinical Atherosclerotic Cardiovascular Disease or at Risk for a First Atherosclerotic Cardiovascular Disease Event",RECRUITING,2025-05-28,2027-03-24,2027-03-24,INTERVENTIONAL,PHASE3,2800,['Cardiovascular Disease'],Cardiovascular Disease,AstraZeneca,[],"['Bulgaria', 'Japan', 'Slovakia', 'Australia', 'Hungary', 'Chile', 'South Korea', 'Czechia', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Vietnam', 'Ukraine', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Argentina']"
NCT06430359,Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients,Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients Treated With Chelators or Zinc Salts,RECRUITING,2025-01-10,2027-02-10,2027-02-10,OBSERVATIONAL,,30,['Wilson Disease'],Wilson Disease,Hospices Civils de Lyon,[],['France']
NCT07251608,"Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® Plus","Randomized, Open-Label, Safety Pilot Study of Multiple Subcutaneous and Intramuscular Injections of Niagen® Plus",RECRUITING,2025-10-01,2026-02-15,2026-02-15,INTERVENTIONAL,PHASE1,40,"['Healthy Volunteer', 'Fatigue']",Healthy Volunteer,"ChromaDex, Inc.",[],['United States']
NCT07251218,"Assessing the Effects of Cool Roofs on Mental Health in Ahmedabad, India","A Cluster Randomised Controlled Trial (cRCT) Evaluating the Effects of Cool Roofs on Mental Health Outcomes in Ahmedabad, India",ACTIVE_NOT_RECRUITING,2024-12-01,2026-01-01,2026-01-01,INTERVENTIONAL,NA,800,"['Eco-anxiety', 'PTSD - Post Traumatic Stress Disorder', 'Resilience', 'Anxiety']",Eco-anxiety,Aditi Bunker,"['Heidelberg University', 'Rutgers University', 'Boston University', 'Indian Institute of Public Health, India', 'Sika', 'University of Auckland, New Zealand']",['India']
NCT06736990,A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis,A Randomized Double-Blind Trial to Evaluate the Efficacy and Safety of CAL101 in Patients With Idiopathic Pulmonary Fibrosis,RECRUITING,2025-06-20,2027-08,2027-11,INTERVENTIONAL,PHASE2,150,['Idiopathic Pulmonary Fibrosis'],Idiopathic Pulmonary Fibrosis,Calluna Pharma AS,[],"['Turkey (Türkiye)', 'Netherlands', 'Norway', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'Romania', 'South Korea', 'United Kingdom']"
NCT07252323,A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE),A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE),RECRUITING,2024-11-12,2026-11,2026-11,INTERVENTIONAL,NA,48,"['Carcinoma', 'Hepatocellular Carcinoma']",Carcinoma,Yonsei University,[],['South Korea']
NCT06872125,"A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome","EMPEROR: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel Group, Phase 3 Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen (STK-001) in Patients With Dravet Syndrome",RECRUITING,2025-06-04,2027-03,2027-08,INTERVENTIONAL,PHASE3,150,['Dravet Syndrome'],Dravet Syndrome,"Stoke Therapeutics, Inc",[],"['United Kingdom', 'Japan', 'United States']"
NCT07048197,"A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease","An Open-label, Multi-center, Phase 1/2 Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Participants With Difficult-to-treat Rheumatoid Arthritis and Severe, Refractory Sjogren's Disease With Organ Involvement",RECRUITING,2025-06-20,2028-11-01,2028-11-01,INTERVENTIONAL,PHASE1,27,"[""Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)""]",Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD),Novartis Pharmaceuticals,[],"['Singapore', 'Spain', 'France', 'Germany']"
NCT05393388,Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study,Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study,ACTIVE_NOT_RECRUITING,2022-07-06,2027-05,2027-05,OBSERVATIONAL,,111,"['Cognitive Decline', 'Alzheimer Disease']",Cognitive Decline,University of Pennsylvania,['Pennsylvania Department of Health'],['United States']
NCT06931769,TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer,TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer,RECRUITING,2025-11-06,2029-07-01,2030-07-01,OBSERVATIONAL,,100,['Breast Cancer'],Breast Cancer,The Netherlands Cancer Institute,['Dutch Cancer Society'],['Netherlands']
NCT06637462,A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer,DISCRN in Rectal Cancer: DISseCting Response to Neoadjuvant Therapy in Rectal Cancer,RECRUITING,2024-10-09,2027-10-09,2027-10-09,INTERVENTIONAL,NA,30,"['Rectal Cancer', 'Adenocarcinoma of the Rectum']",Rectal Cancer,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT03998735,Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure,Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure,ACTIVE_NOT_RECRUITING,2021-10-19,2025-08-01,2026-08,INTERVENTIONAL,PHASE1,55,['Smokeless Tobacco'],Smokeless Tobacco,"Masonic Cancer Center, University of Minnesota",['National Institutes of Health (NIH)'],['United States']
NCT07105215,A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors,A Multicenter Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RC278 for Injection in the Treatment of Locally Advanced Unresectable or Metastatic Malignant Solid Tumor,RECRUITING,2025-08-11,2027-12-31,2030-05-31,INTERVENTIONAL,PHASE1,312,['Solid Tumors'],Solid Tumors,"RemeGen Co., Ltd.",[],['China']
NCT06051617,Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis,"AFFIRM: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis",RECRUITING,2023-09-07,2030-08,2030-08,INTERVENTIONAL,PHASE3,318,['Primary Biliary Cholangitis'],Primary Biliary Cholangitis,Gilead Sciences,[],"['Australia', 'Belgium', 'Hungary', 'France', 'Chile', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Switzerland', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07118098,INNODIA Family & Friends Early-Stage T1D Detection Protocol,INNODIA Family & Friends Early-Stage T1D Detection Protocol,RECRUITING,2025-06-25,2027-12,2027-12,OBSERVATIONAL,,30000,"['Type 1 Diabetes (T1D)', 'Pre Diabetes']",Type 1 Diabetes (T1D),INNODIA iVZW,[],"['Belgium', 'Slovenia', 'France', 'Italy', 'Poland']"
NCT06847724,"Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis","A Randomized, Double-blind, Parallel-group Study to Compare the Pharmacokinetics, Efficacy, Pharmacodynamics, Safety, and Immunogenicity of CYB704 (Proposed Ocrelizumab Biosimilar) and Ocrevus® in Participants With Relapsing Multiple Sclerosis (RMS) [STRIVE-MS].",RECRUITING,2025-06-10,2026-10-14,2029-10-14,INTERVENTIONAL,PHASE3,175,['Relapsing Multiple Sclerosis'],Relapsing Multiple Sclerosis,Sandoz,[],"['Bulgaria', 'North Macedonia', 'United States', 'Georgia', 'Croatia', 'Bosnia and Herzegovina', 'Poland', 'Serbia']"
NCT01177527,"Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders","Medical Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders",ACTIVE_NOT_RECRUITING,2009-12,2026-01,2026-01,OBSERVATIONAL,,656,"['Multiple Myeloma', ""Waldenstrom's Macroglobulinemia"", 'Smoldering Multiple Myeloma', 'Lymphoblastic Lymphoma']",Multiple Myeloma,Dana-Farber Cancer Institute,[],['United States']
NCT05102019,Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II,Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II,RECRUITING,2022-01-04,2027-07,2032-01,INTERVENTIONAL,NA,380,['Refractory Angina'],Refractory Angina,"Shockwave Medical, Inc.",[],"['United Kingdom', 'United States', 'Canada']"
NCT06613477,PK/PD of Digoxin in Infants With SVHD,Pharmacokinetics and Pharmacodynamics of Digoxin in Infants With Single Ventricle Heart Disease,RECRUITING,2024-10-10,2026-11-30,2026-11-30,INTERVENTIONAL,PHASE1,20,"['Single-ventricle', 'Infant Conditions', 'Infant, Newborn, Diseases', 'Infant, Premature, Diseases']",Single-ventricle,Duke University,"['Medical University of South Carolina', 'Duke Clinical Research Institute', 'National Center for Child Health and Development (NICHD)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06184919,Preparing Older Adults for Major Surgery With Preoperative Comprehensive Geriatric Assessments,Preparing Older Adults for Major Abdominal Surgery: a Systems Engineering Approach to Implement Preoperative Comprehensive Geriatric Assessments,ACTIVE_NOT_RECRUITING,2023-06-14,2026-03-31,2028-04-30,OBSERVATIONAL,,50,"['Surgery', 'Aging', 'Health Care Utilization', 'Frailty']",Surgery,"University of Wisconsin, Madison",['National Institute on Aging (NIA)'],['United States']
NCT04411043,Observatory of Prolymphocytic Leukemia T,"Prospective and Retrospective Study Evaluating Epidemiological, Clinical, Molecular and Therapeutic Data of Prolymphocytic Leukemia T. A FILO Study.",RECRUITING,2020-07-01,2025-12-30,2026-06-30,OBSERVATIONAL,,50,"['Prolymphocytic Leukemia', 'T-cell Leukemia']",Prolymphocytic Leukemia,French Innovative Leukemia Organisation,"['University Hospital, Lille']",['France']
NCT07224750,A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer,A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer,RECRUITING,2024-06-21,2026-06-18,2026-06-18,OBSERVATIONAL,,1000,"['Hepatocellular Carcinoma (HCC)', 'Cholangiocarcinoma', 'Pancreatic Ductal Adenocarcinoma (PDAC)', 'Esophageal Squamous Cell Carcinoma (ESCC)', 'Gastric Cancer (GC)', 'Colorectal Cancer Screening']",Hepatocellular Carcinoma (HCC),City of Hope Medical Center,[],['United States']
NCT04785989,In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia),Metabolic Profiling of Leukemic Cells Through Isotope Tracing in Patients With CLL,RECRUITING,2022-06-13,2026-10,2026-10,OBSERVATIONAL,,16,['Chronic Lymphocytic Leukemia'],Chronic Lymphocytic Leukemia,"University of Wisconsin, Madison",[],['United States']
NCT05329766,A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies,A Phase 2 Trial to Evaluate the Safety and Efficacy of Combination Therapies in Patients With Advanced Upper Gastrointestinal Tract Malignancies (EDGE-Gastric),ACTIVE_NOT_RECRUITING,2022-06-10,2027-01,2027-06,INTERVENTIONAL,PHASE2,332,['Gastrointestinal Tract Malignancies'],Gastrointestinal Tract Malignancies,"Arcus Biosciences, Inc.",['Gilead Sciences'],"['United States', 'France', 'Chile', 'South Korea', 'Canada', 'Serbia']"
NCT05027945,"A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome","A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome",RECRUITING,2023-02-23,2026-07-01,2026-07-01,INTERVENTIONAL,PHASE2,54,"['Immunodeficiency', 'Hematopoietic Stem Cell Transplantation']",Immunodeficiency,National Cancer Institute (NCI),[],['United States']
NCT06714253,Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1,"A Phase I/IIa, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Intraductal Administration of RXRG001 to Parotid Gland(s) in Adults With Radiation-Induced Xerostomia and Hyposalivation",RECRUITING,2025-03-05,2027-08,2027-08,INTERVENTIONAL,PHASE1,42,['Radiation-Induced Xerostomia and Hyposalivation'],Radiation-Induced Xerostomia and Hyposalivation,RiboX Therapeutics Ltd.,[],['United States']
NCT06724172,CHIME: Comparing Health Interventions for Maternal Equity,CHIME: Comparing Health Interventions for Maternal Equity,RECRUITING,2026-04-01,2030-01-15,2030-04-01,INTERVENTIONAL,NA,795,"['Obesity and Overweight', 'Nutrition', 'Chronic Disease', 'Diabetes', 'Pregnancy']",Obesity and Overweight,Stanford University,['Patient-Centered Outcomes Research Institute'],['United States']
NCT04153292,The ENCIRCLE Trial,SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access,RECRUITING,2020-11-12,2027-02,2031-02,INTERVENTIONAL,NA,900,"['Mitral Regurgitation', 'Mitral Valve Insufficiency']",Mitral Regurgitation,Edwards Lifesciences,[],"['Israel', 'Netherlands', 'United States', 'Canada', 'United Kingdom', 'Australia']"
NCT05205967,REFLECTION: A Clinical Practice Learning Program for Galleri®,"REFLECTION: Real World Evidence for Learnings in Early Cancer Detection, a Clinical Practice Learning Program for Galleri®",ACTIVE_NOT_RECRUITING,2021-08-23,2025-09-30,2026-10-30,OBSERVATIONAL,,14633,"['Early Detection of Cancer', 'Cancer']",Early Detection of Cancer,"GRAIL, Inc.",[],['United States']
NCT06838845,An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC),Prospective Observational Study Of Upadacitinib in Ulcerative Colitis in China,RECRUITING,2025-04-09,2026-12,2026-12,OBSERVATIONAL,,80,['Ulcerative Colitis'],Ulcerative Colitis,AbbVie,[],['China']
NCT05232877,Effects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment,Effects of t-DCS Combined With Concurrent Cognitive Training on Apathy in Elderly Subjects With Minor Neurocognitive Impairment,ACTIVE_NOT_RECRUITING,2022-04-05,2025-04-04,2026-06-10,INTERVENTIONAL,NA,27,"['Apathy', 'Neurocognitive Disorders']",Apathy,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06056102,CAR-T Cell Therapy for Desensitization in Kidney Transplantation,Autologous Chimeric Antigen Receptor Engineered T Cell Immunotherapy for Desensitization in Patients Awaiting Kidney Transplantation,RECRUITING,2024-05-09,2028-12-15,2042-12-15,INTERVENTIONAL,PHASE1,20,"['Kidney Transplant', 'Kidney Failure', 'End Stage Renal Failure on Dialysis']",Kidney Transplant,National Institute of Allergy and Infectious Diseases (NIAID),['University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF)'],['United States']
NCT07195864,"Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the ""Medicines in Special Situations"" (Medicamentos en Situaciones Especiales) Program in Spain.","Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the ""Medicines in Special Situations"" (Medicamentos en Situaciones Especiales) Program in Spain.",RECRUITING,2025-10-30,2026-01-31,2026-06-30,OBSERVATIONAL,,24,['Acanthamoeba Keratitis'],Acanthamoeba Keratitis,SIFI SpA,[],['Spain']
NCT06431022,Web-administered STAIR for Patients on Behavioral Health Waitlists,"The Feasibility, Acceptability, and Initial Effectiveness of Web-administered Skills Training in Affective and Interpersonal Regulation (webSTAIR) for Posttraumatic Stress Disorder (PTSD) for Patients on Behavioral Health Waitlists",ACTIVE_NOT_RECRUITING,2024-11-15,2026-02,2026-05,INTERVENTIONAL,NA,70,['Post Traumatic Stress Disorder'],Post Traumatic Stress Disorder,Boston Medical Center,[],['United States']
NCT05633654,Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63),"A Randomized, Open-label, Phase 3 Study of Adjuvant Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy",RECRUITING,2022-12-12,2027-06,2031-08,INTERVENTIONAL,PHASE3,1514,['Triple Negative Breast Cancer'],Triple Negative Breast Cancer,Gilead Sciences,"['Alliance Foundation Trials, LLC.', 'NSABP Foundation Inc', 'GBG Forschungs GmbH']","['United States', 'France', 'Ireland', 'Spain', 'South Korea', 'Australia', 'United Kingdom', 'Germany']"
NCT06919302,The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care.,An Innovative Technology-based Approach to Translating Clinical Practice Guidelines of Nutrition Therapy in Primary Care: The Coronary Heart Effectiveness Assessment of the Portfolio Diet in Primary Care (CHEAP) Trial,RECRUITING,2025-08-15,2034-06-01,2035-06-01,INTERVENTIONAL,NA,1100,"['Cardiovascular Diseases', 'Cardiovascular Risk Factors', 'Dyslipidemia', 'Cholesterol', 'Major Cardiovascular Event']",Cardiovascular Diseases,University of Toronto,['Canadian Institutes of Health Research (CIHR)'],['Canada']
NCT06377579,OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia,OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia,RECRUITING,2024-07-31,2025-08-30,2026-06-01,OBSERVATIONAL,,250,"['AML, Adult']","AML, Adult",French Innovative Leukemia Organisation,['Acute Leukemia French Association'],['France']
NCT07039578,Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis,"An Open-Label, Multi-Center, Phase II Clinical Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Relapsed or Refractory Primary Light-Chain Amyloidosis",RECRUITING,2025-07-25,2026-06-30,2029-07-31,INTERVENTIONAL,PHASE2,90,['Primary Light-Chain Amyloidosis'],Primary Light-Chain Amyloidosis,Keymed Biosciences Co.Ltd,[],['China']
NCT05899608,Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients,"A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-line Treatment of Metastatic Non-small Cell Lung Cancer (HARMONi-3)",RECRUITING,2023-10-26,2028-12-31,2029-12-31,INTERVENTIONAL,PHASE3,1600,['Non-Small Cell Lung Cancer'],Non-Small Cell Lung Cancer,Summit Therapeutics,[],"['Belgium', 'Japan', 'China', 'United States', 'France', 'Mexico', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Greece', 'Poland', 'Serbia', 'Sweden', 'Germany']"
NCT05774691,Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI),Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation,RECRUITING,2023-11-01,2025-12,2025-12,INTERVENTIONAL,PHASE4,1000,['Aortic Valve Stenosis'],Aortic Valve Stenosis,St. Antonius Hospital,['St. Antonius Research Fund'],"['Belgium', 'Netherlands']"
NCT05498181,Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation,Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation,RECRUITING,2022-10-11,2026-03-31,2026-07-30,INTERVENTIONAL,PHASE2,100,['Hemodialysis'],Hemodialysis,Brigham and Women's Hospital,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT07137208,Bilevel Erector Spinae Plane Block Versus Transversus Abdominis Plane Block for Analgesia After Cesarean Delivery.,Bilevel Erector Spinae Plane Block Versus Transversus Abdominis Plane Block for Analgesia After Cesarean Delivery Under Spinal Anesthesia: A Randomized Controlled Trial,RECRUITING,2025-10-01,2025-12,2026-01,INTERVENTIONAL,NA,90,['Cesarean Section Wound'],Cesarean Section Wound,Mansoura University,[],['Egypt']
NCT05023785,"The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial","The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial",RECRUITING,2024-01-01,2026-09,2027-03,INTERVENTIONAL,NA,336,"['Heart Failure', 'Cardiotoxicity', 'Cancer']",Heart Failure,"University Health Network, Toronto","[""Centre hospitalier de l'Université de Montréal (CHUM)"", 'Queen Elizabeth II Health Sciences Centre', 'Alberta Health services', 'Vancouver General Hospital', 'Université de Montréal', 'Dalhousie University', 'University of Alberta', 'University of British Columbia', 'University of Toronto']",['Canada']
NCT06407115,Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain,Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain,ACTIVE_NOT_RECRUITING,2024-05-28,2028-05,2028-07,INTERVENTIONAL,NA,30,['Chronic Pain'],Chronic Pain,University of Washington,['National Institute of Nursing Research (NINR)'],['United States']
NCT05088876,Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control,"Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control - a Randomized, Double-blind, Placebo-controlled, Non-inferiority Study",RECRUITING,2024-08-28,2026-07-31,2026-07-31,INTERVENTIONAL,PHASE4,140,['Pain'],Pain,"Insel Gruppe AG, University Hospital Bern",['Swiss National Science Foundation'],['Switzerland']
NCT05465174,Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults,Tovorafenib for the Treatment of Newly Diagnosed or Recurrent Craniopharyngioma in Children and Young Adults,RECRUITING,2022-09-12,2027-03-01,2028-03-01,INTERVENTIONAL,PHASE2,57,"['Craniopharyngioma, Child', 'Craniopharyngioma', 'Recurrent Craniopharyngioma']","Craniopharyngioma, Child","Sabine Mueller, MD, PhD","['Day One Biopharmaceuticals, Inc.']","['United States', 'Australia']"
NCT06161532,"Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...","A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer",RECRUITING,2024-08-01,2027-11-01,2028-11-01,INTERVENTIONAL,PHASE2,60,"['Small Cell Carcinoma of the Bladder', 'Small Cell Carcinoma of the Urinary Tract', 'Squamous Cell Carcinoma of the Bladder', 'Squamous Cell Carcinoma of the Urinary Tract', 'Primary Adenocarcinoma of the Bladder', 'Primary Adenocarcinoma of the Urinary Tract', 'Renal Medullary Carcinoma', 'Squamous Cell Carcinoma of the Penis']",Small Cell Carcinoma of the Bladder,National Cancer Institute (NCI),[],['United States']
NCT07250321,Efficacy of tDCS in Degenerative Ataxia,Efficacy of Cerebellar Transcranial Direct Current Stimulation in Degenerative Ataxia. A Sham-controlled Clinical and Quantitative Analysis.,ACTIVE_NOT_RECRUITING,2023-10-09,2025-07-21,2025-12,INTERVENTIONAL,NA,16,"['Ataxia, Cerebellar', 'Ataxia - Genetic Diagnosis - Unknown', 'Ataxia, Spinocerebellar', 'Ataxias, Hereditary']","Ataxia, Cerebellar",University of Cagliari,[],['Italy']
NCT07252440,A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease,"A Prospective, International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease",RECRUITING,2025-12-05,2028-10-23,2028-11-23,INTERVENTIONAL,PHASE2,180,"['AD', ""Early Alzheimer's Disease""]",AD,"Shanghai Auzone Biological Technology Co., Ltd.",[],['China']
NCT05006404,Autus Valve Pivotal Study,Autus Size-Adjustable Valve for Surgical Pulmonary Valve Replacement Pivotal Study,RECRUITING,2024-02-05,2026-08-01,2036-02-05,INTERVENTIONAL,NA,50,['Congenital Heart Disease'],Congenital Heart Disease,"Autus Valve Technologies, Inc.",[],['United States']
NCT06840899,CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury,Cannabinoid Modulation for Neurogenic Lower Urinary Tract Dysfunction in Spinal Cord Injury,RECRUITING,2025-12,2027-04,2027-04,INTERVENTIONAL,PHASE2,20,"['Supra-sacral Spinal Cord Injury', 'Spinal Cord Injury', 'Urinary Incontinence']",Supra-sacral Spinal Cord Injury,"University of Wisconsin, Madison",[],['United States']
NCT05627245,Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment,Phase 1/Expansion Study of Tazemetostat Plus Belinostat for the Treatment of Relapsed or Refractory Lymphoma,RECRUITING,2023-03-01,2026-09-01,2026-09-01,INTERVENTIONAL,PHASE1,48,"['Recurrent B-Cell Non-Hodgkin Lymphoma', 'Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Recurrent Follicular Lymphoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma', 'Recurrent T-Cell Non-Hodgkin Lymphoma', 'Recurrent Transformed Non-Hodgkin Lymphoma', 'Refractory B-Cell Non-Hodgkin Lymphoma', 'Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Refractory Follicular Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma', 'Refractory T-Cell Non-Hodgkin Lymphoma', 'Refractory Transformed Non-Hodgkin Lymphoma']",Recurrent B-Cell Non-Hodgkin Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT07251309,"A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia","A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of WS016 in Patients With Hyperkalemia",RECRUITING,2024-12-23,2026-11,2026-11,INTERVENTIONAL,PHASE3,420,['Hyperkalemia'],Hyperkalemia,"Waterstone Pharmaceutical (Wuhan) Co., LTD.",[],['China']
NCT04969926,Natural History Study of Parathyroid Disorders,Natural History Study of Parathyroid Disorders,RECRUITING,2021-11-30,2031-01-22,2031-01-22,OBSERVATIONAL,,3000,"['Parathyroid Cancer', 'Primary Hyperparathyroidism', 'Pseudohypoparathyroidism', 'Inheritable Bone Diseases', 'Multiple Endocrine Neoplasia, Type 1']",Parathyroid Cancer,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT05777889,Infrared Images for Spinal Cord Stimulation in Complex Regional Pain Syndrome Patients,The Effect of Spinal Cord Stimulation on Thermal Forward Looking InfraRed (FLIR) Imaging in Complex Regional Pain Syndrome (CRPS),RECRUITING,2023-02-22,2027-02,2027-02,OBSERVATIONAL,,12,['Complex Regional Pain Syndromes'],Complex Regional Pain Syndromes,"Hospital for Special Surgery, New York",[],['United States']
NCT03656835,Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma,A Pilot Study of Nanochip Technology for Monitoring Treatment Response and Detection of Relapse in Patients With Diffuse Large B-Cell Lymphoma,ACTIVE_NOT_RECRUITING,2018-09-26,2024-11-20,2025-11-19,INTERVENTIONAL,NA,73,"['Diffuse Large B-Cell Lymphoma', 'Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Diffuse Large B-Cell Lymphoma, Not Otherwise Specified', 'High Grade B-Cell Lymphoma']",Diffuse Large B-Cell Lymphoma,Ohio State University Comprehensive Cancer Center,[],['United States']
NCT06791837,Brain Blood Flow and Lactate in Non-obese and Obese Subjects,Cerebral Lactate Uptake and Transport in Obese and Non-Obese Individuals,RECRUITING,2025-05-01,2027-03-01,2027-03-01,OBSERVATIONAL,,24,"['Diabetes', 'Obesity']",Diabetes,University of Missouri-Columbia,[],['United States']
NCT06188741,Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1,Phase 2 Trial of Selumetinib for the Prevention of Plexiform Neurofibroma Growth and Morbidity in Neurofibromatosis Type 1,RECRUITING,2025-08-27,2031-09-01,2032-09-01,INTERVENTIONAL,PHASE2,200,"['Neurofibromatosis 1', 'Plexiform Neurofibroma']",Neurofibromatosis 1,University of Alabama at Birmingham,"[""Children's Hospital of Philadelphia"", 'Congressionally Directed Medical Research Programs']",['United States']
NCT02810743,Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer,Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer Patients With Personalized Therapy (SUBITO) - an International Randomized Phase III Trial,ACTIVE_NOT_RECRUITING,2017-01-25,2024-07-18,2033-12-01,INTERVENTIONAL,PHASE3,174,['Breast Cancer'],Breast Cancer,The Netherlands Cancer Institute,[],"['France', 'Netherlands']"
NCT05867173,Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces,Development and Assessment of Listener-tailored Programming for Cochlear Implant Listeners,RECRUITING,2022-09-16,2027-03-31,2027-03-31,INTERVENTIONAL,NA,200,['Deafness'],Deafness,Massachusetts Eye and Ear Infirmary,"[""Boston Children's Hospital"", 'University of Washington']",['United States']
NCT06410352,Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome,"Effectiveness of Pharmacologic, Surgical, and Dietetic Weight Loss Methods on Lifespan in Patients With Metabolic Syndrome: a Comparative Clinical Trial",RECRUITING,2024-03-01,2025-09-30,2026-07-31,INTERVENTIONAL,PHASE4,220,['Metabolic Syndrome'],Metabolic Syndrome,"University Medical Center, Kazakhstan","['Nazarbayev University School of Medicine', 'Nazarbayev University', 'Astana Medical University', 'Public Association ""Eurasian Society of Personalized Medicine""', 'Ministry of Science and Higher Education of the Republic of Kazakhstan']",['Kazakhstan']
NCT05084053,A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN),"A Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of TAK-771 for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) in Japanese Subjects",ACTIVE_NOT_RECRUITING,2022-01-19,2024-03-05,2026-05-31,INTERVENTIONAL,PHASE3,26,"['Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)', 'Multifocal Motor Neuropathy (MMN)']",Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP),Takeda,[],['Japan']
NCT01266915,Cutaneous Lupus Registry,Molecular Studies on Cutaneous Lupus,RECRUITING,2009-01,2030-12,2030-12,OBSERVATIONAL,,1000,['Lupus Erythematosus'],Lupus Erythematosus,University of Texas Southwestern Medical Center,[],['United States']
NCT04708418,A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma,Phase II Randomized Study of Neoadjuvant Pembrolizumab Alone or in Combination With CMP-001 in Patients With Operable Melanoma: Efficacy and Biomarker Study,ACTIVE_NOT_RECRUITING,2021-10-15,2026-06-30,2026-06-30,INTERVENTIONAL,PHASE2,60,"['Clinical Stage III Cutaneous Melanoma AJCC v8', 'Melanoma of Unknown Primary', 'Pathologic Stage IIIB Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIIC Cutaneous Melanoma AJCC v8', 'Pathologic Stage IIID Cutaneous Melanoma AJCC v8', 'Recurrent Cutaneous Melanoma']",Clinical Stage III Cutaneous Melanoma AJCC v8,National Cancer Institute (NCI),[],['United States']
NCT06815653,Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs,Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.,RECRUITING,2025-03-01,2026-03,2026-12,INTERVENTIONAL,PHASE1,40,['Healthy'],Healthy,"University College, London",[],['United Kingdom']
NCT04453293,Immunization With BCG Vaccine to Prevent Tuberculosis Infection,"A Proof-of Concept, Randomized, Controlled Study of Tuberculosis Immunization With BCG to Prevent Infection in Healthy Adults (TIPI Trial)",RECRUITING,2021-12-01,2027-09-30,2027-09-30,INTERVENTIONAL,PHASE3,2000,['Tuberculosis Infection'],Tuberculosis Infection,Henry M. Jackson Foundation for the Advancement of Military Medicine,"['United States Department of Defense', 'Uniformed Services University of the Health Sciences']",['United States']
NCT06580275,The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure,The GLACE Study: A Prospective Multi-center Single Arm Study Evaluating the Safety and Performance of the CLAAS Device With ICE Guided LAA Closure.,RECRUITING,2024-09-24,2025-12,2025-12,INTERVENTIONAL,NA,80,"['Atrial Fibrillation', 'Stroke Prevention']",Atrial Fibrillation,"Conformal Medical, Inc",[],"['Denmark', 'Italy', 'Czechia']"
NCT06567210,The Effects of Insomnia Treatment on Overnight Regulation of Emotional Memories and Risk for Mental Disorders,A Delayed-start Randomized Controlled Trial Comparing the Effects of Online Therapist-guided Cognitive Behavioural and Circadian Therapy for Insomnia Versus Control on Overnight Emotion Regulation and Mental Health Outcomes,RECRUITING,2026-01-06,2029-06,2030-06,INTERVENTIONAL,NA,98,"['Insomnia Chronic', 'Anxiety']",Insomnia Chronic,Woolcock Institute of Medical Research,"['Macquarie University, Australia']",['Australia']
NCT06647069,DR-0201 in Subjects With Autoimmune Diseases,"A Phase 1, Open-label, Multiple Ascending Dose Basket Study to Evaluate the Safety and Activity of DR-0201 in Patients With Select Autoimmune Rheumatic Diseases",RECRUITING,2025-03-27,2026-12,2026-12,INTERVENTIONAL,PHASE1,36,"['SLE', 'SLE (Systemic Lupus)', 'CLE', 'Cutaneous Lupus', ""Sjogren's Syndrome"", 'Primary Sjögren Syndrome', 'Dermatomyositis', 'Polymyositis', 'Scleroderma', 'SSc, Diffuse Sclerosis', 'dcSSc', 'Diffuse Cutaneous Systemic Sclerosis']",SLE,Dren Bio,[],"['New Zealand', 'Bosnia and Herzegovina', 'South Africa', 'Australia']"
NCT05985161,A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors,A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors,RECRUITING,2023-08-01,2029-08-01,2029-08-01,INTERVENTIONAL,PHASE2,45,"['Wilms Tumor', 'Rhabdoid Tumor', 'Malignant Peripheral Nerve Sheath Tumors', 'MPNST', 'Nephroblastoma', 'XPO1 Gene Mutation', 'Solid Tumor']",Wilms Tumor,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT07250893,Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression,Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression,RECRUITING,2025-10-25,2027-08-15,2028-08-15,INTERVENTIONAL,NA,50,"['Depression - Major Depressive Disorder', 'Childhood Traumas']",Depression - Major Depressive Disorder,St. Joseph's Healthcare Hamilton,['Sun Life Financial Movement Disorders Research and Rehabilitation Centre'],['Canada']
NCT06858319,Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.,A Multicenter Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Zigakibart in Adults With Primary IgA Nephropathy.,RECRUITING,2025-07-28,2031-06-25,2031-06-25,INTERVENTIONAL,PHASE3,223,"['Kidney Diseases', 'Kidney Diseases, Chronic', 'Urological Diseases', 'Glomerulonephritis', 'Glomerular Disease', 'Glomerulonephritis, IGA', 'Glomerulopathy', 'Immunoglobulin Disease']",Kidney Diseases,Novartis Pharmaceuticals,[],"['Argentina', 'United States', 'South Korea']"
NCT07005128,"A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)","A Phase 3, Open Label, Multicenter, Randomized Study of First Line Tarlatamab in Combination With Durvalumab, Carboplatin and Etoposide Versus Durvalumab, Carboplatin and Etoposide in Untreated Extensive Stage Small-Cell Lung Cancer (DeLLphi-312)",RECRUITING,2025-08-18,2029-01-04,2029-07-15,INTERVENTIONAL,PHASE3,330,"['Small-cell Lung Cancer', 'Extensive Stage Small-cell Lung Cancer']",Small-cell Lung Cancer,Amgen,['AstraZeneca'],"['Japan', 'Hong Kong', 'Netherlands', 'China', 'Australia', 'Belgium', 'Hungary', 'France', 'Denmark', 'South Korea', 'Poland', 'Switzerland', 'Spain', 'Taiwan', 'Greece', 'Germany', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy']"
NCT07250100,The Role of Microbiota in Pancreatic Cancer and Precursor Lesions,The Role of Microbiota in Pancreatic Cancer and Precursor Lesions,RECRUITING,2025-11-01,2030-10,2037-12,OBSERVATIONAL,,300,"['Pancreatic Cancer', 'Microbiome']",Pancreatic Cancer,Herlev Hospital,['Danish Cancer Society'],['Denmark']
NCT07213245,Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF),Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF): a Randomized Controlled Trial,RECRUITING,2025-12-01,2026-04-30,2026-04-30,INTERVENTIONAL,NA,24,"['Appetite', 'Obesity and Obesity-related Medical Conditions']",Appetite,Göteborg University,[],['Sweden']
NCT07109570,"Surface Electrical Myography, Oxygen Consumption, Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit","Surface Electrical Myography, Oxygen Consumption (VO2), Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit (ICU): SERA-Effort Study",RECRUITING,2025-07-08,2028-12-31,2029-06,OBSERVATIONAL,,60,"['Critical Illness', 'Intensive Care Units (ICUs)', 'Weaning Failure', 'Mechanical Ventilation', 'Spontaneous Breathing Trial', 'Diaphragm Electrical Activity', 'Oxygen Consumption']",Critical Illness,Leiden University Medical Center,['Demcon-Macawi'],['Netherlands']
NCT07189676,Sustainable Diets and Cardiometabolic Health,PLANETDIET: Sustainable Diets and Cardiometabolic Health: a Multi-omics Approach in a Randomized Controlled Trial (RCT),RECRUITING,2025-11-24,2027-04,2027-04,INTERVENTIONAL,NA,180,['Cardiometabolic Diseases'],Cardiometabolic Diseases,University of Copenhagen,"['Novo Nordisk Foundation (NNF)', 'Danish Heart Foundation']",['Denmark']
NCT07251205,Evaluating a Culinary Curriculum Program for Residents of Medication Assisted Therapy (MAT) Recovery Houses,Evaluation of a Culinary Curriculum Program for Persons Living in Recovery Residences for Opioid Use on Medication Assisted Therapy in Texas,RECRUITING,2025-08-11,2025-12-01,2025-12-01,INTERVENTIONAL,NA,50,['Cooking Skills'],Cooking Skills,"The University of Texas Health Science Center, Houston",['Texas Health and Human Services Commission'],['United States']
NCT06316856,CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies,"CD5 Chimeric Antigen Receptors (CAR) T Cells in Subjects With Relapsed or Refractory T-Cell Malignancies: a Multi-center, Open-label, Non-randomized, Phase 1/2 Clinical Trial",RECRUITING,2024-06-18,2025-12-31,2026-06-30,INTERVENTIONAL,PHASE1,54,"['T-Cell Acute Lymphocytic Leukemia', 'Acute Lymphoblastic Leukemia, in Relapse', 'Refractory Acute Lymphoblastic Leukemia', 'T-cell Malignancies']",T-Cell Acute Lymphocytic Leukemia,Beijing GoBroad Hospital,"['The General Hospital of Western Theater Command', 'Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai', 'Shanghai Liquan Hospital', ""Central People's Hospital of Zhanjiang"", 'First Affiliated Hospital of Guangxi Medical University']",['China']
NCT06612268,A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease,"A Global Phase 3, Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of Etavopivat in Adolescents and Adults With Sickle Cell Disease",RECRUITING,2025-02-17,2027-08-27,2029-03-12,INTERVENTIONAL,PHASE3,408,['Sickle Cell Disease'],Sickle Cell Disease,Novo Nordisk A/S,[],"['Netherlands', 'Saudi Arabia', 'Kenya', 'Australia', 'Belgium', 'Oman', 'France', 'Ghana', 'Uganda', 'Nigeria', 'Colombia', 'India', 'Lebanon', 'Spain', 'Canada', 'United Kingdom', 'Greece', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy']"
NCT05966467,Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies,"A Long-Term, Prospective, Observational, Registry of Patients With Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated With Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)",RECRUITING,2024-02-01,2030-03-01,2030-03-01,OBSERVATIONAL,,122,"['Neuromyelitis Optica Spectrum Disorder', 'NMOSD', 'AQP4+ NMOSD']",Neuromyelitis Optica Spectrum Disorder,"Alexion Pharmaceuticals, Inc.",[],"['Japan', 'China', 'United States', 'Italy', 'Canada', 'South Korea', 'Argentina', 'Germany']"
NCT02180724,"An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia","An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia",ACTIVE_NOT_RECRUITING,2014-09-11,2019-10-01,2026-12-31,INTERVENTIONAL,PHASE2,107,['Waldenström Macroglobulinemia (WM)'],Waldenström Macroglobulinemia (WM),Acerta Pharma BV,[],"['Netherlands', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Greece']"
NCT04808427,Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer,Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation,RECRUITING,2023-11-20,2027-05-01,2027-09-01,INTERVENTIONAL,NA,21,['Prostate Cancer'],Prostate Cancer,National Cancer Institute (NCI),[],['United States']
NCT03900468,Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS),Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS),RECRUITING,2020-03-05,2028-09,2028-09,INTERVENTIONAL,NA,140,['Epilepsy'],Epilepsy,MedtronicNeuro,[],"['Belgium', 'Portugal', 'United States', 'Czechia']"
NCT07151040,Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors,"A First-in-human, Phase 1/2, Multicenter, Open-label, Dose Escalation, Confirmation and Expansion Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of TH9619 in Subjects With Advanced Solid Tumors",RECRUITING,2025-08-22,2026-12,2026-12,INTERVENTIONAL,PHASE1,43,"['Solid Tumor', 'Colorectal Cancer (CRC)', 'Squamous Cell Carcinoma of Head and Neck', 'Non-Small Cell Lung Cancer (NSCLC)', 'Gastrooesophageal Junction Cancer', 'Gastric Cancer']",Solid Tumor,One-carbon Therapeutics AB,[],"['United Kingdom', 'Spain', 'France']"
NCT06824103,Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease,A Single-arm Multi-center Study of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft Versus Host Disease After Allogeneic Stem Cell Transplantation,RECRUITING,2025-09-09,2029-11-29,2032-01-11,INTERVENTIONAL,PHASE4,50,"['Graft vs. Host Disease', 'Chronic Graft vs. Host Disease', 'Corticosteroid-refractory Chronic Graft vs. Host Disease']",Graft vs. Host Disease,Novartis Pharmaceuticals,[],['China']
NCT06316427,Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies,"Autologous and Donor-derived CD7 CAR T-cell Therapy in Refractory or Relapsed T-cell Malignancies: a Multi-center, Open-label, Phase Ⅰ/Ⅱ Clinical Trial",RECRUITING,2024-03-22,2026-04-01,2028-03-30,INTERVENTIONAL,PHASE1,80,"['T-cell Acute Lymphoblastic Leukemia', 'Acute Lymphoblastic Leukemia, in Relapse', 'Refractory Acute Lymphoblastic Leukemia', 'T-cell Malignancies']",T-cell Acute Lymphoblastic Leukemia,Beijing GoBroad Hospital,"['The General Hospital of Western Theater Command', 'Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai', 'Shanghai Liquan Hospital', ""Central People's Hospital of Zhanjiang"", 'First Affiliated Hospital of Guangxi Medical University']",['China']
NCT07250542,A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer,A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer,RECRUITING,2024-07-05,2025-12-30,2026-12-30,INTERVENTIONAL,PHASE2,30,['Prostate Cancer'],Prostate Cancer,baotai Liang,[],['China']
NCT05236465,A 3-day Course for CFS/ME,A 3-day Course for Adults With Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME): a Randomized Controlled Trial,RECRUITING,2022-03-21,2027-01-01,2028-12-01,INTERVENTIONAL,NA,100,"['Chronic Fatigue Syndrome', 'Myalgic Encephalomyelitis']",Chronic Fatigue Syndrome,Norwegian University of Science and Technology,"['University of Oslo', 'Haukeland University Hospital', 'Lørenskog municipality', 'The Research Council of Norway']",['Norway']
NCT02639299,"Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge","Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge",RECRUITING,2016-12-08,2030-09-30,2030-09-30,OBSERVATIONAL,,1500,['Malaria'],Malaria,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT05673915,Study of Transcranial Direct Current Stimulation to Treat Epilepsy,Pilot Study of Transcranial Direct Current Stimulation (tDCS) to Treat Epilepsy,RECRUITING,2023-04-12,2025-12,2026-02,INTERVENTIONAL,NA,30,"['Focal Epilepsy', 'Generalized Onset Epilepsy', 'Sleep-related Epileptic Encephalopathy']",Focal Epilepsy,Mayo Clinic,[],['United States']
NCT07250555,Analysis of Bioenergetics and Fatigue Responses in Basketball (TEAM),sTudy of the bioEnergetics and fAtigue Responses of a Basketball gaMe: The TEAM Trial,RECRUITING,2025-05-30,2025-11-30,2026-02-28,INTERVENTIONAL,NA,30,['Metabolic Stress'],Metabolic Stress,University of Thessaly,"['University of Southern Denmark', 'Democritus University of Thrace']",['Greece']
NCT06594926,Working Out M0 Bipolar Androgen Therapy,Evaluating the Efficacy of Bipolar Androgen Therapy in Extending Metastasis-free Survival in Patients With M0 Castrate-resistant Prostate Cancer With PSA Progression But Not Radiological or Clinical Progression on Darolutamide,RECRUITING,2024-08-14,2026-12-31,2028-12-31,INTERVENTIONAL,PHASE2,69,['Prostate Cancer'],Prostate Cancer,Australian and New Zealand Urogenital and Prostate Cancer Trials Group,"['Bayer', 'The George Institute', 'HMRI']",['Australia']
NCT06534255,"A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.","A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.",ACTIVE_NOT_RECRUITING,2024-12-04,2025-06-19,2026-05-22,INTERVENTIONAL,PHASE1,10,['Refractory Thrombocytopenia'],Refractory Thrombocytopenia,Anhui Provincial Hospital,[],['China']
NCT07215260,A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body,"The Effect of BI 3000202 on the Pharmacokinetics of Rosuvastatin and Digoxin Given as a Cocktail - an Open-label, Non-randomised, 2-period Fixed-sequence Trial in Healthy Male and Female Trial Participants",ACTIVE_NOT_RECRUITING,2025-11-05,2025-11-28,2025-12-22,INTERVENTIONAL,PHASE1,14,['Healthy'],Healthy,Boehringer Ingelheim,[],['Germany']
NCT03271762,Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery,Multicentre and Randomized Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery,ACTIVE_NOT_RECRUITING,2018-03-02,2026-12,2028-01,INTERVENTIONAL,NA,330,['Mitral Regurgitation'],Mitral Regurgitation,Nantes University Hospital,"['Ministère de la Santé', 'Abbott']",['France']
NCT02257866,"Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis","Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis",RECRUITING,2014-09-29,2050-01-01,2050-01-01,OBSERVATIONAL,,4000,"[""Takayasu's Arteritis"", 'Giant Cell Arteritis', 'Polyarteritis Nodosa', 'Relapsing Polychondritis', 'ANCA-Associated Vasculitis']",Takayasu's Arteritis,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT07184242,"Strength Training and Proprioceptive Stimulation on Pain, Function, Quality of Life, Sleep Quality, and Psychosocial Factors in Older Adults With Shoulder Pain","Multi-joint Strength Exercises and Proprioceptive Somatosensory Stimulation on Pain, Function, Quality of Life, Sleep Quality, and Psychosocial Factors in Patients Over 60 Years of Age With Chronic Rotator Cuff-related Shoulder Pain",RECRUITING,2025-09-18,2025-09-23,2025-12-19,INTERVENTIONAL,NA,80,['Shoulder Pain'],Shoulder Pain,University of Jaén,[],['Spain']
NCT07252583,Relationships Between Sexuality and Mental Health in Older People,Relationships Between Sexuality and Mental Health in Older People,RECRUITING,2025-10-01,2026-09,2026-09,INTERVENTIONAL,NA,200,['Old Age'],Old Age,"University Hospital, Clermont-Ferrand",[],['France']
NCT06748001,Avapritinib Rollover Study,"An Open-label, Multicenter, Rollover Study in Patients Who Participated in an Avapritinib Clinical Study",RECRUITING,2024-11-28,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE4,60,"['Mastocytosis, Systemic']","Mastocytosis, Systemic",Blueprint Medicines Corporation,[],"['Belgium', 'Norway', 'Netherlands', 'Italy', 'Canada', 'United Kingdom']"
NCT06668493,Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis,"A Phase 1/2, Single-arm, Open-Label Trial to Evaluate the Safety and Efficacy of Nadofaragene Firadenovec Instilled to the Renal Pelvis in Adult Subjects With Low-grade Upper Tract Urothelial Carcinoma (LG-UTUC)",RECRUITING,2025-06-12,2029-11-30,2029-11-30,INTERVENTIONAL,PHASE1,20,['Low-grade Upper Tract Urothelial Carcinoma'],Low-grade Upper Tract Urothelial Carcinoma,Ferring Pharmaceuticals,[],['United States']
NCT06709014,A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD,"A 6-month & 18-month Prospective, Randomized, Placebo-controlled, Double-blind Dual Clinical Trial Investigating Efficacy and Safety of Buntanetap in Treating Participants of Early Alzheimer's Disease",RECRUITING,2025-02-04,2027-12,2028-06,INTERVENTIONAL,PHASE3,760,['Early Alzheimers Disease'],Early Alzheimers Disease,Annovis Bio Inc.,['Prevail Infoworks'],['United States']
NCT03774732,PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer,PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer,RECRUITING,2018-01-24,2026-12-22,2026-12-22,INTERVENTIONAL,PHASE3,327,"['Non Small Cell Lung Cancer', 'Non Small Cell Lung Cancer Metastatic', 'Non-Small Cell Carcinoma of Lung, TNM Stage 4']",Non Small Cell Lung Cancer,UNICANCER,"['National Cancer Institute, France']","['Monaco', 'France']"
NCT06656884,FARAPULSE Workflow Assessment Registry,FARAPULSE Workflow Assessment Registry,RECRUITING,2025-05-06,2026-02-15,2027-02-15,OBSERVATIONAL,,500,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),Boston Scientific Corporation,[],"['Belgium', 'Netherlands', 'Saudi Arabia', 'Austria', 'France', 'Spain', 'Italy', 'United Kingdom', 'Greece', 'Sweden', 'Germany']"
NCT02471352,Studies of Dermatologic Diseases Biospecimen Acquisition Protocol,Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol,RECRUITING,2015-06-19,2027-01-31,2027-01-31,OBSERVATIONAL,,700,"['Dermatologic Conditions', 'Healthy Volunteers', 'Normal Volunteers', 'Carcinoma, Merkel Cell']",Dermatologic Conditions,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),[],['United States']
NCT07252518,Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia,Effect of Pentoxifylline Plus Coenzyme Q10 Combination Therapy Compared to Coenzyme Q10 Alone on Sperm Motility in Sub-fertile Male With Asthenozoospermia,RECRUITING,2025-10-01,2026-07-01,2027-03-01,INTERVENTIONAL,NA,56,['Asthenozoospermia'],Asthenozoospermia,Mst.Sumyara Khatun,['Bangladesh Medical University'],['Bangladesh']
NCT07206212,A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder,Efficacy and Cost-effectiveness of a Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder: A Randomized Controlled Trial,RECRUITING,2025-12-01,2027-11-01,2028-11-01,INTERVENTIONAL,NA,108,"['Obsessive Compulsive Disorder (OCD)', 'Lifestyle (Sedentary Behavior and Physical Activity)']",Obsessive Compulsive Disorder (OCD),Karolinska Institutet,['Region Stockholm'],['Sweden']
NCT05538091,"Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer","Phase II Clinical Trial Combining the Hedgehog Inhibitor Vismodegib With the PD-L1 Inhibitor Atezolizumab in Patients With Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer",RECRUITING,2023-05-15,2031-03-17,2033-03-17,INTERVENTIONAL,PHASE2,48,"['Platinum-Resistant Fallopian Tube Carcinoma', 'Platinum-Resistant Primary Peritoneal Carcinoma', 'PARP Inhibitor', 'Hedgehog Inhibitor']",Platinum-Resistant Fallopian Tube Carcinoma,Ronald Buckanovich,"['Genentech, Inc.']",['United States']
NCT06496646,Antidepressant Adherence for Depressed Adults in Primary Care,Antidepressant Medication Adherence in Adults With Depression,RECRUITING,2025-03-19,2029-03-31,2029-03-31,INTERVENTIONAL,NA,525,['Depression'],Depression,University of Pennsylvania,[],['United States']
NCT07251582,Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer,A Prospective Study on the Effect of Infusion Timing of Immune Checkpoint Inhibitors on Pathologic Response in Patients With Resectable Stage II-III Non-Small Cell Lung Cancer Undergoing Neoadjuvant Therapy,RECRUITING,2025-12-07,2028-10-31,2029-05-31,INTERVENTIONAL,PHASE3,156,['Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)'],Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC),Hunan Province Tumor Hospital,[],['China']
NCT07122843,VR AI Meditation for Pain,Real Time Guided Meditations for Pain in Virtual Reality Study,RECRUITING,2025-11-06,2026-10-20,2027-01-20,INTERVENTIONAL,NA,38,['Pain and Anxiety'],Pain and Anxiety,Christopher Almario,[],['United States']
NCT02811523,In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma,In Vivo Lung Perfusion (IVLP) as an Adjuvant Treatment for Patients Undergoing Surgical Resection of Pulmonary Metastases of Bone and Soft Tissues Sarcomas,RECRUITING,2016-02,2030-09,2030-09,INTERVENTIONAL,PHASE1,17,"['Bone Sarcoma', 'Soft Tissue Sarcoma', 'Pulmonary Metastases']",Bone Sarcoma,"University Health Network, Toronto",[],['Canada']
NCT06107686,A Study of YL202 in Selected Patients With Advanced Solid Tumors,"A Multicenter, Open-Label, Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of YL202 in Selected Patients With Advanced Solid Tumors",RECRUITING,2023-12-15,2026-11,2028-11,INTERVENTIONAL,PHASE2,200,"['NSCLC', 'Breast Cancer', 'HNSCC', 'Locally Advanced or Metastatic Solid Tumors']",NSCLC,"MediLink Therapeutics (Suzhou) Co., Ltd.",[],['China']
NCT05963633,Future Thinking to Improve Parent-Child Relationships,Further Forward: Future Thinking to Improve Parent-Child Relationships,ACTIVE_NOT_RECRUITING,2023-09-01,2025-12-01,2025-12-01,INTERVENTIONAL,NA,72,"['Behavior, Health']","Behavior, Health",Henry Ford Health System,"['University of Kansas', 'University of Maryland, College Park']",['United States']
NCT01898117,Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer,Biomarker Discovery Randomized Phase IIb Trial With Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer,ACTIVE_NOT_RECRUITING,2013-07,2024-04-01,2030-12,INTERVENTIONAL,PHASE2,304,['Breast Cancer'],Breast Cancer,The Netherlands Cancer Institute,"['Borstkanker Onderzoek Groep', 'Roche Pharma AG']",['Netherlands']
NCT03892785,"MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial","MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial",ACTIVE_NOT_RECRUITING,2020-01-27,2026-01,2027-03,INTERVENTIONAL,PHASE3,230,['Giant Cell Arteritis'],Giant Cell Arteritis,Centre Hospitalier Universitaire Dijon,[],['France']
NCT04225611,Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema,"Randomized, Prospective, Vehicle-Controlled, Phase I/II Clinical Trial to Evaluate the Safety and Feasibility of a Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema",RECRUITING,2021-03-15,2027-12-31,2027-12-31,INTERVENTIONAL,PHASE1,6,['Cystoid Macular Edema'],Cystoid Macular Edema,Massachusetts Eye and Ear Infirmary,[],['United States']
NCT07240558,Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial),Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial): Safety and Immunogenicity of Pandemic Influenza Vaccine in Kidney Transplant Recipients,RECRUITING,2025-11-03,2026-06-30,2026-12-31,INTERVENTIONAL,PHASE3,120,"['Influenza (Pandemic)', 'Avian Influenza', 'Vaccination']",Influenza (Pandemic),"University Health Network, Toronto",['Laval University'],['Canada']
NCT03571633,Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer,"A Multicenter, Randomized, Open-label, Phase II Trial Aiming to Evaluate the Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2 Positive Breast Cancer Patients",ACTIVE_NOT_RECRUITING,2018-08-06,2027-01,2027-09,INTERVENTIONAL,PHASE2,90,"['HER2-positive Breast Cancer', 'Operable Breast Cancer']",HER2-positive Breast Cancer,Centre Leon Berard,['Amgen'],['France']
NCT06739096,Investigation of the Effectiveness of Short Wave Diathermy Treatment in Patients With Hand Osteoarthritis,Investigation of the Effectiveness of Short Wave Diathermy Treatment in Patients With Hand Osteoarthritis,ACTIVE_NOT_RECRUITING,2024-03-18,2025-02-18,2026-02-28,INTERVENTIONAL,NA,36,"['Hand Osteoarthritis', 'Osteoarthritis']",Hand Osteoarthritis,Omer Sezgin,[],['Turkey (Türkiye)']
NCT07252115,TLSA Versus TBSA Surgical Approach for Hiatal Hernia With Gastroesophageal Reflux Disease,Multicenter Randomized Clinical Trial on the Efficacy and Safety of the Total Left-side Surgical Approach (TLSA) Versus the Traditional Bilateral Surgical Approach (TBSA) for Hiatal Hernia With Gastroesophageal Reflux Disease,RECRUITING,2024-04-04,2025-11-30,2026-12-31,INTERVENTIONAL,NA,143,"['Hernia, Hiatal', 'GERD (Gastroesophageal Reflux Disease)']","Hernia, Hiatal",Beijing Friendship Hospital,"['Beijing Chao Yang Hospital', 'Xuanwu Hospital, Beijing']",['China']
NCT06984146,Nivo40-AVD for Advanced Classic Hodgkin Lymphoma,"Flat-dose Nivolumab (40 mg) in Combination With Doxorubicin, Vinblastine, and Dacarbazine (AVD) for Newly Diagnosed Advanced Classic Hodgkin Lymphoma",RECRUITING,2025-04-15,2028-01,2029-01,INTERVENTIONAL,PHASE2,54,"['Hodgkin Lymphoma, Adult']","Hodgkin Lymphoma, Adult",National Medical Research Radiological Centre of the Ministry of Health of Russia,[],['Russia']
NCT06955403,Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses,How Does PRECISION7® for Astigmatism Perform in Current and Successful Acuvue® Oasys for Astigmatism Wearers?,RECRUITING,2025-04-15,2025-08-31,2025-11-30,INTERVENTIONAL,NA,40,['Contact Lens Comfort'],Contact Lens Comfort,Southern College of Optometry,['Eminent Ophthalmic Services'],['United States']
NCT06439836,Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy,Phase 1 Trial of CA-4948 in Combination With Pembrolizumab to Overcome Resistance to PD-1/PD-L1 Blockade in Metastatic Urothelial Cancer,RECRUITING,2025-05-05,2027-06-01,2027-06-01,INTERVENTIONAL,PHASE1,27,"['Metastatic Urothelial Carcinoma', 'Unresectable Urothelial Carcinoma']",Metastatic Urothelial Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT06094543,Improving Overactive Bladder Treatment Access and Adherence,Improving Overactive Bladder Treatment Access and Adherence Through Personalized Behavioral Modifications and Mobile Technology-Based Interventions,RECRUITING,2024-11-01,2026-08,2026-12,INTERVENTIONAL,NA,30,"['Overactive Bladder Syndrome', 'Urinary Incontinence']",Overactive Bladder Syndrome,Stanford University,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT07252492,"Evaluation of Performances, Clinical Benefits and Safety of the 'Audiocap' Connected Hearing Rehabilitation Device for Improving Audibility in Hearing-impaired People in the Context of CE Marking - AUDIOCAP-2","Evaluation of Performances, Clinical Benefits and Safety of the 'Audiocap' Connected Hearing Rehabilitation Device for Improving Audibility in Hearing-impaired People in the Context of CE Marking",RECRUITING,2025-09-10,2027-09,2027-09,INTERVENTIONAL,NA,100,"['Hearing Loss, Adult-Onset', 'Hearing Aid']","Hearing Loss, Adult-Onset",Archean Technologies,[],['France']
NCT06919484,The Physiological Effect of RCexp on Ventilation/Perfusion Distribution,The Physiological Effect of RCexp on Ventilation/Perfusion Distribution in Patients With ARDS,RECRUITING,2025-11-30,2026-12-31,2026-12-31,OBSERVATIONAL,,60,"['Acute Respiratory Distress Syndrome', 'Mechanical Ventilation']",Acute Respiratory Distress Syndrome,"Southeast University, China",[],['China']
NCT06672237,A Phase 3 Study of NTLA-2001 in ATTRv-PN,"MAGNITUDE-2: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN)",ACTIVE_NOT_RECRUITING,2024-11-22,2027-07,2028-08,INTERVENTIONAL,PHASE3,50,"['Neuromuscular Disease', 'Neuromuscular Diseases (NMD)', 'Neurodegenerative Disease', 'Neurodegenerative Disease, Hereditary', 'Neurodegenerative Diseases', 'Neuromuscular Diseases', 'Nerve Disorders', 'Nervous System Disease', 'Nervous System Diseases', 'Genetic Disease, Inborn', 'Amyloidosis, Familial', 'Amyloidosis, Hereditary', 'Amyloidosis', 'Polyneuropathies', 'Amyloid Neuropathies', 'Amyloid Neuropathies, Familial', 'Peripheral Nervous System Disease', 'Peripheral Nervous System Diseases', 'Metabolism, Inborn Errors', 'Metabolic Diseases']",Neuromuscular Disease,Intellia Therapeutics,['Regeneron Pharmaceuticals'],"['Brazil', 'Singapore', 'New Zealand', 'Mexico', 'Taiwan', 'Thailand', 'Argentina', 'Australia']"
NCT05841628,Tolerability of 532 nm Laser Treatment of Port Wine Stains,Tolerability of 532 nm Laser Treatment of Port Wine Stains,RECRUITING,2023-05-01,2026-12,2026-12,INTERVENTIONAL,NA,15,['Port-Wine Stain'],Port-Wine Stain,Massachusetts General Hospital,[],['United States']
NCT05904080,"Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer",Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy,RECRUITING,2024-02-19,2028-06-16,2028-06-16,INTERVENTIONAL,PHASE2,50,"['Metastatic Nasopharyngeal Carcinoma', 'Recurrent Nasopharyngeal Carcinoma', 'Stage IV Nasopharyngeal Carcinoma AJCC v8']",Metastatic Nasopharyngeal Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT07021079,Muscle Vibration as a Countermeasure Against Hypoactivity-induced,Effects of Focal Muscle Vibration as a Countermeasure Against Hypoactivity-induced Neuromuscular Deconditioning,RECRUITING,2025-06-16,2027-06-01,2027-08-31,INTERVENTIONAL,NA,42,"['Vibration Therapy', 'Healthy Volunteer Study', 'Hypoactivity']",Vibration Therapy,Centre Hospitalier Universitaire de Saint Etienne,[],['France']
NCT06284486,A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib,A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib,RECRUITING,2024-09-23,2026-12-30,2028-12-30,INTERVENTIONAL,PHASE1,8,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,M.D. Anderson Cancer Center,"['Syndax Pharmaceuticals', 'AbbVie']",['United States']
NCT07217873,IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study,IntraVenous Iron in Kids With Iron Deficiency and Scoliosis,RECRUITING,2025-11-21,2027-08-31,2027-10-31,INTERVENTIONAL,PHASE2,120,"['Scoliosis Correction', 'Iron Deficiency', 'Transfusion Blood', 'Surgery Complications', 'Spinal Fusion', 'Scoliosis Idiopathic Adolescent', 'Scoliosis Neuromuscular']",Scoliosis Correction,Columbia University,['Association for the Advancement of Blood & Biotherapies'],['United States']
NCT05911802,Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease,"Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease: Validation of International Prognostic Indexes, Evaluation of Progression-free Survival as a Surrogate Endpoint for Overall Survival. A FILO Study.",RECRUITING,2023-08-11,2030-06-15,2030-06-15,OBSERVATIONAL,,500,"[""Waldenstrom's Disease"", 'Prognostic Index']",Waldenstrom's Disease,French Innovative Leukemia Organisation,[],['France']
NCT02921022,"Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma","Pilot Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma",ACTIVE_NOT_RECRUITING,2016-10,2026-10,2026-10,INTERVENTIONAL,NA,110,"['Pancreatic Cancer', 'Advanced Pancreatic Ductal Adenocarcinoma']",Pancreatic Cancer,Memorial Sloan Kettering Cancer Center,"['Halozyme Therapeutics', 'Miami Cancer Institute']",['United States']
NCT06621329,Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache,Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache,RECRUITING,2024-10-17,2026-07,2026-10,INTERVENTIONAL,PHASE2,40,"['SAH (Subarachnoid Hemorrhage)', 'Headache']",SAH (Subarachnoid Hemorrhage),"University of California, Davis",['Agnes Marshall Walker Foundation'],['United States']
NCT06607302,Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study,"Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - a Prospective, Multicenter, Observational Study in Germany",RECRUITING,2024-10-08,2027-12,2027-12,OBSERVATIONAL,,100,['Cholangiocarcinoma'],Cholangiocarcinoma,iOMEDICO AG,['Servier Deutschland GmbH'],['Germany']
NCT07211867,A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder,A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder,RECRUITING,2025-11-24,2027-03,2027-05,INTERVENTIONAL,NA,152,['Substance Use Disorder'],Substance Use Disorder,Washington University School of Medicine,['National Institute on Drug Abuse (NIDA)'],['United States']
NCT03702309,Liquid Biopsy Evaluation and Repository Development at Princess Margaret,Liquid Biopsy Evaluation and Repository Development at Princess Margaret,RECRUITING,2017-08-03,2026-07-06,2026-07-06,OBSERVATIONAL,,2500,"['Cancer', 'Breast Cancer', 'Lung Cancer', 'Colon Cancer', 'Ovarian Cancer', 'Melanoma', 'Lymphoma', 'Leukemia', 'Mutation', 'Lynch Syndrome', 'Cowden Syndrome', 'BRCA1 Mutation', 'BRCA2 Mutation', 'Uterine Cancer', 'Myeloma', 'Kidney Cancer', 'Head and Neck Cancer', 'Meningioma']",Cancer,"University Health Network, Toronto",[],['Canada']
NCT07251725,GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis,Unravelling the Genetic Basis of Familial Pulmonary Fibrosis: A Next-Generation Sequencing Approach to Fibrogenesis and Surfactant Disorder Genes,RECRUITING,2025-09-17,2028-09,2028-09,OBSERVATIONAL,,126,['Familial Pulmonary Fibrosis'],Familial Pulmonary Fibrosis,Fondazione IRCCS Policlinico San Matteo di Pavia,[],['Italy']
NCT06453213,Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy,Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy,ACTIVE_NOT_RECRUITING,2024-10-14,2027-05-26,2027-07-09,INTERVENTIONAL,PHASE4,49,['Focal Onset Seizure'],Focal Onset Seizure,"SK Life Science, Inc.",[],['United States']
NCT05026138,"Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)","Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)",RECRUITING,2021-11-17,2047-03-31,2047-03-31,OBSERVATIONAL,,850,['Human Papillomavirus'],Human Papillomavirus,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07237074,The Effect of Using Finger Puppets and Showing Cartoons on Pain and Fear in Preschool Children During Blood Collection,The Effect of Using Finger Puppets and Showing Cartoons on Pain and Fear in Preschool Children (3-6 Years Old) During Blood Collection,ACTIVE_NOT_RECRUITING,2025-05-10,2025-07-25,2025-12-01,INTERVENTIONAL,NA,120,"['Fear', 'Pain']",Fear,Hitit University,[],['Turkey (Türkiye)']
NCT06180382,Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.,"Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration: A Randomized, Multicentre, Controlled Trial",RECRUITING,2024-10-31,2026-01,2027-01,INTERVENTIONAL,PHASE4,220,"[""Crohn's Disease""]",Crohn's Disease,Centre Hospitalier Universitaire de Saint Etienne,['Takeda France'],['France']
NCT05502237,Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer,"A Randomized, Open-Label, Phase 3 Study to Evaluate Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With No Epidermal Growth Factor Receptor or Anaplastic Lymphoma Kinase Genomic Tumor Aberrations",RECRUITING,2022-10-12,2028-06,2028-06,INTERVENTIONAL,PHASE3,1069,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Gilead Sciences,"['Arcus Biosciences, Inc.']","['Japan', 'Hong Kong', 'Netherlands', 'China', 'Belgium', 'Israel', 'France', 'Chile', 'South Korea', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Portugal', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT02386800,CINC424A2X01B Rollover Protocol,"Open Label, Multi-center, Phase IV Study of Ruxolitinib or Ruxolitinib and Panobinostat Combination, for Patients Who Have Completed Prior Global Novartis or Incyte Sponsored Studies",ACTIVE_NOT_RECRUITING,2015-03-05,2027-09-16,2027-09-16,INTERVENTIONAL,PHASE4,279,"['Primary Myelofibrosis', 'Polycythemia Vera', 'Graft Versus Host Disease', 'Acute Myeloid Leukemia', 'Thalassemia']",Primary Myelofibrosis,Novartis Pharmaceuticals,[],"['Bulgaria', 'Japan', 'China', 'Australia', 'Belgium', 'Israel', 'Hungary', 'Russia', 'France', 'Chile', 'South Korea', 'Thailand', 'Poland', 'India', 'Lebanon', 'South Africa', 'Mexico', 'Spain', 'Canada', 'Greece', 'Portugal', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Italy']"
NCT06108219,"A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)","A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)",ACTIVE_NOT_RECRUITING,2023-10-25,2026-09,2026-09,INTERVENTIONAL,PHASE2,175,"['Nonalcoholic Steatohepatitis (NASH)', 'Metabolic Dysfunction-associated Steatohepatitis (MASH)']",Nonalcoholic Steatohepatitis (NASH),Corcept Therapeutics,[],"['Puerto Rico', 'United States', 'India']"
NCT06893107,Study on Treatment Results and Bone Changes After Replanting Severely Affected Teeth - A Before-and-After Study.,"Assessment of Treatment Outcomes and Alveolar Bone Changes Following Intentional Replantation of Hopeless Periodontally Involved Single-Rooted Teeth - A Pre-test, Post-test Interventional Study",RECRUITING,2024-03-25,2025-07-01,2026-03-15,INTERVENTIONAL,NA,45,['Chronic Periodontitis'],Chronic Periodontitis,University of Fujairah,[],['United Arab Emirates']
NCT06504446,"Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough","A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Taplucainium Inhalation Powder (NOC-110) in Adults With Refractory or Unexplained Chronic Cough",RECRUITING,2024-09-24,2026-04-10,2026-04-10,INTERVENTIONAL,PHASE2,455,['Refractory or Unexplained Chronic Cough'],Refractory or Unexplained Chronic Cough,Nocion Therapeutics,['Iqvia Pty Ltd'],"['Belgium', 'United States', 'Canada', 'United Kingdom', 'Poland', 'Germany']"
NCT07070323,"A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies","A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies",RECRUITING,2025-07-09,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,54,"['T-Cell Acute Lymphocytic Leukemia', 'Acute Lymphoblastic Leukemia, in Relapse', 'Refractory Acute Lymphoblastic Leukemia', 'T-cell Malignancies']",T-Cell Acute Lymphocytic Leukemia,Beijing GoBroad Hospital,"['The General Hospital of Western Theater Command', 'Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai', 'Shanghai Liquan Hospital', ""Central People's Hospital of Zhanjiang"", 'First Affiliated Hospital of Guangxi Medical University']",['China']
NCT07187115,A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation,A Global Randomized Trial Comparing Pulsed Field Ablation of Pulmonary Veins Plus Extra-PV Sources Utilizing Electrographic Flow Mapping Versus Pulmonary Veins Plus Posterior Wall in Persistent Atrial Fibrillation Patients.,RECRUITING,2025-11-07,2028-07,2030-12,INTERVENTIONAL,NA,699,"['Atrial Fibrillation (AF)', 'Persistant Atrial Fibrillation']",Atrial Fibrillation (AF),Boston Scientific Corporation,[],"['Belgium', 'Netherlands', 'United States', 'France', 'Spain', 'Germany']"
NCT07003568,Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration,Practical Clinical Study of Dual-targeting BCMA-GPRC5D CAR-T Cell Therapy for Extramedullary Infiltration in Refractory/Relapsed Multiple Myeloma,RECRUITING,2025-05-25,2027-05-25,2027-06-25,INTERVENTIONAL,PHASE1,18,['Relapsed or Refractory Multiple Myeloma (RRMM)'],Relapsed or Refractory Multiple Myeloma (RRMM),Beijing GoBroad Hospital,"['Shanghai Liquan Hospital', 'Ruijin Hospital']",['China']
NCT03870360,Preventing Anxiety and Depression in Older Hispanics,Health Promotion in the Prevention of Anxiety and Depression: the Happy Older Latinos Are Active (HOLA Study),ACTIVE_NOT_RECRUITING,2022-11-01,2026-06-01,2026-06-01,INTERVENTIONAL,NA,240,"['Depression', 'Anxiety']",Depression,University of Miami,['National Institute on Minority Health and Health Disparities (NIMHD)'],['United States']
NCT06706284,Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes,Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes,RECRUITING,2025-04-11,2028-05-01,2029-01-01,INTERVENTIONAL,PHASE4,50,"['Spinal Cord Injuries', 'Type 2 Diabetes']",Spinal Cord Injuries,Marzieh Salehi,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT04401917,Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls,Evaluation of in Vivo Neuroinflammation Using 18F-NOS Positron Emission Tomography (PET/CT) in HIV Positive and Negative Subjects With Opioid Use Disorder and Healthy Controls,ACTIVE_NOT_RECRUITING,2020-12-07,2026-12-07,2026-12-07,INTERVENTIONAL,EARLY_PHASE1,26,"['HIV Infections', 'Opioid Use']",HIV Infections,University of Pennsylvania,[],['United States']
NCT07250139,Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation,Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation,RECRUITING,2025-12-08,2026-05-31,2026-09-30,INTERVENTIONAL,NA,50,"['Dermatochalasis of Upper Eyelid', 'Ptosis, Eyelid', 'Blepharoplasty']",Dermatochalasis of Upper Eyelid,Osheru Inc.,[],['United States']
NCT07226258,Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain,"A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 Injectable for the Treatment of Knee Pain in Patients With Osteoarthritis of the Knee",RECRUITING,2025-11-07,2026-11-30,2027-02-28,INTERVENTIONAL,PHASE3,150,['Osteoarthritis Knee Pain'],Osteoarthritis Knee Pain,Saol Therapeutics Inc,[],['United States']
NCT06831552,Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma,A Randomized Phase II Trial Evaluation of the Addition of the Resource Intervention to Support Equity (RISE) to Usual Supportive Care for Children With Newly Diagnosed High-Risk Neuroblastoma,RECRUITING,2025-04-30,2029-06-01,2029-06-01,INTERVENTIONAL,NA,84,"['Neuroblastoma', 'High-risk Neuroblastoma']",Neuroblastoma,Dana-Farber Cancer Institute,[],['United States']
NCT07251400,Analgesic Efficacy of Erector Spinae and Rectus Sheath Block in Patients Undergoing Laparoscopic Inguinal Hernia Repair,The Analgesic Efficacy of Ultrasound-guided Erector Spinae and Rectus Sheath Block in Patients Undergoing Laparoscopic Inguinal Hernia Repair: a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-10-15,2026-02-28,2026-03-15,INTERVENTIONAL,NA,10,"['Erector Spinae Plane Block', 'Laparoscopic Inguinal Hernia Repair']",Erector Spinae Plane Block,Umraniye Education and Research Hospital,[],['Turkey (Türkiye)']
NCT06762275,The Impact of a Diagnostic Strategy for Acute Appendicitis in Children With Acute Abdominal Pain in Primary Care,Optimizing Management of Children Presenting With Acute Abdominal Pain in Primary Care: a Cluster Randomized Controlled Trial Evaluating the Impact of a Clinical Prediction Rule Including C-reactive Protein for Appendicitis,RECRUITING,2025-03-06,2028-03-31,2029-03-01,INTERVENTIONAL,NA,566,"['Appendicitis Acute', 'Acute Abdomen in Children']",Appendicitis Acute,University Medical Center Groningen,"['ZonMw: The Netherlands Organisation for Health Research and Development', 'Leiden University Medical Center', 'UMC Utrecht']",['Netherlands']
NCT06327529,Zinc and Iron Absorption From Common Beans in Young Adult Women,Zinc and Iron Absorption From Common Beans in Young Adult Women,RECRUITING,2024-05-01,2025-12-31,2025-12-31,INTERVENTIONAL,NA,15,"['Zinc Absorption', 'Iron Absorption']",Zinc Absorption,"University of California, Davis",[],['United States']
NCT03621254,Investigation Into Optimal FES Training Characteristics After Spinal Cord Injury,Investigation Into Optimal FES Training Characteristics After Spinal Cord Injury,RECRUITING,2019-01-07,2026-12,2026-12,INTERVENTIONAL,NA,20,['Spinal Cord Injury'],Spinal Cord Injury,"Swiss Paraplegic Research, Nottwil",[],['Switzerland']
NCT03538600,Sample Collection From Healthy Volunteers for Assay Optimization,Sample Collection From Healthy Volunteers for Assay Optimization,RECRUITING,2018-06-28,2043-06-30,2043-06-30,OBSERVATIONAL,,600,['Healthy Volunteers'],Healthy Volunteers,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT07003555,Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration,Practical Clinical Study of Dual-targeting BCMA-CD19 CAR-T Cell Therapy for Extramedullary Infiltration in Refractory/Relapsed Multiple Myeloma,RECRUITING,2025-05-25,2027-05-25,2027-06-25,INTERVENTIONAL,PHASE1,18,['Relapsed or Refractory Multiple Myeloma (RRMM)'],Relapsed or Refractory Multiple Myeloma (RRMM),Beijing GoBroad Hospital,"['Shanghai Liquan Hospital', 'Ruijin Hospital']",['China']
NCT06096038,Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC,Administration of T Cells Expressing Chondroitin-Sulfate-Proteoglycan-4 Specific Chimeric Antigen Receptors (CAR) in Subjects With Head and Neck Squamous Cell Carcinoma (HNSCC),RECRUITING,2024-04-05,2026-08,2028-08,INTERVENTIONAL,PHASE1,33,"['Head and Neck Cancer', 'Relapse', 'Recurrent', 'Refractory Cancer']",Head and Neck Cancer,UNC Lineberger Comprehensive Cancer Center,"['Bellicum Pharmaceuticals', 'National Cancer Institute (NCI)']",['United States']
NCT05351294,Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet,Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Management of Metastatic Malignancies,RECRUITING,2023-07-13,2026-12-30,2027-12-30,INTERVENTIONAL,PHASE3,156,"['Radiation Therapy', 'Metastatic Cancer']",Radiation Therapy,"Rutgers, The State University of New Jersey",[],['United States']
NCT06533059,A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors,AKTive-001: A Phase 1/1b Multiple Cohort Trial of ALTA2618 in Patients With Advanced Solid Tumors With AKT1 E17K Mutation,RECRUITING,2024-08-22,2026-12-29,2027-12-29,INTERVENTIONAL,PHASE1,110,"['Cancer', 'Breast Cancer', 'Endometrial Cancer', 'Metastatic Cancer', 'Advanced Solid Tumor']",Cancer,"Alterome Therapeutics, Inc.",[],"['Japan', 'United States', 'France', 'Spain', 'Taiwan', 'South Korea', 'United Kingdom', 'Australia']"
NCT07252258,Comparison of Frequency of Calcium Hydroxide Mixed With 0.2% Chlorhexidine Versus Saline as Intracanal Medicament in Periapical Periodontitis-A Randomized Controlled Trial,Comparison of Frequency of Calcium Hydroxide Mixed With 0.2% Chlorhexidine Versus Saline as Intracanal Medicament in Periapical Periodontitis-A Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-07-15,2026-02-01,2026-02-15,INTERVENTIONAL,NA,80,['Periapical Periodontitis'],Periapical Periodontitis,Aqsa Afzal,[],['Pakistan']
NCT01656447,Scleroderma Registry & Repository at the Hospital for Special Surgery,The Scleroderma Registry & Repository,RECRUITING,2006-08,2030-01,2030-01,OBSERVATIONAL,,300,['Scleroderma'],Scleroderma,"Hospital for Special Surgery, New York",[],['United States']
NCT06698575,"A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes","A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple Ascending Doses of ABI-1179 in Healthy Subjects and in Subjects Who Are Seropositive for Herpes Simplex Virus Type 2 With Recurrent Genital Herpes",ACTIVE_NOT_RECRUITING,2024-12-08,2025-12,2026-01,INTERVENTIONAL,PHASE1,146,['Recurrent Genital Herpes Simplex Type 2'],Recurrent Genital Herpes Simplex Type 2,Assembly Biosciences,[],"['New Zealand', 'United States', 'Australia']"
NCT07102381,A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer,"A Phase 2, Randomized, Multicenter, Open-label Neoadjuvant Study Evaluating Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer",RECRUITING,2025-09-24,2028-01-01,2030-08-01,INTERVENTIONAL,PHASE2,125,"['HER2-positive Breast Cancer', 'Breast Cancer']",HER2-positive Breast Cancer,Jazz Pharmaceuticals,['Jazz Pharmaceuticals Ireland Limited'],['United States']
NCT05939414,An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.,"An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease Recurrence in Adult Male Patients With Prostate-specific Membrane Antigen (PSMA) Positive Oligometastatic Prostate Cancer (OMPC)",RECRUITING,2024-03-12,2028-04-25,2031-10-03,INTERVENTIONAL,PHASE3,450,['Oligometastatic Prostate Cancer (OMPC)'],Oligometastatic Prostate Cancer (OMPC),Novartis Pharmaceuticals,[],"['Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Belgium', 'Israel', 'Hungary', 'France', 'Puerto Rico', 'Czechia', 'Singapore', 'Mexico', 'Switzerland', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07251335,Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria,Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria,RECRUITING,2025-07-07,2027-04,2027-11,OBSERVATIONAL,,300,"['Skin Melanoma', 'Cutaneous Melanoma']",Skin Melanoma,University of Modena and Reggio Emilia,[],['Italy']
NCT07119489,A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial,A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial,RECRUITING,2026-02,2026-11,2026-11,INTERVENTIONAL,NA,16,['Smoking Behavior'],Smoking Behavior,Wake Forest University Health Sciences,['Atrium Health Wake Forest Baptist'],['United States']
NCT07183774,Does Sarcopenia Influence Rotator Cuff Tear Patterns? Radiological Insights From Patients With Rotator Cuff Syndrome,Does Sarcopenia Influence Rotator Cuff Tear Patterns? Radiological Insights From Patients With Rotator Cuff Syndrome,RECRUITING,2025-01-01,2025-12-01,2025-12-30,OBSERVATIONAL,,104,"['Rotator Cuff Tears', 'Sarcopenia', 'Shoulder Pain', 'Rotator Cuff Syndrome']",Rotator Cuff Tears,Haydarpasa Numune Training and Research Hospital,[],['Turkey (Türkiye)']
NCT06132178,Psilocybin rTMS for Treatment Resistant Depression,"Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder",RECRUITING,2025-01-10,2029-12-31,2030-12-31,INTERVENTIONAL,PHASE2,100,"['Treatment Resistant Depression', 'MDD', 'Major Depressive Disorder', 'Recurrent Depression', 'Depression']",Treatment Resistant Depression,University of Texas at Austin,[],['United States']
NCT04279158,Attention Modulation of Local and Global Inhibition Mechanisms,Attention Modulation of Local and Global Inhibition Mechanisms,RECRUITING,2022-11-26,2031-11-26,2031-11-26,INTERVENTIONAL,NA,120,['Optical Phenomena'],Optical Phenomena,Hospices Civils de Lyon,[],['France']
NCT01992952,Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer,A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor,ACTIVE_NOT_RECRUITING,2014-05-07,2019-03,2025-12-31,INTERVENTIONAL,PHASE1,149,['Estrogen Receptor Positive Breast Cancer'],Estrogen Receptor Positive Breast Cancer,Velindre NHS Trust,"['AstraZeneca', 'Cenduit LLC', 'Covance', 'Cardiff and Vale University Health Board']",['United Kingdom']
NCT06023199,Assessing Physical Function in Sickle Cell Patients Taking Voxelotor,Assessing Functional Capacity in Sickle Cell Patients Receiving Voxelotor,ACTIVE_NOT_RECRUITING,2023-10-23,2025-09-17,2025-12-23,INTERVENTIONAL,PHASE2,6,['Sickle Cell Disease'],Sickle Cell Disease,Inova Health Care Services,['Pfizer'],['United States']
NCT05263206,Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC),"Master Protocol of Two Randomized, Double Blind, Placebo-controlled, Multi-center, Parallel Group Studies to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Chronic Pruritus of Unknown Origin (CPUO)",RECRUITING,2022-02-15,2027-06-02,2027-08-25,INTERVENTIONAL,PHASE3,284,['Pruritus'],Pruritus,Sanofi,[],"['Japan', 'Hungary', 'China', 'United States', 'Spain', 'Taiwan', 'Italy', 'Canada', 'South Korea', 'Poland', 'Argentina', 'Germany']"
NCT06469333,Theories of Working Memory and Consolidation/RECOnsolidation in the Process of Resorption of Post-traumatic Symptoms.,"Theories of Working Memory and Consolidation/RECOnsolidation in the Process of Resorption of Certain Post-traumatic Symptoms: Interventional, Randomized Single-center Study",RECRUITING,2024-09-06,2026-06,2026-06,INTERVENTIONAL,NA,150,"['Working Memory', 'Consolidation/Recconsolidation Memory', 'Eye Movement Desensitization and Reprocessing', 'Alterning Bilateral Stimulation', 'Stress Disorders, Post-Traumatic', 'Intrusive Memories', 'Vividness', 'Emotivity']",Working Memory,University of Lorraine,[],['France']
NCT06179511,Study of AZD9829 in CD123+ Hematological Malignancies,"A Modular Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of AZD9829 as Monotherapy or in Combination in Patients With CD123-Positive Hematological Malignancies",RECRUITING,2024-01-31,2027-01-07,2027-01-07,INTERVENTIONAL,PHASE1,104,['Hematological Malignancies'],Hematological Malignancies,AstraZeneca,[],"['Japan', 'China', 'United States', 'Spain', 'Taiwan', 'Italy', 'South Korea', 'Australia', 'United Kingdom', 'Germany']"
NCT06146231,Motiva Flora® Aesthetic Breast Recon® Clinical Study,Motiva Flora® Tissue Expander as a Support for the Creation of an Autologous Adipose Matrix for Hybrid Breast Reconstruction: a Pivotal Study,RECRUITING,2023-08-18,2026-04,2027-04,INTERVENTIONAL,NA,66,"['Mammaplasty', 'Breast Cancer', 'Poland Syndrome']",Mammaplasty,Establishment Labs,['NAMSA'],"['Belgium', 'Spain', 'Costa Rica', 'Colombia']"
NCT05970172,A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease,"A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants With Chronic Kidney Disease",RECRUITING,2024-01-16,2027-10-30,2027-10-30,INTERVENTIONAL,PHASE3,100,"['Chronic Kidney Disease', 'Renal Anemia']",Chronic Kidney Disease,"Astellas Pharma Global Development, Inc.",[],"['Bulgaria', 'Netherlands', 'Saudi Arabia', 'Slovakia', 'Lithuania', 'Belgium', 'Denmark', 'Croatia', 'Czechia', 'Poland', 'Lebanon', 'Spain', 'Romania', 'United Kingdom', 'Greece', 'Sweden', 'Germany', 'Turkey (Türkiye)', 'Norway', 'Ireland', 'Italy']"
NCT04842162,Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery,Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery,RECRUITING,2020-12-15,2026-11,2026-11,INTERVENTIONAL,PHASE2,65,['Head and Neck Cancer'],Head and Neck Cancer,"Gustave Roussy, Cancer Campus, Grand Paris",[],"['Belgium', 'France']"
NCT02573532,Incidence and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery,"Basel Incidence, Patient Characteristics, Outcome and Possible Strategies to Improve Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery: 1-Year Follow-up",RECRUITING,2015-10,2025-12,2026-12,OBSERVATIONAL,,19645,['Perioperative Myocardial Injury'],Perioperative Myocardial Injury,"University Hospital, Basel, Switzerland","['Cantonal Hospital of Aarau, Switzerland']",['Switzerland']
NCT03689595,Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE),Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE),RECRUITING,2018-10-31,2033-10-31,2033-10-31,OBSERVATIONAL,,30000,['Multiple Myeloma'],Multiple Myeloma,Dana-Farber Cancer Institute,[],['United States']
NCT07250763,Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital,Optimization of Intravenous Unfractionated Heparin Starting Infusion Rate for Adult Patients With Deep Vein Thrombosis/Pulmonary Embolism or Cardiac Indications,ACTIVE_NOT_RECRUITING,2023-09-20,2027-02-28,2027-05-31,INTERVENTIONAL,PHASE4,145,"['Pulmonary Embolism', 'Deep Vein Thrombosis', 'Atrial Fibrillation', 'Acute Cardiac Syndrome', 'Mechanical Heart Valve Recipients']",Pulmonary Embolism,Inova Health Care Services,[],['United States']
NCT04380649,Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People,Brain Computer Interface Prototype Development for Assisted Alternative Communication in ALS,ACTIVE_NOT_RECRUITING,2023-02-13,2024-08-12,2026-08-12,INTERVENTIONAL,NA,5,"['Amyotrophic Lateral Sclerosis', 'Motor Neuron Disease', 'Spinal Cord Diseases', 'Alternative Communication Devices', 'Neurodegenerative Diseases', 'Nervous System Diseases', 'Neuromuscular Diseases']",Amyotrophic Lateral Sclerosis,Centre Hospitalier Universitaire de Nice,[],['France']
NCT06473506,Group A Streptococcus Saliva Study,Exploring the Use of Saliva for the Detection of Group A Streptococcus,ACTIVE_NOT_RECRUITING,2024-06-10,2025-02-28,2026-04-30,INTERVENTIONAL,NA,200,['Group A Streptococcal Infections'],Group A Streptococcal Infections,The Hospital for Sick Children,[],['Canada']
NCT07016230,"Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)","Phase 2, Multicenter, Open Label, Platform Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance",RECRUITING,2025-07-02,2027-04-15,2030-01-15,INTERVENTIONAL,PHASE2,40,"['Metastatic/Locally Advanced Small-Cell Lung Cancer', 'Metastatic/Locally Advanced Poorly Differentiated NEC', 'Metastatic/Locally Advanced High-grade MTC']",Metastatic/Locally Advanced Small-Cell Lung Cancer,"Gustave Roussy, Cancer Campus, Grand Paris",['Amgen'],['France']
NCT07129616,Remote Monitoring of Asthma in Children and Young People,Remote Monitoring of Asthma in Children and Young People - Reducing Risk of Asthma Attack Using a Connected Patient Approach,RECRUITING,2025-11-20,2026-10-01,2027-03-01,OBSERVATIONAL,,900,"['Asthma Childhood', 'Asthma Attack', 'Remote Monitoring', 'Risk Assessment', 'Machine Learning']",Asthma Childhood,University of Edinburgh,[],['United Kingdom']
NCT07252232,Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC),"RASolute 304: A Phase 3 Multicenter, Open-label, Randomized, 2-Arm Study of Adjuvant Daraxonrasib Versus Standard of Care Observation Following Completion of Neoadjuvant and/or Adjuvant Chemotherapy in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)",RECRUITING,2025-12-10,2029-05-10,2030-07-10,INTERVENTIONAL,PHASE3,500,"['Pancreatic Cancer', 'PDAC', 'PDAC - Pancreatic Ductal Adenocarcinoma', 'Resectable Pancreatic Ductal Adenocarcinoma (PDAC)', 'Resected Pancreatic Adenocarcinoma']",Pancreatic Cancer,"Revolution Medicines, Inc.",[],"['Puerto Rico', 'United States']"
NCT07209462,Study of MRM-3379 in Male Participants With Fragile X Syndrome,"Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of MRM-3379 in Male Participants With Fragile X Syndrome",RECRUITING,2025-12,2027-10,2027-10,INTERVENTIONAL,PHASE2,60,['Fragile X Syndrome'],Fragile X Syndrome,"Mirum Pharmaceuticals, Inc.",[],['United States']
NCT07069569,A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs,"A Randomized, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Combination With Hepatitis B Vaccine or Pegylated Interferon α-2b (Peg-IFN) in Participants With HBeAg-Negative Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogue (NAs)",ACTIVE_NOT_RECRUITING,2025-05-30,2027-01-01,2027-05-01,INTERVENTIONAL,PHASE2,127,['Chronic Hepatitis B'],Chronic Hepatitis B,"Ausper Biopharma Co., Ltd.",[],['China']
NCT05377242,"Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI","Curcumin, Resveratrol, and Stinging Nettle as Treatments for Gulf War Illness",ACTIVE_NOT_RECRUITING,2023-05-31,2026-06,2026-06-30,INTERVENTIONAL,NA,390,['Gulf War Illness'],Gulf War Illness,University of Alabama at Birmingham,['Congressionally Directed Medical Research Programs'],['United States']
NCT07246161,Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women,Detection of Orally Delivered Probiotic Strains in the Vaginal Microbiome of Healthy Female Adults,RECRUITING,2025-10-20,2026-06,2026-06,INTERVENTIONAL,PHASE2,72,['Focus is on Healthy Subjects'],Focus is on Healthy Subjects,Lallemand Health Solutions,[],['Canada']
NCT04193059,Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer,Study Comparing the Efficacy and Safety of Epirubicin Combined With Cyclophosphamide Followed by Docetaxel (EC-T) Verses Paclitaxel Combined With Carboplatin (PCb) in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer,ACTIVE_NOT_RECRUITING,2019-12-20,2026-07,2027-07,INTERVENTIONAL,PHASE3,1560,['Breast Cancer'],Breast Cancer,Fudan University,[],['China']
NCT01708941,Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery,A Randomized Phase II Study of Ipilimumab at 3 mg/kg or 10 mg/kg Alone or in Combination With High Dose Interferon-Alpha in Advanced Melanoma,ACTIVE_NOT_RECRUITING,2013-01-18,2017-08-08,2026-03-19,INTERVENTIONAL,PHASE2,88,"['Recurrent Melanoma', 'Stage IIIA Cutaneous Melanoma AJCC v7', 'Stage IIIB Cutaneous Melanoma AJCC v7', 'Stage IIIC Cutaneous Melanoma AJCC v7', 'Stage IV Cutaneous Melanoma AJCC v6 and v7']",Recurrent Melanoma,National Cancer Institute (NCI),[],['United States']
NCT03889912,Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma,"A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients With Cutaneous Squamous Cell Carcinoma (CSCC) or Basal Cell Carcinoma (BCC)",ACTIVE_NOT_RECRUITING,2019-04-11,2025-11-13,2026-02-02,INTERVENTIONAL,PHASE1,97,"['Cutaneous Squamous Cell Carcinoma', 'Basal Cell Carcinoma']",Cutaneous Squamous Cell Carcinoma,Regeneron Pharmaceuticals,[],"['United States', 'Netherlands', 'Australia']"
NCT06322537,Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective,"Albumin Utilization for Intravascular Volume Replacement in Adult Cardiac Surgical Patients : A Multi-centre, Retrospective, Cohort Study",ACTIVE_NOT_RECRUITING,2024-05-23,2025-12-01,2026-01-01,OBSERVATIONAL,,505,"['Cardiovascular Surgical Procedures', 'Albumin']",Cardiovascular Surgical Procedures,"University Health Network, Toronto","['Kingston Health Sciences Centre', 'Unity Health Toronto', 'McMaster University', 'Sunnybrook Health Sciences Centre', 'London Health Sciences Centre', 'The Ottawa Hospital', 'Vancouver General Hospital', 'Royal Columbian Hospital Foundation', 'Nova Scotia Health Authority']",['Canada']
NCT01274338,Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery,A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma,ACTIVE_NOT_RECRUITING,2011-05-25,2019-02-15,2026-03-19,INTERVENTIONAL,PHASE3,1673,"['Melanoma of Unknown Primary', 'Recurrent Melanoma', 'Stage IIIB Cutaneous Melanoma AJCC v7', 'Stage IIIC Cutaneous Melanoma AJCC v7', 'Stage IV Cutaneous Melanoma AJCC v6 and v7']",Melanoma of Unknown Primary,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT03296592,Diffusion MRI in Cervical Spondylotic Myelopathy (CSM),Predictive Value of Diffusion MRI in Cervical Spondylotic Myelopathy,ACTIVE_NOT_RECRUITING,2018-01-29,2024-03-30,2025-12-30,OBSERVATIONAL,,71,['Cervical Spondylotic Myelopathy'],Cervical Spondylotic Myelopathy,Washington University School of Medicine,['National Institute of Neurological Disorders and Stroke (NINDS)'],['United States']
NCT04166877,Magnesium Infusion for Pain Management in Critically Ill Trauma Patients,Magnesium Infusion for Pain Management in Critically Ill Trauma Patients,RECRUITING,2019-12-07,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE4,156,"['Trauma', 'Acute Pain']",Trauma,"University of California, Davis",[],['United States']
NCT06273800,Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients,Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients,RECRUITING,2025-10-14,2035-07-15,2036-07-15,INTERVENTIONAL,NA,100,['Breast Cancer'],Breast Cancer,The Netherlands Cancer Institute,[],['Netherlands']
NCT01371981,Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia,"A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD",ACTIVE_NOT_RECRUITING,2011-06-20,2019-03-31,2027-09-30,INTERVENTIONAL,PHASE3,1645,"['Acute Myeloid Leukemia', 'Leukemia Cutis', 'Myeloid Neoplasm', 'Myeloid Sarcoma']",Acute Myeloid Leukemia,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Puerto Rico', 'Canada', 'Australia']"
NCT06139328,IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack,"Randomised Study for Double-blind, Placebo-controlled Evaluation of a Single Intravenous Infusion of BI 765845 and Partially-blinded Evaluation of a Single Bolus Administration of BI 765845 on Top of Standard of Care in Patients With Acute Myocardial Infarction",ACTIVE_NOT_RECRUITING,2023-12-05,2025-09-02,2025-12-03,INTERVENTIONAL,PHASE2,160,['Myocardial Infarction'],Myocardial Infarction,Boehringer Ingelheim,[],"['Singapore', 'New Zealand', 'Hungary', 'Slovakia', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'Australia', 'South Korea', 'Poland', 'United Kingdom', 'Germany']"
NCT07242365,Soylent in Reducing Gastrostomy Tube Rates in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy,A Phase II Study Integrating Soylent&#8482; Meal Replacement to Reduce Gastrostomy Tube Rates in Patients With Head &Amp; Neck Cancer Undergoing Chemoradiotherapy,ACTIVE_NOT_RECRUITING,2017-06-19,2025-12-31,2026-12-31,INTERVENTIONAL,PHASE2,60,['Locally Advanced Head and Neck Carcinoma'],Locally Advanced Head and Neck Carcinoma,Jonsson Comprehensive Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT05387551,CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance,Effect of Adding Continuous Glucose Monitoring (CGM) to Lifestyle Changes on Insulin Sensitivity in Patients With Impaired Glucose Tolerance,RECRUITING,2022-12-01,2026-06,2026-12,INTERVENTIONAL,NA,15,"['Impaired Glucose Tolerance', 'Prediabetes']",Impaired Glucose Tolerance,Nemours Children's Clinic,[],['United States']
NCT06747455,BCG for Therapeutic Use Phase Ⅲ Clinical Trial,"A Randomized, Double-blind, Active-controlled, Multicenter Phase III Clinical Trial Evaluating the Efficacy and Safety of Therapeutic BCG for the Prevention of Postoperative Recurrence of Non-muscle-invasive Bladder Cancer in People Aged 18 Years and Older",RECRUITING,2025-04-08,2028-10-01,2028-12-31,INTERVENTIONAL,PHASE3,438,['BCG'],BCG,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",[],['China']
NCT05884658,Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery Versus or Laparoscopic Hysterectomy,vNOTEsHC: Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery Versus or Laparoscopic Hysterectomy: a Randomized Controlled Trial,RECRUITING,2024-12-23,2026-06,2026-08,INTERVENTIONAL,NA,200,"['Hysterectomy, Vaginal']","Hysterectomy, Vaginal",Centre Hospitalier Universitaire de Saint Etienne,"['Ministry of Health, France']",['France']
NCT04230148,"Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).","A Phase IV, Multi-center, Open-label Study to Determine the Safety, Tolerability and Clinical Outcomes Following Oral Administration of EGATEN™ (Triclabendazole) in Patients (6 Years of Age or Older) With Fascioliasis.",RECRUITING,2022-02-11,2026-05-13,2026-05-13,INTERVENTIONAL,PHASE4,300,['Fascioliasis'],Fascioliasis,Novartis Pharmaceuticals,[],"['Turkey (Türkiye)', 'Vietnam', 'Peru', 'Colombia', 'Egypt']"
NCT05739942,Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma,Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-NeoB in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma and as a Single Agent in Recurrent Glioblastoma,RECRUITING,2024-05-15,2026-12-10,2032-07-01,INTERVENTIONAL,PHASE1,48,['Newly Diagnosed and Recurrent Glioblastoma'],Newly Diagnosed and Recurrent Glioblastoma,Novartis Pharmaceuticals,[],"['Israel', 'United States', 'France', 'Spain', 'Italy', 'United Kingdom', 'Portugal', 'Germany']"
NCT04704661,"Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial",Phase 1/1B Study of DS-8201a in Combination With ATR Inhibition (AZD6738) in Advanced Solid Tumors With HER2 Expression (DASH Trial),RECRUITING,2021-08-09,2026-03-31,2026-03-31,INTERVENTIONAL,PHASE1,51,"['Advanced Breast Carcinoma', 'Advanced Colon Carcinoma', 'Advanced Colorectal Carcinoma', 'Advanced Endometrial Carcinoma', 'Advanced Gastric Carcinoma', 'Advanced Gastroesophageal Junction Adenocarcinoma', 'Advanced Malignant Solid Neoplasm', 'Advanced Salivary Gland Carcinoma', 'Anatomic Stage III Breast Cancer AJCC v8', 'Anatomic Stage IV Breast Cancer AJCC v8', 'Clinical Stage III Gastric Cancer AJCC v8', 'Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8', 'Clinical Stage IV Gastric Cancer AJCC v8', 'Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8', 'HER2-Positive Breast Carcinoma', 'Malignant Hepatobiliary Neoplasm', 'Metastatic Breast Carcinoma', 'Metastatic Colon Carcinoma', 'Metastatic Colorectal Carcinoma', 'Metastatic Endometrial Carcinoma', 'Metastatic Gastric Carcinoma', 'Metastatic Gastroesophageal Junction Adenocarcinoma', 'Metastatic Malignant Solid Neoplasm', 'Metastatic Salivary Gland Carcinoma', 'Stage III Colon Cancer AJCC v8', 'Stage III Colorectal Cancer AJCC v8', 'Stage III Major Salivary Gland Cancer AJCC v8', 'Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8', 'Stage IV Colon Cancer AJCC v8', 'Stage IV Colorectal Cancer AJCC v8', 'Stage IV Major Salivary Gland Cancer AJCC v8', 'Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8', 'Unresectable Breast Carcinoma', 'Unresectable Colon Carcinoma', 'Unresectable Colorectal Carcinoma', 'Unresectable Endometrial Carcinoma', 'Unresectable Gastric Carcinoma', 'Unresectable Gastroesophageal Junction Adenocarcinoma', 'Unresectable Malignant Solid Neoplasm', 'Unresectable Salivary Gland Carcinoma']",Advanced Breast Carcinoma,National Cancer Institute (NCI),[],['United States']
NCT04999969,"Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours","A Phase II Study to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumours",ACTIVE_NOT_RECRUITING,2021-12-10,2024-10-07,2025-12-15,INTERVENTIONAL,PHASE2,126,['Locally Advanced or Metastatic Solid Tumours'],Locally Advanced or Metastatic Solid Tumours,AstraZeneca,[],"['Spain', 'United States', 'South Korea', 'Canada']"
NCT07251972,Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns,Comparison of Two Methods of Immunoprophylaxis Against RSV in Term Newborns in a Level 3 Maternity Unit During Winter 2025-2026,ACTIVE_NOT_RECRUITING,2025-09-01,2026-04-30,2026-05-31,OBSERVATIONAL,,1050,['Bronchiolitis'],Bronchiolitis,Jean-Michel HASCOET,[],['France']
NCT06392477,A Study of DR-0201 in Subjects With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma,"A Multicenter, Multiple Expansion Cohort Phase 1 Study Evaluating the Safety and Activity of DR-0201 as Multiple Ascending Doses in Patients With Relapsed/Refractory B Cell Non-Hodgkin Lymphoma",RECRUITING,2024-07-08,2026-04,2026-12,INTERVENTIONAL,PHASE1,48,['B-cell Non Hodgkin Lymphoma'],B-cell Non Hodgkin Lymphoma,Dren Bio,[],"['Singapore', 'Hong Kong', 'Taiwan', 'South Korea', 'Australia', 'Serbia']"
NCT05774184,A Study of CDX-0159 in Patients With Eosinophilic Esophagitis,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults With Active Eosinophilic Esophagitis (The ""EvolvE"" Study)",ACTIVE_NOT_RECRUITING,2023-06-01,2025-06-04,2025-12,INTERVENTIONAL,PHASE2,86,['Eosinophilic Esophagitis'],Eosinophilic Esophagitis,Celldex Therapeutics,[],"['United States', 'Spain', 'Italy', 'Canada', 'Australia', 'Poland', 'United Kingdom', 'Germany']"
NCT02327884,Characterization of Diseases With Salivary Gland Involvement,Characterization of Diseases With Salivary Gland Involvement,RECRUITING,2015-04-03,2032-04-01,2032-04-01,OBSERVATIONAL,,1150,"['Healthy Volunteer', ""Sjogren's Syndrome"", 'Salivary Gland Disease']",Healthy Volunteer,National Institute of Dental and Craniofacial Research (NIDCR),[],['United States']
NCT05856552,The Health and Social Consequences of Depression Among the Elderly,The Health and Social Consequences of Depression Among the Elderly: Evidence From India,RECRUITING,2024-11-20,2028-12,2028-12,INTERVENTIONAL,NA,5370,"['Depression', 'Functional Impairment']",Depression,"National Bureau of Economic Research, Inc.",['Abdul Latif Jameel Poverty Action Lab'],['India']
NCT07251049,Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing,Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing,RECRUITING,2023-11-16,2028-11-16,2028-11-16,OBSERVATIONAL,,100,"['Acute Encephalitis', 'Acute Myelitis']",Acute Encephalitis,Centre Hospitalier Universitaire de la Guadeloupe,[],['Guadeloupe']
NCT00428987,Physical and Behavioral Traits of Overweight and Obese Adults,Study of the Phenotype of Overweight and Obese Adults,RECRUITING,2007-03-08,,,OBSERVATIONAL,,2000,"['Obesity', 'Healthy Volunteers']",Obesity,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT04484012,Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma,A Phase 2 Study to Evaluate CD19-Specific Chimeric Antigen Receptor (CAR)-T Cells Combined With Acalabrutinib for Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL),RECRUITING,2020-12-31,2026-09-02,2026-09-02,INTERVENTIONAL,PHASE2,36,"['Recurrent Mantle Cell Lymphoma', 'Refractory Mantle Cell Lymphoma']",Recurrent Mantle Cell Lymphoma,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT06631222,to Stuidy the Effect of Cognitive Behavior Threapy CBT on Smartphone Addiction Patients With Tension Type Headache,Effect of Cognitive Behaviour Approach on Subjects With Smartphone Addiction,RECRUITING,2025-01-29,2025-11,2026-01,INTERVENTIONAL,NA,40,"['Tension Type Headache', 'Smartphone Addiction']",Tension Type Headache,Hatem Mostafa,[],['Egypt']
NCT05835310,An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants,"A Phase III, Randomized, Double-blind, Parallel-group, Placebo Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus (SLE) While on Background Standard of Care Therapy",RECRUITING,2024-03-14,2028-10-05,2030-03-12,INTERVENTIONAL,PHASE3,100,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,AstraZeneca,[],"['Brazil', 'Japan', 'South Africa', 'Turkey (Türkiye)', 'China', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Canada', 'Colombia', 'United Kingdom', 'Poland', 'Portugal', 'Argentina', 'Germany']"
NCT07123480,The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance,The Impact of Informed Consent Type on Participation in an Implementation Science Pilot Study to Improve Cardiac Rehabilitation Participation,ACTIVE_NOT_RECRUITING,2025-07-16,2026-01-31,2026-06-30,INTERVENTIONAL,NA,160,"['Ethics', 'Cardiac Rehabilitation', 'Coronary Heart Disease (CHD)', 'Heart Failure', 'Percutaneous Coronary Intervention (PCI)', 'Aortic Valve Replacement', 'Myocardial Infarction (MI)']",Ethics,Baystate Medical Center,[],['United States']
NCT07187817,SEquential Treatment of PSoriasis With Biologics,SEquential Treatment of PSoriasis With Biologics,RECRUITING,2025-10-14,2025-12-31,2026-04-02,OBSERVATIONAL,,366,['Psoriasis'],Psoriasis,Royal United Hospitals Bath NHS Foundation Trust,"['University of Bath', 'University of Leeds']",['United Kingdom']
NCT05755087,Tegavivint for Treating Patients With Relapsed or Refractory Large B-Cell Lymphoma,Phase Ib Trial of Tegavivint in Patients With Relapsed/Refractory C-MYC Overexpressing Large B-Cell Lymphoma,RECRUITING,2023-03-06,2027-03-05,2027-03-05,INTERVENTIONAL,PHASE1,18,"['Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type', 'Recurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements', 'Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements', 'Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type', 'Refractory Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type', 'Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements', 'Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements', 'Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma']",Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type,Lapo Alinari,[],['United States']
NCT06431334,Protein Requirements Amongst Male Masters-Level Athletes Following a Cycling Exercise Bout as Determined by the Indicator Amino Acid Oxidation Technique,Protein Requirements Amongst Male Masters-Level Athletes Following a Cycling Exercise Bout as Determined by the Indicator Amino Acid Oxidation Technique,RECRUITING,2024-06-21,2025-12,2025-12,INTERVENTIONAL,NA,8,"['Healthy', 'Increased Metabolic Requirements', 'Dietary Reference Intakes']",Healthy,McGill University,[],['Canada']
NCT06934239,A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients,A Randomized Controlled Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients,RECRUITING,2025-10-15,2028-03-01,2030-03-01,INTERVENTIONAL,PHASE4,400000,"['Breast Cancer Screening', 'Artificial Intelligence (AI)']",Breast Cancer Screening,Jonsson Comprehensive Cancer Center,"['University of California, Los Angeles', 'University of California, San Diego', 'University of Wisconsin, Madison', 'Boston Medical Center', 'Patient-Centered Outcomes Research Institute', 'University of Washington', 'California Breast Cancer Research Program', 'University of Miami', 'University of California, Davis']",['United States']
NCT06469281,"A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers","A Phase 1a/1b Study of 27T51, an Anti-MUC16 CAR T Cell Drug Product Administered Alone or in Combination for Participants With Recurrent or Refractory Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer",RECRUITING,2024-08-06,2030-05-27,2030-05-27,INTERVENTIONAL,PHASE1,90,"['Epithelial Ovarian Cancer', 'Primary Peritoneal Carcinoma', 'Fallopian Tube Cancer']",Epithelial Ovarian Cancer,Regeneron Pharmaceuticals,[],['United States']
NCT06545604,Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer,Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer,RECRUITING,2025-06-06,2027-06-30,2027-06-30,INTERVENTIONAL,NA,40,['Ovarian Cancer'],Ovarian Cancer,M.D. Anderson Cancer Center,[],['United States']
NCT04942717,Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values,Communicating With Oncology Nurses About Values From the Outset (CONVO): An Innovative Primary Palliative Care Intervention in English and Espanol,RECRUITING,2021-06-18,2026-06-18,2026-06-18,INTERVENTIONAL,NA,234,"['Solid Tumor', 'Solid Tumor, Adult', 'Solid Tumor, Unspecified, Adult']",Solid Tumor,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT04940325,"Datopotamab Deruxtecan (Dato-DXd, DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer","Phase 2, Open Label Study of DS-1062a, an Anti-TROP-2-Antibody-Drug Conjugate (ADC), in Patients With Advanced and/or Unresectable Non-Small Cell Lung Cancer (NSCLC), With Biomarker Analysis to Characterize Response to Therapy",ACTIVE_NOT_RECRUITING,2021-05-12,2028-04,2028-09,INTERVENTIONAL,PHASE2,100,"['Metastatic Lung Cancer', 'Advanced Non Small Cell Lung Cancer', 'Unresectable Non-small Lung Cancer']",Metastatic Lung Cancer,"Gustave Roussy, Cancer Campus, Grand Paris",['Daiichi Sankyo'],['France']
NCT07088926,"A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization","A Phase IIb Randomized, Double-blind, Placebo-controlled, Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization",RECRUITING,2025-11-06,2027-12-09,2028-06-14,INTERVENTIONAL,PHASE2,435,['Bronchiectasis With Pseudomonas Aeruginosa Colonization'],Bronchiectasis With Pseudomonas Aeruginosa Colonization,AstraZeneca,[],"['Netherlands', 'Australia', 'Belgium', 'Israel', 'France', 'Chile', 'Denmark', 'Peru', 'South Korea', 'Thailand', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Greece', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT03479268,Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma,"A Phase I Study of Pevonedistat (MLN4924, TAK924) in Combination With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma",ACTIVE_NOT_RECRUITING,2018-03-22,2026-11-05,2026-11-05,INTERVENTIONAL,PHASE1,18,"['B-Cell Prolymphocytic Leukemia', 'Recurrent Chronic Lymphocytic Leukemia', 'Recurrent Diffuse Large B-Cell Lymphoma', 'Recurrent Follicular Lymphoma', 'Recurrent Lymphoplasmacytic Lymphoma', 'Recurrent Mantle Cell Lymphoma', 'Recurrent Marginal Zone Lymphoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Small Lymphocytic Lymphoma', 'Refractory Chronic Lymphocytic Leukemia', 'Refractory Diffuse Large B-Cell Lymphoma', 'Refractory Follicular Lymphoma', 'Refractory Lymphoplasmacytic Lymphoma', 'Refractory Mantle Cell Lymphoma', 'Refractory Marginal Zone Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Small Lymphocytic Lymphoma', 'Richter Syndrome']",B-Cell Prolymphocytic Leukemia,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT06535776,Effects of Matrix Rhythm Therapy in Axial Spondyloarthritis Patients,"Investigation of the Effect of Matrix Rhythm Therapy on Functional Status, Quality of Life, Respiratory Functions and Physical Performance in Axial Spondyloarthritis Patients",RECRUITING,2024-10-20,2025-09-06,2025-12-05,INTERVENTIONAL,NA,40,"['Functional Status', 'Physical Performance']",Functional Status,Izmir Democracy University,[],['Turkey (Türkiye)']
NCT07250568,"Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers","Effects of Exercise, Posture Education, and Standing Advice on Pain, Lumbar Posture, Core Stability, Flexibility, Fatigue, Endurance, Ergonomics, Stress, and Quality of Life in Office Workers With Low Back Pain: A Three-Arm RCT",RECRUITING,2026-03-23,2026-06-17,2026-08-01,INTERVENTIONAL,NA,60,['Low Back Pain'],Low Back Pain,Suci Wahyu Ismiyasa,['Pembangunan Nasional Veteran Jakarta University'],['Indonesia']
NCT06576427,Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II,Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II,RECRUITING,2024-10-15,2026-02,2026-03,INTERVENTIONAL,NA,145,['Pulmonary Embolism'],Pulmonary Embolism,Jupiter Endovascular,[],"['Switzerland', 'Poland', 'Austria', 'United States']"
NCT03608631,iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation,Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation,RECRUITING,2021-01-27,2027-04-30,2027-04-30,INTERVENTIONAL,PHASE1,28,"['KRAS NP_004976.2:p.G12D', 'Metastatic Pancreatic Adenocarcinoma', 'Pancreatic Ductal Adenocarcinoma', 'Stage IV Pancreatic Cancer AJCC v8']",KRAS NP_004976.2:p.G12D,M.D. Anderson Cancer Center,[],['United States']
NCT05828589,"A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies",A Phase 1/1b Open-Label Dose-Escalation and Dose-Optimization Study of Bcl-2 Inhibitor BGB-21447 in Patients With Mature B-Cell Malignancies,ACTIVE_NOT_RECRUITING,2023-06-20,2027-04,2027-04,INTERVENTIONAL,PHASE1,112,"['Relapsed Non-Hodgkin Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Relapsed Chronic Lymphocytic Leukemia', 'Refractory Chronic Lymphocytic Leukemia', 'Relapsed Follicular Lymphoma', 'Relapsed Marginal Zone Lymphoma', 'Relapse Diffuse Large B Cell Lymphoma', 'Relapsed Small Lymphocytic Lymphoma', 'Refractory Follicular Lymphoma', 'Refractory Marginal Zone Lymphoma', 'Refractory Small Lymphocytic Lymphoma', 'Richter Transformation', 'Refractory Diffuse Large B-cell Lymphoma', 'Transformed Non-Hodgkin Lymphoma']",Relapsed Non-Hodgkin Lymphoma,BeiGene,[],"['China', 'New Zealand', 'United States', 'Australia']"
NCT06712355,"Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer","A Phase III, Multisite, Double-blinded Randomized Trial of BNT327 in Combination With Chemotherapy (Etoposide/Carboplatin) Compared to Atezolizumab in Combination With Chemotherapy (Etoposide/Carboplatin) in Participants With First-line Extensive-stage Small-cell Lung Cancer",RECRUITING,2025-02-03,2028-12,2029-03,INTERVENTIONAL,PHASE3,621,['Extensive-stage Small-cell Lung Cancer'],Extensive-stage Small-cell Lung Cancer,BioNTech SE,['Bristol-Myers Squibb'],"['Turkey (Türkiye)', 'China', 'United States', 'South Korea', 'United Kingdom', 'Australia']"
NCT06593210,RSV Vaccine in Transplant Recipients,"Safety and Immunogenicity of Non-live, Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine in Allogeneic Stem Cell Transplant and Lung Transplant Recipients",RECRUITING,2024-10-01,2026-03,2026-03,INTERVENTIONAL,PHASE3,100,"['Vaccine Response Impaired', 'Respiratory Syncytial Virus Infections', 'Immune Suppression']",Vaccine Response Impaired,"University Health Network, Toronto","['The PSI Foundation, Ontario', 'University of British Columbia']",['Canada']
NCT06898515,Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258),Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II),RECRUITING,2025-07-14,2027-08,2027-12,INTERVENTIONAL,PHASE3,400,['Acute Decompensated Heart Failure'],Acute Decompensated Heart Failure,"Reprieve Cardiovascular, Inc",[],"['United States', 'Spain', 'Italy', 'Poland', 'Germany']"
NCT06613360,"A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus","A Phase 1b, Open-label, Pilot Study of CLN-978 for the Treatment of Moderate to Severe Systemic Lupus Erythematosus (SLE)",RECRUITING,2025-01-21,2026-12,2027-12,INTERVENTIONAL,PHASE1,24,"['SLE', 'SLE (Systemic Lupus)']",SLE,Cullinan Therapeutics Inc.,[],"['Moldova', 'United States', 'Georgia', 'Australia']"
NCT07078461,Investigating the Safety and Efficacy of the 1927-nm Thulium Laser in Keratosis Pilaris,Investigating the Safety and Efficacy of the 1927-nm Thulium Laser for Soft Tissue Coagulation in Keratosis Pilaris,RECRUITING,2025-10-23,2026-12,2026-12,INTERVENTIONAL,NA,25,['Keratosis Pilaris (KP)'],Keratosis Pilaris (KP),Johns Hopkins University,[],['United States']
NCT07166419,"Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia","Phase I Clinical Trial of Caring Cross Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia) (C3PO)",RECRUITING,2025-12-01,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE1,24,"['Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive', 'Recurrent Acute Lymphoblastic Leukemia', 'Recurrent Chronic Lymphocytic Leukemia', 'Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive', 'Recurrent Indolent Non-Hodgkin Lymphoma', 'Recurrent Lymphoblastic Lymphoma', 'Recurrent Non-Hodgkin Lymphoma', 'Recurrent Transformed Chronic Lymphocytic Leukemia', 'Refractory Acute Lymphoblastic Leukemia', 'Refractory Chronic Lymphocytic Leukemia', 'Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive', 'Refractory Indolent Non-Hodgkin Lymphoma', 'Refractory Lymphoblastic Lymphoma', 'Refractory Non-Hodgkin Lymphoma', 'Refractory Transformed Chronic Lymphocytic Leukemia']","Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",Ohio State University Comprehensive Cancer Center,[],['United States']
NCT06632600,"A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.","A Randomized, Participant- and Investigator-blinded, Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LXE408 in Participants With Chronic Chagas Disease Without Severe Organ Dysfunction.",RECRUITING,2025-04-28,2027-03-22,2027-09-22,INTERVENTIONAL,PHASE2,130,['Chagas Disease'],Chagas Disease,Novartis Pharmaceuticals,[],"['Argentina', 'Brazil', 'United States', 'Colombia']"
NCT03271892,Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer,Deciding on Active Surveillance as an Alternative Option to Surgery in the Primary Management of Low Risk Papillary Thyroid Cancer,ACTIVE_NOT_RECRUITING,2016-05-11,2031-12-31,2031-12-31,OBSERVATIONAL,,200,['Thyroid Cancer Stage I'],Thyroid Cancer Stage I,"University Health Network, Toronto","['Canadian Cancer Society (CCS)', 'Ontario Ministry of Health and Long Term Care', 'Canadian Institutes of Health Research (CIHR)']",['Canada']
NCT07251114,"AI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study","AI-assisted Endoscopic Ultrasound Grading of Early Esophageal Cancer Invasion Depth: A Multicenter, Prospective, Randomized Cohort Study",RECRUITING,2025-11-20,2027-10-31,2028-12-31,INTERVENTIONAL,NA,200,"['Esophageal Cancer Stage', 'Early Esophageal Cancer']",Esophageal Cancer Stage,Fujian Provincial Hospital,[],['China']
NCT06808217,A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation,A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation,RECRUITING,2025-07-30,2026-08-01,2027-08-01,OBSERVATIONAL,,500,"['Atrial Fibrillation', 'Pulsed Field Ablation', 'FARAPULSE']",Atrial Fibrillation,Boston Scientific Corporation,[],"['Monaco', 'Netherlands', 'Saudi Arabia', 'Austria', 'France', 'Switzerland', 'Croatia', 'Ireland', 'Spain', 'Italy', 'United Kingdom', 'Greece', 'Poland', 'Kuwait', 'Germany']"
NCT07251517,The CIPS-TER Study,Cognitive Impairment Post Stroke: a Single-blinded Randomized Trial on the Efficacy of TEleRehabilitation. The CIPS-TER Study,RECRUITING,2024-04-22,2025-11,2026-02,INTERVENTIONAL,NA,100,"['Cognitive Impairment', 'Stroke Acute']",Cognitive Impairment,University of Florence,"['University of Milan', 'Università di Pavia']",['Italy']
NCT07084662,Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma,"A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Xinlikang Capsule in the Treatment of Chemotherapy-induced Fatigue and Immune Disorders in Patients With Diffuse Large B Lymphoma",RECRUITING,2025-09-11,2028-08-01,2030-08-01,INTERVENTIONAL,PHASE2,80,['Diffuse Large B-Cell Lymphoma (DLBCL)'],Diffuse Large B-Cell Lymphoma (DLBCL),Sun Yat-sen University,[],['China']
NCT07223411,Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma,Dose-response Analysis of Nivolumab/Relatlimab in the Fixed-dosed Combination 'Opdualag' vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood for Participants With Unresectable or Metastatic Melanoma: A Corollary Study of HCC 24-056 (NCT06246916),RECRUITING,2025-11-19,2028-11-01,2031-11-01,OBSERVATIONAL,,20,['Locally Advanced Melanoma'],Locally Advanced Melanoma,John Kirkwood,['Regeneron Pharmaceuticals'],['United States']
NCT06113211,Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures,Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures,RECRUITING,2024-10-01,2026-09-15,2026-09-15,INTERVENTIONAL,PHASE4,75,"['Opioid Use', 'Fractures, Bone', 'Trauma']",Opioid Use,Henry Ford Health System,[],['United States']
NCT02570542,Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL),A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL),ACTIVE_NOT_RECRUITING,2015-10,2026-10,2026-10,INTERVENTIONAL,PHASE2,59,"['Diffuse Large B-cell Lymphoma (DLBCL)', 'Relapsed Diffuse Large B-cell Lymphoma (DLBCL)', 'Refractory Diffuse Large B-cell Lymphoma (DLBCL)']",Diffuse Large B-cell Lymphoma (DLBCL),Memorial Sloan Kettering Cancer Center,"['Columbia University', 'Endeavor Health', 'University of Rochester', 'Medical College of Wisconsin', 'University of Nebraska', 'Sanofi', 'University Hospitals Seidman Cancer Center']",['United States']
NCT02861573,Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365),Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365),RECRUITING,2016-11-17,2027-10-22,2027-10-22,INTERVENTIONAL,PHASE1,1200,['Metastatic Castration-Resistant Prostate Cancer'],Metastatic Castration-Resistant Prostate Cancer,Merck Sharp & Dohme LLC,[],"['New Zealand', 'Turkey (Türkiye)', 'Netherlands', 'United States', 'France', 'Mexico', 'Denmark', 'Ireland', 'Spain', 'Italy', 'Canada', 'United Kingdom', 'Poland', 'Sweden', 'Germany']"
NCT07185269,The Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLE,"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ib/II Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Anti-BDCA2 Antibody SSGJ-626 in Subjects With Systemic Lupus Erythematosus",RECRUITING,2025-09-24,2028-08-12,2028-11-04,INTERVENTIONAL,PHASE1,198,['Systemic Lupus Erythematosus (SLE)'],Systemic Lupus Erythematosus (SLE),"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.",[],['China']
NCT07251153,Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions,"A Phase 1, Two Parts, Open-label, Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt (EYP651) in Healthy Volunteers and Evaluation of Potential Drug-Drug Interactions",RECRUITING,2025-10-28,2025-12-18,2026-10-28,INTERVENTIONAL,PHASE1,40,['Healthy Adult Male and Female Volunteers'],Healthy Adult Male and Female Volunteers,Enyo Pharma,[],['France']
NCT01048853,Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer,"Conservative Surgery for Women With Low-Risk, Early Stage Cervical Cancer",ACTIVE_NOT_RECRUITING,2010-04-15,2024-12-31,2025-12-31,INTERVENTIONAL,NA,100,"['Cervical Adenocarcinoma', 'Cervical Squamous Cell Carcinoma, Not Otherwise Specified', 'Stage IA2 Cervical Cancer AJCC v6 and v7', 'Stage IB1 Cervical Cancer AJCC v6 and v7']",Cervical Adenocarcinoma,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],"['Brazil', 'United States', 'Mexico', 'Peru', 'Thailand', 'Colombia', 'Argentina', 'Australia']"
NCT06464237,Metacognitive Intervention in Youth With Oncological Disease - the Mio Study,Metacognitive Intervention in Youth With Oncological Disease - the Mio Study,RECRUITING,2025-08-01,2027-05-01,2027-05-01,INTERVENTIONAL,NA,40,['Cancer'],Cancer,"Insel Gruppe AG, University Hospital Bern",['University of Bern'],['Switzerland']
NCT06761365,LUMENS-1 EU EFS CIP,"A SINGLE-ARM, OPEN LABEL, MULTI-CENTER EARLY FEASIBILITY STUDY OF THE LUSEED ANEURYSM EMBOLIZATION SYSTEM IN INDIVIDUALS WITH UPRUPTURED INTRACRANIAL ANEURYSMS",RECRUITING,2024-10-07,2026-12,2027-06,INTERVENTIONAL,NA,30,"['Aneurysm Cerebral', 'Bifurcation', 'Unruptured Intracranial Aneurysm', 'Saccular Aneurysm', 'Brain Aneurysm']",Aneurysm Cerebral,LuSeed Vascular LTD.,[],"['Bulgaria', 'Poland', 'Israel', 'Germany']"
NCT06628375,A Multimodal Study of the Relationship Between Exposure to Endocrine Disruptors and Occurrence of Hypospadias - HYPOLLUT,"Exposure to Endocrine Disruptors and Occurrence of Hypospadias: Toxicological, Environmental and Hormonal Imbalance Study",RECRUITING,2024-10-03,2027-09-30,2027-10-03,OBSERVATIONAL,,200,['Hypospadias'],Hypospadias,"University Hospital, Montpellier",[],['France']
NCT05155332,A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors),"Phase I Open-label, Dose Escalation Trial of BI 1831169 Monotherapy and in Combination With an Anti-PD-1 mAb in Patients With Advanced or Metastatic Solid Tumors",RECRUITING,2022-03-28,2027-12-13,2028-10-31,INTERVENTIONAL,PHASE1,190,['Solid Tumors'],Solid Tumors,Boehringer Ingelheim,[],"['Belgium', 'Austria', 'United States', 'France', 'Germany', 'Switzerland', 'Spain', 'Italy', 'Canada', 'Australia']"
NCT06189157,MB-CART19.1 in Refractory SLE,"An Open-label Phase I/IIa, Multicentre, Interventional Single-arm Trial of MB-CART19.1 in Patients With Refractory SLE",RECRUITING,2024-08-12,2027-09-30,2027-09-30,INTERVENTIONAL,PHASE1,29,['SLE - Systemic Lupus Erythematosus'],SLE - Systemic Lupus Erythematosus,Miltenyi Biomedicine GmbH,[],['Germany']
NCT06731907,A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01),"KEYMAKER-U01 Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC)",RECRUITING,2025-03-30,2032-03-12,2032-03-12,INTERVENTIONAL,PHASE2,90,['Non-small Cell Lung Cancer'],Non-small Cell Lung Cancer,Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Hungary', 'Turkey (Türkiye)', 'United States', 'Chile', 'Spain', 'Italy', 'Greece', 'Poland', 'Ukraine']"
NCT06246136,Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery,"A Prospective, Multicenter, Randomized Clinical Trial to Evaluate the Safety and Effectiveness of ELIOS vs Competitor in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery",RECRUITING,2023-12-05,2025-12-31,2028-03-31,INTERVENTIONAL,NA,194,['Open Angle Glaucoma'],Open Angle Glaucoma,"Elios Vision, Inc.",[],"['Belgium', 'Netherlands', 'France', 'Spain', 'United Kingdom', 'Germany']"
NCT07252167,Comparison Between Emdogain and Amniotic Membrane as a Scaffold in Endodontic Regeneration of Immature Anterior Teeth,A Comparative Evaluation of Clinical Outcomes and Cone-Beam Computed Tomography Findings of Enamel Matrix Derivative and Amniotic Membrane in Regenerative Endodontic Treatment of Non Vital Immature Permanent Anterior Teeth: A Randomized Clinical Trial,ACTIVE_NOT_RECRUITING,2025-03-01,2026-03-01,2026-04-01,INTERVENTIONAL,NA,39,['Non-vital Immature Anterior Teeth'],Non-vital Immature Anterior Teeth,Al-Azhar University,[],['Egypt']
NCT04802759,A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer,"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Breast Cancer (MORPHEUS-BREAST CANCER)",RECRUITING,2021-06-22,2027-11-30,2027-11-30,INTERVENTIONAL,PHASE1,316,"['Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer']","Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer",Hoffmann-La Roche,[],"['Israel', 'United States', 'Spain', 'South Korea', 'Australia']"
NCT06948591,BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures,Real World Evaluation of the Safety and Effectiveness of BioBrace® Augmentation in Anterior Cruciate Ligament (ACL) Reconstruction Procedures,RECRUITING,2025-04-08,2030-06,2030-06,OBSERVATIONAL,,500,['ACL Tears'],ACL Tears,CONMED Corporation,[],['United States']
NCT03734198,Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction,A Phase II Pilot Study to Evaluate the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction. IDA53 Trial. A FILO Study.,ACTIVE_NOT_RECRUITING,2018-12-19,2023-06-17,2025-12-19,INTERVENTIONAL,PHASE2,29,['Relapsed or Refractory Chronic Lymphocytic Leukemia'],Relapsed or Refractory Chronic Lymphocytic Leukemia,French Innovative Leukemia Organisation,"['Janssen, LP']",['France']
NCT07251504,Mitochondrial Metabolism and Oxidative Stress in Function of the Physical Exercise and Nutritional Counseling in T2DM,Mitochondrial Metabolism and Oxidative Stress in Function of the Type of Physical Exercise and Nutritional Counseling in Type 2 Diabetes Mellitus,ACTIVE_NOT_RECRUITING,2022-03-10,2025-12-31,2025-12-31,INTERVENTIONAL,NA,146,"['Diabetes Mellitus, Type 2']","Diabetes Mellitus, Type 2",University of Cadiz,['Instituto de investigación e innovación biomédica de Cádiz'],['Spain']
NCT05885594,Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study,Imaging Inflammation in Individuals With Alcohol Use Disorder: an [18F]NOS Study,ACTIVE_NOT_RECRUITING,2023-08-08,2027-03-15,2027-03-15,INTERVENTIONAL,EARLY_PHASE1,4,['Alcohol Use Disorder'],Alcohol Use Disorder,University of Pennsylvania,[],['United States']
NCT07252427,Gut Microbiota in IBD With Comorbid Depressive Disorder,Gut Microbial Characteristics in Patients With Comorbid Inflammatory Bowel Disease and Depressive Disorder,RECRUITING,2025-03-16,2025-12-31,2026-03-31,OBSERVATIONAL,,120,"['Inflammatory Bowel Disease', 'Depressive Disorder']",Inflammatory Bowel Disease,Fang Tang,[],['China']
NCT03143322,Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases,Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases,ACTIVE_NOT_RECRUITING,2018-07-24,2025-07-31,2027-07-31,INTERVENTIONAL,NA,168,"['Metastatic Breast Cancer', 'Metastatic Lung Cancer', 'Metastatic Prostate Cancer', 'Bone Metastases']",Metastatic Breast Cancer,UNICANCER,[],['France']
NCT05681026,"Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States","Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States",RECRUITING,2023-08-28,2026-01-31,2026-01-31,INTERVENTIONAL,NA,60,"['Hematopoietic Stem Cell Transplantation', 'Cancer']",Hematopoietic Stem Cell Transplantation,M.D. Anderson Cancer Center,['National Cancer Institute (NCI)'],"['Tanzania', 'United States', 'India']"
NCT01961063,Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma,Safety and Feasibility of Gene Transfer After Frontline Chemotherapy for Non-Hodgkin Lymphoma in AIDS Patients Using Peripheral Blood Stem/Progenitor Cells Treated With a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs,ACTIVE_NOT_RECRUITING,2015-12-31,2026-08-05,2026-08-05,INTERVENTIONAL,PHASE1,3,"['AIDS-related Non-Hodgkin Lymphoma', 'AIDS-related Plasmablastic Lymphoma', 'AIDS-related Primary Effusion Lymphoma', 'HIV Infection']",AIDS-related Non-Hodgkin Lymphoma,City of Hope Medical Center,[],['United States']
NCT03779334,A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy,An Open-Label Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy,ACTIVE_NOT_RECRUITING,2019-08-07,2023-02-20,2027-03-31,INTERVENTIONAL,PHASE2,26,"['Muscular Atrophy, Spinal']","Muscular Atrophy, Spinal",Hoffmann-La Roche,[],"['Brazil', 'Belgium', 'Russia', 'United States', 'Taiwan', 'Poland', 'Australia']"
NCT06326021,Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia,"Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia：a Multi-center, Open-label, Non-randomised, Single-arm Phase Ⅰ Clinical Trial",RECRUITING,2024-04-02,2026-06-15,2026-12-30,INTERVENTIONAL,PHASE1,27,['Refractory/Relapsed Acute Myeloid Leukaemia'],Refractory/Relapsed Acute Myeloid Leukaemia,Beijing GoBroad Hospital,"['The General Hospital of Western Theater Command', 'Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai', 'Shanghai Liquan Hospital', 'Ruijin Hospital']",['China']
NCT07139132,The AHA Oneida Study,Transforming Risk Factors in a High Stroke Risk Native American Population Through a Cultural Nutritional Program,RECRUITING,2025-09-11,2027-09,2027-09,INTERVENTIONAL,NA,85,['Oneida Nation Members'],Oneida Nation Members,"University of Wisconsin, Madison",['American Heart Association (AHA)'],['United States']
NCT07252193,Generative AI-Based Simulation for Diagnostic Communication in Type 2 Diabetes (DIALOGUE-DM2),Generative AI Simulation for Diagnostic Communication in Type 2 Diabetes: A Randomized Controlled Trial (DIALOGUE-DM2),ACTIVE_NOT_RECRUITING,2025-09-22,2025-12-31,2026-02-01,INTERVENTIONAL,NA,120,"['Type 2 Diabetes Mellitus', 'Medical Education', 'Diagnostic Communication', 'Artificial Intelligence Simulation']",Type 2 Diabetes Mellitus,Universidad Nacional Autonoma de Mexico,[],['Mexico']
NCT06313944,German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation,German (GE) Multicenter Prospective Data Collection (Registry) on Treatment With Transcranial Pulse Wave Stimulation (TPS) in Patients With Alzheimer's Disease (A),RECRUITING,2025-08-06,2026-10-01,2026-10-01,OBSERVATIONAL,,100,['Alzheimer Disease'],Alzheimer Disease,"Heinrich-Heine University, Duesseldorf",['Storz Medical AG'],['Germany']
NCT05287464,International Multicentric Study ARON-1,International Multicentric Study ARON-1,RECRUITING,2022-03-10,2024-06-01,2027-09-30,OBSERVATIONAL,,1220,['Metastatic Renal Cell Carcinoma (mRCC)'],Metastatic Renal Cell Carcinoma (mRCC),Hospital of Macerata,[],['Italy']
NCT02883049,Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations,A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations,ACTIVE_NOT_RECRUITING,2012-02-29,2022-12-31,2026-10-03,INTERVENTIONAL,PHASE3,5949,"['B Acute Lymphoblastic Leukemia', 'B Acute Lymphoblastic Leukemia, BCR-ABL1-Like', 'Central Nervous System Leukemia', 'Testicular Leukemia']",B Acute Lymphoblastic Leukemia,National Cancer Institute (NCI),[],"['New Zealand', 'United States', 'Switzerland', 'Puerto Rico', 'Ireland', 'Canada', 'Australia']"
NCT05448326,The Diagnostic Observatory: Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network,The Diagnostic Observatory: Combating Diagnostic Wandering and Impasse Within the AnDDI-Rares Network,RECRUITING,2022-03-28,2029-03,2029-03,OBSERVATIONAL,,1280,['Developmental Abnormality'],Developmental Abnormality,Centre Hospitalier Universitaire Dijon,[],['France']
NCT06473623,Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder,Non-invasive Auricular Fiber Vagus Nerve Stimulation (afVNS) for Treatment of Autism Spectrum Disorder: An Open-Label Trial,RECRUITING,2025-12-01,2026-02-01,2026-02-10,INTERVENTIONAL,NA,20,['Autism Spectrum Disorder'],Autism Spectrum Disorder,Neuropix,[],['Hong Kong']
NCT06109779,Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01),"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)",RECRUITING,2023-12-04,2029-01-02,2030-05-03,INTERVENTIONAL,PHASE3,750,['Biliary Tract Cancer'],Biliary Tract Cancer,AstraZeneca,[],"['Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'France', 'Denmark', 'South Korea', 'Thailand', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'United Kingdom', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Norway', 'United States', 'Italy']"
NCT06079398,A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia,"A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-controlled Trial, Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 52 Weeks in Infants (0 to <2 Years of Age) With Achondroplasia Followed by an Open Label Extension (OLE) Period",RECRUITING,2024-01-23,2026-03,2027-03,INTERVENTIONAL,PHASE2,72,['Achondroplasia'],Achondroplasia,Ascendis Pharma A/S,[],"['New Zealand', 'Norway', 'Austria', 'United States', 'France', 'Germany', 'Finland', 'Denmark', 'Ireland', 'Italy', 'United Kingdom', 'Portugal', 'Sweden', 'Australia']"
NCT07251244,Supplement and Exercise Effects on Stationary Immunity and Health in Older Adults,"Effects of a Nutritional Supplement and Functional Exercise Program on Seasonal Immunity, Perceived Health, and Oxidative Stress in Older Adults",RECRUITING,2025-12-15,2026-07,2026-07,INTERVENTIONAL,NA,60,"['Aging', 'Older Adults']",Aging,University of Valencia,[],['Spain']
NCT07058519,A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC,"The Efficacy and Safety of Osimertinib-based Adaptive Treatment Guided by Circulating Tumour DNA (ctDNA) Epidermal Growth Factor Receptor Mutation-positive (EGFRm) Dynamic Monitoring in Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) Participants With ctDNA EGFRm Clearance After First-line Osimertinib Plus Chemotherapy: A Phase II, Multicentre, Prospective Study (Adaptive)",RECRUITING,2025-09-23,2029-01-24,2029-01-24,INTERVENTIONAL,PHASE2,250,['Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)'],Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC),Shanghai Chest Hospital,['AstraZeneca'],['China']
NCT07207707,A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies,"A Phase 1a, Open-label, Multicenter, Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB548 in Participants With Advanced Solid Malignancies With a KRAS G12D Mutation",RECRUITING,2025-09-16,2026-09,2027-03,INTERVENTIONAL,PHASE1,78,['Solid Tumor Malignancies'],Solid Tumor Malignancies,Kumquat Biosciences Inc.,[],['United States']
NCT06129864,A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy,"A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)",RECRUITING,2023-12-14,2028-04-18,2030-09-12,INTERVENTIONAL,PHASE3,1145,['Locally Advanced Head and Neck Squamous Cell Carcinoma'],Locally Advanced Head and Neck Squamous Cell Carcinoma,AstraZeneca,[],"['Japan', 'China', 'Belgium', 'Hungary', 'France', 'Puerto Rico', 'South Korea', 'Thailand', 'Poland', 'India', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'United Kingdom', 'Vietnam', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Philippines']"
NCT05126277,"Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis","A Randomized, Double-blind, Parallel Group, Placebo-controlled, Multicenter Phase 3 Trial to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Participants With Active Lupus Nephritis (SIRIUS-LN).",RECRUITING,2022-07-14,2027-06-22,2030-11-05,INTERVENTIONAL,PHASE3,462,['Lupus Nephritis'],Lupus Nephritis,Novartis Pharmaceuticals,[],"['Hong Kong', 'China', 'Lithuania', 'Hungary', 'Estonia', 'France', 'Chile', 'Guatemala', 'South Korea', 'Colombia', 'Czechia', 'Thailand', 'India', 'Singapore', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'United Kingdom', 'Vietnam', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT04165798,KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01),"KEYMAKER-U01 Master Study: A Phase 1/2, Umbrella Study With Rolling Arms of Investigational Agents, Pembrolizumab, and Chemotherapy, Alone or in Combination, in Participants With Non-small Cell Lung Cancer (NSCLC)",RECRUITING,2019-12-19,2032-02-13,2032-02-13,OBSERVATIONAL,,1065,"['Carcinoma, Non-Small-Cell Lung']","Carcinoma, Non-Small-Cell Lung",Merck Sharp & Dohme LLC,['Daiichi Sankyo'],"['Israel', 'Hungary', 'United States', 'Spain', 'Italy', 'South Korea', 'Poland']"
NCT06894511,An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC,"A Phase II, Open-label, Multi-Center, Randomized Study Comparing the Combination of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) and Androgen Receptor Pathway Inhibitor (ARPI) vs. Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in First-line Treatment of Patients With Prostate-Specific Membrane Antigen (PSMA)-Positive Progressive Metastatic Castration Resistant Prostate Cancer (mCRPC)",RECRUITING,2025-09-11,2029-04-09,2029-04-09,INTERVENTIONAL,PHASE2,420,['Metastatic Castration Resistant Prostate Cancer (mCRPC)'],Metastatic Castration Resistant Prostate Cancer (mCRPC),Novartis Pharmaceuticals,[],['United States']
NCT06455319,Precision Administration of Anti-thymocyte Globulin With or Without Verapamil,Precision Administration of Anti-thymocyte Globulin With or Without Verapamil in Adolescents and Young Adults With Type 1 Diabetes,RECRUITING,2025-11-12,2028-11,2030-08,INTERVENTIONAL,PHASE2,60,['Type 1 Diabetes'],Type 1 Diabetes,University of Florida,"['University of Colorado, Denver', 'University of Miami']",['United States']
NCT05519475,A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition,"A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors",RECRUITING,2023-02-09,2027-09-08,2027-09-08,INTERVENTIONAL,PHASE2,90,['Metabolic Dysfunction-associated Steatohepatitis (MASH)'],Metabolic Dysfunction-associated Steatohepatitis (MASH),Regeneron Pharmaceuticals,[],"['Puerto Rico', 'Japan', 'United States', 'South Korea']"
NCT06520982,Early Neurovascular Adaptations in Aging Women,Early Neurovascular Adaptations in Aging Women,RECRUITING,2024-09-20,2027-06-30,2028-06-30,INTERVENTIONAL,EARLY_PHASE1,64,"['Women', 'Sympathetic Nervous System', 'Aging', 'Blood Flow']",Women,University of Missouri-Columbia,['American Heart Association (AHA)'],['United States']
NCT06484179,Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type,Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type: A Pilot Randomized Control Trial (RCT),RECRUITING,2024-08-28,2027-07,2027-07,INTERVENTIONAL,NA,100,"['Cancer', 'Smoking']",Cancer,University of Utah,['National Cancer Institute (NCI)'],['United States']
NCT06948786,"Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial",PROMOTE-FL: Pirtobrutinib and Mosunetuzumab to Enhance Treatment Efficacy for Patients With Relapsed/Refractory Follicular Lymphoma,RECRUITING,2025-11-17,2031-07-31,2031-07-31,INTERVENTIONAL,PHASE2,22,"['Grade 1 Follicular Lymphoma', 'Grade 2 Follicular Lymphoma', 'Grade 3a Follicular Lymphoma', 'Recurrent Follicular Lymphoma', 'Refractory Follicular Lymphoma']",Grade 1 Follicular Lymphoma,University of Washington,['Eli Lilly and Company'],['United States']
NCT07250373,Serratus Posterior Superior Intercostal Plane (SPSIP) Block Versus Intercostal Nerve (ICN) Block in Patients Undergoing Uniportal-VATS.,Serratus Posterior Superior Intercostal Nerve (SPSIP) Block Versus Intercostal Nerve (ICN) Block in Patients Undergoing Uniportal Video-Assisted Thoracic Surgery (Uniportal-VATS): a Randomized Controlled Trial,ACTIVE_NOT_RECRUITING,2025-08-01,2027-04-30,2027-04-30,INTERVENTIONAL,NA,28,"['Uniportal-VATS', 'Lung Resection Procedures', 'Locoregional Anesthesia', 'Post-operative Pain Management', 'Serratus Posterior Superior Intercostal Plane Block', 'Intercostal Nerve Block', 'Uniportal Video Assisted Thoracic Surgery']",Uniportal-VATS,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,[],['Italy']
NCT07169331,A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglobulinemia,"A Phase 4, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Patients With Treatment-Naive Waldenström Macroglobulinemia",RECRUITING,2025-10-17,2028-10-31,2028-10-31,INTERVENTIONAL,PHASE4,18,"[""Waldenström's Macroglobulinemia""]",Waldenström's Macroglobulinemia,BeiGene,[],['China']
NCT07044583,SAVE Trial: SAfe Opioid Use Video Education,SAVE Trial: SAfe Opioid Use Video Education,RECRUITING,2025-10-27,2027-08,2027-08,INTERVENTIONAL,NA,68,"['Breast Reconstruction', 'Breast Cancer']",Breast Reconstruction,University of Utah,[],['United States']
NCT05201469,VIBRANT: VIB4920 for Active Lupus Nephritis,A Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis (ITN091AI),RECRUITING,2022-05-16,2026-08,2027-03,INTERVENTIONAL,PHASE2,74,['Lupus Nephritis'],Lupus Nephritis,National Institute of Allergy and Infectious Diseases (NIAID),[],['United States']
NCT06765317,A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma,"Optimizing Frontline Therapy for DLBCL in Older Adults: A GLOfitamab-based, Response-adapted, Window-stYle Study (GLORY)",RECRUITING,2025-01-16,2028-01,2028-01,INTERVENTIONAL,PHASE2,42,"['Diffuse Large B Cell Lymphoma (DLBCL)', 'High Grade B Cell Lymphoma']",Diffuse Large B Cell Lymphoma (DLBCL),Memorial Sloan Kettering Cancer Center,"['Genentech, Inc.']",['United States']
NCT07251673,Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation,Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation,RECRUITING,2025-10-01,2030-10-01,2030-10-01,OBSERVATIONAL,,50,['Dravet Syndrome'],Dravet Syndrome,Assistance Publique - Hôpitaux de Paris,['Encoded Therapeutics'],['France']
NCT06886464,Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin,"The Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin (PONTiAK) Trial: A Phase 2B Vanguard Design, Randomized, Double-Blind, Placebo-Controlled Study",RECRUITING,2025-07-16,2027-12-31,2029-12,INTERVENTIONAL,PHASE2,698,['Acute Kidney Injury'],Acute Kidney Injury,Matthew James,"['Alberta Health services', 'University of Alberta']",['Canada']
NCT06550128,Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).,"Randomized, Multi-center Phase II Study to Evaluate the Efficacy and Safety of AHB-137 in HBeAg-negative CHB Subjects Under Stable Nucleos(t)Ide Analogue (NA) Treatment",ACTIVE_NOT_RECRUITING,2024-07-10,2026-02-02,2026-06-30,INTERVENTIONAL,PHASE2,86,"['Hepatitis B, Chronic']","Hepatitis B, Chronic","Ausper Biopharma Co., Ltd.",[],['China']
NCT05723055,Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma,A Proof-of-Concept Multicenter Trial Evaluating Response Adapted Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma,RECRUITING,2023-05-03,2026-05,2028-04,INTERVENTIONAL,PHASE2,9,['Hodgkin Lymphoma'],Hodgkin Lymphoma,University of Utah,['Incyte Corporation'],['United States']
NCT07236606,RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome),"A Phase 3, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RGX 121 in Pediatric Participants With Neuronopathic MPS II (Hunter Syndrome)",RECRUITING,2025-11-25,2028-04-30,2031-05-30,INTERVENTIONAL,PHASE3,2,"['MPS II', 'Hunter Syndrome (MPS II)']",MPS II,REGENXBIO Inc.,[],['United States']
NCT07061652,Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes,Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes,RECRUITING,2025-07-03,2026-06,2026-06,INTERVENTIONAL,NA,162,"['Cancer', 'Diabetes']",Cancer,UNC Lineberger Comprehensive Cancer Center,['Humana Foundation'],['United States']
NCT07250347,AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT,Langue and Imaging-integrated Foundation Model for Gastric Cancer Detection and Staging Via Contrast-Enhanced CT: a Multicenter Study,RECRUITING,2025-08-01,2028-12-30,2028-12-30,OBSERVATIONAL,,8000,"['Gastric Cancer Stage', 'Gastric Cancer Patients Undergoing Gastrectomy']",Gastric Cancer Stage,The First Affiliated Hospital with Nanjing Medical University,"['Jiangsu Cancer Institute & Hospital', 'The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital', 'Peking University First Hospital']",['China']
NCT03471845,RESOLUTE ONYX China Single Arm Study,A Single Arm Clinical Evaluation of Safety and Efficacy of the Medtronic Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Subjects Eligible for Percutaneous Transluminal Coronary Angioplasty (PTCA) in China,ACTIVE_NOT_RECRUITING,2018-03-30,2021-02-24,2026-04-30,INTERVENTIONAL,NA,591,"['Ischemic Heart Disease', 'Stenotic Coronary Lesion', 'Cardiovascular Diseases', 'Arteriosclerosis', 'Coronary Artery Disease']",Ischemic Heart Disease,Medtronic Vascular,[],['China']
NCT03766763,Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A,"Preemptive Therapy With Venetoclax for High Risk Chronic Lymphoid Leukemia Stage A Patients, a Phase II Trial of the FILO",ACTIVE_NOT_RECRUITING,2019-05-22,2022-01-01,2030-04-24,INTERVENTIONAL,PHASE2,82,['Chronic Lymphoid Leukemia'],Chronic Lymphoid Leukemia,French Innovative Leukemia Organisation,[],['France']
NCT06505798,Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart,Cryoballoon/Radiofrequency/Pulsed Field Ablation of Atrial Fibrillation Versus Medical Treatment for Heart,RECRUITING,2024-11-21,2031-12-15,2031-12-15,INTERVENTIONAL,NA,1200,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),"University College, London",[],['United Kingdom']
NCT04948658,"Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy","Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy",RECRUITING,2021-09-13,2030-07-31,2030-07-31,OBSERVATIONAL,,100,"['Turner Syndrome', 'Post-menarcheal Adolescents', 'Ovarian Disfunction', 'Galactosemia', 'Variations in Sex Characteristics', 'Differences in Sex Development']",Turner Syndrome,Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),[],['United States']
NCT07239258,"The Effects of Mir Shakeel Teleintegrated Therapy Plan on Pain, Range of Motion, Gait, Functional Outcomes and Quality of Life in Patients Undergoing Total Knee Arthroplasty","The Effects of Mir Shakeel Teleintegrated Therapy Plan and Conventional Physical Therapy on Pain, Range of Motion, Gait, Functional Outcomes and Quality of Life in Patients Undergoing Total Knee Arthroplasty",RECRUITING,2025-11,2026-05,2026-06,INTERVENTIONAL,NA,120,"['Total Knee Anthroplasty', 'Total Knee Arthroplasty Recovery']",Total Knee Anthroplasty,Mir Shakeel Ahmad,[],['Pakistan']
NCT06288763,Nerve Transfer to Improve Function in High Level Tetraplegia,Nerve Transfer to Restore Upper Limb Function and Quality of Life in High Tetraplegia,RECRUITING,2024-02-05,2028-03-01,2028-12-31,OBSERVATIONAL,,30,"['Cervical Spinal Cord Injury', 'Tetraplegia']",Cervical Spinal Cord Injury,Wilson Z. Ray,"['University of Michigan', 'The Methodist Hospital Research Institute', 'University of Pennsylvania', 'University of Utah', 'Stanford University', 'University of Miami', 'Johns Hopkins University', 'University of Alberta', 'Wake Forest University Health Sciences', 'Department of Defense / Congressionally Mandated Research Program (CDMRP)']","['United States', 'Canada']"
NCT07085481,Effect of Warm Bupivacaine on Subtenon Block.,"The Influence Of Bupivacaine Temperature On Subtenon Block Characteristics: A Prospective, Randomized, Controlled Trial",RECRUITING,2025-10-01,2025-12,2026-01,INTERVENTIONAL,NA,120,['Cataract'],Cataract,Mansoura University,[],['Egypt']
NCT07251036,Serum Chordecone Concentration in Guadeloupean Population: Impact of a Multidisciplinary Support Program on the Reduction of the Contamination Level.,Serum Chordecone Concentration in Guadeloupean Population: Impact of a Multidisciplinary Support Program on the Reduction of the Contamination Level.,RECRUITING,2022-06-26,2028-06,2028-06,INTERVENTIONAL,NA,3000,['Chlordecone Level'],Chlordecone Level,Centre Hospitalier Universitaire de la Guadeloupe,[],['Guadeloupe']
NCT07250399,Effect of Instrumentation Kinematics on Intraoperative and Post-operative Pain in Maxillary Premolars With Acute Irreversible Pulpitis,Effect of Instrumentation Kinematics on Intraoperative and Post-operative Pain in Maxillary Premolars With Acute Irreversible Pulpitis: A Randomized Clinical Trial,RECRUITING,2025-10-15,2027-01-15,2027-05-10,INTERVENTIONAL,NA,56,['the Effect of Instrumentation Kinematics on Intraoperative and Post-operative Pain'],the Effect of Instrumentation Kinematics on Intraoperative and Post-operative Pain,Al-Azhar University,[],['Egypt']
NCT06704958,Augmented Momentary Personal Ecological Risk Evaluation,Augmented Momentary Personal Ecological Risk Evaluation,RECRUITING,2025-09-25,2026-06-01,2026-07-01,INTERVENTIONAL,NA,50,"['Suicidal Ideation', 'Self Harm']",Suicidal Ideation,University of Washington,['National Institute of Mental Health (NIMH)'],['United States']
NCT07084779,Investigation of Impact of AI on Prostate Cancer Workflow,Investigation of Impact of AI on Prostate Cancer Workflow,RECRUITING,2025-09-09,2026-03-30,2026-03-30,INTERVENTIONAL,NA,150,"['Prostate Cancer', 'Prostatic Neoplasm', 'Cancer of the Prostate', 'Neoplasms, Prostate']",Prostate Cancer,Case Comprehensive Cancer Center,['Siemens Medical Solutions'],['United States']
NCT04525716,The Effect of the Covid-19 Pandemic Among Operated Patients,"What Are the Effects of the Covid-19 Pandemic Among Operated Patients? A Hospital Based Cohort in Stockholm, Sweden",RECRUITING,2020-01-01,2027-12-31,2029-12-31,OBSERVATIONAL,,300000,"['Covid19', 'Surgery']",Covid19,Karolinska Institutet,[],['Sweden']
NCT05651659,Preventing and Approaching Crises for Frail Community-dwelling Patients Through Through Innovative Care (PRACTIC),Preventing and Approaching Crises for Frail Community-dwelling Patients Through Innovative Care (PRACTIC) - an Effectiveness Study,ACTIVE_NOT_RECRUITING,2023-01-09,2026-04-01,2026-04-01,INTERVENTIONAL,NA,150,['Frailty'],Frailty,Sykehuset Innlandet HF,"['Norwegian University of Science and Technology', 'The Norwegian National Advisory Unit on Ageing and Health', 'Helse Stavanger HF', 'Hochschule für Gesundheit, University of Applied Sciences, Bochum, Germany']",['Norway']
NCT07252362,LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals,LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individuals,RECRUITING,2023-11-11,2025-12-30,2026-03-30,INTERVENTIONAL,NA,20,['The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals'],The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals,Zhejiang Cancer Hospital,[],['China']
NCT06966375,Worldwide Yearly Screening for Hypospadias,Pilot Testing of the Worldwide Yearly Screening for Hypospadias,RECRUITING,2025-07-23,2026-11,2026-11,INTERVENTIONAL,NA,20,['Hypospadias'],Hypospadias,"University of Wisconsin, Madison",['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT02832193,"Retrospective Evaluation of POCD Data of Studies From KAI, Charité - Universitätsmedizin Berlin","Retrospective Evaluation of POCD Data of Studies From the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK) Charité - Universitätsmedizin Berlin",RECRUITING,2009-03,2027-12,2027-12,OBSERVATIONAL,,5000,['Postoperative Cognitive Dysfunction'],Postoperative Cognitive Dysfunction,"Charite University, Berlin, Germany",[],['Germany']
NCT07252219,Effects of Ankle Evertor Fatigue on Force Sense and Neuromuscular Activation in Subjects With Chronic Ankle Instability,Effects of Ankle Evertor Fatigue on Force Sense and Neuromuscular Activation During Submaximal Isometric Contractions in Individuals With and Without Chronic Ankle Instability,RECRUITING,2025-05-15,2026-01,2026-03,OBSERVATIONAL,,50,"['Chronic Ankle Instability, CAI']","Chronic Ankle Instability, CAI",University of Ljubljana,[],['Slovenia']
NCT07250503,Compare the Difference in Occlusal Force Distribution and Denture Retention Using 2 Different Denture Base Materials in Implant Retained Overdenture,Impact of Wearing Two Different Implant Retained Mandibular Overdentures on Occlusal Force Distribution and Denture Retention (Randomized Clinical Trial),ACTIVE_NOT_RECRUITING,2024-09-01,2026-01-01,2026-02-01,INTERVENTIONAL,NA,24,"['Edentulous Alveolar Ridge In Mandible', 'Complete Edentulism', 'Dental Implant', 'Attachments', 'Implant Retained Overdenture', 'Edentulous Mouth']",Edentulous Alveolar Ridge In Mandible,Al-Azhar University,[],['Egypt']
NCT07240519,"To Compare Inflammatory Biomarkers Before and After Treatment With Clobetasol or Fractional CO2 Laser, in Women With Histologically Confirmed Vulvar Lichen Sclerosus, Without Prior Corticosteroid Treatment.",Vulvar Lichen Sclerosus: Expression of Inflammatory Markers in a Randomized Clinical Trial With Clobetasol Versus Laser,RECRUITING,2022-06-22,2025-09-10,2026-06,INTERVENTIONAL,NA,40,['Vulvar Lichen Sclerosus'],Vulvar Lichen Sclerosus,Universidade Federal do Rio de Janeiro,[],['Brazil']
NCT04388839,Evolutionary Therapy for Rhabdomyosarcoma,"Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma",ACTIVE_NOT_RECRUITING,2020-12-29,2026-08,2027-08,INTERVENTIONAL,PHASE2,12,['Rhabdomyosarcoma'],Rhabdomyosarcoma,H. Lee Moffitt Cancer Center and Research Institute,['National Pediatric Cancer Foundation'],['United States']
NCT07170007,Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma,Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Postpartum Primiparas After Perineal Trauma: A Type 1 Hybrid Effectiveness-Implementation Randomized Controlled Trial With Economic Evaluation,RECRUITING,2025-11-11,2027-08-31,2029-03-20,INTERVENTIONAL,NA,82,"['Episiotomy', 'Lacerations Perineal', 'Obstetric Anal Sphincter Injury', 'Perineal Injury', 'Perineal Laceration, Tear, or Rupture During Delivery', 'Perineal Pain', 'Perineal Tear Resulting From Childbirth', 'Perineal Tear and Episiotomy']",Episiotomy,University of Sao Paulo,[],['Brazil']
NCT07136584,SOS for Caregiver Wellbeing,"SOS for Caregiver Wellbeing: Testing the Feasibility of a Screening, Outcomes and Support (SOS) Model for Parents and Caregivers of Children With Chronic Conditions",RECRUITING,2025-10-22,2026-04-28,2026-04-28,INTERVENTIONAL,NA,100,"['Mental Health', 'Depression and Burden in Caregivers', 'Anxiety Depression', 'Stress', 'Caregiver Anxiety', 'Parent of Child With Chronic Life-threatening Illness']",Mental Health,Murdoch Childrens Research Institute,"['National Health and Medical Research Council, Australia', 'University of Melbourne', ""Royal Children's Hospital""]",['Australia']
NCT07250087,Asciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL,Phase 1 Study of Asciminib Maintenance Therapy Following Allogeneic Stem Cell Transplant or Chimeric Antigen Receptor T Cell Therapy (CAR T) to Prevent Relapse in Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia,RECRUITING,2025-11,2029-11,2029-11,INTERVENTIONAL,PHASE1,36,['Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia'],Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia,H. Lee Moffitt Cancer Center and Research Institute,['Novartis'],['United States']
NCT01923506,Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery,Stereotactic Body Radiation Therapy to the Prostate Fossa: Phase I Dose Escalation Study,ACTIVE_NOT_RECRUITING,2013-11-25,2026-07-28,2026-07-28,INTERVENTIONAL,PHASE1,26,"['Recurrent Prostate Cancer', 'Stage I Prostate Cancer', 'Stage IIA Prostate Cancer', 'Stage IIB Prostate Cancer', 'Stage III Prostate Cancer']",Recurrent Prostate Cancer,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT05208190,Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial,Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial,RECRUITING,2022-03-17,2027-01-23,2027-02-28,INTERVENTIONAL,PHASE4,280,"['Schizophrenia', 'Schizoaffective Disorder']",Schizophrenia,New York State Psychiatric Institute,['National Institute of Mental Health (NIMH)'],['United States']
NCT07251868,Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study,Evaluation of Efficacy and Safety of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Multicenter Real-World Study,RECRUITING,2024-08-01,2026-12-31,2027-12-31,OBSERVATIONAL,,100,"['Breast Cancer', 'Brain Metastases From Breast Cancer', 'Trop2']",Breast Cancer,Peking University Cancer Hospital & Institute,[],['China']
NCT07042243,The Florida ASCENT Study,The Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (Florida ASCENT),RECRUITING,2026-01-01,2027-08,2027-08,INTERVENTIONAL,NA,100,"['Cancer', 'Food Deprivation', 'Food Habits', 'Food Selection', 'Colorectal Cancer', 'Prostate Cancer', 'Lung Cancer', 'Breast Cancer', 'Gynecologic Cancer', 'Hematologic Cancer', 'Skin Cancer', 'Melanoma', 'Nutrition Poor', 'Nutritional Deficiency']",Cancer,University of Florida,['University of Miami'],['United States']
NCT07132918,HEARTS Trial for Thoracic Cancers,The cARdiac Radiation Therapy Sparing (HEARTS) for Thoracic Cancers,RECRUITING,2025-10-08,2029-03,2029-03,INTERVENTIONAL,PHASE2,60,"['Non-Small Cell Lung Cancer (Stage III)', 'Esophageal Cancer Stage I-III', 'Esophagogastric Cancer Stage I-III', 'Thymoma and Thymic Carcinoma Stage II-III', 'Other Cancers in the Thoracic Region']",Non-Small Cell Lung Cancer (Stage III),"University of Wisconsin, Madison","['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07252076,PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa,"PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa. An International Multicentric, Prospective, Diagnostic Accuracy Trial",RECRUITING,2025-07-17,2026-12-17,2027-01-17,OBSERVATIONAL,,120,['Pancreatic Ductal Adenocarcinoma'],Pancreatic Ductal Adenocarcinoma,Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria,[],['Italy']
NCT03589326,A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia,"A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)",ACTIVE_NOT_RECRUITING,2018-10-04,2022-08-12,2027-07-31,INTERVENTIONAL,PHASE3,245,['Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)'],Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL),Takeda,[],"['Bulgaria', 'Japan', 'China', 'Australia', 'Russia', 'France', 'Finland', 'South Korea', 'Poland', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Greece', 'Brazil', 'Turkey (Türkiye)', 'Austria', 'United States', 'Italy', 'Argentina']"
NCT07252063,Sensory Distribution and Postoperative Analgesia of Ultrasound-Guided Interfascial Plane Blocks in Living Liver Donors,Assessment of Sensory Block Distribution and Postoperative Analgesia Following Ultrasound-Guided Interfascial Plane Blocks in Living Liver Donors: A Prospective Observational Study,RECRUITING,2025-11-01,2025-12-31,2026-01,OBSERVATIONAL,,20,['Pain'],Pain,Bahçeşehir University,[],['Turkey (Türkiye)']
NCT05806749,Immunological Tolerance in Patients With Mismatched Kidney Transplants,Use of the Immunomodulating Agent Belumosudil (KD025) After Combined Kidney and Hematopoeitic Stem Cell Transplantation to Induce Transplant Tolerance: A Pilot Study,ACTIVE_NOT_RECRUITING,2023-07-07,2028-08,2028-08,INTERVENTIONAL,PHASE1,16,"['End Stage Kidney Disease', 'Immunological Tolerance', 'Kidney Transplant Failure and Rejection', 'Chronic Kidney Diseases']",End Stage Kidney Disease,"University of California, Los Angeles",[],['United States']
NCT07252284,CHina Adrenal Venous saMPling InvestigatiON,China Adrenal Venous Sampling Investigation: A National Multicenter Study,RECRUITING,2025-05-01,2029-08-31,2029-08-31,OBSERVATIONAL,,5000,"['Hyperaldosteronism', 'Adrenal Venous Sampling', 'Adrenalectomy']",Hyperaldosteronism,"Chinese Academy of Medical Sciences, Fuwai Hospital",[],['China']
NCT06401421,EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD),EXActDNA-003 / NSABP B-64: Breast Cancer Clinical Validation Study to Predict Recurrence of High-Risk Early Breast Cancer Treated With Neoadjuvant Therapy Using a Bespoke Circulating Tumor DNA Assay to Detect Molecular Residual Disease,RECRUITING,2024-06-07,2030-04,2030-04,OBSERVATIONAL,,1800,['Breast Cancer'],Breast Cancer,Exact Sciences Corporation,['NSABP Foundation Inc'],"['United States', 'Canada']"
NCT06572228,Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma,AIM4: Next Step - Asthma Uncontrolled With ICS in Medium Dose (GINA 4): Next Step; Efficacy of Dupilumab Added to Medium Dose ICS/LABA in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Patients With Uncontrolled Asthma,RECRUITING,2024-08-26,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE4,250,['Asthma'],Asthma,Regeneron Pharmaceuticals,['Sanofi'],"['United States', 'Puerto Rico', 'Denmark', 'Canada', 'Poland', 'Germany']"
NCT06411249,A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE),"A Phase 4, Multicenter, Prospective, Open-Label Study Describing the Efficacy and Safety of Belimumab Administered Subcutaneously in Adult Participants With Early Systemic Lupus Erythematosus",RECRUITING,2024-06-06,2027-05-31,2029-05-29,INTERVENTIONAL,PHASE4,350,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,GlaxoSmithKline,[],"['Brazil', 'Japan', 'United States', 'France', 'Mexico', 'Spain', 'Italy', 'Greece', 'Portugal', 'Argentina', 'Germany']"
NCT07168148,Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants,Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants,RECRUITING,2025-11-10,2026-12,2026-12,INTERVENTIONAL,PHASE2,100,"['Nasal Obstruction', 'Chronic Rhinitis']",Nasal Obstruction,Washington University School of Medicine,[],['United States']
NCT07250126,3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT),3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT),RECRUITING,2025-11-04,2027-10,2027-10,OBSERVATIONAL,,5,['Degenrative Disc Disease'],Degenrative Disc Disease,I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio,[],['Italy']
NCT07047326,Urokinase for Thrombolysis in Acute Ischemic Stroke,A Dose-Escalation Safety Study of Urokinase for Thrombolysis in Patients With Acute Ischemic Stroke,RECRUITING,2025-10-01,2026-10-02,2027-01-02,INTERVENTIONAL,NA,24,['Acute Ischemic Stroke'],Acute Ischemic Stroke,Capital Medical University,[],['China']
NCT06210776,A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH),A Multi-center Prospective Observational Study to Assess the Effectiveness and Safety of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH),RECRUITING,2024-01-15,2028-03-01,2028-03-01,OBSERVATIONAL,,800,"['HER2-positive Breast Cancer', 'HER2-low Breast Cancer', 'Breast Cancer', 'Advanced Cancer']",HER2-positive Breast Cancer,Daiichi Sankyo,[],['China']
NCT07250789,Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study),Cognitive Screening of Individuals Diagnosed With Type 2 Diabetes and the Impact of a Multidomain Intervention Targeting Cognitive Decline (The Brain Care Study),RECRUITING,2024-06-01,2029-06,2029-06,INTERVENTIONAL,NA,420,"['Diabetes', 'Diabetes Mellitus Type 2', 'Type 2 Diabetes', 'Type 2 Diabetes Mellitus (T2DM)', 'Cognitive Impairment', 'Cognitive Decline']",Diabetes,Steno Diabetes Center Copenhagen,[],['Denmark']
NCT05501873,Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System,Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System,ACTIVE_NOT_RECRUITING,2023-03-24,2025-10-21,2027-08-15,OBSERVATIONAL,,1173,['Atrial Fibrillation'],Atrial Fibrillation,Boston Scientific Corporation,[],"['Hong Kong', 'Netherlands', 'Saudi Arabia', 'Australia', 'Monaco', 'Belgium', 'Israel', 'Hungary', 'France', 'Finland', 'Czechia', 'Poland', 'Spain', 'Malaysia', 'United Kingdom', 'Greece', 'Portugal', 'Germany', 'Austria', 'Ireland', 'Italy']"
NCT07250386,A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors,A Clinical Study to Evaluate the Safety and Efficacy of CEA-Targeted Chimeric Antigen Receptor T (CAR-T) Cells in Patients With CEA-Positive Advanced Malignant Solid Tumors,RECRUITING,2025-10-13,2028-06-30,2028-09-30,INTERVENTIONAL,PHASE1,48,"['NSCLC (Advanced Non-small Cell Lung Cancer)', 'Breast Cancer']",NSCLC (Advanced Non-small Cell Lung Cancer),"Second Affiliated Hospital, School of Medicine, Zhejiang University","['Chongqing Precision Biotech Co., Ltd']",['China']
NCT05536141,A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors,"A Phase 1, Open-label, Dose Escalation and Dose Expansion Study, to Investigate the Safety, Tolerability, and Pharmacokinetic Profile of AB521 Monotherapy and Combination Therapies in Participants With Clear Cell Renal Cell Carcinoma and Other Solid Tumors",RECRUITING,2022-10-26,2027-07,2027-07,INTERVENTIONAL,PHASE1,302,"['Clear Cell Renal Cell Carcinoma', 'Solid Tumors']",Clear Cell Renal Cell Carcinoma,"Arcus Biosciences, Inc.",[],"['United States', 'South Korea', 'Australia']"
NCT07205822,"A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer","A Phase IIIb, Open-label, Multinational Study Assessing the Efficacy and Safety of Dato-DXd Treatment in Patients With HRpositive, HER2 IHC 0, Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy (TROPION-Breast06)",RECRUITING,2025-10-30,2028-02-02,2028-02-02,INTERVENTIONAL,PHASE3,100,['Breast Cancer'],Breast Cancer,AstraZeneca,['Daiichi Sankyo'],"['China', 'United States', 'France', 'Spain', 'Italy', 'South Korea']"
NCT07241091,SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery,A Randomized Controlled Trial of High-Purity Type-I Collagen-Based Biomaterial (Surgicoll-Mesh®) as a Peritoneal Substitute to Prevent Post-Peritonectomy Complications in Patients Undergoing Cytoreductive Surgery,RECRUITING,2025-10-20,2026-02,2026-03,INTERVENTIONAL,NA,60,"['Peritoneal Surface Malignancy', 'Postoperative Adhesion', 'Bowel Obstruction', 'Wound Complications', 'Surgical Site Infection After Major Surgery', 'Ovarian Cancer (OvCa)']",Peritoneal Surface Malignancy,"Adichunchanagiri Institute of Medical Sciences, B G Nagara",['JSS Medical College Hospital'],['India']
NCT06787586,"Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus","A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multi-Part, Single Ascending Dose and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and PK of ATTO1310 in Adult Volunteers, Patients With Atopic Dermatitis, and Patients With Chronic Pruritus",RECRUITING,2025-01-14,2026-05,2026-05,INTERVENTIONAL,PHASE1,104,"['Normal Volunteers', 'Atopic Dermatitis (AD)', 'Atopic Eczema', 'Chronic Pruritus']",Normal Volunteers,Attovia Therapeutics Inc,[],"['United States', 'Canada']"
NCT05628207,Evaluation of the SCALED (SCaling AcceptabLE cDs),Evaluation of the SCALED (SCaling AcceptabLE cDs) Approach for the Implementation of Interoperable CDS for Venous Thromboembolism Prevention - CDS Data,RECRUITING,2023-05-16,2026-06-30,2026-06-30,OBSERVATIONAL,,15000,"['Traumatic Brain Injury', 'Venous Thromboembolism']",Traumatic Brain Injury,University of Minnesota,['Agency for Healthcare Research and Quality (AHRQ)'],['United States']
NCT05492032,Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct Current Stimulation in Adolescents With ASD,Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct-Current Stimulation (tDCS) on Cognitive and Social Impairments in Adolescents With Autism Spectrum Disorder,RECRUITING,2022-06-02,2026-09-30,2026-12-31,INTERVENTIONAL,NA,150,"['Transcranial Direct Current Stimulation', 'Autistic Spectrum Disorder', 'Electroencephalography', 'Booster Effects']",Transcranial Direct Current Stimulation,The Hong Kong Polytechnic University,[],['Hong Kong']
NCT07122544,Pulmonary Rehabilitation in Salt Chambers for Patients With COPD,The Impact of Pulmonary Rehabilitation Conducted in Therapeutic Salt Chambers on the Clinical Status of Patients With Chronic Obstructive Pulmonary Disease (COPD),RECRUITING,2025-09-01,2027-01-01,2028-01-01,INTERVENTIONAL,NA,80,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),"University School of Physical Education, Krakow, Poland",[],['Poland']
NCT05164016,"Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients","Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients",ACTIVE_NOT_RECRUITING,2022-06-29,2025-05-01,2027-12-31,OBSERVATIONAL,,21,"['Cancer', 'Hematopoietic System--Cancer', 'Transplant-Related Cancer', 'Solid Tumor Malignancy', 'Hematologic Malignancy', 'Solid Organ Transplant', 'Hematopoietic Cell Transplant', 'Cellular Therapy']",Cancer,St. Jude Children's Research Hospital,[],['United States']
NCT07063979,"Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.","Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband to Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient",RECRUITING,2025-11-04,2026-07,2026-07,INTERVENTIONAL,NA,100,"['Postoperative Nausea and Vomiting', 'Bariatric Sleeve Gastrectomy']",Postoperative Nausea and Vomiting,University of Pennsylvania,[],['United States']
NCT07119840,Comparison Of Clinical Effects Of Listerine And Chlorhexidine Mouth Wash In Patients Undergoing Fixed Orthodontic Treatment,Comparison Of Clinical Effects Of Listerine And Chlorhexidine Mouth Wash In Patients Undergoing Fixed Orthodontic Treatment,RECRUITING,2025-08-01,2025-11-29,2025-12-30,INTERVENTIONAL,NA,60,"['Gingivitis', 'Dental Plaque']",Gingivitis,Khyber Medical University Peshawar,['Saidu College of Dentistry'],['Pakistan']
NCT06467435,Evaluation of K9 in Subjects With Thyroid Eye Disease (TED),Evaluation of K9 in Subjects With Thyroid Eye Disease (TED),RECRUITING,2024-11-06,2026-12,2027-08,INTERVENTIONAL,PHASE1,13,['Thyroid Eye Disease'],Thyroid Eye Disease,Peter Timoney,['Inflammasome Therapeutics'],['United States']
NCT06984185,Early Detection of Type 1 Diabetes,Contribution of a Combined T1D Autoantibody Test and Immunoreactive Trypsin Assay on Blotting Paper in the Detection of Type 1 Diabetes (Stage 3) in the Pediatric Population With a View to Its Subsequent Use in Early Detection (Stages 1 and 2),RECRUITING,2025-11-05,2026-12-05,2026-12-05,OBSERVATIONAL,,106,['Type 1 Diabetes'],Type 1 Diabetes,Hospices Civils de Lyon,[],['France']
NCT01522976,Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia,A Randomized Phase II/III Study of Azacitidine in Combination With Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination With Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML),ACTIVE_NOT_RECRUITING,2012-03-01,2015-06-01,2026-03-19,INTERVENTIONAL,PHASE2,282,"['Chronic Myelomonocytic Leukemia', 'Chronic Myelomonocytic Leukemia-1', 'Chronic Myelomonocytic Leukemia-2', 'Myelodysplastic Syndrome', 'Myelodysplastic Syndrome With Excess Blasts', 'Myelodysplastic Syndrome With Excess Blasts-1', 'Myelodysplastic Syndrome/Acute Myeloid Leukemia']",Chronic Myelomonocytic Leukemia,National Cancer Institute (NCI),[],"['United States', 'Canada']"
NCT06343090,Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients,Pragmatic Clinical Trial of CD19 and CD22 CAR T-cell Sequential Therapy Versus Single CD19 CAR T-cell Bridging to Transplantation for Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia,RECRUITING,2024-04-12,2042-12-01,2043-09-30,INTERVENTIONAL,NA,353,"['B-cell Acute Lymphoblastic Leukemia', 'Acute Lymphoblastic Leukemia, in Relapse', 'Refractory Acute Lymphoid Leukemia']",B-cell Acute Lymphoblastic Leukemia,Beijing GoBroad Hospital,"['The General Hospital of Western Theater Command', 'Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai', 'Shanghai Liquan Hospital', 'Ruijin Hospital', ""Central People's Hospital of Zhanjiang"", 'First Affiliated Hospital of Guangxi Medical University']",['China']
NCT04190446,"A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer","A Randomized, Parallel Phase II Trial of Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer Involving Only Pelvic and/or Para-Aortic Lymph Nodes Following Primary Localized Treatment",ACTIVE_NOT_RECRUITING,2020-01-06,2025-11-22,2028-11-22,INTERVENTIONAL,PHASE2,84,"['Metastatic Prostate Adenocarcinoma', 'Oligometastatic Prostate Carcinoma', 'Prostate Adenocarcinoma', 'Recurrent Prostate Carcinoma', 'Stage IV Prostate Cancer AJCC v8']",Metastatic Prostate Adenocarcinoma,Mayo Clinic,[],['United States']
NCT06689085,"52 Week Study of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism","Open-Label, Multiple-Dose, 52-Week Study to Evaluate the Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Deficiency or Absence of Endogenous Testosterone Due to Primary or Secondary Hypogonadism",RECRUITING,2025-02-05,2027-10,2027-12,INTERVENTIONAL,PHASE3,100,"['Hypogonadism, Male']","Hypogonadism, Male",Halozyme Therapeutics,[],['United States']
NCT06622291,Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients,Efficacy of Nitric Oxide Administration for Reducing the Risk of Acute Kidney Injury in Patients With Acute Type A Aortic Dissection: a Randomized Controlled Trial,RECRUITING,2024-11-30,2025-11-01,2026-06-01,INTERVENTIONAL,PHASE4,216,"['Acute Kidney Injury', 'Nitrous Oxide', 'Acute Type A Aortic Dissection']",Acute Kidney Injury,Beijing Anzhen Hospital,[],['China']
NCT06632535,Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain,Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain,RECRUITING,2025-07-01,2026-10-05,2026-10-05,INTERVENTIONAL,NA,10,"['Chronic Pain', 'Musculoskeletal Pain']",Chronic Pain,Brigham and Women's Hospital,[],['United States']
NCT07250308,Correlation Study of Atrophic Gastritis and Dyspepsia Symptoms,A Prospective Observational Study on the Correlation Between Pathologically Confirmed Chronic Atrophic Gastritis and Functional Dyspepsia Symptoms,RECRUITING,2025-10-01,2026-07-31,2026-08-31,OBSERVATIONAL,,315,"['Functional Dyspepsia', 'Chronic Atrophic Gastritis (CAG)']",Functional Dyspepsia,The Third Affiliated hospital of Zhejiang Chinese Medical University,[],['China']
NCT06366750,A Study of Barzolvolimab in Patients With Prurigo Nodularis,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Patients With Prurigo Nodularis",RECRUITING,2024-04-12,2026-01,2026-06,INTERVENTIONAL,PHASE2,120,['Prurigo Nodularis'],Prurigo Nodularis,Celldex Therapeutics,[],"['United States', 'Croatia', 'Spain', 'Canada', 'Poland', 'Germany']"
NCT07203326,Microderm for Root Coverage Procedures,Microsurfaced Acellular Dermal Matrix for Root Coverage Procedures,ACTIVE_NOT_RECRUITING,2025-02-13,2026-08-31,2026-12,INTERVENTIONAL,PHASE4,20,"['Connective Tissue Graft', 'Gum Recession']",Connective Tissue Graft,Ohio State University,[],['United States']
NCT01534299,Global SYMPLICITY Registry (GSR) DEFINE,Global SYMPLICITY Registry (GSR) Denervation Findings in Real World (DEFINE),RECRUITING,2012-02,2027-06,2031-12,OBSERVATIONAL,,5000,['Hypertension'],Hypertension,Medtronic Vascular,[],"['Switzerland', 'Germany']"
NCT07228468,Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME),"Home-Based Transcranial Direct Current Stimulation in Major Depressive Disorder: a Multi-Centre, Two-Parallel Group, Superiority Randomised Controlled Trial",RECRUITING,2025-11-18,2027-05-15,2027-12-31,INTERVENTIONAL,NA,438,['Major Depressive Disorder (MDD)'],Major Depressive Disorder (MDD),King's College London,"['Nottinghamshire Healthcare NHS Trust', 'Cardiff and Vale University Health Board', 'Northumberland, Tyne and Wear NHS Foundation Trust', 'Northamptonshire Healthcare NHS Foundation Trust', 'South London and Maudsley NHS Foundation Trust', 'Southern Health NHS Foundation Trust']",['United Kingdom']
NCT05797740,Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA),Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA),ACTIVE_NOT_RECRUITING,2023-08-03,2029-01-31,2029-01-31,OBSERVATIONAL,,367,['Multiple Sclerosis'],Multiple Sclerosis,"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",[],"['Belgium', 'Netherlands', 'Czechia', 'Greece', 'Poland', 'Portugal']"
NCT07030686,"Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors","Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors",RECRUITING,2020-03-19,2026-03-19,2026-03-19,OBSERVATIONAL,,1000,"['Survivorship', 'Recurrent', 'Recurrence', 'Cancer', 'Remission']",Survivorship,Memorial Sloan Kettering Cancer Center,[],['United States']
NCT06965127,Implant for Walking After Incomplete SCI,Enhancing Walking and Independence After Incomplete SCI With a Fully Implanted Neuroprosthesis,RECRUITING,2025-08-27,2028-08,2031-08,INTERVENTIONAL,NA,5,"['Spinal Cord Injury (SCI)', 'Gait']",Spinal Cord Injury (SCI),Louis Stokes VA Medical Center,"['MetroHealth Medical Center', 'CDMRP']",['United States']
NCT05958615,Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners,"Evaluation of Feasibility, Acceptability, and Preliminary Efficacy of a Dyadic Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners: A Pilot Randomized Controlled Trial",ACTIVE_NOT_RECRUITING,2024-02-12,2025-03-19,2026-11-30,INTERVENTIONAL,NA,80,"['Obesity, Morbid']","Obesity, Morbid","Larissa McGarrity, Ph.D.",['National Center for Advancing Translational Sciences (NCATS)'],['United States']
NCT07252297,The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer,The Role of SIX6 as a Universal Cancer Marker in the Diagnosis of Non-Muscle Invasive Bladder Cancer,ACTIVE_NOT_RECRUITING,2024-01-01,2026-12-30,2026-12-30,INTERVENTIONAL,NA,177,['Non-muscle Invasive Bladder Cancer'],Non-muscle Invasive Bladder Cancer,Xijing Hospital,[],['China']
NCT06080503,Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy,G-FORCE: Phase II Randomized Study of Glottic Larynx Hypofractionated Radiotherapy Versus ConvEntional Radiotherapy,RECRUITING,2024-03-14,2028-11-01,2029-03-14,INTERVENTIONAL,NA,67,['Laryngeal Carcinoma'],Laryngeal Carcinoma,University of Texas Southwestern Medical Center,[],['United States']
NCT07252453,Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal Neuralgia,Comparison of Carbamazepine and Oxcarbazepine In the Treatment of Trigeminal Neuralgia,ACTIVE_NOT_RECRUITING,2025-05-20,2025-11-20,2025-12-01,INTERVENTIONAL,NA,122,['Trigeminal Neuralgia'],Trigeminal Neuralgia,Abbasi Shaheed Hospital,[],['Pakistan']
NCT06157931,Resilient Students Training (ReST) : A Pilot RCT,Resilient Students Training (ReST): A Pilot Randomized Controlled Trial,RECRUITING,2024-06-01,2026-06-30,2026-06-30,INTERVENTIONAL,NA,100,['Psychological Wellness'],Psychological Wellness,The Hong Kong Polytechnic University,[],['Hong Kong']
NCT06765356,Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias,Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias,RECRUITING,2025-04-15,2027-03-30,2027-03-30,INTERVENTIONAL,PHASE4,275,"['Persistent Atrial Fibrillation', 'Paroxysmal Atrial Fibrillation', 'Long-standing Persistent Atrial Fibrillation']",Persistent Atrial Fibrillation,Vivek Reddy,['Boston Scientific Corporation'],['United States']
NCT03407079,Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study),Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study),RECRUITING,2018-04-05,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,150,"['Healthy Volunteers', 'Overweight']",Healthy Volunteers,National Institute on Alcohol Abuse and Alcoholism (NIAAA),[],['United States']
NCT06367972,A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP),A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP),RECRUITING,2024-06-06,2028-10-10,2030-10-10,INTERVENTIONAL,PHASE2,400,['OligoProgressive Metastatic Disease'],OligoProgressive Metastatic Disease,M.D. Anderson Cancer Center,[],['United States']
NCT06123481,Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis,Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head,RECRUITING,2025-04-01,2029-03-31,2029-07-31,INTERVENTIONAL,NA,192,"['Osteonecrosis of the Femoral Head', 'Avascular Necrosis of the Femoral Head']",Osteonecrosis of the Femoral Head,Johns Hopkins University,['National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)'],['United States']
NCT07057063,Light Therapy on Pain and Synovitis,Effect of Light Therapy on Pain and Synovitis in Patients With Knee Synovitis: Study Protocol for a Randomized Controlled Trial,RECRUITING,2025-07-13,2026-05-28,2026-05-28,INTERVENTIONAL,NA,80,"['Knee Pain Chronic', 'Synovitis of Knee', 'Light Therapy']",Knee Pain Chronic,The Hong Kong Polytechnic University,[],"['China', 'Hong Kong']"
NCT06719921,Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Lab,"Efficacy and Safety of Catheter Ablation for Atrial Fibrillation in Non-Fluoroscopic Cardiac Electrophysiology Lab: A Non-Inferior, Multi-Center, Prospective Randomized Controlled Trial",RECRUITING,2025-04-22,2028-04-30,2028-05-31,INTERVENTIONAL,NA,724,['Atrial Fibrillation (AF)'],Atrial Fibrillation (AF),Sir Run Run Shaw Hospital,[],['China']
NCT06950008,A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer,Feasibility Testing of a Patient Navigation Intervention to Improve Risk Management Among Women at High Risk of Breast Cancer,RECRUITING,2026-01-10,2026-12-31,2026-12-31,INTERVENTIONAL,NA,75,['Breast Carcinoma'],Breast Carcinoma,Ohio State University Comprehensive Cancer Center,['National Cancer Institute (NCI)'],['United States']
NCT04903223,Liver Adiposity Effects on Pediatric Statin,Effects of Pediatric Liver Adiposity on Statin Disposition and Response,RECRUITING,2021-04-01,2026-06-30,2026-12-31,INTERVENTIONAL,PHASE1,50,['Cholesterol; Lipidosis'],Cholesterol; Lipidosis,Children's Mercy Hospital Kansas City,[],['United States']
NCT06706310,Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection,Evaluate TQ-A3334 Tablets Combined Nucleoside (Acid) Analogs in the Initial Treatment/Chronic Hepatitis B Virus (HBV) Infection Subjects of Chronic HBV Infection,ACTIVE_NOT_RECRUITING,2024-12-04,2025-06-22,2026-06,INTERVENTIONAL,PHASE2,116,['Chronic Hepatitis B'],Chronic Hepatitis B,"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.",[],['China']
NCT07228650,ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes,ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes,RECRUITING,2025-02-17,2028-04,2028-04,OBSERVATIONAL,,500,['Attention Deficit Hyerpactivity Disorder'],Attention Deficit Hyerpactivity Disorder,King's College London,"['South London and Maudsley NHS Foundation Trust', ""South West London and St George's Mental Health NHS Trust"", 'Northamptonshire Healthcare NHS Foundation Trust']",['United Kingdom']
NCT07020117,A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors,"NECTINIUM-2: A Phase 1b, 2 Part, Multicenter, Single Arm, Open Label Study to Evaluate the Safety and Efficacy of a Nectin-4 Radiopharmaceutical ([225Ac]Ac-AKY-1189) in Patients With Previously Treated Locally Advanced or Metastatic Solid Tumors",RECRUITING,2025-08-22,2027-12,2032-06,INTERVENTIONAL,PHASE1,150,"['Urothelial Carcinoma Bladder', 'Triple Negative Breast Cancer (TNBC)', 'Hormone Receptor Positive Breast Adenocarcinoma', 'Non Small Cell Lung Cancer', 'Cervical Adenocarcinoma', 'Colorectal Adenocarcinoma', 'Head and Neck Cancer']",Urothelial Carcinoma Bladder,"Aktis Oncology, Inc.",[],['United States']
NCT06904326,CLUBE (UBE Stability / Dynamic Radio),Assessment of Spinal Stability by Dynamic Radiography After Unilateral Biportal Endoscopic Lumbar Decompression Surgery,RECRUITING,2025-05-22,2027-08,2027-08,INTERVENTIONAL,NA,400,['Spinal Instability'],Spinal Instability,"Clinique Saint Jean, France",[],['France']
NCT04191304,A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES),"A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 24-Week Phase III Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)",ACTIVE_NOT_RECRUITING,2020-07-20,2025-05-07,2026-12-30,INTERVENTIONAL,PHASE3,134,['Hypereosinophilic Syndrome'],Hypereosinophilic Syndrome,AstraZeneca,[],"['Belgium', 'Israel', 'Japan', 'Netherlands', 'China', 'India', 'Austria', 'United States', 'France', 'Denmark', 'Spain', 'Italy', 'South Korea', 'United Kingdom', 'Poland', 'Argentina', 'Germany']"
NCT06765304,Preconceptional Period and Transtheoretically Based Education,Preconceptional Period and Transtheoretically Based Education,RECRUITING,2025-11-17,2026-01-11,2026-02-28,INTERVENTIONAL,NA,108,"['Preconceptional Care', 'Education']",Preconceptional Care,Ankara Medipol University,[],['Turkey (Türkiye)']
NCT06200558,ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa,ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa,RECRUITING,2024-01-31,2024-05-31,2028-02-01,OBSERVATIONAL,,534,['Prostate Cancer'],Prostate Cancer,Hospital of Macerata,[],['Italy']
NCT06395480,Albumin Utilization in Adult Cardiac Surgical Patients : A Multicentre Prospective Cohort Study,Albumin Utilization for Intravascular Volume Replacement in Adult Cardiac Surgical Patients : A Multicentre Prospective Cohort Study,ACTIVE_NOT_RECRUITING,2024-06-11,2025-12-01,2026-01-01,OBSERVATIONAL,,104,"['Antithrombin III Levels', 'Albumin Levels']",Antithrombin III Levels,"University Health Network, Toronto",['Kingston Health Sciences Centre'],['Canada']
NCT06809179,"A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder","A Phase 2, Three-arm, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol (PH94B) Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension",RECRUITING,2025-01-09,2026-04,2026-12,INTERVENTIONAL,PHASE2,60,['Social Anxiety Disorder'],Social Anxiety Disorder,"VistaGen Therapeutics, Inc.",[],['United States']
NCT07057180,The Impact of Intensive Care Nurses' Caring Behaviors on the Quality of Nursing Care,The Impact of Intensive Care Nurses' Caring Behaviors on the Quality of Nursing Care,RECRUITING,2025-10-10,2026-03-03,2026-04-01,OBSERVATIONAL,,70,"['Perception of Caring Behaviors', 'Quality of Nursing Care']",Perception of Caring Behaviors,Abant Izzet Baysal University,[],['Turkey (Türkiye)']
NCT07151599,Efficacy of Combined Fractional Er:Glass and Thulium Lasers Versus Microneedling for Atrophic Acne Scars,Randomized Controlled Trial Comparing Fractional Erbium:Glass (1540-1550 nm) and Thulium (1927 nm) Lasers Versus Microneedling for the Treatment of Atrophic Acne Scars,RECRUITING,2025-10-16,2026-05,2026-07,INTERVENTIONAL,NA,84,['Acne Scars'],Acne Scars,University of Nove de Julho,[],['Brazil']
NCT05142696,"A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab","A Phase Ib/II Dose Finding Study Assessing Safety and Efficacy of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide, and Atezolizumab in Induction and With Atezolizumab in Maintenance Phase",RECRUITING,2022-07-13,2029-03-09,2029-03-23,INTERVENTIONAL,PHASE1,200,['Extensive Stage Small Cell Lung Cancer'],Extensive Stage Small Cell Lung Cancer,Novartis Pharmaceuticals,[],"['Singapore', 'Israel', 'Hong Kong', 'Netherlands', 'China', 'Austria', 'United States', 'France', 'Spain', 'Taiwan', 'Italy', 'Canada', 'Czechia', 'South Korea', 'United Kingdom', 'Germany']"
NCT06004063,"Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study","Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study",RECRUITING,2023-08-04,2027-12-31,2029-12-31,INTERVENTIONAL,NA,40,['Stem Cell'],Stem Cell,M.D. Anderson Cancer Center,[],['United States']
NCT07241663,Surgery for Locally Unresectable Pancreatic Cancer,Conversion Surgery for Locally Unresectable Pancreatic Cancer - International Multi-center Observational Trial (ROBIN= suRgery for lOcally unresectaBle pancreatIc Cancer),RECRUITING,2025-01-01,2026-12-31,2028-12-31,OBSERVATIONAL,,150,['Locally Advanced Pancreatic Adenocarcinoma'],Locally Advanced Pancreatic Adenocarcinoma,Azienda Ospedaliera di Padova,['University of Padova'],['Italy']
NCT04924088,Medical-legal Partnerships to Prevent Evictions and Homelessness Among Veterans,Medical-legal Partnerships to Prevent Evictions and Homelessness Among Veterans,ACTIVE_NOT_RECRUITING,2022-02-01,2026-03-01,2026-10-30,INTERVENTIONAL,NA,85,"['Homelessness', 'Mental Health']",Homelessness,VA Office of Research and Development,['Connecticut Veterans Legal Center'],['United States']
NCT06627179,Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene,"A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene",RECRUITING,2024-12-11,2027-12,2027-12,INTERVENTIONAL,PHASE2,81,"['Retinitis Pigmentosa (RP)', 'Usher Syndrome Type 2', 'Deaf Blind', 'Retinal Disease', 'Eye Diseases, Hereditary', 'Eye Disorders Congenital', 'Vision Disorders']",Retinitis Pigmentosa (RP),Laboratoires Thea,['Sepul Bio'],"['Belgium', 'Netherlands', 'United States', 'France', 'Denmark', 'Italy', 'Canada', 'United Kingdom', 'Germany']"
NCT07050173,Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation,Patients With Repetitive Head Impact Orally Supplemented With Gamma-glutamylcysteine: An Open Label Trial With MR Spectroscopy and Neuropsychological Testing,RECRUITING,2026-01-01,2027-11-01,2027-12-27,INTERVENTIONAL,PHASE1,30,['Repetitive Head Impacts'],Repetitive Head Impacts,Pravat Mandal,['Chuck Noll Foundation'],['United States']
NCT05057702,Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma,A Pilot Feasibility and Efficacy (Phase 2) Trial of Real Time Drug Screening and Genomic Testing to Determine an Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma,RECRUITING,2022-02-22,2025-12-31,2028-01-31,INTERVENTIONAL,NA,74,"['Medulloblastoma', 'Medulloblastoma, Childhood', 'Medulloblastoma Recurrent', 'Ependymoma', 'Ependymoma Malignant', 'Ependymoma of Brain']",Medulloblastoma,"University of California, San Francisco","['Washington University School of Medicine', ""St. Baldrick's Foundation"", 'Ashion Analytics', 'University of Washington', 'Pediatric Neuro-Oncology Consortium']",['United States']
NCT07250581,A Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation,Endoscopic Discectomy With Repair of Annulus Fibrosus Versus Discectomy Alone for Lumber Disc Herniation:A Prospective Multicenter Randomized Controlled Trial,RECRUITING,2025-08-01,2026-12-31,2026-12-31,INTERVENTIONAL,NA,300,['Lumbar Intervertebral Disc Herniation'],Lumbar Intervertebral Disc Herniation,The Affiliated Hospital of Qingdao University,"['Qilu Hospital of Shandong University', 'Shandong Provincial Hospital', 'Qianfoshan Hospital', 'Peking Union Medical College Hospital', 'First Affiliated Hospital of Harbin Medical University', 'First Affiliated Hospital of Wenzhou Medical University', 'The Fourth Affiliated Hospital of Zhejiang University School of Medicine', 'The Third Xiangya Hospital of Central South University', ""Second Affiliated Hospital of Xi'an Jiaotong University""]",['China']
NCT07251283,Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2,Food Insecurity and Eating Behavior Among Adults Receiving Buprenorphine or Methadone Maintenance Treatment: Pilot Study 2,RECRUITING,2025-11-07,2027-07,2027-07,INTERVENTIONAL,NA,40,['Food Security'],Food Security,University of Vermont,[],['United States']
NCT07250269,"Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis","A Phase 1b Study of GC012F, a Chimeric Antigen Receptor T Cell Therapy Targeting CD19 and B-cell Maturation Antigen in Chinese Participants With Relapsed or Refractory AL Amyloidosis",RECRUITING,2025-10-29,2028-11-24,2028-11-24,INTERVENTIONAL,PHASE1,9,['Relapsed/Refractory AL Amyloidosis'],Relapsed/Refractory AL Amyloidosis,"Gracell Biotechnologies (Shanghai) Co., Ltd.","['Suzhou Gracell Biotechnologies Co., Ltd.']",['China']
NCT06325722,Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change,Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change,RECRUITING,2024-08-28,2026-07-31,2026-07-31,INTERVENTIONAL,NA,42,"['Overweight', 'Obesity']",Overweight,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06508775,Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies,Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies,RECRUITING,2024-05-05,2040-12-31,2040-12-31,INTERVENTIONAL,NA,40,"['Melanoma Stage III', 'B-cell Non Hodgkin Lymphoma', 'Pediatric ALL', 'Childhood Non-Hodgkin Lymphoma', 'Acute Lymphatic Leukemia', 'Chronic Lymphatic Leukemia', 'Melanoma Stage IV']",Melanoma Stage III,Miltenyi Biomedicine GmbH,[],['Germany']
NCT04551222,The Re-Prosper HF Study,Treatment of Veterans With Heart Failure With Reduced Ejection Fraction With Probenecid,ACTIVE_NOT_RECRUITING,2021-06-09,2025-12-31,2025-12-31,INTERVENTIONAL,PHASE2,99,['Heart Failure'],Heart Failure,VA Office of Research and Development,[],['United States']
NCT07024641,"A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection","A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 Administered as a Single Ascending Dose and Multiple Ascending Doses in Participants With Chronic Hepatitis B Virus Infection",RECRUITING,2024-11-13,2027-09,2027-09,INTERVENTIONAL,PHASE1,48,['Hepatitis B Virus Infection'],Hepatitis B Virus Infection,"GigaGen, Inc.",[],"['United States', 'Australia']"
NCT03707262,Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor,Donor Chimerism and Graft Survival Following Combined HLA-Identical Sibling Living Donor Kidney and Hematopoietic Stem Cell Transplantation Utilizing a Conditioning Regimen of Total Lymphoid Irradiation and Rabbit Anti-Thymocyte Globulin,RECRUITING,2019-11-06,2026-02,2026-02,INTERVENTIONAL,PHASE1,15,"['Renal Transplant Rejection', 'Tolerance', 'Kidney Transplant']",Renal Transplant Rejection,"Jeffrey Veale, MD",['OneLegacy Foundation'],['United States']
NCT07212803,Effects of Energy Drinks on Cardiovascular Endpoints,"Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study",RECRUITING,2025-11-01,2026-03,2026-09,INTERVENTIONAL,PHASE4,3,"['Healthy Volunteers', 'Safety After Oral Intake']",Healthy Volunteers,University of the Pacific,[],['United States']
NCT06295588,Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer,Minimizing Fatigue and Inflammation in Survivors of Cancer: A Pilot Randomized Clinical Trial of the Seaweed Supplement Fucoidan,RECRUITING,2025-07-26,2026-12-31,2027-06-01,INTERVENTIONAL,PHASE2,40,"['Fatigue', 'Inflammation']",Fatigue,University of Rochester,['National Cancer Institute (NCI)'],['United States']
NCT06940635,Exploratory Study on the Potential Cross-System Effects of BCI-FES Hand Therapy on Dysphagia and Aphasia in Chronic Stroke Patients,Cross-Stroke Therapy Effects With BCI and FES Stimulation: A Pilot Study,RECRUITING,2025-06-04,2026-06-30,2026-06-30,INTERVENTIONAL,NA,10,"['Ischaemic Stroke', 'Hemorrhagic Stroke']",Ischaemic Stroke,VASCage GmbH,"['g.tec medical engineering GmbH', 'Medical University Innsbruck']",['Austria']
NCT05738096,Trigeminal Evoked Responses to Improve Rhizotomy,Trigeminal Evoked Responses to Improve Rhizotomy,RECRUITING,2023-11-01,2026-11-01,2026-11-01,INTERVENTIONAL,EARLY_PHASE1,30,"['Trigeminal Neuralgia', 'Rhizotomy']",Trigeminal Neuralgia,University of Minnesota,[],['United States']
NCT06412510,"Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT","Prehabilitation for Elderly Patients With Advanced Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer Undergoing Neoadjuvant Chemotherapy",RECRUITING,2025-09-05,2026-03-10,2026-03-10,INTERVENTIONAL,PHASE1,22,"['Ovarian Cancer', 'Epithelial Ovarian Cancer', 'Pancreatic Adenocarcinoma']",Ovarian Cancer,Case Comprehensive Cancer Center,[],['United States']
NCT07044622,Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain,Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Pain,ACTIVE_NOT_RECRUITING,2025-10-01,2025-12,2025-12,INTERVENTIONAL,NA,58,['Pain'],Pain,Yale University,['Society of Family Planning'],['United States']
NCT07072039,Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation,Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation (PEACE) Intervention,RECRUITING,2025-10-01,2029-07-01,2029-09-01,INTERVENTIONAL,NA,50,['COPD (Chronic Obstructive Pulmonary Disease)'],COPD (Chronic Obstructive Pulmonary Disease),"University of Massachusetts, Worcester","['National Heart, Lung, and Blood Institute (NHLBI)']",['United States']
NCT07095140,Studying the Effects of Nicotine Concentration and Flavor on Alcohol Use in Young Adults,Assessing Co-Use of Oral Nicotine Pouches and Alcohol Among Young Adults,RECRUITING,2025-09-03,2027-12-31,2027-12-31,INTERVENTIONAL,NA,20,['Alcohol-Related Carcinoma'],Alcohol-Related Carcinoma,Ohio State University Comprehensive Cancer Center,[],['United States']
NCT07156201,"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years","A First-in-Human, Phase 1a, Randomized, Double-Blinded, Placebo-Controlled, Single- and Multiple-Ascending Dose and Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Administered Orally to Healthy Adults",RECRUITING,2025-08-28,2026-03,2026-03,INTERVENTIONAL,PHASE1,74,['KCNT1-Related Epilepsy'],KCNT1-Related Epilepsy,"Actio Biosciences, Inc.",[],['Australia']
NCT07252102,Effect of High Flow Nasal Cannula Oxygenation on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients : A Multicentre Randomised Controlled Trial.,Effect of High Flow Nasal Cannula Oxygenation on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients : A Multicentre Randomised Controlled Trial.,RECRUITING,2025-06-10,2026-02-28,2026-11-30,INTERVENTIONAL,NA,450,"['Liver Cirrhosis', 'Polyps of Colon', 'Gastrointestinal Dysfunction']",Liver Cirrhosis,Zhejiang University,[],['China']
NCT05020912,Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy,Alteration of the Immune Microenvironment in Basal Cell Carcinoma (BCC) Following Photodynamic Therapy (PDT),RECRUITING,2021-12-13,2027-09,2027-12,INTERVENTIONAL,PHASE2,28,['Basal Cell Carcinoma'],Basal Cell Carcinoma,Case Comprehensive Cancer Center,[],['United States']
NCT06358651,Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3),"US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-3)",ACTIVE_NOT_RECRUITING,2024-03-28,2025-10-31,2026-10,INTERVENTIONAL,PHASE3,238,['Social Anxiety Disorder'],Social Anxiety Disorder,"VistaGen Therapeutics, Inc.",[],['United States']
NCT06004700,Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits,Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visits (An Electronic Health Record Integrated Application for Psoriatic Arthritis Patient Reported Outcomes) (RAPID-PsA),ACTIVE_NOT_RECRUITING,2024-04-11,2026-10-01,2026-10-01,INTERVENTIONAL,NA,278,"['Arthritis', 'Psoriatic Arthritis']",Arthritis,Brigham and Women's Hospital,"['Janssen Scientific Affairs, LLC']",['United States']
NCT06615557,Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4),"US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)",RECRUITING,2024-09-16,2026-04,2027-04,INTERVENTIONAL,PHASE3,236,['Social Anxiety Disorder (SAD)'],Social Anxiety Disorder (SAD),"VistaGen Therapeutics, Inc.",[],['United States']
NCT05562466,A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma,"Double-blind, Randomized, Active-controlled, Two-way Cross-over Study, With 12-week Treatment Duration Per Period, to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate / Mometasone Furoate) Compared to Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma",RECRUITING,2023-05-11,2028-02-01,2028-05-30,INTERVENTIONAL,PHASE3,200,['Asthma'],Asthma,Novartis Pharmaceuticals,[],"['Bulgaria', 'Hungary', 'Panama', 'South Africa', 'Austria', 'Mexico', 'Spain', 'Guatemala', 'Italy', 'Colombia', 'Czechia', 'Romania', 'Greece', 'Vietnam', 'Portugal', 'Argentina']"
NCT07247929,Postoperative Pain and Swelling After Flap vsFlapless Technique For Mandibular Third Molar Surgery,Comparison of Postoperative Pain and Swelling in Flap Versus Flapless Technique for Surgical Removal of Partially Impacted Mandibular Third Molars: A Randomized Controlled Trial,RECRUITING,2024-08-15,2026-02-15,2026-04-15,INTERVENTIONAL,NA,160,"['Pain (Visceral, Somatic, or Neuropathic)']","Pain (Visceral, Somatic, or Neuropathic)",Watim Medical & Dental College,[],['Pakistan']
NCT07247669,Evaluation and Optimization of Telephone Triage Using Artificial Intelligence (AI) Models for the Detection of Demands for Time-dependent Pathology at the Emergency and Urgent Care Coordination Center (CCUE).,"Proyecto ""trIAje"": evaluación y optimización Del Triaje telefónico Mediante Modelos de Inteligencia Artificial (IA) Para la detección de Demandas Por patología Tiempo-dependiente en el Centro Coordinador de Urgencias y Emergencias (CCUE).",ACTIVE_NOT_RECRUITING,2025-01-01,2025-12-01,2027-12-31,OBSERVATIONAL,,5000000,"['Chest Pain', 'Stroke Acute', 'Respiratory Failure', 'Cardiac Arrest (CA)', 'Coma']",Chest Pain,Centro de Emergencias Sanitarias 061 Andalucía,"['Junta de Andalucia', 'Andaluz Health Service']",['Spain']
NCT04595565,Sacituzumab Govitecan in Primary HER2-negative Breast Cancer,"Phase III Postneoadjuvant Study Evaluating Sacituzumab Govitecan, an Antibody Drug Conjugate in Primary HER2-negative Breast Cancer Patients With High Relapse Risk After Standard Neoadjuvant Treatment - SASCIA",ACTIVE_NOT_RECRUITING,2020-10-28,2027-03-30,2029-03-30,INTERVENTIONAL,PHASE3,1332,"['HER2-negative Breast Cancer', 'Triple Negative Breast Cancer']",HER2-negative Breast Cancer,GBG Forschungs GmbH,"['Gilead Sciences', 'Austrian Breast & Colorectal Cancer Study Group', 'Spanish Breast Cancer Research Group (GEICAM)', 'ETOP IBCSG Partners Foundation', 'Cancer Trials Ireland', 'UNICANCER']","['Belgium', 'Austria', 'France', 'Switzerland', 'Ireland', 'Spain', 'Germany']"
NCT05226871,Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies,A TREATMENT PROTOCOL FOR PARTICIPANTS CONTINUING FROM PFIZER-SPONSORED PALBOCICLIB CLINICAL STUDIES,ACTIVE_NOT_RECRUITING,2022-07-07,2026-12-31,2026-12-31,INTERVENTIONAL,PHASE2,35,"['Breast Cancer', 'Head and Neck Cancer']",Breast Cancer,Pfizer,[],"['China', 'United States', 'Mexico', 'Taiwan', 'South Korea', 'Thailand', 'Ukraine']"
NCT04966624,Ventilatory Strategy Based on Ultrasound Lung Morphology in Patients With Focal ARDS,Ventilatory Strategy Based on Ultrasound Lung Morphology in Patients With Focal ARDS,RECRUITING,2021-10-13,2028-07,2028-07,INTERVENTIONAL,NA,84,['Focal Acute Respiratory Distress Syndrome'],Focal Acute Respiratory Distress Syndrome,Centre Hospitalier Universitaire Dijon,[],['France']
NCT04727242,CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma,Phase 2 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Gemcitabine Followed by Systemic Adjuvant Chemotherapy With Dacarbazine for Locally Recurrent Uterine Leiomyosarcoma (LMS),ACTIVE_NOT_RECRUITING,2021-01-28,2026-05,2026-05,INTERVENTIONAL,PHASE2,17,"['LMS - Leiomyosarcoma', 'Uterine Leiomyosarcoma']",LMS - Leiomyosarcoma,Stanford University,[],['United States']
NCT07134335,UBT251 Injection Phase II Clinical Study (CKD),A Phase II Clinical Study to Evaluate the Efficacy and Safety of UBT251 Injection in Obese/Overweight Chronic Kidney Disease (CKD) Population,RECRUITING,2025-09-01,2030-07-11,2030-07-11,INTERVENTIONAL,PHASE2,180,"['Obesity &Amp; Overweight', 'Chronic Kidney Disease']",Obesity &Amp; Overweight,"The United Bio-Technology (Hengqin) Co., Ltd.",[],['China']
NCT05371054,"Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies","Phase 1/2 Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies",ACTIVE_NOT_RECRUITING,2023-04-05,2024-07-22,2026-01-31,INTERVENTIONAL,PHASE1,8,"['Lymphoma', 'Non-Hodgkin Lymphoma', 'NHL', 'Hematologic Malignancies', 'Lymphoid Malignancies']",Lymphoma,National Cancer Institute (NCI),[],['United States']
NCT06680830,A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease,"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease",RECRUITING,2025-01-17,2026-09,2027-09,INTERVENTIONAL,PHASE2,150,"['Parkinson Disease', 'Parkinson', 'Idiopathic Parkinson Disease', 'Early Parkinson Disease (Early PD)', 'Parkinson Disease, Idiopathic']",Parkinson Disease,Neuron23 Inc.,"['Qiagen Manchester Limited', 'Roche Diagnostic Ltd.']","['United States', 'Spain', 'Italy', 'United Kingdom', 'Poland']"
NCT05701280,Pilot/Pivotal Study of DBS+Rehab After Stroke,Rehab With Electrical Stimulation Therapy to Optimize Rehabilitation Effect (RESTORE): A Pivotal Study,RECRUITING,2023-02-03,2026-06,2030-06,INTERVENTIONAL,NA,202,"['Stroke', 'Upper Extremity Paresis']",Stroke,"Enspire DBS Therapy, Inc.",[],['United States']
NCT01700543,Sidus(TM) Post Market Clinical Follow-up (PMCF) Study,"Sidus(TM) Stem-Free Shoulder - A Multi-center, Prospective, Non-controlled Post Market Clinical Follow-up Study.",ACTIVE_NOT_RECRUITING,2012-10,2020-07,2026-03,OBSERVATIONAL,,152,"['Non-inflammatory Degenerative Joint Disease (NIDJD)', 'Avascular Necrosis', 'Osteoarthritis', 'Inflammatory Joint Disease (IJD)', 'Rheumatoid Arthritis']",Non-inflammatory Degenerative Joint Disease (NIDJD),Zimmer Biomet,"['Zimmer, GmbH']","['Austria', 'France', 'Italy', 'United Kingdom', 'Germany']"
NCT07036315,Meaning in Music-Based Pain Modulation,An Investigation of the Intersection of Affect and Meaning in Music-Based Pain Modulation,RECRUITING,2025-10-25,2026-06-15,2026-08-15,INTERVENTIONAL,NA,50,['The Focus of the Study is Healthy Volunteers'],The Focus of the Study is Healthy Volunteers,University of Virginia,['National Center for Complementary and Integrative Health (NCCIH)'],['United States']
NCT06917690,A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa,"Multi-centeR, Open-label Study to EValuate the Safety, Efficacy, and Pharmacokinetics of FIlsuVEz (Oleogel-S10) in Japanese Subjects With Epidermolysis Bullosa (REVIVE)",RECRUITING,2025-04-18,2026-03,2029-09,INTERVENTIONAL,PHASE3,6,"['Epidermolysis Bullosa', 'Junctional Epidermolysis Bullosa', 'Epidermolysis Bullosa, Dystrophic', 'Epidermolysis Bullosa, Junctional', 'Skin Abnormalities', 'Connective Tissue Disease', 'Collagen Diseases', 'Skin Diseases', 'Genetic Diseases, Inborn', 'Congenital Abnormalities']",Epidermolysis Bullosa,Chiesi Farmaceutici S.p.A.,[],['Japan']
NCT07104760,"Longitudinal Evaluation of Regenerative Treatment of Peri-implantitis Assited by Er,Cr:YSGG Laser: up to 10 Years Follow-up","Longitudinal Evaluation of Regenerative Treatment of Peri-implantitis Assited by Er,Cr:YSGG Laser: up to 10 Years Follow-up",ACTIVE_NOT_RECRUITING,2025-07-29,2025-11-01,2026-10-10,OBSERVATIONAL,,80,"['Peri-Implantitis and Peri-implant Mucositis', 'Peri-Implantitis and Systemic Inflammation']",Peri-Implantitis and Peri-implant Mucositis,University of Guarulhos,[],['Brazil']
NCT06910709,Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants,"A Phase 1 Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose and Food-effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics of AMG 378 in Healthy Participants",RECRUITING,2025-04-08,2026-09-17,2026-10-16,INTERVENTIONAL,PHASE1,92,['Healthy Volunteers'],Healthy Volunteers,Amgen,[],['United States']
NCT05951179,Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer,"A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer",RECRUITING,2023-09-15,2030-05,2030-08,INTERVENTIONAL,PHASE2,131,['Non-muscle Invasive Bladder Cancer'],Non-muscle Invasive Bladder Cancer,Protara Therapeutics,[],"['Brazil', 'Japan', 'United States', 'Canada', 'Ukraine', 'Argentina']"
NCT06037889,Efficacy and Safety of Tirofiban for Patients With BAD (BRANT),Efficacy and Safety of Tirofiban in Patients With Acute Branch Atheromatous Disease (BAD)- Related Stroke (BRANT),ACTIVE_NOT_RECRUITING,2023-11-09,2026-02-22,2026-03-20,INTERVENTIONAL,PHASE3,516,['Branch Atheromatous Disease'],Branch Atheromatous Disease,Peking Union Medical College Hospital,"['Pharmaron (Chengdu) Clinical Services Co., Ltd.']",['China']
NCT07249281,MR Microstructural Imaging for Prostate Cancer Diagnosis,Development of MR Microstructural Imaging Markers for Prostate Cancer Diagnosis and Investigation of the Associated Molecular Mechanisms,RECRUITING,2020-09-01,2028-12-31,2028-12-31,OBSERVATIONAL,,2000,"['Prostate Cancer', 'Diffusion MRI']",Prostate Cancer,First Affiliated Hospital of Zhejiang University,"['Zhejiang University', ""Jiangsu Provincial People's Hospital"", 'The First Affiliated Hospital of Dalian Medical University', 'Zhejiang Hospital', 'Henan Cancer Hospital', 'Beijing Hospital']",['China']
NCT06783309,CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D),"A Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-103 in Subjects Ages 12-35 With Recent Onset Stage 3 Type 1 Diabetes",RECRUITING,2025-05-12,2026-12,2027-06,INTERVENTIONAL,PHASE1,72,"['Type 1 Diabetes Mellitus', 'T1D', 'T1DM', 'T1DM - Type 1 Diabetes Mellitus', 'Type 1 Diabetes in Adolescence', 'Type 1 Diabetes in Children', 'Type 1 Diabetes (Juvenile Onset)', 'Type 1 Diabetes', 'Type 1 Diabetes Patients', 'Type 1 Diabetes Mellitis']",Type 1 Diabetes Mellitus,"COUR Pharmaceutical Development Company, Inc.",[],['United States']
NCT07248969,HERO System - Health Monitoring for the Detection of Vital Signs and Emotional States,"Observational Pilot Study on the Use of the HERO Health Monitoring System for the Detection of Vital Signs, Emotional States, and Body Postures",ACTIVE_NOT_RECRUITING,2024-04-01,2025-08-01,2025-12-31,OBSERVATIONAL,,100,['Cardiovascular'],Cardiovascular,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,[],['Italy']
NCT06193356,Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable,Detection of Endoscopic Resection Scars and Delineation of Recurrence Amongst Non-experts is Less Accurate Than Experts But Trainable in a Short Learning Intervention,RECRUITING,2024-11-11,2026-01-01,2027-01-01,INTERVENTIONAL,NA,141,"['Colorectal Polyp', 'Colorectal Cancer']",Colorectal Polyp,"University Hospital, Ghent",[],['Belgium']
NCT03841617,The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer,The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer,RECRUITING,2019-07-29,2035-11-01,2035-11-01,INTERVENTIONAL,PHASE2,30,['Thyroid Cancer'],Thyroid Cancer,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT07220408,Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis,"A Single Center, Randomized, Double-masked, Vehicle Controlled Phase 2 Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Seasonal Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model",RECRUITING,2025-10-23,2026-02,2026-02,INTERVENTIONAL,PHASE2,60,['Allergic Conjunctivitis'],Allergic Conjunctivitis,"Telios Pharma, Inc.",[],['United States']
NCT05689190,Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD),Non-invasive Flow Measurements in Patients With Lower Extremity Arterial Disease (LEAD),RECRUITING,2023-04-25,2026-03-31,2026-03-31,OBSERVATIONAL,,30,['Lower Extremity Arterial Disease'],Lower Extremity Arterial Disease,Philips Clinical & Medical Affairs Global,['Leiden University Medical Center'],['Netherlands']
NCT07044687,Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India,A Phase 4 Study of Venetoclax in Combination With Azacitidine in Indian Subjects With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy,RECRUITING,2025-07-24,2027-11,2027-11,INTERVENTIONAL,PHASE4,100,['Acute Myeloid Leukemia'],Acute Myeloid Leukemia,AbbVie,[],['India']
NCT07248397,Development and Validation of a Screening Tool for Preschool Children Aged 1-6 Years,Development and Validation of a Screening Tool for Preschool Children Aged 1-6 Years,ACTIVE_NOT_RECRUITING,2024-09-23,2027-09-22,2027-09-22,OBSERVATIONAL,,180,['Early Childhood Development (ECD)'],Early Childhood Development (ECD),Chang Gung Memorial Hospital,[],['Taiwan']
NCT07033741,Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms,Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms: Protocol for a Real-world Prospective Observational Study,RECRUITING,2025-01-08,2027-12,2027-12,OBSERVATIONAL,,40,"['Depression, Anxiety', 'Post-traumatic Stress Symptoms', 'Dissociation', 'Psychotherapy Research and Outcome Measures']","Depression, Anxiety","University of Turin, Italy",[],['Italy']
NCT07249801,Closed-loop rTMS-EEG During Visuomotor Integration.,State-dependent Entrainment of Intrinsic Brain Rhythms to Improve Interregional Functional Coupling.,RECRUITING,2025-11-01,2026-08-31,2027-08-31,INTERVENTIONAL,NA,20,"['Visuomotor Skills', 'Brain Lesion (General)']",Visuomotor Skills,Medical University of South Carolina,"['National Institutes of Health (NIH)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)']",['United States']
NCT06976229,Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial,"A Phase I Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Human Allogeneic Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor Cells (XS228 Cell Injection) in Patients With Subacute Spinal Cord Injury",RECRUITING,2025-07-02,2028-02-21,2028-05-30,INTERVENTIONAL,PHASE1,12,"['Spinal Cord Injury', 'Safety', 'Clinical Trials', 'Efficacy', 'Induced Pluripotent Stem Cells', 'Human Motor Neuron Progenitor', 'Transplantation']",Spinal Cord Injury,"XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.","['Third Affiliated Hospital, Sun Yat-Sen University']",['China']
NCT06294236,Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM),"A Phase 1 Study Evaluating SC291, a Hypoimmune, Allogeneic CD19-directed CAR T Cell Therapy, in Subjects With Severe Relapsed or Refractory Autoimmune Diseases (GLEAM)",ACTIVE_NOT_RECRUITING,2024-04-29,2027-12,2028-03,INTERVENTIONAL,PHASE1,7,"['Lupus Erythematosus', 'Systemic Lupus Erythematosus', 'SLE (Systemic Lupus)', 'Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis', 'Granulomatous Polyangiitis', 'Microscopic Polyangiitis']",Lupus Erythematosus,Sana Biotechnology,[],['United States']
NCT04266912,Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors,DNA Damage Repair (DDR) Inhibitor-Based Basket of Baskets Phase I/II Trial in Patients With Advanced Solid Tumors Harboring Aberrations in DDR Genes (D-BoB),ACTIVE_NOT_RECRUITING,2020-03-17,2024-11-13,2025-12-31,INTERVENTIONAL,PHASE1,23,"['Metastatic Malignant Solid Neoplasm', 'Refractory Malignant Solid Neoplasm', 'Unresectable Malignant Solid Neoplasm']",Metastatic Malignant Solid Neoplasm,M.D. Anderson Cancer Center,[],['United States']
NCT06601322,Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right),Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony The FOCUS-Right Pilot Study (FOCUS-Right),RECRUITING,2024-08-23,2025-12,2025-12,INTERVENTIONAL,NA,20,"['Left Branch Bundle Block', 'RV - Right Ventricular Abnormality']",Left Branch Bundle Block,Virginia Commonwealth University,[],['United States']
NCT06422923,A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE),A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Temporal Lobe Epilepsy (MTLE),RECRUITING,2024-11-14,2027-06-15,2042-06-15,INTERVENTIONAL,PHASE1,10,"['Epilepsy, Temporal Lobe']","Epilepsy, Temporal Lobe",Neurona Therapeutics,[],['United States']
NCT06922539,ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer,"A Phase 1a/1b Trial in Relapsed/Refractory Small Cell Lung Cancer to Determine the Safety Profile, Pharmacology, and Maximum Tolerated Dose of ST-001, a Fenretinide Phospholipid Suspension (12.5 mg/mL) for Intravenous Infusion",RECRUITING,2025-11-28,2027-05-01,2028-10-01,INTERVENTIONAL,PHASE1,44,['Small Cell Lung Cancer'],Small Cell Lung Cancer,"SciTech Development, Inc.",[],['United States']
NCT06659029,Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users,PRIMULA Preg (Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users): The AstraZeneca Pregnancy Study for Anifrolumab,RECRUITING,2025-07-01,2031-04-15,2031-04-15,OBSERVATIONAL,,442,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,AstraZeneca,"['PPD Development, LP']",['United States']
NCT07093671,Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P),Mentalization Based Treatment (MBT) in Help Seeking Youths With a Clinical High-Risk Condition for Psychosis (CHR-P): a Randomized Controlled Trial,RECRUITING,2025-08-01,2028-08-31,2028-08-31,INTERVENTIONAL,NA,212,['Psychosis'],Psychosis,Marco Armando,[],['Switzerland']
NCT06043531,Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients,Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients,RECRUITING,2024-01-18,2025-12,2025-12,INTERVENTIONAL,NA,30,['Liver Transplant'],Liver Transplant,Virginia Commonwealth University,[],['United States']
NCT04585269,Bright IDEAS - Young Adults Problem-Solving Skills Training,Bright IDEAS-Young Adults: Problem-Solving Skills Training to Reduce Distress Among Young Adults With Cancer,ACTIVE_NOT_RECRUITING,2021-02-10,2024-09-29,2026-04,INTERVENTIONAL,NA,344,"['Cancer Patients', 'Young Adult', 'Supportive Care']",Cancer Patients,"Rutgers, The State University of New Jersey","['National Cancer Institute (NCI)', 'Memorial Sloan Kettering Cancer Center', 'H. Lee Moffitt Cancer Center and Research Institute', 'University of Rochester']",['United States']
NCT04088370,"Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis","Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis",RECRUITING,2019-10-08,2026-12,2026-12,OBSERVATIONAL,,30,['Alcoholic Hepatitis'],Alcoholic Hepatitis,The Cleveland Clinic,[],['United States']
NCT07169474,Treatment of Peritrapezial Osteoarthritis With Isolated Trapeziometacarpal Arthroplasty in 300 Patients,Treatment of Peri-trapezial Osteoarthritis With Isolated Trapeziometacarpal Arthroplasty,RECRUITING,2025-09-09,2027-07-30,2027-07-30,INTERVENTIONAL,NA,300,['Trapeziometacarpal Osteoarthritis'],Trapeziometacarpal Osteoarthritis,"Clinique Saint Jean, France",[],['France']
NCT07200466,"Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation",ENDORISK Clinical Implementation Study,RECRUITING,2025-10-23,2027-10-16,2032-10-16,INTERVENTIONAL,NA,735,['Endometrial Cancer'],Endometrial Cancer,Radboud University Medical Center,"['Elisabeth-TweeSteden Ziekenhuis', 'Amphia Hospital', 'Catharina Ziekenhuis Eindhoven', 'Elkerliek Hospital', 'St. Anna Ziekenhuis, Geldrop, Netherlands', ""Jeroen Bosch Ziekenhuis, s'-Hertogenbosch"", 'Rijnstate Hospital', 'Canisius Wilhelmina Ziekenhuis (CWZ)', 'Maxima Medical Center', 'Bernhoven Hospital', 'Maas Hospital Pantein', 'Slingeland Hospital', 'Streekziekenhuis Koningin Beatrix', 'Gelderse Vallei Hospital', 'Comprehensive Cancer Centre The Netherlands', 'Stichting PAMM']",['Netherlands']
NCT06829264,Testing an Evidence-Based Supported Employment Model in Autistic Young Adults,A Pilot Trial of the Individualized Placement and Support Model in Autistic Adults in the Community,RECRUITING,2025-08-01,2026-12-01,2027-12-31,INTERVENTIONAL,NA,60,"['Autism Spectrum Disorder', 'Intellectual Disability']",Autism Spectrum Disorder,"University of California, Davis",[],['United States']
NCT07073235,Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Lower Extremity in Chronic Stroke Patients,Neuroplastic Changes and Effects of Intermittent Theta Burst Stimulation (iTBS) on Motor Recovery of Upper and Lower Extremity in Chronic Stroke Patients,RECRUITING,2025-11,2030-12,2030-12,INTERVENTIONAL,NA,56,"['Stroke', 'Hemiparesis After Stroke', 'Chronic Stroke Patients', 'Hemiplegia', 'Ambulatory Difficulty']",Stroke,Danderyd Hospital,['Karolinska Institutet'],['Sweden']
NCT06132087,PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy,PROACTIVE Pilot Study: Pancreatic Resection Outcomes in Locally Advanced Pancreatic Cancer Involving Visceral Arteries Treated With Neoadjuvant Chemotherapy,ACTIVE_NOT_RECRUITING,2023-12-01,2027-12-01,2028-12-01,INTERVENTIONAL,NA,2,"['Locally Advanced Pancreatic Adenocarcinoma', 'Stage III Pancreatic Cancer American Joint Committee on Cancer v8', 'Unresectable Pancreatic Adenocarcinoma']",Locally Advanced Pancreatic Adenocarcinoma,University of Southern California,['National Cancer Institute (NCI)'],['United States']
NCT05798338,Characterization of Extracellular Vesicles in Breast Cancer Patients,Characterization of Extracellular Vesicles in Breast Cancer Patients' Plasma by Single Molecule Detection Array (SiMoA) Digital ELISA,RECRUITING,2020-12-01,2023-09-30,2026-09-30,OBSERVATIONAL,,105,['Breast Cancer'],Breast Cancer,Istituti Clinici Scientifici Maugeri SpA,[],['Italy']
NCT05403086,Pragmatic Trial of Psilocybin Therapy in Palliative Care,Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life,RECRUITING,2025-01-19,2026-12-31,2027-12-31,INTERVENTIONAL,PHASE2,100,['Demoralization'],Demoralization,"Charles S. Grob, M.D.","['University of California, San Francisco']",['United States']
NCT05922085,Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU,Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU,RECRUITING,2023-11-09,2027-06,2027-06,INTERVENTIONAL,NA,100,['Patient Under Mechanical Ventilation'],Patient Under Mechanical Ventilation,Centre Hospitalier Universitaire Dijon,[],['France']
NCT06048835,Circulating Tumour Cells Characterization in Breast Cancer Patients,Ultrasensitive BIOsensing Platform for Multiplex CELLular Protein PHEnotyping at Single-cell Level,RECRUITING,2022-12-01,2025-09-30,2025-12-31,OBSERVATIONAL,,80,['Breast Cancer'],Breast Cancer,Istituti Clinici Scientifici Maugeri SpA,['Carlo Morasso'],['Italy']
NCT06762717,FARAPULSE™ Pulsed Field Ablation System,Real World Data Collection in Chinese Population Treated With the FARAPULSE™ Pulsed Field Ablation System,RECRUITING,2025-10-23,2027-12-31,2029-12-31,OBSERVATIONAL,,500,['Paroxysmal AF'],Paroxysmal AF,Boston Scientific Corporation,[],['China']
NCT07247526,Effect of Foot Bath on Anxiety and Physiological Parameters,The Effect of Preoperative Hot Water Foot Bath on Anxiety Level and Physiological Parameters in Patients With Pituitary Adenoma,RECRUITING,2024-04-15,2025-12-31,2025-12-31,INTERVENTIONAL,NA,100,"['Pituitary Adenoma', 'Surgery']",Pituitary Adenoma,Trakya University,[],['Turkey (Türkiye)']
NCT06495164,A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer,Palbociclib Treatment Patterns and Outcomes in HR+/HER2- MBC: Flatiron Database Analysis,ACTIVE_NOT_RECRUITING,2024-06-24,2026-12-30,2026-12-30,OBSERVATIONAL,,1,"['Breast Cancer', 'Malignant Neoplasm of Breast']",Breast Cancer,Pfizer,[],['United States']
NCT07132736,Impact of Underwater Exercise Versus Regular Aerobic Exercise on Quality of Life and Power of Muscle,Impact of Underwater Exercise Versus Regular Aerobic Exercise on Quality of Life and Power of Muscle,RECRUITING,2025-12-01,2025-12-28,2026-01-20,INTERVENTIONAL,NA,100,"['Muscle Weakness | Patient', 'Quality of Life']",Muscle Weakness | Patient,October 6 University,[],['Jordan']
NCT07210086,Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R),Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R),RECRUITING,2025-12-11,2028-05-13,2028-05-13,INTERVENTIONAL,PHASE2,50,['Prostate Cancer'],Prostate Cancer,City of Hope Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT00646022,Natural History of Familial Carcinoid Tumor,Natural History of Familial Carcinoid Tumor,RECRUITING,2008-08-25,,,OBSERVATIONAL,,1600,['Carcinoid'],Carcinoid,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),[],['United States']
NCT06297993,"Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)",A Global Multi-Center Prospective Observational Cohort to Support Drug Development in Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC),RECRUITING,2024-05-06,2029-01,2031-01,OBSERVATIONAL,,2000,['PSC'],PSC,PSC Partners Seeking a Cure,[],"['New Zealand', 'United States', 'Canada', 'Germany']"
NCT07163338,Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS),"A Prospective, Single-center Cohort Study to Determine the Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)",RECRUITING,2025-09-16,2027-12-16,2028-03-16,INTERVENTIONAL,NA,400,['Antiphospholipid Syndrome'],Antiphospholipid Syndrome,CHU de Reims,[],['France']
NCT05370469,Real-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted Therapies,Real-Time Monitoring and Modeling of Symptoms and Adverse Events in Lung Cancer Patients Receiving Oral Targeted Therapies for Tumors With Actionable Mutations,ACTIVE_NOT_RECRUITING,2022-08-25,2024-06-14,2026-05,INTERVENTIONAL,NA,30,"['Lung Cancer', 'EGFR Gene Mutation', 'EGFR', 'ALK Gene Mutation', 'RET Gene Mutation', 'MET Gene Mutation', 'KRAS Mutation-Related Tumors', 'BRAF', 'ROS1 Gene Mutation']",Lung Cancer,University of Virginia,[],['United States']
NCT02310854,Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?,Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?,ACTIVE_NOT_RECRUITING,2014-11,2016-12,2029-11,INTERVENTIONAL,NA,48,['Anterior Cruciate Ligament Injury'],Anterior Cruciate Ligament Injury,Orthopedisch Centrum Oost Nederland,[],['Netherlands']
NCT05710510,Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions,Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL),ACTIVE_NOT_RECRUITING,2023-03-10,2026-10-27,2026-10-27,INTERVENTIONAL,NA,560,"['Obesity', 'Obesity, Morbid']",Obesity,University of Kansas Medical Center,['National Cancer Institute (NCI)'],['United States']
NCT05646381,A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis,"A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis [Lp(a)FRONTIERS CAVS]",RECRUITING,2024-03-07,2030-03-12,2030-03-12,INTERVENTIONAL,PHASE2,502,['Aortic Stenosis'],Aortic Stenosis,Novartis Pharmaceuticals,[],"['Belgium', 'Israel', 'Netherlands', 'Austria', 'United States', 'France', 'Switzerland', 'Denmark', 'Spain', 'Italy', 'Canada', 'Czechia', 'United Kingdom', 'Portugal', 'Germany']"
NCT05873231,Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea,Role of the Gut Microbiome in Anti-tumor Therapy Induced Diarrhea,RECRUITING,2021-04-28,2030-12,2032-12,OBSERVATIONAL,,150,['Cancer'],Cancer,Medical University of Graz,[],['Austria']
NCT06887595,Linear Micro-Perforation Ridge Split Approach,A Comparative Study of AI-Powered/Computer-Guided Versus Conventional Linear Micro-Perforation Split Approach for Treatment of Horizontal Mandibular Ridge Atrophy (A Randomized Clinical Trial),ACTIVE_NOT_RECRUITING,2025-03-18,2026-03-20,2026-03-30,INTERVENTIONAL,NA,22,"['Alveolar Bone Loss', 'Dental Implant Failed']",Alveolar Bone Loss,Kafrelsheikh University,[],['Egypt']
NCT06778967,A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus,"A Multicenter, Randomized, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Chinese Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Metformin Monotherapy or in Combination With Sodium-dependent Glucose Transporter 2 (SGLT2) Inhibitors or Sulfonylureas",ACTIVE_NOT_RECRUITING,2025-02-13,2026-12-11,2026-12-11,INTERVENTIONAL,PHASE3,1100,['Type 2 Diabetes Mellitus (T2DM)'],Type 2 Diabetes Mellitus (T2DM),Gan & Lee Pharmaceuticals.,[],['China']
NCT07012226,Comparison of Cardiometabolic Markers in Individuals With Hypertriglyceridemia With Low and High Weight Loss Responses to an Energy-restricted Diet,"Effects of an Energy-restricted Diet on the Expression of the Sirtuin-1 and Leptin Receptor Genes in White Blood Cells, and Cardiometabolic Markers in Individuals With Hypertriglyceridemia: Comparison Between Low and High Weight Loss Responders",RECRUITING,2025-06-10,2025-12-21,2026-01-01,INTERVENTIONAL,NA,90,"['Obesity and Overweight', 'Hypertriglyceridaemia']",Obesity and Overweight,Shahid Beheshti University of Medical Sciences,[],['Iran']
NCT01754025,INHERIT EGFR - Studying Germline EGFR Mutations,INHERIT EGFR - INvestigating HEreditary RIsk From T790M: A Multi-Centered Study to Identify and Characterize Individuals Carrying Germline EGFR Mutations,ACTIVE_NOT_RECRUITING,2012-12-28,2018-11-07,2029-12-31,OBSERVATIONAL,,121,['Lung Cancer'],Lung Cancer,Dana-Farber Cancer Institute,['Addario Lung Cancer Medical Institute'],['United States']
NCT07225296,"A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants","A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-effect Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GNS-3545 in Healthy Adult Subjects",RECRUITING,2025-11-12,2026-06-12,2026-10-31,INTERVENTIONAL,PHASE1,72,['Idiopathic Pulmonary Fibrosis'],Idiopathic Pulmonary Fibrosis,Genosco Inc.,[],['United States']
NCT06459973,A Clinical Study of YL205 in Patients With Advanced Solid Tumors,"A Multi-center, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of YL205 in Patients With Advanced Solid Tumors",RECRUITING,2024-06-04,2027-07-31,2030-07-31,INTERVENTIONAL,PHASE1,252,['Advanced Solid Tumors'],Advanced Solid Tumors,"MediLink Therapeutics (Suzhou) Co., Ltd.",[],['China']
NCT07248501,Effects of Bulgarian Exercises on Lower Limb Function in Children,"Effects of Bulgarian Bag Exercise on Lower Limb Function, Posture and Balance Among School Going Children",RECRUITING,2025-10-30,2026-01-25,2026-01-30,INTERVENTIONAL,NA,345,"['Child, Only']","Child, Only",Riphah International University,[],['Pakistan']
NCT06088290,Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo),"Randomized, Controlled, Open-label, Phase III Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Patients With Metastatic Leiomyosarcoma",RECRUITING,2023-09-21,2029-08-30,2029-08-30,INTERVENTIONAL,PHASE3,450,['Leiomyosarcoma'],Leiomyosarcoma,PharmaMar,[],"['Belgium', 'Netherlands', 'Austria', 'United States', 'France', 'Switzerland', 'Spain', 'Italy', 'United Kingdom', 'Poland', 'Portugal', 'Germany']"
NCT07235111,Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases,Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases,RECRUITING,2025-02-28,2034-09-17,2039-09-17,OBSERVATIONAL,,1200,"['Alzheimer Disease', 'FTD', 'Young-onset Dementia', 'MCI', 'Parkinson Disease', 'ALS (Amyotrophic Lateral Sclerosis)']",Alzheimer Disease,Ospedale Policlinico San Martino,['Istituto Italiano di Tecnologia'],['Italy']
NCT04742634,Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant,A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant,RECRUITING,2022-05-12,2033-11-30,2033-11-30,INTERVENTIONAL,PHASE1,209,['Myelodysplastic Syndromes'],Myelodysplastic Syndromes,Washington University School of Medicine,"['Taiho Oncology, Inc.']",['United States']
NCT07249216,Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting,Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to VEGF Inhibition in nAMD Within a Clinical Trial Setting,RECRUITING,2025-07-18,2029-06,2029-07,INTERVENTIONAL,NA,117,['Age Related Macular Degeneration'],Age Related Macular Degeneration,Singapore National Eye Centre,[],['Singapore']
NCT07248163,Universal CAR-T Cell Therapy for NHL,A Clinical Study of the Safety and Efficacy of Universal CAR-T Cells Targeting CD19 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma,RECRUITING,2025-03-11,2027-08-15,2028-03-11,INTERVENTIONAL,NA,6,"['Non-hodgkin Lymphoma,B Cell']","Non-hodgkin Lymphoma,B Cell",Bioray Laboratories,['Shanghai Tongji Hospital (Tongji Hospital of Tongji University)'],['China']
NCT06229288,"Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward","Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward: a Non-inferiority Randomized Controlled Trial",RECRUITING,2024-04-25,2027-05-25,2027-05-25,INTERVENTIONAL,PHASE3,326,['Community-acquired Pneumonia'],Community-acquired Pneumonia,Nantes University Hospital,[],['France']
NCT03460769,Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT),Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT),RECRUITING,2021-04-01,2027-06-30,2027-06-30,OBSERVATIONAL,,775,"['Pancreatic Cancer', 'Chronic Pancreatitis', 'Diabetes Mellitus Type 3c']",Pancreatic Cancer,M.D. Anderson Cancer Center,['National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'],['United States']
NCT04250545,Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer,A Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Advanced NSCLC Patients,ACTIVE_NOT_RECRUITING,2020-10-26,2025-11-21,2026-11-21,INTERVENTIONAL,PHASE1,22,"['Leptomeningeal Neoplasm', 'Metastatic Lung Non-Small Cell Carcinoma', 'Metastatic Malignant Neoplasm in the Brain', 'Recurrent Lung Non-Small Cell Carcinoma', 'Stage IV Lung Cancer AJCC v8', 'Stage IVA Lung Cancer AJCC v8', 'Stage IVB Lung Cancer AJCC v8']",Leptomeningeal Neoplasm,National Cancer Institute (NCI),[],['United States']
NCT06677060,Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin,"A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death",RECRUITING,2025-03-14,2029-12-17,2029-12-17,INTERVENTIONAL,PHASE3,11300,['Heart Failure'],Heart Failure,AstraZeneca,[],"['Bulgaria', 'Japan', 'Netherlands', 'China', 'Slovakia', 'Australia', 'Israel', 'Hungary', 'France', 'Denmark', 'Peru', 'South Korea', 'Thailand', 'Czechia', 'Poland', 'India', 'South Africa', 'Mexico', 'Spain', 'Taiwan', 'Canada', 'Malaysia', 'Romania', 'Greece', 'United Kingdom', 'Vietnam', 'Ukraine', 'Sweden', 'Germany', 'Brazil', 'Turkey (Türkiye)', 'United States', 'Italy', 'Argentina', 'Philippines']"
NCT04877691,Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus,"A Multicentre, Randomised, Double-Blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus",ACTIVE_NOT_RECRUITING,2021-06-08,2025-08-22,2026-11-18,INTERVENTIONAL,PHASE3,367,['Systemic Lupus Erythematosus'],Systemic Lupus Erythematosus,AstraZeneca,['Iqvia Pty Ltd'],"['Bulgaria', 'Japan', 'Hungary', 'United States', 'Mexico', 'Chile', 'Spain', 'Thailand', 'Colombia', 'Ukraine', 'United Kingdom', 'Poland', 'Philippines', 'Argentina', 'Germany']"
NCT07248254,Effects Of DPPT On Motor Skills And Sleep In Children With Autism,Effects of Wilbarger Deep Pressure and Proprioceptive Technique (DPPT) on Motor Skills and Sleep Pattern in Children With Autism Spectrum Disorder.,RECRUITING,2025-10-29,2026-01-15,2026-01-30,INTERVENTIONAL,NA,40,['Autism Spectrum Disorder'],Autism Spectrum Disorder,Riphah International University,[],['Pakistan']
NCT05600686,Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma,A Phase 2 Study of Loncastuximab Tesirine and Rituximab (Lonca-R) Followed by DA-EPOCH-R in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma,RECRUITING,2023-05-24,2026-02-01,2028-02-01,INTERVENTIONAL,PHASE2,24,"['Double-Expressor Lymphoma', 'High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements', 'High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements', 'High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements']",Double-Expressor Lymphoma,Joseph Tuscano,"['National Cancer Institute (NCI)', 'ADC Therapeutics S.A.']",['United States']
NCT07183605,Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients,Central Catheter Anti-Xa Sampling Study for Accurate aNalysis and Reliable Dosage Assessment,RECRUITING,2025-09-22,2026-09,2026-10,INTERVENTIONAL,NA,30,['Anticoagulants and Bleeding Disorders'],Anticoagulants and Bleeding Disorders,Centre Hospitalier Régional d'Orléans,[],['France']
NCT07225790,Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases,Emulation of the MONARCH-3 Trial Using Specialty Oncology Electronic Health Records Databases,ACTIVE_NOT_RECRUITING,2025-11-03,2026-01,2026-01,OBSERVATIONAL,,3883,['Advanced Breast Cancer'],Advanced Breast Cancer,Brigham and Women's Hospital,['Food and Drug Administration (FDA)'],['United States']
NCT01961713,Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy,Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy,RECRUITING,2010-04,2025-12,2025-12,OBSERVATIONAL,,200,['Prostate Cancer'],Prostate Cancer,Massachusetts General Hospital,['Prostate Cancer Foundation Clinical Research Consortium'],['United States']
NCT07248540,IV Magnesium in the Treatment of Acute Dysmenorrhea,Evaluation of Intravenous Magnesium Administration in the Treatment of Dysmenorrhea,RECRUITING,2025-07-01,2026-01-01,2026-01-01,INTERVENTIONAL,NA,60,['Dysmenorrhea'],Dysmenorrhea,Havva Betül Bacak,[],['Turkey (Türkiye)']
NCT05334368,"Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial","A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES)",RECRUITING,2022-09-06,2028-12-19,2028-12-19,INTERVENTIONAL,PHASE3,123,['Hypereosinophilic Syndrome'],Hypereosinophilic Syndrome,GlaxoSmithKline,[],"['Japan', 'Hong Kong', 'China', 'Australia', 'Belgium', 'Israel', 'Denmark', 'South Korea', 'Czechia', 'Poland', 'Mexico', 'Spain', 'Canada', 'Romania', 'United Kingdom', 'Greece', 'Germany', 'Brazil', 'United States', 'Italy', 'Argentina']"
NCT07248124,"Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse Test, in Carpal Tunnel Syndrome.","Pilot Study, Aimed at Describing in Myography, the Collapse of the Muscular Response Visualized in the Scratch Collapse Test, in Carpal Tunnel Syndrome",RECRUITING,2025-11-04,2026-05-04,2026-05-05,INTERVENTIONAL,NA,25,['Carpal Tunnel Syndrome (CTS)'],Carpal Tunnel Syndrome (CTS),Elsan,[],['France']
NCT04813718,Post COVID-19 Syndrome and the Gut-lung Axis,Post COVID-19 Syndrome: A Pilot Study to Explore the Gut-lung Axis,ACTIVE_NOT_RECRUITING,2021-06-02,2022-07-11,2025-12,INTERVENTIONAL,NA,20,['Covid19'],Covid19,Medical University of Graz,['CBmed Ges.m.b.H.'],['Austria']
NCT06615726,Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis,Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis: a Prospective Randomized Open-label Blinded Endpoint Trial,ACTIVE_NOT_RECRUITING,2024-10-10,2026-11-19,2026-11-19,INTERVENTIONAL,PHASE3,1300,"['Ischemic Stroke', 'Transient Ischemic Attack']",Ischemic Stroke,Capital Medical University,[],['China']
NCT06767761,A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin,A Phase III Clinical Study Comparing the Efficacy and Safety of Once-weekly GZR4 Versus Once-daily Insulin Glargine U100 in Combination With Insulin Aspart (With or Without Non-Insulin Antidiabetic Agents) in Subjects With Type 2 Diabetes Mellitus (T2DM) Treated With Basal+Prandial Insulin Treatment,ACTIVE_NOT_RECRUITING,2025-02-18,2026-03-19,2026-04-09,INTERVENTIONAL,PHASE3,580,['Diabetes'],Diabetes,Gan & Lee Pharmaceuticals.,[],['China']
NCT07238985,Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease,Evaluating the Safety and Efficacy of Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease Patients.,RECRUITING,2025-11-01,2026-11-20,2026-11-20,INTERVENTIONAL,PHASE1,50,['Fatty Liver'],Fatty Liver,Tanta University,[],['Egypt']
NCT07247227,Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC,"Sugemalimab Plus Platinum-based Chemotherapy as First-line Therapy for Patients With Locally Advanced and Metastatic Non-small Cell Lung Cancer (NSCLC) in a Real-world Setting: a Single-arm, Multi-center Study",RECRUITING,2023-10-10,2027-05,2027-05,INTERVENTIONAL,NA,150,['NSCLC'],NSCLC,Peking Union Medical College,[],['China']
NCT06478251,T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor,"An Open-Label, Dose-Escalation Phase I Clinical Study of T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor",RECRUITING,2024-02-01,2026-06,2027-06,INTERVENTIONAL,PHASE1,9,"['Tumor, Solid']","Tumor, Solid",TingBo Liang,['Neowise Biotechnology'],['China']
NCT04503551,"A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm","A Phase III, Multicenter, Randomized Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Retinopathy",ACTIVE_NOT_RECRUITING,2020-08-10,2022-10-03,2026-01-31,INTERVENTIONAL,PHASE3,174,['Diabetic Retinopathy'],Diabetic Retinopathy,Hoffmann-La Roche,[],"['Puerto Rico', 'United States']"
